PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Howan, K; Smith, AJ; Westblade, LF; Joly, N; Grange, W; Zorman, S; Darst, SA; Savery, NJ; Strick, TR				Howan, Kevin; Smith, Abigail J.; Westblade, Lars F.; Joly, Nicolas; Grange, Wilfried; Zorman, Sylvain; Darst, Seth A.; Savery, Nigel J.; Strick, Terence R.			Initiation of transcription-coupled repair characterized at single-molecule resolution	NATURE			English	Article							RNA-POLYMERASE; DNA-REPAIR; STRUCTURAL BASIS; MECHANISM; MFD; NANOMANIPULATION; TRANSLOCATION; TERMINATION; MUTATION; STRAND	Transcription-coupled DNA repair uses components of the transcription machinery to identify DNA lesions and initiate their repair. These repair pathways are complex, so their mechanistic features remain poorly understood. Bacterial transcription-coupled repair is initiated when RNA polymerase stalled at a DNA lesion is removed by Mfd, an ATP-dependent DNA translocase(1-3). Here we use single-molecule DNA nanomanipulation to observe the dynamic interactions of Escherichia coli Mfd with RNA polymerase elongation complexes stalled by a cyclopyrimidine dimer or by nucleotide starvation. We show that Mfd acts by catalysing two irreversible, ATP-dependent transitions with different structural, kinetic and mechanistic features. Mfd remains bound to the DNA in a long-lived complex that could act as a marker for sites of DNA damage, directing assembly of subsequent DNA repair factors. These results provide a framework for considering the kinetics of transcription-coupled repair in vivo, and open the way to reconstruction of complete DNA repair pathways at single-molecule resolution.	[Howan, Kevin; Joly, Nicolas; Grange, Wilfried; Zorman, Sylvain; Strick, Terence R.] Univ Paris Diderot, CNRS, Inst Jacques Monod, UMR 7592, F-75205 Paris, France; [Smith, Abigail J.; Savery, Nigel J.] Univ Bristol, Sch Biochem, DNA Prot Interact Unit, Bristol BS8 1TD, Avon, England; [Westblade, Lars F.; Darst, Seth A.] Rockefeller Univ, New York, NY 10065 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; University of Bristol; Rockefeller University	Strick, TR (corresponding author), Univ Paris Diderot, CNRS, Inst Jacques Monod, UMR 7592, F-75205 Paris, France.	strick.terence@ijm.univ-paris-diderot.fr	Joly, Nicolas/H-6851-2018	Joly, Nicolas/0000-0003-2731-3827; Savery, Nigel/0000-0002-0803-4075; Strick, Terence/0000-0003-1744-3679	Frontieres Interdisciplinaires du Vivant Doctoral Program; Fondation pour la Recherche Medicale; BBSRC [BB/I003142/1]; National Institutes of Health [GM073829]; EURYI grant; CNRS; University of Paris Diderot; BBSRC [BB/I001859/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I001859/1, BB/I003142/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073829] Funding Source: NIH RePORTER	Frontieres Interdisciplinaires du Vivant Doctoral Program; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EURYI grant; CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Paris Diderot; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Neumann for showing us how to perform global fitting with the Igor software package. K.H. was supported by a PhD scholarship from the Frontieres Interdisciplinaires du Vivant Doctoral Program and the Fondation pour la Recherche Medicale. Work in the laboratory of N.J.S. was supported by BBSRC grant BB/I003142/1, and work in the laboratory of S.A.D. was supported by National Institutes of Health grant GM073829. This work was also made possible by a EURYI grant, in addition to CNRS and University of Paris Diderot core funding, to T.R.S.	Brueckner F, 2007, SCIENCE, V315, P859, DOI 10.1126/science.1135400; Chambers AL, 2003, NUCLEIC ACIDS RES, V31, P6409, DOI 10.1093/nar/gkg868; Deaconescu AM, 2007, CURR OPIN STRUC BIOL, V17, P96, DOI 10.1016/j.sbi.2007.01.005; Deaconescu AM, 2012, P NATL ACAD SCI USA, V109, P3353, DOI 10.1073/pnas.1115105109; Deaconescu AM, 2006, CELL, V124, P507, DOI 10.1016/j.cell.2005.11.045; Deaconescu AM, 2005, ACTA CRYSTALLOGR F, V61, P1062, DOI 10.1107/S1744309105035876; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Komissarova N, 2002, MOL CELL, V10, P1151, DOI 10.1016/S1097-2765(02)00738-4; Kou SC, 2005, J PHYS CHEM B, V109, P19068, DOI 10.1021/jp051490q; Landick R, 2006, BIOCHEM SOC T, V34, P1062, DOI 10.1042/BST0341062; Manelyte L, 2010, MOL CELL, V40, P714, DOI 10.1016/j.molcel.2010.11.012; MELLON I, 1989, NATURE, V342, P95, DOI 10.1038/342095a0; Park JS, 2006, P NATL ACAD SCI USA, V103, P4870, DOI 10.1073/pnas.0600145103; Park JS, 2002, CELL, V109, P757, DOI 10.1016/S0092-8674(02)00769-9; Revyakin A, 2004, P NATL ACAD SCI USA, V101, P4776, DOI 10.1073/pnas.0307241101; Revyakin A, 2003, METHOD ENZYMOL, V370, P577; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; Savery NJ, 2007, TRENDS MICROBIOL, V15, P326, DOI 10.1016/j.tim.2007.05.005; SELBY CP, 1993, J BACTERIOL, V175, P7509, DOI 10.1128/JB.175.23.7509-7514.1993; SELBY CP, 1991, P NATL ACAD SCI USA, V88, P8232, DOI 10.1073/pnas.88.18.8232; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; SELBY CP, 1995, J BIOL CHEM, V270, P4882, DOI 10.1074/jbc.270.9.4882; Smith AJ, 2008, DNA REPAIR, V7, P1670, DOI 10.1016/j.dnarep.2008.06.020; Smith AJ, 2007, NUCLEIC ACIDS RES, V35, P1802, DOI 10.1093/nar/gkm019; Smith AJ, 2005, NUCLEIC ACIDS RES, V33, P755, DOI 10.1093/nar/gki225; Srivastava DB, 2011, J MOL BIOL, V406, P275, DOI 10.1016/j.jmb.2010.12.004; Westblade LF, 2010, NUCLEIC ACIDS RES, V38, P8357, DOI 10.1093/nar/gkq692; WITKIN EM, 1956, COLD SPRING HARB SYM, V21, P123, DOI 10.1101/SQB.1956.021.01.011	28	65	66	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2012	490	7420					431	434		10.1038/nature11430	http://dx.doi.org/10.1038/nature11430			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021XI	22960746	Green Accepted			2022-12-24	WOS:000309918500052
J	Van den Bruel, A; Thompson, M; Buntinx, F; Mant, D				Van den Bruel, Ann; Thompson, Matthew; Buntinx, Frank; Mant, David			Clinicians' gut feeling about serious infections in children: observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRIMARY-CARE; YOUNG-CHILDREN; MODEL; RECOGNITION; BACTEREMIA; DIAGNOSIS; SIGNS	Objective To investigate the basis and added value of clinicians' "gut feeling" that infections in children are more serious than suggested by clinical assessment. Design Observational study. Setting Primary care setting, Flanders, Belgium. Participants Consecutive series of 3890 children and young people aged 0-16 years presenting in primary care. Main outcome measures Presenting features, clinical assessment, doctors' intuitive response at first contact with children in primary care, and any subsequent diagnosis of serious infection determined from hospital records. Results Of the 3369 children and young people assessed clinically as having a non-severe illness, six (0.2%) were subsequently admitted to hospital with a serious infection. Intuition that something was wrong despite the clinical assessment of non-severe illness substantially increased the risk of serious illness (likelihood ratio 25.5, 95% confidence interval 7.9 to 82.0) and acting on this gut feeling had the potential to prevent two of the six cases being missed (33%, 95% confidence interval 4.0% to 100%) at a cost of 44 false alarms (1.3%, 95% confidence interval 0.95% to 1.75%). The clinical features most strongly associated with gut feeling were the children's overall response (drowsiness, no laughing), abnormal breathing, weight loss, and convulsions. The strongest contextual factor was the parents' concern that the illness was different from their previous experience (odds ratio 36.3, 95% confidence interval 12.3 to 107). Conclusions A gut feeling about the seriousness of illness in children is an instinctive response by clinicians to the concerns of the parents and the appearance of the children. It should trigger action such as seeking a second opinion or further investigations. The observed association between intuition and clinical markers of serious infection means that by reflecting on the genesis of their gut feeling, clinicians should be able to hone their clinical skills.	[Van den Bruel, Ann; Thompson, Matthew; Mant, David] Radcliffe Observ Quarter, Dept Primary Care Hlth Sci, Oxford OX2 6GG, England; [Buntinx, Frank] Catholic Univ Louvain, Dept Gen Practice, B-3000 Louvain, Belgium	Universite Catholique Louvain	Van den Bruel, A (corresponding author), Radcliffe Observ Quarter, Dept Primary Care Hlth Sci, Oxford OX2 6GG, England.	ann.vandenbruel@phc.ox.ac.uk	Van den Bruel, Ann/AAC-2442-2020	Van den Bruel, Ann/0000-0001-9012-2009	Research Foundation-Flanders (FWO); Eurogenerics; National Institute for Health Research [RP-PG-0407-10347]; National Institute for Health Research [CL-2009-13-007, NF-SI-0507-10198, CDF-2011-04-052] Funding Source: researchfish	Research Foundation-Flanders (FWO)(FWO); Eurogenerics; National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	The original study was funded by a grant of the Research Foundation-Flanders (FWO) and an unconditional grant from Eurogenerics. None of the funders had any role in the design or analysis of the original study nor of the current analyses. The present analyses were done as part of the MaDOx programme, which presents independent research commissioned by the National Institute for Health Research under its programme grants for applied research funding scheme (RP-PG-0407-10347). MT is funded by a career development fellowship supported by the National Institute for Health Research. The views expressed in this publication are those of the authors and not necessarily those of the National Health Service, the National Institute for Health Research, or the Department of Health.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Almond S, 2009, BRIT J GEN PRACT, V59, P872, DOI 10.3399/bjgp09X472971; Balla JI, 2009, J EVAL CLIN PRACT, V15, P964, DOI 10.1111/j.1365-2753.2009.01243.x; Berger RMF, 1996, EUR J PEDIATR, V155, P468, DOI 10.1007/BF01955183; Bruyninckx R, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-55; Fleming S, 2011, LANCET, V377, P1011, DOI 10.1016/S0140-6736(10)62226-X; Grant CC, 2012, ARCH DIS CHILD, V97, P21, DOI 10.1136/archdischild-2011-300604; Greenhalgh R, 2002, BRIT J GEN PRACT, V52, P395; Haddon RA, 1999, MED J AUSTRALIA, V170, P475, DOI 10.5694/j.1326-5377.1999.tb127847.x; Harnden A, 2007, BRIT MED J, V335, P409, DOI 10.1136/bmj.39295.383843.AD; Lykke K, 2008, FAM PRACT, V25, P146, DOI 10.1093/fampra/cmn021; MCCARTHY PL, 1987, J PEDIATR-US, V110, P26, DOI 10.1016/S0022-3476(87)80282-2; Pearson GA, 2008, CONFIDENTIAL ENQUIRY; Shavit I, 2006, PEDIATRICS, V118, P2402, DOI 10.1542/peds.2006-1108; Slack MPE, 1998, PEDIATR INFECT DIS J, V17, pS204, DOI 10.1097/00006454-199809001-00026; Stolper E, 2011, J GEN INTERN MED, V26, P197, DOI 10.1007/s11606-010-1524-5; Stolper E, 2010, EUR J GEN PRACT, V16, P72, DOI 10.3109/13814781003653424; Thompson M, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16150; Thompson MJ, 2006, LANCET, V367, P397, DOI 10.1016/S0140-6736(06)67932-4; Trotter CL, 2004, LANCET, V364, P365, DOI 10.1016/S0140-6736(04)16725-1; Van den Bruel A, 2007, BRIT J GEN PRACT, V57, P538; Van den Bruel Ann, 2006, BMC Fam Pract, V7, P23, DOI 10.1186/1471-2296-7-23; Van den Bruel A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3082; Van den Bruel A, 2010, LANCET, V375, P834, DOI 10.1016/S0140-6736(09)62000-6; WASKERWITZ S, 1981, J PEDIATR-US, V99, P231, DOI 10.1016/S0022-3476(81)80458-1; Wells LC, 2001, ARCH DIS CHILD, V85, P218, DOI 10.1136/adc.85.3.218	26	105	106	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 25	2012	345								e6144	10.1136/bmj.e6144	http://dx.doi.org/10.1136/bmj.e6144			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014ON	23015034	hybrid, Green Published			2022-12-24	WOS:000309385500004
J	Sherratt, TN; Roberts, G				Sherratt, Thomas N.; Roberts, Gilbert			When Paths to Cooperation Converge	SCIENCE			English	Editorial Material							RECIPROCAL ALTRUISM; EVOLUTION		[Sherratt, Thomas N.] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Roberts, Gilbert] Newcastle Univ, Ctr Behav & Evolut, Inst Neurosci, Fac Med Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Carleton University; Newcastle University - UK	Sherratt, TN (corresponding author), Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada.	tom_sherratt@carleton.ca	Roberts, Gilbert/K-5449-2019					Akcay E, 2011, P ROY SOC B-BIOL SCI, V278, P2198, DOI 10.1098/rspb.2010.2105; Andre JB, 2011, EVOLUTION, V65, P1447, DOI 10.1111/j.1558-5646.2011.01232.x; Archetti M, 2012, J THEOR BIOL, V299, P9, DOI 10.1016/j.jtbi.2011.06.018; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Backwell PRY, 2004, NATURE, V430, P417, DOI 10.1038/430417a; BENDOR J, 1995, P NATL ACAD SCI USA, V92, P3596, DOI 10.1073/pnas.92.8.3596; Binmore K., 2007, PLAYING REAL; Clutton-Brock T, 2009, NATURE, V462, P51, DOI 10.1038/nature08366; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; NOWAK MA, 1994, P NATL ACAD SCI USA, V91, P4877, DOI 10.1073/pnas.91.11.4877; QUELLER DC, 1985, NATURE, V318, P366, DOI 10.1038/318366a0; Sherratt TN, 2001, BEHAV ECOL, V12, P313, DOI 10.1093/beheco/12.3.313; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; van Veelen M, 2012, P NATL ACAD SCI USA, V109, P9929, DOI 10.1073/pnas.1206694109; West SA, 2011, EVOL HUM BEHAV, V32, P231, DOI 10.1016/j.evolhumbehav.2010.08.001	15	6	6	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2012	337	6100					1304	1305		10.1126/science.1226328	http://dx.doi.org/10.1126/science.1226328			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	004TW	22984060				2022-12-24	WOS:000308705000030
J	Coulthard, G; Erb, W; Aggarwal, VK				Coulthard, Graeme; Erb, William; Aggarwal, Varinder K.			Stereocontrolled organocatalytic synthesis of prostaglandin PGF(2 alpha) in seven steps	NATURE			English	Article							PROSTACYCLIN; ANALOGS; ROUTE	Prostaglandins are hormone-like chemical messengers that regulate a broad range of physiological activities, including blood circulation, digestion and reproduction(1,2). Their biological activities and their complex molecular architectures have made prostaglandins popular targets for synthetic organic chemists for over 40 years(3,4). Prostaglandin analogues are widely used as pharmaceuticals and some, such as latanoprost, which is used to treat glaucoma(5,6), have become billion-dollar drugs. Previously reported syntheses of these compounds are quite lengthy, and every chemical step costs time and energy, generates waste and is accompanied by material losses. Using a new bond disconnection, here we report a concise synthesis of the most complex prostaglandin, PGF(2 alpha), with high levels of control of relative and absolute stereochemistry, and fewer steps. The key step is an aldol cascade reaction of succinaldehyde using proline organocatalysis to create a bicyclic enal in one step and an enantiomeric excess of 98%. This intermediate bicyclic enal is fully primed with the appropriate functionality for attachment of the remaining groups(7). Access to this bicyclic enal will not only render existing prostaglandin-based drugs more affordable, but will also facilitate the rapid exploration of related chemical structures around the ubiquitous five-membered ring motif, such as potentially therapeutic prostaglandin analogues.	[Coulthard, Graeme; Erb, William; Aggarwal, Varinder K.] Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England	University of Bristol	Aggarwal, VK (corresponding author), Univ Bristol, Sch Chem, Cantocks Close, Bristol BS8 1TS, Avon, England.	v.aggarwal@bristol.ac.uk	Aggarwal, Varinder/AAG-8504-2019	Erb, William/0000-0002-2906-2091; Aggarwal, Varinder/0000-0003-0344-6430	EPSRC; European Research Council [246785]; Royal Society; EPSRC [EP/E052185/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/E052185/1, EP/D501725/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Research Council(European Research Council (ERC)European Commission); Royal Society(Royal Society of London); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank EPSRC and the European Research Council (FP7/2007-2013, ERC grant no. 246785) for financial support. V. K. A. thanks the Royal Society for a Wolfson Research Merit Award and EPSRC for a Senior Research Fellowship.	[Anonymous], 2011, PFIZER REPORTS 4 QUA; Bahmanyar S, 2003, J AM CHEM SOC, V125, P2475, DOI 10.1021/ja028812d; Bindra J. S., 1981, TOTAL SYNTHESIS NATU, V4, P353; Bindra J. S., 1977, PROSTAGLANDIN SYNTHE; COLLINS PW, 1993, CHEM REV, V93, P1533, DOI 10.1021/cr00020a007; Corey E.J., 1995, LOGIC CHEM SYNTHESIS; COREY EJ, 1978, J AM CHEM SOC, V100, P8031, DOI 10.1021/ja00493a055; COREY EJ, 1969, J AM CHEM SOC, V91, P5675, DOI 10.1021/ja01048a062; COREY EJ, 1971, TETRAHEDRON LETT, P4753; COREY EJ, 1974, TETRAHEDRON LETT, P2439; DANISHEFSKY SJ, 1989, J AM CHEM SOC, V111, P3456, DOI 10.1021/ja00191a067; Das S, 2007, CHEM REV, V107, P3286, DOI 10.1021/cr068365a; EULER U. S. v., 1934, ARCH EXP PATH U PHARMAKOL, V175, P78; Flower RJ, 2006, BRIT J PHARMACOL, V147, pS182, DOI 10.1038/sj.bjp.0706506; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gourlay BS, 2006, TETRAHEDRON LETT, V47, P799, DOI 10.1016/j.tetlet.2005.11.104; HOWARD CC, 1980, J CHEM SOC PERK T 1, P852, DOI 10.1039/p19800000852; LIPSHUTZ BH, 1985, J ORGANOMET CHEM, V285, P437, DOI 10.1016/0022-328X(85)87388-5; List B, 2000, J AM CHEM SOC, V122, P2395, DOI 10.1021/ja994280y; Mukherjee S, 2007, CHEM REV, V107, P5471, DOI 10.1021/cr0684016; Nair S. K., 2010, MODERN DRUG SYNTHESI, P329; Northrup AB, 2002, J AM CHEM SOC, V124, P6798, DOI 10.1021/ja0262378; RESUL B, 1993, J MED CHEM, V36, P243, DOI 10.1021/jm00054a008; Rey MDA, 1999, J ORG CHEM, V64, P3196; Sheddan NA, 2006, ORG LETT, V8, P3101, DOI 10.1021/ol061141u; Stix G, 2006, SCI AM, V294, P60, DOI 10.1038/scientificamerican0506-60; STORK G, 1986, J AM CHEM SOC, V108, P6384, DOI 10.1021/ja00280a043; SUZUKI M, 1988, J AM CHEM SOC, V110, P4718, DOI 10.1021/ja00222a033; Ungrin MD, 2001, MOL PHARMACOL, V59, P1446, DOI 10.1124/mol.59.6.1446; WOODWARD RB, 1973, J AM CHEM SOC, V95, P6853, DOI 10.1021/ja00801a066	30	101	104	2	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2012	489	7415					278	281		10.1038/nature11411	http://dx.doi.org/10.1038/nature11411			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003UC	22895192				2022-12-24	WOS:000308635900038
J	Yang, LC; Rieves, D; Ganley, C				Yang, Lucie; Rieves, Dwaine; Ganley, Charles			Brain Amyloid Imaging - FDA Approval of Florbetapir F18 Injection	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Yang, Lucie; Rieves, Dwaine] Food & Drug Adm, Ctr Drug Evaluat & Res, Div Med Imaging Prod, Silver Spring, MD USA; [Ganley, Charles] Food & Drug Adm, Ctr Drug Evaluat & Res, Off New Drugs, Silver Spring, MD USA; [Ganley, Charles] Food & Drug Adm, Ctr Drug Evaluat & Res, Off Drug Evaluat 4, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Yang, LC (corresponding author), Food & Drug Adm, Ctr Drug Evaluat & Res, Div Med Imaging Prod, Silver Spring, MD USA.							[Anonymous], 2011, PROM BRAIN HLTH; [Anonymous], HIGHL PRESCR INF AM; Department of Energy National Energy Technology Laboratory, 2004, GUID US ANT AG HIV 1, P2; Lister-James J, 2011, SEMIN NUCL MED, V41, P300, DOI 10.1053/j.semnuclmed.2011.03.001; Okie S, 2011, NEW ENGL J MED, V365, P1069, DOI 10.1056/NEJMp1107288	5	125	127	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 6	2012	367	10					885	887		10.1056/NEJMp1208061	http://dx.doi.org/10.1056/NEJMp1208061			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	999VO	22931256	Bronze			2022-12-24	WOS:000308343300002
J	Einstein, DJ				Einstein, David J.			ON BEING A DOCTOR Knot	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Tufts Med Ctr, Boston, MA 02111 USA	Tufts Medical Center	Einstein, DJ (corresponding author), Tufts Med Ctr, 800 Washington St, Boston, MA 02111 USA.	deinstein@tuftsmedicalcenter.org	Einstein, David/ABB-3748-2020						0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 4	2012	157	5					381	382		10.7326/0003-4819-157-5-201209040-00012	http://dx.doi.org/10.7326/0003-4819-157-5-201209040-00012			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	000BM	22944877				2022-12-24	WOS:000308361500009
J	Dong, N; Zhu, YQ; Lu, QH; Hu, LY; Zheng, YQ; Shao, F				Dong, Na; Zhu, Yongqun; Lu, Qiuhe; Hu, Liyan; Zheng, Yuqing; Shao, Feng			Structurally Distinct Bacterial TBC-like GAPs Link Arf GTPase to Rab1 Inactivation to Counteract Host Defenses	CELL			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; MATRIX PROTEIN GM130; ENDOPLASMIC-RETICULUM; ACTIVATING PROTEIN; EFFECTOR PROTEIN; SHIGELLA; VIRA; COMPLEX; DOMAIN; IDENTIFICATION	Rab GTPases are frequent targets of vacuole-living bacterial pathogens for appropriate trafficking of the vacuole. Here we discover that bacterial effectors including VirA from nonvacuole Shigella flexneri and EspG from extracellular Enteropathogenic Escherichia coli (EPEC) harbor TBC-like dual-finger motifs and exhibits potent RabGAP activities. Specific inactivation of Rab1 by VirA/EspG disrupts ER-to-Golgi trafficking. S. flexneri intracellular persistence requires VirA TBC-like GAP activity that mediates bacterial escape from autophagy-mediated host defense. Rab1 inactivation by EspG severely blocks host secretory pathway, resulting in inhibited interleukin-8 secretion from infected cells. Crystal structures of VirA/EspG-Rab1-GDP-aluminum fluoride complexes highlight TBC-like catalytic role for the arginine and glutamine finger residues and reveal a 3D architecture distinct from that of the TBC domain. Structure of Arf6-EspG-Rab1 ternary complex illustrates a pathogenic signaling complex that rewires host Arf signaling to Rab1 inactivation. Structural distinctions of VirA/EspG further predict a possible extensive presence of TBC-like RabGAP effectors in counteracting various host defenses.	[Zhu, Yongqun] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Dong, Na; Lu, Qiuhe; Hu, Liyan; Zheng, Yuqing; Shao, Feng] Natl Inst Biol Sci, Beijing 102206, Peoples R China	Zhejiang University; National Institute of Biological Sciences, Beijing	Zhu, YQ (corresponding author), Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.	zhuyongqun@zju.edu.cn; shaofeng@nibs.ac.cn	Zheng, Yuqing/AAO-6891-2020	Lu, Qiuhe/0000-0002-0202-7448	Howard Hughes Medical Institute; Zhejiang University; National Basic Research Program of China (973 Programs) [2010CB835400, 2012CB518700]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Zhejiang University; National Basic Research Program of China (973 Programs)(National Basic Research Program of China)	We thank Dr. David G. Lambright for kindly providing bacterial expression constructs for 30 Rabs. We thank the staff at the KEK Synchrotron Facility (Tsukuba, Japan) and Argonne Advanced Photon Source (Chicago, IL) for assistances with data collection. We also thank Yan Zhou, Jieling Yang, Yin Xu, and Jianjin Shi for technical assistance. The research was supported in part by an International Early Career Scientist grant from the Howard Hughes Medical Institute to F.S. Y.Z. was supported by new faculty start-up funds from Zhejiang University. This work was also supported by the National Basic Research Program of China (973 Programs 2010CB835400 and 2012CB518700) to F.S.	Albert S, 1999, EMBO J, V18, P5216, DOI 10.1093/emboj/18.19.5216; Ashida H, 2011, CURR OPIN MICROBIOL, V14, P16, DOI 10.1016/j.mib.2010.08.014; Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; Brurnell JH, 2007, MICROBIOL MOL BIOL R, V71, P636, DOI 10.1128/MMBR.00023-07; Chen H, 2005, P NATL ACAD SCI USA, V102, P2766, DOI 10.1073/pnas.0409719102; Clements A, 2011, CELL MICROBIOL, V13, P1429, DOI 10.1111/j.1462-5822.2011.01631.x; Davis J, 2008, PROTEIN SCI, V17, P2167, DOI 10.1110/ps.037978.108; De Antoni A, 2002, J BIOL CHEM, V277, P41023, DOI 10.1074/jbc.M205783200; Dong N, 2010, EMBO J, V29, P1363, DOI 10.1038/emboj.2010.33; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; Elliott SJ, 2001, INFECT IMMUN, V69, P4027, DOI 10.1128/IAI.69.6.4027-4033.2001; Germane KL, 2008, BIOCHEMISTRY-US, V47, P10241, DOI 10.1021/bi801533k; Germane KL, 2011, BIOCHEMISTRY-US, V50, P917, DOI 10.1021/bi1020138; Hardwidge PR, 2005, INFECT IMMUN, V73, P2586, DOI 10.1128/IAI.73.5.2586-2594.2005; Huang J, 2011, AUTOPHAGY, V7, P17, DOI 10.4161/auto.7.1.13840; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Ingmundson A, 2007, NATURE, V450, P365, DOI 10.1038/nature06336; Zoppino FCM, 2010, TRAFFIC, V11, P1246, DOI 10.1111/j.1600-0854.2010.01086.x; Masuda ES, 2000, FEBS LETT, V470, P61, DOI 10.1016/S0014-5793(00)01288-6; Nottingham RM, 2009, P NATL ACAD SCI USA, V106, P14185, DOI 10.1073/pnas.0907725106; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Pan XJ, 2006, NATURE, V442, P303, DOI 10.1038/nature04847; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; Pfeffer SR, 2007, ANNU REV BIOCHEM, V76, P629, DOI 10.1146/annurev.biochem.76.061705.130002; Rak A, 2000, EMBO J, V19, P5105, DOI 10.1093/emboj/19.19.5105; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; Rivera VM, 2000, SCIENCE, V287, P826, DOI 10.1126/science.287.5454.826; Rivera-Molina FE, 2009, P NATL ACAD SCI USA, V106, P14408, DOI 10.1073/pnas.0906536106; Salcedo SP, 2005, CURR OPIN MICROBIOL, V8, P92, DOI 10.1016/j.mib.2004.12.007; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Selyunin AS, 2011, NATURE, V469, P107, DOI 10.1038/nature09593; Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3; Slagowski NL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040009; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; STROM M, 1993, NATURE, V361, P736, DOI 10.1038/361736a0; UCHIYA KI, 1995, MOL MICROBIOL, V17, P241, DOI 10.1111/j.1365-2958.1995.mmi_17020241.x; Volpicelli-Daley LA, 2005, MOL BIOL CELL, V16, P4495, DOI 10.1091/mbc.E04-12-1042; Weide T, 2001, EMBO REP, V2, P336, DOI 10.1093/embo-reports/kve065; Yoshida S, 2006, SCIENCE, V314, P985, DOI 10.1126/science.1133174	39	158	164	6	82	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 31	2012	150	5					1029	1041		10.1016/j.cell.2012.06.050	http://dx.doi.org/10.1016/j.cell.2012.06.050			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22939626	Bronze			2022-12-24	WOS:000308500200016
J	Vargas-Parada, L				Vargas-Parada, Laura			PATHOLOGY Three questions	NATURE			English	Editorial Material							CANCER											Gravitt PE, 2011, J CLIN INVEST, V121, P4593, DOI 10.1172/JCI57149; Herfs M, 2012, P NATL ACAD SCI USA, V109, P10516, DOI 10.1073/pnas.1202684109; Maglennon GA, 2011, VIROLOGY, V414, P153, DOI 10.1016/j.virol.2011.03.019; Woo YL, 2010, INT J CANCER, V126, P133, DOI 10.1002/ijc.24804; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	5	7	7	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2012	488	7413					S14	S15		10.1038/488S14a	http://dx.doi.org/10.1038/488S14a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	996NC	22932435				2022-12-24	WOS:000308095100010
J	Wheeler, TM; Leger, AJ; Pandey, SK; MacLeod, AR; Nakamori, M; Cheng, SH; Wentworth, BM; Bennett, CF; Thornton, CA				Wheeler, Thurman M.; Leger, Andrew J.; Pandey, Sanjay K.; MacLeod, A. Robert; Nakamori, Masayuki; Cheng, Seng H.; Wentworth, Bruce M.; Bennett, C. Frank; Thornton, Charles A.			Targeting nuclear RNA for in vivo correction of myotonic dystrophy	NATURE			English	Article							MODIFIED ANTISENSE OLIGONUCLEOTIDE; TRINUCLEOTIDE REPEAT; PHOSPHOROTHIOATE OLIGONUCLEOTIDES; GENE-EXPRESSION; MESSENGER-RNA; MOUSE MODELS; CTG REPEAT; TOXIC RNA; 3' END; PROTEIN	Antisense oligonucleotides (ASOs) hold promise for gene-specific knockdown in diseases that involve RNA or protein gain-of-function effects. In the hereditary degenerative disease myotonic dystrophy type 1 (DM1), transcripts from the mutant allele contain an expanded CUG repeat(1-3) and are retained in the nucleus(4,5). The mutant RNA exerts a toxic gain-of-function effect(6), making it an appropriate target for therapeutic ASOs. However, despite improvements in ASO chemistry and design, systemic use of ASOs is limited because uptake in many tissues, including skeletal and cardiac muscle, is not sufficient to silence target messenger RNAs7,8. Here we show that nuclear-retained transcripts containing expanded CUG (CUG(exp)) repeats are unusually sensitive to antisense silencing. In a transgenic mouse model of DM1, systemic administration of ASOs caused a rapid knockdown of CUG(exp) RNA in skeletal muscle, correcting the physiological, histopathologic and transcriptomic features of the disease. The effect was sustained for up to 1 year after treatment was discontinued. Systemically administered ASOs were also effective for muscle knockdown of Malat(1), a long non-coding RNA (lncRNA) that is retained in the nucleus(9). These results provide a general strategy to correct RNA gain-of-function effects and to modulate the expression of expanded repeats, lncRNAs and other transcripts with prolonged nuclear residence.	[Wheeler, Thurman M.; Nakamori, Masayuki; Thornton, Charles A.] Univ Rochester, Dept Neurol, Rochester, NY 14642 USA; [Wheeler, Thurman M.; Nakamori, Masayuki; Thornton, Charles A.] Univ Rochester, Ctr Neural Dev & Dis, Rochester, NY 14642 USA; [Leger, Andrew J.; Cheng, Seng H.; Wentworth, Bruce M.] Genzyme Corp, Framingham, MA 01701 USA; [Pandey, Sanjay K.; MacLeod, A. Robert; Bennett, C. Frank] Isis Pharmaceut, Carlsbad, CA 92010 USA	University of Rochester; University of Rochester; Sanofi-Aventis; Genzyme Corporation; Isis Pharmaceuticals Inc	Thornton, CA (corresponding author), Univ Rochester, Dept Neurol, 601 Elmwood Ave, Rochester, NY 14642 USA.	charles_thornton@urmc.rochester.edu	Nakamori, Masayuki/ABE-2169-2020; Cheng, Seng H/AAC-6564-2022	Nakamori, Masayuki/0000-0003-4714-3044; 	US National Institutes of Health (NIH) [AR049077, U54NS48843, AR/NS48143, K08NS064293, U01NS072323]; Saunders Family Neuromuscular Research Fund; Run America; Muscular Dystrophy Association; Uehara Memorial Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049077, K24AR048143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS072323, U54NS048843, K08NS064293] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Saunders Family Neuromuscular Research Fund; Run America; Muscular Dystrophy Association(Muscular Dystrophy Association); Uehara Memorial Foundation(Uehara Memorial Foundation); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was carried out at the Wellstone Muscular Dystrophy Cooperative Research Center and Center for RNA Biology at the University of Rochester, with support from the US National Institutes of Health (NIH) (grants AR049077, U54NS48843, AR/NS48143, K08NS064293 and U01NS072323), the Saunders Family Neuromuscular Research Fund, Run America and a fellowship (to M.N.) from the Muscular Dystrophy Association and Uehara Memorial Foundation. The authors thank G. Gourdon for providing DM328XL mice, M. Sabripour for assistance with principal components analysis and L. Richardson and S. Leistman for technical assistance.	Alter J, 2006, NAT MED, V12, P175, DOI 10.1038/nm1345; Bennett CF, 2010, ANNU REV PHARMACOL, V50, P259, DOI 10.1146/annurev.pharmtox.010909.105654; Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; Cheruvallath ZS, 2003, NUCLEOS NUCLEOT NUCL, V22, P461, DOI 10.1081/NCN-120022050; Davis BM, 1997, P NATL ACAD SCI USA, V94, P7388, DOI 10.1073/pnas.94.14.7388; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Du HQ, 2010, NAT STRUCT MOL BIOL, V17, P187, DOI 10.1038/nsmb.1720; Geary RS, 1999, ANAL BIOCHEM, V274, P241, DOI 10.1006/abio.1999.4290; Geary RS, 2003, DRUG METAB DISPOS, V31, P1419, DOI 10.1124/dmd.31.11.1419; Gomes-Pereira M, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030052; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; Hasselblatt P, 2005, NUCLEIC ACIDS RES, V33, P114, DOI 10.1093/nar/gki155; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Koller E, 2011, NUCLEIC ACIDS RES, V39, P4795, DOI 10.1093/nar/gkr089; Lee JE, 2012, P NATL ACAD SCI USA, V109, P4221, DOI 10.1073/pnas.1117019109; Leeds JM, 1996, ANAL BIOCHEM, V235, P36, DOI 10.1006/abio.1996.0088; Li LB, 2010, TRENDS NEUROSCI, V33, P292, DOI 10.1016/j.tins.2010.03.004; Lin XY, 2006, HUM MOL GENET, V15, P2087, DOI 10.1093/hmg/ddl132; Lorenz P, 2000, NUCLEIC ACIDS RES, V28, P582, DOI 10.1093/nar/28.2.582; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Mankodi A, 2002, MOL CELL, V10, P35, DOI 10.1016/S1097-2765(02)00563-4; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Mulders SAM, 2009, P NATL ACAD SCI USA, V106, P13915, DOI 10.1073/pnas.0905780106; Nakamori M, 2011, MOL THER, V19, P2222, DOI 10.1038/mt.2011.191; Napierala M, 1997, J BIOL CHEM, V272, P31079, DOI 10.1074/jbc.272.49.31079; Osborne RJ, 2009, HUM MOL GENET, V18, P1471, DOI 10.1093/hmg/ddp058; PONTIUS BW, 1992, J BIOL CHEM, V267, P13815; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; Raychaudhuri S, 2000, Pac Symp Biocomput, P455; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Seznec H, 2000, HUM MOL GENET, V9, P1185, DOI 10.1093/hmg/9.8.1185; Seznec H, 2001, HUM MOL GENET, V10, P2717, DOI 10.1093/hmg/10.23.2717; Suzuki Y, 2010, MOL CELL BIOL, V30, P5123, DOI 10.1128/MCB.00619-10; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Vickers TA, 2003, J BIOL CHEM, V278, P7108, DOI 10.1074/jbc.M210326200; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Wheeler TM, 2007, J CLIN INVEST, V117, P3952, DOI 10.1172/JCI33355; Wheeler TM, 2009, SCIENCE, V325, P336, DOI 10.1126/science.1173110; Wilusz JE, 2008, CELL, V135, P919, DOI 10.1016/j.cell.2008.10.012; Wu HJ, 2004, J BIOL CHEM, V279, P17181, DOI 10.1074/jbc.M311683200	43	346	358	0	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 2	2012	488	7409					111	+		10.1038/nature11362	http://dx.doi.org/10.1038/nature11362			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ZE	22859208	Green Accepted			2022-12-24	WOS:000307010700043
J	Fried, TR; Fragoso, CAV; Rabow, MW				Fried, Terri R.; Fragoso, Carlos A. Vaz; Rabow, Michael W.			Caring for the Older Person With Chronic Obstructive Pulmonary Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICAL-PRACTICE GUIDELINES; RANDOMIZED CONTROLLED-TRIAL; MULTIPLE CHRONIC CONDITIONS; SERIOUSLY ILL PATIENTS; CHRONIC LUNG-DISEASE; QUALITY-OF-LIFE; PALLIATIVE CARE; REFRACTORY DYSPNEA; COPD PATIENTS; INHALED ANTICHOLINERGICS	Chronic obstructive pulmonary disease (COPD), a common disease in elderly patients, is characterized by high symptom burden, health care utilization, mortality, and unmet needs of patients and caregivers. Respiratory failure and dyspnea maybe exacerbated by heart failure, pulmonary embolism, and anxiety; by medication effects; and by other conditions, including deconditioning and malnutrition. Randomized controlled trials, which provide the strongest evidence for guideline recommendations, may underestimate the risk of adverse effects of interventions for older patients with COPD. The focus of guidelines on disease-modifying therapies may not address the full spectrum of patient and caregiver needs, particularly the high rates of bothersome symptoms, risk of functional and cognitive decline, and need for end-of-life care planning. Meeting the many needs of older patients with COPD and their families requires that clinicians supplement guideline-recommended care with treatment decision making that takes into account older persons' comorbid conditions, recognizes the trade-offs engendered by the increased risk of adverse events, focuses on symptom relief and function, and prepares patients and their loved ones for further declines in the patient's health and their end-of-life care. A case of COPD in an 81-year-old man hospitalized with severe dyspnea and respiratory failure highlights both the challenges in managing COPD in the elderly and the limitations in applying guidelines to geriatric patients. JAMA. 2012;308(12):1254-1263 www.jama.com	[Fried, Terri R.; Fragoso, Carlos A. Vaz] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Fried, Terri R.; Fragoso, Carlos A. Vaz] VA Connecticut Healthcare Syst, Clin Epidemiol Res Ctr, Washington, DC USA; [Rabow, Michael W.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	Yale University; University of California System; University of California San Francisco	Fried, TR (corresponding author), VA Connecticut Healthcare Syst, Clin Epidemiol Res Ctr 151B, 950 Campbell Ave, West Haven, CT 06516 USA.	terri.fried@yale.edu		Vaz Fragoso, Carlos/0000-0002-7045-3334	National Institute on Aging [K24AG028443, R03AG037051]; Department of Veterans Affairs; SCAN Foundation; NATIONAL INSTITUTE ON AGING [K24AG028443, R03AG037051, P30AG021342] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Department of Veterans Affairs(US Department of Veterans Affairs); SCAN Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr Fried is the recipient of amid-career development award from the National Institute on Aging (K24AG028443). Dr Vaz Fragoso is a recipient of a Career Development Award from the Department of Veterans Affairs and an R03 award from the National Institute on Aging (R03AG037051). The Care of the Aging Patient series is made possible by funding from The SCAN Foundation.	Abernethy AP, 2010, LANCET, V376, P784, DOI 10.1016/S0140-6736(10)61115-4; Abernethy AP, 2009, WIEN MED WOCHENSCHR, V159, P583, DOI 10.1007/s10354-009-0727-z; Agostini JV, 2004, J AM GERIATR SOC, V52, P1719, DOI 10.1111/j.1532-5415.2004.52467.x; Allen SC, 2003, AGE AGEING, V32, P299, DOI 10.1093/ageing/32.3.299; Allen SC, 1997, AGE AGEING, V26, P83, DOI 10.1093/ageing/26.2.83; Alonso-Coello P, 2012, CHEST, V141, pE669S, DOI 10.1378/chest.11-2307; *AM THOR SOC, STAND DIAGN MAN PAT; ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; Au DH, 2003, CHEST, V123, P1964, DOI 10.1378/chest.123.6.1964; Back AL, 2006, J CLIN ONCOL, V24, P4209, DOI 10.1200/JCO.2006.06.007; Baltzan Marcel A, 2004, Can Respir J, V11, P407; Bausewein C, 2010, J PALLIAT MED, V13, P1109, DOI 10.1089/jpm.2010.0068; Beauchamp MK, 2009, RESP MED, V103, P1885, DOI 10.1016/j.rmed.2009.06.008; Berger RL, 2010, CHEST, V138, P407, DOI 10.1378/chest.09-1822; Bharucha AJ, 2004, J AM GERIATR SOC, V52, P434, DOI 10.1111/j.1532-5415.2004.52118.x; BORSON S, 1992, PSYCHOSOMATICS, V33, P190, DOI 10.1016/S0033-3182(92)71995-1; Borson S, 2000, INT J GERIATR PSYCH, V15, P1021, DOI 10.1002/1099-1166(200011)15:11<1021::AID-GPS234>3.0.CO;2-6; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Casaburi R, 2009, NEW ENGL J MED, V360, P1329, DOI 10.1056/NEJMct0804632; Chan ED, 1998, CHEST, V114, P1704, DOI 10.1378/chest.114.6.1704; Chatham K, 2009, PHYS THER, V89, P257, DOI 10.2522/ptj.20080155; Claessens MT, 2000, J AM GERIATR SOC, V48, pS146, DOI 10.1111/j.1532-5415.2000.tb03124.x; Clemens KE, 2012, CURR OPIN SUPPORT PA, V6, P163, DOI 10.1097/SPC.0b013e3283530fee; Clini EM, 2008, EUR RESPIR J, V32, P218, DOI 10.1183/09031936.00134007; Connors AF, 1996, AM J RESP CRIT CARE, V154, P959, DOI 10.1164/ajrccm.154.4.8887592; Currow DC, 2011, J PAIN SYMPTOM MANAG, V42, P388, DOI 10.1016/j.jpainsymman.2010.11.021; Curtis JR, 2008, EUR RESPIR J, V32, P796, DOI 10.1183/09031936.00126107; Curtis JR, 1997, AM J RESP CRIT CARE, V156, P1032, DOI 10.1164/ajrccm.156.4.97-02011; Di Meo F, 2008, AGE AGEING, V37, P530, DOI 10.1093/ageing/afn126; Dodd JW, 2010, EUR RESPIR J, V35, P913, DOI 10.1183/09031936.00125109; Eisner MD, 2008, AM J MED, V121, P789, DOI 10.1016/j.amjmed.2008.04.030; Elliott MW, 2011, CLIN MED, V11, P150, DOI 10.7861/clinmedicine.11-2-150; Emery CF, 2008, RESP CARE, V53, P1208; Fan VS, 2012, ANN INTERN MED, V156, P673, DOI 10.7326/0003-4819-156-10-201205150-00003; Field TS, 2004, J AM GERIATR SOC, V52, P1349, DOI 10.1111/j.1532-5415.2004.52367.x; Fishman A, 2003, NEW ENGL J MED, V348, P2059; Fragoso CAV, 2011, J AM GERIATR SOC, V59, P1847, DOI 10.1111/j.1532-5415.2011.03596.x; Fried TR, 2011, ARCH INTERN MED, V171, P1854, DOI 10.1001/archinternmed.2011.424; Fried TR, 2002, NEW ENGL J MED, V346, P1061, DOI 10.1056/NEJMsa012528; Fried TR, 2003, J AM GERIATR SOC, V51, P1398, DOI 10.1046/j.1532-5415.2003.51457.x; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2011, GLOB STRAT DIAGN MAN; Gore JM, 2000, THORAX, V55, P1000, DOI 10.1136/thorax.55.12.1000; Graat-Verboom L, 2009, EUR RESPIR J, V34, P209, DOI 10.1183/09031936.50130408; Harrison RA, 2007, J BONE MINER RES, V22, P447, DOI 10.1359/jbmr.061202; HEATON RK, 1983, ARCH INTERN MED, V143, P1941, DOI 10.1001/archinte.143.10.1941; Hordijk-Trion M, 2006, EUR HEART J, V27, P671, DOI 10.1093/eurheartj/ehi731; Horton Robert, 2010, Curr Opin Support Palliat Care, V4, P56, DOI 10.1097/SPC.0b013e328338c1c6; Howard C, 2010, PSYCHOL HEALTH MED, V15, P371, DOI 10.1080/13548506.2010.482142; Hunt T, 2010, EUR RESPIR REV, V19, P30, DOI 10.1183/09059180.00006009; Inouye SK, 1998, JAMA-J AM MED ASSOC, V279, P1187, DOI 10.1001/jama.279.15.1187; Ioannidis JPA, 2009, ARCH INTERN MED, V169, P1737, DOI 10.1001/archinternmed.2009.313; Jessup M, 2009, CIRCULATION, V119, P1977, DOI 10.1161/CIRCULATIONAHA.109.192064; Johnson MJ, 2012, J PAIN SYMPTOM MANAG, V43, P614, DOI 10.1016/j.jpainsymman.2011.04.024; Kallet RH, 2007, RESP CARE, V52, P900; Kamal AH, 2012, J PALLIAT MED, V15, P106, DOI 10.1089/jpm.2011.0110; Karapolat H, 2008, CHINESE MED J-PEKING, V121, P592; Katsura H, 2004, RESPIROLOGY, V9, P230, DOI 10.1111/j.1440-1843.2004.00561.x; Kunik ME, 2008, PSYCHOL MED, V38, P385, DOI 10.1017/S0033291707001687; Kunik ME, 2007, PSYCHOSOMATICS, V48, P16, DOI 10.1176/appi.psy.48.1.16; Lanken PN, 2008, AM J RESP CRIT CARE, V177, P912, DOI 10.1164/rccm.200605-587ST; Lehouck A, 2011, CHEST, V139, P648, DOI 10.1378/chest.10-1427; Luce JM, 2001, JAMA-J AM MED ASSOC, V285, P1331, DOI 10.1001/jama.285.10.1331; Mahler Donald A, 2011, Curr Opin Support Palliat Care, V5, P71, DOI 10.1097/SPC.0b013e328345bc84; Marciniuk DD, 2011, CAN RESPIR J, V18, P69, DOI 10.1155/2011/745047; Maurer J, 2008, CHEST, V134, p43S, DOI 10.1378/chest.08-0342; Meek PM, 1999, AM J RESP CRIT CARE, V159, P321; MORRISON NJ, 1989, CHEST, V95, P90, DOI 10.1378/chest.95.1.90; ODONNELL DE, 1994, CHEST, V106, P904, DOI 10.1378/chest.106.3.904; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Pinnock H, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d142; Quill TE, 2000, JAMA-J AM MED ASSOC, V284, P2502, DOI 10.1001/jama.284.19.2502; Quill TE, 2011, JAMA-J AM MED ASSOC, V306, P1483, DOI 10.1001/jama.2011.1413; Rafii R, 2011, PULM MED, V2011, DOI 10.1155/2011/257496; REUBEN DB, 1992, AM J MED, V93, P663, DOI 10.1016/0002-9343(92)90200-U; Reuben DB, 2009, HAZZARDS GERIATRIC M; Ries AL, 2007, CHEST, V131, p4S, DOI 10.1378/chest.06-2418; Rocker G, 2012, CAN MED ASSOC J, V184, pE497, DOI 10.1503/cmaj.111758; Roig M, 2009, RESP MED, V103, P1257, DOI 10.1016/j.rmed.2009.03.022; Saliba D, 2001, J AM GERIATR SOC, V49, P1691, DOI 10.1046/j.1532-5415.2001.49281.x; SCHWARTZSTEIN RM, 1987, AM REV RESPIR DIS, V136, P58, DOI 10.1164/ajrccm/136.1.58; Simon ST, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007354.pub2; Singh S, 2008, JAMA-J AM MED ASSOC, V300, P1439, DOI 10.1001/jama.300.12.1439; Singh S, 2011, ARCH INTERN MED, V171, P920, DOI 10.1001/archinternmed.2011.171; Smith TA, 2012, RESPIROLOGY, V17, P300, DOI 10.1111/j.1440-1843.2011.02085.x; Solano JP, 2006, J PAIN SYMPTOM MANAG, V31, P58, DOI 10.1016/j.jpainsymman.2005.06.007; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; Stephenson A, 2011, ARCH INTERN MED, V171, P914, DOI 10.1001/archinternmed.2011.170; Sudore RL, 2010, ANN INTERN MED, V153, P256, DOI 10.7326/0003-4819-153-4-201008170-00008; Suzuki M, 2012, ARCH INTERN MED, V172, P878, DOI 10.1001/archinternmed.2012.1233; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Thakur Neeta, 2010, Int J Chron Obstruct Pulmon Dis, V5, P263; Tinetti ME, 2003, NEW ENGL J MED, V348, P42, DOI 10.1056/NEJMcp020719; Tulsky JA, 2005, JAMA-J AM MED ASSOC, V294, P359, DOI 10.1001/jama.294.3.359; Vandenbroucke JP, 2008, JAMA-J AM MED ASSOC, V300, P2417, DOI 10.1001/jama.2008.723; Vandenbroucke JP, 2006, CAN MED ASSOC J, V174, P645, DOI 10.1503/cmaj.051484; Varkey B, 2010, CURR OPIN PULM MED, V16, P150, DOI 10.1097/MCP.0b013e3283364378; Vaz Fragoso CA, 2012, J GERONTOL A-BIOL, V67, P264, DOI 10.1093/gerona/glr198; White P, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X578043; WILLIAMS SJ, 1989, SOC SCI MED, V29, P609, DOI 10.1016/0277-9536(89)90180-9; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269; ZuWallack R, 2008, AM J MED, V121, pS25, DOI 10.1016/j.amjmed.2008.04.004; Zvezdin B, 2009, CHEST, V136, P376, DOI 10.1378/chest.08-2918	103	42	45	1	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 26	2012	308	12					1254	1263		10.1001/jama.2012.12422	http://dx.doi.org/10.1001/jama.2012.12422			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	010OK	23011715	Green Accepted			2022-12-24	WOS:000309103600029
J	Lutter, CK; Lutter, R				Lutter, Chessa K.; Lutter, Randall			Fetal and Early Childhood Undernutrition, Mortality, and Lifelong Health	SCIENCE			English	Editorial Material							FEEDING PATTERNS; WEIGHT-GAIN; BIRTH; NUTRITION; INFANT; RISK; ORIGINS; COHORTS; BURDEN; IMPACT	Child undernutrition is a major public health challenge, estimated to be responsible for 2.2 million annual deaths. Implementation of available interventions could prevent one-third of these deaths. Emerging evidence suggests that breast-feeding can lead to improvements in intelligence quotient in children and lower risks of noncommunicable diseases in mothers and children decades later. Nonetheless, breast-feeding and complementary feeding practices differ greatly from global recommendations. Although the World Health Organization recommends that infants receive solely breast milk for the first 6 months of life, only about one-third of infants in low-income countries meet this goal, just one-third of children 6 to 24 months old in low-income countries meet the minimum criteria for dietary diversity, and only one in five who are breast-fed receive a minimum acceptable diet. Although the potential effects of improved breast-feeding and complementary feeding appear large, funding for research and greater use of existing effective interventions seems low compared with other life-saving child health interventions.	[Lutter, Chessa K.] PAHO WHO, Washington, DC 20037 USA; [Lutter, Randall] Resources Future Inc, Washington, DC 20036 USA	Resources for the Future	Lutter, CK (corresponding author), PAHO WHO, 525 23rd St NW, Washington, DC 20037 USA.	lutterch@paho.org		Lutter, Chessa/0000-0003-1601-4645				Adair LS, 2012, NUTR METAB CARDIOVAS, V22, P765, DOI 10.1016/j.numecd.2012.03.011; Adair LS, 2009, AM J CLIN NUTR, V89, P1383, DOI 10.3945/ajcn.2008.27139; AKERLOF GA, 1970, Q J ECON, V84, P488, DOI 10.2307/1879431; Almond D, 2011, J ECON PERSPECT, V25, P153, DOI 10.1257/jep.25.3.153; Archer C., 2012, IMPACT BREASTFEEDING; Arimond M., 2010, COMBATING MICRONUTRI; Backhed F, 2011, ANN NUTR METAB, V58, P44, DOI 10.1159/000328042; Barker DJP, 2012, PUBLIC HEALTH, V126, P185, DOI 10.1016/j.puhe.2011.11.014; Bartick M, 2010, PEDIATRICS, V125, pE1048, DOI 10.1542/peds.2009-1616; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Black RE, 2009, LANCET, V373, P1584, DOI 10.1016/S0140-6736(09)60886-2; Bloom DE, 2011, GLOBAL EC BURDEN NON; Brady JP, 2012, ARCH DIS CHILD, V97, P529, DOI 10.1136/archdischild-2011-301299; Chapman DJ, 2010, J HUM LACT, V26, P314, DOI 10.1177/0890334410369481; Clinton H. Rodham, 2010, 1000 DAYS CHANGE LIF; Edmond K., 2006, OPTIMAL FEEDING LOW; Fall CHD, 2011, INT J EPIDEMIOL, V40, P47, DOI 10.1093/ije/dyq155; Field E, 2009, AM ECON J-APPL ECON, V1, P1, DOI 10.1257/app.1.1.1; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Gribble JN, 2009, MATERN CHILD NUTR, V5, P49, DOI 10.1111/j.1740-8709.2008.00158.x; Hoddinott J, 2008, LANCET, V371, P411, DOI 10.1016/S0140-6736(08)60205-6; Horta BL, 2007, EVIDENCE LONG TERM E; Horton S, 1996, HEALTH POLICY PLANN, V11, P156, DOI 10.1093/heapol/11.2.156; Humphrey JH, 2009, LANCET, V374, P1032, DOI 10.1016/S0140-6736(09)60950-8; Ip Stanley, 2007, Evid Rep Technol Assess (Full Rep), P1; Jelliffe D B, 1972, Nutr Rev, V30, P199; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Kramer MS, 2008, ARCH GEN PSYCHIAT, V65, P578, DOI 10.1001/archpsyc.65.5.578; Leroy JL, 2009, J DEV EFFECT, V1, P103, DOI 10.1080/19439340902924043; LESTER RT, 2010, J GERONTOL B-PSYCHOL, V376, P1838, DOI DOI 10.1016/S0140-6736(10)61997-6; Lutter CK, 2011, PEDIATRICS, V128, pE1418, DOI 10.1542/peds.2011-1392; Lutter CK, 2011, AM J PUBLIC HEALTH, V101, P2130, DOI 10.2105/AJPH.2011.300244; Lutter Chessa K., 1992, Food and Nutrition Bulletin, V14, P36; Martorell R, 2012, PAEDIATR PERINAT EP, V26, P302, DOI 10.1111/j.1365-3016.2012.01298.x; Mullany LC, 2008, J NUTR, V138, P599, DOI 10.1093/jn/138.3.599; Norris SA, 2012, DIABETES CARE, V35, P72, DOI 10.2337/dc11-0456; Poskitt EME, 2012, NUTR METAB CARDIOVAS, V22, P819, DOI 10.1016/j.numecd.2012.08.005; Rea M. F., 2003, CAUDE SALUD PUB, V19, P119; Rutstein SO, 2005, INT J GYNECOL OBSTET, V89, pS7, DOI 10.1016/j.ijgo.2004.11.012; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; SHORT RV, 1991, LANCET, V337, P715, DOI 10.1016/0140-6736(91)90288-Z; Strazzullo P, 2012, NUTR METAB CARDIOVAS, V22, P787, DOI 10.1016/j.numecd.2012.04.003; Stuebe AM, 2011, AM J EPIDEMIOL, V174, P1147, DOI 10.1093/aje/kwr227; U.S. EPA, 2008, REG IMP AN PROP REV; U. S. EPA (U. S. Environmental Protection Agency), 1997, BEN COSTS CLEAN AIR; [UN UNGA], 2011, PREV CONTR NONC DIS; United States Office of Management and Budget (OMB), 2003, A4 US OMB; WHO and partners, 2010, IND ASS INF YOUNG 3; WHO UNICEF, 2008, AFR HLTH 2010 LEARN; Woo JG, 2012, J PEDIATR GASTR NUTR, V54, P532, DOI 10.1097/MPG.0b013e31823fde04; World Health Organization, 1981, INT COD MARK BREAST	52	27	32	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2012	337	6101					1495	1499		10.1126/science.1224616	http://dx.doi.org/10.1126/science.1224616			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	007UC	22997328	Green Published			2022-12-24	WOS:000308912900040
J	Yumoto, N; Kim, N; Burden, SJ				Yumoto, Norihiro; Kim, Natalie; Burden, Steven J.			Lrp4 is a retrograde signal for presynaptic differentiation at neuromuscular synapses	NATURE			English	Article							IN-VIVO; ORGANIZING MOLECULES; NEURAL DEVELOPMENT; SKELETAL-MUSCLE; RECEPTOR; JUNCTION; AGRIN; MUSK; FORM; NEUROTRANSMITTER	Motor axons receive retrograde signals from skeletal muscle that are essential for the differentiation and stabilization of motor nerve terminals(1). Identification of these retrograde signals has proved elusive, but their production by muscle depends on the receptor tyrosine kinase, MuSK (muscle, skeletal receptor tyrosine-protein kinase), and Lrp4 (low-density lipoprotein receptor (LDLR)-related protein 4), an LDLR family member that forms a complex with MuSK, binds neural agrin and stimulates MuSK kinase activity(2-5). Here we show that Lrp4 also functions as a direct muscle-derived retrograde signal for early steps in presynaptic differentiation. We demonstrate that Lrp4 is necessary, independent of MuSK activation, for presynaptic differentiation in vivo, and we show that Lrp4 binds to motor axons and induces clustering of synaptic-vesicle and active-zone proteins. Thus, Lrp4 acts bidirectionally and coordinates synapse formation by binding agrin, activating MuSK and stimulating postsynaptic differentiation, and functioning in turn as a muscle-derived retrograde signal that is necessary and sufficient for presynaptic differentiation.	[Yumoto, Norihiro; Kim, Natalie; Burden, Steven J.] NYU, Sch Med, Mol Neurobiol Program,Skirball Inst Biomol Med, Helen L & Martin S Kimmel Ctr Biol & Med, New York, NY 10012 USA	New York University	Burden, SJ (corresponding author), NYU, Sch Med, Mol Neurobiol Program,Skirball Inst Biomol Med, Helen L & Martin S Kimmel Ctr Biol & Med, 540 1st Ave, New York, NY 10012 USA.	burden@saturn.med.nyu.edu		Burden, Steven/0000-0002-3550-6891	New York University Cancer Institute Center Support Grant (National Institutes of Health (NIH)/National Cancer Institute (NCI)) [5 P30CA16087-31]; National Institutes of Health [NS36193]; Skirball Institute; New York State Stem Cell Science (NYSTEM); NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036193, R37NS036193] Funding Source: NIH RePORTER	New York University Cancer Institute Center Support Grant (National Institutes of Health (NIH)/National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skirball Institute; New York State Stem Cell Science (NYSTEM); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L. Landmesser and K. Hata for helping us to establish a motor-neuron and muscle co-culture system, W. Zhang for constructs encoding Fc- and AP-tagged forms of Lrp4, T. Jessell and J. Dasen for HB9::GFP mice, J. Sanes for agrin-mutant mice, K. Anderson and L. Niswander for Lrp4-mutant mice, and D. Littman and R. Lehmann for comments on the manuscript. We are grateful to P. Lopez and M. J. Sunshine and personnel in the transgenic mouse core for their assistance. The flow cytometry and transgenic mouse cores are supported by a New York University Cancer Institute Center Support Grant (National Institutes of Health (NIH)/National Cancer Institute (NCI) 5 P30CA16087-31). This work was supported with funds from the National Institutes of Health (NS36193 to S. J. B.), the Skirball Institute and postdoctoral training support to N.Y. from New York State Stem Cell Science (NYSTEM).	Arber S, 2002, CURR OPIN NEUROBIOL, V12, P100, DOI 10.1016/S0959-4388(02)00296-9; Bao JX, 2003, J CELL BIOL, V161, P1133, DOI 10.1083/jcb.200212085; Burden SJ, 2011, CELL, V144, P826, DOI 10.1016/j.cell.2011.02.037; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Drescher U, 1997, CURR BIOL, V7, pR799, DOI 10.1016/S0960-9822(06)00409-X; Engel AG, 2003, NAT REV NEUROSCI, V4, P339, DOI 10.1038/nrn1101; Flanagan-Steet H, 2005, DEVELOPMENT, V132, P4471, DOI 10.1242/dev.02044; Fox MA, 2007, CELL, V129, P179, DOI 10.1016/j.cell.2007.02.035; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; Gomez AM, 2011, DEV DYNAM, V240, P2626, DOI 10.1002/dvdy.22772; Hata K, 2007, J NEUROSCI, V27, P14481, DOI 10.1523/JNEUROSCI.3847-07.2007; Higuchi O, 2011, ANN NEUROL, V69, P418, DOI 10.1002/ana.22312; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Kim N, 2008, NAT NEUROSCI, V11, P19, DOI 10.1038/nn2026; Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; Lin WC, 2005, NEURON, V46, P569, DOI 10.1016/j.neuron.2005.04.002; Misgeld T, 2005, P NATL ACAD SCI USA, V102, P11088, DOI 10.1073/pnas.0504806102; Panzer JA, 2006, J NEUROSCI, V26, P934, DOI 10.1523/JNEUROSCI.3656-05.2006; Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Umemori H, 2004, CELL, V118, P257, DOI 10.1016/j.cell.2004.06.025; Umemori H, 2008, J BIOL CHEM, V283, P34053, DOI 10.1074/jbc.M805729200; Valdez G, 2010, P NATL ACAD SCI USA, V107, P14863, DOI 10.1073/pnas.1002220107; Weatherbee SD, 2006, DEVELOPMENT, V133, P4993, DOI 10.1242/dev.02696; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Yang X, 2000, SCIENCE, V287, P131, DOI 10.1126/science.287.5450.131; Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006; Zhang W, 2011, J BIOL CHEM	29	136	146	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2012	489	7416					438	U130		10.1038/nature11348	http://dx.doi.org/10.1038/nature11348			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AK	22854782	Green Accepted			2022-12-24	WOS:000308860900047
J	Aldy, JE; Stavins, RN				Aldy, Joseph E.; Stavins, Robert N.			Climate Negotiators Create an Opportunity for Scholars	SCIENCE			English	Editorial Material									[Stavins, Robert N.] Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA; Resources Future Inc, Washington, DC 20036 USA; Natl Bur Econ Res, Cambridge, MA 02138 USA	Harvard University; Resources for the Future; National Bureau of Economic Research	Stavins, RN (corresponding author), Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA.	robert_stavins@harvard.edu						Aldy J. E., 2012, DESIGNING BRETTON WO; Bosetti V., 2011, 201146 HARV KENN SCH; Jaffe J, 2009, ECOL LAW QUART, V36, P789; Newell R. G., 2010, POSTKYOTO INT CLIMAT; Nordhaus WD., 2008, QUESTION BALANCE; United States Energy Information Administration, 2012, INT EN STAT; World Resources Institute, 2012, CLIM AN IND TOOL	7	28	28	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2012	337	6098					1043	1044		10.1126/science.1223836	http://dx.doi.org/10.1126/science.1223836			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	996WP	22936761				2022-12-24	WOS:000308125800028
J	Spence, D				Spence, Des			Methadone is no panacea	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						[Anonymous], 2012, BBC NEWS	1	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 22	2012	345								e5670	10.1136/bmj.e5670	http://dx.doi.org/10.1136/bmj.e5670			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	996GV	22915733				2022-12-24	WOS:000308073800004
J	Lalmohamed, A; de Vries, F; Bazelier, MT; Cooper, A; van Staa, TP; Cooper, C; Harvey, NC				Lalmohamed, Arief; de Vries, Frank; Bazelier, Marloes T.; Cooper, Alun; van Staa, Tjeerd-Pieter; Cooper, Cyrus; Harvey, Nicholas C.			Risk of fracture after bariatric surgery in the United Kingdom: population based, retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BONE-MINERAL DENSITY; VERTICAL-BANDED GASTROPLASTY; GASTRIC BYPASS-SURGERY; MORBIDLY OBESE WOMEN; PARATHYROID-HORMONE; SECONDARY HYPERPARATHYROIDISM; SURGICAL-TREATMENT; HIP/FEMUR FRACTURE; CALCIUM-METABOLISM; WEIGHT-LOSS	Objectives To estimate fracture risk in patients receiving bariatric surgery versus matched controls. Design Population based, retrospective cohort study. Setting Use of records from the United Kingdom General Practice Research Database, now known as the Clinical Practice Research Datalink (from January 1987 to December 2010). Participants Patients with a body mass index of at least 30, with a record of bariatric surgery (n=2079), and matched controls without a record (n=10 442). Each bariatric surgery patient was matched to up to six controls by age, sex, practice, year, and body mass index. Patients were followed from the date of bariatric surgery for the occurrence of any fracture. We used time dependent Cox regression to calculate relative rates of fracture, adjusted for disease and previous drug treatment, and time-interaction terms to evaluate fracture timing patterns. Main outcome measure Relative rates of any, osteoporotic, and non-osteoporotic fractures. Results Mean follow-up time was 2.2 years. Overall, there was no significantly increased risk of fracture in patients who underwent bariatric surgery, compared with controls (8.8 v 8.2 per 1000 person years; adjusted relative risk 0.89, 95% confidence interval 0.60 to 1.33). Bariatric surgery also did not affect risk of osteoporotic and non-osteoporotic fractures. However, we saw a trend towards an increased fracture risk after three to five years following surgery, as well as in patients who had a greater decrease in body mass index after surgery, but this was not significant. Conclusion Bariatric surgery does not have a significant effect on the risk of fracture. For the first few years after surgery, these results are reassuring for patients undergoing such operations, but do not exclude a more protracted adverse influence on skeletal health in the longer term.	[de Vries, Frank; van Staa, Tjeerd-Pieter; Cooper, Cyrus; Harvey, Nicholas C.] Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton Gen Hosp, Southampton SO16 6YD, Hants, England; [Lalmohamed, Arief; de Vries, Frank; Bazelier, Marloes T.; van Staa, Tjeerd-Pieter] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands; [de Vries, Frank] Maastricht Univ, Med Ctr, Dept Clin Pharm & Toxicol, Maastricht, Netherlands; [Cooper, Alun] Bridge Med Ctr, Crawley, England; [van Staa, Tjeerd-Pieter] Medicines & Healthcare Prod Regulatory Agcy, London, England; [Cooper, Cyrus] Univ Oxford, Inst Musculoskeletal Sci, Oxford, England	University of Southampton; Utrecht University; Maastricht University; The Medicines & Healthcare Products Regulatory Agency; University of Oxford	Cooper, C (corresponding author), Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton Gen Hosp, Southampton SO16 6YD, Hants, England.	cc@mrc.soton.ac.uk	de Vries, Frank/E-4934-2011	de Vries, Frank/0000-0003-3837-8319; Cooper, Cyrus/0000-0003-3510-0709; van Staa, Tjeerd/0000-0001-9363-742X; Harvey, Nicholas/0000-0002-8194-2512	International Osteoporosis Foundation; SERVIER; Netherlands Organisation for Health Research; Development, Dutch Health Care Insurance Board; Royal Dutch Pharmacists Association; Top Institute Pharma; EU Innovative Medicines Initiative; EU; Dutch Medicines Evaluation Board; Dutch Ministry of Health and industry (including GlaxoSmithKline, Pfizer)	International Osteoporosis Foundation; SERVIER(Servier); Netherlands Organisation for Health Research(Netherlands Organization for Health Research and Development); Development, Dutch Health Care Insurance Board; Royal Dutch Pharmacists Association; Top Institute Pharma; EU Innovative Medicines Initiative; EU(European Commission); Dutch Medicines Evaluation Board; Dutch Ministry of Health and industry (including GlaxoSmithKline, Pfizer)	This study was funded by a research grant from the International Osteoporosis Foundation and SERVIER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: support from the International Osteoporosis Foundation and SERVIER for the submitted work; AL, FV, MB, and TS are employed by the Division of Pharmacoepidemiology and Clinical Pharmacology at Utrecht Institute for Pharmaceutical Sciences, which has received unrestricted research funding from the Netherlands Organisation for Health Research and Development, Dutch Health Care Insurance Board, Royal Dutch Pharmacists Association, private-publicly funded Top Institute Pharma (www.tipharma.nl, which includes cofunding from universities, government, and industry), EU Innovative Medicines Initiative, EU 7th Framework Program, Dutch Medicines Evaluation Board, Dutch Ministry of Health and industry (including GlaxoSmithKline, Pfizer); no financial relationships with any organisations that might have an interest in the submitted work in the previous 3 years; no other relationships or activities that could appear to have influenced the submitted work.	Adachi Y, 2000, CALCIFIED TISSUE INT, V66, P119, DOI 10.1007/s002230010025; Bano G, 1999, INT J OBESITY, V23, P361, DOI 10.1038/sj.ijo.0800827; Bjorntorp P, 1997, LANCET, V350, P423, DOI 10.1016/S0140-6736(97)04503-0; Chapin BL, 1996, ARCH SURG-CHICAGO, V131, P1048; Coates PS, 2004, J CLIN ENDOCR METAB, V89, P1061, DOI 10.1210/jc.2003-031756; Cundy T, 1996, BRIT J SURG, V83, P1468, DOI 10.1002/bjs.1800831046; De Laet C, 2005, OSTEOPOROSIS INT, V16, P1330, DOI 10.1007/s00198-005-1863-y; de Vries F, 2007, J INTERN MED, V261, P170, DOI 10.1111/j.1365-2796.2006.01754.x; DiGiorgi M, 2008, OBES SURG, V18, P1144, DOI 10.1007/s11695-007-9408-4; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; FRAX, 2001, FRAX WHO FRACTURE RI; Giusti V, 2005, INT J OBESITY, V29, P1429, DOI 10.1038/sj.ijo.0803040; Gomez JM, 2009, OBES SURG, V19, P345, DOI 10.1007/s11695-008-9529-4; Goode LR, 2004, OBES RES, V12, P40, DOI 10.1038/oby.2004.7; Guney E, 2003, OBES SURG, V13, P383, DOI 10.1381/096089203765887705; Hamoui N, 2003, ARCH SURG-CHICAGO, V138, P891, DOI 10.1001/archsurg.138.8.891; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Johnson JM, 2005, J GASTROINTEST SURG, V9, P1106, DOI 10.1016/j.gassur.2005.07.012; Khan NF, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483562; Kolanowski J, 1997, BRIT MED BULL, V53, P433, DOI 10.1093/oxfordjournals.bmb.a011621; Lalmohamed A, 2012, OSTEOPOROSIS INT, V23, P861, DOI 10.1007/s00198-011-1852-2; Lalmohamed A, 2012, ARCH INTERN MED, V172, P1229, DOI 10.1001/archinternmed.2012.2713; Leff DR, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3402; Lewis JD, 2004, PHARMACOEPIDEM DR S, V13, P437, DOI 10.1002/pds.902; Madsen OR, 1997, EUR J APPL PHYSIOL O, V75, P554, DOI 10.1007/s004210050204; Marceau P, 2002, J GASTROINTEST SURG, V6, P690, DOI 10.1016/S1091-255X(01)00086-5; MARTIN LF, 1995, SOUTH MED J, V88, P895, DOI 10.1097/00007611-199509000-00001; Meier CA, 2002, J CLIN ENDOCR METAB, V87, P1184, DOI 10.1210/jc.87.3.1184; Nakamura K, 2009, ENDO C; Newbury L, 2003, OBES SURG, V13, P893, DOI 10.1381/096089203322618722; Olmos JM, 2008, OBES SURG, V18, P197, DOI 10.1007/s11695-007-9307-8; Pouwels S, 2011, OSTEOPOROSIS INT, V22, P903, DOI 10.1007/s00198-010-1337-8; Pouwels S, 2009, OSTEOPOROSIS INT, V20, P1499, DOI 10.1007/s00198-008-0826-5; Pouwels S, 2009, STROKE, V40, P3281, DOI 10.1161/STROKEAHA.109.554055; Pugnale N, 2003, INT J OBESITY, V27, P110, DOI 10.1038/sj.ijo.0802177; Recker R, 2000, J BONE MINER RES, V15, P1965, DOI 10.1359/jbmr.2000.15.10.1965; Reid IR, 2002, BONE, V31, P547, DOI 10.1016/S8756-3282(02)00864-5; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Slater GH, 2004, J GASTROINTEST SURG, V8, P48, DOI 10.1016/j.gassur.2003.09.020; Stunkard AJ, 1996, AM J MED, V100, P230, DOI 10.1016/S0002-9343(97)89464-8; Valderas JP, 2009, OBES SURG, V19, P1132, DOI 10.1007/s11695-009-9890-y; Van Loan MD, 1998, AM J CLIN NUTR, V67, P734, DOI 10.1093/ajcn/67.4.734; Van Staa TP, 2000, PHARMACOEPIDEM DR S, V9, P359, DOI 10.1002/1099-1557(200009/10)9:5<359::AID-PDS507>3.0.CO;2-E; Viegas M, 2010, ARQ BRAS ENDOCRINOL, V54, P158, DOI 10.1590/S0004-27302010000200011; Vilarrasa N, 2009, OBES SURG, V19, P860, DOI 10.1007/s11695-009-9843-5; von Mach MA, 2004, METABOLISM, V53, P918, DOI 10.1016/j.metabol.2004.01.015	46	119	122	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 7	2012	345								e5085	10.1136/bmj.e5085	http://dx.doi.org/10.1136/bmj.e5085			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988NA	22867649	hybrid, Green Published, Green Submitted, Green Accepted			2022-12-24	WOS:000307496500003
J	Lyle, M; Heusser, L; Ravelo, C; Yamamoto, M; Barron, J; Diffenbaugh, NS; Herbert, T; Andreasen, D				Lyle, Mitchell; Heusser, Linda; Ravelo, Christina; Yamamoto, Masanobu; Barron, John; Diffenbaugh, Noah S.; Herbert, Timothy; Andreasen, Dyke			Out of the Tropics: The Pacific, Great Basin Lakes, and Late Pleistocene Water Cycle in the Western United States	SCIENCE			English	Article							CALIFORNIA CURRENT SYSTEM; NORTH-AMERICA; SURFACE WATERS; CLIMATE-CHANGE; LAHONTAN; RECORD; OCEAN; OSCILLATIONS; TEMPERATURE; EVAPORATION	The water cycle in the western United States changed dramatically over glacial cycles. In the past 20,000 years, higher precipitation caused desert lakes to form which have since dried out. Higher glacial precipitation has been hypothesized to result from a southward shift of Pacific winter storm tracks. We compared Pacific Ocean data to lake levels from the interior west and found that Great Basin lake high stands are older than coastal wet periods at the same latitude. Westerly storms were not the source of high precipitation. Instead, air masses from the tropical Pacific were transported northward, bringing more precipitation into the Great Basin when coastal California was still dry. The changing climate during the deglaciation altered precipitation source regions and strongly affected the regional water cycle.	[Lyle, Mitchell] Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA; [Heusser, Linda] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Ravelo, Christina; Andreasen, Dyke] Univ Calif Santa Cruz, Ocean Sci Dept, Santa Cruz, CA 95064 USA; [Yamamoto, Masanobu] Hokkaido Univ, Fac Environm Earth Sci, Sapporo, Hokkaido 0600810, Japan; [Barron, John] US Geol Survey, Menlo Pk, CA 94025 USA; [Diffenbaugh, Noah S.] Stanford Univ, Dept Environm Earth Syst Sci, Stanford, CA 94305 USA; [Diffenbaugh, Noah S.] Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA; [Herbert, Timothy] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA	Texas A&M University System; Texas A&M University College Station; Columbia University; University of California System; University of California Santa Cruz; Hokkaido University; United States Department of the Interior; United States Geological Survey; Stanford University; Stanford University; Brown University	Lyle, M (corresponding author), Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA.	mlyle@ocean.tamu.edu	Diffenbaugh, Noah S/I-5920-2014; Yamamoto, Masanobu/A-6990-2012	Diffenbaugh, Noah S/0000-0002-8856-4964; Yamamoto, Masanobu/0000-0003-1312-825X; Barron, John/0000-0002-9309-1145	U.S. National Science Foundation [EAR-0450211, OCE-9809438]	U.S. National Science Foundation(National Science Foundation (NSF))	We thank the Ocean Drilling Program and its successor program, IODP, for collecting and archiving the drill cores used. We also thank M. Reheis for her insights in a thorough internal U.S. Geological Surbey review. The U.S. National Science Foundation supported this research through grants EAR-0450211 and OCE-9809438.	Anderson RY, 2002, QUATERNARY RES, V57, P371, DOI 10.1006/qres.2002.2323; Barron JA, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000768; BENSON L V, 1991, Journal of Paleolimnology, V5, P115; Bradbury JP, 2004, J PALEOLIMNOL, V31, P167; Briggs RW, 2005, QUATERNARY RES, V64, P257, DOI 10.1016/j.yqres.2005.02.011; Broecker WS, 2009, QUATERNARY SCI REV, V28, P2557, DOI 10.1016/j.quascirev.2009.07.007; BROECKER WS, 1958, GEOL SOC AM BULL, V69, P1009, DOI 10.1130/0016-7606(1958)69[1009:RCOLLA]2.0.CO;2; Doose H, 1997, PALEOCEANOGRAPHY, V12, P615, DOI 10.1029/97PA00821; Freidel D. E., 1993, THESIS U OREGON; Herbert TD, 2001, SCIENCE, V293, P71, DOI 10.1126/science.1059209; Heusser L, 1998, PALEOCEANOGRAPHY, V13, P252, DOI 10.1029/98PA00670; Heusser L. E., 2000, P OC DRILL PROGR SCI, V167, P239; Heusser L.E., 1995, PROC OCEAN DRILL SCI, V146, P265; HEUSSER LE, 1979, SCIENCE, V204, P837, DOI 10.1126/science.204.4395.837; Heusser LE, 2000, PALAEOGEOGR PALAEOCL, V161, P407, DOI 10.1016/S0031-0182(00)00096-1; Hostetler S., 1990, CLIM DYNAM, V4, P207, DOI DOI 10.1007/BF00209522; Hostetler S.W., 1991, CLIM DYNAM, V6, P43, DOI DOI 10.1007/BF00210581; HOSTETLER SW, 1994, SCIENCE, V263, P665, DOI 10.1126/science.263.5147.665; HUYER A, 1983, PROG OCEANOGR, V12, P259, DOI 10.1016/0079-6611(83)90010-1; Kennett J. P., 1995, P OCEAN DRILLING P 2, V146; Kim SJ, 2008, CLIM DYNAM, V31, P1, DOI 10.1007/s00382-007-0332-z; Kreitz S.F, 2000, PROC OCEAN DRILL SCI, V167, P153; KUTZBACH JE, 1988, SCIENCE, V241, P1043, DOI 10.1126/science.241.4869.1043; Lyle M, 2001, GEOLOGY, V29, P1115, DOI 10.1130/0091-7613(2001)029<1115:ITAVKY>2.0.CO;2; Lyle M., 2000, P OCEAN DRILL PROGRA, V167, P163, DOI DOI 10.2973/ODP.PROC.SR.167.214.2000; Lyle M., 2000, P OCEAN DRILLING PRO, V167; Lyle M, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001836; McClymont EL, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2011PA002226; McIntyre A., 1976, Science, V191, P1131, DOI 10.1126/science.191.4232.1131; Mock CJ, 1996, J CLIMATE, V9, P1111, DOI 10.1175/1520-0442(1996)009<1111:CCASVO>2.0.CO;2; Oster JL, 2009, EARTH PLANET SC LETT, V288, P434, DOI 10.1016/j.epsl.2009.10.003; Pisias NG, 2001, QUATERNARY SCI REV, V20, P1561, DOI 10.1016/S0277-3791(01)00018-X; PRAHL FG, 1995, PALEOCEANOGRAPHY, V10, P763, DOI 10.1029/95PA01394; REA DK, 1988, PALAEOGEOGR PALAEOCL, V66, P1, DOI 10.1016/0031-0182(88)90076-4; SANCETTA C, 1992, QUATERNARY RES, V38, P359, DOI 10.1016/0033-5894(92)90044-J; Seki O, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015200; Toracinta ER, 2004, J CLIMATE, V17, P504, DOI 10.1175/1520-0442(2004)017<0504:ARTMCO>2.0.CO;2; Unterman MB, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049599; Waelbroeck C, 2009, NAT GEOSCI, V2, P127, DOI 10.1038/NGEO411; Whitlock C, 2000, PALAEOGEOGR PALAEOCL, V155, P7, DOI 10.1016/S0031-0182(99)00092-9; Winograd IJ, 2006, QUATERNARY RES, V66, P202, DOI 10.1016/j.yqres.2006.06.003; Yamamato M, 2007, QUATERNARY SCI REV, V26, P405, DOI 10.1016/j.quascirev.2006.07.014; Yamamoto M., 2005, GEOPHYS RES LETT, V32	43	99	100	3	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2012	337	6102					1629	1633		10.1126/science.1218390	http://dx.doi.org/10.1126/science.1218390			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	23019644				2022-12-24	WOS:000309215400038
J	Liu, W; Huang, XY; Cheng, MJ; Nielsen, RJ; Goddard, WA; Groves, JT				Liu, Wei; Huang, Xiongyi; Cheng, Mu-Jeng; Nielsen, Robert J.; Goddard, William A., III; Groves, John T.			Oxidative Aliphatic C-H Fluorination with Fluoride Ion Catalyzed by a Manganese Porphyrin	SCIENCE			English	Article							ELEMENTAL FLUORINE; MECHANISM; PHARMACEUTICALS; REACTIVITY; REAGENT; ACIDS	Despite the growing importance of fluorinated organic compounds in drug development, there are no direct protocols for the fluorination of aliphatic C-H bonds using conveniently handled fluoride salts. We have discovered that a manganese porphyrin complex catalyzes alkyl fluorination by fluoride ion under mild conditions in conjunction with stoichiometric oxidation by iodosylbenzene. Simple alkanes, terpenoids, and even steroids were selectively fluorinated at otherwise inaccessible sites in 50 to 60% yield. Decalin was fluorinated predominantly at the C2 and C3 methylene positions. Bornyl acetate was converted to exo-5-fluoro-bornyl acetate, and 5a-androstan-17-one was fluorinated selectively in the A ring. Mechanistic analysis suggests that the regioselectivity for C-H bond cleavage is directed by an oxomanganese(V) catalytic intermediate followed by F delivery via an unusual manganese(IV) fluoride that has been isolated and structurally characterized.	[Liu, Wei; Huang, Xiongyi; Groves, John T.] Princeton Univ, Dept Chem, Frick Chem Lab, Princeton, NJ 08544 USA; [Cheng, Mu-Jeng; Nielsen, Robert J.; Goddard, William A., III] CALTECH, Dept Chem, Mat & Proc Simulat Ctr MC 139 74, Pasadena, CA 91125 USA	Princeton University; California Institute of Technology	Groves, JT (corresponding author), Princeton Univ, Dept Chem, Frick Chem Lab, Princeton, NJ 08544 USA.	jtgroves@princeton.edu	Huang, Xiongyi/H-3079-2013; Groves, John T./GPP-7588-2022; Cheng, Mu-Jeng/I-7316-2012	Groves, John T./0000-0002-9944-5899; Huang, Xiongyi/0000-0001-7156-8881	NSF [CHE-0616633, CHE-1148597]; Center for Catalytic Hydrocarbon Functionalization, an Energy Frontier Research Center, U.S. Department of Energy, Office of Science, Basic Energy Sciences [DE-SC0001298]; Division Of Chemistry [1148597] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Center for Catalytic Hydrocarbon Functionalization, an Energy Frontier Research Center, U.S. Department of Energy, Office of Science, Basic Energy Sciences(United States Department of Energy (DOE)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We are grateful to NSF (grants CHE-0616633 and CHE-1148597 to J.T.G.) for support of this research. DFT calculations, hydrocarbon C-H activation, and the CalTech-Princeton collaboration were supported by the Center for Catalytic Hydrocarbon Functionalization, an Energy Frontier Research Center, U.S. Department of Energy, Office of Science, Basic Energy Sciences, under award no. DE-SC0001298 to W. A. G. and J.T.G. A patent application has been filed through Princeton University on methods and catalysts presented in this paper. We thank S. Semproni for assistance with the x-ray crystal structure of Mn<SUP>IV</SUP>(TMP)F<INF>2</INF>, data for which are available free of charge from the Cambridge Crystallographic Data Centre under reference no. CCDC 893742.	Ametamey SM, 2008, CHEM REV, V108, P1501, DOI 10.1021/cr0782426; Auclair K, 2002, J AM CHEM SOC, V124, P6020, DOI 10.1021/ja025608h; Begue JP, 2006, J FLUORINE CHEM, V127, P992, DOI 10.1016/j.jfluchem.2006.05.006; Chambers RD, 2002, J CHEM SOC PERK T 1, P2190, DOI 10.1039/b204776b; Chen K, 2009, ANGEW CHEM INT EDIT, V48, P9705, DOI 10.1002/anie.200904474; Chen MS, 2010, SCIENCE, V327, P566, DOI 10.1126/science.1183602; Eustaquio AS, 2010, J NAT PROD, V73, P378, DOI 10.1021/np900719u; Furuya T, 2011, NATURE, V473, P470, DOI 10.1038/nature10108; Groves JT, 2006, J INORG BIOCHEM, V100, P434, DOI 10.1016/j.jinorgbio.2006.01.012; GROVES JT, 1988, J AM CHEM SOC, V110, P8628, DOI 10.1021/ja00234a009; Harki DA, 2008, P NATL ACAD SCI USA, V105, P13039, DOI 10.1073/pnas.0806308105; Herrmann P, 2008, COLLECT CZECH CHEM C, V73, P1825, DOI 10.1135/cccc20081825; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Hull KL, 2006, J AM CHEM SOC, V128, P7134, DOI 10.1021/ja061943k; Jin N, 2007, J AM CHEM SOC, V129, P12416, DOI 10.1021/ja0761737; Jin N, 2010, INORG CHEM, V49, P11516, DOI 10.1021/ic1015274; Kalow JA, 2010, J AM CHEM SOC, V132, P3268, DOI 10.1021/ja100161d; Kaskel S, 1997, Z ANORG ALLG CHEM, V623, P1259, DOI 10.1002/zaac.19976230813; Kaustov L, 1997, INORG CHEM, V36, P3503, DOI 10.1021/ic961207p; Lee E, 2011, SCIENCE, V334, P639, DOI 10.1126/science.1212625; Lewis JC, 2011, CHEM SOC REV, V40, P2003, DOI 10.1039/c0cs00067a; Liu W, 2010, J AM CHEM SOC, V132, P12847, DOI 10.1021/ja105548x; Lourie LF, 2006, J FLUORINE CHEM, V127, P377, DOI 10.1016/j.jfluchem.2005.12.027; Matthews ML, 2009, P NATL ACAD SCI USA, V106, P17723, DOI 10.1073/pnas.0909649106; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Newhouse T, 2011, ANGEW CHEM INT EDIT, V50, P3362, DOI 10.1002/anie.201006368; O'Hagan D, 2002, NATURE, V416, P279, DOI 10.1038/416279a; Rentmeister A, 2009, NAT CHEM BIOL, V5, P26, DOI 10.1038/nchembio.128; Rozen S, 2005, EUR J ORG CHEM, V2005, P2433, DOI 10.1002/ejoc.200400876; ROZEN S, 1987, J ORG CHEM, V52, P2769, DOI 10.1021/jo00389a024; Rueda-Becerril M, 2012, J AM CHEM SOC, V134, P4026, DOI 10.1021/ja211679v; Sandford G, 2007, J FLUORINE CHEM, V128, P90, DOI 10.1016/j.jfluchem.2006.10.019; SCHEINMAN RI, 1995, SCIENCE, V270, P283, DOI 10.1126/science.270.5234.283; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; STAVBER S, 1989, TETRAHEDRON, V45, P2737, DOI 10.1016/S0040-4020(01)80103-4; Tang PP, 2010, J AM CHEM SOC, V132, P12150, DOI 10.1021/ja105834t; Umile TP, 2011, INORG CHEM, V50, P10353, DOI 10.1021/ic201430v; Watson DA, 2009, SCIENCE, V325, P1661, DOI 10.1126/science.1178239; Yin F, 2012, J AM CHEM SOC, V134, P10401, DOI 10.1021/ja3048255; Zanzonico PB, 2004, J NUCL MED, V45, P1966; Zhao YJ, 2012, ORG BIOMOL CHEM, V10, P479, DOI 10.1039/c1ob05840a	41	213	220	4	412	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2012	337	6100					1322	1325		10.1126/science.1222327	http://dx.doi.org/10.1126/science.1222327			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	004TW	22984066				2022-12-24	WOS:000308705000037
J	Greene, JA; Choudhry, NK; Kesselheim, AS; Brennan, TA; Shrank, W				Greene, Jeremy A.; Choudhry, Niteesh K.; Kesselheim, Aaron S.; Brennan, Troyen A.; Shrank, William			Changes in Direct-to-Consumer Pharmaceutical Advertising Following Shifts From Prescription-Only to Over-the-Counter Status	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							DRUGS		[Greene, Jeremy A.; Choudhry, Niteesh K.; Kesselheim, Aaron S.; Shrank, William] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Greene, JA (corresponding author), Johns Hopkins Univ, Baltimore, MD 21218 USA.	greene@jhmi.edu	Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666				Donohue JM, 2007, NEW ENGL J MED, V357, P673, DOI 10.1056/NEJMsa070502; Faerber AE, 2012, HEALTH COMMUN, V27, P66, DOI 10.1080/10410236.2011.569001; *IMS HLTH, TOT US PROM SPEND TY; Sharfstein JM, 2007, NEW ENGL J MED, V357, P2321, DOI 10.1056/NEJMp0707400; VMS, 2010, ADS PROD SHEET; World Health Organization, ETH CRIT MED DRUG PR	6	11	11	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2012	308	10					973	975		10.1001/2012.jama.10647	http://dx.doi.org/10.1001/2012.jama.10647			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003AA	22968881				2022-12-24	WOS:000308579300015
J	Shigemura, J; Tanigawa, T; Saito, I; Nomura, S				Shigemura, Jun; Tanigawa, Takeshi; Saito, Isao; Nomura, Soichiro			Psychological Distress in Workers at the Fukushima Nuclear Power Plants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Shigemura, Jun; Nomura, Soichiro] Natl Def Med Coll, Dept Psychiat, Saitama, Japan; [Tanigawa, Takeshi; Saito, Isao] Ehime Univ, Grad Sch Med, Dept Publ Hlth, Matsuyama, Ehime 790, Japan	National Defense Medical College - Japan; Ehime University	Shigemura, J (corresponding author), Natl Def Med Coll, Dept Psychiat, Saitama, Japan.	tt9178tt9178@gmail.com	Ley, Sarah/Y-9216-2019; Shigemura, Jun/ACX-4803-2022	Shigemura, Jun/0000-0002-7907-5034				Asukai N, 2002, J NERV MENT DIS, V190, P175, DOI 10.1097/00005053-200203000-00006; Bromet EJ, 2011, CLIN ONCOL-UK, V23, P297, DOI 10.1016/j.clon.2011.01.501; FONTANA A, 1994, J NERV MENT DIS, V182, P677, DOI 10.1097/00005053-199412000-00001; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; Sakurai K, 2011, PSYCHIAT CLIN NEUROS, V65, P434, DOI 10.1111/j.1440-1819.2011.02236.x; Shigemura J, 2011, JAPAN J TRAUMA STRES, V9, P141	6	65	67	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2012	308	7					667	669		10.1001/jama.2012.9699	http://dx.doi.org/10.1001/jama.2012.9699			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988NC	22893158	Bronze			2022-12-24	WOS:000307496700016
J	Garber, K				Garber, Ken			BIOCHEMISTRY A radical treatment	NATURE			English	Editorial Material																		Chen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020333; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Harvey CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002042; Lee SH, 2007, NAT MED, V13, P567, DOI 10.1038/nm1583; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Shan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003041; Shan M, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranlsmed.3000154; Shibata T, 2008, P NATL ACAD SCI USA, V105, P13568, DOI 10.1073/pnas.0806268105; Sporn MB, 2012, NAT REV CANCER, V12, P564, DOI 10.1038/nrc3278	9	18	18	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 27	2012	489	7417					S4	S6		10.1038/489S4a	http://dx.doi.org/10.1038/489S4a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011LT	23013714	Bronze			2022-12-24	WOS:000309167100003
J	Bygbjerg, IC				Bygbjerg, I. C.			Double Burden of Noncommunicable and Infectious Diseases in Developing Countries	SCIENCE			English	Editorial Material							LOW-BIRTH-WEIGHT; FETAL; POPULATION; TUBERCULOSIS; PREVENTION; MALARIA	On top of the unfinished agenda of infectious diseases in low- and middle-income countries, development, industrialization, urbanization, investment, and aging are drivers of an epidemic of noncommunicable diseases (NCDs). Malnutrition and infection in early life increase the risk of chronic NCDs in later life, and in adult life, combinations of major NCDs and infections, such as diabetes and tuberculosis, can interact adversely. Because intervention against either health problem will affect the other, intervening jointly against noncommunicable and infectious diseases, rather than competing for limited funds, is an important policy consideration requiring new thinking and approaches.	Univ Copenhagen, Copenhagen Sch Global Hlth, Dept Int Hlth Immunol & Microbiol, Fac Hlth Sci, DK-1014 Copenhagen K, Denmark	University of Copenhagen	Bygbjerg, IC (corresponding author), Univ Copenhagen, Copenhagen Sch Global Hlth, Dept Int Hlth Immunol & Microbiol, Fac Hlth Sci, 5 Oster Farimagsgade, DK-1014 Copenhagen K, Denmark.	iby@sund.ku.dk		Bygbjerg, Ib/0000-0001-9100-2754				Agrasada GV, 2011, ASIA PAC J CLIN NUTR, V20, P62; Allain TJ, 2011, TROP MED INT HEALTH, V16, P1077, DOI 10.1111/j.1365-3156.2011.02808.x; [Anonymous], WHOHTMTB201115; [Anonymous], 2005, PREV CHRON DIS VIT I; Barker D. J., 1986, J GERONTOL B-PSYCHOL, V327, P1077, DOI 10.1016/S0140-6736(86)91340-1; Bygbjerg Ib Christian, 2012, Ugeskr Laeger, V174, P1516; C. Y, 2008, PLOS MED, V15, pe152; Christensen DL, 2011, INT J GYNECOL OBSTET, V115, pS16, DOI 10.1016/S0020-7292(11)60006-4; Dartell M, 2012, SEX TRANSM DIS, V39, P201, DOI 10.1097/OLQ.0b013e31823b50ad; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Dye C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021161; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Harries AD, 2011, INT J TUBERC LUNG D, V15, P1436, DOI 10.5588/ijtld.11.0503; Harries AD, 2011, INT J TUBERC LUNG D, V15, pi; Lau C, 2011, OBSTET GYNECOL, V117, P978, DOI 10.1097/AOG.0b013e318212140e; LEIKIN EL, 1987, OBSTET GYNECOL, V69, P570; Li L., 2012, TROP MED INT HEALTH, DOI [10.1111/j.13652012.03068.x, DOI 10.1111/J.13652012.03068.X]; Lutter CK, 2012, SCIENCE, V337, P1495, DOI 10.1126/science.1224616; Mathers C.D., 2005, UPDATED PROJECTIONS; MCGREGOR IA, 1983, T ROY SOC TROP MED H, V77, P232, DOI 10.1016/0035-9203(83)90081-0; Murray CJL, 1996, GLOBAL BURDEN DIS IN, V1; Nolan CJ, 2011, LANCET, V378, P169, DOI 10.1016/S0140-6736(11)60614-4; OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375; Philips I., 1968, BRIT MED J, V5589, P407; Stuckler D, 2008, MILBANK Q, V86, P273, DOI 10.1111/j.1468-0009.2008.00522.x; Stuckler D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000241; Uplekar M, 2007, B WORLD HEALTH ORGAN, V85, P413, DOI 10.2471/BLT.07.041756; WHO, 2003, WHOCDSTB2003319, P319; WHO, MAL HIV AIDS INT IMP; WHO, 2011, UN HIGH LEV M NONC D; WHO UNAIDS, 2001, WHOCDSCPESMT200113 U, P13; World Bank, 2007, PUBL POL CHALL CHRON; World Health Organization, 1999, WORLD HLTH REP, P13; Yach D, 2004, JAMA-J AM MED ASSOC, V291, P2616, DOI 10.1001/jama.291.21.2616	34	186	189	1	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2012	337	6101					1499	1501		10.1126/science.1223466	http://dx.doi.org/10.1126/science.1223466			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	007UC	22997329	Green Submitted			2022-12-24	WOS:000308912900041
J	Williams, Z				Williams, Zev			Inducing Tolerance to Pregnancy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Albert Einstein Coll Med, Montefiore Med Ctr, Program Early & Recurrent Pregnancy Loss, Dept Obstet & Gynecol & Womens Hlth, New York, NY 10033 USA	Montefiore Medical Center; Yeshiva University	Williams, Z (corresponding author), Albert Einstein Coll Med, Montefiore Med Ctr, Program Early & Recurrent Pregnancy Loss, Dept Obstet & Gynecol & Womens Hlth, New York, NY 10033 USA.				NICHD NIH HHS [K08 HD068546] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD068546] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Samstein RM, 2012, CELL, V150, P29, DOI 10.1016/j.cell.2012.05.031; Scarpellini F, 2009, HUM REPROD, V24, P2703, DOI 10.1093/humrep/dep240; Somerset DA, 2004, IMMUNOLOGY, V112, P38, DOI 10.1111/j.1365-2567.2004.01869.x; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750	4	74	86	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 20	2012	367	12					1159	1161		10.1056/NEJMcibr1207279	http://dx.doi.org/10.1056/NEJMcibr1207279			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	007AS	22992082	Green Accepted			2022-12-24	WOS:000308861800016
J	Wilding, J				Wilding, John			Are the causes of obesity primarily environmental? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BODY-MASS INDEX; CHILDHOOD OBESITY		Univ Liverpool, Dept Obes & Endocrinol, Ctr Clin Sci, Univ Hosp Aintree, Liverpool L9 7AL, Merseyside, England	University of Liverpool	Wilding, J (corresponding author), Univ Liverpool, Dept Obes & Endocrinol, Ctr Clin Sci, Univ Hosp Aintree, Liverpool L9 7AL, Merseyside, England.	j.p.h.wilding@liv.ac.uk	Wilding, John PH/A-7106-2008; Wilding, John/ABB-6443-2020	Wilding, John PH/0000-0003-2839-8404; Wilding, John/0000-0003-2839-8404				Allison DB, 1996, INT J OBESITY, V20, P501; Borys JM, 2012, OBES REV, V13, P299, DOI 10.1111/j.1467-789X.2011.00950.x; Farooqi IS, 2007, OBES REV, V8, P37, DOI 10.1111/j.1467-789X.2007.00315.x; Foresight, 2007, TACKL OB FUT CHOIC P; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gilmore AB, 2011, J PUBLIC HEALTH-UK, V33, P2, DOI 10.1093/pubmed/fdr008; Harris JL, 2009, ANNU REV PUBL HEALTH, V30, P211, DOI 10.1146/annurev.publhealth.031308.100304; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Mayor S, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6688; Romon M, 2009, PUBLIC HEALTH NUTR, V12, P1735, DOI 10.1017/S1368980008004278; ROTHWELL NJ, 1982, BRIT J NUTR, V47, P461, DOI 10.1079/BJN19820058; World Health Organization, 2009, GLOB HLTH RISKS MORT	12	17	17	0	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 11	2012	345								e5843	10.1136/bmj.e5843	http://dx.doi.org/10.1136/bmj.e5843			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	007BG	22968528				2022-12-24	WOS:000308863200005
J	Lima, WF; Prakash, TP; Murray, HM; Kinberger, GA; Li, WY; Chappell, AE; Li, CS; Murray, SF; Gaus, H; Seth, PP; Swayze, EE; Crooke, ST				Lima, Walt F.; Prakash, Thazha P.; Murray, Heather M.; Kinberger, Garth A.; Li, Wenyu; Chappell, Alfred E.; Li, Cheryl S.; Murray, Susan F.; Gaus, Hans; Seth, Punit P.; Swayze, Eric E.; Crooke, Stanley T.			Single-Stranded siRNAs Activate RNAi in Animals	CELL			English	Article							SMALL INTERFERING RNA; MAMMALIAN-CELLS; CHEMICAL-MODIFICATIONS; HUMAN DICER; OLIGONUCLEOTIDE; IDENTIFICATION; ARGONAUTE2; STABILITY; CLEAVAGE; DUPLEXES	The therapeutic utility of siRNAs is limited by the requirement for complex formulations to deliver them to tissues. If potent single-stranded RNAs could be identified, they would provide a simpler path to pharmacological agents. Here, we describe single-stranded siRNAs (ss-siRNAs) that silence gene expression in animals absent lipid formulation. Effective ss-siRNAs were identified by iterative design by determining structure-activity relationships correlating chemically modified single strands and Argonaute 2 (AGO2) activities, potency in cells, nuclease stability, and pharmacokinetics. We find that the passenger strand is not necessary for potent gene silencing. The guide-strand activity requires AGO2, demonstrating action through the RNAi pathway. ss-siRNA action requires a 5' phosphate to achieve activity in vivo, and we developed a metabolically stable 5'-(E)-vinylphosphonate (5'-VP) with conformation and sterioelectronic properties similar to the natural phosphate. Identification of potent ss-siRNAs offers an additional option for RNAi therapeutics and an alternate perspective on RNAi mechanism.	[Lima, Walt F.; Murray, Heather M.; Li, Cheryl S.; Crooke, Stanley T.] Isis Pharmaceut Inc, Core Antisense Res, Carlsbad, CA 92010 USA; [Prakash, Thazha P.; Kinberger, Garth A.; Li, Wenyu; Seth, Punit P.; Swayze, Eric E.] Isis Pharmaceut Inc, Med Chem, Carlsbad, CA 92010 USA; [Chappell, Alfred E.; Gaus, Hans] Isis Pharmaceut Inc, Struct Biol, Carlsbad, CA 92010 USA; [Murray, Susan F.] Isis Pharmaceut Inc, Mol Pharmacol, Carlsbad, CA 92010 USA	Isis Pharmaceuticals Inc; Isis Pharmaceuticals Inc; Isis Pharmaceuticals Inc; Isis Pharmaceuticals Inc	Lima, WF (corresponding author), Isis Pharmaceut Inc, Core Antisense Res, Carlsbad, CA 92010 USA.	wlima@isisph.com	Murray, Heather/GQY-8016-2022; Seth, Punit/M-2205-2019	Seth, Punit/0000-0002-1783-7806; Gaus, Hans/0000-0002-7471-8619; Swayze, Eric/0000-0001-6430-6576				Allerson CR, 2005, J MED CHEM, V48, P901, DOI 10.1021/jm049167j; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Braasch DA, 2003, BIOCHEMISTRY-US, V42, P7967, DOI 10.1021/bi0343774; Caplen NJ, 2003, EXPERT OPIN BIOL TH, V3, P575, DOI 10.1517/14712598.3.4.575; Chen PY, 2008, RNA, V14, P263, DOI 10.1261/rna.789808; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Crooke S. T., 2008, ANTISENSE DRUG TECHN; Dande P, 2006, J MED CHEM, V49, P1624, DOI 10.1021/jm050822c; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Graham MJ, 1998, J PHARMACOL EXP THER, V286, P447; Graham MJ, 2001, BIOCHEM PHARMACOL, V62, P297, DOI 10.1016/S0006-2952(01)00669-4; Guzaev AP, 2003, J AM CHEM SOC, V125, P2380, DOI 10.1021/ja0284613; Hall AHS, 2004, NUCLEIC ACIDS RES, V32, P5991, DOI 10.1093/nar/gkh936; Haringsma HJ, 2012, NUCLEIC ACIDS RES, V40, P4125, DOI 10.1093/nar/gkr1301; Holen T, 2003, NUCLEIC ACIDS RES, V31, P2401, DOI 10.1093/nar/gkg338; Kini HK, 2007, FEBS LETT, V581, P5611, DOI 10.1016/j.febslet.2007.11.010; Lima WF, 2009, J BIOL CHEM, V284, P26017, DOI 10.1074/jbc.M109.010835; Lima WF, 2009, J BIOL CHEM, V284, P2535, DOI 10.1074/jbc.M803748200; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Prakash TP, 2005, J MED CHEM, V48, P4247, DOI 10.1021/jm050044o; Rand TA, 2004, P NATL ACAD SCI USA, V101, P14385, DOI 10.1073/pnas.0405913101; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Rose SD, 2005, NUCLEIC ACIDS RES, V33, P4140, DOI 10.1093/nar/gki732; Schwarz DS, 2002, MOL CELL, V10, P537, DOI 10.1016/S1097-2765(02)00651-2; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Tao WK, 2011, MOL THER, V19, P567, DOI 10.1038/mt.2010.282; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Vaishnaw Akshay K, 2010, Silence, V1, P14, DOI 10.1186/1758-907X-1-14; Wu HJ, 1998, J BIOL CHEM, V273, P2532, DOI 10.1074/jbc.273.5.2532; Yu DB, 2012, CELL, V150, P895, DOI 10.1016/j.cell.2012.08.002	34	185	246	1	64	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 31	2012	150	5					883	894		10.1016/j.cell.2012.08.014	http://dx.doi.org/10.1016/j.cell.2012.08.014			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22939618	Bronze			2022-12-24	WOS:000308500200005
J	Rapley, C				Rapley, Chris			Time to raft up	NATURE			English	Editorial Material							CLIMATE		UCL, Dept Earth Sci, London WC1E 6BT, England	University of London; University College London	Rapley, C (corresponding author), UCL, Dept Earth Sci, London WC1E 6BT, England.	christopher.rapley@ucl.ac.uk						Festinger L., 1957, THEORY COGNITIVE DIS, V2; Grundmann R., 2012, SCI TECHNOL HUM VALU; International Council for Science, 2012, FUT EARTH RES GLOB S; Kahan D, 2012, NATURE CLIM CHANGE; McCallie E, 2007, MUS SOC ISS, V2, P165, DOI 10.1179/msi.2007.2.2.165; Poortinga W, 2011, GLOBAL ENVIRON CHANG, V21, P1015, DOI 10.1016/j.gloenvcha.2011.03.001; Sarewitz D., 2012, WORKSH AAAS SCI RESP; Shuckburgh E., CLIMATE SCI IN PRESS; Weintrobe S., ENGAGING CL IN PRESS	10	11	11	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2012	488	7413					583	585		10.1038/488583a	http://dx.doi.org/10.1038/488583a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996NC	22932363				2022-12-24	WOS:000308095100025
J	Driessens, G; Beck, B; Caauwe, A; Simons, BD; Blanpain, C				Driessens, Gregory; Beck, Benjamin; Caauwe, Amelie; Simons, Benjamin D.; Blanpain, Cedric			Defining the mode of tumour growth by clonal analysis	NATURE			English	Article							CANCER STEM-CELLS; MOUSE SKIN; ADULT TISSUES; EVOLUTION; EPIDERMIS; REPLACEMENT; UNITS; FATE; BETA	Recent studies using the isolation of a subpopulation of tumour cells followed by their transplantation into immunodeficient mice provide evidence that certain tumours(1,2), including squamous skin tumours(3-5), contain cells with high clonogenic potential that have been referred to as cancer stem cells (CSCs). Until now, CSC properties have only been investigated by transplantation assays, and their existence in unperturbed tumour growth is unproven. Here we make use of clonal analysis of squamous skin tumours using genetic lineage tracing to unravel the mode of tumour growth in vivo in its native environment. To this end, we used a genetic labelling strategy that allows individual tumour cells to be marked and traced over time at different stages of tumour progression. Surprisingly, we found that the majority of labelled tumour cells in benign papilloma have only limited proliferative potential, whereas a fraction has the capacity to persist long term, giving rise to progeny that occupy a significant part of the tumour. As well as confirming the presence of two distinct proliferative cell compartments within the papilloma, mirroring the composition, hierarchy and fate behaviour of normal tissue, quantitative analysis of clonal fate data indicates that the more persistent population has stem-cell-like characteristics and cycles twice per day, whereas the second represents a slower cycling transient population that gives rise to terminally differentiated tumour cells. Such behaviour is shown to be consistent with double-labelling experiments and detailed clonal fate characteristics. By contrast, measurements of clone size and proliferative potential in invasive squamous cell carcinoma show a different pattern of behaviour, consistent with geometric expansion of a single CSC population with limited potential for terminal differentiation. This study presents the first experimental evidence for the existence of CSCs during unperturbed solid tumour growth.	[Simons, Benjamin D.] Univ Cambridge, Cavendish Lab, Dept Phys, Cambridge CB3 0HE, England; [Driessens, Gregory; Beck, Benjamin; Caauwe, Amelie; Blanpain, Cedric] Univ Libre Brussels, IRIBHM, B-1070 Brussels, Belgium; [Simons, Benjamin D.] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Blanpain, Cedric] WELBIO, B-1070 Brussels, Belgium	University of Cambridge; Universite Libre de Bruxelles; University of Cambridge; WELBIO	Simons, BD (corresponding author), Univ Cambridge, Cavendish Lab, Dept Phys, JJ Thomson Ave, Cambridge CB3 0HE, England.	bds10@cam.ac.uk; Cedric.Blanpain@ulb.ac.be	Blanpain, Cedric/ABD-8392-2021; Simons, Benjamin/AAY-8920-2020	Simons, Benjamin/0000-0002-3875-7071; Beck, Benjamin/0000-0001-8162-7566	Brussels Region; FNRS; program d'excellence CIBLES of the Wallonia Region; Fondation Contre le Cancer; ULB foundation; fond Gaston Ithier; European Research Council (ERC); EMBO; Engineering and Physical Sciences Research Council [EP/F032773/1] Funding Source: researchfish; EPSRC [EP/F032773/1] Funding Source: UKRI	Brussels Region; FNRS(Fonds de la Recherche Scientifique - FNRS); program d'excellence CIBLES of the Wallonia Region; Fondation Contre le Cancer; ULB foundation; fond Gaston Ithier; European Research Council (ERC)(European Research Council (ERC)); EMBO(European Molecular Biology Organization (EMBO)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	C.B. is investigator of WELBIO and chercheur qualifie of the FRS/FNRS. B.B. is charge de recherche of the FRS/FNRS and G.D. is supported by the Brussels Region. This work was supported by the FNRS, the program d'excellence CIBLES of the Wallonia Region, a research grant from the Fondation Contre le Cancer, the ULB foundation and the fond Gaston Ithier, a starting grant of the European Research Council (ERC), and the EMBO Young Investigator Program. We thank F. Bollet-Quivogne and J.-M. Vanderwinden for their help with confocal imaging.	Abel EL, 2009, NAT PROTOC, V4, P1350, DOI 10.1038/nprot.2009.120; Beck B, 2011, NATURE, V478, P399, DOI 10.1038/nature10525; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Doupe DP, 2010, DEV CELL, V18, P317, DOI 10.1016/j.devcel.2009.12.016; Ghazizadeh S, 2001, EMBO J, V20, P1215, DOI 10.1093/emboj/20.6.1215; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Kemp CJ, 2005, SEMIN CANCER BIOL, V15, P460, DOI 10.1016/j.semcancer.2005.06.003; Klein AM, 2011, DEVELOPMENT, V138, P3103, DOI 10.1242/dev.060103; Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; Mackenzie IC, 1997, J INVEST DERMATOL, V109, P377, DOI 10.1111/1523-1747.ep12336255; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Nguyen LV, 2012, NAT REV CANCER, V12, P133, DOI 10.1038/nrc3184; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Owens DM, 2003, NAT REV CANCER, V3, P444, DOI 10.1038/nrc1096; Perez-Losada J, 2003, NAT REV CANCER, V3, P434, DOI 10.1038/nrc1095; Potten C S, 1981, Int Rev Cytol, V69, P271; Rocheteau P, 2012, CELL, V148, P112, DOI 10.1016/j.cell.2011.11.049; Schober M, 2011, P NATL ACAD SCI USA, V108, P10544, DOI 10.1073/pnas.1107807108; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Van Keymeulen A, 2009, J CELL BIOL, V187, P91, DOI 10.1083/jcb.200907080; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551	26	522	547	2	148	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2012	488	7412					527	+		10.1038/nature11344	http://dx.doi.org/10.1038/nature11344			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992FS	22854777	Green Accepted			2022-12-24	WOS:000307761600040
J	Cresswell, JA; Campbell, OMR; De Silva, MJ; Filippi, V				Cresswell, Jenny A.; Campbell, Oona M. R.; De Silva, Mary J.; Filippi, Veronique			Effect of maternal obesity on neonatal death in sub-Saharan Africa: multivariable analysis of 27 national datasets	LANCET			English	Article							BODY-MASS INDEX; UTERINE CONTRACTILITY; NUTRITION TRANSITION; DEVELOPING-COUNTRIES; PREPREGNANCY WEIGHT; PREGNANCY OUTCOMES; RISK; WOMEN; STILLBIRTHS; UNDERWEIGHT	Background Rates of obesity are increasing worldwide, including in sub-Saharan Africa. Neonates born to obese mothers in low-income settings are at increased risk of complications including admission to neonatal intensive care, macrosomia, low Apgar scores, and perinatal death. We investigated whether maternal obesity is a risk factor for neonatal death in sub-Saharan Africa and the effect on the detailed timing of death within the neonatal period. Methods Cross-sectional Demographic and Health Surveys from 27 sub-Saharan countries (2003-09) were pooled. We used multivariable logistic regression to assess the risk of neonatal death (in women's most recent singleton livebirth in the 5 years preceding the survey) by maternal body-mass index (BMI) category (measured during the survey). Timing of death was investigated with a discrete-time survival model. Findings 15 518 of 81 126 eligible women were overweight (4266 were obese), 52 006 had an optimum BMI, and 13 602 were underweight. Maternal obesity was associated with an increased odds of neonatal death after adjustment for confounding factors (adjusted odds ratio 1.46, 95% CI 1.11-1.91). Maternal obesity was a significant risk factor for neonatal deaths occurring during the first 2 days of life (1.62, 1.11-2.37). We noted no statistically significant relation later in the neonatal period (days 2-6 1.36, 0.84-2.21; days 7-27 1.19, 0.65-2.18), possibly because of low statistical power. Interpretation Maternal obesity in sub-Saharan Africa is associated with increased risk of early neonatal death. Potential mechanisms include prematurity, intrapartum events, or infections. Strategies to prevent and reduce obesity need to be considered; obese women should be advised to deliver in a health-care facility that can provide emergency obstetric and neonatal care.	[Cresswell, Jenny A.; Campbell, Oona M. R.; De Silva, Mary J.; Filippi, Veronique] Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Cresswell, JA (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.	jenny.cresswell@lshtm.ac.uk		Campbell, Oona/0000-0002-9311-0115; Cresswell, Jenny/0000-0002-9553-1132	Economic and Social Research Council [PTA-031-2006-00109]	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	Economic and Social Research Council.; JC was funded by a PhD studentship from the Economic and Social Research Council (PTA-031-2006-00109). We thank Emma Slaymaker for her support and advice during data analysis, and the reviewers who provided us with many helpful suggestions.	[Anonymous], 2006, DHS METHODOLOGICAL R; Bhattacharya S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-168; Cedergren MI, 2009, EUR J OBSTET GYN R B, V145, P163, DOI 10.1016/j.ejogrb.2009.05.022; Cedergren MI, 2004, OBSTET GYNECOL, V103, P219, DOI 10.1097/01.AOG.0000107291.46159.00; Chen MH, 2010, J MATERN-FETAL NEO M, V23, P89, DOI 10.3109/14767050903168440; Cnattingius S, 1998, NEW ENGL J MED, V338, P147, DOI 10.1056/NEJM199801153380302; Ehrenberg HM, 2004, AM J OBSTET GYNECOL, V191, P964, DOI 10.1016/j.ajog.2004.05.052; Hill K, 2006, DEMOGR RES, V14, P429, DOI 10.4054/DemRes.2006.14.18; Idemyor V, 2010, J NATL MED ASSOC, V102, P650, DOI 10.1016/S0027-9684(15)30643-X; Kalk P, 2009, EUR J MED RES, V14, P216; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Kristensen J, 2005, BJOG-INT J OBSTET GY, V112, P403, DOI 10.1111/j.1471-0528.2005.00437.x; Law DCG, 2007, HUM REPROD, V22, P414, DOI 10.1093/humrep/de1400; Lawn J, 2005, B WORLD HEALTH ORGAN, V83, P409; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2010, SEMIN PERINATOL, V34, P371, DOI 10.1053/j.semperi.2010.09.011; Lawn JE, 2009, INT J GYNECOL OBSTET, V107, pS5, DOI 10.1016/j.ijgo.2009.07.016; Levitt NS, 2008, HEART, V94, P1376, DOI 10.1136/hrt.2008.147306; Mbanya JCN, 2010, LANCET, V375, P2254, DOI 10.1016/S0140-6736(10)60550-8; Mendez MA, 2005, AM J CLIN NUTR, V81, P714; Nohr EA, 2007, OBSTET GYNECOL, V110, P1083, DOI 10.1097/01.AOG.0000286760.46679.f8; Popkin BM, 2004, NUTR REV, V62, pS140, DOI 10.1111/j.1753-4887.2004.tb00084.x; POPKIN BM, 1994, NUTR REV, V52, P285, DOI 10.1111/j.1753-4887.1994.tb01460.x; Prentice AM, 2006, INT J EPIDEMIOL, V35, P93, DOI 10.1093/ije/dyi272; Pullum TW, 2008, DHS METHODOLOGICAL R; Sebire NJ, 2001, BRIT J OBSTET GYNAEC, V108, P61, DOI 10.1111/j.1471-0528.2001.00021.x; The NHS Information Centre, 2010, LIF STAT STAT OB PHY; Verdiales M, 2009, J PERINAT MED, V37, P651, DOI 10.1515/JPM.2009.110; Zhang J, 2007, BJOG-INT J OBSTET GY, V114, P343, DOI 10.1111/j.1471-0528.2006.01233.x	29	61	62	0	25	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 13	2012	380	9850					1325	1330		10.1016/S0140-6736(12)60869-1	http://dx.doi.org/10.1016/S0140-6736(12)60869-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	022BZ	22884609				2022-12-24	WOS:000309931400031
J	Graham-Rowe, D				Graham-Rowe, Duncan			THERAPEUTICS Strength in numbers	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2012	489	7417					S16	S17		10.1038/489S16a	http://dx.doi.org/10.1038/489S16a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011LT	23013711	Bronze			2022-12-24	WOS:000309167100009
J	Cheng, JK				Cheng, Jennifer K.			Food for Thought	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Boston Childrens Hosp, Dept Med, Div Gen Pediat, Boston, MA USA	Harvard University; Boston Children's Hospital	Cheng, JK (corresponding author), Boston Childrens Hosp, Dept Med, Div Gen Pediat, Boston, MA USA.	jennifer.cheng@childrens.harvard.edu						American Academy of Pediatrics, PED GUID CHILDR OR H; Le Billon K, 2012, FRENCH KIDS EAT EVER, P320; Maier A, 2007, APPETITE, V49, P429, DOI 10.1016/j.appet.2007.02.007	3	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	2012	308	11					1101	1102		10.1001/jama.2012.7198	http://dx.doi.org/10.1001/jama.2012.7198			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007AL	22990268				2022-12-24	WOS:000308861000025
J	Birney, E				Birney, Ewan			Lessons for big-data projects	NATURE			English	Editorial Material									European Bioinformat Inst, European Mol Biol Labs, Hinxton, England	European Molecular Biology Laboratory (EMBL)	Birney, E (corresponding author), European Bioinformat Inst, European Mol Biol Labs, Hinxton, England.	birney@ebi.ac.uk		Birney, Ewan/0000-0001-8314-8497					0	66	71	0	250	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2012	489	7414					49	51		10.1038/489049a	http://dx.doi.org/10.1038/489049a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999WW	22955613	Bronze			2022-12-24	WOS:000308347000033
J	Meddings, JA; Reichert, H; Rogers, MAM; Saint, S; Stephansky, J; McMahon, LF				Meddings, Jennifer A.; Reichert, Heidi; Rogers, Mary A. M.; Saint, Sanjay; Stephansky, Joe; McMahon, Laurence F., Jr.			Effect of Nonpayment for Hospital-Acquired, Catheter-Associated Urinary Tract Infection	ANNALS OF INTERNAL MEDICINE			English	Article							SAFETY-NET; MEDICARE POLICY; CARE; PREVENTION; PAYMENT; IMPACT; RISK	Background: Most (59% to 86%) hospital-acquired urinary tract infections (UTIs) are catheter-associated urinary tract infections (CAUTIs). As of 2008, claims data are used to deny payment for certain hospital-acquired conditions, including CAUTIs, and publicly report hospital performance. Objective: To examine rates of UTIs in adults that are coded in claims data as hospital-acquired and catheter-associated events and evaluate how often nonpayment for CAUTI lowers hospital payment. Design: Before-and-after study of all-payer cross-sectional claims data. Setting: 96 nonfederal acute care Michigan hospitals. Patients: Nonobstetric adults discharged in 2007 (n = 767 531) and 2009 (n = 781 343). Measurements: Hospital rates of UTIs (categorized as catheter-associated or hospital-acquired) and frequency of reduced payment for hospital-acquired CAUTIs. Results: Hospitals frequently requested payment for non-CAUTIs as secondary diagnoses: 10.0% (95% CI, 9.5% to 10.5%) of discharges in 2007 and 10.3% (CI, 9.8% to 10.9%) in 2009. Hospital rates of CAUTI were very low: 0.09% (CI, 0.06% to 0.12%) in 2007 and 0.14% (CI, 0.11% to 0.17%) in 2009. In 2009, 2.6% (CI, 1.6% to 3.6%) of hospital-acquired UTIs were described as CAUTIs. Nonpayment for hospital-acquired CAUTIs reduced payment for 25 of 781 343 (0.003%) hospitalizations in 2009. Limitations: Data are from only 1 state and involved only 1 year before and after nonpayment for complications. Hospital prevention practices were not examined. Conclusion: Catheter-associated UTI rates determined by claims data seem to be inaccurate and are much lower than expected from epidemiologic surveillance data. The financial impact of current nonpayment policy for hospital-acquired CAUTI is low. Claims data are currently not valid data sets for comparing hospital-acquired CAUTI rates for the purpose of public reporting or imposing financial incentives or penalties. Primary Funding Source: Blue Cross Blue Shield of Michigan Foundation.	Univ Michigan, Sch Med, Hosp Outcomes Program Excellence, Ann Arbor Vet Affairs Med Ctr, Ann Arbor, MI USA; Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA; Michigan Hlth & Hosp Assoc, Lansing, MI 48933 USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan	Meddings, JA (corresponding author), Div Gen Med, N Campus Res Complex,2800 Plymouth Rd,Bldg 16,Roo, Ann Arbor, MI 48109 USA.	meddings@umich.edu	Saint, Sanjay/AAF-5126-2019	Rogers, Mary/0000-0001-5519-3223; Meddings, Jennifer/0000-0001-9503-0293	Blue Cross Blue Shield of Michigan Foundation [1452.11]; Agency for Healthcare Research and Quality [1R010HS018344-01A1, 1K08-HS019767- 01]; National Institute of Diabetes and Digestive and Kidney Diseases [R21-DK078717]; National Institute of Nursing Research [R01-NR010700]; National Institutes of Health Clinical Loan Repayment Program; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS019767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK078717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR010700] Funding Source: NIH RePORTER	Blue Cross Blue Shield of Michigan Foundation; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); National Institutes of Health Clinical Loan Repayment Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	The study was funded by grant 1452.11 from the Blue Cross Blue Shield of Michigan Foundation. The authors were also supported by awards 1R010HS018344-01A1 (Dr. McMahon) and 1K08-HS019767- 01 (Dr. Meddings) from the Agency for Healthcare Research and Quality; award R21-DK078717 (Dr. Saint) from the National Institute of Diabetes and Digestive and Kidney Diseases; and award R01-NR010700 (Dr. Saint) from the National Institute of Nursing Research. Dr. Meddings is also a recipient of the National Institutes of Health Clinical Loan Repayment Program for 2009 to 2012.	[Anonymous], 2010, BLUE CROSS BLUE SHIE; [Anonymous], 2008, FED REGISTER, V73; Centers for Medicare and Medicaid Services (CMS) HHS, 2007, Fed Regist, V72, P47129; Centers for Medicare and Medicaid Services (CMS) HHS, 2011, Fed Regist, V76, P32816; Centers for Medicare & Medicaid Services (CMS) National Center for Health Statistics (NCHS), 2009, ICD 9 CM OFF GUID CO; Edwards JR, 2007, AM J INFECT CONTROL, V35, P290, DOI 10.1016/j.ajic.2007.04.001; Foxman B, 2002, AM J MED, V113, p5S; GARIBALDI RA, 1982, INFECT CONT HOSP EP, V3, P466, DOI 10.1017/S0195941700056599; Gaskin DJ, 2001, HEALTH SERV RES, V36, P25; Gould CV, 2010, INFECT CONT HOSP EP, V31, P319, DOI 10.1086/651091; Hadley J, 2004, HEALTH SERV RES, V39, P1527, DOI 10.1111/j.1475-6773.2004.00302.x; HALEY RW, 1981, AM J MED, V70, P947, DOI 10.1016/0002-9343(81)90561-1; Healthcare Cost and Utilization Project, 2012, OV STAT INP DAT SID; Hooton TM, 2010, CLIN INFECT DIS, V50, P625, DOI 10.1086/650482; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; KRIEGER JN, 1983, J INFECT DIS, V148, P57, DOI 10.1093/infdis/148.1.57; Maki DG, 2001, EMERG INFECT DIS, V7, P342, DOI 10.3201/eid0702.010240; McHugh M, 2011, J HEALTH CARE POOR U, V22, P638, DOI 10.1353/hpu.2011.0058; McNair PD, 2009, HEALTH AFFAIR, V28, P1485, DOI 10.1377/hlthaff.28.5.1485; Meddings J, 2010, INFECT CONT HOSP EP, V31, P627, DOI 10.1086/652523; Pennsylvania Health Care Cost Containment Council, 2012, IMP HEALTHC ASS INF; Saint S, 1999, J AM GERIATR SOC, V47, P1453, DOI 10.1111/j.1532-5415.1999.tb01567.x; Saint S, 2002, ANN INTERN MED, V137, P125, DOI 10.7326/0003-4819-137-2-200207160-00012; Saint S, 2009, ANN INTERN MED, V150, P877, DOI 10.7326/0003-4819-150-12-200906160-00013; Stone Patricia W, 2011, Policy Polit Nurs Pract, V12, P73, DOI 10.1177/1527154411416129; Werner RM, 2008, JAMA-J AM MED ASSOC, V299, P2180, DOI 10.1001/jama.299.18.2180; 2008, FED REG, V73, P23547	27	53	52	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 4	2012	157	5					305	U33		10.7326/0003-4819-157-5-201209040-00003	http://dx.doi.org/10.7326/0003-4819-157-5-201209040-00003			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	000BM	22944872	Green Accepted			2022-12-24	WOS:000308361500001
J	Senthilan, PR; Piepenbrock, D; Ovezmyradov, G; Nadrowski, B; Bechstedt, S; Pauls, S; Winkler, M; Mobius, W; Howard, J; Gopfert, MC				Senthilan, Pingkalai R.; Piepenbrock, David; Ovezmyradov, Guvanch; Nadrowski, Bjoern; Bechstedt, Susanne; Pauls, Stephanie; Winkler, Margret; Moebius, Wiebke; Howard, Jonathon; Goepfert, Martin C.			Drosophila Auditory Organ Genes and Genetic Hearing Defects	CELL			English	Article							NOMPC TRP CHANNEL; OUTER HAIR-CELLS; PRONEURAL GENE; MECHANOSENSORY TRANSDUCTION; PHOTORECEPTOR CELLS; SIGNALING COMPLEX; COMPOUND EYE; PROTEIN; MELANOGASTER; EXPRESSION	The Drosophila auditory organ shares equivalent transduction mechanisms with vertebrate hair cells, and both are specified by atonal family genes. Using a whole-organ knockout strategy based on atonal, we have identified 274 Drosophila auditory organ genes. Only four of these genes had previously been associated with fly hearing, yet one in five of the genes that we identified has a human cognate that is implicated in hearing disorders. Mutant analysis of 42 genes shows that more than half of them contribute to auditory organ function, with phenotypes including hearing loss, auditory hypersusceptibility, and ringing ears. We not only discover ion channels and motors important for hearing, but also show that auditory stimulus processing involves chemoreceptor proteins as well as phototransducer components. Our findings demonstrate mechanosensory roles for ionotropic receptors and visual rhodopsins and indicate that different sensory modalities utilize common signaling cascades.	[Senthilan, Pingkalai R.; Piepenbrock, David; Ovezmyradov, Guvanch; Nadrowski, Bjoern; Pauls, Stephanie; Winkler, Margret; Goepfert, Martin C.] Univ Gottingen, Dept Cellular Neurobiol, D-37077 Gottingen, Germany; [Bechstedt, Susanne; Howard, Jonathon] Max Planck Inst Cell Biol & Genet, D-01307 Dresden, Germany; [Moebius, Wiebke] Max Planck Inst Expt Med, D-37075 Gottingen, Germany	University of Gottingen; Max Planck Society; Max Planck Society	Gopfert, MC (corresponding author), Univ Gottingen, Dept Cellular Neurobiol, Julia Lermontowa Weg 3, D-37077 Gottingen, Germany.	mgoepfe@gwdg.de	Senthilan, Pingkalai/A-9387-2019; 889, CRC/L-1607-2018; Howard, Jonathon/J-7492-2016; Senthilan, Pingkalai R/A-3466-2013; Howard, Jonathon/D-4229-2011	Senthilan, Pingkalai/0000-0003-3921-8886; 889, CRC/0000-0002-6678-3138; Howard, Jonathon/0000-0003-0086-1196; Senthilan, Pingkalai R/0000-0003-3921-8886; Howard, Jonathon/0000-0003-0086-1196; Kok, Kivanc/0000-0002-1502-1600; /0000-0002-2902-7165; Gopfert, Martin/0000-0001-8201-5334	International Graduate School in Genetics and Functional Genomics; German National Academic Foundation; Volkswagen Foundation; DFG [Go1092/1-1];  [SFB 889]	International Graduate School in Genetics and Functional Genomics; German National Academic Foundation; Volkswagen Foundation(Volkswagen); DFG(German Research Foundation (DFG)); 	We thank Claude Desplan, Roger Hardy, Charlotte Helfrich-Forster, Andrew Jarman, Bloomington Stock Centre, Exelixis Collection at Harvard Medical School, the Nippon Consortium, and Fly-Till for fly lines; BestGene, Inc. for fly injections; Steve Britt for antibodies; Thomas Effertz and Swantje Gratsch for help with physiology; and Matthias Schink and Torben Ruhwedel for technical support. This work was supported by the International Graduate School in Genetics and Functional Genomics (to P.R.S. and G.O.), the German National Academic Foundation (to D.P.), the Volkswagen Foundation (to B.N. and M.C.G.), the SFB 889 (A1 to M.C.G.) and a research grant from the DFG (Go1092/1-1, to M.C.G.).	Albert JT, 2007, CURR BIOL, V17, P1000, DOI 10.1016/j.cub.2007.05.004; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baker DA, 2007, J COMP NEUROL, V501, P756, DOI 10.1002/cne.21257; Bechstedt S, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1007; Bechstedt S, 2008, CURR BIOL, V18, pR869, DOI 10.1016/j.cub.2008.07.069; Bellen HJ, 2011, GENETICS, V188, P731, DOI 10.1534/genetics.111.126995; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; Cachero S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000568; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Chevesich J, 1997, NEURON, V18, P95, DOI 10.1016/S0896-6273(01)80049-0; Chien S, 2002, NUCLEIC ACIDS RES, V30, P149, DOI 10.1093/nar/30.1.149; Chou WH, 1999, DEVELOPMENT, V126, P607; Cook B, 2008, NATURE, V452, P361, DOI 10.1038/nature06603; Cooper JL, 2008, FLY, V2, P300, DOI 10.4161/fly.7366; Dror AA, 2009, ANNU REV GENET, V43, P411, DOI 10.1146/annurev-genet-102108-134135; Eberl DF, 2007, INT J DEV BIOL, V51, P679, DOI 10.1387/ijdb.072364de; Eberl DF, 1997, P NATL ACAD SCI USA, V94, P14837, DOI 10.1073/pnas.94.26.14837; Eberl DF, 2000, J NEUROSCI, V20, P5981, DOI 10.1523/JNEUROSCI.20-16-05981.2000; Effertz T, 2011, CURR BIOL, V21, P592, DOI 10.1016/j.cub.2011.02.048; Fritzsch B, 2007, INT J DEV BIOL, V51, P663, DOI 10.1387/ijdb.072367bf; Gillespie PG, 2009, CELL, V139, P33, DOI 10.1016/j.cell.2009.09.010; Gopfert MC, 2006, NAT NEUROSCI, V9, P999, DOI 10.1038/nn1735; Gong ZF, 2004, J NEUROSCI, V24, P9059, DOI 10.1523/JNEUROSCI.1645-04.2004; Gopfert MC, 2001, NATURE, V411, P908, DOI 10.1038/35082144; Gupta BP, 1997, GENES CELLS, V2, P225, DOI 10.1046/j.1365-2443.1997.d01-312.x; Haeberle H, 2004, P NATL ACAD SCI USA, V101, P14503, DOI 10.1073/pnas.0406308101; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; HARRIS WA, 1977, J GEN PHYSIOL, V69, P261, DOI 10.1085/jgp.69.3.261; Herrero J, 2003, NUCLEIC ACIDS RES, V31, P3461, DOI 10.1093/nar/gkg591; Hildebrand MS, 2008, MOL THER, V16, P224, DOI 10.1038/sj.mt.6300351; Hudspeth AJ, 2008, NEURON, V59, P530, DOI 10.1016/j.neuron.2008.07.012; JARMAN AP, 1995, DEVELOPMENT, V121, P2019; JARMAN AP, 1993, CELL, V73, P1307, DOI 10.1016/0092-8674(93)90358-W; JARMAN AP, 1994, NATURE, V369, P398, DOI 10.1038/369398a0; Kamikouchi A, 2009, NATURE, V458, P165, DOI 10.1038/nature07810; Kang LJ, 2010, NEURON, V67, P381, DOI 10.1016/j.neuron.2010.06.032; Kapushesky M, 2004, NUCLEIC ACIDS RES, V32, pW465, DOI 10.1093/nar/gkh470; Kavlie RG, 2010, GENETICS, V185, P177, DOI 10.1534/genetics.110.114009; KERNAN M, 1994, NEURON, V12, P1195, DOI 10.1016/0896-6273(94)90437-5; Kim J, 2003, NATURE, V424, P81, DOI 10.1038/nature01733; Laurencon A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r195; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liu L, 2007, NATURE, V450, P294, DOI 10.1038/nature06223; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu QH, 2009, INTEGR COMP BIOL, V49, P674, DOI 10.1093/icb/icp072; Ma L, 2011, J CELL SCI, V124, P2622, DOI 10.1242/jcs.084798; McDermott BM, 2007, P NATL ACAD SCI USA, V104, P11820, DOI 10.1073/pnas.0704476104; MCKENNA MP, 1994, J BIOL CHEM, V269, P16340; Miron M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-333; MONTELL C, 1985, SCIENCE, V230, P1040, DOI 10.1126/science.3933112; Nadrowski B, 2008, CURR BIOL, V18, P1365, DOI 10.1016/j.cub.2008.07.095; Nelson HB, 1997, GENETICS, V147, P1783; Niemeyer BA, 1996, CELL, V85, P651, DOI 10.1016/S0092-8674(00)81232-5; Niwa N, 2004, NAT GENET, V36, P293, DOI 10.1038/ng1308; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Petit C, 2006, TRENDS MOL MED, V12, P57, DOI 10.1016/j.molmed.2005.12.006; Raybould NP, 2007, J PHYSIOL-LONDON, V579, P101, DOI 10.1113/jphysiol.2006.122929; Roche JP, 2005, AUDIOL NEURO-OTOL, V10, P310, DOI 10.1159/000087348; Rosenzweig M, 2008, P NATL ACAD SCI USA, V105, P14668, DOI 10.1073/pnas.0805041105; Sarpal R, 2003, CURR BIOL, V13, P1687, DOI 10.1016/j.cub.2003.09.025; Savary E, 2007, STEM CELLS, V25, P332, DOI 10.1634/stemcells.2006-0303; SCHAEFFER E, 1989, CELL, V57, P403, DOI 10.1016/0092-8674(89)90915-X; Schulz S, 1999, J BIOL CHEM, V274, P37605, DOI 10.1074/jbc.274.53.37605; Scott K, 1998, NATURE, V395, P805, DOI 10.1038/27448; Sharma Y, 2002, GENESIS, V34, P115, DOI 10.1002/gene.10127; Shen WL, 2011, SCIENCE, V331, P1333, DOI 10.1126/science.1198904; SHIEH BH, 1995, NEURON, V14, P201, DOI 10.1016/0896-6273(95)90255-4; Sidi S, 2003, SCIENCE, V301, P96, DOI 10.1126/science.1084370; Thisse B, 2004, ZFIN DIRECT DATA SUB; Tinevez JY, 2007, BIOPHYS J, V93, P4053, DOI 10.1529/biophysj.107.108498; Todi SV, 2005, CURR BIOL, V15, P862, DOI 10.1016/j.cub.2005.03.050; Vasiliauskas D, 2011, NATURE, V479, P108, DOI 10.1038/nature10451; Walker RG, 1996, P NATL ACAD SCI USA, V93, P2203, DOI 10.1073/pnas.93.5.2203; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Wang T, 2007, J CELL BIOL, V177, P305, DOI 10.1083/jcb.200610081; Weber T, 2003, P NATL ACAD SCI USA, V100, P7690, DOI 10.1073/pnas.1330557100; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; YAMADA T, 1990, SCIENCE, V248, P483, DOI 10.1126/science.2158671; YARFITZ S, 1991, NEURON, V7, P429, DOI 10.1016/0896-6273(91)90295-B; Yorozu S, 2009, NATURE, V458, P201, DOI 10.1038/nature07843; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009	83	132	135	1	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 31	2012	150	5					1042	1054		10.1016/j.cell.2012.06.043	http://dx.doi.org/10.1016/j.cell.2012.06.043			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22939627	Bronze			2022-12-24	WOS:000308500200017
J	Stanley, M				Stanley, Margaret			PERSPECTIVE Vaccinate boys too	NATURE			English	Editorial Material									Univ Cambridge, Dept Pathol, Cambridge CB2 1TN, England	University of Cambridge	Stanley, M (corresponding author), Univ Cambridge, Dept Pathol, Cambridge CB2 1TN, England.	mas1001@cam.ac.uk						Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7; Frisch M, 2002, DAN MED BULL, V49, P194; Garnett GP, 2005, J INFECT DIS, V191, pS97, DOI 10.1086/425271; Hartwig S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-30; Kim JJ, 2011, NEW ENGL J MED, V364, P393, DOI 10.1056/NEJMp1012246	6	34	37	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2012	488	7413					S10	S10		10.1038/488S10a	http://dx.doi.org/10.1038/488S10a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	996NC	22932433	Bronze			2022-12-24	WOS:000308095100008
J	Tsubokura, M; Gilmour, S; Takahashi, K; Oikawa, T; Kanazawa, Y				Tsubokura, Masaharu; Gilmour, Stuart; Takahashi, Kyohei; Oikawa, Tomoyoshi; Kanazawa, Yukio			Internal Radiation Exposure After the Fukushima Nuclear Power Plant Disaster	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							CHERNOBYL		[Tsubokura, Masaharu] Univ Tokyo, Inst Med Sci, Div Social Commun Syst Adv Clin Res, Tokyo, Japan; [Gilmour, Stuart] Univ Tokyo, Dept Global Hlth Policy, Tokyo, Japan; [Takahashi, Kyohei] Hara Machi Cent Obstet & Gynecol Clin, Minamisoma, Fukushima, Japan; [Oikawa, Tomoyoshi; Kanazawa, Yukio] Minamisoma Municipal Gen Hosp, Dept Internal Med, Minamisoma, Fukushima, Japan	University of Tokyo; University of Tokyo	Tsubokura, M (corresponding author), Univ Tokyo, Inst Med Sci, Div Social Commun Syst Adv Clin Res, Tokyo, Japan.	tsubokura-tky@umin.ac.jp	Ley, Sarah/Y-9216-2019; Tsubokura, Masaharu/D-7300-2017; Tsubokura, Masaharu/AAV-4364-2021	Tsubokura, Masaharu/0000-0001-8027-202X; Tsubokura, Masaharu/0000-0001-8027-202X				Brumfiel G, 2011, NATURE, V471, P273, DOI 10.1038/471273a; Hoshi M, 2000, HEALTH PHYS, V79, P182, DOI 10.1097/00004032-200008000-00011; National Council on Radiation Protection and Measurement, 2008, HDB NAT COUNC RAD PR; Ruhm W, 1999, HEALTH PHYS, V77, P373, DOI 10.1097/00004032-199910000-00004; Takatsuji T, 2000, HEALTH PHYS, V78, P86, DOI 10.1097/00004032-200001000-00014	5	98	99	1	31	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2012	308	7					669	670		10.1001/jama.2012.9839	http://dx.doi.org/10.1001/jama.2012.9839			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988NC	22893159	Bronze			2022-12-24	WOS:000307496700017
J	Kaelin, WG				Kaelin, William G., Jr.			Use and Abuse of RNAi to Study Mammalian Gene Function	SCIENCE			English	Editorial Material							HUMAN-CELLS; SCREENS; INTERFERENCE; EXPRESSION		Dana Farber Canc Inst, Dept Adult Oncol, Off M457, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute	Kaelin, WG (corresponding author), Dana Farber Canc Inst, Dept Adult Oncol, Off M457, 450 Brookline Ave, Boston, MA 02215 USA.	william_kaelin@dfci.harvard.edu			NATIONAL CANCER INSTITUTE [R01CA076120, R01CA068490] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R01 CA076120, R01 CA068490] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Barrows NJ, 2010, J BIOMOL SCREEN, V15, P735, DOI 10.1177/1087057110374994; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Goff SP, 2008, CELL, V135, P417, DOI 10.1016/j.cell.2008.10.007; Khan IF, 2011, NAT PROTOC, V6, P482, DOI 10.1038/nprot.2011.301; Kittler R, 2005, P NATL ACAD SCI USA, V102, P2396, DOI 10.1073/pnas.0409861102; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599	15	117	122	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2012	337	6093					421	422		10.1126/science.1225787	http://dx.doi.org/10.1126/science.1225787			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979FS	22837515	Green Accepted			2022-12-24	WOS:000306802300029
J	Petersen, LR; Fischer, M				Petersen, Lyle R.; Fischer, Marc			Unpredictable and Difficult to Control - The Adolescence of West Nile Virus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Petersen, Lyle R.; Fischer, Marc] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA	Centers for Disease Control & Prevention - USA	Petersen, LR (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA.							[Anonymous], 2005, MMWR MORB MORTAL WKL, V54, P529; Carney RM, 2008, EMERG INFECT DIS, V14, P747, DOI 10.3201/eid1405.071347; Duprey Z, 2008, J AM MOSQUITO CONTR, V24, P42, DOI 10.2987/5559.1; Petersen LR, 2012, EPIDEMIOL I IN PRESS; Reisen WK, 2010, ANNU REV ENTOMOL, V55, P461, DOI 10.1146/annurev-ento-112408-085419	5	38	38	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 4	2012	367	14					1281	1284		10.1056/NEJMp1210537	http://dx.doi.org/10.1056/NEJMp1210537			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014WJ	23013055				2022-12-24	WOS:000309406100003
J	Guillette, LJ; Iguchi, T				Guillette, Louis J., Jr.; Iguchi, Taisen			Life in a Contaminated World	SCIENCE			English	Editorial Material							ENDOCRINE-DISRUPTING CHEMICALS; ATRAZINE		[Guillette, Louis J., Jr.] Med Univ S Carolina, Dept Obstet & Gynecol, Charleston, SC 29412 USA; [Guillette, Louis J., Jr.] Hollings Marine Lab, Charleston, SC 29412 USA; [Iguchi, Taisen] Natl Inst Basic Biol, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan	Medical University of South Carolina; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB)	Guillette, LJ (corresponding author), Med Univ S Carolina, Dept Obstet & Gynecol, 221 Ft Johnson Rd, Charleston, SC 29412 USA.	guillett@musc.edu	Iguchi, Taisen/AAL-4225-2021					Blount BC, 2006, ENVIRON HEALTH PERSP, V114, P1865, DOI 10.1289/ehp.9466; Carr JA, 2003, ENVIRON TOXICOL CHEM, V22, P396, DOI [10.1897/1551-5028(2003)022&lt;0396:ROLXLT&gt;2.0.CO;2, 10.1002/etc.5620220222]; Carson Rachel, 1994, SILENT SPRING; Crain DA, 2008, FERTIL STERIL, V90, P911, DOI 10.1016/j.fertnstert.2008.08.067; Crews D, 2011, ENVIRON HEALTH PERSP, V119, P1208, DOI 10.1289/ehp.1103451; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Gore AC, 2010, FRONT NEUROENDOCRIN, V31, P395, DOI 10.1016/j.yfrne.2010.07.003; Grun F, 2009, MOL ENDOCRINOL, V23, P1127, DOI 10.1210/me.2008-0485; Hamlin HJ, 2011, BIRTH DEFECTS RES C, V93, P19, DOI 10.1002/bdrc.20202; Hayes TB, 2002, P NATL ACAD SCI USA, V99, P5476, DOI 10.1073/pnas.082121499; Hayes TB, 2004, BIOSCIENCE, V54, P1138, DOI 10.1641/0006-3568(2004)054[1138:TINDTD]2.0.CO;2; Hayes TB, 2011, J STEROID BIOCHEM, V127, P64, DOI 10.1016/j.jsbmb.2011.03.015; Heckel DG, 2012, SCIENCE, V337, P1613, DOI 10.1126/science.1226994; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Kloas W, 2009, ANN NY ACAD SCI, V1163, P437, DOI 10.1111/j.1749-6632.2009.04456.x; Myers JP, 2009, ENVIRON HEALTH PERSP, V117, P309, DOI 10.1289/ehp.0800173; Nilsson E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036129; Rahman MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040825; Sharpe RM, 2011, NAT REV ENDOCRINOL, V7, P633, DOI 10.1038/nrendo.2011.165; Skinner MK, 2010, TRENDS ENDOCRIN MET, V21, P214, DOI 10.1016/j.tem.2009.12.007; Spearow JL, 1999, SCIENCE, V285, P1259, DOI 10.1126/science.285.5431.1259; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050	22	51	52	4	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2012	337	6102					1614	1615		10.1126/science.1226985	http://dx.doi.org/10.1126/science.1226985			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	23019638				2022-12-24	WOS:000309215400031
J	Taylor, CM; de Jeu, RAM; Guichard, F; Harris, PP; Dorigo, WA				Taylor, Christopher M.; de Jeu, Richard A. M.; Guichard, Francoise; Harris, Phil P.; Dorigo, Wouter A.			Afternoon rain more likely over drier soils	NATURE			English	Article							BOUNDARY LAYER INTERACTIONS; PART II; ATMOSPHERIC CONTROLS; DIURNAL CYCLE; UNITED-STATES; MOISTURE; PRECIPITATION; LAND; CONVECTION; FEEDBACK	Land surface properties, such as vegetation cover and soil moisture, influence the partitioning of radiative energy between latent and sensible heat fluxes in daytime hours. During dry periods, soil-water deficit can limit evapotranspiration, leading to warmer and drier conditions in the lower atmosphere(1,2). Soil moisture can influence the development of convective storms through such modifications of low-level atmospheric temperature and humidity(1,3), which in turn feeds back on soil moisture. Yet there is considerable uncertainty in how soil moisture affects convective storms across the world, owing to a lack of observational evidence and uncertainty in large-scale models(4). Here we present a global-scale observational analysis of the coupling between soil moisture and precipitation. We show that across all six continents studied, afternoon rain falls preferentially over soils that are relatively dry compared to the surrounding area. The signal emerges most clearly in the observations over semi-arid regions, where surface fluxes are sensitive to soil moisture, and convective events are frequent. Mechanistically, our results are consistent with enhanced afternoon moist convection driven by increased sensible heat flux over drier soils, and/or mesoscale variability in soil moisture. We find no evidence in our analysis of a positive feedback-that is, a preference for rain over wetter soils-at the spatial scale (50-100 kilometres) studied. In contrast, we find that a positive feedback of soil moisture on simulated precipitation does dominate in six state-of-the-art global weather and climate models-a difference that may contribute to excessive simulated droughts in large-scale models.	[Taylor, Christopher M.; Harris, Phil P.] NERC Ctr Ecol & Hydrol, Wallingford OX10 8BB, Oxon, England; [de Jeu, Richard A. M.] Vrije Univ Amsterdam, Dept Earth Sci, Fac Earth & Life Sci, NL-1081 HV Amsterdam, Netherlands; [Guichard, Francoise] CNRM GAME CNRS, F-31057 Toulouse, France; [Guichard, Francoise] Meteo France, F-31057 Toulouse, France; [Dorigo, Wouter A.] Vienna Univ Technol, Inst Photogrammetry & Remote Sensing IPF, A-1040 Vienna, Austria	UK Centre for Ecology & Hydrology (UKCEH); Vrije Universiteit Amsterdam; Centre National de la Recherche Scientifique (CNRS); Technische Universitat Wien	Taylor, CM (corresponding author), NERC Ctr Ecol & Hydrol, Maclean Bldg,Benson Lane, Wallingford OX10 8BB, Oxon, England.	cmt@ceh.ac.uk	Taylor, Christopher/Y-7529-2019; Taylor, Chris/K-2319-2012; Dorigo, Wouter A/C-7794-2014; de Jeu, Richard/AAE-6922-2019; Harris, Phil P/A-1933-2010	Taylor, Chris/0000-0002-0120-3198; Dorigo, Wouter A/0000-0001-8054-7572; Harris, Phil P/0000-0002-4834-7746	European Union (FP6) WATCH Integrated Project [036946]; UK National Centre for Earth Observation; European Space Agency STSE Water Cycle Multi-mission Observation Strategy (WACMOS) project (ESRIN) [22086/08/I-EC]; NERC [NE/G018499/1, earth010002] Funding Source: UKRI; Natural Environment Research Council [earth010002, NE/G018499/1, NE/B505538/1, ceh010023] Funding Source: researchfish	European Union (FP6) WATCH Integrated Project; UK National Centre for Earth Observation; European Space Agency STSE Water Cycle Multi-mission Observation Strategy (WACMOS) project (ESRIN); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was partly funded by the European Union (FP6) WATCH Integrated Project (contract 036946), the UK National Centre for Earth Observation and the European Space Agency STSE Water Cycle Multi-mission Observation Strategy (WACMOS) project (ESRIN/contract number 22086/08/I-EC. We thank A. Beljaars, S. Seneviratne and D. Parker for discussions on this topic. We also thank the CMORPH, TRMM, PERSIANN and GPROF teams for the provision of their precipitation data, the World Climate Research Programme's Working Group on Coupled Modelling, and the centres who provided modelling data in Figure 3.	ANTHES RA, 1984, J CLIM APPL METEOROL, V23, P541, DOI 10.1175/1520-0450(1984)023<0541:EOCPBM>2.0.CO;2; Bartalis Z, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031088; Betts AK, 1998, J ATMOS SCI, V55, P1091, DOI 10.1175/1520-0469(1998)055<1091:FSCASA>2.0.CO;2; Carleton AM, 2008, J CLIMATE, V21, P3617, DOI 10.1175/2007JCLI1584.1; Cheng WYY, 2004, J HYDROMETEOROL, V5, P934, DOI 10.1175/1525-7541(2004)005<0934:SOACSO>2.0.CO;2; Dai A, 2006, J CLIMATE, V19, P4605, DOI 10.1175/JCLI3884.1; Ek MB, 2004, J HYDROMETEOROL, V5, P86, DOI 10.1175/1525-7541(2004)005<0086:IOSMOB>2.0.CO;2; Eltahir EAB, 1998, WATER RESOUR RES, V34, P765, DOI 10.1029/97WR03499; Ferguson CR, 2011, J HYDROMETEOROL, V12, P1221, DOI 10.1175/2011JHM1380.1; Findell KL, 2011, NAT GEOSCI, V4, P434, DOI [10.1038/NGEO1174, 10.1038/ngeo1174]; Findell KL, 1997, WATER RESOUR RES, V33, P725, DOI 10.1029/96WR03756; Findell KL, 2003, J HYDROMETEOROL, V4, P570, DOI 10.1175/1525-7541(2003)004<0570:ACOSML>2.0.CO;2; Findell KL, 2003, J HYDROMETEOROL, V4, P552, DOI 10.1175/1525-7541(2003)004<0552:ACOSML>2.0.CO;2; Fischer EM, 2007, J CLIMATE, V20, P5081, DOI 10.1175/JCLI4288.1; Goessling HF, 2011, HYDROL EARTH SYST SC, V15, P3217, DOI 10.5194/hess-15-3217-2011; Guichard F, 2004, Q J ROY METEOR SOC, V130, P3139, DOI 10.1256/qj.03.145; Guo ZC, 2006, J HYDROMETEOROL, V7, P611, DOI 10.1175/JHM511.1; Hohenegger C, 2009, J CLIMATE, V22, P5003, DOI 10.1175/2009JCLI2604.1; Joyce RJ, 2004, J HYDROMETEOROL, V5, P487, DOI 10.1175/1525-7541(2004)005<0487:CAMTPG>2.0.CO;2; Koster RD, 2004, SCIENCE, V305, P1138, DOI 10.1126/science.1100217; McCrary RR, 2010, J CLIMATE, V23, P2178, DOI 10.1175/2009JCLI3061.1; OOKOUCHI Y, 1984, MON WEATHER REV, V112, P2281, DOI 10.1175/1520-0493(1984)112<2281:EOSMEO>2.0.CO;2; Owe M, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2007JF000769; Santanello JA, 2011, J HYDROMETEOROL, V12, P766, DOI 10.1175/JHM-D-10-05014.1; Taylor CM, 2011, NAT GEOSCI, V4, P430, DOI 10.1038/ngeo1173; Taylor CM, 1998, MON WEATHER REV, V126, P1597, DOI 10.1175/1520-0493(1998)126<1597:OEOPCS>2.0.CO;2; van der Ent RJ, 2010, WATER RESOUR RES, V46, DOI 10.1029/2010WR009127; Wang JF, 2009, P NATL ACAD SCI USA, V106, P3670, DOI 10.1073/pnas.0810156106; WEBSTER PJ, 1983, J ATMOS SCI, V40, P2110, DOI 10.1175/1520-0469(1983)040<2110:MOMLFV>2.0.CO;2; Zhang YY, 2010, J ATMOS SCI, V67, P2943, DOI 10.1175/2010JAS3366.1	30	393	405	20	251	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2012	489	7416					423	426		10.1038/nature11377	http://dx.doi.org/10.1038/nature11377			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AK	22972193	Green Accepted			2022-12-24	WOS:000308860900043
J	McClelland, L				McClelland, Laura			Terminally ill people shouldn't have to travel abroad for assisted dying	BRITISH MEDICAL JOURNAL			English	Editorial Material									Prince Charles Hosp, Merthyr Tydfil, M Glam, Wales		McClelland, L (corresponding author), Prince Charles Hosp, Merthyr Tydfil, M Glam, Wales.	doctormac@doctors.org.uk							0	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 14	2012	345								e6201	10.1136/bmj.e6201	http://dx.doi.org/10.1136/bmj.e6201			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	007BZ	22983534				2022-12-24	WOS:000308865100006
J	von Messling, V; Cattaneo, R				von Messling, Veronika; Cattaneo, Roberto			A Henipavirus Vaccine in Sight	SCIENCE			English	Editorial Material							NIPAH VIRUS; REACTIVITY; PROTECTS; MEASLES; HENDRA		[von Messling, Veronika] Duke NUS Grad Med Sch Singapore, Emerging Infect Dis Program, Singapore 169857, Singapore; [Cattaneo, Roberto] Mayo Clin, Dept Mol Med, Coll Med, Rochester, MN 55905 USA	National University of Singapore; Mayo Clinic	von Messling, V (corresponding author), Duke NUS Grad Med Sch Singapore, Emerging Infect Dis Program, Singapore 169857, Singapore.	veronika.vonmessling@duke-nus.edu.sg; cattaneo.roberto@mayo.edu						Balzer M, 2011, AUST VET J, V89, pN2; Bossart KN, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004241; Callaway T. R., 2004, Animal Health Research Reviews, V5, P35, DOI 10.1079/AHR200462; Chua KB, 1999, LANCET, V354, P1257, DOI 10.1016/S0140-6736(99)04299-3; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Drexler JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1796; FULGINITI VA, 1967, J AMER MED ASSOC, V202, P1075, DOI 10.1001/jama.202.12.1075; KAPIKIAN AZ, 1969, AM J EPIDEMIOL, V89, P405, DOI 10.1093/oxfordjournals.aje.a120954; Luby SP, 2009, CLIN INFECT DIS, V49, P1743, DOI 10.1086/647951; Marsh GA, 2012, CURR OPIN VIROL, V2, P242, DOI 10.1016/j.coviro.2012.03.006; McEachern JA, 2008, VACCINE, V26, P3842, DOI 10.1016/j.vaccine.2008.05.016; Pallister J, 2011, VACCINE, V29, P5623, DOI 10.1016/j.vaccine.2011.06.015; Playford EG, 2010, EMERG INFECT DIS, V16, P219, DOI 10.3201/eid1602.090552; West R, 1999, BIODRUGS, V12, P423, DOI 10.2165/00063030-199912060-00002	14	2	2	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2012	337	6095					651	652		10.1126/science.1227810	http://dx.doi.org/10.1126/science.1227810			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986PE	22879489				2022-12-24	WOS:000307354500026
J	Mayor, S				Mayor, Susan			Advertising watchdog orders website to remove claims linking MMR vaccine with autism	BRITISH MEDICAL JOURNAL			English	News Item																		BabyJabs, MMR VACC	1	1	1	0	17	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 9	2012	345								e5420	10.1136/bmj.e5420	http://dx.doi.org/10.1136/bmj.e5420			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988NF	22879643				2022-12-24	WOS:000307497000004
J	Rabar, S; Lau, R; O'Flynn, N; Li, LL; Barry, P				Rabar, Silvia; Lau, Rosa; O'Flynn, Norma; Li, Lilian; Barry, Peter		Guideline Dev Grp	Risk assessment of fragility fractures: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Rabar, Silvia; Lau, Rosa; O'Flynn, Norma; Li, Lilian] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England; [Barry, Peter] Leicester Royal Infirm, Dept Child Hlth, Leicester LE2 7LX, Leics, England	Royal College of Physicians; University of Leicester	Rabar, S (corresponding author), Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England.	silvia.rabar@rcplondon.ac.uk	Collins, Gary Stephen/A-2258-2014	Collins, Gary Stephen/0000-0002-2772-2316; Selby, Peter/0000-0001-9465-9268				Kanis JA, 2007, 20041068 USGS; National Institute for Health and Care Excellence, 2012, NICE CLIN GUID 146 O	2	55	54	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 8	2012	345								e3698	10.1136/bmj.e3698	http://dx.doi.org/10.1136/bmj.e3698			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988ND	22875946				2022-12-24	WOS:000307496800008
J	Sobotnik, J; Bourguignon, T; Hanus, R; Demianova, Z; Pytelkova, J; Mares, M; Foltynova, P; Preisler, J; Cvacka, J; Krasulova, J; Roisin, Y				Sobotnik, J.; Bourguignon, T.; Hanus, R.; Demianova, Z.; Pytelkova, J.; Mares, M.; Foltynova, P.; Preisler, J.; Cvacka, J.; Krasulova, J.; Roisin, Y.			Explosive Backpacks in Old Termite Workers	SCIENCE			English	Article									[Sobotnik, J.; Hanus, R.; Demianova, Z.; Pytelkova, J.; Mares, M.; Cvacka, J.; Krasulova, J.] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague 16610, Czech Republic; [Bourguignon, T.; Hanus, R.; Roisin, Y.] Univ Libre Bruxelles, B-1050 Brussels, Belgium; [Bourguignon, T.] Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido 0600810, Japan; [Foltynova, P.; Preisler, J.] Masaryk Univ, Fac Sci, CEITEC Cent European Inst Technol, Brno 62500, Czech Republic; [Foltynova, P.; Preisler, J.] Masaryk Univ, Fac Sci, Dept Chem, Brno 62500, Czech Republic; [Krasulova, J.] Charles Univ Prague, Fac Sci, Dept Analyt Chem, Prague 12843, Czech Republic	Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Universite Libre de Bruxelles; Hokkaido University; Masaryk University Brno; Masaryk University Brno; Charles University Prague	Hanus, R (corresponding author), Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague 16610, Czech Republic.	robert@uochb.cas.cz	Hanus, Robert/D-4765-2013; Preisler, Jan/B-2005-2009; Pytelkova, Jana/G-6179-2014; Cvačka, Josef/A-6126-2014; Krasulova, Jana/G-8107-2014; Mares, Michael/B-2413-2009; Foltynova, Pavla/B-6856-2012	Hanus, Robert/0000-0002-7054-1975; Preisler, Jan/0000-0002-9819-1284; Cvačka, Josef/0000-0002-3590-9009; Mares, Michael/0000-0002-0847-5022; Foltynova, Pavla/0000-0002-4768-1910; demianova, zuzana/0000-0003-2822-2177; Roisin, Yves/0000-0001-6635-3552; Sobotnik, Jan/0000-0002-8581-637X; Bourguignon, Thomas/0000-0002-4035-8977	Fund for Scientific Research (F.R.S.-FNRS, Belgium); Japan Society for Promotion of Science [22-00393]; Grant Agency of the Czech Republic [P600/525/09, P206/12/0538]; Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic [Z40550506]; CEITEC from the European Regional Development Fund [CZ.1.05/1.1.00/02.0068]	Fund for Scientific Research (F.R.S.-FNRS, Belgium)(Fonds de la Recherche Scientifique - FNRS); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic(Czech Academy of Sciences); CEITEC from the European Regional Development Fund	We are grateful to P. Cerdan and the staff of the Hydreco lab at Petit Saut for logistical help. Support was provided by the Fund for Scientific Research (F.R.S.-FNRS, Belgium); the Japan Society for Promotion of Science (no. 22-00393); the Grant Agency of the Czech Republic (P600/525/09, P206/12/0538); the Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic (Z40550506); and the project CEITEC (CZ.1.05/1.1.00/02.0068) from the European Regional Development Fund. The data reported in this paper are presented in the supplementary materials.	Bourguignon T, 2011, ECOL ENTOMOL, V36, P261, DOI 10.1111/j.1365-2311.2011.01265.x; Decker H, 2000, TRENDS BIOCHEM SCI, V25, P392, DOI 10.1016/S0968-0004(00)01602-9; Holldobler B., 1990, pi; Kaiser P., 1956, Mitteilungen der Hamburgischen Zoologischen Museum, V54, P129; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; Shorter JR, 2012, INSECT SOC, V59, P1, DOI 10.1007/s00040-011-0210-x; Sobotnik J, 2010, J INSECT PHYSIOL, V56, P1012, DOI 10.1016/j.jinsphys.2010.02.012	7	46	49	1	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2012	337	6093					436	436		10.1126/science.1219129	http://dx.doi.org/10.1126/science.1219129			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979FS	22837520				2022-12-24	WOS:000306802300034
J	Haley, RW				Haley, Robert W.			Controlling Urban Epidemics of West Nile Virus Infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COUNTY		Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Epidemiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Haley, RW (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Epidemiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Robert.Haley@UTSouthwestern.edu	Haley, Robert/P-9026-2014	Haley, Robert/0000-0001-8849-9579				Centers for Disease Control and Prevention, 2012, W NIL VIR INF GUID C; Centers for Disease Control and Prevention, 2012, MOSQ STUD; Chung W, 2012, W NILE VIRUS OUTBREA; Dallas County Medical Society, 2012, DCMS PHYS D MCCOY MD; Goodman Denise M, 2012, JAMA, V308, P1052, DOI 10.1001/2012.jama.11678; Macedo PA, 2010, J AM MOSQUITO CONTR, V26, P57, DOI 10.2987/09-5961.1; National Pesticide Telecommunications Network, 1998, PYR PYR; Petersen LR, 2003, JAMA-J AM MED ASSOC, V290, P524, DOI 10.1001/jama.290.4.524; Savage HM, 2008, J MED ENTOMOL, V45, P276, DOI 10.1603/0022-2585(2008)45[276:HHHAPA]2.0.CO;2	9	9	10	2	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 3	2012	308	13					1325	1326		10.1001/2012.jama.11930	http://dx.doi.org/10.1001/2012.jama.11930			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014IV	22922679	Bronze			2022-12-24	WOS:000309369300023
J	Ball, LT; Lloyd-Jones, GC; Russell, CA				Ball, Liam T.; Lloyd-Jones, Guy C.; Russell, Christopher A.			Gold-Catalyzed Direct Arylation	SCIENCE			English	Article							(HETERO)ARENES; OXYARYLATION	Biaryls (two directly connected aromatic rings, Ar-1-Ar-2) are common motifs in pharmaceuticals, agrochemicals, and organic materials. Current methods for establishing the Ar-1-Ar-2 bond are dominated by the cross-coupling of aryl halides (Ar-1-X) with aryl metallics (Ar-2-M). We report that, in the presence of 1 to 2 mole percent of a gold catalyst and a mild oxidant, a wide range of arenes (Ar-1-H) undergo site-selective arylation by arylsilanes (Ar-2-SiMe3) to generate biaryls (Ar-1-Ar-2), with little or no homocoupling (Ar-1-Ar-1/Ar-2-Ar-2). Catalysis proceeds at room temperature and tolerates a broad range of functional groups, including those incompatible with cross-coupling. These features expedite biaryl preparation, as demonstrated by synthesis of the nonsteroidal anti-inflammatory diflunisal.					Lloyd-Jones, Guy/A-3417-2009	Russell, Christopher/0000-0003-2921-5278; Ball, Liam/0000-0003-3849-9006; Lloyd-Jones, Guy/0000-0003-2128-6864	Engineering and Physical Sciences Research Council [EP/G036764/1]; AstraZeneca; GlaxoSmithKline; Novartis; Pfizer; Syngenta; University of Bristol; Royal Society	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); AstraZeneca(AstraZeneca); GlaxoSmithKline(GlaxoSmithKline); Novartis(Novartis); Pfizer(Pfizer); Syngenta(Syngenta); University of Bristol; Royal Society(Royal Society of London)	Experimental procedures and compound characterization data are both presented in the supplementary materials. L. T. B., G.C.L.-J., and C. A. R contributed equally to the conception and direction of this work and to the preparation of the manuscript. L. T. B. conducted all of the experimental work. We thank Umicore AG & Co. KG for the generous donation of HAuCl<INF>4</INF>. L. T. B. thanks the Bristol Chemical Synthesis Doctoral Training Centre, funded by the Engineering and Physical Sciences Research Council (grant EP/G036764/1); AstraZeneca; GlaxoSmithKline; Novartis; Pfizer; Syngenta; and the University of Bristol, for the provision of a Ph.D. studentship. G.C.L.-J. is a Royal Society Wolfson Research Merit Award holder.	Ackermann L, 2009, ANGEW CHEM INT EDIT, V48, P9792, DOI 10.1002/anie.200902996; Alberico D, 2007, CHEM REV, V107, P174, DOI 10.1021/cr0509760; Ball LT, 2012, CHEM-EUR J, V18, P2931, DOI 10.1002/chem.201103061; Ball LT, 2010, ORG LETT, V12, P4724, DOI 10.1021/ol1019162; Ciana CL, 2011, ANGEW CHEM INT EDIT, V50, P458, DOI 10.1002/anie.201004703; Funaki K, 2011, CHEM LETT, V40, P1050, DOI 10.1246/cl.2011.1050; Hachiya H, 2010, ANGEW CHEM INT EDIT, V49, P2202, DOI 10.1002/anie.200906996; HANNAH J, 1978, J MED CHEM, V21, P1093, DOI 10.1021/jm00209a001; Kar A, 2008, CHEM COMMUN, P386, DOI 10.1039/b714928j; Kar A, 2009, J ORGANOMET CHEM, V694, P524, DOI 10.1016/j.jorganchem.2008.11.016; Lafrance M, 2006, J AM CHEM SOC, V128, P16496, DOI 10.1021/ja067144j; Li BJ, 2011, CHEM-EUR J, V17, P1728, DOI 10.1002/chem.201002273; Lyons TW, 2010, CHEM REV, V110, P1147, DOI 10.1021/cr900184e; McGlacken GP, 2009, CHEM SOC REV, V38, P2447, DOI 10.1039/b805701j; Neufeldt SR, 2012, ACCOUNTS CHEM RES, V45, P936, DOI 10.1021/ar300014f; NORMAN ROC, 1976, J CHEM SOC PERK T 1, P1983, DOI 10.1039/p19760001983; Phipps RJ, 2009, SCIENCE, V323, P1593, DOI 10.1126/science.1169975; Rombke P, 2001, J CHEM SOC DALTON, P2482, DOI 10.1039/b104001b; Ruyle W. V., 1973, U. S. Patent, Patent No. [3,714,226, 3714226]; Seechurn CCCJ, 2012, ANGEW CHEM INT EDIT, V51, P5062, DOI 10.1002/anie.201107017; Taylor R., 1990, ELECTROPHILIC AROMAT; Tsuji J., 2004, PALLADIUM REAGENTS C; Wen J, 2008, ANGEW CHEM INT EDIT, V47, P8897, DOI 10.1002/anie.200802526; Yang SD, 2008, ANGEW CHEM INT EDIT, V47, P1473, DOI 10.1002/anie.200704619	24	266	274	3	163	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2012	337	6102					1644	1648		10.1126/science.1225709	http://dx.doi.org/10.1126/science.1225709			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	23019647	Green Accepted			2022-12-24	WOS:000309215400042
J	Weber, T; Deutsch, C				Weber, Thomas; Deutsch, Curtis			Oceanic nitrogen reservoir regulated by plankton diversity and ocean circulation	NATURE			English	Article							TO-PHOSPHORUS STOICHIOMETRY; MARINE PROCHLOROCOCCUS; ELEMENTAL COMPOSITION; COMMUNITY STRUCTURE; NUTRIENT RATIOS; SOUTHERN-OCEAN; PHYTOPLANKTON; FIXATION; DENITRIFICATION; IRON	The average nitrogen-to-phosphorus ratio of marine phytoplankton (16N:1P) is closely matched to the nutrient content of mean ocean waters (14.3N:1P). This condition is thought to arise from biological control over the ocean's nitrogen budget, in which removal of bioavailable nitrogen by denitrifying bacteria ensures widespread selection for diazotrophic phytoplankton that replenish this essential nutrient when it limits the growth of other species(1-3). Here we show that in the context of a realistic ocean circulation model, and a uniform N:P ratio of plankton biomass, this feedback mechanism yields an oceanic nitrate deficit more than double its observed value. The critical missing phenomenon is diversity in the metabolic N: P requirement of phytoplankton, which has recently been shown to exhibit large-scale patterns associated with species composition(4). When we model these variations, such that diazotrophs compete with high N: P communities in subtropical regions, the ocean nitrogen inventory rises and may even exceed the average N: P ratio of plankton. The latter condition, previously considered impossible, is prevented in the modern ocean by shallow circulations that communicate stoichiometric signals from remote biomes dominated by diatoms with low N: P ratios. Large-scale patterns of plankton diversity and the circulation pathways connecting them are thus key factors determining the availability of fixed nitrogen in the ocean.	[Weber, Thomas; Deutsch, Curtis] Univ Calif Los Angeles, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Weber, T (corresponding author), Univ Calif Los Angeles, Los Angeles, CA 90095 USA.	tweber@atmos.ucla.edu			NASA Earth Systems Science Fellowship; Gordon and Betty Moore Foundation	NASA Earth Systems Science Fellowship; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	We thank T. DeVries for providing the ocean circulation model. This work was funded by a NASA Earth Systems Science Fellowship (T. W.) and a grant from the Gordon and Betty Moore Foundation (C.D.).	Alvain S, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003154; Arrigo KR, 1999, SCIENCE, V283, P365, DOI 10.1126/science.283.5400.365; Berman-Frank I, 2001, LIMNOL OCEANOGR, V46, P1249, DOI 10.4319/lo.2001.46.6.1249; Bertilsson S, 2003, LIMNOL OCEANOGR, V48, P1721, DOI 10.4319/lo.2003.48.5.1721; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P352, DOI 10.1029/98PA00920; Brzezinski MA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014349; Capone DG, 1997, SCIENCE, V276, P1221, DOI 10.1126/science.276.5316.1221; CODISPOTI LA, 1995, NATURE, V376, P724, DOI 10.1038/376724a0; CODISPOTI LA, 1989, LIFE SCI R, V44, P377; Deutsch C, 2007, NATURE, V445, P163, DOI 10.1038/nature05392; Deutsch C, 2012, ANNU REV MAR SCI, V4, P113, DOI 10.1146/annurev-marine-120709-142821; DeVries T, 2012, NAT GEOSCI, V5, P547, DOI [10.1038/ngeo1515, 10.1038/NGEO1515]; DeVries T, 2011, J PHYS OCEANOGR, V41, P2381, DOI 10.1175/JPO-D-10-05011.1; EGGE JK, 1992, MAR ECOL PROG SER, V83, P281, DOI 10.3354/meps083281; Falkowski PG, 2000, J PHYCOL, V36, P3, DOI 10.1046/j.1529-8817.2000.99161.x; Green SE, 2006, DEEP-SEA RES PT II, V53, P620, DOI 10.1016/j.dsr2.2006.01.022; Heldal M, 2003, LIMNOL OCEANOGR, V48, P1732, DOI 10.4319/lo.2003.48.5.1732; Jin X, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002532; Karl D, 2002, BIOGEOCHEMISTRY, V57, P47, DOI 10.1023/A:1015798105851; Karl DM, 2001, DEEP-SEA RES PT II, V48, P1529, DOI 10.1016/S0967-0645(00)00152-1; Khatiwala S, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2007GB002923; Klausmeier CA, 2004, NATURE, V429, P171, DOI 10.1038/nature02454; Kustka A, 2002, RES MICROBIOL, V153, P255, DOI 10.1016/S0923-2508(02)01325-6; Kwon EY, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002631; Lam P, 2011, ANNU REV MAR SCI, V3, P317, DOI 10.1146/annurev-marine-120709-142814; Lenton TM, 2007, BIOGEOSCIENCES, V4, P353, DOI 10.5194/bg-4-353-2007; Lenton TM, 2000, GLOBAL BIOGEOCHEM CY, V14, P225, DOI 10.1029/1999GB900065; MARTIN JH, 1989, DEEP-SEA RES, V36, P649, DOI 10.1016/0198-0149(89)90144-1; Middelburg JJ, 1996, GLOBAL BIOGEOCHEM CY, V10, P661, DOI 10.1029/96GB02562; Mills MM, 2010, NAT GEOSCI, V3, P412, DOI 10.1038/NGEO856; Polovina JJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031745; Quigg A, 2003, NATURE, V425, P291, DOI 10.1038/nature01953; Redfield A. C, 1963, SEA, P26, DOI DOI 10.1016/J.ORGGEOCHEM.2014.06.002; REDFIELD AC, 1958, AM SCI, V46, P205; Sarmiento J.L., 2013, OCEAN BIOGEOCHEMICAL, DOI [DOI 10.2307/J.CTT3FGXQX, 10.1515/9781400849079, DOI 10.1515/9781400849079]; Tyrrell T, 1999, NATURE, V400, P525, DOI 10.1038/22941; Ward BB, 2009, NATURE, V461, P78, DOI 10.1038/nature08276; Weber TS, 2010, NATURE, V467, P550, DOI 10.1038/nature09403	38	76	78	6	176	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2012	489	7416					419	U105		10.1038/nature11357	http://dx.doi.org/10.1038/nature11357			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AK	22996557				2022-12-24	WOS:000308860900042
J	Morrato, EH; Allison, DB				Morrato, Elaine H.; Allison, David B.			FDA Approval of Obesity Drugs A Difference in Risk-Benefit Perceptions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ROFECOXIB		[Morrato, Elaine H.] Univ Colorado Denver, Dept Hlth Syst Management & Policy, Aurora, CO 80045 USA; [Allison, David B.] Univ Alabama Birmingham, Off Energet, Nutr & Obes Res Ctr, Birmingham, AL USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Alabama System; University of Alabama Birmingham	Morrato, EH (corresponding author), Univ Colorado Denver, Dept Hlth Syst Management & Policy, 13199 E Montview Blvd,Ste 300,Mail Stop F443, Aurora, CO 80045 USA.	elaine.morrato@ucdenver.edu		Allison, David/0000-0003-3566-9399	AHRQ HHS [K12 HS019464, K12HS019464] Funding Source: Medline; NIDDK NIH HHS [P30 DK056336, P30DK056336] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K12HS019464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056336] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BERLIN SB, 1990, SOC SERV REV, V64, P46, DOI 10.1086/603741; Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs, 2012, ETH SCI ISS STUD SAF; Juni P, 2004, LANCET, V364, P2021, DOI 10.1016/S0140-6736(04)17514-4; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Topol EJ, 2004, NEW ENGL J MED, V351, P1707, DOI 10.1056/NEJMp048286; US Department of Health and Human Services Food and Drug Administration (FDA), 2012 M END MET DRUGS; [US Department of Health and Human Services Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER)], 2007, GUID IND DEV PROD WE	7	9	10	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	2012	308	11					1097	1098		10.1001/jama.2012.10007	http://dx.doi.org/10.1001/jama.2012.10007			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	007AL	22990266	Green Accepted			2022-12-24	WOS:000308861000023
J	Andreux, PA; Williams, EG; Koutnikova, H; Houtkooper, RH; Champy, MF; Henry, H; Schoonjans, K; Williams, RW; Auwerx, J				Andreux, Penelope A.; Williams, Evan G.; Koutnikova, Hana; Houtkooper, Riekelt H.; Champy, Marie-France; Henry, Hugues; Schoonjans, Kristina; Williams, Robert W.; Auwerx, Johan			Systems Genetics of Metabolism: The Use of the BXD Murine Reference Panel for Multiscalar Integration of Traits	CELL			English	Article							INNATE IMMUNITY; COMPLEX TRAITS; DISSECTION; SUBSTITUTION; ASSOCIATION; REGULATOR; GENOMICS; VARIANT; LOCI; MASS	Metabolic homeostasis is achieved by complex molecular and cellular networks that differ significantly among individuals and are difficult to model with genetically engineered lines of mice optimized to study single gene function. Here, we systematically acquired metabolic phenotypes by using the EUMODIC EMPReSS protocols across a large panel of isogenic but diverse strains of mice (BXD type) to study the genetic control of metabolism. We generated and analyzed 140 classical phenotypes and deposited these in an open-access web service for systems genetics (www.genenetwork.org). Heritability, influence of sex, and genetic modifiers of traits were examined singly and jointly by using quantitative-trait locus (QTL) and expression QTL-mapping methods. Traits and networks were linked to loci encompassing both known variants and novel candidate genes, including alkaline phosphatase (ALPL), here linked to hypophosphatasia. The assembled and curated phenotypes provide key resources and exemplars that can be used to dissect complex metabolic traits and disorders.	[Williams, Robert W.] Univ Tennessee, Hlth Sci Ctr, Ctr Integrat & Translat Genom, Dept Anat & Neurobiol, Memphis, TN 38163 USA; [Andreux, Penelope A.; Williams, Evan G.; Houtkooper, Riekelt H.; Schoonjans, Kristina; Auwerx, Johan] Ecole Polytech Fed Lausanne, Sch Life Sci, Lab Integrat & Syst Physiol, CH-1015 Lausanne, Switzerland; [Koutnikova, Hana; Champy, Marie-France; Auwerx, Johan] Inst Clin Souris, F-67404 Illkirch Graffenstaden, France; [Henry, Hugues] CHU Vaudois, CH-1011 Lausanne, Switzerland	University of Tennessee System; University of Tennessee Health Science Center; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Williams, RW (corresponding author), Univ Tennessee, Hlth Sci Ctr, Ctr Integrat & Translat Genom, Dept Anat & Neurobiol, Memphis, TN 38163 USA.	rwilliams@uthsc.edu; admin.auwerx@epfl.ch	Koutnikova, Hana/I-7758-2017; Auwerx, Johan/ABE-9307-2021; Houtkooper, Riekelt H/E-1602-2011; Houtkooper, Riekelt/P-5001-2019; Williams, Robert W./H-8789-2016	Houtkooper, Riekelt H/0000-0001-9961-0842; Auwerx, Johan/0000-0002-5065-5393; Williams, Evan/0000-0002-9746-376X; Williams, Robert W./0000-0001-8924-4447; Schoonjans, Kristina/0000-0003-1247-4265	Rubicon fellowship of the NWO; Ecole Polytechnique Federale de Lausanne; EU Ideas program [ERC-2008-AdG-23118]; Velux Stiftung; Swiss National Science Foundation [31003A-124713, 31003A-125487, CSRII3-136201]; NIH [P20-DA 21131, UO1AA13499, U01AA14425]; UT Center for Integrative and Translational Genomics; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA014425, U01AA016662, U01AA017590, U01AA013499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P20DA021131] Funding Source: NIH RePORTER	Rubicon fellowship of the NWO; Ecole Polytechnique Federale de Lausanne; EU Ideas program; Velux Stiftung; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UT Center for Integrative and Translational Genomics; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We would like to thank Laurent Pouilly, Tania Sorg, Hongbo Zhang, and Ulrike Kettenberger for technical assistance with various aspects of mouse phenotyping. Discussions with Thomas Vogt (Merck Research Laboratories), Carmen Argmann and Sander Houten (University of Amsterdam), Vincent Mooser (CHUV), Stephan Morgenthaler (EPFL), Dominique Pioletti (EPFL), Bernard Thorens (UNIL), Paul Franken (UNIL), and Ioannis Xenarios (UNIL) and the team members of the Auwerx lab are acknowledged. R.H.H. is supported by a Rubicon fellowship of the NWO. J.A. is the Nestle Chair in Energy Metabolism and the J.A./K.S. laboratory is supported by grants of the Ecole Polytechnique Federale de Lausanne, the EU Ideas program (ERC-2008-AdG-23118), the Velux Stiftung, the Swiss National Science Foundation (31003A-124713, 31003A-125487, and the Sinergia grant CSRII3-136201). R.W.W. and GeneNetwork are supported by NIH (P20-DA 21131 UO1AA13499 and U01AA14425) and the UT Center for Integrative and Translational Genomics.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Andersen EC, 2012, NAT GENET, V44, P285, DOI 10.1038/ng.1050; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Astner I, 2005, EMBO J, V24, P3166, DOI 10.1038/sj.emboj.7600792; Auwerx J, 2006, NAT MED, V12, P44, DOI 10.1038/nm0106-44; Auwerx J, 2004, NAT GENET, V36, P925, DOI 10.1038/ng0904-925; Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Bystrykh L, 2005, NAT GENET, V37, P225, DOI 10.1038/ng1497; Champy MF, 2008, MAMM GENOME, V19, P318, DOI 10.1007/s00335-008-9107-z; Champy MF, 2004, MAMM GENOME, V15, P768, DOI 10.1007/s00335-004-2393-1; Chen HN, 2005, DIABETES, V54, P1437, DOI 10.2337/diabetes.54.5.1437; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Chesler EJ, 2004, NAT NEUROSCI, V7, P485, DOI 10.1038/nn0504-485; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Ehrenreich IM, 2010, NATURE, V464, P1039, DOI 10.1038/nature08923; Fossey SC, 2001, GENOMICS, V76, P45, DOI 10.1006/geno.2001.6584; Gaglani SM, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-44; Gatti D, 2007, HEPATOLOGY, V46, P548, DOI 10.1002/hep.21682; Haack TB, 2010, NAT GENET, V42, P1131, DOI 10.1038/ng.706; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Joshi MA, 2006, BIOCHEM J, V400, P153, DOI 10.1042/BJ20060869; Kelsall IR, 2009, CELL SIGNAL, V21, P1123, DOI 10.1016/j.cellsig.2009.03.001; King EG, 2012, GENETICS, V191, P935, DOI 10.1534/genetics.112.138537; Konheim YL, 2003, HUM GENET, V113, P377, DOI 10.1007/s00439-003-1000-y; Koutnikova H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000591; Laughlin RE, 2011, BIOL PSYCHIAT, V69, P1109, DOI 10.1016/j.biopsych.2011.01.014; Leitges M, 2002, MOL ENDOCRINOL, V16, P1203; Lynch M., 1998, GENETICS ANAL QUANTI; Lyssenko V, 2011, DIABETES, V60, P2424, DOI 10.2337/db10-1532; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; Mehrabian M, 1998, J CLIN INVEST, V101, P2485, DOI 10.1172/JCI1748; Midorikawa R, 2006, CELL, V125, P371, DOI 10.1016/j.cell.2006.02.039; Mitchell Joyce A, 2003, AMIA Annu Symp Proc, P460; Mitchell KJ, 2004, DIABETES, V53, P393, DOI 10.2337/diabetes.53.2.393; Miyairi I, 2007, J IMMUNOL, V179, P1814, DOI 10.4049/jimmunol.179.3.1814; Mornet E, 2008, BEST PRACT RES CL RH, V22, P113, DOI 10.1016/j.berh.2007.11.003; Mozhui K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000260; Nelson D. L., 2008, LEHNINGER PRINCIPLES, V5th, P926; Nielson CM, 2012, J BONE MINER RES, V27, P93, DOI 10.1002/jbmr.527; Nouws J, 2010, CELL METAB, V12, P283, DOI 10.1016/j.cmet.2010.08.002; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Philip VM, 2010, GENES BRAIN BEHAV, V9, P129, DOI 10.1111/j.1601-183X.2009.00540.x; POPP RA, 1962, J HERED, V53, P73, DOI 10.1093/oxfordjournals.jhered.a107127; Riu E, 1996, P NATL ACAD SCI USA, V93, P2198, DOI 10.1073/pnas.93.5.2198; Seo J, 2009, DIABETES, V58, P2565, DOI 10.2337/db09-0335; Singer JB, 2004, SCIENCE, V304, P445, DOI 10.1126/science.1093139; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Wang XS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S4-O7; Weigert J, 2008, FEBS LETT, V582, P2965, DOI 10.1016/j.febslet.2008.07.034; Wen JH, 2009, DIABETOLOGIA, V52, P504, DOI 10.1007/s00125-008-1210-x; Whyte M., 2000, METABOLIC MOL BASES, P5313; Williams RW, 2001, GENOME BIOL, V2; Windahl SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021402; Wolford JK, 2003, MOL GENET METAB, V79, P61, DOI 10.1016/S1096-7192(03)00051-9; Xie QF, 2007, MOL IMMUNOL, V44, P3453, DOI 10.1016/j.molimm.2007.03.018; Yamamoto H, 2011, CELL, V147, P827, DOI 10.1016/j.cell.2011.10.017; Zu LY, 2011, EUR J PHARMACOL, V650, P298, DOI 10.1016/j.ejphar.2010.09.069	62	145	148	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 14	2012	150	6					1287	1299		10.1016/j.cell.2012.08.012	http://dx.doi.org/10.1016/j.cell.2012.08.012			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22939713	Green Submitted, Green Accepted, Green Published, Bronze			2022-12-24	WOS:000308928100020
J	Ecker, JR				Ecker, Joseph R.			FORUM: Genomics ENCODE explained	NATURE			English	Editorial Material									[Ecker, Joseph R.] Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Ecker, Joseph R.] Salk Inst Biol Studies, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute	Ecker, JR (corresponding author), Howard Hughes Med Inst, La Jolla, CA 92037 USA.	ecker@salk.edu	Ecker, Joseph R/B-9144-2008; Bickmore, Wendy A/C-7314-2013	Ecker, Joseph R/0000-0001-5799-5895; Bickmore, Wendy A/0000-0001-6660-7735; Barroso, Ines/0000-0001-5800-4520; Segal, Eran/0000-0002-6859-1164	MRC [MC_PC_U127527202] Funding Source: UKRI; Medical Research Council [MC_PC_U127527202] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)			0	164	176	1	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2012	489	7414					52	53		10.1038/489052a	http://dx.doi.org/10.1038/489052a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999WW	22955614	Bronze			2022-12-24	WOS:000308347000034
J	Rizzuto, D; Orsini, N; Qiu, CX; Wang, HX; Fratiglioni, L				Rizzuto, Debora; Orsini, Nicola; Qiu, Chengxuan; Wang, Hui-Xin; Fratiglioni, Laura			Lifestyle, social factors, and survival after age 75: population based study	BRITISH MEDICAL JOURNAL			English	Article							ALL-CAUSE MORTALITY; KUNGSHOLMEN-PROJECT; ALZHEIMERS-DISEASE; MULTIPLE IMPUTATION; ALCOHOL-CONSUMPTION; 5-YEAR MORTALITY; OLDER-ADULTS; RISK-FACTORS; DEMENTIA; LONGEVITY	Objective To identify modifiable factors associated with longevity among adults aged 75 and older. Design Population based cohort study. Setting Kungsholmen, Stockholm, Sweden. Participants 1810 adults aged 75 or more participating in the Kungsholmen Project, with follow-up for 18 years. Main outcome measure Median age at death. Vital status from 1987 to 2005. Results During follow-up 1661 (91.8%) participants died. Half of the participants lived longer than 90 years. Half of the current smokers died 1.0 year (95% confidence interval 0.0 to 1.9 years) earlier than non-smokers. Of the leisure activities, physical activity was most strongly associated with survival; the median age at death of participants who regularly swam, walked, or did gymnastics was 2.0 years (0.7 to 3.3 years) greater than those who did not. The median survival of people with a low risk profile (healthy lifestyle behaviours, participation in at least one leisure activity, and a rich or moderate social network) was 5.4 years longer than those with a high risk profile (unhealthy lifestyle behaviours, no participation in leisure activities, and a limited or poor social network). Even among the oldest old (85 years or older) and people with chronic conditions, the median age at death was four years higher for those with a low risk profile compared with those with a high risk profile. Conclusion Even after age 75 lifestyle behaviours such as not smoking and physical activity are associated with longer survival. A low risk profile can add five years to women's lives and six years to men's. These associations, although attenuated, were also present among the oldest old (>= 85 years) and in people with chronic conditions.	[Rizzuto, Debora; Qiu, Chengxuan; Wang, Hui-Xin; Fratiglioni, Laura] Karolinska Inst, Dept Neurobiol Hlth Care Sci & Soc, Aging Res Ctr, S-11330 Stockholm, Sweden; [Rizzuto, Debora; Qiu, Chengxuan; Wang, Hui-Xin; Fratiglioni, Laura] Stockholm Univ, S-11330 Stockholm, Sweden; [Orsini, Nicola] Karolinska Inst, Natl Inst Environm Med, Unit Nutr Epidemiol, S-11330 Stockholm, Sweden; [Orsini, Nicola] Karolinska Inst, Natl Inst Environm Med, Biostat Unit, S-11330 Stockholm, Sweden; [Fratiglioni, Laura] Stockholm Gerontol Res Ctr, Stockholm, Sweden	Karolinska Institutet; Stockholm University; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Rizzuto, D (corresponding author), Karolinska Inst, Dept Neurobiol Hlth Care Sci & Soc, Aging Res Ctr, S-11330 Stockholm, Sweden.	debora.rizzuto@ki.se	Rizzuto, Debora/X-7065-2019; Orsini, Nicola/A-3602-2012; Rizzuto, Debora/V-1890-2018	Rizzuto, Debora/0000-0001-6199-9629; Orsini, Nicola/0000-0002-2210-5634; Qiu, Chengxuan/0000-0003-1922-4912; Wang, Hui-Xin/0000-0002-5051-4929	Swedish Council for Working Life and Social Research; Swedish Research Council for Medicine; Swedish Brain Power; Karolinska Institutet's Faculty; Stiftelsen Ragnhild och Einar Lundstroms Minne	Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Research Council for Medicine; Swedish Brain Power; Karolinska Institutet's Faculty; Stiftelsen Ragnhild och Einar Lundstroms Minne	This study was funded by the Swedish Council for Working Life and Social Research, Swedish Research Council for Medicine, Swedish Brain Power, Karolinska Institutet's Faculty funding for postgraduate students, and the Stiftelsen Ragnhild och Einar Lundstroms Minne. The sponsor had no role in study design, data collection, data analysis, data interpretation, the writing of the report, or in the decision to submit the paper for publication. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Benetos A, 2005, J HYPERTENS, V23, P1803, DOI 10.1097/01.hjh.0000179512.71018.40; Bottai M, BIOM J, V52, P487; Candore G, 2006, ANN NY ACAD SCI, V1089, P516, DOI 10.1196/annals.1386.051; de Groot LCPMG, 2004, J GERONTOL A-BIOL, V59, P1277, DOI 10.1093/gerona/59.12.1277; Demissie S, 2003, STAT MED, V22, P545, DOI 10.1002/sim.1340; Diehr P, 2002, CURR CONTR TRIALS C, V3, DOI 10.1186/1468-6708-3-1; Dupre ME, 2008, AM J PUBLIC HEALTH, V98, P1203, DOI 10.2105/AJPH.2007.113886; Fratiglioni L, 2000, LANCET, V355, P1315, DOI 10.1016/S0140-6736(00)02113-9; Fratiglioni L, 1997, NEUROLOGY, V48, P132, DOI 10.1212/WNL.48.1.132; FRATIGLIONI L, 1992, NEUROEPIDEMIOLOGY, V11, P29, DOI 10.1159/000110958; Fried LP, 1998, JAMA-J AM MED ASSOC, V279, P585, DOI 10.1001/jama.279.8.585; Glymour MM, 2008, NEUROPSYCHOL REV, V18, P194, DOI 10.1007/s11065-008-9066-x; Hagberg B, 2008, J GERONTOL A-BIOL, V63, P1219, DOI 10.1093/gerona/63.11.1219; Halme JT, 2010, DRUG ALCOHOL DEPEN, V106, P212, DOI 10.1016/j.drugalcdep.2009.08.017; Haveman-Nies A, 2002, AM J EPIDEMIOL, V156, P962, DOI 10.1093/aje/kwf144; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Huang WY, 2002, J CLIN EPIDEMIOL, V55, P959, DOI 10.1016/S0895-4356(02)00462-6; Karp A, 2004, AM J EPIDEMIOL, V159, P175, DOI 10.1093/aje/kwh018; Knoops KTB, 2004, JAMA-J AM MED ASSOC, V292, P1433, DOI 10.1001/jama.292.12.1433; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Menotti A, 1996, PREV MED, V25, P319, DOI 10.1006/pmed.1996.0062; Newson RS, 2010, AGE, V32, P521, DOI 10.1007/s11357-010-9154-8; Nybo H, 2003, J AM GERIATR SOC, V51, P1365, DOI 10.1046/j.1532-5415.2003.51453.x; Orsini N, 2012, EPIDEMIOLOGY, V23, P770, DOI 10.1097/EDE.0b013e3182625eff; Rodriguez-Laso A., 2007, BMC GERIATR, V1, P7; Rousson V, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-18; RUBIN DB, 1986, J AM STAT ASSOC, V81, P366, DOI 10.2307/2289225; RUIGOMEZ A, 1995, AGE AGEING, V24, P113, DOI 10.1093/ageing/24.2.113; Spencer CA, 2005, PREV MED, V40, P712, DOI 10.1016/j.ypmed.2004.09.012; Timmreck T C, 1987, Health Educ, V18, P23; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; Wang HX, 1999, AM J EPIDEMIOL, V149, P640; Wang HX, 2002, AM J EPIDEMIOL, V155, P1081, DOI 10.1093/aje/155.12.1081; Yates LB, 2008, ARCH INTERN MED, V168, P284, DOI 10.1001/archinternmed.2007.77	34	89	91	2	31	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 30	2012	345								e5568	10.1136/bmj.e5568	http://dx.doi.org/10.1136/bmj.e5568			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	036SM	22936786	hybrid, Green Published			2022-12-24	WOS:000311050800003
J	Gleeson, T; Wada, Y; Bierkens, MFP; van Beek, LPH				Gleeson, Tom; Wada, Yoshihide; Bierkens, Marc F. P.; van Beek, Ludovicus P. H.			Water balance of global aquifers revealed by groundwater footprint	NATURE			English	Article							HUMAN APPROPRIATION; RESOURCES	Groundwater is a life-sustaining resource that supplies water to billions of people, plays a central part in irrigated agriculture and influences the health of many ecosystems(1,2). Most assessments of global water resources have focused on surface water(3-6), but unsustainable depletion of groundwater has recently been documented on both regional(7,8) and global scales(9-11). It remains unclear how the rate of global groundwater depletion compares to the rate of natural renewal and the supply needed to support ecosystems. Here we define the groundwater footprint (the area required to sustain groundwater use and groundwater-dependent ecosystem services) and show that humans are overexploiting groundwater in many large aquifers that are critical to agriculture, especially in Asia and North America. We estimate that the size of the global groundwater footprint is currently about 3.5 times the actual area of aquifers and that about 1.7 billion people live in areas where groundwater resources and/or groundwater-dependent ecosystems are under threat. That said, 80 per cent of aquifers have a groundwater footprint that is less than their area, meaning that the net global value is driven by a few heavily overexploited aquifers. The groundwater footprint is the first tool suitable for consistently evaluating the use, renewal and ecosystem requirements of groundwater at an aquifer scale. It can be combined with the water footprint and virtual water calculations(12-14), and be used to assess the potential for increasing agricultural yields with renewable groundwaterref(15). The method could be modified to evaluate other resources with renewal rates that are slow and spatially heterogeneous, such as fisheries, forestry or soil.	[Gleeson, Tom] McGill Univ, Dept Civil Engn, Montreal, PQ H3A 0C3, Canada; [Wada, Yoshihide; Bierkens, Marc F. P.; van Beek, Ludovicus P. H.] Univ Utrecht, Fac Geosci, Dept Phys Geog, NL-3508 TC Utrecht, Netherlands; [Bierkens, Marc F. P.] Deltares, NL-3508 AL Utrecht, Netherlands	McGill University; Utrecht University; Deltares	Gleeson, T (corresponding author), McGill Univ, Dept Civil Engn, Montreal, PQ H3A 0C3, Canada.	tom.gleeson@mcgill.ca	Gleeson, Tom/F-2552-2011; Van Beek, Rens/B-4904-2014; Wada, Yoshihide/F-3595-2012; Bierkens, Marc F.P./AAE-8176-2019	Gleeson, Tom/0000-0001-9493-7707; Van Beek, Rens/0000-0002-4758-108X; Wada, Yoshihide/0000-0003-4770-2539; Bierkens, Marc F.P./0000-0002-7411-6562	Natural Sciences and Engineering Research Council of Canada; Canadian Institute for Advanced Research junior fellowship; Utrecht University Focus Areas Theme 'Earth and sustainability'	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institute for Advanced Research junior fellowship(Canadian Institute for Advanced Research (CIFAR)); Utrecht University Focus Areas Theme 'Earth and sustainability'	S. Siebert, M. Jellinek, M. Lathuilliere, A. Henderson and W. Rees read or discussed earlier versions of the manuscript, which markedly improved it. T. G. was supported by the Natural Sciences and Engineering Research Council of Canada and a Canadian Institute for Advanced Research junior fellowship. Y.W. was supported by Utrecht University Focus Areas Theme 'Earth and sustainability'.	Alcamo J, 2003, HYDROLOG SCI J, V48, P339, DOI 10.1623/hysj.48.3.339.45278; Allan JA, 1998, GROUND WATER, V36, P545, DOI 10.1111/j.1745-6584.1998.tb02825.x; CIESIN, 2011, GRIDD POP WORLD VER; Doll P, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/3/035006; Famiglietti JS, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046442; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Foster S, 2004, HYDROGEOL J, V12, P81, DOI 10.1007/s10040-003-0300-6; Giordano M, 2009, ANNU REV ENV RESOUR, V34, P153, DOI 10.1146/annurev.environ.030308.100251; Gleeson T, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL045565; Hoekstra AY, 2009, ECOL ECON, V68, P1963, DOI 10.1016/j.ecolecon.2008.06.021; Hoekstra A.Y., 2011, WATER FOOTPRINT ASSE, DOI DOI 10.1080/0969160X.2011.593864; Hoekstra AY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032688; Hoekstra AY, 2012, P NATL ACAD SCI USA, V109, P3232, DOI 10.1073/pnas.1109936109; Hoekstra AY, 2009, P NATL ACAD SCI USA, V106, pE114, DOI 10.1073/pnas.0909948106; Konikow LF, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048604; Oki T, 2006, SCIENCE, V313, P1068, DOI 10.1126/science.1128845; Poff NL, 2010, FRESHWATER BIOL, V55, P147, DOI 10.1111/j.1365-2427.2009.02204.x; Postel SL, 1996, SCIENCE, V271, P785, DOI 10.1126/science.271.5250.785; Rees, 1996, ECOLOGICAL FOOTPRINT; Rodell M, 2009, NATURE, V460, P999, DOI 10.1038/nature08238; Smakhtin V, 2004, WATER INT, V29, P307, DOI 10.1080/02508060408691785; Smakhtin VU, 2001, J HYDROL, V240, P147, DOI 10.1016/S0022-1694(00)00340-1; Sophocleous M, 2010, HYDROGEOL J, V18, P559, DOI 10.1007/s10040-009-0540-1; van Beek LPH, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR009791; Vorosmarty CJ, 2000, SCIENCE, V289, P284, DOI 10.1126/science.289.5477.284; Wada Y, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR010562; Wada Y, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR009792; Wada Y, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044571; [No title captured], DOI DOI 10.5194/hess-14-1863-2010	29	740	753	33	694	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2012	488	7410					197	200		10.1038/nature11295	http://dx.doi.org/10.1038/nature11295			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985LE	22874965				2022-12-24	WOS:000307267000030
J	Yu, HB; Remer, LA; Chin, M; Bian, HS; Tan, Q; Yuan, TL; Zhang, Y				Yu, Hongbin; Remer, Lorraine A.; Chin, Mian; Bian, Huisheng; Tan, Qian; Yuan, Tianle; Zhang, Yan			Aerosols from Overseas Rival Domestic Emissions over North America	SCIENCE			English	Article							DUST; TRANSPORT; POLLUTION; AERONET; CALIPSO	Many types of aerosols have lifetimes long enough for their transcontinental transport, making them potentially important contributors to air quality and climate change in remote locations. We estimate that the mass of aerosols arriving at North American shores from overseas is comparable with the total mass of particulates emitted domestically. Curbing domestic emissions of particulates and precursor gases, therefore, is not sufficient to mitigate aerosol impacts in North America. The imported contribution is dominated by dust leaving Asia, not by combustion-generated particles. Thus, even a reduction of industrial emissions of the emerging economies of Asia could be overwhelmed by an increase of dust emissions due to changes in meteorological conditions and potential desertification.	[Yu, Hongbin] Univ Maryland, Earth Syst Sci Interdisciplinary Ctr, College Pk, MD 20740 USA; [Yu, Hongbin; Chin, Mian; Bian, Huisheng; Tan, Qian; Yuan, Tianle; Zhang, Yan] NASA, Earth Sci Directorate, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Remer, Lorraine A.; Bian, Huisheng; Yuan, Tianle] Univ Maryland Baltimore Cty, Joint Ctr Earth Syst Technol, Baltimore, MD 21228 USA; [Tan, Qian; Zhang, Yan] Univ Space Res Assoc, Goddard Earth Sci Technol & Res Ctr, Columbia, MD 21044 USA	University System of Maryland; University of Maryland College Park; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University System of Maryland; University of Maryland Baltimore County; Universities Space Research Association (USRA)	Yu, HB (corresponding author), Univ Maryland, Earth Syst Sci Interdisciplinary Ctr, College Pk, MD 20740 USA.	hongbin.yu@nasa.gov	Chin, Mian/J-8354-2012; Zhang, Yan/C-4792-2012; Yuan, Tianle/D-3323-2011; Yu, Hongbin/C-6485-2008	Yuan, Tianle/0000-0002-2187-3017; Yu, Hongbin/0000-0003-4706-1575; ZHANG, Yan/0000-0002-6954-5178	NASA [NNXAH66G, NNX11AJ91G]; GMI [NNX10AK61G]	NASA(National Aeronautics & Space Administration (NASA)); GMI	We acknowledge the NASA support of this work via NNXAH66G (The Science of Terra and Aqua Program) and NNX11AJ91G (Atmospheric Composition Modeling and Analysis Program) (H.Y.), both managed by R. Eckman. The NASA Modeling, Analysis, and Prediction program managed by D. Considine is acknowledged for supporting the model development of GOCART (M. C.) and GMI (H. B., under NNX10AK61G). We are grateful to J. Zhang for providing his reprocessed MODIS data, Z. Liu for providing insights in the lidar characterization of Asian dust, and X. Pan for acquiring CALIOP data. The MODIS data were obtained from the NASA Level 1 and Atmosphere Archive and Distribution System. The CALIOP data were obtained from the NASA Langley Research Center Atmospheric Science Data Center.	Bian H, 2009, ATMOS CHEM PHYS, V9, P2375, DOI 10.5194/acp-9-2375-2009; Biscaye PE, 2000, SCIENCE, V290, P2258, DOI 10.1126/science.290.5500.2258; Chin M, 2007, ATMOS CHEM PHYS, V7, P5501, DOI 10.5194/acp-7-5501-2007; Chin M, 2009, ANN GEOPHYS-GERMANY, V27, P3439, DOI 10.5194/angeo-27-3439-2009; Dentener F., 2010, AIR POLLUTION STUDIE, V17; Eck TF, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005274; Hadley OL, 2010, ATMOS CHEM PHYS, V10, P7505, DOI 10.5194/acp-10-7505-2010; Heald CL, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006847; Husar RB, 2001, J GEOPHYS RES-ATMOS, V106, P18317, DOI 10.1029/2000JD900788; Kalashnikova OV, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD010083; KAUFMAN YJ, 2005, J GEOPHYS RES, V110, DOI DOI 10.1029/2003JD004436; Liu J, 2008, ATMOS CHEM PHYS, V8, P3721, DOI 10.5194/acp-8-3721-2008; Liu ZY, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008878; Maring H, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002536; Prospero JM, 2005, AEROBIOLOGIA, V21, P1, DOI 10.1007/s10453-004-5872-7; Ramanathan V, 2008, NAT GEOSCI, V1, P221, DOI 10.1038/ngeo156; Remer LA, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009661; Sassen K, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014051; Stith JL, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010924; Su L, 2011, ATMOS CHEM PHYS, V11, P3263, DOI 10.5194/acp-11-3263-2011; Warneke C, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036194; Winker DM, 2010, B AM METEOROL SOC, V91, P1211, DOI 10.1175/2010BAMS3009.1; Yu H., 2009, ATMOSPHERIC AEROSOL; Yu HB, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000754; Yu HB, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009349; Yu HB, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010648; Zhu P, 2007, J GEOPHYS RES-SPACE, V112, DOI 10.1029/2006JA011991	27	172	177	1	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 3	2012	337	6094					566	569		10.1126/science.1217576	http://dx.doi.org/10.1126/science.1217576			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982PU	22859485				2022-12-24	WOS:000307058700041
J	Van Brabandt, H; Neyt, M; Hulstaert, F				Van Brabandt, Hans; Neyt, Mattias; Hulstaert, Frank			Transcatheter aortic valve implantation (TAVI): risky and costly	BRITISH MEDICAL JOURNAL			English	Editorial Material							ELDERLY-PATIENTS; REPLACEMENT; STENOSIS; SURGERY		[Van Brabandt, Hans; Neyt, Mattias; Hulstaert, Frank] KCE, Belgian Hlth Care Knowledge Ctr, Adm Ctr Kruidtuin, B-1000 Brussels, Belgium; [Van Brabandt, Hans] CEBAM, Belgian Ctr Evidence Based Med, Louvain, Belgium; [Van Brabandt, Hans] Branch Dutch Cochrane Ctr, Louvain, Belgium		Neyt, M (corresponding author), KCE, Belgian Hlth Care Knowledge Ctr, Adm Ctr Kruidtuin, Kruidtuinlaan 55, B-1000 Brussels, Belgium.	mattias.neyt@kce.fgov.be		Hulstaert, Frank/0000-0003-2879-9910				[Anonymous], 2012, HEARTWIRE        MAY; [Anonymous], 2006, BUSINESSWEEK; Blackman D, 2011, OUTCOME TAVI VALVE A; [British Cardiovascular Intervention Society Society of Cardiothoracic Surgeons], TRANSC AORT VALV IMP; Cortez M, 2011, BLOOMBERG NEWS  0404; FDA, 2011, SAPIEN THV BRIEF DOC, P301; FDA, EDW SAPIEN TRANSC HE; FDA, 2011, FDA EX SUMM EDW SAPI; Guard M, 2011, EUROPCR C PAR 17 20; Hirschler B, 2012, EU MED HEAD URGES TO; Hulstaert F, 2011, 158CD20111027331 KCE; Iung B, 2005, EUR HEART J, V26, P2714, DOI 10.1093/eurheartj/ehi471; Kodali SK, 2012, NEW ENGL J MED, V366, P1686, DOI 10.1056/NEJMoa1200384; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Makkar RR, 2012, NEW ENGL J MED, V366, P1696, DOI 10.1056/NEJMoa1202277; Nainggolan L, 2011, GERMANY TOPS TAVI TA; National Institute for Health and Care Excellence (NICE), 2012, TRANSC AORT VALV IMP; Neyt M, 2011, KCE REPORTS C; Neyt M, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001032; Nielsen HH, 2012, EUROINTERVENTION; O'Riordan M, 2011, HEARTWIRE       1110; Ray S, 2008, CONS M 16 DEC 2008; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Stewart BF, 1997, J AM COLL CARDIOL, V29, P630, DOI 10.1016/S0735-1097(96)00563-3; Varadarajan P, 2006, EUR J CARDIO-THORAC, V30, P722, DOI 10.1016/j.ejcts.2006.07.028; Wood S, 2012, HEARTWIRE       0614	26	42	42	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUL 31	2012	345								e4710	10.1136/bmj.e4710	http://dx.doi.org/10.1136/bmj.e4710			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	985XB	22849955				2022-12-24	WOS:000307302700001
J	Dolgin, E				Dolgin, Elie			DEVICES Artificial inspiration	NATURE			English	Editorial Material							LUNG TRANSPLANTATION											Bonser RS, 2012, LANCET, V380, P747, DOI 10.1016/S0140-6736(12)60160-3; Cypel M, 2011, NEW ENGL J MED, V364, P1431, DOI 10.1056/NEJMoa1014597; Hoganson DM, 2011, LAB CHIP, V11, P700, DOI 10.1039/c0lc00158a; Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193; Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345; Potkay JA, 2011, LAB CHIP, V11, P2901, DOI 10.1039/c1lc20020h	6	2	2	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2012	489	7417					S12	S14		10.1038/489S12a	http://dx.doi.org/10.1038/489S12a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011LT	23013709	Bronze			2022-12-24	WOS:000309167100007
J	Ringe, D; Petsko, GA				Ringe, Dagmar; Petsko, Gregory A.			Behind the Movement	CELL			English	Editorial Material							SQUID GIANT-AXON; MOTOR DOMAIN; CRYSTAL-STRUCTURE; MYOSIN; FILAMENTS; ACTIN; MICROTUBULES; ORGANELLES; MECHANISM; AXOPLASM		[Ringe, Dagmar; Petsko, Gregory A.] Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA; [Ringe, Dagmar; Petsko, Gregory A.] Brandeis Univ, Dept Chem, Waltham, MA 02454 USA; [Ringe, Dagmar; Petsko, Gregory A.] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02454 USA; [Petsko, Gregory A.] Weill Cornell Med Coll, Dept Neurol & Neurosci, New York, NY 10065 USA	Brandeis University; Brandeis University; Brandeis University; Cornell University	Ringe, D (corresponding author), Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA.	ringe@brandeis.edu; petsko@brandeis.edu						Bryant Z, 2007, P NATL ACAD SCI USA, V104, P772, DOI 10.1073/pnas.0610144104; Carter AP, 2011, SCIENCE, V331, P1159, DOI 10.1126/science.1202393; Cho C, 2012, BBA-MOL CELL RES, V1823, P182, DOI 10.1016/j.bbamcr.2011.10.009; Huxley HE, 2004, PHILOS T ROY SOC B, V359, P1879, DOI 10.1098/rstb.2004.1556; Kull FJ, 1996, NATURE, V380, P550, DOI 10.1038/380550a0; Robinson DN, 2004, CURR OPIN CELL BIOL, V16, P182, DOI 10.1016/j.ceb.2004.02.002; SCHNAPP BJ, 1985, CELL, V40, P455, DOI 10.1016/0092-8674(85)90160-6; SHEETZ MP, 1983, NATURE, V303, P31, DOI 10.1038/303031a0; SPUDICH JA, 1985, NATURE, V315, P584, DOI 10.1038/315584a0; Sweeney HL, 2010, ANNU REV BIOPHYS, V39, P539, DOI 10.1146/annurev.biophys.050708.133751; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; VALE RD, 1985, CELL, V43, P623, DOI 10.1016/0092-8674(85)90234-X; VALE RD, 1985, CELL, V40, P559, DOI 10.1016/0092-8674(85)90204-1; VALE RD, 1985, CELL, V40, P449, DOI 10.1016/0092-8674(85)90159-X; VALE RD, 1984, P NATL ACAD SCI-BIOL, V81, P6775, DOI 10.1073/pnas.81.21.6775	16	1	1	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 14	2012	150	6					1093	1095		10.1016/j.cell.2012.08.031	http://dx.doi.org/10.1016/j.cell.2012.08.031			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22980970	Bronze			2022-12-24	WOS:000308928100001
J	Duhren-von Minden, M; Ubelhart, R; Schneider, D; Wossning, T; Bach, MP; Buchner, M; Hofmann, D; Surova, E; Follo, M; Kohler, F; Wardemann, H; Zirlik, K; Veelken, H; Jumaa, H				Duehren-von Minden, Marcus; Uebelhart, Rudolf; Schneider, Dunja; Wossning, Thomas; Bach, Martina P.; Buchner, Maike; Hofmann, Daniel; Surova, Elena; Follo, Marie; Koehler, Fabian; Wardemann, Hedda; Zirlik, Katja; Veelken, Hendrik; Jumaa, Hassan			Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling	NATURE			English	Article							B-CELLS; FOSTAMATINIB DISODIUM; RECEPTOR; LYMPHOMA; SYK; PROLIFERATION; INHIBITION; PRECURSORS; EXPRESSION; CLONING	B-cell antigen receptor (BCR) expression is an important feature of chronic lymphocytic leukaemia (CLL), one of the most prevalent B-cell neoplasias in Western countries(1). The presence of stereotyped and quasi-identical BCRs in different CLL patients suggests that recognition of specific antigens might drive CLL pathogenesis. Here we show that, in contrast to other B-cell neoplasias, CLL-derived BCRs induce antigen-independent cell-autonomous signalling, which is dependent on the heavy-chain complementarity-determining region (HCDR3) and an internal epitope of the BCR. Indeed, transferring the HCDR3 of a CLL-derived BCR provides autonomous signalling capacity to a non-autonomously active BCR, whereas mutations in the internal epitope abolish this capacity. Because BCR expression was required for the binding of secreted CLL-derived BCRs to target cells, and mutations in the internal epitope reduced this binding, our results indicate a new model for CLL pathogenesis, with cell-autonomous antigen-independent signalling as a crucial pathogenic mechanism.	[Duehren-von Minden, Marcus; Uebelhart, Rudolf; Schneider, Dunja; Wossning, Thomas; Bach, Martina P.; Hofmann, Daniel; Surova, Elena; Koehler, Fabian; Jumaa, Hassan] Univ Freiburg, Ctr Biol Signaling Studies BIOSS, D-79104 Freiburg, Germany; [Uebelhart, Rudolf; Surova, Elena] Univ Freiburg, Spemann Grad Sch Biol & Med, D-79104 Freiburg, Germany; [Buchner, Maike; Follo, Marie; Zirlik, Katja] Univ Med Ctr Freiburg, Dept Hematol Oncol, D-79106 Freiburg, Germany; [Wardemann, Hedda] Max Planck Inst Infect Biol, Max Planck Res Grp Mol Immunol, D-10117 Berlin, Germany; [Veelken, Hendrik] Leiden Univ, Med Ctr, Dept Hematol, NL-2333 ZA Leiden, Netherlands; [Jumaa, Hassan] Univ Freiburg, Fac Biol, Dept Mol Immunol, D-79108 Freiburg, Germany; [Jumaa, Hassan] Max Planck Inst Immunobiol & Epigenet, D-79108 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; Max Planck Society; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Freiburg; Max Planck Society	Jumaa, H (corresponding author), Univ Freiburg, Ctr Biol Signaling Studies BIOSS, D-79104 Freiburg, Germany.	jumaa@immunbio.mpg.de		Wardemann, Hedda/0000-0003-3921-5933; Veelken, Hendrik/0000-0002-9108-3125; Follo, Marie/0000-0002-3090-7442	Deutsche Krebshilfe [108935]; Deutsche Forschungsgemeinschaft [SFB746, JU463/2-1]; Excellence Initiative of the German Federal and State Governments [GSC-4]	Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal and State Governments	We thank C. Croce for providing the TCL1 mice, M. Reth and P. Nielsen for scientific discussion and reading the manuscript, C. Wehr for help cloning TCL1-derived BCRs, A. Ott, A. Wurch, S. Hopitz and B. Wehrle for help with FACS experiments and cloning, and D. Pfeifer and M. Pantic for providing clinical data. This work was supported by the Deutsche Krebshilfe (Project 108935), the Deutsche Forschungsgemeinschaft (SFB746 and JU463/2-1) and the Excellence Initiative of the German Federal and State Governments (GSC-4, Spemann Graduate School).	Bertinetti C, 2006, EUR J HAEMATOL, V77, P395, DOI 10.1111/j.1600-0609.2006.00740.x; Bichi R, 2002, P NATL ACAD SCI USA, V99, P6955, DOI 10.1073/pnas.102181599; Bikos V, 2012, LEUKEMIA, V26, P1638, DOI 10.1038/leu.2012.3; Binder M, 2011, CANCER-AM CANCER SOC, V117, P1891, DOI 10.1002/cncr.25755; Buchner M, 2010, BLOOD, V115, P4497, DOI 10.1182/blood-2009-07-233692; Friedberg JW, 2010, BLOOD, V115, P2578, DOI 10.1182/blood-2009-08-236471; Ghia P, 2008, J INTERN MED, V264, P549, DOI 10.1111/j.1365-2796.2008.02030.x; Ghiotto F, 2004, J CLIN INVEST, V113, P1008, DOI 10.1172/JCI200419399; Herishanu Y, 2011, BLOOD, V117, P563, DOI 10.1182/blood-2010-05-284984; Herling M, 2009, BLOOD, V114, P4675, DOI 10.1182/blood-2009-03-208256; Herve M, 2005, J CLIN INVEST, V115, P1636, DOI 10.1172/JCI24387; Koehler F, 2008, IMMUNITY, V29, P912, DOI 10.1016/j.immuni.2008.10.013; Kulathu Y, 2009, IMMUNOL REV, V232, P286, DOI 10.1111/j.1600-065X.2009.00837.x; Meixlsperger S, 2007, IMMUNITY, V26, P323, DOI 10.1016/j.immuni.2007.01.012; Morton LM, 2006, BLOOD, V107, P265, DOI 10.1182/blood-2005-06-2508; Osterroth F, 1999, J IMMUNOL METHODS, V229, P141, DOI 10.1016/S0022-1759(99)00111-8; Seiler T, 2009, BLOOD, V114, P3615, DOI 10.1182/blood-2009-01-197822; Stamatopoulos K, 2007, BLOOD, V109, P259, DOI 10.1182/blood-2006-03-012948; Stevenson FK, 2011, BLOOD, V118, P4313, DOI 10.1182/blood-2011-06-338855; STHOEGER ZM, 1989, J EXP MED, V169, P255, DOI 10.1084/jem.169.1.255; Storch B, 2007, EUR J IMMUNOL, V37, P252, DOI 10.1002/eji.200636667; Su YW, 2003, IMMUNITY, V19, P295, DOI 10.1016/S1074-7613(03)00202-4; Suljagic M, 2010, BLOOD, V116, P4894, DOI 10.1182/blood-2010-03-275180; Tiller T, 2010, J EXP MED, V207, P2767, DOI 10.1084/jem.20100171; Ubelhart R, 2010, NAT IMMUNOL, V11, P759, DOI 10.1038/ni.1903; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Widhopf GF, 2004, BLOOD, V104, P2499, DOI 10.1182/blood-2004-03-0818; Yan XJ, 2006, P NATL ACAD SCI USA, V103, P11713, DOI 10.1073/pnas.0604564103	28	357	363	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2012	489	7415					309	+		10.1038/nature11309	http://dx.doi.org/10.1038/nature11309			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003UC	22885698				2022-12-24	WOS:000308635900045
J	Bakker, K				Bakker, Karen			Water Security: Research Challenges and Opportunities	SCIENCE			English	Editorial Material							RESOURCES MANAGEMENT		[Bakker, Karen] Univ British Columbia, Dept Geog, Program Water Governance, Vancouver, BC V6T 1Z2, Canada; [Bakker, Karen] Univ British Columbia, Inst Resources Environm & Sustainabil, Vancouver, BC V6T 1Z2, Canada	University of British Columbia; University of British Columbia	Bakker, K (corresponding author), Univ British Columbia, Dept Geog, Program Water Governance, Vancouver, BC V6T 1Z2, Canada.	karen.bakker@ubc.ca	Quinn, Patrick/B-5489-2010					Alcamo Joseph M., 2008, Environmental Research Letters, V3, P010202, DOI 10.1088/1748-9326/3/1/010202; Allan JA, 2003, WATER INT, V28, P106, DOI 10.1080/02508060.2003.9724812; Bogardi JJ, 2012, CURR OPIN ENV SUST, V4, P35, DOI 10.1016/j.cosust.2011.12.002; Braden JB, 2009, WATER RESOUR RES, V45, DOI 10.1029/2009WR008216; Briscoe J., 2009, Innovations: Technology / Governance / Globalisation, V4, P3, DOI 10.1162/itgg.2009.4.3.3; Cook C, 2012, GLOBAL ENVIRON CHANG, V22, P94, DOI 10.1016/j.gloenvcha.2011.10.011; Dominic W, 2011, CHOICE REV ONLINE; Falkenmark M., 2004, EARTHSCAN; Gleick PH, 2000, WATER INT, V25, P127, DOI 10.1080/02508060008686804; Grey D, 2007, WATER POLICY, V9, P545, DOI 10.2166/wp.2007.021; GWP, 2000, GLOBAL WATER PARTNER; Hering JG, 2012, SCIENCE, V336, P1234, DOI 10.1126/science.1218230; Hope R., 2012, SYNTHESIS REPORT SUB; Mehta L., 2012, Water Alternatives, V5, P193; Milly PCD, 2008, SCIENCE, V319, P573, DOI 10.1126/science.1151915; Nuzzo JB, 2006, BIOSECUR BIOTERROR, V4, P147, DOI 10.1089/bsp.2006.4.147; Office of the Director of National Intelligence, 2012, GLOB WAT SEC; Pahl-Wostl C, 2008, ECOL SOC, V13; Palmer MA, 2010, NATURE, V467, P534, DOI 10.1038/467534a; Priscoli J.D., 2009, MANAGING TRANSFORMIN; Rockstrom J, 2009, WATER RESOUR RES, V45, DOI 10.1029/2007WR006767; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Sivapalan M, 2012, HYDROL PROCESS, V26, P1270, DOI 10.1002/hyp.8426; Sophocleous M, 2002, HYDROGEOL J, V10, P52, DOI 10.1007/s10040-001-0170-8; Swyngedouw E, 2009, J CONTEMP WAT RES ED, V142, P56, DOI 10.1111/j.1936-704X.2009.00054.x; United Nations Environment Program, 2009, WAT SEC EC SERV CRIT; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Vorosmarty C., 2004, EOS, V85, P509, DOI DOI 10.1029/2004EO480001; Warner J, 2008, WATER POLICY, V10, P121, DOI 10.2166/wp.2008.210; WHO, 2005, EC HUM WELL BEING HL; WWAP U. N, 2003, WAT PEOPL WAT LIF UN; Zeitoun M, 2011, GLOB POLICY, V2, P286, DOI 10.1111/j.1758-5899.2011.00097.x; [No title captured]; [No title captured]; [No title captured]	35	301	313	26	304	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2012	337	6097					914	915		10.1126/science.1226337	http://dx.doi.org/10.1126/science.1226337			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	992VI	22923564				2022-12-24	WOS:000307807600027
J	Frost, PJ; Wise, MP				Frost, Paul J.; Wise, Matt P.			Early management of acutely ill ward patients	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EARLY WARNING SCORE; CARE		[Frost, Paul J.] Cardiff Univ, Inst Med Educ, Sch Med, Cardiff CF14 4XN, S Glam, Wales; [Frost, Paul J.; Wise, Matt P.] Univ Wales Hosp, Crit Care Directorate, Cardiff CF14 4XW, S Glam, Wales	Cardiff University; Cardiff University	Frost, PJ (corresponding author), Cardiff Univ, Inst Med Educ, Sch Med, Cardiff CF14 4XN, S Glam, Wales.	frostp2@cf.ac.uk		Wise, Matt/0000-0002-2763-4316				Cecconi M, 2011, CURR OPIN CRIT CARE, V17, P290, DOI 10.1097/MCC.0b013e32834699cd; Gordon CF, 2011, SCOT MED J, V56, P15, DOI 10.1258/smj.2010.010009; Kause J, 2004, RESUSCITATION, V62, P275, DOI 10.1016/j.resuscitation.2004.05.016; *NAT CONF ENQ PAT, 2005, AC PROBL; National Institute for Health and Clinical Excellence, 2007, AC ILL PAT HOSP; NHS Institute for Innovation and Improvement, SBAR SIT BACKGR ASS; O'Driscoll BR, 2008, THORAX, V63, DOI 10.1136/thx.2008.102947; Royal College of Physicians, NAT EARL WARN SCOR N; Royal College of Physicians, 2011, AC CAR TOOLK 2 HIGH; Smith CM, 2007, INTENS CARE MED, V33, P901, DOI 10.1007/s00134-007-0564-8; Smith T, 2012, BRIT J SURG, V99, P192, DOI 10.1002/bjs.7777; STACPOOLE PW, 1994, AM J MED, V97, P47, DOI 10.1016/0002-9343(94)90047-7; Subbe CP, 2001, QJM-MON J ASSOC PHYS, V94, P521, DOI 10.1093/qjmed/94.10.521; The General Medical Council, 2010, TREATM CAR END LIF; Turkington PM, 2002, STROKE, V33, P2037, DOI 10.1161/01.STR.0000023576.94311.27	15	11	11	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 24	2012	345								e5677	10.1136/bmj.e5677	http://dx.doi.org/10.1136/bmj.e5677			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	996HC	22923534				2022-12-24	WOS:000308074500005
J	Krupic, J; Burgess, N; O'Keefe, J				Krupic, Julija; Burgess, Neil; O'Keefe, John			Neural Representations of Location Composed of Spatially Periodic Bands	SCIENCE			English	Article							MEDIAL ENTORHINAL CORTEX; GRID CELLS; OSCILLATORY INTERFERENCE; PATH-INTEGRATION; PLACE CELLS; THETA; RAT; PHASE; MODEL; PARASUBICULUM	The mammalian hippocampal formation provides neuronal representations of environmental location, but the underlying mechanisms are poorly understood. Here, we report a class of cells whose spatially periodic firing patterns are composed of plane waves (or bands) drawn from a discrete set of orientations and wavelengths. The majority of cells recorded in parasubicular and medial entorhinal cortices of freely moving rats belonged to this class and included grid cells, an important subset that corresponds to three bands at 60 orientations and has the most stable firing pattern. Occasional changes between hexagonal and nonhexagonal patterns imply a common underlying mechanism. Our results indicate a Fourier-like spatial analysis underlying neuronal representations of location, and suggest that path integration is performed by integrating displacement along a restricted set of directions.	[Krupic, Julija; O'Keefe, John] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Burgess, Neil] UCL, Inst Cognit Neurosci, London WC1N 3AR, England; [Burgess, Neil] UCL, Inst Neurol, London WC1N 3BG, England; [O'Keefe, John] UCL, Sainsbury Wellcome Ctr Neural Circuits & Behav, London WC1E 6BT, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London	O'Keefe, J (corresponding author), UCL, Dept Cell & Dev Biol, London WC1E 6BT, England.	j.okeefe@ucl.ac.uk	Burgess, Neil/B-2420-2009	Burgess, Neil/0000-0003-0646-6584; Krupic, Julija/0000-0001-6299-1629; O'Keefe, John/0000-0001-5697-4881	European Union; UK Medical Research Council; Gatsby Charitable Foundation; Wellcome Trust; CoMPLEX studentship; Medical Research Council [G1000854] Funding Source: researchfish; MRC [G1000854] Funding Source: UKRI	European Union(European Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Gatsby Charitable Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); CoMPLEX studentship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the European Union Framework 7 (SPACEBRAIN) grant, the UK Medical Research Council, the Gatsby Charitable Foundation, and the Wellcome Trust. J.K. received support from a CoMPLEX studentship. We thank M. Bauza, T. Wills, C. Barry, F. Cacucci, and M. Witter for useful discussions and S. Burton for help with histology. This work was conducted in accordance with the UK Animals (Scientific Procedures) Act (1986).	Barry C., 2009, SOC NEUR ANN M CHIC; Barry C, 2007, NAT NEUROSCI, V10, P682, DOI 10.1038/nn1905; Blair HT, 2007, J NEUROSCI, V27, P3211, DOI 10.1523/JNEUROSCI.4724-06.2007; Blair HT, 2008, HIPPOCAMPUS, V18, P1239, DOI 10.1002/hipo.20509; Boccara CN, 2010, NAT NEUROSCI, V13, P987, DOI 10.1038/nn.2602; Borckmans P, 2002, INT J BIFURCAT CHAOS, V12, P2307, DOI 10.1142/S0218127402005881; Burgalossi A, 2011, NEURON, V70, P773, DOI 10.1016/j.neuron.2011.04.003; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; Burgess N, 2008, HIPPOCAMPUS, V18, P1157, DOI 10.1002/hipo.20518; Doeller CF, 2010, NATURE, V463, P657, DOI 10.1038/nature08704; Fiete IR, 2008, J NEUROSCI, V28, P6858, DOI 10.1523/JNEUROSCI.5684-07.2008; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; Geisler C, 2007, P NATL ACAD SCI USA, V104, P8149, DOI 10.1073/pnas.0610121104; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hasselmo ME, 2008, HIPPOCAMPUS, V18, P1213, DOI 10.1002/hipo.20512; KOHLER C, 1985, J COMP NEUROL, V236, P504, DOI 10.1002/cne.902360407; Maurer AP, 2005, HIPPOCAMPUS, V15, P841, DOI 10.1002/hipo.20114; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Mhatre H, 2012, HIPPOCAMPUS, V22, P320, DOI 10.1002/hipo.20901; O'Keefe J, 2005, HIPPOCAMPUS, V15, P853, DOI 10.1002/hipo.20115; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Sreenivasan S, 2011, NAT NEUROSCI, V14, P1330, DOI 10.1038/nn.2901; VANGROEN T, 1990, BRAIN RES, V518, P227, DOI 10.1016/0006-8993(90)90976-I; Welday AC, 2011, J NEUROSCI, V31, P16157, DOI 10.1523/JNEUROSCI.0712-11.2011	26	103	107	2	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2012	337	6096					853	857		10.1126/science.1222403	http://dx.doi.org/10.1126/science.1222403			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	989BQ	22904012	Green Submitted, Green Accepted			2022-12-24	WOS:000307535600046
J	Lesser, LI; Cohen, DA; Brook, RH				Lesser, Lenard I.; Cohen, Deborah A.; Brook, Robert H.			Changing Eating Habits for the Medical Profession	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PHYSICIANS		[Lesser, Lenard I.] Palo Alto Med Fdn Res Inst, Palo Alto, CA 94306 USA; [Cohen, Deborah A.; Brook, Robert H.] RAND Corp, Santa Monica, CA USA; [Brook, Robert H.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	Palo Alto Medical Foundation Research Institute; RAND Corporation; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Lesser, LI (corresponding author), Palo Alto Med Fdn Res Inst, 795 El Camion Real Ames Bldg, Palo Alto, CA 94306 USA.	LesserL@pamfri.org		Lesser, Lenard/0000-0002-0713-6707				Ajani UA, 2004, ANN EPIDEMIOL, V14, P731, DOI 10.1016/j.annepidem.2003.10.008; [Anonymous], 2011, ACCME ANN REP DAT 20; Arora R, 2004, MIL MED, V169, P522, DOI 10.7205/MILMED.169.7.522; Institute of Medicine, 2012, ACC PROGR OB PREV, P478; La Puma John, 2003, Dis Manag, V6, P191; Lesser LI, 2012, ACAD PEDIATR, V12, P62, DOI 10.1016/j.acap.2011.09.004; WELLS KB, 1984, JAMA-J AM MED ASSOC, V252, P2846, DOI 10.1001/jama.252.20.2846	7	16	16	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2012	308	10					983	984		10.1001/2012.jama.10427	http://dx.doi.org/10.1001/2012.jama.10427			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003AA	22968886				2022-12-24	WOS:000308579300020
J	Mello, MM; Goodman, SN; Faden, RR				Mello, Michelle M.; Goodman, Steven N.; Faden, Ruth R.			Ethical Considerations in Studying Drug Safety - The Institute of Medicine Report	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CARDIOVASCULAR EVENTS; MYOCARDIAL-INFARCTION; RISK; ROSIGLITAZONE; DEATH; PIOGLITAZONE; NESIRITIDE		[Mello, Michelle M.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Goodman, Steven N.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Goodman, Steven N.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Faden, Ruth R.] Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD USA	Harvard University; Harvard T.H. Chan School of Public Health; Stanford University; Stanford University; Johns Hopkins University	Mello, MM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 665 Huntington Ave, Boston, MA 02115 USA.			Goodman, Steven/0000-0002-3872-5723; Mello, Michelle/0000-0003-2877-4270				Baucus M, 2010, PREFECT POLICE F PEC; Chen JY, 2010, AM J BIOETHICS, V10, P35, DOI 10.1080/15265161.2010.494220; Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs Institute of Medicine, 2010, ETH ISS STUD SAF APP; Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs Institute of Medicine, 2012, ETH SCI ISS STUD SAF; Committee on the Assessment of the U.S. Drug Safety System Institute of Medicine, 2007, FUT DRUG SAF PROM PR; Curfman GD, 2005, NEW ENGL J MED, V353, P2813, DOI 10.1056/NEJMe058314; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Doshi P, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001201; Food and Drug Administration Center for Drug Evaluation and Research, 2010, JOINT M END MET DRUG; Graham D, 2008, PREFECT POLICE F PEC; Hamburg M, 2010, PREFECT POLICE F PEC; Kesselheim AS, 2007, HEALTH AFFAIR, V26, P483, DOI 10.1377/hlthaff.26.2.483; Krumholz H., FORBES          0516; Levine C, 1988, Law Med Health Care, V16, P167, DOI 10.1111/j.1748-720X.1988.tb01942.x; Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; London AJ, 2012, SCIENCE, V336, P544, DOI 10.1126/science.1216086; Mahoney K, 2010, ADV COMM CLIN BRIEF; Misbin RI, 2007, DIABETES CARE, V30, P3141, DOI 10.2337/dc07-1908; Nissen SE, 2005, JAMA-J AM MED ASSOC, V294, P2581, DOI 10.1001/JAMA.294.20.JOC50147; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Nissen SE, 2010, ARCH INTERN MED, V170, P1191, DOI 10.1001/archinternmed.2010.207; Nissen SE, 2010, EUR HEART J, V31, P773, DOI 10.1093/eurheartj/ehq016; Punthakee Z, 2012, DIABETOLOGIA, V55, P36, DOI 10.1007/s00125-011-2357-4; Rising K, 2009, PLOS MED, V6, P117, DOI 10.1371/journal.pmed.1000017; Rising K, 2008, PLOS MED, V5, P1561, DOI 10.1371/journal.pmed.0050217; Sackner-Bernstein, 2005, CIRCULATION, V111, P2274; Sackner-Bernstein JD, 2005, JAMA-J AM MED ASSOC, V293, P1900, DOI 10.1001/jama.293.15.1900; Sackner-Bernstein JD, 2005, CIRCULATION, V111, P1487, DOI 10.1161/01.CIR.0000159340.93220.E4; Solomon DH, 2005, ARTHRITIS RHEUM, V52, P1968, DOI 10.1002/art.21132; Woodcock J, 2010, NEW ENGL J MED, V363, P1489, DOI 10.1056/NEJMp1010788	30	15	15	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 6	2012	367	10					959	964		10.1056/NEJMhle1207160	http://dx.doi.org/10.1056/NEJMhle1207160			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	999VO	22913661				2022-12-24	WOS:000308343300017
J	Vonk, JE; Sanchez-Garcia, L; van Dongen, BE; Alling, V; Kosmach, D; Charkin, A; Semiletov, IP; Dudarev, OV; Shakhova, N; Roos, P; Eglinton, TI; Andersson, A; Gustafsson, O				Vonk, J. E.; Sanchez-Garcia, L.; van Dongen, B. E.; Alling, V.; Kosmach, D.; Charkin, A.; Semiletov, I. P.; Dudarev, O. V.; Shakhova, N.; Roos, P.; Eglinton, T. I.; Andersson, A.; Gustafsson, O.			Activation of old carbon by erosion of coastal and subsea permafrost in Arctic Siberia	NATURE			English	Article							OFFSHORE PERMAFROST; SHELF; DEGRADATION; RELEASE; MATTER; LAPTEV; CYCLE	The future trajectory of greenhouse gas concentrations depends on interactions between climate and the biogeosphere(1,2). Thawing of Arctic permafrost could release significant amounts of carbon into the atmosphere in this century(3). Ancient Ice Complex deposits outcropping along the similar to 7,000-kilometre-long coastline of the East Siberian Arctic Shelf (ESAS)(4,5), and associated shallow subsea permafrost(6,7), are two large pools of permafrost carbon(8), yet their vulnerabilities towards thawing and decomposition are largely unknown(9-11). Recent Arctic warming is stronger than has been predicted by several degrees, and is particularly pronounced over the coastal ESAS region(12,13). There is thus a pressing need to improve our understanding of the links between permafrost carbon and climate in this relatively inaccessible region. Here we show that extensive release of carbon from these Ice Complex deposits dominates (57 +/- 2 per cent) the sedimentary carbon budget of the ESAS, the world's largest continental shelf, overwhelming the marine and topsoil terrestrial components. Inverse modelling of the dual-carbon isotope composition of organic carbon accumulating in ESAS surface sediments, using Monte Carlo simulations to account for uncertainties, suggests that 44 +/- 10 teragrams of old carbon is activated annually from Ice Complex permafrost, an order of magnitude more than has been suggested by previous studies(14). We estimate that about two-thirds (66 +/- 16 per cent) of this old carbon escapes to the atmosphere as carbon dioxide, with the remainder being re-buried in shelf sediments. Thermal collapse and erosion of these carbon-rich Pleistocene coastline and seafloor deposits may accelerate with Arctic amplification of climate warming(2,13).	[Vonk, J. E.; Sanchez-Garcia, L.; van Dongen, B. E.; Alling, V.; Andersson, A.; Gustafsson, O.] Stockholm Univ, Dept Appl Environm Sci ITM, SE-11418 Stockholm, Sweden; [Vonk, J. E.; Sanchez-Garcia, L.; van Dongen, B. E.; Alling, V.; Andersson, A.; Gustafsson, O.] Stockholm Univ, Bert Bolin Ctr Climate Res, SE-11418 Stockholm, Sweden; [Kosmach, D.; Charkin, A.; Semiletov, I. P.; Dudarev, O. V.; Shakhova, N.] Russian Acad Sci, Pacific Oceanol Inst, Vladivostok 690041, Russia; [Semiletov, I. P.; Shakhova, N.] Univ Alaska, Int Arctic Res Ctr, Fairbanks, AK 99775 USA; [Roos, P.] Riso Natl Lab Sustainable Energy, DK-4000 Roskilde, Denmark; [Eglinton, T. I.] Swiss Fed Inst Technol, Inst Geol, CH-8092 Zurich, Switzerland	Stockholm University; Stockholm University; Ilichev Pacific Oceanological Institute; Russian Academy of Sciences; University of Alaska System; University of Alaska Fairbanks; Technical University of Denmark; Swiss Federal Institutes of Technology Domain; ETH Zurich	Gustafsson, O (corresponding author), Stockholm Univ, Dept Appl Environm Sci ITM, Svante Arrhenius Vag 8, SE-11418 Stockholm, Sweden.	orjan.gustafsson@itm.su.se	Oleg, Dudarev Victorovich/A-8269-2019; Kosmach, Denis Alekseevich/AAT-5710-2020; Vonk, Jorien E/H-5422-2011; Shakhova, Natalia Evgenievna/H-6691-2016; Semiletov, Igor/CAJ-4412-2022; Sanchez-Garcia, Laura/N-1172-2013; Charkin, Alexander/G-8883-2019; Semiletov, Igor P/B-3616-2013	Kosmach, Denis Alekseevich/0000-0002-2276-324X; Vonk, Jorien E/0000-0002-1206-5878; Sanchez-Garcia, Laura/0000-0002-7444-1242; van Dongen, Bart/0000-0003-1189-142X; Charkin, Alexander/0000-0001-9273-9950; Eglinton, Timothy/0000-0001-5060-2155	Knut and Alice Wallenberg Foundation; Far Eastern Branch of the Russian Academy of Sciences; Swedish Research Council; US National Oceanic and Atmospheric Administration; Russian Foundation of Basic Research; Swedish Polar Research Secretariat; Nordic Council of Ministers; Swedish Royal Academy of Sciences; EU Marie Curie grant; US National Science Foundation; NOAA OAR Climate Program Office; Natural Environment Research Council [NE/I024798/1] Funding Source: researchfish; NERC [NE/I024798/1] Funding Source: UKRI	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Far Eastern Branch of the Russian Academy of Sciences(Russian Academy of Sciences); Swedish Research Council(Swedish Research CouncilEuropean Commission); US National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR)); Swedish Polar Research Secretariat; Nordic Council of Ministers; Swedish Royal Academy of Sciences; EU Marie Curie grant; US National Science Foundation(National Science Foundation (NSF)); NOAA OAR Climate Program Office; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank all ISSS-08 colleagues and crew, in particular M. Krusa, P. Andersson and V. Mordukhovich, who helped with sampling. The ISSS program is supported by the Knut and Alice Wallenberg Foundation, the Far Eastern Branch of the Russian Academy of Sciences, the Swedish Research Council, the US National Oceanic and Atmospheric Administration, the Russian Foundation of Basic Research, the Swedish Polar Research Secretariat and the Nordic Council of Ministers (Arctic Co-Op and TRI-DEFROST programs). O.G. and L.S.-G. acknowledge an Academy Research Fellow grant from the Swedish Royal Academy of Sciences and an EU Marie Curie grant, respectively. N.S. and I. P. S. acknowledge grants from the US National Science Foundation and the NOAA OAR Climate Program Office.	Dmitrenko IA, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC007218; Dudarev OV, 2006, DOKL EARTH SCI, V409, P1000, DOI 10.1134/S1028334X06060389; Dutta K, 2006, GLOBAL CHANGE BIOL, V12, P2336, DOI 10.1111/j.1365-2486.2006.01259.x; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Grigoriev M. N, 2008, THESIS YAKUTSK MELNI; Gruber N, 2004, SCOPE SER, V62, P45; Keil RG, 2004, MAR CHEM, V92, P157, DOI 10.1016/j.marchem.2004.06.024; Lantuit H, 2009, MAR GEOL, V257, P1, DOI 10.1016/j.margeo.2008.10.004; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; Mastepanov M, 2008, NATURE, V456, P628, DOI 10.1038/nature07464; Nicolsky D, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/1/015006; Overduin PP, 2007, GEOL SOC AM SPEC PAP, V426, P97, DOI 10.1130/2007.2426(07); Rachold V, 2000, INT J EARTH SCI, V89, P450, DOI 10.1007/s005310000113; Razumov S.O., 2000, GEOMORPHOLOGY, V3, P88; Richter-Menge J., 2010, ARCTIC REPORT CARD 2; Rivkina E, 1998, GEOMICROBIOL J, V15, P187, DOI 10.1080/01490459809378075; Romanovskii N. N., 1993, FUNDAMENTALS CRYOGEN; Romanovskii NN, 2005, GEO-MAR LETT, V25, P167, DOI 10.1007/s00367-004-0198-6; Sanchez-Garcia L, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003862; Schirrmeister L, 2011, QUATERN INT, V241, P3, DOI 10.1016/j.quaint.2010.04.004; Schuur EAG, 2009, NATURE, V459, P556, DOI 10.1038/nature08031; Semiletov I. P, 1999, DOKL EARTH SCI, V369, P1140; Shakhova N, 2010, SCIENCE, V327, P1246, DOI 10.1126/science.1182221; Soloviev V.A., 1987, CRYOTHERMIA GAS HYDR; Stein R., 2004, ORGANIC CARBON CYCLE; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; Vonk JE, 2010, BIOGEOSCIENCES, V7, P3153, DOI 10.5194/bg-7-3153-2010; Vonk JE, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042909; Wegner C, 2003, ESTUAR COAST SHELF S, V57, P55, DOI 10.1016/S0272-7714(02)00328-1; Zimov SA, 2006, SCIENCE, V312, P1612, DOI 10.1126/science.1128908	30	229	248	6	297	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2012	489	7414					137	140		10.1038/nature11392	http://dx.doi.org/10.1038/nature11392			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999WW	22932271				2022-12-24	WOS:000308347000050
J	Hoofnagle, JH; Nelson, KE; Purcell, RH				Hoofnagle, Jay H.; Nelson, Kenrad E.; Purcell, Robert H.			CURRENT CONCEPTS Hepatitis E	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							NON-B HEPATITIS; E VIRUS-INFECTION; UNITED-STATES; NON-A; IGG SEROPREVALENCE; RISK-FACTORS; PATIENT; DISEASE; FOOD; EPIDEMIOLOGY		[Hoofnagle, Jay H.] NIDDKD, Liver Dis Res Branch, Div Digest Dis & Nutr, NIH, Bethesda, MD 20892 USA; [Purcell, Robert H.] NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA; [Nelson, Kenrad E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Hoofnagle, JH (corresponding author), NIDDKD, Liver Dis Res Branch, Div Digest Dis & Nutr, NIH, Rm 9A27,31 Ctr Dr, Bethesda, MD 20892 USA.	hoofnaglej@extra.niddk.nih.gov						Ahmad I, 2011, VIRUS RES, V161, P47, DOI 10.1016/j.virusres.2011.02.011; Alric L, 2010, ANN INTERN MED, V153, P135, DOI 10.7326/0003-4819-153-2-201007200-00256; BALAYAN MS, 1983, INTERVIROLOGY, V20, P23, DOI 10.1159/000149370; Barnaud E, 2012, APPL ENVIRON MICROB, V78, P5153, DOI 10.1128/AEM.00436-12; Batts W, 2011, VIRUS RES, V158, P116, DOI 10.1016/j.virusres.2011.03.019; Baylis SA, 2012, VOX SANG, V103, P89, DOI 10.1111/j.1423-0410.2011.01583.x; Bendall R, 2010, J MED VIROL, V82, P799, DOI 10.1002/jmv.21656; Borgen K, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-61; Boxall E, 2006, TRANSFUSION MED, V16, P79, DOI 10.1111/j.1365-3148.2006.00652.x; Chandra NS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-213; Colson P, 2010, J INFECT DIS, V202, P825, DOI 10.1086/655898; Cossaboom CM, 2011, EMERG INFECT DIS, V17, P2047, DOI 10.3201/eid1711.110428; Dalton HR, 2008, EUR J GASTROEN HEPAT, V20, P784, DOI 10.1097/MEG.0b013e3282f5195a; Dalton HR, 2009, NEW ENGL J MED, V361, P1025, DOI 10.1056/NEJMc0903778; Davern TJ, 2011, GASTROENTEROLOGY, V141, P1665, DOI 10.1053/j.gastro.2011.07.051; Emerson SU, 2010, J VIROL, V84, P9059, DOI 10.1128/JVI.00593-10; Feagins AR, 2008, INT J FOOD MICROBIOL, V123, P32, DOI 10.1016/j.ijfoodmicro.2007.11.068; Fontana RJ, HEPATITIS E CAUSE AC; Gerolami R, 2011, J CLIN VIROL, V52, P60, DOI 10.1016/j.jcv.2011.06.004; Tallon AIG, 2011, GASTROENT HEPAT-BARC, V34, P398, DOI 10.1016/j.gastrohep.2011.02.011; Haqshenas G, 2001, J GEN VIROL, V82, P2449, DOI 10.1099/0022-1317-82-10-2449; Holmberg SD, HEPATITIS E US; Kamar N, 2008, NEW ENGL J MED, V358, P811, DOI 10.1056/NEJMoa0706992; Kamar N, 2012, LANCET, V379, P2477, DOI 10.1016/S0140-6736(11)61849-7; Kamar N, 2011, GASTROENTEROLOGY, V140, P1481, DOI 10.1053/j.gastro.2011.02.050; Kamar N, 2011, EMERG INFECT DIS, V17, P173, DOI 10.3201/eid1702.100856; Kamar N, 2010, GASTROENTEROLOGY, V139, P1612, DOI 10.1053/j.gastro.2010.08.002; Kase JA, 2009, J WATER HEALTH, V7, P344, DOI 10.2166/wh.2009.137; KHUROO MS, 1980, AM J MED, V68, P818, DOI 10.1016/0002-9343(80)90200-4; Kuniholm MH, 2009, J INFECT DIS, V200, P48, DOI 10.1086/599319; Labrique AB, 2010, AM J EPIDEMIOL, V172, P952, DOI 10.1093/aje/kwq225; Mast EE, 1998, HEPATOLOGY, V27, P857, DOI 10.1002/hep.510270331; Masuda JI, 2005, HEPATOL RES, V31, P178, DOI 10.1016/j.hepres.2005.01.008; Matsubayashi K, 2008, TRANSFUSION, V48, P1368, DOI 10.1111/j.1537-2995.2008.01722.x; Meng XJ, 2011, VIRUS RES, V161, P23, DOI 10.1016/j.virusres.2011.01.016; Meng XJ, 1997, P NATL ACAD SCI USA, V94, P9860, DOI 10.1073/pnas.94.18.9860; Ollier L, 2009, ANN INTERN MED, V150, P430, DOI 10.7326/0003-4819-150-6-200903170-00026; Peron JM, 2007, J VIRAL HEPATITIS, V14, P298, DOI 10.1111/j.1365-2893.2007.00858.x; Purcell RH, 2008, J HEPATOL, V48, P494, DOI 10.1016/j.jhep.2007.12.008; Purcell RH, 2011, EMERG INFECT DIS, V17, P2216, DOI 10.3201/eid1712.110482; REYES GR, 1990, SCIENCE, V247, P1335, DOI 10.1126/science.2107574; Said B, 2009, EMERG INFECT DIS, V15, P1738, DOI 10.3201/eid1511.091094; Sainokami S, 2004, J GASTROENTEROL, V39, P640, DOI 10.1007/s00535-003-1359-5; Schlauder GG, 1998, J GEN VIROL, V79, P447, DOI 10.1099/0022-1317-79-3-447; Shrestha MP, 2007, NEW ENGL J MED, V356, P895, DOI 10.1056/NEJMoa061847; Shukla P, 2011, P NATL ACAD SCI USA, V108, P2438, DOI 10.1073/pnas.1018878108; Takahashi H, 2012, ARCH VIROL, V157, P235, DOI 10.1007/s00705-011-1153-2; Tang XH, 2011, P NATL ACAD SCI USA, V108, P10266, DOI 10.1073/pnas.1101309108; Thomas DL, 1997, J CLIN MICROBIOL, V35, P1244, DOI 10.1128/JCM.35.5.1244-1247.1997; Wichmann Ole, 2008, J Infect Dis, V198, P1732, DOI 10.1086/593211; WONG DC, 1980, LANCET, V2, P876; Xing L, 2010, J BIOL CHEM, V285, P33175, DOI 10.1074/jbc.M110.106336; Xu C, ASSESSMENT HEV PREVA; Zhang SJ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-152; Zhu FC, 2010, LANCET, V376, P895, DOI 10.1016/S0140-6736(10)61030-6	55	361	377	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 27	2012	367	13					1237	1244		10.1056/NEJMra1204512	http://dx.doi.org/10.1056/NEJMra1204512			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	011JO	23013075				2022-12-24	WOS:000309161100010
J	Selkoe, DJ				Selkoe, Dennis J.			Preventing Alzheimer's Disease	SCIENCE			English	Editorial Material							MILD COGNITIVE IMPAIRMENT; CEREBROSPINAL-FLUID; LEISURE ACTIVITIES; PHYSICAL-ACTIVITY; OLDER-ADULTS; RISK; MODEL; THERAPEUTICS; BIOMARKERS; OLIGOMERS	Despite intensive laboratory and clinical research over three decades, an effective treatment to delay the onset and progression of Alzheimer's disease is not at hand. Recent clinical trial failures suggest that we must treat the disease earlier than in its mild to moderate stages, and major progress in validating presymptomatic biomarkers now makes secondary prevention trials possible. We will learn more about the natural history of the disease and any partial therapeutic responses from detailed analyses of recent trial results. This process will likely position the field for success, but only with much greater investment in all aspects of Alzheimer research and with careful design of future trials.	Harvard Univ, Brigham & Womens Hosp, Ctr Neurol Dis, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Selkoe, DJ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Ctr Neurol Dis, Sch Med, Boston, MA 02115 USA.	dselkoe@rics.bwh.harvard.edu						Alzheimer Research Forum, 2012, ALZHEIMER RES F 0515; Alzheimer Research Forum, 2011, ALZHEIMER RES F 1227; Bateman R. J., 2012, NEW ENGL J MED; Bateman RJ, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt59; Blennow K., ARCH NEUROL; Brookmeyer R, 2011, ALZHEIMERS DEMENT, V7, P61, DOI 10.1016/j.jalz.2010.11.007; Brown MS, 1996, SCIENCE, V272, P629, DOI 10.1126/science.272.5262.629; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Costa DA, 2007, NEUROBIOL AGING, V28, P831, DOI 10.1016/j.neurobiolaging.2006.04.009; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; Fagan AM, 2007, ARCH NEUROL-CHICAGO, V64, P343, DOI 10.1001/archneur.64.3.noc60123; Fagan AM, 2009, ANN NEUROL, V65, P176, DOI 10.1002/ana.21559; Golde TE, 2011, NEURON, V69, P203, DOI 10.1016/j.neuron.2011.01.002; Grant JL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004145; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; Intlekofer K. A., NEUROBIOL DIS; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; LANDAU SM, 2012, ARCH NEUROL; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; Mahley RW, 2009, ANN NEUROL, V65, P623, DOI 10.1002/ana.21736; Mattsson N, 2012, J ALZHEIMERS DIS, V30, P767, DOI 10.3233/JAD-2012-120019; Morris J. C., 2011, NEUROBIOL AGING S1, V32, pS1; MOTTER R, 1995, ANN NEUROL, V38, P643, DOI 10.1002/ana.410380413; Muller U. C., 2012, BIOL ALZHEIMERS DIS, P231; NIH Fogarty International Center, 2012, 1 EV ALZH PREV TRIAL; Ostrowitzki S, 2012, ARCH NEUROL-CHICAGO, V69, P198, DOI 10.1001/archneurol.2011.1538; Pankevich D. E., 2012, ALZHEIMERS DIAGNOSTI; RINNE JO, 2010, OPTN SRTR ANN REP, V9, P363, DOI DOI 10.1016/S1474-4422(10)70043-0; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Sattler C, 2012, PSYCHIAT RES, V196, P90, DOI 10.1016/j.psychres.2011.11.012; Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Sperling R, 2012, LANCET NEUROL, V11, P241, DOI 10.1016/S1474-4422(12)70015-7; Sperling RA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002609; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Verghese J, 2006, NEUROLOGY, V66, P821, DOI 10.1212/01.wnl.0000202520.68987.48; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang HX, 2002, AM J EPIDEMIOL, V155, P1081, DOI 10.1093/aje/155.12.1081; Wimo A, 2010, WORLD ALZHEIMER REPO; Wolf SA, 2006, BIOL PSYCHIAT, V60, P1314, DOI 10.1016/j.biopsych.2006.04.004	44	296	306	2	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2012	337	6101					1488	1492		10.1126/science.1228541	http://dx.doi.org/10.1126/science.1228541			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	007UC	22997326	Green Published			2022-12-24	WOS:000308912900038
J	Blair, AC; Fisher, ER; Rickey, D				Blair, A. Colin; Fisher, Ellen R.; Rickey, Dawn			Discovering Nanoscience	SCIENCE			English	Editorial Material							GOLD NANOPARTICLE; ALTERNATIVE TOOL		[Blair, A. Colin; Fisher, Ellen R.; Rickey, Dawn] Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA	Colorado State University	Blair, AC (corresponding author), Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA.	dawn.rickey@colostate.edu						Mattox AC, 2006, J CHEM EDUC, V83, P622, DOI 10.1021/ed083p622; McFarland A.D., 2004, J CHEM EDUC, V81, P544, DOI DOI 10.1021/ED081P544A; President's Council of Advisors on Science and Technology, 2012, ENG EXC PROD ON MILL; Rickey D., 1999, THESIS U CALIFORNIA; Rojanathanes R, 2008, TAIWAN J OBSTET GYNE, V47, P296, DOI 10.1016/S1028-4559(08)60127-8; Schwartz DL, 2011, J EDUC PSYCHOL, V103, P759, DOI 10.1037/a0025140; Tien L. T., 1998, THESIS U CALIFORNIA; Tien L. T., 1999, J COLL SCI TEACH, V28, P318; Wiwanitkit V, 2007, RENAL FAILURE, V29, P1047, DOI 10.1080/08860220701643575	9	3	4	0	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2012	337	6098					1056	1057		10.1126/science.1215151	http://dx.doi.org/10.1126/science.1215151			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22936769				2022-12-24	WOS:000308125800036
J	Eisenstein, M				Eisenstein, Michael			PUBLIC HEALTH Prevention comes of age	NATURE			English	Editorial Material																		LaMontagne DS, 2011, B WORLD HEALTH ORGAN, V89, P821, DOI [10.2471/BLT.11.089862, 10.2471/BLT.11.08986]; Ovedraogo N, 2011, LANCET, V378, P315, DOI 10.1016/S0140-6736(11)61164-1; Sauvaget C, 2011, INT J GYNECOL OBSTET, V113, P14, DOI 10.1016/j.ijgo.2010.10.012	3	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2012	488	7413					S11	S13		10.1038/488S11a	http://dx.doi.org/10.1038/488S11a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	996NC	22932434				2022-12-24	WOS:000308095100009
J	Ayaz, P; Ye, XC; Huddleston, P; Brautigam, CA; Rice, LM				Ayaz, Pelin; Ye, Xuecheng; Huddleston, Patrick; Brautigam, Chad A.; Rice, Luke M.			A TOG:alpha beta-tubulin Complex Structure Reveals Conformation-Based Mechanisms for a Microtubule Polymerase	SCIENCE			English	Article							CRYSTAL-STRUCTURE; GAMMA-TUBULIN; PLUS-END; BINDING; XMAP215; YEAST; STU2P; DYNAMICS; MUTANTS; PROTEIN	Stu2p/XMAP215/Dis1 family proteins are evolutionarily conserved regulatory factors that use alpha beta-tubulin-interacting tumor overexpressed gene (TOG) domains to catalyze fast microtubule growth. Catalysis requires that these polymerases discriminate between unpolymerized and polymerized forms of alpha beta-tubulin, but the mechanism by which they do so has remained unclear. Here, we report the structure of the TOG1 domain from Stu2p bound to yeast alpha beta-tubulin. TOG1 binds alpha beta-tubulin in a way that excludes equivalent binding of a second TOG domain. Furthermore, TOG1 preferentially binds a curved conformation of alpha beta-tubulin that cannot be incorporated into microtubules, contacting alpha- and beta-tubulin surfaces that do not participate in microtubule assembly. Conformation-selective interactions with alpha beta-tubulin explain how TOG-containing polymerases discriminate between unpolymerized and polymerized forms of alpha beta-tubulin and how they selectively recognize the growing end of the microtubule.	[Rice, Luke M.] Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Rice, LM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biophys, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	luke.rice@utsouthwestern.edu		Brautigam, Chad/0000-0001-6563-1338; Rice, Luke/0000-0001-6551-3307	U.S. Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; Robert A. Welch Foundation [I-1692]; NIH [GM-098543]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098543] Funding Source: NIH RePORTER	U.S. Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Robert A. Welch Foundation(The Welch Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Borek for assistance with diffraction data processing; D. Tomchick in the Univ. of Texas Southwestern Structural Biology Core Facility for advice and assistance; M. Rosen, Y. Jiang, and M. Moritz for sharing equipment/reagents; and S. Padrick for help with fluorescence anisotropy. H. Yu, X. Zhang, and M. Rosen gave critical comments on the manuscript. L.M.R. is the Thomas O. Hicks Scholar in Medical Research. Results shown in this report are derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source, beamline 19-ID. Argonne is operated by UChicago Argonne, LLC, for the U.S. Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357. This work was supported by grants I-1692 (from the Robert A. Welch Foundation) and GM-098543 (from the NIH). Coordinates have been deposited in the Protein Data Bank with accession code 4FFB.	Al-Bassam J, 2006, J CELL BIOL, V172, P1009, DOI 10.1083/jcb.200511010; Al-Bassam J, 2007, STRUCTURE, V15, P355, DOI 10.1016/j.str.2007.01.012; Aldaz H, 2005, NATURE, V435, P523, DOI 10.1038/nature03586; Brouhard GJ, 2008, CELL, V132, P79, DOI 10.1016/j.cell.2007.11.043; Buey RM, 2006, BIOCHEMISTRY-US, V45, P5933, DOI 10.1021/bi060334m; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; GARD DL, 1987, J CELL BIOL, V105, P2203, DOI 10.1083/jcb.105.5.2203; Johnson V, 2011, BIOCHEMISTRY-US, V50, P8636, DOI 10.1021/bi2005174; Kosco KA, 2001, MOL BIOL CELL, V12, P2870, DOI 10.1091/mbc.12.9.2870; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; OHKURA H, 1988, EMBO J, V7, P1465, DOI 10.1002/j.1460-2075.1988.tb02964.x; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Rice LM, 2008, P NATL ACAD SCI USA, V105, P5378, DOI 10.1073/pnas.0801155105; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Wang PJJ, 1997, J CELL BIOL, V139, P1271, DOI 10.1083/jcb.139.5.1271; Widlund PO, 2011, P NATL ACAD SCI USA, V108, P2741, DOI 10.1073/pnas.1016498108	16	152	153	3	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2012	337	6096					857	860		10.1126/science.1221698	http://dx.doi.org/10.1126/science.1221698			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	989BQ	22904013	Green Accepted			2022-12-24	WOS:000307535600047
J	Buxton, OM; Ellenbogen, JM; Wang, W; Carballeira, A; O'Connor, S; Cooper, D; Gordhandas, AJ; McKinney, SM; Solet, JM				Buxton, Orfeu M.; Ellenbogen, Jeffrey M.; Wang, Wei; Carballeira, Andy; O'Connor, Shawn; Cooper, Dan; Gordhandas, Ankit J.; McKinney, Scott M.; Solet, Jo M.			Sleep Disruption due to Hospital Noises A Prospective Evaluation	ANNALS OF INTERNAL MEDICINE			English	Article							NEONATAL INTENSIVE-CARE; AIRCRAFT NOISE; AROUSAL; QUALITY; DEPRIVATION; AGE; IDENTIFICATION; ENVIRONMENT; ACTIVATION; DURATION	Background: Sleep plays a critical role in maintaining health and well-being; however, patients who are hospitalized are frequently exposed to noise that can disrupt sleep. Efforts to attenuate hospital noise have been limited by incomplete information on the interaction between sounds and sleep physiology. Objective: To determine profiles of acoustic disruption of sleep by examining the cortical (encephalographic) arousal responses during sleep to typical hospital noises by sound level and type and sleep stage. Design: 3-day polysomnographic study. Setting: Sound-attenuated sleep laboratory. Participants: Volunteer sample of 12 healthy participants. Intervention: Baseline (sham) night followed by 2 intervention nights with controlled presentation of 14 sounds that are common in hospitals (for example, voice, intravenous alarm, phone, ice machine, outside traffic, and helicopter). The sounds were administered at calibrated, increasing decibel levels (40 to 70 dBA [decibels, adjusted for the range of normal hearing]) during specific sleep stages. Measurements: Encephalographic arousals, by using established criteria, during rapid eye movement (REM) sleep and non-REM (NREM) sleep stages 2 and 3. Results: Sound presentations yielded arousal response curves that varied because of sound level and type and sleep stage. Electronic sounds were more arousing than other sounds, including human voices, and there were large differences in responses by sound type. As expected, sounds in NREM stage 3 were less likely to cause arousals than sounds in NREM stage 2; unexpectedly, the probability of arousal to sounds presented in REM sleep varied less by sound type than when presented in NREM sleep and caused a greater and more sustained elevation of instantaneous heart rate. Limitations: The study included only 12 participants. Results for these healthy persons may underestimate the effects of noise on sleep in patients who are hospitalized. Conclusion: Sounds during sleep influence both cortical brain activity and cardiovascular function. This study systematically quantifies the disruptive capacity of a range of hospital sounds on sleep, providing evidence that is essential to improving the acoustic environments of new and existing health care facilities to enable the highest quality of care.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Brigham & Womens Hosp, Boston, MA USA; Berklee Coll Mus, Boston, MA USA; Cambridge Hlth Alliance, Cambridge, England; Cavanaugh Tocci Assoc, Sudbury, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Massachusetts General Hospital	Buxton, OM (corresponding author), 221 Longwood Ave,BLI438-K, Boston, MA 02115 USA.	orfeu_buxton@hms.harvard.edu		Buxton, Orfeu/0000-0001-5057-633X	Academy of Architecture for Health; Facilities Guidelines Institute; Center for Health Design	Academy of Architecture for Health; Facilities Guidelines Institute; Center for Health Design	This study was funded by investigator-initiated grants (Dr. Solet) from the Academy of Architecture for Health, the Facilities Guidelines Institute, and The Center for Health Design. Sleep laboratory work was completed through the generosity of Massachusetts General Hospital and with acoustic consultation by Cavanaugh Tocci Associates.	Ancoli-Israel S, 2005, J AM GERIATR SOC, V53, pS264, DOI 10.1111/j.1532-5415.2005.53392.x; [Anonymous], GUID DES CONSTR HLTH; Bartick Melissa C, 2010, J Hosp Med, V5, pE20, DOI 10.1002/jhm.549; Basner M, 2008, SLEEP MED, V9, P382, DOI 10.1016/j.sleep.2007.07.002; Basner M, 2007, SLEEP, V30, P1349, DOI 10.1093/sleep/30.10.1349; Basner M, 2006, J ACOUST SOC AM, V119, P2772, DOI 10.1121/1.2184247; Basner M, 2010, NOISE HEALTH, V12, P95, DOI 10.4103/1463-1741.63210; Berg S, 2001, SLEEP, V24, P289, DOI 10.1093/sleep/24.3.289; Bonnet MH, 2007, J CLIN SLEEP MED, V3, P133; Bonnet MH, 2007, J CLIN SLEEP MED, V3, P271; Braun AR, 1997, BRAIN, V120, P1173, DOI 10.1093/brain/120.7.1173; Bruck D, 2009, J SLEEP RES, V18, P196, DOI 10.1111/j.1365-2869.2008.00710.x; Busch-Vishniac IJ, 2005, J ACOUST SOC AM, V118, P3629, DOI 10.1121/1.2118327; Buxton OM, 2010, DIABETES, V59, P2126, DOI 10.2337/db09-0699; Cappuccio FP, 2007, HYPERTENSION, V50, P693, DOI 10.1161/HYPERTENSIONAHA.107.095471; Carpenter Dave, 2010, Health Facil Manage, V23, P11; Catcheside PG, 2002, SLEEP, V25, P797, DOI 10.1093/sleep/25.7.797; Cmiel CA, 2004, AM J NURS, V104, P40, DOI 10.1097/00000446-200402000-00019; Cohen S, 2009, ARCH INTERN MED, V169, P62, DOI 10.1001/archinternmed.2008.505; Colten HR, 2006, SLEEP DISORDERS SLEE; Dang-Vu TT, 2010, CURR BIOL, V20, pR626, DOI 10.1016/j.cub.2010.06.032; DEGENNARO L, 1995, ELECTROEN CLIN NEURO, V95, P252, DOI 10.1016/0013-4694(95)00090-L; Dijk DJ, 2001, SLEEP, V24, P565, DOI 10.1093/sleep/24.5.565; Drummond SPA, 2001, NEUROPSYCHOPHARMACOL, V25, pS68, DOI 10.1016/S0893-133X(01)00325-6; Elmenhorst EM, 2010, INT ARCH OCC ENV HEA, V83, P743, DOI 10.1007/s00420-010-0515-5; Griefahn B, 2008, SLEEP, V31, P569, DOI 10.1093/sleep/31.4.569; Hagerman I, 2005, INT J CARDIOL, V98, P267, DOI 10.1016/j.ijcard.2003.11.006; Halasz P, 2004, J SLEEP RES, V13, P1, DOI 10.1111/j.1365-2869.2004.00388.x; Hoevenaar-Blom MP, 2011, SLEEP, V34, P1487, DOI 10.5665/sleep.1382; Iber C., 2007, RULES TERMINOL TECH, V176, P2012; Inouye SK, 1999, NEW ENGL J MED, V340, P669, DOI 10.1056/NEJM199903043400901; Jha AK, 2008, NEW ENGL J MED, V359, P1921, DOI 10.1056/NEJMsa0804116; Johnson AN, 2003, J PERINAT NEONAT NUR, V17, P280, DOI 10.1097/00005237-200310000-00006; Kahn DM, 1998, CHEST, V114, P535, DOI 10.1378/chest.114.2.535; Landolt HP, 1996, BRAIN RES, V738, P205, DOI 10.1016/S0006-8993(96)00770-6; Mayers AG, 2005, HUM PSYCHOPHARM CLIN, V20, P533, DOI 10.1002/hup.726; McNeer Richard R, 2007, J Clin Monit Comput, V21, P353, DOI 10.1007/s10877-007-9096-6; Montague KN, 2009, AM J NURS, V109, P65, DOI 10.1097/01.NAJ.0000360316.54373.0d; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Perrin F, 1999, CLIN NEUROPHYSIOL, V110, P2153, DOI 10.1016/S1388-2457(99)00177-7; Ryherd EE, 2008, J ACOUST SOC AM, V123, P747, DOI 10.1121/1.2822661; Schweitzer PK, 2010, PRINCIPLES PRACTICE, P542; Sforza E, 2000, CLIN NEUROPHYSIOL, V111, P1611, DOI 10.1016/S1388-2457(00)00363-1; Sforza E, 2004, CLIN NEUROPHYSIOL, V115, P2442, DOI 10.1016/j.clinph.2004.06.002; Siegel JM, 2010, PRINCIPLES PRACTICE, P92; Solet JM, 2012, PROG PEDIATR CARDIOL, V33, P85, DOI 10.1016/j.ppedcard.2011.12.014; SOUTHWELL MT, 1995, J ADV NURS, V21, P1101, DOI 10.1046/j.1365-2648.1995.21061101.x; Topf M, 1996, J ADV NURS, V24, P545, DOI 10.1046/j.1365-2648.1996.22315.x; Topf M, 2001, HEART LUNG, V30, P237, DOI 10.1067/mhl.2001.116592; Weinhouse GL, 2009, CRIT CARE, V13, DOI 10.1186/cc8131; Williams AL, 2007, J ACOUST SOC AM, V121, P2681, DOI 10.1121/1.2717500; Witmans M, 2005, J CLIN SLEEP MED, V1, pE488; World Health Organization Regional Office for Europe, 2010, NIGHT NOIS GUID EUR; YINNON AM, 1992, BRIT J CLIN PRACT, V46, P88	54	94	95	1	28	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 7	2012	157	3					170	+		10.7326/0003-4819-156-12-201208070-00472	http://dx.doi.org/10.7326/0003-4819-156-12-201208070-00472			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	992PB	22868834				2022-12-24	WOS:000307789900004
J	Tsugawa, Y; Mukamal, KJ; Davis, RB; Taylor, WC; Wee, CC				Tsugawa, Yusuke; Mukamal, Kenneth J.; Davis, Roger B.; Taylor, William C.; Wee, Christina C.			Should the Hemoglobin A(1c) Diagnostic Cutoff Differ Between Blacks and Whites? A Cross-sectional Study	ANNALS OF INTERNAL MEDICINE			English	Article							HBA(1C) LEVELS; MICROVASCULAR COMPLICATIONS; DIABETIC-RETINOPATHY; ETHNIC-DIFFERENCES; GLUCOSE-TOLERANCE; PLASMA-GLUCOSE; A1C; ADULTS; ASSOCIATION; CHILDREN	Background: Hemoglobin A(1c) (HbA(1c)) levels are known to be consistently higher in black persons than in white persons at any given glycemic level. Whether the optimal diagnostic threshold of HbA1c should differ between blacks and whites is unclear. Objective: To compare the relationships between HbA(1c) level and the prevalence of retinopathy in black and white U. S. adults. Design: Cross-sectional study. Setting: A nationally representative sample of the National Health and Nutrition Examination Survey from 2005 through 2008. Patients: 2804 white persons and 1008 black persons aged 40 years or older in the United States. Measurements: Prevalence of retinopathy. Logistic regression models and restricted cubic spline models were constructed separately for white and black populations to test the HbA(1c) levels at which risk for retinopathy begins to increase. Results: After adjustment for age, sex, hypertension, body mass index, family history of diabetes, and use of antidiabetes medications or insulin, the lowest HbA(1c) category for which the prevalence of retinopathy was significantly higher than the reference category (<5.5%) was 6.0% to 6.4% for white persons (risk difference, 4.8% [95% CI, 0.5% to 9.1%]) and 5.5% to 5.9% for black persons (risk difference, 5.3% [CI, 1.0% to 9.5%]). The restricted cubic spline models indicated that the risk for retinopathy increased at lower HbA(1c) levels in black persons than in white persons. Limitation: The cross-sectional design of the study precluded examining the effect of the duration at each HbA(1c) level. Conclusion: The prevalence of retinopathy begins to increase at a lower HbA(1c) level in black Americans than in white Americans. The findings do not support increasing the diagnostic threshold of HbA(1c) in black persons.	[Tsugawa, Yusuke; Mukamal, Kenneth J.; Davis, Roger B.; Taylor, William C.; Wee, Christina C.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Tsugawa, Y (corresponding author), Harvard Univ, Sch Med, Div Gen Med & Primary Care, Beth Israel Deaconess Med Ctr, 1309 Beacon St, Brookline, MA 02446 USA.	ytsugawa@bidmc.harvard.edu	Mukamal, Kenneth/GVR-7978-2022	Tsugawa, Yusuke/0000-0002-1937-4833	Shigeaki Hinohara, MD, Primary Care Fellowship at Beth Israel Deaconess Medical Center; Joint Japan/World Bank Graduate Scholarship Program; St. Luke's Life Science Institute, Tokyo, Japan; Harvard Catalyst, The Harvard Clinical and Translational Science Center (National Institutes of Health) [UL1 RR 025758]; Harvard University; National Institutes of Health [K24DK087932]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK087932] Funding Source: NIH RePORTER	Shigeaki Hinohara, MD, Primary Care Fellowship at Beth Israel Deaconess Medical Center; Joint Japan/World Bank Graduate Scholarship Program; St. Luke's Life Science Institute, Tokyo, Japan; Harvard Catalyst, The Harvard Clinical and Translational Science Center (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr. Tsugawa is supported by the Shigeaki Hinohara, MD, Primary Care Fellowship at Beth Israel Deaconess Medical Center; the Joint Japan/World Bank Graduate Scholarship Program; and St. Luke's Life Science Institute, Tokyo, Japan. Dr. Davis is supported by Harvard Catalyst, The Harvard Clinical and Translational Science Center (National Institutes of Health Award UL1 RR 025758), and financial contributions from Harvard University and its affiliated academic health care centers. Dr. Wee is supported by a midcareer mentorship award from the National Institutes of Health (K24DK087932).	Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; American Diabetes Association, 2012, DAT 2011 NAT DIAB FA; [Anonymous], 1991, Ophthalmology, V98, P786; Bao YQ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2249; Brown AF, 2005, DIABETES CARE, V28, P2864, DOI 10.2337/diacare.28.12.2864; Centers for Disease Control and Prevention National Center for Health Statistics, 2012, NAT HLTH NUTR EX SUR; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Cohen RM, 2008, BLOOD, V112, P4284, DOI 10.1182/blood-2008-04-154112; Cohen RM, 2007, DIABETES CARE, V30, P2756, DOI 10.2337/dc07-1301; Dagogo-Jack S, 2010, NAT REV ENDOCRINOL, V6, P589, DOI 10.1038/nrendo.2010.126; Davidson MB, 2010, DIABETES RES CLIN PR, V87, P415, DOI 10.1016/j.diabres.2009.12.013; Engelgau MM, 1997, DIABETES CARE, V20, P785, DOI 10.2337/diacare.20.5.785; Gama R, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b5648; Gavin JR, 1997, DIABETES CARE, V20, P1183; Groenwold RHH, 2012, AM J EPIDEMIOL, V175, P210, DOI 10.1093/aje/kwr302; HARRELL FE, 1988, J NATL CANCER I, V80, P1198, DOI 10.1093/jnci/80.15.1198; Herman WH, 2007, DIABETES CARE, V30, P2453, DOI 10.2337/dc06-2003; Herman WH, 2010, ANN INTERN MED, V152, P815, DOI 10.7326/0003-4819-152-12-201006150-00011; Herman WH, 2009, J CLIN ENDOCR METAB, V94, P1689, DOI 10.1210/jc.2008-1940; Kamps JL, 2010, DIABETES CARE, V33, P1025, DOI 10.2337/dc09-1440; Kilpatrick ES, 2009, DIABETES CARE, V32, P1901, DOI [10.2337/dc09-0109, 10.2337/dc09-1231]; Kirk JK, 2006, DIABETES CARE, V29, P2130, DOI 10.2337/dc05-1973; Korn E. L., 1999, ANAL HLTH SURVEYS; MCCANCE DR, 1994, BRIT MED J, V308, P1323, DOI 10.1136/bmj.308.6940.1323; McCance DR, 1997, DIABETOLOGIA, V40, P247, DOI 10.1007/s001250050671; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Olabi B, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4354; Porta M, 2002, DIABETOLOGIA, V45, P1617, DOI 10.1007/s00125-002-0990-7; Porta M, 2001, DIABETOLOGIA, V44, P2203, DOI 10.1007/s001250100030; Saaddine JB, 2002, DIABETES CARE, V25, P1326, DOI 10.2337/diacare.25.8.1326; Sacks DB, 2011, DIABETES CARE, V34, P518, DOI 10.2337/dc10-1546; Schwartz RS, 2001, NEW ENGL J MED, V344, P1392, DOI 10.1056/NEJM200105033441810; Selvin E, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-5-201103010-00004; SHAMOON H, 1995, ARCH OPHTHALMOL-CHIC, V113, P36; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Wisdom K, 1997, DIABETES CARE, V20, P971, DOI 10.2337/diacare.20.6.971; Ziemer DC, 2010, ANN INTERN MED, V152, P770, DOI 10.7326/0003-4819-152-12-201006150-00004	40	61	62	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 7	2012	157	3					153	+		10.7326/0003-4819-157-3-201208070-00004	http://dx.doi.org/10.7326/0003-4819-157-3-201208070-00004			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992PB	22868832	Green Accepted			2022-12-24	WOS:000307789900002
J	Gornall, J				Gornall, Jonathan			SMOKING CESSATION Electronic cigarettes: medical device or consumer product?	BRITISH MEDICAL JOURNAL			English	Editorial Material												jgornall@mac.com						MHRA, 2010, PUBL CONS MLX 364 RE; MHRA, 2010, DRUG SAFETY UPDATE, V3, P6; MHRA (Medicines Healthcare products Regulatory Agency), 2010, CONS LETT MLX 364 RE	3	5	5	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 25	2012	345								e6417	10.1136/bmj.e6417	http://dx.doi.org/10.1136/bmj.e6417			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	014ON	23014904				2022-12-24	WOS:000309385500010
J	Andersen, CBF; Torvund-Jensen, M; Nielsen, MJ; de Oliveira, CLP; Hersleth, HP; Andersen, NH; Pedersen, JS; Andersen, GR; Moestrup, SK				Andersen, Christian Brix Folsted; Torvund-Jensen, Morten; Nielsen, Marianne Jensby; Pinto de Oliveira, Cristiano Luis; Hersleth, Hans-Petter; Andersen, Niels Hojmark; Pedersen, Jan Skov; Andersen, Gregers Rom; Moestrup, Soren Kragh			Structure of the haptoglobin-haemoglobin complex	NATURE			English	Article							SERINE-PROTEASE; BIOLOGICAL MACROMOLECULES; SUBUNIT DISSOCIATION; SOLUTION SCATTERING; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; BINDING; RESOLUTION; CD163; EQUILIBRIUM	Red cell haemoglobin is the fundamental oxygen-transporting molecule in blood, but also a potentially tissue-damaging compound owing to its highly reactive haem groups. During intravascular haemolysis, such as in malaria and haemoglobinopathies(1), haemoglobin is released into the plasma, where it is captured by the protective acute-phase protein haptoglobin. This leads to formation of the haptoglobin-haemoglobin complex, which represents a virtually irreversible non-covalent protein-protein interaction(2). Here we present the crystal structure of the dimeric porcine haptoglobin-haemoglobin complex determined at 2.9 angstrom resolution. This structure reveals that haptoglobin molecules dimerize through an unexpected beta-strand swap between two complement control protein (CCP) domains, defining a new fusion CCP domain structure. The haptoglobin serine protease domain forms extensive interactions with both the alpha- and beta-subunits of haemoglobin, explaining the tight binding between haptoglobin and haemoglobin. The haemoglobin-interacting region in the alpha beta dimer is highly overlapping with the interface between the two alpha beta dimers that constitute the native haemoglobin tetramer. Several haemoglobin residues prone to oxidative modification after exposure to haem-induced reactive oxygen species are buried in the haptoglobin-haemoglobin interface, thus showing a direct protective role of haptoglobin. The haptoglobin loop previously shown to be essential for binding of haptoglobin-haemoglobin to the macrophage scavenger receptor CD163 (ref. 3) protrudes from the surface of the distal end of the complex, adjacent to the associated haemoglobin alpha-subunit. Small-angle X-ray scattering measurements of human haptoglobin-haemoglobin bound to the ligand-binding fragment of CD163 confirm receptor binding in this area, and show that the rigid dimeric complex can bind two receptors. Such receptor cross-linkage may facilitate scavenging and explain the increased functional affinity of multimeric haptoglobin-haemoglobin for CD163 (ref. 4).	[Andersen, Christian Brix Folsted; Torvund-Jensen, Morten; Nielsen, Marianne Jensby; Moestrup, Soren Kragh] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark; [Pinto de Oliveira, Cristiano Luis] Univ Sao Paulo, Inst Phys, BR-0531497 Sao Paulo, Brazil; [Pinto de Oliveira, Cristiano Luis; Pedersen, Jan Skov] Aarhus Univ, Dept Chem, DK-8000 Aarhus C, Denmark; [Pinto de Oliveira, Cristiano Luis; Pedersen, Jan Skov] Aarhus Univ, INANO Interdisciplinary Nanosci Ctr, DK-8000 Aarhus C, Denmark; [Hersleth, Hans-Petter] Univ Oslo, Dept Mol Biosci, NO-0316 Oslo, Norway; [Andersen, Niels Hojmark] Univ Oslo, Dept Chem, NO-0315 Oslo, Norway; [Andersen, Gregers Rom] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark	Aarhus University; Universidade de Sao Paulo; Aarhus University; Aarhus University; University of Oslo; University of Oslo; Aarhus University	Andersen, CBF (corresponding author), Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark.	cbfa@biokemi.au.dk; skm@biokemi.au.dk	Oliveira, Cristiano L P/B-4403-2008; Moestrup, Søren Kragh/AAD-1735-2019; Moestrup, Søren Kragh/A-1403-2014; Nielsen, Marina/F-5625-2012; Complexos, INCT Fluidos/H-9172-2013; Pedersen, Jan Skov/A-8346-2008	Oliveira, Cristiano L P/0000-0002-3426-6507; Moestrup, Søren Kragh/0000-0003-3862-2107; Pedersen, Jan Skov/0000-0002-7768-0206; Andersen, Gregers Rom/0000-0001-6292-3319; Hersleth, Hans-Petter/0000-0002-1142-9983; Andersen, Niels Hojmark/0000-0003-3668-2800	Lundbeck Foundation; Novo Nordisk Foundation; Research Council of Norway; European Research Council; Danish Council for Independent Research; Lundbeck Foundation [R54-2010-5637] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Research Council of Norway(Research Council of Norway); European Research Council(European Research Council (ERC)European Commission); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Lundbeck Foundation(Lundbeckfonden)	We are grateful to G. Ratz for technical assistance, R. Kidmose, N. S. Laursen and the staff at the Swiss Light Source beamlines for help with data collection. We thank G. V. Jensen for performing SAXS measurements and R. E. Weber for scientific discussion. The research was supported by The Lundbeck Foundation, The Novo Nordisk Foundation, The Research Council of Norway, The European Research Council and The Danish Council for Independent Research.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Azarov I, 2008, NITRIC OXIDE-BIOL CH, V18, P296, DOI 10.1016/j.niox.2008.02.006; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Budayova-Spano M, 2002, EMBO J, V21, P231, DOI 10.1093/emboj/21.3.231; Buehler PW, 2009, BLOOD, V113, P2578, DOI 10.1182/blood-2008-08-174466; Bunn H. F., 1977, HEMOGLOBINOPATHIES, V308; Dickerson R.E., 1983, HEMOGLOBIN STRUCTURE; Fagoonee S, 2005, AM J PATHOL, V166, P973, DOI 10.1016/S0002-9440(10)62319-X; Gaboriaud C, 2000, EMBO J, V19, P1755, DOI 10.1093/emboj/19.8.1755; GLATTER O, 1977, J APPL CRYSTALLOGR, V10, P415, DOI 10.1107/S0021889877013879; IP SHC, 1976, BIOCHEMISTRY-US, V15, P654, DOI 10.1021/bi00648a032; Jia YP, 2007, J BIOL CHEM, V282, P4894, DOI 10.1074/jbc.M609955200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kardos J, 2008, MOL IMMUNOL, V45, P1752, DOI 10.1016/j.molimm.2007.09.031; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lim SK, 1998, BLOOD, V92, P1870, DOI 10.1182/blood.V92.6.1870.418k38_1870_1877; Madsen M, 2004, J BIOL CHEM, V279, P51561, DOI 10.1074/jbc.M409629200; MAEDA N, 1984, NATURE, V309, P131, DOI 10.1038/309131a0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller YI, 1997, BIOCHEMISTRY-US, V36, P12189, DOI 10.1021/bi970258a; NAGEL RL, 1971, J BIOL CHEM, V246, P69; NAGEL RL, 1965, BIOCHIM BIOPHYS ACTA, V100, P286, DOI 10.1016/0304-4165(65)90454-X; Nielsen MJ, 2007, J BIOL CHEM, V282, P1072, DOI 10.1074/jbc.M605684200; Nielsen MJ, 2006, BLOOD, V108, P2846, DOI 10.1182/blood-2006-05-022327; Oliveira CLP, 2009, J MOL BIOL, V387, P147, DOI 10.1016/j.jmb.2009.01.020; Park SY, 2006, J MOL BIOL, V360, P690, DOI 10.1016/j.jmb.2006.05.036; Pedersen JS, 2004, J APPL CRYSTALLOGR, V37, P369, DOI 10.1107/S0021889804004170; PEDERSEN JS, 1994, EUR BIOPHYS J BIOPHY, V22, P379, DOI 10.1007/BF00180159; Perona JJ, 1997, J BIOL CHEM, V272, P29987, DOI 10.1074/jbc.272.48.29987; PERUTZ MF, 1960, NATURE, V185, P416, DOI 10.1038/185416a0; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Pimenova T, 2010, J PROTEOME RES, V9, P4061, DOI 10.1021/pr100252e; SADRZADEH SMH, 1984, J BIOL CHEM, V259, P4354; Schrodinger LLC, 2010, PYMOL MOL GRAPH SYST; SHIM BS, 1965, NATURE, V207, P1264, DOI 10.1038/2071264a0; SMITHIES O, 1956, NATURE, V178, P694, DOI 10.1038/178694a0; Smulevich G, 1998, J RAMAN SPECTROSC, V29, P57, DOI 10.1002/(SICI)1097-4555(199801)29:1<57::AID-JRS209>3.0.CO;2-P; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Vanhollebeke B, 2008, SCIENCE, V320, P677, DOI 10.1126/science.1156296; Venkatesh B, 2004, J BIOCHEM, V136, P595, DOI 10.1093/jb/mvh166; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; WEJMAN JC, 1984, J MOL BIOL, V174, P319, DOI 10.1016/0022-2836(84)90341-3	47	171	179	1	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 20	2012	489	7416					456	U150		10.1038/nature11369	http://dx.doi.org/10.1038/nature11369			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AK	22922649				2022-12-24	WOS:000308860900051
J	Cherry, JD				Cherry, James D.			Epidemic Pertussis in 2012-The Resurgence of a Vaccine-Preventable Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Cherry, JD (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA.							[Anonymous], 2012, MMWR MORB MORTAL WKL, V61, P517; Cherry JD, 2012, PEDIATRICS, V129, P968, DOI 10.1542/peds.2011-2594; Cherry JD, 2010, CLIN INFECT DIS, V51, P663, DOI 10.1086/655826; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; Winter K., 2012, J PEDIAT	5	339	363	2	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 30	2012	367	9					785	787		10.1056/NEJMp1209051	http://dx.doi.org/10.1056/NEJMp1209051			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	996EN	22894554				2022-12-24	WOS:000308067400013
J	Morin, SA; Shepherd, RF; Kwok, SW; Stokes, AA; Nemiroski, A; Whitesides, GM				Morin, Stephen A.; Shepherd, Robert F.; Kwok, Sen Wai; Stokes, Adam A.; Nemiroski, Alex; Whitesides, George M.			Camouflage and Display for Soft Machines	SCIENCE			English	Article							CEPHALOPOD DYNAMIC CAMOUFLAGE; DISRUPTIVE COLORATION; EVOLUTION; VISION; CHROMATOPHORES; IRIDOPHORES; ORIGINS; LIGHT	Synthetic systems cannot easily mimic the color-changing abilities of animals such as cephalopods. Soft machines-machines fabricated from soft polymers and flexible reinforcing sheets-are rapidly increasing in functionality. This manuscript describes simple microfluidic networks that can change the color, contrast, pattern, apparent shape, luminescence, and surface temperature of soft machines for camouflage and display. The color of these microfluidic networks can be changed simultaneously in the visible and infrared-a capability that organisms do not have. These strategies begin to imitate the functions, although not the anatomies, of color-changing animals.	[Morin, Stephen A.; Shepherd, Robert F.; Kwok, Sen Wai; Stokes, Adam A.; Nemiroski, Alex; Whitesides, George M.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Whitesides, George M.] Harvard Univ, Wyss Inst Biologically Inspired Engn, Cambridge, MA 02138 USA	Harvard University; Harvard University	Whitesides, GM (corresponding author), Harvard Univ, Dept Chem & Chem Biol, 12 Oxford St, Cambridge, MA 02138 USA.	gwhitesides@gmwgroup.harvard.edu	Shepherd, Robert/A-7081-2018	Shepherd, Robert/0000-0002-0631-9587; Stokes, Adam/0000-0002-6140-619X	U.S. Department of Energy [DE-FG02-00ER45852]; Defense Advanced Research Projects Agency [W911NF-11-1-0094]	U.S. Department of Energy(United States Department of Energy (DOE)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	The development of biomimetic camouflage strategies was supported by the U.S. Department of Energy under award DE-FG02-00ER45852. Soft machine development was supported by the Defense Advanced Research Projects Agency under award W911NF-11-1-0094. Patent applications "Flexible Robotic Actuators" and "Soft Robotic Actuators" have been filed but not yet published.	Cott H. B, 1957, ADAPTIVE COLORATION; Cuthill IC, 2005, NATURE, V434, P72, DOI 10.1038/nature03312; ENDLER JA, 1990, BIOL J LINN SOC, V41, P315, DOI 10.1111/j.1095-8312.1990.tb00839.x; GOLDSMITH TH, 1990, Q REV BIOL, V65, P281, DOI 10.1086/416840; Goris RC, 2011, J HERPETOL, V45, P2, DOI 10.1670/10-238.1; Hanlon RT, 2009, PHILOS T R SOC B, V364, P429, DOI 10.1098/rstb.2008.0270; Hanlon R, 2007, CURR BIOL, V17, pR400, DOI 10.1016/j.cub.2007.03.034; HASTINGS JW, 1983, J MOL EVOL, V19, P309, DOI 10.1007/BF02101634; Hayes RA, 2003, NATURE, V425, P383, DOI 10.1038/nature01988; Heikenfeld J, 2009, NAT PHOTONICS, V3, P292, DOI 10.1038/NPHOTON.2009.68; Hunt DM, 2001, CELL MOL LIFE SCI, V58, P1583, DOI 10.1007/PL00000798; Ilievski F, 2011, ANGEW CHEM INT EDIT, V50, P1890, DOI 10.1002/anie.201006464; JACOBS GH, 1993, BIOL REV, V68, P413, DOI 10.1111/j.1469-185X.1993.tb00738.x; Langridge KV, 2009, ANIM BEHAV, V77, P847, DOI 10.1016/j.anbehav.2008.11.023; Luo DG, 2011, SCIENCE, V332, P1307, DOI 10.1126/science.1200172; Martinez RV, 2012, ADV FUNCT MATER, V22, P1376, DOI 10.1002/adfm.201102978; Mathger LM, 2007, CELL TISSUE RES, V329, P179, DOI 10.1007/s00441-007-0384-8; Merilaita S, 2005, P ROY SOC B-BIOL SCI, V272, P665, DOI 10.1098/rspb.2004.3000; Norman MD, 1999, P ROY SOC B-BIOL SCI, V266, P1347, DOI 10.1098/rspb.1999.0786; PETRIE M, 1991, ANIM BEHAV, V41, P323, DOI 10.1016/S0003-3472(05)80484-1; Rogalski A, 2003, PROG QUANT ELECTRON, V27, P59, DOI 10.1016/S0079-6727(02)00024-1; Scholes E, 2008, BIOL J LINN SOC, V94, P491, DOI 10.1111/j.1095-8312.2008.01012.x; Stevens M, 2009, PHILOS T R SOC B, V364, P423, DOI 10.1098/rstb.2008.0217; Stuart-Fox D, 2009, PHILOS T R SOC B, V364, P463, DOI 10.1098/rstb.2008.0254; Sutherland RL, 2008, J OPT SOC AM A, V25, P588, DOI 10.1364/JOSAA.25.000588; Thayer GH, 1909, CONCEALING COLORATIO; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Wilson T, 1998, ANNU REV CELL DEV BI, V14, P197, DOI 10.1146/annurev.cellbio.14.1.197	28	526	552	42	667	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2012	337	6096					828	832		10.1126/science.1222149	http://dx.doi.org/10.1126/science.1222149			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	989BQ	22904008	Green Submitted			2022-12-24	WOS:000307535600039
J	Jing, SS; Newman, SDS; Baghla, DPS				Jing, S. S.; Newman, S. D. S.; Baghla, D. P. S.			Shoulder injury	BRITISH MEDICAL JOURNAL			English	Editorial Material							PROXIMAL HUMERAL FRACTURES; CLASSIFICATION; AXILLARY		[Jing, S. S.; Newman, S. D. S.; Baghla, D. P. S.] Ealing Gen Hosp, Dept Trauma & Orthopaed Surg, Southall UB1 3HW, Middx, England		Jing, SS (corresponding author), Ealing Gen Hosp, Dept Trauma & Orthopaed Surg, Southall UB1 3HW, Middx, England.	shanshan.jing@gmail.com						Bahrs C, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-33; BLOOM MH, 1967, J BONE JOINT SURG AM, VA 49, P943, DOI 10.2106/00004623-196749050-00011; Brorson S, 2009, INT ORTHOP, V33, P323, DOI 10.1007/s00264-008-0591-2; Cornell Charles N, 2003, J Am Acad Orthop Surg, V11, P109; Court-Brown CM, 2001, ACTA ORTHOP SCAND, V72, P365, DOI 10.1080/000164701753542023; Hodgson S, 2006, CLIN ORTHOP RELAT R, P131, DOI 10.1097/01.blo.0000194677.02506.45; Iyengar JJ, 2011, PHYSICIAN SPORTSMED, V39, P52, DOI 10.3810/psm.2011.02.1862; Kralinger F, 2004, J BONE JOINT SURG BR, V86B, P217, DOI 10.1302/0301-620X.86B2.14553; Mathei J, 2008, ACTA CHIR BELG, V108, P625, DOI 10.1080/00015458.2008.11680305; Monga Puneet, 2009, J Orthop Surg (Hong Kong), V17, P142; Muller ME, 1991, MANUAL INTERNAL FIXA, P118; Murray IR, 2011, J BONE JOINT SURG BR, V93B, P1, DOI 10.1302/0301-620X.93B1.25702; NEER CS, 1970, J BONE JOINT SURG AM, VA 52, P1077, DOI 10.2106/00004623-197052060-00001; Rohilla M, 2008, PAK J MED SCI, V24, P609; STROMQVIST B, 1987, INJURY, V18, P423, DOI 10.1016/0020-1383(87)90298-1; YOUNG TB, 1985, J BONE JOINT SURG BR, V67, P373, DOI 10.1302/0301-620X.67B3.3997943	16	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 3	2012	345								e3172	10.1136/bmj.e3172	http://dx.doi.org/10.1136/bmj.e3172			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	985XF	22864305				2022-12-24	WOS:000307303100001
J	Willyard, C				Willyard, Cassandra			DIAGNOSIS To catch a killer	NATURE			English	Editorial Material																			0	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2012	489	7417					S8	S9		10.1038/489S8a	http://dx.doi.org/10.1038/489S8a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011LT	23013716	Bronze			2022-12-24	WOS:000309167100005
J	Lian, CG; Xu, YF; Ceol, C; Wu, FZ; Larson, A; Dresser, K; Xu, WQ; Tan, L; Hu, YG; Zhan, Q; Lee, CW; Hu, D; Lian, BQ; Kleffel, S; Yang, YJ; Neiswender, J; Khorasani, AJ; Fang, R; Lezcano, C; Duncan, LM; Scolyer, RA; Thompson, JF; Kakavand, H; Houvras, Y; Zon, LI; Mihm, MC; Kaiser, UB; Schatton, T; Woda, BA; Murphy, GF; Shi, YJG				Lian, Christine Guo; Xu, Yufei; Ceol, Craig; Wu, Feizhen; Larson, Allison; Dresser, Karen; Xu, Wenqi; Tan, Li; Hu, Yeguang; Zhan, Qian; Lee, Chung-wei; Hu, Di; Lian, Bill Q.; Kleffel, Sonja; Yang, Yijun; Neiswender, James; Khorasani, Abraham J.; Fang, Rui; Lezcano, Cecilia; Duncan, Lyn M.; Scolyer, Richard A.; Thompson, John F.; Kakavand, Hojabr; Houvras, Yariv; Zon, Leonard I.; Mihm, Martin C., Jr.; Kaiser, Ursula B.; Schatton, Tobias; Woda, Bruce A.; Murphy, George F.; Shi, Yujiang G.			Loss of 5-Hydroxymethylcytosine Is an Epigenetic Hallmark of Melanoma	CELL			English	Article							GENE-EXPRESSION; DNA-METHYLATION; ONCOMETABOLITE 2-HYDROXYGLUTARATE; CELL-LINES; 5-METHYLCYTOSINE; MUTATIONS; TET1; DIFFERENTIATION; IDENTIFICATION; PROGRESSION	DNA methylation at the 5 position of cytosine (5-mC) is a key epigenetic mark that is critical for various biological and pathological processes. 5-mC can be converted to 5-hydroxymethylcytosine (5-hmC) by the ten-eleven translocation (TET) family of DNA hydroxylases. Here, we report that "loss of 5-hmC'' is an epigenetic hallmark of melanoma, with diagnostic and prognostic implications. Genome-wide mapping of 5-hmC reveals loss of the 5-hmC landscape in the melanoma epigenome. We show that downregulation of isocitrate dehydrogenase 2 (IDH2) and TET family enzymes is likely one of the mechanisms underlying 5-hmC loss in melanoma. Rebuilding the 5-hmC landscape in melanoma cells by reintroducing active TET2 or IDH2 suppresses melanoma growth and increases tumor-free survival in animal models. Thus, our study reveals a critical function of 5-hmC in melanoma development and directly links the IDH and TET activity-dependent epigenetic pathway to 5-hmC-mediated suppression of melanoma progression, suggesting a new strategy for epigenetic cancer therapy.	[Lian, Christine Guo; Zhan, Qian; Lee, Chung-wei; Lezcano, Cecilia; Murphy, George F.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Dermatopathol,Dept Pathol, Boston, MA 02115 USA; [Lian, Christine Guo; Xu, Yufei; Hu, Yeguang; Hu, Di; Lian, Bill Q.; Khorasani, Abraham J.; Fang, Rui; Kaiser, Ursula B.; Shi, Yujiang G.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens,Dept Med, Boston, MA 02115 USA; [Ceol, Craig; Houvras, Yariv; Zon, Leonard I.] Harvard Univ, Sch Med, Howard Hughes Med Inst,Harvard Stem Cell Inst, Stem Cell Program & Hematol Oncol,Childrens Hosp, Boston, MA 02115 USA; [Duncan, Lyn M.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Div Dermatopathol,Dept Pathol, Boston, MA 02115 USA; [Larson, Allison; Kleffel, Sonja; Mihm, Martin C., Jr.; Schatton, Tobias] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; [Ceol, Craig; Neiswender, James] Univ Massachusetts, Dept Canc Biol, Worcester, MA 01605 USA; [Dresser, Karen; Woda, Bruce A.] Univ Massachusetts, Dept Pathol, Worcester, MA 01605 USA; [Lian, Bill Q.] Univ Massachusetts, Dept Med, Worcester, MA 01605 USA; [Wu, Feizhen; Xu, Wenqi; Tan, Li; Shi, Yujiang G.] Fudan Univ, Inst Biomed Sci, Lab Epigenet, Shanghai 200032, Peoples R China; [Yang, Yijun] ZIOPHARM Oncol Inc, Charlestown, MA 02129 USA; [Scolyer, Richard A.; Thompson, John F.; Kakavand, Hojabr] Univ Sydney, Melanoma Inst Australia, Royal Prince Alfred Hosp, Sydney, NSW 2006, Australia; [Scolyer, Richard A.; Thompson, John F.; Kakavand, Hojabr] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Houvras, Yariv] Weill Cornell Med Coll, Dept Surg, New York, NY 10065 USA; [Houvras, Yariv] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Houvras, Yariv] New York Presbyterian Hosp, New York, NY 10065 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Fudan University; Melanoma Institute Australia; University of Sydney; University of Sydney; Cornell University; Cornell University; NewYork-Presbyterian Hospital	Murphy, GF (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Dermatopathol,Dept Pathol, Boston, MA 02115 USA.	gmurphy@rics.bwh.harvard.edu; yujiang_shi@hms.harvard.edu	Wu, Feizhen/R-6415-2019; Woda, Bruce/AAS-5898-2020; Larson, Allison/N-4263-2015; Wu, Feizhen/AGR-5215-2022; Schatton, Tobias/N-9898-2018; Scolyer, Richard/AAE-8511-2019; Thompson, John/F-9075-2013	Wu, Feizhen/0000-0002-1265-9887; Larson, Allison/0000-0001-8534-7078; Schatton, Tobias/0000-0003-1386-680X; Scolyer, Richard/0000-0002-8991-0013; Thompson, John/0000-0002-2816-2496; Neiswender, James/0000-0003-4135-6479; Kakavand, Hojabr/0000-0002-3458-7853; Houvras, Yariv/0000-0003-0751-3215; Lian, Christine/0000-0003-4626-1612	National Institutes of Health (NIH) [GM078458]; NIH-NCI [5P50CA093683-09]; Brigham and Women's Hospital Biomedical Research Institute; Chinese Ministry of Education [985]; NATIONAL CANCER INSTITUTE [P50CA093683] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078458, F32GM070690] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Brigham and Women's Hospital Biomedical Research Institute; Chinese Ministry of Education(Ministry of Education, China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. David E. Fisher for his critical reading of the manuscript. This project was supported by grant number GM078458 from National Institutes of Health (NIH) to Y.G.S., grant number 5P50CA093683-09 from NIH-NCI to SPORE Core, and Brigham and Women's Hospital Biomedical Research Institute fund to sustain research excellence, and Chinese Ministry of Education Project 985 to Biomedical Core Facility, Fudan University. Y.G.S. is a PEW scholar. The authors acknowledge Dr. David E. Elder, Dr. Victor G. Prieto, and Dr. Jeffrey E. Gershenwald in the the development of the SPORE TMA.	Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Cimmino L, 2011, CELL STEM CELL, V9, P193, DOI 10.1016/j.stem.2011.08.007; Conway K, 2011, PIGM CELL MELANOMA R, V24, P352, DOI 10.1111/j.1755-148X.2011.00828.x; Dang LN, 2010, TRENDS MOL MED, V16, P387, DOI 10.1016/j.molmed.2010.07.002; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Haffner MC, 2011, ONCOTARGET, V2, P627; Haqq C, 2005, P NATL ACAD SCI USA, V102, P6092, DOI 10.1073/pnas.0501564102; Hoon DSB, 2004, ONCOGENE, V23, P4014, DOI 10.1038/sj.onc.1207505; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jemal A, 2001, JNCI-J NATL CANCER I, V93, P678, DOI 10.1093/jnci/93.9.678; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Kabbarah O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010770; Krell D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019868; Langemeijer SMC, 2009, NAT GENET, V41, P838, DOI 10.1038/ng.391; Liu SH, 2008, PIGM CELL MELANOMA R, V21, P545, DOI 10.1111/j.1755-148X.2008.00484.x; Marks R, 2000, CLIN EXP DERMATOL, V25, P459, DOI 10.1046/j.1365-2230.2000.00693.x; Paz MF, 2003, CANCER RES, V63, P1114; Reitman ZJ, 2011, P NATL ACAD SCI USA, V108, P3270, DOI 10.1073/pnas.1019393108; Riker AI, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-13; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Shen L, 2007, PLOS GENET, V3, P2023, DOI 10.1371/journal.pgen.0030181; Shibata T, 2011, AM J PATHOL, V178, P1395, DOI 10.1016/j.ajpath.2010.12.011; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Talantov D, 2005, CLIN CANCER RES, V11, P7234, DOI 10.1158/1078-0432.CCR-05-0683; Tellez CS, 2009, MELANOMA RES, V19, P146, DOI 10.1097/CMR.0b013e32832b274e; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Wrzeszczynski KO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028503; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yang H, 2012, ONCOGENE; Zhang HK, 2010, CELL RES, V20, P1390, DOI 10.1038/cr.2010.156	36	563	589	4	118	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 14	2012	150	6					1135	1146		10.1016/j.cell.2012.07.033	http://dx.doi.org/10.1016/j.cell.2012.07.033			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22980977	Green Accepted, Bronze			2022-12-24	WOS:000308928100008
J	Pijpe, A; Andrieu, N; Easton, DF; Kesminiene, A; Cardis, E; Nogues, C; Gauthier-Villars, M; Lasset, C; Fricker, JP; Peock, S; Frost, D; Evans, DG; Eeles, RA; Paterson, J; Manders, P; van Asperen, CJ; Ausems, MGEM; Meijers-Heijboer, H; Thierry-Chef, I; Hauptmann, M; Goldgar, D; Rookus, MA; van Leeuwen, FE				Pijpe, Anouk; Andrieu, Nadine; Easton, Douglas F.; Kesminiene, Ausrele; Cardis, Elisabeth; Nogues, Catherine; Gauthier-Villars, Marion; Lasset, Christine; Fricker, Jean-Pierre; Peock, Susan; Frost, Debra; Evans, D. Gareth; Eeles, Rosalind A.; Paterson, Joan; Manders, Peggy; van Asperen, Christi J.; Ausems, Margreet G. E. M.; Meijers-Heijboer, Hanne; Thierry-Chef, Isabelle; Hauptmann, Michael; Goldgar, David; Rookus, Matti A.; van Leeuwen, Flora E.		GENEPSO; EMBRACE; HEBON	Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK)	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ATOMIC-BOMB SURVIVORS; SCREENING MAMMOGRAPHY; IONIZING-RADIATION; VALIDATION; WOMEN; SUSCEPTIBILITY; PROGRAM; HISTORY; REPAIR	Objective To estimate the risk of breast cancer associated with diagnostic radiation in carriers of BRCA1/2 mutations. Design Retrospective cohort study (GENE-RAD-RISK). Setting Three nationwide studies (GENEPSO, EMBRACE, HEBON) in France, United Kingdom, and the Netherlands, Participants 1993 female carriers of BRCA1/2 mutations recruited in 2006-09. Main outcome measure Risk of breast cancer estimated with a weighted Cox proportional hazards model with a time dependent individually estimated cumulative breast dose, based on nominal estimates of organ dose and frequency of self reported diagnostic procedures. To correct for potential survival bias, the analysis excluded carriers who were diagnosed more than five years before completion of the study questionnaire. Results In carriers of BRCA1/2 mutations any exposure to diagnostic radiation before the age of 30 was associated with an increased risk of breast cancer (hazard ratio 1.90, 95% confidence interval 1.20 to 3.00), with a dose-response pattern. The risks by quarter of estimated cumulative dose <0.0020 Gy, >= 0.0020-0.0065 Gy, >= 0.0066-0.0173 Gy, and >= 0.0174 Gy were 1.63 (0.96 to 2.77), 1.78 (0.88 to 3.58), 1.75 (0.72 to 4.25), and 3.84 (1.67 to 8.79), respectively. Analyses on the different types of diagnostic procedures showed a pattern of increasing risk with increasing number of radiographs before age 20 and before age 30 compared with no exposure. A history of mammography before age 30 was also associated with an increased risk of breast cancer (hazard ratio 1.43, 0.85 to 2.40). Sensitivity analysis showed that this finding was not caused by confounding by indication of family history. Conclusion In this large European study among carriers of BRCA1/2 mutations, exposure to diagnostic radiation before age 30 was associated with an increased risk of breast cancer at dose levels considerably lower than those at which increases have been found in other cohorts exposed to radiation. The results of this study support the use of non-ionising radiation imaging techniques (such as magnetic resonance imaging) as the main tool for surveillance in young women with BRCA1/2 mutations.	[Pijpe, Anouk; Rookus, Matti A.; van Leeuwen, Flora E.] Netherlands Canc Inst, Dept Epidemiol & Biostat, NL-1066 CX Amsterdam, Netherlands; [Andrieu, Nadine] Inst Natl Sante & Rech Med, Unite U900, F-75248 Paris, France; [Andrieu, Nadine] Res Ctr & Serv Biostat, Inst Curie, F-75248 Paris, France; [Andrieu, Nadine] Paris Tech, Ecole Mines Paris, F-77300 Fontainebleau, France; [Easton, Douglas F.] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Cambridge CB1 8RN, England; [Kesminiene, Ausrele] Int Agcy Res Canc, Sect Environm & Radiat, F-69372 Lyon 08, France; [Nogues, Catherine] Hop Rene Huguenin, Inst Curie, F-92210 Paris, France; [Gauthier-Villars, Marion] Inst Curie, Serv Oncogenet, F-75005 Paris, France; [Fricker, Jean-Pierre] Ctr Paul Strauss, F-67065 Strasbourg, France; [Lasset, Christine] Ctr Leon Berard, F-69008 Lyon, France; [Evans, D. Gareth] St Marys Hosp, Dept Genet Med, Manchester M13 9WL, Lancs, England; [Eeles, Rosalind A.] Inst Canc Res, Oncogenet Team, Surrey SM2 5PT, England; [Paterson, Joan] Addenbrookes Hosp, Dept Clin Genet, E Anglian Reg Genet Serv, Cambridge CB2 0QQ, England; [Manders, Peggy] Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, NL-6525 GA Nijmegen, Netherlands; [van Asperen, Christi J.] Leiden Univ, Dept Clin Genet, Med Ctr, NL-2333 ZA Leiden, Netherlands; [Ausems, Margreet G. E. M.] Univ Med Ctr Utrecht, Dept Med Genet, NL-3584 CX Utrecht, Netherlands; [Meijers-Heijboer, Hanne] Vrije Univ Amsterdam, Dept Clin Genet & Human Genet, Med Ctr, Amsterdam, Netherlands; [Goldgar, David] Univ Utah, Dept Dermatol, Sch Med, Salt Lake City, UT 84132 USA	Netherlands Cancer Institute; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; University of Cambridge; World Health Organization; International Agency for Research on Cancer (IARC); Rene Huguenin Hospital; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UNICANCER; Centre Paul Strauss; UNICANCER; Centre Leon Berard; University of Manchester; University of London; Institute of Cancer Research - UK; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; Utah System of Higher Education; University of Utah	van Leeuwen, FE (corresponding author), Netherlands Canc Inst, Dept Epidemiol & Biostat, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	f.v.leeuwen@nki.nl	van Asperen, Christi J/D-3970-2012; Oosterwijk, Jan C./G-5770-2011; ANDRIEU, Nadine/H-4255-2014; Ligtenberg, Marjolijn/N-9666-2013; Evans, D Gareth/AAB-4308-2022; GLADIEFF, Laurence/O-5129-2014; THIERRY-CHEF, Isabelle/P-8324-2018; Hauptmann, Michael/AAQ-8420-2021; Cardis, Elisabeth/C-3904-2017	van Asperen, Christi J/0000-0002-1436-7650; Ligtenberg, Marjolijn/0000-0003-1290-1474; Evans, D Gareth/0000-0002-8482-5784; GLADIEFF, Laurence/0000-0002-6980-9719; THIERRY-CHEF, Isabelle/0000-0001-6304-2783; Hauptmann, Michael/0000-0001-8539-0148; Cardis, Elisabeth/0000-0003-0999-6839; Bancroft, Elizabeth/0000-0002-5482-5660; Vasen, Hans/0000-0003-2682-2603; Pijpe, Anouk/0000-0002-3594-4621; van der Luijt, Rob/0000-0002-0018-1089; Gomez-Garcia, Encarna/0000-0003-4999-8847; Eeles, Rosalind/0000-0002-3698-6241; Devilee, Peter/0000-0002-8023-2009	NIHR; Cancer Research UK [C5047/A8385]; Euratom Programme [012926 (FI6R)]; GENEPSO: Fondation de France; GENEPSO: Ligue National Contre le Cancer; EMBRACE: Cancer Research UK [C1287/A10118, C1287/A8874]; HEBON: Dutch Cancer Society [NKI1998-1854, NKI2004-3088, NKI 2007-3756]; Tepnel; Illumina; Vista Diagnostics; NATIONAL CANCER INSTITUTE [R01CA142657] Funding Source: NIH RePORTER; Cancer Research UK [10118, 11022, 15007] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10096] Funding Source: researchfish	NIHR(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK); Euratom Programme; GENEPSO: Fondation de France; GENEPSO: Ligue National Contre le Cancer; EMBRACE: Cancer Research UK; HEBON: Dutch Cancer Society; Tepnel; Illumina; Vista Diagnostics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	Coordinating Centre, Cambridge: Susan Peock, Margaret Cook, Debra Frost, Clare Oliver; North of Scotland Regional Genetics Service, Aberdeen: Helen Gregory; West Midlands Regional Clinical Genetics Service, Birmingham: Trevor Cole, Lucy Burgess; East Anglian Regional Genetics Service, Cambridge: Joan Paterson; Medical Genetics Services for Wales, Cardiff: Mark Rogers, Lisa Hughes; Peninsula Clinical Genetics Service, Exeter: Carole Brewer; West of Scotland Regional Genetics Service, Glasgow: Rosemarie Davidson, Nicola Bradshaw; South East Thames Regional Genetics Service, London: Louise Izatt, Gabriella Pichert, Caroline Langman; Yorkshire Regional Genetics Service, Leeds: Carol Chu, Julie Miller; Manchester Regional Genetics Service, Manchester: Gareth Evans, Fiona Lalloo, Andrew Shenton; Oxford Regional Genetics Service, Oxford: Lucy Side; Department of Cancer Genetics, Royal Marsden NHS Foundation Trust: Ros Eeles, Elizabeth Bancroft, Elizabeth Page, Elena Castro, Audray Ardern-Jones, Richard Houlston, Nazneen Rahman, Susan Shanley; North Trent Clinical Genetics Service, Sheffield: Jackie Cook, Lauren Baxter; South West Thames Regional Genetics Service, London: Shirley Hodgson, Sheila Goff; and Wessex Clinical Genetics Service, Southampton: Diana Eccles. Gareth Evans and Fiona Lalloo are supported by an NIHR grant to the Biomedical Research Centre, Manchester. The investigators at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust are supported by an NIHR grant to the Biomedical Research Centre at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust. Ros Eeles and Elizabeth Bancroft are also supported by Cancer Research UK Grant C5047/A8385.; The GENE-RAD-RISK study was supported by grant No 012926 (FI6R) under Euratom Programme; GENEPSO: Fondation de France and Ligue National Contre le Cancer; EMBRACE: Cancer Research UK (grant C1287/A10118 and C1287/A8874); HEBON: Dutch Cancer Society (grants NKI1998-1854, NKI2004-3088, NKI 2007-3756). DFE is a principal research fellow of Cancer Research UK. The sponsors had no role in the design of the study; in the collection, analysis, and interpretation of the data; in the writing of the report; and in the decision to submit the paper for publication.; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: DFE is board member of Genome Canada. RAE receives royalties for the book Genetic Predisposition to Cancer, has received educational grants from Tepnel, Illumina, and Vista Diagnostics and has received honoraria for BRCA-related lectures from MD Anderson and University of Southampton. DG receives royalties from BRCA1 testing.	Andrieu N, 2006, J CLIN ONCOL, V24, P3361, DOI 10.1200/JCO.2005.03.3126; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Antoniou AC, 2005, GENET EPIDEMIOL, V29, P1, DOI 10.1002/gepi.20074; Berrington de Gonzalez A, 2003, AM J EPIDEMIOL, V157, P652, DOI 10.1093/aje/kwg026; Boulton SJ, 2006, BIOCHEM SOC T, V34, P633, DOI 10.1042/BST0340633; Broeks A, 2010, INT J RADIAT ONCOL, V76, P540, DOI 10.1016/j.ijrobp.2009.09.004; Chen SN, 2007, J CLIN ONCOL, V25, P1329, DOI 10.1200/JCO.2006.09.1066; DRION R, 1961, Ned Tijdschr Geneeskd, V105, P1920; Eleveld H, 2003, 861020002 RIVM; Goldfrank D, 2006, CANCER EPIDEM BIOMAR, V15, P2311, DOI 10.1158/1055-9965.EPI-06-0176; Gronwald J, 2008, BREAST CANCER RES TR, V112, P581, DOI 10.1007/s10549-008-9892-9; Howe GR, 1996, RADIAT RES, V145, P694, DOI 10.2307/3579360; ICRP, 2007, ICRP PUBL, V103, DOI 10.1016/j.icrp.2007.10.003; Land CE, 2003, RADIAT RES, V160, P707, DOI 10.1667/RR3082; LAND CE, 1995, JAMA-J AM MED ASSOC, V274, P402, DOI 10.1001/jama.274.5.402; LAND CE, 1980, CANCER, V46, P868, DOI 10.1002/1097-0142(19800815)46:4+<868::AID-CNCR2820461304>3.0.CO;2-S; Langholz B, 2010, AM J EPIDEMIOL, V171, P377, DOI 10.1093/aje/kwp403; Meeuwsen EJ, 2007, 300081001 RIVM; Mullenders L, 2009, NAT REV CANCER, V9, P596, DOI 10.1038/nrc2677; Narod SA, 2006, LANCET ONCOL, V7, P402, DOI 10.1016/S1470-2045(06)70624-6; National Research Council, 1999, HLTH RISKS EXP LOW L; Nieuwenhuis B, 2002, INT J RADIAT BIOL, V78, P285, DOI 10.1080/09553000110097974; Norman SA, 2003, AM J EPIDEMIOL, V158, P264, DOI 10.1093/aje/kwg136; Pijpe A, 2011, J CLIN EPIDEMIOL, V64, P1434, DOI 10.1016/j.jclinepi.2011.04.005; Pijpe A, 2010, EUR J EPIDEMIOL, V25, P103, DOI 10.1007/s10654-009-9416-x; Pijpe A, 2010, BREAST CANCER RES TR, V120, P235, DOI 10.1007/s10549-009-0476-0; Pogoda JM, 2002, HEALTH PHYS, V83, P907, DOI 10.1097/00004032-200212000-00019; Powell SN, 2003, ONCOGENE, V22, P5784, DOI 10.1038/sj.onc.1206678; Preston DL, 2002, RADIAT RES, V158, P220, DOI 10.1667/0033-7587(2002)158[0220:REOBCR]2.0.CO;2; PRESTONMARTIN S, 1985, AM J EPIDEMIOL, V121, P430, DOI 10.1093/oxfordjournals.aje.a114015; Ronckers CM, 2005, BREAST CANCER RES, V7, P21, DOI 10.1186/bcr970; SICKENGA F N, 1959, Ned Tijdschr Geneeskd, V103, P1998; Sickenga FN, 1961, NED TIJDSCHR GENEES, V105, P2417; SICKENGA FN, 1980, SHORT HIST TUBERCULO; Sigurdson AJ, 2007, CANCER EPIDEM BIOMAR, V16, P2000, DOI 10.1158/1055-9965.EPI-07-0282; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Yoshida K, 2004, CANCER SCI, V95, P866, DOI 10.1111/j.1349-7006.2004.tb02195.x; Young KC, 2005, BRIT J RADIOL, V78, P207, DOI 10.1259/bjr/41095952; Young KC, 2000, BRIT J RADIOL, V73, P278, DOI 10.1259/bjr.73.867.10817044	39	143	147	0	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 6	2012	345								e5660	10.1136/bmj.e5660	http://dx.doi.org/10.1136/bmj.e5660			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003TL	22956590	Green Published, hybrid			2022-12-24	WOS:000308634100002
J	Spence, D				Spence, Des			Why do we overtreat hypertension?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						Diao D, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006742.pub2; National Institute for Health and Clinical Excellence, 2011, HYPERT CLIN MAN PRI; Willis EA, 2012, RE NHS HLTH CHECKS Q	3	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 4	2012	345								e5923	10.1136/bmj.e5923	http://dx.doi.org/10.1136/bmj.e5923			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	003TI	22951565				2022-12-24	WOS:000308633800020
J	Glowacki, DR; Lockhart, J; Blitz, MA; Klippenstein, SJ; Pilling, MJ; Robertson, SH; Seakins, PW				Glowacki, David R.; Lockhart, James; Blitz, Mark A.; Klippenstein, Stephen J.; Pilling, Michael J.; Robertson, Struan H.; Seakins, Paul W.			Interception of Excited Vibrational Quantum States by O-2 in Atmospheric Association Reactions	SCIENCE			English	Article							PHASE BIMOLECULAR REACTIONS; REACTION DYNAMICS; MASTER EQUATION; CHEMICAL-DYNAMICS; CHLORINE ATOM; KINETICS; RADICALS; GASES; OH; CHEMISTRY	Bimolecular reactions in Earth's atmosphere are generally assumed to proceed between reactants whose internal quantum states are fully thermally relaxed. Here, we highlight a dramatic role for vibrationally excited bimolecular reactants in the oxidation of acetylene. The reaction proceeds by preliminary adduct formation between the alkyne and OH radical, with subsequent O-2 addition. Using a detailed theoretical model, we show that the product-branching ratio is determined by the excited vibrational quantum-state distribution of the adduct at the moment it reacts with O-2. Experimentally, we found that under the simulated atmospheric conditions O-2 intercepts similar to 25% of the excited adducts before their vibrational quantum states have fully relaxed. Analogous interception of excited-state radicals by O-2 is likely common to a range of atmospheric reactions that proceed through peroxy complexes.	[Glowacki, David R.] Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England; [Lockhart, James; Blitz, Mark A.; Pilling, Michael J.; Seakins, Paul W.] Univ Leeds, Sch Chem, Leeds LS2 9JT, W Yorkshire, England; [Klippenstein, Stephen J.] Argonne Natl Lab, Chem Sci & Engn Div, Argonne, IL 60439 USA; [Robertson, Struan H.] Accelrys, Cambridge CB4 0WN, England	University of Bristol; University of Leeds; United States Department of Energy (DOE); Argonne National Laboratory; BIOVIA	Glowacki, DR (corresponding author), Univ Bristol, Sch Chem, Cantocks Close, Bristol BS8 1TS, Avon, England.	drglowacki@gmail.com; p.w.seakins@leeds.ac.uk	Klippenstein, Stephen/AAF-1741-2021; blitz, mark/A-1195-2009	blitz, mark/0000-0001-6710-4021; Klippenstein, Stephen/0000-0001-6297-9187	Engineering and Physical Sciences Research Council [EP/G00224X]; Natural Environment Research Council via the National Centre for Atmospheric Science; U.S. Department of Energy, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences [DE-AC02-06CH11357];  [NE/F018754/1]; EPSRC [EP/J010871/1] Funding Source: UKRI; NERC [ncas10006, NE/F018754/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/J010871/1] Funding Source: researchfish; Natural Environment Research Council [ncas10006, NE/F018754/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council via the National Centre for Atmospheric Science; U.S. Department of Energy, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences(United States Department of Energy (DOE)); ; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	D.R.G. is supported by Engineering and Physical Sciences Research Council Programme Grant EP/G00224X. M. A. B., P. W. S., and J.L. received support from the Natural Environment Research Council via the National Centre for Atmospheric Science and grant NE/F018754/1. S.J.K. was supported by the U.S. Department of Energy, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences, under contract DE-AC02-06CH11357.	Blake NJ, 1996, J GEOPHYS RES-ATMOS, V101, P24151, DOI 10.1029/96JD00561; Bohn B, 1998, J CHEM SOC FARADAY T, V94, P1203, DOI 10.1039/a708536b; Bohn B, 1996, J CHEM SOC FARADAY T, V92, P1459, DOI 10.1039/ft9969201459; Carr SA, 2011, J PHYS CHEM A, V115, P1069, DOI 10.1021/jp1099199; Clary DC, 2008, P NATL ACAD SCI USA, V105, P12649, DOI 10.1073/pnas.0800088105; Crim FF, 2008, P NATL ACAD SCI USA, V105, P12654, DOI 10.1073/pnas.0803010105; Czako G, 2011, SCIENCE, V334, P343, DOI 10.1126/science.1208514; Dibble TS, 2002, J PHYS CHEM A, V106, P6643, DOI 10.1021/jp025682m; Elles CG, 2006, ANNU REV PHYS CHEM, V57, P273, DOI 10.1146/annurev.physchem.57.032905.104538; Fernandez-Ramos A, 2006, CHEM REV, V106, P4518, DOI 10.1021/cr050205w; Fleming DG, 2011, SCIENCE, V331, P448, DOI 10.1126/science.1199421; Frankcombe TJ, 2003, J THEOR COMPUT CHEM, V2, P179, DOI 10.1142/S0219633603000483; Georgievskii Y, 2003, J CHEM PHYS, V118, P5442, DOI 10.1063/1.1539035; Glowacki DR, 2011, NAT CHEM, V3, P850, DOI [10.1038/NCHEM.1154, 10.1038/nchem.1154]; Glowacki DR, 2010, CHEMPHYSCHEM, V11, P3836, DOI 10.1002/cphc.201000469; Glowacki DR, 2010, J AM CHEM SOC, V132, P13621, DOI 10.1021/ja105100f; Goldman LM, 2011, J AM CHEM SOC, V133, P5312, DOI 10.1021/ja1095717; Greaves SJ, 2011, SCIENCE, V331, P1423, DOI 10.1126/science.1197796; Grubb MP, 2012, SCIENCE, V335, P1075, DOI 10.1126/science.1216911; Maranzana A, 2008, J PHYS CHEM A, V112, P3666, DOI 10.1021/jp077180k; Maranzana A, 2008, J PHYS CHEM A, V112, P3656, DOI 10.1021/jp077174o; Mckee KW, 2007, J PHYS CHEM A, V111, P4043, DOI 10.1021/jp067594y; Miller JA, 2006, J PHYS CHEM A, V110, P10528, DOI 10.1021/jp062693x; Mollner AK, 2010, SCIENCE, V330, P646, DOI 10.1126/science.1193030; Olzmann M, 2002, PHYS CHEM CHEM PHYS, V4, P3614, DOI 10.1039/b203244a; POLANYI JC, 1987, SCIENCE, V236, P680, DOI 10.1126/science.236.4802.680; RAFTERY D, 1994, J CHEM PHYS, V101, P8572, DOI 10.1063/1.468052; SCHMIDT V, 1985, BER BUNSEN PHYS CHEM, V89, P321, DOI 10.1002/bbpc.19850890337; Senosiain JP, 2005, J PHYS CHEM A, V109, P6045, DOI 10.1021/jp050737g; SINHA A, 1990, J CHEM PHYS, V92, P6333, DOI 10.1063/1.458312; Skouteris D, 1999, SCIENCE, V286, P1713, DOI 10.1126/science.286.5445.1713; Wu T, 2004, SCIENCE, V306, P2227, DOI 10.1126/science.1104085; Yan S, 2007, SCIENCE, V316, P1723, DOI 10.1126/science.1142313; Zare RN, 1998, SCIENCE, V279, P1875, DOI 10.1126/science.279.5358.1875	35	77	77	3	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2012	337	6098					1066	1069		10.1126/science.1224106	http://dx.doi.org/10.1126/science.1224106			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22936771				2022-12-24	WOS:000308125800038
J	Barron, AB; Brown, MJF				Barron, Andrew B.; Brown, Mark J. F.			Let's talk about sex	NATURE			English	Editorial Material									[Barron, Andrew B.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Brown, Mark J. F.] Royal Holloway Univ London, Sch Biol Sci, London, England	Macquarie University; University of London; Royal Holloway University London	Barron, AB (corresponding author), Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia.	andrew.barron@mq.edu.au		Barron, Andrew/0000-0002-8135-6628	Biotechnology and Biological Sciences Research Council [BB/J019453/1] Funding Source: researchfish; BBSRC [BB/J019453/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Bailey NW, 2009, TRENDS ECOL EVOL, V24, P439, DOI 10.1016/j.tree.2009.03.014; Brennan Zoe, 2010, DAILY MAIL; Casselman A, 2007, NATL GEOGR      1025; Cloud J., 2007, TIME MAGAZINE; Dolgin E., 2007, NATURE, DOI org/10.1038/news070917-7; Fox M, 2005, REUTERS         0624; Holmes B, 2008, NEW SCI; Hooper Rowan, 2007, NEW SCI; Levan KE, 2009, J EVOLUTION BIOL, V22, P60, DOI 10.1111/j.1420-9101.2008.01616.x; Milius S, 2001, SCIENCENEWS, V160, P311; Mooallem J., 2010, INDEPENDENT; Mooallem J, 2010, NY TIMES; Oakeshott I., 2006, SUNDAY TIMES; Perkins A, 2007, HORM BEHAV, V52, P70, DOI 10.1016/j.yhbeh.2007.03.016; Reinhardt K, 2007, AM NAT, V170, P931, DOI 10.1086/522844; Saletan William, 2007, WASHINGTON POST; Schwartz J, 2007, NY TIMES        0330; Shine R, 2001, NATURE, V414, P267, DOI 10.1038/35104687; White JQ, 2007, CURR BIOL, V17, P1847, DOI 10.1016/j.cub.2007.09.011; Young LC, 2008, BIOL LETTERS, V4, P323, DOI 10.1098/rsbl.2008.0191	20	8	8	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 9	2012	488	7410					151	152		10.1038/488151a	http://dx.doi.org/10.1038/488151a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	985LE	22874947	Bronze			2022-12-24	WOS:000307267000011
J	Desai, CS; Bonow, RO				Desai, Chintan S.; Bonow, Robert O.			Transcatheter Valve Replacement for Aortic Stenosis Balancing Benefits, Risks, and Expectations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							IMPLANTATION; REGISTRY; OUTCOMES		[Bonow, Robert O.] Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, Chicago, IL 60611 USA; [Bonow, Robert O.] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA; [Desai, Chintan S.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Bonow, RO (corresponding author), Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, 645 N Michigan Ave,Ste 1006, Chicago, IL 60611 USA.	r-bonow@northwestern.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069771] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32 HL 69771-8] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Gilard M, 2012, NEW ENGL J MED, V366, P1705, DOI 10.1056/NEJMoa1114705; Kodali SK, 2012, NEW ENGL J MED, V366, P1686, DOI 10.1056/NEJMoa1200384; Mack MJ, 2011, JAMA-J AM MED ASSOC, V306, P2149, DOI 10.1001/jama.2011.1675; Moat NE, 2011, J AM COLL CARDIOL, V58, P2130, DOI 10.1016/j.jacc.2011.08.050; Nietlispach F, 2010, JACC-CARDIOVASC INTE, V3, P1133, DOI 10.1016/j.jcin.2010.05.022; Piazza N, 2010, HEART, V96, P19, DOI 10.1136/hrt.2009.172809; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Tamburino C, 2011, CIRCULATION, V123, P299, DOI 10.1161/CIRCULATIONAHA.110.946533; Zahn R, 2011, EUR HEART J, V32, P198, DOI 10.1093/eurheartj/ehq339	9	11	12	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2012	308	6					573	574		10.1001/jama.2012.9427	http://dx.doi.org/10.1001/jama.2012.9427			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	984YA	22871866				2022-12-24	WOS:000307228400021
J	Doronin, K; Flatt, JW; Di Paolo, NC; Khare, R; Kalyuzhniy, O; Acchione, M; Sumida, JP; Ohto, U; Shimizu, T; Akashi-Takamura, S; Miyake, K; MacDonald, JW; Bammler, TK; Beyer, RP; Farin, FM; Stewart, PL; Shayakhmetov, DM				Doronin, Konstantin; Flatt, Justin W.; Di Paolo, Nelson C.; Khare, Reeti; Kalyuzhniy, Oleksandr; Acchione, Mauro; Sumida, John P.; Ohto, Umeharu; Shimizu, Toshiyuki; Akashi-Takamura, Sachiko; Miyake, Kensuke; MacDonald, James W.; Bammler, Theo K.; Beyer, Richard P.; Farin, Frederico M.; Stewart, Phoebe L.; Shayakhmetov, Dmitry M.			Coagulation Factor X Activates Innate Immunity to Human Species C Adenovirus	SCIENCE			English	Article							GENE-TRANSFER; IMMUNOCOMPROMISED PATIENTS; VIRUS-INFECTION; IN-VIVO; BINDING; HEXON; TRIGGERS; VECTORS; PATIENT; CELL	Although coagulation factors play a role in host defense for "living fossils" such as horseshoe crabs, the role of the coagulation system in immunity in higher organisms remains unclear. We modeled the interface of human species C adenovirus (HAdv) interaction with coagulation factor X (FX) and introduced a mutation that abrogated formation of the HAdv-FX complex. In vivo genome-wide transcriptional profiling revealed that FX-binding-ablated virus failed to activate a distinct network of nuclear factor kappa B-dependent early-response genes that are activated by HAdv-FX complex downstream of TLR4/MyD88/TRIF/TRAF6 signaling. Our study implicates host factor "decoration" of the virus as a mechanism to trigger an innate immune sensor that responds to a misplacement of coagulation FX from the blood into intracellular macrophage compartments upon virus entry into the cell.	[Doronin, Konstantin; Di Paolo, Nelson C.; Khare, Reeti; Shayakhmetov, Dmitry M.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Flatt, Justin W.; Stewart, Phoebe L.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Flatt, Justin W.; Stewart, Phoebe L.] Case Western Reserve Univ, Cleveland Ctr Membrane & Struct Biol, Cleveland, OH 44106 USA; [Kalyuzhniy, Oleksandr] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Acchione, Mauro; Sumida, John P.] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA; [Ohto, Umeharu; Shimizu, Toshiyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Ohto, Umeharu; Shimizu, Toshiyuki] RIKEN SPring 8 Ctr, Sayo, Hyogo 6795148, Japan; [Akashi-Takamura, Sachiko; Miyake, Kensuke] Univ Tokyo, Dept Microbiol & Immunol, Div Innate Immun, Minato Ku, Tokyo 1088639, Japan; [Miyake, Kensuke] Univ Tokyo, Lab Innate Immun, Ctr Expt Med & Syst Biol, Inst Med Sci,Minato Ku, Tokyo 1088639, Japan; [MacDonald, James W.; Bammler, Theo K.; Beyer, Richard P.; Farin, Frederico M.] Univ Washington, Funct Genom & Prote Core Facil, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Case Western Reserve University; Case Western Reserve University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Tokyo; RIKEN; University of Tokyo; University of Tokyo; University of Washington; University of Washington Seattle	Shayakhmetov, DM (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	dshax@uw.edu		Flatt, Justin/0000-0003-3227-8763; Flatt, Justin/0000-0003-2985-0386; Kalyuzhniy, Oleksandr/0000-0002-5273-1951; Flatt, Justin/0000-0001-5406-8156	U.S. NIH [AI065429, CA141439]; University of Washington National Institute of Environmental Health Sciences [P30ES07033]; Washington State Life Sciences Discovery Fund; Center for Intracellular Delivery of Biologics Analytical Biopharmacy Core facility; NATIONAL CANCER INSTITUTE [R01CA141439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007033] Funding Source: NIH RePORTER	U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington National Institute of Environmental Health Sciences; Washington State Life Sciences Discovery Fund; Center for Intracellular Delivery of Biologics Analytical Biopharmacy Core facility; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank S. Akira (Osaka University, Japan) for providing mice deficient in MyD88, MD2, TLR4, TLR7/8, and TLR9; J.-I. Inoue (University of Tokyo, Japan) for TRAF6-deficient mice; R.A. Flavell (Yale University, CT) for Caspase-1-deficient mice; and V. Dixit (Roche, CA) for ASC-deficient mice. We acknowledge the assistance of D. R. Williams during cryo-EM data acquisition. The cryo-EM data was collected while J.W.F. and P.L.S. were at Vanderbilt University. We thank M. D. Hollenberg (University of Calgary, Canada), A. Aderem, and D. Zak (SeattleBioMed, USA) for helpful discussion and L. K. Baldwin for manuscript editing. This study was supported by U.S. NIH grants AI065429 and CA141439 to D.M.S., the University of Washington National Institute of Environmental Health Sciences-sponsored Center for Ecogenetics & Environmental Health (P30ES07033), and Center for Intracellular Delivery of Biologics Analytical Biopharmacy Core facility, which is funded by the Washington State Life Sciences Discovery Fund. D.M.S. and P.L.S. designed the research; K.D., J.W.F., N.C.D.P., R.K., M.A., J.P.S., and O.K. conducted experiments and collected and analyzed the data; U.O, T.S., S.A.-T., and K.M. expressed, purified, and provided critical reagents; J.W.M., T.K.B., R.P.B., and F.M.F. collected and processed all the microarray data; and P.S. and D.S. wrote the paper. The data are tabulated in the main paper and supplementary materials. The cryo-EM structure has been deposited in the Electron Microscopy Data Bank with accession no. EMD-5494. The microarray data have been submitted in Minimum Information About a Microarray Experiment (MIAME)-compliant format to the Gene Expression Omnibus database (accession no. GSE36078).	Alba R, 2009, BLOOD, V114, P965, DOI 10.1182/blood-2009-03-208835; Ardehali H, 2001, TRANSPLANTATION, V71, P998, DOI 10.1097/00007890-200104150-00029; Chen J, 2007, ANNU REV IMMUNOL, V25, P443, DOI 10.1146/annurev.immunol.25.022106.141706; Di Paolo NC, 2009, IMMUNITY, V31, P110, DOI 10.1016/j.immuni.2009.04.015; Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kalyuzhniy O, 2008, P NATL ACAD SCI USA, V105, P5483, DOI 10.1073/pnas.0711757105; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kim YJ, 2007, SEMIN RESP CRIT CARE, V28, P222, DOI 10.1055/s-2007-976494; Leen AM, 2005, BRIT J HAEMATOL, V128, P135, DOI 10.1111/j.1365-2141.2004.05218.x; Livingston JR, 2006, BIOCHEM J, V393, P529, DOI 10.1042/BJ20051313; Lynch JP, 2011, SEMIN RESP CRIT CARE, V32, P494, DOI 10.1055/s-0031-1283287; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Morral N, 2002, HUM GENE THER, V13, P143, DOI 10.1089/10430340152712692; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Raper SE, 2003, MOL GENET METAB, V80, P148, DOI 10.1016/j.ymgme.2003.08.016; Thomas CE, 2000, P NATL ACAD SCI USA, V97, P7482, DOI 10.1073/pnas.120474397; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; Wen HT, 2010, J EXP MED, V207, P2943, DOI 10.1084/jem.20101138; Zhang Y, 2001, MOL THER, V3, P697, DOI 10.1006/mthe.2001.0329	21	109	112	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2012	338	6108					795	798		10.1126/science.1226625	http://dx.doi.org/10.1126/science.1226625			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033ZI	23019612	Green Accepted			2022-12-24	WOS:000310839500043
J	Gross, L; Mohn, F; Moll, N; Schuler, B; Criado, A; Guitian, E; Pena, D; Gourdon, A; Meyer, G				Gross, Leo; Mohn, Fabian; Moll, Nikolaj; Schuler, Bruno; Criado, Alejandro; Guitian, Enrique; Pena, Diego; Gourdon, Andre; Meyer, Gerhard			Bond-Order Discrimination by Atomic Force Microscopy	SCIENCE			English	Article							CHEMICAL-STRUCTURE; CRYSTAL-STRUCTURE; SINGLE; RESOLUTION; C60; BUCKMINSTERFULLERENE; MOLECULES; LENGTHS	We show that the different bond orders of individual carbon-carbon bonds in polycyclic aromatic hydrocarbons and fullerenes can be distinguished by noncontact atomic force microscopy (AFM) with a carbon monoxide (CO)-functionalized tip. We found two different contrast mechanisms, which were corroborated by density functional theory calculations: The greater electron density in bonds of higher bond order led to a stronger Pauli repulsion, which enhanced the brightness of these bonds in high-resolution AFM images. The apparent bond length in the AFM images decreased with increasing bond order because of tilting of the CO molecule at the tip apex.	[Criado, Alejandro; Guitian, Enrique; Pena, Diego] Univ Santiago de Compostela, CIQUS, E-15782 Santiago De Compostela, Spain; [Gross, Leo; Mohn, Fabian; Moll, Nikolaj; Schuler, Bruno; Meyer, Gerhard] IBM Res Zurich, CH-8803 Ruschlikon, Switzerland; [Gourdon, Andre] CEMES CNRS, F-31055 Toulouse, France	Universidade de Santiago de Compostela; CiQUS; International Business Machines (IBM); Centre National de la Recherche Scientifique (CNRS)	Gross, L (corresponding author), IBM Res Zurich, CH-8803 Ruschlikon, Switzerland.	lgr@zurich.ibm.com	Schuler, Bruno/B-8545-2012; Peña, Diego/D-2051-2009; Criado, Alejandro/I-9826-2017; Gross, Leo/E-1789-2011; Guitián, Enrique/H-9018-2015; Gross, Leo/M-8564-2019; Gourdon, André/C-9799-2009; Criado, Alejandro/HDO-0316-2022; Moll, Nikolaj/C-5674-2013	Schuler, Bruno/0000-0002-9641-0340; Peña, Diego/0000-0003-3814-589X; Criado, Alejandro/0000-0002-9732-513X; Gross, Leo/0000-0002-5337-4159; Guitián, Enrique/0000-0003-4785-3812; Gross, Leo/0000-0002-5337-4159; Gourdon, André/0000-0002-0370-1019; Criado, Alejandro/0000-0002-9732-513X; Moll, Nikolaj/0000-0001-5645-4667	European Union [243421, 214954]; European Research Council; Spanish Ministry of Economy and Competitiveness (MINECO) [CTQ2010-18208]; Xunta de Galicia [10PXIB2200222PR]; Fondo Europeo de Desarrollo Regional (FEDER)	European Union(European Commission); European Research Council(European Research Council (ERC)European Commission); Spanish Ministry of Economy and Competitiveness (MINECO); Xunta de Galicia(Xunta de GaliciaEuropean Commission); Fondo Europeo de Desarrollo Regional (FEDER)(European Commission)	We thank R. Allenspach, J. Repp, and A. Curioni for comments and European Union projects ARTIST (contract no. 243421) and HERODOT (contract no. 214954), the European Research Council advanced grant CEMAS, the Spanish Ministry of Economy and Competitiveness (MINECO, CTQ2010-18208), Xunta de Galicia (10PXIB2200222PR), and Fondo Europeo de Desarrollo Regional (FEDER) for financial support.	Alemani M, 2006, J AM CHEM SOC, V128, P14446, DOI 10.1021/ja065449s; Ashino M, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.136101; Buhl M, 2001, CHEM REV, V101, P1153, DOI 10.1021/cr990332q; Comstock MJ, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.038301; Criado A, 2010, CHEM-EUR J, V16, P9736, DOI 10.1002/chem.201001057; DAVID WIF, 1991, NATURE, V353, P147, DOI 10.1038/353147a0; FAGAN PJ, 1991, SCIENCE, V252, P1160, DOI 10.1126/science.252.5009.1160; Giessibl FJ, 2000, APPL PHYS LETT, V76, P1470, DOI 10.1063/1.126067; GODDARD R, 1995, J AM CHEM SOC, V117, P30, DOI 10.1021/ja00106a004; Gross L, 2010, NAT CHEM, V2, P821, DOI [10.1038/NCHEM.765, 10.1038/nchem.765]; Gross L, 2009, SCIENCE, V325, P1110, DOI 10.1126/science.1176210; Guo CS, 2010, LANGMUIR, V26, P16271, DOI 10.1021/la101317s; HEDBERG K, 1991, SCIENCE, V254, P410, DOI 10.1126/science.254.5030.410; Larsson JA, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.115434; LIU SZ, 1991, SCIENCE, V254, P408, DOI 10.1126/science.254.5030.408; Mohn F, 2012, NAT NANOTECHNOL, V7, P227, DOI [10.1038/NNANO.2012.20, 10.1038/nnano.2012.20]; Mohn F, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3619829; Moll N, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/12/125020; Narita S, 2000, J MOL STRUC-THEOCHEM, V532, P37, DOI 10.1016/S0166-1280(00)00563-7; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Pauling L, 1935, J AM CHEM SOC, V57, P2705, DOI 10.1021/ja01315a105; Pavlicek N, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.086101; Pawlak R, 2011, ACS NANO, V5, P6349, DOI 10.1021/nn201462g; Schleyer PV, 2001, CHEM REV, V101, P1115, DOI 10.1021/cr0103221; Schull G, 2011, NANO LETT, V11, P3142, DOI 10.1021/nl201185y; Sedlar J, 2006, CHEM PHYS LETT, V427, P418, DOI 10.1016/j.cplett.2006.06.026; Sugimoto Y, 2007, NATURE, V446, P64, DOI 10.1038/nature05530; Sun ZX, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.046104; Ugeda MM, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.116803; Wang HT, 2012, NANO LETT, V12, P141, DOI 10.1021/nl2031629; Welker J, 2012, SCIENCE, V336, P444, DOI 10.1126/science.1219850	31	357	364	8	472	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2012	337	6100					1326	1329		10.1126/science.1225621	http://dx.doi.org/10.1126/science.1225621			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	004TW	22984067				2022-12-24	WOS:000308705000038
J	Feld, ED				Feld, Ellen D.			Worries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Drexel Univ, Coll Nursing & Hlth Profess, Phys Assistant Dept, Philadelphia, PA 19104 USA	Drexel University	Feld, ED (corresponding author), Drexel Univ, Coll Nursing & Hlth Profess, Phys Assistant Dept, Philadelphia, PA 19104 USA.	edf26@drexel.edu							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2012	308	9					873	874		10.1001/2012.jama.10452	http://dx.doi.org/10.1001/2012.jama.10452			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999ET	22948696				2022-12-24	WOS:000308292900016
J	Jay, JS; Gostin, LO				Jay, Jonathan S.; Gostin, Lawrence O.			Ethical Challenges of Preexposure Prophylaxis for HIV	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PREVENTION; INFECTION		[Jay, Jonathan S.; Gostin, Lawrence O.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044; Jay, Jonathan/0000-0002-7543-4247				Anderson P., 2012, 19 C RETR OPP INF MA; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Juusola JL, 2012, ANN INTERN MED, V156, P541, DOI [10.7326/0003-4819-156-8-201204170-00004, 10.7326/0003-4819-156-8-201204170-00001]; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E	10	19	19	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2012	308	9					867	868		10.1001/2012.jama.10158	http://dx.doi.org/10.1001/2012.jama.10158			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999ET	22847147	Green Published, Bronze			2022-12-24	WOS:000308292900013
J	Pinheiro, I; Margueron, R; Shukeir, N; Eisold, M; Fritzsch, C; Richter, FM; Mittler, G; Genoud, C; Goyama, S; Kurokawa, M; Son, J; Reinberg, D; Lachner, M; Jenuwein, T				Pinheiro, Ines; Margueron, Raphael; Shukeir, Nicholas; Eisold, Michael; Fritzsch, Christoph; Richter, Florian M.; Mittler, Gerhard; Genoud, Christel; Goyama, Susumu; Kurokawa, Mineo; Son, Jinsook; Reinberg, Danny; Lachner, Monika; Jenuwein, Thomas			Prdm3 and Prdm16 are H3K9me1 Methyltransferases Required for Mammalian Heterochromatin Integrity	CELL			English	Article							GERM-CELL LINEAGE; HISTONE H3; LYSINE 9; PERICENTRIC HETEROCHROMATIN; NONHISTONE PROTEINS; CHROMATIN-STRUCTURE; METHYLATION STATES; GENES; MOUSE; MONOMETHYLATION	Heterochromatin serves important functions, protecting genome integrity and stabilizing gene expression programs. Although the Suv39h methyltransferases (KMTs) are known to ensure pericentric H3K9me3 methylation, the mechanisms that initiate and maintain mammalian heterochromatin organization remain elusive. We developed a biochemical assay and used in vivo analyses in mouse embryonic fibroblasts to identify Prdm3 and Prdm16 as redundant H3K9me1-specific KMTs that direct cytoplasmic H3K9me1 methylation. The H3K9me1 is converted in the nucleus to H3K9me3 by the Suv39h enzymes to reinforce heterochromatin. Simultaneous depletion of Prdm3 and Prdm16 abrogates H3K9me1 methylation, prevents Suv39h-dependent H3K9me3 trimethylation, and derepresses major satellite transcription. Most strikingly, DNA-FISH and electron microscopy reveal that combined impairment of Prdm3 and Prdm16 results in disintegration of heterochromatic foci and disruption of the nuclear lamina. Our data identify Prdm3 and Prdm16 as H3K9me1 methyltransferases and expose a functional framework in which anchoring to the nuclear periphery helps maintain the integrity of mammalian heterochromatin.	[Pinheiro, Ines; Shukeir, Nicholas; Eisold, Michael; Fritzsch, Christoph; Richter, Florian M.; Mittler, Gerhard; Lachner, Monika; Jenuwein, Thomas] Max Planck Inst Immunobiol & Epigenet, Dept Epigenet, D-79108 Freiburg, Germany; [Pinheiro, Ines; Jenuwein, Thomas] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Margueron, Raphael; Son, Jinsook; Reinberg, Danny] NYU, Sch Med, Dept Biochem, Smilow Res Ctr, New York, NY 10016 USA; [Genoud, Christel] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Goyama, Susumu; Kurokawa, Mineo] Tokyo Univ Hosp, Dept Hematol & Oncol, Bunkyo Ku, Tokyo 1138655, Japan	Max Planck Society; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); New York University; Friedrich Miescher Institute for Biomedical Research; University of Tokyo	Jenuwein, T (corresponding author), Max Planck Inst Immunobiol & Epigenet, Dept Epigenet, Stubeweg 51, D-79108 Freiburg, Germany.	jenuwein@ie-freiburg.mpg.de	Margueron, Raphael F/B-9996-2015	Margueron, Raphael F/0000-0002-9093-7977; genoud, christel/0000-0002-0933-9911; Reinberg, Danny/0000-0003-4288-2016	IMP through Boehringer Ingelheim; European Union NoE network "The Epigenome" [LSHG-CT-2004-503433]; Austrian GEN-AU initiative; Max-Planck Society; Boehringer Ingelheim	IMP through Boehringer Ingelheim(Boehringer Ingelheim); European Union NoE network "The Epigenome"; Austrian GEN-AU initiative; Max-Planck Society(Max Planck Society); Boehringer Ingelheim(Boehringer Ingelheim)	We thank the MS facility at Rutgers University, New Jersey, USA, for analyzing fractions enriched for H3K9me1 activity. We are also grateful to Masato Yonezawa (University of Tokyo) for providing the Eset Baculovirus expression construct, to Gunter Reuter (Martin Luther University Halle-Wittenberg) for sharing information on Prdm orthologues in Drosophila and to Antoine Peters (FMI Basel) for insightful discussions and help with IF analysis. We further acknowledge interactions and discussions with Susan Gasser (FMI Basel) on the general relevance of H3K9 methylation for anchoring heterochromatin to the nuclear lamina in C. elegans. We would also like to thank Rudi Grosschedl (MPI of Immunobiology and Epigenetics) for insightful comments. Research in the laboratory of T.J. was sponsored by the IMP through Boehringer Ingelheim, the European Union NoE network "The Epigenome" (LSHG-CT-2004-503433), the Austrian GEN-AU initiative, and is now provided by the Max-Planck Society. During part of this work, I.P. was supported by a Boehringer Ingelheim doctoral Fellowship (2007-2009).	Aguilo F, 2011, BLOOD, V117, P5057, DOI 10.1182/blood-2010-08-300145; An S, 2011, J BIOL CHEM, V286, P8369, DOI 10.1074/jbc.M110.203380; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Chuikov S, 2010, NAT CELL BIOL, V12, P999, DOI 10.1038/ncb2101; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dodge JE, 2004, MOL CELL BIOL, V24, P2478, DOI 10.1128/MCB.24.6.2478-2486.2004; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Fodor BD, 2010, ANNU REV CELL DEV BI, V26, P471, DOI 10.1146/annurev.cellbio.042308.113225; Fritsch L, 2010, MOL CELL, V37, P46, DOI 10.1016/j.molcel.2009.12.017; Fumasoni I, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-187; Goyama S, 2008, CELL STEM CELL, V3, P207, DOI 10.1016/j.stem.2008.06.002; Gregory GD, 2007, MOL CELL BIOL, V27, P8466, DOI 10.1128/MCB.00993-07; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Huang J, 2008, CURR OPIN GENET DEV, V18, P152, DOI 10.1016/j.gde.2008.01.012; Huang S, 2002, NAT REV CANCER, V2, P469, DOI 10.1038/nrc819; Jacob Y, 2009, NAT STRUCT MOL BIOL, V16, P763, DOI 10.1038/nsmb.1611; Karslioglu A.B., 2012, NAT STRUCT IN PRESS; Kim KC, 2003, CANCER RES, V63, P7619; Kind J, 2010, CURR OPIN CELL BIOL, V22, P320, DOI 10.1016/j.ceb.2010.04.002; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lan F, 2009, SCI CHINA SER C, V52, P311, DOI 10.1007/s11427-009-0054-z; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; LeRoy G, 1998, SCIENCE, V282, P1900, DOI 10.1126/science.282.5395.1900; Loyola A, 2006, MOL CELL, V24, P309, DOI 10.1016/j.molcel.2006.08.019; Loyola A, 2009, EMBO REP, V10, P769, DOI 10.1038/embor.2009.90; Ma ZY, 2011, NAT STRUCT MOL BIOL, V18, P120, DOI 10.1038/nsmb.2000; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; Mochizuki N, 2000, BLOOD, V96, P3209, DOI 10.1182/blood.V96.9.3209.h8003209_3209_3214; Morishita K, 2007, INT J HEMATOL, V85, P279, DOI 10.1532/IJH97.06174; Nemeth A, 2011, TRENDS GENET, V27, P149, DOI 10.1016/j.tig.2011.01.002; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Oda H, 2009, MOL CELL BIOL, V29, P2278, DOI 10.1128/MCB.01768-08; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Peng JC, 2007, NAT CELL BIOL, V9, P25, DOI 10.1038/ncb1514; PERKINS AS, 1991, MOL CELL BIOL, V11, P2665, DOI 10.1128/MCB.11.5.2665; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Reimann M, 2010, CANCER CELL, V17, P262, DOI 10.1016/j.ccr.2009.12.043; Rouquette J, 2009, CHROMOSOME RES, V17, P801, DOI 10.1007/s10577-009-9070-x; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schotta G, 2008, GENE DEV, V22, P2048, DOI 10.1101/gad.476008; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Towbin BD, 2012, CELL, V150, P934, DOI 10.1016/j.cell.2012.06.051; Towbin BD, 2009, CURR OPIN GENET DEV, V19, P180, DOI 10.1016/j.gde.2009.01.006; Wang HB, 2003, MOL CELL, V12, P475, DOI 10.1016/j.molcel.2003.08.007; Wu H, 2011, CELL RES, V21, P365, DOI 10.1038/cr.2010.157; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Yatsula B, 2005, J BIOL CHEM, V280, P30712, DOI 10.1074/jbc.M504293200; Ye QA, 1997, J BIOL CHEM, V272, P14983, DOI 10.1074/jbc.272.23.14983	53	206	213	2	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 31	2012	150	5					948	960		10.1016/j.cell.2012.06.048	http://dx.doi.org/10.1016/j.cell.2012.06.048			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22939622	Bronze			2022-12-24	WOS:000308500200010
J	Gamuyao, R; Chin, JH; Pariasca-Tanaka, J; Pesaresi, P; Catausan, S; Dalid, C; Slamet-Loedin, I; Tecson-Mendoza, EM; Wissuwa, M; Heuer, S				Gamuyao, Rico; Chin, Joong Hyoun; Pariasca-Tanaka, Juan; Pesaresi, Paolo; Catausan, Sheryl; Dalid, Cheryl; Slamet-Loedin, Inez; Tecson-Mendoza, Evelyn Mae; Wissuwa, Matthias; Heuer, Sigrid			The protein kinase Pstol1 from traditional rice confers tolerance of phosphorus deficiency	NATURE			English	Article							REPRODUCTIVE-STAGE; RESPONSE-FACTOR; DROUGHT STRESS; GENE; PUP1; EXPRESSION; INFERENCE; SEQUENCE; FAMILY; YIELD	As an essential macroelement for all living cells, phosphorus is indispensable in agricultural production systems. Natural phosphorus reserves are limited(1), and it is therefore important to develop phosphorus-efficient crops. A major quantitative trait locus for phosphorus-deficiency tolerance, Pup1, was identified in the traditional aus-type rice variety Kasalath about a decade ago(2,3). However, its functional mechanism remained elusive(4,5) until the locus was sequenced, showing the presence of a Pup1-specific protein kinase gene(6), which we have named phosphorus-starvation tolerance 1 (PSTOL1). This gene is absent from the rice reference genome and other phosphorus-starvation-intolerant modern varieties(7,8). Here we show that overexpression of PSTOL1 in such varieties significantly enhances grain yield in phosphorus-deficient soil. Further analyses show that PSTOL1 acts as an enhancer of early root growth, thereby enabling plants to acquire more phosphorus and other nutrients. The absence of PSTOL1 and other genes-for example, the submergence-tolerance gene SUB1A-from modern rice varieties underlines the importance of conserving and exploring traditional germplasm. Introgression of this quantitative trait locus into locally adapted rice varieties in Asia and Africa is expected to considerably enhance productivity under low phosphorus conditions.	[Gamuyao, Rico; Chin, Joong Hyoun; Catausan, Sheryl; Dalid, Cheryl; Slamet-Loedin, Inez; Heuer, Sigrid] Int Rice Res Inst, Manila 1301, Philippines; [Pariasca-Tanaka, Juan; Wissuwa, Matthias] JIRCAS, Tsukuba, Ibaraki 3058686, Japan; [Pesaresi, Paolo] Univ Milan, Dipartimento Biosci, I-20133 Milan, Italy; [Tecson-Mendoza, Evelyn Mae] Univ Philippines, Los Banos 4031, Laguna, Philippines	CGIAR; International Rice Research Institute (IRRI); Japan International Research Center for Agricultural Sciences; University of Milan; University of the Philippines System; University of the Philippines Los Banos; University of the Philippines Open University	Heuer, S (corresponding author), Int Rice Res Inst, DAPO Box 7777, Manila 1301, Philippines.	s.heuer@cgiar.org	Chin, Joong Hyoun/L-1307-2015; Dalid, Cheryl/AAI-8043-2021; Pesaresi, Paolo/F-9476-2014	Chin, Joong Hyoun/0000-0003-3932-8639; Dalid, Cheryl/0000-0001-6327-404X; Gamuyao, Rico/0000-0002-0112-6428; Pesaresi, Paolo/0000-0002-3236-7005; Wissuwa, Matthias/0000-0003-3505-9398; Slamet-Loedin, Inez/0000-0001-9145-3571	Generation Challenge Program (GCP)	Generation Challenge Program (GCP)	We would like to thank A. Cruz, E. Ramos and L. Olivo for technical and secretarial support, the staff at the transformation laboratory, F. Rossi for help with the Pstol1 kinase assay, M. Akutsu for help with the analysis of transgenic plants, and S. Haefele and his team for their support. We thank J. Prasetiyono, M. Bustamam and S. Moeljopawiro for their long-term collaboration. This project has been primarily funded by the Generation Challenge Program (GCP) since 2005.	[Anonymous], 2010, WORLD PHOSPHATE ROCK; Bernier J, 2007, CROP SCI, V47, P507, DOI 10.2135/cropsci2006.07.0495; Bi DL, 2010, PLANT PHYSIOL, V153, P1771, DOI 10.1104/pp.110.158501; Bimpong I.K., 2011, J PLANT BREED CROP S, V3, P60; Bonardi V, 2005, NATURE, V437, P1179, DOI 10.1038/nature04016; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Chin JH, 2011, PLANT PHYSIOL, V156, P1202, DOI 10.1104/pp.111.175471; Chin JH, 2010, THEOR APPL GENET, V120, P1073, DOI 10.1007/s00122-009-1235-7; Cordell D, 2009, GLOBAL ENVIRON CHANG, V19, P292, DOI 10.1016/j.gloenvcha.2008.10.009; Courtois B, 2009, RICE, V2, P115, DOI 10.1007/s12284-009-9028-9; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Dardick C, 2007, PLANT PHYSIOL, V143, P579, DOI 10.1104/pp.106.087270; Dawe D., 2010, RICE GLOBAL EC STRAT, P5; Falush D, 2003, GENETICS, V164, P1567; Gomez MS., 2006, AM, V2, P161, DOI [10.3844/ajbbsp.2006.161.169, DOI 10.3844/AJBBSP.2006.161.169]; Gowda VRP, 2012, FUNCT PLANT BIOL, V39, P402, DOI 10.1071/FP12015; Gregory PD, 2000, FOOD TECHNOL BIOTECH, V38, P295; Haefele S. M., 2009, RICE TODAY, V8, P30; HAEFELE SM, 2007, SCI TECHNOLOGY TRADE, P297; Haldrup A, 1999, PLANT J, V17, P689, DOI 10.1046/j.1365-313X.1999.00419.x; Heuer S, 2009, PLANT BIOTECHNOL J, V7, P456, DOI 10.1111/j.1467-7652.2009.00415.x; Hiei Y, 2006, PLANT CELL TISS ORG, V87, P233, DOI 10.1007/s11240-006-9157-4; Inukai Y, 2005, PLANT CELL, V17, P1387, DOI 10.1105/tpc.105.030981; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kong ZS, 2006, PLANT PHYSIOL, V141, P1376, DOI 10.1104/pp.106.082941; Lanceras JC, 2004, PLANT PHYSIOL, V135, P384, DOI 10.1104/pp.103.035527; Lohrmann J, 2002, PLANT PHYSIOL, V128, P363, DOI 10.1104/pp.010907; Londo JP, 2006, P NATL ACAD SCI USA, V103, P9578, DOI 10.1073/pnas.0603152103; Manzanilla DO, 2011, AGR SYST, V104, P335, DOI 10.1016/j.agsy.2010.12.005; Miki D, 2004, PLANT CELL PHYSIOL, V45, P490, DOI 10.1093/pcp/pch048; Ni JJ, 1998, THEOR APPL GENET, V97, P1361, DOI 10.1007/s001220051030; Ouyang J, 2010, PLANT SCI, V179, P374, DOI 10.1016/j.plantsci.2010.06.013; Pariasca-Tanaka J, 2009, RICE, V2, P167, DOI 10.1007/s12284-009-9032-0; Pribil M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000288; Pritchard JK, 2000, GENETICS, V155, P945; Scarpella E, 2005, PLANT CELL PHYSIOL, V46, P1400, DOI 10.1093/pcp/pci153; Thomson MJ, 2012, MOL BREEDING, V29, P875, DOI 10.1007/s11032-011-9663-x; Vij S, 2008, MOL PLANT, V1, P732, DOI 10.1093/mp/ssn047; Wang XQ, 1996, P NATL ACAD SCI USA, V93, P2598, DOI 10.1073/pnas.93.6.2598; Wissuwa M, 2005, PLANT SOIL, V269, P57, DOI 10.1007/s11104-004-2026-1; Wissuwa M, 1998, THEOR APPL GENET, V97, P777, DOI 10.1007/s001220050955; Wissuwa M, 2002, THEOR APPL GENET, V105, P890, DOI 10.1007/s00122-002-1051-9; Wissuwa M, 2001, PLANT BREEDING, V120, P43, DOI 10.1046/j.1439-0523.2001.00561.x; Xu K, 2006, NATURE, V442, P705, DOI 10.1038/nature04920; Yang XJ, 2010, ANN BOT-LONDON, V105, P513, DOI 10.1093/aob/mcq015; Yoshida S., 1972, LAB MANUAL PHYSL STU, V2nd edn, P1; Zhao Y, 2009, PLANT CELL, V21, P736, DOI 10.1105/tpc.108.061655	47	464	494	25	352	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 23	2012	488	7412					535	+		10.1038/nature11346	http://dx.doi.org/10.1038/nature11346			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992FS	22914168				2022-12-24	WOS:000307761600042
J	Rosenbaum, JT				Rosenbaum, James T.			Eyeing Macular Degeneration - A Few Inflammatory Remarks	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rosenbaum, James T.] Oregon Hlth & Sci Univ, Dept Ophthalmol, Portland, OR 97201 USA; [Rosenbaum, James T.] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97201 USA; [Rosenbaum, James T.] Oregon Hlth & Sci Univ, Dept Cell Biol, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Rosenbaum, JT (corresponding author), Oregon Hlth & Sci Univ, Dept Ophthalmol, Portland, OR 97201 USA.							Doyle SL, 2012, NAT MED, V18, P791, DOI 10.1038/nm.2717; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Tarallo V, 2012, CELL, V149, P847, DOI 10.1016/j.cell.2012.03.036	5	10	13	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 23	2012	367	8					768	770		10.1056/NEJMcibr1204973	http://dx.doi.org/10.1056/NEJMcibr1204973			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	992CX	22913688				2022-12-24	WOS:000307754200015
J	Brosi, BJ; Biber, EGN				Brosi, Berry J.; Biber, Eric G. N.			Citizen Involvement in the US Endangered Species Act	SCIENCE			English	Editorial Material							EXTINCTION		[Brosi, Berry J.] Emory Univ, Dept Environm Studies, Atlanta, GA 30322 USA; [Biber, Eric G. N.] Univ Calif Berkeley, Sch Law, Berkeley, CA 94720 USA	Emory University; University of California System; University of California Berkeley	Brosi, BJ (corresponding author), Emory Univ, Dept Environm Studies, Atlanta, GA 30322 USA.	bbrosi@emory.edu		Brosi, Berry/0000-0002-9233-1151				Biber E, 2010, UCLA LAW REV, V58, P321; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Cronin M. A., 2006, RANGE MAGAZINE, V2006, P14; Holthouse David, 2005, DENVER WESTWORD 0120; Patlis JM., 2003, TULANE ENV LAW J, V16, P257; Restani M, 2002, BIOSCIENCE, V52, P169, DOI 10.1641/0006-3568(2002)052[0169:FEBNAP]2.0.CO;2; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sugg IC, 1993, CUMB L REV, V24, P1; 1983, FED REG, V48, P43098	9	18	19	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2012	337	6096					802	803		10.1126/science.1220660	http://dx.doi.org/10.1126/science.1220660			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	989BQ	22903999				2022-12-24	WOS:000307535600027
J	Castanon, A; Brocklehurst, P; Evans, H; Peebles, D; Singh, N; Walker, P; Patnick, J; Sasieni, P				Castanon, Alejandra; Brocklehurst, Peter; Evans, Heather; Peebles, Donald; Singh, Naveena; Walker, Patrick; Patnick, Julietta; Sasieni, Peter		PaCT Study Grp	Risk of preterm birth after treatment for cervical intraepithelial neoplasia among women attending colposcopy in England: retrospective-prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LARGE LOOP EXCISION; PRECANCEROUS CHANGES; TRANSFORMATION ZONE; PREGNANCY; METAANALYSIS; CONIZATION; DELIVERY; OUTCOMES	Objective To explore the association between preterm delivery and treatment at colposcopy. Design Retrospective-prospective cohort study using record linkage. Setting 12 National Health Service hospitals in England. Participants Women who had a cervical histology sample taken between 1987 and 2009. These women were linked by hospital episode statistics to hospital obstetric records between 1998 and 2009 for the whole of England to identify singleton live births between 20-43 gestational weeks before or after cervical histology. Main outcome measures Proportion of preterm births (<37 weeks); the relative risk for the strength of association between preterm births and treatment for cervical intraepithelial neoplasia. Results 18 441 singleton births occurred: 4176 before histology and 14 265 after histology. Of the singleton births after histology, 9.0% (n=1284) were preterm compared with 6.7% of all births in England over the same period (excess risk 2.3 per 100 births, 95% confidence interval 1.8% to 2.8%). Among first births after histology, the adjusted relative risk associated with previous treatment was 1.19 (95% confidence interval 1.01 to 1.41); among first births before histology the relative risk associated with subsequent treatment was 1.47 (1.05 to 2.05). Combining these, the relative risk associated with treatment adjusted for timing relative to histology was 0.91 (0.66 to 1.26) corresponding to an absolute difference of -0.25 (-2.61 to 2.11) per 100 singleton births. Among 372 women who gave birth both before and after treatment, there were 30 preterm births after treatment and 32 before treatment (relative risk 0.94, 0.62 to 1.43). Conclusion The risk of preterm delivery in women treated by colposcopy in England was substantially less than that in many other studies, predominantly from Nordic countries. The increased risk may be a consequence of confounding and not caused by treatment. Although this study is reassuring for large loop excision of the transformation zone overall, it is possible that deep conisation or repeated treatment leads to an increased risk of preterm delivery.	[Castanon, Alejandra; Sasieni, Peter] Queen Mary Univ London, Wolfson Inst Prevent Med, Ctr Canc Prevent, London EC1M 6BQ, England; [Brocklehurst, Peter; Peebles, Donald] Inst Womens Hlth UCL, London, England; [Evans, Heather; Walker, Patrick] Royal Free Hampstead NHS Trust, Dept Gynaecol, London, England; [Singh, Naveena] Barts Hlth NHS Trust, Div Cellular Pathol, London, England; [Patnick, Julietta] NHS Canc Screening Programmes, Sheffield, S Yorkshire, England	University of London; Queen Mary University London; University of London; University College London; University of London; University College London; Barts Health NHS Trust	Sasieni, P (corresponding author), Queen Mary Univ London, Wolfson Inst Prevent Med, Ctr Canc Prevent, London EC1M 6BQ, England.	p.sasieni@qmul.ac.uk	Wood, Nicholas/E-7124-2018; Singh, Naveena/AAH-2651-2020; Castanon, Alejandra/G-1506-2013	Wood, Nicholas/0000-0002-5909-7885; Sasieni, Peter/0000-0003-1509-8744; Castanon, Alejandra/0000-0002-1101-6548	National Institute for Health Research (NIHR) [PB-PG-1208-16187]; National Institute for Health Research [PB-PG-1208-16187] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This manuscript presents independent research funded by the National Institute for Health Research (NIHR) under its research for patient benefit programme (No PB-PG-1208-16187). The views expressed are those of the authors and not necessarily those of the National Health Service, the NIHR, or the Department of Health. Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; and no other relationships or activities that could appear to have influenced the submitted work. Ethical approval: This study was approved by the Brompton, Harefield, and NHLI research ethics committee, Charing Cross Hospital, London (No 09/H0708/65).	Acharya Ganesh, 2005, Archives of Gynecology and Obstetrics, V272, P109, DOI 10.1007/s00404-005-0727-1; Albrechtsen S, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1343; British Society for Colposcopy and Cervical Pathology, 1975, CONST BSCCP; Bruinsma FJ, 2011, BJOG-INT J OBSTET GY, V118, P1031, DOI 10.1111/j.1471-0528.2011.02944.x; CRUICKSHANK ME, 1995, BRIT J OBSTET GYNAEC, V102, P467, DOI 10.1111/j.1471-0528.1995.tb11319.x; HAFFENDEN DK, 1993, BRIT J OBSTET GYNAEC, V100, P1059, DOI 10.1111/j.1471-0528.1993.tb15153.x; HES Online, 2011, WHAT IS HES 2005 200; Jakobsson M, 2009, OBSTET GYNECOL, V114, P504, DOI 10.1097/AOG.0b013e3181b052de; Kyrgiou M, 2006, LANCET, V367, P489, DOI 10.1016/S0140-6736(06)68181-6; Lancucki L, 2006, CERVICAL SCREENING P; Luesley D, 2004, GUIDELINES NHS CERVI; NHS Information Centre, 2010, NHS MAT STAT 2000 20; Noehr B, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.02.004; Office for National Statistics, 2009, GEST SPEC INF MORT E; Ortoft G, 2010, BJOG-INT J OBSTET GY, V117, P258, DOI 10.1111/j.1471-0528.2009.02438.x; Reilly R, 2012, BJOG-INT J OBSTET GY, V119, P236, DOI 10.1111/j.1471-0528.2011.03052.x; Sadler L, 2004, JAMA-J AM MED ASSOC, V291, P2100, DOI 10.1001/jama.291.17.2100; Shanbhag S, 2009, OBSTET GYNECOL, V114, P727, DOI 10.1097/AOG.0b013e3181b5cba3; Tan Linda, 2004, J Obstet Gynaecol, V24, P25	19	83	91	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 17	2012	345								e5174	10.1136/bmj.e5174	http://dx.doi.org/10.1136/bmj.e5174			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992CV	22899563	Green Published, Green Submitted, hybrid			2022-12-24	WOS:000307754000002
J	Lake, A				Lake, Anthony			A tipping point for child survival, health, and nutrition	LANCET			English	Editorial Material									UNICEF, New York, NY 10017 USA	UNICEF	Lake, A (corresponding author), UNICEF, New York, NY 10017 USA.	alake@unicef.org						Amouzou A, 2012, LANCET; [Anonymous], LEV TRENDS CHILD MOR; Carrera C, 2012, LANCET; Chopra M, 2012, LANCET; United Nations Children's Fund (UNICEF), COMM CHILD SURV PROM; Victora CG, 2012, LANCET; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990	7	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 13	2012	380	9850					1286	1287		10.1016/S0140-6736(12)61539-6	http://dx.doi.org/10.1016/S0140-6736(12)61539-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	022BZ	22999429				2022-12-24	WOS:000309931400005
J	Chen, W; Jongkamonwiwat, N; Abbas, L; Eshtan, SJ; Johnson, SL; Kuhn, S; Milo, M; Thurlow, JK; Andrews, PW; Marcotti, W; Moore, HD; Rivolta, MN				Chen, Wei; Jongkamonwiwat, Nopporn; Abbas, Leila; Eshtan, Sarah Jacob; Johnson, Stuart L.; Kuhn, Stephanie; Milo, Marta; Thurlow, Johanna K.; Andrews, Peter W.; Marcotti, Walter; Moore, Harry D.; Rivolta, Marcelo N.			Restoration of auditory evoked responses by human ES-cell-derived otic progenitors	NATURE			English	Article							EMBRYONIC STEM-CELLS; INNER-EAR; SPIRAL GANGLION; IN-VITRO; PLACODE INDUCTION; HAIR-CELLS; DIFFERENTIATION; NEURONS; NERVE; TRANSPLANTATION	Deafness is a condition with a high prevalence worldwide, produced primarily by the loss of the sensory hair cells and their associated spiral ganglion neurons (SGNs). Of all the forms of deafness, auditory neuropathy is of particular concern. This condition, defined primarily by damage to the SGNs with relative preservation of the hair cells(1), is responsible for a substantial proportion of patients with hearing impairment(2). Although the loss of hair cells can be circumvented partially by a cochlear implant, no routine treatment is available for sensory neuron loss, as poor innervation limits the prospective performance of an implant(3). Using stem cells to recover the damaged sensory circuitry is a potential therapeutic strategy. Here we present a protocol to induce differentiation from human embryonic stem cells (hESCs) using signals involved in the initial specification of the otic placode. We obtained two types of otic progenitors able to differentiate in vitro into hair-cell-like cells and auditory neurons that display expected electrophysiological properties. Moreover, when transplanted into an auditory neuropathy model, otic neuroprogenitors engraft, differentiate and significantly improve auditory-evoked response thresholds. These results should stimulate further research into the development of a cell-based therapy for deafness.	[Chen, Wei; Jongkamonwiwat, Nopporn; Abbas, Leila; Eshtan, Sarah Jacob; Thurlow, Johanna K.; Andrews, Peter W.; Moore, Harry D.; Rivolta, Marcelo N.] Univ Sheffield, Ctr Stem Cell Biol, Sheffield S10 2TN, S Yorkshire, England; [Chen, Wei; Jongkamonwiwat, Nopporn; Abbas, Leila; Eshtan, Sarah Jacob; Johnson, Stuart L.; Kuhn, Stephanie; Milo, Marta; Thurlow, Johanna K.; Andrews, Peter W.; Marcotti, Walter; Moore, Harry D.; Rivolta, Marcelo N.] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England; [Jongkamonwiwat, Nopporn] Srinakharinwirot Univ, Fac Hlth Sci, Ongkharak 26120, Nakhonnayok, Thailand	University of Sheffield; University of Sheffield; Srinakharinwirot University	Rivolta, MN (corresponding author), Univ Sheffield, Ctr Stem Cell Biol, Sheffield S10 2TN, S Yorkshire, England.	m.n.rivolta@sheffield.ac.uk		Andrews, Peter/0000-0001-7215-4410; , Stephanie/0000-0001-6633-9478; Jongkamonwiwat, Nopporn/0000-0002-3592-8787	Action on Hearing Loss (RNID); Deafness Research UK; Wellcome Trust [088719]; Medical Research Council; ESTOOLS; Wellcome Trust VIP award; RNID; MRC [G0801059, G0900919, G0700785] Funding Source: UKRI; Medical Research Council [G0801059, G0900919, G0700785] Funding Source: researchfish; RNID [G44, 515:SHE:MR] Funding Source: researchfish	Action on Hearing Loss (RNID); Deafness Research UK; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ESTOOLS(European Commission); Wellcome Trust VIP award(Wellcome Trust); RNID; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); RNID	This work was supported primarily by grants from Action on Hearing Loss (RNID) to M.N.R. Other support included Deafness Research UK (M.N.R and W. M.), the Wellcome Trust (088719, W. M.), Medical Research Council (P. W. A, H. D. M. and M.N.R) and ESTOOLS (P. W. A). S.L.J. was supported by a Wellcome Trust VIP award and the RNID. W. M. and S.L.J. are Royal Society university research fellows. Confocal images were taken at the Light Microscopy Facility of the Department of Biomedical Sciences, University of Sheffield. We are grateful for the advice of M. Mulheran and I. Russell on the tests of auditory function, provided at the earlier stages of this project, and to the assistance of P. Gokhale on the use of the InCell Analyzer. M.N.R. acknowledges the support and encouragement of his late parents, Noemi Lujan-Ceballos and Juan Carlos Rivolta.	Alvarez Y, 2003, DEVELOPMENT, V130, P6329, DOI 10.1242/dev.00881; BOETTCHER FA, 1993, HEARING RES, V71, P137, DOI 10.1016/0378-5955(93)90029-Z; Bradley Jane, 2008, Cochlear Implants Int, V9, P34, DOI 10.1179/cim.2008.9.1.34; BURKARD R, 1993, J ACOUST SOC AM, V94, P2441, DOI 10.1121/1.407465; Chen W, 2009, STEM CELLS, V27, P1196, DOI 10.1002/stem.62; Coleman B, 2007, EXP CELL RES, V313, P232, DOI 10.1016/j.yexcr.2006.10.010; Corrales CE, 2006, J NEUROBIOL, V66, P1489, DOI 10.1002/neu.20310; Freter S, 2008, DEVELOPMENT, V135, P3415, DOI 10.1242/dev.026674; Hildebrand MS, 2005, JARO-J ASSOC RES OTO, V6, P341, DOI 10.1007/s10162-005-0012-9; Hu ZQ, 2004, BRAIN RES, V1026, P68, DOI 10.1016/j.brainres.2004.08.013; Jeon SJ, 2007, MOL CELL NEUROSCI, V34, P59, DOI 10.1016/j.mcn.2006.10.003; Kondo T, 2005, P NATL ACAD SCI USA, V102, P4789, DOI 10.1073/pnas.0408239102; Lang H, 2005, JARO-J ASSOC RES OTO, V6, P63, DOI 10.1007/s10162-004-5021-6; Lang HN, 2008, JARO-J ASSOC RES OTO, V9, P225, DOI 10.1007/s10162-008-0119-x; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; Li HW, 2003, P NATL ACAD SCI USA, V100, P13495, DOI 10.1073/pnas.2334503100; Li HW, 2003, NAT MED, V9, P1293, DOI 10.1038/nm925; Martin K, 2006, DEVELOPMENT, V133, P877, DOI 10.1242/dev.02267; McLean WJ, 2009, JARO-J ASSOC RES OTO, V10, P37, DOI 10.1007/s10162-008-0152-9; Oshima K, 2010, CELL, V141, P704, DOI 10.1016/j.cell.2010.03.035; Rask-Andersen H, 2005, HEARING RES, V203, P180, DOI 10.1016/j.heares.2004.12.005; Reyes JH, 2008, J NEUROSCI, V28, P12622, DOI 10.1523/JNEUROSCI.0563-08.2008; Schmiedt RA, 2002, JARO, V3, P223, DOI 10.1007/s1016200220017; Sekiya T, 2007, EUR J NEUROSCI, V25, P2307, DOI 10.1111/j.1460-9568.2007.05478.x; Shi FX, 2007, EUR J NEUROSCI, V26, P3016, DOI 10.1111/j.1460-9568.2007.05909.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Uus K, 2006, PEDIATRICS, V117, pE887, DOI 10.1542/peds.2005-1064; Vlastarakos PV, 2008, INT J PEDIATR OTORHI, V72, P1135, DOI 10.1016/j.ijporl.2008.04.004; Wright TJ, 2003, DEVELOPMENT, V130, P3379, DOI 10.1242/dev.00555	29	240	255	3	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2012	490	7419					278	+		10.1038/nature11415	http://dx.doi.org/10.1038/nature11415			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019IY	22972191	Green Accepted			2022-12-24	WOS:000309733300053
J	Machin, JT; Wordsworth, DR; Raja, S; Burtt, S				Machin, John T.; Wordsworth, David R.; Raja, Senthooran; Burtt, Simon			Hip pain in an adolescent after injury while playing football	BRITISH MEDICAL JOURNAL			English	Editorial Material							INFERIOR ILIAC SPINE; AVULSION FRACTURES; PELVIS; ATHLETE		[Machin, John T.; Wordsworth, David R.; Raja, Senthooran; Burtt, Simon] Luton & Dunstable Hosp NHS Fdn Trust, Dept Trauma & Orthopaed, Luton, Beds, England		Machin, JT (corresponding author), 15 Denholme Rd, London W9 3HU, England.	johnmachin@doctors.org.uk						Clancy W G Jr, 1976, Am J Sports Med, V4, P214, DOI 10.1177/036354657600400504; FERNBACH SK, 1981, AM J ROENTGENOL, V137, P581, DOI 10.2214/ajr.137.3.581; Kocher MS, 2006, CLIN SPORT MED, V25, P241, DOI 10.1016/j.csm.2006.01.001; METZMAKER JN, 1985, AM J SPORT MED, V13, P349, DOI 10.1177/036354658501300510; Miller MD, 2008, REV ORTHOPEDICS, P509; Moeller James L, 2003, Curr Sports Med Rep, V2, P110; Perry DC, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3565; Rajasekhar C, 2001, INT ORTHOP, V24, P364, DOI 10.1007/s002640000184; Rossi F, 2001, SKELETAL RADIOL, V30, P127, DOI 10.1007/s002560000319; Saluan PM, 1997, ORTHOPEDICS, V20, P558; Sanders TG, 2008, SEMIN MUSCULOSKEL R, V12, P42, DOI 10.1055/s-2008-1067936; SUNDAR M, 1994, SKELETAL RADIOL, V23, P85, DOI 10.1007/BF00563198; VESELKO M, 1994, J TRAUMA, V36, P444, DOI 10.1097/00005373-199403000-00039; WATERS PM, 1988, CLIN SPORT MED, V7, P513; Weinstein SL, 1984, AAOS INSTRUCTIONAL C, V33	15	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 26	2012	345								e6265	10.1136/bmj.e6265	http://dx.doi.org/10.1136/bmj.e6265			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	014OV	23015300				2022-12-24	WOS:000309386300005
J	Singh, D; Chan, JM; Zoppoli, P; Niola, F; Sullivan, R; Castano, A; Liu, EM; Reichel, J; Porrati, P; Pellegatta, S; Qiu, KL; Gao, ZB; Ceccarelli, M; Riccardi, R; Brat, DJ; Guha, A; Aldape, K; Golfinos, JG; Zagzag, D; Mikkelsen, T; Finocchiaro, G; Lasorella, A; Rabadan, R; Iavarone, A				Singh, Devendra; Chan, Joseph Minhow; Zoppoli, Pietro; Niola, Francesco; Sullivan, Ryan; Castano, Angelica; Liu, Eric Minwei; Reichel, Jonathan; Porrati, Paola; Pellegatta, Serena; Qiu, Kunlong; Gao, Zhibo; Ceccarelli, Michele; Riccardi, Riccardo; Brat, Daniel J.; Guha, Abhijit; Aldape, Ken; Golfinos, John G.; Zagzag, David; Mikkelsen, Tom; Finocchiaro, Gaetano; Lasorella, Anna; Rabadan, Raul; Iavarone, Antonio			Transforming Fusions of FGFR and TACC Genes in Human Glioblastoma	SCIENCE			English	Article							RECEPTOR TYROSINE KINASE; CHROMOSOMAL INSTABILITY; SELECTIVE INHIBITOR; CANCER; ANEUPLOIDY; FAMILY; DISCOVERY; POTENT	The brain tumor glioblastoma multiforme (GBM) is among the most lethal forms of human cancer. Here, we report that a small subset of GBMs (3.1%; 3 of 97 tumors examined) harbors oncogenic chromosomal translocations that fuse in-frame the tyrosine kinase coding domains of fibroblast growth factor receptor (FGFR) genes (FGFR1 or FGFR3) to the transforming acidic coiled-coil (TACC) coding domains of TACC1 or TACC3, respectively. The FGFR-TACC fusion protein displays oncogenic activity when introduced into astrocytes or stereotactically transduced in the mouse brain. The fusion protein, which localizes to mitotic spindle poles, has constitutive kinase activity and induces mitotic and chromosomal segregation defects and triggers aneuploidy. Inhibition of FGFR kinase corrects the aneuploidy, and oral administration of an FGFR inhibitor prolongs survival of mice harboring intracranial FGFR3-TACC3-initiated glioma. FGFR-TACC fusions could potentially identify a subset of GBM patients who would benefit from targeted FGFR kinase inhibition.	[Singh, Devendra; Zoppoli, Pietro; Niola, Francesco; Sullivan, Ryan; Castano, Angelica; Lasorella, Anna; Iavarone, Antonio] Columbia Univ, Med Ctr, Inst Canc Genet, New York, NY 10027 USA; [Chan, Joseph Minhow; Liu, Eric Minwei; Reichel, Jonathan; Rabadan, Raul] Columbia Univ, Med Ctr, Dept Biomed Informat, New York, NY USA; [Chan, Joseph Minhow; Liu, Eric Minwei; Reichel, Jonathan; Rabadan, Raul] Columbia Univ, Med Ctr, Ctr Computat Biol & Bioinformat, New York, NY USA; [Reichel, Jonathan] Cornell Univ, Triinst Program Computat Biol & Med, New York, NY 10021 USA; [Reichel, Jonathan] Weill Cornell Med Coll, New York, NY USA; [Porrati, Paola; Pellegatta, Serena; Finocchiaro, Gaetano] Carattere Sci Ist Neurol C, Fdn Ist Ricovero & Cura, Milan, Italy; [Qiu, Kunlong; Gao, Zhibo] Beijing Genome Inst, Bioinformat Ctr, Shenzhen, Peoples R China; [Ceccarelli, Michele] Biogem, Ist Ric Genet Gaetano Salvatore, Ariano Irpino, AV, Italy; [Ceccarelli, Michele] Univ Sannio, Dipartimento Sci Biol & Ambientali, Benevento, Italy; [Riccardi, Riccardo] Univ Cattolica Sacro Cuore, Dept Pediat Oncol, Rome, Italy; [Brat, Daniel J.] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA; [Brat, Daniel J.] Emory Univ, Sch Med, Dept Lab Med, Atlanta, GA 30322 USA; [Guha, Abhijit] Univ Toronto, Univ Hlth Network, Toronto Western Hosp, Div Neurosurg, Toronto, ON M5S 1A1, Canada; [Aldape, Ken] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Golfinos, John G.; Zagzag, David] NYU, Dept Neurosurg, Langone Med Ctr, New York, NY 10016 USA; [Zagzag, David] NYU, Dept Neuropathol, Langone Med Ctr, New York, NY USA; [Mikkelsen, Tom] Henry Ford Hlth Syst, Dept Neurol, Detroit, MI USA; [Mikkelsen, Tom] Henry Ford Hlth Syst, Dept Neurosurg, Detroit, MI USA; [Lasorella, Anna] Columbia Univ, Dept Pediat, Med Ctr, New York, NY 10027 USA; [Lasorella, Anna; Iavarone, Antonio] Columbia Univ, Med Ctr, Dept Pathol, New York, NY USA; [Iavarone, Antonio] Columbia Univ, Med Ctr, Dept Neurol, New York, NY USA	Columbia University; Columbia University; Columbia University; Cornell University; Cornell University; Beijing Genomics Institute (BGI); University of Sannio; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Emory University; Emory University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Texas System; UTMD Anderson Cancer Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Columbia University; Columbia University; Columbia University	Lasorella, A (corresponding author), Columbia Univ, Med Ctr, Inst Canc Genet, New York, NY 10027 USA.	al2179@columbia.edu; rabadan@dbmi.columbia.edu; ai2102@columbia.edu	Rabadan, Raul/AAZ-7367-2020; Zoppoli, Pietro/J-9954-2018; Ceccarelli, Michele/AGP-1739-2022; Liu, Eric Minwei/V-1738-2019; Finocchiaro, Gaetano/AAG-6791-2020; Pellegatta, Serena/AAL-3693-2021	Zoppoli, Pietro/0000-0002-7860-9655; Liu, Eric Minwei/0000-0002-3594-6678; Pellegatta, Serena/0000-0001-7804-9486; Finocchiaro, Gaetano/0000-0003-3583-4040; Iavarone, Antonio/0000-0002-0683-4634; Chan, Joseph/0000-0001-5249-7395; Rabadan, Raul/0000-0001-7946-9255; Ceccarelli, Michele/0000-0002-4702-6617; RICCARDI, RICCARDO/0000-0001-7515-6622	National Cancer Institute [R01CA101644, R01CA131126, R01CA085628, R01CA127643, U54 CA121852-05]; National Library of Medicine [1R01LM010140-01]; National Institute of Neurological Disorders and Stroke [R01NS061776]; Partnership for Cure [7-78947]; Chemotherapy Foundation; Italian Ministry of Welfare/Provincia di Benevento; Associazione Italiana per la Ricerca sul Cancro; Italian Ministry of Health; NATIONAL CANCER INSTITUTE [R01CA085628, U54CA121852, R01CA131126, R01CA127643, R01CA101644, R01CA190891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061776] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010140] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Partnership for Cure; Chemotherapy Foundation; Italian Ministry of Welfare/Provincia di Benevento; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health(Ministry of Health, Italy); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by National Cancer Institute grants R01CA101644 and R01CA131126 (A. L.), R01CA085628 and R01CA127643 (A. I.), U54 CA121852-05 (R. R.), National Library of Medicine grant 1R01LM010140-01 (R. R.), National Institute of Neurological Disorders and Stroke grant R01NS061776 (A. I.), a grant from Partnership for Cure (R. R., 7-78947), and a grant from The Chemotherapy Foundation (A. I.). P.Z. and F.N. are supported by fellowships from the Italian Ministry of Welfare/Provincia di Benevento. G. F. was supported by grants from the Associazione Italiana per la Ricerca sul Cancro and from the Italian Ministry of Health. Three of the authors (A. I., A. L., and R. R.) and Columbia University Medical Center have filed a patent application related to the diagnostic and therapeutic use of FGFR-TACC gene fusions. Next-generation RNA-sequencing data have been deposited into the Database of Genotypes and Phenotypes (accession no. phs000505.v1.p1).	Ablain J, 2011, CANCER DISCOV, V1, P117, DOI 10.1158/2159-8290.CD-11-0087; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Charest A, 2003, GENE CHROMOSOME CANC, V37, P58, DOI 10.1002/gcc.10207; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Coschi CH, 2012, CELL MOL LIFE SCI, V69, P2009, DOI 10.1007/s00018-011-0910-4; Druker BJ, 2009, NAT MED, V15, P1149, DOI 10.1038/nm1009-1149; Duncan CG, 2010, ONCOTARGET, V1, P265, DOI 10.18632/oncotarget.137; Gavine PR, 2012, CANCER RES, V72, P2045, DOI 10.1158/0008-5472.CAN-11-3034; Gerber DE, 2010, CANCER CELL, V18, P548, DOI 10.1016/j.ccr.2010.11.033; Gordon DJ, 2012, NAT REV GENET, V13, P189, DOI 10.1038/nrg3123; Guagnano V, 2011, J MED CHEM, V54, P7066, DOI 10.1021/jm2006222; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Hood Fiona E, 2011, Bioarchitecture, V1, P105; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Marumoto T, 2009, NAT MED, V15, P110, DOI 10.1038/nm.1863; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; Peset I, 2008, TRENDS CELL BIOL, V18, P379, DOI 10.1016/j.tcb.2008.06.005; Sheltzer JM, 2011, TRENDS GENET, V27, P446, DOI 10.1016/j.tig.2011.07.003; Solomon DA, 2011, SCIENCE, V333, P1039, DOI 10.1126/science.1203619; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Still IH, 1999, GENOMICS, V58, P165, DOI 10.1006/geno.1999.5829; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Weaver BAA, 2009, J CELL BIOL, V185, P934, DOI 10.1083/jcb.200905098; Wesche J, 2011, BIOCHEM J, V437, P199, DOI 10.1042/BJ20101603; Yao R, 2012, ONCOGENE, V31, P135, DOI 10.1038/onc.2011.235	28	518	569	3	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 7	2012	337	6099					1231	1235		10.1126/science.1220834	http://dx.doi.org/10.1126/science.1220834			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	000UJ	22837387	Green Accepted			2022-12-24	WOS:000308414000040
J	Haskel-Ittah, M; Ben-Zvi, D; Branski-Arieli, M; Schejter, ED; Shilo, BZ; Barkai, N				Haskel-Ittah, Michal; Ben-Zvi, Danny; Branski-Arieli, Merav; Schejter, Eyal D.; Shilo, Ben-Zion; Barkai, Naama			Self-Organized Shuttling: Generating Sharp Dorsoventral Polarity in the Early Drosophila Embryo	CELL			English	Article							DORSAL-VENTRAL POLARITY; MORPHOGEN GRADIENT; SPATZLE PROTEIN; POSITIONAL INFORMATION; BLASTODERM EMBRYO; NUCLEAR GRADIENT; GENE-EXPRESSION; NERVOUS-SYSTEM; AXIS FORMATION; TRANSPORT	Morphogen gradients pattern tissues and organs during development. When morphogen production is spatially restricted, diffusion and degradation are sufficient to generate sharp concentration gradients. It is less clear how sharp gradients can arise within the source of a broadly expressed morphogen. A recent solution relies on localized production of an inhibitor outside the domain of morphogen production, which effectively redistributes (shuttles) and concentrates the morphogen within its expression domain. Here, we study how a sharp gradient is established without a localized inhibitor, focusing on early dorsoventral patterning of the Drosophila embryo, where an active ligand and its inhibitor are concomitantly generated in a broad ventral domain. Using theory and experiments, we show that a sharp Toll activation gradient is produced through "self-organized shuttling," which dynamically relocalizes inhibitor production to lateral regions, followed by inhibitor-dependent ventral shuttling of the activating ligand Spatzle. Shuttling may represent a general paradigm for patterning early embryos.	[Haskel-Ittah, Michal; Ben-Zvi, Danny; Branski-Arieli, Merav; Schejter, Eyal D.; Shilo, Ben-Zion; Barkai, Naama] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Shilo, BZ (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	benny.shilo@weizmann.ac.il; naama.barkai@weizmann.ac.il		Haskel-Ittah, Michal/0000-0003-2626-5835; Ben-Zvi, Danny/0000-0002-8697-9744	Adams Fellowship Program of the Israeli Academy of Sciences and Humanities; European Research Council; Israel Science Foundation; Minerva; Helen and Martin Kimmel Award for Innovative Investigations; Minerva Foundation	Adams Fellowship Program of the Israeli Academy of Sciences and Humanities; European Research Council(European Research Council (ERC)European Commission); Israel Science Foundation(Israel Science Foundation); Minerva; Helen and Martin Kimmel Award for Innovative Investigations; Minerva Foundation	We thank R. DeLotto, T. Ip, Z. Paroush, and D. Stein for reagents; Y. Gilad, A. Rubinstein, and I. Koren for technical help; T. Volk for insightful suggestions; and Orit Bechar, Tali Wiesel, and Itzchak Reuven for their dedicated graphic design and animation work. We thank members of our groups for fruitful discussions. D.B.-Z. is supported by the Adams Fellowship Program of the Israeli Academy of Sciences and Humanities. This work was supported by the European Research Council, Israel Science Foundation, Minerva, and the Helen and Martin Kimmel Award for Innovative Investigations to N.B., who is the incumbent of the Lorna Greenberg Scherzer Professorial Chair, and the Minerva Foundation to B.-Z.S., who is an incumbent of the Hilda and Cecil Lewis Professorial Chair in Molecular Genetics.	Anderson KV, 1998, CELL, V95, P439, DOI 10.1016/S0092-8674(00)81610-4; Ben-Yaacov S, 2001, J CELL BIOL, V152, P1, DOI 10.1083/jcb.152.1.1; Ben-Zvi D, 2008, NATURE, V453, P1205, DOI 10.1038/nature07059; BIER E, 1990, GENE DEV, V4, P190, DOI 10.1101/gad.4.2.190; Bollenbach T, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018103; Cadigan KM, 2002, SEMIN CELL DEV BIOL, V13, P83, DOI 10.1016/S1084-9521(02)00014-9; Cho YS, 2012, CURR BIOL, V22, P1013, DOI 10.1016/j.cub.2012.03.065; Cho YS, 2010, CURR BIOL, V20, P1133, DOI 10.1016/j.cub.2010.04.056; Chu H, 1998, GENE DEV, V12, P3613, DOI 10.1101/gad.12.22.3613; DeLotto R, 2007, DEVELOPMENT, V134, P4233, DOI 10.1242/dev.010934; DeLotto Y, 2001, MOL GEN GENET, V264, P643, DOI 10.1007/s004380000350; DeLotto Y, 1998, MECH DEVELOP, V72, P141, DOI 10.1016/S0925-4773(98)00024-0; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; Eldar A, 2003, DEV CELL, V5, P635, DOI 10.1016/S1534-5807(03)00292-2; Eldar A, 2002, NATURE, V419, P304, DOI 10.1038/nature01061; Ephrussi A, 2004, CELL, V116, P143, DOI 10.1016/S0092-8674(04)00037-6; Ge GX, 2005, MOL CELL BIOL, V25, P5846, DOI 10.1128/MCB.25.14.5846-5858.2005; Huang AM, 1997, GENE DEV, V11, P1963, DOI 10.1101/gad.11.15.1963; James KE, 2002, DEVELOPMENT, V129, P2209; Kanodia JS, 2009, P NATL ACAD SCI USA, V106, P21707, DOI 10.1073/pnas.0912395106; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; LeMosy EK, 1999, TRENDS CELL BIOL, V9, P102, DOI 10.1016/S0962-8924(98)01494-9; Liberman LM, 2009, P NATL ACAD SCI USA, V106, P22317, DOI 10.1073/pnas.0906227106; Matsuda S, 2012, DEV BIOL, V366, P153, DOI 10.1016/j.ydbio.2012.04.009; Meinhardt H, 2002, NATURE, V419, P261, DOI 10.1038/419261a; Melen GJ, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100036; Mizutani CM, 2005, DEV CELL, V8, P915, DOI 10.1016/j.devcel.2005.04.009; Morisato D, 1995, ANNU REV GENET, V29, P371, DOI 10.1146/annurev.genet.29.1.371; MORISATO D, 1994, CELL, V76, P677, DOI 10.1016/0092-8674(94)90507-X; Morisato D, 2001, DEVELOPMENT, V128, P2309; Moussian B, 2005, CURR BIOL, V15, pR887, DOI 10.1016/j.cub.2005.10.026; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Paulsen M, 2011, P NATL ACAD SCI USA, V108, P10202, DOI 10.1073/pnas.1100179108; Peri F, 2002, DEVELOPMENT, V129, P2965; Plouhinec JL, 2011, CURR OPIN GENET DEV, V21, P696, DOI 10.1016/j.gde.2011.09.001; Reeves GT, 2012, DEV CELL, V22, P544, DOI 10.1016/j.devcel.2011.12.007; ROTH S, 1994, DEVELOPMENT, V120, P2245; ROTH S, 1989, CELL, V59, P1189, DOI 10.1016/0092-8674(89)90774-5; Rusch J, 1996, CURR OPIN GENET DEV, V6, P416, DOI 10.1016/S0959-437X(96)80062-1; RUSHLOW CA, 1989, CELL, V59, P1165, DOI 10.1016/0092-8674(89)90772-1; Schier AF, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003459; Schlesinger A, 2004, DEV CELL, V7, P535, DOI 10.1016/j.devcel.2004.09.001; SCHNEIDER DS, 1994, DEVELOPMENT, V120, P1243; Sen J, 1998, CELL, V95, P471, DOI 10.1016/S0092-8674(00)81615-3; Shimmi O, 2005, CELL, V120, P873, DOI 10.1016/j.cell.2005.02.009; Stathopoulos A, 2002, DEVELOPMENT, V129, P3411; Stein D, 1995, CURR BIOL, V5, P1360, DOI 10.1016/S0960-9822(95)00270-3; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; van der Zee M, 2006, P NATL ACAD SCI USA, V103, P16307, DOI 10.1073/pnas.0605154103; Wang YC, 2005, NATURE, V434, P229, DOI 10.1038/nature03318; Weber ANR, 2007, J BIOL CHEM, V282, P13522, DOI 10.1074/jbc.M700068200; Wolfman NM, 2003, P NATL ACAD SCI USA, V100, P15842, DOI 10.1073/pnas.2534946100; WOLPERT L, 1989, DEVELOPMENT, V107, P3; Zhang ZY, 2009, CURR BIOL, V19, P1200, DOI 10.1016/j.cub.2009.05.050; Zhao GY, 2007, INT J DEV BIOL, V51, P107, DOI 10.1387/ijdb.062188gz; Zhu XJ, 2007, DEVELOPMENT, V134, P1465, DOI 10.1242/dev.003426	56	35	35	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 31	2012	150	5					1016	1028		10.1016/j.cell.2012.06.044	http://dx.doi.org/10.1016/j.cell.2012.06.044			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22939625	Bronze			2022-12-24	WOS:000308500200015
J	Chaki, M; Airik, R; Ghosh, AK; Giles, RH; Chen, R; Slaats, GG; Wang, H; Hurd, TW; Zhou, WB; Cluckey, A; Gee, HY; Ramaswami, G; Hong, CJ; Hamilton, BA; Cervenka, I; Ganji, RS; Bryja, V; Arts, HH; van Reeuwijk, J; Oud, MM; Letteboer, SJF; Roepman, R; Husson, H; Ibraghimov-Beskrovnaya, O; Yasunaga, T; Walz, G; Eley, L; Sayer, JA; Schermer, B; Liebau, MC; Benzing, T; Le Corre, S; Drummond, I; Janssen, S; Allen, SJ; Natarajan, S; O'Toole, JF; Attanasio, M; Saunier, S; Antignac, C; Koenekoop, RK; Ren, HN; Lopez, I; Nayir, A; Stoetzel, C; Dollfus, H; Massoudi, R; Gleeson, JG; Andreoli, SP; Doherty, DG; Lindstrad, A; Golzio, C; Katsanis, N; Pape, L; Abboud, EB; Al-Rajhi, AA; Lewis, RA; Omran, H; Lee, EYHP; Wang, SH; Sekiguchi, JM; Saunders, R; Johnson, CA; Garner, E; Vanselow, K; Andersen, JS; Shlomai, J; Nurnberg, G; Nurnberg, P; Levy, S; Smogorzewska, A; Otto, EA; Hildebrandt, F				Chaki, Moumita; Airik, Rannar; Ghosh, Amiya K.; Giles, Rachel H.; Chen, Rui; Slaats, Gisela G.; Wang, Hui; Hurd, Toby W.; Zhou, Weibin; Cluckey, Andrew; Gee, Heon Yung; Ramaswami, Gokul; Hong, Chen-Jei; Hamilton, Bruce A.; Cervenka, Igor; Ganji, Ranjani Sri; Bryja, Vitezslav; Arts, Heleen H.; van Reeuwijk, Jeroen; Oud, Machteld M.; Letteboer, Stef J. F.; Roepman, Ronald; Husson, Herve; Ibraghimov-Beskrovnaya, Oxana; Yasunaga, Takayuki; Walz, Gerd; Eley, Lorraine; Sayer, John A.; Schermer, Bernhard; Liebau, Max C.; Benzing, Thomas; Le Corre, Stephanie; Drummond, Iain; Janssen, Sabine; Allen, Susan J.; Natarajan, Sivakumar; O'Toole, John F.; Attanasio, Massimo; Saunier, Sophie; Antignac, Corinne; Koenekoop, Robert K.; Ren, Huanan; Lopez, Irma; Nayir, Ahmet; Stoetzel, Corinne; Dollfus, Helene; Massoudi, Rustin; Gleeson, Joseph G.; Andreoli, Sharon P.; Doherty, Dan G.; Lindstrad, Anna; Golzio, Christelle; Katsanis, Nicholas; Pape, Lars; Abboud, Emad B.; Al-Rajhi, Ali A.; Lewis, Richard A.; Omran, Heymut; Lee, Eva Y. -H. P.; Wang, Shaohui; Sekiguchi, Joann M.; Saunders, Rudel; Johnson, Colin A.; Garner, Elizabeth; Vanselow, Katja; Andersen, Jens S.; Shlomai, Joseph; Nurnberg, Gudrun; Nurnberg, Peter; Levy, Shawn; Smogorzewska, Agata; Otto, Edgar A.; Hildebrandt, Friedhelm			Exome Capture Reveals ZNF423 and CEP164 Mutations, Linking Renal Ciliopathies to DNA Damage Response Signaling	CELL			English	Article							MULTIPOINT LINKAGE ANALYSIS; POLYCYSTIC KIDNEY-DISEASE; ATAXIA-TELANGIECTASIA; SECKEL-SYNDROME; CENTROSOMAL PROTEIN; GENOMIC STABILITY; JOUBERT-SYNDROME; HUMAN-CELLS; GENE; MOUSE	Nephronophthisis-related ciliopathies (NPHP-RC) are degenerative recessive diseases that affect kidney, retina, and brain. Genetic defects in NPHP gene products that localize to cilia and centrosomes defined them as "ciliopathies.'' However, disease mechanisms remain poorly understood. Here, we identify by whole-exome resequencing, mutations of MRE11, ZNF423, and CEP164 as causing NPHP-RC. All three genes function within the DNA damage response (DDR) pathway. We demonstrate that, upon induced DNA damage, the NPHP-RC proteins ZNF423, CEP164, and NPHP10 colocalize to nuclear foci positive for TIP60, known to activate ATM at sites of DNA damage. We show that knockdown of CEP164 or ZNF423 causes sensitivity to DNA damaging agents and that cep164 knockdown in zebrafish results in dysregulated DDR and an NPHP-RC phenotype. Our findings link degenerative diseases of the kidney and retina, disorders of increasing prevalence, to mechanisms of DDR.	[Chaki, Moumita; Airik, Rannar; Ghosh, Amiya K.; Hurd, Toby W.; Zhou, Weibin; Cluckey, Andrew; Gee, Heon Yung; Ramaswami, Gokul; Janssen, Sabine; Allen, Susan J.; Natarajan, Sivakumar; Otto, Edgar A.; Hildebrandt, Friedhelm] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Sekiguchi, Joann M.; Saunders, Rudel; Hildebrandt, Friedhelm] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Giles, Rachel H.; Slaats, Gisela G.] Univ Med Ctr, Dept Hypertens & Nephrol, Utrecht, Netherlands; [Chen, Rui; Wang, Hui] Baylor Coll Med, HGSC Dept Mol & Human Genet, Houston, TX 77030 USA; [Lewis, Richard A.] Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; [Hong, Chen-Jei; Hamilton, Bruce A.] Univ Calif San Diego, Sch Med, Dept Med, Div Med Genet,Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Hong, Chen-Jei; Hamilton, Bruce A.] Univ Calif San Diego, Sch Med, Inst Genom Med, George Palade Labs, La Jolla, CA 92093 USA; [Cervenka, Igor; Ganji, Ranjani Sri; Bryja, Vitezslav] Masaryk Univ, Fac Sci, Inst Expt Biol, CS-61137 Brno, Czech Republic; [Bryja, Vitezslav] Acad Sci Czech Republic, Inst Biophys, Dept Cytokinet, CS-61265 Brno, Czech Republic; [Arts, Heleen H.; van Reeuwijk, Jeroen; Oud, Machteld M.; Letteboer, Stef J. F.; Roepman, Ronald] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands; [Arts, Heleen H.; van Reeuwijk, Jeroen; Oud, Machteld M.; Letteboer, Stef J. F.; Roepman, Ronald] Radboud Univ Nijmegen, Med Ctr, Inst Genet & Metab Dis, NL-6525 GA Nijmegen, Netherlands; [Husson, Herve; Ibraghimov-Beskrovnaya, Oxana] Genzyme Corp, Cell Biol, Framingham, MA 01701 USA; [Yasunaga, Takayuki; Walz, Gerd] Univ Freiburg, Div Renal, Med Ctr, D-79001 Freiburg, Germany; [Eley, Lorraine; Sayer, John A.] Newcastle Univ, Inst Genet Med, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Schermer, Bernhard; Liebau, Max C.; Benzing, Thomas] Univ Cologne, Dept Internal Med 2, D-50937 Cologne, Germany; [Schermer, Bernhard; Liebau, Max C.; Benzing, Thomas] Univ Cologne, Ctr Mol Med, D-50937 Cologne, Germany; [Schermer, Bernhard; Benzing, Thomas; Nurnberg, Gudrun; Nurnberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50937 Cologne, Germany; [Liebau, Max C.] Univ Cologne, Dept Pediat & Adolescent Med, D-50937 Cologne, Germany; [Schermer, Bernhard; Benzing, Thomas] Univ Cologne, Syst Biol Aging, D-50937 Cologne, Germany; [Nurnberg, Gudrun; Nurnberg, Peter] Univ Cologne, Cologne Ctr Genom & Mol Med, D-50937 Cologne, Germany; [Shlomai, Joseph] Hebrew Univ Hadassah Med Sch, Fac Med, Dept Microbiol & Mol Genet, IMRIC, IL-91120 Jerusalem, Israel; [Le Corre, Stephanie; Drummond, Iain] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Nephrol Div, Charlestown, MA 02129 USA; [Le Corre, Stephanie; Drummond, Iain] Harvard Univ, Sch Med, Dept Genet, Charlestown, MA 02129 USA; [O'Toole, John F.] Metrohlth Med Ctr, Dept Internal Med, Div Nephrol, Cleveland, OH 44109 USA; [O'Toole, John F.] Case Western Reserve Univ, Sch Med, Cleveland, OH 44109 USA; [Attanasio, Massimo] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Attanasio, Massimo] Univ Texas SW Med Ctr Dallas, Eugene McDermott Ctr Growth & Dev, Dallas, TX 75390 USA; [Saunier, Sophie; Antignac, Corinne] Paris Descartes Univ, Hop Necker Enfants Malades, Inserm U983, AP HP, Paris, France; [Koenekoop, Robert K.; Ren, Huanan; Lopez, Irma] McGill Univ, Montreal Childrens Hosp, McGill Ocular Genet Lab, Ctr Hlth, Montreal, PQ H3H 1P3, Canada; [Nayir, Ahmet] Istanbul Univ, Fac Med, Dept Pediat Nephrol, Istanbul, Turkey; [Stoetzel, Corinne; Dollfus, Helene] Univ Strasbourg, Fac Med, Lab Genet Med EA3949, Equipe AVENIR Inserm, F-67000 Strasbourg, France; [Massoudi, Rustin; Gleeson, Joseph G.] Univ Calif San Diego, Howard Hughes Med Inst, Dept Pediat, La Jolla, CA 92093 USA; [Andreoli, Sharon P.] Indiana Univ, James Whitcomb Riley Hosp Children, Dept Pediat, Med Ctr, Indianapolis, IN 46202 USA; [Doherty, Dan G.] Univ Washington, Seattle Childrens Hosp, Dept Pediat, Div Genet Med,Ctr Integrat Brain Res, Seattle, WA 98101 USA; [Lindstrad, Anna; Golzio, Christelle; Katsanis, Nicholas] Duke Univ, Ctr Human Dis Modeling, Med Ctr, Durham, NC 27710 USA; [Pape, Lars] Hannover Med Sch, Dept Pediat Nephrol, D-30625 Hannover, Germany; [Abboud, Emad B.; Al-Rajhi, Ali A.] King Khalid Eye Specialist Hosp, Riyadh 11462, Saudi Arabia; [Omran, Heymut] Univ Klinikum Munster, Klin & Poliklin Kinder & Jugendmed Allgemeine Pad, D-48149 Munster, Germany; [Lee, Eva Y. -H. P.; Wang, Shaohui] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; [Johnson, Colin A.] St James Univ Hosp, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England; [Garner, Elizabeth; Smogorzewska, Agata] Rockefeller Univ, Lab Genome Maintenance, New York, NY 10065 USA; [Vanselow, Katja; Andersen, Jens S.] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark; [Levy, Shawn] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Hildebrandt, Friedhelm] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Utrecht University; Utrecht University Medical Center; Baylor College of Medicine; Baylor College of Medicine; University of California System; University of California San Diego; University of California System; University of California San Diego; Masaryk University Brno; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Radboud University Nijmegen; Radboud University Nijmegen; Sanofi-Aventis; Genzyme Corporation; University of Freiburg; Newcastle University - UK; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; Hebrew University of Jerusalem; Harvard University; Massachusetts General Hospital; Harvard University; MetroHealth System; Case Western Reserve University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; McGill University; Istanbul University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Howard Hughes Medical Institute; University of California System; University of California San Diego; Indiana University System; Indiana University-Purdue University Indianapolis; James Whitcomb Riley Hospital Children; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Duke University; Hannover Medical School; King Khaled Eye Specialist Hospital; University of Munster; University of California System; University of California Irvine; Saint James's University Hospital; University of Leeds; Rockefeller University; University of Southern Denmark; HudsonAlpha Institute for Biotechnology; Howard Hughes Medical Institute	Hildebrandt, F (corresponding author), Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA.	fhilde@umich.edu	Letteboer, Stef JF/P-8272-2015; Katsanis, Nicholas/E-1837-2012; Pape, Lars/AAF-1477-2021; Airik, Rannar/AAS-7810-2021; Lindstrand, Anna/AAT-9969-2021; Ganji, Ranjani/AGD-5702-2022; Bryja, Vít?zslav/H-1925-2014; van Reeuwijk, Jeroen/P-8665-2015; Bryja, Vítězslav/P-4217-2019; Lindstrand, Anna/J-3566-2012; ANTIGNAC, Corinne/H-8945-2017; Gee, Heon Yung/K-7781-2019; Andersen, Jens S/L-2100-2015; Oud, Machteld/P-6939-2015; Schermer, Bernhard/E-9972-2014; Oud, Machteld/S-9062-2019; NAYIR, AHMET NEVZAT/A-9276-2019; Saunier, Sophie/G-6044-2015; Benzing, Thomas/X-5476-2019; Liebau, Max Christoph/K-3470-2019; Koenekoop, Robert/AAT-6676-2021; Roepman, Ronald/B-1339-2014; arts, heleen/ACL-6040-2022; Slaats, Gisela/HDO-1608-2022; Janssen, S./F-2917-2016; Sayer, John A./AAN-2729-2020	Pape, Lars/0000-0002-3635-6418; Airik, Rannar/0000-0002-7055-6325; Lindstrand, Anna/0000-0003-0806-5602; Bryja, Vít?zslav/0000-0002-9136-5085; van Reeuwijk, Jeroen/0000-0002-0658-4399; Bryja, Vítězslav/0000-0002-9136-5085; Lindstrand, Anna/0000-0003-0806-5602; ANTIGNAC, Corinne/0000-0002-9934-4940; Gee, Heon Yung/0000-0002-8741-6177; Andersen, Jens S/0000-0002-6091-140X; Oud, Machteld/0000-0003-4864-9346; Schermer, Bernhard/0000-0002-5194-9000; Saunier, Sophie/0000-0002-1069-0047; Liebau, Max Christoph/0000-0003-0494-9080; Roepman, Ronald/0000-0002-5178-8163; Slaats, Gisela/0000-0002-4567-0134; Janssen, S./0000-0001-8470-3050; Sayer, John A./0000-0003-1881-3782; Hamilton, Bruce/0000-0001-5599-9139; Omran, Heymut/0000-0003-0282-6765; Levy, Shawn/0000-0002-1369-5740; Golzio, Christelle/0000-0002-4420-3921; Attanasio, Massimo/0000-0002-1278-3650; Smogorzewska, Agata/0000-0001-6285-1562; Katsanis, Nicholas/0000-0002-2480-0171; Giles, Rachel/0000-0001-9133-2008; Johnson, Colin/0000-0002-2979-8234; Arts, Heleen/0000-0002-9860-3744; Otto, Edgar/0000-0002-2387-9973; Sekiguchi, JoAnn/0000-0002-7178-4258; Saunders, Rudel/0000-0001-6042-556X; Dollfus, Helene/0000-0002-2249-895X	NIH [DK068306, DK090917, NS054871, NS060109, HD042601, DK075972, DK072301, DK091405, F32EY19430]; March of Dimes Foundation; Center for Organogenesis of the University of Michigan; Netherlands Organization for Scientific Research [NWO Vidi-91786396, NWO Vidi-917.66.354]; Avenir-INSERM program; Agence Nationale pour la Recherche; Union Nationale pour les Aveugles et Deficients Visuels; RETINA France; Programme Hospitalier de Recherche National; Association Bardet-Biedl, France; European Community [241955, SYSCILIA]; Dutch Kidney Foundation [KJPB09.009, IP11.58]; Retina Research Foundation; National Eye Institute [R01EY018571]; DFG [SCHE1562, SFB832, SFB829, SFB592]; FFB-Canada; CIHR; FRSQ; Reseau Vision; Lundbeck Foundation; Ministry of Education, Youth and Sports of the Czech Republic [MSM0021622430]; Czech Science Foundation [204/09/H058, 204/09/0498]; EMBO Installation Grant; Brno PhD Talent of South Moravian Center for International Mobility; Burroughs Wellcome Fund Career Award for Medical Scientists; Doris Duke Charitable Foundation; MRC [G0700073] Funding Source: UKRI; Medical Research Council [G0700073] Funding Source: researchfish; The Sir Jules Thorn Charitable Trust [09JTA] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042601] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026550] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY018571, F32EY019430] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095545] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068306, R00DK091405, RC4DK090917, R01DK076683, R01DK072301, P30DK020572, R01DK075972, R01DK088767, K99DK091405, P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054871, R01NS060109] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Foundation(March of Dimes); Center for Organogenesis of the University of Michigan; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Avenir-INSERM program; Agence Nationale pour la Recherche(French National Research Agency (ANR)); Union Nationale pour les Aveugles et Deficients Visuels; RETINA France; Programme Hospitalier de Recherche National; Association Bardet-Biedl, France; European Community(European Commission); Dutch Kidney Foundation; Retina Research Foundation; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); DFG(German Research Foundation (DFG)); FFB-Canada; CIHR(Canadian Institutes of Health Research (CIHR)); FRSQ(Fonds de la Recherche en Sante du Quebec); Reseau Vision; Lundbeck Foundation(Lundbeckfonden); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic); EMBO Installation Grant; Brno PhD Talent of South Moravian Center for International Mobility; Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Sir Jules Thorn Charitable Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to the study individuals for their contributions. This research was supported by grants from the NIH to F. H. (DK068306, DK090917), B. A. H (NS054871, NS060109), N.K. (HD042601, DK075972, DK072301), and W.Z. (DK091405); the March of Dimes Foundation and the Center for Organogenesis of the University of Michigan to F. H.; the Netherlands Organization for Scientific Research to R. R. (NWO Vidi-91786396) and R. H. G. (NWO Vidi-917.66.354), the Avenir-INSERM program, the Agence Nationale pour la Recherche, the Union Nationale pour les Aveugles et Deficients Visuels, RETINA France, Programme Hospitalier de Recherche National 2007, and the Association Bardet-Biedl, France to H. D. and C. S.; the European Community's Seventh Framework Programme FP7/2009 under grant agreement no: 241955, SYSCILIA (to R. H. G., G. G. S., N.K., R. R., H.O., C.A.J. and G. W.); the Dutch Kidney Foundation (KJPB09.009 and IP11.58 to H. H. A); the Retina Research Foundation and the National Eye Institute (R01EY018571) to R.C.; the NIH to H. W. (F32EY19430); and the DFG (SCHE1562 and SFB832 to B. S.; SFB829 to T. B.; SFB592 to H.O.). R. K. K. is supported by FFB-Canada, CIHR, FRSQ, and Reseau Vision. J.S.A. is supported by the Lundbeck Foundation. V. B. is supported by MSM0021622430 (Ministry of Education, Youth and Sports of the Czech Republic), 204/09/H058, and 204/09/0498 (Czech Science Foundation) and EMBO Installation Grant; I. C. is supported by the programme, Brno PhD Talent of South Moravian Center for International Mobility. S. S. is a laureate of the "Equipe FRM" (DEQ20071210558) and the Agence National de la Recherche (R09087KS, R11012KK). W.Z. is a Carl. W. Gottschalk research scholar of the American Society of Nephrology. J.A.S. is a GlaxoSmithKline clinician scientist. A. S. is supported by the Burroughs Wellcome Fund Career Award for Medical Scientists and the Doris Duke Charitable Foundation Clinical Scientist Development Awards and is a Rita Allen Foundation and an Irma T. Hirschl scholar. F. H. is an Investigator of the Howard Hughes Medical Institute, a Frederick G. L. Huetwell Professor, and a Doris Duke Distinguished Clinical Scientist.	Alcaraz WA, 2006, P NATL ACAD SCI USA, V103, P19424, DOI 10.1073/pnas.0609184103; Alcaraz WA, 2011, HUM MOL GENET, V20, P3822, DOI 10.1093/hmg/ddr300; Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Attanasio M, 2007, NAT GENET, V39, P1018, DOI 10.1038/ng2072; Blachon S, 2008, GENETICS, V180, P2081, DOI 10.1534/genetics.108.095141; Bryja V, 2007, J CELL SCI, V120, P586, DOI 10.1242/jcs.03368; Bukanov NO, 2006, NATURE, V444, P949, DOI 10.1038/nature05348; Chaki M, 2011, KIDNEY INT, V80, P1239, DOI 10.1038/ki.2011.284; Cheng LE, 2007, DEV BIOL, V307, P43, DOI 10.1016/j.ydbio.2007.04.005; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; DOXSEY SJ, 1994, CELL, V76, P639, DOI 10.1016/0092-8674(94)90504-5; Edmond V, 2011, EMBO J, V30, P510, DOI 10.1038/emboj.2010.333; Elias E, 2003, EXP CELL RES, V291, P176, DOI 10.1016/S0014-4827(03)00377-X; Fischer E, 2006, NAT GENET, V38, P21, DOI 10.1038/ng1701; Germino GG, 2005, NAT GENET, V37, P455, DOI 10.1038/ng0505-455; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; Griffith E, 2008, NAT GENET, V40, P232, DOI 10.1038/ng.2007.80; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Hildebrandt F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000353; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Janderovd-Rossmeislova L, 2007, J STRUCT BIOL, V159, P56, DOI 10.1016/j.jsb.2007.02.008; Kalay E, 2011, NAT GENET, V43, P23, DOI 10.1038/ng.725; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Ku MC, 2003, BIOCHEM BIOPH RES CO, V311, P702, DOI 10.1016/j.bbrc.2003.10.053; Liu Q, 2007, MOL CELL PROTEOMICS, V6, P1299, DOI 10.1074/mcp.M700054-MCP200; Maude SL, 2005, CANCER RES, V65, P780; Murga M, 2009, NAT GENET, V41, P891, DOI 10.1038/ng.420; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Otto EA, 2011, J MED GENET, V48, P105, DOI 10.1136/jmg.2010.082552; Otto EA, 2010, NAT GENET, V42, P840, DOI 10.1038/ng.662; Pan YR, 2009, CELL CYCLE, V8, P655, DOI 10.4161/cc.8.4.7844; Piontek K, 2007, NAT MED, V13, P1490, DOI 10.1038/nm1675; Rauch A, 2008, SCIENCE, V319, P816, DOI 10.1126/science.1151174; Reinhardt HC, 2011, CELL CYCLE, V10, P23, DOI 10.4161/cc.10.1.14351; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Schafer T, 2008, HUM MOL GENET, V17, P3655, DOI 10.1093/hmg/ddn260; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Sivasubramaniam S, 2008, GENE DEV, V22, P587, DOI 10.1101/gad.1627708; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Strauch K, 2000, AM J HUM GENET, V66, P1945, DOI 10.1086/302911; Szczerbal I, 2010, CHROMOSOME RES, V18, P887, DOI 10.1007/s10577-010-9176-1; Valente EM, 2006, NAT GENET, V38, P623, DOI 10.1038/ng1805; Xiao R, 2007, MOL CELL BIOL, V27, P5393, DOI 10.1128/MCB.00288-07; Yu J, 2009, DEVELOPMENT, V136, P161, DOI 10.1242/dev.022087	51	244	258	1	63	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 3	2012	150	3					533	548		10.1016/j.cell.2012.06.028	http://dx.doi.org/10.1016/j.cell.2012.06.028			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	985WO	22863007	Bronze, Green Accepted			2022-12-24	WOS:000307301400013
J	Thorogood, R; Davies, NB				Thorogood, Rose; Davies, Nicholas B.			Cuckoos Combat Socially Transmitted Defenses of Reed Warbler Hosts with a Plumage Polymorphism	SCIENCE			English	Article							NEST DEFENSE; COLOR POLYMORPHISM; MIMICRY; EVOLUTION; BIRDS; COMMUNICATION; PARASITISM; SELECTION; ECOLOGY; SIGNALS	In predator-prey and host-parasite interactions, an individual's ability to combat an opponent often improves with experience-for example, by learning to identify enemy signals. Although learning occurs through individual experience, individuals can also assess threats from social information. Such recognition could promote the evolution of polymorphisms if socially transmitted defenses depend on enemy morph frequency. This would allow rare variants to evade detection. Female brood parasitic common cuckoos, Cuculus canorus, are either gray or rufous. The gray morph is a Batesian mimic whose hawk-like appearance deters host attack. Hosts reject this disguise through social learning, increasing their own defenses when they witness neighbors mobbing a cuckoo. Our experiments reveal that social learning is specific to the cuckoo morph that neighbors mob. Therefore, while neighbors alert hosts to local cuckoo activity, frequency-dependent social information selects for a cuckoo plumage polymorphism to thwart host detection. Our results suggest that selection for mimicry and polymorphisms comes not only from personal experience but also from social learning.	[Thorogood, Rose; Davies, Nicholas B.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Cambridge	Thorogood, R (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	rt303@cam.ac.uk		Thorogood, Rose/0000-0001-5010-2177	Natural Environment Research Council; NERC [NE/H003444/1] Funding Source: UKRI; Natural Environment Research Council [NE/H003444/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank J. Davies for making the wooden models, illustrations, and help in the field; C. Lindstedt, J. Mappes, and attendees of the Coevolution Symposium at the University of Jyvaskyla (October 2011) for helpful discussion; R. Kilner, M. Stevens, H. Rowland, and three anonymous referees for constructive comments on the manuscript; the National Trust, C. Thorne, and the Wicken Fen Group for facilitating our work at Wicken Fen; Natural England for a license for experimental work at reed warbler nests; and the Natural Environment Research Council for funding. Both authors contributed equally to the work, and data for all analyses are included within the supplementary materials.	Bleay C, 2007, P ROY SOC B-BIOL SCI, V274, P2019, DOI 10.1098/rspb.2007.0361; Campobello D, 2011, BEHAV ECOL, V22, P422, DOI 10.1093/beheco/arq225; Campobello D, 2010, ETHOLOGY, V116, P498, DOI 10.1111/j.1439-0310.2010.01764.x; Chittka L, 2009, TRENDS ECOL EVOL, V24, P400, DOI 10.1016/j.tree.2009.02.010; Comeault AA, 2011, J EVOLUTION BIOL, V24, P1374, DOI 10.1111/j.1420-9101.2011.02258.x; Darst CR, 2006, NATURE, V440, P208, DOI 10.1038/nature04297; Davies NB, 2011, J ZOOL, V284, P1, DOI 10.1111/j.1469-7998.2011.00810.x; Davies NB, 2009, SCIENCE, V324, P1318, DOI 10.1126/science.1172227; Endler JA, 2004, AM NAT, V163, P532, DOI 10.1086/382662; Endler JA, 2009, AM NAT, V173, pE62, DOI 10.1086/596528; Galeotti P, 2003, J EVOLUTION BIOL, V16, P635, DOI 10.1046/j.1420-9101.2003.00569.x; Honza M, 2006, J ORNITHOL, V147, P629, DOI 10.1007/s10336-006-0088-y; Kendal RL, 2005, ADV STUD BEHAV, V35, P333, DOI 10.1016/S0065-3454(05)35008-X; Mallet J, 1999, ANNU REV ECOL SYST, V30, P201, DOI 10.1146/annurev.ecolsys.30.1.201; Olendorf R, 2006, NATURE, V441, P633, DOI 10.1038/nature04646; PAYNE RB, 1967, AM NAT, V101, P363, DOI 10.1086/282504; Pfennig D, 2012, CURR ZOOL, V58, P604, DOI 10.1093/czoolo/58.4.604; Plotnick RE, 2010, PALEOBIOLOGY, V36, P303, DOI 10.1666/08062.1; Roulin A, 2004, BIOL REV, V79, P815, DOI 10.1017/S1464793104006487; Ruxton GD, 2004, AVOIDING ATTACK EVOL; Speed MP, 1999, BIOL J LINN SOC, V67, P281, DOI 10.1006/bijl.1998.0310; Stoddard MC, 2012, CURR ZOOL, V58, P630, DOI 10.1093/czoolo/58.4.630; Voipio P., 1953, ORNIS FENNICA, V30, P99; Welbergen JA, 2011, BEHAV ECOL, V22, P574, DOI 10.1093/beheco/arr008; Welbergen JA, 2009, CURR BIOL, V19, P235, DOI 10.1016/j.cub.2008.12.041; Wiley RH, 2006, ADV STUD BEHAV, V36, P217, DOI 10.1016/S0065-3454(06)36005-6	26	68	70	1	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2012	337	6094					578	580		10.1126/science.1220759	http://dx.doi.org/10.1126/science.1220759			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982PU	22859487				2022-12-24	WOS:000307058700044
J	Tseng, VL; Yu, F; Lum, F; Coleman, AL				Tseng, Victoria L.; Yu, Fei; Lum, Flora; Coleman, Anne L.			Risk of Fractures Following Cataract Surgery in Medicare Beneficiaries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED CONTROLLED-TRIAL; HIP FRACTURE; HEALTH-STATUS; OLDER-ADULTS; 2ND EYE; WOMEN; FALLS; VISION	Context Visual impairment is a known risk factor for fractures. Little is known about the association of cataract surgery with fracture risk. Objective To determine the association of cataract surgery with subsequent fracture risk in US Medicare beneficiaries with a diagnosis of cataract. Design, Setting, and Participants Retrospective study of 1-year fracture incidence in a 5% random sample of Medicare Part B beneficiaries with cataract who received and did not receive cataract surgery from 2002 through 2009. Main Outcome Measures One-year incidence of hip fractures. Analyses were adjusted for age; sex; race/ethnicity; US region of residence; systemic comorbidities, including Charlson Comorbidity Index (CCI) score; ocular comorbidities; cataract severity; and presence of physically limiting conditions. Adjusted odds ratios (ORs) of hip fractures were calculated using logistic regression modeling. Results There were 1 113 640 US Medicare beneficiaries 65 years and older with a diagnosis of cataract between 2002 and 2009 in the 5% random sample; of these patients, 410 809 (36.9%) received cataract surgery during the study period. There were 13 976 patients (1.3%) who sustained a hip fracture during the study period. The most common fracture-related comorbidity was osteoporosis (n = 134 335; 12.1%). The most common ocular comorbidity was glaucoma (n = 212 382; 19.1%). Compared with 1-year hip fracture incidence in patients with cataract who did not have cataract surgery, adjusted OR of hip fracture within 1 year after cataract surgery was 0.84 (95% CI, 0.81-0.87) with an absolute risk difference of 0.20%. Compared with matched subgroups of patients who did not receive cataract surgery, patient subgroups that experienced lower odds of hip fracture after cataract surgery included patients with severe cataract, patients most likely to receive cataract surgery based on propensity score, patients 75 years and older, and patients with a CCI score of 3 or greater. Conclusion In a cohort of US Medicare beneficiaries aged 65 years and older with a diagnosis of cataract, patients who had cataract surgery had lower odds of hip fracture within 1 year after surgery compared with patients who had not undergone cataract surgery. JAMA. 2012;308(5):493-501 www.jama.com	[Yu, Fei; Coleman, Anne L.] Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Ctr Eye Epidemiol, Los Angeles, CA 90095 USA; [Tseng, Victoria L.] Brown Univ, Warren Alpert Med Sch, Div Ophthalmol, Providence, RI 02912 USA; [Yu, Fei] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Biostat, Los Angeles, CA USA; [Coleman, Anne L.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA USA; [Lum, Flora; Coleman, Anne L.] Amer Acad Ophthalmol, H Dunbar Hoskins Jr MD Ctr Qual Eye Care, San Francisco, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Brown University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Coleman, AL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Ctr Eye Epidemiol, 100 Stein Plaza 2-118, Los Angeles, CA 90095 USA.	colemana@ucla.edu			Center for Eye Epidemiology, Jules Stein Eye Institute	Center for Eye Epidemiology, Jules Stein Eye Institute	This study was supported by the Center for Eye Epidemiology, Jules Stein Eye Institute.	Anand V, 2003, INVEST OPHTH VIS SCI, V44, P4670, DOI 10.1167/iovs.03-0455; [Anonymous], 2009, DAT COMP 2010 TABL 4; [Anonymous], 2009, NCEST200901 US CENS; Beebe M, 2007, CURRENT PROCEDURAL T, P282; Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; Bliuc D, 2009, JAMA-J AM MED ASSOC, V301, P513, DOI 10.1001/jama.2009.50; Brannan S, 2003, BRIT J OPHTHALMOL, V87, P560, DOI 10.1136/bjo.87.5.560; Busbee BG, 2003, OPHTHALMOLOGY, V110, P2310, DOI 10.1016/S0161-6420(03)00796-6; Busbee BG, 2002, OPHTHALMOLOGY, V109, P606, DOI 10.1016/S0161-6420(01)00971-X; Centers for Medicare & Medicaid Services, AR YOU HOSP INP OUTP; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Coleman AL, 2009, J AM GERIATR SOC, V57, P1825, DOI 10.1111/j.1532-5415.2009.02432.x; Cox A, 2005, EYE, V19, P652, DOI 10.1038/sj.eye.6701610; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; DargentMolina P, 1996, LANCET, V348, P145, DOI 10.1016/S0140-6736(96)01440-7; Desapriya E, 2010, J CATARACT REFR SURG, V36, P13, DOI 10.1016/j.jcrs.2009.07.032; Ensrud KE, 1997, AM J MED, V103, P274, DOI 10.1016/S0002-9343(97)00025-9; FELSON DT, 1989, J AM GERIATR SOC, V37, P495, DOI 10.1111/j.1532-5415.1989.tb05678.x; Foss AJE, 2006, AGE AGEING, V35, P66, DOI 10.1093/ageing/afj005; GRISSO JA, 1991, NEW ENGL J MED, V324, P1326, DOI 10.1056/NEJM199105093241905; Harwood RH, 2005, BRIT J OPHTHALMOL, V89, P53, DOI 10.1136/bjo.2004.049478; Hodge W, 2007, CAN MED ASSOC J, V176, P1285, DOI 10.1503/cmaj.060962; JAVITT JC, 1992, OPHTHALMOLOGY, V99, P1487, DOI 10.1016/s0161-6420(92)31775-0; McGwin G, 2006, J AM GERIATR SOC, V54, P1089, DOI 10.1111/j.1532-5415.2006.00770.x; SACKS H, 1982, AM J MED, V72, P233, DOI 10.1016/0002-9343(82)90815-4; Stevens JA, 2006, INJURY PREV, V12, P290, DOI 10.1136/ip.2005.011015; Waldo DR, HLTH CARE FINANCING	27	137	139	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2012	308	5					493	501		10.1001/jama.2012.9014	http://dx.doi.org/10.1001/jama.2012.9014			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	981DQ	22851116				2022-12-24	WOS:000306947400027
J	Silverman, EK				Silverman, Edwin K.			PERSPECTIVE How can genetics help?	NATURE			English	Editorial Material							OBSTRUCTIVE PULMONARY-DISEASE; GENOME		[Silverman, Edwin K.] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Silverman, Edwin K.] Harvard Univ, Sch Med, Cambridge, MA 02138 USA	Harvard University; Brigham & Women's Hospital; Harvard University	Silverman, EK (corresponding author), Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.	ed.silverman@channing.harvard.edu						Cho MH, 2012, HUM MOL GENET, V21, P947, DOI 10.1093/hmg/ddr524; Cho MH, 2010, NAT GENET, V42, P200, DOI 10.1038/ng.535; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; Wan ES, 2012, HUM MOL GENET, V21, P3073, DOI 10.1093/hmg/dds135; Wilk JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000429; Zhou XB, 2012, HUM MOL GENET, V21, P1325, DOI 10.1093/hmg/ddr569	8	4	4	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2012	489	7417					S7	S7		10.1038/489S7a	http://dx.doi.org/10.1038/489S7a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011LT	23013715				2022-12-24	WOS:000309167100004
J	Kamerow, D				Kamerow, Douglas			YANKEE DOODLING The key to longevity	BRITISH MEDICAL JOURNAL			English	Editorial Material									RTI Int, Res Triangle Pk, NC 27709 USA	Research Triangle Institute	Kamerow, D (corresponding author), RTI Int, Res Triangle Pk, NC 27709 USA.	dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957				Black D, 1982, INEQUALITIES HLTH BL; Kamerow D, 2007, BRIT MED J, V334, P126, DOI 10.1136/bmj.39097.516609.59; Link BG, 2005, POLICY CHALLENGES MO, P71; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Olshansky SJ, 2012, HEALTH AFFAIR, V31, P1803, DOI 10.1377/hlthaff.2011.0746; Tavernise Sabrina, 2012, NEW YORK TIMES  0112, pA1	6	0	0	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 25	2012	345								e6456	10.1136/bmj.e6456	http://dx.doi.org/10.1136/bmj.e6456			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	014ON	23014907				2022-12-24	WOS:000309385500013
J	Wagschal, A; Rousset, E; Basavarajaiah, P; Contreras, X; Harwig, A; Laurent-Chabalier, S; Nakamura, M; Chen, X; Zhang, K; Meziane, O; Boyer, F; Parrinello, H; Berkhout, B; Terzian, C; Benkirane, M; Kiernan, R				Wagschal, Alexandre; Rousset, Emilie; Basavarajaiah, Poornima; Contreras, Xavier; Harwig, Alex; Laurent-Chabalier, Sabine; Nakamura, Mirai; Chen, Xin; Zhang, Ke; Meziane, Oussama; Boyer, Frederic; Parrinello, Hugues; Berkhout, Ben; Terzian, Christophe; Benkirane, Monsef; Kiernan, Rosemary			Microprocessor, Setx, Xrn2, and Rrp6 Co-operate to Induce Premature Termination of Transcription by RNAPII	CELL			English	Article							POLYMERASE-II; PAUSE SITES; HIV-1; GENE; COMPLEX; INTERFERENCE; RECRUITMENT; PROTEASOME; INITIATION; DOMAIN	Transcription elongation is increasingly recognized as an important mechanism of gene regulation. Here, we show that microprocessor controls gene expression in an RNAi-independent manner. Microprocessor orchestrates the recruitment of termination factors Setx and Xrn2, and the 30-50 exoribonuclease, Rrp6, to initiate RNAPII pausing and premature termination at the HIV-1 promoter through cleavage of the stem-loop RNA, TAR. Rrp6 further processes the cleavage product, which generates a small RNA that is required to mediate potent transcriptional repression and chromatin remodeling at the HIV-1 promoter. Using chromatin immunoprecipitation coupled to high-throughput sequencing (ChIP-seq), we identified cellular gene targets whose transcription is modulated by microprocessor. Our study reveals RNAPII pausing and premature termination mediated by the co-operative activity of ribonucleases, Drosha/Dgcr8, Xrn2, and Rrp6, as a regulatory mechanism of RNAPII-dependent transcription elongation.	[Wagschal, Alexandre; Laurent-Chabalier, Sabine; Zhang, Ke; Meziane, Oussama; Benkirane, Monsef; Kiernan, Rosemary] CNRS UPR1142, Inst Genet Humaine, Mol Virol Lab, F-34396 Montpellier, France; [Harwig, Alex; Berkhout, Ben] Univ Amsterdam, Lab Expt Virol, NL-1105 AZ Amsterdam, Netherlands; [Boyer, Frederic; Terzian, Christophe] Univ Lyon 1, INRA, EPHE, ENVL,Retrovirus & Pathol Comparee, F-69366 Lyon 07, France; [Parrinello, Hugues] MGX Montpellier GenomiX, F-34396 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; University of Amsterdam; INRAE; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite Claude Bernard Lyon 1; VetAgro Sup; Universite de Montpellier	Kiernan, R (corresponding author), CNRS UPR1142, Inst Genet Humaine, Mol Virol Lab, F-34396 Montpellier, France.	rosemary.kiernan@igh.cnrs.fr	contreras, xavier/ABA-3533-2020; Boyer, Frédéric/Y-2184-2018; Kiernan, Rosemary/GXV-8695-2022; Harwig, Alex/AAG-9952-2020; Boyer, Frédéric/AAR-8176-2020	contreras, xavier/0000-0003-0748-6923; Boyer, Frédéric/0000-0003-0021-9590; Boyer, Frédéric/0000-0003-0021-9590; Harwig, Alex/0000-0002-1117-9216; Kiernan, Rosemary/0000-0001-6645-0686	ERC [250333]; ANR-BLAN [0040]; Sidaction; ANRS; FRM "equipe labellisee''; ANR; ERC; CNRS; FRM; RTRS grand Sud; The Netherlands Organization for Scientific Research (NWO-CW); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER	ERC(European Research Council (ERC)European Commission); ANR-BLAN(French National Research Agency (ANR)); Sidaction; ANRS(ANRSFrench National Research Agency (ANR)); FRM "equipe labellisee''; ANR(French National Research Agency (ANR)); ERC(European Research Council (ERC)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); FRM(Fondation pour la Recherche Medicale); RTRS grand Sud; The Netherlands Organization for Scientific Research (NWO-CW)(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of the Molecular Virology and Gene Regulation labs for critical reading of the manuscript, N. Kim for Drosha WT and mutant plasmids, and S. Emiliani for HeLa-LTR-luc. ChIP-seq experiments were performed using MGX-Montpellier facilities. This work was supported by grants from the ERC (250333), ANR-BLAN-0040, Sidaction, ANRS, and FRM "equipe labellisee'' to M.B. and ANRS and Sidaction to R.K. A.W. was supported by ANR and ERC; E.R. and M.N. by Sidaction; P.B. by ANRS; S.L.-C. by ERC; X. Chen by CNRS and FRM; K.Z. by CNRS; O.M. by RTRS grand Sud; and B.B. by The Netherlands Organization for Scientific Research (NWO-CW, Top grant).	Abruzzi KC, 2004, EMBO J, V23, P2620, DOI 10.1038/sj.emboj.7600261; Ballarino M, 2009, MOL CELL BIOL, V29, P5632, DOI 10.1128/MCB.00664-09; Benhamed M, 2012, NAT CELL BIOL, V14, P266, DOI 10.1038/ncb2443; Bennasser Y, 2006, J BIOL CHEM, V281, P27674, DOI 10.1074/jbc.C600072200; Bisgrove Dwayne, 2005, Expert Rev Anti Infect Ther, V3, P805, DOI 10.1586/14787210.3.5.805; Brannan K, 2012, MOL CELL, V46, P311, DOI 10.1016/j.molcel.2012.03.006; Bres V, 2008, CURR OPIN CELL BIOL, V20, P334, DOI 10.1016/j.ceb.2008.04.008; Cernilogar FM, 2011, NATURE, V480, P391, DOI 10.1038/nature10492; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; de Parseval N, 2003, J VIROL, V77, P10414, DOI 10.1128/JVI.77.19.10414-10422.2003; de Parseval N, 2001, VIROLOGY, V279, P558, DOI 10.1006/viro.2000.0737; du Chene I, 2007, EMBO J, V26, P424, DOI 10.1038/sj.emboj.7601517; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; Gromak N, 2006, MOL CELL BIOL, V26, P3986, DOI 10.1128/MCB.26.10.3986-3996.2006; Guang SH, 2010, NATURE, V465, P1097, DOI 10.1038/nature09095; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han J, 2009, CELL, V136, P75, DOI 10.1016/j.cell.2008.10.053; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Kawauchi J, 2008, GENE DEV, V22, P1082, DOI 10.1101/gad.463408; Kiernan RE, 2001, MOL CELL BIOL, V21, P7956, DOI 10.1128/MCB.21.23.7956-7970.2001; Kim H, 2010, NAT STRUCT MOL BIOL, V17, P1279, DOI 10.1038/nsmb.1913; Kim KY, 2011, CELL, V144, P745, DOI 10.1016/j.cell.2011.01.034; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Klase Z, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-63; Lassot I, 2007, MOL CELL, V25, P369, DOI 10.1016/j.molcel.2006.12.020; Moser MJ, 1997, NUCLEIC ACIDS RES, V25, P5110, DOI 10.1093/nar/25.24.5110; Nakamura M, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-13; Nechaev Sergei, 2011, Biochim Biophys Acta, V1809, P34, DOI 10.1016/j.bbagrm.2010.11.001; Newman MA, 2010, GENE DEV, V24, P1086, DOI 10.1101/gad.1919710; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Schmitz KM, 2010, GENE DEV, V24, P2264, DOI 10.1101/gad.590910; Schopman NCT, 2012, NUCLEIC ACIDS RES, V40, P414, DOI 10.1093/nar/gkr719; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Seitz H, 2006, CELL, V125, P827, DOI 10.1016/j.cell.2006.05.018; Siliciano RF, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a007096; Skourti-Stathaki K, 2011, MOL CELL, V42, P794, DOI 10.1016/j.molcel.2011.04.026; Steinmetz EJ, 2006, MOL CELL, V24, P735, DOI 10.1016/j.molcel.2006.10.023; Treand C, 2006, EMBO J, V25, P1690, DOI 10.1038/sj.emboj.7601074; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Ursic D, 1997, NUCLEIC ACIDS RES, V25, P4778, DOI 10.1093/nar/25.23.4778; Wagschal Alexandre, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.prot4767; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	45	126	126	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 14	2012	150	6					1147	1157		10.1016/j.cell.2012.08.004	http://dx.doi.org/10.1016/j.cell.2012.08.004			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22980978	Bronze, Green Accepted			2022-12-24	WOS:000308928100009
J	McCartney, M				McCartney, Margaret			Statins for all?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Cohen JD, 2012, J CLIN LIPIDOL, V6, P208, DOI 10.1016/j.jacl.2012.03.003; Collins N, DAILY TELEGRAPH; Collins R, TOP NEWS        0829; European Society of Cardiology, CAS STAT WID POP; Gaskell S, WALES ONLINE    0830; Hippisley-Cox J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2197; Hope J, ADELAIDE NOW    0829; Hope J, DAILY MAIL; Lefever R, DAILY MAIL; MRC/BHF Heart Protection Study Collaborative Group, 2009, BMC Clin Pharmacol, V9, P6, DOI 10.1186/1472-6904-9-6; Rosenbaum D, 2013, NUTR METAB CARDIOVAS, V23, P871, DOI 10.1016/j.numecd.2012.04.012; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Taylor F, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub4	13	7	7	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 12	2012	345								e6044	10.1136/bmj.e6044	http://dx.doi.org/10.1136/bmj.e6044			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007BP	22977108				2022-12-24	WOS:000308864100010
J	Prasad, KVSK; Song, BH; Olson-Manning, C; Anderson, JT; Lee, CR; Schranz, ME; Windsor, AJ; Clauss, MJ; Manzaneda, AJ; Naqvi, I; Reichelt, M; Gershenzon, J; Rupasinghe, SG; Schuler, MA; Mitchell-Olds, T				Prasad, Kasavajhala V. S. K.; Song, Bao-Hua; Olson-Manning, Carrie; Anderson, Jill T.; Lee, Cheng-Ruei; Schranz, M. Eric; Windsor, Aaron J.; Clauss, Maria J.; Manzaneda, Antonio J.; Naqvi, Ibtehaj; Reichelt, Michael; Gershenzon, Jonathan; Rupasinghe, Sanjeewa G.; Schuler, Mary A.; Mitchell-Olds, Thomas			A Gain-of-Function Polymorphism Controlling Complex Traits and Fitness in Nature	SCIENCE			English	Article							BOECHERA-STRICTA; BIOSYNTHESIS; CYTOCHROME-P450; CYP79F1; CYP83B1	Identification of the causal genes that control complex trait variation remains challenging, limiting our appreciation of the evolutionary processes that influence polymorphisms in nature. We cloned a quantitative trait locus that controls plant defensive chemistry, damage by insect herbivores, survival, and reproduction in the natural environments where this polymorphism evolved. These ecological effects are driven by duplications in the BCMA (branched-chain methionine allocation) loci controlling this variation and by two selectively favored amino acid changes in the glucosinolate-biosynthetic cytochrome P450 proteins that they encode. These changes cause a gain of novel enzyme function, modulated by allelic differences in catalytic rate and gene copy number. Ecological interactions in diverse environments likely contribute to the widespread polymorphism of this biochemical function.	[Prasad, Kasavajhala V. S. K.; Song, Bao-Hua; Olson-Manning, Carrie; Anderson, Jill T.; Lee, Cheng-Ruei; Schranz, M. Eric; Windsor, Aaron J.; Manzaneda, Antonio J.; Naqvi, Ibtehaj; Mitchell-Olds, Thomas] Duke Univ, Dept Biol, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Clauss, Maria J.; Reichelt, Michael; Gershenzon, Jonathan] Max Planck Inst Chem Ecol, D-07745 Jena, Germany; [Rupasinghe, Sanjeewa G.; Schuler, Mary A.] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA	Duke University; Max Planck Society; University of Illinois System; University of Illinois Urbana-Champaign	Mitchell-Olds, T (corresponding author), Duke Univ, Dept Biol, Inst Genome Sci & Policy, Durham, NC 27708 USA.	tmo1@duke.edu	Manzaneda, Antonio/AAG-1776-2019; Mitchell-Olds, Thomas/K-8121-2012; Gershenzon, Jonathan/K-1331-2013; Schranz, M. Eric/AAB-7601-2022; Schranz, Michael/D-7155-2017; Olson-Manning, Carrie/K-2724-2012; Song, Bao-Hua/B-4867-2017	Mitchell-Olds, Thomas/0000-0003-3439-9921; Gershenzon, Jonathan/0000-0002-1812-1551; Schranz, M. Eric/0000-0001-6777-6565; Schranz, Michael/0000-0001-6777-6565; Anderson, Jill/0000-0002-3253-8142; Lee, Cheng-Ruei/0000-0002-1913-9964; Manzaneda Avila, Antonio Jose/0000-0001-9384-7910; Olson-Manning, Carrie/0000-0001-8054-3889; Song, Bao-Hua/0000-0003-3537-7783	Heald family; NIH [R01-GM086496, R01-GM079530]; NSF [EF-0723447, 1011167, 1110445]; Netherlands Organization for Scientific Research (NWO); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086496, R01GM079530] Funding Source: NIH RePORTER; Division Of Environmental Biology [1011167] Funding Source: National Science Foundation	Heald family; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank R. Colautti, K. Donohue, M. Feder, T. Pendergast, M. Rausher, C. Rushworth, A. Shumate, M. Wagner, J. Willis, and two anonymous reviewers for helpful comments. K. Springer, E. Ballweg, M. Cameron, K. Chu, S. Hurst, V. Cousins, K. Dales, R. Doll, J. Lutkenhaus, M. Mitchell-Olds, S. Mitchell-Olds, E. Raskin, J. Rivera, L. Saucier, M. Wagner, and T. Weiss-Lehman helped in lab and field. N. Wicks and Bitterroot National Forest allowed us to work on their property. We thank the Heald family for support and hospitality. Supported by NIH grants R01-GM086496 (T.M.-O.) and R01-GM079530 (M. A. S.), NSF grant EF-0723447 (T.M.-O.); NSF dissertation grants 1011167 (C.O.-M.) and 1110445 (C.-R.L.); and a Netherlands Organization for Scientific Research (NWO) Ecogenomics grant (M. E. S.). Data in the supplementary materials are also available as GenBank accession nos. JX185680, JX185681, and BCMA JQ337904 to BCMA JQ337909. Data are deposited in the Dryad Repository: http://dx.doi.org/10.5061/dryad.kc6m8.	Bak S, 2001, PLANT CELL, V13, P101, DOI 10.1105/tpc.13.1.101; Barrett RDH, 2011, NAT REV GENET, V12, P767, DOI 10.1038/nrg3015; Brader G, 2006, PLANT J, V46, P758, DOI 10.1111/j.1365-313X.2006.02743.x; Bressan M, 2009, ISME J, V3, P1243, DOI 10.1038/ismej.2009.68; Brunelle A, 2005, QUATERNARY SCI REV, V24, P2281, DOI 10.1016/j.quascirev.2004.11.010; Chen SX, 2003, PLANT J, V33, P923, DOI 10.1046/j.1365-313X.2003.01679.x; Futuyma DJ, 2009, P NATL ACAD SCI USA, V106, P18054, DOI 10.1073/pnas.0904106106; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hopkins RJ, 2009, ANNU REV ENTOMOL, V54, P57, DOI 10.1146/annurev.ento.54.110807.090623; Naur P, 2003, PLANT PHYSIOL, V133, P63, DOI 10.1104/pp.102.019240; Poulos T. L., 2005, CYTOCHROME P450 STRU, P217; Poulos T. L., 2007, UBIQUITOUS ROLES CYT, P57; Reintanz B, 2001, PLANT CELL, V13, P351, DOI 10.1105/tpc.13.2.351; Rogers RL, 2012, MOL BIOL EVOL, V29, P517, DOI 10.1093/molbev/msr184; Rushworth CA, 2011, MOL ECOL, V20, P4843, DOI 10.1111/j.1365-294X.2011.05340.x; Schranz ME, 2009, HEREDITY, V102, P465, DOI 10.1038/hdy.2009.12; Schranz ME, 2007, PLANT PHYSIOL, V144, P286, DOI 10.1104/pp.107.096685; Windsor AJ, 2005, PHYTOCHEMISTRY, V66, P1321, DOI 10.1016/j.phytochem.2005.04.016; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	19	123	123	2	155	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2012	337	6098					1081	1084		10.1126/science.1221636	http://dx.doi.org/10.1126/science.1221636			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22936775	Green Accepted			2022-12-24	WOS:000308125800043
J	Lum, L; Clevers, H				Lum, Lawrence; Clevers, Hans			The Unusual Case of Porcupine	SCIENCE			English	Editorial Material							INTESTINAL STEM-CELLS; LUNG ADENOCARCINOMA; WNT; MUTATIONS; METASTASIS; PATHWAYS; DISEASE; CANCER; GENES		[Lum, Lawrence] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Clevers, Hans] Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Clevers, Hans] Univ Med Ctr Utrecht, Utrecht, Netherlands	University of Texas System; University of Texas Southwestern Medical Center Dallas; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Lum, L (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	lawrence.lum@utsouthwestern.edu; h.clevers@hubrecht.eu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD061303] Funding Source: NIH RePORTER; NICHD NIH HHS [R21 HD061303] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		[Anonymous], 2012, EMBO C 30 YEARS WNT; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Durand A, 2012, P NATL ACAD SCI USA, V109, P8965, DOI 10.1073/pnas.1201652109; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Jacob LS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001225; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Kim TH, 2012, P NATL ACAD SCI USA, V109, P3932, DOI 10.1073/pnas.1113890109; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; VANDENHEUVEL M, 1993, EMBO J, V12, P5293, DOI 10.1002/j.1460-2075.1993.tb06225.x; Wu J, 2011, P NATL ACAD SCI USA, V108, P21188, DOI 10.1073/pnas.1118046108; Yu M, 2012, NATURE, V487, P510, DOI 10.1038/nature11217	18	53	53	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2012	337	6097					922	923		10.1126/science.1228179	http://dx.doi.org/10.1126/science.1228179			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992VI	22923569	Green Accepted			2022-12-24	WOS:000307807600032
J	Kahan, D				Kahan, Dan			Why we are poles apart on climate change	NATURE			English	Editorial Material									Yale Univ, Sch Law, New Haven, CT 06520 USA	Yale University	Kahan, D (corresponding author), Yale Univ, Sch Law, New Haven, CT 06520 USA.	dmkahan@gmail.com						Goebbert K, 2012, WEATHER CLIM SOC, V4, P132, DOI 10.1175/WCAS-D-11-00044.1; Kahan DM, 2012, NAT CLIM CHANGE, V2, P732, DOI 10.1038/NCLIMATE1547; Kahan DM, 2011, J RISK RES, V14, P147, DOI 10.1080/13669877.2010.511246	3	112	112	1	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2012	488	7411					255	255		10.1038/488255a	http://dx.doi.org/10.1038/488255a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	988OS	22895298	Bronze			2022-12-24	WOS:000307501000003
J	Leslie, T; Mikhail, A; Mayan, I; Anwar, M; Bakhtash, S; Nader, M; Chandler, C; Whitty, CJM; Rowland, M				Leslie, Toby; Mikhail, Amy; Mayan, Ismail; Anwar, Mohammed; Bakhtash, Sayed; Nader, Mohammed; Chandler, Clare; Whitty, Christopher J. M.; Rowland, Mark			Overdiagnosis and mistreatment of malaria among febrile patients at primary healthcare level in Afghanistan: observational study	BRITISH MEDICAL JOURNAL			English	Article							RAPID DIAGNOSTIC-TESTS; PLASMODIUM-VIVAX; CHILDREN; TANZANIA; AREA; TRANSMISSION; MISDIAGNOSIS; CHALLENGES; MICROSCOPY; MANAGEMENT	Objective To assess the accuracy of malaria diagnosis and treatment at primary level clinics in Afghanistan. Design Prospective observational study. Setting 22 clinics in two Afghan provinces, one in the north (adjoining Tajikistan) and one in the east (adjoining Pakistan); areas with seasonal transmission of Plasmodium vivax and Plasmodium falciparum. Participants 2357 patients of all ages enrolled if clinicians suspected malaria. Interventions Established (>5 years) microscopy (12 clinics in east Afghanistan), newly established microscopy (five clinics in north Afghanistan), and no laboratory (five clinics in north Afghanistan). All clinics used the national malaria treatment guidelines. Main outcome measures Proportion of patients positive and negative for malaria who received a malaria drug; sensitivity and specificity of clinic based diagnosis; prescriber's response to the result of the clinic slide; and proportion of patients positive and negative for malaria who were prescribed antibiotics. Outcomes were measured against a double read reference blood slide. Results In health centres using clinical diagnosis, although 413 of 414 patients were negative by the reference slide, 412 (99%) received a malaria drug and 47 (11%) received an antibiotic. In clinics using new microscopy, 37% (75/202) of patients who were negative by the reference slide received a malaria drug and 60% (103/202) received an antibiotic. In clinics using established microscopy, 50.8% (645/1269) of patients who were negative by the reference slide received a malaria drug and 27.0% (342/1269) received an antibiotic. Among the patients who tested positive for malaria, 94% (443/472) correctly received a malaria drug but only 1 of 6 cases of falciparum malaria was detected and appropriately treated. The specificity of established and new microscopy was 72.9% and 79.9%, respectively. In response to negative clinic slide results, malaria drugs were prescribed to 270/905 (28.8%) and 32/154 (21%) and antibiotics to 347/930 (37.3%) and 99/154 (64%) patients in established and new microscopy arms, respectively. Nurses were less likely to misprescribe than doctors. Conclusions Despite a much lower incidence of malaria in Afghanistan than in Africa, fever was substantially misdiagnosed as malaria in this south Asian setting. Inaccuracy was attributable to false positive laboratory diagnoses of malaria and the clinicians' disregard of negative slide results. Rare but potentially fatal cases of falciparum malaria were not detected, emphasising the potential role of rapid diagnostic tests. Microscopy increased the proportion of patients treated with antibiotics producing a trade-off between overtreatment with malaria drugs and probable overtreatment with antibiotics.	[Leslie, Toby; Mikhail, Amy; Chandler, Clare; Whitty, Christopher J. M.; Rowland, Mark] London Sch Hyg & Trop Med, London WC1E 7HT, England; [Leslie, Toby; Mikhail, Amy; Mayan, Ismail] Hlth Protect & Res Org, Kabul, Afghanistan; [Anwar, Mohammed; Nader, Mohammed] HealthNet TPO, Karte Se, Kabul, Afghanistan; [Bakhtash, Sayed] Med Emergency Relief Int, Kabul, Afghanistan	University of London; London School of Hygiene & Tropical Medicine	Leslie, T (corresponding author), London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	toby.leslie@lshtm.ac.uk	nader, mohammed/AAH-3475-2021	nader, mohammed/0000-0002-9994-9077; Chandler, Clare/0000-0001-6499-7522; Whitty, Christopher/0000-0002-6076-5027; Mikhail, Amy Frances Wahid/0000-0003-3414-2173	Bill and Melinda Gates Foundation as part of the ACT Consortium; London School of Hygiene and Tropical Medicine	Bill and Melinda Gates Foundation as part of the ACT Consortium; London School of Hygiene and Tropical Medicine	The study was funded by a grant from the Bill and Melinda Gates Foundation as part of the ACT Consortium (www.actconsortium.org) and sponsored by the London School of Hygiene and Tropical Medicine. Neither the funder nor sponsor had any role in the design or conduct of the study, analysis or interpretation of the data, or in the decision to publish.	A-Elgayoum SME, 2009, DIAGN MICR INFEC DIS, V64, P20, DOI 10.1016/j.diagmicrobio.2009.01.029; Acerra JR, 2009, INT J EMERG MED, V2, P77, DOI 10.1007/s12245-009-0106-y; Ansah EK, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c930; Anstey NM, 2009, TRENDS PARASITOL, V25, P220, DOI 10.1016/j.pt.2009.02.003; Ashton RA, MALAR J, V9, P297; Bailey MS, 2011, J ROY ARMY MED CORPS, V157, P150, DOI 10.1136/jramc-157-02-05; Berkley JA, 2005, BMJ-BRIT MED J, V330, P995, DOI 10.1136/bmj.38408.471991.8F; Bisoffi Z, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000063; Brent AJ, 2006, LANCET, V367, P482, DOI 10.1016/S0140-6736(06)68180-4; Brooker S, 2006, EMERG INFECT DIS, V12, P1600, DOI 10.3201/eid1210.060051; Chandler CI, MALAR J, V9, P95; Chandler CIR, 2008, TROP MED INT HEALTH, V13, P1131, DOI 10.1111/j.1365-3156.2008.02118.x; Chandler CIR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-53; Chandramohan D, 2002, TROP MED INT HEALTH, V7, P45, DOI 10.1046/j.1365-3156.2002.00827.x; Guerra CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000774; Hamer DH, 2007, JAMA-J AM MED ASSOC, V297, P2227, DOI 10.1001/jama.297.20.2227; Hay SI, PLOS MED, V7; Joshi R, 2008, AM J TROP MED HYG, V78, P393, DOI 10.4269/ajtmh.2008.78.393; Kolaczinski J, 2005, LANCET, V365, P1506, DOI 10.1016/S0140-6736(05)66423-9; Lubell Y, 2008, BMJ-BRIT MED J, V336, P202, DOI 10.1136/bmj.39395.696065.47; Luxemburger C, 1998, T ROY SOC TROP MED H, V92, P45, DOI 10.1016/S0035-9203(98)90950-6; Mtove G, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-290; Mtove G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009244; Nadjm B, BMJ             0617, V340, pc1350; Nankabirwa J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-66; Peters DH, 2007, B WORLD HEALTH ORGAN, V85, P146, DOI 10.2471/BLT.06.033746; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Rowland M, 2002, SOC SCI MED, V55, P2061, DOI 10.1016/S0277-9536(01)00341-0; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; Wallace MR, 2002, CLIN INFECT DIS, V34, pS171, DOI 10.1086/340704; Weber MW, 1997, B WORLD HEALTH ORGAN, V75, P25; Whitty CJM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S7; WHO, 2010, GUID TREATM MAL; WHO, 2010, GUID TREATM MAL, V2nd; Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119; Yeboah-Antwi K, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000340; Zurovac D, 2008, AM J TROP MED HYG, V78, P884, DOI 10.4269/ajtmh.2008.78.884	37	47	49	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUL 24	2012	345								e4389	10.1136/bmj.e4389	http://dx.doi.org/10.1136/bmj.e4389			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	981UQ	22833603	Green Published, Green Submitted, Green Accepted, hybrid			2022-12-24	WOS:000306996900001
J	Chen, SX; Cherry, A; Tari, PK; Podgorski, K; Kwong, YKK; Haas, K				Chen, Simon Xuan; Cherry, Angus; Tari, Parisa Karimi; Podgorski, Kaspar; Kwong, Yue Kay Kali; Haas, Kurt			The Transcription Factor MEF2 Directs Developmental Visually Driven Functional and Structural Metaplasticity	CELL			English	Article							LONG-TERM DEPRESSION; DENDRITIC ARBOR GROWTH; IN-VIVO; SYNAPTIC PLASTICITY; CORTICAL CIRCUITS; EMBRYONIC BRAIN; NERVOUS-SYSTEM; NMDA RECEPTOR; CORTEX; DIFFERENTIATION	Natural sensory input shapes both structure and function of developing neurons, but how early experience-driven morphological and physiological plasticity are interrelated remains unclear. Using rapid time-lapse two-photon calcium imaging of network activity and single-neuron growth within the unanesthetized developing brain, we demonstrate that visual stimulation induces coordinated changes to neuronal responses and dendritogenesis. Further, we identify the transcription factor MEF2A/2D as a major regulator of neuronal response to plasticity-inducing stimuli directing both structural and functional changes. Unpatterned sensory stimuli that change plasticity thresholds induce rapid degradation of MEF2A/2D through a classical apoptotic pathway requiring NMDA receptors and caspases-9 and -3/7. Knockdown of MEF2A/2D alone is sufficient to induce a metaplastic shift in threshold of both functional and morphological plasticity. These findings demonstrate how sensory experience acting through altered levels of the transcription factor MEF2 fine-tunes the plasticity thresholds of brain neurons during neural circuit formation.	[Chen, Simon Xuan; Cherry, Angus; Tari, Parisa Karimi; Podgorski, Kaspar; Kwong, Yue Kay Kali; Haas, Kurt] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 2B5, Canada; [Chen, Simon Xuan; Cherry, Angus; Tari, Parisa Karimi; Podgorski, Kaspar; Kwong, Yue Kay Kali; Haas, Kurt] Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 2B5, Canada	University of British Columbia; University of British Columbia	Haas, K (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 2B5, Canada.	kurt.haas@ubc.ca	Haas, Kurt/B-3812-2009	Haas, Kurt/0000-0003-4754-1560; Chen, Simon/0000-0002-7595-7443; Podgorski, Kaspar/0000-0002-0374-2005	Canadian Institutes of Health Research (CIHR); Michael Smith Foundation for Health Research (MSFHR); Tula Foundation; EJLB Foundation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); Tula Foundation; EJLB Foundation	This work was funded by grants from the Canadian Institutes of Health Research (CIHR), the Michael Smith Foundation for Health Research (MSFHR), the Tula Foundation, and the EJLB Foundation.	Abraham WC, 2001, P NATL ACAD SCI USA, V98, P10924, DOI 10.1073/pnas.181342098; Abraham WC, 2008, NAT REV NEUROSCI, V9, P387, DOI 10.1038/nrn2356; Barbosa AC, 2008, P NATL ACAD SCI USA, V105, P9391, DOI 10.1073/pnas.0802679105; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Chen SX, 2010, NEURON, V67, P967, DOI 10.1016/j.neuron.2010.08.016; COLEMAN PD, 1968, J ANAT, V102, P363; della Gaspera B, 2009, DEV BIOL, V328, P392, DOI 10.1016/j.ydbio.2009.01.039; Dunfield D, 2010, NAT PROTOC, V5, P841, DOI 10.1038/nprot.2010.10; Dunfield D, 2009, NEURON, V64, P240, DOI 10.1016/j.neuron.2009.08.034; Engert F, 2002, NATURE, V419, P470, DOI 10.1038/nature00988; Fiore R, 2009, EMBO J, V28, P697, DOI 10.1038/emboj.2009.10; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Haas K, 2001, NEURON, V29, P583, DOI 10.1016/S0896-6273(01)00235-5; Haas K, 2006, P NATL ACAD SCI USA, V103, P12127, DOI 10.1073/pnas.0602670103; Hofer SB, 2009, NATURE, V457, P313, DOI 10.1038/nature07487; Hossain S, 2012, DEV NEUROBIOL, V72, P615, DOI 10.1002/dneu.20959; Jiao S, 2011, NEURON, V70, P758, DOI 10.1016/j.neuron.2011.04.004; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; Lee MC, 2010, NEURON, V66, P859, DOI 10.1016/j.neuron.2010.05.015; Li MT, 2001, J NEUROSCI, V21, P6544, DOI 10.1523/JNEUROSCI.21-17-06544.2001; Li Z, 2010, CELL, V141, P859, DOI 10.1016/j.cell.2010.03.053; Liu XF, 2009, J NEUROSCI, V29, P12229, DOI 10.1523/JNEUROSCI.2842-09.2009; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Okamoto S, 2002, P NATL ACAD SCI USA, V99, P3974, DOI 10.1073/pnas.022036399; OLSON EN, 1995, DEV BIOL, V172, P2, DOI 10.1006/dbio.1995.0002; Philpot BD, 2003, J NEUROSCI, V23, P5583; Podgorski K, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001236; Ramdya P, 2008, NAT NEUROSCI, V11, P1083, DOI 10.1038/nn.2166; Ruthazer ES, 2003, SCIENCE, V301, P66, DOI 10.1126/science.1082545; SAKAGUCHI DS, 1985, J NEUROSCI, V5, P3228; Schwartz N, 2009, NEURON, V62, P655, DOI 10.1016/j.neuron.2009.05.007; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Shalizi AK, 2005, CURR TOP DEV BIOL, V69, P239, DOI 10.1016/S0070-2153(05)69009-6; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Slee EA, 1999, CELL DEATH DIFFER, V6, P1067, DOI 10.1038/sj.cdd.4400601; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; VAUGHN JE, 1989, SYNAPSE, V3, P255, DOI 10.1002/syn.890030312; Vetere G, 2011, P NATL ACAD SCI USA, V108, P8456, DOI 10.1073/pnas.1016275108; VOLKMAR FR, 1972, SCIENCE, V176, P1445, DOI 10.1126/science.176.4042.1445; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Zhou Q, 2003, SCIENCE, V300, P1953, DOI 10.1126/science.1082212	46	42	43	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 28	2012	151	1					41	55		10.1016/j.cell.2012.08.028	http://dx.doi.org/10.1016/j.cell.2012.08.028			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	23021214	Bronze			2022-12-24	WOS:000309544200009
J	Paige, SL; Thomas, S; Stoick-Cooper, CL; Wang, H; Maves, L; Sandstrom, R; Pabon, L; Reinecke, H; Pratt, G; Keller, G; Moon, RT; Stamatoyannopoulos, J; Murry, CE				Paige, Sharon L.; Thomas, Sean; Stoick-Cooper, Cristi L.; Wang, Hao; Maves, Lisa; Sandstrom, Richard; Pabon, Lil; Reinecke, Hans; Pratt, Gabriel; Keller, Gordon; Moon, Randall T.; Stamatoyannopoulos, John; Murry, Charles E.			A Temporal Chromatin Signature in Human Embryonic Stem Cells Identifies Regulators of Cardiac Development	CELL			English	Article							CARDIOVASCULAR PROGENITOR CELLS; DIRECTED DIFFERENTIATION; PLURIPOTENT; METHYLATION; ZEBRAFISH; POLYCOMB; GENES; EXPRESSION; PROMOTERS; MOUSE	Directed differentiation of human embryonic stem cells(ESCs) into cardiovascular cells provides a model for studying molecular mechanisms of human cardiovascular development. Although it is known that chromatin modification patterns in ESCs differ markedly from those in lineage-committed progenitors and differentiated cells, the temporal dynamics of chromatin alterations during differentiation along a defined lineage have not been studied. We show that differentiation of human ESCs into cardiovascular cells is accompanied by programmed temporal alterations in chromatin structure that distinguish key regulators of cardiovascular development from other genes. We used this temporal chromatin signature to identify regulators of cardiac development, including the homeobox gene MEIS2. Using the zebrafish model, we demonstrate that MEIS2 is critical for proper heart tube formation and subsequent cardiac looping. Temporal chromatin signatures should be broadly applicable to other models of stem cell differentiation to identify regulators and provide key insights into major developmental decisions.	[Wang, Hao; Sandstrom, Richard; Moon, Randall T.; Stamatoyannopoulos, John] Univ Washington, Dept Genome Sci, Seattle, WA 98109 USA; [Paige, Sharon L.; Pabon, Lil; Reinecke, Hans; Pratt, Gabriel; Murry, Charles E.] Univ Washington, Dept Pathol, Seattle, WA 98109 USA; [Paige, Sharon L.; Stoick-Cooper, Cristi L.; Pabon, Lil; Reinecke, Hans; Pratt, Gabriel; Moon, Randall T.; Murry, Charles E.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98109 USA; [Paige, Sharon L.; Pabon, Lil; Reinecke, Hans; Pratt, Gabriel; Murry, Charles E.] Univ Washington, Ctr Cardiovasc Biol, Seattle, WA 98109 USA; [Stoick-Cooper, Cristi L.] Univ Washington, Dept Pharmacol, Seattle, WA 98109 USA; [Stoick-Cooper, Cristi L.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98109 USA; [Stamatoyannopoulos, John] Univ Washington, Dept Med, Seattle, WA 98109 USA; [Murry, Charles E.] Univ Washington, Dept Bioengn, Seattle, WA 98109 USA; [Murry, Charles E.] Univ Washington, Dept Med Cardiol, Seattle, WA 98109 USA; [Thomas, Sean] Gladstone Inst, San Francisco, CA 94158 USA; [Maves, Lisa] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Keller, Gordon] Ontario Canc Inst, McEwen Ctr Regenerat Med, Toronto, ON M5G 2C4, Canada	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; The J David Gladstone Institutes; Fred Hutchinson Cancer Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Stamatoyannopoulos, J (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98109 USA.	jstam@u.washington.edu; murry@uw.edu	Moon, Randall/M-5605-2019; Moon, Randall T/B-1743-2014	Moon, Randall/0000-0002-9352-1408; Moon, Randall T/0000-0002-9352-1408; Sandstrom, Richard/0000-0002-3356-1547; Pratt, Gabriel/0000-0003-1670-4507; Keller, Gordon/0000-0001-9309-9297	NIH [P01 GM081719, U01 HL100405, P01 HL094374, R01 HL084642, R01 HL64387, R03 AR057477, F30 HL095343]; UW ENCODE Center [U54HG004592];  [R90HG004152]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL095343, R01HL064387, U01HL100405, R01HL084642, P01HL094374] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R90HG004152, U54HG004592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR057477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081619] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UW ENCODE Center; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Nina Tan, Mark Saiget, James Fugate, Kristen Lee, Rajinder Kaul, and Stanley Kim for technical expertise. This work was supported by NIH grants P01 GM081719, U01 HL100405, P01 HL094374, R01 HL084642, R01 HL64387, R03 AR057477, and UW ENCODE Center (U54HG004592). S.P. was supported through NIH F30 HL095343. H.W. was supported by R90HG004152. R.T.M. is an investigator of the HHMI.	Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Collas P, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12517; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Dahl JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009150; Domian IJ, 2009, SCIENCE, V326, P426, DOI 10.1126/science.1177350; Glickman NS, 2002, SEMIN CELL DEV BIOL, V13, P507, DOI 10.1016/S1084952102001040; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Higashijima S, 1997, DEV BIOL, V192, P289, DOI 10.1006/dbio.1997.8779; James RG, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000230; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lee H, 2007, STEM CELLS, V25, P1931, DOI 10.1634/stemcells.2007-0097; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lindeman LC, 2010, INT J DEV BIOL, V54, P803, DOI 10.1387/ijdb.103081ll; Maves L, 2009, DEV BIOL, V333, P409, DOI 10.1016/j.ydbio.2009.07.004; Mazzarella L, 2011, BLOOD, V117, P83, DOI 10.1182/blood-2010-03-273128; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Minehata K, 2008, BIOCHEM BIOPH RES CO, V374, P647, DOI 10.1016/j.bbrc.2008.07.075; Mobius W, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000891; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Phillips BW, 2007, STEM CELLS DEV, V16, P561, DOI 10.1089/scd.2007.0029; Pjanic M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-181; Rada-Iglesias A, 2011, GENOME MED, V3, DOI 10.1186/gm252; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Stankunas K, 2008, CIRC RES, V103, P702, DOI 10.1161/CIRCRESAHA.108.175489; Takeuchi JK, 2003, DEVELOPMENT, V130, P5953, DOI 10.1242/dev.00797; Talbot JC, 2010, DEVELOPMENT, V137, P2506, DOI 10.1242/dev.049700; Vakoc CR, 2006, MOL CELL BIOL, V26, P9185, DOI 10.1128/MCB.01529-06; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yelon D, 1999, DEV BIOL, V214, P23, DOI 10.1006/dbio.1999.9406; Zerucha T, 2001, MECH DEVELOP, V102, P247, DOI 10.1016/S0925-4773(01)00299-4	42	239	248	3	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 28	2012	151	1					221	232		10.1016/j.cell.2012.08.027	http://dx.doi.org/10.1016/j.cell.2012.08.027			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	22981225	Green Accepted, Bronze			2022-12-24	WOS:000309544200022
J	Duncan, SR				Duncan, Steven R.			PERSPECTIVE Clues, not conclusions	NATURE			English	Editorial Material							OBSTRUCTIVE PULMONARY-DISEASE		Univ Pittsburgh, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Duncan, SR (corresponding author), Univ Pittsburgh, Pittsburgh, PA 15260 USA.	duncsr@upmc.edu						Agusti A, 2003, THORAX, V58, P832, DOI 10.1136/thorax.58.10.832; Cancro MP, 2009, J CLIN INVEST, V119, P1066, DOI 10.1172/JCI38010; Feghali-Bostwick CA, 2008, AM J RESP CRIT CARE, V177, P156, DOI 10.1164/rccm.200701-014OC; Kirkham PA, 2011, AM J RESP CRIT CARE, V184, P796, DOI 10.1164/rccm.201010-1605OC; Marrack P, 2001, NAT MED, V7, P899, DOI 10.1038/90935	5	5	5	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2012	489	7417					S15	S15		10.1038/489S15a	http://dx.doi.org/10.1038/489S15a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011LT	23013710	Bronze			2022-12-24	WOS:000309167100008
J	Kaelin, CB; Xu, X; Hong, LZ; David, VA; McGowan, KA; Schmidt-Kuntzel, A; Roelke, ME; Pino, J; Pontius, J; Cooper, GM; Manuel, H; Swanson, WF; Marker, L; Harper, CK; van Dyk, A; Yue, BS; Mullikin, JC; Warren, WC; Eizirik, E; Kos, L; O'Brien, SJ; Barsh, GS; Menotti-Raymond, M				Kaelin, Christopher B.; Xu, Xiao; Hong, Lewis Z.; David, Victor A.; McGowan, Kelly A.; Schmidt-Kuentzel, Anne; Roelke, Melody E.; Pino, Javier; Pontius, Joan; Cooper, Gregory M.; Manuel, Hermogenes; Swanson, William F.; Marker, Laurie; Harper, Cindy K.; van Dyk, Ann; Yue, Bisong; Mullikin, James C.; Warren, Wesley C.; Eizirik, Eduardo; Kos, Lidia; O'Brien, Stephen J.; Barsh, Gregory S.; Menotti-Raymond, Marilyn			Specifying and Sustaining Pigmentation Patterns in Domestic and Wild Cats	SCIENCE			English	Article							COAT COLOR; SKIN COLOR; EXPRESSION; GENETICS; FAMILY; MODEL	Color markings among felid species display both a remarkable diversity and a common underlying periodicity. A similar range of patterns in domestic cats suggests a conserved mechanism whose appearance can be altered by selection. We identified the gene responsible for tabby pattern variation in domestic cats as Transmembrane aminopeptidase Q (Taqpep), which encodes a membrane-bound metalloprotease. Analyzing 31 other felid species, we identified Taqpep as the cause of the rare king cheetah phenotype, in which spots coalesce into blotches and stripes. Histologic, genomic expression, and transgenic mouse studies indicate that paracrine expression of Endothelin3 (Edn3) coordinates localized color differences. We propose a two-stage model in which Taqpep helps to establish a periodic pre-pattern during skin development that is later implemented by differential expression of Edn3.	[Kaelin, Christopher B.; Cooper, Gregory M.; Barsh, Gregory S.] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Kaelin, Christopher B.; Hong, Lewis Z.; McGowan, Kelly A.; Manuel, Hermogenes; Barsh, Gregory S.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Xu, Xiao; David, Victor A.; Schmidt-Kuentzel, Anne; Roelke, Melody E.; Pino, Javier; O'Brien, Stephen J.; Menotti-Raymond, Marilyn] Frederick Natl Lab Canc Res, Lab Genom Divers, Frederick, MD 21702 USA; [Xu, Xiao; Yue, Bisong] Sichuan Univ, Coll Life Sci, Sichuan Key Lab Conservat Biol Endangered Wildlif, Chengdu 610064, Sichuan, Peoples R China; [Schmidt-Kuentzel, Anne; Marker, Laurie] Cheetah Conservat Fund, Otjiwarongo, Namibia; [Roelke, Melody E.; Pontius, Joan] Frederick Natl Lab Canc Res, SAIC Frederick, Frederick, MD 21702 USA; [Pino, Javier; Kos, Lidia] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; [Swanson, William F.] Cincinnati Zoo & Bot Garden, Ctr Conservat & Res Endangered Wildlife, Cincinnati, OH 45220 USA; [Harper, Cindy K.] Univ Pretoria, Fac Vet Sci Onderstepoort, Vet Genet Lab, ZA-0002 Pretoria, South Africa; [van Dyk, Ann] Ann van Dyk Cheetah Ctr, De Wildt, South Africa; [Mullikin, James C.] NHGRI, Comparat Genom Unit, NIH, Rockville, MD 20892 USA; [Warren, Wesley C.] Washington Univ, Genome Ctr, St Louis, MO 63108 USA; [Eizirik, Eduardo] Pontificia Univ Catolica Rio Grande do Sul, Fac Biociencias, BR-90619900 Porto Alegre, RS, Brazil; [Eizirik, Eduardo] Inst Pro Carnivoros, Atibaia, Brazil	HudsonAlpha Institute for Biotechnology; Stanford University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Sichuan University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; State University System of Florida; Florida International University; University of Pretoria; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Washington University (WUSTL); Pontificia Universidade Catolica Do Rio Grande Do Sul	O'Brien, SJ (corresponding author), St Petersburg State Univ, Theodosius Dobzhansky Ctr Genome Informat, St Petersburg, Russia.	lgdchief@gmail.com; gbarsh@hudsonalpha.org	Eizirik, Eduardo/K-8034-2012; David, Victor A/I-9330-2012; OBRIEN, STEPHEN/ABD-1346-2020	Eizirik, Eduardo/0000-0002-9658-0999; OBRIEN, STEPHEN/0000-0001-7857-0757; O'Brien, Stephen J./0000-0001-7353-8301; Yue, Bisong/0000-0001-6731-538X	Wild Cat Education and Conservation Fund; HudsonAlpha Institute for Biotechnology; Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research; federal funds [N01-CO-12400]; Genentech; National Institutes of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200330, U54HG003079] Funding Source: NIH RePORTER	Wild Cat Education and Conservation Fund; HudsonAlpha Institute for Biotechnology; Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); federal funds; Genentech(Roche HoldingGenentech); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank San Jose Animal Care and Services, Fix Our Ferals, the Berkeley East-Bay Humane Society, Pets In Need, the Monterey Animal Hospital, and the City of Huntsville Animal Shelter for assistance with sample collection; the Wild Cat Education and Conservation Fund for contributing king cheetah samples; R. Finn for assistance with Norwegian Forest Cat samples and phenotypes; H. Flick for domestic cat photographs; and J. C. Kaelin for help with feral cat sample collection. We thank the Production Sequencing Group of the Washington University School of Medicine Genome Center for cDNA sequencing. Namibian samples were collected with the approval of the Ministry of Environment and Tourism (permit 1532). Supported in part by the HudsonAlpha Institute for Biotechnology and by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research, using federal funds under contract N01-CO-12400. L.Z.H. and J.P. were supported by fellowships from Genentech and the National Institutes of Health, respectively. A.vD. is the founder and director of the Ann van Dyk Cheetah Centre, a nonprofit conservation organization. DNA sequence data for this study are available at http://genome.wustl.edu/genomes/view/felis_catus/ and the NIH Short Read Archive (SRA056885).	April CS, 2006, PIGM CELL RES, V19, P194, DOI 10.1111/j.1600-0749.2006.00305.x; Driscoll CA, 2007, SCIENCE, V317, P519, DOI 10.1126/science.1139518; Eizirik E, 2003, CURR BIOL, V13, P448, DOI 10.1016/S0960-9822(03)00128-3; Eizirik E, 2010, GENETICS, V184, P267, DOI 10.1534/genetics.109.109629; Garcia RJ, 2008, J INVEST DERMATOL, V128, P131, DOI 10.1038/sj.jid.5700948; Hong LZ, 2011, GENOME RES, V21, P1905, DOI 10.1101/gr.122135.111; Iwashita M, 2006, PLOS GENET, V2, P1861, DOI 10.1371/journal.pgen.0020197; JACKSON IJ, 1994, ANNU REV GENET, V28, P189, DOI 10.1146/annurev.ge.28.120194.001201; KOBAYASHI T, 1995, J CELL SCI, V108, P2301; LOMAX TD, 1988, J HERED, V79, P21, DOI 10.1093/oxfordjournals.jhered.a110438; Maruyama M, 2007, J BIOL CHEM, V282, P20088, DOI 10.1074/jbc.M702650200; MILLAR SE, 1995, DEVELOPMENT, V121, P3223; Nakamasu A, 2009, P NATL ACAD SCI USA, V106, P8429, DOI 10.1073/pnas.0808622106; Peterschmitt M, 2009, ANIM GENET, V40, P547, DOI 10.1111/j.1365-2052.2009.01864.x; Pocock R. I., 1927, P ZOOL SOC LOND, V97, P245; Searle A.G., 1968, COMP GENETICS COAT C; Stone EA, 2005, GENOME RES, V15, P978, DOI 10.1101/gr.3804205; Van Raamsdonk CD, 2009, PIGM CELL MELANOMA R, V22, P819, DOI 10.1111/j.1755-148X.2009.00609.x; Van Raamsdonk CD, 2004, NAT GENET, V36, P961, DOI 10.1038/ng1412; VANAARDE RJ, 1986, J ZOOL, V209, P573, DOI 10.1111/j.1469-7998.1986.tb03612.x; Watanabe M, 2006, EMBO REP, V7, P893, DOI 10.1038/sj.embor.7400757	21	82	96	11	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2012	337	6101					1536	1541		10.1126/science.1220893	http://dx.doi.org/10.1126/science.1220893			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007UC	22997338	Green Accepted, Green Submitted			2022-12-24	WOS:000308912900051
J	McCartney, M				McCartney, Margaret			Cosmetic approval	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				[Anonymous], 2009, OFFICIAL J EUROPEA L, V342, P59; Aveda, FAQ; Church and Dwight, FEMFRESH DAILY INTIM; Johnson and Johnson, JOHNS BAB OIL; Unilever, PERSL NONB	5	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 14	2012	345								e6046	10.1136/bmj.e6046	http://dx.doi.org/10.1136/bmj.e6046			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007BZ	22983532				2022-12-24	WOS:000308865100002
J	Rodwin, MA; Abramson, JD				Rodwin, Marc A.; Abramson, John D.			Clinical Trial Data as a Public Good	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Rodwin, Marc A.] Harvard Univ, Edmond J Safra Ctr Eth, Cambridge, MA 02138 USA; [Rodwin, Marc A.] Suffolk Univ, Sch Law, Boston, MA 02114 USA; [Abramson, John D.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA	Harvard University; Suffolk University; Harvard University; Harvard Medical School	Rodwin, MA (corresponding author), Harvard Univ, Edmond J Safra Ctr Eth, 124 Mt Auburn St,Ste 520N, Cambridge, MA 02138 USA.	mrodwin@ethics.harvard.edu						Department of Health and Human Services, 1996, FED REGISTER, V61, P37320; Doshi P, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001201; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Graham DY, 2011, AM J MED SCI, V342, P356, DOI 10.1097/MAJ.0b013e3182113658; Kesselheim AS, 2007, HEALTH AFFAIR, V26, P483, DOI 10.1377/hlthaff.26.2.483; Krumholz HM, 2011, JAMA-J AM MED ASSOC, V306, P1593, DOI 10.1001/jama.2011.1459; Mathieu S, 2009, JAMA-J AM MED ASSOC, V302, P977, DOI 10.1001/jama.2009.1242; Turner EH, 2004, PLOS MED, V1, P180, DOI 10.1371/journal.pmed.0010060; Vedula SS, 2009, NEW ENGL J MED, V361, P1963, DOI 10.1056/NEJMsa0906126	9	37	37	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2012	308	9					871	872		10.1001/jama.2012.9661	http://dx.doi.org/10.1001/jama.2012.9661			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999ET	22948695				2022-12-24	WOS:000308292900015
J	Kamerow, D				Kamerow, Douglas			The myth of an AIDS free world	BRITISH MEDICAL JOURNAL			English	Editorial Material									RTI Int, Res Triangle Pk, NC USA	Research Triangle Institute	Kamerow, D (corresponding author), RTI Int, Res Triangle Pk, NC USA.	dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957				Brown D., 2012, WASHINGTON POST, pWashington; Roehr B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5265; Roehr B, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4879	3	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 14	2012	345								e5479	10.1136/bmj.e5479	http://dx.doi.org/10.1136/bmj.e5479			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	992CD	22893652				2022-12-24	WOS:000307752000002
J	Barry, CL; Gollust, SE; Niederdeppe, J				Barry, Colleen L.; Gollust, Sarah E.; Niederdeppe, Jeff			Are Americans Ready to Solve the Weight of the Nation?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEALTH		[Barry, Colleen L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; [Gollust, Sarah E.] Univ Minnesota, Sch Publ Hlth, Div Hlth Policy & Management, Minneapolis, MN USA; [Niederdeppe, Jeff] Cornell Univ, Dept Commun, Ithaca, NY USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Minnesota System; University of Minnesota Twin Cities; Cornell University	Barry, CL (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA.							Bleich S, 2011, AM PUBLIC OPINION HL; Center for Consumer Freedom, 2012, I MED NEW OB PREV ST; DOWNS A, 1972, PUBLIC INTEREST, P38; Madison KM, 2011, J LAW MED ETHICS, V39, P450, DOI 10.1111/j.1748-720X.2011.00614.x; Puhl RM, 2007, PSYCHOL BULL, V133, P557, DOI 10.1037/0033-2909.133.4.557	5	32	32	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 2	2012	367	5					389	391		10.1056/NEJMp1206519	http://dx.doi.org/10.1056/NEJMp1206519			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	981VZ	22853011				2022-12-24	WOS:000307001900001
J	Rolland, M; Edlefsen, PT; Larsen, BB; Tovanabutra, S; Sanders-Buell, E; Hertz, T; deCamp, AC; Carrico, C; Menis, S; Magaret, CA; Ahmed, H; Juraska, M; Chen, L; Konopa, P; Nariya, S; Stoddard, JN; Wong, K; Zhao, H; Deng, WJ; Maust, BS; Bose, M; Howell, S; Bates, A; Lazzaro, M; O'Sullivan, A; Lei, E; Bradfield, A; Ibitamuno, G; Assawadarachai, V; O'Connell, RJ; deSouza, MS; Nitayaphan, S; Rerks-Ngarm, S; Robb, ML; McLellan, JS; Georgiev, I; Kwong, PD; Carlson, JM; Michael, NL; Schief, WR; Gilbert, PB; Mullins, JI; Kim, JH				Rolland, Morgane; Edlefsen, Paul T.; Larsen, Brendan B.; Tovanabutra, Sodsai; Sanders-Buell, Eric; Hertz, Tomer; deCamp, Allan C.; Carrico, Chris; Menis, Sergey; Magaret, Craig A.; Ahmed, Hasan; Juraska, Michal; Chen, Lennie; Konopa, Philip; Nariya, Snehal; Stoddard, Julia N.; Wong, Kim; Zhao, Hong; Deng, Wenjie; Maust, Brandon S.; Bose, Meera; Howell, Shana; Bates, Adam; Lazzaro, Michelle; O'Sullivan, Annemarie; Lei, Esther; Bradfield, Andrea; Ibitamuno, Grace; Assawadarachai, Vatcharain; O'Connell, Robert J.; deSouza, Mark S.; Nitayaphan, Sorachai; Rerks-Ngarm, Supachai; Robb, Merlin L.; McLellan, Jason S.; Georgiev, Ivelin; Kwong, Peter D.; Carlson, Jonathan M.; Michael, Nelson L.; Schief, William R.; Gilbert, Peter B.; Mullins, James I.; Kim, Jerome H.			Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2	NATURE			English	Article							COMPETING RISKS; SUBTYPE-C; TRIAL; NEUTRALIZATION; PROTECTION; INFECTION; SEQUENCES; EPITOPES; THAILAND; AIDSVAX	The RV144 trial demonstrated 31% vaccine efficacy at preventing human immunodeficiency virus (HIV)-1 infection(1). Antibodies against the HIV-1 envelope variable loops 1 and 2 (Env V1 and V2) correlated inversely with infection risk(2). We proposed that vaccine-induced immune responses against V1/V2 would have a selective effect against, or sieve, HIV-1 breakthrough viruses. A total of 936 HIV-1 genome sequences from 44 vaccine and 66 placebo recipients were examined. We show that vaccine-induced immune responses were associated with two signatures in V2 at amino acid positions 169 and 181. Vaccine efficacy against viruses matching the vaccine at position 169 was 48% (confidence interval 18% to 66%; P = 0.0036), whereas vaccine efficacy against viruses mismatching the vaccine at position 181 was 78% (confidence interval 35% to 93%; P = 0.0028). Residue 169 is in a cationic glycosylated region recognized by broadly neutralizing and RV144-derived antibodies. The predicted distance between the two signature sites (21 +/- 7 angstrom) and their match/mismatch dichotomy indicate that multiple factors may be involved in the protection observed in RV144. Genetic signatures of RV144 vaccination in V2 complement the finding of an association between high V1/V2-binding antibodies and reduced risk of HIV-1 acquisition, and provide evidence that vaccine-induced V2 responses plausibly had a role in the partial protection conferred by the RV144 regimen.	[Rolland, Morgane; Tovanabutra, Sodsai; Sanders-Buell, Eric; Bose, Meera; Howell, Shana; Bates, Adam; Lazzaro, Michelle; O'Sullivan, Annemarie; Lei, Esther; Bradfield, Andrea; Ibitamuno, Grace; O'Connell, Robert J.; Robb, Merlin L.; Michael, Nelson L.; Kim, Jerome H.] US Mil HIV Res Program, Silver Spring, MD 20910 USA; [Edlefsen, Paul T.; Hertz, Tomer; deCamp, Allan C.; Magaret, Craig A.; Ahmed, Hasan; Juraska, Michal; Gilbert, Peter B.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA 98109 USA; [Larsen, Brendan B.; Chen, Lennie; Konopa, Philip; Nariya, Snehal; Stoddard, Julia N.; Wong, Kim; Zhao, Hong; Deng, Wenjie; Maust, Brandon S.; Mullins, James I.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Carrico, Chris; Menis, Sergey; Schief, William R.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Carrico, Chris; Menis, Sergey; Schief, William R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Carrico, Chris; Menis, Sergey; Schief, William R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Assawadarachai, Vatcharain; deSouza, Mark S.; Nitayaphan, Sorachai] Royal Thai Army Component, AFRIMS, Bangkok 10400, Thailand; [Rerks-Ngarm, Supachai] Thai Minist Publ Hlth, Nonthaburi 11000, Thailand; [McLellan, Jason S.; Georgiev, Ivelin; Kwong, Peter D.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Carlson, Jonathan M.] Microsoft Res, Redmond, WA 98052 USA	Walter Reed Army Institute of Research (WRAIR); Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Ministry of Public Health - Thailand; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Microsoft	Rolland, M (corresponding author), US Mil HIV Res Program, Silver Spring, MD 20910 USA.	mrolland@hivresearch.org	Hertz, Tomer/S-5744-2016; Schief, William/ABF-3645-2020	Hertz, Tomer/0000-0002-0561-1578; Schief, William/0000-0002-1120-0150; McLellan, Jason/0000-0003-3991-542X; Carrico, Chris/0000-0003-0939-9006	US Army Medical Research and Material Command (USAMRMC) [Y1-AI-2642-12]; National Institutes of Allergy and Infectious Diseases [Y1-AI-2642-12]; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. [W81XWH-07-2-0067]; US Department of Defense (DOD) [W81XWH-07-2-0067]; NIH [2R37AI05465-10]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI054165, UM1AI068635, ZIAAI005023, R01AI054165, N01AI002642, U01AI068635, K25AI087397] Funding Source: NIH RePORTER	US Army Medical Research and Material Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; US Department of Defense (DOD)(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank B. F. Haynes and F. A. Matsen for advice and comments, and I. A. Wilson and R. L. Stanfield for assistance. This study was supported in part by an Interagency Agreement Y1-AI-2642-12 between US Army Medical Research and Material Command (USAMRMC) and the National Institutes of Allergy and Infectious Diseases. This work was also supported by a cooperative agreement (W81XWH-07-2-0067) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., and the US Department of Defense (DOD). Additional support was provided to P.B.G. through the NIH grant 2R37AI05465-10. The opinions herein are those of the authors and should not be construed as official or representing the views of the US Department of Defense or the Department of the Army.	Carlson JM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000225; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Doria-Rose NA, 2012, J VIROL, V86, P8319, DOI 10.1128/JVI.00696-12; Edlefsen P. T., 2012, MODEL BASED SIEVE AN; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Gilbert P, 2001, J CLIN EPIDEMIOL, V54, P68, DOI 10.1016/S0895-4356(00)00258-4; Gilbert PB, 2000, STAT MED, V19, P3065; Gilbert PB, 1998, BIOMETRICS, V54, P799, DOI 10.2307/2533835; Gilbert PB, 2005, AIDS RES HUM RETROV, V21, P1016, DOI 10.1089/aid.2005.21.1016; Gilbert PB, 2008, BIOMETRICS, V64, P198, DOI 10.1111/j.1541-0420.2007.00845.x; Gilbert PB, 2011, J INFECT DIS, V203, P969, DOI 10.1093/infdis/jiq152; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; LUNN M, 1995, BIOMETRICS, V51, P524, DOI 10.2307/2532940; Lynch RM, 2011, J VIROL, V85, P905, DOI 10.1128/JVI.02006-10; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Moore PL, 2011, J VIROL, V85, P3128, DOI 10.1128/JVI.02658-10; Moore PL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000598; Plotkin SA, 2012, CLIN INFECT DIS, V54, P1615, DOI 10.1093/cid/cis238; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Poon AFY, 2007, PLOS COMPUT BIOL, V3, P2279, DOI 10.1371/journal.pcbi.0030231; PRENTICE RL, 1978, BIOMETRICS, V34, P541, DOI 10.2307/2530374; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Robb ML, 2012, LANCET INFECT DIS, V12, P531, DOI 10.1016/S1473-3099(12)70088-9; Rolland M, 2012, AIDS RES HUM RETROV, V28, P400, DOI [10.1089/aid.2011.0240, 10.1089/AID.2011.0240]; Rolland M, 2011, NAT MED, V17, P366, DOI 10.1038/nm.2316; Rubinstein ND, 2008, MOL IMMUNOL, V45, P3477, DOI 10.1016/j.molimm.2007.10.016; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Tomaras GD, 2011, J VIROL, V85, P11502, DOI 10.1128/JVI.05363-11; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470	30	323	331	1	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2012	490	7420					417	+		10.1038/nature11519	http://dx.doi.org/10.1038/nature11519			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021XI	22960785	Green Accepted			2022-12-24	WOS:000309918500049
J	Puymirat, E; Simon, T; Steg, PG; Schiele, F; Gueret, P; Blanchard, D; Khalife, K; Goldstein, P; Cattan, S; Vaur, L; Cambou, JP; Ferrieres, J; Danchin, N				Puymirat, Etienne; Simon, Tabassome; Steg, Philippe Gabriel; Schiele, Francois; Gueret, Pascal; Blanchard, Didier; Khalife, Khalife; Goldstein, Patrick; Cattan, Simon; Vaur, Laurent; Cambou, Jean-Pierre; Ferrieres, Jean; Danchin, Nicolas		USIK USIC 2000 Investigator; FAST MI Investigator	Association of Changes in Clinical Characteristics and Management With Improvement in Survival Among Patients With ST-Elevation Myocardial Infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE CORONARY SYNDROMES; INTENSIVE-CARE UNITS; HOSPITAL MORTALITY; FAST-MI; TRENDS; REGISTRY; DECREASE; DECLINE; DISEASE	Context The contemporary decline in mortality reported in patients with ST-segment elevation myocardial infarction (STEMI) has been attributed mainly to improved use of reperfusion therapy. Objective To determine potential factors-beyond reperfusion therapy-associated with improved survival in patients with STEMI over a 15-year period. Design, Setting, and Patients Four 1-month French nationwide registries, conducted 5 years apart (between 1995, 2000, 2005, 2010), including a total of 6707 STEMI patients admitted to intensive care or coronary care units. Main Outcome Measures Changes over time in crude 30-day mortality, and mortality standardized to the 2010 population characteristics. Results Mean(SD) age decreased from 66.2 (14.0) to 63.3 (14.5) years, with a concomitant decline in history of cardiovascular events and comorbidities. The proportion of younger patients increased, particularly in women younger than 60 years (from 11.8% to 25.5%), in whom prevalence of current smoking (37.3% to 73.1%) and obesity (17.6% to 27.1%) increased. Time from symptom onset to hospital admission decreased, with a shorter time from onset to first call, and broader use of mobile intensive care units. Reperfusion therapy increased from 49.4% to 74.7%, driven by primary percutaneous coronary intervention (11.9% to 60.8%). Early use of recommended medications increased, particularly low-molecular-weight heparins and statins. Crude 30-day mortality decreased from 13.7% (95% CI, 12.0-15.4) to 4.4% (95% CI, 3.5-5.4), whereas standardized mortality decreased from 11.3% (95% CI, 9.5-13.2) to 4.4% (95% CI, 3.5-5.4). Multivariable analysis showed a consistent reduction in mortality from 1995 to 2010 after controlling for clinical characteristics in addition to the initial population risk score and use of reperfusion therapy, with odds mortality ratios of 0.39 (95%, 0.29-0.53, P < .001) in 2010 compared with 1995. Conclusion In France, the overall rate of cardiovascular mortality among patients with STEMI decreased from 1995 to 2010, accompanied by an increase in the proportion of women younger than 60 years with STEMI, changes in other population characteristics, and greater use of reperfusion therapy and recommended medications. JAMA. 2012;308(10):998-1006 Published online August 27, 2012. doi:10.1001/jama.2012.11348 www.jama.com	[Puymirat, Etienne; Danchin, Nicolas] Univ Paris 05, Hop Europeen Georges Pompidou, AP HP, Dept Cardiol, F-75015 Paris, France; [Puymirat, Etienne] INSERM, U970, Paris, France; [Simon, Tabassome] Hop St Antoine, AP HP, Dept Clin Pharmacol, F-75571 Paris, France; [Simon, Tabassome] Unite Rech Clin URCEST, Paris, France; [Simon, Tabassome] Univ Paris 06, Paris, France; [Steg, Philippe Gabriel] Hop Bichat Claude Bernard, AP HP, F-75877 Paris, France; [Steg, Philippe Gabriel] Univ Paris Diderot, Paris, France; [Steg, Philippe Gabriel] INSERM, U698, Paris, France; [Schiele, Francois] Univ Hosp Jean Minjoz, Dept Cardiol, Besancon, France; [Gueret, Pascal] Univ Hosp Henri Mondor, Dept Cardiol, Creteil, France; [Blanchard, Didier] Clin St Gatien, Tours, France; [Khalife, Khalife] Metz Reg Hosp, Dept Cardiol, Metz, France; [Goldstein, Patrick] Lille Reg Univ Hosp, Emergency Dept, Lille, France; [Vaur, Laurent] Novo Nordisk, Paris, France; [Cambou, Jean-Pierre; Ferrieres, Jean] Toulouse Rangueil Univ Hosp, Dept Cardiol, Toulouse, France; [Cambou, Jean-Pierre; Ferrieres, Jean] Fac Med Toulouse, INSERM, UMR1027, F-31073 Toulouse, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte; CHU Besancon; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; CHR Metz-Thionville; Universite de Lille - ISITE; CHU Lille; Novo Nordisk; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm)	Danchin, N (corresponding author), Univ Paris 05, Hop Europeen Georges Pompidou, AP HP, Dept Cardiol, 20 Rue Leblanc, F-75015 Paris, France.	nicolas.danchin@egp.aphp.fr	Danchin, Nicolas/AAN-8291-2020; Puymirat, Etienne/AAP-8895-2021; STEG, Philippe Gabriel/Z-1567-2019; Ferrieres, Jean/S-7993-2016	Puymirat, Etienne/0000-0002-0533-9682; Ferrieres, Jean/0000-0001-6144-1297; SIMON, Tabassome/0000-0002-4550-0450; STEG, Philippe Gabriel/0000-0001-6896-2941	Astra-Zeneca; Daiichi-Sankyo; Eli-Lilly; Glaxo-Smith-Kline; MSD; Novartis; Pfizer; sanofi-aventis; Servier; AstraZeneca; Bayer-Schering; NYU School of Medicine; Ablynx; Amarin; Astellas; Bayer; Boehringer-Ingelheim; BMS; Daiichi-Sankyo-Lilly; GSK; Medtronic; Otsuka; Roche; Medicines Company; Lilly; Takeda; Toshiba; General Electric Systems; Ipsen; Lilly Daiichi Sankyo; Boehringer Ingelheim; Boston Scientific; Genzyme; Merck; Bristol-Myers Squibb; Menarini; Merck-Serono; Novo-Nordisk; Laboratoire Roussel; Aventis-France; Caisse Nationale d'Assurance Maladie-Travailleurs Salaries; Daiichi-Sankyo-Eli-Lilly alliance; GlaxoSmithKline; French Society of Cardiology	Astra-Zeneca(AstraZeneca); Daiichi-Sankyo(Daiichi Sankyo Company Limited); Eli-Lilly(Eli Lilly); Glaxo-Smith-Kline(GlaxoSmithKline); MSD; Novartis(Novartis); Pfizer(Pfizer); sanofi-aventis(Sanofi-Aventis); Servier(Servier); AstraZeneca(AstraZeneca); Bayer-Schering(Bayer AG); NYU School of Medicine; Ablynx(Ablynx); Amarin; Astellas(Astellas Pharmaceuticals); Bayer(Bayer AG); Boehringer-Ingelheim(Boehringer Ingelheim); BMS(Bristol-Myers Squibb); Daiichi-Sankyo-Lilly(Daiichi Sankyo Company LimitedEli Lilly); GSK(GlaxoSmithKline); Medtronic(Medtronic); Otsuka(Otsuka Pharmaceutical); Roche(Roche Holding); Medicines Company; Lilly(Eli Lilly); Takeda(Takeda Pharmaceutical Company Ltd); Toshiba; General Electric Systems(General Electric); Ipsen(Ipsen); Lilly Daiichi Sankyo(Daiichi Sankyo Company LimitedEli Lilly); Boehringer Ingelheim(Boehringer Ingelheim); Boston Scientific(Boston Scientific); Genzyme(Sanofi-AventisGenzyme Corporation); Merck(Merck & Company); Bristol-Myers Squibb(Bristol-Myers Squibb); Menarini(Menarini Group); Merck-Serono(Merck & Company); Novo-Nordisk(Novo Nordisk); Laboratoire Roussel; Aventis-France(Sanofi-Aventis); Caisse Nationale d'Assurance Maladie-Travailleurs Salaries; Daiichi-Sankyo-Eli-Lilly alliance(Daiichi Sankyo Company Limited); GlaxoSmithKline(GlaxoSmithKline); French Society of Cardiology	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Simon reported receiving research grants: Astra-Zeneca, Daiichi-Sankyo, Eli-Lilly, Glaxo-Smith-Kline, MSD, Novartis, Pfizer, sanofi-aventis, and Servier and speaker and consulting fees: AstraZeneca, Bayer-Schering, Eli-Lilly, and sanofi-aventis. Dr Steg reported receiving institutional research grant support: NYU School of Medicine, sanofi-aventis, and Servier; Consulting/advisory board fees: Ablynx, Amarin, Astellas, AstraZeneca, Bayer, Boehringer-Ingelheim, BMS, Daiichi-Sankyo-Lilly, GSK, Medtronic, MSD, Novartis, Otsuka, Pfizer, Roche, sanofi-aventis, Servier, and The Medicines Company; and being a stockholder and co-founder: Aterovax. Dr Schiele reported receiving grant support to his institution and travel support for scientific meetings: AstraZeneca, Boehringer-Ingelheim, Daiichi-Sankyo, Lilly, Medtronic, Pfizer; sanofi-aventis, Servier, and Takeda. Dr Gueret reported receiving research grants: Toshiba and General Electric Systems and consulting and speaker's fees: Boehringer-Ingelheim, Daiichi-Sankyo, Eli-Lilly, General Electric Systems, Ipsen, Pfizer, sanofi-aventis, and Servier. Dr Goldstein reported speaker, board membership, and consulting fees: Boeringer-Ingelheim, The Medicines Company, sanofi-aventis, BMS, AstraZeneca, Bayer, and Lilly Daiichi Sankyo. Dr Cattan reported receiving grants: AstraZeneca, Boehringer Ingelheim, Boston Scientific, Medtronic, and Servier. Dr Vaur reported being a former full-time employee of Roussel and Aventis-France and being currently employed at Novo-Nordisk. Dr Ferrieres reported receiving grants and speaker fees: AstraZeneca, Genzyme, Merck, Novartis, and Servier. Dr Danchin reported receiving research grants: AstraZeneca, Daiichi-Sankyo, Eli-Lilly, Glaxo-Smith-Kline, MSD, Novartis, Pfizer, sanofi-aventis, Servier, and The Medicines Company and advisory panels or lecture fees: AstraZeneca, Boehringer-Ingelheim, Bristol-Myers Squibb, Eli-Lilly, Menarini, Merck-Serono, Novo-Nordisk, Servier, and sanofi-aventis. Drs Puymirat, Blanchard, Khalife, and Cambou reported no conflicts of interest.; USIK 1995 was funded by Laboratoire Roussel, which was involved in the design and conduct of the study, as well as data collection and management. USIC 2000 was funded by Aventis-France, which was involved in the design and conduct of the study, as well as data collection and management. FAST-MI 2005 and FAST-MI 2010 are registries of the French Society of Cardiology. FAST-MI 2005 was supported by unrestricted grants from Pfizer and Servier, and an additional grant from the Caisse Nationale d'Assurance Maladie-Travailleurs Salaries. FAST-MI 2010 was supported by unrestricted grants from AstraZeneca, the Daiichi-Sankyo-Eli-Lilly alliance, GlaxoSmithKline, Merck, Novartis, and sanofi-aventis. Sophie Rushton-Smith provided editorial assistance on the first submitted version of the manuscript and was funded by the French Society of Cardiology.	Beck F., 2011, Bulletin Epidemiologique Hebdomadaire, P230; Berry JD, 2012, NEW ENGL J MED, V366, P321, DOI 10.1056/NEJMoa1012848; Cambou JP, 2007, ARCH MAL COEUR VAISS, V100, P524; Danchin N, 1997, J AM COLL CARDIOL, V30, P1598, DOI 10.1016/S0735-1097(97)00371-9; Danchin N, 1999, CIRCULATION, V99, P2639, DOI 10.1161/01.CIR.99.20.2639; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Ford ES, 2012, CIRCULATION, V125, P987, DOI 10.1161/CIRCULATIONAHA.111.049122; Fox KAA, 2007, JAMA-J AM MED ASSOC, V297, P1892, DOI 10.1001/jama.297.17.1892; Gale CP, 2009, HEART, V95, P221, DOI 10.1136/hrt.2008.144022; Hanania G, 2004, HEART, V90, P1404, DOI 10.1136/hrt.2003.025460; Hanssen M, 2012, HEART, V98, P699, DOI 10.1136/heartjnl-2012-301700; Hardoon SL, 2008, CIRCULATION, V117, P598, DOI 10.1161/CIRCULATIONAHA.107.705947; Jernberg T, 2011, JAMA-J AM MED ASSOC, V305, P1677, DOI 10.1001/jama.2011.522; Kostis WJ, 2010, CIRC-CARDIOVASC QUAL, V3, P581, DOI 10.1161/CIRCOUTCOMES.110.957803; Movahed MR, 2009, AM J CARDIOL, V104, P1030, DOI 10.1016/j.amjcard.2009.05.051; Rogers WJ, 2008, AM HEART J, V156, P1026, DOI 10.1016/j.ahj.2008.07.030; Rosamond WD, 2012, CIRCULATION, V125, P1848, DOI 10.1161/CIRCULATIONAHA.111.047480; Schiele F, 2010, EUR HEART J, V31, P2614, DOI 10.1093/eurheartj/ehq305; Steiger VS, 2009, SWISS MED WKLY, V139, P453, DOI smw-12607; Wagner A., 2011, BEH, V40-41, P414; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610	21	319	334	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2012	308	10					998	1006		10.1001/2012.jama.11348	http://dx.doi.org/10.1001/2012.jama.11348			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003AA	22928184	Bronze			2022-12-24	WOS:000308579300023
J	Wadham, JL; Arndt, S; Tulaczyk, S; Stibal, M; Tranter, M; Telling, J; Lis, GP; Lawson, E; Ridgwell, A; Dubnick, A; Sharp, MJ; Anesio, AM; Butler, CEH				Wadham, J. L.; Arndt, S.; Tulaczyk, S.; Stibal, M.; Tranter, M.; Telling, J.; Lis, G. P.; Lawson, E.; Ridgwell, A.; Dubnick, A.; Sharp, M. J.; Anesio, A. M.; Butler, C. E. H.			Potential methane reservoirs beneath Antarctica	NATURE			English	Article							GAS-HYDRATE; PRODUCTION-RATES; CASCADIA MARGIN; ICE-SHEET; SEDIMENTS; DEEP; LAKE; GEOCHEMISTRY; POPULATIONS; DIAGENESIS	Once thought to be devoid of life, the ice-covered parts of Antarctica are now known to be a reservoir of metabolically active microbial cells and organic carbon(1). The potential for methanogenic archaea to support the degradation of organic carbon to methane beneath the ice, however, has not yet been evaluated. Large sedimentary basins containing marine sequences up to 14 kilometres thick(2) and an estimated 21,000 petagrams (1 Pg equals 10(15) g) of organic carbon are buried beneath the Antarctic Ice Sheet. No data exist for rates of methanogenesis in sub-Antarctic marine sediments. Here we present experimental data from other subglacial environments that demonstrate the potential for overridden organic matter beneath glacial systems to produce methane. We also numerically simulate the accumulation of methane in Antarctic sedimentary basins using an established one-dimensional hydrate model(3) and show that pressure/temperature conditions favour methane hydrate formation down to sediment depths of about 300 metres in West Antarctica and 700 metres in East Antarctica. Our results demonstrate the potential for methane hydrate accumulation in Antarctic sedimentary basins, where the total inventory depends on rates of organic carbon degradation and conditions at the ice-sheet bed. We calculate that the sub-Antarctic hydrate inventory could be of the same order of magnitude as that of recent estimates made for Arctic permafrost. Our findings suggest that the Antarctic Ice Sheet may be a neglected but important component of the global methane budget, with the potential to act as a positive feedback on climate warming during ice-sheet wastage.	[Wadham, J. L.; Arndt, S.; Stibal, M.; Tranter, M.; Telling, J.; Lis, G. P.; Lawson, E.; Ridgwell, A.; Anesio, A. M.; Butler, C. E. H.] Univ Bristol, Sch Geog Sci, Bristol BS8 1SS, Avon, England; [Arndt, S.] Univ Utrecht, Dept Earth Sci Geochem, NL-3508 Utrecht, Netherlands; [Tulaczyk, S.; Sharp, M. J.] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Dubnick, A.] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada	University of Bristol; Utrecht University; University of California System; University of California Santa Cruz; University of Alberta	Wadham, JL (corresponding author), Univ Bristol, Sch Geog Sci, Bristol BS8 1SS, Avon, England.	j.l.wadham@bris.ac.uk	Stibal, Marek/I-3852-2016; Wadham, Jemma L/G-3138-2014; Wadham, Jemma L/A-8352-2012; Telling, Jon/M-7643-2013; Tranter, Martyn/E-3722-2010; Arndt, Sandra/E-7639-2017; Ridgwell, Andy/AAD-9487-2021; Tulaczyk, Slawek/O-7375-2018; Anesio, Alexandre/A-7597-2008	Stibal, Marek/0000-0002-9998-5086; Tranter, Martyn/0000-0003-2071-3094; Arndt, Sandra/0000-0002-0235-8124; Ridgwell, Andy/0000-0003-2333-0128; Tulaczyk, Slawek/0000-0002-9711-4332; Anesio, Alexandre/0000-0003-2990-4014; O'Donnell, Emily/0000-0003-4303-4705; Telling, Jon/0000-0002-8180-0979; Lis, Grzegorz/0000-0001-5796-7798	Natural Environment Research Council (UK-NERC) [NE/E004016/1]; National Science Foundation WISSARD project [NSF-AISS 0839142]; Leverhulme Trust via a Phillip Leverhulme award; Netherlands Organisation for Scientific Research (NWO); NSERC; Antarctica New Zealand; Polar Continental Shelf Project; NSERC Undergraduate Student Research Award; US National Science Foundation; Natural Environment Research Council [NE/I021322/1, NE/E004016/1] Funding Source: researchfish; NERC [NE/E004016/1, NE/I021322/1] Funding Source: UKRI; Directorate For Geosciences [0838947, 0839142] Funding Source: National Science Foundation	Natural Environment Research Council (UK-NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); National Science Foundation WISSARD project; Leverhulme Trust via a Phillip Leverhulme award; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Antarctica New Zealand; Polar Continental Shelf Project(Natural Resources Canada); NSERC Undergraduate Student Research Award(Natural Sciences and Engineering Research Council of Canada (NSERC)); US National Science Foundation(National Science Foundation (NSF)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was funded by the Natural Environment Research Council (UK-NERC grant NE/E004016/1) and the National Science Foundation WISSARD project (NSF-AISS 0839142). Support to J.L.W. was also provided by the Leverhulme Trust via a Phillip Leverhulme award and to S. A. by the Netherlands Organisation for Scientific Research (NWO). We acknowledge NSERC and Antarctica New Zealand for financial and logistic support for sampling in Antarctica and the Polar Continental Shelf Project for financial and logistic support for sampling in Arctic Canada. We thank S. Fitzsimons for assistance with sampling in Antarctica. A. D. was funded by an NSERC Undergraduate Student Research Award. This research used data provided by the Ocean Drilling Program. The Ocean Drilling Program is sponsored by the US National Science Foundation and participating countries under the management of the Joint Oceanographic Institutions, Inc. We thank C. Ruppel for comments on this manuscript.	Archer D, 2007, BIOGEOSCIENCES, V4, P521, DOI 10.5194/bg-4-521-2007; Barker P. F., 1999, P ODP INIT REP, V178, P60; Boswell R, 2011, ENERG ENVIRON SCI, V4, P1206, DOI 10.1039/c0ee00203h; BOUDREAU BP, 1991, AM J SCI, V291, P507, DOI 10.2475/ajs.291.5.507; Boyd ES, 2010, ENV MICROBIOL REP, V2, P685, DOI 10.1111/j.1758-2229.2010.00162.x; Claypool G., 2004, PROC OCEAN DRILL SCI, V188, P1, DOI DOI 10.2973/0DP.PR0C.SR.188.004.2003; Colwell FS, 2008, APPL ENVIRON MICROB, V74, P3444, DOI 10.1128/AEM.02114-07; Cragg BA, 1996, EARTH PLANET SC LETT, V139, P497, DOI 10.1016/0012-821X(95)00246-9; Davie MK, 2001, J GEOPHYS RES-SOL EA, V106, P497, DOI 10.1029/2000JB900363; Dickens GR, 1997, NATURE, V385, P426, DOI 10.1038/385426a0; Dyke A. S., 1987, MAP GEOLOGICAL SURVE; ELLISEVANS JC, 1984, POLAR BIOL, V3, P63, DOI 10.1007/BF00258149; Etiope G, 2002, CHEMOSPHERE, V49, P777, DOI 10.1016/S0045-6535(02)00380-6; Ferraccioli F, 2009, TECTONOPHYSICS, V478, P62, DOI 10.1016/j.tecto.2009.03.013; FRANZMANN PD, 1991, HYDROBIOLOGIA, V210, P191, DOI 10.1007/BF00034677; Houghton RA, 2007, ANNU REV EARTH PL SC, V35, P313, DOI 10.1146/annurev.earth.35.031306.140057; Kotsyurbenko OR, 2004, ENVIRON MICROBIOL, V6, P1159, DOI 10.1111/j.1462-2920.2004.00634.x; Lanoil B, 2009, ENVIRON MICROBIOL, V11, P609, DOI 10.1111/j.1462-2920.2008.01831.x; Maule CF, 2005, SCIENCE, V309, P464, DOI 10.1126/science.1106888; MEYERS PA, 1993, ORG GEOCHEM, V20, P867, DOI 10.1016/0146-6380(93)90100-P; PARKES RJ, 1990, PHILOS T R SOC A, V331, P139, DOI 10.1098/rsta.1990.0061; Pattyn F, 2010, EARTH PLANET SC LETT, V295, P451, DOI 10.1016/j.epsl.2010.04.025; Pollard D, 2009, NATURE, V458, P329, DOI 10.1038/nature07809; Priscu J, 2009, POLAR LAKES RIVERS, P320; Reeburgh W. S., 1993, P1; SMITH RL, 1993, BIOGEOCHEMISTRY, V21, P95, DOI 10.1007/BF00000873; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; Torres ME, 2002, EARTH PLANET SC LETT, V201, P525, DOI 10.1016/S0012-821X(02)00733-1; Wadham JL, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002951; Wallmann K, 2006, EARTH PLANET SC LETT, V248, P545, DOI 10.1016/j.epsl.2006.06.026; Wellsbury P, 2002, FEMS MICROBIOL ECOL, V42, P59, DOI 10.1111/j.1574-6941.2002.tb00995.x; Yoshioka H, 2009, GEOCHEM J, V43, P315, DOI 10.2343/geochemj.1.0028	32	113	121	8	227	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2012	488	7413					633	637		10.1038/nature11374	http://dx.doi.org/10.1038/nature11374			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996NC	22932387				2022-12-24	WOS:000308095100051
J	Hu, ZT; Hom, S; Kudze, T; Tong, XJ; Choi, S; Aramuni, G; Zhang, WQ; Kaplan, JM				Hu, Zhitao; Hom, Sabrina; Kudze, Tambudzai; Tong, Xia-Jing; Choi, Seungwon; Aramuni, Gayane; Zhang, Weiqi; Kaplan, Joshua M.			Neurexin and Neuroligin Mediate Retrograde Synaptic Inhibition in C. elegans	SCIENCE			English	Article							SPECTRUM DISORDERS; AUTISM; MATURATION; MUTATIONS; CELL	The synaptic adhesion molecules neurexin and neuroligin alter the development and function of synapses and are linked to autism in humans. Here, we found that Caenorhabditis elegans neurexin (NRX-1) and neuroligin (NLG-1) mediated a retrograde synaptic signal that inhibited neurotransmitter release at neuromuscular junctions. Retrograde signaling was induced in mutants lacking a muscle microRNA (miR-1) and was blocked in mutants lacking NLG-1 or NRX-1. Release was rapid and abbreviated when the retrograde signal was on, whereas release was slow and prolonged when retrograde signaling was blocked. The retrograde signal adjusted release kinetics by inhibiting exocytosis of synaptic vesicles (SVs) that are distal to the site of calcium entry. Inhibition of release was mediated by increased presynaptic levels of tomosyn, an inhibitor of SV fusion.	[Hu, Zhitao; Hom, Sabrina; Kudze, Tambudzai; Tong, Xia-Jing; Choi, Seungwon; Kaplan, Joshua M.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Hu, Zhitao; Hom, Sabrina; Tong, Xia-Jing; Choi, Seungwon; Kaplan, Joshua M.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Hom, Sabrina; Choi, Seungwon; Kaplan, Joshua M.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Aramuni, Gayane] Max Planck Inst Neurobiol, D-82152 Martinsried, Germany; [Zhang, Weiqi] Univ Munster, Dept Psychiat, D-48149 Munster, Germany	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Max Planck Society; University of Munster	Kaplan, JM (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	kaplan@molbio.mgh.harvard.edu		Choi, Seungwon/0000-0002-8644-3659; Hu, Zhitao/0000-0002-2948-3339	NSF; NIH [NS32196]; Simons Foundation for Autism Research [SF177948]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032196, R37NS032196] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation for Autism Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the following for strains, advice, reagents, and comments on the manuscript: C. elegans stock center, S. Mitani, S. Sassi, B. Seed, and members of the Kaplan and Ruvkun labs. This work was supported by an NSF predoctoral fellowship (S. H.) and by research grants to J.M.K. from the NIH (NS32196) and from the Simons Foundation for Autism Research (SF177948). Additional data described in the manuscript are presented in the supplementary materials.	Arnold PD, 2006, ARCH GEN PSYCHIAT, V63, P769, DOI 10.1001/archpsyc.63.7.769; Atluri PP, 1996, J NEUROSCI, V16, P5661; Bai JH, 2010, CELL, V143, P430, DOI 10.1016/j.cell.2010.09.024; Chen KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011115; Etherton M, 2011, P NATL ACAD SCI USA, V108, P13764, DOI 10.1073/pnas.1111093108; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Foss-Feig JH, 2010, EXP BRAIN RES, V203, P381, DOI 10.1007/s00221-010-2240-4; Futai K, 2007, NAT NEUROSCI, V10, P186, DOI 10.1038/nn1837; Gracheva EO, 2006, PLOS BIOL, V4, P1426, DOI 10.1371/journal.pbio.0040261; Hoon M, 2011, P NATL ACAD SCI USA, V108, P3053, DOI 10.1073/pnas.1006946108; Hunter JW, 2010, DIS MODEL MECH, V3, P366, DOI 10.1242/dmm.003442; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kattenstroth G, 2004, P NATL ACAD SCI USA, V101, P2607, DOI 10.1073/pnas.0308626100; Liu Q, 2005, J NEUROSCI, V25, P6745, DOI 10.1523/JNEUROSCI.1730-05.2005; McEwen JM, 2006, NEURON, V51, P303, DOI 10.1016/j.neuron.2006.06.025; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Novara F, 2010, CLIN GENET, V78, P471, DOI 10.1111/j.1399-0004.2010.01413.x; Roberts TPL, 2010, AUTISM RES, V3, P8, DOI 10.1002/aur.111; Simon DJ, 2008, CELL, V133, P903, DOI 10.1016/j.cell.2008.04.035; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Taniguchi H, 2007, J NEUROSCI, V27, P2815, DOI 10.1523/JNEUROSCI.0032-07.2007; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104; Wittenmayer N, 2009, P NATL ACAD SCI USA, V106, P13564, DOI 10.1073/pnas.0905819106	24	72	75	2	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 24	2012	337	6097					980	984		10.1126/science.1224896	http://dx.doi.org/10.1126/science.1224896			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992VI	22859820	Green Accepted			2022-12-24	WOS:000307807600049
J	Lasker, SS; Chowdhury, TA				Lasker, Shawarna S.; Chowdhury, Tahseen A.			Myalgia while taking statins	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Chowdhury, Tahseen A.] Royal London Hosp, Dept Diabet & Metab, London E1 1BB, England	Barts Health NHS Trust; Royal London Hospital	Chowdhury, TA (corresponding author), Royal London Hosp, Dept Diabet & Metab, London E1 1BB, England.	Tahseen.Chowdhury@bartshealth.nhs.uk						Eckel RH, 2010, J CLIN ENDOCR METAB, V95, P2015, DOI 10.1210/jc.2009-2689; Stein EA, 2008, AM J CARDIOL, V101, P490, DOI 10.1016/j.amjcard.2007.09.099	2	5	5	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 14	2012	345								e5348	10.1136/bmj.e5348	http://dx.doi.org/10.1136/bmj.e5348			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992CD	22893641				2022-12-24	WOS:000307752000005
J	Becker, WC; Fiellin, DA				Becker, William C.; Fiellin, David A.			Federal Plan for Prescriber Education on Opioids Misses Opportunities	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							OVERDOSE; PAIN		[Becker, William C.; Fiellin, David A.] Yale Univ, Sch Med, New Haven, CT 06520 USA	Yale University	Becker, WC (corresponding author), Yale Univ, Sch Med, 367 Cedar St,POB 208056, New Haven, CT 06520 USA.	william.becker@yale.edu		Becker, William/0000-0002-0788-1467; Fiellin, David/0000-0002-4006-010X	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA020795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020576, R01DA025991] Funding Source: NIH RePORTER; NIAAA NIH HHS [U01 AA020795] Funding Source: Medline; NIDA NIH HHS [R01 DA020576, R01 DA025991] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		American Medical Association, 2011, 1 AM MED ASS COUNC E; Center for Substance Abuse Treatment, 2004, TREATM IMPR PROT TIP, V40; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P869; Dunn KM, 2010, ANN INTERN MED, V152, P85, DOI 10.7326/0003-4819-152-2-201001190-00006; Egan JE, 2010, J GEN INTERN MED, V25, P936, DOI 10.1007/s11606-010-1377-y; FDA, 2011, FED REG; Food and Drug Administration, BLUEPR PRESCR CONT E; Holmboe ES, 2008, J CONTIN EDUC HEALTH, V28, pS4, DOI 10.1002/chp.200; Institute of Medicine, 2009, CONFL INT MED RES ED; Institute of Medicine, 2007, FUT DRUG SAF PROM PR; McLellan AT, 2010, ANN INTERN MED, V152, P123, DOI 10.7326/0003-4819-152-2-201001190-00012; Meier Barry, 2007, NY TIMES; Office of National Drug Control Policy US Executive Office of the President, 2011, EP RESP AM PRESCR DR; Rothman DJ, 2009, JAMA-J AM MED ASSOC, V301, P1367, DOI 10.1001/jama.2009.407	14	9	9	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 7	2012	157	3					205	+		10.7326/0003-4819-156-11-201206050-00448	http://dx.doi.org/10.7326/0003-4819-156-11-201206050-00448			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992PB	22868838				2022-12-24	WOS:000307789900007
J	Rand, DG; Greene, JD; Nowak, MA				Rand, David G.; Greene, Joshua D.; Nowak, Martin A.			Spontaneous giving and calculated greed	NATURE			English	Article							EVOLUTION; COOPERATION; SYSTEMS	Cooperation is central to human social behaviour(1-9). However, choosing to cooperate requires individuals to incur a personal cost to benefit others. Here we explore the cognitive basis of cooperative decision-making in humans using a dual-process framework(10-18). We ask whether people are predisposed towards selfishness, behaving cooperatively only through active self-control; or whether they are intuitively cooperative, with reflection and prospective reasoning favouring 'rational' self-interest. To investigate this issue, we perform ten studies using economic games. We find that across a range of experimental designs, subjects who reach their decisions more quickly are more cooperative. Furthermore, forcing subjects to decide quickly increases contributions, whereas instructing them to reflect and forcing them to decide slowly decreases contributions. Finally, an induction that primes subjects to trust their intuitions increases contributions compared with an induction that promotes greater reflection. To explain these results, we propose that cooperation is intuitive because cooperative heuristics are developed in daily life where cooperation is typically advantageous. We then validate predictions generated by this proposed mechanism. Our results provide convergent evidence that intuition supports cooperation in social dilemmas, and that reflection can undermine these cooperative impulses.	[Rand, David G.; Nowak, Martin A.] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Rand, David G.; Greene, Joshua D.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Rand, David G.] Yale Univ, Dept Psychol, New Haven, CT 06520 USA; [Nowak, Martin A.] Harvard Univ, Dept Math, Cambridge, MA 02138 USA; [Nowak, Martin A.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University; Yale University; Harvard University; Harvard University	Rand, DG (corresponding author), Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA.	drand@fas.harvard.edu	Rand, David G./B-3716-2009; Nowak, Martin A/A-6977-2008	Rand, David G./0000-0002-2821-468X; Rand, David/0000-0001-8975-2783	National Science Foundation [SES-0821978]; John Templeton Foundation; Direct For Social, Behav & Economic Scie [0821978] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); John Templeton Foundation; Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	We thank H. Ahlblad, O. Amir, F. Fu, O. Hauser, J. Horton and R. Kane for assistance with carrying out the experiments, and P. Blake, S. Bowles, N. Christakis, F. Cushman, A. Dreber, T. Ellingsen, F. Fu, D. Fudenberg, O. Hauser, J. Jordan, M. Johannesson, M. Manapat, J. Paxton, A. Peysakhovich, A. Shenhav, J. Sirlin-Rand, M. van Veelen and O. Wurzbacher for discussion and comments. This work was supported in part by a National Science Foundation grant (SES-0821978 to J. D. G.). D. G. R. and M. A. N. are supported by grants from the John Templeton Foundation.	Benhabib J, 2005, GAME ECON BEHAV, V52, P460, DOI 10.1016/j.geb.2004.10.004; Bowles S, 2002, EC EVOLVING COMPLEX, V3, P339; Bowles S, 2008, SCIENCE, V320, P1605, DOI 10.1126/science.1152110; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Boyd R., 2005, ORIGIN EVOLUTION CUL; Chen S, 1999, DUAL-PROCESS THEORIES IN SOCIAL PSYCHOLOGY, P73; Dreber A, 2008, NATURE, V452, P348, DOI 10.1038/nature06723; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Frederick S, 2005, J ECON PERSPECT, V19, P25, DOI 10.1257/089533005775196732; FUDENBERG D, 1986, ECONOMETRICA, V54, P533, DOI 10.2307/1911307; Fudenberg D, 2006, AM ECON REV, V96, P1449, DOI 10.1257/aer.96.5.1449; Fudenberg D, 2012, AM ECON REV, V102, P720, DOI 10.1257/aer.102.2.720; Horton JJ, 2011, EXP ECON, V14, P399, DOI 10.1007/s10683-011-9273-9; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; Kahneman D., 2011, THINKING FAST SLOW; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Pfeiffer T., 2012, J R SOC INTERFACE; Plessner H, 2008, INTUITION IN JUDGMENT AND DECISION MAKING, P1; Rand DG, 2011, P NATL ACAD SCI USA, V108, P19193, DOI 10.1073/pnas.1108243108; Rand DG, 2009, SCIENCE, V325, P1272, DOI 10.1126/science.1177418; Rockenbach B, 2006, NATURE, V444, P718, DOI 10.1038/nature05229; Shenhav A, 2012, J EXP PSYCHOL GEN, V141, P423, DOI 10.1037/a0025391; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Sloman SA, 1996, PSYCHOL BULL, V119, P3, DOI 10.1037/0033-2909.119.1.3; Stanovich KE, 1998, J EXP PSYCHOL GEN, V127, P161, DOI 10.1037/0096-3445.127.2.161; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Warneken F, 2006, SCIENCE, V311, P1301, DOI 10.1126/science.1121448	30	715	737	33	412	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 20	2012	489	7416					427	430		10.1038/nature11467	http://dx.doi.org/10.1038/nature11467			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	007AK	22996558				2022-12-24	WOS:000308860900044
J	Takahashi, S; Brunel, LC; Edwards, DT; van Tol, J; Ramian, G; Han, S; Sherwin, MS				Takahashi, S.; Brunel, L. -C.; Edwards, D. T.; van Tol, J.; Ramian, G.; Han, S.; Sherwin, M. S.			Pulsed electron paramagnetic resonance spectroscopy powered by a free-electron laser	NATURE			English	Article							SPIN-RESONANCE; DISTANCE MEASUREMENTS; GENERATION; SPECTROMETER; COMPOSITES; SWITCHES; FIELD; ESR	Electron paramagnetic resonance (EPR) spectroscopy interrogates unpaired electron spins in solids and liquids to reveal local structure and dynamics; for example, EPR has elucidated parts of the structure of protein complexes that other techniques in structural biology have not been able to reveal(1-4). EPR can also probe the interplay of light and electricity in organic solar cells(5-7) and light-emitting diodes(8), and the origin of decoherence in condensed matter, which is of fundamental importance to the development of quantum information processors(9-13). Like nuclear magnetic resonance, EPR spectroscopy becomes more powerful at high magnetic fields and frequencies, and with excitation by coherent pulses rather than continuous waves. However, the difficulty of generating sequences of powerful pulses at frequencies above 100 gigahertz has, until now, confined high-power pulsed EPR to magnetic fields of 3.5 teslas and below. Here we demonstrate that one-kilowatt pulses from a free-electron laser can power a pulsed EPR spectrometer at 240 gigahertz (8.5 teslas), providing transformative enhancements over the alternative, a state-of-the-art similar to 30-milliwatt solid-state source. Our spectrometer can rotate spin-1/2 electrons through pi/2 in only 6 nanoseconds (compared to 300 nanoseconds with the solid-state source). Fourier-transform EPR on nitrogen impurities in diamond demonstrates excitation and detection of EPR lines separated by about 200 megahertz. We measured decoherence times as short as 63 nanoseconds, in a frozen solution of nitroxide free-radicals at temperatures as high as 190 kelvin. Both free-electron lasers and the quasi-optical technology developed for the spectrometer are scalable to frequencies well in excess of one terahertz, opening the way to high-power pulsed EPR spectroscopy up to the highest static magnetic fields currently available.	[Takahashi, S.; Brunel, L. -C.; Han, S.; Sherwin, M. S.] Univ Calif Santa Barbara, Inst Terahertz Sci & Technol, Santa Barbara, CA 93106 USA; [Takahashi, S.] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA; [Edwards, D. T.; Sherwin, M. S.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [van Tol, J.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; [Han, S.] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of Southern California; University of California System; University of California Santa Barbara; State University System of Florida; Florida State University; University of California System; University of California Santa Barbara	Sherwin, MS (corresponding author), Univ Calif Santa Barbara, Inst Terahertz Sci & Technol, Santa Barbara, CA 93106 USA.	sherwin@physics.ucsb.edu	van Tol, Johan/G-4190-2011; Han, Songi/E-4723-2012; Sherwin, Mark S/Q-4762-2017; Takahashi, Susumu/K-2616-2014; Takahashi, Susumu/ABI-2675-2020	van Tol, Johan/0000-0001-6972-2149; Han, Songi/0000-0001-6489-6246; Sherwin, Mark S/0000-0002-3869-1893; Takahashi, Susumu/0000-0002-1302-2845; Takahashi, Susumu/0000-0002-1302-2845; EDWARDS, DEVIN/0000-0002-2612-9561	NSF [CHE-0821589, DMR-0520481, DMR-0703925]; W. M. Keck Foundation; Division Of Chemistry [0821589] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); W. M. Keck Foundation(W.M. Keck Foundation); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by the NSF (CHE-0821589, DMR-0520481 and DMR-0703925) and the W. M. Keck Foundation. We thank D. Enyeart, S. El Abbadi, N. Krauss, K. Akabori, M. Anholm, T. Visher, J. Bricker and G. Kontsevich for support of the development and operation of the FEL.	Borbat PP, 1999, CHEM PHYS LETT, V313, P145, DOI 10.1016/S0009-2614(99)00972-0; Cruickshank PAS, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3239402; Doty MF, 2004, REV SCI INSTRUM, V75, P2921, DOI 10.1063/1.1783594; Dyakonov V, 1999, PHYS REV B, V59, P8019, DOI 10.1103/PhysRevB.59.8019; Earle KA, 2005, MAGN RESON CHEM, V43, pS256, DOI 10.1002/mrc.1684; Freed JH, 2000, ANNU REV PHYS CHEM, V51, P655, DOI 10.1146/annurev.physchem.51.1.655; Gruber A, 1997, SCIENCE, V276, P2012, DOI 10.1126/science.276.5321.2012; Hanson R, 2007, REV MOD PHYS, V79, P1217, DOI 10.1103/RevModPhys.79.1217; Hegmann FA, 1996, P SOC PHOTO-OPT INS, V2842, P90; Hofbauer W, 2004, REV SCI INSTRUM, V75, P1194, DOI 10.1063/1.1710700; Hubbell WL, 1996, STRUCTURE, V4, P779, DOI 10.1016/S0969-2126(96)00085-8; Lyon SA, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.052338; McCamey DR, 2008, NAT MATER, V7, P723, DOI 10.1038/nmat2252; Mitsudo S., 2010, P IRMMW THZ 2010; Nanni E. A., 2010, 2010 IEEE INT VAC EL; Ogiwara T, 2005, CHEM PHYS LETT, V411, P378, DOI 10.1016/j.cplett.2005.06.066; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Rabi II, 1937, PHYS REV, V51, P0652, DOI 10.1103/PhysRev.51.652; RAMIAN G, 1992, NUCL INSTRUM METH A, V318, P225, DOI 10.1016/0168-9002(92)91056-F; ROLLAND C, 1986, J OPT SOC AM B, V3, P1625, DOI 10.1364/JOSAB.3.001625; Saxena S, 1996, CHEM PHYS LETT, V251, P102, DOI 10.1016/0009-2614(96)00075-9; SMILOWITZ L, 1993, PHYS REV B, V47, P13835, DOI 10.1103/PhysRevB.47.13835; Smith GM, 1998, REV SCI INSTRUM, V69, P3924, DOI 10.1063/1.1149200; Takahashi S, 2011, NATURE, V476, P76, DOI 10.1038/nature10314; Takahashi S, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2801700; Takahashi S, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3270041; Takahashi S, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.047601; van Tol J, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1942533; van Tol J, 2009, APPL MAGN RESON, V36, P259, DOI 10.1007/s00723-009-0014-6	29	56	57	4	151	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2012	489	7416					409	413		10.1038/nature11437	http://dx.doi.org/10.1038/nature11437			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AK	22996555				2022-12-24	WOS:000308860900040
J	Andersson, C; Lyngbaek, S; Nguyen, CD; Nielsen, M; Gislason, GH; Kober, L; Torp-Pedersen, C				Andersson, Charlotte; Lyngbaek, Stig; Cu Dinh Nguyen; Nielsen, Mia; Gislason, Gunnar H.; Kober, Lars; Torp-Pedersen, Christian			Association of Clopidogrel Treatment With Risk of Mortality and Cardiovascular Events Following Myocardial Infarction in Patients With and Without Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERCUTANEOUS CORONARY INTERVENTION; ORAL ANTIPLATELET THERAPY; ARTERY-DISEASE; PRACTICE GUIDELINES; FOCUSED UPDATE; HEART-FAILURE; TASK-FORCE; ASPIRIN; PRASUGREL; INHIBITION	Context Pharmacodynamic studies have shown that persistently high platelet reactivity is common in patients with diabetes in spite of clopidogrel treatment. Clinical trials have not convincingly demonstrated that clopidogrel benefits patients with diabetes as much patients without diabetes. Objectives To estimate the clinical effectiveness associated with clopidogrel treatment after myocardial infarction (MI) in patients with diabetes. Design, Setting, and Patients By individual-level linkage of the Danish nationwide administrative registries between 2002-2009, patients who were hospitalized with incident MI and who had survived and not undergone coronary artery bypass surgery 30 days after discharge were followed up for as long as 1 year (maximally until December 31, 2009). Adjusted for age, sex, comorbidity, calendar year, concomitant pharmacotherapy, and invasive interventions, hazard ratios that were associated with clopidogrel in patients with and without diabetes were analyzed by Cox proportional-hazard models and propensity score-matched models. Main Outcome Measures All-cause mortality, cardiovascular mortality, and a composite end point of recurrent MI and all-cause mortality. Results Of the 58 851 patients included in the study, 7247 (12%) had diabetes and 35 380 (60%) received clopidogrel. In total, 1790 patients (25%) with diabetes and 7931 patients (15%) without diabetes met the composite end point. Of these, 1225 (17%) with and 5377 (10%) without diabetes died. In total, 978 patients (80%) with and 4100 patients (76%) without diabetes died of events of cardiovascular origin. For patients with diabetes who were treated with clopidogrel, the unadjusted mortality rates (events/100 person-years) were 13.4 (95% CI, 12.8-14.0) vs 29.3 (95% CI, 28.3-30.4) for those not treated. For patients without diabetes who were treated with clopidogrel, the unadjusted mortality rates were 6.4 (95% CI, 6.3-6.6) vs 21.3 (95% CI, 21.0-21.7) for those not treated. However, among patients with diabetes vs those without diabetes, clopidogrel was associated with less effectiveness for all-cause mortality (HR, 0.89 [95% CI, 0.79-1.00] vs 0.75 [95% CI, 0.70-0.80]; P for interaction, .001) and for cardiovascular mortality (HR, 0.93 [95% CI, 0.81-1.06] vs 0.77 [95% CI, 0.72-0.83]; P for interaction, .01) but not for the composite end point (HR, 1.00 [95% CI, 0.91-1.10] vs 0.91 [95% CI, 0.87-0.96]; P for interaction, .08). Propensity score-matched models gave similar results. Conclusion Among patients with diabetes compared with patients without diabetes, the use of conventional clopidogrel treatment after MI was associated with lower reduction in the risk of all-cause death and cardiovascular death. JAMA. 2012;308(9):882-889	[Andersson, Charlotte; Lyngbaek, Stig; Cu Dinh Nguyen; Nielsen, Mia; Gislason, Gunnar H.; Torp-Pedersen, Christian] Gentofte Univ Hosp, Dept Cardiol, DK-2900 Hellerup, Denmark; [Kober, Lars] Univ Copenhagen, Rigshosp, Dept Cardiol, Ctr Heart, DK-1168 Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen	Andersson, C (corresponding author), Gentofte Univ Hosp, Dept Cardiol, Niels Andersens Vej 65, DK-2900 Hellerup, Denmark.	ca@heart.dk	Andersson, Charlotte/P-4849-2014; Gislason, Gunnar/B-7561-2009; Torp-Pedersen, Christian/E-5931-2013	Gislason, Gunnar/0000-0002-0548-402X; Kober, Lars/0000-0002-6635-1466	Bristol-Myers Squibb; Sanofi; internal research foundation at Department of Cardiology, Gentofte Hospital	Bristol-Myers Squibb(Bristol-Myers Squibb); Sanofi(Sanofi-Aventis); internal research foundation at Department of Cardiology, Gentofte Hospital	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Kober reported that he has received honorarium as speaker for Servier. Dr Torp-Pedersen reported that he has served on advisory boards and served on study steering committees for Cardiome, Sanofi, and Merck; and has obtained research grants from Bristol-Myers Squibb, and Sanofi. Dr Andersson reported receiving a month's salary for work on the study.; The study was founded by an internal research foundation at Department of Cardiology, Gentofte Hospital.	Andersson C, 2011, DIABETES CARE, V34, P1788, DOI 10.2337/dc11-0154; Andersson C, 2010, ESSENTIAL DURER, P12; Angiolillo DJ, 2005, DIABETES, V54, P2430, DOI 10.2337/diabetes.54.8.2430; Angiolillo DJ, 2007, J AM COLL CARDIOL, V50, P1541, DOI 10.1016/j.jacc.2007.05.049; Angiolillo DJ, 2007, CIRCULATION, V115, P708, DOI 10.1161/CIRCULATIONAHA.106.667741; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Eshaghian S, 2006, AM J CARDIOL, V97, P1759, DOI 10.1016/j.amjcard.2005.12.072; Gaist D, 1997, DAN MED BULL, V44, P445; Gurbel PA, 2012, JAMA-J AM MED ASSOC, V307, P2495, DOI 10.1001/jama.2012.5930; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Jernberg T, 2006, EUR HEART J, V27, P1166, DOI 10.1093/eurheartj/ehi877; Kumler T, 2008, EUR J HEART FAIL, V10, P658, DOI 10.1016/j.ejheart.2008.05.006; Kushner FG, 2009, CATHETER CARDIO INTE, V74, pE25, DOI [10.1016/j.jacc.2009.10.015, 10.1002/ccd.22351]; Ferreiro JL, 2011, CIRCULATION, V123, P798, DOI 10.1161/CIRCULATIONAHA.109.913376; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Norgaard ML, 2010, DIABETOLOGIA, V53, P1612, DOI 10.1007/s00125-010-1783-z; Schramm TK, 2008, CIRCULATION, V117, P1945, DOI 10.1161/CIRCULATIONAHA.107.720847; Sorensen R, 2011, J AM COLL CARDIOL, V57, P1202, DOI 10.1016/j.jacc.2010.09.069; Sorensen R, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-6; Sorensen R, 2009, LANCET, V374, P1967, DOI 10.1016/S0140-6736(09)61751-7; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Tu JV, 2001, J AM COLL CARDIOL, V37, P992, DOI 10.1016/S0735-1097(01)01109-3; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wiviott SD, 2008, CIRCULATION, V118, P1626, DOI 10.1161/CIRCULATIONAHA.108.791061; Wiviott SD, 2007, CIRCULATION, V116, P2923, DOI 10.1161/CIRCULATIONAHA.107.740324; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Wright RS, 2011, J AM COLL CARDIOL, V57, P1920, DOI 10.1016/j.jacc.2011.02.009; Yusuf S, 2001, NEW ENGL J MED, V345, P494	29	41	42	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2012	308	9					882	889		10.1001/2012.jama.10779	http://dx.doi.org/10.1001/2012.jama.10779			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999ET	22948698	Bronze			2022-12-24	WOS:000308292900018
J	Vamos, EP; Harris, M; Millett, C; Pape, UJ; Khunti, K; Curcin, V; Molokhia, M; Majeed, A				Vamos, Eszter Panna; Harris, Matthew; Millett, Christopher; Pape, Utz J.; Khunti, Kamlesh; Curcin, Vasa; Molokhia, Mariam; Majeed, Azeem			Association of systolic and diastolic blood pressure and all cause mortality in people with newly diagnosed type 2 diabetes: retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HYPERTENSIVE PATIENTS; CARDIOVASCULAR OUTCOMES; DISEASE; METAANALYSIS; MANAGEMENT; HOT	Objective To examine the effect of systolic and diastolic blood pressure achieved in the first year of treatment on all cause mortality in patients newly diagnosed with type 2 diabetes, with and without established cardiovascular disease. Design Retrospective cohort study. Setting United Kingdom General Practice Research Database, between 1990 and 2005. Participants 126 092 adult patients (age >= 18 years) with a new diagnosis of type 2 diabetes who had been registered with participating practices for at least 12 months. Main outcome measure All cause mortality. Results Before diagnosis, 12 379 (9.8%) patients had established cardiovascular disease (myocardial infarction or stroke). During a median follow-up of 3.5 years, we recorded 25 495 (20.2%) deaths. In people with cardiovascular disease, tight control of systolic (<130 mm Hg) and diastolic (<80 mm Hg) blood pressure was not associated with improved survival, after adjustment for baseline characteristics (age at diagnosis, sex, practice level clustering, deprivation score, body mass index, smoking, HbA(1c) and cholesterol levels, and blood pressure). Low blood pressure was also associated with an increased risk of all cause mortality. Compared with patients who received usual control of systolic blood pressure (130-139 mm Hg), the hazard ratio of all cause mortality was 2.79 (95% confidence interval 1.74 to 4.48, P<0.001) for systolic blood pressure at 110 mm Hg. Compared with patients who received usual control of diastolic blood pressure (80-84 mm Hg), the hazard ratios were 1.32 (1.02 to 1.78, P=0.04) and 1.89 (1.40 to 2.56, P<0.001) for diastolic blood pressures at 70-74 mm Hg and lower than 70 mm Hg, respectively. Similar associations were found in people without cardiovascular disease. Subgroup analyses of people diagnosed with hypertension and who received treatment for hypertension confirmed initial findings. Conclusion Blood pressure below 130/80 mm Hg was not associated with reduced risk of all cause mortality in patients with newly diagnosed diabetes, with or without known cardiovascular disease. Low blood pressure, particularly below 110/75 mm Hg, was associated with an increased risk for poor outcomes.	[Vamos, Eszter Panna; Harris, Matthew; Millett, Christopher; Pape, Utz J.; Majeed, Azeem] Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London W6 8RP, England; [Khunti, Kamlesh] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Curcin, Vasa] Univ London Imperial Coll Sci Technol & Med, Dept Comp, London W6 8RP, England; [Molokhia, Mariam] Kings Coll London, Dept Primary Care & Publ Hlth Sci, London WC2R 2LS, England	Imperial College London; University of Leicester; Imperial College London; University of London; King's College London	Harris, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London W6 8RP, England.	m.harris@imperial.ac.uk	/ABC-9527-2021	Curcin, Vasa/0000-0002-8308-2886; Millett, Christopher/0000-0002-0793-9884; Majeed, Azeem/0000-0002-2357-9858; Harris, Matthew/0000-0002-0005-9710; Khunti, Kamlesh/0000-0003-2343-7099	National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) scheme; NIHR Biomedical Research Centre scheme; Imperial Centre for Patient Safety and Service Quality; European Community Seventh Framework Programme [277047]; Higher Education Funding Council for England; NIHR; National Institute for Health Research [CL-2010-21-014] Funding Source: researchfish	National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) scheme(National Institute for Health Research (NIHR)); NIHR Biomedical Research Centre scheme(National Institute for Health Research (NIHR)); Imperial Centre for Patient Safety and Service Quality; European Community Seventh Framework Programme(European Commission); Higher Education Funding Council for England(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); NIHR(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	The Department of Primary Care and Public Health at Imperial College thank the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) scheme, NIHR Biomedical Research Centre scheme, and Imperial Centre for Patient Safety and Service Quality for their support. The Department of Health Sciences at Leicester University thank the NIHR CLAHRC scheme for their support. This study uses data from the Full Feature General Practice Research Database, obtained under license from the UK Medicines and Healthcare Products Regulatory Agency (MHRA). The interpretation and conclusions contained in this study are those of the authors alone. Access to the General Practice Research Database was funded through the Medical Research Council's licence agreement with the MHRA.; This study received funding from the European Community Seventh Framework Programme under grant agreement 277047. Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: support from the European Community Seventh Framework Programme for the submitted work; CM is funded by the Higher Education Funding Council for England and the NIHR; EV and MH are partly funded by the NIHR; no other relationships or activities that could appear to have influenced the submitted work.	American Diabetes Association, 2010, DIABETES CARE S1, V33, P692, DOI [10.2337/dc10-S011, DOI 10.2337/DC10-S011]; [Anonymous], 2007, INDEX MULTIPLE DEPRI; Bakris GL, 2004, HYPERTENSION, V44, P637, DOI 10.1161/01.HYP.0000143851.23721.26; Bangalore S, 2010, EUR HEART J, V31, P2897, DOI 10.1093/eurheartj/ehq328; Berl T, 2005, J AM SOC NEPHROL, V16, P2170, DOI 10.1681/ASN.2004090763; Chen YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021404; Cooper-DeHoff RM, 2010, JAMA-J AM MED ASSOC, V304, P61, DOI 10.1001/jama.2010.884; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Estacio RO, 2000, DIABETES CARE, V23, pB54; Gray J, 2003, BRIT MED J, V326, P1130, DOI 10.1136/bmj.326.7399.1130; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Hollowell J, 1997, Popul Trends, P36; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; Mancia G, 2009, J HYPERTENS, V27, P2121, DOI 10.1097/HJH.0b013e328333146d; Messerli FH, 2006, ANN INTERN MED, V144, P884, DOI 10.7326/0003-4819-144-12-200606200-00005; Reboldi G, 2011, J HYPERTENS, V29, P1253, DOI 10.1097/HJH.0b013e3283469976; Rutter MK, 2011, EUR HEART J, V32, P2247, DOI 10.1093/eurheartj/ehr154; STAESSEN J, 1989, BMJ-BRIT MED J, V298, P1552, DOI 10.1136/bmj.298.6687.1552; Stearne MR, 1998, BRIT MED J, V317, P713; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; TURNER RC, 1993, J HYPERTENS, V11, P319; Turner RC, 1998, BMJ-BRIT MED J, V316, P823, DOI 10.1136/bmj.316.7134.823; Zanchetti A, 2003, J HYPERTENS, V21, P797, DOI 10.1097/00004872-200304000-00024; Zanchetti A, 2009, J HYPERTENS, V27, P923, DOI 10.1097/HJH.0b013e32832aa6b5	25	70	72	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 30	2012	345								e5567	10.1136/bmj.e5567	http://dx.doi.org/10.1136/bmj.e5567			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036SM	22936794	Green Published, hybrid			2022-12-24	WOS:000311050800004
J	Krishnan, E; Lingala, B; Bhalla, V				Krishnan, Eswar; Lingala, Bharathi; Bhalla, Vivek			Low-Level Lead Exposure and the Prevalence of Gout An Observational Study	ANNALS OF INTERNAL MEDICINE			English	Article							BLOOD LEAD; SERUM CREATININE; NATIONAL-HEALTH; KIDNEY-FUNCTION; SATURNINE GOUT; BONE LEAD; RISK; MEN; NEPHROPATHY; MORTALITY	Background: Blood lead levels (BLLs) less than 1.21 mu mol/L (<25 mu g/dL) among adults are considered acceptable by current national standards. Lead toxicity can lead to gouty arthritis (gout), but whether the low lead exposure in the contemporary general population confers risk for gout is not known. Objective: To determine whether BLLs within the range currently considered acceptable are associated with gout. Design: Population-based cross-sectional study. Setting: The National Health and Nutrition Examination Survey for 2005 through 2008. Patients: 6153 civilians aged 40 years or older with an estimated glomerular filtration rate greater than 10 mL/min per 1.73 m(2). Measurements: Outcome variables were self-reported physician diagnosis of gout and serum urate level. Blood lead level was the principal exposure variable. Additional data collected were anthropometric measures, blood pressure, dietary purine intake, medication use, medical history, and serum creatinine concentration. Results: The prevalence of gout was 6.05% (95% CI, 4.49% to 7.62%) among patients in the highest BLL quartile (mean, 0.19 mu mol/L [3.95 mu g/dL]) compared with 1.76% (CI, 1.10% to 2.42%) among those in the lowest quartile (mean, 0.04 mu mol/L [0.89 mu g/dL]). Each doubling of BLL was associated with an unadjusted odds ratio of 1.74 (CI, 1.47 to 2.05) for gout and 1.25 (CI, 1.12 to 1.40) for hyperuricemia. After adjustment for renal function, diabetes, diuretic use, hypertension, race, body mass index, income, and education level, the highest BLL quartile was associated with a 3.6-fold higher risk for gout and a 1.9-fold higher risk for hyperuricemia compared with the lowest quartile. Limitation: Blood lead level does not necessarily reflect the total body lead burden. Conclusion: Blood lead levels in the range currently considered acceptable are associated with increased prevalence of gout and hyperuricemia.	[Krishnan, Eswar; Lingala, Bharathi; Bhalla, Vivek] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA	Stanford University	Krishnan, E (corresponding author), Stanford Univ, Sch Med, 1000 Welch Rd,Suite 203, Palo Alto, CA 94304 USA.		krishnan, Eswar/AAY-1269-2020	Bhalla, Vivek/0000-0002-5420-9657				Alarcon W. A., 2009, Morbidity and Mortality Weekly Report, V58, P365; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; BAKER MD, 1981, RHEUMATOL REHABIL, V20, P208, DOI 10.1093/rheumatology/20.4.208; Barbosa F, 2005, ENVIRON HEALTH PERSP, V113, P1669, DOI 10.1289/ehp.7917; BARRY PSI, 1970, BRIT J IND MED, V27, P339; BATUMAN V, 1981, NEW ENGL J MED, V304, P520, DOI 10.1056/NEJM198102263040905; BATUMAN V, 1993, AM J MED SCI, V305, P241, DOI 10.1097/00000441-199304000-00008; CAMPBELL BC, 1978, BRIT MED J, V2, P1403, DOI 10.1136/bmj.2.6149.1403; Centers for Disease Control and Prevention, 2012, LAB PROC MAN LEAD CA; Centers for Disease Control and Prevention, LAB PROC MAN UR AC; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Choi HK, 2008, RHEUMATOLOGY, V47, P1567, DOI 10.1093/rheumatology/ken305; Choi HK, 2004, LANCET, V363, P1277, DOI 10.1016/S0140-6736(04)16000-5; Choi HK, 2004, NEW ENGL J MED, V350, P1093, DOI 10.1056/NEJMoa035700; Choi HK, 2007, CIRCULATION, V116, P894, DOI 10.1161/CIRCULATIONAHA.107.703389; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Coresh J, 2006, CURR OPIN NEPHROL HY, V15, P276, DOI 10.1097/01.mnh.0000222695.84464.61; DEKLERK NH, 1989, INT J EPIDEMIOL, V18, P705, DOI 10.1093/ije/18.3.705; EMMERSON BT, 1963, AUSTRALAS ANN MED, V12, P310, DOI 10.1111/imj.1963.12.4.310; EMMERSON BT, 1968, ARTHRITIS RHEUM-US, V11, P623, DOI 10.1002/art.1780110504; Gelber AC, 1997, ARCH INTERN MED, V157, P1436, DOI 10.1001/archinte.157.13.1436; Gulson BL, 1996, B ENVIRON CONTAM TOX, V56, P543; GULSON BL, 1995, J LAB CLIN MED, V125, P703; Hernberg S, 2000, AM J IND MED, V38, P244, DOI 10.1002/1097-0274(200009)38:3<244::AID-AJIM3>3.3.CO;2-6; Hu H, 1998, ENVIRON HEALTH PERSP, V106, P1, DOI 10.2307/3433626; Kim R, 1996, JAMA-J AM MED ASSOC, V275, P1177, DOI 10.1001/jama.275.15.1177; KLINENBERG JR, 1969, NEW ENGL J MED, V280, P1238, DOI 10.1056/NEJM196905292802213; Kosnett MJ, 2010, CLIN PHARMACOL THER, V88, P412, DOI 10.1038/clpt.2010.132; KOSTER J, 1989, EUR J CLIN INVEST, V19, P228, DOI 10.1111/j.1365-2362.1989.tb00222.x; Krishnan E, 2006, ARTHRITIS RHEUM-US, V54, P2688, DOI 10.1002/art.22014; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Lin JL, 2002, AM J MED, V113, P563, DOI 10.1016/S0002-9343(02)01296-2; LoghmanAdham M, 1997, ENVIRON HEALTH PERSP, V105, P928, DOI 10.4103/0019-5278.44689; LUDWIG GD, 1957, ARCH INTERN MED, V100, P802, DOI 10.1001/archinte.1957.00260110118017; Madero M, 2006, CURR OPIN NEPHROL HY, V15, P610, DOI 10.1097/01.mnh.0000247505.71915.05; McAdams MA, 2011, J RHEUMATOL, V38, P135, DOI 10.3899/jrheum.100418; Menke A, 2006, CIRCULATION, V114, P1388, DOI 10.1161/CIRCULATIONAHA.106.628321; MIRANDA ME, 1991, ADV EXP MED BIOL, V309, P209; Morgan BW, 2001, ANN EMERG MED, V37, P51, DOI 10.1067/mem.2001.111708; MORGAN JM, 1972, ARCH INTERN MED, V130, P335, DOI 10.1001/archinte.130.3.335; Muntner P, 2005, ARCH INTERN MED, V165, P2155, DOI 10.1001/archinte.165.18.2155; Perazella M A, 1996, Conn Med, V60, P521; POOR G, 1989, BAILLIERE CLIN RHEUM, V3, P51, DOI 10.1016/S0950-3579(89)80035-4; Roberts JR, 2001, J TOXICOL-CLIN TOXIC, V39, P153, DOI 10.1081/CLT-100103831; Rothman KJ, 1998, MODERN EPIDEMIOLOGY, V4; Schock MR, 2008, ENVIRON SCI TECHNOL, V42, P4285, DOI 10.1021/es702488v; Selvin E, 2007, AM J KIDNEY DIS, V50, P918, DOI 10.1053/j.ajkd.2007.08.020; Shadick NA, 2000, J RHEUMATOL, V27, P1708; Smith DR, 1996, ENVIRON HEALTH PERSP, V104, P60, DOI 10.2307/3432761; Souci SW., 2000, FOOD COMPOSITION NUT; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Thottam Jyoti, 2007, Time, V170, P50; U.S. Environmental Protection Agency, 1995, REV STUD ADDR LEAD A; WALLACE SL, 1977, ARTHRITIS RHEUM, V20, P895, DOI 10.1002/art.1780200320; WEDEEN RP, 1988, ENVIRON HEALTH PERSP, V78, P57, DOI 10.2307/3430500; Wengrovitz Anne M., 2009, Morbidity and Mortality Weekly Report, V58, P1; Wigle DT, 2005, PLOS MED, V2, P1232, DOI 10.1371/journal.pmed.0020350	57	39	39	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 21	2012	157	4					233	+		10.7326/0003-4819-157-4-201208210-00003	http://dx.doi.org/10.7326/0003-4819-157-4-201208210-00003			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992XG	22910934				2022-12-24	WOS:000307813200014
J	Logan, BE; Elimelech, M				Logan, Bruce E.; Elimelech, Menachem			Membrane-based processes for sustainable power generation using water	NATURE			English	Review							MICROBIAL FUEL-CELLS; PRESSURE-RETARDED OSMOSIS; AMMONIA-CARBON DIOXIDE; ELECTRODIALYSIS ELECTROLYSIS CELLS; REVERSE-ELECTRODIALYSIS; SALINITY GRADIENTS; HYDROGEN-PRODUCTION; OSMOTIC POWER; BIOELECTROCHEMICAL SYSTEMS; ENERGY EFFICIENCY	Water has always been crucial to combustion and hydroelectric processes, but it could become the source of power in membrane-based systems that capture energy from natural and waste waters. Two processes are emerging as sustainable methods for capturing energy from sea water: pressure-retarded osmosis and reverse electrodialysis. These processes can also capture energy from waste heat by generating artificial salinity gradients using synthetic solutions, such as thermolytic salts. A further source of energy comes from organic matter in waste waters, which can be harnessed using microbial fuel-cell technology, allowing both wastewater treatment and power production.	[Logan, Bruce E.] Penn State Univ, Dept Civil & Environm Engn, University Pk, PA 16802 USA; [Elimelech, Menachem] Yale Univ, Dept Chem & Environm Engn, New Haven, CT 06520 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Yale University	Logan, BE (corresponding author), Penn State Univ, Dept Civil & Environm Engn, 212 Sackett Bldg, University Pk, PA 16802 USA.	blogan@psu.edu	Elimelech, Menachem/E-7137-2012	Elimelech, Menachem/0000-0003-4186-1563	King Abdullah University of Science and Technology (KAUST) [KUS-I1-003-13]; National Research Foundation of Korea; Ministry of Education, Science and Technology [R33-10046]	King Abdullah University of Science and Technology (KAUST)(King Abdullah University of Science & Technology); National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	The authors acknowledge support from the King Abdullah University of Science and Technology (KAUST) by Award KUS-I1-003-13 (BEL), and the World Class University (WCU) Program (Case III) through the National Research Foundation of Korea and the Ministry of Education, Science and Technology (R33-10046) (ME).	Achilli A, 2010, J MEMBRANE SCI, V364, P233, DOI 10.1016/j.memsci.2010.08.010; Achilli A, 2010, DESALINATION, V261, P205, DOI 10.1016/j.desal.2010.06.017; Achilli A, 2009, J MEMBRANE SCI, V343, P42, DOI 10.1016/j.memsci.2009.07.006; Alkhudhiri A, 2012, DESALINATION, V287, P2, DOI 10.1016/j.desal.2011.08.027; Borole AP, 2011, BIOFUEL BIOPROD BIOR, V5, P28, DOI 10.1002/bbb.265; Brogioli D, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.058501; Cath T. Y., 2011, US Patent, Patent No. [8,029,671, 8029671]; Cath TY, 2006, J MEMBRANE SCI, V281, P70, DOI 10.1016/j.memsci.2006.05.048; Cheng SA, 2011, BIORESOURCE TECHNOL, V102, P4468, DOI 10.1016/j.biortech.2010.12.104; Chou SR, 2012, J MEMBRANE SCI, V389, P25, DOI 10.1016/j.memsci.2011.10.002; Clauwaert P, 2007, ENVIRON SCI TECHNOL, V41, P3354, DOI 10.1021/es062580r; Cusick RD, 2012, SCIENCE, V335, P1474, DOI [10.1126/science.1219330, 10.1126/science.1218781]; Dekker A, 2009, ENVIRON SCI TECHNOL, V43, P9038, DOI 10.1021/es901939r; Dlugolecki P, 2010, J MEMBRANE SCI, V347, P101, DOI 10.1016/j.memsci.2009.10.011; Elimelech M, 2011, SCIENCE, V333, P712, DOI 10.1126/science.1200488; Fan YZ, 2008, ENVIRON SCI TECHNOL, V42, P8101, DOI 10.1021/es801229j; Fan YZ, 2007, ENVIRON SCI TECHNOL, V41, P8154, DOI 10.1021/es071739c; Gerstandt K, 2008, DESALINATION, V224, P64, DOI 10.1016/j.desal.2007.02.080; Heidrich ES, 2011, ENVIRON SCI TECHNOL, V45, P827, DOI 10.1021/es103058w; Hoover LA, 2011, ENVIRON SCI TECHNOL, V45, P9824, DOI 10.1021/es202576h; Jiang DQ, 2011, INT J HYDROGEN ENERG, V36, P876, DOI 10.1016/j.ijhydene.2010.08.074; Kim Y, 2011, P NATL ACAD SCI USA, V108, P16176, DOI 10.1073/pnas.1106335108; Kim Y, 2011, ENVIRON SCI TECHNOL, V45, P5834, DOI 10.1021/es200979b; La Mantia F, 2011, NANO LETT, V11, P1810, DOI 10.1021/nl200500s; Lalaurette E, 2009, INT J HYDROGEN ENERG, V34, P6201, DOI 10.1016/j.ijhydene.2009.05.112; Lay WCL, 2011, DESALINATION, V283, P123, DOI 10.1016/j.desal.2011.01.036; Lee KP, 2011, J MEMBRANE SCI, V370, P1, DOI 10.1016/j.memsci.2010.12.036; LEE KL, 1981, J MEMBRANE SCI, V8, P141, DOI 10.1016/S0376-7388(00)82088-8; Liu H, 2005, ENVIRON SCI TECHNOL, V39, P4317, DOI 10.1021/es050244p; Liu H, 2004, ENVIRON SCI TECHNOL, V38, P4040, DOI 10.1021/es0499344; Liu H, 2008, J POWER SOURCES, V179, P274, DOI 10.1016/j.jpowsour.2007.12.120; LOEB S, 1975, SCIENCE, V189, P654, DOI 10.1126/science.189.4203.654; Loeb S., 1980, US Patent, Patent No. [4,193,267, 4193267]; Logan B.E., 2008, MICROBIAL FUEL CELLS; Logan B, 2007, ENVIRON SCI TECHNOL, V41, P3341, DOI 10.1021/es062644y; Logan BE, 2006, ENVIRON SCI TECHNOL, V40, P5181, DOI 10.1021/es0605016; Logan BE, 2006, ENVIRON SCI TECHNOL, V40, P5172, DOI 10.1021/es0627592; Logan BE, 2010, APPL MICROBIOL BIOT, V85, P1665, DOI 10.1007/s00253-009-2378-9; Logan BE, 2009, NAT REV MICROBIOL, V7, P375, DOI 10.1038/nrmicro2113; Lu L, 2009, BIOSENS BIOELECTRON, V24, P3055, DOI 10.1016/j.bios.2009.03.024; McCarty PL, 2011, ENVIRON SCI TECHNOL, V45, P7100, DOI 10.1021/es2014264; McCutcheon JR, 2005, DESALINATION, V174, P1, DOI 10.1016/j.desal.2004.11.002; McGinnis RL, 2007, J MEMBRANE SCI, V305, P13, DOI 10.1016/j.memsci.2007.08.027; McGinnis RL, 2007, DESALINATION, V207, P370, DOI 10.1016/j.desal.2006.08.012; McGinnis RL, 2008, ENVIRON SCI TECHNOL, V42, P8625, DOI 10.1021/es800812m; Nam JY, 2012, ENVIRON SCI TECHNOL, V46, P5240, DOI 10.1021/es300228m; Nevin KP, 2011, APPL ENVIRON MICROB, V77, P2882, DOI 10.1128/AEM.02642-10; Nevin KP, 2010, MBIO, V1, DOI 10.1128/mBio.00103-10; Nijmeijer K, 2010, SUSTAIN SCI ENG, V2, P95, DOI 10.1016/S1871-2711(09)00205-0; Pant D, 2010, BIORESOURCE TECHNOL, V101, P1533, DOI 10.1016/j.biortech.2009.10.017; PATTLE RE, 1954, NATURE, V174, P660, DOI 10.1038/174660a0; Perlack R.D., 2005, BIOMASS FEEDSTOCK BI; Post JW, 2008, ENVIRON SCI TECHNOL, V42, P5785, DOI 10.1021/es8004317; Rabaey K, 2010, NAT REV MICROBIOL, V8, P706, DOI 10.1038/nrmicro2422; Ramon GZ, 2011, ENERG ENVIRON SCI, V4, P4423, DOI 10.1039/c1ee01913a; Ren ZY, 2007, ENVIRON SCI TECHNOL, V41, P4781, DOI 10.1021/es070577h; Rozendal RA, 2006, INT J HYDROGEN ENERG, V31, P1632, DOI 10.1016/j.ijhydene.2005.12.006; Sales BB, 2010, ENVIRON SCI TECHNOL, V44, P5661, DOI 10.1021/es100852a; Skilhagen SE, 2010, DESALIN WATER TREAT, V15, P271, DOI 10.5004/dwt.2010.1759; Souhaimi M.K., 2011, MEMBRANE DISTILLATIO; STOUGHTON RW, 1965, J CHEM ENG DATA, V10, P254, DOI 10.1021/je60026a016; Ter Heijne A, 2006, ENVIRON SCI TECHNOL, V40, P5200, DOI 10.1021/es0608545; Ter Heijne A, 2010, ENVIRON SCI TECHNOL, V44, P4376, DOI 10.1021/es100526g; Thorsen T, 2009, J MEMBRANE SCI, V335, P103, DOI 10.1016/j.memsci.2009.03.003; Veerman J, 2010, J APPL ELECTROCHEM, V40, P1461, DOI 10.1007/s10800-010-0124-8; Veerman J, 2009, J MEMBRANE SCI, V343, P7, DOI 10.1016/j.memsci.2009.05.047; Veerman J, 2009, J MEMBRANE SCI, V327, P136, DOI 10.1016/j.memsci.2008.11.015; Veerman J, 2010, ENVIRON SCI TECHNOL, V44, P9207, DOI 10.1021/es1009345; Velasquez-Orta SB, 2009, BIOTECHNOL BIOENG, V103, P1068, DOI 10.1002/bit.22346; Vermaas DA, 2011, J MEMBRANE SCI, V385, P234, DOI 10.1016/j.memsci.2011.09.043; Vermaas DA, 2011, ENVIRON SCI TECHNOL, V45, P7089, DOI 10.1021/es2012758; WICK GL, 1978, SCIENCE, V199, P1436, DOI 10.1126/science.199.4336.1436; Xie X, 2012, ENERG ENVIRON SCI, V5, P5265, DOI 10.1039/c1ee02122b; Xu Y, 2010, J MEMBRANE SCI, V348, P298, DOI 10.1016/j.memsci.2009.11.013; Yip NY, 2012, ENVIRON SCI TECHNOL, V46, P5230, DOI 10.1021/es300060m; Yip NY, 2011, ENVIRON SCI TECHNOL, V45, P10273, DOI 10.1021/es203197e; Yip NY, 2011, ENVIRON SCI TECHNOL, V45, P4360, DOI 10.1021/es104325z; Yip NY, 2010, ENVIRON SCI TECHNOL, V44, P3812, DOI 10.1021/es1002555; Zhang BG, 2012, J POWER SOURCES, V204, P34, DOI 10.1016/j.jpowsour.2012.01.013; Zhang F, 2011, BIOSENS BIOELECTRON, V30, P49, DOI 10.1016/j.bios.2011.08.025; Zhang F, 2009, ELECTROCHEM COMMUN, V11, P2177, DOI 10.1016/j.elecom.2009.09.024; Zhang F, 2011, ENVIRON SCI TECHNOL, V45, P6690, DOI 10.1021/es201505t; Zhao SF, 2012, J MEMBRANE SCI, V396, P1, DOI 10.1016/j.memsci.2011.12.023	83	1008	1036	97	1757	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2012	488	7411					313	319		10.1038/nature11477	http://dx.doi.org/10.1038/nature11477			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OS	22895336				2022-12-24	WOS:000307501000030
J	Olesen, JB; Lip, GYH; Kamper, AL; Hommel, K; Kober, L; Lane, DA; Lindhardsen, J; Gislason, GH; Torp-Pedersen, C				Olesen, Jonas Bjerring; Lip, Gregory Y. H.; Kamper, Anne-Lise; Hommel, Kristine; Kober, Lars; Lane, Deirdre A.; Lindhardsen, Jesper; Gislason, Gunnar Hilmar; Torp-Pedersen, Christian			Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; RISK STRATIFICATION; PREDICTING STROKE; MORTALITY; VALIDITY; WARFARIN; ASPIRIN; THROMBOEMBOLISM; CLOPIDOGREL; PREVENTION	BACKGROUND Both atrial fibrillation and chronic kidney disease increase the risk of stroke and systemic thromboembolism. However, these risks, and the effects of antithrombotic treatment, have not been thoroughly investigated in patients with both conditions. METHODS Using Danish national registries, we identified all patients discharged from the hospital with a diagnosis of nonvalvular atrial fibrillation between 1997 and 2008. The risk of stroke or systemic thromboembolism and bleeding associated with non-end-stage chronic kidney disease and with end-stage chronic kidney disease (i.e., disease requiring renal-replacement therapy) was estimated with the use of time-dependent Cox regression analyses. In addition, the effects of treatment with warfarin, aspirin, or both in patients with chronic kidney disease were compared with the effects in patients with no renal disease. RESULTS Of 132,372 patients included in the analysis, 3587 (2.7%) had non-end-stage chronic kidney disease and 901 (0.7%) required renal-replacement therapy at the time of inclusion. As compared with patients who did not have renal disease, patients with non-end-stage chronic kidney disease had an increased risk of stroke or systemic thromboembolism (hazard ratio, 1.49; 95% confidence interval [CI], 1.38 to 1.59; P<0.001), as did those requiring renal-replacement therapy (hazard ratio, 1.83; 95% CI, 1.57 to 2.14; P<0.001); this risk was significantly decreased for both groups of patients with warfarin but not with aspirin. The risk of bleeding was also increased among patients who had non-end-stage chronic kidney disease or required renal-replacement therapy and was further increased with warfarin, aspirin, or both. CONCLUSIONS Chronic kidney disease was associated with an increased risk of stroke or systemic thromboembolism and bleeding among patients with atrial fibrillation. Warfarin treatment was associated with a decreased risk of stroke or systemic thromboembolism among patients with chronic kidney disease, whereas warfarin and aspirin were associated with an increased risk of bleeding. (Funded by the Lundbeck Foundation.)	[Olesen, Jonas Bjerring; Lindhardsen, Jesper; Gislason, Gunnar Hilmar; Torp-Pedersen, Christian] Univ Copenhagen, Gentofte Hosp, Dept Cardiol, DK-2900 Hellerup, Denmark; [Kamper, Anne-Lise; Hommel, Kristine] Univ Copenhagen, Rigshosp, Dept Nephrol, DK-2100 Copenhagen, Denmark; [Kober, Lars] Univ Copenhagen, Rigshosp, Ctr Heart, DK-2100 Copenhagen, Denmark; [Olesen, Jonas Bjerring; Lip, Gregory Y. H.; Lane, Deirdre A.] Univ Birmingham, Ctr Cardiovasc Sci, City Hosp, Birmingham, W Midlands, England	University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Birmingham	Olesen, JB (corresponding author), Univ Copenhagen, Gentofte Hosp, Dept Cardiol, Post 635,Niels Andersens Vej 65, DK-2900 Hellerup, Denmark.	jo@heart.dk	Torp-Pedersen, Christian/E-5931-2013; Lane, Deirdre/AAX-1866-2020; Gislason, Gunnar/B-7561-2009	Lane, Deirdre/0000-0002-5604-9378; Gislason, Gunnar/0000-0002-0548-402X; Kober, Lars/0000-0002-6635-1466; Kamper, Anne-Lise/0000-0001-7523-6569	Lundbeck Foundation; Bristol-Myers Squibb; Bayer HealthCare	Lundbeck Foundation(Lundbeckfonden); Bristol-Myers Squibb(Bristol-Myers Squibb); Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals)	(Funded by the Lundbeck Foundation.); Supported by the Lundbeck Foundation.; Dr. Olesen reports receiving travel support from AstraZeneca and Boehringer Ingelheim on behalf of his institution; Dr. Lip, receiving consulting fees from Astellas, AstraZeneca, Bayer, Biotronik, Bristol-Myers Squibb/Pfizer, Boehringer Ingelheim, Merck, Portola, and Sanofi Aventis, and being on speakers bureaus for Bayer, Bristol-Myers Squibb/Pfizer, Boehringer Ingelheim, and Sanofi Aventis; Dr. Kober, being on a speakers bureau for Servier; Dr. Lane, receiving grant support from Bayer HealthCare on behalf of her institution, lecture fees from Bayer HealthCare, Bristol-Myers Squibb/Pfizer, and Boehringer Ingelheim, and payment for the development of educational presentations from Bayer HealthCare, Bristol-Myers Squibb/Pfizer, and Boehringer Ingelheim; and Dr. Torp-Pedersen, receiving consulting fees from Cardiome and Merck on behalf of himself and from Sanofi Aventis on behalf of himself and his institution, grant support from Bristol-Myers Squibb on behalf of his institution, lecture fees from Cardiome, Merck, and Sanofi Aventis, and travel support from Bristol-Myers Squibb/Pfizer. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 1994, ARCH INTERN MED, V154, P2254; Atar I, 2006, INT J CARDIOL, V106, P47, DOI 10.1016/j.ijcard.2004.12.048; Camm AJ, 2011, EUR HEART J, V32, P1172, DOI 10.1093/eurheartj/ehq512; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Chan KE, 2009, J AM SOC NEPHROL, V20, P2223, DOI 10.1681/ASN.2009030319; Conen D, 2011, JAMA-J AM MED ASSOC, V305, P2080, DOI 10.1001/jama.2011.659; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Di Angelantonio E, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4986; FEINBERG WM, 1995, ARCH INTERN MED, V155, P469, DOI 10.1001/archinte.155.5.469; Frost L, 2007, AM J MED, V120, P47, DOI 10.1016/j.amjmed.2005.12.027; Gaist D, 1997, DAN MED BULL, V44, P445; Hansen ML, 2010, ARCH INTERN MED, V170, P1433, DOI 10.1001/archinternmed.2010.271; Hommel K, 2010, NEPHROL DIAL TRANSPL, V25, P947, DOI 10.1093/ndt/gfp571; Krarup LH, 2007, NEUROEPIDEMIOLOGY, V28, P150, DOI 10.1159/000102143; LAUPACIS A, 1994, ARCH INTERN MED, V154, P1449; Lee M, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4249; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Marinigh R, 2011, J AM COLL CARDIOL, V57, P1339, DOI 10.1016/j.jacc.2010.12.013; Olesen JB, 2011, J THROMB HAEMOST, V9, P1460, DOI 10.1111/j.1538-7836.2011.04378.x; Olesen JB, 2011, THROMB HAEMOSTASIS, V106, P739, DOI 10.1160/TH11-05-0364; Olesen JB, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d124; Olesen JB, 2011, PHARMACOEPIDEM DR S, V20, P146, DOI 10.1002/pds.2073; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Reinecke H, 2009, J AM SOC NEPHROL, V20, P705, DOI 10.1681/ASN.2007111207; Rietbrock S, 2009, THROMB HAEMOSTASIS, V101, P527, DOI 10.1160/TH08-08-0499; Rocket Af Study Investigators, 2010, AM HEART J, V159; Soliman EZ, 2010, AM HEART J, V159, P1102, DOI 10.1016/j.ahj.2010.03.027; Sorensen R, 2009, LANCET, V374, P1967, DOI 10.1016/S0140-6736(09)61751-7; US Renal Data System, 2006, USRDS 2006 ANN DAT R; Wizemann V, 2010, KIDNEY INT, V77, P1098, DOI 10.1038/ki.2009.477; Yang F, 2010, EUROPACE, V12, P1666, DOI 10.1093/europace/euq387	32	655	683	3	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 16	2012	367	7					625	635		10.1056/NEJMoa1105594	http://dx.doi.org/10.1056/NEJMoa1105594			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988NB	22894575				2022-12-24	WOS:000307496600006
J	Flamand, M; Duchaine, TF				Flamand, Mathieu; Duchaine, Thomas F.			SnapShot: Endogenous RNAi Machinery and Mechanisms	CELL			English	Editorial Material							INTERFERENCE; PATHWAYS; PROTEINS; ELEGANS; PIRNAS		[Flamand, Mathieu; Duchaine, Thomas F.] McGill Univ, Dept Biochem, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada	McGill University	Flamand, M (corresponding author), McGill Univ, Dept Biochem, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada.		Flamand, Mathieu/R-6102-2019; Duchaine, Thomas/U-2399-2019	Duchaine, Thomas/0000-0002-3454-1839	Canadian Institutes of Health Research Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Couvillion MT, 2009, GENE DEV, V23, P2016, DOI 10.1101/gad.1821209; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Ketting RF, 2011, DEV CELL, V20, P148, DOI 10.1016/j.devcel.2011.01.012; Li LD, 2011, METHODS MOL BIOL, V764, P169, DOI 10.1007/978-1-61779-188-8_11; Martienssen RA, 2005, TRENDS GENET, V21, P450, DOI 10.1016/j.tig.2005.06.005; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Tushir JS, 2009, CELL, V139, P830, DOI 10.1016/j.cell.2009.10.042	10	2	2	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 3	2012	150	3					662	+		10.1016/j.cell.2012.07.016	http://dx.doi.org/10.1016/j.cell.2012.07.016			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	985WO	22863015	Bronze			2022-12-24	WOS:000307301400023
J	Qiang, L; Wang, LH; Kon, N; Zhao, WH; Lee, S; Zhang, YY; Rosenbaum, M; Zhao, YM; Gu, W; Farmer, SR; Accili, D				Qiang, Li; Wang, Liheng; Kon, Ning; Zhao, Wenhui; Lee, Sangkyu; Zhang, Yiying; Rosenbaum, Michael; Zhao, Yingming; Gu, Wei; Farmer, Stephen R.; Accili, Domenico			Brown Remodeling of White Adipose Tissue by SirT1-Dependent Deacetylation of Ppar gamma	CELL			English	Article							ACTIVATED-RECEPTOR-GAMMA; INSULIN-RESISTANCE; SIRT1; FAT; PGC-1-ALPHA; METABOLISM; ADIPOCYTES; OBESITY; MICE; THERMOGENESIS	Brown adipose tissue (BAT) can disperse stored energy as heat. Promoting BAT-like features in white adipose (WAT) is an attractive, if elusive, therapeutic approach to staunch the current obesity epidemic. Here we report that gain of function of the NAD-dependent deacetylase SirT1 or loss of function of its endogenous inhibitor Deleted in breast cancer-1 (Dbc1) promote "browning" of WAT by deacetylating peroxisome proliferator-activated receptor (Ppar)-gamma on Lys268 and Lys293. SirT1-dependent deacetylation of Lys268 and Lys293 is required to recruit the BAT program coactivator Prdm16 to Ppar gamma, leading to selective induction of BAT genes and repression of visceral WAT genes associated with insulin resistance. An acetylation-defective Pparg mutant induces a brown phenotype in white adipocytes, whereas an acetylated mimetic fails to induce "brown" genes but retains the ability to activate "white" genes. We propose that SirT1-dependent Pparg deacetylation is a form of selective Ppar gamma modulation of potential therapeutic import.	[Qiang, Li; Wang, Liheng; Accili, Domenico] Columbia Univ, Dept Med, Naomi Berrie Diabet Ctr, Coll Phys & Surg, New York, NY 10032 USA; [Kon, Ning; Zhao, Wenhui; Gu, Wei] Columbia Univ, Dept Pathol, Inst Canc Genet, Coll Phys & Surg, New York, NY 10032 USA; [Zhang, Yiying; Rosenbaum, Michael] Columbia Univ, Coll Phys & Surg, Dept Pediat, Div Mol Genet, New York, NY 10032 USA; [Lee, Sangkyu; Zhao, Yingming] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Farmer, Stephen R.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Columbia University; Columbia University; Columbia University; University of Chicago; Boston University	Accili, D (corresponding author), Columbia Univ, Dept Med, Naomi Berrie Diabet Ctr, Coll Phys & Surg, New York, NY 10032 USA.	da230@columbia.edu	Qiang, Li/C-9560-2012	Qiang, Li/0000-0001-8322-1797; ZHAO, WENHUI/0000-0002-7703-7106; Farmer, Stephen/0000-0003-2483-2795	NIH [HL087123, DK58282, DK64773, DK063608, RR024156]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024156] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL087123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064773, R37DK058282, R01DK058282, P30DK026687, P30DK063608, R01DK064819, R01DK057539] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank K. Tsuchiya and L. Ozcan for help with different aspects of this work, T. Kolar and A. Flete for technical support, Q. Zhang for help with structural analysis, U. Pajvani and G. Heinrich for comments on the manuscript, and members of the Accili laboratory for discussion of the data. We thank B. Spiegelman for providing HIB-1B cells. This work was supported by NIH grants HL087123, DK58282, DK64773, DK063608 (Columbia Diabetes Research Center), and RR024156 (Columbia University CTSA).	Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Barroso I, 1999, NATURE, V402, P880, DOI 10.1038/47254; Bartness TJ, 2010, INT J OBESITY, V34, pS36, DOI 10.1038/ijo.2010.182; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; Chen W, 2009, MOL CELL, V35, P755, DOI 10.1016/j.molcel.2009.09.015; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062; Escande C, 2010, J CLIN INVEST, V120, P545, DOI 10.1172/JCI39319; Farmer SR, 2009, NATURE, V458, P839, DOI 10.1038/458839a; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Hauser S, 2000, J BIOL CHEM, V275, P18527, DOI 10.1074/jbc.M001297200; Tran KV, 2012, CELL METAB, V15, P222, DOI 10.1016/j.cmet.2012.01.008; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Kim-Muller JY, 2011, SCIENCE, V331, P1529, DOI 10.1126/science.1204504; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Kozak LP, 2010, CELL METAB, V11, P263, DOI 10.1016/j.cmet.2010.03.009; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Liu JJ, 2006, MOL CELL BIOL, V26, P5827, DOI 10.1128/MCB.00441-06; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nakae J, 2006, J CLIN INVEST, V116, P2473, DOI 10.1172/JCI25518; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Powelka AM, 2006, J CLIN INVEST, V116, P125, DOI 10.1172/JCI26040; Qiang L, 2012, CELL, V148, P397, DOI 10.1016/j.cell.2012.01.020; Qiang L, 2011, CELL METAB, V14, P758, DOI 10.1016/j.cmet.2011.10.007; Qiang L, 2010, J BIOL CHEM, V285, P27396, DOI 10.1074/jbc.M110.140228; Ravussin E, 2011, ANNU REV NUTR, V31, P33, DOI 10.1146/annurev-nutr-072610-145209; Rosen CJ, 2010, NEW ENGL J MED, V363, P803, DOI 10.1056/NEJMp1008233; Scime A, 2005, CELL METAB, V2, P283, DOI 10.1016/j.cmet.2005.10.002; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002; TONTONOZ P, 1994, NUCLEIC ACIDS RES, V22, P5628, DOI 10.1093/nar/22.25.5628; Tsukiyama-Kohara K, 2001, NAT MED, V7, P1128, DOI 10.1038/nm1001-1128; Vernochet C, 2009, MOL CELL BIOL, V29, P4714, DOI 10.1128/MCB.01899-08; Virtanen KA, 2011, CURR OPIN LIPIDOL, V22, P49, DOI 10.1097/MOL.0b013e3283425243; Waku T, 2009, J MOL BIOL, V385, P188, DOI 10.1016/j.jmb.2008.10.039; Wang H, 2008, MOL CELL BIOL, V28, P188, DOI 10.1128/MCB.00992-07; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Yamauchi T, 2002, NAT GENET, V30, P221, DOI 10.1038/ng829; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515	48	533	572	13	126	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 3	2012	150	3					620	632		10.1016/j.cell.2012.06.027	http://dx.doi.org/10.1016/j.cell.2012.06.027			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	985WO	22863012	Green Accepted, Bronze			2022-12-24	WOS:000307301400019
J	Makela, KT; Visuri, T; Pulkkinen, P; Eskelinen, A; Remes, V; Virolainen, P; Junnila, M; Pukkala, E				Makela, Keijo T.; Visuri, Tuomo; Pulkkinen, Pekka; Eskelinen, Antti; Remes, Ville; Virolainen, Petri; Junnila, Mika; Pukkala, Eero			Risk of cancer with metal-on-metal hip replacements: population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							KNEE ARTHROPLASTY; WEAR DEBRIS; FOLLOW-UP; OSTEOARTHRITIS; DISSEMINATION; POLYETHYLENE; NATIONWIDE; FAILURE; COHORT	Objective To assess the risk of cancer associated with modern primary metal-on-metal hip replacements. Design Population based study. Setting Nationwide retrospective comparative register. Participants 10 728 patients who underwent metal-on-metal total hip arthroplasty and 18 235 patients who underwent conventional metal-on-polyethylene, ceramic-on-polyethylene, and ceramic-on-ceramic total hip arthroplasty (the non-metal-on-metal cohort) in the Finnish Arthroplasty Register 2001-10. Data on cancer cases up to 2010 for these cohorts were extracted from the Finnish Cancer Registry. Main outcome measures The relative risk of cancer was expressed as the ratio of observed to expected number of cases from the Finnish population-that is, the standardised incidence ratio. The relative risk of cancer in the metal-on-metal cohort compared with the non-metal-on-metal cohort was estimated with analyses of these ratios and Poisson regression. Results The overall risk of cancer in patients with metal-on-metal hip implants was similar to that in the Finnish population (378 observed v 400 expected, standardised incidence ratio 0.95, 95% confidence interval 0.85 to 1.04). The overall risk of cancer in patients with metal-on-metal hip implants was also no higher than in patients who had received non-metal-on-metal hip implants (relative risk 0.92, 0.81 to 1.05). Conclusions Metal-on-metal hip replacements are not associated with an increased overall risk of cancer during a mean follow-up of four years.	[Makela, Keijo T.; Virolainen, Petri; Junnila, Mika] Turku Univ Hosp, Surg Hosp, Dept Orthopaed & Traumatol, FI-20701 Turku, Finland; [Visuri, Tuomo; Pulkkinen, Pekka] Univ Helsinki, Hjelt Inst, FI-00014 Helsinki, Finland; [Eskelinen, Antti] Coxa Hosp Joint Replacement, FI-33101 Tampere, Finland; [Remes, Ville] Univ Helsinki, Cent Hosp, Peijas Hosp, Dept Orthopaed & Traumatol, FI-00029 Helsinki, Finland; [Pukkala, Eero] Univ Tampere, Sch Hlth Sci, FI-33100 Tampere, Finland; [Pukkala, Eero] Finnish Canc Registry, Inst Stat & Epidemiol Canc Res, FI-00130 Helsinki, Finland	University of Turku; University of Helsinki; Coxa Hospital for Joint Replacement; University of Helsinki; Helsinki University Central Hospital; Tampere University; Finnish Cancer Registry	Makela, KT (corresponding author), Turku Univ Hosp, Surg Hosp, Dept Orthopaed & Traumatol, FI-20701 Turku, Finland.	keijo.makela@fimnet.fi	Eskelinen, Antti/E-6433-2015; Eskelinen, Antti/AAW-9209-2021; Eskelinen, Antti/AAW-9223-2021	Eskelinen, Antti/0000-0003-0302-0253; Eskelinen, Antti/0000-0003-0302-0253; Makela, Keijo/0000-0002-4115-1767	Turku University Hospital; Sigrid Juselius Foundation; Helsinki University Central Hospital	Turku University Hospital; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Helsinki University Central Hospital	This study was funded by Turku University Hospital (KTM) and Sigrid Juselius Foundation and Helsinki University Central Hospital (VR).	Australian Orthopaedic Association, 2010, ANN REP 2010; Bonassi S, 2000, CANCER RES, V60, P1619; CASE CP, 1994, J BONE JOINT SURG BR, V76B, P701, DOI 10.1302/0301-620X.76B5.8083255; Case CP, 1996, CLIN ORTHOP RELAT R, pS269; Cohen D, 2011, BMJ-BRIT MED J, V13, P342; Cohen D, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1410; Daley B, 2004, J BONE JOINT SURG BR, V86B, P598, DOI 10.1302/0301-620X.86B4.14368; Garbuz DS, 2010, CLIN ORTHOP RELAT R, V468, P318, DOI 10.1007/s11999-009-1029-x; GILLESPIE WJ, 1988, J BONE JOINT SURG BR, V70, P539, DOI 10.1302/0301-620X.70B4.3403594; Gillispie WJ, 1996, CLIN ORTHOP S, V329s, P290; Goldacre MJ, 2005, BRIT J CANCER, V92, P1298, DOI 10.1038/sj.bjc.6602511; Grammatopoulos G, 2009, J BONE JOINT SURG BR, V91B, P1019, DOI 10.1302/0301-620X.91B8.22562; Gross TP, 2012, J ARTHROPLASTY, V27, P533, DOI 10.1016/j.arth.2011.06.019; Hart AJ, 2009, J BONE JOINT SURG BR, V91B, P835, DOI 10.1302/0301-620X.91B6.21844; Jarvholm B, 2005, EUR J EPIDEMIOL, V20, P537, DOI 10.1007/s10654-005-4263-x; Kauppi MJ, 1996, ACTA PAEDIATR, V85, P248, DOI 10.1111/j.1651-2227.1996.tb14004.x; Kwasniak LA, 2011, INT J DERMATOL, V50, P645, DOI 10.1111/j.1365-4632.2010.04826.x; LANGKAMER VG, 1992, J BONE JOINT SURG BR, V74, P831, DOI 10.1302/0301-620X.74B6.1447243; MacDonald SJ, 2003, CLIN ORTHOP RELAT R, P282, DOI 10.1097/01.blo.0000043066.62337.9d; Meding JB, 2012, CLIN ORTHOP RELAT R, V470, P388, DOI 10.1007/s11999-011-2069-6; Min WK, 2008, JOINT BONE SPINE, V75, P319, DOI 10.1016/j.jbspin.2007.05.007; National Joint Registry for England and Wales (NJR England-Wales), 2011, 8 NJR ENGL WAL; NYREN O, 1995, JNCI-J NATL CANCER I, V87, P28, DOI 10.1093/jnci/87.1.28; Ollivere B, 2009, J BONE JOINT SURG BR, V91B, P1025, DOI 10.1302/0301-620X.91B8.21701; Olsen JH, 1999, INT J CANCER, V81, P719, DOI 10.1002/(SICI)1097-0215(19990531)81:5<719::AID-IJC8>3.0.CO;2-D; Onega T, 2006, CANCER EPIDEM BIOMAR, V15, P1532, DOI 10.1158/1055-9965.EPI-06-0127; PAAVOLAINEN P, 1991, ACTA ORTHOP SCAND, V62, P27, DOI 10.3109/17453679109155101; Paavolainen P, 1999, J ARTHROPLASTY, V14, P272, DOI 10.1016/S0883-5403(99)90051-7; Pandit H, 2008, J BONE JOINT SURG BR, V90B, P847, DOI 10.1302/0301-620X.90B7.20213; SANTANA V, 1992, CLIN IMMUNOL IMMUNOP, V63, P205, DOI 10.1016/0090-1229(92)90224-C; Seppanen M, 2012, ACTA ORTHOP, V83, P207, DOI 10.3109/17453674.2012.693016; Shea KG, 1997, CLIN ORTHOP RELAT R, P219; Shimmin AJ, 2005, ORTHOP CLIN N AM, V36, P187, DOI 10.1016/j.ocl.2005.01.002; Treacy RBC, 2011, J BONE JOINT SURG BR, V93B, P27, DOI 10.1302/0301-620X.93B1.24134; Urban RM, 2000, J BONE JOINT SURG AM, V82A, P457, DOI 10.2106/00004623-200004000-00002; VISURI T, 1991, ORTHOPEDICS, V14, P137; Visuri T, 2006, J ARTHROPLASTY, V21, P311, DOI 10.1016/j.arth.2005.03.046; Visuri T, 2003, ACTA ORTHOP SCAND, V74, P351, DOI 10.1080/00016470310014300; Visuri T, 1996, CLIN ORTHOP RELAT R, pS280; Visuri T, 2010, ACTA ORTHOP, V81, P77, DOI 10.3109/17453671003667150; Zahiri CA, 1999, J ARTHROPLASTY, V14, P326, DOI 10.1016/S0883-5403(99)90059-1	41	41	41	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 25	2012	345								e4646	10.1136/bmj.e4646	http://dx.doi.org/10.1136/bmj.e4646			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	981UW	22833626	Green Submitted, Green Published, hybrid			2022-12-24	WOS:000306997500002
J	Roland, M; Abel, G				Roland, Martin; Abel, Gary			Reducing emergency admissions: are we on the right track?	BRITISH MEDICAL JOURNAL			English	Editorial Material							CONTROLLED-TRIAL; HOSPITALIZATIONS; IMPACT; CARE		[Roland, Martin; Abel, Gary] Univ Cambridge, Cambridge Ctr Hlth Serv Res, Cambridge CB2 8PN, England	University of Cambridge	Roland, M (corresponding author), Univ Cambridge, Cambridge Ctr Hlth Serv Res, Cambridge CB2 8PN, England.	mr108@cam.ac.uk	Abel, Gary/ABE-1765-2021	Abel, Gary/0000-0003-2231-5161; Roland, Martin/0000-0002-8533-3060				Blunt I, 2010, TRENDS EMERGENCY ADM; Bottle A, 2006, J ROY SOC MED, V99, P406, DOI 10.1258/jrsm.99.8.406; Department of Health, 2010, PAYM RES BACKGR; Evidence Adoption Centre, 2011, EFF PRED MOD TOOLS I; Fan VS, 2012, ANN INTERN MED, V156, P673, DOI 10.7326/0003-4819-156-10-201205150-00003; Gravelle H, 2007, BMJ-BRIT MED J, V334, P31, DOI 10.1136/bmj.39020.413310.55; King's Health Partners, INT CAR PROGR; Munro J, 2005, BRIT J GEN PRACT, V55, P790; NHS Information Centre, 2011, HOSP EP STAT HEADL F; Northamptonshire Observatory, JOINT STRAT NEEDS AS; Nuffield Trust, 2011, PRED RISK HLTH CAR O; Ovretveit J., 2009, DOES IMPROVING QUALI; Powell Davies G, 2006, COORDINATION CARE PR; Purdy S, 2012, INTERVENTIONS REDUCE; Purdy S., 2010, AVOIDING HOSP ADMISS; Roland M, 2005, BRIT MED J, V330, P289, DOI 10.1136/bmj.330.7486.289; Roland M., 2012, INT J INTEGRATED CAR, V12; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Sargent P, 2008, J NURS MANAGE, V16, P38, DOI 10.1111/j.1365-2934.2007.00785.x; Takahashi PY, 2012, ARCH INTERN MED, V172, P773, DOI 10.1001/archinternmed.2012.256; Wennberg D, 2006, COMBINED PREDICTIVE	21	78	78	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 18	2012	345								e6017	10.1136/bmj.e6017	http://dx.doi.org/10.1136/bmj.e6017			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	011JH	22990102				2022-12-24	WOS:000309160400006
J	Pohlker, C; Wiedemann, KT; Sinha, B; Shiraiwa, M; Gunthe, SS; Smith, M; Su, H; Artaxo, P; Chen, Q; Cheng, YF; Elbert, W; Gilles, MK; Kilcoyne, ALD; Moffet, RC; Weigand, M; Martin, ST; Poeschl, U; Andreae, MO				Poehlker, Christopher; Wiedemann, Kenia T.; Sinha, Baerbel; Shiraiwa, Manabu; Gunthe, Sachin S.; Smith, Mackenzie; Su, Hang; Artaxo, Paulo; Chen, Qi; Cheng, Yafang; Elbert, Wolfgang; Gilles, Mary K.; Kilcoyne, Arthur L. D.; Moffet, Ryan C.; Weigand, Markus; Martin, Scot T.; Poeschl, Ulrich; Andreae, Meinrat O.			Biogenic Potassium Salt Particles as Seeds for Secondary Organic Aerosol in the Amazon	SCIENCE			English	Article							LIQUID PHASE-SEPARATION; ATMOSPHERE; FOREST; BASIN; RELEASE; NUCLEI; SULFUR; CLOUDS; CARBON; WET	The fine particles serving as cloud condensation nuclei in pristine Amazonian rainforest air consist mostly of secondary organic aerosol. Their origin is enigmatic, however, because new particle formation in the atmosphere is not observed. Here, we show that the growth of organic aerosol particles can be initiated by potassium-salt-rich particles emitted by biota in the rainforest. These particles act as seeds for the condensation of low- or semi-volatile organic compounds from the atmospheric gas phase or multiphase oxidation of isoprene and terpenes. Our findings suggest that the primary emission of biogenic salt particles directly influences the number concentration of cloud condensation nuclei and affects the microphysics of cloud formation and precipitation over the rainforest.	[Poehlker, Christopher; Shiraiwa, Manabu; Gunthe, Sachin S.; Su, Hang; Cheng, Yafang; Elbert, Wolfgang; Poeschl, Ulrich; Andreae, Meinrat O.] Max Planck Inst Chem, Biogeochem Dept, D-55020 Mainz, Germany; [Wiedemann, Kenia T.; Artaxo, Paulo] Univ Sao Paulo, Inst Phys, BR-05508900 Sao Paulo, Brazil; [Wiedemann, Kenia T.; Smith, Mackenzie; Chen, Qi; Martin, Scot T.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Wiedemann, Kenia T.] Univ Arizona, Ecol & Evolutionary Biol Dept, Tucson, AZ 85721 USA; [Sinha, Baerbel] Max Planck Inst Chem, Particle Chem Dept, D-55020 Mainz, Germany; [Sinha, Baerbel] Indian Inst Sci Educ & Res Mohali, Dept Earth & Environm Sci, Sas Nagar, Manauli PO, India; [Shiraiwa, Manabu] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Gunthe, Sachin S.; Moffet, Ryan C.] Indian Inst Technol, Environm & Water Resources Engn Div, Dept Civil Engn, Madras 600036, Tamil Nadu, India; [Gilles, Mary K.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Chem Sci, Berkeley, CA 94720 USA; [Kilcoyne, Arthur L. D.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA 94720 USA; [Moffet, Ryan C.] Univ Pacific, Dept Chem, Stockton, CA 95211 USA; [Weigand, Markus] Max Planck Inst Intelligent Syst, D-70569 Stuttgart, Germany	Max Planck Society; Universidade de Sao Paulo; Harvard University; University of Arizona; Max Planck Society; Indian Institute of Science Education & Research (IISER) - Mohali; California Institute of Technology; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of the Pacific; Max Planck Society	Pohlker, C (corresponding author), Max Planck Inst Chem, Biogeochem Dept, D-55020 Mainz, Germany.	c.pohlker@mpic.de; u.poschl@mpic.de; u.poschl@mpic.de	Gunthe, Sachin/A-1970-2010; Gunthe, Sachin/E-4934-2016; Artaxo, Paulo/E-8874-2010; Kilcoyne, Arthur A L/I-1465-2013; Su, Hang/A-6226-2010; Andreae, Meinrat O./B-1068-2008; Pöhlker, Christopher/S-5207-2016; Cheng, Yafang/F-9362-2010; Pöschl, Ulrich/A-6263-2010; Martin, Scot/G-1094-2015; Sinha, Baerbel/H-1250-2012; Shiraiwa, Manabu/A-6246-2010	Gunthe, Sachin/0000-0002-7903-7783; Artaxo, Paulo/0000-0001-7754-3036; Kilcoyne, Arthur A L/0000-0002-8805-8690; Su, Hang/0000-0003-4889-1669; Andreae, Meinrat O./0000-0003-1968-7925; Pöhlker, Christopher/0000-0001-6958-425X; Cheng, Yafang/0000-0003-4912-9879; Pöschl, Ulrich/0000-0003-1412-3557; Martin, Scot/0000-0002-8996-7554; Sinha, Baerbel/0000-0001-8614-7473; Shiraiwa, Manabu/0000-0003-2532-5373; Moffet, Ryan/0000-0002-2352-5454	Max Planck Society; Max Planck Graduate Center; Geocycles Cluster Mainz (Landesexzellenzcluster Rheinland-Pfalz); European Community (PEGASOS) [FP7-265148]; Office of Science, Office of Basic Energy Sciences (BES), U.S. Department of Energy (DOE) [DE-FG02-08ER6452]; U.S. NSF [0925467]; Office of Science, BES, of the U.S. DOE [DE-AC02-05CH11231]	Max Planck Society(Max Planck Society); Max Planck Graduate Center(Max Planck Society); Geocycles Cluster Mainz (Landesexzellenzcluster Rheinland-Pfalz); European Community (PEGASOS); Office of Science, Office of Basic Energy Sciences (BES), U.S. Department of Energy (DOE); U.S. NSF(National Science Foundation (NSF)); Office of Science, BES, of the U.S. DOE(United States Department of Energy (DOE))	This work has been supported by the Max Planck Society, the Max Planck Graduate Center, the Geocycles Cluster Mainz (Landesexzellenzcluster Rheinland-Pfalz), and the European Community (PEGASOS, FP7-265148). The Harvard Environmental Chamber was supported by the Office of Science, Office of Basic Energy Sciences (BES), U.S. Department of Energy (DOE), grant no. DE-FG02-08ER6452, and the U.S. NSF under grant no. 0925467. The Advanced Light Source is supported by the Director, Office of Science, BES, of the U.S. DOE under contract no. DE-AC02-05CH11231. We thank the Helmholtz-Zentrum Berlin for the allocation of synchrotron radiation beamtime at BESSY II. We thank the Instituto Nacional de Pesquisas da Amazonia (INPA), Manaus, and the ATTO team under the Brazilian coordinator, A. O. Manzi, for their collaboration and field support. We also thank G. R. Carmichael and the Center for Global and Regional Environmental Research at the University of Iowa for support in the Weather Research and Forecasting (WRF) model simulations. We gratefully acknowledge R. Ditz, I. Trebs, X. Chi, J. A. Huffman, J. Kesselmeier, J. Schongart, M. Kuwata, T. Tyliszczak, J. Huth, G. Schutz, E. Goering, M. Bechtel, J.-D. Forster, and T. Behrendt for support and helpful discussions.	Andreae MO, 2007, SCIENCE, V315, P50, DOI 10.1126/science.1136529; Andreae MO, 1997, SCIENCE, V276, P1052, DOI 10.1126/science.276.5315.1052; ANDREAE MO, 1983, SCIENCE, V220, P1148, DOI 10.1126/science.220.4602.1148; ARTAXO P, 1990, J GEOPHYS RES-ATMOS, V95, P16971, DOI 10.1029/JD095iD10p16971; ARTAXO P, 1995, ATMOS ENVIRON, V29, P393, DOI 10.1016/1352-2310(94)00178-N; BEAUFORD W, 1975, NATURE, V256, P35, DOI 10.1038/256035a0; BEAUFORD W, 1977, SCIENCE, V195, P571, DOI 10.1126/science.195.4278.571; Bertram AK, 2011, ATMOS CHEM PHYS, V11, P10995, DOI 10.5194/acp-11-10995-2011; Chen Q, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039880; Claeys M, 2004, SCIENCE, V303, P1173, DOI 10.1126/science.1092805; CROZAT G, 1979, TELLUS, V31, P52, DOI 10.1111/j.2153-3490.1979.tb00881.x; Ekman AML, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034970; Elbert W, 2007, ATMOS CHEM PHYS, V7, P4569, DOI 10.5194/acp-7-4569-2007; GOATLEY JL, 1966, PLANT PHYSIOL, V41, P373, DOI 10.1104/pp.41.3.373; Gunthe SS, 2009, ATMOS CHEM PHYS, V9, P7551, DOI 10.5194/acp-9-7551-2009; Hallquist M, 2009, ATMOS CHEM PHYS, V9, P5155, DOI 10.5194/acp-9-5155-2009; Jimenez JL, 2009, SCIENCE, V326, P1525, DOI 10.1126/science.1180353; LAWSON DR, 1978, GEOPHYS RES LETT, V5, P195, DOI 10.1029/GL005i003p00195; LAWSON DR, 1979, J GEOPHYS RES-OC ATM, V84, P3723, DOI 10.1029/JC084iC07p03723; Li J, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002310; Maria SF, 2004, SCIENCE, V306, P1921, DOI 10.1126/science.1103491; Martin ST, 2010, REV GEOPHYS, V48, DOI 10.1029/2008RG000280; NEMERYUK G E, 1970, Soviet Plant Physiology, V17, P560; Poschl U, 2010, SCIENCE, V329, P1513, DOI 10.1126/science.1191056; Solomon S., 2007, 4 IPCC; Song M, 2012, ATMOS CHEM PHYS, V12, P2691, DOI 10.5194/acp-12-2691-2012; Spracklen DV, 2006, ATMOS CHEM PHYS, V6, P5631, DOI 10.5194/acp-6-5631-2006; Tivanski AV, 2007, J PHYS CHEM A, V111, P5448, DOI 10.1021/jp070155u; Weigel R, 2011, ATMOS CHEM PHYS, V11, P9983, DOI 10.5194/acp-11-9983-2011; Worobiec A, 2007, ATMOS ENVIRON, V41, P9217, DOI 10.1016/j.atmosenv.2007.07.056; Zuend A, 2012, ATMOS CHEM PHYS, V12, P3857, DOI 10.5194/acp-12-3857-2012	31	134	136	11	255	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2012	337	6098					1075	1078		10.1126/science.1223264	http://dx.doi.org/10.1126/science.1223264			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22936773				2022-12-24	WOS:000308125800041
J	Sutcliffe, AG; Barnes, J; Belsky, J; Gardiner, J; Melhuish, E				Sutcliffe, Alastair G.; Barnes, Jacqueline; Belsky, Jay; Gardiner, Julian; Melhuish, Edward			The health and development of children born to older mothers in the United Kingdom: observational study using longitudinal cohort data	BRITISH MEDICAL JOURNAL			English	Article							YOUNG MATERNAL AGE; PATERNAL AGE; RISK; SCHIZOPHRENIA; OUTCOMES; AUTISM	Objective To assess relations between children's health and development and maternal age. Design Observational study of longitudinal cohorts. Setting Millennium Cohort Study (a random sample of UK children) and the National Evaluation of Sure Start study (a random sample of children in deprived areas in England), 2001 to 2007. Participants 31 257 children at age 9 months, 24 781 children at age 3 years, and 22 504 at age 5 years. Main outcome measures Childhood unintentional injuries and hospital admissions (aged 9 months, 3 years, and 5 years), immunisations (aged 9 months and 3 years), body mass index, language development, and difficulties with social development (aged 3 and 5 years). Results Associations were independent of personal and family characteristics and parity. The risk of children having unintentional injuries requiring medical attention or being admitted to hospital both declined with increasing maternal age. For example, at three years the risk of unintentional injuries declined from 36.6% for mothers aged 20 to 28.6% for mothers aged 40 and hospital admissions declined, respectively, from 27.1% to 21.6%. Immunisation rates at nine months increased with maternal age from 94.6% for mothers aged 20 to 98.1% for mothers aged 40. At three years, immunisation rates reached a maximum, at 81.3% for mothers aged 27, being lower for younger and older mothers. This was linked to rates for the combined measles, mumps, and rubella immunisation because excluding these resulted in no significant relation with maternal age. An increase in overweight children at ages 3 and 5 years associated with increasing maternal age was eliminated once maternal body mass index was included as a covariate. Language development was associated with improvements with increasing maternal age, with scores for children of mothers aged 20 being lower than those of children of mothers aged 40 by 0.21 to 0.22 standard deviations at ages 3 and 4 years. There were fewer social and emotional difficulties associated with increasing maternal age. Children of teenage mothers had more difficulties than children of mothers aged 40 (difference 0.28 SD at age 3 and 0.16 SD at age 5). Conclusion Increasing maternal age was associated with improved health and development for children up to 5 years of age.	[Barnes, Jacqueline; Belsky, Jay; Gardiner, Julian; Melhuish, Edward] Univ London, Inst Study Children Families & Social Issues, London WC1E 7HX, England; [Sutcliffe, Alastair G.] UCL, Inst Child Hlth, London WC1E 6BT, England; [Belsky, Jay] Univ Calif Davis, Davis, CA 95616 USA	University of London; Birkbeck University London; University of London; University College London; University of California System; University of California Davis	Melhuish, E (corresponding author), Univ London, Inst Study Children Families & Social Issues, London WC1E 7HX, England.	e.melhuish@bbk.ac.uk	Gardiner, Julian/AAO-2583-2020	Belsky, Jay/0000-0003-2191-2503; Sutcliffe, Alastair/0000-0001-8542-6155; Gardiner, Julian/0000-0001-8988-3812	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This research was funded by the Wellcome Trust through a grant entitled "Health of children born to older mothers"; the funding body had no involvement in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript. All authors are independent of the funding agency.	Berryman J., 1995, OLDER MOTHERS CONCEP; Botting B, 1998, Popul Trends, P19; Centers for Disease Control and Prevention, 2010, PERC DAT FIL LMS VAL; Centers for Disease Control and Prevention, 2007, MEASL MUMPS RUB MMR; Croen LA, 2007, ARCH PEDIAT ADOL MED, V161, P334, DOI 10.1001/archpedi.161.4.334; Dex S, 2004, MILLENNIUM COHORT ST; Eisenberg DTA, 2012, P NATL ACAD SCI US; Elliott C., 1996, ADM SCORING MANUAL; Fergusson DM, 1999, J CHILD PSYCHOL PSYC, V40, P479, DOI 10.1111/1469-7610.00464; FRASER AM, 1995, NEW ENGL J MED, V332, P1113, DOI 10.1056/NEJM199504273321701; Gilbert William, 2004, J Matern Fetal Neonatal Med, V16, P265, DOI 10.1080/14767050400018064; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Hesterberg T, 1998, 75 MATHSOFT; Honaker J, 2010, AMELIA 2 R PACKAGE; Irwin LG, 2007, EARLY CHILD DEV POWE; Kiernan KE, 2009, MATERNAL INDICATORS; Martin JA, 2004, NATL VITAL STAT REPO, V55; Melhuish E, 2008, LANCET, V372, P1641, DOI 10.1016/S0140-6736(08)61687-6; Moffitt TE, 2002, J CHILD PSYCHOL PSYC, V43, P727, DOI 10.1111/1469-7610.00082; Noble M, 2000, MEASURING MULTIPLE D; Office for National Statistics, 2007, SER FM1, V35; Phipps MG, 2002, OBSTET GYNECOL, V100, P481, DOI 10.1016/S0029-7844(02)02172-5; Plewis I., 2007, MILLENNIUM COHORT ST; Rubin DB, 2004, MULTIPLE IMPUTATION; Statistics New Zealand, 2012, BIRTHS DEATHS YEAR E; Sutcliffe A, 2009, REPROD AGEING, P173; Venables WN, MASS R PACKAGE; Vohr BR, 2009, J PEDIATR-US, V154, P498, DOI 10.1016/j.jpeds.2008.10.044; Weiser M, 2008, SCHIZOPHRENIA BULL, V34, P1042, DOI 10.1093/schbul/sbn109; Zammit S, 2003, BRIT J PSYCHIAT, V183, P405, DOI 10.1192/bjp.183.5.405	31	77	78	0	24	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 21	2012	345								e5116	10.1136/bmj.e5116	http://dx.doi.org/10.1136/bmj.e5116			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	996GP	22915663	hybrid, Green Submitted, Green Published, Green Accepted			2022-12-24	WOS:000308073200001
J	LaFerla, FM				LaFerla, Frank M.			Preclinical Success against Alzheimer's Disease with an Old Drug	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							BETA		Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Irvine, CA 92717 USA	University of California System; University of California Irvine	LaFerla, FM (corresponding author), Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Irvine, CA 92717 USA.							Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Lowenthal J, 2012, NEW ENGL J MED, V367, P488, DOI 10.1056/NEJMp1203104; Querfurth HW, 2011, NEW ENGL J MED, V364, P588; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142	5	24	24	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 9	2012	367	6					570	572		10.1056/NEJMcibr1204890	http://dx.doi.org/10.1056/NEJMcibr1204890			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	986AE	22873540				2022-12-24	WOS:000307310800014
J	Rai, A				Rai, Arti			Use Patents, Carve-Outs, and Incentives - A New Battle in the Drug-Patent Wars	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Duke Univ, Sch Law, Durham, NC 27706 USA	Duke University	Rai, A (corresponding author), Duke Univ, Sch Law, Durham, NC 27706 USA.							Eisenberg Rebecca S, 2005, Yale J Health Policy Law Ethics, V5, P717; Radley DC, 2006, ARCH INTERN MED, V166, P1021, DOI 10.1001/archinte.166.9.1021; Stevens AJ, 2011, NEW ENGL J MED, V364, P535, DOI 10.1056/NEJMsa1008268; 2003, FED REG, V68, P36683	4	11	11	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 9	2012	367	6					491	493		10.1056/NEJMp1206573	http://dx.doi.org/10.1056/NEJMp1206573			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	986AE	22873529	Green Published			2022-12-24	WOS:000307310800003
J	Foster, EA; Franks, DW; Mazzi, S; Darden, SK; Balcomb, KC; Ford, JKB; Croft, DP				Foster, Emma A.; Franks, Daniel W.; Mazzi, Sonia; Darden, Safi K.; Balcomb, Ken C.; Ford, John K. B.; Croft, Darren P.			Adaptive Prolonged Postreproductive Life Span in Killer Whales	SCIENCE			English	Article							MENOPAUSE; HUMANS		[Foster, Emma A.; Darden, Safi K.; Croft, Darren P.] Univ Exeter, Ctr Res Anim Behav, Coll Life & Environm Sci, Exeter EX4 4QG, Devon, England; [Foster, Emma A.; Balcomb, Ken C.] Ctr Whale Res, Friday Harbor, WA 98250 USA; [Franks, Daniel W.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Mazzi, Sonia] Univ York, Dept Math, York YO10 5DD, N Yorkshire, England; [Ford, John K. B.] Fisheries & Oceans Canada, Pacific Biol Stn, Nanaimo, BC V9T 6N7, Canada	University of Exeter; University of York - UK; University of York - UK; Fisheries & Oceans Canada	Croft, DP (corresponding author), Univ Exeter, Ctr Res Anim Behav, Coll Life & Environm Sci, Exeter EX4 4QG, Devon, England.	d.p.croft@exeter.ac.uk	Croft, Darren P/B-5503-2009; Darden, Safi/C-5940-2016	Croft, Darren P/0000-0001-6869-5097; Darden, Safi/0000-0002-2567-7902; Franks, Daniel Wayne/0000-0002-4832-7470	Biotechnology and Biological Sciences Research Council; Leverhulme Trust	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leverhulme Trust(Leverhulme Trust)	We thank our colleagues for their important roles in data collection over the past 35 years, particularly M. Bigg, D. Ellifrit, G. Ellis, E. Heydenrich, and A. van Ginneken and the Biotechnology and Biological Sciences Research Council and the Leverhulme Trust for funding. Data are available in the supplementary materials.	Baird RW, 2000, CETACEAN SOCIETIES, P127; Bigg M.A., 1990, REP INT WHALING COMM, V12, P384; Cant MA, 2008, P NATL ACAD SCI USA, V105, P5332, DOI 10.1073/pnas.0711911105; Ford MJ, 2011, J HERED, V102, P537, DOI 10.1093/jhered/esr067; Hill K, 2012, NATURE, V483, P160, DOI 10.1038/483160a; Johnstone RA, 2010, P ROY SOC B-BIOL SCI, V277, P3765, DOI 10.1098/rspb.2010.0988; Lahdenpera M, 2004, NATURE, V428, P178, DOI 10.1038/nature02367; Olesiuk P.F., 1990, Reports of the International Whaling Commission Special Issue, P209; Ward EJ, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-4	9	114	117	5	170	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2012	337	6100					1313	1313		10.1126/science.1224198	http://dx.doi.org/10.1126/science.1224198			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	004TW	22984064	Green Submitted			2022-12-24	WOS:000308705000034
J	Gozem, S; Schapiro, I; Ferre, N; Olivucci, M				Gozem, Samer; Schapiro, Igor; Ferre, Nicolas; Olivucci, Massimo			The Molecular Mechanism of Thermal Noise in Rod Photoreceptors	SCIENCE			English	Article							POTENTIAL-ENERGY SURFACES; VISUAL PIGMENTS; CONICAL INTERSECTION; RHODOPSIN; ISOMERIZATION; VISION; ACTIVATION; DARK; PHOTOISOMERIZATION; PHOTOACTIVATION	Spontaneous electrical signals in the retina's photoreceptors impose a limit on visual sensitivity. Their origin is attributed to a thermal, rather than photochemical, activation of the transduction cascade. Although the mechanism of such a process is under debate, the observation of a relationship between the maximum absorption wavelength (lambda(max)) and the thermal activation kinetic constant (k) of different visual pigments (the Barlow correlation) indicates that the thermal and photochemical activations are related. Here we show that a quantum chemical model of the bovine rod pigment provides a molecular-level understanding of the Barlow correlation. The transition state mediating thermal activation has the same electronic structure as the photoreceptor excited state, thus creating a direct link between lambda(max) and k. Such a link appears to be the manifestation of intrinsic chromophore features associated with the existence of a conical intersection between its ground and excited states.	[Gozem, Samer; Schapiro, Igor; Olivucci, Massimo] Bowling Green State Univ, Dept Chem, Bowling Green, OH 43403 USA; [Ferre, Nicolas] Univ Aix Marseille, Inst Chim Radicalaire, UMR 7273, F-13397 Marseille 20, France; [Olivucci, Massimo] Univ Siena, Dipartimento Chim, I-53100 Siena, Italy	University System of Ohio; Bowling Green State University; UDICE-French Research Universities; Aix-Marseille Universite; University of Siena	Olivucci, M (corresponding author), Bowling Green State Univ, Dept Chem, Bowling Green, OH 43403 USA.	molivuc@bgsu.edu	OLIVUCCI, MASSIMO/O-2588-2019; Ferré, Nicolas/K-8228-2012; Schapiro, Igor/C-7335-2014	OLIVUCCI, MASSIMO/0000-0002-8247-209X; Ferré, Nicolas/0000-0002-5583-8834; Gozem, Samer/0000-0002-6429-2853; Schapiro, Igor/0000-0001-8536-6869	Bowling Green State University; Center for Photochemical Sciences of Bowling Green State University; School of Arts and Sciences of Bowling Green State University	Bowling Green State University; Center for Photochemical Sciences of Bowling Green State University; School of Arts and Sciences of Bowling Green State University	We are grateful to M. A. Robb for a critical reading of the manuscript. This work was supported by the Bowling Green State University. M.O. is grateful to the Center for Photochemical Sciences and the School of Arts and Sciences of Bowling Green State University for startup funds. We are grateful to the Ohio Supercomputer Center for granted computer time.	Ala-Laurila P, 2004, VISION RES, V44, P2153, DOI 10.1016/j.visres.2004.03.031; Ala-Laurila P, 2004, BIOPHYS J, V86, P3653, DOI 10.1529/biophysj.103.035626; Andruniow T, 2004, P NATL ACAD SCI USA, V101, P17908, DOI 10.1073/pnas.0407997101; ATCHITY GJ, 1991, J CHEM PHYS, V95, P1862, DOI 10.1063/1.461036; BARLOW HB, 1957, NATURE, V179, P255, DOI 10.1038/179255b0; BARLOW RB, 1993, NATURE, V366, P64, DOI 10.1038/366064a0; BAYLOR DA, 1980, J PHYSIOL-LONDON, V309, P591, DOI 10.1113/jphysiol.1980.sp013529; Bokkon I, 2009, J PHOTOCH PHOTOBIO B, V96, P255, DOI 10.1016/j.jphotobiol.2009.07.002; Coto PB, 2006, MOL PHYS, V104, P983, DOI 10.1080/00268970500415865; De Vico L, 2005, J CHEM THEORY COMPUT, V1, P1029, DOI 10.1021/ct0500949; Frutos LM, 2007, P NATL ACAD SCI USA, V104, P7764, DOI 10.1073/pnas.0701732104; HERZBERG G, 1963, DISCUSS FARADAY SOC, P77, DOI 10.1039/df9633500077; Kaila VRI, 2012, J PHYS CHEM B, V116, P2249, DOI 10.1021/jp205918m; Kandori H, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1197, DOI 10.1023/A:1013123016803; Khrenova MG, 2010, PROTEINS, V78, P614, DOI 10.1002/prot.22590; Kukura P, 2005, SCIENCE, V310, P1006, DOI 10.1126/science.1118379; Liu J, 2011, J BIOL CHEM, V286, P27622, DOI 10.1074/jbc.M111.233312; Liu J, 2009, J AM CHEM SOC, V131, P8750, DOI 10.1021/ja903154u; Lorenz-Fonfria VA, 2010, J AM CHEM SOC, V132, P5693, DOI 10.1021/ja907756e; Luo DG, 2011, SCIENCE, V332, P1307, DOI 10.1126/science.1200172; MILDER SJ, 1991, BIOPHYS J, V60, P440, DOI 10.1016/S0006-3495(91)82070-7; Polli D, 2010, NATURE, V467, P440, DOI 10.1038/nature09346; Sampath AP, 2002, BIOPHYS J, V83, P184, DOI 10.1016/S0006-3495(02)75160-6; SCHICK GA, 1987, BIOCHEMISTRY-US, V26, P2556, DOI 10.1021/bi00383a022; SCHOENLEIN RW, 1991, SCIENCE, V254, P412, DOI 10.1126/science.1925597; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; WALD G, 1968, NATURE, V219, P800, DOI 10.1038/219800a0; WANG Q, 1994, SCIENCE, V266, P422, DOI 10.1126/science.7939680; WARSHEL A, 1978, P NATL ACAD SCI USA, V75, P2558, DOI 10.1073/pnas.75.6.2558; Zilberg S, 2003, PHOTOCH PHOTOBIO SCI, V2, P1256, DOI 10.1039/b306137j	30	84	85	1	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2012	337	6099					1225	1228		10.1126/science.1220461	http://dx.doi.org/10.1126/science.1220461			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	000UJ	22955833				2022-12-24	WOS:000308414000038
J	Cho, I; Yamanishi, S; Cox, L; Methe, BA; Zavadil, J; Li, K; Gao, Z; Mahana, D; Raju, K; Teitler, I; Li, HL; Alekseyenko, AV; Blaser, MJ				Cho, Ilseung; Yamanishi, Shingo; Cox, Laura; Methe, Barbara A.; Zavadil, Jiri; Li, Kelvin; Gao, Zhan; Mahana, Douglas; Raju, Kartik; Teitler, Isabel; Li, Huilin; Alekseyenko, Alexander V.; Blaser, Martin J.			Antibiotics in early life alter the murine colonic microbiome and adiposity	NATURE			English	Article							GASTRIC-INHIBITORY POLYPEPTIDE; CHAIN FATTY-ACIDS; RECEPTOR KNOCKOUT MICE; DIET-INDUCED OBESITY; GUT MICROBIOME; INTESTINAL MICROBIOTA; COMMUNITIES; DIVERSITY; SEQUENCES; DISEASE	Antibiotics administered in low doses have been widely used as growth promoters in the agricultural industry since the 1950s, yet the mechanisms for this effect are unclear. Because antimicrobial agents of different classes and varying activity are effective across several vertebrate species, we proposed that such subtherapeutic administration alters the population structure of the gut microbiome as well as its metabolic capabilities. We generated a model of adiposity by giving subtherapeutic antibiotic therapy to young mice and evaluated changes in the composition and capabilities of the gut microbiome. Administration of subtherapeutic antibiotic therapy increased adiposity in young mice and increased hormone levels related to metabolism. We observed substantial taxonomic changes in the microbiome, changes in copies of key genes involved in the metabolism of carbohydrates to short-chain fatty acids, increases in colonic short-chain fatty acid levels, and alterations in the regulation of hepatic metabolism of lipids and cholesterol. In this model, we demonstrate the alteration of early-life murine metabolic homeostasis through antibiotic manipulation.	[Cho, Ilseung; Yamanishi, Shingo; Alekseyenko, Alexander V.; Blaser, Martin J.] NYU, Sch Med, Dept Med, New York, NY 10016 USA; [Cho, Ilseung; Blaser, Martin J.] VA New York Harbor Healthcare Syst, Med Serv, New York, NY 10010 USA; [Cox, Laura; Gao, Zhan; Mahana, Douglas; Raju, Kartik; Teitler, Isabel; Blaser, Martin J.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Methe, Barbara A.; Li, Kelvin] J Craig Venter Inst, Rockville, MD 20850 USA; [Zavadil, Jiri] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Zavadil, Jiri; Alekseyenko, Alexander V.] NYU, Sch Med, Ctr Hlth Informat & Bioinformat, New York, NY 10016 USA; [Li, Huilin] NYU, Sch Med, Dept Populat Hlth, New York, NY 10016 USA	New York University; New York University; J. Craig Venter Institute; New York University; New York University; New York University	Blaser, MJ (corresponding author), NYU, Sch Med, Dept Med, New York, NY 10016 USA.	martin.blaser@med.nyu.edu	Blaser, Martin/ABF-6878-2021; Zavadil, Jiri/ABG-1780-2020; Cox, Laura/ABG-5883-2020	Zavadil, Jiri/0000-0003-0640-5562; Cox, Laura/0000-0002-9564-9894; Alekseyenko, Alexander/0000-0002-5748-2085; Li, Huilin/0000-0002-8288-7068; Cho, Ilseung/0000-0002-7308-8707	NIH [T-RO1-DK090989, 1UL1-RR029893, UL1-TR000038]; Diane Belfer Program in Human Microbial Ecology; Philip and Janice Levin Foundation; Michael Saperstein Fellowship; J. Craig Venter Institute; NYU Genome Technology Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000038] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090989] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diane Belfer Program in Human Microbial Ecology; Philip and Janice Levin Foundation; Michael Saperstein Fellowship; J. Craig Venter Institute; NYU Genome Technology Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part with grants from the NIH (T-RO1-DK090989, 1UL1-RR029893, UL1-TR000038), the Diane Belfer Program in Human Microbial Ecology, the Philip and Janice Levin Foundation, the Michael Saperstein Fellowship, and institutional funds provided by the J. Craig Venter Institute, and the NYU Genome Technology Center. We thank N. Javitt for advice and J. Chung for technical assistance.	Abreu MT, 2005, J IMMUNOL, V174, P4453, DOI 10.4049/jimmunol.174.8.4453; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Blaser MJ, 2007, NATURE, V449, P843, DOI 10.1038/nature06198; Blaser MJ, 2009, NAT REV MICROBIOL, V7, P887, DOI 10.1038/nrmicro2245; BUFFA R, 1975, HISTOCHEMISTRY, V43, P249, DOI 10.1007/BF00499706; Butaye P, 2003, CLIN MICROBIOL REV, V16, P175, DOI 10.1128/CMR.16.2.175-188.2003; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Favier CF, 2002, APPL ENVIRON MICROB, V68, P219, DOI 10.1128/AEM.68.1.219-226.2002; Fleissner CK, 2010, BRIT J NUTR, V104, P919, DOI 10.1017/S0007114510001303; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Hansotia T, 2005, REGUL PEPTIDES, V128, P125, DOI 10.1016/j.regpep.2004.07.019; Harkness J.E., 1989, BIOL MED RABBITS ROD, V3rd ed.; Henderson G, 2010, APPL ENVIRON MICROB, V76, P2058, DOI 10.1128/AEM.02580-09; Hong F, 2004, HEPATOLOGY, V40, P933, DOI 10.1002/hep.20400; Hong YH, 2005, ENDOCRINOLOGY, V146, P5092, DOI 10.1210/en.2005-0545; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; JUKES TH, 1970, NEW ENGL J MED, V282, P49; Kozyrskyj AL, 2007, CHEST, V131, P1753, DOI 10.1378/chest.06-3008; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Li Kelvin, 2010, BMC Res Notes, V3, P199, DOI 10.1186/1756-0500-3-199; Lovell CR, 2005, METHOD ENZYMOL, V397, P454, DOI 10.1016/S0076-6879(05)97028-6; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Manichanh C, 2010, GENOME RES, V20, P1411, DOI 10.1101/gr.107987.110; MARTINEZMURCIA AJ, 1995, FEMS MICROBIOL ECOL, V17, P247, DOI 10.1111/j.1574-6941.1995.tb00149.x; MCCAIG LF, 1995, JAMA-J AM MED ASSOC, V273, P214, DOI 10.1001/jama.273.3.214; McCracken VJ, 2001, J NUTR, V131, P1862, DOI 10.1093/jn/131.6.1862; Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727; Murphy EF, 2010, GUT, V59, P1635, DOI 10.1136/gut.2010.215665; OZAWA E, 1955, J ANTIBIOT, V8, P205; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Paine RT, 1998, ECOSYSTEMS, V1, P535, DOI 10.1007/s100219900049; Pavoine S, 2004, J THEOR BIOL, V228, P523, DOI 10.1016/j.jtbi.2004.02.014; Pavoine S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-156; Pickett S. T. A., 1985, ECOLOGY NATURAL DIST; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Reeder SB, 2005, MAGNET RESON MED, V54, P636, DOI 10.1002/mrm.20624; Reikvam DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017996; Robinson CJ, 2010, GUT MICROBES, V1, P279, DOI 10.4161/gmic.1.4.12614; Sole RV, 2001, P ROY SOC B-BIOL SCI, V268, P2039, DOI 10.1098/rspb.2001.1767; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tsukiyama K, 2004, EUR J ENDOCRINOL, V151, P407, DOI 10.1530/eje.0.1510407; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wlodarska M, 2011, INFECT IMMUN, V79, P1536, DOI 10.1128/IAI.01104-10; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; Yamada Y, 2004, HORM METAB RES, V36, P771, DOI 10.1055/s-2004-826162; Yip RGC, 1998, ENDOCRINOLOGY, V139, P4004, DOI 10.1210/en.139.9.4004; Zhao GH, 2006, BIOMED CHROMATOGR, V20, P674, DOI 10.1002/bmc.580; Zhou HY, 2005, BIOCHEM BIOPH RES CO, V335, P937, DOI 10.1016/j.bbrc.2005.07.164	62	1044	1108	15	426	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2012	488	7413					621	+		10.1038/nature11400	http://dx.doi.org/10.1038/nature11400			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996NC	22914093	Green Accepted			2022-12-24	WOS:000308095100049
J	Sanderson, K				Sanderson, Katharine			VACCINATION A durable design	NATURE			English	Editorial Material																		Wick DA, 2011, VACCINE, V29, P7857, DOI 10.1016/j.vaccine.2011.07.090	1	2	2	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2012	488	7413					S7	S7		10.1038/488S7a	http://dx.doi.org/10.1038/488S7a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	996NC	22932439	Bronze			2022-12-24	WOS:000308095100006
J	Brewer, C				Brewer, Colin			"Beau de Jour"-a male doctor who bought and sold sex	BRITISH MEDICAL JOURNAL			English	Editorial Material									Stapleford Ctr, London SW1W 9NP, England		Brewer, C (corresponding author), Stapleford Ctr, London SW1W 9NP, England.								0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 1	2012	345								e5115	10.1136/bmj.e5115	http://dx.doi.org/10.1136/bmj.e5115			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	985XC	22859772				2022-12-24	WOS:000307302800009
J	Lesku, JA; Rattenborg, NC; Valcu, M; Vyssotski, AL; Kuhn, S; Kuemmeth, F; Heidrich, W; Kempenaers, B				Lesku, John A.; Rattenborg, Niels C.; Valcu, Mihai; Vyssotski, Alexei L.; Kuhn, Sylvia; Kuemmeth, Franz; Heidrich, Wolfgang; Kempenaers, Bart			Adaptive Sleep Loss in Polygynous Pectoral Sandpipers	SCIENCE			English	Article							LOCAL SLEEP; POLYMORPHISM; HOMEOSTASIS	The functions of sleep remain elusive. Extensive evidence suggests that sleep performs restorative processes that sustain waking brain performance. An alternative view proposes that sleep simply enforces adaptive inactivity to conserve energy when activity is unproductive. Under this hypothesis, animals may evolve the ability to dispense with sleep when ecological demands favor wakefulness. Here, we show that male pectoral sandpipers (Calidris melanotos), a polygynous Arctic breeding shorebird, are able to maintain high neurobehavioral performance despite greatly reducing their time spent sleeping during a 3-week period of intense male-male competition for access to fertile females. Males that slept the least sired the most offspring. Our results challenge the view that decreased performance is an inescapable outcome of sleep loss.	[Valcu, Mihai; Kuhn, Sylvia; Kempenaers, Bart] Max Planck Inst Ornithol, Dept Behav Ecol & Evolutionary Genet, D-82319 Seewiesen, Germany; [Lesku, John A.; Rattenborg, Niels C.] Max Planck Inst Ornithol, Avian Sleep Grp, D-82319 Seewiesen, Germany; [Vyssotski, Alexei L.] Univ Zurich, Inst Neuroinformat, ETH, CH-8092 Zurich, Switzerland; [Kuemmeth, Franz; Heidrich, Wolfgang] E Obs GmbH, D-82031 Gruenwald, Germany	Max Planck Society; Max Planck Society; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Kempenaers, B (corresponding author), Max Planck Inst Ornithol, Dept Behav Ecol & Evolutionary Genet, D-82319 Seewiesen, Germany.	b.kempenaers@orn.mpg.de	/ABD-1334-2021; Valcu, Mihai/B-6497-2014; Valcu, Mihai/AAX-8842-2021	Valcu, Mihai/0000-0002-6907-7802; Lesku, John/0000-0001-5073-6954; Kempenaers, Bart/0000-0002-7505-5458; Vyssotski, Alexei/0000-0002-9021-1471	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	We thank R. Barth, E. Bolund, W. Forstmeier, A. Jacot, L. Langlois, P. Loes, C. Muck, A. Mutzel, M. Oltrogge, H. Schielzeth, X. Schleuning, S. Steiger, K. Teltscher, K. Temnow, and A. Wittenzellner for help in the field; R. Lanctot from the U.S. Fish and Wildlife Service (Anchorage) and G. Sheehan from Barrow Arctic Science Consortium for logistical support; and four anonymous reviewers for comments. W. Forstmeier kindly made his photos available. This work was funded by the Max Planck Society. B. K. and M. V. designed the study. B. K., J.A.L., and N.C.R. designed the EEG/EMG component. B. K. and M. V. collected and analyzed the activity/interaction data. J.A.L. and N.C.R. conducted the surgeries and analyzed the EEG/EMG data. A. L. V. developed and provided Neurologgers. S. K. incubated eggs and genetically determined paternity. W. H. and F. K. developed the iTags. B. K., J.A.L., N.C.R., and M. V. wrote the manuscript. Data from this study can be found in the supplementary materials.	Andersson Malte, 1994; Bachmann V, 2012, CEREB CORTEX, V22, P962, DOI 10.1093/cercor/bhr173; Barske J, 2011, P ROY SOC B-BIOL SCI, V278, P3523, DOI 10.1098/rspb.2011.0382; Byers J, 2010, ANIM BEHAV, V79, P771, DOI 10.1016/j.anbehav.2010.01.009; Cirelli C, 2008, PLOS BIOL, V6, P1605, DOI 10.1371/journal.pbio.0060216; Daan S, 2011, SLEEP BIOL RHYTHMS, V9, P1, DOI 10.1111/j.1479-8425.2010.00482.x; Dawson D, 1997, NATURE, V388, P235, DOI 10.1038/40775; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; Fuchs T, 2009, BIOL LETTERS, V5, P77, DOI 10.1098/rsbl.2008.0405; Horne J, 2011, BIOL PSYCHOL, V87, P1, DOI 10.1016/j.biopsycho.2010.10.004; Johnsen A, 2007, MOL ECOL, V16, P4867, DOI 10.1111/j.1365-294X.2007.03552.x; Jones SG, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-87; Jung CM, 2011, J PHYSIOL-LONDON, V589, P235, DOI 10.1113/jphysiol.2010.197517; Klein BA, 2010, P NATL ACAD SCI USA, V107, P22705, DOI 10.1073/pnas.1009439108; Kripke DF, 2011, SLEEP MED, V12, P28, DOI 10.1016/j.sleep.2010.04.016; Leemburg S, 2010, P NATL ACAD SCI USA, V107, P15939, DOI 10.1073/pnas.1002570107; Lesku JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023203; Lesku JA, 2011, P ROY SOC B-BIOL SCI, V278, P2419, DOI 10.1098/rspb.2010.2316; Lima SL, 2005, ANIM BEHAV, V70, P723, DOI 10.1016/j.anbehav.2005.01.008; Lyamin O, 2005, NATURE, V435, P1177, DOI 10.1038/4351177a; Lyamin OI, 2008, NEUROSCI BIOBEHAV R, V32, P1451, DOI 10.1016/j.neubiorev.2008.05.023; PITELKA FA, 1974, AM ZOOL, V14, P185; Rattenborg NC, 2004, PLOS BIOL, V2, P924, DOI 10.1371/journal.pbio.0020212; Rolls A, 2011, P NATL ACAD SCI USA, V108, P13305, DOI 10.1073/pnas.1015633108; Siegel JM, 2009, NAT REV NEUROSCI, V10, P747, DOI 10.1038/nrn2697; Vyazovskiy VV, 2011, NATURE, V472, P443, DOI 10.1038/nature10009; Vyssotski AL, 2009, CURR BIOL, V19, P1159, DOI 10.1016/j.cub.2009.05.070	27	143	146	2	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2012	337	6102					1654	1658		10.1126/science.1220939	http://dx.doi.org/10.1126/science.1220939			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	22878501				2022-12-24	WOS:000309215400045
J	Wang, Y; Kim, E; Wang, XJ; Novitch, BG; Yoshikawa, K; Chang, LS; Zhu, Y				Wang, Yuan; Kim, Edward; Wang, Xiaojing; Novitch, Bennett G.; Yoshikawa, Kazuaki; Chang, Long-Sheng; Zhu, Yuan			ERK Inhibition Rescues Defects in Fate Specification of Nf1-Deficient Neural Progenitors and Brain Abnormalities	CELL			English	Article							NEUROFIBROMATOSIS TYPE-1; SUBVENTRICULAR ZONE; SIGNALING PATHWAYS; CORPUS-CALLOSUM; SONIC HEDGEHOG; NF1; RAS; OLIGODENDROCYTES; NEURONS; NEUROGENESIS	Germline mutations in the RAS/ERK signaling pathway underlie several related developmental disorders collectively termed neuro-cardio-facial-cutaneous (NCFC) syndromes. NCFC patients manifest varying degrees of cognitive impairment, but the developmental basis of their brain abnormalities remains largely unknown. Neurofibromatosis type 1 (NF1), an NCFC syndrome, is caused by loss-of-function heterozygous mutations in the NF1 gene, which encodes neurofibromin, a RAS GTPase-activating protein. Here, we show that biallelic Nf1 inactivation promotes Erk-dependent, ectopic Olig2 expression specifically in transit-amplifying progenitors, leading to increased gliogenesis at the expense of neurogenesis in neonatal and adult subventricular zone (SVZ). Nf1-deficient brains exhibit enlarged corpus callosum, a structural defect linked to severe learning deficits in NF1 patients. Strikingly, these NF1-associated developmental defects are rescued by transient treatment with an MEK/ERK inhibitor during neonatal stages. This study reveals a critical role for Nf1 in maintaining postnatal SVZ-derived neurogenesis and identifies a potential therapeutic window for treating NF1-associated brain abnormalities.	[Wang, Yuan; Kim, Edward; Wang, Xiaojing; Zhu, Yuan] Univ Michigan, Sch Med, Div Mol Med & Genet, Dept Internal Med, Ann Arbor, MI 48109 USA; [Wang, Yuan; Kim, Edward; Wang, Xiaojing; Zhu, Yuan] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Novitch, Bennett G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Yoshikawa, Kazuaki] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Chang, Long-Sheng] Nationwide Childrens Hosp, Dept Pediat, Columbus, OH 43205 USA; [Chang, Long-Sheng] Ohio State Univ, Columbus, OH 43205 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Osaka University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University	Zhu, Y (corresponding author), Univ Michigan, Sch Med, Div Mol Med & Genet, Dept Internal Med, Ann Arbor, MI 48109 USA.	yuanzhu@umich.edu	Chang, Long-sheng/E-2871-2011; Zhu, Yuan/ABF-8405-2020; Wang, Yuan/I-7717-2014	Chang, Long-Sheng/0000-0002-5178-2992; Wang, Yuan/0000-0002-6324-6134; Wang, Yuan/0000-0003-1681-9566; Novitch, Bennett/0000-0002-2696-3708	NIH [1R01 NS053900]; DOD [W81XWH-11-1-0251]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053900, R01NS073762, R01NS053976, R01NS072804] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Best, L. Cregan, and G. Tomasek for technical assistance; members of the Y.Z. lab for support; J. Harrison, D. Sorenson, and S. Meshinchi at the MIL core facility for EM analysis; A. Messing for providing hGFAP-cre mice; and Dr. H. Song, D. Wellik, K. S. O'Shea, J. Sebolt-Leopold, and E. Fearon for critically reading the manuscript. This work is supported by grants from the NIH (1R01 NS053900) and DOD (W81XWH-11-1-0251) (to Y.Z.).	Bentires-Alj M, 2006, NAT MED, V12, P283, DOI 10.1038/nm0306-283; Bilican B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002863; BOS JL, 1989, CANCER RES, V49, P4682; Burns KA, 2007, CEREB CORTEX, V17, P2585, DOI 10.1093/cercor/bhl164; Cai J, 2007, DEVELOPMENT, V134, P1887, DOI 10.1242/dev.02847; Chandran S, 2003, DEVELOPMENT, V130, P6599, DOI 10.1242/dev.00871; Cichowski K, 2001, CELL, V104, P593, DOI 10.1016/S0092-8674(01)00245-8; Cui YJ, 2008, CELL, V135, P549, DOI 10.1016/j.cell.2008.09.060; Davis S, 2006, GENES BRAIN BEHAV, V5, P61, DOI 10.1111/j.1601-183X.2006.00230.x; De Schepper S, 2008, J INVEST DERMATOL, V128, P1050, DOI 10.1038/sj.jid.5701095; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Hegedus B, 2007, CELL STEM CELL, V1, P443, DOI 10.1016/j.stem.2007.07.008; Hyman SL, 2005, NEUROLOGY, V65, P1037, DOI 10.1212/01.wnl.0000179303.72345.ce; Ihrie RA, 2011, NEURON, V70, P674, DOI 10.1016/j.neuron.2011.05.004; Kessaris N, 2004, DEVELOPMENT, V131, P1289, DOI 10.1242/dev.01027; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Lee DY, 2010, GENE DEV, V24, P2317, DOI 10.1101/gad.1957110; Listernick R, 1999, AM J MED GENET, V89, P38, DOI 10.1002/(SICI)1096-8628(19990326)89:1<38::AID-AJMG8>3.0.CO;2-M; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Marshall CAG, 2005, J NEUROSCI, V25, P7289, DOI 10.1523/JNEUROSCI.1924-05.2005; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Moore BD, 2000, NEUROLOGY, V54, P914, DOI 10.1212/WNL.54.4.914; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Payne JM, 2010, J NEUROL NEUROSUR PS, V81, P304, DOI 10.1136/jnnp.2009.179630; Petryniak MA, 2007, NEURON, V55, P417, DOI 10.1016/j.neuron.2007.06.036; Pride N, 2010, J CHILD NEUROL, V25, P834, DOI 10.1177/0883073809350723; Riccardi V. M., 1992, NEUROFIBROMATOSIS PH; Richards LJ, 2004, CLIN GENET, V66, P276, DOI 10.1111/j.1399-0004.2004.00354.x; Richardson WD, 2006, NAT REV NEUROSCI, V7, P11, DOI 10.1038/nrn1826; Rowitch DH, 2010, NATURE, V468, P214, DOI 10.1038/nature09611; Rubinfeld H, 2005, MOL BIOTECHNOL, V31, P151, DOI 10.1385/MB:31:2:151; Samuels IS, 2008, J NEUROSCI, V28, P6983, DOI 10.1523/JNEUROSCI.0679-08.2008; Samuels IS, 2009, NEURON, V61, P160, DOI 10.1016/j.neuron.2009.01.001; Satoh Y, 2011, J NEUROSCI, V31, P1149, DOI 10.1523/JNEUROSCI.2243-10.2011; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Stevenson DA, 2006, AM J HUM GENET, V79, P143, DOI 10.1086/504441; Tan MJ, 2011, DEV CELL, V21, P1062, DOI 10.1016/j.devcel.2011.09.014; Tidyman WE, 2009, CURR OPIN GENET DEV, V19, P230, DOI 10.1016/j.gde.2009.04.001; Waggoner DJ, 2000, AM J MED GENET, V92, P132, DOI 10.1002/(SICI)1096-8628(20000515)92:2<132::AID-AJMG10>3.0.CO;2-6; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3; Zhu Y, 2005, DEVELOPMENT, V132, P5577, DOI 10.1242/dev.02162; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	48	98	102	2	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 17	2012	150	4					816	830		10.1016/j.cell.2012.06.034	http://dx.doi.org/10.1016/j.cell.2012.06.034			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22901811	Green Accepted, Bronze			2022-12-24	WOS:000308002300015
J	Chakraborty, A; Wang, DY; Ebright, YW; Korlann, Y; Kortkhonjia, E; Kim, T; Chowdhury, S; Wigneshweraraj, S; Irschik, H; Jansen, R; Nixon, BT; Knight, J; Weiss, S; Ebright, RH				Chakraborty, Anirban; Wang, Dongye; Ebright, Yon W.; Korlann, You; Kortkhonjia, Ekaterine; Kim, Taiho; Chowdhury, Saikat; Wigneshweraraj, Sivaramesh; Irschik, Herbert; Jansen, Rolf; Nixon, B. Tracy; Knight, Jennifer; Weiss, Shimon; Ebright, Richard H.			Opening and Closing of the Bacterial RNA Polymerase Clamp	SCIENCE			English	Article							ALTERNATING-LASER EXCITATION; 3.3 ANGSTROM RESOLUTION; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; TRANSCRIPTION ELONGATION; SINGLE MOLECULES; SWITCH REGION; INITIATION; PROTEIN	Using single-molecule fluorescence resonance energy transfer, we have defined bacterial RNA polymerase (RNAP) clamp conformation at each step in transcription initiation and elongation. We find that the clamp predominantly is open in free RNAP and early intermediates in transcription initiation but closes upon formation of a catalytically competent transcription initiation complex and remains closed during initial transcription and transcription elongation. We show that four RNAP inhibitors interfere with clamp opening. We propose that clamp opening allows DNA to be loaded into and unwound in the RNAP active-center cleft, that DNA loading and unwinding trigger clamp closure, and that clamp closure accounts for the high stability of initiation complexes and the high stability and processivity of elongation complexes.	[Chakraborty, Anirban; Wang, Dongye; Ebright, Yon W.; Kortkhonjia, Ekaterine; Ebright, Richard H.] Rutgers State Univ, Waksman Inst, Howard Hughes Med Inst, Piscataway, NJ 08854 USA; [Chakraborty, Anirban; Wang, Dongye; Ebright, Yon W.; Kortkhonjia, Ekaterine; Ebright, Richard H.] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA; [Korlann, You; Kortkhonjia, Ekaterine; Weiss, Shimon] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Kim, Taiho] Nesher Technol Inc, Los Angeles, CA 90057 USA; [Chowdhury, Saikat; Nixon, B. Tracy] Penn State Univ, Dept Biochem, University Pk, PA 16802 USA; [Wigneshweraraj, Sivaramesh] Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol & Infect, London SW7 2AZ, England; [Irschik, Herbert; Jansen, Rolf] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany; [Knight, Jennifer] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA	Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of California System; University of California Los Angeles; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Imperial College London; Helmholtz Association; Helmholtz-Center for Infection Research; University of Michigan System; University of Michigan	Ebright, RH (corresponding author), Rutgers State Univ, Waksman Inst, Howard Hughes Med Inst, POB 759, Piscataway, NJ 08854 USA.	ebright@waksman.rutgers.edu	weiss, shimon/B-4164-2009; Jansen, Rolf/C-1570-2011; CHOWDHURY, SAIKAT/J-6016-2019; Ebright, Richard/O-3321-2019	weiss, shimon/0000-0002-0720-5426; Jansen, Rolf/0000-0002-3592-4807; CHOWDHURY, SAIKAT/0000-0001-8043-5028; Ebright, Richard/0000-0001-8915-7140; Wigneshweraraj, Sivaramesh/0000-0002-1418-4029	NIH [GM037554, GM069937, GM069709, GM41376, AI072766]; Howard Hughes Medical Institute Investigatorship; BBSRC [BB/K000233/1, BB/E023703/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E023703/1, BB/K000233/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069937, R01GM069709, R01GM041376, R37GM041376, R01GM037554] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute Investigatorship(Howard Hughes Medical Institute); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Schultz and R. Mehl for plasmids and A. Reitmar for assistance with instrument set-up. This work was funded by NIH grants GM037554 to C. L. Brooks III, GM069937 to B.T.N., GM069709 to S. W., and GM41376 and AI072766 to R. H. E., and a Howard Hughes Medical Institute Investigatorship to R.H.E.	Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Belogurov GA, 2009, NATURE, V457, P332, DOI 10.1038/nature07510; Camara B, 2010, P NATL ACAD SCI USA, V107, P2247, DOI 10.1073/pnas.0907908107; Chakraborty A, 2010, METHOD ENZYMOL, V472, P19, DOI 10.1016/S0076-6879(10)72018-8; Chin JW, 2002, J AM CHEM SOC, V124, P9026, DOI 10.1021/ja027007w; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Darst SA, 2002, P NATL ACAD SCI USA, V99, P4296, DOI 10.1073/pnas.052054099; Ghosh T, 2010, FEMS MICROBIOL REV, V34, P611, DOI 10.1111/j.1574-6976.2010.00239.x; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Hartzog GA, 2011, MOL CELL, V43, P161, DOI 10.1016/j.molcel.2011.07.002; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; Kapanidis AN, 2005, MOL CELL, V20, P347, DOI 10.1016/j.molcel.2005.10.012; Kapanidis AN, 2004, P NATL ACAD SCI USA, V101, P8936, DOI 10.1073/pnas.0401690101; Landick R, 2001, CELL, V105, P567, DOI 10.1016/S0092-8674(01)00381-6; Lee NK, 2007, BIOPHYS J, V92, P303, DOI 10.1529/biophysj.106.093211; Lee NK, 2005, BIOPHYS J, V88, P2939, DOI 10.1529/biophysj.104.054114; Mariani R, 2009, CURR MED CHEM, V16, P430, DOI 10.2174/092986709787315559; Mekler V, 2011, J MOL BIOL, V413, P1016, DOI 10.1016/j.jmb.2011.09.029; Mukhopadhyay J, 2008, CELL, V135, P295, DOI 10.1016/j.cell.2008.09.033; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; Saecker RM, 2011, J MOL BIOL, V412, P754, DOI 10.1016/j.jmb.2011.01.018; Saxon E, 2000, SCIENCE, V287, P2007, DOI 10.1126/science.287.5460.2007; Srivastava A, 2011, CURR OPIN MICROBIOL, V14, P532, DOI 10.1016/j.mib.2011.07.030; Tagami S, 2010, NATURE, V468, P978, DOI 10.1038/nature09573; TANG H, 1995, P NATL ACAD SCI USA, V92, P4902, DOI 10.1073/pnas.92.11.4902; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	29	151	155	0	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2012	337	6094					591	595		10.1126/science.1218716	http://dx.doi.org/10.1126/science.1218716			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982PU	22859489	Green Accepted, Green Submitted			2022-12-24	WOS:000307058700048
J	Papouin, T; Ladepeche, L; Ruel, J; Sacchi, S; Labasque, M; Hanini, M; Groc, L; Pollegioni, L; Mothet, JP; Oliet, SHR				Papouin, Thomas; Ladepeche, Laurent; Ruel, Jerome; Sacchi, Silvia; Labasque, Marilyne; Hanini, Marwa; Groc, Laurent; Pollegioni, Loredano; Mothet, Jean-Pierre; Oliet, Stephane H. R.			Synaptic and Extrasynaptic NMDA Receptors Are Gated by Different Endogenous Coagonists	CELL			English	Article							METHYL-D-ASPARTATE; LONG-TERM POTENTIATION; D-SERINE; GLYCINE TRANSPORTER; SUBUNIT COMPOSITION; AMBIENT GLUTAMATE; TONIC ACTIVATION; RELEASE; DEPRESSION; SYNAPSES	N-methyl-D-aspartate receptors (NMDARs) are located in neuronal cell membranes at synaptic and extrasynaptic locations, where they are believed to mediate distinct physiological and pathological processes. Activation of NMDARs requires glutamate and a coagonist whose nature and impact on NMDAR physiology remain elusive. We report that synaptic and extrasynaptic NMDARs are gated by different endogenous coagonists, D-serine and glycine, respectively. The regionalized availability of the coagonists matches the preferential affinity of synaptic NMDARs for D-serine and extrasynaptic NMDARs for glycine. Furthermore, glycine and D-serine inhibit NMDAR surface trafficking in a subunit-dependent manner, which is likely to influence NMDARs subcellular location. Taking advantage of this coagonist segregation, we demonstrate that long-term potentiation and NMDA-induced neurotoxicity rely on synaptic NMDARs only. Conversely, long-term depression requires both synaptic and extrasynaptic receptors. Our observations provide key insights into the operating mode of NMDARs, emphasizing functional distinctions between synaptic and extrasynaptic NMDARs in brain physiology.	[Papouin, Thomas; Mothet, Jean-Pierre; Oliet, Stephane H. R.] INSERM, U862, Neuroctr Magendie, F-33077 Bordeaux, France; [Papouin, Thomas; Ladepeche, Laurent; Groc, Laurent; Mothet, Jean-Pierre; Oliet, Stephane H. R.] Univ Bordeaux, F-33077 Bordeaux, France; [Ladepeche, Laurent; Groc, Laurent] CNRS, Interdisciplinary Inst NeuroSci, UMR 5297, F-33077 Bordeaux, France; [Ruel, Jerome; Labasque, Marilyne; Hanini, Marwa; Mothet, Jean-Pierre] CNRS, CRN2M UMR 6231, F-13344 Marseille, France; [Ruel, Jerome; Mothet, Jean-Pierre] Univ Aix Marseille, F-13344 Marseille, France; [Pollegioni, Loredano] Univ Insubria, Dipartimento Biotecnol & Sci Mol, Varese, Italy; [Pollegioni, Loredano] Politecn Milan, Prot Factory, Ctr Interuniv Biotecnol Prot, Varese, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; University of Insubria; Polytechnic University of Milan	Oliet, SHR (corresponding author), INSERM, U862, Neuroctr Magendie, F-33077 Bordeaux, France.	stephane.oliet@inserm.fr	Labasque, Marilyne/AAE-2498-2022; Papouin, Thomas/W-2769-2019; Mothet, Jean-Pierre/ABE-3066-2020; Ladépêche, Laurent/G-3418-2015	Papouin, Thomas/0000-0001-5288-1944; Ladépêche, Laurent/0000-0002-2566-1206; MOTHET, Jean-Pierre/0000-0003-4991-0614; Ruel, Jerome/0000-0003-2871-7321; Labasque, Marilyne/0000-0002-1467-2866; SACCHI, SILVIA/0000-0002-2338-2561; POLLEGIONI, LOREDANO/0000-0003-1733-7243; Oliet, Stephane/0000-0003-0595-9029	INSERM; CNRS; Agence National pour la Recherche; Conseil Regional d'Aquitaine; Universite Bordeaux Segalen; Universite Aix-Marseille; NARSAD; Fondation pour la Recherche Medicale (Equipe FRM); Federation pour la Recherche sur le Cerveau; Human Frontier Science Program; Ministere de l'Enseignement Superieur et de la Recherche; Fondo di Ateneo per la Ricerca (Universita dell'Insubria); Fondazione Cariplo	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence National pour la Recherche(French National Research Agency (ANR)); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); Universite Bordeaux Segalen; Universite Aix-Marseille; NARSAD(NARSAD); Fondation pour la Recherche Medicale (Equipe FRM)(Fondation pour la Recherche Medicale); Federation pour la Recherche sur le Cerveau; Human Frontier Science Program(Human Frontier Science Program); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Fondo di Ateneo per la Ricerca (Universita dell'Insubria); Fondazione Cariplo(Fondazione Cariplo)	We thank Dr. Henneberger, Pr. Rusakov, and Pr. Voisin for critical reading of the manuscript and M. P. Blanchard and Dr. Choquet for their technical assistance. We are very grateful to Drs. Abrous and Sage for performing pilot experiments. This work was supported by grants from INSERM, CNRS, Agence National pour la Recherche, Conseil Regional d'Aquitaine, Universite Bordeaux Segalen, Universite Aix-Marseille, NARSAD, Fondation pour la Recherche Medicale (Equipe FRM), Federation pour la Recherche sur le Cerveau, and the Human Frontier Science Program. TP and LL were recipients of studentships from the Ministere de l'Enseignement Superieur et de la Recherche. S. S. and L. P. were supported by grants from Fondo di Ateneo per la Ricerca (Universita dell'Insubria) and from Fondazione Cariplo.	Ahmadi S, 2003, SCIENCE, V300, P2094, DOI 10.1126/science.1083970; Angulo MC, 2004, J NEUROSCI, V24, P6920, DOI 10.1523/JNEUROSCI.0473-04.2004; Arundine M, 2003, CELL CALCIUM, V34, P325, DOI 10.1016/S0143-4160(03)00141-6; Atkinson BN, 2001, MOL PHARMACOL, V60, P1414, DOI 10.1124/mol.60.6.1414; Bard L, 2010, P NATL ACAD SCI USA, V107, P19561, DOI 10.1073/pnas.1002690107; Basu AC, 2009, MOL PSYCHIATR, V14, P719, DOI 10.1038/mp.2008.130; Berberich S, 2005, J NEUROSCI, V25, P6907, DOI 10.1523/JNEUROSCI.1905-05.2005; Berger AJ, 1998, J NEUROPHYSIOL, V80, P3336, DOI 10.1152/jn.1998.80.6.3336; Bergeron R, 1998, P NATL ACAD SCI USA, V95, P15730, DOI 10.1073/pnas.95.26.15730; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bordji K, 2010, J NEUROSCI, V30, P15927, DOI 10.1523/JNEUROSCI.3021-10.2010; Cubelos B, 2005, CEREB CORTEX, V15, P448, DOI 10.1093/cercor/bhh147; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; FORSYTHE ID, 1988, J NEUROSCI, V8, P3733; Fossat P, 2012, CEREB CORTEX, V22, P595, DOI 10.1093/cercor/bhr130; Ge YA, 2010, P NATL ACAD SCI USA, V107, P16697, DOI 10.1073/pnas.1008200107; Groc L, 2007, J NEUROSCI, V27, P12433, DOI 10.1523/JNEUROSCI.3349-07.2007; Groc L, 2006, P NATL ACAD SCI USA, V103, P18769, DOI 10.1073/pnas.0605238103; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Harris AZ, 2008, J NEUROPHYSIOL, V99, P524, DOI 10.1152/jn.01169.2007; Harris AZ, 2007, J PHYSIOL-LONDON, V584, P509, DOI 10.1113/jphysiol.2007.137679; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Horio M, 2011, NEUROCHEM INT, V59, P853, DOI 10.1016/j.neuint.2011.08.017; Inoue R, 2008, J NEUROSCI, V28, P14486, DOI 10.1523/JNEUROSCI.5034-08.2008; Job V, 2002, EUR J BIOCHEM, V269, P1456, DOI 10.1046/j.1432-1033.2002.02790.x; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Kalbaugh TL, 2009, J NEUROSCI, V29, P1469, DOI 10.1523/JNEUROSCI.4240-08.2009; Katsuki H, 2004, J PHARMACOL EXP THER, V311, P836, DOI 10.1124/jpet.104.070912; Kirson ED, 1996, J PHYSIOL-LONDON, V497, P437, DOI 10.1113/jphysiol.1996.sp021779; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; Kohr G, 2006, CELL TISSUE RES, V326, P439, DOI 10.1007/s00441-006-0273-6; Le Meur K, 2007, J PHYSIOL-LONDON, V580, P373, DOI 10.1113/jphysiol.2006.123570; Leveille F, 2008, FASEB J, V22, P4258, DOI 10.1096/fj.08-107268; Lin CH, 2012, PHARMACOL BIOCHEM BE, V100, P665, DOI 10.1016/j.pbb.2011.03.023; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Madry C, 2007, MOL PHARMACOL, V72, P1535, DOI 10.1124/mol.107.040071; Massey PV, 2004, J NEUROSCI, V24, P7821, DOI 10.1523/JNEUROSCI.1697-04.2004; MATSUI T, 1995, J NEUROCHEM, V65, P454; Milnerwood AJ, 2010, NEURON, V65, P178, DOI 10.1016/j.neuron.2010.01.008; Molla G, 2000, J BIOL CHEM, V275, P24715, DOI 10.1074/jbc.M908193199; Molla G, 1998, PROTEIN EXPRES PURIF, V14, P289, DOI 10.1006/prep.1998.0956; Morishita W, 2007, NEUROPHARMACOLOGY, V52, P71, DOI 10.1016/j.neuropharm.2006.07.005; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; Mustafa AK, 2010, J NEUROSCI, V30, P1413, DOI 10.1523/JNEUROSCI.4297-09.2010; Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Paoletti P, 1997, J NEUROSCI, V17, P5711; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; Petralia RS, 2010, NEUROSCIENCE, V167, P68, DOI 10.1016/j.neuroscience.2010.01.022; POLLEGIONI L, 1992, BIOCHIM BIOPHYS ACTA, V1120, P11, DOI 10.1016/0167-4838(92)90418-D; PRIESTLEY T, 1995, MOL PHARMACOL, V48, P841; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Rusakov DA, 2004, SCIENCE, V305, p1912B, DOI 10.1126/science.1101128; SAH P, 1989, SCIENCE, V246, P815, DOI 10.1126/science.2573153; SCHELL MJ, 1995, P NATL ACAD SCI USA, V92, P3948, DOI 10.1073/pnas.92.9.3948; Shleper M, 2005, J NEUROSCI, V25, P9413, DOI 10.1523/JNEUROSCI.3190-05.2005; Stevens ER, 2010, EUR J NEUROSCI, V31, P808, DOI 10.1111/j.1460-9568.2010.07135.x; Stocca G, 1998, J PHYSIOL-LONDON, V507, P13, DOI 10.1111/j.1469-7793.1998.013bu.x; Tovar KR, 1999, J NEUROSCI, V19, P4180; Tsai GC, 2004, BIOL PSYCHIAT, V55, P452, DOI 10.1016/j.biopsych.2003.09.012; WAFFORD KA, 1995, MOL PHARMACOL, V47, P374; Wake K, 2001, NEUROSCI LETT, V297, P25, DOI 10.1016/S0304-3940(00)01658-X; Weitlauf C, 2005, J NEUROSCI, V25, P8386, DOI 10.1523/JNEUROSCI.2388-05.2005; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Yamamoto S, 2010, J PSYCHIATR RES, V44, P1069, DOI 10.1016/j.jpsychires.2010.03.013; Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100; ZAFRA F, 1995, EUR J NEUROSCI, V7, P1342, DOI 10.1111/j.1460-9568.1995.tb01125.x; Zhang Z, 2008, CEREB CORTEX, V18, P2391, DOI 10.1093/cercor/bhn008; Zhao JP, 2007, J NEUROSCI, V27, P13649, DOI 10.1523/JNEUROSCI.3153-07.2007	72	468	474	2	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 3	2012	150	3					633	646		10.1016/j.cell.2012.06.029	http://dx.doi.org/10.1016/j.cell.2012.06.029			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	985WO	22863013	Green Submitted, Bronze			2022-12-24	WOS:000307301400020
J	Farrell, L				Farrell, Liam			The dance of death	BRITISH MEDICAL JOURNAL			English	Editorial Material												drfarrell@hotmail.co.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUL 24	2012	345								e4956	10.1136/bmj.e4956	http://dx.doi.org/10.1136/bmj.e4956			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	981UQ	22833582				2022-12-24	WOS:000306996900007
J	Chng, SS; Xue, MY; Garner, RA; Kadokura, H; Boyd, D; Beckwith, J; Kahne, D				Chng, Shu-Sin; Xue, Mingyu; Garner, Ronald A.; Kadokura, Hiroshi; Boyd, Dana; Beckwith, Jonathan; Kahne, Daniel			Disulfide Rearrangement Triggered by Translocon Assembly Controls Lipopolysaccharide Export	SCIENCE			English	Article							OUTER-MEMBRANE; PROTEIN COMPLEX; IDENTIFICATION; BIOGENESIS	The presence of lipopolysaccharide (LPS) on the cell surface of Gram-negative bacteria is critical for viability. A conserved beta-barrel membrane protein LptD (lipopolysaccharide transport protein D) translocates LPS from the periplasm across the outer membrane (OM). In Escherichia coli, this protein contains two disulfide bonds and forms the OM LPS translocon with the lipoprotein LptE. Here, we identified seven in vivo states on the oxidative-folding pathway of LptD. Proper assembly involved a nonfunctional intermediate containing non-native disulfides. Intermediate formation required the oxidase DsbA, and subsequent maturation to the active form with native disulfides was triggered by LptE. Thus, disulfide bond-dependent protein folding of LptD requires the proper assembly of a two-protein complex to promote disulfide bond rearrangement.	[Chng, Shu-Sin; Xue, Mingyu; Garner, Ronald A.; Kahne, Daniel] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Chng, Shu-Sin; Kadokura, Hiroshi; Boyd, Dana; Beckwith, Jonathan] Harvard Univ, Dept Microbiol & Immunobiol, Sch Med, Boston, MA 02115 USA; [Kadokura, Hiroshi] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300192, Japan; [Kahne, Daniel] Harvard Univ, Dept Biol Chem & Mol Pharmacol, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard Medical School; Nara Institute of Science & Technology; Harvard University; Harvard Medical School	Kahne, D (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	kahne@chemistry.harvard.edu	Kadokura, Hiroshi/AAE-1645-2019; Chng, Shu Sin/B-1759-2018	Chng, Shu Sin/0000-0001-5466-7183; Kadokura, Hiroshi/0000-0001-7308-7141	NIH [AI081059]; NIGMS [41883]; Japan Society for the Promotion of Science [21580092]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041883] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Freinkman for pET23/42lptD-FLAG<INF>3</INF>. J.B. is an American Cancer Society Professor. This work is supported by NIH grants AI081059 (to D. K.) and NIGMS 41883 (to J.B.) and in part by Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (C) 21580092 (to H.K.).	Braun M, 2002, MOL MICROBIOL, V45, P1289, DOI 10.1046/j.1365-2958.2002.03091.x; Chimalakonda G, 2011, P NATL ACAD SCI USA, V108, P2492, DOI 10.1073/pnas.1019089108; Chng SS, 2010, BIOCHEMISTRY-US, V49, P4565, DOI 10.1021/bi100493e; Chng SS, 2010, P NATL ACAD SCI USA, V107, P5363, DOI 10.1073/pnas.0912872107; Eggert US, 2001, SCIENCE, V294, P361, DOI 10.1126/science.1063611; Freinkman E, 2012, BIOCHEMISTRY-US, V51, P4800, DOI 10.1021/bi300592c; Freinkman E, 2011, P NATL ACAD SCI USA, V108, P2486, DOI 10.1073/pnas.1015617108; Jansens A, 2002, SCIENCE, V298, P2401, DOI 10.1126/science.1078376; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; Kadokura H, 2009, CELL, V138, P1164, DOI 10.1016/j.cell.2009.07.030; MUHLRADT PF, 1975, EUR J BIOCHEM, V51, P343, DOI 10.1111/j.1432-1033.1975.tb03934.x; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Ruiz N, 2010, P NATL ACAD SCI USA, V107, P12245, DOI 10.1073/pnas.1007319107; SAMPSON BA, 1989, GENETICS, V122, P491; Sklar JG, 2007, P NATL ACAD SCI USA, V104, P6400, DOI 10.1073/pnas.0701579104; Ureta AR, 2007, J BACTERIOL, V189, P446, DOI 10.1128/JB.01103-06; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; Wu T, 2006, P NATL ACAD SCI USA, V103, P11754, DOI 10.1073/pnas.0604744103	19	76	79	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2012	337	6102					1665	1668		10.1126/science.1227215	http://dx.doi.org/10.1126/science.1227215			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	22936569	Green Accepted			2022-12-24	WOS:000309215400048
J	Spence, D				Spence, Des			Good medicine: homeopathy	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						[Anonymous], 2010, NHS NEWS        0727; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; NHS Health and Social Care Information Centre, 2011, PRESCR COST AN ENGL; Starfield B, 2000, JAMA-J AM MED ASSOC, V284, P483, DOI 10.1001/jama.284.4.483	4	4	4	0	11	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 14	2012	345								e6184	10.1136/bmj.e6184	http://dx.doi.org/10.1136/bmj.e6184			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	007BZ	22983533				2022-12-24	WOS:000308865100004
J	Young, NE; Briner, JP; Rood, DH; Finkel, RC				Young, Nicolas E.; Briner, Jason P.; Rood, Dylan H.; Finkel, Robert C.			Glacier Extent During the Younger Dryas and 8.2-ka Event on Baffin Island, Arctic Canada	SCIENCE			English	Article							ABRUPT CLIMATE-CHANGE; LAURENTIDE; GREENLAND; SEASONALITY; LANDSCAPES; INTERVAL; RETREAT; HISTORY; END	Greenland ice cores reveal that mean annual temperatures during the Younger Dryas (YD) cold interval-about 12.9 to 11.7 thousand years ago (ka)-and the similar to 150-year-long cold reversal that occurred 8.2 thousand years ago were similar to 15 degrees and 3 degrees to 4 degrees C colder than today, respectively. Reconstructing ice-sheet response to these climate perturbations can help evaluate ice-sheet sensitivity to climate change. Here, we report the widespread advance of Laurentide Ice Sheet outlet glaciers and independent mountain glaciers on Baffin Island, Arctic Canada, in response to the 8.2-ka event and show that mountain glaciers during the 8.2-ka event were larger than their YD predecessors. In contrast to the wintertime bias of YD cooling, we suggest that cooling during the 8.2-ka event was more evenly distributed across the seasons.	[Young, Nicolas E.; Briner, Jason P.] SUNY Buffalo, Dept Geol, Buffalo, NY 14260 USA; [Rood, Dylan H.] SUERC, Accelerator Mass Spectrometry Lab, E Kilbride, Lanark, Scotland; [Rood, Dylan H.] Univ Calif Santa Barbara, Earth Res Inst, Santa Barbara, CA 93106 USA; [Finkel, Robert C.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Scottish Universities Research & Reactor Center; University of California System; University of California Santa Barbara; University of California System; University of California Berkeley	Young, NE (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, New York, NY 10964 USA.	nicolasy@ldeo.columbia.edu			U.S. National Science Foundation [ARC-909334, BCS-1002597, BCS-752848]	U.S. National Science Foundation(National Science Foundation (NSF))	We thank M. Badding, D. Bedard, S. McGrane, N. Michelutti, and E. Thomas, who aided in sample collection. We also thank G. Miller for insightful discussions and the helpful comments from two anonymous reviewers. This work was funded in part by U.S. National Science Foundation awards ARC-909334, BCS-1002597, and BCS-752848 to J.P.B.	Alley R., 2003, EOS T AM GEOPHYS UN, V84; Alley RB, 1997, GEOLOGY, V25, P483, DOI 10.1130/0091-7613(1997)025<0483:HCIAPW>2.3.CO;2; Alley RB, 2005, QUATERNARY SCI REV, V24, P1123, DOI 10.1016/j.quascirev.2004.12.004; Alley RB, 2000, QUATERNARY SCI REV, V19, P213, DOI 10.1016/S0277-3791(99)00062-1; ANDREWS JT, 1978, ARCTIC ALPINE RES, V10, P617, DOI 10.2307/1550683; ANDREWS JT, 1995, PALEOCEANOGRAPHY, V10, P943, DOI 10.1029/95PA01426; Axford Y, 2009, QUATERNARY RES, V71, P142, DOI 10.1016/j.yqres.2008.09.006; Barber DC, 1999, NATURE, V400, P344, DOI 10.1038/22504; Bjorck S, 2002, GEOLOGY, V30, P427, DOI 10.1130/0091-7613(2002)030<0427:AMYDSC>2.0.CO;2; Born A, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC003024; Briner JP, 2007, J QUATERNARY SCI, V22, P223, DOI 10.1002/jqs.1057; Briner JP, 2009, NAT GEOSCI, V2, P496, DOI 10.1038/ngeo556; Briner JP, 2006, GEOL SOC AM BULL, V118, P406, DOI 10.1130/B25716.1; Briner JP, 2005, CAN J EARTH SCI, V42, P67, DOI 10.1139/E04-102; Broecker WS, 2010, QUATERNARY SCI REV, V29, P1078, DOI 10.1016/j.quascirev.2010.02.019; Cheng H, 2009, SCIENCE, V326, P248, DOI 10.1126/science.1177840; Denton GH, 2005, QUATERNARY SCI REV, V24, P1159, DOI 10.1016/j.quascirev.2004.12.002; Dyke AS, 2002, QUATERNARY SCI REV, V21, P9, DOI 10.1016/S0277-3791(01)00095-6; FALCONER G, 1965, SCIENCE, V147, P608, DOI 10.1126/science.147.3658.608; Hillaire-Marcel C, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030396; Kaplan MR, 2010, NATURE, V467, P194, DOI 10.1038/nature09313; KAPSNER WR, 1995, NATURE, V373, P52, DOI 10.1038/373052a0; Kelly MA, 2008, QUATERNARY SCI REV, V27, P2273, DOI 10.1016/j.quascirev.2008.08.004; Kobashi T, 2007, QUATERNARY SCI REV, V26, P1212, DOI 10.1016/j.quascirev.2007.01.009; Koerner RM, 2005, ANN GLACIOL-SER, V42, P417, DOI 10.3189/172756405781813122; Lohne OS, 2012, J QUATERNARY SCI, V27, P81, DOI 10.1002/jqs.1516; LOWELL TV, 2005, EOS, V86, P365, DOI DOI 10.1029/2005EO400001; Miller G. H., 1974, GEOLOGY, V2, P125; Oerlemans J., 2001, GLACIERS CLIMATE CHA; Putnam AE, 2010, NAT GEOSCI, V3, P700, DOI 10.1038/NGEO962; Rasmussen SO, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006079; Severinghaus JP, 1998, NATURE, V391, P141, DOI 10.1038/34346; Smith J. E., 1966, THESIS MCGILL U MONT; Vinther BM, 2009, NATURE, V461, P385, DOI 10.1038/nature08355; Young NE, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049639	35	42	42	2	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2012	337	6100					1330	1333		10.1126/science.1222759	http://dx.doi.org/10.1126/science.1222759			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	004TW	22984068				2022-12-24	WOS:000308705000039
J	Guermazi, A; Niu, JB; Hayashi, D; Roemer, FW; Englund, M; Neogi, T; Aliabadi, P; McLennan, CE; Felson, DT				Guermazi, Ali; Niu, Jingbo; Hayashi, Daichi; Roemer, Frank W.; Englund, Martin; Neogi, Tuhina; Aliabadi, Piran; McLennan, Christine E.; Felson, David T.			Prevalence of abnormalities in knees detected by MRI in adults without knee osteoarthritis: population based observational study (Framingham Osteoarthritis Study)	BRITISH MEDICAL JOURNAL			English	Article							BONE-MARROW LESIONS; JOINT SPACE WIDTH; BODY-MASS INDEX; CARTILAGE LOSS; RADIOGRAPHIC FEATURES; RHEUMATIC CONDITIONS; UNITED-STATES; RISK-FACTORS; PAIN; ASSOCIATION	Objective To examine use of magnetic resonance imaging (MRI) of knees with no radiographic evidence of osteoarthritis to determine the prevalence of structural lesions associated with osteoarthritis and their relation to age, sex, and obesity. Design Population based observational study. Setting Community cohort in Framingham, MA, United States (Framingham osteoarthritis study). Participants 710 people aged >50 who had no radiographic evidence of knee osteoarthritis (Kellgren-Lawrence grade 0) and who underwent MRI of the knee. Main outcome measures Prevalence of MRI findings that are suggestive of knee osteoarthritis (osteophytes, cartilage damage, bone marrow lesions, subchondral cysts, meniscal lesions, synovitis, attrition, and ligamentous lesions) in all participants and after stratification by age, sex, body mass index (BMI), and the presence or absence of knee pain. Pain was assessed by three different questions and also by WOMAC questionnaire. Results Of the 710 participants, 393 (55%) were women, 660 (93%) were white, and 206 (29%) had knee pain in the past month. The mean age was 62.3 years and mean BMI was 27.9. Prevalence of "any abnormality" was 89% (631/710) overall. Osteophytes were the most common abnormality among all participants (74%, 524/710), followed by cartilage damage (69%, 492/710) and bone marrow lesions (52%, 371/710). The higher the age, the higher the prevalence of all types of abnormalities detectable by MRI. There were no significant differences in the prevalence of any of the features between BMI groups. The prevalence of at least one type of pathology ("any abnormality") was high in both painful (90-97%, depending on pain definition) and painless (86-88%) knees. Conclusions MRI shows lesions in the tibiofemoral joint in most middle aged and elderly people in whom knee radiographs do not show any features of osteoarthritis, regardless of pain.	[Guermazi, Ali; Hayashi, Daichi; Roemer, Frank W.] Boston Univ, Sch Med, Dept Radiol, Boston, MA 02118 USA; [Niu, Jingbo; Englund, Martin; Neogi, Tuhina; Felson, David T.] Boston Univ, Sch Med, Clin Epidemiol Res & Training Unit, Boston, MA 02118 USA; [Roemer, Frank W.] Klinikum Augsburg, Dept Radiol, Augsburg, Germany; [Englund, Martin] Lund Univ, Dept Orthopaed, Lund, Sweden; [Aliabadi, Piran] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA; [McLennan, Christine E.] OptumInsight Life Sci, Waltham, MA 02451 USA	Boston University; Boston University; Klinikum Augsburg; Lund University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Optum	Guermazi, A (corresponding author), Boston Univ, Sch Med, Dept Radiol, FGH Bldg,820 Harrison Ave, Boston, MA 02118 USA.	guermazi@bu.edu	Englund, Martin/J-7245-2012; Roemer, Frank/AAS-6317-2020; Hayashi, Daichi/J-9875-2012; Neogi, Tuhina/AAM-1110-2020	Englund, Martin/0000-0003-3320-2437; Niu, Jingbo/0000-0002-6170-1965; Neogi, Tuhina/0000-0002-9515-1711; Felson, David/0000-0002-2668-2447	National Institutes of Health [AG18393, AR47785]; Arthritis Foundation; Swedish Research Council; Greta and Johan Kock Foundation; King Gustaf V 80-year Birthday Foundation; Faculty of Medicine, Lund University, Sweden; NIAMS [AR055127]; Arthritis Foundation Arthritis Investigator Award; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR055127, P60AR047785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Greta and Johan Kock Foundation; King Gustaf V 80-year Birthday Foundation; Faculty of Medicine, Lund University, Sweden; NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Arthritis Foundation Arthritis Investigator Award; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by the National Institutes of Health (AG18393 and AR47785) and the Arthritis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The researchers work independently of their funders.; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: AG is the president of Boston Imaging Core Lab (BICL), LLC, and a consultant to Merck Serono, Stryker, Genzyme, AstraZeneca, and Novartis; FWR a vice president and shareholder of BICL and is a consultant to Merck Serono and National Institute of Health; ME is funded by the Swedish Research Council, the Greta and Johan Kock Foundation, King Gustaf V 80-year Birthday Foundation, and the Faculty of Medicine, Lund University, Sweden; TN is supported by NIAMS AR055127 and the Arthritis Foundation Arthritis Investigator Award.	Amin S, 2005, ARTHRITIS RHEUM, V52, P3152, DOI 10.1002/art.21296; Avasthi S, 2009, INT J ORTHOPED SURG, V13, P1; Bedson J, 2005, FAM PRACT, V22, P103, DOI 10.1093/fampra/cmh700; Chou R, 2009, LANCET, V373, P463, DOI 10.1016/S0140-6736(09)60172-0; Conaghan PG, 2006, OSTEOARTHR CARTILAGE, V14, pA87, DOI 10.1016/j.joca.2006.02.028; Englund M, 2008, NEW ENGL J MED, V359, P1108, DOI 10.1056/NEJMoa0800777; Felson DT, 2001, ANN INTERN MED, V134, P541, DOI 10.7326/0003-4819-134-7-200104030-00007; Felson DT, 1998, ARTHRITIS RHEUM, V41, P1343, DOI 10.1002/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO;2-9; Felson DT, 2005, RHEUMATOLOGY, V44, P100, DOI 10.1093/rheumatology/keh411; FELSON DT, 1987, ARTHRITIS RHEUM, V30, P914, DOI 10.1002/art.1780300811; Guermazi A, 2012, SKELETAL RADIOL, V41, P179, DOI 10.1007/s00256-011-1142-2; Guermazi A, 2011, CURR OPIN RHEUMATOL, V23, P484, DOI 10.1097/BOR.0b013e328349c2d2; Hill CL, 2001, J RHEUMATOL, V28, P1330; Hunter DJ, 2006, ARTHRITIS RHEUM-US, V54, P2488, DOI 10.1002/art.22016; Javaid MK, 2010, OSTEOARTHR CARTILAGE, V18, P323, DOI 10.1016/j.joca.2009.11.002; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kothari M, 2004, EUR RADIOL, V14, P1568, DOI 10.1007/s00330-004-2312-6; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Murphy L, 2008, ARTHRIT RHEUM-ARTHR, V59, P1207, DOI 10.1002/art.24021; Neogi T, 2011, CURR OPIN RHEUMATOL, V23, P185, DOI 10.1097/BOR.0b013e32834307eb; Neogi T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2844; Peterfy CG, 2006, OSTEOARTHR CARTILAGE, V14, pA95, DOI 10.1016/j.joca.2006.02.029; Peterfy CG, 2004, OSTEOARTHR CARTILAGE, V12, P177, DOI 10.1016/j.joca.2003.11.003; Roemer FW, 2009, OSTEOARTHR CARTILAGE, V17, P1115, DOI 10.1016/j.joca.2009.03.012; Roemer FW, 2009, ANN RHEUM DIS, V68, P1461, DOI 10.1136/ard.2008.096834; Roemer FW, 2009, RADIOLOGY, V252, P772, DOI 10.1148/radiol.2523082197; Sacks JJ, 2010, ARTHRIT CARE RES, V62, P460, DOI 10.1002/acr.20041; Sanghi D, 2011, J ORTHOP SCI, V16, P719, DOI 10.1007/s00776-011-0147-y; Szebenyi B, 2006, ARTHRITIS RHEUM-US, V54, P230, DOI 10.1002/art.21534; Theiler R, 1999, OSTEOARTHR CARTILAGE, V7, P515, DOI 10.1053/joca.1999.0262; Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056/NEJMoa070972; Wills AK, 2012, ANN RHEUM DIS, V71, P655, DOI 10.1136/ard.2011.154021; Yusuf E, 2011, OSTEOARTHR CARTILAGE, V19, P1117, DOI 10.1016/j.joca.2011.06.001; Yusuf E, 2011, ANN RHEUM DIS, V70, P60, DOI 10.1136/ard.2010.131904; Zhang YQ, 2011, ARTHRITIS RHEUM-US, V63, P691, DOI 10.1002/art.30148	35	274	279	8	36	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 29	2012	345								e5339	10.1136/bmj.e5339	http://dx.doi.org/10.1136/bmj.e5339			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036SK	22932918	Green Submitted, Green Published, hybrid			2022-12-24	WOS:000311050600002
J	Herbst, CT; Stoeger, AS; Frey, R; Lohscheller, J; Titze, IR; Gumpenberger, M; Fitch, WT				Herbst, Christian T.; Stoeger, Angela S.; Frey, Roland; Lohscheller, Joerg; Titze, Ingo R.; Gumpenberger, Michaela; Fitch, W. Tecumseh			How Low Can You Go? Physical Production Mechanism of Elephant Infrasonic Vocalizations	SCIENCE			English	Article							AFRICAN ELEPHANTS; LONG-DISTANCE; ACOUSTIC CUES; RED DEER; COMMUNICATION; EVOLUTION; LARYNGES; IDENTITY; WEIGHT; CALLS	Elephants can communicate using sounds below the range of human hearing ("infrasounds" below 20 hertz). It is commonly speculated that these vocalizations are produced in the larynx, either by neurally controlled muscle twitching (as in cat purring) or by flow-induced self-sustained vibrations of the vocal folds (as in human speech and song). We used direct high-speed video observations of an excised elephant larynx to demonstrate flow-induced self-sustained vocal fold vibration in the absence of any neural signals, thus excluding the need for any "purring" mechanism. The observed physical principles of voice production apply to a wide variety of mammals, extending across a remarkably large range of fundamental frequencies and body sizes, spanning more than five orders of magnitude.	[Herbst, Christian T.; Stoeger, Angela S.; Fitch, W. Tecumseh] Univ Vienna, Dept Cognit Biol, A-1090 Vienna, Austria; [Frey, Roland] Leibniz Inst Zoo & Wildlife Res, D-10252 Berlin, Germany; [Lohscheller, Joerg] Univ Appl Sci, Dept Comp Sci, D-54293 Trier, Germany; [Titze, Ingo R.] Univ Utah, Natl Ctr Voice & Speech, Salt Lake City, UT USA; [Gumpenberger, Michaela] Univ Vet Med Vienna, Clin Diagnost Imaging, A-1210 Vienna, Austria; [Fitch, W. Tecumseh] Univ Vet Med Vienna, Haidlhof Res Stn, Univ Vienna, Bad Voslau, Austria	University of Vienna; Leibniz Institut fur Zoo und Wildtierforschung; Utah System of Higher Education; University of Utah; University of Veterinary Medicine Vienna; University of Vienna	Herbst, CT (corresponding author), Univ Vienna, Dept Cognit Biol, Althanstr 14, A-1090 Vienna, Austria.	christian.herbst@univie.ac.at; tecumseh.fitch@univie.ac.at	Herbst, Christian T/D-6470-2011	Stoeger, Angela S/0000-0002-6714-8291; Gumpenberger, Michaela/0000-0003-2412-0501; Herbst, Christian/0000-0001-9095-3953	European Research Council Advanced Grant SOMACCA; University of Vienna; Austrian Science Fund (FWF) [P 23099]; Deutsche Forschungsgemeinschaft [LO1413/2]; National Institute for Deafness and Other Communication Disorders [R01 DC 008612]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008612] Funding Source: NIH RePORTER	European Research Council Advanced Grant SOMACCA; University of Vienna; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institute for Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by European Research Council Advanced Grant SOMACCA and a startup grant from the University of Vienna (W. T. F.); an Austrian Science Fund (FWF) grant, P 23099 (A. S.); grant no. LO1413/2 by the Deutsche Forschungsgemeinschaft (J.L.); and grant R01 DC 008612 (A Simulator for Sound Production in Airways) from the National Institute for Deafness and Other Communication Disorders (I. R. T.). Our sincere thanks go to B. Blaszkiewitz (Direktor, Tierpark Berlin Friedrichsfelde) for supplying us with the elephant larynx. We thank R. Hofer for contributing to the setup of the excised larynx experiment, P. Pesak for assisting in the computed tomography scan of the larynx specimen, and N. Kavcik for creating the artwork in Fig. 1 and the figure of the excised larynx setup in Fig. 2. The data reported in this manuscript are available in the supplementary materials.	Alipour F, 2009, J VOICE, V23, P40, DOI 10.1016/j.jvoice.2007.03.007; Elemans CPH, 2010, J NEUROSCI, V30, P13246, DOI 10.1523/JNEUROSCI.1130-10.2010; Fee MS, 1998, NATURE, V395, P67, DOI 10.1038/25725; Garstang M, 2004, J COMP PHYSIOL A, V190, P791, DOI 10.1007/s00359-004-0553-0; GRIFFITHS TA, 1983, MAMMALIA, V47, P377; Harrison D.F.N., 1995, ANATOMY PHYSL MAMMAL; HAUSER MD, 1993, AM NAT, V142, P528, DOI 10.1086/285553; Husson R., 1950, THESIS; Jones G, 1999, J EXP BIOL, V202, P3359; Langbauer WR, 2000, ZOO BIOL, V19, P425, DOI 10.1002/1098-2361(2000)19:5&lt;425::AID-ZOO11&gt;3.0.CO;2-A; Leong K. M., 2003, Bioacoustics, V13, P213; McComb K, 2003, ANIM BEHAV, V65, P317, DOI 10.1006/anbe.2003.2047; MCCOMB KE, 1991, ANIM BEHAV, V41, P79, DOI 10.1016/S0003-3472(05)80504-4; Mellinger DK, 2003, J ACOUST SOC AM, V114, P1108, DOI 10.1121/1.1593066; Mohres F. P., 1967, SYSTEMES SONARS ANIM, P401; PAYNE KB, 1986, BEHAV ECOL SOCIOBIOL, V18, P297, DOI 10.1007/BF00300007; Peters G, 2002, MAMMAL REV, V32, P245, DOI 10.1046/j.1365-2907.2002.00113.x; POOLE JH, 1988, BEHAV ECOL SOCIOBIOL, V22, P385, DOI 10.1007/BF00294975; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; REMMERS JE, 1972, RESP PHYSIOL, V16, P351, DOI 10.1016/0034-5687(72)90064-3; Shoshani J, 1998, TRENDS ECOL EVOL, V13, P480, DOI 10.1016/S0169-5347(98)01491-8; Shoshani J., ENCY BRITANNICA; SISSOM DEF, 1991, J ZOOL, V223, P67, DOI 10.1111/j.1469-7998.1991.tb04749.x; Soltis J, 2005, ANIM BEHAV, V70, P589, DOI 10.1016/j.anbehav.2004.11.016; Stoeger-Horwath AS, 2007, J ACOUST SOC AM, V121, P3922, DOI 10.1121/1.2722216; Titze I., 2006, MYOELASTIC AERODYNAM; Titze I. R., 2000, PRINCIPLES VOICE PRO; Titze IR, 2010, J EXP BIOL, V213, P3866, DOI 10.1242/jeb.044982; TITZE IR, 1988, J ACOUST SOC AM, V83, P1536, DOI 10.1121/1.395910; VANDENBERG J, 1958, J SPEECH HEAR RES, V1, P227, DOI 10.1044/jshr.0103.227	30	84	84	3	125	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2012	337	6094					595	599		10.1126/science.1219712	http://dx.doi.org/10.1126/science.1219712			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982PU	22859490				2022-12-24	WOS:000307058700049
J	Mueller, ND; Gerber, JS; Johnston, M; Ray, DK; Ramankutty, N; Foley, JA				Mueller, Nathaniel D.; Gerber, James S.; Johnston, Matt; Ray, Deepak K.; Ramankutty, Navin; Foley, Jonathan A.			Closing yield gaps through nutrient and water management	NATURE			English	Article							INTENSIFICATION; CLIMATE; IMBALANCES; CHALLENGE; DEMAND	In the coming decades, a crucial challenge for humanity will be meeting future food demands without undermining further the integrity of the Earth's environmental systems(1-6). Agricultural systems are already major forces of global environmental degradation(4,7), but population growth and increasing consumption of calorie- and meat-intensive diets are expected to roughly double human food demand by 2050 (ref. 3). Responding to these pressures, there is increasing focus on 'sustainable intensification' as a means to increase yields on underperforming landscapes while simultaneously decreasing the environmental impacts of agricultural systems(2-4,8-11). However, it is unclear what such efforts might entail for the future of global agricultural landscapes. Here we present a global-scale assessment of intensification prospects from closing 'yield gaps' (differences between observed yields and those attainable in a given region), the spatial patterns of agricultural management practices and yield limitation, and the management changes that may be necessary to achieve increased yields. We find that global yield variability is heavily controlled by fertilizer use, irrigation and climate. Large production increases (45% to 70% for most crops) are possible from closing yield gaps to 100% of attainable yields, and the changes to management practices that are needed to close yield gaps vary considerably by region and current intensity. Furthermore, we find that there are large opportunities to reduce the environmental impact of agriculture by eliminating nutrient overuse, while still allowing an approximately 30% increase in production of major cereals (maize, wheat and rice). Meeting the food security and sustainability challenges of the coming decades is possible, but will require considerable changes in nutrient and water management.	[Mueller, Nathaniel D.; Gerber, James S.; Johnston, Matt; Ray, Deepak K.; Foley, Jonathan A.] Univ Minnesota, Inst Environm IonE, St Paul, MN 55108 USA; [Ramankutty, Navin] McGill Univ, Dept Geog, Montreal, PQ H3A 2K6, Canada; [Ramankutty, Navin] McGill Univ, Global Environm & Climate Change Ctr, Montreal, PQ H3A 2K6, Canada	University of Minnesota System; University of Minnesota Twin Cities; McGill University; McGill University	Mueller, ND (corresponding author), Univ Minnesota, Inst Environm IonE, St Paul, MN 55108 USA.	muell512@umn.edu	Ray, Deepak K/F-7720-2012; Foley, Jonathan A/GRS-5522-2022; Mueller, Nathan D/E-5864-2010; Ramankutty, Navin/AAM-6074-2020	Mueller, Nathan D/0000-0003-1857-5104; Ramankutty, Navin/0000-0002-3737-5717; Gerber, James/0000-0002-6890-0481; Ray, Deepak/0000-0002-2856-9608	National Science Foundation Graduate Research Fellowship; University of Minnesota College of Food, Agricultural and Natural Resource Sciences Fellowship; Natural Sciences and Engineering Research Council (NSERC) of Canada Discovery Grant; Gordon and Betty Moore Foundation; University of Minnesota Institute on the Environment	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); University of Minnesota College of Food, Agricultural and Natural Resource Sciences Fellowship; Natural Sciences and Engineering Research Council (NSERC) of Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); University of Minnesota Institute on the Environment	We thank G. Allez and K. Milligan for assistance with data collection. We are grateful to R. Licker, G. MacDonald, M. Mueller, S. Polasky, P. Potter, P. Reich, L. Schulte-Moore, D. Tilman, J. Van Wart and the Foley Laboratory for helpful conversations. We thank P. Robertson and P. Smith for helpful comments on the manuscript. Funding was provided by a National Science Foundation Graduate Research Fellowship and a University of Minnesota College of Food, Agricultural and Natural Resource Sciences Fellowship to N.D.M., a Natural Sciences and Engineering Research Council (NSERC) of Canada Discovery Grant to N.R., Gordon and Betty Moore Foundation funding to J. A. F., and support from the University of Minnesota Institute on the Environment.	[Anonymous], 2009, REAP BEN SCI SUST IN, p[1, 47]; Burney JA, 2010, P NATL ACAD SCI USA, V107, P12052, DOI 10.1073/pnas.0914216107; Cassman KG, 2002, AMBIO, V31, P132, DOI 10.1639/0044-7447(2002)031[0132:ANUEAN]2.0.CO;2; Cassman KG, 1999, P NATL ACAD SCI USA, V96, P5952, DOI 10.1073/pnas.96.11.5952; Cassman KG, 2003, ANNU REV ENV RESOUR, V28, P315, DOI 10.1146/annurev.energy.28.040202.122858; Clough Y, 2011, P NATL ACAD SCI USA, V108, P8311, DOI 10.1073/pnas.1016799108; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Howden SM, 2007, P NATL ACAD SCI USA, V104, P19691, DOI 10.1073/pnas.0701890104; Johnston M, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/3/034028; Jordan N, 2007, SCIENCE, V316, P1570, DOI 10.1126/science.1141700; Ju XT, 2009, P NATL ACAD SCI USA, V106, P3041, DOI 10.1073/pnas.0813417106; Lambin EF, 2001, GLOBAL ENVIRON CHANG, V11, P261, DOI 10.1016/S0959-3780(01)00007-3; Licker R, 2010, GLOBAL ECOL BIOGEOGR, V19, P769, DOI 10.1111/j.1466-8238.2010.00563.x; Liu JG, 2010, P NATL ACAD SCI USA, V107, P8035, DOI 10.1073/pnas.0913658107; Lobell DB, 2009, ANNU REV ENV RESOUR, V34, P179, DOI 10.1146/annurev.environ.041008.093740; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; MacDonald GK, 2011, P NATL ACAD SCI USA, V108, P3086, DOI 10.1073/pnas.1010808108; Matson PA, 2006, CONSERV BIOL, V20, P709, DOI 10.1111/j.1523-1739.2006.00442.x; Monfreda C, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002947; Oenema O, 2002, AMBIO, V31, P159, DOI 10.1639/0044-7447(2002)031[0159:NMIFPA]2.0.CO;2; Parry M. L., 2007, CLIMATE CHANGE 2007, P23; Portmann FT, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2008GB003435; Ramankutty N, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002952; Robertson GP, 2005, FRONT ECOL ENVIRON, V3, P38, DOI 10.2307/3868443; Sanchez PA, 2010, NAT GEOSCI, V3, P299, DOI 10.1038/ngeo853; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Vitousek PM, 2009, SCIENCE, V324, P1519, DOI 10.1126/science.1170261	29	1525	1602	102	2038	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2012	490	7419					254	257		10.1038/nature11420	http://dx.doi.org/10.1038/nature11420			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019IY	22932270				2022-12-24	WOS:000309733300048
J	Hughes, V				Hughes, Virginia			PUBLIC HEALTH Where there's smoke	NATURE			English	Editorial Material							OBSTRUCTIVE PULMONARY-DISEASE; COPD; EXPOSURE; CHINA; RISK											Han Jing-Xiu, 2006, Wei Sheng Yan Jiu, V35, P609; He Y, 2012, CHEST; Hu GP, 2010, CHEST, V138, P20, DOI 10.1378/chest.08-2114; Jiang Y, 2007, AM J PREV MED, V33, P15, DOI 10.1016/j.amepre.2007.02.037; Yin P, 2007, LANCET, V370, P751, DOI 10.1016/S0140-6736(07)61378-6; Zheng JP, 2008, LANCET, V371, P2013, DOI 10.1016/S0140-6736(08)60869-7; Zhong N, 2007, AM J RESP CRIT CARE, V176, P753, DOI 10.1164/rccm.200612-1749OC; Zhou YM, 2006, RESPIROLOGY, V11, P603, DOI 10.1111/j.1440-1843.2006.00897.x	8	14	14	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 27	2012	489	7417					S18	S20		10.1038/489S18a	http://dx.doi.org/10.1038/489S18a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	011LT	23013712	Bronze			2022-12-24	WOS:000309167100010
J	Baconguis, I; Gouaux, E				Baconguis, Isabelle; Gouaux, Eric			Structural plasticity and dynamic selectivity of acid-sensing ion channel-spider toxin complexes	NATURE			English	Article							EPITHELIAL SODIUM-CHANNEL; GATED CATION CHANNEL; FUNCTIONAL EXPRESSION; EXTRACELLULAR DOMAIN; TARANTULA PEPTIDE; ASIC1A CHANNELS; NERVOUS-SYSTEM; P2X RECEPTORS; NA+ CHANNEL; PORE	Acid-sensing ion channels (ASICs) are voltage-independent, amiloride-sensitive channels involved in diverse physiological processes ranging from nociception to taste. Despite the importance of ASICs in physiology, we know little about the mechanism of channel activation. Here we show that psalmotoxin activates non-selective and Na+-selective currents in chicken ASIC1a at pH 7.25 and 5.5, respectively. Crystal structures of ASIC1a-psalmotoxin complexes map the toxin binding site to the extracellular domain and show how toxin binding triggers an expansion of the extracellular vestibule and stabilization of the open channel pore. At pH 7.25 the pore is approximately 10 angstrom in diameter, whereas at pH 5.5 the pore is largely hydrophobic and elliptical in cross-section with dimensions of approximately 5 by 7 angstrom, consistent with a barrier mechanism for ion selectivity. These studies define mechanisms for activation of ASICs, illuminate the basis for dynamic ion selectivity and provide the blueprints for new therapeutic agents.	[Baconguis, Isabelle; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	gouauxe@ohsu.edu	Baconguis, Isabelle/AAH-3790-2021; Gouaux, Eric/Y-4370-2019	Baconguis, Isabelle/0000-0002-5440-2289; Gouaux, Eric/0000-0002-8549-2360	National Institute of Neurological Disorders and Stroke; NIH; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS070597, P30NS061800, R37NS038631] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We appreciate assistance in the initial characterization of the action of PcTx1 on chicken ASIC1a by D. Samways and T. Egan, mass spectrometry analysis by D. King, together with comments from C. Jahr and R. MacKinnon. We are grateful to K. C. Garcia, C. Lee and A. Goehring for assistance with protein expression in mammalian cells. We thank L. Vaskalis for assistance with figures, H. Owen for help with manuscript preparation, H. Krishnamurthy for assistance in initial data collection, and Gouaux lab members for helpful discussion. This work was supported by an individual National Research Service Award from the National Institute of Neurological Disorders and Stroke (I. B.) and by the NIH (E. G.). E. G. is an investigator with the Howard Hughes Medical Institute.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bohlen CJ, 2011, NATURE, V479, P410, DOI 10.1038/nature10607; CANESSA CM, 1993, NATURE, V361, P467, DOI 10.1038/361467a0; Chang SS, 1996, NAT GENET, V12, P248, DOI 10.1038/ng0396-248; Chen XM, 2006, J GEN PHYSIOL, V127, P267, DOI 10.1085/jgp.200509409; Chen XM, 2005, J GEN PHYSIOL, V126, P71, DOI 10.1085/jgp.200509303; Coryell MW, 2008, J NEUROSCI, V28, P13738, DOI 10.1523/JNEUROSCI.3907-08.2008; Cushman KA, 2007, J GEN PHYSIOL, V129, P345, DOI 10.1085/jgp.200709757; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dawson RJP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1917; de la Rosa DA, 2003, J PHYSIOL-LONDON, V546, P77, DOI 10.1113/jphysiol.2002.030692; de Weille JR, 1998, FEBS LETT, V433, P257, DOI 10.1016/S0014-5793(98)00916-8; Deval E, 2010, PHARMACOL THERAPEUT, V128, P549, DOI 10.1016/j.pharmthera.2010.08.006; Dukkipati A, 2008, PROTEIN EXPRES PURIF, V62, P160, DOI 10.1016/j.pep.2008.08.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Escoubas P, 2003, PROTEIN SCI, V12, P1332, DOI 10.1110/ps.0307003; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Grunder Stefan, 2010, Int J Physiol Pathophysiol Pharmacol, V2, P73; Hattori M, 2012, NATURE, V485, P207, DOI 10.1038/nature11010; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kashlan OB, 2011, AM J PHYSIOL-RENAL, V301, pF684, DOI 10.1152/ajprenal.00259.2011; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Khakh BS, 1999, NEURON, V23, P653, DOI 10.1016/S0896-6273(01)80025-8; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; KRISHTAL OA, 1980, NEUROSCIENCE, V5, P2325, DOI 10.1016/0306-4522(80)90149-9; Li JQ, 2003, J BIOL CHEM, V278, P13867, DOI 10.1074/jbc.M300149200; Li TB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1409; Li TB, 2011, J GEN PHYSIOL, V137, P289, DOI 10.1085/jgp.201010576; Li TB, 2010, J BIOL CHEM, V285, P31285, DOI 10.1074/jbc.M110.160382; Li TB, 2010, J BIOL CHEM, V285, P22706, DOI 10.1074/jbc.M110.134114; Li TB, 2010, AM J PHYSIOL-CELL PH, V299, pC66, DOI 10.1152/ajpcell.00100.2010; Li WG, 2011, J BIOL CHEM, V286, P42635, DOI 10.1074/jbc.M111.289058; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; Mazzuca M, 2007, NAT NEUROSCI, V10, P943, DOI 10.1038/nn1940; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PALMER LG, 1982, J MEMBRANE BIOL, V67, P91, DOI 10.1007/BF01868651; Pietra F, 2009, J CHEM INF MODEL, V49, P972, DOI 10.1021/ci800463h; Poet M, 2001, EMBO J, V20, P5595, DOI 10.1093/emboj/20.20.5595; Saez NJ, 2011, MOL PHARMACOL, V80, P796, DOI 10.1124/mol.111.072207; Salinas M, 2006, J PHYSIOL-LONDON, V570, P339, DOI 10.1113/jphysiol.2005.095810; Samways DSK, 2009, CELL CALCIUM, V45, P319, DOI 10.1016/j.ceca.2008.12.002; Schild L, 2010, BBA-MOL BASIS DIS, V1802, P1159, DOI 10.1016/j.bbadis.2010.06.014; Sherwood T, 2009, J BIOL CHEM, V284, P27899, DOI 10.1074/jbc.M109.029009; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; SNYDER PM, 1995, CELL, V83, P969, DOI 10.1016/0092-8674(95)90212-0; Springauf A, 2011, J BIOL CHEM, V286, P24374, DOI 10.1074/jbc.M111.230797; Waldmann R, 2001, ADV EXP MED BIOL, V502, P293; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; WALDMANN R, 1995, J BIOL CHEM, V270, P27411, DOI 10.1074/jbc.270.46.27411; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yagi J, 2006, CIRC RES, V99, P501, DOI 10.1161/01.RES.0000238388.79295.4c; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P6752, DOI 10.1073/pnas.0308636100; Yu Y, 2010, NEURON, V68, P61, DOI 10.1016/j.neuron.2010.09.001	58	201	205	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2012	489	7416					400	U86		10.1038/nature11375	http://dx.doi.org/10.1038/nature11375			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AK	22842900	Green Accepted			2022-12-24	WOS:000308860900038
J	Adams, TD; Davidson, LE; Litwin, SE; Kolotkin, RL; LaMonte, MJ; Pendleton, RC; Strong, MB; Vinik, R; Wanner, NA; Hopkins, PN; Gress, RE; Walker, JM; Cloward, TV; Nuttall, RT; Hammoud, A; Greenwood, JLJ; Crosby, RD; McKinlay, R; Simper, SC; Smith, SC; Hunt, SC				Adams, Ted D.; Davidson, Lance E.; Litwin, Sheldon E.; Kolotkin, Ronette L.; LaMonte, Michael J.; Pendleton, Robert C.; Strong, Michael B.; Vinik, Russell; Wanner, Nathan A.; Hopkins, Paul N.; Gress, Richard E.; Walker, James M.; Cloward, Tom V.; Nuttall, R. Tom; Hammoud, Ahmad; Greenwood, Jessica L. J.; Crosby, Ross D.; McKinlay, Rodrick; Simper, Steven C.; Smith, Sherman C.; Hunt, Steven C.			Health Benefits of Gastric Bypass Surgery After 6 Years	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ROUX-EN-Y; CARDIOVASCULAR RISK-FACTORS; TYPE-2 DIABETES-MELLITUS; LIFE-STYLE INTERVENTION; BARIATRIC SURGERY; MEDICAL THERAPY; UNITED-STATES; OBESITY; WEIGHT; MORBIDITY	Context Extreme obesity is associated with health and cardiovascular disease risks. Although gastric bypass surgery induces rapid weight loss and ameliorates many of these risks in the short term, long-term outcomes are uncertain. Objective To examine the association of Roux-en-Y gastric bypass (RYGB) surgery with weight loss, diabetes mellitus, and other health risks 6 years after surgery. Design, Setting, and Participants A prospective Utah-based study conducted between July 2000 and June 2011 of 1156 severely obese (body mass index [BMI] >= 35) participants aged 18 to 72 years (82% women; mean BMI, 45.9; 95% CI, 31.2-60.6) who sought and received RYGB surgery (n = 418), sought but did not have surgery (n = 417; control group 1), or who were randomly selected from a population-based sample not seeking weight loss surgery (n = 321; control group 2). Main Outcome Measures Weight loss, diabetes, hypertension, dyslipidemia, and health-related quality of life were compared between participants having RYGB surgery and control participants using propensity score adjustment. Results Six years after surgery, patients who received RYGB surgery (with 92.6% follow-up) lost 27.7% (95% CI, 26.6%-28.9%) of their initial body weight compared with 0.2% (95% CI, -1.1% to 1.4%) gain in control group 1 and 0% (95% CI, -1.2% to 1.2%) in control group 2. Weight loss maintenance was superior in patients who received RYGB surgery, with 94% (95% CI, 92%-96%) and 76% (95% CI, 72%-81%) of patients receiving RYGB surgery maintaining at least 20% weight loss 2 and 6 years after surgery, respectively. Diabetes remission rates 6 years after surgery were 62% (95% CI, 49%-75%) in the RYGB surgery group, 8% (95% CI, 0%-16%) in control group 1, and 6% (95% CI, 0%-13%) in control group 2, with remission odds ratios (ORs) of 16.5 (95% CI, 4.7-57.6; P < .001) vs control group 1 and 21.5 (95% CI, 5.4-85.6; P < .001) vs control group 2. The incidence of diabetes throughout the course of the study was reduced after RYGB surgery (2%; 95% CI, 0%-4%; vs 17%; 95% CI, 10%-24%; OR, 0.11; 95% CI, 0.04-0.34 compared with control group 1 and 15%; 95% CI, 9%-21%; OR, 0.21; 95% CI, 0.060.67 compared with control group 2; both P < .001). The numbers of participants with bariatric surgery-related hospitalizations were 33 (7.9%), 13 (3.9%), and 6 (2.0%) for the RYGB surgery group and 2 control groups, respectively. Conclusion Among severely obese patients, compared with nonsurgical control patients, the use of RYGB surgery was associated with higher rates of diabetes remission and lower risk of cardiovascular and other health outcomes over 6 years. JAMA. 2012;308(11):1122-1131 www.jama.com	[Adams, Ted D.; Davidson, Lance E.; Litwin, Sheldon E.; Pendleton, Robert C.; Strong, Michael B.; Vinik, Russell; Wanner, Nathan A.; Hopkins, Paul N.; Gress, Richard E.; Walker, James M.; Hunt, Steven C.] Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT 84108 USA; [Hammoud, Ahmad] Univ Utah, Sch Med, Dept Obstet & Gynecol, Salt Lake City, UT 84108 USA; [Greenwood, Jessica L. J.] Univ Utah, Sch Med, Dept Family & Prevent Med, Salt Lake City, UT 84108 USA; [Adams, Ted D.] Intermt Healthcare, Intermt Hlth & Fitness Inst, LDS Hosp, Salt Lake City, UT USA; [Walker, James M.; Cloward, Tom V.; Nuttall, R. Tom] Intermt Healthcare, Intermt Sleep Disorders Ctr, Salt Lake City, UT USA; [McKinlay, Rodrick; Simper, Steven C.; Smith, Sherman C.] Rocky Mt Associated Phy Inc, Salt Lake City, UT USA; [Litwin, Sheldon E.] Georgia Hlth Sci Univ, Dept Med, Augusta, GA USA; [Kolotkin, Ronette L.] Duke Univ Hlth Syst, Obes & Qual Life Consulting, Durham, NC USA; [Kolotkin, Ronette L.] Duke Univ Hlth Syst, Dept Community & Family Med, Durham, NC USA; [LaMonte, Michael J.] SUNY Buffalo, Dept Social & Prevent Med, Buffalo, NY 14260 USA; [Crosby, Ross D.] Univ N Dakota, Sch Med, Neuropsychiat Res Inst, Fargo, ND USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Intermountain Healthcare; Intermountain Medical Center; Intermountain Healthcare; Intermountain Medical Center; University System of Georgia; Augusta University; Duke University; Duke University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Neuropsychiatric Research Institute; University of North Dakota Grand Forks	Adams, TD (corresponding author), Univ Utah, Sch Med, Dept Internal Med, 420 Chipeta Way,Room 1160, Salt Lake City, UT 84108 USA.	ted.adams@utah.edu	Davidson, Lance E./AAA-9689-2019; LaMonte, Mike/AAC-9953-2021	Davidson, Lance E./0000-0002-1383-0666; Kolotkin, Ronette/0000-0002-1300-2131; Crosby, Ross/0000-0001-9131-1629	National Institutes of Health/The National Institute of Diabetes and Digestive and Kidney Diseases [DK-55006]; Public Health Service from the National Center for Research Resources [M01-RR00064]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001067, KL2TR001065] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055006, Z01DK055006] Funding Source: NIH RePORTER	National Institutes of Health/The National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Public Health Service from the National Center for Research Resources; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grant DK-55006 from the National Institutes of Health/The National Institute of Diabetes and Digestive and Kidney Diseases and Public Health Service research grant M01-RR00064 from the National Center for Research Resources.	Adams TD, 2005, CONTEMP CLIN TRIALS, V26, P534, DOI 10.1016/j.cct.2005.05.003; Adams TD, 2007, NEW ENGL J MED, V357, P753, DOI 10.1056/NEJMoa066603; Adams TD, 2010, OBESITY, V18, P121, DOI 10.1038/oby.2009.178; Benraouane F, 2011, CURR OPIN CARDIOL, V26, P555, DOI 10.1097/HCO.0b013e32834b7fc4; Bocchieri LE, 2002, OBES SURG, V12, P781, DOI 10.1381/096089202320995556; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Buchwald H, 2009, AM J MED, V122, P248, DOI 10.1016/j.amjmed.2008.09.041; Buse JB, 2009, DIABETES CARE, V32, P2133, DOI 10.2337/dc09-9036; Crosby RD, 2004, J CLIN EPIDEMIOL, V57, P1153, DOI 10.1016/j.jclinepi.2004.04.004; DiGiorgi M, 2010, SURG OBES RELAT DIS, V6, P249, DOI 10.1016/j.soard.2009.09.019; Dixon JB, 2012, OBES REV, V13, P57, DOI 10.1111/j.1467-789X.2011.00928.x; Dixon JB, 2008, JAMA-J AM MED ASSOC, V299, P316, DOI 10.1001/jama.299.3.316; Espeland M, 2007, DIABETES CARE, V30, P1374; Flum DR, 2009, NEW ENGL J MED, V361, P445, DOI 10.1056/NEJMoa0901836; Freedman DS, 2002, JAMA-J AM MED ASSOC, V288, P1758, DOI 10.1001/jama.288.14.1758; Horm J., 1996, NATL DEATH INDEX PLU, pA5; HUNT SC, 1986, J CHRON DIS, V39, P809, DOI 10.1016/0021-9681(86)90083-4; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kushner RF, 2006, MAYO CLIN PROC, V81, pS46; Madala MC, 2008, J AM COLL CARDIOL, V52, P979, DOI 10.1016/j.jacc.2008.04.067; Mingrone G, 2012, NEW ENGL J MED, V366, P1577, DOI 10.1056/NEJMoa1200111; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Poirier P, 2011, CIRCULATION, V123, P1683, DOI 10.1161/CIR.0b013e3182149099; Santry HP, 2005, JAMA-J AM MED ASSOC, V294, P1909, DOI 10.1001/jama.294.15.1909; Schauer PR, 2012, NEW ENGL J MED, V366, P1567, DOI 10.1056/NEJMoa1200225; Schauer PR, 2003, ANN SURG, V238, P467, DOI 10.1097/01.sla.0000089851.41115.1b; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Smith SC, 2004, OBES SURG, V14, P73, DOI 10.1381/096089204772787329; SMITH SC, 1995, OBES SURG, V5, P314, DOI 10.1381/096089295765557700; Sturm R, 2003, ARCH INTERN MED, V163, P2146, DOI 10.1001/archinte.163.18.2146; Thaler JP, 2009, ENDOCRINOLOGY, V150, P2518, DOI 10.1210/en.2009-0367; Torquati A, 2005, J GASTROINTEST SURG, V9, P1112, DOI 10.1016/j.gassur.2005.07.016; Wadden TA, 2009, OBESITY, V17, P713, DOI 10.1038/oby.2008.637; Wee CC, 2008, J AM COLL CARDIOL, V52, P620, DOI 10.1016/j.jacc.2008.05.021; WILLIAMS RR, 1988, AM J PUBLIC HEALTH, V78, P1283, DOI 10.2105/AJPH.78.10.1283; Wing RR, 2010, ARCH INTERN MED, V170, P1566, DOI 10.1001/archinternmed.2010.334; Wittgrove AC, 2000, OBES SURG, V10, P233, DOI 10.1381/096089200321643511; Zimmet P, 2012, NEW ENGL J MED, V366, P1635, DOI 10.1056/NEJMe1202443	40	449	455	3	38	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	2012	308	11					1122	1131		10.1001/2012.jama.11164	http://dx.doi.org/10.1001/2012.jama.11164			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007AL	22990271	Green Accepted			2022-12-24	WOS:000308861000028
J	Farley, TA				Farley, Thomas A.			The Role of Government in Preventing Excess Calorie Consumption The Example of New York City	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									New York City Dept Hlth & Mental Hyg, Queens, NY 11101 USA	New York City Department of Health & Mental Hygiene	Farley, TA (corresponding author), New York City Dept Hlth & Mental Hyg, 42-09 28th St,8th Floor, Queens, NY 11101 USA.	tfarley@health.nyc.gov						Alcorn T, 2012, LANCET, V379, P2037, DOI 10.1016/S0140-6736(12)60879-4; [Anonymous], 2010, REP DIET GUID ADV D; Bauerlein Valerie, 2011, WALL STREET J; Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185; Nielsen SJ, 2004, AM J PREV MED, V27, P205, DOI 10.1016/j.amepre.2004.05.005; Rolls BJ, 2007, OBESITY, V15, P1535, DOI 10.1038/oby.2007.182	8	14	14	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	2012	308	11					1093	1094		10.1001/2012.jama.11623	http://dx.doi.org/10.1001/2012.jama.11623			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007AL	22990264				2022-12-24	WOS:000308861000021
J	Hiatt, WR; Goldfine, AB; Kaul, S				Hiatt, William R.; Goldfine, Allison B.; Kaul, Sanjay			Cardiovascular Risk Assessment in the Development of New Drugs for Obesity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Hiatt, William R.] Univ Colorado, Sch Med, CPC Clin Res, Aurora, CO 80045 USA; [Hiatt, William R.] Univ Colorado, Sch Med, Div Cardiol, Aurora, CO 80045 USA; [Goldfine, Allison B.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02115 USA; [Kaul, Sanjay] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Div Cardiol, Los Angeles, CA 90048 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Cedars Sinai Medical Center; University of California System; University of California Los Angeles	Hiatt, WR (corresponding author), Univ Colorado, Sch Med, CPC Clin Res, 13199 E Montview Blvd,Ste 200, Aurora, CO 80045 USA.	will.hiatt@ucdenver.edu		Goldfine, Allison/0000-0002-0345-1048				[Anonymous], GUID IND DIAB MELL E; Hiatt WR, 2012, CIRCULATION, V125, P1171, DOI 10.1161/CIRCULATIONAHA.111.023499; James WPT, 2010, NEW ENGL J MED, V363, P905, DOI 10.1056/NEJMoa1003114; US Food and Drug Administration, CLIN BRIEF DOC NEW D; US Food and Drug Administration, GUID IND DEV PROD WE	5	13	13	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	2012	308	11					1099	1100		10.1001/jama.2012.9931	http://dx.doi.org/10.1001/jama.2012.9931			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007AL	22990267				2022-12-24	WOS:000308861000024
J	Cruz-Ramirez, A; Diaz-Trivino, S; Blilou, I; Grieneisen, VA; Sozzani, R; Zamioudis, C; Miskolczi, P; Nieuwland, J; Benjamins, R; Dhonukshe, P; Caballero-Perez, J; Horvath, B; Long, YC; Mahonen, AP; Zhang, HT; Xu, J; Murray, JAH; Benfey, PN; Bako, L; Maree, AFM; Scheres, B				Cruz-Ramirez, Alfredo; Diaz-Trivino, Sara; Blilou, Ikram; Grieneisen, Veronica A.; Sozzani, Rosangela; Zamioudis, Christos; Miskolczi, Pal; Nieuwland, Jeroen; Benjamins, Rene; Dhonukshe, Pankaj; Caballero-Perez, Juan; Horvath, Beatrix; Long, Yuchen; Mahonen, Ari Pekka; Zhang, Hongtao; Xu, Jian; Murray, James A. H.; Benfey, Philip N.; Bako, Laszlo; Maree, Athanasius F. M.; Scheres, Ben			A Bistable Circuit Involving SCARECROW-RETINOBLASTOMA Integrates Cues to Inform Asymmetric Stem Cell Division	CELL			English	Article							PROTEIN-PROTEIN INTERACTIONS; ARABIDOPSIS ROOT-MERISTEM; TUMOR-SUPPRESSOR; SPLIT LUCIFERASE; AUXIN TRANSPORT; CYCLE; GENE; DIFFERENTIATION; PLANTS; GROWTH	In plants, where cells cannot migrate, asymmetric cell divisions (ACDs) must be confined to the appropriate spatial context. We investigate tissue-generating asymmetric divisions in a stem cell daughter within the Arabidopsis root. Spatial restriction of these divisions requires physical binding of the stem cell regulator SCARECROW (SCR) by the RETINOBLASTOM-RELATED (RBR) protein. In the stem cell niche, SCR activity is counteracted by phosphorylation of RBR through a cyclinD6;1-CDK complex. This cyclin is itself under transcriptional control of SCR and its partner SHORT ROOT (SHR), creating a robust bistable circuit with either high or low SHR-SCR complex activity. Auxin biases this circuit by promoting CYCD6;1 transcription. Mathematical modeling shows that ACDs are only switched on after integration of radial and longitudinal information, determined by SHR and auxin distribution, respectively. Coupling of cell-cycle progression to protein degradation resets the circuit, resulting in a "flip flop" that constrains asymmetric cell division to the stem cell region.	[Grieneisen, Veronica A.; Maree, Athanasius F. M.] John Innes Ctr, Dept Computat & Syst Biol, Norwich NR4 7UH, Norfolk, England; [Cruz-Ramirez, Alfredo; Diaz-Trivino, Sara; Blilou, Ikram; Zamioudis, Christos; Benjamins, Rene; Dhonukshe, Pankaj; Horvath, Beatrix; Long, Yuchen; Mahonen, Ari Pekka; Zhang, Hongtao; Xu, Jian; Scheres, Ben] Univ Utrecht, Dept Biol, NL-3584 CH Utrecht, Netherlands; [Grieneisen, Veronica A.] Univ E Anglia, Sch Biol Sci, Dept Cell & Dev Biol, Norwich NR4 7TJ, Norfolk, England; [Sozzani, Rosangela; Benfey, Philip N.] Duke Univ, Dept Biol, Ctr Syst Biol, Durham, NC 27708 USA; [Sozzani, Rosangela; Benfey, Philip N.] Duke Univ, Inst Genome Sci & Policy, Ctr Syst Biol, Durham, NC 27708 USA; [Miskolczi, Pal; Bako, Laszlo] Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden; [Miskolczi, Pal; Bako, Laszlo] Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, S-90183 Umea, Sweden; [Nieuwland, Jeroen; Murray, James A. H.] Cardiff Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Caballero-Perez, Juan] Inst Syst Biol, Seattle, WA 98109 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Utrecht University; University of East Anglia; Duke University; Duke University; Umea University; Swedish University of Agricultural Sciences; Umea University; Cardiff University; Institute for Systems Biology (ISB)	Maree, AFM (corresponding author), John Innes Ctr, Dept Computat & Syst Biol, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	stan.maree@jic.ac.uk; b.scheres@uu.nl	Ramírez, Luis Alfredo Cruz/K-2548-2019; Long, Yuchen/GZA-6989-2022; Cruz-Ramirez, Luis Alfredo/B-7588-2009; Mähönen, Ari Pekka/B-9764-2015; Murray, James AH/D-3399-2009; Zhang, Hongtao/HGU-4141-2022; Zamioudis, Christos/AAO-2325-2021; Xu, Jian/I-2921-2012	Ramírez, Luis Alfredo Cruz/0000-0001-9973-5784; Long, Yuchen/0000-0001-5071-4632; Cruz-Ramirez, Luis Alfredo/0000-0001-9973-5784; Mähönen, Ari Pekka/0000-0001-6051-866X; Murray, James AH/0000-0002-2282-3839; Xu, Jian/0000-0001-6194-6316; Maree, Athanasius F. M./0000-0003-2689-2484; Zhang, Hongtao/0000-0002-4903-571X; Caballero Perez, Juan/0000-0002-6160-3644; Sozzani, Rosangela/0000-0003-3316-2367; Grieneisen, Veronica/0000-0001-6780-8301; Miskolczi, Pal/0000-0003-1036-5831; Blilou, Ikram/0000-0001-8003-3782; Scheres, Ben/0000-0001-5400-9578	ERC; ALW-ERAPG [855.50.017]; EMBO-ALTF [1114-2006]; CONACYT [000000000092916]; Ministerio de Educacion y Ciencia, Spain; Marie Curie IEF [IEF-2008-237643]; Dorothy Hodgkin Fellowship; UK Biological and Biotechnology Research Council (BBSRC) [BB/J004553/1]; NWO VIDI grant; NIH [R01-GM043778]; Swedish Research Council; Carl Tryggers Stiftelse grants; BBSRC [BB/G00482X]; ERASysBio+ initiative under the EU FP7 ERA-NET Plus scheme; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043778, P50GM081883] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/E022383/2, BB/G00482X/1, BBS/E/J/000C0645, BB/E022383/1, BBS/E/J/000C0646, BB/J009199/1] Funding Source: researchfish; BBSRC [BBS/E/J/000C0645, BB/G00482X/1, BBS/E/J/000C0646, BB/E022383/2, BB/E022383/1, BB/J009199/1] Funding Source: UKRI	ERC(European Research Council (ERC)European Commission); ALW-ERAPG; EMBO-ALTF; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Ministerio de Educacion y Ciencia, Spain(Spanish Government); Marie Curie IEF(European Commission); Dorothy Hodgkin Fellowship; UK Biological and Biotechnology Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NWO VIDI grant(Netherlands Organization for Scientific Research (NWO)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Carl Tryggers Stiftelse grants; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ERASysBio+ initiative under the EU FP7 ERA-NET Plus scheme; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank Dominique Bergmann for critically reviewing this manuscript; Fred Sack, Lieven de Veylder, Naohiro Kato, Dorus Gadella, Joachim Goedhart, Tom Beeckman, and Tom Bennett for materials; and Anahi Perez-Torres, Luis Herrera-Estrella, and Juan Carlos del Pozo for technical advice. B. S. was supported by an ERC Advanced Investigator Fellowship and by ALW-ERAPG grant 855.50.017. A.C.-R. was supported by EMBO-ALTF 1114-2006 and CONACYT 000000000092916 grants. S.D.-T. was funded by Ministerio de Educacion y Ciencia, Spain, and by Marie Curie IEF (IEF-2008-237643). V. A. G. was supported by the Dorothy Hodgkin Fellowship. V. A. G. and A. F. M. M. were supported by the UK Biological and Biotechnology Research Council (BBSRC) via grant BB/J004553/1 to the John Innes Centre. I. B. was sponsored by an NWO VIDI grant. P.N.B. was funded by NIH grant R01-GM043778. L. B. was supported by Swedish Research Council and by Carl Tryggers Stiftelse grants. Work in James A. H. Murray laboratory was supported by the BBSRC grant BB/G00482X and by the ERASysBio+ initiative under the EU FP7 ERA-NET Plus scheme.	Abrash EB, 2009, DEV CELL, V16, P783, DOI 10.1016/j.devcel.2009.05.014; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Berman SD, 2008, MOL CANCER RES, V6, P1440, DOI 10.1158/1541-7786.MCR-08-0176; Boniotti MB, 2001, PLANT J, V28, P341, DOI 10.1046/j.1365-313X.2001.01160.x; Borghi L, 2010, PLANT CELL, V22, P1792, DOI 10.1105/tpc.110.074591; Boruc J, 2010, PLANT CELL, V22, P1264, DOI 10.1105/tpc.109.073635; Calo E, 2010, NATURE, V466, P1110, DOI 10.1038/nature09264; Chen D, 2007, PLOS BIOL, V5, P1504, DOI 10.1371/journal.pbio.0050179; Chen HM, 2008, PLANT PHYSIOL, V146, P368, DOI 10.1104/pp.107.111740; Chen PL, 1996, GENE DEV, V10, P2794, DOI 10.1101/gad.10.21.2794; Cools T, 2010, PLANT J, V64, P705, DOI 10.1111/j.1365-313X.2010.04361.x; Cui HC, 2007, SCIENCE, V316, P421, DOI 10.1126/science.1139531; Dhonukshe P, 2012, CELL, V149, P383, DOI 10.1016/j.cell.2012.02.051; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; Fujikawa Y, 2007, PLANT J, V52, P185, DOI 10.1111/j.1365-313X.2007.03214.x; Fulop K, 2005, CELL CYCLE, V4, P1084; Genschik P, 1998, PLANT CELL, V10, P2063; Grieneisen VA, 2007, NATURE, V449, P1008, DOI 10.1038/nature06215; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Heidstra R, 2004, GENE DEV, V18, P1964, DOI 10.1101/gad.305504; Helariutta Y, 2000, CELL, V101, P555, DOI 10.1016/S0092-8674(00)80865-X; Horvath BM, 2006, EMBO J, V25, P4909, DOI 10.1038/sj.emboj.7601362; Kosugi S, 2002, PLANT J, V29, P45, DOI 10.1046/j.1365-313x.2002.01196.x; KREK W, 1994, CELL, V78, P161, DOI 10.1016/0092-8674(94)90582-7; Laskowski M, 2008, PLOS BIOL, V6, P2721, DOI 10.1371/journal.pbio.0060307; Lechner E, 2002, J BIOL CHEM, V277, P50069, DOI 10.1074/jbc.M204254200; Lee JO, 1998, NATURE, V391, P859, DOI 10.1038/36038; Lendvai A, 2007, J EXP BOT, V58, P1663, DOI 10.1093/jxb/erm022; Lux A, 2005, ANN BOT-LONDON, V96, P989, DOI 10.1093/aob/mci266; Nakagami H, 2002, PLANT CELL, V14, P1847, DOI 10.1105/tpc.002550; Nalam RL, 2009, MOL ENDOCRINOL, V23, P1900, DOI 10.1210/me.2009-0184; Nieuwland J, 2009, P NATL ACAD SCI USA, V106, P22528, DOI 10.1073/pnas.0906354106; Ozawa T, 2001, ANAL CHEM, V73, P2516, DOI 10.1021/ac0013296; PEACEMAN DW, 1955, J SOC IND APPL MATH, V3, P28, DOI 10.1137/0103003; Perez-Torres CA, 2008, PLANT CELL, V20, P3258, DOI 10.1105/tpc.108.058719; Planchais S, 2004, PLANT J, V38, P616, DOI 10.1111/j.0960-7412.2004.02071.x; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Sabatini S, 2003, GENE DEV, V17, P354, DOI 10.1101/gad.252503; Sanz L, 2011, PLANT CELL, V23, P641, DOI 10.1105/tpc.110.080002; Sarkar AK, 2007, NATURE, V446, P811, DOI 10.1038/nature05703; Segers G, 1996, PLANT J, V10, P601, DOI 10.1046/j.1365-313X.1996.10040601.x; Sena G, 2004, DEVELOPMENT, V131, P2817, DOI 10.1242/dev.01144; Sozzani R, 2010, NATURE, V466, P128, DOI 10.1038/nature09143; Takahashi I, 2010, PLANT CELL REP, V29, P307, DOI 10.1007/s00299-010-0817-9; TEMPLETON DJ, 1991, P NATL ACAD SCI USA, V88, P3033, DOI 10.1073/pnas.88.8.3033; vandenBerg C, 1997, NATURE, V390, P287, DOI 10.1038/36856; Welch D, 2007, GENE DEV, V21, P2196, DOI 10.1101/gad.440307; Wildwater M, 2005, CELL, V123, P1337, DOI 10.1016/j.cell.2005.09.042; Willemsen V, 1998, DEVELOPMENT, V125, P521; Xu J, 2006, SCIENCE, V311, P385, DOI 10.1126/science.1121790; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199	52	203	220	2	120	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 31	2012	150	5					1002	1015		10.1016/j.cell.2012.07.017	http://dx.doi.org/10.1016/j.cell.2012.07.017			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22921914	Bronze, Green Accepted			2022-12-24	WOS:000308500200014
J	van Luenen, HGAM; Farris, C; Jan, S; Genest, PA; Tripathi, P; Velds, A; Kerkhoven, RM; Nieuwland, M; Haydock, A; Ramasamy, G; Vainio, S; Heidebrecht, T; Perrakis, A; Pagie, L; van Steensel, B; Myler, PJ; Borst, P				van Luenen, Henri G. A. M.; Farris, Carol; Jan, Sabrina; Genest, Paul-Andre; Tripathi, Pankaj; Velds, Arno; Kerkhoven, Ron M.; Nieuwland, Marja; Haydock, Andrew; Ramasamy, Gowthaman; Vainio, Saara; Heidebrecht, Tatjana; Perrakis, Anastassis; Pagie, Ludo; van Steensel, Bas; Myler, Peter J.; Borst, Piet			Glucosylated Hydroxymethyluracil, DNA Base J, Prevents Transcriptional Readthrough in Leishmania	CELL			English	Article							PROTOZOAN PARASITE LEISHMANIA; MAJOR FRIEDLIN CHROMOSOME-1; SURFACE GLYCOPROTEIN GENES; J-BINDING PROTEIN; TRYPANOSOMA-BRUCEI; POLYCISTRONIC TRANSCRIPTION; KINETOPLASTID PROTOZOANS; GENOMIC ORGANIZATION; MESSENGER-RNAS; SEQUENCE	Some Ts in nuclear DNA of trypanosomes and Leishmania are hydroxylated and glucosylated to yield base J (beta-D-glucosyl-hydroxymethyluracil). In Leishmania, about 99% of J is located in telomeric repeats. We show here that most of the remaining J is located at chromosome-internal RNA polymerase II termination sites. This internal J and telomeric J can be reduced by a knockout of J-binding protein 2 (JBP2), an enzyme involved in the first step of J biosynthesis. J levels are further reduced by growing Leishmania JBP2 knockout cells in BrdU-containing medium, resulting in cell death. The loss of internal J in JBP2 knockout cells is accompanied by massive readthrough at RNA polymerase II termination sites. The readthrough varies between transcription units but may extend over 100 kb. We conclude that J is required for proper transcription termination and infer that the absence of internal J kills Leishmania by massive readthrough of transcriptional stops.	[van Luenen, Henri G. A. M.; Jan, Sabrina; Genest, Paul-Andre; Tripathi, Pankaj; Vainio, Saara; Borst, Piet] Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, Netherlands; [Velds, Arno; Kerkhoven, Ron M.; Nieuwland, Marja] Netherlands Canc Inst, Microarray & Deep Sequencing Facil, NL-1066 CX Amsterdam, Netherlands; [Heidebrecht, Tatjana; Perrakis, Anastassis] Netherlands Canc Inst, Div Biochem, NL-1066 CX Amsterdam, Netherlands; [Pagie, Ludo; van Steensel, Bas] Netherlands Canc Inst, Div Gene Regulat, NL-1066 CX Amsterdam, Netherlands; [Farris, Carol; Haydock, Andrew; Ramasamy, Gowthaman; Myler, Peter J.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Farris, Carol; Myler, Peter J.] Univ Washington, Dept Biomed Informat & Med Educ, Seattle, WA 98195 USA; [Myler, Peter J.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Center for Infectious Disease Research; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Borst, P (corresponding author), Netherlands Canc Inst, Div Mol Biol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	p.borst@nki.nl	Myler, Peter John/AAR-9535-2021; Perrakis, Anastassis/E-8704-2013	Perrakis, Anastassis/0000-0002-1151-6227; Genest, Paul-Andre/0000-0001-6341-900X; Myler, Peter/0000-0002-0056-0513; Velds, Arno/0000-0003-4333-8872; van Luenen, Henri/0000-0002-5584-7968	PHS from the National Institute of Allergy and Infectious Diseases [R01 AI053667]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053667] Funding Source: NIH RePORTER	PHS from the National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank F. Raymond, B. Papadopoulou, M. Olivier, M.J. Tremblay, M. Ouellette, and J. Corbeil at CIHR in Quebec, Canada, for sharing the genomic sequence of L. tarentolae before publication. We thank U. Desselberger, University of Cambridge, UK, for providing purified rotavirus RNA preparations. We thank E. Christodoulou for help with JBP1 production. We are grateful to K. de Visser and F. van Leeuwen for critical reading of the manuscript and discussions. This work was supported by PHS grant R01 AI053667 from the National Institute of Allergy and Infectious Diseases to P.J.M.	AGABIAN N, 1990, CELL, V61, P1157, DOI 10.1016/0092-8674(90)90674-4; Beisel C, 2011, NAT REV GENET, V12, P123, DOI 10.1038/nrg2932; Belli SI, 2003, INT J PARASITOL, V33, P965, DOI 10.1016/S0020-7519(03)00126-7; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; BOOTHROYD JC, 1982, GENE, V20, P281, DOI 10.1016/0378-1119(82)90046-4; BORST P, 1965, P NATL ACAD SCI USA, V54, P982, DOI 10.1073/pnas.54.3.982; Borst P, 2008, ANNU REV MICROBIOL, V62, P235, DOI 10.1146/annurev.micro.62.081307.162750; Cliffe LJ, 2010, NUCLEIC ACIDS RES, V38, P3923, DOI 10.1093/nar/gkq146; Cliffe LJ, 2009, NUCLEIC ACIDS RES, V37, P1452, DOI 10.1093/nar/gkn1067; Cross M, 1999, EMBO J, V18, P6573, DOI 10.1093/emboj/18.22.6573; Cross M, 2002, MOL MICROBIOL, V46, P37, DOI 10.1046/j.1365-2958.2002.03144.x; DELANGE T, 1984, NUCLEIC ACIDS RES, V12, P4431, DOI 10.1093/nar/12.11.4431; DELANGE T, 1983, CELL, V34, P891, DOI 10.1016/0092-8674(83)90546-9; DiPaolo C, 2005, MOL CELL, V17, P441, DOI 10.1016/j.molcel.2004.12.022; Dossin FD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002313; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ekanayake DK, 2011, MOL CELL BIOL, V31, P1690, DOI 10.1128/MCB.01277-10; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Flusberg BA, 2010, NAT METHODS, V7, P461, DOI [10.1038/NMETH.1459, 10.1038/nmeth.1459]; Fujii M, 2010, MOL GENET GENOMICS, V283, P461, DOI 10.1007/s00438-010-0535-6; Genest PA, 2005, NUCLEIC ACIDS RES, V33, P1699, DOI 10.1093/nar/gki304; Genest PA, 2007, NUCLEIC ACIDS RES, V35, P2116, DOI 10.1093/nar/gkm050; GOMMERSAMPT JH, 1993, CELL, V75, P1129, DOI 10.1016/0092-8674(93)90322-H; Grover RK, 2007, ANGEW CHEM INT EDIT, V46, P2839, DOI 10.1002/anie.200604635; Heidebrecht T, 2011, NUCLEIC ACIDS RES, V39, P5715, DOI 10.1093/nar/gkr125; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Iyer LM, 2009, CELL CYCLE, V8, P1698, DOI 10.4161/cc.8.11.8580; Jackson AP, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000658; KOOTER JM, 1984, NUCLEIC ACIDS RES, V12, P9457, DOI 10.1093/nar/12.24.9457; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lye LF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001161; Martinez-Calvillo S, 2003, MOL CELL, V11, P1291, DOI 10.1016/S1097-2765(03)00143-6; Martinez-Calvillo S, 2004, EUKARYOT CELL, V3, P506, DOI 10.1128/EC.3.2.506-517.2004; Miki K, 2010, FEBS J, V277, P4539, DOI 10.1111/j.1742-4658.2010.07868.x; Monnerat S, 2004, MOL BIOCHEM PARASIT, V134, P233, DOI 10.1016/j.molbiopara.2003.12.004; Myler PJ, 1999, P NATL ACAD SCI USA, V96, P2902, DOI 10.1073/pnas.96.6.2902; Myler PJ, 2000, BIOCHEM SOC T, V28, P527, DOI 10.1042/bst0280527; NELSON RG, 1983, CELL, V34, P901, DOI 10.1016/0092-8674(83)90547-0; Otto TD, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1268; Padilla-Mejia NE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-232; Raymond F, 2012, NUCLEIC ACIDS RES, V40, P1131, DOI 10.1093/nar/gkr834; Richard P, 2009, GENE DEV, V23, P1247, DOI 10.1101/gad.1792809; Robinson KA, 2003, MOL BIOCHEM PARASIT, V128, P217, DOI 10.1016/S0166-6851(03)00079-3; Sabatini R, 2002, J BIOL CHEM, V277, P958, DOI 10.1074/jbc.M109000200; SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138, DOI 10.1038/nbt1093-1138; Shearwin KE, 2005, TRENDS GENET, V21, P339, DOI 10.1016/j.tig.2005.04.009; Siegel TN, 2009, GENE DEV, V23, P1063, DOI 10.1101/gad.1790409; Simpson AGB, 2006, TRENDS PARASITOL, V22, P168, DOI 10.1016/j.pt.2006.02.006; Stevens JR, 2008, PARASITE, V15, P226, DOI 10.1051/parasite/2008153226; SUTTON RE, 1986, CELL, V47, P527, DOI 10.1016/0092-8674(86)90617-3; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Thomas S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-152; Toaldo CB, 2005, MOL BIOCHEM PARASIT, V143, P111, DOI 10.1016/j.molbiopara.2005.05.001; ULLU E, 1993, MOL CELL BIOL, V13, P720, DOI 10.1128/MCB.13.1.720; Vainio S, 2009, MOL BIOCHEM PARASIT, V164, P157, DOI 10.1016/j.molbiopara.2008.12.001; van Leeuwen F, 1998, MOL CELL BIOL, V18, P5643, DOI 10.1128/MCB.18.10.5643; van Leeuwen F, 1998, P NATL ACAD SCI USA, V95, P2366, DOI 10.1073/pnas.95.5.2366; van Leeuwen F, 2000, MOL BIOCHEM PARASIT, V109, P133, DOI 10.1016/S0166-6851(00)00247-4; VANDERPLOEG LHT, 1982, NUCLEIC ACIDS RES, V10, P3591, DOI 10.1093/nar/10.12.3591; vanLeeuwen F, 1996, NUCLEIC ACIDS RES, V24, P2476, DOI 10.1093/nar/24.13.2476; vanLeeuwen F, 1997, GENE DEV, V11, P3232, DOI 10.1101/gad.11.23.3232; Yu Z, 2007, NUCLEIC ACIDS RES, V35, P2107, DOI 10.1093/nar/gkm049	63	102	103	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 31	2012	150	5					909	921		10.1016/j.cell.2012.07.030	http://dx.doi.org/10.1016/j.cell.2012.07.030			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22939620	Bronze, Green Accepted			2022-12-24	WOS:000308500200007
J	Weng, JK; Li, Y; Mo, HP; Chapple, C				Weng, Jing-Ke; Li, Yi; Mo, Huaping; Chapple, Clint			Assembly of an Evolutionarily New Pathway for alpha-Pyrone Biosynthesis in Arabidopsis	SCIENCE			English	Article							LIGNIN BIOSYNTHESIS; SYRINGYL LIGNIN; PLANTS	Plants possess arrays of functionally diverse specialized metabolites, many of which are distributed taxonomically. Here, we describe the evolution of a class of substituted alpha-pyrone metabolites in Arabidopsis, which we have named arabidopyrones. The biosynthesis of arabidopyrones requires a cytochrome P450 enzyme (CYP84A4) to generate the catechol-substituted substrate for an extradiol ring-cleavage dioxygenase (AtLigB). Unlike other ring-cleavage-derived plant metabolites made from tyrosine, arabidopyrones are instead derived from phenylalanine through the early steps of phenylpropanoid metabolism. Whereas CYP84A4, an Arabidopsis-specific paralog of the lignin-biosynthetic enzyme CYP84A1, has neofunctionalized relative to its ancestor, AtLigB homologs are widespread among land plants and many bacteria. This study exemplifies the rapid evolution of a biochemical pathway formed by the addition of a new biological activity into an existing metabolic infrastructure.	[Weng, Jing-Ke; Li, Yi; Chapple, Clint] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Mo, Huaping] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Chapple, C (corresponding author), Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA.	chapple@purdue.edu	Weng, Jing-Ke/E-7343-2013; Chapple, Clint CS/Q-5456-2017; Weng, Jing-Ke/A-6900-2015; Weng, Jing-Ke/V-5934-2019	Weng, Jing-Ke/0000-0003-1079-3668; Chapple, Clint CS/0000-0002-5195-562X; Weng, Jing-Ke/0000-0003-3059-0075; Weng, Jing-Ke/0000-0003-3059-0075	NSF [MCB-1121925]; Global Climate and Energy Project	NSF(National Science Foundation (NSF)); Global Climate and Energy Project	This work is supported by NSF grant MCB-1121925 and the Global Climate and Energy Project (to C. C.). We thank D. A. Colby for helpful discussions about the chemical synthesis of APs and J. Ralph and H. Kim for providing authentic standards. Supporting data and figures relevant to this paper are presented online in the supplementary materials.	Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; CHAPPLE CCS, 1992, PLANT CELL, V4, P1413, DOI 10.1105/tpc.4.11.1413; Christinet L, 2004, PLANT PHYSIOL, V134, P265, DOI 10.1104/pp.103.031914; Eckermann S, 1998, NATURE, V396, P387, DOI 10.1038/24652; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Matsuno M, 2009, SCIENCE, V325, P1688, DOI 10.1126/science.1174095; Meyer K, 1998, P NATL ACAD SCI USA, V95, P6619, DOI 10.1073/pnas.95.12.6619; Pichersky E, 2006, SCIENCE, V311, P808, DOI 10.1126/science.1118510; Pichersky E, 2000, TRENDS PLANT SCI, V5, P439, DOI 10.1016/S1360-1385(00)01741-6; SAITO K, 1976, EUR J BIOCHEM, V68, P237, DOI 10.1111/j.1432-1033.1976.tb10783.x; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; Weng JK, 2008, P NATL ACAD SCI USA, V105, P7887, DOI 10.1073/pnas.0801696105; Weng JK, 2010, NEW PHYTOL, V187, P273, DOI 10.1111/j.1469-8137.2010.03327.x; Weng JK, 2010, PLANT CELL, V22, P1033, DOI 10.1105/tpc.109.073528; Wink M., 2010, BIOCH PLANT SECONDAR, V2nd; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	16	65	68	3	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 24	2012	337	6097					960	964		10.1126/science.1221614	http://dx.doi.org/10.1126/science.1221614			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992VI	22923580				2022-12-24	WOS:000307807600044
J	Bach, PB; Gould, MK				Bach, Peter B.; Gould, Michael K.			When the Average Applies to No One: Personalized Decision Making About Potential Benefits of Lung Cancer Screening	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RISK PREDICTION; MORTALITY; MODEL		Mem Sloan Kettering Canc Ctr, New York, NY USA; Kaiser Permanente So Calif, Pasadena, CA USA	Memorial Sloan Kettering Cancer Center; Kaiser Permanente	Bach, PB (corresponding author), 1275 York Ave, New York, NY 10065 USA.							Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; American Lung Association, 2012, PROV GUID LUNG CANC; Bach PB, 2003, JNCI-J NATL CANCER I, V95, P470, DOI 10.1093/jnci/95.6.470; Bach PB, 2004, CHEST, V126, P1742, DOI 10.1378/chest.126.6.1742; Bach PB, 2012, JAMA-J AM MED ASSOC, P1; Bach PB, 2007, JAMA-J AM MED ASSOC, V297, P953, DOI 10.1001/jama.297.9.953; Cronin KA, 2006, JNCI-J NATL CANCER I, V98, P637, DOI 10.1093/jnci/djj163; Elmore JG, 2005, NEW ENGL J MED, V353, P297, DOI 10.1056/NEJMe058111; Etzel CJ, 2011, SEMIN RESP CRIT CARE, V32, P3, DOI 10.1055/s-0031-1272864; Gigerenzer G, 2009, B WORLD HEALTH ORGAN, V87, P567, DOI 10.2471/BLT.09.069872; Gohagan JK, 2005, LUNG CANCER, V47, P9, DOI 10.1016/j.lungcan.2004.06.007; Schwartz Lisa M., 1999, Journal of the National Cancer Institute Monographs, P124; Spitz MR, 2007, JNCI-J NATL CANCER I, V99, P715, DOI 10.1093/jnci/djk153; Tammemagi CM, 2011, JNCI-J NATL CANCER I, V103, P1058, DOI 10.1093/jnci/djr173	14	71	70	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2012	157	8					571	+		10.7326/0003-4819-157-8-201210160-00524	http://dx.doi.org/10.7326/0003-4819-157-8-201210160-00524			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021SP	22893040				2022-12-24	WOS:000309906000018
J	Farley, T				Farley, Thomas			Support Regulation of Sugar-Sweetened Beverages	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									New York City Dept Hlth & Mental Hyg, New York, NY USA	New York City Department of Health & Mental Hygiene	Farley, T (corresponding author), New York City Dept Hlth & Mental Hyg, New York, NY USA.								0	12	12	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 11	2012	367	15					1464	1465						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	018ID	22998342				2022-12-24	WOS:000309652700015
J	Kourtis, N; Nikoletopoulou, V; Tavernarakis, N				Kourtis, Nikos; Nikoletopoulou, Vassiliki; Tavernarakis, Nektarios			Small heat-shock proteins protect from heat-stroke-associated neurodegeneration	NATURE			English	Article							NECROTIC CELL-DEATH; CAENORHABDITIS-ELEGANS; C-ELEGANS; ENDOPLASMIC-RETICULUM; GOLGI-APPARATUS; LIFE-SPAN; MOLECULAR CHAPERONES; STRESS-RESPONSE; NEURONS; GENE	Heat stroke is a life-threatening condition, characterized by catastrophic collapse of thermoregulation and extreme hyperthermia. In recent years, intensification of heat waves has caused a surge of heat-stroke fatalities. The mechanisms underlying heat-related pathology are poorly understood. Here we show that heat stroke triggers pervasive necrotic cell death and neurodegeneration in Caenorhabditis elegans. Preconditioning of animals at a mildly elevated temperature strongly protects from heat-induced necrosis. The heat-shock transcription factor HSF-1 and the small heat-shock protein HSP-16.1 mediate cytoprotection by preconditioning. HSP-16.1 localizes to the Golgi, where it functions with the Ca2+- and Mn2+-transporting ATPase PMR-1 to maintain Ca2+ homeostasis under heat stroke. Preconditioning also suppresses cell death inflicted by diverse insults, and protects mammalian neurons from heat cytotoxicity. These findings reveal an evolutionarily conserved mechanism that defends against diverse necrotic stimuli, and may be relevant to heat stroke and other pathological conditions involving necrosis in humans.	[Kourtis, Nikos; Nikoletopoulou, Vassiliki; Tavernarakis, Nektarios] Fdn Res & Technol, Inst Mol Biol & Biotechnol, Iraklion 71110, Crete, Greece		Tavernarakis, N (corresponding author), Fdn Res & Technol, Inst Mol Biol & Biotechnol, Iraklion 71110, Crete, Greece.	tavernarakis@imbb.forth.gr	Tavernarakis, Nektarios/B-9684-2013	Tavernarakis, Nektarios/0000-0002-5253-1466; Nikoletopoulou, Vassiliki/0000-0003-3646-992X	National Center for Research Resources (NCRR) of the National Institutes of Health (NIH); National Bioresource Project in Japan; European Molecular Biology Organization (EMBO) Long Term Fellowship; European Research Council (ERC); European Commission 7th Framework Programme	National Center for Research Resources (NCRR) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Bioresource Project in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); European Molecular Biology Organization (EMBO) Long Term Fellowship; European Research Council (ERC)(European Research Council (ERC)European Commission); European Commission 7th Framework Programme(European Commission)	We thank K. Georgila, K. Palikaras and E. Bessa for help with cell-death assays, A. Pasparaki for technical support with experiments and C. Olendrowitz for help with electron microscopy. We thank S. Eimer for providing the Golgi and endosomal reporter constructs and for support with the electron microscopy, N. Chronis for providing the pN1-GCaMP2.0 plasmid, G. Caldwell for the alpha-synuclein-expressing C. elegans strain and K. Palikaras for the skn-1 RNAi plasmid. We thank J. Vanoevelen and F. Wuytack for the antibody against PMR-1, S. Mitrovic for the antibody against mannosidase II, G. Sourvinos for lentiviral plasmids, and S. Gascon for the pLV plasmid. Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the National Center for Research Resources (NCRR) of the National Institutes of Health (NIH), and S. Mitani (National Bioresource Project) in Japan. We thank A. Fire for plasmid vectors. V. N. is supported by an European Molecular Biology Organization (EMBO) Long Term Fellowship. This work was funded by grants from the European Research Council (ERC) and the European Commission 7th Framework Programme.	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Artal-Sanz M, 2006, J CELL BIOL, V173, P231, DOI 10.1083/jcb.200511103; Bibel M, 2007, NAT PROTOC, V2, P1034, DOI 10.1038/nprot.2007.147; Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089; Brady JP, 1997, P NATL ACAD SCI USA, V94, P884, DOI 10.1073/pnas.94.3.884; BRENNER S, 1974, GENETICS, V77, P71; Calabrese EJ, 2004, EMBO REP, V5, pS37, DOI 10.1038/sj.embor.7400222; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cao SS, 2005, J NEUROSCI, V25, P3801, DOI 10.1523/JNEUROSCI.5157-04.2005; Chiang WC, 2012, CELL, V148, P322, DOI 10.1016/j.cell.2011.12.019; DHOPESH VP, 1976, NEW ENGL J MED, V294, P557; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Gascon S, 2008, J NEUROSCI METH, V168, P104, DOI 10.1016/j.jneumeth.2007.09.023; Gidday JM, 2006, NAT REV NEUROSCI, V7, P437, DOI 10.1038/nrn1927; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Greffrath W, 2001, NEUROSCIENCE, V104, P539, DOI 10.1016/S0306-4522(01)00088-4; Hall DM, 2001, AM J PHYSIOL-HEART C, V280, pH509, DOI 10.1152/ajpheart.2001.280.2.H509; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Kourtis N, 2011, EMBO J, V30, P2520, DOI 10.1038/emboj.2011.162; Lanner JT, 2012, NAT MED, V18, P244, DOI 10.1038/nm.2598; Lehotsky J, 2002, GEN PHYSIOL BIOPHYS, V21, P31; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin P, 1999, J CELL BIOL, V145, P279, DOI 10.1083/jcb.145.2.279; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Lowe M, 2011, CURR OPIN CELL BIOL, V23, P85, DOI 10.1016/j.ceb.2010.10.004; McCall K, 2010, CURR OPIN CELL BIOL, V22, P882, DOI 10.1016/j.ceb.2010.09.002; McColl G, 2010, CELL METAB, V12, P260, DOI 10.1016/j.cmet.2010.08.004; Michelangeli F, 2005, CURR OPIN CELL BIOL, V17, P135, DOI 10.1016/j.ceb.2005.01.005; Missiaen L, 2007, CELL CALCIUM, V41, P405, DOI 10.1016/j.ceca.2006.11.001; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Pavlikova M, 2009, CELL MOL NEUROBIOL, V29, P909, DOI 10.1007/s10571-009-9374-6; Pinton P, 1998, EMBO J, V17, P5298, DOI 10.1093/emboj/17.18.5298; Protasi F, 2009, J PHYSIOL-LONDON, V587, P3095, DOI 10.1113/jphysiol.2009.171967; Richardson CE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002391; Rostaing P, 2004, J HISTOCHEM CYTOCHEM, V52, P1, DOI 10.1177/002215540405200101; Rowlands DJ, 2012, NAT GEOSCI, V5, P256, DOI [10.1038/NGEO1430, 10.1038/ngeo1430]; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Scott BA, 2002, SCIENCE, V296, P2388, DOI 10.1126/science.1072302; Shull GE, 2003, ANN NY ACAD SCI, V986, P453, DOI 10.1111/j.1749-6632.2003.tb07229.x; Syntichaki P, 2003, NAT REV NEUROSCI, V4, P672, DOI 10.1038/nrn1174; Syntichaki P, 2002, NATURE, V419, P939, DOI 10.1038/nature01108; Van Baelen K, 2004, BBA-MOL CELL RES, V1742, P103, DOI 10.1016/j.bbamcr.2004.08.018; Van Baelen K, 2001, J BIOL CHEM, V276, P10683, DOI 10.1074/jbc.M010553200; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; von Blume J, 2011, DEV CELL, V20, P652, DOI 10.1016/j.devcel.2011.03.014; Walker GA, 2003, AGING CELL, V2, P131, DOI 10.1046/j.1474-9728.2003.00045.x; Xu KL, 2001, NEURON, V31, P957, DOI 10.1016/S0896-6273(01)00432-9; Yamashima T, 2003, HIPPOCAMPUS, V13, P791, DOI 10.1002/hipo.10127; Yamashima T, 2000, PROG NEUROBIOL, V62, P273, DOI 10.1016/S0301-0082(00)00006-X; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275	56	108	127	0	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2012	490	7419					213	+		10.1038/nature11417	http://dx.doi.org/10.1038/nature11417			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019IY	22972192				2022-12-24	WOS:000309733300040
J	Carville, S; Padhi, S; Reason, T; Underwood, M				Carville, Serena; Padhi, Smita; Reason, Tim; Underwood, Martin		Guideline Dev Grp	Diagnosis and management of headaches in young people and adults: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Underwood, Martin] Univ Warwick, Warwick Med Sch, Div Hlth Sci, Coventry CV4 7AL, W Midlands, England; [Carville, Serena; Padhi, Smita; Reason, Tim] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England	University of Warwick; Royal College of Physicians	Underwood, M (corresponding author), Univ Warwick, Warwick Med Sch, Div Hlth Sci, Coventry CV4 7AL, W Midlands, England.	m.underwood@warwick.ac.uk	Whitehouse, William P/F-9065-2017; Underwood, Martin/D-6364-2015	Whitehouse, William P/0000-0001-5207-5731; Underwood, Martin/0000-0002-0309-1708				Dias S, 2011, 2 NICE DSU; Faculty of Sexual and Reproductive Healthcare clinical guidance, 2011, DRUG INT HORM CONTR; International Headache Society, IHS CLASS ICHD 2; Latinovic R, 2006, J NEUROL NEUROSUR PS, V77, P385, DOI 10.1136/jnnp.2005.073221; National Institute for Health and Clinical Excellence, 2012, HEAD DIAGN MAN HEAD; National Institute for Health and Clinical Excellence, 2012, BOT TOX TYP A PREV H; Weatherall MW, 2006, J ROY COLL PHYS EDIN, V36, P196	7	41	43	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 19	2012	345								e5765	10.1136/bmj.e5765	http://dx.doi.org/10.1136/bmj.e5765			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	011JI	22993393				2022-12-24	WOS:000309160500002
J	Ludwig, DS; Ebbeling, CB; Livingston, EH				Ludwig, David S.; Ebbeling, Cara B.; Livingston, Edward H.			Surgical vs Lifestyle Treatment for Type 2 Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BARIATRIC SURGERY; RISK-FACTORS; WEIGHT		[Ludwig, David S.; Ebbeling, Cara B.] Boston Childrens Hosp, New Balance Fdn Obes Prevent Ctr, Boston, MA 02115 USA; [Livingston, Edward H.] Univ Texas SW Med Ctr Dallas, Div Gastrointestinal & Endocrine Surg, Dallas, TX 75390 USA	Harvard University; Boston Children's Hospital; University of Texas System; University of Texas Southwestern Medical Center Dallas	Ludwig, DS (corresponding author), Boston Childrens Hosp, New Balance Fdn Obes Prevent Ctr, 300 Longwood Ave, Boston, MA 02115 USA.	david.ludwig@childrens.harvard.edu		Ludwig, David/0000-0003-3307-8544	NIDDK NIH HHS [K24DK082730] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK082730] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 1990, METABOLISM, V39, P905, DOI 10.1016/0026-0495(90)90299-R; Gardner CD, 2007, JAMA-J AM MED ASSOC, V297, P969, DOI 10.1001/jama.297.9.969; HENRY RR, 1985, J CLIN ENDOCR METAB, V61, P917, DOI 10.1210/jcem-61-5-917; Lim EL, 2011, DIABETOLOGIA, V54, P2506, DOI 10.1007/s00125-011-2204-7; Ludwig DS, 2011, JAMA-J AM MED ASSOC, V305, P1352, DOI 10.1001/jama.2011.380; May AL, 2012, PEDIATRICS, V129, P1035, DOI 10.1542/peds.2011-1082; Mingrone G, 2012, NEW ENGL J MED, V366, P1577, DOI 10.1056/NEJMoa1200111; Shah M, 2006, J CLIN ENDOCR METAB, V91, P4223, DOI 10.1210/jc.2006-0557; Zeitler P, 2012, NEW ENGL J MED, V366, P2247, DOI 10.1056/NEJMoa1109333	9	9	10	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2012	308	10					981	982		10.1001/2012.jama.10156	http://dx.doi.org/10.1001/2012.jama.10156			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003AA	22968885				2022-12-24	WOS:000308579300019
J	Brenner, H; Chang-Claude, J; Jansen, L; Seiler, CM; Hoffmeister, M				Brenner, Hermann; Chang-Claude, Jenny; Jansen, Lina; Seiler, Christoph M.; Hoffmeister, Michael			Role of Colonoscopy and Polyp Characteristics in Colorectal Cancer After Colonoscopic Polyp Detection A Population-Based Case-Control Study	ANNALS OF INTERNAL MEDICINE			English	Article							SURVEILLANCE COLONOSCOPY; ADENOMA CHARACTERISTICS; SCREENING COLONOSCOPY; RISK-FACTORS; FOLLOW-UP; RECURRENCE; PREDICTORS; PROTECTION; NEOPLASMS; HISTORY	Background: Studies have identified characteristics of adenomas detected on colonoscopy to be predictive of adenoma recurrence. Objective: To assess the role of both colonoscopy-related factors and polyp characteristics on the risk for colorectal cancer after colonoscopic polyp detection. Design: Population-based case-control study (3148 case participants and 3274 control participants). Setting: Rhine-Neckar region of Germany. Patients: Case and control participants with physician-validated detection of polyps (other than hyperplastic polyps) at a previous colonoscopy in the past 10 years. Measurements: Detailed history and results of previous colonoscopies were obtained through interviews and medical records. Case and control participants were compared according to colonoscopy-related factors (incompleteness, poor bowel preparation, incomplete removal of all polyps, and no surveillance colonoscopy within 5 years) and polyp characteristics (>= 1 cm, villous components or high-grade dysplasia, >= 3 polyps, and >= 1 proximal polyp). Odds ratios (ORs) and attributable fractions were derived by using multiple logistic regression and the Levin formula. Results: 155 case participants and 260 control participants with physician-validated polyp detection in the past 10 years were identified. The following characteristics were significantly more common among case participants than among control participants: not all polyps completely removed (29.0% vs. 9.6%; OR, 3.73 [95% CI, 2.11 to 6.60]), no surveillance colonoscopy within 5 years (26.5% vs. 11.5%; OR, 2.96 [CI, 1.70 to 5.16]), and detection of 3 or more polyps (14.2% vs. 7.3%; OR, 2.21 [CI, 1.07 to 4.54]). Odds ratios ranged from 1.12 to 1.42 and CIs included 1.00 for all other variables. Overall, 41.1% and 21.7% of cancer cases were statistically attributable to colonoscopy-related factors and polyp characteristics, respectively. Limitation: This was an observational study with potential for residual confounding and selection bias. Conclusion: Colonoscopy-related factors are more important than polyp characteristics for stratification of colorectal cancer risk after colonoscopic polyp detection in the community setting.	[Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, D-69120 Heidelberg, Germany; Heidelberg Univ, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Brenner, H (corresponding author), German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	h.brenner@dkfz.de	Hoffmeister, Michael/T-7187-2019; Jansen, Lina/D-7255-2016; Hoffmeister, Michael/AAB-2321-2022; Brenner, Hermann/ABE-6383-2020; Seiler, Christoph/AAG-7056-2021; Brenner, Hermann/B-4627-2017	Hoffmeister, Michael/0000-0002-8307-3197; Jansen, Lina/0000-0001-8004-4940; Hoffmeister, Michael/0000-0002-8307-3197; Brenner, Hermann/0000-0002-6129-1572; Brenner, Hermann/0000-0002-6129-1572	German Research Council (Deutsche Forschungsgemeinschaft) [BR 1704/6-1, BR 1704/6-3, BR 1704/6-4, CH 117/1-1]; German Federal Ministry of Education and Research [01KH0404, 01ER0814]; German Research Council	German Research Council (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Council(German Research Foundation (DFG))	By grants BR 1704/6-1, BR 1704/6-3, BR 1704/6-4, and CH 117/1-1 from the German Research Council (Deutsche Forschungsgemeinschaft) and grants 01KH0404 and 01ER0814 from the German Federal Ministry of Education and Research.; Primary Funding Source: German Research Council and German Federal Ministry of Education and Research.	Avidan B, 2002, AM J GASTROENTEROL, V97, P1524, DOI 10.1016/S0002-9270(02)04157-6; Bertario L, 2003, INT J CANCER, V105, P82, DOI 10.1002/ijc.11036; Bonithon-Kopp C, 2004, DIS COLON RECTUM, V47, P323, DOI 10.1007/s10350-003-0054-1; Brenner H, 2011, J CLIN ONCOL, V29, P3761, DOI 10.1200/JCO.2011.35.9307; Brenner H, 2011, ANN INTERN MED, V154, P22, DOI 10.7326/0003-4819-154-1-201101040-00004; Cafferty FH, 2007, CANCER J, V13, P263, DOI 10.1097/PPO.0b013e318046ebf1; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Imperiale TF, 2008, NEW ENGL J MED, V359, P1218, DOI 10.1056/NEJMoa0803597; Kaminski MF, 2010, NEW ENGL J MED, V362, P1795, DOI 10.1056/NEJMoa0907667; Laiyemo AO, 2008, ANN INTERN MED, V148, P419, DOI 10.7326/0003-4819-148-6-200803180-00004; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Lieberman DA, 2007, GASTROENTEROLOGY, V133, P1077, DOI 10.1053/j.gastro.2007.07.006; Mannath J, 2011, DIGEST DIS SCI, V56, P2389, DOI 10.1007/s10620-011-1609-y; Martinez ME, 2009, GASTROENTEROLOGY, V136, P832, DOI 10.1053/j.gastro.2008.12.007; Martinez ME, 2001, GASTROENTEROLOGY, V120, P1077, DOI 10.1053/gast.2001.23247; MULLER AD, 1995, ARCH INTERN MED, V155, P1741, DOI 10.1001/archinte.155.16.1741; Noshirwani KC, 2000, GASTROINTEST ENDOSC, V51, P433, DOI 10.1016/S0016-5107(00)70444-5; Pinsky PF, 2009, CLIN GASTROENTEROL H, V7, P86, DOI 10.1016/j.cgh.2008.07.014; Ruckinger S, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-7; Saini SD, 2006, GASTROINTEST ENDOSC, V64, P614, DOI 10.1016/j.gie.2006.06.057; Schmiegel W, 2008, Z GASTROENTEROL, V46, P799, DOI 10.1055/s-2008-1027726; van Stolk RU, 1998, GASTROENTEROLOGY, V115, P13, DOI 10.1016/S0016-5085(98)70359-2; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701	23	56	59	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 21	2012	157	4					225	233		10.7326/0003-4819-157-4-201208210-00002	http://dx.doi.org/10.7326/0003-4819-157-4-201208210-00002			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992XG	22910933				2022-12-24	WOS:000307813200013
J	Rabe, KF; Ward, B				Rabe, Klaus F.; Ward, Brian			Uncovering and tackling Europe's hidden respiratory illness	LANCET			English	Editorial Material									[Rabe, Klaus F.] Univ Kiel, D-24118 Kiel, Germany; [Ward, Brian] European Resp Soc, Brussels, Belgium	University of Kiel	Rabe, KF (corresponding author), Univ Kiel, D-24118 Kiel, Germany.	k.f.rabe@kh-grosshansdorf.de	Rabe, Klaus F./AAW-6296-2021	Rabe, Klaus F./0000-0002-7020-1401				Department of Health, 2011, OUTC STRAT CHRON OBS; European Commission, 2012, REV EU AIR POL; European Respiratory Roadmap, PREV; London Health Observatory, 2010, JUB LIN HLTH IN 2004; Mackenbach J.P, 2007, EC IMPLICATIONS SOCI; Samolinski B, 2012, LANCET, V379, pE45, DOI 10.1016/S0140-6736(12)60514-5; World Health Organization, 2008, TALL CHART HLTH SYST	7	8	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 18	2012	380	9842					623	624		10.1016/S0140-6736(12)61306-3	http://dx.doi.org/10.1016/S0140-6736(12)61306-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	991SE	22901869				2022-12-24	WOS:000307721000004
J	Peralta-Yahya, PP; Zhang, FZ; del Cardayre, SB; Keasling, JD				Peralta-Yahya, Pamela P.; Zhang, Fuzhong; del Cardayre, Stephen B.; Keasling, Jay D.			Microbial engineering for the production of advanced biofuels	NATURE			English	Review							MODULAR POLYKETIDE SYNTHASE; ESCHERICHIA-COLI; SYNTHETIC BIOLOGY; SACCHAROMYCES-CEREVISIAE; BUTANOL PRODUCTION; BACILLUS-SUBTILIS; BIOSYNTHESIS; PRECURSOR; ACID; CONVERSION	Advanced biofuels produced by microorganisms have similar properties to petroleum-based fuels, and can 'drop in' to the existing transportation infrastructure. However, producing these biofuels in yields high enough to be useful requires the engineering of the microorganism's metabolism. Such engineering is not based on just one specific feedstock or host organism. Data-driven and synthetic-biology approaches can be used to optimize both the host and pathways to maximize fuel production. Despite some success, challenges still need to be met to move advanced biofuels towards commercialization, and to compete with more conventional fuels.	[Peralta-Yahya, Pamela P.; Zhang, Fuzhong; Keasling, Jay D.] Joint BioEnergy Inst, Emeryville, CA 94608 USA; [Peralta-Yahya, Pamela P.; Zhang, Fuzhong; Keasling, Jay D.] Univ Calif Berkeley, Inst QB3, Berkeley, CA 94720 USA; [del Cardayre, Stephen B.] LS9, San Francisco, CA 94080 USA; [Keasling, Jay D.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Bioengn, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Keasling, JD (corresponding author), Joint BioEnergy Inst, 5885 Hollis St, Emeryville, CA 94608 USA.	keasling@berkeley.edu	Keasling, Jay D/J-9162-2012	Keasling, Jay D/0000-0003-4170-6088; Zhang, Fuzhong/0000-0001-6979-7909	Joint BioEnergy Institute; U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]; Synthetic Biology Engineering Research Center; National Science Foundation [0540879]	Joint BioEnergy Institute; U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Synthetic Biology Engineering Research Center; National Science Foundation(National Science Foundation (NSF))	P.P.P.-Y. and F.Z. contributed equally to this work. This work was supported in part by the Joint BioEnergy Institute, which is funded by the U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231, and by the Synthetic Biology Engineering Research Center, which is funded by National Science Foundation Award No. 0540879.	Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; Asadollahi MA, 2009, METAB ENG, V11, P328, DOI 10.1016/j.ymben.2009.07.001; Atsumi S, 2008, METAB ENG, V10, P305, DOI 10.1016/j.ymben.2007.08.003; Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; Atsumi S, 2009, NAT BIOTECHNOL, V27, P1177, DOI 10.1038/nbt.1586; Banerjee A, 2002, CRIT REV BIOTECHNOL, V22, P245, DOI 10.1080/07388550290789513; Beller HR, 2010, APPL ENVIRON MICROB, V76, P1212, DOI 10.1128/AEM.02312-09; Berezina OV, 2010, APPL MICROBIOL BIOT, V87, P635, DOI 10.1007/s00253-010-2480-z; Betancor L, 2008, CHEMBIOCHEM, V9, P2962, DOI 10.1002/cbic.200800475; Bokinsky G, 2011, P NATL ACAD SCI USA, V108, P19949, DOI 10.1073/pnas.1106958108; Bond-Watts BB, 2011, NAT CHEM BIOL, V7, P222, DOI 10.1038/NCHEMBIO.537; Buelter T., 2012, US patent, Patent No. [0,058,532 A1, 0058532]; CARAFA YD, 1990, J MOL BIOL, V216, P835, DOI 10.1016/S0022-2836(99)80005-9; Chen X, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-21; Davis MS, 2001, J BACTERIOL, V183, P1499, DOI 10.1128/JB.183.4.1499-1503.2001; de Jong B., 2011, CURR OPIN BIOTECHNOL; De Mey M, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-34; Dellomonaco C, 2011, NATURE, V476, P355, DOI 10.1038/nature10333; Donaldson G. K., 2007, US Patent, Patent No. [0313206, 0,313,206 A1]; Donaldson G. K., 2011, US patent, Patent No. [0,313,206 A1, 0313206]; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; Dunlop MJ, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.21; Ezeji T, 2010, APPL MICROBIOL BIOT, V85, P1697, DOI 10.1007/s00253-009-2390-0; Ezeji TC, 2007, J IND MICROBIOL BIOT, V34, P771, DOI 10.1007/s10295-007-0253-1; Festel G., 2011, US patent, Patent No. [0,053,235 A1, 0053235]; Fortman JL, 2008, TRENDS BIOTECHNOL, V26, P375, DOI 10.1016/j.tibtech.2008.03.008; Goh EB, 2012, APPL ENVIRON MICROB, V78, P70, DOI 10.1128/AEM.06785-11; Griffith KL, 2008, MOL MICROBIOL, V70, P1012, DOI 10.1111/j.1365-2958.2008.06467.x; Handke P, 2011, METAB ENG, V13, P28, DOI 10.1016/j.ymben.2010.10.007; Harvey BG, 2010, ENERG FUEL, V24, P267, DOI 10.1021/ef900799c; Higashide W, 2011, APPL ENVIRON MICROB, V77, P2727, DOI 10.1128/AEM.02454-10; Holtz WJ, 2010, CELL, V140, P19, DOI 10.1016/j.cell.2009.12.029; Hong K. K., 2012, CELL MOL LIFE SCI; Jacobsen JR, 1997, SCIENCE, V277, P367, DOI 10.1126/science.277.5324.367; Jones KL, 2000, METAB ENG, V2, P328, DOI 10.1006/mben.2000.0161; Kalscheuer R, 2006, MICROBIOL-SGM, V152, P2529, DOI 10.1099/mic.0.29028-0; Katz L., 2011, US patent, Patent No. [CN102014623, 102014623]; Keasling JD, 2010, SCIENCE, V330, P1355, DOI 10.1126/science.1193990; Kerr RA, 2007, SCIENCE, V316, P188, DOI 10.1126/science.316.5822.188; Kirby J, 2009, ANNU REV PLANT BIOL, V60, P335, DOI 10.1146/annurev.arplant.043008.091955; Knothe G, 2010, PROG ENERG COMBUST, V36, P364, DOI 10.1016/j.pecs.2009.11.004; Kopke M, 2010, P NATL ACAD SCI USA, V107, P13087, DOI 10.1073/pnas.1004716107; Kuzuyama T, 2002, BIOSCI BIOTECH BIOCH, V66, P1619, DOI 10.1271/bbb.66.1619; Lan EI, 2012, P NATL ACAD SCI USA, V109, P6018, DOI 10.1073/pnas.1200074109; Lee SY, 2008, BIOTECHNOL BIOENG, V101, P209, DOI 10.1002/bit.22003; Lee SK, 2008, CURR OPIN BIOTECH, V19, P556, DOI 10.1016/j.copbio.2008.10.014; Lee TS, 2011, J BIOL ENG, V5, DOI 10.1186/1754-1611-5-12; Lennen RM, 2010, BIOTECHNOL BIOENG, V106, P193, DOI 10.1002/bit.22660; Leonard E, 2010, P NATL ACAD SCI USA, V107, P13654, DOI 10.1073/pnas.1006138107; Li H, 2012, SCIENCE, V335, P1596, DOI 10.1126/science.1217643; Liu TG, 2010, METAB ENG, V12, P378, DOI 10.1016/j.ymben.2010.02.003; Lutke-Eversloh T, 2011, CURR OPIN BIOTECH, V22, P634, DOI 10.1016/j.copbio.2011.01.011; Malaviya A, 2012, APPL MICROBIOL BIOT, V93, P1485, DOI 10.1007/s00253-011-3629-0; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; McAndrew RP, 2011, STRUCTURE, V19, P1876, DOI 10.1016/j.str.2011.09.013; Meades G, 2010, NUCLEIC ACIDS RES, V38, P1217, DOI 10.1093/nar/gkp1079; Mendez-Perez D, 2011, APPL ENVIRON MICROB, V77, P4264, DOI 10.1128/AEM.00467-11; Menzella HG, 2005, NAT BIOTECHNOL, V23, P1171, DOI 10.1038/nbt1128; Michener JK, 2012, METAB ENG, V14, P212, DOI 10.1016/j.ymben.2011.09.004; Nawabi P, 2011, APPL ENVIRON MICROB, V77, P8052, DOI 10.1128/AEM.05046-11; Nielsen DR, 2009, METAB ENG, V11, P262, DOI 10.1016/j.ymben.2009.05.003; Nielsen J, 2011, NAT BIOTECHNOL, V29, P693, DOI 10.1038/nbt.1937; Peralta-Yahya PP, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1494; Peralta-Yahya PP, 2010, BIOTECHNOL J, V5, P147, DOI 10.1002/biot.200900220; Pfeifer BA, 2001, MICROBIOL MOL BIOL R, V65, P106, DOI 10.1128/MMBR.65.1.106-118.2001; Pfleger BF, 2006, NAT BIOTECHNOL, V24, P1027, DOI 10.1038/nbt1226; Primak YA, 2011, APPL ENVIRON MICROB, V77, P7772, DOI 10.1128/AEM.05761-11; Qureshi N, 1999, BIOTECHNOL PROGR, V15, P594, DOI 10.1021/bp990080e; Redding-Johanson AM, 2011, METAB ENG, V13, P194, DOI 10.1016/j.ymben.2010.12.005; Reiser S, 1997, J BACTERIOL, V179, P2969, DOI 10.1128/jb.179.9.2969-2975.1997; Renninger N, 2008, U.S. Patent, Patent No. 7399323; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Rude MA, 2011, APPL ENVIRON MICROB, V77, P1718, DOI 10.1128/AEM.02580-10; Rude MA, 2009, CURR OPIN MICROBIOL, V12, P274, DOI 10.1016/j.mib.2009.04.004; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Seregina TA, 2010, APPL BIOCHEM MICRO+, V46, P745, DOI 10.1134/S000368381008003X; Shen CR, 2011, APPL ENVIRON MICROB, V77, P2905, DOI 10.1128/AEM.03034-10; Smith KM, 2010, APPL MICROBIOL BIOT, V87, P1045, DOI 10.1007/s00253-010-2522-6; Smolke CD, 2000, APPL ENVIRON MICROB, V66, P5399, DOI 10.1128/AEM.66.12.5399-5405.2000; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Steen EJ, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-36; Stephanopoulos G, 2007, SCIENCE, V315, P801, DOI 10.1126/science.1139612; Sukovich DJ, 2010, APPL ENVIRON MICROB, V76, P3850, DOI 10.1128/AEM.00436-10; Sun J., 2012, US patent, Patent No. [0,040,426 A1, 0040426]; Tan XM, 2011, METAB ENG, V13, P169, DOI 10.1016/j.ymben.2011.01.001; Tracewell CA, 2009, CURR OPIN CHEM BIOL, V13, P3, DOI 10.1016/j.cbpa.2009.01.017; Trimbur D., 2011, US patent, Patent No. [0,047,863 A1, 0047863]; Tsukahara K, 1999, J BIOSCI BIOENG, V87, P554, DOI 10.1016/S1389-1723(99)80112-1; Tsuruta H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004489; Tyo KEJ, 2009, NAT BIOTECHNOL, V27, P760, DOI 10.1038/nbt.1555; Ubersax J., 2010, Genetically modified microbes producing isoprenoids patent world, Patent No. [1,414,52 A1, 141452]; Westfall PJ, 2012, P NATL ACAD SCI USA, V109, P111, DOI 10.1073/pnas.1110740109; Withers ST, 2007, APPL ENVIRON MICROB, V73, P6277, DOI 10.1128/AEM.00861-07; Yan Y, 2009, J IND MICROBIOL BIOT, V36, P471, DOI 10.1007/s10295-009-0532-0; Yu XY, 2011, P NATL ACAD SCI USA, V108, P18643, DOI 10.1073/pnas.1110852108; Yuzawa S., CURR OPIN BIOTECHNOL; Yuzawa S., 2012, CURR OPIN BIOTECHNOL; Zhang FZ, 2012, NAT BIOTECHNOL, V30, P354, DOI 10.1038/nbt.2149	100	749	783	21	871	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2012	488	7411					320	328		10.1038/nature11478	http://dx.doi.org/10.1038/nature11478			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OS	22895337				2022-12-24	WOS:000307501000031
J	Rist, PM; Kang, JH; Buring, JE; Glymour, MM; Grodstein, F; Kurth, T				Rist, Pamela M.; Kang, Jae H.; Buring, Julie E.; Glymour, M. Maria; Grodstein, Fran; Kurth, Tobias			Migraine and cognitive decline among women: prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							LOW-DOSE ASPIRIN; CARDIOVASCULAR-DISEASE; PRIMARY PREVENTION; RANDOMIZED-TRIAL; BRAIN INFARCTS; OLDER-ADULTS; VITAMIN-E; HEALTH; RISK; HEADACHE	Objective To evaluate the association between migraine and cognitive decline among women. Design Prospective cohort study. Setting Women's Health Study, United States. Participants 6349 women aged 65 or older enrolled in the Women's Health Study who provided information about migraine status at baseline and participated in cognitive testing during follow-up. Participants were classified into four groups: no history of migraine, migraine with aura, migraine without aura, and past history of migraine (reports of migraine history but no migraine in the year prior to baseline). Main outcome measures Cognitive testing was carried out at two year intervals up to three times using the telephone interview for cognitive status, immediate and delayed recall trials of the east Boston memory test, delayed recall trial of the telephone interview for cognitive status 10 word list, and a category fluency test. All tests were combined into a global cognitive score, and tests assessing verbal memory were combined to create a verbal memory score. Results Of the 6349 women, 853 (13.4%) reported any migraine; of these, 195 (22.9%) reported migraine with aura, 248 (29.1%) migraine without aura, and 410 (48.1%) a past history of migraine. Compared with women with no history of migraine, those who experienced migraine with or without aura or had a past history of migraine did not have significantly different rates of cognitive decline in any of the cognitive scores: values for the rate of change of the global cognitive score between baseline and the last observation ranged from -0.01 (SE 0.04) for past history of migraine to 0.08 (SE 0.04) for migraine with aura when compared with women without any history of migraine. Women who experienced migraine were also not at increased risk of substantial cognitive decline (worst 10% of the distribution of decline). When compared with women without a history of migraine, the relative risks for the global score ranged from 0.77 (95% confidence interval 0.46 to 1.28) for women with migraine without aura to 1.17 (0.84 to 1.63) for women with a past history of migraine. Conclusion In this prospective cohort of women, migraine status was not associated with faster rates of cognitive decline.	[Kurth, Tobias] Univ Bordeaux Segalen, INSERM, Unit Neuroepidemiol 708, F-33076 Bordeaux, France; [Rist, Pamela M.; Buring, Julie E.; Kurth, Tobias] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Prevent Med,Dept Med, Boston, MA 02115 USA; [Rist, Pamela M.; Buring, Julie E.; Grodstein, Fran; Kurth, Tobias] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Kang, Jae H.; Grodstein, Fran] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Glymour, M. Maria] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Cambridge, MA 02138 USA; [Kurth, Tobias] Univ Bordeaux, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; UDICE-French Research Universities; Universite de Bordeaux	Kurth, T (corresponding author), Univ Bordeaux Segalen, INSERM, Unit Neuroepidemiol 708, 146 Rue Leo Saignat,Case 11, F-33076 Bordeaux, France.	tobias.kurth@univ-bordeaux.fr	Kurth, Tobias/A-9243-2012	Kurth, Tobias/0000-0001-7169-2620	National Heart, Lung, and Blood Institute [HL-043851, HL-080467, HL-099355]; National Cancer Institute [CA-47988]; National Institute of Aging [AG-15933, AG-00158]; Chair of Excellence grant of the French National Research Agency (Agence Nationale de la Recherche) [R09177DD]; NATIONAL CANCER INSTITUTE [R01CA047988] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL099355, R01HL080467, R01HL043851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015933] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Chair of Excellence grant of the French National Research Agency (Agence Nationale de la Recherche)(French National Research Agency (ANR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Women's Health Study is supported by grants from the National Heart, Lung, and Blood Institute (HL-043851, HL-080467, HL-099355) and the National Cancer Institute (CA-47988). The cognitive substudy of the Women's Health Study was supported by a grant from the National Institute of Aging (AG-15933). PMR was supported by a training grant from the National Institute of Aging (AG-00158). TK is supported in part by a Chair of Excellence grant of the French National Research Agency (Agence Nationale de la Recherche, R09177DD).	ALBERT M, 1991, INT J NEUROSCI, V57, P167, DOI 10.3109/00207459109150691; Baars MAE, 2010, HEADACHE, V50, P176, DOI 10.1111/j.1526-4610.2009.01572.x; Bigal ME, 2009, NEUROL CLIN, V27, P321, DOI 10.1016/j.ncl.2008.11.011; Calandre EP, 2002, CEPHALALGIA, V22, P291, DOI 10.1046/j.1468-2982.2002.00370.x; de Jager CA, 2003, INT J GERIATR PSYCH, V18, P318, DOI 10.1002/gps.830; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gaist D, 2005, NEUROLOGY, V64, P600, DOI 10.1212/01.WNL.0000151858.15482.66; Haverkamp F, 2002, HEADACHE, V42, P776, DOI 10.1046/j.1526-4610.2002.02179.x; HOOKER WD, 1986, ARCH NEUROL-CHICAGO, V43, P709, DOI 10.1001/archneur.1986.00520070065020; Jelicic M, 2000, HEADACHE, V40, P715, DOI 10.1046/j.1526-4610.2000.00124.x; Kalaydjian A, 2007, NEUROLOGY, V68, P1417, DOI 10.1212/01.wnl.0000268250.10171.b3; Kang JH, 2007, BMJ-BRIT MED J, V334, P987, DOI 10.1136/bmj.39166.597836.BE; Kang JH, 2006, ARCH INTERN MED, V166, P2462, DOI 10.1001/archinte.166.22.2462; Kruit MC, 2004, JAMA-J AM MED ASSOC, V291, P427, DOI 10.1001/jama.291.4.427; Kurth T, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7357; Kurth T, 2006, JAMA-J AM MED ASSOC, V296, P283, DOI 10.1001/jama.296.3.283; Le Pira F, 2000, CEPHALALGIA, V20, P475, DOI 10.1046/j.1468-2982.2000.00074.x; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Lee SM, 2006, NEUROEPIDEMIOLOGY, V26, P93, DOI 10.1159/000090254; LEIJDEKKERS MLA, 1990, HEADACHE, V30, P352, DOI 10.1111/j.1526-4610.1990.hed3006352.x; Lipton RB, 2004, JAMA-J AM MED ASSOC, V291, P493, DOI 10.1001/jama.291.4.493; Lopez Oscar L, 2010, Neuroepidemiology, V34, P63, DOI 10.1159/000264678; Mulder EJCM, 1999, CEPHALALGIA, V19, P557, DOI 10.1046/j.1468-2982.1999.019006557.x; Okereke OI, 2008, J AM GERIATR SOC, V56, P1028, DOI 10.1111/j.1532-5415.2008.01686.x; Ott A, 1998, AM J EPIDEMIOL, V147, P574; Palmer JE, 1998, CEPHALALGIA, V18, P125, DOI 10.1046/j.1468-2982.1998.1803125.x; Pearson AJ, 2006, CEPHALALGIA, V26, P74, DOI 10.1111/j.1468-2982.2005.01001.x; Rexrode KM, 2000, J WOMEN HEALTH GEN-B, V9, P19, DOI 10.1089/152460900318911; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Rist PM, 2011, CEPHALALGIA, V31, P1291, DOI 10.1177/0333102411417466; Scher AI, 2009, JAMA-J AM MED ASSOC, V301, P2563, DOI 10.1001/jama.2009.932; Schurks M, 2009, CEPHALALGIA, V29, P1086, DOI 10.1111/j.1468-2982.2008.01835.x; Schurks M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3914; Vermeer SE, 2003, NEW ENGL J MED, V348, P1215, DOI 10.1056/NEJMoa022066; Weuve J, 2006, EPIDEMIOLOGY, V17, P183, DOI 10.1097/01.ede.0000198183.60572.c9; ZEITLIN C, 1984, BRIT J CLIN PSYCHOL, V23, P27, DOI 10.1111/j.2044-8260.1984.tb00623.x	36	31	32	0	18	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 8	2012	345								e5027	10.1136/bmj.e5027	http://dx.doi.org/10.1136/bmj.e5027			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988ND	22875950	Green Submitted, hybrid, Green Published			2022-12-24	WOS:000307496800002
J	Kjaer, KH; Khan, SA; Korsgaard, NJ; Wahr, J; Bamber, JL; Hurkmans, R; van den Broeke, M; Timm, LH; Kjeldsen, KK; Bjork, AA; Larsen, NK; Jorgensen, LT; Faerch-Jensen, A; Willerslev, E				Kjaer, Kurt H.; Khan, Shfaqat A.; Korsgaard, Niels J.; Wahr, John; Bamber, Jonathan L.; Hurkmans, Ruud; van den Broeke, Michiel; Timm, Lars H.; Kjeldsen, Kristian K.; Bjork, Anders A.; Larsen, Nicolaj K.; Jorgensen, Lars Tyge; Faerch-Jensen, Anders; Willerslev, Eske			Aerial Photographs Reveal Late-20th-Century Dynamic Ice Loss in Northwestern Greenland	SCIENCE			English	Article							RESOLUTION CLIMATE MODEL; JAKOBSHAVN ISBRAE; MASS-LOSS	Global warming is predicted to have a profound impact on the Greenland Ice Sheet and its contribution to global sea-level rise. Recent mass loss in the northwest of Greenland has been substantial. Using aerial photographs, we produced digital elevation models and extended the time record of recent observed marginal dynamic thinning back to the mid-1980s. We reveal two independent dynamic ice loss events on the northwestern Greenland Ice Sheet margin: from 1985 to 1993 and 2005 to 2010, which were separated by limited mass changes. Our results suggest that the ice mass changes in this sector were primarily caused by short-lived dynamic ice loss events rather than changes in the surface mass balance. This finding challenges predictions about the future response of the Greenland Ice Sheet to increasing global temperatures.	[Kjaer, Kurt H.; Korsgaard, Niels J.; Timm, Lars H.; Kjeldsen, Kristian K.; Bjork, Anders A.; Willerslev, Eske] Univ Copenhagen, Ctr GeoGenet, Nat Hist Museum, Copenhagen, Denmark; [Khan, Shfaqat A.] Tech Univ Denmark, DTU Space Natl Space Inst, Dept Geodesy, DK-2800 Lyngby, Denmark; [Wahr, John] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Wahr, John] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Bamber, Jonathan L.; Hurkmans, Ruud] Univ Bristol, Bristol Glaciol Ctr, Bristol, Avon, England; [van den Broeke, Michiel] Univ Utrecht, Inst Marine & Atmospher Res, Utrecht, Netherlands; [Larsen, Nicolaj K.] Aarhus Univ, Dept Geosci, Aarhus, Denmark; [Jorgensen, Lars Tyge; Faerch-Jensen, Anders] Danish Natl Cadastre & Survey, Copenhagen, Denmark	University of Copenhagen; Technical University of Denmark; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Bristol; Utrecht University; Aarhus University	Kjaer, KH (corresponding author), Univ Copenhagen, Ctr GeoGenet, Nat Hist Museum, Copenhagen, Denmark.	kurtk@snm.ku.dk	Khan, Shfaqat A/B-2664-2012; Bjørk, Anders/B-1625-2013; Khan, Shfaqat Abbas/AAP-6627-2021; Larsen, Nicolaj K./A-3509-2012; Hurkmans, Ruud/B-8286-2012; Van den Broeke, Michiel R./F-7867-2011; Korsgaard, Niels Jákup/D-8256-2013; Willerslev, Eske/A-9619-2011; Willerslev, Eske/AAA-5686-2019; Kjaer, Kurt/A-4199-2013; Kjeldsen, Kristian Kjellerup/A-9592-2013; Bamber, Jonathan/C-7608-2011	Khan, Shfaqat A/0000-0002-2689-8563; Bjørk, Anders/0000-0002-4919-792X; Khan, Shfaqat Abbas/0000-0002-2689-8563; Larsen, Nicolaj K./0000-0002-0117-1106; Hurkmans, Ruud/0000-0002-9164-7445; Van den Broeke, Michiel R./0000-0003-4662-7565; Korsgaard, Niels Jákup/0000-0002-8700-7023; Willerslev, Eske/0000-0002-7081-6748; Kjaer, Kurt/0000-0002-8871-5179; Kjeldsen, Kristian Kjellerup/0000-0002-8557-5131; Bamber, Jonathan/0000-0002-2280-2819	Danish Research Council [272-08-0415]; Commission for Scientific Research in Greenland; European Union [226375]; NASA [NNX08AF02G, NNXI0AR66G]; NASA's Making Earth Science Data Records for Use in Research Environments (MEaSUREs) program; Utrecht University; Netherlands Polar Program	Danish Research Council(Det Frie Forskningsrad (DFF)); Commission for Scientific Research in Greenland; European Union(European Commission); NASA(National Aeronautics & Space Administration (NASA)); NASA's Making Earth Science Data Records for Use in Research Environments (MEaSUREs) program; Utrecht University; Netherlands Polar Program	This work is a part of the RinkProject, within the Centre for GeoGenetics, funded by the Danish Research Council, grant no. 272-08-0415, and the Commission for Scientific Research in Greenland. J.L.B. and R. H. were supported by funding from the ice2sea program from the European Union 7th Framework Programme, grant number 226375. J.W. was partially supported by NASA grants NNX08AF02G and NNXI0AR66G, and by NASA's Making Earth Science Data Records for Use in Research Environments (MEaSUREs) program. M.v.d.B. acknowledges support from Utrecht University and the Netherlands Polar Program. Finally, we extend our gratitude toward the Danish National Cadastre and Survey for facilitating the erection of AirBase: a database containing registrations of aerial photographs from Greenland and their metadata. K. H. K., S. A. K., N.K.L., and E. W. wrote the majority of the main text with significant input from all authors. All authors contributed with interpretation and discussion of results. N.J.K. completed the aerial photogrammetric and validation analyses together with L. H. T., K. H. K., L.T.J., and A.F.-J. J.W. provided the GRACE data and analyses. K. K. K. handled the Geographical Information System and database management. J.B., M.v.d.B., and R. H. provided SMB and firn density data. A. A. B., L. H. T., and N.K.L. collected ice marginal data and analyzed their long-term significance.	AMAP, 2009, GREENL IC SHEET CHAN; Carstensen L. S., 2011, 1110 DMI TR; Chen JL, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB007789; Ettema J, 2010, CRYOSPHERE, V4, P511, DOI 10.5194/tc-4-511-2010; Ettema J, 2010, CRYOSPHERE, V4, P529, DOI 10.5194/tc-4-529-2010; Ettema J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038110; Ewert H., 2011, J GEODYN; Holland DM, 2008, NAT GEOSCI, V1, P659, DOI 10.1038/ngeo316; Howat IM, 2007, SCIENCE, V315, P1559, DOI 10.1126/science.1138478; Howat IM, 2011, J GLACIOL, V57, P389, DOI 10.3189/002214311796905631; Jacob T, 2012, NATURE, V482, P514, DOI 10.1038/nature10847; Joughin I, 2010, J GLACIOL, V56, P415, DOI 10.3189/002214310792447734; Khan SA, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042460; Krabill W.B, 2010, ICEBRIDGE ATM L2 ICE; Murray T, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001522; Nick FM, 2009, NAT GEOSCI, V2, P110, DOI 10.1038/NGEO394; Pritchard HD, 2009, NATURE, V461, P971, DOI 10.1038/nature08471; Reeh N, 2005, ANN GLACIOL-SER, V42, P101, DOI 10.3189/172756405781812871; Reeh N, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2007JF000746; Rignot E, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046583; Sasgen I, 2012, EARTH PLANET SC LETT, V333, P293, DOI 10.1016/j.epsl.2012.03.033; Straneo F, 2010, NAT GEOSCI, V3, P182, DOI 10.1038/NGEO764; Thomas RH, 2003, J GLACIOL, V49, P231, DOI 10.3189/172756503781830764; van As D, 2011, J GLACIOL, V57, P208, DOI 10.3189/002214311796405898; van den Broeke M, 2009, SCIENCE, V326, P984, DOI 10.1126/science.1178176; Velicogna I, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040222; Wahr J, 1998, J GEOPHYS RES-SOL EA, V103, P30205, DOI 10.1029/98JB02844; Wouters B, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034816; Zwally H. J., 2011, GLAS ICESAT L2 ANTAR; Zwally HJ, 2011, J GLACIOL, V57, P88, DOI 10.3189/002214311795306682	30	68	68	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 3	2012	337	6094					569	573		10.1126/science.1220614	http://dx.doi.org/10.1126/science.1220614			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982PU	22859486				2022-12-24	WOS:000307058700042
J	Rupar, PA; Chabanne, L; Winnik, MA; Manners, I				Rupar, Paul A.; Chabanne, Laurent; Winnik, Mitchell A.; Manners, Ian			Non-Centrosymmetric Cylindrical Micelles by Unidirectional Growth	SCIENCE			English	Article							BLOCK-COPOLYMER MICELLES; DIBLOCK COPOLYMERS; CONTROLLED LENGTH; ARCHITECTURES; MORPHOLOGIES; COMPLEX; WATER; CORE	Although solution self-assembly of block copolymers (BCPs) represents one of the most promising approaches to the creation of nanoparticles from soft matter, the formation of non-centrosymmetric nanostructures with shape anisotropy remains a major challenge. Through a combination of crystallization-driven self-assembly of crystalline-coil BCPs in solution and selective micelle corona cross-linking, we have created short (about 130 nanometers), monodisperse cylindrical seed micelles that grow unidirectionally. These nanostructures grow to form long, non-centrosymmetric cylindrical A-B and A-B-C block co-micelles upon the addition of further BCPs. We also illustrate the formation of amphiphilic cylindrical A-B-C block co-micelles, which spontaneously self-assemble into hierarchical star-shaped supermicelle architectures with a diameter of about 3 micrometers. The method described enables the rational creation of non-centrosymmetric, high aspect ratio, colloidally stable core-shell nanoparticles in a manner that until now has been restricted to the biological domain.	[Winnik, Mitchell A.] Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada; [Rupar, Paul A.; Chabanne, Laurent; Manners, Ian] Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England	University of Toronto; University of Bristol	Winnik, MA (corresponding author), Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada.	mwinnik@chem.utoronto.ca; ian.manners@bristol.ac.uk	Rupar, Paul/E-6496-2010; Winnik, Mitchell A/R-8621-2018	Rupar, Paul/0000-0002-9532-116X; Manners, Ian/0000-0002-3794-967X	Natural Science and Engineering Research Council (NSERC) of Canada; European Union (EU); Engineering and Physical Sciences Research Council; European Research Council Advanced Investigator Grant; Royal Society for a Wolfson Research Merit Award; NSERC of Canada	Natural Science and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); European Union (EU)(CGIAREuropean Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Research Council Advanced Investigator Grant(European Research Council (ERC)); Royal Society for a Wolfson Research Merit Award(Royal Society of London); NSERC of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	P.A.R. is grateful to the Natural Science and Engineering Research Council (NSERC) of Canada for a postdoctoral fellowship and the European Union (EU) for a Marie Curie fellowship. L. C. thanks the EU and Engineering and Physical Sciences Research Council for support. I. M. thanks the EU for a Marie Curie Chair, a Reintegration Grant, and a European Research Council Advanced Investigator Grant and the Royal Society for a Wolfson Research Merit Award. M. A. W. thanks the NSERC of Canada for financial support. The authors also thank T. Gadt for synthesizing PFS<INF>28</INF>-b-PDMS<INF>560</INF> and PFS<INF>64</INF>-b-P2VP<INF>837</INF>.	Chen Q, 2011, SCIENCE, V331, P199, DOI 10.1126/science.1197451; Cheng L, 2008, ANGEW CHEM INT EDIT, V47, P10171, DOI 10.1002/anie.200803315; Christian DA, 2009, NAT MATER, V8, P843, DOI [10.1038/NMAT2512, 10.1038/nmat2512]; Cui HG, 2007, SCIENCE, V317, P647, DOI 10.1126/science.1141768; Du ZX, 2007, MACROMOLECULES, V40, P7633, DOI 10.1021/ma070977p; Dupont J, 2010, SOFT MATTER, V6, P3654, DOI 10.1039/c0sm00044b; Gadt T, 2009, NAT MATER, V8, P144, DOI [10.1038/NMAT2356, 10.1038/nmat2356]; Gilroy JB, 2010, NAT CHEM, V2, P566, DOI [10.1038/NCHEM.664, 10.1038/nchem.664]; Glotzer SC, 2007, NAT MATER, V6, P557, DOI 10.1038/nmat1949; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; Jain S, 2003, SCIENCE, V300, P460, DOI 10.1126/science.1082193; Lazzari M, 2008, MACROMOL RAPID COMM, V29, P352, DOI 10.1002/marc.200700818; Lee E, 2011, J AM CHEM SOC, V133, P10390, DOI 10.1021/ja2038547; Li ZB, 2004, SCIENCE, V306, P98, DOI 10.1126/science.1103350; O'Reilly RK, 2006, CHEM SOC REV, V35, P1068, DOI 10.1039/b514858h; Park S, 2004, SCIENCE, V303, P348, DOI 10.1126/science.1093276; Patra SK, 2011, J AM CHEM SOC, V133, P8842, DOI 10.1021/ja202408w; Petzetakis N, 2011, CHEM SCI, V2, P955, DOI 10.1039/c0sc00596g; Pochan DJ, 2011, SOFT MATTER, V7, P2500, DOI 10.1039/c0sm00960a; Qian JS, 2011, ANGEW CHEM INT EDIT, V50, P1622, DOI 10.1002/anie.201006223; Rupar PA, 2011, J AM CHEM SOC, V133, P16947, DOI 10.1021/ja206370k; Schmelz J, 2011, ACS NANO, V5, P9523, DOI 10.1021/nn202638t; Voets IK, 2006, ANGEW CHEM INT EDIT, V45, P6673, DOI 10.1002/anie.200601000; Walther A, 2008, SOFT MATTER, V4, P663, DOI 10.1039/b718131k; Walther A, 2007, J AM CHEM SOC, V129, P6187, DOI 10.1021/ja068153v; Walther A, 2009, J AM CHEM SOC, V131, P4720, DOI 10.1021/ja808614q; Walther A, 2009, SOFT MATTER, V5, P385, DOI 10.1039/b812321g; Wang H, 2007, MACROMOLECULES, V40, P3784, DOI 10.1021/ma062728r; Wang XS, 2007, SCIENCE, V317, P644, DOI 10.1126/science.1141382; Wang XS, 2007, J AM CHEM SOC, V129, P5630, DOI 10.1021/ja068730f; Xia Y, 2009, J AM CHEM SOC, V131, P18525, DOI 10.1021/ja908379q; ZHANG LF, 1995, SCIENCE, V268, P1728, DOI 10.1126/science.268.5218.1728; Zhang W, 2011, SCIENCE, V334, P340, DOI 10.1126/science.1210369	33	301	301	8	499	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 3	2012	337	6094					559	562		10.1126/science.1221206	http://dx.doi.org/10.1126/science.1221206			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982PU	22859484				2022-12-24	WOS:000307058700039
J	Moore, M				Moore, Mike			Looking for a good night's sleep	LANCET			English	Editorial Material							CHRONIC INSOMNIA; THERAPY; TRIAL		Pacific NW Univ Hlth Sci, Dept Clin Sci, Washington, WA 98901 USA		Moore, M (corresponding author), Pacific NW Univ Hlth Sci, Dept Clin Sci, Washington, WA 98901 USA.	mmoore@pnwu.edu						Espie CA, 2007, SLEEP, V30, P574, DOI 10.1093/sleep/30.5.574; Espie CA, 2012, SLEEP, V35, P769, DOI 10.5665/sleep.1872; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Perlis ML, 2008, J CLIN SLEEP MED, V4, P11; Riemann D, 2009, SLEEP MED REV, V13, P205, DOI 10.1016/j.smrv.2008.06.001; Rosekind MR, 2010, AM J MANAG CARE, V16, P617; Wilson SJ, 2010, J PSYCHOPHARMACOL, V24, P1577, DOI 10.1177/0269881110379307	7	6	8	1	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 28	2012	380	9839					322	323		10.1016/S0140-6736(12)61220-3	http://dx.doi.org/10.1016/S0140-6736(12)61220-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	979TN	22841325				2022-12-24	WOS:000306842800011
J	Venditti, R; Scanu, T; Santoro, M; Di Tullio, G; Spaar, A; Gaibisso, R; Beznoussenko, GV; Mironov, AA; Mironov, A; Zelante, L; Piemontese, MR; Notarangelo, A; Malhotra, V; Vertel, BM; Wilson, C; De Matteis, MA				Venditti, Rossella; Scanu, Tiziana; Santoro, Michele; Di Tullio, Giuseppe; Spaar, Alexander; Gaibisso, Renato; Beznoussenko, Galina V.; Mironov, Alexander A.; Mironov, Alexander, Jr.; Zelante, Leopoldo; Piemontese, Maria Rosaria; Notarangelo, Angelo; Malhotra, Vivek; Vertel, Barbara M.; Wilson, Cathal; De Matteis, Maria Antonietta			Sedlin Controls the ER Export of Procollagen by Regulating the Sar1 Cycle	SCIENCE			English	Article							SPONDYLOEPIPHYSEAL DYSPLASIA-TARDA; COPII; PROTEIN; MUTATION; COL2A1; SEC23; COAT	Newly synthesized proteins exit the endoplasmic reticulum (ER) via coat protein complex II (COPII) vesicles. Procollagen (PC), however, forms prefibrils that are too large to fit into typical COPII vesicles; PC thus needs large transport carriers, which we term megacarriers. TANGO1 assists PC packing, but its role in promoting the growth of megacarriers is not known. We found that TANGO1 recruited Sedlin, a TRAPP component that is defective in spondyloepiphyseal dysplasia tarda (SEDT), and that Sedlin was required for the ER export of PC. Sedlin bound and promoted efficient cycling of Sar1, a guanosine triphosphatase that can constrict membranes, and thus allowed nascent carriers to grow and incorporate PC prefibrils. This joint action of TANGO1 and Sedlin sustained the ER export of PC, and its derangement may explain the defective chondrogenesis underlying SEDT.	[Venditti, Rossella; Santoro, Michele; Wilson, Cathal; De Matteis, Maria Antonietta] Telethon Inst Genet & Med, I-80131 Naples, Italy; [Scanu, Tiziana; Di Tullio, Giuseppe; Spaar, Alexander; Gaibisso, Renato; Beznoussenko, Galina V.; Mironov, Alexander A.; Mironov, Alexander, Jr.] Consorzio Mario Negri Sud, I-66030 Chieti, Italy; [Zelante, Leopoldo; Piemontese, Maria Rosaria; Notarangelo, Angelo] IRCCS Casa Sollievo Sofferenza, Med Genet Unit, I-71013 Foggia, Italy; [Malhotra, Vivek] Ctr Regulacio Genom, Dept Cell & Dev Biol, Barcelona 08010, Spain; [Malhotra, Vivek] Pg Lluis Co 23, Inst Catalana Recerca Estudis Avancats, Barcelona 08010, Spain; [Vertel, Barbara M.] Rosalind Franklin Univ Med & Sci, Dept Cell Biol & Anat, N Chicago, IL 60064 USA	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Consorzio Mario Negri Sud; IRCCS Casa Sollievo Della Sofferenza; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); ICREA; Rosalind Franklin University Medical & Science	De Matteis, MA (corresponding author), Telethon Inst Genet & Med, Via Pietro Castellino 111, I-80131 Naples, Italy.	dematteis@tigem.it	Venditti, Rossella/AAT-4281-2020; Malhotra, Vivek/O-9811-2014; De Matteis, Maria Antonietta/AHE-5161-2022	Venditti, Rossella/0000-0002-1884-6501; Malhotra, Vivek/0000-0001-6198-7943; De Matteis, Maria Antonietta/0000-0003-0053-3061; Notarangelo, Angelantonio/0000-0002-1540-8530; Mironov, Aleksandr/0000-0002-1497-328X; Wilson, Cathal/0000-0002-0637-8608	Telethon EM Core Facility [GTF08001]; Telethon [GSP08002, GGP06166]; AIRC [IG 8623]; Programma Operativo Nazionale [01_00862]; Telethon grant [GGP07075]; NIH [NIH/AR053696]; Plan Nacional [BFU2008-00414]; Consolider [CSD2009-00016]; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) Grups de Recerca Emergents; AGAUR-Catalan Government [SGR2009-1488]; European Research Council [268692]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR053696] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	Telethon EM Core Facility(Fondazione Telethon); Telethon(Fondazione Telethon); AIRC(Fondazione AIRC per la ricerca sul cancro); Programma Operativo Nazionale; Telethon grant(Fondazione Telethon); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Plan Nacional; Consolider(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) Grups de Recerca Emergents; AGAUR-Catalan Government; European Research Council(European Research Council (ERC)European Commission); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); ICREA(ICREA)	We thank A. Luini, G. D'Angelo, B. Franco, and G. Manco for insightful discussions; the Telethon EM Core Facility (project no. GTF08001) for the EM analysis; J. Gecz for the Sedlin cDNAs; R. Schekman for the Sar1A cDNA; W. Balch for the Sar1B and Sec23 cDNAs; and J. Kimura for the use of Rx chondrocytes. Supported by Telethon grants GSP08002 and GGP06166, AIRC grant IG 8623, and Programma Operativo Nazionale grant 01_00862 (M. A. D. M.), Telethon grant GGP07075 (C. W.), NIH grant NIH/AR053696 (B. M. V.), and grants from Plan Nacional (BFU2008-00414), Consolider (CSD2009-00016), Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) Grups de Recerca Emergents (SGR2009-1488; AGAUR-Catalan Government), the European Research Council (268692). (V. M.), and an AIRC fellowship (R.V.).	Bacia K, 2011, SCI REP-UK, V1, DOI 10.1038/srep00017; Barrowman J, 2010, NAT REV MOL CELL BIO, V11, P759, DOI 10.1038/nrm2999; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; BLEASEL JF, 1995, J RHEUMATOL, V22, P255; Cai HQ, 2007, NATURE, V445, P941, DOI 10.1038/nature05527; Gedeon AK, 1999, NAT GENET, V22, P400, DOI 10.1038/11976; Jang SB, 2002, J BIOL CHEM, V277, P49863, DOI 10.1074/jbc.M207436200; Long KR, 2010, J CELL BIOL, V190, P115, DOI 10.1083/jcb.201004132; Lord C, 2011, NATURE, V473, P181, DOI 10.1038/nature09969; Malhotra V, 2011, EMBO J, V30, P3475, DOI 10.1038/emboj.2011.255; Mironov AA, 2001, J CELL BIOL, V155, P1225, DOI 10.1083/jcb.200108073; Pepperkok R, 1998, J CELL SCI, V111, P1877; Saito K, 2009, CELL, V136, P891, DOI 10.1016/j.cell.2008.12.025; Schlenker O, 2006, J BIOL CHEM, V281, P8898, DOI 10.1074/jbc.M512415200; Scrivens PJ, 2009, TRAFFIC, V10, P724, DOI 10.1111/j.1600-0854.2009.00906.x; Tiller GE, 2001, AM J HUM GENET, V68, P1398, DOI 10.1086/320594; Wilson DG, 2011, J CELL BIOL, V193, P935, DOI 10.1083/jcb.201007162; Zanetti G, 2012, NAT CELL BIOL, V14, P20, DOI 10.1038/ncb2390; Zankl A, 2004, AM J MED GENET A, V129A, P144, DOI 10.1002/ajmg.a.30222	19	121	126	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2012	337	6102					1668	1672		10.1126/science.1224947	http://dx.doi.org/10.1126/science.1224947			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	23019651	Green Accepted			2022-12-24	WOS:000309215400049
J	Wamstad, JA; Alexander, JM; Truty, RM; Shrikumar, A; Li, FG; Eilertson, KE; Ding, HM; Wylie, JN; Pico, AR; Capra, JA; Erwin, G; Kattman, SJ; Keller, GM; Srivastava, D; Levine, SS; Pollard, KS; Holloway, AK; Boyer, LA; Bruneau, BG				Wamstad, Joseph A.; Alexander, Jeffrey M.; Truty, Rebecca M.; Shrikumar, Avanti; Li, Fugen; Eilertson, Kirsten E.; Ding, Huiming; Wylie, John N.; Pico, Alexander R.; Capra, John A.; Erwin, Genevieve; Kattman, Steven J.; Keller, Gordon M.; Srivastava, Deepak; Levine, Stuart S.; Pollard, Katherine S.; Holloway, Alisha K.; Boyer, Laurie A.; Bruneau, Benoit G.			Dynamic and Coordinated Epigenetic Regulation of Developmental Transitions in the Cardiac Lineage	CELL			English	Article							EMBRYONIC STEM-CELLS; HISTONE MODIFICATIONS; NONCODING RNAS; CHROMATIN SIGNATURES; HEART; TRANSCRIPTION; ENHANCERS; DIFFERENTIATION; MOUSE; GATA4	Heart development is exquisitely sensitive to the precise temporal regulation of thousands of genes that govern developmental decisions during differentiation. However, we currently lack a detailed understanding of how chromatin and gene expression patterns are coordinated during developmental transitions in the cardiac lineage. Here, we interrogated the transcriptome and several histone modifications across the genome during defined stages of cardiac differentiation. We find distinct chromatin patterns that are coordinated with stage-specific expression of functionally related genes, including many human disease-associated genes. Moreover, we discover a novel preactivation chromatin pattern at the promoters of genes associated with heart development and cardiac function. We further identify stage-specific distal enhancer elements and find enriched DNA binding motifs within these regions that predict sets of transcription factors that orchestrate cardiac differentiation. Together, these findings form a basis for understanding developmentally regulated chromatin transitions during lineage commitment and the molecular etiology of congenital heart disease.	[Wamstad, Joseph A.; Shrikumar, Avanti; Li, Fugen; Ding, Huiming; Levine, Stuart S.; Boyer, Laurie A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Alexander, Jeffrey M.; Truty, Rebecca M.; Eilertson, Kirsten E.; Wylie, John N.; Pico, Alexander R.; Capra, John A.; Erwin, Genevieve; Srivastava, Deepak; Pollard, Katherine S.; Holloway, Alisha K.; Bruneau, Benoit G.] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Alexander, Jeffrey M.; Srivastava, Deepak; Bruneau, Benoit G.] Univ Calif San Francisco, Program Biomed Sci, San Francisco, CA 94158 USA; [Erwin, Genevieve] Univ Calif San Francisco, Integrat Program Quantitat Biol, San Francisco, CA 94158 USA; [Kattman, Steven J.; Keller, Gordon M.] Univ Hlth Network, McEwen Ctr Regenerat Med, Toronto, ON M5G 1L7, Canada; [Srivastava, Deepak] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Srivastava, Deepak; Bruneau, Benoit G.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94158 USA; [Pollard, Katherine S.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94158 USA; [Pollard, Katherine S.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94158 USA; [Bruneau, Benoit G.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA	Massachusetts Institute of Technology (MIT); University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Boyer, LA (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	lboyer@mit.edu; bbruneau@gladstone.ucsf.edu	Pico, Alexander/HCH-4305-2022; Alexander, Jeffrey/D-8809-2015; Holloway, Alisha/H-9574-2013; Capra, Tony/C-7784-2013	Alexander, Jeffrey/0000-0002-2258-5738; Holloway, Alisha/0000-0001-9810-389X; Keller, Gordon/0000-0001-9309-9297; Bruneau, Benoit/0000-0002-0804-7597; Eilertson, Kirsten/0000-0003-4850-1210; Pico, Alexander/0000-0001-5706-2163; Levine, Stuart/0000-0001-7363-562X	NHLBI Bench to Bassinet Program [U01HL098179]; NIH [F32-HL104913]; Lawrence J. and Florence A. DeGeorge Charitable Trust/American Heart Association; Massachusetts Life Sciences Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL104913, U01HL098179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067547] Funding Source: NIH RePORTER	NHLBI Bench to Bassinet Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lawrence J. and Florence A. DeGeorge Charitable Trust/American Heart Association(American Heart Association); Massachusetts Life Sciences Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Sukonnik for cloning enhancer fragments; S. Thomas (Gladstone Bioinformatics Core) for help with Figure 3; J. Wythe and P. Devine for the modified pGL3 constructs; M. Cleary, E.N. Olson, and D. Wotton for constructs; and Bruneau, Boyer, and Pollard lab members for helpful discussions. This work was supported by the NHLBI Bench to Bassinet Program (U01HL098179, to B.G.B., L.A.B., K.S.P., and D.S.), NIH F32-HL104913 (J.A.W.), the Lawrence J. and Florence A. DeGeorge Charitable Trust/American Heart Association Established Investigator Award (B.G.B.), by William H. Younger, Jr. (B.G.B.) and Massachusetts Life Sciences Center (L.A.B.). L.A.B. is a Pew Scholar in the Biomedical Sciences. D. S. is a scientific founder of iPierian, and member of the Scientific Advisory Boards of iPieirian and RegeneRx Biopharmaceuticals.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; Bruneau BG, 2008, NATURE, V451, P943, DOI 10.1038/nature06801; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Chang CP, 2012, ANNU REV PHYSIOL, V74, P41, DOI 10.1146/annurev-physiol-020911-153242; Creemers EE, 2006, DEVELOPMENT, V133, P4245, DOI 10.1242/dev.02610; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Davidson EH, 2010, NATURE, V468, P911, DOI 10.1038/nature09645; Delgado-Olguin P, 2012, NAT GENET, V44, P343, DOI 10.1038/ng.1068; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Evans SM, 2010, CIRC RES, V107, P1428, DOI 10.1161/CIRCRESAHA.110.227405; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; He AB, 2012, CIRC RES, V110, P406, DOI 10.1161/CIRCRESAHA.111.252205; He AB, 2011, P NATL ACAD SCI USA, V108, P5632, DOI 10.1073/pnas.1016959108; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hsiao EC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002532; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; May D, 2012, NAT GENET, V44, P89, DOI 10.1038/ng.1006; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miller SA, 2008, GENE DEV, V22, P2980, DOI 10.1101/gad.1689708; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Nimura K, 2009, NATURE, V460, P287, DOI 10.1038/nature08086; Nix DA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-523; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pauli A, 2011, NAT REV GENET, V12, P136, DOI 10.1038/nrg2904; Pfeufer A, 2010, NAT GENET, V42, P153, DOI 10.1038/ng.517; Pollard KS., 2005, BIOINFORMATICS COMPU, P251; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Stankunas K, 2008, CIRC RES, V103, P702, DOI 10.1161/CIRCRESAHA.108.175489; Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039; Verzi MP, 2010, DEV CELL, V19, P713, DOI 10.1016/j.devcel.2010.10.006; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111; Zhang JLA, 2012, CELL, V149, P467, DOI 10.1016/j.cell.2012.01.056; Zhao R, 2008, DEV BIOL, V317, P614, DOI 10.1016/j.ydbio.2008.03.013; Zhou PZ, 2012, CURR TOP DEV BIOL, V100, P143, DOI 10.1016/B978-0-12-387786-4.00005-1; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	52	438	447	1	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 28	2012	151	1					206	220		10.1016/j.cell.2012.07.035	http://dx.doi.org/10.1016/j.cell.2012.07.035			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	22981692	Green Accepted, Green Submitted, Bronze			2022-12-24	WOS:000309544200021
J	Randall, DW; Fickling, WE				Randall, David W.; Fickling, William E.			PICTURE QUIZ A swollen leg in the middle of the night	BRITISH MEDICAL JOURNAL			English	Editorial Material							GAS-GANGRENE; INFECTIONS		[Randall, David W.; Fickling, William E.] Queens Univ Hosp, Romford RM7 0AG, Essex, England		Randall, DW (corresponding author), Queens Univ Hosp, Romford RM7 0AG, Essex, England.	drandall@uclh.nhs.uk						Gibson Michael A, 2008, Cases J, V1, P300, DOI 10.1186/1757-1626-1-300; Jackisch T, 2006, ZBL CHIR, V131, P84, DOI 10.1055/s-2006-921399; Jamieson NF, 2001, POSTGRAD MED J, V77, P47, DOI 10.1136/pmj.77.903.47; MEYER RD, 1976, SOUTHERN MED J, V69, P1178, DOI 10.1097/00007611-197609000-00025; Schneeweiss S, 2009, ALIMENT PHARM THER, V30, P253, DOI 10.1111/j.1365-2036.2009.04037.x	5	0	0	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 25	2012	345								e6189	10.1136/bmj.e6189	http://dx.doi.org/10.1136/bmj.e6189			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	014ON	23014902				2022-12-24	WOS:000309385500005
J	LeBlanc, PM; Hollinger, KA; Klontz, KC				LeBlanc, Pamela M.; Hollinger, Katherine A.; Klontz, Karl C.			Tattoo Ink-Related Infections - Awareness, Diagnosis, Reporting, and Prevention	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[LeBlanc, Pamela M.; Hollinger, Katherine A.; Klontz, Karl C.] US FDA, Ctr Food Safety & Appl Nutr, College Pk, MD USA	US Food & Drug Administration (FDA)	LeBlanc, PM (corresponding author), US FDA, Ctr Food Safety & Appl Nutr, College Pk, MD USA.							[Anonymous], 2012, ONE 5 US ADULTS NOW; Armstrong ML, 2005, J ENVIRON HEALTH, V67, P38; Drage LA, 2010, J AM ACAD DERMATOL, V62, P501, DOI 10.1016/j.jaad.2009.03.034; Food and Drug Administration, 2010, COSM TATT PERM MAK; Food and Drug Administration, 2012, REP SER PROBL FDA	5	35	35	1	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2012	367	11					985	987		10.1056/NEJMp1206063	http://dx.doi.org/10.1056/NEJMp1206063			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	003ZE	22913662	Bronze			2022-12-24	WOS:000308649100003
J	Liu, XP; Betzenhauser, MJ; Reiken, S; Meli, AC; Xie, WJ; Chen, BX; Arancio, O; Marks, AR				Liu, Xiaoping; Betzenhauser, Matthew J.; Reiken, Steve; Meli, Albano C.; Xie, Wenjun; Chen, Bi-Xing; Arancio, Ottavio; Marks, Andrew R.			Role of Leaky Neuronal Ryanodine Receptors in Stress-Induced Cognitive Dysfunction	CELL			English	Article							INTRACELLULAR CALCIUM LEAK; SKELETAL-MUSCLE; HEART-FAILURE; PKA PHOSPHORYLATION; REPEATED IMMOBILIZATION; NUCLEAR TRANSLOCATION; TYROSINE-HYDROXYLASE; DEFECTIVE REGULATION; SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE	The type 2 ryanodine receptor/calcium release channel (RyR2), required for excitation-contraction coupling in the heart, is abundant in the brain. Chronic stress induces catecholamine biosynthesis and release, stimulating beta-adrenergic receptors and activating cAMP signaling pathways in neurons. In a murine chronic restraint stress model, neuronal RyR2 were phosphorylated by protein kinase A (PKA), oxidized, and nitrosylated, resulting in depletion of the stabilizing subunit calstabin2 (FKBP12.6) from the channel complex and intracellular calcium leak. Stress-induced cognitive dysfunction, including deficits in learning and memory, and reduced long-term potentiation (LTP) at the hippocampal CA3-CA1 connection were rescued by oral administration of S107, a compound developed in our laboratory that stabilizes RyR2-calstabin2 interaction, or by genetic ablation of the RyR2 PKA phosphorylation site at serine 2808. Thus, neuronal RyR2 remodeling contributes to stress-induced cognitive dysfunction. Leaky RyR2 could be a therapeutic target for treatment of stress-induced cognitive dysfunction.	[Liu, Xiaoping; Betzenhauser, Matthew J.; Reiken, Steve; Meli, Albano C.; Xie, Wenjun; Chen, Bi-Xing; Marks, Andrew R.] Columbia Univ Coll Phys & Surg, Clyde & Helen Wu Ctr Mol Cardiol, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Arancio, Ottavio] Columbia Univ Coll Phys & Surg, Dept Pathol & Cell Biol, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA	Columbia University; Columbia University	Marks, AR (corresponding author), Columbia Univ Coll Phys & Surg, Clyde & Helen Wu Ctr Mol Cardiol, Dept Physiol & Cellular Biophys, 630 W 168th St, New York, NY 10032 USA.	arm42@columbia.edu	Xie, Wenjun/O-4637-2019; arancio, ottavio/AAB-7959-2019; Xie, Wenjun/G-3869-2015; Xie, Wenjun/AAD-6881-2021; Meli, Albano C./O-7647-2018	Xie, Wenjun/0000-0003-0493-062X; Xie, Wenjun/0000-0003-0493-062X; Xie, Wenjun/0000-0003-0493-062X; Meli, Albano C./0000-0002-1727-3027; arancio, ottavio/0000-0001-6335-164X	 [RO1-HL56180];  [RO1-NS049442]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061503, R01HL056180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049442] Funding Source: NIH RePORTER	; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Drs. Steven Siegelbaum and Michael Shelanski for helpful comments and Shi-Xian Deng for synthesis of S107. This work was supported by RO1-HL56180 and RO1-NS049442. A.R.M. is a consultant for a startup company, ARMGO Pharma, Inc., which is targeting RyR channels for therapeutic purposes.	AGUILERA G, 1994, FRONT NEUROENDOCRIN, V15, P321, DOI 10.1006/frne.1994.1013; Airan RD, 2007, SCIENCE, V317, P819, DOI 10.1126/science.1144400; Andersson DC, 2011, CELL METAB, V14, P196, DOI 10.1016/j.cmet.2011.05.014; Bellinger AM, 2008, P NATL ACAD SCI USA, V105, P2198, DOI 10.1073/pnas.0711074105; Bellinger AM, 2008, J CLIN INVEST, V118, P445, DOI 10.1172/JCI34006; Bellinger AM, 2009, NAT MED, V15, P325, DOI 10.1038/nm.1916; Berridge MJ, 2010, PFLUG ARCH EUR J PHY, V459, P441, DOI 10.1007/s00424-009-0736-1; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Bickler PE, 2009, NEUROSCIENCE, V160, P51, DOI 10.1016/j.neuroscience.2009.02.013; Brennan AR, 2008, LEARN MEMORY, V15, P93, DOI 10.1101/lm.767408; Carrasco GA, 2003, EUR J PHARMACOL, V463, P235, DOI 10.1016/S0014-2999(03)01285-8; Cavallaro S, 1997, P NATL ACAD SCI USA, V94, P9669, DOI 10.1073/pnas.94.18.9669; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; COLQUHOUN D, 1982, PHILOS T ROY SOC B, V300, P1, DOI 10.1098/rstb.1982.0156; Copeland BJ, 2005, SYNAPSE, V57, P167, DOI 10.1002/syn.20169; Copello JA, 2001, CELL CALCIUM, V30, P269, DOI 10.1054/ceca.2001.0235; Denny CA, 2012, HIPPOCAMPUS, V22, P1188, DOI 10.1002/hipo.20964; Deshpande LS, 2008, NEUROSCI LETT, V441, P115, DOI 10.1016/j.neulet.2008.05.113; Etgen T, 2009, FORTSCHR NEUROL PSYC, V77, P72, DOI 10.1055/s-0028-1109116; Fitzjohn SM, 2002, CELL CALCIUM, V32, P405, DOI 10.1016/S0143416002001999; Fukui Y, 1997, J NEUROIMMUNOL, V79, P211, DOI 10.1016/S0165-5728(97)00126-4; Galeotti N, 2008, LEARN MEMORY, V15, P315, DOI 10.1101/lm.929008; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; GIANNINI G, 1995, J CELL BIOL, V128, P893, DOI 10.1083/jcb.128.5.893; Hall CS, 1934, J COMP PSYCHOL, V18, P385, DOI 10.1037/h0071444; HARTLEY DM, 1993, J NEUROSCI, V13, P1993; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; JAYARAMAN T, 1992, J BIOL CHEM, V267, P9474; KEEFE KA, 1989, ARCH NEUROL-CHICAGO, V46, P1070, DOI 10.1001/archneur.1989.00520460046012; KHACHATURIAN ZS, 1994, ANN NY ACAD SCI, V747, P1; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Lehnart SE, 2004, ANN NY ACAD SCI, V1015, P144, DOI 10.1196/annals.1302.012; Lehnart SE, 2008, J CLIN INVEST, V118, P2230, DOI 10.1172/JCI35346; Lehnart SE, 2006, P NATL ACAD SCI USA, V103, P7906, DOI 10.1073/pnas.0602133103; Liu XP, 2008, ANN NY ACAD SCI, V1148, P1, DOI 10.1196/annals.1410.082; Liu XP, 2005, MOL BRAIN RES, V141, P19, DOI 10.1016/j.molbrainres.2005.07.019; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Mattson MP, 2007, AGING CELL, V6, P337, DOI 10.1111/j.1474-9726.2007.00275.x; McEwen BS, 2008, EUR J PHARMACOL, V583, P174, DOI 10.1016/j.ejphar.2007.11.071; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; McEwen BS, 2004, ANN NY ACAD SCI, V1032, P1, DOI 10.1196/annals.1314.001; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; MCMAHON A, 1992, J NEUROCHEM, V58, P2124, DOI 10.1111/j.1471-4159.1992.tb10954.x; Miller MM, 2006, ANN NY ACAD SCI, V1071, P294, DOI 10.1196/annals.1364.023; Mirescu C, 2006, HIPPOCAMPUS, V16, P233, DOI 10.1002/hipo.20155; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Patel S, 2004, ENDOCRINOLOGY, V145, P5431, DOI 10.1210/en.2004-0638; Patterson SL, 2001, NEURON, V32, P123, DOI 10.1016/S0896-6273(01)00443-3; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Perrotti LI, 2004, J NEUROSCI, V24, P10594, DOI 10.1523/JNEUROSCI.2542-04.2004; Reiken S, 2003, J CELL BIOL, V160, P919, DOI 10.1083/jcb.200211012; Reiken S, 2003, J BIOL CHEM, V278, P444, DOI 10.1074/jbc.M207028200; Sabban EL, 2004, ANN NY ACAD SCI, V1032, P130, DOI 10.1196/annals.1314.010; SCHENK F, 1985, EXP BRAIN RES, V58, P11; Shan J, 2010, J CLIN INVEST, V120, P4375, DOI 10.1172/JCI37649; Shan J, 2010, J CLIN INVEST, V120, P4388, DOI 10.1172/JCI32726; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Sherin Jonathan E, 2011, Dialogues Clin Neurosci, V13, P263; Son H, 1998, LEARN MEMORY, V5, P231; Southwick SM, 1999, BIOL PSYCHIAT, V46, P1192, DOI 10.1016/S0006-3223(99)00219-X; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; TSUDA A, 1985, BEHAV NEUROSCI, V99, P802; Ward CW, 2003, FASEB J, V17, P1517, DOI 10.1096/fj.02-1083fje; Wehrens XHT, 2006, P NATL ACAD SCI USA, V103, P511, DOI 10.1073/pnas.0510113103; Wehrens XHT, 2005, P NATL ACAD SCI USA, V102, P9607, DOI 10.1073/pnas.0500353102; Wehrens XHT, 2004, SCIENCE, V304, P292, DOI 10.1126/science.1094301; Yano M, 2003, CIRCULATION, V107, P477, DOI 10.1161/01.CIR.0000044917.74408.BE; Yehuda R, 1998, AM J PSYCHIAT, V155, P841; ZIGMOND RE, 1989, ANNU REV NEUROSCI, V12, P415, DOI 10.1146/annurev.ne.12.030189.002215	71	102	106	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 31	2012	150	5					1055	1067		10.1016/j.cell.2012.06.052	http://dx.doi.org/10.1016/j.cell.2012.06.052			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22939628	Green Accepted, Bronze			2022-12-24	WOS:000308500200018
J	Marquez, PV; Farrington, JL				Marquez, Patricio V.; Farrington, Jill L.			No more disease silos for sub-Saharan Africa	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SOUTH EAST-ASIA; NONCOMMUNICABLE DISEASES; SCALE-UP; CARE; PARTNERSHIP; PREGNANCY; LESSONS; RECORDS		[Marquez, Patricio V.] World Bank, Washington, DC 20433 USA; [Farrington, Jill L.] Nuffield Ctr Int Hlth & Dev, Leeds, W Yorkshire, England	The World Bank; University of Leeds	Marquez, PV (corresponding author), World Bank, 1818 H St NW, Washington, DC 20433 USA.	pmarquez@worldbank.org						Agyei-Mensah S, 2010, J URBAN HEALTH, V87, P879, DOI 10.1007/s11524-010-9492-y; Alamo ST, 2012, AIDS BEHAV, V16, P368, DOI 10.1007/s10461-011-9996-9; Allain TJ, 2011, TROP MED INT HEALTH, V16, P1077, DOI 10.1111/j.1365-3156.2011.02808.x; Arnuna P, 2008, P NUTR SOC, V67, P82, DOI 10.1017/S0029665108006058; Baingana FK, 2006, DISEASE AND MORTALITY IN SUB-SAHARAN AFRICA, 2ND EDITION, P1; Bischoff A, 2009, INT J ENV RES PUB HE, V6, P2258, DOI 10.3390/ijerph6082258; Braitstein P, 2009, JAIDS-J ACQ IMM DEF, V52, pS54, DOI 10.1097/QAI.0b013e3181bbcb67; Callaghan M, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-8; Chisholm D, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e586; Delisle H, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-S2-S10; Dybul M, 2012, POLICY REV, V174; Gangopadhyay R, 2011, INT J GYNECOL OBSTET, V115, pS11, DOI 10.1016/S0020-7292(11)60005-2; GAVI Alliance, 2012, HUM PAP VACC SUPP; Ginsberg GM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e614; Grepin KA, 2011, JAIDS-J ACQ IMM DEF, V57, pS77, DOI 10.1097/QAI.0b013e31821f6afa; Haazen D, 2012, MAKING HEALTH FINANCING WORK FOR POOR PEOPLE IN TANZANIA, P1, DOI 10.1596/978-0-8213-9473-1; Harding R, 2005, LANCET, V365, P1971, DOI 10.1016/S0140-6736(05)66666-4; Isenhower W, 2011, CHRON CAR DES M TRAN; KOBER K, 2006, EXPERT PATIENTS AIDS; Levitt NS, 2011, AM J CLIN NUTR, V94, p1690S, DOI 10.3945/ajcn.111.019075; Magnussen EB, 2009, OBSTET GYNECOL, V114, P961, DOI 10.1097/AOG.0b013e3181bb0dfc; Mbewu A, 2006, DISEASE AND MORTALITY IN SUB-SAHARAN AFRICA, 2ND EDITION, P305; Narayan KMV, 2011, NEW ENGL J MED, V365, P876, DOI 10.1056/NEJMp1107189; Nolte E, 2008, CARING PEOPLE CHRONI; Rabkin M, 2011, GLOB PUBLIC HEALTH, V6, P247, DOI 10.1080/17441692.2011.552068; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; Schneider M, 2009, SCAND J PUBLIC HEALT, V37, P176, DOI 10.1177/1403494808100272; Starfield B, 1988, PRIMARY CARE BALANCI; Steyn K, 2006, DISEASE AND MORTALITY IN SUB-SAHARAN AFRICA, 2ND EDITION, P247; Sunley EM, 2009, TAXATION CIGARETTES; Swartz L, 2002, BMJ-BRIT MED J, V325, P914, DOI 10.1136/bmj.325.7370.914; The Joint United Nations Programme on HIV/AIDS (UNAIDS) New York, 2011, CHRON CAR HIV NONC D; Tseng ZH, 2012, J AM COLL CARDIOL, V59, P1891, DOI 10.1016/j.jacc.2012.02.024; Wagner E H, 1998, Eff Clin Pract, V1, P2; WHO, 2011, GLOB STAT REP NONC D; WHO, 2008, PHARMAFORUM 0121; WHO Global Forum for Government Chief Nursing and Midwifery Officers, 2012, FOR STAT STRENGTH RO; World Bank, 2011, AFR FUT WORLD BANKS; World Health Organization, 2008, GLOB BURD DIS 2004 U	39	20	20	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 31	2012	345								e5812	10.1136/bmj.e5812	http://dx.doi.org/10.1136/bmj.e5812			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	036SN	22942189				2022-12-24	WOS:000311050900004
J	Rothballer, A; Kutay, U				Rothballer, Andrea; Kutay, Ulrike			SnapShot: The Nuclear Envelope II	CELL			English	Editorial Material							PORE COMPLEX		[Rothballer, Andrea; Kutay, Ulrike] ETH, Inst Biochem, CH-8093 Zurich, Switzerland	ETH Zurich	Rothballer, A (corresponding author), ETH, Inst Biochem, CH-8093 Zurich, Switzerland.							Brachner A, 2011, BIOCHEM SOC T, V39, P1735, DOI 10.1042/BST20110724; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; Hoelz A, 2011, ANNU REV BIOCHEM, V80, P613, DOI 10.1146/annurev-biochem-060109-151030; Mellad JA, 2011, CURR OPIN CELL BIOL, V23, P47, DOI 10.1016/j.ceb.2010.11.006; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Starr DA, 2010, ANNU REV CELL DEV BI, V26, P421, DOI 10.1146/annurev-cellbio-100109-104037	6	9	9	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 31	2012	150	5					1084	+		10.1016/j.cell.2012.08.003	http://dx.doi.org/10.1016/j.cell.2012.08.003			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22939630	Bronze			2022-12-24	WOS:000308500200021
J	Barone-Adesi, F; Chapman, RS; Silverman, DT; He, XZ; Hu, W; Vermeulen, R; Ning, BF; Fraumeni, JF; Rothman, N; Lan, Q				Barone-Adesi, Francesco; Chapman, Robert S.; Silverman, Debra T.; He, Xinghzhou; Hu, Wei; Vermeulen, Roel; Ning, Bofu; Fraumeni, Joseph F., Jr.; Rothman, Nathaniel; Lan, Qing			Risk of lung cancer associated with domestic use of coal in Xuanwei, China: retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HOUSEHOLD STOVE IMPROVEMENT; INDOOR AIR-POLLUTION; MORTALITY; MUTATIONS; SMOKING	Objective To estimate the risk of lung cancer associated with the use of different types of coal for household cooking and heating. Setting Xuanwei County, Yunnan Province, China. Design Retrospective cohort study (follow-up 1976-96) comparing mortality from lung cancer between lifelong users of "smoky coal" (bituminous) and "smokeless coal" (anthracite). Participants 27 310 individuals using smoky coal and 9962 individuals using smokeless coal during their entire life. Main outcome measures Primary outcomes were absolute and relative risk of death from lung cancer among users of different types of coal. Unadjusted survival analysis was used to estimate the absolute risk of lung cancer, while Cox regression models compared mortality hazards for lung cancer between smoky and smokeless coal users. Results Lung cancer mortality was substantially higher among users of smoky coal than users of smokeless coal. The absolute risks of lung cancer death before 70 years of age for men and women using smoky coal were 18% and 20%, respectively, compared with less than 0.5% among smokeless coal users of both sexes. Lung cancer alone accounted for about 40% of all deaths before age 60 among individuals using smoky coal. Compared with smokeless coal, use of smoky coal was associated with an increased risk of lung cancer death (for men, hazard ratio 36 (95% confidence interval 20 to 65); for women, 99 (37 to 266)). Conclusions In Xuanwei, the domestic use of smoky coal is associated with a substantial increase in the absolute lifetime risk of developing lung cancer and is likely to represent one of the strongest effects of environmental pollution reported for cancer risk. Use of less carcinogenic types of coal could translate to a substantial reduction of lung cancer risk.	[Barone-Adesi, Francesco; Silverman, Debra T.; Hu, Wei; Fraumeni, Joseph F., Jr.; Rothman, Nathaniel; Lan, Qing] NCI, Div Canc Epidemiol & Genet, NIH, DHHS, Bethesda, MD 20892 USA; [Chapman, Robert S.] Chulalongkorn Univ, Coll Publ Hlth Sci, Bangkok 10330, Thailand; [He, Xinghzhou] Chinese Acad Prevent Med, Inst Environm Hlth & Engn, Beijing 100050, Peoples R China; [Vermeulen, Roel] Univ Utrecht, Div Environm Epidemiol, Inst Risk Assessment Sci, NL-3584 CK Utrecht, Netherlands; [Ning, Bofu] Xuanwei Ctr Dis Control, Qujing 655400, Yunnan, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Chulalongkorn University; Chinese Center for Disease Control & Prevention; National Institute of Environmental Health, Chinese Center for Disease Control & Prevention; Utrecht University	Barone-Adesi, F (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, DHHS, 6120 Executive Blv,EPS 8015, Bethesda, MD 20892 USA.	baroneadesif@mail.nih.gov	wei, hu/GXW-2391-2022; Vermeulen, Roel/F-8037-2011; Barone-Adesi, Francesco/ABG-1580-2020	Vermeulen, Roel/0000-0003-4082-8163; Barone-Adesi, Francesco/0000-0003-1550-436X	Chinese Academy of Preventive Medicine, Beijing, China; Yunnan Province Antiepidemic Station, Kunming, China; US Environmental Protection Agency [5D2290NFFX]; Intramural Research Program of the National Cancer Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIACP010121] Funding Source: NIH RePORTER	Chinese Academy of Preventive Medicine, Beijing, China; Yunnan Province Antiepidemic Station, Kunming, China; US Environmental Protection Agency(United States Environmental Protection Agency); Intramural Research Program of the National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was supported by the Chinese Academy of Preventive Medicine, Beijing, China, by the Yunnan Province Antiepidemic Station, Kunming, China, and by contract 5D2290NFFX from the US Environmental Protection Agency. This study was also supported by the Intramural Research Program of the National Cancer Institute, National Institutes of Health. The Xuanwei cohort study has been reviewed by the US Environmental Protection Agency and the National Cancer Institute. The contents do not necessarily reflect the views or policies of these institutions, nor does mention of trade names or commercial products constitute endorsement or recommendation for use. The funding source had no role in design or conduct of the study; collection, management, analysis, or interpretation of the data; preparation, review, or approval of the manuscript.	Chapman RS, 2005, BMJ-BRIT MED J, V331, P1050, DOI 10.1136/bmj.38628.676088.55; Chen J., 2006, MORTALITY BIOCH DIET; Coviello V, 2004, STATA J, V4, P103, DOI 10.1177/1536867X0400400201; Crispo A, 2004, BRIT J CANCER, V91, P1280, DOI 10.1038/sj.bjc.6602078; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Granville CA, 2003, MUTAT RES-FUND MOL M, V525, P77, DOI 10.1016/S0027-5107(02)00314-7; Hosgood HD, 2008, BRIT J CANCER, V99, P1934, DOI 10.1038/sj.bjc.6604744; Hosgood HD, 2011, INT J EPIDEMIOL, V40, P719, DOI 10.1093/ije/dyq259; Hosgood HD, 2010, ENVIRON HEALTH PERSP, V118, P1743, DOI 10.1289/ehp.1002217; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010, IARC Monogr Eval Carcinog Risks Hum, V95, P1; Keohavong P, 2003, LUNG CANCER-J IASLC, V41, P21, DOI 10.1016/S0169-5002(03)00125-9; Lan Q, 2002, J NATL CANCER I, V94, P826, DOI 10.1093/jnci/94.11.826; Lan Q, 2008, INT J CANCER, V123, P2164, DOI 10.1002/ijc.23748; Lee KM, 2010, BRIT J CANCER, V103, P727, DOI 10.1038/sj.bjc.6605791; LUBIN JH, 1990, CANCER RES, V50, P174; MUMFORD JL, 1987, SCIENCE, V235, P217, DOI 10.1126/science.3798109; PEPE MS, 1993, STAT MED, V12, P737, DOI 10.1002/sim.4780120803; Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323; Royston P, 2007, STATA J, V7, P45, DOI 10.1177/1536867X0700700103; Shen M, 2009, ENVIRON HEALTH PERSP, V117, P261, DOI 10.1289/ehp.11521; Smith KR, 2000, THORAX, V55, P518, DOI 10.1136/thorax.55.6.518; TAYLOR PR, 1989, BRIT J IND MED, V46, P881; World Health Organization, 1977, INT CLASS DIS; Zhang JJ, 2007, ENVIRON HEALTH PERSP, V115, P848, DOI 10.1289/ehp.9479	24	97	104	1	41	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 30	2012	345								e5414	10.1136/bmj.e5414	http://dx.doi.org/10.1136/bmj.e5414			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036SM	22936785	Green Submitted, Green Accepted, Green Published, hybrid			2022-12-24	WOS:000311050800002
J	Chen, ZH; Schaap, P				Chen, Zhi-hui; Schaap, Pauline			The prokaryote messenger c-di-GMP triggers stalk cell differentiation in Dictyostelium	NATURE			English	Article							GENE-EXPRESSION; PHYLOGENY; PHOSPHODIESTERASE; EVOLUTION; PATTERN	Cyclic di-(3':5')-guanosine monophosphate (c-di-GMP) is a major prokaryote signalling intermediate that is synthesized by diguanylate cyclases and triggers sessility and biofilm formation(1,2). We detected the first eukaryote diguanylate cyclases in all major groups of Dictyostelia. On food depletion, Dictyostelium discoideum amoebas collect into aggregates, which first transform into migrating slugs and then into sessile fruiting structures(3). These structures consist of a spherical spore mass that is supported by a column of stalk cells and a basal disk. Apolyketide, DIF-1, which induces stalklike cells in vitro, was isolated earlier(4). However, its role in vivo proved recently to be restricted to basal disk formation(5). Here we show that the Dictyostelium diguanylate cyclase, DgcA, produces c-di-GMP as the morphogen responsible for stalk cell differentiation. Dictyostelium discoideum DgcA synthesized c-di-GMP in a GTP-dependent manner and was expressed at the slug tip, which is the site of stalk cell differentiation. Disruption of the DgcA gene blocked the transition from slug migration to fructification and the expression of stalk genes. Fructification and stalk formation were restored by exposing DgcA-null slugs to wild-type secretion products or to c-di-GMP. Moreover, c-di-GMP, but not cyclic di-(3':5')-adenosine monophosphate, induced stalk gene expression in dilute cell monolayers. Apart from identifying the long-elusive stalk-inducing morphogen, our work also identifies a role for c-di-GMP in eukaryotes.	[Chen, Zhi-hui; Schaap, Pauline] Univ Dundee, Coll Life Sci, Dundee DD1 5EH, Scotland	University of Dundee	Schaap, P (corresponding author), Univ Dundee, Coll Life Sci, Dundee DD1 5EH, Scotland.	p.schaap@dundee.ac.uk	Schaap, Pauline/M-5355-2019	Schaap, Pauline/0000-0003-4500-2555	Wellcome Trust [090276]; BBSRC [BB/G020426]; Biotechnology and Biological Sciences Research Council [BB/G020426/1, BB/E016308/1] Funding Source: researchfish; BBSRC [BB/G020426/1, BB/E016308/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank R. R. Kay for alerting us to the presence of a putative diguanylate cyclase in the D. discoideum genome. U. Jenal is gratefully acknowledged for advice and an EAL-PDE construct in an early phase of the project. We are grateful to the late H. MacWilliams for plasmids PspA-ile-gal, EcmA-ile-gal and PstO-ile-gal, and to C.Thompson for dmta<SUP>-</SUP> cells. We thank W. Chen and D. Lamont for mass spectrometry and C. Sugden for guidance with qRT-PCR. We are grateful to H. Urushihara and the A. subglobosum genome project (http://acytodb.biol.tsukuba.ac.jp/cgi-bin/index.cgi?org=as) for the A. subglobosum DgcA sequence. This research was supported by Wellcome Trust Project grant 090276 and BBSRC grant BB/G020426.	Blanton RL, 2000, P NATL ACAD SCI USA, V97, P2391, DOI 10.1073/pnas.040565697; BROOKMAN JJ, 1982, DEV BIOL, V91, P191, DOI 10.1016/0012-1606(82)90022-7; CECCARELLI A, 1991, CELL, V65, P983, DOI 10.1016/0092-8674(91)90550-I; Ceccarelli A, 2000, DIFFERENTIATION, V66, P189, DOI 10.1046/j.1432-0436.2000.660405.x; Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101; DINGERMANN T, 1989, GENE, V85, P353, DOI 10.1016/0378-1119(89)90428-9; EARLY AE, 1988, MOL CELL BIOL, V8, P3458, DOI 10.1128/MCB.8.8.3458; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; HARWOOD AJ, 1990, NUCLEIC ACIDS RES, V18, P4292, DOI 10.1093/nar/18.14.4292; Heidel AJ, 2011, GENOME RES, V21, P1882, DOI 10.1101/gr.121137.111; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; Meima ME, 2002, MOL BIOL CELL, V13, P3870, DOI 10.1091/mbc.E02-05-0285; MORRIS HR, 1987, NATURE, V328, P811, DOI 10.1038/328811a0; Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504; RAPER KENNETH B., 1952, BULL TORREY BOT CLUB, V79, P25, DOI 10.2307/2482103; RICHARDSON DL, 1992, GENE DEV, V6, P1058, DOI 10.1101/gad.6.6.1058; ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0; Saito T, 2008, DEV BIOL, V317, P444, DOI 10.1016/j.ydbio.2008.02.036; SCHAAP P, 1993, J BIOL CHEM, V268, P6323; Schaap P, 2007, BIOESSAYS, V29, P635, DOI 10.1002/bies.20599; Schaap P, 2006, SCIENCE, V314, P661, DOI 10.1126/science.1130670; Shadwick LL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006754; Thompson CRL, 2000, MOL CELL, V6, P1509, DOI 10.1016/S1097-2765(00)00147-7; WANG M, 1988, DEVELOPMENT, V103, P611; Williams JG, 2006, EMBO REP, V7, P694, DOI 10.1038/sj.embor.7400714; WILLIAMS JG, 1987, CELL, V49, P185, DOI 10.1016/0092-8674(87)90559-9	27	76	80	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2012	488	7413					680	683		10.1038/nature11313	http://dx.doi.org/10.1038/nature11313			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996NC	22864416	Green Accepted			2022-12-24	WOS:000308095100061
J	Black, ME				Black, Mary E.			An Olympic legacy for couch potatoes?	BRITISH MEDICAL JOURNAL			English	Editorial Material												drmaryblack@gmail.com							0	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 20	2012	345								e5578	10.1136/bmj.e5578	http://dx.doi.org/10.1136/bmj.e5578			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	996GL	22906869				2022-12-24	WOS:000308072800004
J	Wedzicha, JA; Vestbo, J				Wedzicha, Jadwiga A.; Vestbo, Jorgen			Can patients with COPD self-manage?	LANCET			English	Editorial Material							OBSTRUCTIVE PULMONARY-DISEASE; EXACERBATIONS; IMPACT; CARE		[Wedzicha, Jadwiga A.] UCL, Ctr Resp Med, London NW3 2PF, England; [Vestbo, Jorgen] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Vestbo, Jorgen] Univ So Denmark, Odense, Denmark	University of London; University College London; University of Manchester; University of Southern Denmark	Wedzicha, JA (corresponding author), UCL, Ctr Resp Med, Royal Free Campus, London NW3 2PF, England.	w.wedzicha@ucl.ac.uk	Vestbo, Jorgen/Y-2912-2019	Vestbo, Jorgen/0000-0001-6355-6362				Aaron SD, 2012, THORAX, V67, P238, DOI 10.1136/thoraxjnl-2011-200768; Bischoff EWMA, 2011, THORAX, V66, P26, DOI 10.1136/thx.2009.127621; Bourbeau J, 2003, ARCH INTERN MED, V163, P585, DOI 10.1001/archinte.163.5.585; Bucknall CE, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1060; Fan VS, 2012, ANN INTERN MED, V156, P673, DOI 10.7326/0003-4819-156-10-201205150-00003; Jeppesen E, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003573.pub2; Patel ARC, 2012, CHEST, V141, P851, DOI 10.1378/chest.11-0853; Price LC, 2006, THORAX, V61, P837, DOI 10.1136/thx.2005.049940; Rice KL, 2010, AM J RESP CRIT CARE, V182, P890, DOI 10.1164/rccm.200910-1579OC; Wedzicha JA, 2007, LANCET, V370, P786, DOI 10.1016/S0140-6736(07)61382-8; Wilkinson TMA, 2004, AM J RESP CRIT CARE, V169, P1298, DOI 10.1164/rccm.200310-1443OC	11	13	13	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 18	2012	380	9842					624	625		10.1016/S0140-6736(12)61339-7	http://dx.doi.org/10.1016/S0140-6736(12)61339-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	991SE	22901870				2022-12-24	WOS:000307721000005
J	O'Neill, D				O'Neill, Desmond			To Live (and Die) as an Original	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Trinity Coll Dublin, Ctr Ageing Neurosci & Humanities, Dublin, Ireland	Trinity College Dublin	O'Neill, D (corresponding author), Trinity Coll Dublin, Ctr Ageing Neurosci & Humanities, Dublin, Ireland.	doneill@tcd.ie	O'Neill, Desmond/D-1486-2013	O'Neill, Desmond/0000-0002-5542-9897				Baltes PB, 1990, SUCCESSFUL AGING PER; Ellis G, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6553; Katsushika H, 1988, HOKUSAI 100 VIEWS MT; O'Neill D, 2009, BMJ-BRIT MED J, V339, pb4215; O'Neill D, 2011, LANCET, V377, P1828, DOI 10.1016/S0140-6736(11)60612-0	5	3	3	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2012	308	7					679	680		10.1001/jama.2012.9200	http://dx.doi.org/10.1001/jama.2012.9200			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988NC	22893164				2022-12-24	WOS:000307496700022
J	Morf, J; Rey, G; Schneider, K; Stratmann, M; Fujita, J; Naef, F; Schibler, U				Morf, Joerg; Rey, Guillaume; Schneider, Kim; Stratmann, Markus; Fujita, Jun; Naef, Felix; Schibler, Ueli			Cold-Inducible RNA-Binding Protein Modulates Circadian Gene Expression Posttranscriptionally	SCIENCE			English	Article							BODY-TEMPERATURE; TRANSCRIPTION; CELLS; ENTRAINMENT; INSIGHTS; RHYTHMS; CLOCK	In mammalian tissues, circadian gene expression can be driven by local oscillators or systemic signals controlled by the master pacemaker in the suprachiasmatic nucleus. We show that simulated body temperature cycles, but not peripheral oscillators, controlled the rhythmic expression of cold-inducible RNA-binding protein (CIRP) in cultured fibroblasts. In turn, loss-of-function experiments indicated that CIRP was required for high-amplitude circadian gene expression. The transcriptome-wide identification of CIRP-bound RNAs by a biotin-streptavidin-based cross-linking and immunoprecipitation (CLIP) procedure revealed several transcripts encoding circadian oscillator proteins, including CLOCK. Moreover, CLOCK accumulation was strongly reduced in CIRP-depleted fibroblasts. Because ectopic expression of CLOCK improved circadian gene expression in these cells, we surmise that CIRP confers robustness to circadian oscillators through regulation of CLOCK expression.	[Morf, Joerg; Schneider, Kim; Stratmann, Markus; Schibler, Ueli] Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland; [Morf, Joerg; Schneider, Kim; Stratmann, Markus; Schibler, Ueli] Natl Ctr Competence Res, CH-1211 Geneva, Switzerland; [Rey, Guillaume; Naef, Felix] Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, CH-1015 Lausanne, Switzerland; [Rey, Guillaume; Naef, Felix] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Fujita, Jun] Kyoto Univ, Grad Sch Med, Dept Clin Mol Biol, Sakyo Ku, Kyoto 6058507, Japan	University of Geneva; University of Geneva; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute of Bioinformatics; Kyoto University	Schibler, U (corresponding author), Univ Geneva, Dept Mol Biol, 30 Quai Ernest Ansermet, CH-1211 Geneva, Switzerland.	ueli.schibler@unige.ch	Morf, Jorg/AAH-4825-2020; Rey, Guillaume/F-5303-2012	Morf, Jorg/0000-0002-0485-3380; Rey, Guillaume/0000-0001-7664-7052; Naef, Felix/0000-0001-9786-3037	Swiss National Science Foundation [SNF 31-113565, SNF 31-128656/1]; European Research Council [ERC-2009-AdG 20090506, ERC-2010-StG-260667]; State of Geneva; Louis Jeantet Foundation of Medicine; Smoking Research Foundation of Japan; Swiss National Science Foundation (SNF) [31-130714]; Ecole Polytechnique Federale de Lausanne (EPFL)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission); State of Geneva; Louis Jeantet Foundation of Medicine; Smoking Research Foundation of Japan; Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Ecole Polytechnique Federale de Lausanne (EPFL)	We thank A. Liani and Y.-A. Poget for constructing the bioluminescence recording device; J. Strouboulis (Vari, Greece) for the IRES-BirA vector plasmid (pTRIP-IRES-EGFP-BirA); P. Gos, F. Fleury-Olela, K. Harshman and the Lausanne Genomic Technologies Facility, as well as P. Descombes and the National Center of Competence in Research (NCCR) Genomics Platform, Geneva, for technical help; and N. Roggli for the artwork. The computations were performed at the Vital-IT (www.vital-it.ch) Center for high-performance computing of the SIB Swiss Institute of Bioinformatics. The work in the laboratory of U.S. was supported by the Swiss National Science Foundation (SNF 31-113565, SNF 31-128656/1 and the NCCR program grant Frontiers in Genetics), the European Research Council (ERC-2009-AdG 20090506), the State of Geneva, and the Louis Jeantet Foundation of Medicine. The work in the laboratory of J. F. was supported by the Smoking Research Foundation of Japan. The work in the laboratory of F. N. was supported by the Swiss National Science Foundation (SNF grant 31-130714), the European Research Council (ERC-2010-StG-260667), and the Ecole Polytechnique Federale de Lausanne (EPFL). CLIP-seq and RNA-seq data have been deposited in the Gene Expression Omnibus database (accession no. GSE37685).	Abraham U, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.92; Artero-Castro A, 2009, MOL CELL BIOL, V29, P1855, DOI 10.1128/MCB.01386-08; Brown SA, 2002, CURR BIOL, V12, P1574, DOI 10.1016/S0960-9822(02)01145-4; Brown SA, 2008, P NATL ACAD SCI USA, V105, P1602, DOI 10.1073/pnas.0707772105; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Guo X, 2010, MOL CARCINOGEN, V49, P130, DOI 10.1002/mc.20582; Kornmann B, 2007, COLD SH Q B, V72, P319; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Nishiyama H, 1997, J CELL BIOL, V137, P899, DOI 10.1083/jcb.137.4.899; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rey G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000595; Ripperger JA, 2000, GENE DEV, V14, P679; Saini C, 2012, GENE DEV, V26, P567, DOI 10.1101/gad.183251.111; Saito K, 2010, BRAIN RES, V1358, P20, DOI 10.1016/j.brainres.2010.08.048; Stratmann M, 2006, J BIOL RHYTHM, V21, P494, DOI 10.1177/0748730406293889; Tamaru T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024521; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vitaterna MH, 2006, P NATL ACAD SCI USA, V103, P9327, DOI 10.1073/pnas.0603601103; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545	21	176	184	2	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2012	338	6105					379	383		10.1126/science.1217726	http://dx.doi.org/10.1126/science.1217726			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022JS	22923437				2022-12-24	WOS:000309955800040
J	Dey, A; Seshasayee, D; Noubade, R; French, DM; Liu, JF; Chaurushiya, MS; Kirkpatrick, DS; Pham, VC; Lill, JR; Bakalarski, CE; Wu, JS; Phu, L; Katavolos, P; LaFave, LM; Abdel-Wahab, O; Modrusan, Z; Seshagiri, S; Dong, K; Lin, ZH; Balazs, M; Suriben, R; Newton, K; Hymowitz, S; Garcia-Manero, G; Martin, F; Levine, RL; Dixit, VM				Dey, Anwesha; Seshasayee, Dhaya; Noubade, Rajkumar; French, Dorothy M.; Liu, Jinfeng; Chaurushiya, Mira S.; Kirkpatrick, Donald S.; Pham, Victoria C.; Lill, Jennie R.; Bakalarski, Corey E.; Wu, Jiansheng; Phu, Lilian; Katavolos, Paula; LaFave, Lindsay M.; Abdel-Wahab, Omar; Modrusan, Zora; Seshagiri, Somasekar; Dong, Ken; Lin, Zhonghua; Balazs, Mercedesz; Suriben, Rowena; Newton, Kim; Hymowitz, Sarah; Garcia-Manero, Guillermo; Martin, Flavius; Levine, Ross L.; Dixit, Vishva M.			Loss of the Tumor Suppressor BAP1 Causes Myeloid Transformation	SCIENCE			English	Article							MYELODYSPLASTIC SYNDROMES; UBIQUITIN HYDROLASE; GENE-EXPRESSION; MUTATIONS; MOUSE; PREDISPOSE; LEUKEMIA; ASXL1	De-ubiquitinating enzyme BAP1 is mutated in a hereditary cancer syndrome with increased risk of mesothelioma and uveal melanoma. Somatic BAP1 mutations occur in various malignancies. We show that mouse Bap1 gene deletion is lethal during embryogenesis, but systemic or hematopoietic-restricted deletion in adults recapitulates features of human myelodysplastic syndrome (MDS). Knockin mice expressing BAP1 with a 3xFlag tag revealed that BAP1 interacts with host cell factor-1 (HCF-1), O-linked N-acetylglucosamine transferase (OGT), and the polycomb group proteins ASXL1 and ASXL2 in vivo. OGT and HCF-1 levels were decreased by Bap1 deletion, indicating a critical role for BAP1 in stabilizing these epigenetic regulators. Human ASXL1 is mutated frequently in chronic myelomonocytic leukemia (CMML) so an ASXL/BAP1 complex may suppress CMML. A BAP1 catalytic mutation found in a MDS patient implies that BAP1 loss of function has similar consequences in mice and humans.	[Dey, Anwesha; Chaurushiya, Mira S.; Suriben, Rowena; Newton, Kim; Dixit, Vishva M.] Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA; [Seshasayee, Dhaya; Noubade, Rajkumar; Martin, Flavius] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [French, Dorothy M.] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Liu, Jinfeng; Bakalarski, Corey E.] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Kirkpatrick, Donald S.; Pham, Victoria C.; Lill, Jennie R.; Wu, Jiansheng; Phu, Lilian] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Katavolos, Paula] Genentech Inc, Dept Safety Assessment, San Francisco, CA 94080 USA; [LaFave, Lindsay M.; Abdel-Wahab, Omar; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [LaFave, Lindsay M.; Abdel-Wahab, Omar; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Leukemia Serv, New York, NY 10065 USA; [Modrusan, Zora; Seshagiri, Somasekar] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Dong, Ken; Hymowitz, Sarah] Genentech Inc, Dept Biol Struct, San Francisco, CA 94080 USA; [Lin, Zhonghua; Balazs, Mercedesz] Genentech Inc, Dept Translat Immunol, San Francisco, CA 94080 USA; [Garcia-Manero, Guillermo] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; University of Texas System; UTMD Anderson Cancer Center	Dixit, VM (corresponding author), Genentech Inc, Dept Physiol Chem, 1 DNA Way, San Francisco, CA 94080 USA.	dixit@gene.com	Ferris, Laura/I-7689-2012; levine, ross/AAE-7658-2019; Wu, Jian/AAU-5221-2020; dixit, vishva m/A-4496-2012; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; dixit, vishva m/0000-0001-6983-0326; Wu, Jian/0000-0002-3394-1507; Liu, Jinfeng/0000-0002-0343-8222; Abdel-Wahab, Omar/0000-0002-3907-6171; Kirkpatrick, Donald/0000-0003-3091-2804; Bakalarski, Corey/0000-0003-1085-7828; Seshagiri, Somasekar/0000-0003-4272-6443; Katavolos, Paula/0000-0001-7923-5328	NATIONAL CANCER INSTITUTE [P30CA008748, R01CA173636] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA008748, R01 CA173636] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abdel-Rahman MH, 2011, J MED GENET, V48, P856, DOI 10.1136/jmedgenet-2011-100156; Abdel-Wahab O, 2011, LEUKEMIA, V25, P1200, DOI 10.1038/leu.2011.58; Beachy SH, 2010, HEMATOL ONCOL CLIN N, V24, P361, DOI 10.1016/j.hoc.2010.02.002; Capotosti F, 2011, CELL, V144, P376, DOI 10.1016/j.cell.2010.12.030; Corey SJ, 2007, NAT REV CANCER, V7, P118, DOI 10.1038/nrc2047; Daou S, 2011, P NATL ACAD SCI USA, V108, P2747, DOI 10.1073/pnas.1013822108; Gelsi-Boyer V, 2009, BRIT J HAEMATOL, V145, P788, DOI 10.1111/j.1365-2141.2009.07697.x; Graubert TA, 2012, NAT GENET, V44, P53, DOI 10.1038/ng.1031; Guo GW, 2012, NAT GENET, V44, P17, DOI 10.1038/ng.1014; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Jensen DE, 1999, CANCER LETT, V143, pS13, DOI 10.1016/S0304-3835(99)90004-6; Jensen DE, 1998, ONCOGENE, V16, P1097, DOI 10.1038/sj.onc.1201861; Klinakis A, 2011, NATURE, V473, P230, DOI 10.1038/nature09999; Kobayashi N, 2007, GENE, V396, P236, DOI 10.1016/j.gene.2007.02.032; Kristie TM, 2010, BBA-GENE REGUL MECH, V1799, P257, DOI 10.1016/j.bbagrm.2009.08.003; Kruger M, 2008, CELL, V134, P353, DOI 10.1016/j.cell.2008.05.033; Machida YJ, 2009, J BIOL CHEM, V284, P34179, DOI 10.1074/jbc.M109.046755; Misaghi S, 2009, MOL CELL BIOL, V29, P2181, DOI 10.1128/MCB.01517-08; Pellagatti A, 2004, BRIT J HAEMATOL, V125, P576, DOI 10.1111/j.1365-2141.2004.04958.x; Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966; Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Testa JR, 2011, NAT GENET, V43, P1022, DOI 10.1038/ng.912; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Wiesner T, 2011, NAT GENET, V43, P1018, DOI 10.1038/ng.910	25	290	293	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2012	337	6101					1541	1546		10.1126/science.1221711	http://dx.doi.org/10.1126/science.1221711			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007UC	22878500	Green Accepted			2022-12-24	WOS:000308912900052
J	Smith, R				Smith, Richard			Why a Macroeconomic Perspective Is Critical to the Prevention of Noncommunicable Disease	SCIENCE			English	Editorial Material							PANDEMIC INFLUENZA; HEALTH; EQUILIBRIUM; IMPACT; UK	Effective prevention of noncommunicable diseases will require changes in how we live, and thereby effect important economic changes across populations, sectors, and countries. What we do not know is which populations, sectors, or countries will be positively or negatively affected by such changes, nor by how much. Without this information we cannot know which policies will produce effects that are beneficial both for economies and for health.	Univ London London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London WC1H 9SH, England	University of London; London School of Hygiene & Tropical Medicine	Smith, R (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, 15-17 Tavistock Pl, London WC1H 9SH, England.	richard.smith@lshtm.ac.uk		Smith, Richard/0000-0003-3837-6559				Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Beutels P, 2008, HEALTH ECON, V17, P1317, DOI 10.1002/hec.1339; Bloom DE, 2011, GLOBAL EC BURDEN NON; BLOUIN C, 2009, J GERONTOL B-PSYCHOL, V373, P502, DOI DOI 10.1016/S0140-6736(08)61777-8; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Lock K, 2010, LANCET, V376, P1699, DOI 10.1016/S0140-6736(10)61352-9; Mytton OT, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2931; Pritchett L, 1996, J HUM RESOUR, V31, P841, DOI 10.2307/146149; Ruhm CJ, 2000, Q J ECON, V115, P617, DOI 10.1162/003355300554872; Sachs JD, 2001, MACR HLTH INV HLTH E; Smith JP, 1999, J ECON PERSPECT, V13, P145, DOI 10.1257/jep.13.2.145; Smith R. D., 2011, INTRO HLTH EC, P21; Smith R. D., 2010, J PUBLIC HLTH BANGKO, V32, P2; Smith RD, 2011, SOC SCI MED, V73, P235, DOI 10.1016/j.socscimed.2011.05.025; Smith RD, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4571; Stuckler D, 2009, LANCET, V374, P315, DOI 10.1016/S0140-6736(09)61124-7	18	17	19	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2012	337	6101					1501	1503		10.1126/science.1222569	http://dx.doi.org/10.1126/science.1222569			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	007UC	22997330	Green Published			2022-12-24	WOS:000308912900042
J	Glover, JD; Reganold, JP; Cox, CM				Glover, Jerry D.; Reganold, John P.; Cox, Cindy M.			Plant perennials to save Africa's soils	NATURE			English	Editorial Material							MANAGEMENT; SECURITY; FOOD		[Glover, Jerry D.] USAID Bur Food Secur, Washington, DC 20523 USA; [Reganold, John P.] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA; [Cox, Cindy M.] Int Food Policy Res Inst, Washington, DC 20006 USA	United States Agency for International Development (USAID); Washington State University; CGIAR; International Food Policy Research Institute (IFPRI)	Glover, JD (corresponding author), USAID Bur Food Secur, Washington, DC 20523 USA.	jglover@usaid.gov						Adu-Gyamfi JJ, 2007, PLANT SOIL, V295, P127, DOI 10.1007/s11104-007-9270-0; Bationo A, 2007, AGR SYST, V94, P13, DOI 10.1016/j.agsy.2005.08.011; Betru S, 2010, AFR J AGR RES, V5, P2757; Committee on a Study of Technologies to Benefit Farmers in Africa and South Asia National Research Council, 2008, EM TECHN BEN FARM SU; Eswaran H, 1997, GEODERMA, V77, P1, DOI 10.1016/S0016-7061(97)00007-4; Garrity DP, 2010, FOOD SECUR, V2, P197, DOI 10.1007/s12571-010-0070-7; Glover JD, 2010, SCIENCE, V328, P1638, DOI 10.1126/science.1188761; Hassanali A, 2008, PHILOS T R SOC B, V363, P611, DOI 10.1098/rstb.2007.2173; Henao J., 2006, AGR PRODUCTION SOIL; Snapp SS, 2010, P NATL ACAD SCI USA, V107, P20840, DOI 10.1073/pnas.1007199107	10	64	67	0	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2012	489	7416					359	361		10.1038/489359a	http://dx.doi.org/10.1038/489359a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	007AK	22996532	Bronze			2022-12-24	WOS:000308860900017
J	Gornall, J				Gornall, Jonathan			Proton beam therapy: more than a leap of faith?	BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CLINICAL-TRIAL; NEUTRON TREATMENT; ADVANCED TUMORS; GAMMA-RAYS; NECK; HEAD; CANCER; RADIOTHERAPY; RADIATION					jgornall@mac.com						Agency for Healthcare Research and Quality, 2012, PROT BEAM RAD US MED; [Anonymous], 2012, BMJ; CATTERALL M, 1975, BMJ-BRIT MED J, V2, P653, DOI 10.1136/bmj.2.5972.653; CATTERALL M, 1977, BRIT MED J, V1, P1642, DOI 10.1136/bmj.1.6077.1642; Chung CS, 2008, INT J RADIAT ONCOL, V72, pS8, DOI 10.1016/j.ijrobp.2008.06.785; De Ruysscher D, 2012, RADIOTHER ONCOL, V103, P5, DOI 10.1016/j.radonc.2012.01.003; Department of Health, 2007, CANC REF STRAT; Emanuel E, 2012, NY TIMES        1121; Epstein K, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2488; ERRINGTON RD, 1991, BRIT MED J, V302, P1045, DOI 10.1136/bmj.302.6784.1045; Goitein M, 2008, J CLIN ONCOL, V26, P175, DOI 10.1200/JCO.2007.14.4329; Kunkler IH, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3193; Lundkvist J, 2005, CANCER-AM CANCER SOC, V103, P793, DOI 10.1002/cncr.20844; MACDOUGALL RH, 1990, BRIT MED J, V301, P1241, DOI 10.1136/bmj.301.6763.1241; MAOR MH, 1995, INT J RADIAT ONCOL, V32, P599, DOI 10.1016/0360-3016(94)00595-C; Miralbell R, 2002, INT J RADIAT ONCOL, V54, P824, DOI 10.1016/S0360-3016(02)02982-6; National Radiotherapy Advisory Group, 2007, RAD DEV WORLD CLASS; National Radiotherapy Advisory Group, 2006, PROT TREATM CANC; National Specialised Commissioning Team, 2011, GUID REF PAT ABR NHS; WILSON RR, 1946, RADIOLOGY, V47, P487, DOI 10.1148/47.5.487	20	4	4	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 5	2012	345								e4917	10.1136/bmj.e4917	http://dx.doi.org/10.1136/bmj.e4917			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003TK	22951923				2022-12-24	WOS:000308634000001
J	Vafabakhsh, R; Ha, T				Vafabakhsh, Reza; Ha, Taekjip			Extreme Bendability of DNA Less than 100 Base Pairs Long Revealed by Single-Molecule Cyclization	SCIENCE			English	Article							DOUBLE HELIX; DYNAMICS SIMULATIONS; IN-VIVO; FLEXIBILITY; ELASTICITY; FRAGMENTS; CLOSURE; LOOPS	The classical view of DNA posits that DNA must be stiff below the persistence length [<150 base pairs (bp)], but recent studies addressing this have yielded contradictory results. We developed a fluorescence-based, protein-free assay for studying the cyclization of single DNA molecules in real time. The assay samples the equilibrium population of a sharply bent, transient species that is entirely suppressed in single-molecule mechanical measurements and is biologically more relevant than the annealed species sampled in the traditional ligase-based assay. The looping rate has a weak length dependence between 67 and 106 bp that cannot be described by the worm-like chain model. Many biologically important protein-DNA interactions that involve looping and bending of DNA below 100 bp likely use this intrinsic bendability of DNA.	[Vafabakhsh, Reza; Ha, Taekjip] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Vafabakhsh, Reza; Ha, Taekjip] Univ Illinois, Ctr Phys Living Cells, Urbana, IL 61801 USA; [Ha, Taekjip] Howard Hughes Med Inst, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute	Ha, T (corresponding author), Univ Illinois, Dept Phys, 1110 W Green St, Urbana, IL 61801 USA.	tjha@illinois.edu	Ha, Taekjip/B-9506-2009	Ha, Taekjip/0000-0003-2195-6258	U.S. National Science Foundation [0646550, 0822613]; U.S. National Institutes of Health [GM065367]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065367] Funding Source: NIH RePORTER	U.S. National Science Foundation(National Science Foundation (NSF)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Phillips, H. Garcia, K. Rangunathan, R. Zhou, S. Doganay, A. Jain, K. Lee, G. Lee, and S. Arslan for helpful discussions. We are grateful to the late J. Widom for generous comments on an earlier version of this paper. This work was supported by U.S. National Science Foundation grants 0646550 and 0822613 and U.S. National Institutes of Health grant GM065367 to T. H. T. H. is an employee of the Howard Hughes Medical Institute.	Baumann CG, 1997, P NATL ACAD SCI USA, V94, P6185, DOI 10.1073/pnas.94.12.6185; Becker NA, 2005, J MOL BIOL, V349, P716, DOI 10.1016/j.jmb.2005.04.035; Becker NB, 2009, SCIENCE, V325, DOI 10.1126/science.1168786; Blackwood EM, 1998, SCIENCE, V281, P60, DOI 10.1126/science.281.5373.60; BURKHOFF AM, 1988, NATURE, V331, P455, DOI 10.1038/331455a0; Cisse I, 2007, P NATL ACAD SCI USA, V104, P12646, DOI 10.1073/pnas.0610673104; Cloutier TE, 2005, P NATL ACAD SCI USA, V102, P3645, DOI 10.1073/pnas.0409059102; Curuksu J, 2009, NUCLEIC ACIDS RES, V37, P3766, DOI 10.1093/nar/gkp234; Douarche N, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.061902; Du Q, 2005, P NATL ACAD SCI USA, V102, P5397, DOI 10.1073/pnas.0500983102; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; HAGERMAN PJ, 1988, ANNU REV BIOPHYS BIO, V17, P265; Han L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005621; Lankas F, 2006, STRUCTURE, V14, P1527, DOI 10.1016/j.str.2006.08.004; LEE DH, 1989, P NATL ACAD SCI USA, V86, P476, DOI 10.1073/pnas.86.2.476; Lowary PT, 1997, P NATL ACAD SCI USA, V94, P1183, DOI 10.1073/pnas.94.4.1183; Mastroianni AJ, 2009, BIOPHYS J, V97, P1408, DOI 10.1016/j.bpj.2009.06.031; Mathew-Fenn RS, 2009, SCIENCE, V325, P538, DOI 10.1126/science.1168876; Mathew-Fenn RS, 2008, SCIENCE, V322, P446, DOI 10.1126/science.1158881; Peters JP, 2010, Q REV BIOPHYS, V43, P23, DOI 10.1017/S0033583510000077; PORSCHKE D, 1971, J MOL BIOL, V62, P361, DOI 10.1016/0022-2836(71)90433-5; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; SCHLEIF R, 1992, ANNU REV BIOCHEM, V61, P199, DOI 10.1146/annurev.bi.61.070192.001215; Seol Y, 2007, BIOPHYS J, V93, P4360, DOI 10.1529/biophysj.107.112995; SHIMADA J, 1984, MACROMOLECULES, V17, P689, DOI 10.1021/ma00134a028; SHORE D, 1981, P NATL ACAD SCI-BIOL, V78, P4833, DOI 10.1073/pnas.78.8.4833; Towles KB, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/2/025001; Wiggins PA, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021909; Wiggins PA, 2006, NAT NANOTECHNOL, V1, P137, DOI 10.1038/nnano.2006.63; Wong OK, 2008, PLOS BIOL, V6, P2028, DOI 10.1371/journal.pbio.0060232; Yan J, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.061905; Yan J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.108108; Yuan CL, 2007, NUCLEIC ACIDS RES, V35, P5294, DOI 10.1093/nar/gkm582	34	226	227	1	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2012	337	6098					1097	1101		10.1126/science.1224139	http://dx.doi.org/10.1126/science.1224139			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22936778	Green Accepted			2022-12-24	WOS:000308125800048
J	Alexander, RT; Hemmelgarn, BR; Wiebe, N; Bello, A; Morgan, C; Samuel, S; Klarenbach, SW; Curhan, GC; Tonelli, M				Alexander, R. Todd; Hemmelgarn, Brenda R.; Wiebe, Natasha; Bello, Aminu; Morgan, Catherine; Samuel, Susan; Klarenbach, Scott W.; Curhan, Gary C.; Tonelli, Marcello		Alberta Kidney Dis Network	Kidney stones and kidney function loss: a cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GENETIC-HETEROGENEITY; UNITED-STATES; DISEASE; PREVALENCE; RISK; RECURRENCE	Objective To investigate whether the presence of kidney stones increase the risk of end stage renal disease (ESRD) or other adverse renal outcomes. Design A registry cohort study using validated algorithms based on claims and facility utilisation data. Median follow-up of 11 years. Setting Alberta, Canada, between 1997 and 2009. Participants 3 089 194 adult patients without ESRD at baseline or a history of pyelonephritis. Of these, 1 954 836 had outpatient serum creatinine measurements and were included in analyses of chronic kidney disease and doubling of serum creatinine level. Exposure One or more kidney stones during follow-up. Main outcome measures Incident ESRD, development of stage 3b-5 chronic kidney disease (estimated glomerular filtration rate <45 mL/min/1.73 m(2)), and sustained doubling of serum creatinine concentration from baseline. Results 23 706 (0.8%) patients had at least one kidney stone, 5333 (0.2%) developed ESRD, 68 525 (4%) developed stage 3b-5 chronic kidney disease, and 6581 (0.3%) experienced sustained doubling of serum creatinine. Overall, one or more stone episodes during follow-up was associated with increased risk of ESRD (adjusted hazard ratio 2.16 (95% CI 1.79 to 2.62)), new stage 3b-5 chronic kidney disease (hazard ratio 1.74 (1.61 to 1.88)), and doubling of serum creatinine (hazard ratio 1.94 (1.56 to 2.43)), all compared with those without kidney stones during follow-up. The excess risk of adverse outcomes associated with at least one episode of stones seemed greater in women than in men, and in people aged <50 years than in those aged >= 50. However, the risks of all three adverse outcomes in those with at least one episode of stones were significantly higher than in those without stones in both sexes and age strata. The absolute increase in the rate of adverse renal outcomes associated with stones was small: the unadjusted rate of ESRD was 2.48 per million person days in people with one or more episodes of stones versus 0.52 per million person days in people without stones. Conclusion Even a single kidney stone episode during follow-up was associated with a significant increase in the likelihood of adverse renal outcomes including ESRD. However, the increases were small in absolute terms.	[Alexander, R. Todd; Wiebe, Natasha; Bello, Aminu; Morgan, Catherine; Klarenbach, Scott W.; Tonelli, Marcello] Univ Alberta, Edmonton, AB T6B 2G3, Canada; [Hemmelgarn, Brenda R.; Samuel, Susan] Univ Calgary, Calgary, AB, Canada; [Curhan, Gary C.] Harvard Univ, Channing Lab, Boston, MA 02115 USA	University of Alberta; University of Calgary; Harvard University	Tonelli, M (corresponding author), Univ Alberta, 7-129 Clin Sci Bldg,8440 112 St, Edmonton, AB T6B 2G3, Canada.	mtonelli-admin@med.ualberta.ca	Hemmelgarn, Brenda R./I-6894-2012; Tonelli, Marcello/B-3028-2009; Wiebe, Natasha/V-7803-2019; Klarenbach, Scott/E-7731-2013; Bello, Aminu K/D-2213-2013; Alexander, R. Todd/G-1373-2012	Tonelli, Marcello/0000-0002-0846-3187; Wiebe, Natasha/0000-0002-5613-1582; Klarenbach, Scott/0000-0002-8611-1056; Bello, Aminu K/0000-0002-6905-5937	Alberta Heritage Foundation for Medical Research (AHFMR); Kidney Foundation of Canada; University Hospital Foundation; Canadian Institute of Health Research; KRESCENT New Investigator award; Alberta Innovates Health Solutions Clinical Investigator Award; Canadian Child Health Clinician Scientist Program Career Development award; National Institutes of Health [DK070756]; AHFMR Population Health Scholar award; Government of Canada Research Chair in the optimal care of people with chronic kidney disease; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK070756] Funding Source: NIH RePORTER	Alberta Heritage Foundation for Medical Research (AHFMR)(Alberta Heritage Foundation for Medical Research); Kidney Foundation of Canada; University Hospital Foundation; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); KRESCENT New Investigator award(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions Clinical Investigator Award; Canadian Child Health Clinician Scientist Program Career Development award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHFMR Population Health Scholar award; Government of Canada Research Chair in the optimal care of people with chronic kidney disease; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a team grant to the Interdisciplinary Chronic Disease Collaboration from the Alberta Heritage Foundation for Medical Research (AHFMR), the Kidney Foundation of Canada, and by the University Hospital Foundation. RTA is supported by a Clinician-Scientist award from the Canadian Institute of Health Research, a KRESCENT New Investigator award, and an Alberta Innovates Health Solutions Clinical Investigator Award. SS is supported by a KRESCENT New Investigator award and a Canadian Child Health Clinician Scientist Program Career Development award. GCC is supported by grant DK070756 from the National Institutes of Health. MT is supported by an AHFMR Population Health Scholar award and a Government of Canada Research Chair in the optimal care of people with chronic kidney disease.	Assimos DG, 2002, J UROLOGY, V168, P27, DOI 10.1016/S0022-5347(05)64824-0; Boddana Preetham, 2009, Nephron Clin Pract, V111 Suppl 1, pc269, DOI 10.1159/000210003; Coe FL, 2010, UROL RES, V38, P147, DOI 10.1007/s00240-010-0271-8; Collins AJ, 2010, AM J KIDNEY DIS, V55, pVI, DOI 10.1053/j.ajkd.2009.10.009; Edvardsson V, 2001, AM J KIDNEY DIS, V38, P473, DOI 10.1053/ajkd.2001.26826; Evan AP, 2010, PEDIATR NEPHROL, V25, P831, DOI 10.1007/s00467-009-1116-y; Hemmelgarn BR, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-30; Hippisley-Cox J, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-49; James MT, 2010, LANCET, V376, P2096, DOI 10.1016/S0140-6736(10)61271-8; Jungers P, 2004, AM J KIDNEY DIS, V44, P799, DOI 10.1053/j.ajkd.2004.08.014; Levin A, 2008, CAN MED ASSOC J, V179, P1154, DOI 10.1503/cmaj.080351; Lieske JC, 2005, AM J NEPHROL, V25, P290, DOI 10.1159/000086360; Ludwig M, 2006, NEPHROL DIAL TRANSPL, V21, P2708, DOI 10.1093/ndt/gfl346; McCullough PA, 2010, AM J KIDNEY DIS, V55, pS1, DOI 10.1053/j.ajkd.2009.12.017; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Quan HD, 2009, HYPERTENSION, V54, P1423, DOI 10.1161/HYPERTENSIONAHA.109.139279; Rule AD, 2011, CLIN J AM SOC NEPHRO, V6, P2069, DOI 10.2215/CJN.10651110; Rule AD, 2009, CLIN J AM SOC NEPHRO, V4, P804, DOI 10.2215/CJN.05811108; Stamatelou KK, 2003, KIDNEY INT, V63, P1817, DOI 10.1046/j.1523-1755.2003.00917.x; Stankus N, 2007, UROL RES, V35, P83, DOI 10.1007/s00240-007-0079-3; SUTHERLAND JW, 1985, MINER ELECTROL METAB, V11, P267; Tosetto E, 2006, NEPHROL DIAL TRANSPL, V21, P2452, DOI 10.1093/ndt/gfl274; Trinchieri A, 1999, J UROLOGY, V162, P27, DOI 10.1097/00005392-199907000-00007; United States Renal Data System II, 1997, AM J KIDNEY DIS, V30, pS40	24	171	176	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 30	2012	345								e5287	10.1136/bmj.e5287	http://dx.doi.org/10.1136/bmj.e5287			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036SM	22936784	hybrid, Green Published			2022-12-24	WOS:000311050800001
J	Clayton, J				Clayton, Julie			CLINICAL APPROVAL Trials of an anticancer jab	NATURE			English	Editorial Material							HUMAN-PAPILLOMAVIRUS; VACCINATION PROGRAM; EFFICACY											Australia Dept. Health and Aging, 2011, NAT HPV VACC DAT GIR; Brotherton J. M. L., LANCET INFE IN PRESS; Brotherton JML, 2011, LANCET, V377, P2085, DOI 10.1016/S0140-6736(11)60551-5; Department of Health, ANN HPV VACC COV ENG; Dillner J, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3493; Donovan B, 2011, LANCET INFECT DIS, V11, P39, DOI 10.1016/S1473-3099(10)70225-5; Dorell Christina, 2011, Morbidity and Mortality Weekly Report, V60, P1117; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Kreimer AR, 2011, LANCET ONCOL, V12, P862, DOI 10.1016/S1470-2045(11)70213-3; Lehtinen M, 2012, LANCET ONCOL, V13, P89, DOI 10.1016/S1470-2045(11)70286-8; Munoz N, 2010, JNCI-J NATL CANCER I, V102, P325, DOI 10.1093/jnci/djp534; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Shearer B., 2011, HPV VACCINATION UNDE; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Widgren K, 2011, VACCINE, V29, P9663, DOI 10.1016/j.vaccine.2011.10.021	15	4	4	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2012	488	7413					S4	S6		10.1038/488S4a	http://dx.doi.org/10.1038/488S4a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	996NC	22932438				2022-12-24	WOS:000308095100005
J	McCartney, M				McCartney, Margaret			The V word: selling genital hygiene products to women	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				ADAMS R, 2010, GUARDIAN; Advertising Standards Bureau, 2012, ADV STAND BOARD DET; Brown L, 2012, CNN             0621; NHS Choices, VAG HLTH; YouTube, 2012, CAR ACT AD 2012 AU	5	1	2	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 24	2012	345								e5732	10.1136/bmj.e5732	http://dx.doi.org/10.1136/bmj.e5732			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	996HC	22923540				2022-12-24	WOS:000308074500004
J	Shapiro, D				Shapiro, Daniel			Poolside	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Penn State Coll Med, Dept Humanities, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Shapiro, D (corresponding author), Penn State Coll Med, Dept Humanities, Hershey, PA USA.	shapiro@psu.edu		Shapiro, Daniel/0000-0002-7166-7705					0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2012	308	8					775	776		10.1001/jama.2012.9425	http://dx.doi.org/10.1001/jama.2012.9425			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	991ML	22910754				2022-12-24	WOS:000307705300020
J	Owen, J				Owen, James			Anybody else for warfarin?	BRITISH MEDICAL JOURNAL			English	Editorial Material												J.O.Drife@leeds.ac.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 20	2012	345								e5543	10.1136/bmj.e5543	http://dx.doi.org/10.1136/bmj.e5543			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996GL	22906868				2022-12-24	WOS:000308072800002
J	Rothballer, A; Kutay, U				Rothballer, Andrea; Kutay, Ulrike			SnapShot: The Nuclear Envelope I	CELL			English	Editorial Material							FUNCTIONAL ARCHITECTURE; PORE COMPLEX; PROTEINS; DISEASE		[Rothballer, Andrea; Kutay, Ulrike] ETH, Inst Biochem, CH-8093 Zurich, Switzerland	ETH Zurich	Rothballer, A (corresponding author), ETH, Inst Biochem, CH-8093 Zurich, Switzerland.							Brachner A, 2011, BIOCHEM SOC T, V39, P1735, DOI 10.1042/BST20110724; Burke B, 2006, ANNU REV GENOM HUM G, V7, P369, DOI 10.1146/annurev.genom.7.080505.115732; Grossman E, 2012, ANNU REV BIOPHYS, V41, P557, DOI [10.1146/annurev-biophys-050511-102328, 10.1146/annurev-biophys-850511-102328]; Maimon T, 2012, STRUCTURE, V20, P998, DOI 10.1016/j.str.2012.03.025; Mellad JA, 2011, CURR OPIN CELL BIOL, V23, P47, DOI 10.1016/j.ceb.2010.11.006; Schirmer EC, 2003, SCIENCE, V301, P1380, DOI 10.1126/science.1088176; Shimi T, 2012, CURR OPIN CELL BIOL, V24, P71, DOI 10.1016/j.ceb.2011.11.007; Sosa BA, 2012, CELL, V149, P1035, DOI 10.1016/j.cell.2012.03.046; Starr DA, 2010, ANNU REV CELL DEV BI, V26, P421, DOI 10.1146/annurev-cellbio-100109-104037; Terry LJ, 2009, EUKARYOT CELL, V8, P1814, DOI 10.1128/EC.00225-09	10	6	6	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 17	2012	150	4					868	U226	868.e1	10.1016/j.cell.2012.07.024	http://dx.doi.org/10.1016/j.cell.2012.07.024			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22901815	Bronze			2022-12-24	WOS:000308002300020
J	D'Amico, AV; Smith, MR				D'Amico, Anthony V.; Smith, Matthew R.			Screening for Prostate Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RADICAL PROSTATECTOMY; FOLLOW-UP; MORTALITY		[D'Amico, Anthony V.] Brigham & Womens Hosp, Boston, MA 02115 USA; [D'Amico, Anthony V.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Smith, Matthew R.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital	D'Amico, AV (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.				NATIONAL CANCER INSTITUTE [K24CA121990] Funding Source: NIH RePORTER; NCI NIH HHS [K24 CA121990] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Andriole GL, 2012, J NATL CANCER I, V104, P125, DOI 10.1093/jnci/djr500; Autier P, 2012, NEW ENGL J MED, V366, P2230, DOI 10.1056/NEJMc1204298; Bill-Axelson A, 2011, NEW ENGL J MED, V364, P1708, DOI 10.1056/NEJMoa1011967; Catalona WJ, 2012, ANN INTERN MED, V157, P137, DOI 10.7326/0003-4819-157-2-201207170-00463; Heijnsdijk EAM, 2012, NEW ENGL J MED, V367, P595, DOI 10.1056/NEJMoa1201637; Hugosson J, 2010, LANCET ONCOL, V11, P725, DOI 10.1016/S1470-2045(10)70146-7; IVERSEN P, 1995, SCAND J UROL NEPHROL, P65; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; Wilt TJ, 2012, NEW ENGL J MED, V367, P203, DOI 10.1056/NEJMoa1113162	10	5	5	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 16	2012	367	7								10.1056/NEJMclde1209426	http://dx.doi.org/10.1056/NEJMclde1209426			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988NB	22894598	Green Accepted			2022-12-24	WOS:000307496600013
J	Roehr, B				Roehr, Bob			The slow and unknown route to a cure for AIDS	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HIV					BobRoehr@aol.com						Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262; Deeks SG, 2012, NATURE, V487, P293, DOI 10.1038/487293a; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Roehr B., 2012, BRIT MED J, V345, pe4859; Roehr B., 2009, SCI AM; Roehr B, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4950; Roehr B, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d1373	8	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 10	2012	345								e5265	10.1136/bmj.e5265	http://dx.doi.org/10.1136/bmj.e5265			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988NG	22885397				2022-12-24	WOS:000307497100006
J	Leakey, MG; Spoor, F; Dean, MC; Feibel, CS; Anton, SC; Kiarie, C; Leakey, LN				Leakey, Meave G.; Spoor, Fred; Dean, M. Christopher; Feibel, Craig S.; Anton, Susan C.; Kiarie, Christopher; Leakey, Louise N.			New fossils from Koobi Fora in northern Kenya confirm taxonomic diversity in early Homo	NATURE			English	Article							OLDUVAI-GORGE; TURKANA-BASIN; PLIOPLEISTOCENE HOMINID; EAST RUDOLF; HABILIS; ETHIOPIA; EVOLUTION; TANZANIA; REGION; MA	Since its discovery in 1972 (ref. 1), the cranium KNM-ER 1470 has been at the centre of the debate over the number of species of early Homo present in the early Pleistocene epoch(2) of eastern Africa. KNM-ER 1470 stands out among other specimens attributed to early Homo because of its larger size, and its flat and subnasally orthognathic face with anteriorly placed maxillary zygomatic roots(3). This singular morphology and the incomplete preservation of the fossil have led to different views as to whether KNM-ER 1470 can be accommodated within a single species of early Homo that is highly variable because of sexual, geographical and temporal factors(4-9), or whether it provides evidence of species diversity marked by differences in cranial size and facial or masticatory adaptation(3,10-20). Here we report on three newly discovered fossils, aged between 1.78 and 1.95 million years (Myr) old, that clarify the anatomy and taxonomic status of KNM-ER 1470. KNM-ER 62000, a well-preserved face of a late juvenile hominin, closely resembles KNM-ER 1470 but is notably smaller. It preserves previously unknown morphology, including moderately sized, mesiodistally long postcanine teeth. The nearly complete mandible KNM-ER 60000 and mandibular fragment KNM-ER 62003 have a dental arcade that is short anteroposteriorly and flat across the front, with small incisors; these features are consistent with the arcade morphology of KNM-ER 1470 and KNM-ER 62000. The new fossils confirm the presence of two contemporary species of early Homo, in addition to Homo erectus, in the early Pleistocene of eastern Africa.	[Leakey, Meave G.; Kiarie, Christopher; Leakey, Louise N.] Turkana Basin Inst, Nairobi 00502, Kenya; [Leakey, Meave G.; Leakey, Louise N.] SUNY Stony Brook, Dept Anthropol, Stony Brook, NY 11794 USA; [Spoor, Fred] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, D-04103 Leipzig, Germany; [Spoor, Fred; Dean, M. Christopher] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Feibel, Craig S.] Rutgers State Univ, Dept Earth & Planetary Sci, Piscataway, NJ 08854 USA; [Feibel, Craig S.] Rutgers State Univ, Dept Anthropol, Piscataway, NJ 08854 USA; [Anton, Susan C.] NYU, Dept Anthropol, New York, NY 10003 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Max Planck Society; University of London; University College London; Rutgers State University New Brunswick; Rutgers State University New Brunswick; New York University	Leakey, MG (corresponding author), Turkana Basin Inst, POB 24926, Nairobi 00502, Kenya.	meaveleakey@gmail.com; f.spoor@eva.mpg.de		Leakey, Louise/0000-0003-3420-6341	Turkana Basin Institute; National Geographic Society; Leakey Foundation; Max Planck Society	Turkana Basin Institute; National Geographic Society(National Geographic Society); Leakey Foundation; Max Planck Society(Max Planck Society)	We thank the Governments of Kenya and Tanzania for permission to carry out this research, the Kenya Wildlife Service for permission to work in the Sibiloi National Park, the National Museums of Kenya and the National Museum of Tanzania for access to specimens in their care, and the Turkana Basin Institute for support. The National Geographic Society, the Leakey Foundation and the Max Planck Society funded fieldwork or laboratory studies. Many people helped us with this research, including N. Adamali, R. Blumenschine, C. Boesch, F. Brown, P. Gunz, J. J. Hublin, W. Kimbel, K. Kupczik, R. Leakey, C. Lepre, D. Lieberman, P. Msemwa, R. Odoyo, R. Quinn, P. Rightmire, L. Schroeder, U. Schwarz, M. Skinner, H. Temming, A. Winzer and B. Wood. Curatorial assistance was given by A. Kweka, F. Manthi, E. Mbua, M. Muungu and J. Thiringi. KNM-ER60000 was discovered by C. Nyete, KNM-ER62000 by D. Elgite and KNM-ER 62003 by R. Moru. We particularly thank the Koobi Fora Research Project field crew: A. Aike, S. Aila, D. Elgite, M. Kirinya, D. Gidole, O. Kyalo, A. Longaye, A. Lawri, E. Linga, J. Lonyericho, S. Lomeiku, D. Muema, A. Moru, R. Moru, S. Muge, C. Nyete, L. Nzuve, H. Sale and A. Sharamo whose fieldwork led to the discovery of these specimens, and camp managers J. Mutuku and T. Ngundo. H. Churcher, J. Coreth, A. Hammond, J. LaCarrubba, F. Kirera, C. Lepre, M. Noback, R. Quinn, M. Skinner, I. Wallace and S. Wright participated in one or more of the 2007, 2008 or 2009 field expeditions when these specimens were discovered. We are grateful to F. and J. Pinto, W. Philips, M. Hettwer, P. Sylvester, H. Buchi, N. Seligman, E. von Simpson, J. Doerr and B. and J. Chelberg for their financial support of this fieldwork.	Blumenschine RJ, 2003, SCIENCE, V299, P1217, DOI 10.1126/science.1075374; Braun DR, 2010, P NATL ACAD SCI USA, V107, P10002, DOI 10.1073/pnas.1002181107; BROCK A, 1974, NATURE, V247, P344, DOI 10.1038/247344a0; BROMAGE TG, 1995, J HUM EVOL, V28, P71, DOI 10.1006/jhev.1995.1007; BROWN FH, 1986, J GEOL SOC LONDON, V143, P297, DOI 10.1144/gsjgs.143.2.0297; Clarke R. J., 2012, J HUM EVOL; Dean M. Christopher, 2009, P101, DOI 10.1007/978-1-4020-9980-9_10; Gibbard PL, 2010, J QUATERNARY SCI, V25, P96, DOI 10.1002/jqs.1338; Groves C., 1989, THEORY HUMAN PRIMATE; Howell F.C., 1978, P154; JOHANSON DC, 1987, NATURE, V327, P205, DOI 10.1038/327205a0; Joordens JCA, 2011, EARTH PLANET SC LETT, V307, P1, DOI 10.1016/j.epsl.2011.05.005; Kimbel WH, 1997, AM J PHYS ANTHROPOL, V103, P235, DOI 10.1002/(SICI)1096-8644(199706)103:2<235::AID-AJPA8>3.3.CO;2-V; KRAMER A, 1995, J HUM EVOL, V29, P443, DOI 10.1006/jhev.1995.1068; LEAKEY REF, 1974, NATURE, V248, P653, DOI 10.1038/248653a0; LEAKEY REF, 1973, NATURE, V242, P447, DOI 10.1038/242447a0; LIEBERMAN DE, 1988, J HUM EVOL, V17, P503, DOI 10.1016/0047-2484(88)90039-5; LOURENS L, 2004, GEOLOGIC TIME SCALE, P409, DOI DOI 10.1017/CBO9780511536045.022; McDougall I, 2006, J GEOL SOC LONDON, V163, P205, DOI 10.1144/0016-764904-166; McDougall I, 2012, J GEOL SOC LONDON, V169, P213, DOI 10.1144/0016-76492010-188; Miller JMA, 2000, AM J PHYS ANTHROPOL, V112, P103, DOI 10.1002/(SICI)1096-8644(200005)112:1<103::AID-AJPA10>3.0.CO;2-6; RIGHTMIRE GP, 1993, AM J PHYS ANTHROPOL, V90, P1, DOI 10.1002/ajpa.1330900102; Stringer C.B., 1986, P266; Suwa G, 1996, AM J PHYS ANTHROPOL, V101, P247, DOI 10.1002/(SICI)1096-8644(199610)101:2<247::AID-AJPA9>3.0.CO;2-Z; Suwa G, 2007, ANTHROPOL SCI, V115, P133, DOI 10.1537/ase.061203; Tobias P. V., 1991, GODUVAI GORGE, V4; WOOD B, 1992, NATURE, V355, P783, DOI 10.1038/355783a0; Wood B., 1985, P206; Wood B, 1999, J HUM EVOL, V36, P115, DOI 10.1006/jhev.1998.0246; Wood B., 1991, HOMINID CRANIAL REMA, V4	30	116	121	0	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2012	488	7410					201	204		10.1038/nature11322	http://dx.doi.org/10.1038/nature11322			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	985LE	22874966				2022-12-24	WOS:000307267000031
J	Mauldin, RL; Berndt, T; Sipila, M; Paasonen, P; Petaja, T; Kim, S; Kurten, T; Stratmann, F; Kerminen, VM; Kulmala, M				Mauldin, R. L., III; Berndt, T.; Sipilae, M.; Paasonen, P.; Petaja, T.; Kim, S.; Kurten, T.; Stratmann, F.; Kerminen, V-M; Kulmala, M.			A new atmospherically relevant oxidant of sulphur dioxide	NATURE			English	Article							OH MEASUREMENTS; FOREST; OXIDATION; OZONE; ACID; SO2; MECHANISM; SYSTEM; CH2OO; AIR	Atmospheric oxidation is a key phenomenon that connects atmospheric chemistry with globally challenging environmental issues, such as climate change(1), stratospheric ozone loss(2), acidification of soils and water(3), and health effects of air quality(4). Ozone, the hydroxyl radical and the nitrate radical are generally considered to be the dominant oxidants that initiate the removal of trace gases, including pollutants, from the atmosphere. Here we present atmospheric observations from a boreal forest region in Finland, supported by laboratory experiments and theoretical considerations, that allow us to identify another compound, probably a stabilized Criegee intermediate (a carbonyl oxide with two free-radical sites) or its derivative, which has a significant capacity to oxidize sulphur dioxide and potentially other trace gases. This compound probably enhances the reactivity of the atmosphere, particularly with regard to the production of sulphuric acid, and consequently atmospheric aerosol formation. Our findings suggest that this new atmospherically relevant oxidation route is important relative to oxidation by the hydroxyl radical, at least at moderate concentrations of that radical. We also find that the oxidation chemistry of this compound seems to be tightly linked to the presence of alkenes of biogenic origin.	[Mauldin, R. L., III; Sipilae, M.; Paasonen, P.; Petaja, T.; Kurten, T.; Kerminen, V-M; Kulmala, M.] Univ Helsinki, Dept Phys, FI-00014 Helsinki, Finland; [Mauldin, R. L., III; Kim, S.] Natl Ctr Atmospher Res, Boulder, CO 80307 USA; [Mauldin, R. L., III] Univ Colorado Boulder, Dept Atmospher & Ocean Sci, Boulder, CO 80309 USA; [Berndt, T.; Sipilae, M.; Stratmann, F.] Leibniz Inst Tropospher Res, D-04318 Leipzig, Germany; [Sipilae, M.] Helsinki Inst Phys, FI-00014 Helsinki, Finland; [Kurten, T.] Univ Helsinki, Dept Chem, FI-00014 Helsinki, Finland	University of Helsinki; National Center Atmospheric Research (NCAR) - USA; University of Colorado System; University of Colorado Boulder; Leibniz Institut fur Tropospharenforschung (TROPOS); Helsinki Institute of Physics; University of Helsinki	Mauldin, RL (corresponding author), Univ Helsinki, Dept Phys, FI-00014 Helsinki, Finland.	roy.mauldin@helsinki.fi	Kerminen, Veli-Matti/M-9026-2014; Petäjä, Tuukka/A-8009-2008; Kulmala, Markku T/I-7671-2016; Paasonen, Pauli/M-2972-2013; Kim, Saewung/E-4089-2012; Sipilä, Mikko/G-3024-2010; Kurtén, Theo C/G-2120-2012	Petäjä, Tuukka/0000-0002-1881-9044; Kulmala, Markku T/0000-0003-3464-7825; Paasonen, Pauli/0000-0002-4625-9590; Kim, Saewung/0000-0003-4847-3272; Sipilä, Mikko/0000-0002-8594-7003; Kurtén, Theo C/0000-0002-6416-4931	European Commission Sixth Framework programme project EUCAARI [036833-2]; Academy of Finland [251427, 139656, 141135]; European Research Council (ATMNUCLE); Kone Foundation; Vaisala Foundation; Maj and Tor Nessling Foundation [2010212]; Otto Malm Foundation; US National Science Foundation	European Commission Sixth Framework programme project EUCAARI; Academy of Finland(Academy of Finland); European Research Council (ATMNUCLE)(European Research Council (ERC)); Kone Foundation; Vaisala Foundation; Maj and Tor Nessling Foundation; Otto Malm Foundation; US National Science Foundation(National Science Foundation (NSF))	We thank K. Pielok and A. Rohmer for technical assistance. This work was partially funded by the European Commission Sixth Framework programme project EUCAARI, contract no. 036833-2 (EUCAARI), the Academy of Finland (251427, 139656, Finnish centre of excellence 141135), the European Research Council (ATMNUCLE), the Kone Foundation, the Vaisala Foundation, the Maj and Tor Nessling Foundation (2010212), the Otto Malm Foundation and the US National Science Foundation.	Arneth A, 2010, NAT GEOSCI, V3, P525, DOI [10.1038/NGEO905, 10.1038/ngeo905]; Arneth A, 2009, SCIENCE, V326, P672, DOI 10.1126/science.1181568; Berndt T, 2010, ATMOS CHEM PHYS, V10, P7101, DOI 10.5194/acp-10-7101-2010; COCKS AT, 1986, ATMOS ENVIRON, V20, P2359, DOI 10.1016/0004-6981(86)90066-1; COX RA, 1971, NATURE, V230, P321, DOI 10.1038/230321a0; Demore W., 1997, JPL PUBLICATION, V97-4; Di Carlo P, 2004, SCIENCE, V304, P722, DOI 10.1126/science.1094392; Drozd GT, 2011, J PHYS CHEM A, V115, P161, DOI 10.1021/jp108773d; EISELE FL, 1991, J GEOPHYS RES-ATMOS, V96, P9295, DOI 10.1029/91JD00198; Fenger J, 2009, ATMOS ENVIRON, V43, P13, DOI 10.1016/j.atmosenv.2008.09.061; Hakola H, 2003, ATMOS ENVIRON, V37, P1623, DOI 10.1016/S1352-2310(03)00014-1; Hari P, 2005, BOREAL ENVIRON RES, V10, P315; HATAKEYAMA S, 1986, J PHYS CHEM-US, V90, P4131, DOI 10.1021/j100408a059; Heald CL, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009092; Hofzumahaus A, 2009, SCIENCE, V324, P1702, DOI 10.1126/science.1164566; Jiang L, 2010, J PHYS CHEM A, V114, P12452, DOI 10.1021/jp107783z; Johnson D, 2001, J PHYS CHEM A, V105, P2933, DOI 10.1021/jp003975e; Kurten T, 2011, J PHYS CHEM A, V115, P8669, DOI 10.1021/jp203907d; Kurten T, 2010, PHYS CHEM CHEM PHYS, V12, P12833, DOI 10.1039/c0cp00383b; Lappalainen HK, 2009, ATMOS CHEM PHYS, V9, P5447, DOI 10.5194/acp-9-5447-2009; Lelieveld J, 2008, NATURE, V452, P737, DOI 10.1038/nature06870; Liao H, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010984; LIKENS GE, 1972, ENVIRONMENT, V14, P33, DOI 10.1080/00139157.1972.9933001; Lou S, 2010, ATMOS CHEM PHYS, V10, P11243, DOI 10.5194/acp-10-11243-2010; Mauldin RL, 1998, J GEOPHYS RES-ATMOS, V103, P16713, DOI 10.1029/98JD00882; Montzka SA, 2011, SCIENCE, V331, P67, DOI 10.1126/science.1197640; Petaja T, 2009, ATMOS CHEM PHYS, V9, P7435, DOI 10.5194/acp-9-7435-2009; Rowland FS, 2006, PHILOS T R SOC B, V361, P769, DOI 10.1098/rstb.2005.1783; Sipila M, 2010, SCIENCE, V327, P1243, DOI 10.1126/science.1180315; Spracklen DV, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL033038; Su H, 2011, SCIENCE, V333, P1616, DOI 10.1126/science.1207687; Tanner DJ, 1997, J GEOPHYS RES-ATMOS, V102, P6415, DOI 10.1029/96JD03919; Welz O, 2012, SCIENCE, V335, P204, DOI 10.1126/science.1213229; XIE ZD, 1992, J PHYS CHEM-US, V96, P1543, DOI 10.1021/j100183a011	34	342	344	24	623	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 9	2012	488	7410					193	196		10.1038/nature11278	http://dx.doi.org/10.1038/nature11278			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985LE	22874964	Green Published			2022-12-24	WOS:000307267000029
J	Klein, M; Gogenur, I; Rosenberg, J				Klein, Mads; Gogenur, Ismail; Rosenberg, Jacob			Postoperative use of non-steroidal anti-inflammatory drugs in patients with anastomotic leakage requiring reoperation after colorectal resection: cohort study based on prospective data	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MULTIVARIATE-ANALYSIS; RISK; INHIBITORS; CYCLOOXYGENASE; SURGERY; DEATH; COMPLICATIONS; SELECTIVITY; DICLOFENAC; KETOROLAC	Objectives To evaluate the effect of postoperative use of non-steroidal anti-inflammatory drugs (NSAIDs) on anastomotic leakage requiring reoperation after colorectal resection. Design Cohort study based on data from a prospective clinical database and electronically registered medical records. Setting Six major colorectal centres in eastern Denmark. Participants 2766 patients (1441 (52%) men) undergoing elective operation for colorectal cancer with colonic or rectal resection and primary anastomosis between 1 January 2006 and 31 December 2009. Median age was 70 years (interquartile range 62-77). Intervention Postoperative use of NSAID (defined as at least two days of NSAID treatment in the first seven days after surgery). Main outcome measures Frequency of clinical anastomotic leakage verified at reoperation; mortality at 30 days. Results Of 2756 patients with available data and included in the final analysis, 1871 (68%) did not receive postoperative NSAID treatment (controls) and 885 (32%) did. In the NSAID group, 655 (74%) patients received ibuprofen and 226 (26%) received diclofenac. Anastomotic leakage verified at reoperation was significantly increased among patients receiving diclofenac and ibuprofen treatment, compared with controls (12.8% and 8.2% v 5.1%; P<0.001). After unadjusted analyses and when compared with controls, more patients had anastomotic leakage after treatment with diclofenac (7.8% (95% confidence interval 3.9% to 12.8%)) and ibuprofen (3.2% (1.0% to 5.7%)). But after multivariate logistic regression analysis, only diclofenac treatment was a risk factor for leakage (odds ratio 7.2 (95% confidence interval 3.8 to 13.4), P<0.001; ibuprofen 1.5 (0.8 to 2.9), P=0.18). Other risk factors for anastomotic leakage were male sex, rectal (v colonic) anastomosis, and blood transfusion. 30 day mortality was comparable in the three groups (diclofenac 1.8% v ibuprofen 4.1% v controls 3.2%; P=0.20). Conclusions Diclofenac treatment could result in an increased proportion of patients with anastomotic leakage after colorectal surgery. Cyclo-oxygenase-2 selective NSAIDs should be used with caution after colorectal resections with primary anastomosis. Large scale, randomised controlled trials are urgently needed.	[Klein, Mads; Gogenur, Ismail; Rosenberg, Jacob] Univ Copenhagen, Herlev Hosp, Dept Surg, DK-2730 Herlev, Denmark	University of Copenhagen; Herlev & Gentofte Hospital	Klein, M (corresponding author), Univ Copenhagen, Herlev Hosp, Dept Surg, DK-2730 Herlev, Denmark.	madsklein1@gmail.com		Gogenur, Ismail/0000-0002-3753-268X; Rosenberg, Jacob/0000-0002-0063-1086				Alves A, 2002, WORLD J SURG, V26, P499, DOI 10.1007/s00268-001-0256-4; [Anonymous], 2009, YEARL REP 2009; Antman EM, 2007, CIRCULATION, V115, P1634, DOI 10.1161/CIRCULATIONAHA.106.181424; Cahill RA, 2004, BRIT J SURG, V91, P1613, DOI 10.1002/bjs.4722; Choi HK, 2006, DIS COLON RECTUM, V49, P1719, DOI 10.1007/s10350-006-0703-2; Christensen HK, 2011, EUR SURG RES, V46, P156, DOI 10.1159/000324406; Fosbol EL, 2010, EXPERT OPIN DRUG SAF, V9, P893, DOI 10.1517/14740338.2010.501331; Gillis JC, 1997, DRUGS, V53, P139, DOI 10.2165/00003495-199753010-00012; Gislason GH, 2006, CIRCULATION, V113, P2906, DOI 10.1161/CIRCULATIONAHA.106.616219; Golub R, 1997, J AM COLL SURGEONS, V184, P364; Gorissen KJ, 2012, BRIT J SURG, V99, P721, DOI 10.1002/bjs.8691; Guenaga KK, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001544.pub3, DOI 10.1002/14651858.CD001544.PUB3]]; Haag MDM, 2008, ARCH INTERN MED, V168, P1219, DOI 10.1001/archinte.168.11.1219; Holte K, 2007, BRIT J ANAESTH, V99, P500, DOI 10.1093/bja/aem211; Holte K, 2009, BRIT J SURG, V96, P650, DOI 10.1002/bjs.6598; Hyman N, 2007, ANN SURG, V245, P254, DOI 10.1097/01.sla.0000225083.27182.85; Inan Aydin, 2006, Int J Surg, V4, P222, DOI 10.1016/j.ijsu.2006.01.002; Iversen LH, 2008, BRIT J SURG, V95, P1012, DOI 10.1002/bjs.6114; Kearney PM, 2006, BMJ-BRIT MED J, V332, P1302, DOI 10.1136/bmj.332.7553.1302; Kehlet H, 2008, ANN SURG, V248, P189, DOI 10.1097/SLA.0b013e31817f2c1a; Kendall SJH, 2000, CLIN ORTHOP RELAT R, P145; Kingham TP, 2009, J AM COLL SURGEONS, V208, P269, DOI 10.1016/j.jamcollsurg.2008.10.015; Klein M, 2012, EUR SURG RES, V48, P73, DOI 10.1159/000336208; Klein M, 2009, DIGEST SURG, V26, P27, DOI 10.1159/000193329; Lipska MA, 2006, ANZ J SURG, V76, P579, DOI 10.1111/j.1445-2197.2006.03780.x; Makela JT, 2003, DIS COLON RECTUM, V46, P653, DOI 10.1097/01.DCR.0000059328.10563.8C; McGettigan P, 2006, JAMA-J AM MED ASSOC, V296, P1633, DOI 10.1001/jama.296.13.jrv60011; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Nickelsen Thomas N, 2004, Ugeskr Laeger, V166, P3092; Nussmeier NA, 2005, NEW ENGL J MED, V352, P1081, DOI 10.1056/NEJMoa050330; Olsen AMS, 2011, CIRCULATION, V123, P2226, DOI 10.1161/CIRCULATIONAHA.110.004671; Patrono C, 2001, J CLIN INVEST, V108, P7, DOI 10.1172/JCI13418; PEEL ALG, 1991, ANN ROY COLL SURG, V73, P385; Schlachta CM, 2007, SURG ENDOSC, V21, P2212, DOI 10.1007/s00464-007-9335-4; Stottmeier S, 2011, COLORECTAL DIS, V13, P500, DOI 10.1111/j.1463-1318.2010.02274.x; Winkelmayer WC, 2004, NEPHROL DIAL TRANSPL, V19, P1671, DOI 10.1093/ndt/gfh104	36	103	105	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 26	2012	345								e6166	10.1136/bmj.e6166	http://dx.doi.org/10.1136/bmj.e6166			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014OV	23015299	hybrid, Green Published			2022-12-24	WOS:000309386300004
J	Puig, P; Canals, M; Company, JB; Martin, J; Amblas, D; Lastras, G; Palanques, A; Calafat, AM				Puig, Pere; Canals, Miquel; Company, Joan B.; Martin, Jacobo; Amblas, David; Lastras, Galderic; Palanques, Albert; Calafat, Antoni M.			Ploughing the deep sea floor	NATURE			English	Article							MOBILE-FISHING-GEAR; CONTINENTAL SHELVES; SUBMARINE CANYONS; TRANSPORT; CURRENTS; GEOLOGY; IMPACT; RESUSPENSION; ECOSYSTEMS; SLOPES	Bottom trawling is a non-selective commercial fishing technique whereby heavy nets and gear are pulled along the sea floor. The direct impact of this technique on fish populations(1,2) and benthic communities(3,4) has received much attention, but trawling can also modify the physical properties of seafloor sediments, water-sediment chemical exchanges and sediment fluxes(5,6). Most of the studies addressing the physical disturbances of trawl gear on the seabed have been undertaken in coastal and shelf environments(7,8), however, where the capacity of trawling to modify the seafloor morphology coexists with high-energy natural processes driving sediment erosion, transport and deposition(9). Here we show that on upper continental slopes, the reworking of the deep sea floor by trawling gradually modifies the shape of the submarine landscape over large spatial scales. We found that trawling-induced sediment displacement and removal from fishing grounds causes the morphology of the deep sea floor to become smoother over time, reducing its original complexity as shown by high-resolution seafloor relief maps. Our results suggest that in recent decades, following the industrialization of fishing fleets, bottom trawling has become an important driver of deep seascape evolution. Given the global dimension of this type of fishery, we anticipate that the morphology of the upper continental slope in many parts of the world's oceans could be altered by intensive bottom trawling, producing comparable effects on the deep sea floor to those generated by agricultural ploughing on land.	[Puig, Pere; Company, Joan B.; Martin, Jacobo; Palanques, Albert] CSIC, Inst Marine Sci, E-08003 Barcelona, Spain; [Canals, Miquel; Amblas, David; Lastras, Galderic; Calafat, Antoni M.] Univ Barcelona, CRG Marine Geosci, E-08028 Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); University of Barcelona	Puig, P (corresponding author), CSIC, Inst Marine Sci, E-08003 Barcelona, Spain.	ppuig@icm.csic.es	Company, Joan B./K-7274-2014; Martin, Jacobo/F-1388-2011; Calafat, Antoni/J-5848-2017; Canals, Miquel/F-4922-2013; Puig, Pere/E-5422-2013; Palanques, Albert/C-2661-2013; Amblas, David/A-5482-2015; Lastras, Galderic/A-6487-2013	Company, Joan B./0000-0002-5878-7155; Martin, Jacobo/0000-0001-8933-7731; Calafat, Antoni/0000-0001-7927-3105; Canals, Miquel/0000-0001-5267-7601; Puig, Pere/0000-0001-6189-5504; Amblas, David/0000-0002-6248-5512; Lastras, Galderic/0000-0002-8756-3855; Palanques, Albert/0000-0003-2544-2342	HERMIONE [226354, CTM2010-11084-E]; DOS MARES [CTM2010-21810-C03]; OASIS DEL MAR-Obra Social "la Caixa"; GRACCIE-CONSOLIDER [CSD2007-00067]; REDECO [CTM2008-04973-E]; Catalan Government Grups de Recerca Consolidats grants [SGR 899, 1305]; Spanish General Secretariat of Maritime Fishing (SEGEMAR); Consejo Superior de Investigaciones Cientificas; European Social Fund	HERMIONE; DOS MARES; OASIS DEL MAR-Obra Social "la Caixa"; GRACCIE-CONSOLIDER; REDECO; Catalan Government Grups de Recerca Consolidats grants; Spanish General Secretariat of Maritime Fishing (SEGEMAR); Consejo Superior de Investigaciones Cientificas; European Social Fund(European Social Fund (ESF))	This work was supported by various research projects: HERMIONE (226354 and CTM2010-11084-E), DOS MARES (CTM2010-21810-C03), OASIS DEL MAR-Obra Social "la Caixa", GRACCIE-CONSOLIDER (CSD2007-00067) and REDECO (CTM2008-04973-E). We also received support from Catalan Government Grups de Recerca Consolidats grants (2009 SGR 899 and 1305). VMS data and support were provided by the Spanish General Secretariat of Maritime Fishing (SEGEMAR). Assistance at sea by the crews of RV Hesperides, RV Sarmiento de Gamboa and RV Garcia del Cid is also acknowledged. J.M. was funded through a JAE-DOC contract granted by Consejo Superior de Investigaciones Cientificas and co-financed by the European Social Fund. F. Sarda and T. Milligan provided comments on the manuscript. The final document benefited from a review by P. Talling.	[Anonymous], 2003, OFFICIAL J EUR UNI L, VL333, P17; Benn AR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012730; Brown EJ, 2005, CONT SHELF RES, V25, P1281, DOI 10.1016/j.csr.2004.12.005; Cacchione DA, 2002, SCIENCE, V296, P724, DOI 10.1126/science.1069803; Canals M, 2006, NATURE, V444, P354, DOI 10.1038/nature05271; CHURCHILL JH, 1989, CONT SHELF RES, V9, P841, DOI 10.1016/0278-4343(89)90016-2; Crutzen PJ, 2002, NATURE, V415, P23, DOI 10.1038/415023a; Csorba P, 2010, ANTHROPOGENIC GEOMORPHOLOGY: A GUIDE TO MAN-MADE LANDFORMS, P39, DOI 10.1007/978-90-481-3058-0_4; Ferre B, 2008, CONT SHELF RES, V28, P2071, DOI 10.1016/j.csr.2008.02.002; Gordon J. D. M., 2003, Journal of Northwest Atlantic Fishery Science, V31, P137; Guillen J, 2000, SCI MAR, V64, P427, DOI 10.3989/scimar.2000.64n4427; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; HEEZEN BC, 1966, SCIENCE, V152, P502, DOI 10.1126/science.152.3721.502; JONES JB, 1992, NEW ZEAL J MAR FRESH, V26, P59, DOI 10.1080/00288330.1992.9516500; Lastras G, 2011, MAR GEOL, V280, P20, DOI 10.1016/j.margeo.2010.11.005; Levin LA, 2010, MAR ECOL-EVOL PERSP, V31, P1, DOI 10.1111/j.1439-0485.2009.00358.x; Martin J, 2008, MAR GEOL, V252, P150, DOI 10.1016/j.margeo.2008.03.012; Morato T, 2006, FISH FISH, V7, P24, DOI 10.1111/j.1467-2979.2006.00205.x; NITTROUER CA, 1994, REV GEOPHYS, V32, P85, DOI 10.1029/93RG02603; Norse EA, 2012, MAR POLICY, V36, P307, DOI 10.1016/j.marpol.2011.06.008; Palanques A, 2006, DEEP-SEA RES PT I, V53, P201, DOI 10.1016/j.dsr.2005.10.003; Palanques A, 2006, MAR GEOL, V234, P43, DOI 10.1016/j.margeo.2006.09.002; Piper DJW, 2009, J SEDIMENT RES, V79, P347, DOI 10.2110/jsr.2009.046; Pratson LF, 2007, SPEC PUBL INT ASS SE, V37, P339, DOI 10.1002/9781444304398.ch7; Price SJ, 2011, PHILOS T R SOC A, V369, P1056, DOI 10.1098/rsta.2010.0296; Roberts JM, 2006, SCIENCE, V312, P543, DOI 10.1126/science.1119861; Schwinghamer P, 1998, CONSERV BIOL, V12, P1215, DOI 10.1046/j.1523-1739.1998.0120061215.x; Thurstan RH, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1013; Tobar R., 1987, INF T CN INV PESQ, V142, P3; Tyrrell T, 2011, PHILOS T R SOC A, V369, P887, DOI [10.1098/rsta.2010.0334, 10.1098/rsta.2010.0331]; Watling L, 1998, CONSERV BIOL, V12, P1178, DOI 10.1046/j.1523-1739.1998.0120061178.x; Watling L, 1998, CONSERV BIOL, V12, P1180, DOI 10.1046/j.1523-1739.1998.0120061180.x	32	265	268	3	257	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2012	489	7415					286	+		10.1038/nature11410	http://dx.doi.org/10.1038/nature11410			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003UC	22951970	Green Submitted, Green Accepted			2022-12-24	WOS:000308635900040
J	Basaria, S; Bhasin, S				Basaria, Shehzad; Bhasin, Shalender			BASIC IMPLICATIONS OF CLINICAL OBSERVATIONS Targeting the Skeletal Muscle-Metabolism Axis in Prostate-Cancer Therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ANDROGEN-DEPRIVATION THERAPY; MICE; MASS; MEN; FAT		[Basaria, Shehzad; Bhasin, Shalender] Boston Univ, Sch Med, Dept Med, Div Endocrinol & Metab, Boston, MA 02118 USA	Boston University	Basaria, S (corresponding author), Boston Univ, Sch Med, Dept Med, Div Endocrinol & Metab, Boston, MA 02118 USA.			Basaria, Shehzad/0000-0003-1749-8549; Basaria, Shehzad/0000-0002-8533-2383				Basaria S, 2006, CANCER-AM CANCER SOC, V106, P581, DOI 10.1002/cncr.21642; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Febbraio MA, 2004, DIABETES, V53, P1643, DOI 10.2337/diabetes.53.7.1643; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Keating NL, 2006, J CLIN ONCOL, V24, P4448, DOI 10.1200/JCO.2006.06.2497; Lee SJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000789; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Saigal CS, 2007, CANCER-AM CANCER SOC, V110, P1493, DOI 10.1002/cncr.22933; Shahani S, 2008, J CLIN ENDOCR METAB, V93, P2042, DOI 10.1210/jc.2007-2595; Tu P, 2009, DIABETES, V58, P1739, DOI 10.2337/db09-0349; Zhang C, 2012, DIABETOLOGIA, V55, P183, DOI 10.1007/s00125-011-2304-4	11	30	30	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 6	2012	367	10					965	967		10.1056/NEJMcibr1203160	http://dx.doi.org/10.1056/NEJMcibr1203160			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999VO	22931265				2022-12-24	WOS:000308343300018
J	Nijhawan, D; Zack, TI; Ren, Y; Strickland, MR; Lamothe, R; Schumacher, SE; Tsherniak, A; Besche, HC; Rosenbluh, J; Shehata, S; Cowley, GS; Weir, BA; Goldberg, AL; Mesirov, JP; Root, DE; Bhatia, SN; Beroukhim, R; Hahn, WC				Nijhawan, Deepak; Zack, Travis I.; Ren, Yin; Strickland, Matthew R.; Lamothe, Rebecca; Schumacher, Steven E.; Tsherniak, Aviad; Besche, Henrike C.; Rosenbluh, Joseph; Shehata, Shyemaa; Cowley, Glenn S.; Weir, Barbara A.; Goldberg, Alfred L.; Mesirov, Jill P.; Root, David E.; Bhatia, Sangeeta N.; Beroukhim, Rameen; Hahn, William C.			Cancer Vulnerabilities Unveiled by Genomic Loss	CELL			English	Article							COPY-NUMBER ALTERATION; OVARIAN-CANCER; PROTEASOMAL ATPASES; ONCOGENE ADDICTION; DRUG-SENSITIVITY; LUNG-CANCER; CELLS; GENE; IDENTIFICATION; THERAPY	Due to genome instability, most cancers exhibit loss of regions containing tumor suppressor genes and collateral loss of other genes. To identify cancer-specific vulnerabilities that are the result of copy number losses, we performed integrated analyses of genome-wide copy number and RNAi profiles and identified 56 genes for which gene suppression specifically inhibited the proliferation of cells harboring partial copy number loss of that gene. These CYCLOPS (copy number alterations yielding cancer liabilities owing to partial loss) genes are enriched for spliceosome, proteasome, and ribosome components. One CYCLOPS gene, PSMC2, encodes an essential member of the 19S proteasome. Normal cells express excess PSMC2, which resides in a complex with PSMC1, PSMD2, and PSMD5 and acts as a reservoir protecting cells from PSMC2 suppression. Cells harboring partial PSMC2 copy number loss lack this complex and die after PSMC2 suppression. These observations define a distinct class of cancer-specific liabilities resulting from genome instability.	[Nijhawan, Deepak; Zack, Travis I.; Strickland, Matthew R.; Lamothe, Rebecca; Schumacher, Steven E.; Rosenbluh, Joseph; Shehata, Shyemaa; Beroukhim, Rameen; Hahn, William C.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Nijhawan, Deepak; Zack, Travis I.; Strickland, Matthew R.; Lamothe, Rebecca; Schumacher, Steven E.; Rosenbluh, Joseph; Shehata, Shyemaa; Beroukhim, Rameen; Hahn, William C.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Nijhawan, Deepak; Zack, Travis I.; Schumacher, Steven E.; Tsherniak, Aviad; Rosenbluh, Joseph; Cowley, Glenn S.; Weir, Barbara A.; Mesirov, Jill P.; Root, David E.; Bhatia, Sangeeta N.; Beroukhim, Rameen; Hahn, William C.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Zack, Travis I.] Harvard Univ, Biophys Program, Boston, MA 02115 USA; [Besche, Henrike C.; Goldberg, Alfred L.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Ren, Yin; Bhatia, Sangeeta N.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Bhatia, Sangeeta N.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Nijhawan, Deepak; Rosenbluh, Joseph; Bhatia, Sangeeta N.; Beroukhim, Rameen; Hahn, William C.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Bhatia, Sangeeta N.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute	Beroukhim, R (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA.	rameen_beroukhim@dfci.harvard.edu; william_hahn@dfci.harvard.edu	Schumacher, Steven/E-9821-2013; Ren, Yin/ABD-7707-2021; Mesirov, Jill/AGF-7626-2022; qiao, zhixin/I-3408-2012	Schumacher, Steven/0000-0002-6819-5647; Ren, Yin/0000-0002-7901-2439; Tsherniak, Aviad/0000-0002-3797-1877; Rosenbluh, Joseph/0000-0001-9815-8049; Besche, Henrike/0000-0002-9841-9218	NIH/NCI [RC2 CA148268, U54 CA143798, K08 CA122833, T32 GM008313, RO1 GM051923-17, U54 CA112962]; H.L. Snyder Medical Foundation; V Foundation; Conquer Cancer Foundation Young Investigator Award; Sass Foundation Fellowship; Marie D. & Pierre Casimir-Lambert Fund; NATIONAL CANCER INSTITUTE [K08CA122833, R01CA109467, U54CA151884, P01CA050661, RC2CA148268, U54CA143798, U54CA112962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051923, T32GM008313, T32GM007753] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); H.L. Snyder Medical Foundation; V Foundation; Conquer Cancer Foundation Young Investigator Award; Sass Foundation Fellowship; Marie D. & Pierre Casimir-Lambert Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank Leslie Gaffney and Lauren Solomon for support in generating illustrations and graphics and Jesse Boehm, Scott Carter, George Demartino, and members of the Goldberg and Hahn lab for helpful discussion. This work was supported in part by NIH/NCI grants RC2 CA148268 (W. C. H.), U54 CA143798, K08 CA122833 (R. B.), T32 GM008313 (T.I.Z.), RO1 GM051923-17 (A. L. G and H. C. B.), and U54 CA112962 (A. T., J.P.M., W. C. H.), the H.L. Snyder Medical Foundation (W. C. H.), the V Foundation (R. B.), a Conquer Cancer Foundation Young Investigator Award (D.N.), Sass Foundation Fellowship (D.N.), and the Marie D. & Pierre Casimir-Lambert Fund. S.N.B. is a Howard Hughes Investigator. W. C. H. and R. B. are consultants for Novartis Pharmaceuticals.	Aghajanian C, 2002, CLIN CANCER RES, V8, P2505; Ashworth A, 2011, CELL, V145, P30, DOI 10.1016/j.cell.2011.03.020; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Brose MS, 2002, CANCER RES, V62, P6997; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Elsasser S, 2005, METHOD ENZYMOL, V398, P353, DOI 10.1016/S0076-6879(05)98029-4; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; FREI E, 1993, LANCET, V342, P662, DOI 10.1016/0140-6736(93)91764-D; Funakoshi M, 2009, CELL, V137, P887, DOI 10.1016/j.cell.2009.04.061; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Kaneko T, 2009, CELL, V137, P914, DOI 10.1016/j.cell.2009.05.008; Kisselev AF, 2005, METHOD ENZYMOL, V398, P364, DOI 10.1016/S0076-6879(05)98030-0; Liu JS, 2004, CANCER RES, V64, P1655, DOI 10.1158/0008-5472.CAN-03-3380; Marcotte R, 2012, CANCER DISCOV, V2, P172, DOI 10.1158/2159-8290.CD-11-0224; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Park S, 2009, NATURE, V459, P866, DOI 10.1038/nature08065; Ren Y, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003778; Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445; Roelofs J, 2009, NATURE, V459, P861, DOI 10.1038/nature08063; Saeki Y, 2009, CELL, V137, P900, DOI 10.1016/j.cell.2009.05.005; Sawyers CL, 2005, COLD SH Q B, V70, P479, DOI 10.1101/sqb.2005.70.034; Smith DM, 2011, CELL, V144, P526, DOI 10.1016/j.cell.2011.02.005; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Solimini NL, 2007, CELL, V130, P986, DOI 10.1016/j.cell.2007.09.007; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Thompson D, 2009, J BIOL CHEM, V284, P24891, DOI 10.1074/jbc.M109.023218; Weinstein IB, 2006, NAT CLIN PRACT ONCOL, V3, P448, DOI 10.1038/ncponc0558; Zhang R, 2009, NUCLEIC ACIDS RES, V37, pD455, DOI 10.1093/nar/gkn858	35	162	167	1	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 17	2012	150	4					842	854		10.1016/j.cell.2012.07.023	http://dx.doi.org/10.1016/j.cell.2012.07.023			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22901813	Green Published, Green Accepted, Bronze			2022-12-24	WOS:000308002300017
J	Lowenthal, J; Hull, SC; Pearson, SD				Lowenthal, Justin; Hull, Sara Chandros; Pearson, Steven D.			The Ethics of Early Evidence - Preparing for a Possible Breakthrough in Alzheimer's Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lowenthal, Justin; Hull, Sara Chandros; Pearson, Steven D.] NIH, Dept Bioeth, Ctr Clin, Bethesda, MD 20892 USA; [Hull, Sara Chandros] NHGRI, NIH, Off Clin Director, Bethesda, MD 20892 USA; [Pearson, Steven D.] Massachusetts Gen Hosp, Inst Clin & Econ Review, Inst Technol Assessment, Boston, MA 02114 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Harvard University; Massachusetts General Hospital	Lowenthal, J (corresponding author), NIH, Dept Bioeth, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA.		Lowenthal, Justin/H-3728-2013	Lowenthal, Justin/0000-0001-5909-0520	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIDHG200347] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 HG999999] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Dresser R, 2009, J LAW MED ETHICS, V37, P476, DOI 10.1111/j.1748-720X.2009.00408.x; Food and Drug Administration, 2011, TARGR BEX CAPS 75 MG; Frost J, 2011, J MED INTERNET RES, V13, P129, DOI 10.2196/jmir.1643; Wang SS, 2012, WALL STREET J, pA3	5	16	28	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 9	2012	367	6					488	490		10.1056/NEJMp1203104	http://dx.doi.org/10.1056/NEJMp1203104			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	986AE	22873528	Green Accepted			2022-12-24	WOS:000307310800002
J	Kit, BK; Carroll, MD; Lacher, DA; Sorlie, PD; DeJesus, JM; Ogden, CL				Kit, Brian K.; Carroll, Margaret D.; Lacher, David A.; Sorlie, Paul D.; DeJesus, Janet M.; Ogden, Cynthia L.			Trends in Serum Lipids Among US Youths Aged 6 to 19 Years, 1988-2010	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; CARDIOVASCULAR RISK-FACTORS; UNITED-STATES; CHILDREN; ADOLESCENTS; CHILDHOOD; PREVALENCE; ADULTHOOD; HYPERCHOLESTEROLEMIA; ATHEROSCLEROSIS	Context For more than 20 years, primary prevention of coronary heart disease has included strategies intended to improve overall serum lipid concentrations among youths. Objective To examine trends in lipid concentrations among youths from 19881994 through 2007-2010. Design, Setting, and Participants Cross-sectional analysis of serum lipid concentrations among 16 116 youths aged 6 to 19 years who participated in the nationally representative National Health and Nutrition Examination Survey during 3 time periods: 1988-1994, 1999-2002, and 2007-2010. Main Outcome Measures Among all youths, mean serum total cholesterol (TC), non-high-density lipoprotein cholesterol (non-HDL-C), high-density lipoprotein cholesterol (HDL-C); and among adolescents only, low-density lipoprotein cholesterol (LDL-C) and geometric mean triglyceride levels. Trends in adverse lipid concentrations are reported for TC levels of 200 mg/dL and greater, non-HDL-C levels of 145 mg/dL and greater, HDL-C levels of less than 40 mg/dL, LDL-C levels of 130 mg/dL and greater, and triglyceride levels of 130 mg/dL and greater. Results Among youths aged 6 to 19 years between 1988-1994 and 2007-2010, there was a decrease in mean TC (from 165 mg/dL [95% CI, 164-167] to 160 mg/dL [95% CI, 158-161]; P<.001) and a decrease in the prevalence of elevated TC (from 11.3% [95% CI, 9.8%-12.7%] to 8.1% [95% CI, 6.7%-9.5%]; P=.002). Mean HDL-C significantly increased between 1988-1994 and 2007-2010, but the prevalence of low HDL-C did not change. Mean non-HDL-C and prevalence of elevated non-HDL-C both significantly decreased over the study period. In 2007-2010, 22% (95% CI, 20.3%-23.6%) of youths had either a low HDL-C level or high non-HDL-C, which was lower than the 27.2% (95% CI, 24.6%-29.7%) in 1988-1994 (P=.001). Among adolescents (aged 12-19 years) between 1988-1994 and 2007-2010, there was a decrease in mean LDL-C (from 95 mg/dL [95% CI, 92-98] to 90 mg/dL [95% CI, 88-91]; P=.003) and a decrease in geometric mean triglycerides (from 82 mg/dL [95% CI, 78-86] to 73 mg/dL [95% CI, 70-76]; P<.001). Prevalence of elevated LDL-C and triglycerides between 1988-1994 and 2007-2010 also significantly decreased. Conclusions Between 1988-1994 and 2007-2010, a favorable trend in serum lipid concentrations was observed among youths in the United States but almost 1 in 10 had elevated TC in 2007-2010. JAMA. 2012;308(6):591-600	[Kit, Brian K.; Carroll, Margaret D.; Lacher, David A.; Ogden, Cynthia L.] Ctr Dis Control & Prevent, Div Hlth & Nutr Examinat Surveys, Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA; [Kit, Brian K.] US PHS, Rockville, MD USA; [Sorlie, Paul D.] NHLBI, Div Cardiovasc Sci, NIH, Bethesda, MD 20892 USA; [DeJesus, Janet M.] NHLBI, Div Applicat Res Discoveries, NIH, Bethesda, MD 20892 USA	Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS); United States Public Health Service; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Kit, BK (corresponding author), Ctr Dis Control & Prevent, Div Hlth & Nutr Examinat Surveys, Natl Ctr Hlth Stat, 3311 Toledo Rd,MS PO8,Room 4419, Hyattsville, MD 20782 USA.	bkit@cdc.gov			National Heart, Lung, and Blood Institute, National Institutes of Health [Y1-HC-8039]	National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The laboratory analysis of the lipids described in this paper was funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, Intra-agency Agreement number Y1-HC-8039.	ALLAIN CC, 1974, CLIN CHEM, V20, P470; [Anonymous], 1995, JAMA, V273, P1429; [Anonymous], 1991, ARCH INTERN MED, V151, P1071, DOI 10.1001/archinte.151.6.1071; [Anonymous], 1994, Vital Health Stat 1, P1; [Anonymous], 1992, Pediatrics, V89, P525; [Anonymous], 2011, PEDIATRICS S5, V128, pS213, DOI [10.1542/peds.2009-2107C, DOI 10.1542/PEDS.2009-2107C]; BACHORIK PS, 1984, CLIN CHEM, V30, P839; BERENSON GS, 1981, AM J EPIDEMIOL, V113, P157, DOI 10.1093/oxfordjournals.aje.a113080; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Carroll MD, 2005, JAMA-J AM MED ASSOC, V294, P1773, DOI 10.1001/jama.294.14.1773; Centers for Disease Control and Prevention Division of Adolescent and School Health, 1991, TRENDS PREV TOB US N; Centers for Disease Control and Prevention/National Center for Health Statistics, NHANES 2009 2010 PUB; Centers for Disease Control and Prevention/National Center for Health Statistics, 2010, LAB PROC MAN HIGH DE; Centers for Disease Control and Prevention/National Center for Health Statistics, 2010, LAB PROC MAN TRIGL; Centers for Disease Control and Prevention/National Center for Health Statistics, NHANES 1999 2010; Centers for Disease Control and Prevention/National Center for Health Statistics/Division of Health and Nutrition Surveys, 2010, LAB PROC MAN TOT CHO; Daniels SR, 2008, PEDIATRICS, V122, P198, DOI 10.1542/peds.2008-1349; DONAHUE RP, 1985, AM J EPIDEMIOL, V122, P458, DOI 10.1093/oxfordjournals.aje.a114127; FELDMAN J, 1991, PEDIATRICS, V88, P259; Ford ES, 2009, CIRCULATION, V119, P1108, DOI 10.1161/CIRCULATIONAHA.108.816769; Ford ES, 2004, PEDIATRICS, V114, P1534, DOI 10.1542/peds.2004-0674; Freedman DS, 2012, PEDIATRICS, V130, pE159, DOI 10.1542/peds.2011-3302; Freedman DS, 1999, PEDIATRICS, V103, P1175, DOI 10.1542/peds.103.6.1175; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Friedman LA, 2006, PEDIATRICS, V118, P165, DOI 10.1542/peds.2005-2968; Frontini MG, 2008, PEDIATRICS, V121, P924, DOI 10.1542/peds.2007-1472; Hickman TB, 1998, PREV MED, V27, P879, DOI 10.1006/pmed.1998.0376; Klish WJ, 1998, PEDIATRICS, V101, P141; Kuczmarski RJ, 2002, SERIES-J SPAN ECON, V11, P1, DOI DOI 10.1016/J.BBRC.2015.06.114; LAUER RM, 1990, JAMA-J AM MED ASSOC, V264, P3034, DOI 10.1001/jama.264.23.3034; Li SX, 2003, JAMA-J AM MED ASSOC, V290, P2271, DOI 10.1001/jama.290.17.2271; MCGILL HC, 1990, JAMA-J AM MED ASSOC, V264, P3018; National Center for Health Statistics, NHANES RESP RAT CPS; National Center for Health Statistics, 2010, HLTH US 2010; Neufeld EJ, 1997, CIRCULATION, V96, P1403, DOI 10.1161/01.CIR.96.5.1403; Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.288.14.1728; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Raitakari OT, 2003, JAMA-J AM MED ASSOC, V290, P2277, DOI 10.1001/jama.290.17.2277; Reedy J, 2010, J AM DIET ASSOC, V110, P1477, DOI 10.1016/j.jada.2010.07.010; Research Triangle Institute, SUDAAN LANG MAN REL; Schober S. E., 2008, Morbidity and Mortality Weekly Report, V57, P744; Sofianou A, 2011, J AM DIET ASSOC, V111, P1563, DOI 10.1016/j.jada.2011.07.005; SUGIUCHI H, 1995, CLIN CHEM, V41, P717; The Centers for Disease Control and Prevention /Lipid Standardization Program, 2012, LAB QUAL ASS STAND P; THORLAND WG, 1981, MED SCI SPORT EXER, V13, P316; US Department of Agriculture and US Department of Health and Human Services, 2010, DIET GUID AM 2010; US Dept of Agriculture Agriculture Research Service, PERC EN PROT CARB FA; Vesper HW, 2012, JAMA-J AM MED ASSOC, V307, P562, DOI 10.1001/jama.2012.112; Wahlefeld A.W., 1974, METHODS ENZYMATIC AN, P1604; WEBBER LS, 1991, AM J EPIDEMIOL, V133, P884, DOI 10.1093/oxfordjournals.aje.a115968; Welsh JA, 2011, CIRCULATION, V123, P249, DOI 10.1161/CIRCULATIONAHA.110.972166; Wiegman A, 2004, JAMA-J AM MED ASSOC, V292, P331, DOI 10.1001/jama.292.3.331; Winer BJ, 1971, STAT PRINCIPLES EXPT; Wolters K.M., 1990, VARIANCE ESTIMATION	54	92	95	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2012	308	6					591	600		10.1001/jama.2012.9136	http://dx.doi.org/10.1001/jama.2012.9136			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	984YA	22871871	Bronze			2022-12-24	WOS:000307228400026
J	Kellosalo, J; Kajander, T; Kogan, K; Pokharel, K; Goldman, A				Kellosalo, Juho; Kajander, Tommi; Kogan, Konstantin; Pokharel, Kisun; Goldman, Adrian			The Structure and Catalytic Cycle of a Sodium-Pumping Pyrophosphatase	SCIENCE			English	Article							H+-PYROPHOSPHATASE; SUBSTRATE; K+	Membrane-integral pyrophosphatases (M-PPases) are crucial for the survival of plants, bacteria, and protozoan parasites. They couple pyrophosphate hydrolysis or synthesis to Na+ or H+ pumping. The 2.6-angstrom structure of Thermotoga maritima M-PPase in the resting state reveals a previously unknown solution for ion pumping. The hydrolytic center, 20 angstroms above the membrane, is coupled to the gate formed by the conserved Asp(243), Glu(246), and Lys(707) by an unusual "coupling funnel" of six a helices. Comparison with our 4.0-angstrom resolution structure of the product complex suggests that helix 12 slides down upon substrate binding to open the gate by a simple binding-change mechanism. Below the gate, four helices form the exit channel. Superimposing helices 3 to 6, 9 to 12, and 13 to 16 suggests that M-PPases arose through gene triplication.	[Kellosalo, Juho; Kajander, Tommi; Kogan, Konstantin; Pokharel, Kisun; Goldman, Adrian] Univ Helsinki, Inst Biotechnol, Struct Biol & Biophys Program, FIN-00014 Helsinki, Finland; [Kellosalo, Juho] Grad Sch Informat & Struct Biol, Helsinki, Finland; [Pokharel, Kisun] Univ Turku, Dept Biochem & Food Chem, FIN-20014 Turku, Finland	University of Helsinki; University of Turku	Goldman, A (corresponding author), Univ Helsinki, Inst Biotechnol, Struct Biol & Biophys Program, POB 65, FIN-00014 Helsinki, Finland.	adrian.goldman@helsinki.fi	Pokharel, Kisun/D-4628-2011	Pokharel, Kisun/0000-0002-4924-946X; Kogan, Konstantin/0000-0003-3270-9391; Goldman, Adrian/0000-0001-8032-9700; Kajander, Tommi/0000-0002-5094-227X	European Union Seventh Framework Program EDICT; Sigrid Juselius Foundation; Academy of Finland; Biocenter Finland; National Graduate School of Informational and Structural Biology	European Union Seventh Framework Program EDICT; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Biocenter Finland; National Graduate School of Informational and Structural Biology	We thank D. Bansfield, K. Rosti, and R. Honkanen for technical assistance; S. Maki and the Biocenter Finland crystallization unit; A. Serrano (University of Seville) for the generous gift of plasmid pRS1024; I. Braakman (Utrecht University) for the generous gift of S. cerevisae BJ1991; and R. Kolodziejczyk, M. Wikstrom (University of Helsinki), E. Oksanen (European Spallation Source), and R. Lahti (University of Turku) for fruitful discussions. This work was supported by the European Union Seventh Framework Program EDICT (A.G.), the Sigrid Juselius Foundation (A.G.), the Academy of Finland (A.G. and T.K.), Biocenter Finland (K.K.), and the National Graduate School of Informational and Structural Biology (J.K.). We thank the beamline scientists at ID14-4, ID29, ID23-1 at the European Synchrotron Radiation Facility and at beamline 911-3, Max-Lab. Coordinates and structure factors for the resting state (TmPPase:Ca:Mg) and product complex (TmPPase:Pi<INF>2</INF>:Mg<INF>4</INF>) structures have been deposited in the Protein Data Bank with codes 4AV3 and 4AV6, respectively. The authors declare no competing financial interests.	AGMON N, 1995, CHEM PHYS LETT, V244, P456, DOI 10.1016/0009-2614(95)00905-J; Baltscheffsky M, 1999, FEBS LETT, V457, P525, DOI 10.1016/S0014-5793(99)00914-X; BAYKOV AA, 1994, FEBS LETT, V350, P323, DOI 10.1016/0014-5793(94)00800-0; BAYKOV AA, 1993, EUR J BIOCHEM, V217, P755, DOI 10.1111/j.1432-1033.1993.tb18303.x; Belogurov GA, 2002, J BIOL CHEM, V277, P49651, DOI 10.1074/jbc.M210341200; Hedlund J, 2006, FEBS J, V273, P5183, DOI 10.1111/j.1742-4658.2006.05514.x; Heikinheimo P, 1996, STRUCTURE, V4, P1491, DOI 10.1016/S0969-2126(96)00155-4; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Kellosalo J, 2011, PROTEIN EXPRES PURIF, V79, P25, DOI 10.1016/j.pep.2011.05.020; Lanyi JK, 2006, BBA-BIOENERGETICS, V1757, P1012, DOI 10.1016/j.bbabio.2005.11.003; Lemercier G, 2002, J BIOL CHEM, V277, P37369, DOI 10.1074/jbc.M204744200; Lin SM, 2012, NATURE, V484, P399, DOI 10.1038/nature10963; Luoto HH, 2011, J BIOL CHEM, V286, P21633, DOI 10.1074/jbc.M111.244483; Maeshima M, 2000, BBA-BIOMEMBRANES, V1465, P37, DOI 10.1016/S0005-2736(00)00130-9; Malinen AM, 2007, BIOCHEMISTRY-US, V46, P8872, DOI 10.1021/bi700564b; Malinen AM, 2008, BIOCHEMISTRY-US, V47, P13447, DOI 10.1021/bi801803b; Mimura H, 2004, J BIOL CHEM, V279, P35106, DOI 10.1074/jbc.M406264200; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Stock D, 2000, CURR OPIN STRUC BIOL, V10, P672, DOI 10.1016/S0959-440X(00)00147-0	20	100	102	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2012	337	6093					473	476		10.1126/science.1222505	http://dx.doi.org/10.1126/science.1222505			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979FS	22837527				2022-12-24	WOS:000306802300045
J	Phillips, R; Hancock, B; Graham, J; Bromham, N; Jin, HJ; Berendse, S				Phillips, Robert; Hancock, Barry; Graham, John; Bromham, Nathan; Jin, Huajie; Berendse, Sabine			Prevention and management of neutropenic sepsis in patients with cancer: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Graham, John; Bromham, Nathan; Jin, Huajie; Berendse, Sabine] Natl Collaborating Ctr Canc, Cardiff CF10 3AF, S Glam, Wales; [Phillips, Robert] Leeds Gen Infirm, Leeds LS1 3EX, W Yorkshire, England; [Hancock, Barry] Univ Sheffield, Weston Pk Hosp, Sheffield S10 2SJ, S Yorkshire, England; [Graham, John] Taunton & Somerset NHS Fdn Trust, Taunton TA1 5DA, Somerset, England	Leeds General Infirmary; University of Leeds; University of Sheffield; Weston Park Hospital	Graham, J (corresponding author), Natl Collaborating Ctr Canc, Cardiff CF10 3AF, S Glam, Wales.	john.graham@nhs.net	; Jin, Huajie/J-1332-2014	Graham, John/0000-0003-3381-9787; Jin, Huajie/0000-0002-3872-3998; Bromham, Nathan/0000-0003-2165-4188	MRC [G0800472] Funding Source: UKRI; Medical Research Council [G0800472] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Dommett R, 2009, EUR J CANCER, V45, P2843, DOI 10.1016/j.ejca.2009.06.003; Klastersky J, 2000, J CLIN ONCOL, V18, P3038, DOI 10.1200/JCO.2000.18.16.3038; Kuderer NM, 2006, CANCER-AM CANCER SOC, V106, P2258, DOI 10.1002/cncr.21847; National Cancer Action Team, 2011, MAN CANC SERV AC ONC; National Chemotherapy Advisory Group, 2010, CHEM SERV ENGL ENS Q; National Confidential Enquiry into Patient Outcome and Death, 2008, SYST ANT THER BETT W; National Institute of Health and Clinical Excellence, 2012, NEUTR SEPS PREV MAN	7	36	37	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 19	2012	345								e5368	10.1136/bmj.e5368	http://dx.doi.org/10.1136/bmj.e5368			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	011JI	22993392	Green Submitted			2022-12-24	WOS:000309160500001
J	Franchi, L; Nunez, G				Franchi, Luigi; Nunez, Gabriel			Orchestrating Inflammasomes	SCIENCE			English	Editorial Material							III SECRETION APPARATUS; INNATE IMMUNE RECEPTOR; NLRC4 INFLAMMASOME; HOST TARGET; ACTIVATION; FLAGELLIN; INTERLEUKIN-1-BETA; RECOGNITION; CASPASE-1; IPAF		[Franchi, Luigi] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Comprehens Canc Ctr, Dept Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Franchi, L (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	bclx@umich.edu	Nuñez, Gabriel/A-7160-2014		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091191] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK091191] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Chung EH, 2011, CELL HOST MICROBE, V9, P125, DOI 10.1016/j.chom.2011.01.009; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Liu J, 2011, CELL HOST MICROBE, V9, P137, DOI 10.1016/j.chom.2011.01.010; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Qu Y, 2012, NATURE, V490, P539, DOI 10.1038/nature11429; Rairdan GJ, 2006, PLANT CELL, V18, P2082, DOI 10.1105/tpc.106.042747; Tanabe T, 2004, EMBO J, V23, P1587, DOI 10.1038/sj.emboj.7600175; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	13	51	52	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2012	337	6100					1299	1300		10.1126/science.1229010	http://dx.doi.org/10.1126/science.1229010			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	004TW	22984056	Green Accepted			2022-12-24	WOS:000308705000026
J	Kennedy, BS; Bedard, B; Younge, M; Tuttle, D; Ammerman, E; Ricci, J; Doniger, AS; Escuyer, VE; Mitchell, K; Noble-Wang, JA; O'Connell, HA; Lanier, WA; Katz, LM; Betts, RF; Mercurio, MG; Scott, GA; Lewis, MA; Goldgeier, MH				Kennedy, Byron S.; Bedard, Brenden; Younge, Mary; Tuttle, Deborah; Ammerman, Eric; Ricci, John; Doniger, Andrew S.; Escuyer, Vincent E.; Mitchell, Kara; Noble-Wang, Judith A.; O'Connell, Heather A.; Lanier, William A.; Katz, Linda M.; Betts, Robert F.; Mercurio, Mary Gail; Scott, Glynis A.; Lewis, Matthew A.; Goldgeier, Mark H.			Outbreak of Mycobacterium chelonae Infection Associated with Tattoo Ink	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RAPIDLY GROWING MYCOBACTERIA; ATYPICAL MYCOBACTERIA; SKIN INFECTION; ABSCESSUS; IDENTIFICATION; PATTERNS; VECTOR	Background In January 2012, on the basis of an initial report from a dermatologist, we began to investigate an outbreak of tattoo-associated Mycobacterium chelonae skin and soft-tissue infections in Rochester, New York. The main goals were to identify the extent, cause, and form of transmission of the outbreak and to prevent further cases of infection. Methods We analyzed data from structured interviews with the patients, histopathological testing of skin-biopsy specimens, acid-fast bacilli smears, and microbial cultures and antimicrobial susceptibility testing. We also performed DNA sequencing, pulsed-field gel electrophoresis (PFGE), cultures of the ink and ingredients used in the preparation and packaging of the ink, assessment of source water and faucets at tattoo parlors, and investigation of the ink manufacturer. Results Between October and December 2011, a persistent, raised, erythematous rash in the tattoo area developed in 19 persons (13 men and 6 women) within 3 weeks after they received a tattoo from a single artist who used premixed gray ink; the highest occurrence of tattooing and rash onset was in November (accounting for 15 and 12 patients, respectively). The average age of the patients was 35 years (range, 18 to 48). Skin-biopsy specimens, obtained from 17 patients, showed abnormalities in all 17, with M. chelonae isolated from 14 and confirmed by means of DNA sequencing. PFGE analysis showed indistinguishable patterns in 11 clinical isolates and one of three unopened bottles of premixed ink. Eighteen of the 19 patients were treated with appropriate antibiotics, and their condition improved. Conclusions The premixed ink was the common source of infection in this outbreak. These findings led to a recall by the manufacturer.	[Kennedy, Byron S.; Bedard, Brenden; Younge, Mary; Tuttle, Deborah; Ammerman, Eric; Ricci, John; Doniger, Andrew S.] Monroe Cty Dept Publ Hlth, Rochester, NY 14620 USA; [Escuyer, Vincent E.; Mitchell, Kara] New York State Dept Hlth, Albany, NY USA; [Betts, Robert F.; Mercurio, Mary Gail; Scott, Glynis A.; Lewis, Matthew A.] Univ Rochester, Med Ctr, Rochester, NY 14642 USA; [Goldgeier, Mark H.] Clinton Crossings Dermatol, Rochester, NY USA; [Noble-Wang, Judith A.; O'Connell, Heather A.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Lanier, William A.; Katz, Linda M.] US FDA, College Pk, MD USA	State University of New York (SUNY) System; University of Rochester; Centers for Disease Control & Prevention - USA; US Food & Drug Administration (FDA)	Kennedy, BS (corresponding author), Monroe Cty Dept Publ Hlth, 111 Westfall Rd,Rm 950, Rochester, NY 14620 USA.	bkennedy@monroecounty.gov		Moulton-Meissner, Heather/0000-0002-0728-2552				Adekambi T, 2003, J CLIN MICROBIOL, V41, P5699, DOI 10.1128/JCM.41.12.5699-5708.2003; Bechara C, 2010, DERMATOLOGY, V221, P1, DOI 10.1159/000313974; Binic I, 2011, AM J CLIN DERMATOL, V12, P404, DOI 10.2165/11589500-000000000-00000; Brown-Elliott BA, 2002, CLIN MICROBIOL REV, V15, P716, DOI 10.1128/CMR.15.4.716-746.2002; Drage LA, 2010, J AM ACAD DERMATOL, V62, P501, DOI 10.1016/j.jaad.2009.03.034; Goldman J, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c5483; Hamsch C, 2011, ACTA DERM-VENEREOL, V91, P63, DOI 10.2340/00015555-1015; Hay RJ, 2009, CURR OPIN INFECT DIS, V22, P99, DOI 10.1097/QCO.0b013e328322b440; Hogsberg T, 2011, J EUR ACAD DERMATOL; Kappel S, 2011, J AM ACAD DERMATOL, V64, P998, DOI 10.1016/j.jaad.2009.08.029; Kay MK, 2011, EMERG INFECT DIS, V17, P1734, DOI 10.3201/eid1709.102011; Kluger N, 2008, ARCH DERMATOL, V144, P941, DOI 10.1001/archderm.144.7.941; Martin A, 2007, J MICROBIOL METH, V71, P39, DOI 10.1016/j.mimet.2007.07.008; Meyers H, 2002, CLIN INFECT DIS, V34, P1500, DOI 10.1086/340399; Mitchell Charles B, 2011, J Am Acad Dermatol, V64, pe70, DOI 10.1016/j.jaad.2009.12.037; Preda VA, 2009, MED J AUSTRALIA, V190, P278, DOI 10.5694/j.1326-5377.2009.tb02396.x; Ricciardo B, 2010, AUSTRALAS J DERMATOL, V51, P287, DOI 10.1111/j.1440-0960.2010.00659.x; Rodriguez-Blanco I, 2011, ACTA DERM-VENEREOL, V91, P61, DOI 10.2340/00015555-1034; SAFRANEK TJ, 1987, NEW ENGL J MED, V317, P197, DOI 10.1056/NEJM198707233170403; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Vanitha JD, 2003, APPL ENVIRON MICROB, V69, P4337, DOI 10.1128/AEM.69.7.4337-4341.2003; WALLACE RJ, 1993, J CLIN MICROBIOL, V31, P2697, DOI 10.1128/JCM.31.10.2697-2701.1993; WENGER JD, 1990, JAMA-J AM MED ASSOC, V264, P373, DOI 10.1001/jama.264.3.373; Winthrop KL, 2002, NEW ENGL J MED, V346, P1366, DOI 10.1056/NEJMoa012643; Wolf R, 2003, J AM ACAD DERMATOL, V48, pS73, DOI 10.1067/mjd.2003.166	25	79	84	4	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2012	367	11					1020	1024		10.1056/NEJMoa1205114	http://dx.doi.org/10.1056/NEJMoa1205114			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003ZE	22913660				2022-12-24	WOS:000308649100008
J	Yu, DB; Pendergraff, H; Liu, J; Kordasiewicz, HB; Cleveland, DW; Swayze, EE; Lima, WF; Crooke, ST; Prakash, TP; Corey, DR				Yu, Dongbo; Pendergraff, Hannah; Liu, Jing; Kordasiewicz, Holly B.; Cleveland, Don W.; Swayze, Eric E.; Lima, Walt F.; Crooke, Stanley T.; Prakash, Thazha P.; Corey, David R.			Single-Stranded RNAs Use RNAi to Potently and Allele-Selectively Inhibit Mutant Huntingtin Expression	CELL			English	Article							EXPANDED CAG REPEATS; TRINUCLEOTIDE REPEAT; EMBRYONIC LETHALITY; GENE-EXPRESSION; MESSENGER-RNAS; DISEASE GENES; MOUSE MODEL; INTERFERENCE; ANTISENSE; SIRNAS	Mutant huntingtin (HTT) protein causes Huntington disease (HD), an incurable neurological disorder. Silencing mutant HTT using nucleic acids would eliminate the root cause of HD. Developing nucleic acid drugs is challenging, and an ideal clinical approach to gene silencing would combine the simplicity of single-stranded antisense oligonucleotides with the efficiency of RNAi. Here, we describe RNAi by single-stranded siRNAs (ss-siRNAs). ss-siRNAs are potent (>100-fold more than unmodified RNA) and allele-selective (>30-fold) inhibitors of mutant HTT expression in cells derived from HD patients. Strategic placement of mismatched bases mimics micro-RNA recognition and optimizes discrimination between mutant and wild-type alleles. ss-siRNAs require Argonaute protein and function through the RNAi pathway. Intraventricular infusion of ss-siRNA produced selective silencing of the mutant HTT allele throughout the brain in a mouse HD model. These data demonstrate that chemically modified ss-siRNAs function through the RNAi pathway and provide allele-selective compounds for clinical development.	[Yu, Dongbo; Pendergraff, Hannah; Liu, Jing; Corey, David R.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Yu, Dongbo; Pendergraff, Hannah; Liu, Jing; Corey, David R.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Kordasiewicz, Holly B.; Cleveland, Don W.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Kordasiewicz, Holly B.; Swayze, Eric E.; Lima, Walt F.; Crooke, Stanley T.; Prakash, Thazha P.] ISIS Pharmaceut, Carlsbad, CA 92010 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Diego; Isis Pharmaceuticals Inc	Corey, DR (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	david.corey@utsouthwestern.edu	Cleveland, Don/AAN-9783-2021	Cleveland, Don/0000-0002-1934-3682; Swayze, Eric/0000-0001-6430-6576	US National Institutes of Health [NIGMS 73042]; McKnight Foundation for Neuroscience; CHDI Foundation Inc.; Robert A. Welch Foundation [I-1244]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073042] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Foundation for Neuroscience; CHDI Foundation Inc.; Robert A. Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work in the Corey Laboratory was supported by the US National Institutes of Health (NIGMS 73042), an award from the McKnight Foundation for Neuroscience, CHDI Foundation Inc., and the Robert A. Welch Foundation (I-1244). We thank Dr. Hui Tian and Haoming Liu of Qinghua Liu's Lab for generously providing us with recombinant hAgo2 proteins and the training on Ago2 activity assay and Dr. Keith Gagnon for helpful comments and for assistance setting up the in vitro AGO2 and RNAse H assays. The authors have filed a patent application related to this research.	Boudreau RL, 2009, MOL THER, V17, P1053, DOI 10.1038/mt.2009.17; Braasch DA, 2003, BIOCHEMISTRY-US, V42, P7967, DOI 10.1021/bi0343774; Broderick JA, 2011, RNA, V17, P1858, DOI 10.1261/rna.2778911; Carroll JB, 2011, MOL THER, V19, P2178, DOI 10.1038/mt.2011.201; Davidson BL, 2011, NAT REV GENET, V12, P329, DOI 10.1038/nrg2968; de Mezer M, 2011, NUCLEIC ACIDS RES, V39, P3852, DOI 10.1093/nar/gkq1323; DiFiglia M, 2007, P NATL ACAD SCI USA, V104, P17204, DOI 10.1073/pnas.0708285104; Drouet V, 2009, ANN NEUROL, V65, P276, DOI 10.1002/ana.21569; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Finkbeiner S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007476; Fiszer A, 2011, NUCLEIC ACIDS RES, V39, P5578, DOI 10.1093/nar/gkr156; Gagnon KT, 2011, J AM CHEM SOC, V133, P8404, DOI 10.1021/ja200312y; Gagnon KT, 2010, BIOCHEMISTRY-US, V49, P10166, DOI 10.1021/bi101208k; Godin JD, 2010, NEURON, V67, P392, DOI 10.1016/j.neuron.2010.06.027; Hall AHS, 2006, NUCLEIC ACIDS RES, V34, P2773, DOI 10.1093/nar/gkl339; Haringsma HJ, 2012, NUCLEIC ACIDS RES, V40, P4125, DOI 10.1093/nar/gkr1301; Harper SQ, 2005, P NATL ACAD SCI USA, V102, P5820, DOI 10.1073/pnas.0501507102; Holen T, 2003, NUCLEIC ACIDS RES, V31, P2401, DOI 10.1093/nar/gkg338; Hu JX, 2011, BIOL CHEM, V392, P315, DOI 10.1515/BC.2011.045; Hu JX, 2010, CHEM BIOL, V17, P1183, DOI 10.1016/j.chembiol.2010.10.013; Hu JX, 2009, NAT BIOTECHNOL, V27, P478, DOI 10.1038/nbt.1539; Huang K, 2011, HUM MOL GENET, V20, P3356, DOI 10.1093/hmg/ddr242; Kordasiewicz HB, 2012, NEURON, V74, P1031, DOI 10.1016/j.neuron.2012.05.009; Kozlowski P, 2010, NUCLEIC ACIDS RES, V38, P4027, DOI 10.1093/nar/gkq127; KREMER B, 1994, NEW ENGL J MED, V330, P1401, DOI 10.1056/NEJM199405193302001; Krzyzosiak WJ, 2012, NUCLEIC ACIDS RES, V40, P11, DOI 10.1093/nar/gkr729; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lima WF, 2012, CELL, V150, P883, DOI 10.1016/j.cell.2012.08.014; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Lombardi MS, 2009, EXP NEUROL, V217, P312, DOI 10.1016/j.expneurol.2009.03.004; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Matsui M, 2012, DRUG DISCOV TODAY, V17, P443, DOI 10.1016/j.drudis.2012.01.006; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Michlewski G, 2004, J MOL BIOL, V340, P665, DOI 10.1016/j.jmb.2004.05.021; Miller VM, 2003, P NATL ACAD SCI USA, V100, P7195, DOI 10.1073/pnas.1231012100; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; Omi K, 2005, BIOCHEM BIOPH RES CO, V338, P1229, DOI 10.1016/j.bbrc.2005.10.061; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Pfister EL, 2009, CURR BIOL, V19, P774, DOI 10.1016/j.cub.2009.03.030; Sah DWY, 2011, J CLIN INVEST, V121, P500, DOI 10.1172/JCI45130; Schwarz DS, 2006, PLOS GENET, V2, P1307, DOI 10.1371/journal.pgen.0020140; Schwarz DS, 2002, MOL CELL, V10, P537, DOI 10.1016/S1097-2765(02)00651-2; van Bilsen PHJ, 2008, HUM GENE THER, V19, P710, DOI 10.1089/hum.2007.116; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Warby SC, 2009, AM J HUM GENET, V84, P351, DOI 10.1016/j.ajhg.2009.02.003; Watts JK, 2012, J PATHOL, V226, P365, DOI 10.1002/path.2993; White JK, 1997, NAT GENET, V17, P404, DOI 10.1038/ng1297-404; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155	52	202	241	0	45	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 31	2012	150	5					895	908		10.1016/j.cell.2012.08.002	http://dx.doi.org/10.1016/j.cell.2012.08.002			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22939619	Green Accepted, Bronze			2022-12-24	WOS:000308500200006
J	Humphries, C				Humphries, Courtney			SCREENING Testing times	NATURE			English	Editorial Material																			0	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2012	488	7413					S8	S9		10.1038/488S8a	http://dx.doi.org/10.1038/488S8a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	996NC	22932440	Bronze			2022-12-24	WOS:000308095100007
J	Pronovost, PJ; Bo-Linn, GW				Pronovost, Peter J.; Bo-Linn, George W.			Preventing Patient Harms Through Systems of Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INTENSIVE-CARE		[Pronovost, Peter J.] Johns Hopkins Univ, Dept Hlth Policy & Management, Armstrong Inst Patient Safety & Qual, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [Pronovost, Peter J.] Johns Hopkins Carey Business Sch, Baltimore, MD 21218 USA; [Bo-Linn, George W.] Gordon & Betty Moore Fdn, Patient Care Program, Palo Alto, CA USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Pronovost, PJ (corresponding author), Johns Hopkins Med Inst, Dept Anesthesiol & Crit Care Med, 1909 Thames St,2nd Floor, Baltimore, MD 21231 USA.	ppronovo@jhmi.edu						Classen DC, 2011, HEALTH AFFAIR, V30, P581, DOI 10.1377/hlthaff.2011.0190; Emanuel EJ, 2012, JAMA-J AM MED ASSOC, V307, P39, DOI 10.1001/jama.2011.1927; Grossman C., 2011, ENG LEARNING HEALTHC; Gurses AP, 2008, QUAL SAF HEALTH CARE, V17, P351, DOI 10.1136/qshc.2006.021709; Pronovost P J, 2001, Eff Clin Pract, V4, P199; Pronovost PJ, 2010, AM J RESP CRIT CARE, V182, P1463, DOI 10.1164/rccm.201008-1255ED; US Department of Health and Human Services, PARTN PAT LEARN OUR	7	47	51	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2012	308	8					769	770		10.1001/jama.2012.9537	http://dx.doi.org/10.1001/jama.2012.9537			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	991ML	22910751				2022-12-24	WOS:000307705300017
J	Spence, D				Spence, Des			Unhappy pills	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SEROTONIN REUPTAKE INHIBITORS; DEPRESSION; SEVERITY					destwo@yahoo.co.uk						Arroll B, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007954; Borland S, 2012, DAILY MAIL; Deshauer D, 2008, CAN MED ASSOC J, V178, P1293, DOI 10.1503/cmaj.071068; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Geddes JR, 2003, LANCET, V361, P653, DOI 10.1016/S0140-6736(03)12599-8; Haddad PM., 2007, ADV PSYCHIAT TREATME, V13, P447, DOI [10.1192/apt.bp.105.001966, DOI 10.1192/APT.BP.105.001966]; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; NHS Health and Social Care Information Centre, 2012, PRESCR DISP COMM ENG; *NHS HLTH SOC CAR, 2006, PRESCR COST AN ENGL; Reid IC., 2011, BMJ; Reid S, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1468	11	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 10	2012	345								e5409	10.1136/bmj.e5409	http://dx.doi.org/10.1136/bmj.e5409			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988NG	22885400				2022-12-24	WOS:000307497100004
J	Layden, J; Michaels, J; Bermingham, S; Higgins, B				Layden, Jennifer; Michaels, Jonathan; Bermingham, Sarah; Higgins, Bernard		Guideline Dev Grp	Diagnosis and management of lower limb peripheral arterial disease: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Michaels, Jonathan] Univ Sheffield, Sheffield S10 2TN, S Yorkshire, England; [Layden, Jennifer; Bermingham, Sarah; Higgins, Bernard] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England	University of Sheffield; Royal College of Physicians	Michaels, J (corresponding author), Univ Sheffield, Sheffield S10 2TN, S Yorkshire, England.	j.michaels@sheffield.ac.uk						[Anonymous], 2008, GUID PROM CREAT PHYS; [Anonymous], 2008, INT GUID WORKPL HLTH; Cayir A., 2018, INTERNAL MED REV, V4, DOI [10.18103/imr.v4i12.776, DOI 10.18103/IMR.V4I12.776]; Leng GC, 1996, INT J EPIDEMIOL, V25, P1172, DOI 10.1093/ije/25.6.1172; *NAT I HLTH CLIN E, 2007, EZ TREATM PRIM HET F; National Institute for Health and Clinical Excellence, 2008, SMOK CESS SERV PRIM; National Institute for Health and Clinical Excellence, 2008, CARD RISK ASS MOD BL; National Institute for Health and Clinical Excellence, 2010, CLOP MOD REL DIP PRE; National Institute for Health and Clinical Excellence, 2011, HYPERT CLIN MAN PRI; National Institute for Health and Clinical Excellence, 2006, BRIEF INT REF SMOK C; National Institute for Health and Clinical Excellence, 2009, GUID MAN; National Institute for Health and Clinical Excellence, 2007, VAR SMOK CESS TECHN; National Institute for Health and Clinical Excellence, 2008, SOC VAL JUDG PRINC D, V2nd; National Institute for Health and Clinical Excellence, 2008, GUID PREV UPT SMOK C; National Institute for Health and Clinical Excellence, 2011, PREV TYP 2 DIAB POP; National Institute for Health and Clinical Excellence, 2012, LOW LIMB PER ART DIS; National Institute for Health and Clinical Excellence, 2003, CLIN EFF COST EFF PA; National Institute for Health and Clinical Excellence, 2006, STAT PREV CARD EV PA; National Institute for Health and Clinical Excellence, 2011, DIAB FOOT INP MAN PE; National Institute for Health and Clinical Excellence, 2008, TYP 2 DIAB MAN TYP 2; National Institute for Health & Clinical Excellence, 2006, 4 COMM US METH INCR; National Institute for HealthandClinical Excellence, 2006, OB PREV ID ASS MAN O; The Vascular Society of Great Britain and Ireland: the provision of services for patients with vascular disease, 2012, VAS SOC GREAT BRIT I	23	94	95	0	17	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 8	2012	345								e4947	10.1136/bmj.e4947	http://dx.doi.org/10.1136/bmj.e4947			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	988ND	22875949				2022-12-24	WOS:000307496800006
J	Woloshin, S; Schwartz, LM				Woloshin, Steven; Schwartz, Lisa M.			NOT SO STORIES How a charity oversells mammography	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BREAST-CANCER		[Woloshin, Steven; Schwartz, Lisa M.] Dept Vet Affairs Med Ctr, VA Outcomes Grp, White River Jct, VT 05009 USA; [Woloshin, Steven; Schwartz, Lisa M.] Dartmouth Inst Hlth Policy & Clin Practice, Ctr Med & Media, Lebanon, NH USA	VA Outcomes Group; Dartmouth College	Woloshin, S (corresponding author), Dept Vet Affairs Med Ctr, VA Outcomes Grp, White River Jct, VT 05009 USA.	Lisa.Schwartz@dartmouth.edu						Elmore G, 1998, NEW ENGL J MED, V338, P1089, DOI 10.1056/NEJM199804163381601; Esserman L, 2009, JAMA-J AM MED ASSOC, V302, P1685, DOI 10.1001/jama.2009.1498; Gotzsche PC, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub2; Hofvind S, 2008, JNCI-J NATL CANCER I, V100, P1082, DOI 10.1093/jnci/djn224; Kolata G, 2011, NY TIMES        0330, pA21; Nelson HD, SCREENING BREAST CAN; NHS Cancer Screening Programmes, 2011, BREAST CANC SCREEN I; Singer N, 2011, NY TIMES        0330; Susan G Komen for the Cure, AB US; Susan G Komen For the Cure, 2011, SG KOM CUR WORLDS LA; US Department of Health and Human Services, HEALTHF GOV NAT HLTH; Wegwarth O, 2012, ANN INTERN MED, V156, P340, DOI 10.7326/0003-4819-156-5-201203060-00005; Welch HG, 2007, ARCH INTERN MED, V167, P2289, DOI 10.1001/archinte.167.21.2289; Welch HG, 2000, JAMA-J AM MED ASSOC, V283, P2975, DOI 10.1001/jama.283.22.2975; Zackrisson S, 2006, BRIT MED J, V332, P689, DOI 10.1136/bmj.38764.572569.7C	15	38	39	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 2	2012	345								e5132	10.1136/bmj.e5132	http://dx.doi.org/10.1136/bmj.e5132			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	985XE	22859787				2022-12-24	WOS:000307303000001
J	Hyatt, LA				Hyatt, Laura A.			Personal Plants: Making Botany Meaningful by Experimentation	SCIENCE			English	Editorial Material									Rider Univ, Coll Liberal Arts Educ & Sci, Lawrenceville, NJ 08648 USA	Rider University	Hyatt, LA (corresponding author), Rider Univ, Coll Liberal Arts Educ & Sci, 2083 Lawrenceville Rd, Lawrenceville, NJ 08648 USA.	lhyatt@rider.edu						Garnett T, 2011, FOOD POLICY, V36, pS23, DOI 10.1016/j.foodpol.2010.10.010; Houghton RA, 1998, GLOBAL BIOGEOCHEM CY, V12, P25, DOI 10.1029/97GB02729; Senchina D. S., 2008, PLANT SCI B, V54, P50; UNO GE, 1994, AM BIOL TEACH, V56, P263, DOI 10.2307/4449818; World Health Organization/UN Food and Agriculture Organization, 2003, WHO TECH REP SER	5	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2012	337	6102					1620	1621		10.1126/science.1215226	http://dx.doi.org/10.1126/science.1215226			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	23019642				2022-12-24	WOS:000309215400035
J	Babu, M; Vlasblom, J; Pu, SY; Guo, XH; Graham, C; Bean, BDM; Burston, HE; Vizeacoumar, FJ; Snider, J; Phanse, S; Fong, V; Tam, YYC; Davey, M; Hnatshak, O; Bajaj, N; Chandran, S; Punna, T; Christopolous, C; Wong, V; Yu, A; Zhong, GQ; Li, J; Stagljar, I; Conibear, E; Wodak, SJ; Emili, A; Greenblatt, JF				Babu, Mohan; Vlasblom, James; Pu, Shuye; Guo, Xinghua; Graham, Chris; Bean, Bjoern D. M.; Burston, Helen E.; Vizeacoumar, Franco J.; Snider, Jamie; Phanse, Sadhna; Fong, Vincent; Tam, Yuen Yi C.; Davey, Michael; Hnatshak, Olha; Bajaj, Navgeet; Chandran, Shamanta; Punna, Thanuja; Christopolous, Constantine; Wong, Victoria; Yu, Analyn; Zhong, Gouqing; Li, Joyce; Stagljar, Igor; Conibear, Elizabeth; Wodak, Shoshana J.; Emili, Andrew; Greenblatt, Jack F.			Interaction landscape of membrane-protein complexes in Saccharomyces cerevisiae	NATURE			English	Article							PHYSICAL INTERACTOME; ER EXIT; YEAST; MAP; EXPLORATION; SELECTION	Macromolecular assemblies involving membrane proteins (MPs) serve vital biological roles and are prime drug targets in a variety of diseases(1). Large-scale affinity purification studies of soluble-protein complexes have been accomplished for diverse model organisms, but no global characterization of MP-complex membership has been described so far. Here we report a complete survey of 1,590 putative integral, peripheral and lipid-anchored MPs from Saccharomyces cerevisiae, which were affinity purified in the presence of non-denaturing detergents. The identities of the co-purifying proteins were determined by tandem mass spectrometry and subsequently used to derive a high-confidence physical interaction map encompassing 1,726 membrane protein-protein interactions and 501 putative heteromeric complexes associated with the various cellular membrane systems. Our analysis reveals unexpected physical associations underlying the membrane biology of eukaryotes and delineates the global topological landscape of the membrane interactome.	[Bean, Bjoern D. M.; Burston, Helen E.; Tam, Yuen Yi C.; Davey, Michael; Conibear, Elizabeth] Univ British Columbia, Child & Family Res Inst, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 4H4, Canada; [Babu, Mohan; Guo, Xinghua; Graham, Chris; Vizeacoumar, Franco J.; Snider, Jamie; Phanse, Sadhna; Fong, Vincent; Hnatshak, Olha; Bajaj, Navgeet; Chandran, Shamanta; Punna, Thanuja; Christopolous, Constantine; Wong, Victoria; Yu, Analyn; Zhong, Gouqing; Li, Joyce; Stagljar, Igor; Emili, Andrew; Greenblatt, Jack F.] Univ Toronto, Donnelly Ctr, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Babu, Mohan] Univ Regina, Res & Innovat Ctr, Dept Biochem, Regina, SK S4S 0A2, Canada; [Vlasblom, James; Pu, Shuye; Wodak, Shoshana J.] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Vlasblom, James; Stagljar, Igor; Wodak, Shoshana J.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Stagljar, Igor; Wodak, Shoshana J.; Emili, Andrew; Greenblatt, Jack F.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada	Child & Family Research Institute; University of British Columbia; University of Toronto; University of Regina; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Conibear, E (corresponding author), Univ British Columbia, Child & Family Res Inst, Ctr Mol Med & Therapeut, 950 W 28th Ave, Vancouver, BC V5Z 4H4, Canada.	conibear@cmmt.ubc.ca; shoshana@sickkids.ca; andrew.emili@utoronto.ca; jack.greenblatt@utoronto.ca	Mohan, Babu P./I-7362-2019; Vizeacoumar, Franco/GLS-7161-2022	Conibear, Elizabeth/0000-0001-5129-0499; wodak, shoshana/0000-0002-0701-6545; Davey, Michael/0000-0002-1172-5934; Phanse, Sadhna/0000-0001-6306-0551	Canadian Foundation for Innovation; Canadian Institutes of Health Research (CIHR MOP) [81156, 64394, 82940]; Canadian Cancer Society Research Institute; Heart and Stroke Foundation; Cystic Fibrosis Foundation; Novartis; Ontario Genomics Institute; Genome Canada; SickKids Foundation	Canadian Foundation for Innovation(Canada Foundation for Innovation); Canadian Institutes of Health Research (CIHR MOP)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Heart and Stroke Foundation(Heart & Stroke Foundation of Canada); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Novartis(Novartis); Ontario Genomics Institute; Genome Canada(Genome Canada); SickKids Foundation	We thank H. Riezman, K. Sato and A. Nakano for providing strains and reagents, C. Ungermann for Sec18 antisera, A. Pierleoni for assistance with MemPype and R. Zheng for technical assistance. This research was supported by grants from the Canadian Foundation for Innovation, the Canadian Institutes of Health Research (CIHR MOP no. 81156, MOP no. 64394 and MOP no. 82940), the Canadian Cancer Society Research Institute, the Heart and Stroke Foundation, the Cystic Fibrosis Foundation, Novartis, the Ontario Genomics Institute and Genome Canada. E. C. is a CIHR New Investigator. S.J.W. is a Canada Research Chair Tier-I and acknowledges support from the SickKids Foundation.	Aguilar PS, 2010, NAT STRUCT MOL BIOL, V17, P901, DOI 10.1038/nsmb.1829; Babu M, 2009, METHODS MOL BIOL, V548, P187, DOI 10.1007/978-1-59745-540-4_11; Bao LY, 2009, MOL MEMBR BIOL, V26, P127, DOI 10.1080/09687680802637652; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Conibear E, 2002, METHOD ENZYMOL, V351, P408; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Flinn RJ, 2010, CELL CYCLE, V9, P1869, DOI 10.4161/cc.9.10.11679; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; James P, 1996, GENETICS, V144, P1425; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lam KKY, 2006, J CELL BIOL, V174, P19, DOI 10.1083/jcb.200602049; Li ZJ, 2011, NAT BIOTECHNOL, V29, P361, DOI 10.1038/nbt.1832; Mewes HW, 2006, NUCLEIC ACIDS RES, V34, pD169, DOI 10.1093/nar/gkj148; Miller JP, 2005, P NATL ACAD SCI USA, V102, P12123, DOI 10.1073/pnas.0505482102; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Page LJ, 1999, J CELL BIOL, V146, P993, DOI 10.1083/jcb.146.5.993; Paumi CM, 2007, MOL CELL, V26, P15, DOI 10.1016/j.molcel.2007.03.011; Pieper U, 2011, NUCLEIC ACIDS RES, V39, pD465, DOI 10.1093/nar/gkq1091; Pu SY, 2007, PROTEOMICS, V7, P944, DOI 10.1002/pmic.200600636; Pu SY, 2009, NUCLEIC ACIDS RES, V37, P825, DOI 10.1093/nar/gkn1005; Reguly Teresa, 2006, J Biol, V5, P11, DOI 10.1186/jbiol36; Renard HF, 2010, TRAFFIC, V11, P931, DOI 10.1111/j.1600-0854.2010.01070.x; Rose MD., 1990, METHODS YEAST GENETI; Sato K, 2002, MOL BIOL CELL, V13, P2518, DOI 10.1091/mbc.E02-01-0027; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; SIDHU RS, 1991, GENE, V107, P111, DOI 10.1016/0378-1119(91)90303-S; Snider J, 2010, NAT PROTOC, V5, P1281, DOI 10.1038/nprot.2010.83; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Turner B, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq023; Valdivia RH, 2003, P NATL ACAD SCI USA, V100, P10287, DOI 10.1073/pnas.1834246100; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zhang B, 2009, BRIT J HAEMATOL, V145, P15, DOI 10.1111/j.1365-2141.2008.07559.x	37	168	170	0	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 27	2012	489	7417					585	+		10.1038/nature11354	http://dx.doi.org/10.1038/nature11354			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	046RG	22940862				2022-12-24	WOS:000311781500008
J	Fradkin, JE; Roberts, BT; Rodgers, GP				Fradkin, Judith E.; Roberts, B. Tibor; Rodgers, Griffin P.			What's Preventing Us from Preventing Type 2 Diabetes?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Fradkin, Judith E.] NIDDKD, Div Diabet Endocrinol & Metab Dis, NIH, Bethesda, MD 20892 USA; [Roberts, B. Tibor] NIDDKD, Off Sci Program & Policy Anal, NIH, Bethesda, MD 20892 USA; [Rodgers, Griffin P.] NIDDKD, Off Director, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Fradkin, JE (corresponding author), NIDDKD, Div Diabet Endocrinol & Metab Dis, NIH, Bethesda, MD 20892 USA.							Centers for Disease Control and Prevention, NAT DIAB PREV PROGR; de Boer IH, 2011, NEW ENGL J MED, V365, P2366, DOI 10.1056/NEJMoa1111732; Herman WH, 2012, DIABETES CARE, V35, P723, DOI 10.2337/dc11-1468; Huang ES, 2009, HEALTH AFFAIR, V28, pW978, DOI 10.1377/hlthaff.28.5.w978; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512	5	29	29	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 27	2012	367	13					1177	1179		10.1056/NEJMp1208169	http://dx.doi.org/10.1056/NEJMp1208169			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	011JO	23013070				2022-12-24	WOS:000309161100001
J	Ciraci, C; Hill, RT; Mock, JJ; Urzhumov, Y; Fernandez-Dominguez, AI; Maier, SA; Pendry, JB; Chilkoti, A; Smith, DR				Ciraci, C.; Hill, R. T.; Mock, J. J.; Urzhumov, Y.; Fernandez-Dominguez, A. I.; Maier, S. A.; Pendry, J. B.; Chilkoti, A.; Smith, D. R.			Probing the Ultimate Limits of Plasmonic Enhancement	SCIENCE			English	Article							FIELD ENHANCEMENT; NANOPARTICLES; QUANTUM	Metals support surface plasmons at optical wavelengths and have the ability to localize light to subwavelength regions. The field enhancements that occur in these regions set the ultimate limitations on a wide range of nonlinear and quantum optical phenomena. We found that the dominant limiting factor is not the resistive loss of the metal, but rather the intrinsic nonlocality of its dielectric response. A semiclassical model of the electronic response of a metal places strict bounds on the ultimate field enhancement. To demonstrate the accuracy of this model, we studied optical scattering from gold nanoparticles spaced a few angstroms from a gold film. The bounds derived from the models and experiments impose limitations on all nanophotonic systems.	[Ciraci, C.; Mock, J. J.; Urzhumov, Y.; Smith, D. R.] Duke Univ, Ctr Metamat & Integrated Plasmon, Durham, NC 27708 USA; [Ciraci, C.; Mock, J. J.; Urzhumov, Y.; Smith, D. R.] Duke Univ, Dept Elect & Comp Engn, Durham, NC 27708 USA; [Hill, R. T.; Chilkoti, A.] Duke Univ, Ctr Biol Inspired Mat & Mat Syst, Durham, NC 27708 USA; [Fernandez-Dominguez, A. I.; Maier, S. A.; Pendry, J. B.] Univ London Imperial Coll Sci Technol & Med, Dept Phys, Blackett Lab, London SW7 2AZ, England; [Chilkoti, A.] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA	Duke University; Duke University; Duke University; Imperial College London; Duke University	Ciraci, C (corresponding author), Duke Univ, Ctr Metamat & Integrated Plasmon, Durham, NC 27708 USA.	cristian.ciraci@duke.edu	Ciracì, Cristian/K-3602-2017; Fernandez-Dominguez, Antonio I. I/C-4448-2013; Smith, David R/E-4710-2012; Maier, Stefan/V-2883-2019; Urzhumov, Yaroslav A/E-8360-2010; Fernandez-Dominguez, Antonio I./AGR-3767-2022	Ciracì, Cristian/0000-0003-3349-8389; Fernandez-Dominguez, Antonio I. I/0000-0002-8082-395X; Maier, Stefan/0000-0001-9704-7902; Fernandez-Dominguez, Antonio I./0000-0002-8082-395X; Pendry, John/0000-0001-5145-5441	Air Force Office of Scientific Research [FA9550-09-1-0562]; Army Research Office through Multidisciplinary University Research Initiative [W911NF-09-1-0539]; Leverhulme Trust; Marie Curie Actions; NIH [R21EB009862, F32EB009299]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [F32EB009299, R21EB009862] Funding Source: NIH RePORTER; Engineering and Physical Sciences Research Council [EP/D063329/1, EP/H000917/2] Funding Source: researchfish; EPSRC [EP/H000917/2, EP/D063329/1] Funding Source: UKRI	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Army Research Office through Multidisciplinary University Research Initiative; Leverhulme Trust(Leverhulme Trust); Marie Curie Actions(European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank M. Scalora, S. Wolter, and A. Moreau for helpful input and discussion. Supported by Air Force Office of Scientific Research grant FA9550-09-1-0562 and by the Army Research Office through Multidisciplinary University Research Initiative grant W911NF-09-1-0539. Also supported by the Leverhulme Trust and the Marie Curie Actions (J.B.P., S. A. M., and A.I.F.-D.), NIH grant R21EB009862 (A. C.), and NIH F32 award F32EB009299 (R.T.H.).	BAIN CD, 1989, J AM CHEM SOC, V111, P321, DOI 10.1021/ja00183a049; Boardman A. D., 1982, ELECTROMAGNETIC SURF; David C, 2011, J PHYS CHEM C, V115, P19470, DOI 10.1021/jp204261u; Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232; Esteban R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1806; Fernandez-Dominguez AI, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.106802; Fernandez-Dominguez AI, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.266807; FUCHS R, 1987, PHYS REV B, V35, P3722, DOI 10.1103/PhysRevB.35.3722; Gu Y, 2012, NANO LETT, V12, P2488, DOI 10.1021/nl300655n; Hill RT, 2010, NANO LETT, V10, P4150, DOI 10.1021/nl102443p; Marinica DC, 2012, NANO LETT, V12, P1333, DOI 10.1021/nl300269c; Mock JJ, 2012, NANO LETT, V12, P1757, DOI 10.1021/nl204596h; MOSKOVITS M, 1985, REV MOD PHYS, V57, P783, DOI 10.1103/RevModPhys.57.783; Oulton RF, 2009, NATURE, V461, P629, DOI 10.1038/nature08364; Renger J, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.046803; Scalora M, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.043828; Toscano G, 2012, OPT EXPRESS, V20, P4176, DOI 10.1364/OE.20.004176; Zuloaga J, 2009, NANO LETT, V9, P887, DOI 10.1021/nl803811g	18	859	866	26	653	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2012	337	6098					1072	1074		10.1126/science.1224823	http://dx.doi.org/10.1126/science.1224823			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22936772	Green Accepted, Green Submitted			2022-12-24	WOS:000308125800040
J	Raghu, G				Raghu, Ganesh			Idiopathic pulmonary fibrosis: new evidence and an improved standard of care in 2012	LANCET			English	Editorial Material							GASTROESOPHAGEAL-REFLUX THERAPY; PLACEBO-CONTROLLED TRIAL; ACETYLCYSTEINE; AZATHIOPRINE; GUIDELINES; PREDNISONE; STATEMENT; SURVIVAL; BOSENTAN		[Raghu, Ganesh] Univ Washington, Med Ctr, Div Pulm & Crit Care Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Raghu, G (corresponding author), Box 356175,1959 Pacific Ave, Seattle, WA 98195 USA.	graghu@uw.edu						Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; Demedts M, 2005, NEW ENGL J MED, V353, P2229, DOI 10.1056/NEJMoa042976; Hunninghake GW, 2005, NEW ENGL J MED, V353, P2285, DOI 10.1056/NEJMe058210; King TE, 2008, AM J RESP CRIT CARE, V177, P75, DOI 10.1164/rccm.200705-732OC; King TE, 2011, AM J RESP CRIT CARE, V184, P92, DOI 10.1164/rccm.201011-1874OC; King TE, 2009, LANCET, V374, P222, DOI 10.1016/S0140-6736(09)60551-1; Kubo H, 2005, CHEST, V128, P1475, DOI 10.1378/chest.128.3.1475; Lee JS, 2012, EUR RESPIR J, V39, P352, DOI 10.1183/09031936.00050911; Lee JS, 2011, AM J RESP CRIT CARE, V184, P1390, DOI 10.1164/rccm.201101-0138OC; Noble PW, 2011, LANCET, V377, P1760, DOI 10.1016/S0140-6736(11)60405-4; Noth I, 2012, EUR RESPIR J, V39, P344, DOI 10.1183/09031936.00099910; Noth I, 2012, AM J RESP CRIT CARE, V186, P88, DOI 10.1164/rccm.201202-0314OC; Raghu G, 2004, NEW ENGL J MED, V350, P125, DOI 10.1056/NEJMoa030511; RAGHU G, 1991, AM REV RESPIR DIS, V144, P291, DOI 10.1164/ajrccm/144.2.291; Raghu G, 2012, EUR RESPIR J, V39, P242, DOI 10.1183/09031936.00211311; Raghu G, 2012, AM J RESP CRIT CARE, V185, pA3632; Raghu G, 2012, AM J RESP CRIT CARE, V185, pA3631; Raghu G, 2008, AM J RESP CRIT CARE, V178, P948, DOI 10.1164/rccm.200709-1446OC; Raghu G, 2012, NEW ENGL J MED, V366, P1968, DOI 10.1056/NEJMoa1113354; Raghu G, 2012, AM J RESP CRIT CARE, V185, P1044, DOI 10.1164/rccm.201201-0006PP; Raghu G, 2011, AM J RESP CRIT CARE, V184, P1330, DOI 10.1164/rccm.201110-1842ED; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Richeldi L, 2011, NEW ENGL J MED, V365, P1079, DOI 10.1056/NEJMoa1103690; Schunemann HJ, 2006, AM J RESP CRIT CARE, V174, P605, DOI 10.1164/rccm.200602-197ST; Zisman DA, 2010, NEW ENGL J MED, V363, P620, DOI 10.1056/NEJMoa1002110	25	19	19	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 18	2012	380	9842					699	701		10.1016/S0140-6736(12)61256-2	http://dx.doi.org/10.1016/S0140-6736(12)61256-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	991SE	22901891				2022-12-24	WOS:000307721000035
J	Matzuk, MM; McKeown, MR; Filippakopoulos, P; Li, QL; Ma, L; Agno, JE; Lemieux, ME; Picaud, S; Yu, RN; Qi, J; Knapp, S; Bradner, JE				Matzuk, Martin M.; McKeown, Michael R.; Filippakopoulos, Panagis; Li, Qinglei; Ma, Lang; Agno, Julio E.; Lemieux, Madeleine E.; Picaud, Sarah; Yu, Richard N.; Qi, Jun; Knapp, Stefan; Bradner, James E.			Small-Molecule Inhibition of BRDT for Male Contraception	CELL			English	Article							BET BROMODOMAINS; 1ST BROMODOMAIN; BINDING; TESTIS; MYC; DIFFERENTIATION; IDENTIFICATION; INFERTILITY; EXPRESSION; CHROMATIN	A pharmacologic approach to male contraception remains a longstanding challenge in medicine. Toward this objective, we explored the spermatogenic effects of a selective small-molecule inhibitor (JQ1) of the bromodomain and extraterminal (BET) subfamily of epigenetic reader proteins. Here, we report potent inhibition of the testis-specific member BRDT, which is essential for chromatin remodeling during spermatogenesis. Biochemical and crystallographic studies confirm that occupancy of the BRDT acetyl-lysine binding pocket by JQ1 prevents recognition of acetylated histone H4. Treatment of mice with JQ1 reduced seminiferous tubule area, testis size, and spermatozoa number and motility without affecting hormone levels. Although JQ1-treated males mate normally, inhibitory effects of JQ1 evident at the spermatocyte and round spermatid stages cause a complete and reversible contraceptive effect. These data establish a new contraceptive that can cross the blood: testis boundary and inhibit bromodomain activity during spermatogenesis, providing a lead compound targeting the male germ cell for contraception.	[Matzuk, Martin M.; Ma, Lang; Agno, Julio E.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Matzuk, Martin M.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Matzuk, Martin M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Matzuk, Martin M.] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA; [Matzuk, Martin M.] Baylor Coll Med, Ctr Drug Discovery, Houston, TX 77030 USA; [Matzuk, Martin M.] Baylor Coll Med, Ctr Reprod Med, Houston, TX 77030 USA; [McKeown, Michael R.; Lemieux, Madeleine E.; Qi, Jun; Bradner, James E.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Filippakopoulos, Panagis; Picaud, Sarah; Knapp, Stefan] Univ Oxford, Nuffield Dept Clin Med, Struct Genom Consortium, Oxford OX3 7DQ, England; [Li, Qinglei] Texas A&M Univ, Dept Vet Integrat Biosci, Coll Vet Med & Biomed Sci, College Stn, TX 77843 USA; [Lemieux, Madeleine E.] Bioinfo, Ottawa, ON K1J 8G4, Canada; [Yu, Richard N.] Childrens Hosp, Dept Urol, Boston, MA 02115 USA; [Knapp, Stefan] George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Biol, Washington, DC 20037 USA; [Bradner, James E.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Harvard University; Dana-Farber Cancer Institute; University of Oxford; Texas A&M University System; Texas A&M University College Station; Harvard University; Boston Children's Hospital; George Washington University; Harvard University; Harvard Medical School	Matzuk, MM (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.	mmatzuk@bcm.edu; james_bradner@dfci.harvard.edu	Knapp, Stefan/AAG-2347-2019	Knapp, Stefan/0000-0001-5995-6494; Filippakopoulos, Panagis/0000-0002-1515-1317; Lemieux, Madeleine/0000-0001-6355-8691	Eunice Kennedy Shriver NICHD/NIH [U01-HD060496]; Alkek Award for Pilot Projects in Experimental Therapeutics; Fidelity Foundation; Burroughs Wellcome Fund; NIH [K08CA128972]; Smith Family Foundation; Damon-Runyon Cancer Research Foundation; CIHR [1097737]; Canada Foundation for Innovation; Genome Canada; GlaxoSmithKline; Pfizer; Eli Lilly; Abbott; Takeda; Novartis Research Foundation; Ontario Ministry of Research and Innovation; Wellcome Trust; Wellcome Trust Career Development Fellowship [095751/Z/11/Z]; NICHD (SCCPRR) [U54-HD28934]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD060496, U54HD028934] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [K08CA128972] Funding Source: NIH RePORTER	Eunice Kennedy Shriver NICHD/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Alkek Award for Pilot Projects in Experimental Therapeutics; Fidelity Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Smith Family Foundation; Damon-Runyon Cancer Research Foundation; CIHR(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Genome Canada(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Pfizer(Pfizer); Eli Lilly(Eli Lilly); Abbott(Abbott Laboratories); Takeda(Takeda Pharmaceutical Company Ltd); Novartis Research Foundation; Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust Career Development Fellowship(Wellcome Trust); NICHD (SCCPRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to Drs. J. Brown and J. Plutzky for pharmacodynamic data; Dr. A. Roy for advice on the spermatozoa assays; Y. Vasquez and Dr. Z. Yu for technical help; J. Marineau, K. Shaw, and W. Smith for support of peptide synthesis; Dr. S. Kistler for the generous gift of the anti-TNP2 antibody; and Dr. S. Khochbin for helpful comments. These studies were supported, in part, by the Eunice Kennedy Shriver NICHD/NIH through cooperative agreement U01-HD060496 as part of the Cooperative Program in Male Contraception; an Alkek Award for Pilot Projects in Experimental Therapeutics; and a grant from the Fidelity Foundation (to M. M. M.), the Burroughs Wellcome Fund, the NIH (K08CA128972), the Smith Family Foundation, and Damon-Runyon Cancer Research Foundation (to J. E. B.). The SGC is a registered charity (number 1097737) that receives funds from the CIHR, Canada Foundation for Innovation, Genome Canada, GlaxoSmithKline, Pfizer, Eli Lilly, Abbott, Takeda, Novartis Research Foundation, Ontario Ministry of Research and Innovation, and Wellcome Trust. P. F. is supported by a Wellcome Trust Career Development Fellowship (095751/Z/11/Z). Serum FSH, LH, and testosterone analyses were performed at the University of Virginia Center for Research in Reproduction Ligand Assay and Analysis Core supported by NICHD (SCCPRR) grant U54-HD28934. Baylor College of Medicine and Dana-Farber Cancer Institute have filed patent applications on technologies relating to this work, which have been licensed to Tensha Therapeutics.	Aitken RJ, 2008, J CLIN INVEST, V118, P1330, DOI 10.1172/JCI33873; Aston KI, 2010, HUM REPROD, V25, P1383, DOI 10.1093/humrep/deq081; Berkovits BD, 2011, DEV BIOL, V360, P358, DOI 10.1016/j.ydbio.2011.10.005; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Dieterich K, 2007, NAT GENET, V39, P661, DOI 10.1038/ng2027; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kumar TR, 1997, NAT GENET, V15, P201, DOI 10.1038/ng0297-201; Lin YN, 2007, MOL CELL BIOL, V27, P6794, DOI 10.1128/MCB.01029-07; Liu D, 1998, NAT GENET, V20, P377, DOI 10.1038/3855; Ma L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000635; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Miki K, 2002, DEV BIOL, V248, P331, DOI 10.1006/dbio.2002.0728; Moriniere J, 2009, NATURE, V461, P664, DOI 10.1038/nature08397; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Roy A, 2007, FASEB J, V21, P1013, DOI 10.1096/fj.06-7035com; Schultz N, 2003, P NATL ACAD SCI USA, V100, P12201, DOI 10.1073/pnas.1635054100; Shang EY, 2007, DEVELOPMENT, V134, P3507, DOI 10.1242/dev.004481; Shang EY, 2004, GENE EXPR PATTERNS, V4, P513, DOI 10.1016/j.modgep.2004.03.002; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; WOLFES H, 1989, SCIENCE, V245, P740, DOI 10.1126/science.2475907; Yang JX, 2005, P NATL ACAD SCI USA, V102, P5755, DOI 10.1073/pnas.0408718102; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69; Zhao M, 2004, BIOL REPROD, V71, P1016, DOI 10.1095/biolreprod.104.028191; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	29	274	353	2	97	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 17	2012	150	4					673	684		10.1016/j.cell.2012.06.045	http://dx.doi.org/10.1016/j.cell.2012.06.045			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22901802	Green Published, hybrid			2022-12-24	WOS:000308002300004
J	Schiffrin, EL				Schiffrin, Ernesto L.			Hypertension: treatments, diabetes, and developing regions	LANCET			English	Editorial Material							BLOOD-PRESSURE; PREVALENCE; COMMITTEE; BURDEN; RISK		[Schiffrin, Ernesto L.] McGill Univ, Jewish Gen Hosp, Dept Med, Montreal, PQ H3T 1E2, Canada; [Schiffrin, Ernesto L.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada	McGill University; Lady Davis Institute; McGill University	Schiffrin, EL (corresponding author), McGill Univ, Jewish Gen Hosp, Dept Med, Montreal, PQ H3T 1E2, Canada.	ernesto.schiffrin@mcgill.ca	Schiffrin, Ernesto L/AAB-9061-2019	Schiffrin, Ernesto L/0000-0002-4502-2823				[Anonymous], 2005, PREV CHRON DIS VIT I; Chapman N, 2007, HYPERTENSION, V49, P839, DOI 10.1161/01.HYP.0000259805.18468.8c; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Cloutier L, 2012, CURR CARDIOVASC RISK, V6, P267, DOI 10.1007/s12170-012-0247-z; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Daskalopoulou SS, 2012, CAN J CARDIOL, V28, P270, DOI 10.1016/j.cjca.2012.02.018; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Fagard RH, 2010, J HYPERTENS, V28, P635, DOI 10.1097/01.hjh.0000368700.79444.c1; Ferrannini E, 2012, LANCET, V380, P601, DOI 10.1016/S0140-6736(12)60987-8; Ibrahim MM, 2012, LANCET, V380, P611, DOI 10.1016/S0140-6736(12)60861-7; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Laurent S, 2012, LANCET, V380, P591, DOI 10.1016/S0140-6736(12)60825-3; Leenen FHH, 2010, HYPERTENSION, V56, P571, DOI 10.1161/HYPERTENSIONAHA.110.157818; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; National Institute for Health and Clinical Excellence, 2011, HYPERT CLIN MAN PRI; Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8; Roush GC, 2012, HYPERTENSION, V59, P1110, DOI 10.1161/HYPERTENSIONAHA.112.191106; Sadowski J, 2011, HYPERTENSION, V57, P911, DOI 10.1161/HYPERTENSIONAHA.110.163014; TARNOW L, 1994, DIABETES CARE, V17, P1247, DOI 10.2337/diacare.17.11.1247; Tran C. L., 2012, HYPERTENSION	22	9	9	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 11	2012	380	9841					539	541		10.1016/S0140-6736(12)61219-7	http://dx.doi.org/10.1016/S0140-6736(12)61219-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988SQ	22883490				2022-12-24	WOS:000307511400004
J	Hebert, C; Beaumont, J; Schwartz, G; Robicsek, A				Hebert, Courtney; Beaumont, Jennifer; Schwartz, Gene; Robicsek, Ari			The Influence of Context on Antimicrobial Prescribing for Febrile Respiratory Illness A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							TRACT INFECTIONS; DIAGNOSTIC-ACCURACY; ANTIBIOTICS; PREDICTORS; BRONCHITIS; A(H1N1); COLDS	Background: Little is known about the influence of contextual factors on a physician's likelihood to prescribe antimicrobials for febrile respiratory illness (FRI). Context includes epidemiologic context (for example, a pandemic period) and personal context (for example, recent exposure to other patients with FRI). Objective: To examine the association between contextual factors and antimicrobial prescribing for FRI. Design: 5.5-year retrospective cohort study. Setting: A network of Midwestern primary care providers. Patients: All patients presenting with FRI during influenza seasons between 2006 and 2011. Measurements: Antimicrobial prescribing for FRI during pandemic and seasonal influenza periods. Results: 28 301 unique patient encounters for FRI with 69 physicians in 26 practices were included. An antibiotic was prescribed in 12 795 (45.2%) cases. The range of prescribing among physicians was 17.9% to 83.7%. Antibiotics were prescribed in 47.5% of encounters during the seasonal period and 39.2% during the pandemic period (P < 0.001). After multivariable adjustment for patient and physician characteristics, antibiotic prescribing was lower in the pandemic period (odds ratio [OR], 0.72 [95% CI, 0.68 to 0.77]) than in the seasonal period. The likelihood of prescribing an antibiotic decreased as the number of FRI cases that a physician had seen in the previous week increased (OR, 0.93 [CI, 0.86 to 1.01] for 2 to 3 patients with FRI seen in the previous week; OR, 0.84 [CI, 0.77 to 0.91] for 4 to 6 patients; OR, 0.71 [CI, 0.64 to 0.78] for 7 to 11 patients; and OR, 0.57 [CI, 0.51 to 0.63] for >= 12 patients compared with the reference range of 0 to 1 patients). Pandemic season and recent personal context were also associated with antiviral prescribing. Limitation: Retrospective study in a single geographic area. Conclusion: Epidemiologic context and the number of cases of FRI that a physician had recently seen were associated with his or her likelihood to prescribe antimicrobials for FRI. Interventions that enhance a physician's contextual awareness may improve antimicrobial use.	[Hebert, Courtney] Ohio State Univ, Wexner Med Ctr, Dept Biomed Informat, Columbus, OH 43210 USA; Northwestern Univ, Feinberg Sch Med, Evanston, IL 60208 USA; Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA; NorthShore Univ HealthSyst, Evanston, IL USA	Ohio State University; Northwestern University; Feinberg School of Medicine; University of Chicago; NorthShore University Health System	Hebert, C (corresponding author), Ohio State Univ, Wexner Med Ctr, Dept Biomed Informat, 3190 Graves Hall,333 W 10th Ave, Columbus, OH 43210 USA.	courtney.hebert@osumc.edu	Beaumont, Jennifer/AAA-2825-2020; Hebert, Courtney/G-4900-2016	Beaumont, Jennifer/0000-0002-1484-260X; Schwartz, Gene/0000-0001-6918-1987	NorthShore University HealthSystem	NorthShore University HealthSystem	Dr. Robicsek was supported by a NorthShore University HealthSystem Research Career Development Award.	Aspinall SL, 2009, AM J EMERG MED, V27, P544, DOI 10.1016/j.ajem.2008.04.015; Butler CC, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2242; Cadieux G, 2007, CAN MED ASSOC J, V177, P877, DOI 10.1503/cmaj.070151; *CDCP, 2009, UPD INT REC US ANT M; Centers for Disease Control and Prevention, CDC GIS FLUVIEW; Centers for Disease Control and Prevention, 2009, INV INT REC SWIN FLU; Centers for Disease Control and Prevention, 2010, 2009 H1N1 PANDEMIC S; Centers for Medicare & Medicaid Services (CMS) HHS, 2010, Fed Regist, V75, P44313; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; degli Atti MLC, 2006, EUR J CLIN PHARMACOL, V62, P1055, DOI 10.1007/s00228-006-0198-8; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Dosh SA, 2000, J FAM PRACTICE, V49, P407; Fine AM, 2011, ANN INTERN MED, V155, P345, DOI 10.7326/0003-4819-155-6-201109200-00002; Fischer Thomas, 2005, BMC Fam Pract, V6, P6, DOI 10.1186/1471-2296-6-6; Ganestam F, 2003, SCAND J INFECT DIS, V35, P836, DOI 10.1080/00365540310016880; Glass SK, 2010, J ANTIMICROB CHEMOTH, V65, P148, DOI 10.1093/jac/dkp391; Gonzales R, 1997, JAMA-J AM MED ASSOC, V278, P901, DOI 10.1001/jama.278.11.901; Hopstaken RM, 2006, FAM PRACT, V23, P180, DOI 10.1093/fampra/cmi100; Hopstaken RM, 2005, J CLIN EPIDEMIOL, V58, P175, DOI 10.1016/j.jclinepi.2004.08.004; Horst MA, 2010, J AM BOARD FAM MED, V23, P32, DOI 10.3122/jabfm.2010.01.090137; Illinois Department of Public Health, H1N1 FLU; Khiabanian H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012658; Korppi M, 2008, ACTA PAEDIATR, V97, P943, DOI 10.1111/j.1651-2227.2008.00789.x; Linder JA, 2005, PHARMACOEPIDEM DR S, V14, P531, DOI 10.1002/pds.1067; Linder JA, 2009, J GEN INTERN MED, V24, P504, DOI 10.1007/s11606-009-0933-9; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Macfarlane J, 1997, BMJ-BRIT MED J, V315, P1211, DOI 10.1136/bmj.315.7117.1211; Mamede S, 2010, JAMA-J AM MED ASSOC, V304, P1198, DOI 10.1001/jama.2010.1276; Misurski DA, 2011, AM J MANAG CARE, V17, P601; Moro ML, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-69; Neuzil KM, 2000, NEW ENGL J MED, V342, P225, DOI 10.1056/NEJM200001273420401; Nyquist AC, 1998, JAMA-J AM MED ASSOC, V279, P875, DOI 10.1001/jama.279.11.875; Polgreen PM, 2011, INFECT CONT HOSP EP, V32, P706, DOI 10.1086/660859; Strahilevitz J, 2005, CLIN MICROBIOL INFEC, V11, P955, DOI 10.1111/j.1469-0691.2005.01255.x; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Watson RL, 1999, PEDIATRICS, V104, P1251, DOI 10.1542/peds.104.6.1251	36	12	12	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 7	2012	157	3					160	+		10.7326/0003-4819-157-3-201208070-00005	http://dx.doi.org/10.7326/0003-4819-157-3-201208070-00005			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992PB	22868833				2022-12-24	WOS:000307789900003
J	Rounbehler, RJ; Fallahi, M; Yang, CY; Steeves, MA; Li, WM; Doherty, JR; Schaub, FX; Sanduja, S; Dixon, DA; Blackshear, PJ; Cleveland, JL				Rounbehler, Robert J.; Fallahi, Mohammad; Yang, Chunying; Steeves, Meredith A.; Li, Weimin; Doherty, Joanne R.; Schaub, Franz X.; Sanduja, Sandhya; Dixon, Dan A.; Blackshear, Perry J.; Cleveland, John L.			Tristetraprolin Impairs Myc-Induced Lymphoma and Abolishes the Malignant State	CELL			English	Article							MESSENGER-RNA STABILITY; ELEMENT-BINDING PROTEIN; AU-RICH ELEMENTS; C-MYC; BURKITT-LYMPHOMA; CANCER-CELLS; TRANSCRIPTION FACTOR; TRANSGENIC MICE; GENE; EXPRESSION	Myc oncoproteins directly regulate transcription by binding to target genes, yet this only explains a fraction of the genes affected by Myc. mRNA turnover is controlled via AU-binding proteins (AUBPs) that recognize AU-rich elements (AREs) found within many transcripts. Analyses of precancerous and malignant Myc-expressing B cells revealed that Myc regulates hundreds of ARE-containing (ARED) genes and select AUBPs. Notably, Myc directly suppresses transcription of Tristetraprolin (TTP/ZFP36), an mRNA-destabilizing AUBP, and this circuit is also operational during B lymphopoiesis and IL7 signaling. Importantly, TTP suppression is a hallmark of cancers with MYC involvement, and restoring TTP impairs Myc-induced lymphomagenesis and abolishes maintenance of the malignant state. Further, there is a selection for TTP loss in malignancy; thus, TTP functions as a tumor suppressor. Finally, Myc/TTP-directed control of select cancer-associated ARED genes is disabled during lymphomagenesis. Thus, Myc targets AUBPs to regulate ARED genes that control tumorigenesis.	[Rounbehler, Robert J.; Fallahi, Mohammad; Yang, Chunying; Steeves, Meredith A.; Li, Weimin; Doherty, Joanne R.; Schaub, Franz X.; Cleveland, John L.] Scripps Florida, Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA; [Sanduja, Sandhya; Dixon, Dan A.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Sanduja, Sandhya; Dixon, Dan A.] Univ S Carolina, Ctr Colon Canc Res, Columbia, SC 29208 USA; [Blackshear, Perry J.] NIEHS, Lab Signal Transduct, Res Triangle Pk, NC 27709 USA	Scripps Research Institute; State University System of Florida; University of Florida; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Cleveland, JL (corresponding author), Scripps Florida, Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA.	jcleve@scripps.edu	Doherty, Joanne/AAU-3288-2020; li, wj/HGD-7322-2022; 黎, 伟/GXM-4040-2022; Blackshear, Perry J./C-6206-2019	Blackshear, Perry J./0000-0002-9561-8529	NIH [DK44158, CA167093, F32-CA115075, CA134609]; ThinkPink Kids Foundation; State of Florida; NIH, NIEHS; National City Postdoctoral Fellowship; Glenn W. Bailey Postdoctoral Fellowship; PGA National Women's Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA134609, R01CA167093, F32CA115075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090080] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ThinkPink Kids Foundation; State of Florida; NIH, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National City Postdoctoral Fellowship; Glenn W. Bailey Postdoctoral Fellowship; PGA National Women's Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Jerry Adams for providing the pE mu SR alpha plasmid; Mihaela Onciu and John Sandlund for providing Burkitt lymphoma samples; J. Alan Diehl for providing MSCV-cyclin D1a retrovirus; Thomas Saunders and the Transgenic Animal Model Core of the University of Michigan's Biomedical Research Core Facilities for generating the E mu-TTP and E mu-Tis11b transgenics; Wi Lai and Deborah Stumpo for technical assistance; Shannon Sunday of the Scripps Florida ARC for assistance; Brandon Young and Brad Long of the Scripps Florida Genomics Core; Bivian Torres and Kim Lowe of the Scripps Florida Flow Cytometry Core; Frank C. Dorsey for helpful discussions; and Marika Kernick for editing. This work was supported by NIH grants (DK44158 and CA167093 to J. L. C., F32-CA115075 to R. J. R. and CA134609 to D. A. D.), by monies from the ThinkPink Kids Foundation, and by monies from the State of Florida to TSRI. P. J. B. is supported by the Intramural Research Program of the NIH, NIEHS. R. J. R. also received support from the National City Postdoctoral Fellowship, the Glenn W. Bailey Postdoctoral Fellowship, and the PGA National Women's Cancer Foundation.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; BODRUG SE, 1994, EMBO J, V13, P2124, DOI 10.1002/j.1460-2075.1994.tb06488.x; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Brennan SE, 2009, CANCER RES, V69, P5168, DOI 10.1158/0008-5472.CAN-08-4238; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Carballo E, 2001, BLOOD, V98, P2389, DOI 10.1182/blood.V98.8.2389; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Chen K, 2008, J BIOL CHEM, V283, P2508, DOI 10.1074/jbc.M707307200; DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dang CV, 1999, MOL CELL BIOL, V19, P1; Dean JLE, 2002, BIOCHEM J, V366, P709, DOI 10.1042/BJ20020402; Dixon DA, 2001, J CLIN INVEST, V108, P1657, DOI 10.1172/JCI200112973; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Fawal M, 2006, BLOOD, V108, P2780, DOI 10.1182/blood-2006-04-014902; Franks TM, 2007, GENE DEV, V21, P719, DOI 10.1101/gad.1494707; Gorrini C, 2007, NATURE, V448, P1063, DOI 10.1038/nature06055; Gouble A, 2002, CANCER RES, V62, P1489; Halees AS, 2008, NUCLEIC ACIDS RES, V36, pD137, DOI 10.1093/nar/gkm959; Hemelaar J, 2003, J BIOL CHEM, V278, P51841, DOI 10.1074/jbc.M308762200; Hodson DJ, 2010, NAT IMMUNOL, V11, P717, DOI 10.1038/ni.1901; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; Katz M, 2007, NAT CELL BIOL, V9, P961, DOI 10.1038/ncb1622; Keller UB, 2007, EMBO J, V26, P2562, DOI 10.1038/sj.emboj.7601691; LAI WS, 1995, J BIOL CHEM, V270, P25266, DOI 10.1074/jbc.270.42.25266; Lee HH, 2010, J BIOL CHEM, V285, P17329, DOI 10.1074/jbc.M109.094235; Marderosian M, 2006, ONCOGENE, V25, P6277, DOI 10.1038/sj.onc.1209645; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Miyamae T, 2006, J IMMUNOL, V177, P4758, DOI 10.4049/jimmunol.177.7.4758; MORROW MA, 1992, GENE DEV, V6, P61, DOI 10.1101/gad.6.1.61; Nilsson JA, 2005, CANCER CELL, V7, P433, DOI 10.1016/j.ccr.2005.03.036; Painter MW, 2011, J IMMUNOL, V186, P3047, DOI 10.4049/jimmunol.1002695; Pajic A, 2000, INT J CANCER, V87, P787, DOI 10.1002/1097-0215(20000915)87:6<787::AID-IJC4>3.0.CO;2-6; PETERS G, 1994, J CELL SCI, P89; Rosenbloom KR, 2010, NUCLEIC ACIDS RES, V38, pD620, DOI 10.1093/nar/gkp961; Sakai T, 2004, J BIOL CHEM, V279, P41131, DOI 10.1074/jbc.M402902200; Sanduja S, 2009, AGING-US, V1, P803, DOI 10.18632/aging.100086; Sengupta TK, 2004, J BIOL CHEM, V279, P10855, DOI 10.1074/jbc.M309111200; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Stoecklin G, 2003, ONCOGENE, V22, P3554, DOI 10.1038/sj.onc.1206418; Tabrizifard S, 2004, J IMMUNOL, V173, P1094, DOI 10.4049/jimmunol.173.2.1094; TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Tobias ES, 2001, ONCOGENE, V20, P2844, DOI 10.1038/sj.onc.1204433; Wang Q, 2006, CANCER RES, V66, P6050, DOI 10.1158/0008-5472.CAN-05-4618; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69	49	86	87	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 3	2012	150	3					563	574		10.1016/j.cell.2012.06.033	http://dx.doi.org/10.1016/j.cell.2012.06.033			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	985WO	22863009	Green Accepted, Bronze			2022-12-24	WOS:000307301400015
J	Nelson, LS; Perrone, J				Nelson, Lewis S.; Perrone, Jeanmarie			Curbing the Opioid Epidemic in the United States The Risk Evaluation and Mitigation Strategy (REMS)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PRESCRIPTION; ABUSE		[Nelson, Lewis S.] NYU, Sch Med, Dept Emergency Med, New York, NY 10016 USA; [Perrone, Jeanmarie] Univ Penn, Perelman Sch Med, Dept Emergency Med, Philadelphia, PA 19104 USA	New York University; University of Pennsylvania; Pennsylvania Medicine	Nelson, LS (corresponding author), NYU, Sch Med, Dept Emergency Med, 455 1st Ave,Room 123, New York, NY 10016 USA.	lewis.nelson@nyumc.org		Nelson, Lewis/0000-0001-9551-3922				Cai R., 2010, Morbidity and Mortality Weekly Report, V59, P705; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Gugelmann HM, 2011, JAMA-J AM MED ASSOC, V306, P2258, DOI 10.1001/jama.2011.1712; Paulozzi Leonard, 2012, Morbidity and Mortality Weekly Report, V61, P10; Purdue Pharma, PURD PHARM; Slevin Kieran A, 2011, J Opioid Manag, V7, P109; United States Food and Drug Administration, 2010, JOINT M AN LIF SUPP; US Food and Drug Administration, RISK EV MIT STRAT RE; Wolf MS, 2012, J GEN INTERN MED, V27, P1714, DOI 10.1007/s11606-012-2068-7; Zgierska A, 2012, JAMA-J AM MED ASSOC, V307, P1377, DOI 10.1001/jama.2012.419	10	71	72	1	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2012	308	5					457	458		10.1001/jama.2012.8165	http://dx.doi.org/10.1001/jama.2012.8165			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	981DQ	22851109				2022-12-24	WOS:000306947400020
J	Tischer, T; Hormanseder, E; Mayer, TU				Tischer, Thomas; Hoermanseder, Eva; Mayer, Thomas U.			The APC/C Inhibitor XErp1/Emi2 Is Essential for Xenopus Early Embryonic Divisions	SCIENCE			English	Article							DEPENDENT PROTEIN-KINASE; CYTOSTATIC FACTOR ARREST; MEIOTIC ARREST; CELL-CYCLE; GREATWALL KINASE; PHOSPHATASE 2A; LAEVIS EGGS; PHOSPHORYLATION; EMI2; MITOSIS	Mitotic divisions result from the oscillating activity of cyclin-dependent kinase 1 (Cdk1). Cdk1 activity is terminated by the anaphase-promoting complex/cyclosome (APC/C), a ubiquitin ligase that targets cyclin B for destruction. In somatic divisions, the early mitotic inhibitor 1 (Emi1) and the spindle assembly checkpoint (SAC) regulate cell cycle progression by inhibiting the APC/C. Early embryonic divisions lack these APC/C-inhibitory components, which raises the question of how those cycles are controlled. We found that the APC/C-inhibitory activity of XErp1 (also known as Emi2) was essential for early divisions in Xenopus embryos. Loss of XErp1 resulted in untimely destruction of APC/C substrates and embryonic lethality. XErp1's APC/C-inhibitory function was negatively regulated by Cdk1 and positively by protein phosphatase 2A (PP2A). Thus, Cdk1 and PP2A operate at the core of early mitotic cell cycles by antagonistically controlling XErp1 activity, which results in oscillating APC/C activity.	[Mayer, Thomas U.] Univ Konstanz, Dept Biol, D-78457 Constance, Germany; Univ Konstanz, Konstanz Res Sch Chem Biol, D-78457 Constance, Germany	University of Konstanz; University of Konstanz	Mayer, TU (corresponding author), Univ Konstanz, Dept Biol, Univ Str 10, D-78457 Constance, Germany.	thomas.u.mayer@uni-konstanz.de		Tischer, Thomas/0000-0002-6845-2762; Mayer, Thomas/0000-0001-6954-2287; Hormanseder, Eva/0000-0003-0340-6340	Austrian Academy of Science; Collaborative Research Center 969 of the German Research Foundation (DFG)	Austrian Academy of Science; Collaborative Research Center 969 of the German Research Foundation (DFG)	We thank D. Bertinetti, A. Burkle, J. Gannon, T. Hunt, F. W. Herberg, T. Lorca, S. Mochida, and N. Sagata for reagents; the team of D. Schopper and G. Mende for excellent animal care; and the Mayer group and B. Novak for discussions. The authors declare no competing financial interests. Supported by the Doc-fForte program of the Austrian Academy of Science and by the Collaborative Research Center 969 of the German Research Foundation (DFG).	ASHBY CD, 1973, J BIOL CHEM, V248, P1255; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; CLUTE P, 1992, DEV GROWTH DIFFER, V34, P27; Duncan T, 2004, CURR BIOL, V14, pR305, DOI 10.1016/j.cub.2004.03.050; FERRELL JE, 1991, MOL CELL BIOL, V11, P1965, DOI 10.1128/MCB.11.4.1965; Gharbi-Ayachi A, 2010, SCIENCE, V330, P1673, DOI 10.1126/science.1197048; Hartley RS, 1996, DEV BIOL, V173, P408, DOI 10.1006/dbio.1996.0036; Inoue D, 2007, NATURE, V446, P1100, DOI 10.1038/nature05688; Isoda M, 2011, DEV CELL, V21, P506, DOI 10.1016/j.devcel.2011.06.029; Liu JJ, 2005, CURR BIOL, V15, P1458, DOI 10.1016/j.cub.2005.07.030; Liu JJ, 2006, J BIOL CHEM, V281, P34736, DOI 10.1074/jbc.M606607200; Maller JL, 2001, NOVART FDN SYMP, V237, P58, DOI 10.1002/0470846666.ch6; Mochida S, 2010, SCIENCE, V330, P1670, DOI 10.1126/science.1195689; Nishiyama T, 2007, NATURE, V446, P1096, DOI 10.1038/nature05696; Ohsumi K, 2004, P NATL ACAD SCI USA, V101, P12531, DOI 10.1073/pnas.0405300101; Rauh NR, 2005, NATURE, V437, P1048, DOI 10.1038/nature04093; SAGATA N, 1989, NATURE, V342, P512, DOI 10.1038/342512a0; Schmidt A, 2005, GENE DEV, V19, P502, DOI 10.1101/gad.320705; Smith CM, 1999, PROG BIOPHYS MOL BIO, V71, P313, DOI 10.1016/S0079-6107(98)00059-5; Wu JQ, 2007, P NATL ACAD SCI USA, V104, P16564, DOI 10.1073/pnas.0707537104; Wu QJ, 2007, CURR BIOL, V17, P213, DOI 10.1016/j.cub.2006.12.045; Yu JT, 2006, MOL CELL, V22, P83, DOI 10.1016/j.molcel.2006.02.022	22	33	33	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2012	338	6106					520	524		10.1126/science.1228394	http://dx.doi.org/10.1126/science.1228394			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NH	23019610	Green Submitted			2022-12-24	WOS:000310195800056
J	Rodgers, GP; Collins, FS				Rodgers, Griffin P.; Collins, Francis S.			The Next Generation of Obesity Research No Time to Waste	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							LIFE-STYLE INTERVENTION; TRIAL; RISK		[Rodgers, Griffin P.; Collins, Francis S.] NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Rodgers, GP (corresponding author), NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	griffin.rodgers@nih.gov			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000024] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Drewnowski Adam, 2012, Am J Public Health, V102, pe74, DOI 10.2105/AJPH.2012.300660; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Ludwig J, 2011, NEW ENGL J MED, V365, P1509, DOI 10.1056/NEJMsa1103216; Perkins E, 2012, J PEDIATR-US, V161, P31, DOI 10.1016/j.jpeds.2012.01.015; Spring B, 2012, ARCH INTERN MED, V172, P789, DOI 10.1001/archinternmed.2012.1044; Wing RR, 2010, ARCH INTERN MED, V170, P1566, DOI 10.1001/archinternmed.2010.334; Zeitler P, 2012, NEW ENGL J MED, V366, P2247, DOI 10.1056/NEJMoa1109333	7	20	20	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	2012	308	11					1095	1096		10.1001/2012.jama.11853	http://dx.doi.org/10.1001/2012.jama.11853			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007AL	22990265	Bronze, Green Published			2022-12-24	WOS:000308861000022
J	Nielsen, SF; Bojesen, SE; Schnohr, P; Nordestgaard, BG				Nielsen, Sune F.; Bojesen, Stig E.; Schnohr, Peter; Nordestgaard, Borge G.			Elevated rheumatoid factor and long term risk of rheumatoid arthritis: a prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CYCLIC CITRULLINATED PEPTIDE; HEART-DISEASE; FOLLOW-UP; ANTIBODIES; PREDICTS; REMISSION; CLASSIFICATION; AUTOANTIBODIES; DIAGNOSIS; CRITERIA	Objective To test whether elevated concentration of rheumatoid factor is associated with long term development of rheumatoid arthritis. Design A prospective cohort study, the Copenhagen City Heart Study. Blood was drawn in 1981-83, and participants were followed until 10 August 2010. Setting Copenhagen general population. Participants 9712 white Danish individuals from the general population aged 20-100 years without rheumatoid arthritis at study entry. Main outcome measures Rheumatoid arthritis according to baseline plasma IgM rheumatoid factor level categories of 25-50, 50.1-100, and >100, versus <25 IU/mL. Results Rheumatoid factor levels were similar from age 20 to 100 years. During 187 659 person years, 183 individuals developed rheumatoid arthritis. In healthy individuals, a doubling in levels of rheumatoid factor was associated with a 3.3-fold (95% confidence interval 2.7 to 4.0) increased risk of developing rheumatoid arthritis, with a similar trend for most other autoimmune rheumatic diseases. The cumulative incidence of rheumatoid arthritis increased with increasing rheumatoid factor category (P-trend<0.0001). Multivariable adjusted hazard ratios for rheumatoid arthritis were 3.6 (95% confidence interval 1.7 to 7.3) for rheumatoid factor levels of 25-50 IU/mL, 6.0 (3.4 to 10) for 50.1-100 IU/mL, and 26 (15 to 46) for >100 IU/mL, compared with <25 IU/mL (P-trend<0.0001). The highest absolute 10 year risk of rheumatoid arthritis of 32% was observed in 50-69 years old women who smoked with rheumatoid factor levels >100 IU/mL. Conclusion Individuals in the general population with elevated rheumatoid factor have up to 26-fold greater long term risk of rheumatoid arthritis, and up to 32% 10 year absolute risk of rheumatoid arthritis. These novel findings may lead to revision of guidelines for early referral to a rheumatologist and early arthritis clinics based on rheumatoid factor testing.	[Nielsen, Sune F.; Bojesen, Stig E.; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Dept Clin Biochem, Herlev Hosp, DK-2730 Herlev, Denmark; [Nielsen, Sune F.; Bojesen, Stig E.; Nordestgaard, Borge G.] Univ Copenhagen, Fac Hlth Sci, DK-1168 Copenhagen, Denmark; [Bojesen, Stig E.; Schnohr, Peter; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Copenhagen City Heart Study, Bispebjerg Hosp, DK-2730 Herlev, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital	Nordestgaard, BG (corresponding author), Copenhagen Univ Hosp, Dept Clin Biochem, Herlev Hosp, 54M1,Herlev Ringvej 75, DK-2730 Herlev, Denmark.	Boerge.Nordestgaard@regionh.dk	Nordestgaard, Borge Gronne/ABF-1310-2020	Bojesen, Stig/0000-0002-4061-4133; Nordestgaard, Borge/0000-0002-1954-7220	Herlev Hospital, Copenhagen University Hospital; Danish Heart Foundation	Herlev Hospital, Copenhagen University Hospital; Danish Heart Foundation	This study was funded by Herlev Hospital, Copenhagen University Hospital and the Danish Heart Foundation. The sponsors had no role in the design of the study; collection, analysis, and interpretation of data; writing of the report; or decision to submit the article for publication. The views expressed in this paper are those of the authors and not those of any funding body or others whose support is acknowledged.	AHO K, 1991, J RHEUMATOL, V18, P1282; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Andersen TF, 1999, DAN MED BULL, V46, P263; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Baka Z, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2751; Balsa A, 2010, RHEUMATOLOGY, V49, P458, DOI 10.1093/rheumatology/kep380; Bas S, 2003, RHEUMATOLOGY, V42, P677, DOI 10.1093/rheumatology/keg184; Boutry N, 2009, EUR J RADIOL, V71, P217, DOI 10.1016/j.ejrad.2009.02.013; Catapano AL, 2011, ATHEROSCLEROSIS, V217, P3, DOI 10.1016/j.atherosclerosis.2011.06.028; Cohen SB, 2010, BEST PRACT RES CL RH, V24, P553, DOI 10.1016/j.berh.2009.11.006; Deane KD, 2010, ARTHRITIS RHEUM-US, V62, P3161, DOI 10.1002/art.27638; Don BR, 2010, CLIN NEPHROL, V73, P431; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; FISCHER KM, 1991, MED HYPOTHESES, V34, P116, DOI 10.1016/0306-9877(91)90177-Z; Gaston J. S. H, 1999, RHEUMATIC DIS IMMUNO; Hutchinson D, 2001, ANN RHEUM DIS, V60, P223, DOI 10.1136/ard.60.3.223; Innala L, 2008, J RHEUMATOL, V35, P1002; Johansson M, 2006, SCAND J RHEUMATOL, V35, P29; Julia A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007556; Kastbom A, 2004, ANN RHEUM DIS, V63, P1085, DOI 10.1136/ard.2003.016808; Kuriya B, 2009, ANN RHEUM DIS, V68, P1482, DOI 10.1136/ard.2008.092676; Machold KP, 2002, J RHEUMATOL, V29, P2278; Neovius M, 2011, ANN RHEUM DIS, V70, P624, DOI 10.1136/ard.2010.133371; Nielen MMJ, 2004, ARTHRITIS RHEUM-US, V50, P380, DOI 10.1002/art.20018; Nishimura K, 2007, ANN INTERN MED, V146, P797, DOI 10.7326/0003-4819-146-11-200706050-00008; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Orsted D, 2011, EUR J CANCER, V47, pS504, DOI 10.1016/S0959-8049(11)72015-9; Pedersen CB, 2006, DAN MED BULL, V53, P441; Pedersen M, 2004, EUR J EPIDEMIOL, V19, P1097, DOI 10.1007/s10654-004-1025-0; Rantapaa-Dahlqvist S, 2003, ARTHRITIS RHEUM, V48, P2741, DOI 10.1002/art.11223; Schnohr P, 2002, EUR HEART J, V23, P620, DOI 10.1053/euhj.2001.2842; Song YW, 2010, QJM-INT J MED, V103, P139, DOI 10.1093/qjmed/hcp165; Tamai M, 2010, SCAND J RHEUMATOL, V39, P287, DOI 10.3109/03009741003604534; Turesson C, 2007, ANN RHEUM DIS, V66, P59, DOI 10.1136/ard.2006.054445; Ursum J, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2907; Verschueren P, 2009, SCAND J RHEUMATOL, V38, P166, DOI 10.1080/03009740802484846; Verstappen SMM, 2005, ANN RHEUM DIS, V64, P38, DOI 10.1136/ard.2003.014928; Weischer M, 2007, J CLIN ONCOL, V25, P57, DOI 10.1200/JCO.2005.05.5160	38	85	87	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 6	2012	345								e5244	10.1136/bmj.e5244	http://dx.doi.org/10.1136/bmj.e5244			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003TL	22956589	hybrid, Green Published			2022-12-24	WOS:000308634100001
J	Anderson, JG; Wilmouth, DM; Smith, JB; Sayres, DS				Anderson, James G.; Wilmouth, David M.; Smith, Jessica B.; Sayres, David S.			UV Dosage Levels in Summer: Increased Risk of Ozone Loss from Convectively Injected Water Vapor	SCIENCE			English	Article							IN-SITU MEASUREMENTS; ANTARCTIC OZONE; LOWER STRATOSPHERE; DEPLETION; RADICALS; CHLORINE; VORTEX; OH; REDUCTIONS; EVOLUTION	The observed presence of water vapor convectively injected deep into the stratosphere over the United States can fundamentally change the catalytic chlorine/bromine free-radical chemistry of the lower stratosphere by shifting total available inorganic chlorine into the catalytically active free-radical form, ClO. This chemical shift markedly affects total ozone loss rates and makes the catalytic system extraordinarily sensitive to convective injection into the mid-latitude lower stratosphere in summer. Were the intensity and frequency of convective injection to increase as a result of climate forcing by the continued addition of CO2 and CH4 to the atmosphere, increased risk of ozone loss and associated increases in ultraviolet dosage would follow.	[Anderson, James G.] Harvard Univ, Dept Chem & Chem Biol, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Anderson, JG (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA.	anderson@huarp.harvard.edu		Smith, Jessica/0000-0003-2070-1894	NASA	NASA(National Aeronautics & Space Administration (NASA))	We acknowledge those who have been central to the design of the flight instruments associated with these observations: J. Demusz, N. Allen, C. Tuozzolo, M. Greenberg, M. Rivero, T. Hanisco, J. Paul, L. Moyer, F. Keutsch, and M. Witinski. This research was supported by the NASA Upper Atmosphere Research Program under the technical oversight of K. Jucks.	ANDERSON JG, 1989, J GEOPHYS RES-ATMOS, V94, P11465, DOI 10.1029/JD094iD09p11465; ANDERSON JG, 1991, SCIENCE, V251, P39, DOI 10.1126/science.251.4989.39; ANDERSON JG, 1993, GEOPHYS RES LETT, V20, P2499, DOI 10.1029/93GL03118; COHEN RC, 1994, GEOPHYS RES LETT, V21, P2539, DOI 10.1029/94GL01713; Crutzen PJ, 2006, CLIMATIC CHANGE, V77, P211, DOI 10.1007/s10584-006-9101-y; Dessler AE, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2007JD008609; Dessler AE, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD012075; Dessler AE, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD005209; Diepgen TL, 2002, BRIT J DERMATOL, V146, P1, DOI 10.1046/j.1365-2133.146.s61.2.x; Drdla K., 2010, ATMOS CHEM PHYS DISC, V10, P28687, DOI DOI 10.5194/ACPD-10-28687-2010; Drdla K., 2005, EOS T AGU, V86, pA31D; FARMAN JC, 1985, NATURE, V315, P207, DOI 10.1038/315207a0; Hanisco TF, 2001, J PHYS CHEM A, V105, P1543, DOI 10.1021/jp002334g; Hanisco TF, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL027899; HOFMANN DJ, 1987, NATURE, V326, P59, DOI 10.1038/326059a0; Keim ER, 1996, GEOPHYS RES LETT, V23, P3223, DOI 10.1029/96GL02593; Keith DW, 2010, NATURE, V463, P426, DOI 10.1038/463426a; Keith DW, 2000, J GEOPHYS RES-ATMOS, V105, P15167, DOI 10.1029/2000JD900130; Kirk-Davidoff DB, 1999, NATURE, V402, P399, DOI 10.1038/46521; Lanzendorf EJ, 2001, J PHYS CHEM A, V105, P1535, DOI 10.1021/jp002384l; Liu CT, 2008, J APPL METEOROL CLIM, V47, P2712, DOI 10.1175/2008JAMC1890.1; Manney GL, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002634; Manney GL, 2011, NATURE, V478, P469, DOI 10.1038/nature10556; MCELROY MB, 1986, NATURE, V321, P759, DOI 10.1038/321759a0; MOLINA LT, 1987, J PHYS CHEM-US, V91, P433, DOI 10.1021/j100286a035; Moyer EJ, 1996, GEOPHYS RES LETT, V23, P2385, DOI 10.1029/96GL01489; NEWMAN P, 1991, GEOPHYS RES LETT, V18, P661, DOI 10.1029/91GL00546; Newman P. A., 2007, SCI ASSESSMENT OZONE; Newman PA, 1997, GEOPHYS RES LETT, V24, P2689, DOI 10.1029/97GL52831; Newman PA, 2001, GEOPHYS RES LETT, V28, P959, DOI 10.1029/2000GL011972; NEWMAN PA, 2003, SCI ASSESSMENT OZONE, pCH3; Peter T., 2012, STRATOSPHERIC OZONE, P4, DOI DOI 10.1039/9781849733182-00214; POLLOCK W, 1980, J GEOPHYS RES-OCEANS, V85, P5555, DOI 10.1029/JC085iC10p05555; Salawitch RJ, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021504; Sander S. P., 2011, JPL PUB, V10-6, P1; Sayres DS, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013100; Shi Q, 2001, J GEOPHYS RES-ATMOS, V106, P24259, DOI 10.1029/2000JD000181; Sloan LC, 1998, GEOPHYS RES LETT, V25, P3517, DOI 10.1029/98GL02492; Smith J., 2012, THESIS HARVARD U; Solomon S, 1999, REV GEOPHYS, V37, P275, DOI 10.1029/1999RG900008; SOLOMON S, 1986, NATURE, V321, P755, DOI 10.1038/321755a0; STIMPFLE RM, 1994, GEOPHYS RES LETT, V21, P2543, DOI 10.1029/94GL02373; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; Thornton BF, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007640; Trapp RJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036203; Van Klooster SL, 2009, J CLIMATE, V22, P3317, DOI 10.1175/2009JCLI2697.1; Weinstock MA, 1995, ENVIRON HEALTH PERSP, V103, P251, DOI 10.2307/3432320; WENNBERG PO, 1994, SCIENCE, V266, P398, DOI 10.1126/science.266.5184.398; Wilmouth DM, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006951	49	142	146	5	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2012	337	6096					835	839		10.1126/science.1222978	http://dx.doi.org/10.1126/science.1222978			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	989BQ	22837384				2022-12-24	WOS:000307535600041
J	Lee, D; Lin, BJ; Lee, AK				Lee, Doyun; Lin, Bei-Jung; Lee, Albert K.			Hippocampal Place Fields Emerge upon Single-Cell Manipulation of Excitability During Behavior	SCIENCE			English	Article							SPATIAL MAP; GRID CELLS; INPUT; CA1; DENDRITES; DYNAMICS; NEURONS; REPRESENTATION; INHIBITION; RECORDINGS	The origin of the spatial receptive fields of hippocampal place cells has not been established. A hippocampal CA1 pyramidal cell receives thousands of synaptic inputs, mostly from other spatially tuned neurons; however, how the postsynaptic neuron's cellular properties determine the response to these inputs during behavior is unknown. We discovered that, contrary to expectations from basic models of place cells and neuronal integration, a small, spatially uniform depolarization of the spatially untuned somatic membrane potential of a silent cell leads to the sudden and reversible emergence of a spatially tuned subthreshold response and place-field spiking. Such gating of inputs by postsynaptic neuronal excitability reveals a cellular mechanism for receptive field origin and may be critical for the formation of hippocampal memory representations.	[Lee, Doyun; Lin, Bei-Jung; Lee, Albert K.] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Lee, D (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA 20147 USA.	leed@janelia.hhmi.org; leea@janelia.hhmi.org	Lee, Doyun/AAK-5369-2020	Lee, Doyun/0000-0002-9968-9113; Lin, Bei-Jung/0000-0002-1755-1664	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We would like to thank G. Shtengel, J. Osborne, L. Ramasamy, D. Cabaniss, S. Bassin, C. Werner, B. Shields, A. Hu, M. J. Kim, H.-P. Liaw, G. Crosby, and D. Culley for technical advice and assistance and J. Dudman, N. Spruston, G. Murphy, J. Magee, K. Svoboda, J. Cohen, and D. Rich for valuable discussions about the manuscript. This work was supported by the Howard Hughes Medical Institute.	Brun VH, 2008, NEURON, V57, P290, DOI 10.1016/j.neuron.2007.11.034; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; Burgess N, 1996, HIPPOCAMPUS, V6, P749; Chevaleyre V, 2010, NEURON, V66, P560, DOI 10.1016/j.neuron.2010.04.013; Crochet S, 2011, NEURON, V69, P1160, DOI 10.1016/j.neuron.2011.02.022; de Almeida L, 2009, J NEUROSCI, V29, P7504, DOI 10.1523/JNEUROSCI.6048-08.2009; Epsztein J, 2011, NEURON, V70, P109, DOI 10.1016/j.neuron.2011.03.006; Frank LM, 2004, J NEUROSCI, V24, P7681, DOI 10.1523/JNEUROSCI.1958-04.2004; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Jarsky T, 2005, NAT NEUROSCI, V8, P1667, DOI 10.1038/nn1599; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Johnston D, 2008, TRENDS NEUROSCI, V31, P309, DOI 10.1016/j.tins.2008.03.004; Lee A. K., 2008, SOC NEUR ABSTR, V2008, P69022; Lee AK, 2006, NEURON, V51, P399, DOI 10.1016/j.neuron.2006.07.004; Lee AK, 2009, NAT PROTOC, V4, P385, DOI 10.1038/nprot.2009.5; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Major G, 2008, J NEUROPHYSIOL, V99, P2584, DOI 10.1152/jn.00011.2008; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Priebe NJ, 2008, NEURON, V57, P482, DOI 10.1016/j.neuron.2008.02.005; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Samsonovich A, 1997, J NEUROSCI, V17, P5900; Solstad T, 2006, HIPPOCAMPUS, V16, P1026, DOI 10.1002/hipo.20244; THOMPSON LT, 1989, J NEUROSCI, V9, P2382; Tsodyks M, 1995, INTERNATIONAL JOURNAL OF NEURAL SYSTEMS, SUPPLEMENTARY ISSUE, 1995, P81; Wei DS, 2001, SCIENCE, V293, P2272, DOI 10.1126/science.1061198; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Zhou Y, 2009, NAT NEUROSCI, V12, P1438, DOI 10.1038/nn.2405	32	159	160	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2012	337	6096					849	853		10.1126/science.1221489	http://dx.doi.org/10.1126/science.1221489			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	989BQ	22904011				2022-12-24	WOS:000307535600045
J	Sander, PM				Sander, P. Martin			Reproduction in Early Amniotes	SCIENCE			English	Editorial Material							LIFE-HISTORY; REPTILIA		Univ Bonn, Div Paleontol, Steinmann Inst Geol Mineral & Paleontol, D-53115 Bonn, Germany	University of Bonn	Sander, PM (corresponding author), Univ Bonn, Div Paleontol, Steinmann Inst Geol Mineral & Paleontol, Nussallee 8, D-53115 Bonn, Germany.	martin.sander@uni-bonn.de						BURGIN T, 1989, SCI AM, V260, P74; Caldwell MW, 2001, P ROY SOC B-BIOL SCI, V268, P2397, DOI 10.1098/rspb.2001.1796; Cheng YN, 2009, J VERTEBR PALEONTOL, V29, P401, DOI 10.1671/039.029.0230; Hou LH, 2010, P ROY SOC B-BIOL SCI, V277, P1235, DOI 10.1098/rspb.2009.2035; Houssaye A, 2009, INTEGR ZOOL, V4, P325, DOI 10.1111/j.1749-4877.2009.00146.x; Koenigswald Wighart V., 2004, Palaeontologische Zeitschrift, V78, P417; Modesto SP, 2010, J VERTEBR PALEONTOL, V30, P1378, DOI 10.1080/02724634.2010.501443; O'Keefe FR, 2011, SCIENCE, V333, P870, DOI 10.1126/science.1205689; Pineiro G, 2012, HIST BIOL, V24, P620, DOI 10.1080/08912963.2012.662230; Reisz RR, 2012, P NATL ACAD SCI USA, V109, P2428, DOI 10.1073/pnas.1109385109; Reisz RR, 2004, TRENDS GENET, V20, P237, DOI 10.1016/j.tig.2004.03.007; SANDER PM, 1988, SCIENCE, V239, P780, DOI 10.1126/science.3340859; Sumida S. S., 1997, AMNIOTE ORIGINS COMP; Wilkinson M, 2002, J NAT HIST, V36, P2185, DOI 10.1080/00222930110071714	14	35	35	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2012	337	6096					806	808		10.1126/science.1224301	http://dx.doi.org/10.1126/science.1224301			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	989BQ	22904001				2022-12-24	WOS:000307535600029
J	Wen, Q; Goldenson, B; Silver, SJ; Schenone, M; Dancik, V; Huang, Z; Wang, LZ; Lewis, TA; An, WF; Li, XY; Bray, MA; Thiollier, C; Diebold, L; Gilles, L; Vokes, MS; Moore, CB; Bliss-Moreau, M; VerPlank, L; Tolliday, NJ; Mishra, R; Vemula, S; Shi, JJ; Wei, L; Kapur, R; Lopez, CK; Gerby, B; Ballerini, P; Pflumio, F; Gilliland, DG; Goldberg, L; Birger, Y; Izraeli, S; Gamis, AS; Smith, FO; Woods, WG; Taub, J; Scherer, CA; Bradner, JE; Goh, BC; Mercher, T; Carpenter, AE; Gould, RJ; Clemons, PA; Carr, SA; Root, DE; Schreiber, SL; Stern, AM; Crispino, JD				Wen, Qiang; Goldenson, Benjamin; Silver, Serena J.; Schenone, Monica; Dancik, Vlado; Huang, Zan; Wang, Ling-Zhi; Lewis, Timothy A.; An, W. Frank; Li, Xiaoyu; Bray, Mark-Anthony; Thiollier, Clarisse; Diebold, Lauren; Gilles, Laure; Vokes, Martha S.; Moore, Christopher B.; Bliss-Moreau, Meghan; VerPlank, Lynn; Tolliday, Nicola J.; Mishra, Rama; Vemula, Sasidhar; Shi, Jianjian; Wei, Lei; Kapur, Reuben; Lopez, Cecile K.; Gerby, Bastien; Ballerini, Paola; Pflumio, Francoise; Gilliland, D. Gary; Goldberg, Liat; Birger, Yehudit; Izraeli, Shai; Gamis, Alan S.; Smith, Franklin O.; Woods, William G.; Taub, Jeffrey; Scherer, Christina A.; Bradner, James E.; Goh, Boon-Cher; Mercher, Thomas; Carpenter, Anne E.; Gould, Robert J.; Clemons, Paul A.; Carr, Steven A.; Root, David E.; Schreiber, Stuart L.; Stern, Andrew M.; Crispino, John D.			Identification of Regulators of Polyploidization Presents Therapeutic Targets for Treatment of AMKL	CELL			English	Article							ACUTE MEGAKARYOBLASTIC LEUKEMIA; ACUTE MEGAKARYOCYTIC LEUKEMIA; AURORA-A KINASE; INHIBITOR MLN8237; DOWN-SYNDROME; CELL-CYCLE; B KINASE; PHOSPHORYLATION; MEGAKARYOPOIESIS; VALIDATION	The mechanism by which cells decide to skip mitosis to become polyploid is largely undefined. Here we used a high-content image-based screen to identify small-molecule probes that induce polyploidization of megakaryocytic leukemia cells and serve as perturbagens to help understand this process. Our study implicates five networks of kinases that regulate the switch to polyploidy. Moreover, we find that dimethylfasudil (diMF, H-1152P) selectively increased polyploidization, mature cell-surface marker expression, and apoptosis of malignant megakaryocytes. An integrated target identification approach employing proteomic and shRNA screening revealed that a major target of diMF is Aurora kinase A (AURKA). We further find that MLN8237 (Alisertib), a selective inhibitor of AURKA, induced polyploidization and expression of mature megakaryocyte markers in acute megakaryocytic leukemia (AMKL) blasts and displayed potent anti-AMKL activity in vivo. Our findings provide a rationale to support clinical trials of MLN8237 and other inducers of polyploidization and differentiation in AMKL.	[Silver, Serena J.; Schenone, Monica; Dancik, Vlado; Lewis, Timothy A.; An, W. Frank; Li, Xiaoyu; Bray, Mark-Anthony; Vokes, Martha S.; Moore, Christopher B.; Bliss-Moreau, Meghan; VerPlank, Lynn; Tolliday, Nicola J.; Scherer, Christina A.; Bradner, James E.; Carpenter, Anne E.; Gould, Robert J.; Clemons, Paul A.; Carr, Steven A.; Root, David E.; Schreiber, Stuart L.; Stern, Andrew M.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Wen, Qiang; Goldenson, Benjamin; Huang, Zan; Diebold, Lauren; Gilles, Laure; Crispino, John D.] Northwestern Univ, Div Hematol Oncol, Chicago, IL 60611 USA; [Wang, Ling-Zhi; Goh, Boon-Cher] Natl Univ Singapore, Canc Sci Inst, Singapore 117599, Singapore; [Thiollier, Clarisse; Lopez, Cecile K.; Mercher, Thomas] Inst Gustave Roussy, INSERM, U985, F-94805 Villejuif, France; [Mishra, Rama] CMIDD, Evanston, IL USA; [Mishra, Rama] Northwestern Univ, Chicago, IL 60208 USA; [Vemula, Sasidhar; Shi, Jianjian; Wei, Lei; Kapur, Reuben] Indiana Univ, Dept Pediat, Indianapolis, IN 46202 USA; [Gerby, Bastien; Pflumio, Francoise] INSERM, CEA, Inst Radiobiol Cellulaire & Mol, EA 92265,UMR967, Fontenay Aux Roses, France; [Ballerini, Paola] Hop Trousseau, AP HP, F-75571 Paris, France; [Gilliland, D. Gary] Merck Sharp & Dohme Ltd, West Point, PA 19446 USA; [Goldberg, Liat; Birger, Yehudit; Izraeli, Shai] Tel Aviv Univ, Sheba Med Ctr, IL-52621 Ramat Gan, Israel; [Gamis, Alan S.] Childrens Mercy Hosp & Clin, Kansas City, MO 64108 USA; [Smith, Franklin O.] Univ Cincinnati, Inst Canc, Cincinnati, OH 45229 USA; [Woods, William G.] Childrens Healthcare Atlanta, Aflac Canc Ctr, Atlanta, GA 30322 USA; [Woods, William G.] Emory Univ, Atlanta, GA 30322 USA; [Taub, Jeffrey] Childrens Hosp Michigan, Detroit, MI 48201 USA; [Bradner, James E.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Northwestern University; National University of Singapore; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; Northwestern University; Indiana University System; Indiana University-Purdue University Indianapolis; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Merck & Company; Chaim Sheba Medical Center; Tel Aviv University; Children's Mercy Hospital; University System of Ohio; University of Cincinnati; Children's Healthcare of Atlanta (CHOA); Emory University; Children's Hospital of Michigan; Harvard University; Dana-Farber Cancer Institute	Stern, AM (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.	astern@broadinstitute.org; j-crispino@northwestern.edu	Mercher, Thomas/J-2446-2014; Carpenter, Anne/C-4982-2008; Carr, Steven A./AAH-8366-2019; Gerby, Bastien/D-8623-2017; Bray, Mark/C-5973-2008; Pflumio, Francoise/E-2074-2017; Wang, Lingzhi/AAF-1851-2020	Mercher, Thomas/0000-0003-1552-087X; Carpenter, Anne/0000-0003-1555-8261; Gerby, Bastien/0000-0002-2657-4200; Bray, Mark/0000-0002-9748-3592; Wang, Lingzhi/0000-0001-5585-5426; Lopez, Cecile/0000-0003-4473-6311; Crispino, John/0000-0002-8182-8306; Huang, Zan/0000-0001-5623-6950; Pflumio, Francoise/0000-0001-8995-596X; Goldenson, Benjamin/0000-0001-6724-7858; Lewis, Timothy/0000-0001-9748-9575; Stern, Andrew/0000-0002-8437-2957; Gilles, Laure/0000-0001-6567-256X	Samuel Waxman Cancer Research Foundation; US Israel Binational Science Foundation; Leukemia and Lymphoma Society Translational Research Program; Children with Leukaemia UK; Israel Science Foundation; European Hematology Association; Leukemia Research Foundation; NIH [CA101774, HL077177, HL075816, HL081111, GM089652, U54 HG005032, RL1-CA133834, RL1-GM084437, RL1-HG004671, UL1-DE019585]; Foundation Gustave Roussy; Jose Carreras Leukemia Foundation- European Hematology Association; CEA-EA; Ligue Nationale Contre le Cancer; Association Laurette Fugain; Societe Francaise d'Hematologie; Foundation pour la Recherche Medicale; National Cancer Institute (NCI) [U10 CA98543]; NCI's Initiative for Chemical Genetics [N01-CO-12400]; NATIONAL CANCER INSTITUTE [R01CA101774, RL1CA133834, U10CA098543] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081111, R01HL075816, R56HL075816, R01HL077177, P01HL085098] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RL1HG004671, U54HG005032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [UL1DE019585] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089652, RL1GM084437] Funding Source: NIH RePORTER	Samuel Waxman Cancer Research Foundation; US Israel Binational Science Foundation(US-Israel Binational Science Foundation); Leukemia and Lymphoma Society Translational Research Program(Leukemia and Lymphoma Society); Children with Leukaemia UK; Israel Science Foundation(Israel Science Foundation); European Hematology Association; Leukemia Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Gustave Roussy; Jose Carreras Leukemia Foundation- European Hematology Association; CEA-EA; Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Association Laurette Fugain; Societe Francaise d'Hematologie; Foundation pour la Recherche Medicale(Fondation pour la Recherche Medicale); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI's Initiative for Chemical Genetics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Sandeep Gurbuxani, Alex Minella, and Lou Dore for critical reading of the manuscript and Bang Wong for valuable advice on figures of the manuscript. This research was funded by grants from the Samuel Waxman Cancer Research Foundation (J.D.C. and S. I.), the US Israel Binational Science Foundation (to S. I. and J.D.C.), the Leukemia and Lymphoma Society Translational Research Program (J.D.C.), the Children with Leukaemia UK (S. I.), the Israel Science Foundation (S. I.), European Hematology Association (Y.B.), and the Leukemia Research Foundation (Y.B.) and by NIH grants CA101774 (J.D.C.), HL077177 (R. K.), HL075816 (R. K.), and HL081111 (R. K.). Other support included an NIH grant to A. E. C. supporting CellProfiler (GM089652), an NIH grant supporting screening informatics (U54 HG005032), NIH Genomics Based Drug Discovery U54 grants Discovery Pipeline RL1-CA133834, and Driving Medical Projects RL1-GM084437, administratively linked to NIH grants RL1-HG004671 and UL1-DE019585 (A. E. C., P. A. C., V. D., C. B. M., A. M. S., C. A. S., and M. S.). Y.B. is a European Hematology Association Fellow. In vivo treatment of human AMKL samples was supported by Foundation Gustave Roussy and Jose Carreras Leukemia Foundation- European Hematology Association (T. M.), CEA-EA, Ligue Nationale Contre le Cancer (F. P.), Association Laurette Fugain (F. P.), Societe Francaise d'Hematologie (B. G., F. P.), and Foundation pour la Recherche Medicale (C. T.). The authors would also like to thank Jason Berman, Soheil Meshinchi, Todd Alonzo, and Sommer Castro and the Children's Oncology Group (COG) for their assistance with DS-AMKL specimens. Research with DS-AMKL samples was supported by the Chair's Grant U10 CA98543 (to COG) from the National Cancer Institute (NCI). The project has also been funded in part with Federal funds from the NCI's Initiative for Chemical Genetics under Contract N01-CO-12400. The content of this publication is solely the responsibility of the authors and does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. A part of this work was performed by the Northwestern University ChemCore at the Center for Molecular Innovation and Drug Discovery (CMIDD), which is funded by the Chicago Biomedical Consortium with support from The Searle Funds at The Chicago Community Trust. D. G. G. is an employee and shareholder of Merck and Co., Inc. R.J.G. is an employee, shareholder, and board member of Epizyme, Inc. and a member of the SAB of the Michael J. Fox Foundation.	Bluteau D, 2009, J THROMB HAEMOST, V7, P227, DOI 10.1111/j.1538-7836.2009.03398.x; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cowley DO, 2009, MOL CELL BIOL, V29, P1059, DOI 10.1128/MCB.01062-08; D'Alise AM, 2008, MOL CANCER THER, V7, P1140, DOI 10.1158/1535-7163.MCT-07-2051; Ding J, 2011, MOL REPROD DEV, V78, P80, DOI 10.1002/mrd.21272; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Gorgun G, 2010, BLOOD, V115, P5202, DOI 10.1182/blood-2009-12-259523; Hitchcock IS, 2008, BLOOD, V111, P596, DOI 10.1182/blood-2007-05-089680; Ikenoya M, 2002, J NEUROCHEM, V81, P9, DOI 10.1046/j.1471-4159.2002.00801.x; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Lannutti BJ, 2006, ONCOGENE, V25, P3316, DOI 10.1038/sj.onc.1209351; Lannutti BJ, 2005, BLOOD, V105, P3875, DOI 10.1182/blood-2004-10-3934; Li Z, 2005, NAT GENET, V37, P613, DOI 10.1038/ng1566; Lok W, 2010, ANTI-CANCER DRUG, V21, P339, DOI 10.1097/CAD.0b013e3283350dd1; Lordier L, 2010, BLOOD, V116, P2345, DOI 10.1182/blood-2010-01-265785; Ma ZG, 2001, NAT GENET, V28, P220, DOI 10.1038/90054; Mali RS, 2011, CANCER CELL, V20, P357, DOI 10.1016/j.ccr.2011.07.016; Malinge S, 2009, BLOOD, V113, P2619, DOI 10.1182/blood-2008-11-163501; Manfredi MG, 2011, CLIN CANCER RES, V17, P7614, DOI 10.1158/1078-0432.CCR-11-1536; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Margolin AA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007454; Maris JM, 2010, PEDIATR BLOOD CANCER, V55, P26, DOI 10.1002/pbc.22430; Mercher T, 2001, P NATL ACAD SCI USA, V98, P5776, DOI 10.1073/pnas.101001498; Mercher T, 2009, J CLIN INVEST, V119, P852, DOI 10.1172/JCI35901; Mortlock AA, 2007, J MED CHEM, V50, P2213, DOI 10.1021/jm061335f; Muntean AG, 2007, BLOOD, V109, P5199, DOI 10.1182/blood-2006-11-059378; Ong SE, 2009, P NATL ACAD SCI USA, V106, P4617, DOI 10.1073/pnas.0900191106; Pradines JR, 2005, J COMPUT BIOL, V12, P113, DOI 10.1089/cmb.2005.12.113; SATO T, 1989, BRIT J HAEMATOL, V72, P184, DOI 10.1111/j.1365-2141.1989.tb07681.x; Sloane DA, 2010, ACS CHEM BIOL, V5, P563, DOI 10.1021/cb100053q; Stachura DL, 2006, BLOOD, V107, P87, DOI 10.1182/blood-2005-07-2740; Tallman MS, 2000, BLOOD, V96, P2405; Terstappen GC, 2007, NAT REV DRUG DISCOV, V6, P891, DOI 10.1038/nrd2410; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; Vemula S, 2010, BLOOD, V115, P1785, DOI 10.1182/blood-2009-08-237222; Wechsler J, 2002, NAT GENET, V32, P148, DOI 10.1038/ng955; Wen Q, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411002043; Wen Q, 2009, BLOOD, V114, P153, DOI 10.1182/blood-2008-11-190801; Wilkinson RW, 2007, CLIN CANCER RES, V13, P3682, DOI 10.1158/1078-0432.CCR-06-2979; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	41	111	117	1	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 3	2012	150	3					575	589		10.1016/j.cell.2012.06.032	http://dx.doi.org/10.1016/j.cell.2012.06.032			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	985WO	22863010	Green Submitted, Bronze, Green Accepted			2022-12-24	WOS:000307301400016
J	Kocabas, A; Shen, CH; Guo, ZCV; Ramanathan, S				Kocabas, Askin; Shen, Ching-Han; Guo, Zengcai V.; Ramanathan, Sharad			Controlling interneuron activity in Caenorhabditis elegans to evoke chemotactic behaviour	NATURE			English	Article							LIM HOMEOBOX GENE; C-ELEGANS; NEURAL ACTIVITY; NERVOUS-SYSTEM; OPTICAL CONTROL; NEURONS; WORM; EXPRESSION; CIRCUITS; PROTEIN	Animals locate and track chemoattractive gradients in the environment to find food. With its small nervous system, Caenorhabditis elegans is a good model system(1,2) in which to understand how the dynamics of neural activity control this search behaviour. Extensive work on the nematode has identified the neurons that are necessary for the different locomotory behaviours underlying chemotaxis through the use of laser ablation(3-7), activity recording in immobilized animals and the study of mutants(4,5). However, we do not know the neural activity patterns in C. elegans that are sufficient to control its complex chemotactic behaviour. To understand how the activity in its interneurons coordinate different motor programs to lead the animal to food, here we used optogenetics and new optical tools to manipulate neural activity directly in freely moving animals to evoke chemotactic behaviour. By deducing the classes of activity patterns triggered during chemotaxis and exciting individual neurons with these patterns, we identified interneurons that control the essential locomotory programs for this behaviour. Notably, we discovered that controlling the dynamics of activity in just one interneuron pair (AIY) was sufficient to force the animal to locate, turn towards and track virtual light gradients. Two distinct activity patterns triggered in AIY as the animal moved through the gradient controlled reversals and gradual turns to drive chemotactic behaviour. Because AIY neurons are post-synaptic to most chemosensory and thermosensory neurons(8), it is probable that these activity patterns in AIY have an important role in controlling and coordinating different taxis behaviours of the animal.	[Kocabas, Askin; Shen, Ching-Han; Ramanathan, Sharad] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Kocabas, Askin; Shen, Ching-Han; Ramanathan, Sharad] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Guo, Zengcai V.] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Ramanathan, Sharad] Allen Inst Brain Sci, Seattle, WA 98103 USA; [Ramanathan, Sharad] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Ramanathan, Sharad] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University; Howard Hughes Medical Institute; Allen Institute for Brain Science; Harvard University; Harvard University	Kocabas, A (corresponding author), Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA.	akocabas@cgr.harvard.edu; sharad@post.harvard.edu		Kocabas, Askin/0000-0002-6930-1202	Human Frontier Science Program (HFSP) Postdoctoral Fellowship; National Science Foundation (NSF) Graduate Fellowship; NSF Career Award; Pew Scholar, Klingenstein Fellowship Award; National Institutes of Health (NIH) Pioneer Awards; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH099906] Funding Source: NIH RePORTER	Human Frontier Science Program (HFSP) Postdoctoral Fellowship(Human Frontier Science Program); National Science Foundation (NSF) Graduate Fellowship(National Science Foundation (NSF)); NSF Career Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); Pew Scholar, Klingenstein Fellowship Award; National Institutes of Health (NIH) Pioneer Awards(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank J. Dowling, S. Lockery, J. Lichtman, K. McCormick, A. Murray, E. O'Shea, A. Schier, B. Stern and members of the Ramanathan laboratory for discussions and comments, the Human Frontier Science Program (HFSP) Postdoctoral Fellowship (A. K.), National Science Foundation (NSF) Graduate Fellowship (C.-H.S.), NSF Career Award, Pew Scholar, Klingenstein Fellowship Award and the National Institutes of Health (NIH) Pioneer Awards (S. R.) for support.	Bendena WG, 2008, P NATL ACAD SCI USA, V105, P1339, DOI 10.1073/pnas.0709492105; BOULIN T, 2006, WORMBOOK; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; BRENNER S, 1974, GENETICS, V77, P71; BRENNER S, 1973, BRIT MED BULL, V29, P269, DOI 10.1093/oxfordjournals.bmb.a071019; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Chou JH, 2001, GENETICS, V157, P211; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Edwards SL, 2008, PLOS BIOL, V6, P1715, DOI 10.1371/journal.pbio.0060198; GRANATO M, 1994, NUCLEIC ACIDS RES, V22, P1762, DOI 10.1093/nar/22.9.1762; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Guo ZV, 2009, NAT METHODS, V6, P891, DOI 10.1038/nmeth.1397; Hires SA, 2008, BRAIN CELL BIOL, V36, P69, DOI 10.1007/s11068-008-9029-4; Hobert O, 1997, NEURON, V19, P345, DOI 10.1016/S0896-6273(00)80944-7; Iino Y, 2009, J NEUROSCI, V29, P5370, DOI 10.1523/JNEUROSCI.3633-08.2009; Izquierdo EJ, 2010, J NEUROSCI, V30, P12908, DOI 10.1523/JNEUROSCI.2606-10.2010; Karasawa S, 2004, BIOCHEM J, V381, P307, DOI 10.1042/BJ20040321; Kim D, 2011, J EXP BIOL, V214, P1554, DOI 10.1242/jeb.052092; Leifer AM, 2011, NAT METHODS, V8, P147, DOI 10.1038/NMETH.1554; Lockery SR, 2011, CURR OPIN NEUROBIOL, V21, P782, DOI 10.1016/j.conb.2011.06.009; MCINTIRE SL, 1993, NATURE, V364, P337, DOI 10.1038/364337a0; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Okazaki A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035370; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Ramot D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002208; Stirman JN, 2011, NAT METHODS, V8, P153, DOI 10.1038/NMETH.1555; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; Tsalik EL, 2003, DEV BIOL, V263, P81, DOI 10.1016/S0012-1606(03)00447-0; Tsalik EL, 2003, J NEUROBIOL, V56, P178, DOI 10.1002/neu.10245; Wakabayashi T, 2004, NEUROSCI RES, V50, P103, DOI 10.1016/j.neures.2004.06.005; WARD S, 1973, P NATL ACAD SCI USA, V70, P817, DOI 10.1073/pnas.70.3.817; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	33	83	86	0	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2012	490	7419					273	+		10.1038/nature11431	http://dx.doi.org/10.1038/nature11431			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019IY	23000898	Green Accepted, Green Submitted			2022-12-24	WOS:000309733300052
J	von Moltke, J; Trinidad, NJ; Moayeri, M; Kintzer, AF; Wang, SB; van Rooijen, N; Brown, CR; Krantz, BA; Leppla, SH; Gronert, K; Vance, RE				von Moltke, Jakob; Trinidad, Norver J.; Moayeri, Mahtab; Kintzer, Alexander F.; Wang, Samantha B.; van Rooijen, Nico; Brown, Charles R.; Krantz, Bryan A.; Leppla, Stephen H.; Gronert, Karsten; Vance, Russell E.			Rapid induction of inflammatory lipid mediators by the inflammasome in vivo	NATURE			English	Article							CASPASE-1 ACTIVATION; IMMUNE RECOGNITION; MICE DEFICIENT; PYROPTOSIS; MECHANISM; INFECTION; INJURY; SUSCEPTIBILITY; SUBSTRATE; FLAGELLIN	Detection of microbial products by host inflammasomes is an important mechanism of innate immune surveillance. Inflammasomes activate the caspase-1 (CASP1) protease, which processes the cytokines interleukin (IL)-1 beta and IL-18, and initiates a lytic host cell death called pyroptosis(1). To identify novel CASP1 functions in vivo, we devised a strategy for cytosolic delivery of bacterial flagellin, a specific ligand for the NAIP5 (NLR family, apoptosis inhibitory protein 5)/NLRC4 (NLR family, CARD-domain-containing 4) inflammasome(2-4). Here we show that systemic inflammasome activation by flagellin leads to a loss of vascular fluid into the intestine and peritoneal cavity, resulting in rapid (less than 30 min) death in mice. This unexpected response depends on the inflammasome components NAIP5, NLRC4 and CASP1, but is independent of the production of IL-1 beta or IL-18. Instead, inflammasome activation results, within minutes, in an 'eicosanoid storm'-a pathological release of signalling lipids, including prostaglandins and leukotrienes, that rapidly initiate inflammation and vascular fluid loss. Mice deficient in cyclooxygenase-1, a critical enzyme in prostaglandin biosynthesis, are resistant to these rapid pathological effects of systemic inflammasome activation by either flagellin or anthrax lethal toxin. Inflammasome-dependent biosynthesis of eicosanoids is mediated by the activation of cytosolic phospholipase A(2) in resident peritoneal macrophages, which are specifically primed for the production of eicosanoids by high expression of eicosanoid biosynthetic enzymes. Our results therefore identify eicosanoids as a previously unrecognized cell-type-specific signalling output of the inflammasome with marked physiological consequences in vivo.	[von Moltke, Jakob; Trinidad, Norver J.; Vance, Russell E.] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, Berkeley, CA 94720 USA; [Kintzer, Alexander F.; Krantz, Bryan A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Wang, Samantha B.; Gronert, Karsten] Univ Calif Berkeley, Vis Sci Program, Berkeley, CA 94720 USA; [Moayeri, Mahtab; Leppla, Stephen H.] NIAID, Parasit Dis Lab, Microbial Pathogenesis Sect, NIH, Bethesda, MD 20892 USA; [van Rooijen, Nico] Vrije Univ Amsterdam, Fac Med, Dept Mol Cell Biol, NL-1081 BT Amsterdam, Netherlands; [Brown, Charles R.] Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Vrije Universiteit Amsterdam; University of Missouri System; University of Missouri Columbia	Vance, RE (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, 229 Stanley Hall, Berkeley, CA 94720 USA.	kgronert@berkeley.edu; rvance@berkeley.edu	Van Rooijen, Nico/Z-1578-2019	Krantz, Bryan/0000-0002-4911-5824; Brown, Charles/0000-0002-1914-9601; Kintzer, Alexander/0000-0001-9630-7258; Moayeri, Mahtab/0000-0002-4448-8883	Burroughs Wellcome Fund; Cancer Research Institute; National Institutes of Health (NIH) [AI075039, AI080749, AI063302, EY016136, EY022208]; Cancer Research Coordinating Committee of the University of California; NATIONAL EYE INSTITUTE [R01EY022208, R01EY016136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075039, P01AI063302, ZIAAI001032, R01AI080749] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); Cancer Research Institute; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Coordinating Committee of the University of California(University of California System); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Mariathasan and V. Dixit for Nlrc4<SUP>-/-</SUP> mice; I. Bergin and S. Griffey for pathology reports; D. Crown for help with survival experiments; L. Lopez for support in our animal facility; D. Bautista and R. Nichols for help with calcium imaging; and M. Fontana and members of the Barton and Vance laboratories for discussions. Work in R.E.V.'s laboratory is supported by Investigator Awards from the Burroughs Wellcome Fund and the Cancer Research Institute and by National Institutes of Health (NIH) grants AI075039, AI080749 and AI063302. K.G.'s laboratory is supported by NIH grants EY016136 and EY022208. J.v.M. is supported by a grant from the Cancer Research Coordinating Committee of the University of California.	Agard NJ, 2010, MOL CELL PROTEOMICS, V9, P880, DOI 10.1074/mcp.M900528-MCP200; Amer A, 2006, J BIOL CHEM, V281, P35217, DOI 10.1074/jbc.M604933200; Annacker O, 2005, J EXP MED, V202, P1051, DOI 10.1084/jem.20040662; Bergsbaken T, 2011, J IMMUNOL, V187, P2748, DOI 10.4049/jimmunol.1100477; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Case CL, 2009, INFECT IMMUN, V77, P1981, DOI 10.1128/IAI.01382-08; Fink SL, 2006, CELL MICROBIOL, V8, P1812, DOI 10.1111/j.1462-5822.2006.00751.x; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gijon MA, 2000, ADV ENZYME REGUL, V40, P255, DOI 10.1016/S0065-2571(99)00031-X; Glomski IJ, 2003, INFECT IMMUN, V71, P6754, DOI 10.1128/IAI.71.12.6754-6765.2003; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Hassan IR, 2009, J IMMUNOL, V182, P3223, DOI 10.4049/jimmunol.0802064; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Krantz BA, 2005, SCIENCE, V309, P777, DOI 10.1126/science.1113380; Lamkanfi M, 2010, J IMMUNOL, V185, P4385, DOI 10.4049/jimmunol.1000803; Lamkanfi M, 2008, MOL CELL PROTEOMICS, V7, P2350, DOI 10.1074/mcp.M800132-MCP200; Leedom AJ, 2010, AM J PATHOL, V176, P74, DOI 10.2353/ajpath.2010.090678; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Liclican EL, 2010, INVEST OPHTH VIS SCI, V51, P6311, DOI 10.1167/iovs.10-5455; Lightfield KL, 2008, NAT IMMUNOL, V9, P1171, DOI 10.1038/ni.1646; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Monroe KM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000665; RIVIERE PJM, 1991, J PHARMACOL EXP THER, V256, P547; ROBERT A, 1976, PROSTAG OTH LIPID M, V11, P809, DOI 10.1016/0090-6980(76)90189-1; SAMUELSSON B, 1983, BIOSCIENCE REP, V3, P791, DOI 10.1007/BF01133779; Sapieha P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001571; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Serhan C. N., 2011, FUNDAMENTALS INFLAMM, P153; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Shao W, 2007, J BIOL CHEM, V282, P36321, DOI 10.1074/jbc.M708182200; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Terra JK, 2010, J IMMUNOL, V184, P17, DOI 10.4049/jimmunol.0903114; Tobin DM, 2010, CELL, V140, P717, DOI 10.1016/j.cell.2010.02.013; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	39	312	315	2	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2012	490	7418					107	U126		10.1038/nature11351	http://dx.doi.org/10.1038/nature11351			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015LG	22902502	Green Accepted, Green Submitted			2022-12-24	WOS:000309446800042
J	Makinodan, M; Rosen, KM; Ito, S; Corfas, G				Makinodan, Manabu; Rosen, Kenneth M.; Ito, Susumu; Corfas, Gabriel			A Critical Period for Social Experience-Dependent Oligodendrocyte Maturation and Myelination	SCIENCE			English	Article							MEDIAL PREFRONTAL CORTEX; EARLY DEPRIVATION; WORKING-MEMORY; IN-VIVO; CHILDREN; SCHIZOPHRENIA; DISORDERS; ALTERS; CELLS; ERBB3	Early social isolation results in adult behavioral and cognitive dysfunction that correlates with white matter alterations. However, how social deprivation influences myelination and the significance of these myelin defects in the adult remained undefined. We show that mice isolated for 2 weeks immediately after weaning have alterations in prefrontal cortex function and myelination that do not recover with reintroduction into a social environment. These alterations, which occur only during this critical period, are phenocopied by loss of oligodendrocyte ErbB3 receptors, and social isolation leads to reduced expression of the ErbB3 ligand neuregulin-1. These findings indicate that social experience regulates prefrontal cortex myelination through neuregulin-1/ErbB3 signaling and that this is essential for normal cognitive function, thus providing a cellular and molecular context to understand the consequences of social isolation.	[Makinodan, Manabu; Rosen, Kenneth M.; Corfas, Gabriel] Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Makinodan, Manabu; Corfas, Gabriel] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Rosen, Kenneth M.; Corfas, Gabriel] Harvard Univ, Sch Med, Dept Otolaryngol, Boston, MA 02115 USA; [Ito, Susumu] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Corfas, G (corresponding author), Childrens Hosp, FM Kirby Neurobiol Ctr, 300 Longwood Ave, Boston, MA 02115 USA.	gabriel.corfas@childrens.harvard.edu	Corfas, Gabriel/AAH-2378-2020	Corfas, Gabriel/0000-0001-5412-9473	National Institute of Neurological Disorders and Stroke, NIH [R01 NS35884]; Lori and Joel Freedman; NIH Intellectual and Developmental Disabilities Research Center [P30-HD 18655]; Nara Medical University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035884] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Lori and Joel Freedman; NIH Intellectual and Developmental Disabilities Research Center; Nara Medical University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank T. Schwarz, C. J. Woolf, R. A. Corfas, M. Rao, F. Sher and M. Lozada for critical reading of the manuscript; C. Hart for help with the mouse colony; G. Gorski for help with electron microscopy; C. Arteaga for the generous gift of the ErbB3 floxed mouse line; J. C. Dodart for advice on behavioral tests; M. Fagiolini for allowing us to use behavioral equipment. This research was supported in part by the National Institute of Neurological Disorders and Stroke, NIH, grant R01 NS35884 (to G. C.), by Lori and Joel Freedman (to G. C.), an NIH Intellectual and Developmental Disabilities Research Center grant P30-HD 18655, and Nara Medical University (M.M.).	Bos K, 2011, HARVARD REV PSYCHIAT, V19, P15, DOI 10.3109/10673229.2011.549773; Brinkmann BG, 2008, NEURON, V59, P581, DOI 10.1016/j.neuron.2008.06.028; Buonanno A, 2010, BRAIN RES BULL, V83, P122, DOI 10.1016/j.brainresbull.2010.07.012; Chen S, 2006, J NEUROSCI, V26, P3079, DOI 10.1523/JNEUROSCI.3785-05.2006; Chugani HT, 2001, NEUROIMAGE, V14, P1290, DOI 10.1006/nimg.2001.0917; Corfas G, 2004, NAT NEUROSCI, V7, P575, DOI 10.1038/nn1258; Dias R, 2000, EUR J NEUROSCI, V12, P4457, DOI 10.1046/j.0953-816X.2000.01323.x; Doerflinger NH, 2003, GENESIS, V35, P63, DOI 10.1002/gene.10154; Egeland B, 1983, Child Abuse Negl, V7, P459, DOI 10.1016/0145-2134(83)90053-4; Eluvathingal TJ, 2006, PEDIATRICS, V117, P2093, DOI 10.1542/peds.2005-1727; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; GARIEPY JL, 1995, PHARMACOL BIOCHEM BE, V51, P767, DOI 10.1016/0091-3057(95)00028-U; Hol T, 1999, BEHAV BRAIN RES, V100, P91, DOI 10.1016/S0166-4328(98)00116-8; Kim JY, 2003, J NEUROSCI, V23, P5561; Li CR, 2010, BRAIN RES, V1346, P183, DOI 10.1016/j.brainres.2010.05.064; Liu XH, 2011, J NEUROSCI, V31, P8491, DOI 10.1523/JNEUROSCI.5317-10.2011; Mallon BS, 2002, J NEUROSCI, V22, P876, DOI 10.1523/JNEUROSCI.22-03-00876.2002; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Murtie JC, 2007, J NEUROSCI RES, V85, P2080, DOI 10.1002/jnr.21339; Park SK, 2001, J CELL BIOL, V154, P1245, DOI 10.1083/jcb.200104025; Pollak SD, 2010, CHILD DEV, V81, P224, DOI 10.1111/j.1467-8624.2009.01391.x; Prevot V, 2003, J NEUROSCI, V23, P230; Qu SM, 2006, GENESIS, V44, P477, DOI 10.1002/dvg.20243; Rico B, 2011, CURR OPIN GENET DEV, V21, P262, DOI 10.1016/j.gde.2010.12.010; Roy K, 2007, P NATL ACAD SCI USA, V104, P8131, DOI 10.1073/pnas.0702157104; Sanchez MM, 1998, BRAIN RES, V812, P38, DOI 10.1016/S0006-8993(98)00857-9; Schmucker J, 2003, GLIA, V44, P67, DOI 10.1002/glia.10275; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; Taveggia C, 2008, GLIA, V56, P284, DOI 10.1002/glia.20612; Van de Weerd Heleen A., 2002, Journal of Applied Animal Welfare Science, V5, P87, DOI 10.1207/S15327604JAWS0502_01; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; Wake H, 2011, SCIENCE, V333, P1647, DOI 10.1126/science.1206998; Widom CS, 2007, ARCH GEN PSYCHIAT, V64, P49; Winterfeld KT, 1998, J NEUROSCI RES, V52, P201, DOI 10.1002/(SICI)1097-4547(19980415)52:2<201::AID-JNR8>3.0.CO;2-E; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045	37	539	545	6	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2012	337	6100					1357	1360		10.1126/science.1220845	http://dx.doi.org/10.1126/science.1220845			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	004TW	22984073	Green Accepted			2022-12-24	WOS:000308705000046
J	State, MW; Sestan, N				State, Matthew W.; Sestan, Nenad			The Emerging Biology of Autism Spectrum Disorders	SCIENCE			English	Editorial Material							DE-NOVO MUTATIONS; BRAIN; CHILDREN		[State, Matthew W.] Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06510 USA; [State, Matthew W.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06510 USA; [Sestan, Nenad] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA	Yale University; Yale University; Yale University	State, MW (corresponding author), Yale Univ, Sch Med, Ctr Child Study, 333 Cedar St, New Haven, CT 06510 USA.	matthew.state@yale.edu; nenad.sestan@yale.edu	State, Matthew/W-2256-2019	Candy, Cotton/0000-0002-3032-5872; State, Matthew/0000-0003-1624-8302	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081754, U01MH081896, P50MH081756, RC2MH089956] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054273] Funding Source: NIH RePORTER; NIMH NIH HHS [R01MH081754, RC2MH089956, U01MH081896, U01 MH081896, P50MH081756, P50 MH081756, RC2 MH089956, R01 MH081754] Funding Source: Medline; NINDS NIH HHS [R01 NS054273, R01NS054273] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kwan KY, 2012, CELL, V149, P899, DOI 10.1016/j.cell.2012.02.060; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Rapoport JL, 2008, NEUROPSYCHOPHARMACOL, V33, P181, DOI 10.1038/sj.npp.1301553; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; State MW, 2011, NAT NEUROSCI, V14, P1499, DOI 10.1038/nn.2924; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Walsh CA, 2008, CELL, V135, P396, DOI 10.1016/j.cell.2008.10.015; Zoghbi HY, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a009886	14	112	120	1	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2012	337	6100					1301	1303		10.1126/science.1224989	http://dx.doi.org/10.1126/science.1224989			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	004TW	22984058	Green Accepted			2022-12-24	WOS:000308705000028
J	Sung, JH; Zhang, H; Moseman, EA; Alvarez, D; Iannacone, M; Henrickson, SE; de la Torre, JC; Groom, JR; Luster, AD; von Andrian, UH				Sung, Jung Hwan; Zhang, Han; Moseman, E. Ashley; Alvarez, David; Iannacone, Matteo; Henrickson, Sarah E.; de la Torre, Juan C.; Groom, Joanna R.; Luster, Andrew D.; von Andrian, Ulrich H.			Chemokine Guidance of Central Memory T Cells Is Critical for Antiviral Recall Responses in Lymph Nodes	CELL			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; SUBCAPSULAR SINUS MACROPHAGES; HIGH ENDOTHELIAL VENULES; DENDRITIC CELLS; NONLYMPHOID TISSUE; RECEPTOR CXCR3; IN-VIVO; B-CELLS; EFFECTOR; IMMUNITY	A defining feature of vertebrate immunity is the acquisition of immunological memory, which confers enhanced protection against pathogens by mechanisms that are incompletely understood. Here, we compared responses by virus-specific naive T cells (T-N) and central memory T cells (T-CM) to viral antigen challenge in lymph nodes (LNs). In steady-state LNs, both T cell subsets localized in the deep T cell area and interacted similarly with antigen-presenting dendritic cells. However, upon entry of lymph-borne virus, only T-CM relocalized rapidly and efficiently toward the outermost LN regions in the medullary, interfollicular, and subcapsular areas where viral infection was initially confined. This rapid peripheralization was coordinated by a cascade of cytokines and chemokines, particularly ligands for T-CM-expressed CXCR3. Consequently, in vivo recall responses to viral infection by CXCR3-deficient T-CM were markedly compromised, indicating that early antigen detection afforded by intranodal chemokine guidance of T-CM is essential for efficient antiviral memory.	[Sung, Jung Hwan; Zhang, Han; Moseman, E. Ashley; Alvarez, David; Iannacone, Matteo; Henrickson, Sarah E.; von Andrian, Ulrich H.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [de la Torre, Juan C.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Groom, Joanna R.; Luster, Andrew D.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis,Div Rheumatol Alle, Charlestown, MA 02129 USA	Harvard University; Harvard Medical School; Scripps Research Institute; Harvard University; Massachusetts General Hospital	von Andrian, UH (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.	uva@hms.harvard.edu	von Andrian, Ulrich H/A-5775-2008; Iannacone, Matteo/I-8507-2018; Luster, Andrew/ABE-6504-2020	Iannacone, Matteo/0000-0002-9370-2671; Luster, Andrew/0000-0001-9679-7912; Groom, Joanna/0000-0001-5251-7835; Henrickson, Sarah/0000-0001-5569-4132	NIH [AI078897, AI069259, 5T32-HL07623-20, CA069212]; Samsung Scholarship; Armenise-Harvard Foundation; Canadian Institutes of Health Research; Overseas Biomedical Fellowship from the National Health and Medical Research Council of Australia; NATIONAL CANCER INSTITUTE [R01CA069212] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007623] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, R01AI069259, P01AI078897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Samsung Scholarship(Samsung); Armenise-Harvard Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Overseas Biomedical Fellowship from the National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Flynn and Dr. G. Cheng for technical support, M. Perdue for secretarial assistance, and the members of the von Andrian laboratory for helpful discussion. This work was supported by NIH grants AI078897, AI069259 (to U.H.v.A.), 5T32-HL07623-20 (to E.A.M.), and CA069212 (to A.D.L.); a Samsung Scholarship (to J.H.S.); the Armenise-Harvard Foundation (to M.I.); the Canadian Institutes of Health Research (to D.A.); and an Overseas Biomedical Fellowship from the National Health and Medical Research Council of Australia (to J.R.G.).	Alvarez D, 2008, IMMUNITY, V29, P325, DOI 10.1016/j.immuni.2008.08.006; BATTEGAY M, 1991, J VIROL METHODS, V33, P191, DOI 10.1016/0166-0934(91)90018-U; Buchmeier M J, 1980, Adv Immunol, V30, P275, DOI 10.1016/S0065-2776(08)60197-2; BYRNE JA, 1984, J VIROL, V51, P682, DOI 10.1128/JVI.51.3.682-686.1984; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Chtanova T, 2009, IMMUNITY, V31, P342, DOI 10.1016/j.immuni.2009.06.023; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Emonet SF, 2009, P NATL ACAD SCI USA, V106, P3473, DOI 10.1073/pnas.0900088106; FARBER JM, 1990, P NATL ACAD SCI USA, V87, P5238, DOI 10.1073/pnas.87.14.5238; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Gil-Cruz C, 2012, P NATL ACAD SCI USA, V109, P1233, DOI 10.1073/pnas.1115154109; Gonzalez SF, 2010, NAT IMMUNOL, V11, P427, DOI 10.1038/ni.1856; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Guarda G, 2007, NAT IMMUNOL, V8, P743, DOI 10.1038/ni1469; Halin C, 2005, ANNU REV CELL DEV BI, V21, P581, DOI 10.1146/annurev.cellbio.21.122303.133159; Hancock WW, 2001, J EXP MED, V193, P975, DOI 10.1084/jem.193.8.975; Henrickson SE, 2008, NAT IMMUNOL, V9, P282, DOI 10.1038/ni1559; Henrickson SE, 2007, CURR OPIN IMMUNOL, V19, P249, DOI 10.1016/j.coi.2007.04.013; Hickman HD, 2008, NAT IMMUNOL, V9, P155, DOI 10.1038/ni1557; Hickman HD, 2011, J EXP MED, V208, P2511, DOI 10.1084/jem.20102545; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Hu JK, 2011, P NATL ACAD SCI USA, V108, pE118, DOI 10.1073/pnas.1101881108; Iannacone M, 2010, NATURE, V465, P1079, DOI 10.1038/nature09118; Irla M, 2010, J EXP MED, V207, P1891, DOI 10.1084/jem.20092627; Janatpour MJ, 2001, J EXP MED, V194, P1375, DOI 10.1084/jem.194.9.1375; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kohlmeier JE, 2009, J IMMUNOL, V183, P4378, DOI 10.4049/jimmunol.0902022; Kurachi M, 2011, J EXP MED, V208, P1605, DOI 10.1084/jem.20102101; LUSTER AD, 1985, NATURE, V315, P672, DOI 10.1038/315672a0; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI13296; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Medoff BD, 2006, J IMMUNOL, V176, P7087, DOI 10.4049/jimmunol.176.11.7087; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Mora JR, 2006, CURR TOP MICROBIOL, V308, P83; Moseman EA, 2012, IMMUNITY, V36, P415, DOI 10.1016/j.immuni.2012.01.013; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Palframan RT, 2001, J EXP MED, V194, P1361, DOI 10.1084/jem.194.9.1361; Park MK, 2002, J IMMUNOL, V169, P1433, DOI 10.4049/jimmunol.169.3.1433; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; Tacke F, 2006, J EXP MED, V203, P583, DOI 10.1084/jem.20052119; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; von Herrath M, 2001, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1910s36; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Yoneyama H, 2004, INT IMMUNOL, V16, P915, DOI 10.1093/intimm/dxh093	54	154	155	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 14	2012	150	6					1249	1263		10.1016/j.cell.2012.08.015	http://dx.doi.org/10.1016/j.cell.2012.08.015			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22980984	Green Accepted, Bronze			2022-12-24	WOS:000308928100017
J	Mascre, G; Dekoninck, S; Drogat, B; Youssef, KK; Brohee, S; Sotiropoulou, PA; Simons, BD; Blanpain, C				Mascre, Guilhem; Dekoninck, Sophie; Drogat, Benjamin; Youssef, Khalil Kass; Brohee, Sylvain; Sotiropoulou, Panagiota A.; Simons, Benjamin D.; Blanpain, Cedric			Distinct contribution of stem and progenitor cells to epidermal maintenance	NATURE			English	Article							HAIR FOLLICLE; MOUSE SKIN; IN-VIVO; LINEAGE; PROLIFERATION; HOMEOSTASIS; POPULATIONS; EXPRESSION; MODEL; UNITS	The skin interfollicular epidermis (IFE) is the first barrier against the external environment and its maintenance is critical for survival. Two seemingly opposite theories have been proposed to explain IFE homeostasis. One posits that IFE is maintained by long-lived slow-cycling stem cells that give rise to transit-amplifying cell progeny, whereas the other suggests that homeostasis is achieved by a single committed progenitor population that balances stochastic fate. Here we probe the cellular heterogeneity within the IFE using two different inducible Cre recombinase-oestrogen receptor constructs targeting IFE progenitors in mice. Quantitative analysis of clonal fate data and proliferation dynamics demonstrate the existence of two distinct proliferative cell compartments arranged in a hierarchy involving slow-cycling stem cells and committed progenitor cells. After wounding, only stem cells contribute substantially to the repair and long-term regeneration of the tissue, whereas committed progenitor cells make a limited contribution.	[Mascre, Guilhem; Dekoninck, Sophie; Drogat, Benjamin; Youssef, Khalil Kass; Brohee, Sylvain; Sotiropoulou, Panagiota A.; Blanpain, Cedric] Univ Libre Brussels, IRIBHM, B-1070 Brussels, Belgium; [Brohee, Sylvain] Univ Libre Brussels, Machine Learning Grp, B-1050 Brussels, Belgium; [Simons, Benjamin D.] Univ Cambridge, Cavendish Lab, Dept Phys, Cambridge CB3 0HE, England; [Simons, Benjamin D.] Univ Cambridge, Wellcome Trust, Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Blanpain, Cedric] Univ Libre Brussels, WELBIO, B-1070 Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; University of Cambridge; Cancer Research UK; University of Cambridge; Wellcome Trust Sanger Institute; Universite Libre de Bruxelles; WELBIO	Blanpain, C (corresponding author), Univ Libre Brussels, IRIBHM, B-1070 Brussels, Belgium.	bds10@cam.ac.uk; cedric.blanpain@ulb.ac.be	Youssef, Khalil Kass/AAB-6528-2021; Simons, Benjamin/AAY-8920-2020; Blanpain, Cedric/ABD-8392-2021	Youssef, Khalil Kass/0000-0002-4572-3160; Simons, Benjamin/0000-0002-3875-7071; benjamin, Drogat/0000-0002-0020-4826	FRS/FNRS; TELEVIE; FNRS; program d'excellence CIBLES of the Wallonia Region; Fondation Contre le Cancer; ULB fondation; Gaston Ithier; European Research Council (ERC); EMBO Young Investigator Program; EPSRC [EP/F032773/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F032773/1] Funding Source: researchfish	FRS/FNRS(Fonds de la Recherche Scientifique - FNRS); TELEVIE; FNRS(Fonds de la Recherche Scientifique - FNRS); program d'excellence CIBLES of the Wallonia Region; Fondation Contre le Cancer; ULB fondation; Gaston Ithier; European Research Council (ERC)(European Research Council (ERC)); EMBO Young Investigator Program(European Molecular Biology Organization (EMBO)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank F. Bollet-Quivogne and J.-M. Vanderwinden for their help with confocal imaging. C. B. and P. A. S. are chercheur qualifie, G. M. and S. B. are supported by fellowship of the FRS/FNRS. B. D. is supported by TELEVIE. C. B. is an investigator of WELBIO. This work was supported by the FNRS, the program d'excellence CIBLES of the Wallonia Region, a research grant from the Fondation Contre le Cancer, the ULB fondation, the fond Gaston Ithier, the European Research Council (ERC) and the EMBO Young Investigator Program.	Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; Diamond I, 2000, J INVEST DERMATOL, V115, P788, DOI 10.1046/j.1523-1747.2000.00144.x; Doupe DP, 2010, DEV CELL, V18, P317, DOI 10.1016/j.devcel.2009.12.016; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghazizadeh S, 2001, EMBO J, V20, P1215, DOI 10.1093/emboj/20.6.1215; Ghazizadeh S, 2005, J INVEST DERMATOL, V124, P367, DOI 10.1111/j.0022-202X.2004.23599.x; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; JONES PH, 1995, CELL, V80, P83, DOI 10.1016/0092-8674(95)90453-0; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; Jones P, 2008, NAT REV MOL CELL BIO, V9, P82, DOI 10.1038/nrm2292x; Klein AM, 2011, DEVELOPMENT, V138, P3103, DOI 10.1242/dev.060103; Kolodka TM, 1998, P NATL ACAD SCI USA, V95, P4356, DOI 10.1073/pnas.95.8.4356; Langton AK, 2008, J INVEST DERMATOL, V128, P1311, DOI 10.1038/sj.jid.5701178; Lapouge G, 2011, P NATL ACAD SCI USA, V108, P7431, DOI 10.1073/pnas.1012720108; LAVKER RM, 1982, SCIENCE, V215, P1239, DOI 10.1126/science.7058342; Legg J, 2003, DEVELOPMENT, V130, P6049, DOI 10.1242/dev.00837; Levy V, 2007, FASEB J, V21, P1358, DOI 10.1096/fj.06-6926com; LOEFFLER M, 1987, VIRCHOWS ARCH B, V53, P286, DOI 10.1007/BF02890255; Mackenzie IC, 1997, J INVEST DERMATOL, V109, P377, DOI 10.1111/1523-1747.ep12336255; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; MORRIS RJ, 1985, J INVEST DERMATOL, V84, P277, DOI 10.1111/1523-1747.ep12265358; Pina C, 2012, NAT CELL BIOL, V14, P287, DOI 10.1038/ncb2442; Potten C S, 1981, Int Rev Cytol, V69, P271; POTTEN CS, 1987, CELL TISSUE KINET, V20, P461, DOI 10.1111/j.1365-2184.1987.tb01355.x; POTTEN CS, 1987, VIRCHOWS ARCH B, V53, P279, DOI 10.1007/BF02890254; POTTEN CS, 1982, CELL TISSUE KINET, V15, P305, DOI 10.1111/j.1365-2184.1982.tb01050.x; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Ro S, 2005, EXP DERMATOL, V14, P838, DOI 10.1111/j.1600-0625.2005.00366.x; Ro S, 2004, EMBO REP, V5, P914, DOI 10.1038/sj.embor.7400218; Rocheteau P, 2012, CELL, V148, P112, DOI 10.1016/j.cell.2011.11.049; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tani H, 2000, P NATL ACAD SCI USA, V97, P10960, DOI 10.1073/pnas.97.20.10960; Ting SB, 2005, SCIENCE, V308, P411, DOI 10.1126/science.1107511; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Waghmare SK, 2008, EMBO J, V27, P1309, DOI 10.1038/emboj.2008.72; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Youssef KK, 2010, NAT CELL BIOL, V12, P299, DOI 10.1038/ncb2031; Zhang YV, 2010, CELL CYCLE, V9, P1504, DOI 10.4161/cc.9.8.11252; Zhang YV, 2009, CELL STEM CELL, V5, P267, DOI 10.1016/j.stem.2009.06.004	51	380	388	1	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2012	489	7415					257	+		10.1038/nature11393	http://dx.doi.org/10.1038/nature11393			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003UC	22940863				2022-12-24	WOS:000308635900034
J	Althoff, KN; Buchacz, K; Hall, HI; Zhang, JB; Hanna, DB; Rebeiro, P; Gange, SJ; Moore, RD; Kitahata, MM; Gebo, KA; Martin, J; Justice, AC; Horberg, MA; Hogg, RS; Sterling, TR; Cescon, A; Klein, MB; Thorne, JE; Crane, HM; Mugavero, MJ; Napravnik, S; Kirk, GD; Jacobson, LP; Brooks, JT				Althoff, Keri N.; Buchacz, Kate; Hall, H. Irene; Zhang, Jinbing; Hanna, David B.; Rebeiro, Peter; Gange, Stephen J.; Moore, Richard D.; Kitahata, Mari M.; Gebo, Kelly A.; Martin, Jeffrey; Justice, Amy C.; Horberg, Michael A.; Hogg, Robert S.; Sterling, Timothy R.; Cescon, Angela; Klein, Marina B.; Thorne, Jennifer E.; Crane, Heidi M.; Mugavero, Michael J.; Napravnik, Sonia; Kirk, Gregory D.; Jacobson, Lisa P.; Brooks, John T.		N Amer AIDS Cohort Collaboration	US Trends in Antiretroviral Therapy Use, HIV RNA Plasma Viral Loads, and CD4 T-Lymphocyte Cell Counts Among HIV-Infected Persons, 2000 to 2008	ANNALS OF INTERNAL MEDICINE			English	Article							UNITED-STATES; VIROLOGICAL RESPONSES; CLINICAL COHORT; MEDICAL-CARE; AIDS; ADULTS; IMMUNODEFICIENCY; MORTALITY; HAART; DEATH	Background: The U.S. National HIV/AIDS Strategy targets for 2015 include "increasing access to care and improving health outcomes for persons living with HIV in the United States" (PLWH-US). Objective: To demonstrate the utility of the NA-ACCORD (North American AIDS Cohort Collaboration on Research and Design) for monitoring trends in the HIV epidemic in the United States and to present trends in HIV treatment and related health outcomes. Design: Trends from annual cross-sectional analyses comparing patients from pooled, multicenter, prospective, clinical HIV cohort studies with PLWH-US, as reported to national surveillance systems in 40 states. Setting: U.S. HIV outpatient clinics. Patients: HIV-infected adults with 1 or more HIV RNA plasma viral load (HIV VL) or CD4 T-lymphocyte (CD4) cell count measured in any calendar year from 1 January 2000 to 31 December 2008. Measurements: Annual rates of antiretroviral therapy use, HIV VL, and CD4 cell count at death. Results: 45 529 HIV-infected persons received care in an NA-ACCORD-participating U.S. clinical cohort from 2000 to 2008. In 2008, the 26 030 NA-ACCORD participants in care and the 655 966 PLWH-US had qualitatively similar demographic characteristics. From 2000 to 2008, the proportion of participants prescribed highly active antiretroviral therapy increased by 9 percentage points to 83% (P < 0.001), whereas the proportion with suppressed HIV VL (<= 2.7 log(10) copies/mL) increased by 26 percentage points to 72% (P < 0.001). Median CD4 cell count at death more than tripled to 0.209 x 10(9) cells/L (P < 0.001). Limitation: The usual limitations of observational data apply. Conclusion: The NA-ACCORD is the largest cohort of HIV-infected adults in clinical care in the United States that is demographically similar to PLWH-US in 2008. From 2000 to 2008, increases were observed in the percentage of prescribed HAART, the percentage who achieved a suppressed HIV VL, and the median CD4 cell count at death. Primary Funding Source: National Institutes of Health; Centers for Disease Control and Prevention; Canadian Institutes of Health Research; Canadian HIV Trials Network; and the government of British Columbia, Canada.	Johns Hopkins Univ, Baltimore, MD USA; Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; Univ Washington, Seattle, WA 98104 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Yale Univ, New Haven, CT USA; Vet Affairs Connecticut Healthcare Syst, New Haven, CT USA; Mid Atlantic Permanente Res Inst, Rockville, MD 20852 USA; British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; Simon Fraser Univ, Vancouver, BC, Canada; Vanderbilt Univ, Nashville, TN 37232 USA; McGill Univ, Montreal, PQ H2X 2P4, Canada; Univ Alabama Birmingham, Birmingham, AL 35294 USA; Univ N Carolina, Chapel Hill, NC 27599 USA	Johns Hopkins University; Centers for Disease Control & Prevention - USA; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; B.C. Centre for Excellence in HIV/AIDS; Simon Fraser University; Vanderbilt University; McGill University; University of Alabama System; University of Alabama Birmingham; University of North Carolina; University of North Carolina Chapel Hill	Althoff, KN (corresponding author), 615 N Wolfe St,Room E-7142, Baltimore, MD 21231 USA.	kalthoff@jhsph.edu	Althoff, Keri N/HGC-5595-2022; Gange, Stephen/AGY-5004-2022; Gebo, Kelly/AHA-7533-2022	Gange, Stephen/0000-0001-7842-512X; Gebo, Kelly/0000-0003-4010-398X; Hogg, Robert/0000-0003-3463-5488; Althoff, Keri/0000-0002-5068-6595; Jacobson, Lisa P./0000-0003-1722-6826; Klein, Marina/0000-0002-3063-8430; Rebeiro, Peter/0000-0003-1951-9104	National Institutes of Health [M01-RR025747, P30-AI27757, P30-AI27767, P30-AI27763, P30-AI50410, P30-AI54999, R01-DA04334, R01-DA12568, R01-DA11602, R01-AA16893, R24-AI067039, Z01-CP010176, AHQ290-01-0012, N02-CP55504, AI-69432, AI-69434, K01-AI071725]; CDC [CDC200-2006-18797]; Canadian Institutes of Health Research [TGF-96118, HCP-97105, CBR-86906, CBR-94036, KRS-86251, 169621]; Canadian HIV Trials Network [24]; government of British Columbia; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD032632] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [Z01CP010176] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025747, M01RR000071, M01RR000079, M01RR000083, M01RR000052, UL1RR024131, M01RR000722] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [U10EY008052, U10EY008067, U10EY008057, K23EY013707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069432, U01AI035040, U01AI034994, P30AI094189, P30AI050410, U01AI035039, U01AI068634, U01AI034989, U01AI034993, U01AI042590, UM1AI069432, U01AI035041, P30AI027763, U01AI037613, U01AI035043, U01AI038855, U01AI031834, U01AI038858, U01AI035004, P30AI027757, P30AI054999, U01AI037984, U01AI069918, P30AI027767, K01AI071725, UM1AI069434, U01AI035042, U01AI068636, U01AI069434, R24AI067039, K01AI093197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016893, U10AA013566, R21AA015032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012568, F31DA030254, R01DA011602, K24DA000432, R01DA004334] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CDC(Centre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian HIV Trials Network; government of British Columbia; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	By grants U01-AI069918, U10-AA13566, U01-AI31834, U01-AI34989, U01-AI34993, U01-AI34994, U01-AI35004, U01-AI35039, U01-AI35040, U01-AI35041, U01-AI35042, U01AI35043, U01-AI37613, U01-AI37984, U01-AI38855, U01-AI38858, U01-AI42590, U01-AI68634, U01-AI68636, U01-HD32632, U10-EY08057, U10-EY08052, U10-EY08067, UL1-RR024131, UL1-RR024131, M01-RR-00052, M01-RR00071, M01-RR00079, M01-RR00083, M01-RR00722, M01-RR025747, P30-AI27757, P30-AI27767, P30-AI27763, P30-AI50410, P30-AI54999, R01-DA04334, R01-DA12568, R01-DA11602, R01-AA16893, R24-AI067039, Z01-CP010176, AHQ290-01-0012, N02-CP55504, AI-69432, AI-69434, K01-AI071725, K23-AI610320, K23-EY013707, K24-DA00432, K01-AI093197 (Dr. Althoff) and F31-DA30254 (Mr. Hanna) from the National Institutes of Health; contract CDC200-2006-18797 from the CDC; grants TGF-96118, HCP-97105, CBR-86906, CBR-94036, KRS-86251, and 169621 from the Canadian Institutes of Health Research; the Canadian HIV Trials Network, project 24; and the government of British Columbia. The CDC funds all U.S. states and the District of Columbia to conduct HIV surveillance and provides technical assistance to all funded areas. Participating investigators and contributors are CDC employees. Employees of the CDC conducted the surveillance data analyses, and the report was reviewed and approved by the CDC.	Althoff KN, 2010, CLIN INFECT DIS, V50, P1512, DOI 10.1086/652650; [Anonymous], 2010, NAT HIV AIDS STRAT U; Baeten JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001888; Belperio PS, 2010, HIV MED, V11, P209, DOI 10.1111/j.1468-1293.2009.00764.x; Blair Janet M., 2011, Morbidity and Mortality Weekly Report, V60, P1; Bozzette SA, 1998, NEW ENGL J MED, V339, P1897, DOI 10.1056/NEJM199812243392606; *CDCP, 2005, HIV AIDS SURVEILLA S, V11, P1; Centers for Disease Control and Prevention, 2011, HIV SURV REP 2009, V21; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cole SR, 2010, AM J EPIDEMIOL, V172, P107, DOI 10.1093/aje/kwq084; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Gandhi NR, 2007, MED CARE, V45, P1105, DOI 10.1097/MLR.0b013e3181271476; Gange SJ, 2007, INT J EPIDEMIOL, V36, P294, DOI 10.1093/ije/dyl286; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Gay CL, 2006, AIDS, V20, P775, DOI 10.1097/01.aids.0000216380.30055.4a; Hall HI, 2012, JAIDS-J ACQ IMM DEF, V60, P77, DOI 10.1097/QAI.0b013e318249fe90; Henrich TJ, 2008, J COMMUN HEALTH, V33, P69, DOI 10.1007/s10900-007-9069-1; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; HOLFORD TR, 1991, ANNU REV PUBL HEALTH, V12, P425, DOI 10.1146/annurev.pu.12.050191.002233; Howe CJ, 2010, AIDS RES HUM RETROV, V26, P875, DOI 10.1089/aid.2009.0282; Hughes JP, 1999, BIOMETRICS, V55, P625, DOI 10.1111/j.0006-341X.1999.00625.x; Kelley CF, 2009, CLIN INFECT DIS, V48, P787, DOI 10.1086/597093; Keruly JC, 2007, CLIN INFECT DIS, V45, P1369, DOI 10.1086/522759; Lau B, 2007, AIDS RES HUM RETROV, V23, P769, DOI 10.1089/aid.2006.0171; Lau B, 2007, JAIDS-J ACQ IMM DEF, V44, P179, DOI 10.1097/01.qai.0000247229.68246.c5; Leone S, 2011, INFECTION, V39, P13, DOI 10.1007/s15010-010-0079-z; Lifson AR, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-2; Lok JJ, 2010, AIDS, V24, P1867, DOI 10.1097/QAD.0b013e32833adbcf; Losina E, 2009, CLIN INFECT DIS, V49, P1570, DOI 10.1086/644772; Marin B, 2009, AIDS, V23, P1743, DOI 10.1097/QAD.0b013e32832e9b78; McGowan CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018462; McNaghten AD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000550; Mehta SH, 2007, AIDS CARE, V19, P637, DOI 10.1080/09540120701235644; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Moore RD, 2007, CLIN INFECT DIS, V44, P441, DOI 10.1086/510746; Pacheco AG, 2009, JAIDS-J ACQ IMM DEF, V51, P624, DOI 10.1097/QAI.0b013e3181a4ecf5; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Sackoff JE, 2006, ANN INTERN MED, V145, P397, DOI 10.7326/0003-4819-145-6-200609190-00003; Scott JD, 2009, AIDS PATIENT CARE ST, V23, P925, DOI 10.1089/apc.2009.0099; Seal PS, 2011, J GEN INTERN MED, V26, P745, DOI 10.1007/s11606-011-1693-x; Shapiro MF, 1999, JAMA-J AM MED ASSOC, V281, P2305, DOI 10.1001/jama.281.24.2305; Silverberg MJ, 2009, J GEN INTERN MED, V24, P1065, DOI 10.1007/s11606-009-1049-y; Thiebaut R, 2004, COMPUT METH PROG BIO, V74, P255, DOI 10.1016/j.cmpb.2003.08.004; Torian Lucia, 2011, Morbidity and Mortality Weekly Report, V60, P689; Wood E, 2003, CAN MED ASSOC J, V169, P656; Worm SW, 2010, AIDS, V24, P1537, DOI 10.1097/QAD.0b013e32833a0918	47	91	91	0	18	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 4	2012	157	5					325	U63		10.7326/0003-4819-157-5-201209040-00005	http://dx.doi.org/10.7326/0003-4819-157-5-201209040-00005			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	000BM	22944874	Green Accepted, Green Submitted			2022-12-24	WOS:000308361500003
J	Cheng, L; Booker, FL; Tu, C; Burkey, KO; Zhou, LS; Shew, HD; Rufty, TW; Hu, SJ				Cheng, Lei; Booker, Fitzgerald L.; Tu, Cong; Burkey, Kent O.; Zhou, Lishi; Shew, H. David; Rufty, Thomas W.; Hu, Shuijin			Arbuscular Mycorrhizal Fungi Increase Organic Carbon Decomposition Under Elevated CO2	SCIENCE			English	Article							SOIL MICROBIAL COMMUNITY; RESIDUE DECOMPOSITION; NITROGEN LIMITATION; EXTERNAL HYPHAE; ASSIMILATION; AGGREGATION; ACQUISITION; GRASSLAND; FEEDBACKS; BACTERIA	The extent to which terrestrial ecosystems can sequester carbon to mitigate climate change is a matter of debate. The stimulation of arbuscular mycorrhizal fungi (AMF) by elevated atmospheric carbon dioxide (CO2) has been assumed to be a major mechanism facilitating soil carbon sequestration by increasing carbon inputs to soil and by protecting organic carbon from decomposition via aggregation. We present evidence from four independent microcosm and field experiments demonstrating that CO2 enhancement of AMF results in considerable soil carbon losses. Our findings challenge the assumption that AMF protect against degradation of organic carbon in soil and raise questions about the current prediction of terrestrial ecosystem carbon balance under future climate-change scenarios.	[Cheng, Lei; Tu, Cong; Zhou, Lishi; Shew, H. David; Hu, Shuijin] N Carolina State Univ, Dept Plant Pathol, Raleigh, NC 27695 USA; [Booker, Fitzgerald L.; Burkey, Kent O.] ARS, USDA, Plant Sci Res Unit, Raleigh, NC 27607 USA; [Booker, Fitzgerald L.; Burkey, Kent O.; Rufty, Thomas W.] N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA; [Zhou, Lishi] Chinese Acad Sci, State Key Lab Vegetat & Environm Change, Inst Bot, Beijing 100093, Peoples R China	University of North Carolina; North Carolina State University; United States Department of Agriculture (USDA); University of North Carolina; North Carolina State University; Chinese Academy of Sciences; Institute of Botany, CAS	Hu, SJ (corresponding author), N Carolina State Univ, Dept Plant Pathol, Box 7616, Raleigh, NC 27695 USA.	shuijin_hu@ncsu.edu	Cheng, lei/E-6307-2013; Tu, Cong/H-9750-2013	Cheng, Lei/0000-0002-5486-3632; Hu, Shuijin/0000-0002-3225-5126	U.S. Department of Agriculture (USDA)-Agricultural Research Service Plant Science Research Unit (Raleigh, NC); USDA [2009-35101-05351]	U.S. Department of Agriculture (USDA)-Agricultural Research Service Plant Science Research Unit (Raleigh, NC); USDA(United States Department of Agriculture (USDA))	We thank F. Chapin III, D. Coleman, Y. Luo, R. Miller, and M. Rillig for valuable comments; M. Gumpertz for advice on statistical analyses; J. Barton, W. Pursley, and E. Silva for technical assistance; and D. Watson and J. Morton for providing mycorrhizal inoculum. L. C. was primarily supported by a fellowship from U.S. Department of Agriculture (USDA)-Agricultural Research Service Plant Science Research Unit (Raleigh, NC) and in part by a USDA grant to S. H. (2009-35101-05351). S. H., L. C. and C. T. conceived experiments 1 to 4. K.O.B. and F. L. B. designed and maintained the long-term CO<INF>2</INF> and O<INF>3</INF> study. H. D. S and T. W. R. contributed to design of experiments 1 and 2. L. C. performed experiments 1 to 3 and the meta-analysis study; and C. T., F. L. B., and L.Z. performed experiment 4. L. C. and S. H. analyzed the data and mainly wrote the manuscript with inputs from all coauthors. The data reported in this paper are deposited in the Dryad Repository (http://dx.doi.org/10.5061/dryad.b7f53).	Alberton O, 2005, NEW PHYTOL, V167, P859, DOI 10.1111/j.1469-8137.2005.01458.x; Bloom AJ, 2002, P NATL ACAD SCI USA, V99, P1730, DOI 10.1073/pnas.022627299; Bloom AJ, 2010, SCIENCE, V328, P899, DOI 10.1126/science.1186440; Bonfante P, 2009, ANNU REV MICROBIOL, V63, P363, DOI 10.1146/annurev.micro.091208.073504; Carney KM, 2007, P NATL ACAD SCI USA, V104, P4990, DOI 10.1073/pnas.0610045104; Cheng L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021377; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; de Graaff MA, 2010, NEW PHYTOL, V188, P1055, DOI 10.1111/j.1469-8137.2010.03427.x; Di HJ, 2009, NAT GEOSCI, V2, P621, DOI 10.1038/NGEO613; Drigo B, 2010, P NATL ACAD SCI USA, V107, P10938, DOI 10.1073/pnas.0912421107; Fellbaum CR, 2012, P NATL ACAD SCI USA, V109, P2666, DOI 10.1073/pnas.1118650109; Geisseler D, 2010, SOIL BIOL BIOCHEM, V42, P2058, DOI 10.1016/j.soilbio.2010.08.021; Govindarajulu M, 2005, NATURE, V435, P819, DOI 10.1038/nature03610; Hodge A, 2001, NATURE, V413, P297, DOI 10.1038/35095041; Hodge A, 2010, P NATL ACAD SCI USA, V107, P13754, DOI 10.1073/pnas.1005874107; Hu S, 2001, NATURE, V409, P188, DOI 10.1038/35051576; JAKOBSEN I, 1990, NEW PHYTOL, V115, P77, DOI 10.1111/j.1469-8137.1990.tb00924.x; Kiers ET, 2011, SCIENCE, V333, P880, DOI 10.1126/science.1208473; Orwin KH, 2011, ECOL LETT, V14, P493, DOI 10.1111/j.1461-0248.2011.01611.x; Phillips RP, 2011, ECOL LETT, V14, P187, DOI 10.1111/j.1461-0248.2010.01570.x; Reich PB, 2006, NATURE, V440, P922, DOI 10.1038/nature04486; Rillig MC, 1999, NATURE, V400, P628, DOI 10.1038/23168; Sanders IR, 1998, OECOLOGIA, V117, P496, DOI 10.1007/s004420050685; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Tisdall JM, 1997, AUST J SOIL RES, V35, P55, DOI 10.1071/S96065; Treseder KK, 2000, NEW PHYTOL, V147, P189, DOI 10.1046/j.1469-8137.2000.00690.x; Tu C, 2006, GLOBAL CHANGE BIOL, V12, P793, DOI 10.1111/j.1365-2486.2006.01149.x; van Groenigen KJ, 2011, NATURE, V475, P214, DOI 10.1038/nature10176; Wilson GWT, 2009, ECOL LETT, V12, P452, DOI 10.1111/j.1461-0248.2009.01303.x	30	315	365	43	968	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2012	337	6098					1084	1087		10.1126/science.1224304	http://dx.doi.org/10.1126/science.1224304			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22936776				2022-12-24	WOS:000308125800044
J	Button, B; Cai, LH; Ehre, C; Kesimer, M; Hill, DB; Sheehan, JK; Boucher, RC; Rubinstein, M				Button, Brian; Cai, Li-Heng; Ehre, Camille; Kesimer, Mehmet; Hill, David B.; Sheehan, John K.; Boucher, Richard C.; Rubinstein, Michael			A Periciliary Brush Promotes the Lung Health by Separating the Mucus Layer from Airway Epithelia	SCIENCE			English	Article							CYSTIC-FIBROSIS; SURFACE LIQUID; PSEUDOMONAS-AERUGINOSA; MUCOCILIARY CLEARANCE; RESPIRATORY-TRACT; IN-VIVO; MUCIN; TRANSPORT; DISEASE; IDENTIFICATION	Mucus clearance is the primary defense mechanism that protects airways from inhaled infectious and toxic agents. In the current gel-on-liquid mucus clearance model, a mucus gel is propelled on top of a "watery" periciliary layer surrounding the cilia. However, this model fails to explain the formation of a distinct mucus layer in health or why mucus clearance fails in disease. We propose a gel-on-brush model in which the periciliary layer is occupied by membrane-spanning mucins and mucopolysaccharides densely tethered to the airway surface. This brush prevents mucus penetration into the periciliary space and causes mucus to form a distinct layer. The relative osmotic moduli of the mucus and periciliary brush layers explain both the stability of mucus clearance in health and its failure in airway disease.	[Cai, Li-Heng; Rubinstein, Michael] Univ N Carolina, Curriculum Appl Sci & Engn, Chapel Hill, NC 27599 USA; [Button, Brian; Ehre, Camille; Kesimer, Mehmet; Hill, David B.; Boucher, Richard C.] Univ N Carolina, Cyst Fibrosis Res & Treatment Ctr, Chapel Hill, NC 27599 USA; [Kesimer, Mehmet; Sheehan, John K.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Rubinstein, Michael] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Rubinstein, M (corresponding author), Univ N Carolina, Curriculum Appl Sci & Engn, Chapel Hill, NC 27599 USA.	mr@unc.edu	Cai, Li-Heng/A-1602-2009; , Mehmet Kesimer/AHB-9223-2022; Cai, Liheng/O-2834-2013	Cai, Liheng/0000-0002-6806-0566	Cystic Fibrosis Foundation [BUTTON07XX0, BUTTON11G0, RUBIN09XX0, R026-CRII]; NSF [CHE-0911588, DMR-0907515, DMR-1121107, DMR-1122483, PHY11-25915, CBET-0609087]; NIH [K01DK080847, R01HL077546, P50HL107168, P01HL34322, P01HL108808, P01HL110873-01, P50HL107168-01, P30DK065988, HHSN268200900020, UL1-RR025747, R01HL103940]; Direct For Mathematical & Physical Scien [0911588] Funding Source: National Science Foundation; Division Of Materials Research [0907515] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025747] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL110873, P50HL107168, P01HL034322, P01HL108808, R01HL103940, R01HL077546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK080847, P30DK065988] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding for this work was provided by Cystic Fibrosis Foundation grants BUTTON07XX0 (to B. B.), BUTTON11G0 (to B. B.), RUBIN09XX0 (to M. R.), and R026-CRII (to R. C. B.); NSF grants CHE-0911588, DMR-0907515, DMR-1121107, DMR-1122483, PHY11-25915 (in part), and CBET-0609087 (to M. R.); and NIH grants K01DK080847 (to B. B.), R01HL077546 (in part to M. R.), P50HL107168, P01HL34322, P01HL108808, P01HL110873-01, P50HL107168-01, P30DK065988, HHSN268200900020, and UL1-RR025747 (to R. C. B.), and R01HL103940 (to M. K.). We thank S. Panyukov and E. B. Zhulina for illuminating discussions, L. Brown for graphical and editorial assistance, S. Randell for the human airway epithelial cells, K. Burns for histology assistance, and R. Tarran for use of the Leica SP5 confocal microscope. M. R. conceived the study, and B. B., L.-H. C., R. C. B., and M. R. designed the experiments. B. B. developed experimental approaches for the osmotic pressure measurements and the PCL permeability and osmotic compression experiments. L.-H. C. prepared regents and, along with B. B., performed the PCL permeability and osmotic compression experiments. C. E. conducted the transmission electron microscopy and immunological experiments. M. K., D. B. H., and J.K.S. provided technical assistance in preparing reagents. M. R., L.-H. C., B. B., and R. C. B. discussed and analyzed the results. M. R. and R. C. B. supervised the whole study. B. B., L.-H. C., R. C. B., and M. R. wrote the paper. The authors declare that they have no competing financial interests.	ARFKEN GB, 1999, MATH METHODS PHYS; BALTIMORE RS, 1989, AM REV RESPIR DIS, V140, P1650, DOI 10.1164/ajrccm/140.6.1650; Boucher RC, 2004, EUR RESPIR J, V23, P146, DOI 10.1183/09031936.03.00057003; Boucher RC, 2007, ANNU REV MED, V58, P157, DOI 10.1146/annurev.med.58.071905.105316; Clunes LA, 2012, FASEB J, V26, P533, DOI 10.1096/fj.11-192377; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; Finkbeiner WE, 2011, AM J PHYSIOL-LUNG C, V301, pL402, DOI 10.1152/ajplung.00210.2010; Hattrup CL, 2008, ANNU REV PHYSIOL, V70, P431, DOI 10.1146/annurev.physiol.70.113006.100659; Hilding A C, 1967, Minn Med, V50, P915; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Houtmeyers E, 1999, EUR RESPIR J, V13, P1177, DOI 10.1034/j.1399-3003.1999.13e39.x; Hovenberg HW, 1996, BIOCHEM J, V318, P319, DOI 10.1042/bj3180319; IRAVANI J, 1972, J PATHOL, V106, P81, DOI 10.1002/path.1711060204; Jachimska B, 2008, LANGMUIR, V24, P6866, DOI 10.1021/la800548p; KALINER M, 1984, J ALLERGY CLIN IMMUN, V73, P318, DOI 10.1016/0091-6749(84)90403-2; Kesimer M, 2010, AM J PHYSIOL-LUNG C, V298, pL15, DOI 10.1152/ajplung.00194.2009; Kinsky MP, 2000, J TRAUMA, V49, P844, DOI 10.1097/00005373-200011000-00009; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Lai SK, 2007, P NATL ACAD SCI USA, V104, P1482, DOI 10.1073/pnas.0608611104; Lai SK, 2009, ADV DRUG DELIVER REV, V61, P158, DOI 10.1016/j.addr.2008.11.002; Lucas AM, 1934, ARCHIV OTOLARYNGOL, V20, P518; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Matsui H, 2006, P NATL ACAD SCI USA, V103, P18131, DOI 10.1073/pnas.0606428103; MATTHEWS LW, 1963, AM REV RESPIR DIS, V88, P199; Monzon ME, 2006, AM J RESP CELL MOL, V34, P135, DOI 10.1165/rcmb.2005-0256OC; Pattison J.R., 2000, PRINCIPLES PRACTICE, P645; Quinton Paul M., 1999, Physiological Reviews, V79, pS3; Raphael JH, 1996, BRIT J ANAESTH, V76, P116, DOI 10.1093/bja/76.1.116; Raynal BDE, 2002, BIOCHEM J, V362, P289, DOI 10.1042/0264-6021:3620289; ROSE MC, 1992, AM J PHYSIOL, V263, pL413, DOI 10.1152/ajplung.1992.263.4.L413; Rubinstein M, 2003, POLYM PHYS; Schwab U, 2002, INFECT IMMUN, V70, P4547, DOI 10.1128/IAI.70.8.4547-4555.2002; Sheehan JK, 2000, BIOCHEM J, V347, P37, DOI 10.1042/0264-6021:3470037; Smith DJ, 2007, B MATH BIOL, V69, P817, DOI 10.1007/s11538-006-9163-z; Tang BC, 2009, P NATL ACAD SCI USA, V106, P19268, DOI 10.1073/pnas.0905998106; Tarran R, 2001, J GEN PHYSIOL, V118, P223, DOI 10.1085/jgp.118.2.223; Tarran R, 2001, MOL CELL, V8, P149, DOI 10.1016/S1097-2765(01)00286-6; Tarran Robert, 2004, Proc Am Thorac Soc, V1, P42, DOI 10.1513/pats.2306014; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; Wanner A, 1996, AM J RESP CRIT CARE, V154, P1868, DOI 10.1164/ajrccm.154.6.8970383; Wickstrom C, 1998, BIOCHEM J, V334, P685, DOI 10.1042/bj3340685; WIDDICOMBE JH, 1995, RESP PHYSIOL, V99, P3, DOI 10.1016/0034-5687(94)00095-H; Wine Jeffrey J, 2004, Proc Am Thorac Soc, V1, P47, DOI 10.1513/pats.2306015; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870	44	515	521	13	189	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 24	2012	337	6097					937	941		10.1126/science.1223012	http://dx.doi.org/10.1126/science.1223012			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992VI	22923574	Green Submitted, Green Accepted			2022-12-24	WOS:000307807600037
J	Herzog, F; Kahraman, A; Boehringer, D; Mak, R; Bracher, A; Walzthoeni, T; Leitner, A; Beck, M; Hartl, FU; Ban, N; Malmstrom, L; Aebersold, R				Herzog, Franz; Kahraman, Abdullah; Boehringer, Daniel; Mak, Raymond; Bracher, Andreas; Walzthoeni, Thomas; Leitner, Alexander; Beck, Martin; Hartl, Franz-Ulrich; Ban, Nenad; Malmstroem, Lars; Aebersold, Ruedi			Structural Probing of a Protein Phosphatase 2A Network by Chemical Cross-Linking and Mass Spectrometry	SCIENCE			English	Article							MOLECULAR ARCHITECTURE; CRYSTAL-STRUCTURE; CHAPERONIN; COMPLEX; IDENTIFICATION; OPTIMIZATION; ALPHA-4; BINDING	The identification of proximate amino acids by chemical cross-linking and mass spectrometry (XL-MS) facilitates the structural analysis of homogeneous protein complexes. We gained distance restraints on a modular interaction network of protein complexes affinity-purified from human cells by applying an adapted XL-MS protocol. Systematic analysis of human protein phosphatase 2A (PP2A) complexes identified 176 interprotein and 570 intraprotein cross-links that link specific trimeric PP2A complexes to a multitude of adaptor proteins that control their cellular functions. Spatial restraints guided molecular modeling of the binding interface between immunoglobulin binding protein 1 (IGBP1) and PP2A and revealed the topology of TCP1 ring complex (TRiC) chaperonin interacting with the PP2A regulatory subunit 2ABG. This study establishes XL-MS as an integral part of hybrid structural biology approaches for the analysis of endogenous protein complexes.	[Herzog, Franz; Kahraman, Abdullah; Mak, Raymond; Walzthoeni, Thomas; Leitner, Alexander; Malmstroem, Lars; Aebersold, Ruedi] ETH, Dept Biol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Boehringer, Daniel; Ban, Nenad] ETH, Dept Biol, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Beck, Martin] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Bracher, Andreas; Hartl, Franz-Ulrich] Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; European Molecular Biology Laboratory (EMBL); Max Planck Society	Aebersold, R (corresponding author), ETH, Dept Biol, Inst Mol Syst Biol, Wolfgang Pauli Str 16, CH-8093 Zurich, Switzerland.	aebersold@imsb.biol.ethz.ch	Hartl, F. Ulrich/Y-8206-2019; Malmström, Lars/R-4991-2019; Herzog, Franz/G-4832-2012; Leitner, Alexander/U-1601-2019; Beck, Martin/B-5589-2011	Malmström, Lars/0000-0001-9885-9312; Herzog, Franz/0000-0001-8270-1449; Leitner, Alexander/0000-0003-4126-0725; Beck, Martin/0000-0002-7397-1321; Kahraman, Abdullah/0000-0003-3523-4467; Mak, Raymond/0000-0002-7081-8671	EU; European Molecular Biology Organization; European Commission [FP7-PEOPLE-IEF]; European Research Council [Proteomics v.3.0.]	EU(European Commission); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); European Commission(European CommissionEuropean Commission Joint Research Centre); European Research Council(European Research Council (ERC)European Commission)	We thank S. Hauri, A. Frei, and M. Gstaiger for support. Primary mass spectrometry data are available as mzXML files at www.peptideatlas.org/PASS/PASS00053. This work was supported by the EU FP7 project PROSPECTS. F. H. was supported by the European Molecular Biology Organization and by the European Commission (FP7-PEOPLE-IEF). R. A. was supported by the European Research Council advanced grant Proteomics v.3.0.	Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Alber F, 2007, NATURE, V450, P683, DOI 10.1038/nature06404; Aloy P, 2006, NAT REV MOL CELL BIO, V7, P188, DOI 10.1038/nrm1859; Bradley P, 2006, PROTEINS, V65, P922, DOI 10.1002/prot.21133; Chen LL, 1999, CELL, V99, P757, DOI 10.1016/S0092-8674(00)81673-6; Chen ZA, 2010, EMBO J, V29, P717, DOI 10.1038/emboj.2009.401; Clare DK, 2012, CELL, V149, P113, DOI 10.1016/j.cell.2012.02.047; Cong Y, 2012, EMBO J, V31, P720, DOI 10.1038/emboj.2011.366; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Jennebach S, 2012, NUCLEIC ACIDS RES, V40, P5591, DOI 10.1093/nar/gks220; Kalisman N, 2012, P NATL ACAD SCI USA, V109, P2884, DOI 10.1073/pnas.1119472109; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kong M, 2009, MOL CELL, V36, P51, DOI 10.1016/j.molcel.2009.09.025; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Lauber MA, 2010, ANAL CHEM, V82, P7736, DOI 10.1021/ac101586z; Leitner A, 2012, STRUCTURE, V20, P814, DOI 10.1016/j.str.2012.03.007; Leitner A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014126; Leitner A, 2010, MOL CELL PROTEOMICS, V9, P1634, DOI 10.1074/mcp.R000001-MCP201; LeNoue-Newton M, 2011, J BIOL CHEM, V286, P17665, DOI 10.1074/jbc.M111.222414; Moorhead GBG, 2007, NAT REV MOL CELL BIO, V8, P234, DOI 10.1038/nrm2126; Munoz IG, 2011, NAT STRUCT MOL BIOL, V18, P14, DOI 10.1038/nsmb.1971; Muto S, 2007, P NATL ACAD SCI USA, V104, P4285, DOI 10.1073/pnas.0603762104; Prickett TD, 2004, J BIOL CHEM, V279, P38912, DOI 10.1074/jbc.M401444200; Riedel CG, 2006, NATURE, V441, P53, DOI 10.1038/nature04664; Rinner O, 2008, NAT METHODS, V5, P315, DOI [10.1038/NMETH.1192, 10.1038/nmeth.1192]; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Wang HM, 2003, MOL BIOL CELL, V14, P4342, DOI 10.1091/mbc.E03-02-0072; Wepf A, 2009, NAT METHODS, V6, P203, DOI [10.1038/NMETH.1302, 10.1038/nmeth.1302]; Wurzenberger C, 2011, NAT REV MOL CELL BIO, V12, P469, DOI 10.1038/nrm3149; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Xu Z, 2009, MOL CELL, V35, P426, DOI 10.1016/j.molcel.2009.06.031; Yan XM, 2006, MOL BIOL CELL, V17, P634, DOI 10.1091/mbc.E05-08-0810; Zhang HZ, 2009, MOL CELL PROTEOMICS, V8, P409, DOI 10.1074/mcp.M800232-MCP200	37	303	308	5	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2012	337	6100					1348	1352		10.1126/science.1221483	http://dx.doi.org/10.1126/science.1221483			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	004TW	22984071				2022-12-24	WOS:000308705000044
J	Keleman, K; Vrontou, E; Kruttner, S; Yu, JY; Kurtovic-Kozaric, A; Dickson, BJ				Keleman, Krystyna; Vrontou, Eleftheria; Kruettner, Sebastian; Yu, Jai Y.; Kurtovic-Kozaric, Amina; Dickson, Barry J.			Dopamine neurons modulate pheromone responses in Drosophila courtship learning	NATURE			English	Article							SEX-PEPTIDE; EXPRESSION; BEHAVIOR; MEMORY; FEMALES	Learning through trial-and-error interactions allows animals to adapt innate behavioural 'rules of thumb' to the local environment, improving their prospects for survival and reproduction. Naive Drosophila melanogaster males, for example, court both virgin and mated females, but learn through experience to selectively suppress futile courtship towards females that have already mated(1). Here we show that courtship learning reflects an enhanced response to the male pheromone cis-vaccenyl acetate (cVA), which is deposited on females during mating and thus distinguishes mated females from virgins. Dissociation experiments suggest a simple learning rule in which unsuccessful courtship enhances sensitivity to cVA. The learning experience can be mimicked by artificial activation of dopaminergic neurons, and we identify a specific class of dopaminergic neuron that is critical for courtship learning. These neurons provide input to the mushroom body (MB) gamma lobe, and the DopR1 dopamine receptor is required in MB gamma neurons for both natural and artificial courtship learning. Our work thus reveals critical behavioural, cellular and molecular components of the learning rule by which Drosophila adjusts its innate mating strategy according to experience.	[Keleman, Krystyna; Vrontou, Eleftheria; Kruettner, Sebastian; Yu, Jai Y.; Kurtovic-Kozaric, Amina; Dickson, Barry J.] Res Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Keleman, K (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	keleman@imp.ac.at; dickson@imp.ac.at	Dickson, Barry/AAE-7632-2019	Dickson, Barry/0000-0003-0715-892X; Kozaric, Amina/0000-0002-6063-7260; Yu, Jai/0000-0003-0628-2531	European Research Council; Austrian Science Fund; European Molecular Biology Organization; Boehringer Ingelheim GmbH	European Research Council(European Research Council (ERC)European Commission); Austrian Science Fund(Austrian Science Fund (FWF)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Boehringer Ingelheim GmbH(Boehringer Ingelheim)	We thank E. Leitner for performing the gas chromatography-mass spectrometry analysis; P. Garrity, U. Heberlein, M. Heisenberg, E. Kubli, S. Waddell, the Drosophila Genetic Resource Centre, the Bloomington Stock Center and the VDRC for fly stocks; K. Jandrasits and Z. Portik-Dobos for technical assistance; M. Zimmer for critical comments on the manuscript. Basic research at the Institute of Molecular Pathology is funded in part by Boehringer Ingelheim GmbH. This work was additionally supported by grants from the European Research Council (B.J.D.) and the Austrian Science Fund (K. K.). E. V. was supported by a European Molecular Biology Organization long-term postdoctoral fellowship.	Aso Y, 2010, CURR BIOL, V20, P1445, DOI 10.1016/j.cub.2010.06.048; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BUTTERWORTH FM, 1969, SCIENCE, V163, P1356, DOI 10.1126/science.163.3873.1356; CHEN PS, 1988, CELL, V54, P291, DOI 10.1016/0092-8674(88)90192-4; Claridge-Chang A, 2009, CELL, V139, P405, DOI 10.1016/j.cell.2009.08.034; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Everaerts C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009607; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Ha TS, 2006, J NEUROSCI, V26, P8727, DOI 10.1523/JNEUROSCI.0876-06.2006; Hadjieconomou D, 2011, NAT METHODS, V8, P260, DOI 10.1038/NMETH.1567; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; JALLON JM, 1981, CR ACAD SCI III-VIE, V292, P1147; Kamyshev NG, 1999, LEARN MEMORY, V6, P1; Keleman K, 2007, NAT NEUROSCI, V10, P1587, DOI 10.1038/nn1996; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Krashes MJ, 2007, NEURON, V53, P103, DOI 10.1016/j.neuron.2006.11.021; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Liu HF, 2003, P NATL ACAD SCI USA, V100, P9929, DOI 10.1073/pnas.1631700100; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Nakayama S, 1997, MOL GEN GENET, V254, P449, DOI 10.1007/s004380050438; Neckameyer WS, 1998, LEARN MEMORY, V5, P157; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Root CM, 2007, P NATL ACAD SCI USA, V104, P11826, DOI 10.1073/pnas.0704523104; Saudan P, 2002, EUR J BIOCHEM, V269, P989, DOI 10.1046/j.0014-2956.2001.02733.x; SIEGEL RW, 1979, P NATL ACAD SCI USA, V76, P3430, DOI 10.1073/pnas.76.7.3430; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; TOMPKINS L, 1984, BEHAV GENET, V14, P411, DOI 10.1007/BF01065443; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; Waddell S, 2010, TRENDS NEUROSCI, V33, P457, DOI 10.1016/j.tins.2010.07.001; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Yu JY, 2010, CURR BIOL, V20, P1602, DOI 10.1016/j.cub.2010.08.025; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672	35	137	140	1	69	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 6	2012	489	7414					145	U210		10.1038/nature11345	http://dx.doi.org/10.1038/nature11345			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999WW	22902500				2022-12-24	WOS:000308347000052
J	Koo, BK; Spit, M; Jordens, I; Low, TY; Stange, DE; van de Wetering, M; van Es, JH; Mohammed, S; Heck, AJR; Maurice, MM; Clevers, H				Koo, Bon-Kyoung; Spit, Maureen; Jordens, Ingrid; Low, Teck Y.; Stange, Daniel E.; van de Wetering, Marc; van Es, Johan H.; Mohammed, Shabaz; Heck, Albert J. R.; Maurice, Madelon M.; Clevers, Hans			Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors	NATURE			English	Article							SMALL-INTESTINE; NEGATIVE REGULATOR; BETA-CATENIN; IN-VITRO; LGR5; CANCER; COLON; UBIQUITYLATION; TRANSCRIPTION; INHIBITION	LGR5(+) stem cells reside at crypt bottoms, intermingled with Paneth cells that provide Wnt, Notch and epidermal growth factor signals(1). Here we find that the related RNF43 and ZNRF3 transmembrane E3 ubiquitin ligases are uniquely expressed in LGR5(+) stem cells. Simultaneous deletion of the two genes encoding these proteins in the intestinal epithelium of mice induces rapidly growing adenomas containing high numbers of Paneth and LGR5(+) stem cells. In vitro, growth of organoids derived from these adenomas is arrested when Wnt secretion is inhibited, indicating a dependence of the adenoma stem cells on Wnt produced by adenoma Paneth cells. In the HEK293T human cancer cell line, expression of RNF43 blocks Wnt responses and targets surface-expressed frizzled receptors to lysosomes. In the RNF43-mutant colorectal cancer cell line HCT116, reconstitution of RNF43 expression removes its response to exogenous Wnt. We conclude that RNF43 and ZNRF3 reduce Wnt signals by selectively ubiquitinating frizzled receptors, thereby targeting these Wnt receptors for degradation.	[Spit, Maureen; Jordens, Ingrid; Maurice, Madelon M.] Univ Med Ctr Utrecht, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands; [Koo, Bon-Kyoung; Stange, Daniel E.; van de Wetering, Marc; van Es, Johan H.; Clevers, Hans] KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Koo, Bon-Kyoung; Stange, Daniel E.; van de Wetering, Marc; van Es, Johan H.; Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Low, Teck Y.; Mohammed, Shabaz; Heck, Albert J. R.] Univ Utrecht, Biomol Mass Spectrometry & Prote Grp, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; [Low, Teck Y.; Mohammed, Shabaz; Heck, Albert J. R.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CH Utrecht, Netherlands; [Low, Teck Y.; Mohammed, Shabaz; Heck, Albert J. R.] Netherlands Prote Ctr, NL-3584 CH Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University	Maurice, MM (corresponding author), Univ Med Ctr Utrecht, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands.	M.M.Maurice@umcutrecht.nl; h.clevers@hubrecht.eu	Heck, Albert/D-7098-2011; Low, Teck Yew/J-4403-2014; van+Es, Johan/ABD-5411-2021; Stange, Daniel E/O-1837-2015; Mohammed, Shabaz/AAY-6313-2020; Low, Teck Yew/Q-5946-2019; Mohammed, Shabaz/D-1042-2010; Galmes-Spit, Maureen/T-6013-2019; Koo, Bon-Kyoung/V-5219-2017	Heck, Albert/0000-0002-2405-4404; Low, Teck Yew/0000-0001-7878-7534; Stange, Daniel E/0000-0003-4246-2230; Mohammed, Shabaz/0000-0003-2640-9560; Low, Teck Yew/0000-0001-7878-7534; Mohammed, Shabaz/0000-0003-2640-9560; Koo, Bon-Kyoung/0000-0002-4134-8033; Maurice, Madelon/0000-0001-6885-5361; Spit, Maureen/0000-0002-8593-0447; Jordens, Ingrid/0000-0001-7865-2816	European Research Council [EU/232814-StemCeLLMark]; National Research Foundation of Korea [NRF-2011-357-C00093]; Centre van Biomedical Genetics; European Research Council, ERC-StG [242958]; KNAW/3V-fund;  [EU/Health-F4-2007-200720];  [Ti Pharma/T3-106]	European Research Council(European Research Council (ERC)European Commission); National Research Foundation of Korea(National Research Foundation of Korea); Centre van Biomedical Genetics; European Research Council, ERC-StG(European Research Council (ERC)); KNAW/3V-fund; ; 	We thank A. A. Rolf, I. Kuper, M. van den Born, C. Kroon-Veenboer, H. Begthel, J. Korving and S. van den Brink for technical assistance, L. Lum for providing IWP1 and S. Bartfeld for the schematic drawing. This work was funded in part by grants from the European Research Council, EU/232814-StemCeLLMark and the National Research Foundation of Korea, NRF-2011-357-C00093 (B.-K.K.); EU/Health-F4-2007-200720 (M.v.d.W.); The Centre van Biomedical Genetics (D. E. S.); Ti Pharma/T3-106 (J.H.v.E.); the European Research Council, ERC-StG no. 242958 (M. M. M.) and the KNAW/3V-fund.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Berndt JD, 2011, J CELL BIOL, V194, P737, DOI 10.1083/jcb.201107021; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; CHENG H, 1974, AM J ANAT, V141, P461, DOI 10.1002/aja.1001410403; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Haglund K, 2012, J CELL SCI, V125, P265, DOI 10.1242/jcs.091280; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; Ivanov I, 2007, ONCOGENE, V26, P2873, DOI 10.1038/sj.onc.1210098; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kazanskaya O, 2008, DEVELOPMENT, V135, P3655, DOI 10.1242/dev.027284; Koo BK, 2012, NAT METHODS, V9, P81, DOI [10.1038/NMETH.1802, 10.1038/nmeth.1802]; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Liu GZ, 2003, MOL CELL BIOL, V23, P5825, DOI 10.1128/MCB.23.16.5825-5835.2003; March HN, 2011, NAT GENET, V43, P1202, DOI 10.1038/ng.990; Mukai A, 2010, EMBO J, V29, P2114, DOI 10.1038/emboj.2010.100; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Ong CK, 2012, NAT GENET, V44, P690, DOI 10.1038/ng.2273; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Shimomura Y, 2010, NATURE, V464, P1043, DOI 10.1038/nature08875; Tauriello DVF, 2010, MOL CELL, V37, P607, DOI 10.1016/j.molcel.2010.01.035; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; Wu J, 2011, P NATL ACAD SCI USA, V108, P21188, DOI 10.1073/pnas.1118046108; Yagyu R, 2004, INT J ONCOL, V25, P1343; Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695	31	581	606	11	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2012	488	7413					665	+		10.1038/nature11308	http://dx.doi.org/10.1038/nature11308			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996NC	22895187				2022-12-24	WOS:000308095100058
J	Browne, SK; Burbelo, PD; Chetchotisakd, P; Suputtamongkol, Y; Kiertiburanakul, S; Shaw, PA; Kirk, JL; Jutivorakool, K; Zaman, R; Ding, L; Hsu, AP; Patel, SY; Olivier, KN; Lulitanond, V; Mootsikapun, P; Anunnatsiri, S; Angkasekwinai, N; Sathapatayavongs, B; Hsueh, PR; Shieh, CC; Brown, MR; Thongnoppakhun, W; Claypool, R; Sampaio, EP; Thepthai, C; Waywa, D; Dacombe, C; Reizes, Y; Zelazny, AM; Saleeb, P; Rosen, LB; Mo, A; Iadarola, M; Holland, SM				Browne, Sarah K.; Burbelo, Peter D.; Chetchotisakd, Ploenchan; Suputtamongkol, Yupin; Kiertiburanakul, Sasisopin; Shaw, Pamela A.; Kirk, Jennifer L.; Jutivorakool, Kamonwan; Zaman, Rifat; Ding, Li; Hsu, Amy P.; Patel, Smita Y.; Olivier, Kenneth N.; Lulitanond, Viraphong; Mootsikapun, Piroon; Anunnatsiri, Siriluck; Angkasekwinai, Nasikarn; Sathapatayavongs, Boonmee; Hsueh, Po-Ren; Shieh, Chi-Chang; Brown, Margaret R.; Thongnoppakhun, Wanna; Claypool, Reginald; Sampaio, Elizabeth P.; Thepthai, Charin; Waywa, Duangdao; Dacombe, Camilla; Reizes, Yona; Zelazny, Adrian M.; Saleeb, Paul; Rosen, Lindsey B.; Mo, Allen; Iadarola, Michael; Holland, Steven M.			Adult-Onset Immunodeficiency in Thailand and Taiwan	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NONTUBERCULOUS MYCOBACTERIAL INFECTION; INTERFERON-GAMMA AUTOANTIBODY; IFN-GAMMA; AVIUM COMPLEX; PATIENT; DISEASES; SUSCEPTIBILITY; RECURRENT; HIV	BACKGROUND Autoantibodies against interferon-gamma are associated with severe disseminated opportunistic infection, but their importance and prevalence are unknown. METHODS We enrolled 203 persons from sites in Thailand and Taiwan in five groups: 52 patients with disseminated, rapidly or slowly growing, nontuberculous mycobacterial infection (group 1); 45 patients with another opportunistic infection, with or without nontuberculous mycobacterial infection (group 2); 9 patients with disseminated tuberculosis (group 3); 49 patients with pulmonary tuberculosis (group 4); and 48 healthy controls (group 5). Clinical histories were recorded, and blood specimens were obtained. RESULTS Patients in groups 1 and 2 had CD4+ T-lymphocyte counts that were similar to those in patients in groups 4 and 5, and they were not infected with the human immunodeficiency virus (HIV). Washed cells obtained from patients in groups 1 and 2 had intact cytokine production and a response to cytokine stimulation. In contrast, plasma obtained from these patients inhibited the activity of interferon-gamma in normal cells. High-titer anti-interferon-gamma autoantibodies were detected in 81% of patients in group 1, 96% of patients in group 2, 11% of patients in group 3, 2% of patients in group 4, and 2% of controls (group 5). Forty other anticytokine autoantibodies were assayed. One patient with cryptococcal meningitis had autoantibodies only against granulocyte-macrophage colony-stimulating factor. No other anticytokine autoantibodies or genetic defects correlated with infections. There was no familial clustering. CONCLUSIONS Neutralizing anti-interferon-gamma autoantibodies were detected in 88% of Asian adults with multiple opportunistic infections and were associated with an adult-onset immunodeficiency akin to that of advanced HIV infection. (Funded by the National Institute of Allergy and Infectious Diseases and the National Institute of Dental and Craniofacial Research; ClinicalTrials.gov number, NCT00814827.)	[Browne, Sarah K.; Jutivorakool, Kamonwan; Zaman, Rifat; Ding, Li; Hsu, Amy P.; Olivier, Kenneth N.; Brown, Margaret R.; Claypool, Reginald; Sampaio, Elizabeth P.; Saleeb, Paul; Rosen, Lindsey B.; Mo, Allen; Holland, Steven M.] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Shaw, Pamela A.; Kirk, Jennifer L.] NIAID, Biostat Res Branch, NIH, Bethesda, MD 20892 USA; [Burbelo, Peter D.; Iadarola, Michael] Natl Inst Dent & Craniofacial Res, Lab Sensory Biol, NIH, Bethesda, MD USA; [Zelazny, Adrian M.] NIH, Microbiol Serv, Dept Lab Med, Ctr Clin, Bethesda, MD 20892 USA; [Dacombe, Camilla; Reizes, Yona] Systex, Rockville, MD USA; [Chetchotisakd, Ploenchan; Lulitanond, Viraphong; Mootsikapun, Piroon; Anunnatsiri, Siriluck] Khon Kaen Univ, Srinagarind Hosp, Khon Kaen, Thailand; [Suputtamongkol, Yupin; Angkasekwinai, Nasikarn; Thongnoppakhun, Wanna; Thepthai, Charin; Waywa, Duangdao] Mahidol Univ, Siriraj Hosp, Bangkok 10700, Thailand; [Browne, Sarah K.; Sathapatayavongs, Boonmee] Mahidol Univ, Ramathibodi Hosp, Fac Med, Bangkok 10400, Thailand; [Jutivorakool, Kamonwan] Chulalongkorn Univ, Fac Med, Dept Med, Bangkok 10330, Thailand; [Jutivorakool, Kamonwan] Thai Red Cross Soc, King Chulalongkorn Mem Hosp, Bangkok, Thailand; [Patel, Smita Y.] Univ Oxford, John Radcliffe Hosp, Oxford OX3 9DU, England; [Hsueh, Po-Ren] Natl Taiwan Univ, Taipei 10764, Taiwan; [Shieh, Chi-Chang] Natl Cheng Kung Univ, Tainan 70101, Taiwan; [Sampaio, Elizabeth P.] Inst Oswaldo Cruz, Leprosy Lab, BR-20001 Rio De Janeiro, Brazil; [Mo, Allen] Colgate Univ, Hamilton, NY 13346 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Khon Kaen University; Mahidol University; Mahidol University; Chulalongkorn University; Chulalongkorn University; Thai Red Cross Society; University of Oxford; National Taiwan University; National Cheng Kung University; Fundacao Oswaldo Cruz; Colgate University	Browne, SK (corresponding author), CRC B3-4141,MSC 1684,9000 Rockville Pike, Bethesda, MD 20892 USA.	brownesa@niaid.nih.gov	Angkasekwinai, Nasikarn/AAS-3199-2020; Hsueh, Po-Ren/ABE-1594-2021	Patel, Smita/0000-0002-6207-2208; HSUEH, PO-REN/0000-0002-7502-9225	Division of Intramural Research, National Institute of Allergy and Infectious Diseases; Division of Intramural Research, National Institute of Dental and Craniofacial Research, National Institutes of Health; National Institute of Allergy and Infectious Diseases; National Institute of Dental and Craniofacial Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000724] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL090034, ZIACL080013] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Division of Intramural Research, National Institute of Dental and Craniofacial Research, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); CLINICAL CENTER	Supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, and the Division of Intramural Research, National Institute of Dental and Craniofacial Research, National Institutes of Health.; Funded by the National Institute of Allergy and Infectious Diseases and the National Institute of Dental and Craniofacial Research	Al-Muhsen S, 2008, J ALLERGY CLIN IMMUN, V122, P1043, DOI 10.1016/j.jaci.2008.10.037; Anekthananon Thanomsak, 2004, Journal of the Medical Association of Thailand, V87, P173; Baerlecken N, 2009, CLIN INFECT DIS, V49, pE76, DOI 10.1086/605581; Browne SK, 2012, BLOOD, V119, P3933, DOI 10.1182/blood-2011-12-395707; Browne SK, 2010, LANCET INFECT DIS, V10, P875, DOI 10.1016/S1473-3099(10)70196-1; Burbelo PD, 2010, BLOOD, V116, P4848, DOI 10.1182/blood-2010-05-286161; Burbelo Peter D, 2009, J Vis Exp, DOI 10.3791/1549; Carey B, 2010, CLIN IMMUNOL, V135, P223, DOI 10.1016/j.clim.2010.02.017; *CDCP, 2003, GUID APPR EV HIV TES; Chen YP, 2008, APMIS, V116, P850, DOI 10.1111/j.1600-0463.2008.00935.x; Chetchotisakd P, 2000, CLIN INFECT DIS, V30, P29, DOI 10.1086/313589; Chetchotisakd P, 2007, CLIN INFECT DIS, V45, P421, DOI 10.1086/520030; Clark S, 2011, J ALLERGY CLIN IMMUN, V128, P838, DOI 10.1016/j.jaci.2011.05.025; Crum NF, 2005, MEDICINE, V84, P291, DOI 10.1097/01.md.0000180044.19285.9a; Ding LW, 2006, EPIDEMIOL INFECT, V134, P1060, DOI 10.1017/S0950268805005698; Ding L, 2012, J CLIN IMMUNOL, V32, P238, DOI 10.1007/s10875-011-9621-8; Doffinger R, 2004, CLIN INFECT DIS, V38, pE10, DOI 10.1086/380453; Dorman SE, 2000, CYTOKINE GROWTH F R, V11, P321, DOI 10.1016/S1359-6101(00)00010-1; Hoflich C, 2004, BLOOD, V103, P673, DOI 10.1182/blood-2003-04-1065; Kampitak T, 2011, INFECTION, V39, P65, DOI 10.1007/s15010-010-0067-3; Kampmann B, 2005, J CLIN INVEST, V115, P2480, DOI 10.1172/JCI19316; Kony SJ, 2000, J INFECTION, V41, P167, DOI 10.1053/jinf.2000.0721; Koya T, 2009, J INFECT CHEMOTHER, V15, P118, DOI 10.1007/s10156-008-0662-8; Patel SY, 2005, J IMMUNOL, V175, P4769, DOI 10.4049/jimmunol.175.7.4769; Sungkanuparph Somnuek, 2003, International Journal of Infectious Diseases, V7, P198, DOI 10.1016/S1201-9712(03)90052-X; SUTHERLAND R, 2006, 17 INT AIDS C MEX CI, V20, P821; Tanaka Y, 2007, INTERNAL MED, V46, P1005, DOI 10.2169/internalmedicine.46.6452; Tang BSF, 2010, CLIN VACCINE IMMUNOL, V17, P1132, DOI 10.1128/CVI.00053-10; van de Vosse E, 2004, LANCET INFECT DIS, V4, P739, DOI 10.1016/S1473-3099(04)01203-4; World Health Organization, 2010, WHO GLOB TUB CONTR	30	319	326	3	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 23	2012	367	8					725	734		10.1056/NEJMoa1111160	http://dx.doi.org/10.1056/NEJMoa1111160			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992CX	22913682	Bronze, Green Accepted			2022-12-24	WOS:000307754200007
J	Khalil, AS; Lu, TK; Bashor, CJ; Ramirez, CL; Pyenson, NC; Joung, JK; Collins, JJ				Khalil, Ahmad S.; Lu, Timothy K.; Bashor, Caleb J.; Ramirez, Cherie L.; Pyenson, Nora C.; Joung, J. Keith; Collins, James J.			A Synthetic Biology Framework for Programming Eukaryotic Transcription Functions	CELL			English	Article							ZINC-FINGER NUCLEASES; STRUCTURE-BASED DESIGN; GENE NETWORKS; SYNERGISTIC ACTIVATION; PROTEIN; CELLS; COMPLEX; GAL4; CONSTRUCTION; DIMERIZATION	Eukaryotic transcription factors (TFs) perform complex and combinatorial functions within transcriptional networks. Here, we present a synthetic framework for systematically constructing eukaryotic transcription functions using artificial zinc fingers, modular DNA-binding domains found within many eukaryotic TFs. Utilizing this platform, we construct a library of orthogonal synthetic transcription factors (sTFs) and use these to wire synthetic transcriptional circuits in yeast. We engineer complex functions, such as tunable output strength and transcriptional cooperativity, by rationally adjusting a decomposed set of key component properties, e. g., DNA specificity, affinity, promoter design, protein-protein interactions. We show that subtle perturbations to these properties can transform an individual sTF between distinct roles (activator, cooperative factor, inhibitory factor) within a transcriptional complex, thus drastically altering the signal processing behavior of multi-input systems. This platform provides new genetic components for synthetic biology and enables bottom-up approaches to understanding the design principles of eukaryotic transcriptional complexes and networks.	[Lu, Timothy K.] MIT, Dept Elect Engn & Comp Sci, Synthet Biol Grp, Cambridge, MA 02139 USA; [Khalil, Ahmad S.; Bashor, Caleb J.; Pyenson, Nora C.; Collins, James J.] Boston Univ, Dept Biomed Engn, Howard Hughes Med Inst, Boston, MA 02215 USA; [Khalil, Ahmad S.; Bashor, Caleb J.; Pyenson, Nora C.; Collins, James J.] Boston Univ, Ctr BioDynam, Boston, MA 02215 USA; [Ramirez, Cherie L.; Joung, J. Keith] Massachusetts Gen Hosp, Mol Pathol Unit, Ctr Canc Res, Charlestown, MA 02129 USA; [Ramirez, Cherie L.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Charlestown, MA 02129 USA; [Ramirez, Cherie L.] Harvard Univ, Sch Med, Div Med Sci, Biol & Biomed Sci Program, Boston, MA 02115 USA; [Joung, J. Keith] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Collins, James J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Boston University; Howard Hughes Medical Institute; Boston University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University	Lu, TK (corresponding author), MIT, Dept Elect Engn & Comp Sci, Synthet Biol Grp, Cambridge, MA 02139 USA.	timlu@mit.edu	Lu, Timothy/G-4267-2012	Ramirez, Cherie/0000-0002-0397-6872; Lu, Timothy/0000-0002-3918-8923	Howard Hughes Medical Institute; NIH [DP1 OD003644, DP1 OD006862]; Office of Naval Research Multidisciplinary University Research Initiative (MURI); National Science Foundation [CCF-1124247]; Defense Advanced Research Projects Agency [DARPA-BAA-11-23]; National Science Foundation Graduate Research Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP1GM105378] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006862, DP2OD008435, DP1OD003644] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Naval Research Multidisciplinary University Research Initiative (MURI)(MURI); National Science Foundation(National Science Foundation (NSF)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Collins Lab for helpful discussions, Carl O. Pabo for helpful suggestions on reducing nonspecific affinity of zinc fingers, and Katie M. Flynn for help with artwork. This work was supported by the Howard Hughes Medical Institute (J.J.C.), NIH Director's Pioneer Awards DP1 OD003644 (J.J.C.) and DP1 OD006862 (J.K.J.), an Office of Naval Research Multidisciplinary University Research Initiative (MURI) grant (T. K. L.), the National Science Foundation CCF-1124247 (T. K. L.), a Defense Advanced Research Projects Agency grant (DARPA-BAA-11-23), and a National Science Foundation Graduate Research Fellowship (C.L.R.).	Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Bashor CJ, 2010, ANNU REV BIOPHYS, V39, P515, DOI 10.1146/annurev.biophys.050708.133652; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Beerli RR, 2002, NAT BIOTECHNOL, V20, P135, DOI 10.1038/nbt0202-135; Blancafort P, 2005, P NATL ACAD SCI USA, V102, P11716, DOI 10.1073/pnas.0501162102; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Bryant GO, 2003, MOL CELL, V11, P1301, DOI 10.1016/S1097-2765(03)00144-8; Cormack BP, 1997, MICROBIOL-UK, V143, P303, DOI 10.1099/00221287-143-2-303; Craven SE, 1998, CELL, V93, P495, DOI 10.1016/S0092-8674(00)81179-4; Ellis T, 2009, NAT BIOTECHNOL, V27, P465, DOI 10.1038/nbt.1536; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Elowitz M, 2010, NATURE, V468, P889, DOI 10.1038/468889a; Elrod-Erickson M, 1998, STRUCTURE, V6, P451, DOI 10.1016/S0969-2126(98)00047-1; ElrodErickson M, 1996, STRUCTURE, V4, P1171, DOI 10.1016/S0969-2126(96)00125-6; FISCHER JA, 1988, NATURE, V332, P853, DOI 10.1038/332853a0; Foley JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004348; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407; Hahn S, 2011, GENETICS, V189, P705, DOI 10.1534/genetics.111.127019; Harris BZ, 2001, J CELL SCI, V114, P3219; Harris BZ, 2001, BIOCHEMISTRY-US, V40, P5921, DOI 10.1021/bi010142l; JOUNG JK, 1993, P NATL ACAD SCI USA, V90, P3083, DOI 10.1073/pnas.90.7.3083; JOUNG JK, 1994, SCIENCE, V265, P1863, DOI 10.1126/science.8091212; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Kramer BP, 2004, BIOTECHNOL BIOENG, V87, P478, DOI 10.1002/bit.20142; Lu TK, 2009, NAT BIOTECHNOL, V27, P1139, DOI 10.1038/nbt.1591; MA J, 1988, CELL, V55, P443, DOI 10.1016/0092-8674(88)90030-X; MA J, 1988, NATURE, V334, P631, DOI 10.1038/334631a0; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Maeder ML, 2009, NAT PROTOC, V4, P1471, DOI 10.1038/nprot.2009.98; Maxon ME, 2001, P NATL ACAD SCI USA, V98, P1495, DOI 10.1073/pnas.98.4.1495; Mukherji S, 2009, NAT REV GENET, V10, P859, DOI 10.1038/nrg2697; Murphy KF, 2007, P NATL ACAD SCI USA, V104, P12726, DOI 10.1073/pnas.0608451104; Nandagopal N, 2011, SCIENCE, V333, P1244, DOI 10.1126/science.1207084; Nissim L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.99; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Pomerantz JL, 1998, BIOCHEMISTRY-US, V37, P965, DOI 10.1021/bi972464o; PTASHNE M, 1986, NATURE, V322, P697, DOI 10.1038/322697a0; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; PTASHNE M, 2002, GENES SIGNALS; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; RubinBejerano I, 1996, MOL CELL BIOL, V16, P2518; Sander JD, 2011, NAT METHODS, V8, P67, DOI 10.1038/NMETH.1542; Sebastiano V, 2011, STEM CELLS, V29, P1717, DOI 10.1002/stem.718; Smolke CD, 2011, CELL, V144, P855, DOI 10.1016/j.cell.2011.02.020; Townsend JA, 2009, NATURE, V459, P442, DOI 10.1038/nature07845; Wang BS, 1999, P NATL ACAD SCI USA, V96, P9568, DOI 10.1073/pnas.96.17.9568; Wang BS, 2001, NAT STRUCT BIOL, V8, P589, DOI 10.1038/89617; Weber W, 2009, CHEM BIOL, V16, P287, DOI 10.1016/j.chembiol.2009.02.005; WEBSTER N, 1988, CELL, V52, P169, DOI 10.1016/0092-8674(88)90505-3; Wolfe SA, 2000, STRUCT FOLD DES, V8, P739, DOI 10.1016/S0969-2126(00)00161-1; Wright DA, 2006, NAT PROTOC, V1, P1637, DOI 10.1038/nprot.2006.259; Xie Z, 2011, SCIENCE, V333, P1307, DOI 10.1126/science.1205527; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023	60	222	248	5	120	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 3	2012	150	3					647	658		10.1016/j.cell.2012.05.045	http://dx.doi.org/10.1016/j.cell.2012.05.045			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	985WO	22863014	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000307301400021
J	Tussiwand, R; Lee, WL; Murphy, TL; Mashayekhi, M; Wumesh, KC; Albring, JC; Satpathy, AT; Rotondo, JA; Edelson, BT; Kretzer, NM; Wu, XD; Weiss, LA; Glasmacher, E; Li, P; Liao, W; Behnke, M; Lam, SSK; Aurthur, CT; Leonard, WJ; Singh, H; Stallings, CL; Sibley, LD; Schreiber, RD; Murphy, KM				Tussiwand, Roxane; Lee, Wan-Ling; Murphy, Theresa L.; Mashayekhi, Mona; Wumesh, K. C.; Albring, Joern C.; Satpathy, Ansuman T.; Rotondo, Jeffrey A.; Edelson, Brian T.; Kretzer, Nicole M.; Wu, Xiaodi; Weiss, Leslie A.; Glasmacher, Elke; Li, Peng; Liao, Wei; Behnke, Michael; Lam, Samuel S. K.; Aurthur, Cora T.; Leonard, Warren J.; Singh, Harinder; Stallings, Christina L.; Sibley, L. David; Schreiber, Robert D.; Murphy, Kenneth M.			Compensatory dendritic cell development mediated by BATF-IRF interactions	NATURE			English	Article							NEGATIVE REGULATOR; B-ATF; CD8-ALPHA(+); TRANSCRIPTION; EXPRESSION; INFECTION; AP-1; REVEALS; MICE; ACTIVATION	The AP1 transcription factor Batf3 is required for homeostatic development of CD8 alpha(+) classical dendritic cells that prime CD8 T-cell responses against intracellular pathogens. Here we identify an alternative, Batf3-independent pathway in mice for CD8 alpha(+) dendritic cell development operating during infection with intracellular pathogens and mediated by the cytokines interleukin (IL)-12 and interferon-gamma. This alternative pathway results from molecular compensation for Batf3 provided by the related AP1 factors Batf, which also functions in T and B cells, and Batf2 induced by cytokines in response to infection. Reciprocally, physiological compensation between Batf and Batf3 also occurs in T cells for expression of IL-10 and CTLA4. Compensation among BATF factors is based on the shared capacity of their leucine zipper domains to interact with non-AP1 factors such as IRF4 and IRF8 to mediate cooperative gene activation. Conceivably, manipulating this alternative pathway of dendritic cell development could be of value in augmenting immune responses to vaccines.	[Tussiwand, Roxane; Lee, Wan-Ling; Murphy, Theresa L.; Mashayekhi, Mona; Wumesh, K. C.; Albring, Joern C.; Satpathy, Ansuman T.; Rotondo, Jeffrey A.; Edelson, Brian T.; Kretzer, Nicole M.; Wu, Xiaodi; Lam, Samuel S. K.; Aurthur, Cora T.; Schreiber, Robert D.; Murphy, Kenneth M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Weiss, Leslie A.; Behnke, Michael; Stallings, Christina L.; Sibley, L. David] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Glasmacher, Elke; Singh, Harinder] Genentech Inc, Dept Discovery Immunol, San Francisco, CA 94080 USA; [Li, Peng; Liao, Wei; Leonard, Warren J.] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Li, Peng; Liao, Wei; Leonard, Warren J.] NHLBI, Ctr Immunol, NIH, Bethesda, MD 20892 USA; [Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Roche Holding; Genentech; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Howard Hughes Medical Institute; Washington University (WUSTL)	Murphy, KM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, 660 S Euclid Ave, St Louis, MO 63110 USA.	kmurphy@wustl.edu	Leonard, Warren/AAA-1397-2022; Schreiber, Robert D/A-1276-2013; Behnke, Michael S/R-8839-2016; Schreiber, Robert/Q-7550-2019; Glasmacher, Elke/B-8939-2015	Schreiber, Robert D/0000-0001-6311-0432; Behnke, Michael S/0000-0002-4668-8109; Glasmacher, Elke/0000-0003-1265-2543; Satpathy, Ansuman/0000-0002-5167-537X; Schreiber, Robert/0000-0003-1590-2341; Albring, Jorn/0000-0002-5534-7250; Tussiwand, Roxane/0000-0002-1712-868X; Mashayekhi, Mona/0000-0003-0331-2395; Lam, Siu Kit/0000-0003-1671-3999; Edelson, Brian/0000-0003-2856-7650	Howard Hughes Medical Institute; National Institutes of Health [AI076427-02]; Department of Defense [W81XWH-09-1-0185]; American Heart Association [12PRE8610005]; German Research Foundation [AL 1038/1-1]; American Society of Hematology; Cancer Research Institute; NCI Cancer Center [P30 CA91842]; NATIONAL CANCER INSTITUTE [R01CA043059, P30CA091842] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005402, ZIAHL005408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036629, R01AI076427, T32AI007163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); American Heart Association(American Heart Association); German Research Foundation(German Research Foundation (DFG)); American Society of Hematology; Cancer Research Institute; NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Howard Hughes Medical Institute, National Institutes of Health (AI076427-02) and Department of Defense (W81XWH-09-1-0185) (K.M.M.), the American Heart Association (12PRE8610005) (A.T.S.), German Research Foundation (AL 1038/1-1) (J.C.A), American Society of Hematology Scholar Award and Burroughs Welcome Fund Career Award for Medical Scientists (B.T.E.), and Cancer Research Institute predoctoral fellowship (W.-L.L.). We thank the ImmGen consortium<SUP>34</SUP>, M. White for blastocyst injections and generation of mouse chimaeras, the Alvin J. Siteman Cancer Center at Washington University School of Medicine for use of the Center for Biomedical Informatics and Multiplex Gene Analysis Genechip Core Facility. The Siteman Cancer Center is supported in part by the NCI Cancer Center Support Grant P30 CA91842. IL-12 was a gift from Pfizer.	Aliberti J, 2003, BLOOD, V101, P305, DOI 10.1182/blood-2002-04-1088; Bar-On L, 2010, P NATL ACAD SCI USA, V107, P14745, DOI 10.1073/pnas.1001562107; Behnke MS, 2011, P NATL ACAD SCI USA, V108, P9631, DOI 10.1073/pnas.1015338108; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Betz BC, 2010, J EXP MED, V207, P933, DOI 10.1084/jem.20091548; Brass AL, 1999, EMBO J, V18, P977, DOI 10.1093/emboj/18.4.977; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dorsey MJ, 1995, ONCOGENE, V11, P2255; Echlin DR, 2000, ONCOGENE, V19, P1752, DOI 10.1038/sj.onc.1203491; Edelson BT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025660; Edelson BT, 2011, IMMUNITY, V35, P236, DOI 10.1016/j.immuni.2011.06.012; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; EISENBEIS CF, 1995, GENE DEV, V9, P1377, DOI 10.1101/gad.9.11.1377; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Glasmacher E., SCIENCE IN PRESS; Gorman JR, 1996, IMMUNITY, V5, P241, DOI 10.1016/S1074-7613(00)80319-2; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Iiizumi S, 2006, BIOTECHNIQUES, V41, P311, DOI 10.2144/000112233; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Jackson JT, 2011, EMBO J, V30, P2690, DOI 10.1038/emboj.2011.163; Kanbe E, 2004, BLOOD CELL MOL DIS, V33, P64, DOI 10.1016/j.bcmd.2004.04.001; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li P., 2012, NATURE; Marquis JF, 2009, J IMMUNOL, V182, P3008, DOI 10.4049/jimmunol.0800680; Mashayekhi M, 2011, IMMUNITY, V35, P249, DOI 10.1016/j.immuni.2011.08.008; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Modlin RL, 1995, RES IMMUNOL, V146, P526, DOI 10.1016/0923-2494(96)83027-6; Ranganath S, 1998, J IMMUNOL, V161, P3822; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Saeij JPJ, 2005, INFECT IMMUN, V73, P695, DOI 10.1128/IAI.73.2.695-702.2005; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; Sedy JR, 2005, NAT IMMUNOL, V6, P90, DOI 10.1038/ni1144; Su ZZ, 2008, P NATL ACAD SCI USA, V105, P20906, DOI 10.1073/pnas.0807975106; SZABO SJ, 1993, MOL CELL BIOL, V13, P5928; Tailor P, 2008, BLOOD, V111, P1942, DOI 10.1182/blood-2007-07-100750; Tamura T, 2002, J INTERF CYTOK RES, V22, P145, DOI 10.1089/107999002753452755; Wagner EF, 2005, IMMUNOL REV, V208, P126, DOI 10.1111/j.0105-2896.2005.00332.x; Williams KL, 2001, EUR J IMMUNOL, V31, P1620, DOI 10.1002/1521-4141(200105)31:5<1620::AID-IMMU1620>3.0.CO;2-3; Wilson NS, 2006, NAT IMMUNOL, V7, P165, DOI 10.1038/ni1300	46	280	288	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2012	490	7421					502	+		10.1038/nature11531	http://dx.doi.org/10.1038/nature11531			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NK	22992524	Green Accepted			2022-12-24	WOS:000310196200034
J	Koboldt, DC; Fulton, RS; McLellan, MD; Schmidt, H; Kalicki-Veizer, J; McMichael, JF; Fulton, LL; Dooling, DJ; Ding, L; Mardis, ER; Wilson, RK; Ally, A; Balasundaram, M; Butterfield, YSN; Carlsen, R; Carter, C; Chu, A; Chuah, E; Chun, HJE; Coope, RJN; Dhalla, N; Guin, R; Hirst, C; Hirst, M; Holt, RA; Lee, D; Li, HYI; Mayo, M; Moore, RA; Mungall, AJ; Pleasance, E; Robertson, AG; Schein, JE; Shafiei, A; Sipahimalani, P; Slobodan, JR; Stoll, D; Tam, A; Thiessen, N; Varhol, RJ; Wye, N; Zeng, T; Zhao, YJ; Birol, I; Jones, SJM; Marra, MA; Cherniack, AD; Saksena, G; Onofrio, RC; Pho, NH; Carter, SL; Schumacher, SE; Tabak, B; Hernandez, B; Gentry, J; Nguyen, H; Crenshaw, A; Ardlie, K; Beroukhim, R; Winckler, W; Getz, G; Gabriel, SB; Meyerson, M; Chin, L; Park, PJ; Kucherlapati, R; Hoadley, KA; Auman, JT; Fan, C; Turman, YJ; Shi, Y; Li, L; Topal, MD; He, XP; Chao, HH; Prat, A; Silva, GO; Iglesia, MD; Zhao, W; Usary, J; Berg, JS; Adams, M; Booker, J; Wu, JY; Gulabani, A; Bodenheimer, T; Hoyle, AP; Simons, JV; Soloway, MG; Mose, LE; Jefferys, SR; Balu, S; Parker, JS; Hayes, DN; Perou, CM; Malik, S; Mahurkar, S; Shen, H; Weisenberger, DJ; Triche, T; Lai, PH; Bootwalla, MS; Maglinte, DT; Berman, BP; Van den Berg, DJ; Baylin, SB; Laird, PW; Creighton, CJ; Donehower, LA; Getz, G; Noble, M; Voet, D; Saksena, G; Gehlenborg, N; DiCara, D; Zhang, JH; Zhang, HL; Wu, CJ; Liu, SY; Lawrence, MS; Zou, LH; Sivachenko, A; Lin, P; Stojanov, P; Jing, R; Cho, J; Sinha, R; Park, RW; Nazaire, MD; Robinson, J; Thorvaldsdottir, H; Mesirov, J; Park, PJ; Chin, L; Reynolds, S; Kreisberg, RB; Bernard, B; Bressler, R; Erkkila, T; Lin, J; Thorsson, V; Zhang, W; Shmulevich, I; Ciriello, G; Weinhold, N; Schultz, N; Gao, JJ; Cerami, E; Gross, B; Jacobsen, A; Sinha, R; Aksoy, BA; Antipin, Y; Reva, B; Shen, RL; Taylor, BS; Ladanyi, M; Sander, C; Anur, P; Spellman, PT; Lu, YL; Liu, WB; Verhaak, RRG; Mills, GB; Akbani, R; Zhang, NX; Broom, BM; Casasent, TD; Wakefield, C; Unruh, AK; Baggerly, K; Coombes, K; Weinstein, JN; Haussler, D; Benz, CC; Stuart, JM; Benz, SC; Zhu, JC; Szeto, CC; Scott, GK; Yau, C; Paul, EO; Carlin, D; Wong, C; Sokolov, A; Thusberg, J; Mooney, S; Ng, S; Goldstein, TC; Ellrott, K; Grifford, M; Wilks, C; Ma, S; Craft, B; Yan, CH; Hu, Y; Meerzaman, D; Gastier-Foster, JM; Bowen, J; Ramirez, NC; Black, AD; Pyatt, RE; White, P; Zmuda, EJ; Frick, J; Lichtenberg, T; Brookens, R; George, MM; Gerken, MA; Harper, HA; Leraas, KM; Wise, LJ; Tabler, TR; McAllister, C; Barr, T; Hart-Kothari, M; Tarvin, K; Saller, C; Sandusky, G; Mitchell, C; Iacocca, MV; Brown, J; Rabeno, B; Czerwinski, C; Petrelli, N; Dolzhansky, O; Abramov, M; Voronina, O; Potapova, O; Marks, JR; Suchorska, WM; Murawa, D; Kycler, W; Ibbs, M; Korski, K; Spychala, A; Murawa, P; Brzezinski, JJ; Perz, H; Lazniak, R; Teresiak, M; Tatka, H; Leporowska, E; Bogusz-Czerniewicz, M; Malicki, J; Mackiewicz, A; Wiznerowicz, M; Le, XV; Kohl, B; Tien, NV; Thorp, R; Bang, NV; Sussman, H; Phu, BD; Hajek, R; Hung, NP; Tran, VTP; Thang, HQ; Khan, KZ; Penny, R; Mallery, D; Curley, E; Shelton, C; Yena, P; Ingle, JN; Couch, FJ; Lingle, WL; King, TA; Gonzalez-Angulo, AM; Mills, GB; Dyer, MD; Liu, SY; Meng, XL; Patangan, M; Waldman, F; Stoppler, H; Rathmell, WK; Thorne, L; Huang, M; Boice, L; Hill, A; Morrison, C; Gaudioso, C; Bshara, W; Daily, K; Egea, SC; Pegram, MD; Gomez-Fernandez, C; Dhir, R; Bhargava, R; Brufsky, A; Shriver, CD; Hooke, JA; Campbell, JL; Mural, RJ; Hu, H; Somiari, S; Larson, C; Deyarmin, B; Kvecher, L; Kovatich, AJ; Ellis, MJ; King, TA; Hu, H; Couch, FJ; Mural, RJ; Stricker, T; White, K; Olopade, O; Ingle, JN; Luo, CQ; Chen, YQ; Marks, JR; Waldman, F; Wiznerowicz, M; Bose, R; Chang, LW; Beck, AH; Gonzalez-Angulo, AM; Pihl, T; Jensen, M; Sfeir, R; Kahn, A; Chu, A; Kothiyal, P; Wang, ZN; Snyder, E; Pontius, J; Ayala, B; Backus, M; Walton, J; Baboud, J; Berton, D; Nicholls, M; Srinivasan, D; Raman, R; Girshik, S; Kigonya, P; Alonso, S; Sanbhadti, R; Barletta, S; Pot, D; Sheth, M; Demchok, JA; Shaw, KRM; Yang, LM; Eley, G; Ferguson, ML; Tarnuzzer, RW; Zhang, JS; Dillon, LAL; Buetow, K; Fielding, P; Ozenberger, BA; Guyer, MS; Sofia, HJ; Palchik, JD				Koboldt, Daniel C.; Fulton, Robert S.; McLellan, Michael D.; Schmidt, Heather; Kalicki-Veizer, Joelle; McMichael, Joshua F.; Fulton, Lucinda L.; Dooling, David J.; Ding, Li; Mardis, Elaine R.; Wilson, Richard K.; Ally, Adrian; Balasundaram, Miruna; Butterfield, Yaron S. N.; Carlsen, Rebecca; Carter, Candace; Chu, Andy; Chuah, Eric; Chun, Hye-Jung E.; Coope, Robin J. N.; Dhalla, Noreen; Guin, Ranabir; Hirst, Carrie; Hirst, Martin; Holt, Robert A.; Lee, Darlene; Li, Haiyan I.; Mayo, Michael; Moore, Richard A.; Mungall, Andrew J.; Pleasance, Erin; Robertson, A. Gordon; Schein, Jacqueline E.; Shafiei, Arash; Sipahimalani, Payal; Slobodan, Jared R.; Stoll, Dominik; Tam, Angela; Thiessen, Nina; Varhol, Richard J.; Wye, Natasja; Zeng, Thomas; Zhao, Yongjun; Birol, Inanc; Jones, Steven J. M.; Marra, Marco A.; Cherniack, Andrew D.; Saksena, Gordon; Onofrio, Robert C.; Pho, Nam H.; Carter, Scott L.; Schumacher, Steven E.; Tabak, Barbara; Hernandez, Bryan; Gentry, Jeff; Huy Nguyen; Crenshaw, Andrew; Ardlie, Kristin; Beroukhim, Rameen; Winckler, Wendy; Getz, Gad; Gabriel, Stacey B.; Meyerson, Matthew; Chin, Lynda; Park, Peter J.; Kucherlapati, Raju; Hoadley, Katherine A.; Auman, J. Todd; Fan, Cheng; Turman, Yidi J.; Shi, Yan; Li, Ling; Topal, Michael D.; He, Xiaping; Chao, Hann-Hsiang; Prat, Aleix; Silva, Grace O.; Iglesia, Michael D.; Zhao, Wei; Usary, Jerry; Berg, Jonathan S.; Adams, Michael; Booker, Jessica; Wu, Junyuan; Gulabani, Anisha; Bodenheimer, Tom; Hoyle, Alan P.; Simons, Janae V.; Soloway, Matthew G.; Mose, Lisle E.; Jefferys, Stuart R.; Balu, Saianand; Parker, Joel S.; Hayes, D. Neil; Perou, Charles M.; Malik, Simeen; Mahurkar, Swapna; Shen, Hui; Weisenberger, Daniel J.; Triche, Timothy, Jr.; Lai, Phillip H.; Bootwalla, Moiz S.; Maglinte, Dennis T.; Berman, Benjamin P.; Van den Berg, David J.; Baylin, Stephen B.; Laird, Peter W.; Creighton, Chad J.; Donehower, Lawrence A.; Getz, Gad; Noble, Michael; Voet, Doug; Saksena, Gordon; Gehlenborg, Nils; DiCara, Daniel; Zhang, Juinhua; Zhang, Hailei; Wu, Chang-Jiun; Liu, Spring Yingchun; Lawrence, Michael S.; Zou, Lihua; Sivachenko, Andrey; Lin, Pei; Stojanov, Petar; Jing, Rui; Cho, Juok; Sinha, Raktim; Park, Richard W.; Nazaire, Marc-Danie; Robinson, Jim; Thorvaldsdottir, Helga; Mesirov, Jill; Park, Peter J.; Chin, Lynda; Reynolds, Sheila; Kreisberg, Richard B.; Bernard, Brady; Bressler, Ryan; Erkkila, Timo; Lin, Jake; Thorsson, Vesteinn; Zhang, Wei; Shmulevich, Ilya; Ciriello, Giovanni; Weinhold, Nils; Schultz, Nikolaus; Gao, Jianjiong; Cerami, Ethan; Gross, Benjamin; Jacobsen, Anders; Sinha, Rileen; Aksoy, B. Arman; Antipin, Yevgeniy; Reva, Boris; Shen, Ronglai; Taylor, Barry S.; Ladanyi, Marc; Sander, Chris; Anur, Pavana; Spellman, Paul T.; Lu, Yiling; Liu, Wenbin; Verhaak, Roel R. G.; Mills, Gordon B.; Akbani, Rehan; Zhang, Nianxiang; Broom, Bradley M.; Casasent, Tod D.; Wakefield, Chris; Unruh, Anna K.; Baggerly, Keith; Coombes, Kevin; Weinstein, John N.; Haussler, David; Benz, Christopher C.; Stuart, Joshua M.; Benz, Stephen C.; Zhu, Jingchun; Szeto, Christopher C.; Scott, Gary K.; Yau, Christina; Paul, Evan O.; Carlin, Daniel; Wong, Christopher; Sokolov, Artem; Thusberg, Janita; Mooney, Sean; Sam Ng; Goldstein, Theodore C.; Ellrott, Kyle; Grifford, Mia; Wilks, Christopher; Ma, Singer; Craft, Brian; Yan, Chunhua; Hu, Ying; Meerzaman, Daoud; Gastier-Foster, Julie M.; Bowen, Jay; Ramirez, Nilsa C.; Black, Aaron D.; Pyatt, Robert E.; White, Peter; Zmuda, Erik J.; Frick, Jessica; Lichtenberg, Taram.; Brookens, Robin; George, Myra M.; Gerken, Mark A.; Harper, Hollie A.; Leraas, Kristen M.; Wise, Lisa J.; Tabler, Teresa R.; McAllister, Cynthia; Barr, Thomas; Hart-Kothari, Melissa; Tarvin, Katie; Saller, Charles; Sandusky, George; Mitchell, Colleen; Iacocca, Mary V.; Brown, Jennifer; Rabeno, Brenda; Czerwinski, Christine; Petrelli, Nicholas; Dolzhansky, Oleg; Abramov, Mikhail; Voronina, Olga; Potapova, Olga; Marks, Jeffrey R.; Suchorska, Wiktoria M.; Murawa, Dawid; Kycler, Witold; Ibbs, Matthew; Korski, Konstanty; Spychala, Arkadiusz; Murawa, Pawel; Brzezinski, Jacek J.; Perz, Hanna; Lazniak, Radoslaw; Teresiak, Marek; Tatka, Honorata; Leporowska, Ewa; Bogusz-Czerniewicz, Marta; Malicki, Julian; Mackiewicz, Andrzej; Wiznerowicz, Maciej; Xuan Van Le; Kohl, Bernard; Nguyen Viet Tien; Thorp, Richard; Nguyen Van Bang; Sussman, Howard; Bui Duc Phu; Hajek, Richard; Nguyen Phi Hung; Tran Viet The Phuong; Huynh Quyet Thang; Khan, Khurram Zaki; Penny, Robert; Mallery, David; Curley, Erin; Shelton, Candace; Yena, Peggy; Ingle, James N.; Couch, Fergus J.; Lingle, Wilma L.; King, Tari A.; Gonzalez-Angulo, Ana Maria; Mills, Gordon B.; Dyer, Mary D.; Liu, Shuying; Meng, Xiaolong; Patangan, Modesto; Waldman, Frederic; Stoeppler, Hubert; Rathmell, W. Kimryn; Thorne, Leigh; Huang, Mei; Boice, Lori; Hill, Ashley; Morrison, Carl; Gaudioso, Carmelo; Bshara, Wiam; Daily, Kelly; Egea, Sophie C.; Pegram, Mark D.; Gomez-Fernandez, Carmen; Dhir, Rajiv; Bhargava, Rohit; Brufsky, Adam; Shriver, Craig D.; Hooke, Jeffrey A.; Campbell, Jamie Leigh; Mural, Richard J.; Hu, Hai; Somiari, Stella; Larson, Caroline; Deyarmin, Brenda; Kvecher, Leonid; Kovatich, Albert J.; Ellis, Matthew J.; King, Tari A.; Hu, Hai; Couch, Fergus J.; Mural, Richard J.; Stricker, Thomas; White, Kevin; Olopade, Olufunmilayo; Ingle, James N.; Luo, Chunqing; Chen, Yaqin; Marks, Jeffrey R.; Waldman, Frederic; Wiznerowicz, Maciej; Bose, Ron; Chang, Li-Wei; Beck, Andrew H.; Gonzalez-Angulo, Ana Maria; Pihl, Todd; Jensen, Mark; Sfeir, Robert; Kahn, Ari; Chu, Anna; Kothiyal, Prachi; Wang, Zhining; Snyder, Eric; Pontius, Joan; Ayala, Brenda; Backus, Mark; Walton, Jessica; Baboud, Julien; Berton, Dominique; Nicholls, Matthew; Srinivasan, Deepak; Raman, Rohini; Girshik, Stanley; Kigonya, Peter; Alonso, Shelley; Sanbhadti, Rashmi; Barletta, Sean; Pot, David; Sheth, Margi; Demchok, John A.; Shaw, Kenna R. Mills; Yang, Liming; Eley, Greg; Ferguson, Martin L.; Tarnuzzer, Roy W.; Zhang, Jiashan; Dillon, Laura A. L.; Buetow, Kenneth; Fielding, Peter; Ozenberger, Bradley A.; Guyer, Mark S.; Sofia, Heidi J.; Palchik, Jacqueline D.		Canc Genome Atlas Network	Comprehensive molecular portraits of human breast tumours	NATURE			English	Article							BASAL-LIKE; MUTATIONAL EVOLUTION; HIGH-FREQUENCY; PIK3CA GENE; LUMINAL-B; CANCER; SUPPRESSOR; SUBTYPES; PATHWAYS; TARGET	We analysed primary breast cancers by genomic DNA copy number arrays, DNA methylation, exome sequencing, messenger RNA arrays, microRNA sequencing and reverse-phase protein arrays. Our ability to integrate information across platforms provided key insights into previously defined gene expression subtypes and demonstrated the existence of four main breast cancer classes when combining data from five platforms, each of which shows significant molecular heterogeneity. Somatic mutations in only three genes (TP53, PIK3CA and GATA3) occurred at >10% incidence across all breast cancers; however, there were numerous subtype-associated and novel gene mutations including the enrichment of specific mutations in GATA3, PIK3CA and MAP3K1 with the luminal A subtype. We identified two novel protein-expression-defined subgroups, possibly produced by stromal/microenvironmental elements, and integrated analyses identified specific signalling pathways dominant in each molecular subtype including a HER2/phosphorylated HER2/EGFR/phosphorylated EGFR signature within the HER2-enriched expression subtype. Comparison of basal-like breast tumours with high-grade serous ovarian tumours showed many molecular commonalities, indicating a related aetiology and similar therapeutic opportunities. The biological finding of the four main breast cancer subtypes caused by different subsets of genetic and epigenetic abnormalities raises the hypothesis that much of the clinically observable plasticity and heterogeneity occurs within, and not across, these major biological subtypes of breast cancer.	[Hoadley, Katherine A.; He, Xiaping; Chao, Hann-Hsiang; Prat, Aleix; Silva, Grace O.; Iglesia, Michael D.; Zhao, Wei; Berg, Jonathan S.; Adams, Michael; Weisenberger, Daniel J.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Koboldt, Daniel C.; Fulton, Robert S.; McLellan, Michael D.; Schmidt, Heather; Kalicki-Veizer, Joelle; McMichael, Joshua F.; Fulton, Lucinda L.; Dooling, David J.; Ding, Li; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Genome Inst, St Louis, MO 63108 USA; [Ding, Li; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Dept Genet, St Louis, MO 63110 USA; [Mardis, Elaine R.; Wilson, Richard K.; Ellis, Matthew J.; Bose, Ron] Washington Univ, Siteman Canc Ctr, St Louis, MO 63110 USA; [Ally, Adrian; Balasundaram, Miruna; Butterfield, Yaron S. N.; Carlsen, Rebecca; Carter, Candace; Chu, Andy; Chuah, Eric; Chun, Hye-Jung E.; Coope, Robin J. N.; Dhalla, Noreen; Guin, Ranabir; Hirst, Carrie; Hirst, Martin; Holt, Robert A.; Lee, Darlene; Li, Haiyan I.; Mayo, Michael; Moore, Richard A.; Mungall, Andrew J.; Pleasance, Erin; Robertson, A. Gordon; Schein, Jacqueline E.; Shafiei, Arash; Sipahimalani, Payal; Slobodan, Jared R.; Stoll, Dominik; Tam, Angela; Thiessen, Nina; Varhol, Richard J.; Wye, Natasja; Zeng, Thomas; Zhao, Yongjun; Birol, Inanc; Jones, Steven J. M.; Marra, Marco A.] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z, Canada; [Cherniack, Andrew D.; Saksena, Gordon; Onofrio, Robert C.; Pho, Nam H.; Carter, Scott L.; Schumacher, Steven E.; Tabak, Barbara; Hernandez, Bryan; Gentry, Jeff; Huy Nguyen; Crenshaw, Andrew; Ardlie, Kristin; Beroukhim, Rameen; Winckler, Wendy; Getz, Gad; Gabriel, Stacey B.; Meyerson, Matthew] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Schumacher, Steven E.; Tabak, Barbara; Beroukhim, Rameen; Nguyen Phi Hung] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Beroukhim, Rameen] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Beroukhim, Rameen; Meyerson, Matthew; Chin, Lynda] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Beroukhim, Rameen; Meyerson, Matthew; Chin, Lynda] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Meyerson, Matthew; Beck, Andrew H.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Chin, Lynda] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA; [Park, Peter J.; Gehlenborg, Nils; Park, Peter J.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA; [Kucherlapati, Raju] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Kucherlapati, Raju] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Hoadley, Katherine A.; Fan, Cheng; Turman, Yidi J.; Shi, Yan; Li, Ling; Topal, Michael D.; He, Xiaping; Chao, Hann-Hsiang; Prat, Aleix; Silva, Grace O.; Iglesia, Michael D.; Zhao, Wei; Usary, Jerry; Berg, Jonathan S.; Wu, Junyuan; Gulabani, Anisha; Bodenheimer, Tom; Hoyle, Alan P.; Simons, Janae V.; Soloway, Matthew G.; Mose, Lisle E.; Jefferys, Stuart R.; Balu, Saianand; Parker, Joel S.; Hayes, D. Neil; Perou, Charles M.; Malik, Simeen; Mahurkar, Swapna; Shen, Hui; Weisenberger, Daniel J.; Rathmell, W. Kimryn; Thorne, Leigh; Huang, Mei; Boice, Lori; Hill, Ashley] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Auman, J. Todd] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA; [Auman, J. Todd] Univ N Carolina, Inst Pharmacogenet & Individualized Therapy, Chapel Hill, NC 27599 USA; [Topal, Michael D.; Booker, Jessica; Weisenberger, Daniel J.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Shen, Hui] Univ N Carolina, Div Med Oncol, Dept Internal Med, Chapel Hill, NC 27599 USA; [Triche, Timothy, Jr.; Lai, Phillip H.; Bootwalla, Moiz S.; Maglinte, Dennis T.; Berman, Benjamin P.; Van den Berg, David J.; Laird, Peter W.] Univ So Calif, USC Epigenome Ctr, Los Angeles, CA 90033 USA; [Baylin, Stephen B.] Johns Hopkins Univ, Div Canc Biol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; [Creighton, Chad J.; Donehower, Lawrence A.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Creighton, Chad J.; Donehower, Lawrence A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Donehower, Lawrence A.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Donehower, Lawrence A.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Getz, Gad; Noble, Michael; Voet, Doug; Saksena, Gordon; Gehlenborg, Nils; DiCara, Daniel; Zhang, Hailei; Liu, Spring Yingchun; Lawrence, Michael S.; Zou, Lihua; Sivachenko, Andrey; Lin, Pei; Stojanov, Petar; Jing, Rui; Cho, Juok; Sinha, Raktim; Park, Richard W.; Nazaire, Marc-Danie; Robinson, Jim; Thorvaldsdottir, Helga; Mesirov, Jill; Chin, Lynda] Eli & Edythe L Broad Inst Massachusetts Inst Tech, Cambridge, MA 02142 USA; [Zhang, Juinhua; Chin, Lynda] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Inst Appl Canc Sci, Houston, TX 77054 USA; [Wu, Chang-Jiun] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77054 USA; [Park, Peter J.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Park, Peter J.] Childrens Hosp, Informat Program, Boston, MA 02115 USA; [Reynolds, Sheila; Kreisberg, Richard B.; Bernard, Brady; Bressler, Ryan; Lin, Jake; Thorsson, Vesteinn; Shmulevich, Ilya] Inst Syst Biol, Seattle, WA 98109 USA; [Erkkila, Timo] Tampere Univ Technol, FIN-33101 Tampere, Finland; [Zhang, Wei] Univ Texas MD Anderson Canc Ctr, Canc Genom Core Lab, Houston, TX 77030 USA; [Ciriello, Giovanni; Weinhold, Nils; Schultz, Nikolaus; Gao, Jianjiong; Cerami, Ethan; Gross, Benjamin; Jacobsen, Anders; Sinha, Rileen; Aksoy, B. Arman; Antipin, Yevgeniy; Reva, Boris; Taylor, Barry S.; Sander, Chris] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10065 USA; [Shen, Ronglai] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA; [Ladanyi, Marc] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Anur, Pavana; Spellman, Paul T.] Oregon Hlth & Sci Univ, Portland, OR 97239 USA; [Lu, Yiling; Mills, Gordon B.; Gonzalez-Angulo, Ana Maria] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Lu, Yiling; Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Kleberg Ctr Mol Markers, Houston, TX 77030 USA; [Liu, Wenbin; Verhaak, Roel R. G.; Akbani, Rehan; Zhang, Nianxiang; Broom, Bradley M.; Casasent, Tod D.; Wakefield, Chris; Unruh, Anna K.; Baggerly, Keith; Coombes, Kevin; Weinstein, John N.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Haussler, David; Stuart, Joshua M.; Benz, Stephen C.; Zhu, Jingchun; Szeto, Christopher C.; Paul, Evan O.; Carlin, Daniel; Wong, Christopher; Sokolov, Artem; Sam Ng; Goldstein, Theodore C.; Ellrott, Kyle; Grifford, Mia; Wilks, Christopher; Ma, Singer; Craft, Brian] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Haussler, David; Stuart, Joshua M.; Benz, Stephen C.; Zhu, Jingchun; Szeto, Christopher C.; Paul, Evan O.; Carlin, Daniel; Wong, Christopher; Sokolov, Artem; Sam Ng; Goldstein, Theodore C.; Ellrott, Kyle; Grifford, Mia; Wilks, Christopher; Ma, Singer; Craft, Brian] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Haussler, David] Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; [Benz, Christopher C.; Scott, Gary K.; Yau, Christina; Thusberg, Janita; Mooney, Sean] Buck Inst Res Aging, Novato, CA 94945 USA; [Yan, Chunhua; Hu, Ying; Meerzaman, Daoud; Buetow, Kenneth] NCI, Ctr Bioinformat & Informat Technol, Rockville, MD 20852 USA; [Gastier-Foster, Julie M.; Ramirez, Nilsa C.; Pyatt, Robert E.; White, Peter] Ohio State Univ, Coll Med, Dept Pathol, Columbus, OH 43205 USA; [Gastier-Foster, Julie M.] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43205 USA; [Gastier-Foster, Julie M.; Bowen, Jay; Ramirez, Nilsa C.; Black, Aaron D.; Pyatt, Robert E.; White, Peter; Zmuda, Erik J.; Frick, Jessica; Lichtenberg, Taram.; Brookens, Robin; George, Myra M.; Gerken, Mark A.; Harper, Hollie A.; Leraas, Kristen M.; Wise, Lisa J.; Tabler, Teresa R.; McAllister, Cynthia; Barr, Thomas; Hart-Kothari, Melissa] Nationwide Childrens Hosp, Res Inst, Columbus, OH 43205 USA; [Tarvin, Katie] ABS Inc, Indianapolis, IN 46204 USA; [Saller, Charles] ABS Inc, Wilmington, DE 19801 USA; [Sandusky, George; Mitchell, Colleen] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Iacocca, Mary V.; Brown, Jennifer; Rabeno, Brenda; Czerwinski, Christine; Petrelli, Nicholas] Christiana Care, Helen F Graham Canc Ctr, Newark, DE 19713 USA; [Dolzhansky, Oleg] Moscow Hlth Dept, Moscow City Clin Oncol Dispensary 1, Moscow 105005, Russia; [Dolzhansky, Oleg] Moscow Hlth Dept, Cent IHC Lab, Moscow 105005, Russia; [Abramov, Mikhail] Russian Canc Res Ctr, Moscow 115478, Russia; [Voronina, Olga; Potapova, Olga] Cureline Inc, San Francisco, CA 94080 USA; [Marks, Jeffrey R.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Suchorska, Wiktoria M.; Murawa, Dawid; Kycler, Witold; Ibbs, Matthew; Korski, Konstanty; Spychala, Arkadiusz; Murawa, Pawel; Brzezinski, Jacek J.; Perz, Hanna; Lazniak, Radoslaw; Teresiak, Marek; Tatka, Honorata; Leporowska, Ewa; Bogusz-Czerniewicz, Marta; Malicki, Julian; Mackiewicz, Andrzej; Wiznerowicz, Maciej] Greater Poland Canc Ctr, PL-61866 Poznan, Poland; [Bogusz-Czerniewicz, Marta; Malicki, Julian; Mackiewicz, Andrzej] Poznan Univ Med Sci, PL-61701 Poznan, Poland; [Xuan Van Le; Kohl, Bernard] ILSBio LLC, Chestertown, MD 21620 USA; [Nguyen Viet Tien] Minist Hlth, Hanoi, Vietnam; [Thorp, Richard; Khan, Khurram Zaki] ILSBio LLC, Karachi, Pakistan; [Nguyen Van Bang; Bui Duc Phu] Hue Cent Hosp, Hue City, Vietnam; [Sussman, Howard] Stanford Univ, Med Ctr, Stanford, CA 94305 USA; [Hajek, Richard] Univ Texas MD Anderson Canc Ctr, Ctr Minor Hlth Res, Houston, TX 77030 USA; [Nguyen Phi Hung] Natl Canc Inst, Hanoi, Vietnam; [Tran Viet The Phuong] Ho Chi Minh City Canc Ctr, Ho Chi Minh City, Vietnam; [Huynh Quyet Thang] Can Tho Canc Ctr, Can Tho, Vietnam; [Penny, Robert; Mallery, David; Curley, Erin; Shelton, Candace; Yena, Peggy] Int Genom Consortium, Phoenix, AZ 85004 USA; [Ingle, James N.; Couch, Fergus J.; Lingle, Wilma L.] Mayo Clin, Rochester, MN 55905 USA; [King, Tari A.] Mem Sloan Kettering Canc Ctr, Dept Surg, Breast Serv, New York, NY 10065 USA; [Mills, Gordon B.; Dyer, Mary D.; Liu, Shuying; Meng, Xiaolong; Patangan, Modesto] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; [Waldman, Frederic] Univ Calif San Francisco, San Francisco, CA 94143 USA; Canc Diagnost, San Juan Capistrano, CA 92675 USA; Quest Diagnost, Nichols Inst, San Juan Capistrano, CA 92675 USA; [Stoeppler, Hubert] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94115 USA; [Thorne, Leigh; Huang, Mei; Boice, Lori] UNC Lineberger Canc Ctr, Dept Pathol, UNC Tissue Procurement Facil, Chapel Hill, NC 27599 USA; [Morrison, Carl; Gaudioso, Carmelo; Bshara, Wiam] Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY 14263 USA; [Daily, Kelly; Egea, Sophie C.; Pegram, Mark D.; Gomez-Fernandez, Carmen] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Dept Pathol, Miami, FL 33136 USA; [Dhir, Rajiv] Univ Pittsburgh, Pittsburgh, PA 15213 USA; [Bhargava, Rohit; Brufsky, Adam] Univ Pittsburgh Med Ctr, Magee Womens Hosp, Pittsburgh, PA 15213 USA; [Shriver, Craig D.; Hooke, Jeffrey A.; Campbell, Jamie Leigh] Walter Reed Natl Mil Med Ctr, Bethesda, MD 20899 USA; [Mural, Richard J.; Hu, Hai; Somiari, Stella; Larson, Caroline; Deyarmin, Brenda; Kvecher, Leonid; Luo, Chunqing; Chen, Yaqin] Windber Res Inst, Windber, PA 15963 USA; [Kovatich, Albert J.] MDR Global LLC, Windber, PA 15963 USA; [Ellis, Matthew J.; Bose, Ron] Washington Univ, Breast Canc Program, St Louis, MO 63110 USA; [Ellis, Matthew J.; Bose, Ron] Washington Univ, Dept Internal Med, Div Oncol, St Louis, MO 63110 USA; [Stricker, Thomas; White, Kevin] Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA; [Olopade, Olufunmilayo] Univ Chicago, Ctr Clin Canc Genet, Chicago, IL 60637 USA; [Chang, Li-Wei] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Pihl, Todd; Jensen, Mark; Sfeir, Robert; Kahn, Ari; Chu, Anna; Kothiyal, Prachi; Wang, Zhining; Snyder, Eric; Pontius, Joan; Ayala, Brenda; Backus, Mark; Walton, Jessica; Baboud, Julien; Berton, Dominique; Nicholls, Matthew; Srinivasan, Deepak; Raman, Rohini; Girshik, Stanley; Kigonya, Peter; Alonso, Shelley; Sanbhadti, Rashmi; Barletta, Sean; Pot, David] SRA Int, Fairfax, VA 22033 USA; [Sheth, Margi; Demchok, John A.; Shaw, Kenna R. Mills; Yang, Liming; Tarnuzzer, Roy W.; Zhang, Jiashan; Dillon, Laura A. L.; Fielding, Peter] NCI, Canc Genome Atlas Program Off, Ctr Canc Genom, Bethesda, MD 20892 USA; [Eley, Greg] Scimentis LLC, TCGA, Statham, GA 30666 USA; [Ferguson, Martin L.] MLF Consulting, Arlington, MA 02474 USA; [Ozenberger, Bradley A.; Guyer, Mark S.; Sofia, Heidi J.; Palchik, Jacqueline D.] NHGRI, NIH, Bethesda, MD 20892 USA	University of North Carolina; University of North Carolina Chapel Hill; Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); British Columbia Cancer Agency; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Southern California; Johns Hopkins University; Johns Hopkins Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Institute for Systems Biology (ISB); Tampere University; University of Texas System; UTMD Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Oregon Health & Science University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz; Buck Institute for Research on Aging; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Indiana University System; Indiana University Bloomington; Christiana Care Health System; Helen F. Graham Cancer Center & Research Institute; Duke University; Wielkopolskie Centrum Onkologii; Poznan University of Medical Sciences; Stanford University; University of Texas System; UTMD Anderson Cancer Center; International Genomics Consortium; Mayo Clinic; Memorial Sloan Kettering Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California San Francisco; Nichols Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Roswell Park Cancer Institute; University of Miami; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Walter Reed National Military Medical Center; Windber Research Institute; Washington University (WUSTL); Washington University (WUSTL); University of Chicago; University of Chicago; Washington University (WUSTL); SRA International; International Genomics Consortium; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG); International Genomics Consortium; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Perou, CM (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA.	cperou@med.unc.edu	Perou, Charles M/H-9934-2014; Kucherlapati, Raju/ABC-8807-2021; White, Peter/E-4301-2011; Schumacher, Steven/E-9821-2013; Laird, Peter W/G-8683-2012; Ladanyi, Marc/AAG-8585-2019; , Pathology Services Core/CEZ-2246-2022; wang, edwin/G-5372-2010; Marra, Marco A/B-5987-2008; Jones, Steven J/C-3621-2009; Berman, Benjamin P/D-5942-2014; Gastier-Foster, Julie/E-3105-2011; Weisenberger, Daniel/AAA-8314-2020; Verhaak, Roel/ABE-7058-2020; Reva, Boris A./B-6436-2014; Wilson, Richard K./AAF-4139-2019; Akbani, Rehan/AAG-1490-2019; Skanderup, Anders Jacobsen/K-1081-2013; Suchorska, Wiktoria/CAG-0479-2022; Reva, Boris/AAB-8932-2022; Van Den Berg, David J/G-8598-2017; Auman, James/AAY-7748-2020; Brufsky, Adam/AAE-7470-2020; Parker, Joel/AAG-1108-2019; Holt, Robert A/C-3303-2009; Mesirov, Jill/AGF-7626-2022; Mardis, Elaine/W-2202-2019; Schein, Jacquie E/G-3674-2015; Ganesh, Dunna Sai/AGX-5170-2022; Prat, Aleix/P-8561-2014; Hirst, Martin/B-7684-2016; Ibbs, Matthew/AAU-1511-2021; Cherniack, Andrew/AAC-5310-2019; Stojanov, Petar/GQI-4462-2022; Schultz, Nikolaus/ABE-6347-2020; Gao, JianJiong/B-5673-2016; Mungall, Andrew J./U-7067-2018; BERMAN, BENJAMIN/AAT-3720-2021; Birol, Inanc/G-5440-2011; Lawrence, Michael/AAC-8202-2020; Cherniack, Andrew D./AAY-8132-2020; Shen, Hui/AAO-4387-2020	Perou, Charles M/0000-0001-9827-2247; White, Peter/0000-0002-5218-5903; Schumacher, Steven/0000-0002-6819-5647; Laird, Peter W/0000-0001-9117-3641; Marra, Marco A/0000-0001-7146-7175; Jones, Steven J/0000-0003-3394-2208; Berman, Benjamin P/0000-0002-2099-9005; Weisenberger, Daniel/0000-0001-8303-2603; Reva, Boris A./0000-0002-8805-389X; Wilson, Richard K./0000-0002-1992-1358; Skanderup, Anders Jacobsen/0000-0001-6847-4980; Van Den Berg, David J/0000-0002-5404-5218; Holt, Robert A/0000-0002-7259-1247; Prat, Aleix/0000-0003-2377-540X; Ibbs, Matthew/0000-0003-2510-3447; Stojanov, Petar/0000-0001-7815-776X; Gao, JianJiong/0000-0002-5739-1781; Mungall, Andrew J./0000-0002-0905-2742; BERMAN, BENJAMIN/0000-0002-2099-9005; Birol, Inanc/0000-0003-0950-7839; Cherniack, Andrew D./0000-0003-0470-0111; Brufsky, Adam/0000-0001-8080-7960; Kovatich, Albert/0000-0002-5169-4087; Weinstein, John/0000-0001-9401-6908; Casasent, Anna/0000-0002-7857-179X; MOONEY, SEAN D/0000-0003-2654-0833; Sinha, Rileen/0000-0001-5497-5055; Ciriello, Giovanni/0000-0003-2021-8683; Berg, Jonathan/0000-0003-2360-2664; Park, Peter/0000-0001-9378-960X; Schultz, Nikolaus/0000-0002-0131-4904; Coombes, Kevin/0000-0002-7630-2123; Stoll, Dominik/0000-0003-0701-4301; Hu, Hai/0000-0001-5345-8371; Shen, Hui/0000-0001-9767-4084; Benz, Stephen/0000-0002-4067-0602; Gehlenborg, Nils/0000-0003-0327-8297; Tarnuzzer, Roy/0000-0002-3725-4173; Triche, Tim/0000-0001-5665-946X; Bowen, Jay/0000-0001-6861-9043; Suchorska, Wiktoria/0000-0003-4742-2465; Pot, David/0000-0002-1480-9826; Meyerson, Matthew/0000-0002-9133-8108; Hoadley, Katherine/0000-0002-1216-477X; Stuart, Joshua/0000-0002-2171-565X; Hayes, D. Neil/0000-0001-6203-7771; Mahurkar-Joshi, Swapna/0000-0001-9591-4590; Jensen, Mark/0000-0001-5215-101X; Malicki, Julian/0000-0002-5558-5558; MCLELLAN, MICHAEL/0000-0002-2703-8784; Quyet Thang, Huynh/0000-0002-0788-6380	USA National Institutes of Health [U24CA143883, U24CA143858, U24CA143840, U24CA143799, U24CA143835, U24CA143845, U24CA143882, U24CA143867, U24CA143866, U24CA143848, U24CA144025, U54HG003079, P50CA116201, P50CA58223]; Susan G. Komen for the Cure; US Department of Defense through the Henry M. Jackson Foundation for the Advancement of Military Medicine; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE [U24CA143867, U24CA143799, P50CA058223, U24CA143845, K08CA148912, U24CA143882, U24CA143848, R01CA094143, P30CA016672, U24CA144025, P50CA116201, U24CA143866, U24CA143835, P30CA016058, U24CA143858, U24CA143840, P30CA016086, U24CA143883, U01CA084955] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079, U54HG004028, U54HG003067] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009722] Funding Source: NIH RePORTER	USA National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); US Department of Defense through the Henry M. Jackson Foundation for the Advancement of Military Medicine; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank M. Sheth and S. Lucas for administrative coordination of TCGA activities, and C. Gunter for critical reading of the manuscript. This work was supported by the following grants from the USA National Institutes of Health: U24CA143883, U24CA143858, U24CA143840, U24CA143799, U24CA143835, U24CA143845, U24CA143882, U24CA143867, U24CA143866, U24CA143848, U24CA144025, U54HG003079, P50CA116201 and P50CA58223. Additional support was provided by the Susan G. Komen for the Cure, the US Department of Defense through the Henry M. Jackson Foundation for the Advancement of Military Medicine, and the Breast Cancer Research Foundation. The views expressed in this paper are those of the authors and do not reflect the official policy of the Department of Defense, or US Government.	Audeh MW, 2010, LANCET, V376, P245, DOI 10.1016/S0140-6736(10)60893-8; Bachman KE, 2004, CANCER BIOL THER, V3, P772, DOI 10.4161/cbt.3.8.994; Bamshad M, 1997, NAT GENET, V16, P311, DOI 10.1038/ng0797-311; Baselga J, 2012, NEW ENGL J MED, V366, P109, DOI 10.1056/NEJMoa1113216; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bergamaschi A, 2006, GENE CHROMOSOME CANC, V45, P1033, DOI 10.1002/gcc.20366; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Chandriani S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006693; Cheung LWT, 2011, CANCER DISCOV, V1, P170, DOI 10.1158/2159-8290.CD-11-0039; Chicas A, 2010, CANCER CELL, V17, P376, DOI 10.1016/j.ccr.2010.01.023; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Ciriello G, 2012, GENOME RES, V22, P398, DOI 10.1101/gr.125567.111; Creighton CJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2594; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Dees ND, 2012, GENOME RES, V22, P1589, DOI 10.1101/gr.134635.111; Deisenroth C, 2010, MOL CELL BIOL, V30, P3981, DOI 10.1128/MCB.01284-09; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Fedele CG, 2010, P NATL ACAD SCI USA, V107, P22231, DOI 10.1073/pnas.1015245107; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Foulkes WD, 2003, J NATL CANCER I, V95, P1482, DOI 10.1093/jnci/djg050; Gewinner C, 2009, CANCER CELL, V16, P115, DOI 10.1016/j.ccr.2009.06.006; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Hennessy Bryan T, 2010, Clin Proteomics, V6, P129, DOI 10.1007/s12014-010-9055-y; Herschkowitz JI, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2142; Jiang Z, 2010, J CLIN INVEST, V120, P3296, DOI 10.1172/JCI41490; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kannan K, 2001, ONCOGENE, V20, P2225, DOI 10.1038/sj.onc.1204319; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lara MF, 2008, MOL CARCINOGEN, V47, P209, DOI 10.1002/mc.20376; Li QY, 1997, NAT GENET, V15, P21; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Malcovati L, 2011, BLOOD, V118, P6239, DOI 10.1182/blood-2011-09-377275; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Pei XH, 2009, CANCER CELL, V15, P389, DOI 10.1016/j.ccr.2009.03.004; Perou CM, 2011, ONCOLOGIST, V16, P61, DOI 10.1634/theoncologist.2011-S1-61; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Saal LH, 2008, NAT GENET, V40, P102, DOI 10.1038/ng.2007.39; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Troester MA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-276; Usary J, 2004, ONCOGENE, V23, P7669, DOI 10.1038/sj.onc.1207966; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Walsh T, 2010, P NATL ACAD SCI USA, V107, P12629, DOI 10.1073/pnas.1007983107; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Weigman VJ, 2012, BREAST CANCER RES TR, V133, P865, DOI 10.1007/s10549-011-1846-y	56	7902	8051	69	1466	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2012	490	7418					61	70		10.1038/nature11412	http://dx.doi.org/10.1038/nature11412			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015LG	23000897	Green Published, Green Accepted, Green Submitted, hybrid			2022-12-24	WOS:000309446800032
J	Zenon, A; Krauzlis, RJ				Zenon, Alexandre; Krauzlis, Richard J.			Attention deficits without cortical neuronal deficits	NATURE			English	Article							AREAS MT; MODULATION; MICROSTIMULATION; INACTIVATION; SELECTION; SIGNALS	The ability to process relevant stimuli selectively is a fundamental function of the primate visual system. The best-understood correlate of this function is the enhanced response of neurons in the visual cortex to attended stimuli(1,2). However, recent results show that the superior colliculus (SC), a midbrain structure, also has a crucial role in visual attention(3-5). It has been assumed that the SC acts through the same well-known mechanisms in the visual cortex(3,5). Here we tested this hypothesis by transiently inactivating the SC during a motion-change-detection task and measuring responses in two visual cortical areas. We found that despite large deficits in visual attention, the enhanced responses of neurons in the visual cortex to attended stimuli were unchanged. These results show that the SC contributes to visual attention through mechanisms that are independent of the classic effects in the visual cortex, demonstrating that other processes must have key roles in visual attention.	[Zenon, Alexandre; Krauzlis, Richard J.] Salk Inst Biol Studies, Syst Neurobiol Lab, La Jolla, CA 92037 USA; [Zenon, Alexandre] Catholic Univ Louvain, Inst Neurosci, B-1200 Brussels, Belgium; [Krauzlis, Richard J.] NEI, Lab Sensorimotor Res, Bethesda, MD 20892 USA	Salk Institute; Universite Catholique Louvain; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Krauzlis, RJ (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	richard.krauzlis@nih.gov	Zénon, Alexandre/AGN-7203-2022	Zénon, Alexandre/0000-0001-7989-1261; Richard, Krauzlis/0000-0002-1826-0447	F.M. Kirby Foundation; National Eye Institute Intramural Research Program at the National Institutes of Health; NATIONAL EYE INSTITUTE [ZIAEY000511] Funding Source: NIH RePORTER	F.M. Kirby Foundation; National Eye Institute Intramural Research Program at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank E. Boehle, N. Dill and A. Karnik for technical assistance, and R. Wurtz for discussions and reading of the manuscript. This work was supported by the F.M. Kirby Foundation and the National Eye Institute Intramural Research Program at the National Institutes of Health.	Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; Bender DB, 2001, J NEUROPHYSIOL, V85, P219, DOI 10.1152/jn.2001.85.1.219; Berger J. O., 2001, MONOGRAPH SERIES, V38, P135; Carrasco M, 2004, NAT NEUROSCI, V7, P308, DOI 10.1038/nn1194; Cavanaugh J, 2004, J NEUROSCI, V24, P11236, DOI 10.1523/JNEUROSCI.3724-04.2004; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Dickey AS, 2009, J NEUROPHYSIOL, V102, P1331, DOI 10.1152/jn.90920.2008; Hafed ZM, 2008, J NEUROSCI, V28, P8124, DOI 10.1523/JNEUROSCI.1317-08.2008; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Ignashchenkova A, 2004, NAT NEUROSCI, V7, P56, DOI 10.1038/nn1169; Kustov AA, 1996, NATURE, V384, P74, DOI 10.1038/384074a0; Lovejoy LP, 2010, NAT NEUROSCI, V13, P261, DOI 10.1038/nn.2470; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Mitchell JF, 2009, NEURON, V63, P879, DOI 10.1016/j.neuron.2009.09.013; Moore T, 2006, CURR OPIN NEUROBIOL, V16, P159, DOI 10.1016/j.conb.2006.03.009; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Muller JR, 2005, P NATL ACAD SCI USA, V102, P524, DOI 10.1073/pnas.0408311101; O'Connor DH, 2002, NAT NEUROSCI, V5, P1203, DOI 10.1038/nn957; Palmer J, 2009, VISION RES, V49, P1045, DOI 10.1016/j.visres.2008.02.022; Redgrave P, 1999, NEUROSCIENCE, V89, P1009, DOI 10.1016/S0306-4522(98)00319-4; Rensink RA, 1997, PSYCHOL SCI, V8, P368, DOI 10.1111/j.1467-9280.1997.tb00427.x; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; ROBINSON DL, 1992, TRENDS NEUROSCI, V15, P127, DOI 10.1016/0166-2236(92)90354-B; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Ross TD, 2003, COMPUT BIOL MED, V33, P509, DOI 10.1016/S0010-4825(03)00019-2; Rudolph K, 1999, CEREB CORTEX, V9, P90, DOI 10.1093/cercor/9.1.90; SCHOPPMANN A, 1976, NEUROSCI LETT, V2, P177, DOI 10.1016/0304-3940(76)90011-2; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Treue S, 2001, TRENDS NEUROSCI, V24, P295, DOI 10.1016/S0166-2236(00)01814-2; Wagenmakers EJ, 2007, PSYCHON B REV, V14, P779, DOI 10.3758/BF03194105; Wardak C, 2006, J NEUROSCI, V26, P4228, DOI 10.1523/JNEUROSCI.3336-05.2006; Wetzels R, 2009, PSYCHON B REV, V16, P752, DOI 10.3758/PBR.16.4.752	37	146	147	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 20	2012	489	7416					434	U124		10.1038/nature11497	http://dx.doi.org/10.1038/nature11497			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AK	22972195	Green Accepted			2022-12-24	WOS:000308860900046
J	Gao, Y; Zorman, S; Gundersen, G; Xi, ZQ; Ma, L; Sirinakis, G; Rothman, JE; Zhang, YL				Gao, Ying; Zorman, Sylvain; Gundersen, Gregory; Xi, Zhiqun; Ma, Lu; Sirinakis, George; Rothman, James E.; Zhang, Yongli			Single Reconstituted Neuronal SNARE Complexes Zipper in Three Distinct Stages	SCIENCE			English	Article							MEMBRANE-FUSION; NEUROTRANSMITTER RELEASE; SYNAPTOBREVIN; PROTEINS; EXOCYTOSIS; MOLECULE; COIL; ENERGETICS; MECHANISM; BINDING	Soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins drive membrane fusion by assembling into a four-helix bundle in a zippering process. Here, we used optical tweezers to observe in a cell-free reconstitution experiment in real time a long-sought SNARE assembly intermediate in which only the membrane-distal amino-terminal half of the bundle is assembled. Our findings support the zippering hypothesis, but suggest that zippering proceeds through three sequential binary switches, not continuously, in the amino-and carboxyl-terminal halves of the bundle and the linker domain. The half-zippered intermediate was stabilized by externally applied force that mimicked the repulsion between apposed membranes being forced to fuse. This intermediate then rapidly and forcefully zippered, delivering free energy of 36 k(B)T (where k(B) is Boltzmann's constant and T is temperature) to mediate fusion.	[Gao, Ying; Zorman, Sylvain; Gundersen, Gregory; Xi, Zhiqun; Ma, Lu; Sirinakis, George; Rothman, James E.; Zhang, Yongli] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA	Yale University	Rothman, JE (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, 333 Cedar St, New Haven, CT 06520 USA.	james.rothman@yale.edu; yongli.zhang@yale.edu			NIH [GM093341, DK027044]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK027044, R01DK027044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093341] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Ji and W. Xu for technical assistance and F. Pincet, T. Melia, and E. Karatekin for valuable discussion. This work is supported by NIH grants GM093341 to Y.Z. and DK027044 to J.E.R. Y.Z. designed the experiments; Y.G., S.Z., G. G., Z.X., L. M., and G. S. performed the experiments; Y.Z. and Y.G. analyzed the data; and Y.Z. and J.E.R. wrote the paper. The data and Matlab codes are in the paper and the supplementary materials.	Cecconi C, 2005, SCIENCE, V309, P2057, DOI 10.1126/science.1116702; Cohen FS, 2004, J MEMBRANE BIOL, V199, P1, DOI 10.1007/s00232-004-0669-8; Ellena JF, 2009, P NATL ACAD SCI USA, V106, P20306, DOI 10.1073/pnas.0908317106; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Li F, 2007, NAT STRUCT MOL BIOL, V14, P890, DOI 10.1038/nsmb1310; Gao Y, 2011, J AM CHEM SOC, V133, P12749, DOI 10.1021/ja204005r; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Hua SY, 1999, NAT NEUROSCI, V2, P1078, DOI 10.1038/16005; Karatekin E, 2010, P NATL ACAD SCI USA, V107, P3517, DOI 10.1073/pnas.0914723107; Kubelka J, 2004, CURR OPIN STRUC BIOL, V14, P76, DOI 10.1016/j.sbi.2004.01.013; Kummel D, 2011, NAT STRUCT MOL BIOL, V18, P927, DOI 10.1038/nsmb.2101; Kyoung M, 2011, P NATL ACAD SCI USA, V108, pE304, DOI 10.1073/pnas.1107900108; Li F, 2011, NAT STRUCT MOL BIOL, V18, P941, DOI 10.1038/nsmb.2102; Liu W, 2009, J Nanoneurosci, V1, P120; Melia TJ, 2002, J CELL BIOL, V158, P929, DOI 10.1083/jcb.200112081; Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486; Sabatini BL, 1996, NATURE, V384, P170, DOI 10.1038/384170a0; Shi L, 2012, SCIENCE, V335, P1355, DOI 10.1126/science.1214984; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Walter AM, 2010, J CELL BIOL, V188, P401, DOI 10.1083/jcb.200907018; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weninger K, 2003, P NATL ACAD SCI USA, V100, P14800, DOI 10.1073/pnas.2036428100; Weninger K, 2008, STRUCTURE, V16, P308, DOI 10.1016/j.str.2007.12.010; Wiederhold K, 2009, J BIOL CHEM, V284, P13143, DOI 10.1074/jbc.M900703200; Woodside MT, 2006, SCIENCE, V314, P1001, DOI 10.1126/science.1133601; Xi ZQ, 2012, P NATL ACAD SCI USA, V109, P5711, DOI 10.1073/pnas.1116784109; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4; Xu Y, 2010, BIOCHEMISTRY-US, V49, P1568, DOI 10.1021/bi9021878	31	265	269	1	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2012	337	6100					1340	1343		10.1126/science.1224492	http://dx.doi.org/10.1126/science.1224492			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	004TW	22903523	Green Accepted			2022-12-24	WOS:000308705000042
J	Ibarra, CA; Feng, XQ; Schoft, VK; Hsieh, TF; Uzawa, R; Rodrigues, JA; Zemach, A; Chumak, N; Machlicova, A; Nishimura, T; Rojas, D; Fischer, RL; Tamaru, H; Zilberman, D				Ibarra, Christian A.; Feng, Xiaoqi; Schoft, Vera K.; Hsieh, Tzung-Fu; Uzawa, Rie; Rodrigues, Jessica A.; Zemach, Assaf; Chumak, Nina; Machlicova, Adriana; Nishimura, Toshiro; Rojas, Denisse; Fischer, Robert L.; Tamaru, Hisashi; Zilberman, Daniel			Active DNA Demethylation in Plant Companion Cells Reinforces Transposon Methylation in Gametes	SCIENCE			English	Article							ARABIDOPSIS ENDOSPERM; GENOME; GLYCOSYLASE; CHROMATIN; STATES	The Arabidopsis thaliana central cell, the companion cell of the egg, undergoes DNA demethylation before fertilization, but the targeting preferences, mechanism, and biological significance of this process remain unclear. Here, we show that active DNA demethylation mediated by the DEMETER DNA glycosylase accounts for all of the demethylation in the central cell and preferentially targets small, AT-rich, and nucleosome-depleted euchromatic transposable elements. The vegetative cell, the companion cell of sperm, also undergoes DEMETER-dependent demethylation of similar sequences, and lack of DEMETER in vegetative cells causes reduced small RNA-directed DNA methylation of transposons in sperm. Our results demonstrate that demethylation in companion cells reinforces transposon methylation in plant gametes and likely contributes to stable silencing of transposable elements across generations.	[Ibarra, Christian A.; Feng, Xiaoqi; Hsieh, Tzung-Fu; Uzawa, Rie; Rodrigues, Jessica A.; Zemach, Assaf; Nishimura, Toshiro; Rojas, Denisse; Fischer, Robert L.; Zilberman, Daniel] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Schoft, Vera K.; Chumak, Nina; Machlicova, Adriana; Tamaru, Hisashi] Austrian Acad Sci, Gregor Mendel Inst, A-1030 Vienna, Austria	University of California System; University of California Berkeley; Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI)	Fischer, RL (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	rfischer@berkeley.edu; hisashi.tamaru@gmi.oeaw.ac.at; danielz@berkeley.edu		Rodrigues, Jessica/0000-0002-1562-2211; Zilberman, Daniel/0000-0002-0123-8649; Feng, Xiaoqi/0000-0002-4008-1234; Hsieh, Tzung-Fu/0000-0001-7584-3721; Schoft, Vera/0000-0003-4857-3804; Zemach, Assaf/0000-0003-3282-4445	NIH [GM69415]; NSF [MCB-0918821, IOS-1025890]; Arnold and Mabel Beckman Foundation; Austrian Science Fund (FWF) [P21389-B03]; Ruth L. Kirschstein NIH Predoctoral Fellowship [GM093633]; Fulbright Scholarship; Jane Coffin Childs Memorial Fund; Robert and Colleen Haas Scholarship; Austrian Science Fund (FWF) [P 24918] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069415, F31GM093633] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Arnold and Mabel Beckman Foundation; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Ruth L. Kirschstein NIH Predoctoral Fellowship; Fulbright Scholarship; Jane Coffin Childs Memorial Fund; Robert and Colleen Haas Scholarship; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Harmer for assistance with the analysis of histone modifications, the BioOptics team at the Vienna Biocenter Campus for sorting sperm and vegetative cell nuclei, K. Slotkin for the LAT52p-amiRNA=GFP plasmid, and G. Drews for the DD45p-GFP transgenic line. This work was partially funded by an NIH grant (GM69415) to R. L. F., NSF grants (MCB-0918821 and IOS-1025890) to R. L. F. and D.Z., a Young Investigator Grant from the Arnold and Mabel Beckman Foundation to D.Z., an Austrian Science Fund (FWF) grant P21389-B03 to H. T., a Ruth L. Kirschstein NIH Predoctoral Fellowship (GM093633) to C. A. I., a Fulbright Scholarship to J.A.R., a fellowship from the Jane Coffin Childs Memorial Fund to A.Z., and a Robert and Colleen Haas Scholarship to D. R. Sequencing data are deposited in GEO (GSE38935).	Bauer MJ, 2011, CURR OPIN PLANT BIOL, V14, P162, DOI 10.1016/j.pbi.2011.02.006; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Hsieh TF, 2011, P NATL ACAD SCI USA, V108, P1755, DOI 10.1073/pnas.1019273108; Hsieh TF, 2009, SCIENCE, V324, P1451, DOI [10.1126/science.1172417, 10.1126/science.112417]; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Penterman J, 2007, P NATL ACAD SCI USA, V104, P6752, DOI 10.1073/pnas.0701861104; Pillot M, 2010, PLANT CELL, V22, P307, DOI 10.1105/tpc.109.071647; Qian WQ, 2012, SCIENCE, V336, P1445, DOI 10.1126/science.1219416; Roudier F, 2011, EMBO J, V30, P1928, DOI 10.1038/emboj.2011.103; Schoft VK, 2011, P NATL ACAD SCI USA, V108, P8042, DOI 10.1073/pnas.1105117108; Schoft VK, 2009, EMBO REP, V10, P1015, DOI 10.1038/embor.2009.152; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Zemach A, 2010, P NATL ACAD SCI USA, V107, P18729, DOI 10.1073/pnas.1009695107	14	323	330	3	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2012	337	6100					1360	1364		10.1126/science.1224839	http://dx.doi.org/10.1126/science.1224839			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	004TW	22984074	Green Accepted			2022-12-24	WOS:000308705000047
J	Maurano, MT; Humbert, R; Rynes, E; Thurman, RE; Haugen, E; Wang, H; Reynolds, AP; Sandstrom, R; Qu, HZ; Brody, J; Shafer, A; Neri, F; Lee, K; Kutyavin, T; Stehling-Sun, S; Johnson, AK; Canfield, TK; Giste, E; Diegel, M; Bates, D; Hansen, RS; Neph, S; Sabo, PJ; Heimfeld, S; Raubitschek, A; Ziegler, S; Cotsapas, C; Sotoodehnia, N; Glass, I; Sunyaev, SR; Kaul, R; Stamatoyannopoulos, JA				Maurano, Matthew T.; Humbert, Richard; Rynes, Eric; Thurman, Robert E.; Haugen, Eric; Wang, Hao; Reynolds, Alex P.; Sandstrom, Richard; Qu, Hongzhu; Brody, Jennifer; Shafer, Anthony; Neri, Fidencio; Lee, Kristen; Kutyavin, Tanya; Stehling-Sun, Sandra; Johnson, Audra K.; Canfield, Theresa K.; Giste, Erika; Diegel, Morgan; Bates, Daniel; Hansen, R. Scott; Neph, Shane; Sabo, Peter J.; Heimfeld, Shelly; Raubitschek, Antony; Ziegler, Steven; Cotsapas, Chris; Sotoodehnia, Nona; Glass, Ian; Sunyaev, Shamil R.; Kaul, Rajinder; Stamatoyannopoulos, John A.			Systematic Localization of Common Disease-Associated Variation in Regulatory DNA	SCIENCE			English	Article							CROHNS-DISEASE; 22 LOCI; VARIANTS; EVOLUTION; PROMOTER; CELLS	Genome-wide association studies have identified many noncoding variants associated with common diseases and traits. We show that these variants are concentrated in regulatory DNA marked by deoxyribonuclease I (DNase I) hypersensitive sites (DHSs). Eighty-eight percent of such DHSs are active during fetal development and are enriched in variants associated with gestational exposure-related phenotypes. We identified distant gene targets for hundreds of variant-containing DHSs that may explain phenotype associations. Disease-associated variants systematically perturb transcription factor recognition sequences, frequently alter allelic chromatin states, and form regulatory networks. We also demonstrated tissue-selective enrichment of more weakly disease-associated variants within DHSs and the de novo identification of pathogenic cell types for Crohn's disease, multiple sclerosis, and an electrocardiogram trait, without prior knowledge of physiological mechanisms. Our results suggest pervasive involvement of regulatory DNA variation in common human disease and provide pathogenic insights into diverse disorders.	[Maurano, Matthew T.; Humbert, Richard; Rynes, Eric; Thurman, Robert E.; Haugen, Eric; Wang, Hao; Reynolds, Alex P.; Sandstrom, Richard; Qu, Hongzhu; Shafer, Anthony; Neri, Fidencio; Lee, Kristen; Kutyavin, Tanya; Stehling-Sun, Sandra; Johnson, Audra K.; Canfield, Theresa K.; Giste, Erika; Diegel, Morgan; Bates, Daniel; Neph, Shane; Sabo, Peter J.; Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Qu, Hongzhu] Chinese Acad Sci, Beijing Inst Genom, Lab Dis Genom & Individualized Med, Beijing 100029, Peoples R China; [Brody, Jennifer; Sotoodehnia, Nona] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Hansen, R. Scott; Kaul, Rajinder] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Heimfeld, Shelly] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; [Raubitschek, Antony; Ziegler, Steven] Benaroya Res Inst, Program Immunol, Seattle, WA 98101 USA; [Cotsapas, Chris] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06520 USA; [Cotsapas, Chris] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Sotoodehnia, Nona] Univ Washington, Dept Med, Div Cardiol, Seattle, WA 98195 USA; [Glass, Ian] Univ Washington, Dept Pediat, Div Med Genet, Seattle, WA 98195 USA; [Sunyaev, Shamil R.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Sunyaev, Shamil R.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Stamatoyannopoulos, John A.] Univ Washington, Dept Med, Div Oncol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Benaroya Research Institute; Yale University; Yale University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Washington; University of Washington Seattle	Stamatoyannopoulos, JA (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	jstam@uw.edu		Haugen, Eric/0000-0001-7444-8981; Sandstrom, Richard/0000-0002-3356-1547; Cotsapas, Chris/0000-0002-7772-5910; Kaul, Rajinder/0000-0002-7895-9284	NIH [U54HG004592, U01ES01156, P30 DK056465, R01HL088456, R24HD000836-47]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD000836] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088456] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH094073] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank many colleagues for their insightful comments and critical readings of the manuscript. We also thank many colleagues who provided individual cell samples for DNase I analysis. This work was supported by NIH grants U54HG004592 and U01ES01156 (J.A.S.), P30 DK056465 (S. H.), R01HL088456 (N.S.), and R24HD000836-47 (I. G.). We acknowledge the generous sharing of results from the International MS Genetics, International IBD Genetics, and CHARGE QRS Consortia. DNase I data have been deposited in Gene Expression Omnibus (GEO) under accession nos. GSE29692 and GSE18927 and can be viewed and downloaded at genome.ucsc.edu, www.uwencode.org/data, and www.epigenomebrowser.org.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Booth DR, 2010, NAT GENET, V42, P469, DOI 10.1038/ng0610-469; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; COLLINS FS, 1985, NATURE, V313, P325, DOI 10.1038/313325a0; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Fajans SS, 2001, NEW ENGL J MED, V345, P971, DOI 10.1056/NEJMra002168; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Harismendy O, 2011, NATURE, V470, P264, DOI 10.1038/nature09753; Hindorff LA, CATALOG PUBLISHED GE; International Multiple Sclerosis Genetics Consortium (IMSGC), 2010, NAT GENET       0527, V42, P470; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Knight JC, 2003, NAT GENET, V33, P469, DOI 10.1038/ng1124; Lettice LA, 2002, P NATL ACAD SCI USA, V99, P7548, DOI 10.1073/pnas.112212199; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; Maurano MT, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002599; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Patsopoulos NA, 2011, ANN NEUROL, V70, P897, DOI 10.1002/ana.22609; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rockman MV, 2002, MOL BIOL EVOL, V19, P1991, DOI 10.1093/oxfordjournals.molbev.a004023; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Sotoodehnia N, 2010, NAT GENET, V42, P1068, DOI 10.1038/ng.716; Stranger BE, 2011, GENETICS, V187, P367, DOI 10.1534/genetics.110.120907; Symonds ME, 2009, NAT REV ENDOCRINOL, V5, P604, DOI 10.1038/nrendo.2009.195; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; von Budingen HC, 2011, CURR OPIN IMMUNOL, V23, P713, DOI 10.1016/j.coi.2011.09.003	36	2106	2161	15	191	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2012	337	6099					1190	1195		10.1126/science.1222794	http://dx.doi.org/10.1126/science.1222794			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	000UJ	22955828	Green Accepted			2022-12-24	WOS:000308414000028
J	Zikherman, J; Parameswaran, R; Weiss, A				Zikherman, Julie; Parameswaran, Ramya; Weiss, Arthur			Endogenous antigen tunes the responsiveness of naive B cells but not T cells	NATURE			English	Article							SELF-TOLERANCE; EXPRESSION; CD45; ACTIVATION; RESOLUTION; SELECTION; ANERGY; MOUSE	In humans, up to 75% of newly generated B cells and about 30% of mature B cells show some degree of autoreactivity(1). Yet, how B cells establish and maintain tolerance in the face of autoantigen exposure during and after development is not certain. Studies of model B-cell antigen receptor (BCR) transgenic systems have highlighted the critical role of functional unresponsiveness or 'anergy'(2,3). Unlike T cells, evidence suggests that receptor editing and anergy, rather than deletion, account for much of B-cell tolerance(4,5). However, it remains unclear whether the mature diverse B-cell repertoire of mice contains anergic autoreactive B cells, and if so, whether antigen was encountered during or after their development. By taking advantage of a reporter mouse in which BCR signalling rapidly and robustly induces green fluorescent protein expression under the control of the Nur77 regulatory region, antigen-dependent and antigen-independent BCR signalling events in vivo during B-cell maturation were visualized. Here we show that B cells encounter antigen during development in the spleen, and that this antigen exposure, in turn, tunes the responsiveness of BCR signalling in B cells at least partly by downmodulating expression of surface IgM but not IgD BCRs, and by modifying basal calcium levels. By contrast, no analogous process occurs in naive mature T cells. Our data demonstrate not only that autoreactive B cells persist in the mature repertoire, but that functional unresponsiveness or anergy exists in the mature B-cell repertoire along a continuum, a fact that has long been suspected, but never yet shown. These results have important implications for understanding how tolerance in T and B cells is differently imposed, and how these processes might go awry in disease.	[Zikherman, Julie; Parameswaran, Ramya; Weiss, Arthur] Univ Calif San Francisco, Rosalind Russell Med Res Ctr Arthrit, Dept Med, Div Rheumatol, San Francisco, CA 94143 USA; [Weiss, Arthur] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Weiss, A (corresponding author), Univ Calif San Francisco, Rosalind Russell Med Res Ctr Arthrit, Dept Med, Div Rheumatol, San Francisco, CA 94143 USA.	aweiss@medicine.ucsf.edu	Parameswaran, Ramya/AAH-5791-2019	Zikherman, Julie/0000-0002-0873-192X	Rosalind Russell Medical Research Foundation Bechtel Award; American College of Rheumatology REF Rheumatology Investigator Award; Arthritis National Research Foundation; National Institutes of Health [K08 AR059723]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR059723] Funding Source: NIH RePORTER	Rosalind Russell Medical Research Foundation Bechtel Award; American College of Rheumatology REF Rheumatology Investigator Award; Arthritis National Research Foundation(National Research Foundation of Korea); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank A. Roque for assisting with animal husbandry and Z. Wang and J. Paw for help with cell sorting. This work was supported by the Rosalind Russell Medical Research Foundation Bechtel Award (J. Z.), an American College of Rheumatology REF Rheumatology Investigator Award (J. Z.), an Arthritis National Research Foundation grant (J. Z.) and National Institutes of Health Grant K08 AR059723 (J. Z.), as well as the Howard Hughes Medical Institute (A.W.).	Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; Benschop RJ, 2001, IMMUNITY, V14, P33, DOI 10.1016/S1074-7613(01)00087-5; Cambier JC, 2007, NAT REV IMMUNOL, V7, P633, DOI 10.1038/nri2133; Chung JB, 2003, TRENDS IMMUNOL, V24, P343, DOI 10.1016/S1471-4906(03)00119-4; COOKE MP, 1994, J EXP MED, V179, P425, DOI 10.1084/jem.179.2.425; Cornall RJ, 1998, IMMUNITY, V8, P497, DOI 10.1016/S1074-7613(00)80554-3; Duty JA, 2009, J EXP MED, V206, P139, DOI 10.1084/jem.20080611; Fields ML, 2003, CURR OPIN IMMUNOL, V15, P709, DOI 10.1016/j.coi.2003.09.016; Glynne R, 2000, IMMUNOL REV, V176, P216; Glynne R, 2000, NATURE, V403, P672, DOI 10.1038/35001102; Goodnow CC, 2005, NATURE, V435, P590, DOI 10.1038/nature03724; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Halverson R, 2004, NAT IMMUNOL, V5, P645, DOI 10.1038/ni1076; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Hermiston ML, 2005, IMMUNITY, V23, P635, DOI 10.1016/j.immuni.2005.11.001; Lang J, 1997, J EXP MED, V186, P1513, DOI 10.1084/jem.186.9.1513; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Merrell KT, 2006, IMMUNITY, V25, P953, DOI 10.1016/j.immuni.2006.10.017; MITTELSTADT PR, 1993, J IMMUNOL, V150, P4822; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Teague BN, 2007, J IMMUNOL, V178, P7511, DOI 10.4049/jimmunol.178.12.7511; The Gene Expression Nervous System Atlas (GENSAT) Project, N01NS02331 GENSAT PR; Virts EL, 2003, BLOOD, V101, P849, DOI 10.1182/blood-2002-07-1969; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Winoto A, 2002, CELL, V109, pS57, DOI 10.1016/S0092-8674(02)00710-9; Yarkoni Y, 2010, IMMUNOL REV, V237, P249, DOI 10.1111/j.1600-065X.2010.00936.x; Zikherman J, 2012, P NATL ACAD SCI USA, V109, pE3, DOI 10.1073/pnas.1117374108; Zikherman J, 2010, IMMUNITY, V32, P342, DOI 10.1016/j.immuni.2010.03.006; Zikherman J, 2009, J IMMUNOL, V182, P4093, DOI 10.4049/jimmunol.0803317	29	205	206	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2012	489	7414					160	U185		10.1038/nature11311	http://dx.doi.org/10.1038/nature11311			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999WW	22902503	Green Accepted, Green Submitted			2022-12-24	WOS:000308347000055
J	Qu, Y; Misaghi, S; Izrael-Tomasevic, A; Newton, K; Gilmour, LL; Lamkanfi, M; Louie, S; Kayagaki, N; Liu, JF; Komuves, L; Cupp, JE; Arnott, D; Monack, D; Dixit, VM				Qu, Yan; Misaghi, Shahram; Izrael-Tomasevic, Anita; Newton, Kim; Gilmour, Laurie L.; Lamkanfi, Mohamed; Louie, Salina; Kayagaki, Nobuhiko; Liu, Jinfeng; Koemueves, Laszlo; Cupp, James E.; Arnott, David; Monack, Denise; Dixit, Vishva M.			Phosphorylation of NLRC4 is critical for inflammasome activation	NATURE			English	Article							INNATE IMMUNE RECOGNITION; III SECRETION APPARATUS; PROTEIN-KINASE-C; FRANCISELLA-TULARENSIS; AIM2 INFLAMMASOME; HOST-DEFENSE; IPAF; CASPASE-1; FLAGELLIN; SALMONELLA	NLRC4 is a cytosolic member of the NOD-like receptor family that is expressed in innate immune cells. It senses indirectly bacterial flagellin and type III secretion systems, and responds by assembling an inflammasome complex that promotes caspase-1 activation and pyroptosis(1-6). Here we use knock-in mice expressing NLRC4 with a carboxy-terminal 3xFlag tag to identify phosphorylation of NLRC4 on a single, evolutionarily conserved residue, Ser 533, following infection of macrophages with Salmonella enterica serovar Typhimurium (also known as Salmonella typhimurium). Western blotting with a NLRC4 phospho-Ser 533 antibody confirmed that this post-translational modification occurs only in the presence of stimuli known to engage NLRC4 and not the related protein NLRP3 or AIM2. Nlrc4(-/-) macrophages reconstituted with NLRC4 mutant S533A, unlike those reconstituted with wild-type NLRC4, did not activate caspase-1 and pyroptosis in response to S. typhimurium, indicating that S533 phosphorylation is critical for NLRC4 inflammasome function. Conversely, phosphomimetic NLRC4 S533D caused rapid macrophage pyroptosis without infection. Biochemical purification of the NLRC4-phosphorylating activity and a screen of kinase inhibitors identified PRKCD (PKC delta) as a candidate NLRC4 kinase. Recombinant PKC delta phosphorylated NLRC4 S533 in vitro, immunodepletion of PKC delta from macrophage lysates blocked NLRC4 S533 phosphorylation in vitro, and Prkcd(-/-) macrophages exhibited greatly attenuated caspase-1 activation and IL-1 beta secretion specifically in response to S. typhimurium. Phosphorylation-defective NLRC4 S533A failed to recruit procaspase-1 and did not assemble inflammasome specks(7) during S. typhimurium infection, so phosphorylation of NLRC4 S533 probably drives conformational changes necessary for NLRC4 inflammasome activity and host innate immunity.	[Qu, Yan; Newton, Kim; Kayagaki, Nobuhiko; Dixit, Vishva M.] Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA; [Misaghi, Shahram; Louie, Salina] Genentech Inc, Dept Early Stage Cell Culture, San Francisco, CA 94080 USA; [Izrael-Tomasevic, Anita; Arnott, David] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Gilmour, Laurie L.; Cupp, James E.] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Lamkanfi, Mohamed] VIB, Dept Med Prot Res, B-9000 Ghent, Belgium; [Lamkanfi, Mohamed] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; [Liu, Jinfeng] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Koemueves, Laszlo] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Monack, Denise] Stanford Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Flanders Institute for Biotechnology (VIB); Ghent University; Roche Holding; Genentech; Roche Holding; Genentech; Stanford University	Dixit, VM (corresponding author), Genentech Inc, Dept Physiol Chem, 1 DNA Way, San Francisco, CA 94080 USA.	dixit@gene.com	dixit, vishva m/A-4496-2012	dixit, vishva m/0000-0001-6983-0326; Liu, Jinfeng/0000-0002-0343-8222; Monack, Denise/0000-0003-3804-2209				Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Amer A, 2006, J BIOL CHEM, V281, P35217, DOI 10.1074/jbc.M604933200; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Castellana NE, 2011, PROTEOMICS, V11, P395, DOI 10.1002/pmic.201000487; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Hersh D, 1999, P NATL ACAD SCI USA, V96, P2396, DOI 10.1073/pnas.96.5.2396; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; MIZUNO K, 1993, FEBS LETT, V330, P114, DOI 10.1016/0014-5793(93)80254-R; Poyet JL, 2001, J BIOL CHEM, V276, P28309, DOI 10.1074/jbc.C100250200; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Vendel AC, 2009, J IMMUNOL, V182, P1509, DOI 10.4049/jimmunol.182.3.1509; Wang GG, 2006, NAT METHODS, V3, P287, DOI 10.1038/NMETH865; WOLF M, 1988, BIOCHEM BIOPH RES CO, V154, P1273, DOI 10.1016/0006-291X(88)90277-X; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	22	210	223	0	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2012	490	7421					539	+		10.1038/nature11429	http://dx.doi.org/10.1038/nature11429			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NK	22885697				2022-12-24	WOS:000310196200042
J	Yi, W; Clark, PM; Mason, DE; Keenan, MC; Hill, C; Goddard, WA; Peters, EC; Driggers, EM; Hsieh-Wilson, LC				Yi, Wen; Clark, Peter M.; Mason, Daniel E.; Keenan, Marie C.; Hill, Collin; Goddard, William A., III; Peters, Eric C.; Driggers, Edward M.; Hsieh-Wilson, Linda C.			Phosphofructokinase 1 Glycosylation Regulates Cell Growth and Metabolism	SCIENCE			English	Article							O-GLCNAC MODIFICATION; BETA-N-ACETYLGLUCOSAMINE; NUCLEOCYTOPLASMIC PROTEINS; GLUCOSE-METABOLISM; BREAST-CANCER; TRANSFERASE; INHIBITION; PATHWAY; STRESS	Cancer cells must satisfy the metabolic demands of rapid cell growth within a continually changing microenvironment. We demonstrated that the dynamic posttranslational modification of proteins by O-linked beta-N-acetylglucosamine (O-GlcNAcylation) is a key metabolic regulator of glucose metabolism. O-GlcNAcylation was induced at serine 529 of phosphofructokinase 1 (PFK1) in response to hypoxia. Glycosylation inhibited PFK1 activity and redirected glucose flux through the pentose phosphate pathway, thereby conferring a selective growth advantage on cancer cells. Blocking glycosylation of PFK1 at serine 529 reduced cancer cell proliferation in vitro and impaired tumor formation in vivo. These studies reveal a previously uncharacterized mechanism for the regulation of metabolic pathways in cancer and a possible target for therapeutic intervention.	[Goddard, William A., III; Hsieh-Wilson, Linda C.] CALTECH, Div Chem & Chem Engn, Mat & Proc Simulat Ctr, Pasadena, CA 91125 USA; [Yi, Wen; Clark, Peter M.; Hsieh-Wilson, Linda C.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Mason, Daniel E.; Peters, Eric C.] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Keenan, Marie C.; Hill, Collin; Driggers, Edward M.] Agios Pharmaceut, Cambridge, MA 02139 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; Novartis; Agios Pharmaceuticals	Hsieh-Wilson, LC (corresponding author), CALTECH, Div Chem & Chem Engn, Mat & Proc Simulat Ctr, Pasadena, CA 91125 USA.	lhw@caltech.edu	Peters, Eric/W-2739-2019; Yi, Wen/M-5905-2014		National Institutes of Health [R01 GM084724]; Department of Defense Breast Cancer Research Program [W81XWH-10-1-0988]; Tobacco-Related Disease Research Program Postdoctoral Fellowship [19FT-0078]; Agios Pharmaceuticals; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084724] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research Program(United States Department of Defense); Tobacco-Related Disease Research Program Postdoctoral Fellowship(University of California System); Agios Pharmaceuticals; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Qasba for the Y289L GalT construct, R. Abrol for computational modeling advice, R. Diamond for cell cycle analysis, and L. Cantley and M. Vander Heiden for useful discussions. This work was supported by the National Institutes of Health (grant R01 GM084724 to L. C. H-W), the Department of Defense Breast Cancer Research Program (grant W81XWH-10-1-0988 to W.Y), and a Tobacco-Related Disease Research Program Postdoctoral Fellowship (19FT-0078 to W.Y). We also thank Agios Pharmaceuticals for financial support in providing patient tumor and matched tissue samples.	Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Caldwell SA, 2010, ONCOGENE, V29, P2831, DOI 10.1038/onc.2010.41; Clark PM, 2008, J AM CHEM SOC, V130, P11576, DOI 10.1021/ja8030467; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Ferreras C, 2009, J BIOL CHEM, V284, P9124, DOI 10.1074/jbc.M807737200; Fuhrer T, 2011, ANAL CHEM, V83, P7074, DOI 10.1021/ac201267k; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Herrero-Mendez A, 2009, NAT CELL BIOL, V11, P747, DOI 10.1038/ncb1881; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Lu XH, 2000, CLIN CANCER RES, V6, P271; Lynch TP, 2012, J BIOL CHEM, V287, P11070, DOI 10.1074/jbc.M111.302547; Moseley HNB, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-37; PANDOLFI PP, 1995, EMBO J, V14, P5209, DOI 10.1002/j.1460-2075.1995.tb00205.x; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Ramakrishnan B, 2002, J BIOL CHEM, V277, P20833, DOI 10.1074/jbc.M111183200; Rexach JE, 2012, NAT CHEM BIOL, V8, P253, DOI [10.1038/NCHEMBIO.770, 10.1038/nchembio.770]; Rexach JE, 2010, NAT CHEM BIOL, V6, P645, DOI [10.1038/NCHEMBIO.412, 10.1038/nchembio.412]; Sidorenko Y, 2008, BIOTECHNOL PROGR, V24, P311, DOI 10.1021/bp0702673; Slawson C, 2011, NAT REV CANCER, V11, P678, DOI 10.1038/nrc3114; Sola-Penna M, 2010, IUBMB LIFE, V62, P791, DOI 10.1002/iub.393; Taylor RP, 2008, J BIOL CHEM, V283, P6050, DOI 10.1074/jbc.M707328200; Tong XM, 2009, CURR OPIN GENET DEV, V19, P32, DOI 10.1016/j.gde.2009.01.002; Wellen KE, 2010, GENE DEV, V24, P2784, DOI 10.1101/gad.1985910; Yalcin A, 2009, EXP MOL PATHOL, V86, P174, DOI 10.1016/j.yexmp.2009.01.003; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200	29	393	423	9	213	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2012	337	6097					975	980		10.1126/science.1222278	http://dx.doi.org/10.1126/science.1222278			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992VI	22923583	Green Accepted			2022-12-24	WOS:000307807600048
J	Kukulski, W; Schorb, M; Kaksonen, M; Briggs, JAG				Kukulski, Wanda; Schorb, Martin; Kaksonen, Marko; Briggs, John A. G.			Plasma Membrane Reshaping during Endocytosis Is Revealed by Time-Resolved Electron Tomography	CELL			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; ACTIN CYTOSKELETON; FISSION YEAST; BUDDING YEAST; BAR DOMAINS; IN-VIVO; VESICLE; MICROSCOPY; CURVATURE; MECHANISM	Endocytosis, like many dynamic cellular processes, requires precise temporal and spatial orchestration of complex protein machinery to mediate membrane budding. To understand how this machinery works, we directly correlated fluorescence microscopy of key protein pairs with electron tomography. We systematically located 211 endocytic intermediates, assigned each to a specific time window in endocytosis, and reconstructed their ultrastructure in 3D. The resulting virtual ultrastructural movie defines the protein-mediated membrane shape changes during endocytosis in budding yeast. It reveals that clathrin is recruited to flat membranes and does not initiate curvature. Instead, membrane invagination begins upon actin network assembly followed by amphiphysin binding to parallel membrane segments, which promotes elongation of the invagination into a tubule. Scission occurs on average 9 s after initial bending when invaginations are similar to 100 nm deep, releasing nonspherical vesicles with 6,400 nm(2) mean surface area. Direct correlation of protein dynamics with ultrastructure provides a quantitative 4D resource.	[Kukulski, Wanda; Schorb, Martin; Kaksonen, Marko; Briggs, John A. G.] European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany; [Kukulski, Wanda; Kaksonen, Marko; Briggs, John A. G.] European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL)	Kaksonen, M (corresponding author), European Mol Biol Lab, Struct & Computat Biol Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	kaksonen@embl.de; briggs@embl.de	Kukulski, Wanda/H-1766-2013; Briggs, John/J-3096-2012	Briggs, John/0000-0003-3990-6910; Schorb, Martin/0000-0003-4910-1868; Kaksonen, Marko/0000-0003-3645-7689	EMBL interdisciplinary postdoctoral fellowship; Swiss National Science Foundation	EMBL interdisciplinary postdoctoral fellowship; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was technically supported by Frank Thommen and by the EMBL EM core facility. We thank Jan Ellenberg and Francois Nedelec for critical reading of the manuscript and Wolfgang Huber for statistical advice. W. K. acknowledges an EMBL interdisciplinary postdoctoral fellowship and a fellowship for advanced researchers from the Swiss National Science Foundation.	ANDERSON RGW, 1977, CELL, V10, P351, DOI 10.1016/0092-8674(77)90022-8; Boettner DR, 2012, NAT CELL BIOL, V14, P2, DOI 10.1038/ncb2403; Boettner DR, 2009, CURR BIOL, V19, P1979, DOI 10.1016/j.cub.2009.10.062; Boukellal H, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.061906; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Campelo F, 2010, FEBS LETT, V584, P1830, DOI 10.1016/j.febslet.2009.10.023; Carroll SY, 2012, MOL BIOL CELL, V23, P657, DOI 10.1091/mbc.E11-02-0108; Collins A, 2011, CURR BIOL, V21, P1167, DOI 10.1016/j.cub.2011.05.048; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Cureton DK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001127; den Otter WK, 2011, TRAFFIC, V12, P1407, DOI 10.1111/j.1600-0854.2011.01241.x; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Galletta BJ, 2010, CURR OPIN BIOTECH, V21, P604, DOI 10.1016/j.copbio.2010.06.006; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Henne WM, 2010, SCIENCE, V328, P1281, DOI 10.1126/science.1188462; HEUSER J, 1980, J CELL BIOL, V84, P560, DOI 10.1083/jcb.84.3.560; HEUSER J, 1989, J CELL BIOL, V108, P401, DOI 10.1083/jcb.108.2.401; Hinrichsen L, 2006, P NATL ACAD SCI USA, V103, P8715, DOI 10.1073/pnas.0600312103; Hoffmann A, 2010, TRAFFIC, V11, P1129, DOI 10.1111/j.1600-0854.2010.01084.x; Idrissi FZ, 2008, J CELL BIOL, V180, P1219, DOI 10.1083/jcb.200708060; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Karpova TS, 1998, J CELL BIOL, V142, P1501, DOI 10.1083/jcb.142.6.1501; Kirchhausen T, 2009, TRENDS CELL BIOL, V19, P596, DOI 10.1016/j.tcb.2009.09.002; Kishimoto T, 2011, P NATL ACAD SCI USA, V108, pE979, DOI 10.1073/pnas.1113413108; Kukulski W, 2011, J CELL BIOL, V192, P111, DOI 10.1083/jcb.201009037; Liu J, 2006, P NATL ACAD SCI USA, V103, P10277, DOI 10.1073/pnas.0601045103; Liu J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000204; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; MULHOLLAND J, 1994, J CELL BIOL, V125, P381, DOI 10.1083/jcb.125.2.381; Newpher TM, 2005, DEV CELL, V9, P87, DOI 10.1016/j.devcel.2005.04.014; Nixon SJ, 2009, TRAFFIC, V10, P131, DOI 10.1111/j.1600-0854.2008.00859.x; Perrais D, 2005, DEV CELL, V9, P581, DOI 10.1016/j.devcel.2005.10.002; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pruggnaller S, 2008, J STRUCT BIOL, V164, P161, DOI 10.1016/j.jsb.2008.05.003; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Qualmann B, 2011, EMBO J, V30, P3501, DOI 10.1038/emboj.2011.266; Reider A, 2009, EMBO J, V28, P3103, DOI 10.1038/emboj.2009.248; ROTH TF, 1964, J CELL BIOL, V20, P313, DOI 10.1083/jcb.20.2.313; Sirotkin V, 2010, MOL BIOL CELL, V21, P2894, DOI 10.1091/mbc.E10-02-0157; Stimpson HEM, 2009, MOL BIOL CELL, V20, P4640, DOI 10.1091/mbc.E09-05-0429; Takagi T, 2003, J ELECTRON MICROSC, V52, P161, DOI 10.1093/jmicro/52.2.161; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Toshima JY, 2006, P NATL ACAD SCI USA, V103, P5793, DOI 10.1073/pnas.0601042103; Traub LM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000192; Upadhyaya A, 2003, CURR BIOL, V13, pR734, DOI 10.1016/j.cub.2003.08.051; Wu XF, 2003, MOL BIOL CELL, V14, P516, DOI 10.1091/mbc.E02-06-0353; Wu XF, 2001, J CELL BIOL, V155, P291, DOI 10.1083/jcb.200104085; Yarar D, 2005, MOL BIOL CELL, V16, P964, DOI 10.1091/mbc.e04-09-0774; Youn JY, 2010, MOL BIOL CELL, V21, P3054, DOI 10.1091/mbc.E10-03-0181	51	229	231	1	63	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 3	2012	150	3					508	520		10.1016/j.cell.2012.05.046	http://dx.doi.org/10.1016/j.cell.2012.05.046			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	985WO	22863005	Bronze			2022-12-24	WOS:000307301400011
J	Smith, BE; Braun, RE				Smith, Benjamin E.; Braun, Robert E.			Germ Cell Migration Across Sertoli Cell Tight Junctions	SCIENCE			English	Article							INTERCELLULAR BRIDGES; BARRIER; TESTIS; RAT; SPERMATOGENESIS	The blood-testis barrier includes strands of tight junctions between somatic Sertoli cells that restricts solutes from crossing the paracellular space, creating a microenvironment within seminiferous tubules and providing immune privilege to meiotic and postmeiotic cells. Large cysts of germ cells transit the Sertoli cell tight junctions (SCTJs) without compromising their integrity. We used confocal microscopy to visualize SCTJ components during germ cell cyst migration across the SCTJs. Cysts become enclosed within a network of transient compartments fully bounded by old and new tight junctions. Dissolution of the old tight junctions releases the germ cells into the adluminal compartment, thus completing transit across the blood-testis barrier. Claudin 3, a tight junction protein, is transiently incorporated into new tight junctions and then replaced by claudin 11.	[Smith, Benjamin E.; Braun, Robert E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Braun, Robert E.] Jackson Lab, Bar Harbor, ME 04609 USA	University of Washington; University of Washington Seattle; Jackson Laboratory	Braun, RE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA.	bob.braun@jax.org			National Institute of Child Health and Human Development/NIH [HD12629]; National Cancer Institute [CA34196]; Jackson Laboratories shared services; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD012629] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Jackson Laboratories shared services; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Lessard and J. Denegre for ssistance with confocal imaging and S. Leighton for artistic rendering of the images. This research was supported by a grant to R.E.B. from the National Institute of Child Health and Human Development/NIH (HD12629) as part of the Specialized Cooperative Centers Program in Reproduction Research and from the National Cancer Institute (CA34196) in support of The Jackson Laboratories shared services.	DYM M, 1977, BIOL REPROD, V17, P390, DOI 10.1095/biolreprod17.3.390; Greenbaum MP, 2006, P NATL ACAD SCI USA, V103, P4982, DOI 10.1073/pnas.0505123103; Masuda S, 2011, J CELL SCI, V124, P548, DOI 10.1242/jcs.072058; Meng J, 2005, P NATL ACAD SCI USA, V102, P16696, DOI 10.1073/pnas.0506084102; Morita K, 1999, J CELL BIOL, V145, P579, DOI 10.1083/jcb.145.3.579; OAKBERG EF, 1956, AM J ANAT, V99, P507, DOI 10.1002/aja.1000990307; RUSSELL L, 1977, AM J ANAT, V148, P313, DOI 10.1002/aja.1001480303; RUSSELL LD, 1989, AM J ANAT, V184, P179, DOI 10.1002/aja.1001840302; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Tsukita S, 2008, ONCOGENE, V27, P6930, DOI 10.1038/onc.2008.344; WEBER JE, 1987, AM J ANAT, V180, P1, DOI 10.1002/aja.1001800102	12	123	131	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2012	338	6108					798	802		10.1126/science.1219969	http://dx.doi.org/10.1126/science.1219969			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	033ZI	22997133	Green Accepted			2022-12-24	WOS:000310839500044
J	Garaycoechea, JI; Crossan, GP; Langevin, F; Daly, M; Arends, MJ; Patel, KJ				Garaycoechea, Juan I.; Crossan, Gerry P.; Langevin, Frederic; Daly, Maria; Arends, Mark J.; Patel, Ketan J.			Genotoxic consequences of endogenous aldehydes on mouse haematopoietic stem cell function	NATURE			English	Article							FANCONI-ANEMIA; DEHYDROGENASE-ACTIVITY; PROGENITOR CELLS; DNA-REPAIR; MARROW-CELLS; MICE; TRANSPLANTATION; SUPPRESSION; PATHWAY; ASSAYS	Haematopoietic stem cells (HSCs) regenerate blood cells throughout the lifespan of an organism. With age, the functional quality of HSCs declines, partly owing to the accumulation of damaged DNA(1-3). However, the factors that damage DNA and the protective mechanisms that operate in these cells are poorly understood. We have recently shown that the Fanconi anaemia DNA-repair pathway counteracts the genotoxic effects of reactive aldehydes(4,5). Mice with combined inactivation of aldehyde catabolism (through Aldh2 knockout) and the Fanconi anaemia DNA-repair pathway (Fancd2 knockout) display developmental defects, a predisposition to leukaemia, and are susceptible to the toxic effects of ethanol-an exogenous source of acetaldehyde(4). Here we report that aged Aldh2(-/-) Fancd2(-/-) mutant mice that do not develop leukaemia spontaneously develop aplastic anaemia, with the concomitant accumulation of damaged DNA within the haematopoietic stem and progenitor cell (HSPC) pool. Unexpectedly, we find that only HSPCs, and not more mature blood precursors, require Aldh2 for protection against acetaldehyde toxicity. Additionally, the aldehyde-oxidizing activity of HSPCs, as measured by Aldefluor stain, is due to Aldh2 and correlates with this protection. Finally, there is more than a 600-fold reduction in the HSC pool of mice deficient in both Fanconi anaemia pathway-mediated DNA repair and acetaldehyde detoxification. Therefore, the emergence of bone marrow failure in Fanconi anaemia is probably due to aldehyde-mediated genotoxicity restricted to the HSPC pool. These findings identify a new link between endogenous reactive metabolites and DNA damage in HSCs, and define the protective mechanisms that counteract this threat.	[Garaycoechea, Juan I.; Crossan, Gerry P.; Langevin, Frederic; Daly, Maria; Patel, Ketan J.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Arends, Mark J.] Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Cambridge CB2 2QQ, England; [Patel, Ketan J.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 0QQ, England	MRC Laboratory Molecular Biology; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Patel, KJ (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	kjp@mrc-lmb.cam.ac.uk		Crossan, Gerry/0000-0002-7974-009X	CRUK; Homerton College, Cambridge; Milstein Fund; Darwin Trust of Edinburgh; March of Dimes Foundation; MRC [MC_U105178811] Funding Source: UKRI; Cancer Research UK [13647] Funding Source: researchfish; Medical Research Council [MC_U105178811] Funding Source: researchfish	CRUK(Cancer Research UK); Homerton College, Cambridge; Milstein Fund; Darwin Trust of Edinburgh; March of Dimes Foundation(March of Dimes); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank M. Grompe for Fancd2-deficient mice and M. Milsom and D. Walter for technical advice. We are grateful to T. Langford, R. Berks, A. Middleton, C. Knox and J. Wiles for their help with mouse experimental work. We would also like to thank the Biomed services and ARES staff for animal husbandry and assistance. We thank N. Grant for photography. We thank the Human Research Tissue Bank (NIHR Cambridge Biomedical Research Centre) for processing histology. We also thank F. Zhang for help with FACS. G. P. C. is supported by CRUK and Homerton College, Cambridge. J. I. G. is supported by the Milstein Fund and the Darwin Trust of Edinburgh. F. L. is supported by the March of Dimes Foundation.	Amrani YM, 2011, J EXP MED, V208, P1757, DOI 10.1084/jem.20102170; Armstrong L, 2004, STEM CELLS, V22, P1142, DOI 10.1634/stemcells.2004-0170; Balber AE, 2011, STEM CELLS, V29, P570, DOI 10.1002/stem.613; BECKER AJ, 1963, NATURE, V197, P452, DOI 10.1038/197452a0; Crossan GP, 2012, J PATHOL, V226, P326, DOI 10.1002/path.3002; Crossan GP, 2011, NAT GENET, V43, P147, DOI 10.1038/ng.752; Drost R, 2011, CANCER CELL, V20, P797, DOI 10.1016/j.ccr.2011.11.014; Ema H, 2006, NAT PROTOC, V1, P2979, DOI 10.1038/nprot.2006.447; Hess DA, 2006, BLOOD, V107, P2162, DOI 10.1182/blood-2005-06-2284; Houghtaling S, 2003, GENE DEV, V17, P2021, DOI 10.1101/gad.1103403; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kutler DI, 2003, BLOOD, V101, P1249, DOI 10.1182/blood-2002-07-2170; Langevin F, 2011, NATURE, V475, P53, DOI 10.1038/nature10192; Levi BP, 2009, BLOOD, V113, P1670, DOI 10.1182/blood-2008-05-156752; Lo Celso C, 2007, CURR PROTOC STEM CEL; MCCULLOCH EA, 1960, RADIAT RES, V13, P115, DOI 10.2307/3570877; MEAGHER RC, 1982, NEW ENGL J MED, V307, P845, DOI 10.1056/NEJM198209303071402; Milyavsky M, 2010, CELL STEM CELL, V7, P186, DOI 10.1016/j.stem.2010.05.016; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; Niedernhofer LJ, 2008, DNA REPAIR, V7, P523, DOI 10.1016/j.dnarep.2007.11.012; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Purton LE, 2007, CELL STEM CELL, V1, P263, DOI 10.1016/j.stem.2007.08.016; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rosado IV, 2011, NAT STRUCT MOL BIOL, V18, P1432, DOI 10.1038/nsmb.2173; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Seita J, 2010, CELL STEM CELL, V7, P145, DOI 10.1016/j.stem.2010.07.006; Storms RW, 1999, P NATL ACAD SCI USA, V96, P9118, DOI 10.1073/pnas.96.16.9118; Storms RW, 2005, BLOOD, V106, P95, DOI 10.1182/blood-2004-09-3652; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; SZILVASSY SJ, 1990, P NATL ACAD SCI USA, V87, P8736, DOI 10.1073/pnas.87.22.8736; Wang LJ, 2002, LIVER TRANSPLANT, V8, P822, DOI 10.1053/jlts.2002.34891; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Zhang QS, 2010, BLOOD, V116, P5140, DOI 10.1182/blood-2010-04-278226	34	265	271	0	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2012	489	7417					571	+		10.1038/nature11368	http://dx.doi.org/10.1038/nature11368			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	046RG	22922648				2022-12-24	WOS:000311781500005
J	Govindan, R; Ding, L; Griffith, M; Subramanian, J; Dees, ND; Kanchi, KL; Maher, CA; Fulton, R; Fulton, L; Wallis, J; Chen, K; Walker, J; McDonald, S; Bose, R; Ornitz, D; Xiong, DH; You, M; Dooling, DJ; Watson, M; Mardis, ER; Wilson, RK				Govindan, Ramaswamy; Ding, Li; Griffith, Malachi; Subramanian, Janakiraman; Dees, Nathan D.; Kanchi, Krishna L.; Maher, Christopher A.; Fulton, Robert; Fulton, Lucinda; Wallis, John; Chen, Ken; Walker, Jason; McDonald, Sandra; Bose, Ron; Ornitz, David; Xiong, Donghai; You, Ming; Dooling, David J.; Watson, Mark; Mardis, Elaine R.; Wilson, Richard K.			Genomic Landscape of Non-Small Cell Lung Cancer in Smokers and Never-Smokers	CELL			English	Article							MUTATIONAL SIGNIFICANCE; SOMATIC MUTATIONS; GENE FUSIONS; IDENTIFICATION; REARRANGEMENTS; HETEROGENEITY; TRANSCRIPTION; EXPRESSION; EVOLUTION; ARID1A	We report the results of whole-genome and transcriptome sequencing of tumor and adjacent normal tissue samples from 17 patients with non-small cell lung carcinoma (NSCLC). We identified 3,726 point mutations and more than 90 indels in the coding sequence, with an average mutation frequency more than 10-fold higher in smokers than in never-smokers. Novel alterations in genes involved in chromatin modification and DNA repair pathways were identified, along with DACH1, CFTR, RELN, ABCB5, and HGF. Deep digital sequencing revealed diverse clonality patterns in both never-smokers and smokers. All validated EFGR and KRAS mutations were present in the founder clones, suggesting possible roles in cancer initiation. Analysis revealed 14 fusions, including ROS1 and ALK, as well as novel metabolic enzymes. Cell-cycle and JAK-STAT pathways are significantly altered in lung cancer, along with perturbations in 54 genes that are potentially targetable with currently available drugs.	[Govindan, Ramaswamy; Subramanian, Janakiraman; Maher, Christopher A.; McDonald, Sandra; Bose, Ron; Watson, Mark; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO 63110 USA; [Govindan, Ramaswamy; Ding, Li; Subramanian, Janakiraman; Maher, Christopher A.; Bose, Ron] Washington Univ, Sch Med, Dept Internal Med, Div Oncol, St Louis, MO 63110 USA; [Ding, Li; Griffith, Malachi; Dees, Nathan D.; Kanchi, Krishna L.; Maher, Christopher A.; Fulton, Robert; Fulton, Lucinda; Wallis, John; Walker, Jason; Dooling, David J.; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63110 USA; [Ding, Li; Griffith, Malachi; Fulton, Robert; Fulton, Lucinda; Wallis, John; Dooling, David J.; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Ornitz, David] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [McDonald, Sandra; Watson, Mark] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Xiong, Donghai; You, Ming] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Chen, Ken] Univ Texas MD Anderson Canc Ctr, Div Quantitat Sci, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA	Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Medical College of Wisconsin; University of Texas System; UTMD Anderson Cancer Center	Wilson, RK (corresponding author), Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO 63110 USA.	rwilson@wustl.edu	Griffith, Malachi/P-1285-2014; Chen, Ken/AAU-1432-2021; Mardis, Elaine/W-2202-2019; Walker, Jason/A-9702-2013; Wilson, Richard K./AAF-4139-2019	Griffith, Malachi/0000-0002-6388-446X; Chen, Ken/0000-0003-4013-5279; Walker, Jason/0000-0001-7547-5789; Wilson, Richard K./0000-0002-1992-1358; Ornitz, David/0000-0003-1592-7629	Washington University in St. Louis; National Human Genome Research Institute [NHGRI U54 HG003079]; Washington University Cancer Genome Initiative; Siteman Cancer Center; NATIONAL CANCER INSTITUTE [P30CA016672, R00CA149182] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079] Funding Source: NIH RePORTER	Washington University in St. Louis; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Washington University Cancer Genome Initiative; Siteman Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the following groups at The Genome Institute for their dedicated efforts in this work: the Production group for sequence data production and processing, the Technology Development group for formulation of methods and troubleshooting, the Analysis Pipeline group for developing the automated sequence analysis pipelines, the LIMS group for developing tools and software to manage samples and sequencing, and the Systems group for providing the IT infrastructure and HPC solutions required for sequencing and analysis. We thank Daniel C. Koboldt for his help on tumor clonality analysis, Mike Wendl for help with pathway analysis, Josh Peck for help with manuscript preparation, and Joshua McMichael for help with figure preparation. We also thank the Washington University Cancer Genome Initiative and Siteman Cancer Center for their support. This work was funded by grants to R.K.W. from Washington University in St. Louis and the National Human Genome Research Institute (NHGRI U54 HG003079).	Bergethon K, 2012, J CLIN ONCOL, V30, P863, DOI 10.1200/JCO.2011.35.6345; Chen K, 2012, BIOINFORMATICS, V28, P1923, DOI 10.1093/bioinformatics/bts272; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Dees ND, 2012, GENOME RES, V22, P1589, DOI 10.1101/gr.134635.111; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gu TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015640; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Iyer MK, 2011, BIOINFORMATICS, V27, P2903, DOI 10.1093/bioinformatics/btr467; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Jones SJM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r82; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kendall J, 2007, P NATL ACAD SCI USA, V104, P16663, DOI 10.1073/pnas.0708286104; Kohno T, 2012, NAT MED, V18, P375, DOI 10.1038/nm.2644; Koukourakis MI, 2003, CANCER RES, V63, P5376; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Larson DE, 2012, BIOINFORMATICS, V28, P311, DOI 10.1093/bioinformatics/btr665; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; Lipson D, 2012, NAT MED, V18, P382, DOI 10.1038/nm.2673; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McPherson A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001138; Ng Tze Pin, 1994, Annals Academy of Medicine Singapore, V23, P752; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rodig SJ, 1998, CELL, V93, P373, DOI 10.1016/S0092-8674(00)81166-6; Russ AP, 2005, DRUG DISCOV TODAY, V10, P1607, DOI 10.1016/S1359-6446(05)03666-4; SELLERS TA, 1990, J NATL CANCER I, V82, P1272, DOI 10.1093/jnci/82.15.1272; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Somaiah N, 2011, J THORAC ONCOL, V6, pS1758, DOI 10.1097/01.JTO.0000407557.30793.a6; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Subramanian J, 2007, J CLIN ONCOL, V25, P561, DOI 10.1200/JCO.2006.06.8015; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Watanabe A, 2011, P NATL ACAD SCI USA, V108, P12384, DOI 10.1073/pnas.0906930108; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wendl MC, 2011, BIOINFORMATICS, V27, P1595, DOI 10.1093/bioinformatics/btr193; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Wu KM, 2006, MOL CELL BIOL, V26, P7116, DOI 10.1128/MCB.00268-06; Yang P, 1999, GENET EPIDEMIOL, V17, P253, DOI 10.1002/(SICI)1098-2272(199911)17:4<253::AID-GEPI2>3.0.CO;2-K; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725	51	833	873	20	185	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 14	2012	150	6					1121	1134		10.1016/j.cell.2012.08.024	http://dx.doi.org/10.1016/j.cell.2012.08.024			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22980976	Bronze, Green Accepted			2022-12-24	WOS:000308928100007
J	Imielinski, M; Berger, AH; Hammerman, PS; Hernandez, B; Pugh, TJ; Hodis, E; Cho, J; Suh, J; Capelletti, M; Sivachenko, A; Sougnez, C; Auclair, D; Lawrence, MS; Stojanov, P; Cibulskis, K; Choi, K; de Waal, L; Sharifnia, T; Brooks, A; Greulich, H; Banerji, S; Zander, T; Seidel, D; Leenders, F; Ansen, S; Ludwig, C; Engel-Riedel, W; Stoelben, E; Wolf, J; Goparju, C; Thompson, K; Winckler, W; Kwiatkowski, D; Johnson, BE; Janne, PA; Miller, VA; Pao, W; Travis, WD; Pass, HI; Gabriel, SB; Lander, ES; Thomas, RK; Garraway, LA; Getz, G; Meyerson, M				Imielinski, Marcin; Berger, Alice H.; Hammerman, Peter S.; Hernandez, Bryan; Pugh, Trevor J.; Hodis, Eran; Cho, Jeonghee; Suh, James; Capelletti, Marzia; Sivachenko, Andrey; Sougnez, Carrie; Auclair, Daniel; Lawrence, Michael S.; Stojanov, Petar; Cibulskis, Kristian; Choi, Kyusam; de Waal, Luc; Sharifnia, Tanaz; Brooks, Angela; Greulich, Heidi; Banerji, Shantanu; Zander, Thomas; Seidel, Danila; Leenders, Frauke; Ansen, Sascha; Ludwig, Corinna; Engel-Riedel, Walburga; Stoelben, Erich; Wolf, Juergen; Goparju, Chandra; Thompson, Kristin; Winckler, Wendy; Kwiatkowski, David; Johnson, Bruce E.; Jaenne, Pasi A.; Miller, Vincent A.; Pao, William; Travis, William D.; Pass, Harvey I.; Gabriel, Stacey B.; Lander, Eric S.; Thomas, Roman K.; Garraway, Levi A.; Getz, Gad; Meyerson, Matthew			Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing	CELL			English	Article							GROWTH-FACTOR RECEPTOR; SOMATIC MUTATIONS; GENE-MUTATIONS; CANCER; GENOME; EGFR; LANDSCAPE; GEFITINIB; PATTERNS; REVEALS	Lung adenocarcinoma, the most common subtype of non-small cell lung cancer, is responsible for more than 500,000 deaths per year worldwide. Here, we report exome and genome sequences of 183 lung adenocarcinoma tumor/normal DNA pairs. These analyses revealed a mean exonic somatic mutation rate of 12.0 events/megabase and identified the majority of genes previously reported as significantly mutated in lung adenocarcinoma. In addition, we identified statistically recurrent somatic mutations in the splicing factor gene U2AF1 and truncating mutations affecting RBM10 and ARID1A. Analysis of nucleotide context-specific mutation signatures grouped the sample set into distinct clusters that correlated with smoking history and alterations of reported lung adenocarcinoma genes. Whole-genome sequence analysis revealed frequent structural rearrangements, including in-frame exonic alterations within EGFR and SIK2 kinases. The candidate genes identified in this study are attractive targets for biological characterization and therapeutic targeting of lung adenocarcinoma.	[Imielinski, Marcin; Berger, Alice H.; Hammerman, Peter S.; Hernandez, Bryan; Pugh, Trevor J.; Hodis, Eran; Sivachenko, Andrey; Sougnez, Carrie; Auclair, Daniel; Lawrence, Michael S.; Stojanov, Petar; Cibulskis, Kristian; de Waal, Luc; Sharifnia, Tanaz; Brooks, Angela; Greulich, Heidi; Banerji, Shantanu; Thompson, Kristin; Winckler, Wendy; Gabriel, Stacey B.; Lander, Eric S.; Garraway, Levi A.; Getz, Gad; Meyerson, Matthew] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Imielinski, Marcin] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Imielinski, Marcin; Meyerson, Matthew] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Imielinski, Marcin; Berger, Alice H.; Hammerman, Peter S.; Pugh, Trevor J.; Capelletti, Marzia; Stojanov, Petar; de Waal, Luc; Sharifnia, Tanaz; Brooks, Angela; Greulich, Heidi; Banerji, Shantanu; Kwiatkowski, David; Johnson, Bruce E.; Jaenne, Pasi A.; Garraway, Levi A.; Meyerson, Matthew] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Cho, Jeonghee; Choi, Kyusam] Samsung Med Ctr, Samsung Res Inst, Seoul 135967, South Korea; [Suh, James] NYU, Langone Med Ctr, Dept Pathol, New York, NY 10016 USA; [Goparju, Chandra; Pass, Harvey I.] NYU, Langone Med Ctr, Dept Cardiothorac Surg, New York, NY 10016 USA; [Zander, Thomas; Seidel, Danila; Leenders, Frauke; Ansen, Sascha; Ludwig, Corinna; Engel-Riedel, Walburga; Stoelben, Erich; Wolf, Juergen; Thomas, Roman K.] Univ Cologne, Dept Internal Med, D-50924 Cologne, Germany; [Zander, Thomas; Seidel, Danila; Leenders, Frauke; Ansen, Sascha; Ludwig, Corinna; Engel-Riedel, Walburga; Stoelben, Erich; Wolf, Juergen; Thomas, Roman K.] Univ Cologne, Ctr Integrated Oncol, D-50924 Cologne, Germany; [Thomas, Roman K.] Univ Cologne, Lab Translat Canc Genom Koln Bonn, D-50924 Cologne, Germany; [Zander, Thomas; Thomas, Roman K.] Max Planck Inst Neurol Res, D-50924 Cologne, Germany; [Miller, Vincent A.] Mem Sloan Kettering Canc Ctr, Dept Med, Thorac Oncol Serv, New York, NY 10065 USA; [Travis, William D.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Pao, William] Vanderbilt Ingram Canc Ctr, Div Hematol Oncol, Nashville, TN 37232 USA; [Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Thomas, Roman K.] Univ Cologne, Dept Translat Genom, D-50931 Cologne, Germany; [Thomas, Roman K.] Univ Cologne, Dept Pathol, D-50937 Cologne, Germany	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Sungkyunkwan University (SKKU); Samsung Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; University of Cologne; University of Cologne; University of Cologne; Max Planck Society; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Vanderbilt University; Massachusetts Institute of Technology (MIT); University of Cologne; University of Cologne	Meyerson, M (corresponding author), Broad Inst Harvard & MIT, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	matthew_meyerson@dfci.harvard.edu	Stojanov, Petar/GQI-4462-2022; Lawrence, Michael/AAC-8202-2020; Seidel, Danila/Y-6795-2018; Cibulskis, Kristian/AAC-7380-2019; Pugh, Trevor/Y-2535-2019; Capelletti, Marzia/L-6317-2016	Stojanov, Petar/0000-0001-7815-776X; Seidel, Danila/0000-0003-4388-3117; Pugh, Trevor/0000-0002-8073-5888; Cibulskis, Kristian/0000-0003-1343-1582; Capelletti, Marzia/0000-0001-5095-7060; Meyerson, Matthew/0000-0002-9133-8108; Pass, Harvey/0000-0003-3222-3471	NCI [T32 CA9216]; Canadian Institutes of Health; American Cancer Society; National Lung Cancer Partnership; Dana-Farber/Harvard Cancer Center Lung Cancer SPORE [P50 CA090578]; NIGMS [T32GM07753]; German Ministry of Science and Education (BMBF) [01GS08100]; Max Planck Society [M.I.F.A.NEUR8061]; Deutsche Forschungsgemeinschaft (DFG) [SFB832 (TP6), TH1386/3-1]; EU-Framework Programme CURELUNG [HEALTH-F2-2010-258677]; American Association for Cancer Research [SU2C-AACR-IR60109]; Behrens-Weise Foundation; National Human Genome Research Institute; National Cancer Institute; Uniting Against Lung Cancer, the Lung Cancer Research Foundation; American Lung Association; NATIONAL CANCER INSTITUTE [T32CA009216, P50CA090578, R01CA116020, R01CA109038] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); American Cancer Society(American Cancer Society); National Lung Cancer Partnership; Dana-Farber/Harvard Cancer Center Lung Cancer SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); German Ministry of Science and Education (BMBF)(Federal Ministry of Education & Research (BMBF)); Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); EU-Framework Programme CURELUNG; American Association for Cancer Research; Behrens-Weise Foundation; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Uniting Against Lung Cancer, the Lung Cancer Research Foundation; American Lung Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank all members of the Biological Samples Platform, DNA Sequencing Platform, and Genetic Analysis Platforms of the Broad Institute, without whose work this sequencing project could not have occurred. M.I. is supported by NCI Training Grant T32 CA9216. T.J.P. is supported by a Canadian Institutes of Health Research Fellowship. A.H.B. is supported by a postdoctoral fellowship from the American Cancer Society. P.S.H. is supported by a Young Investigator Award from the National Lung Cancer Partnership and a Career Development Award from the Dana-Farber/Harvard Cancer Center Lung Cancer SPORE P50 CA090578. E.H. is supported by NIGMS training grant T32GM07753. R.K.T. is supported by the German Ministry of Science and Education (BMBF) as a member of the NGFN-Plus program (grant 01GS08100), by the Max Planck Society (M.I.F.A.NEUR8061), by the Deutsche Forschungsgemeinschaft (DFG) through SFB832 (TP6) and grant TH1386/3-1, by the EU-Framework Programme CURELUNG (HEALTH-F2-2010-258677), by Stand Up To Cancer-American Association for Cancer Research Innovative Research Grant (SU2C-AACR-IR60109), by the Behrens-Weise Foundation, and by an anonymous foundation. This work was supported by the National Human Genome Research Institute (E.S.L.) and by the National Cancer Institute, Uniting Against Lung Cancer, the Lung Cancer Research Foundation, and the American Lung Association (M.M.). M.M., E.L., and L.A.G. are founders and equity holders of Foundation Medicine, a for-profit company that provides next-generation sequencing diagnostic services. V.A.M. is an employee of Foundation Medicine.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Bergethon K, 2012, J CLIN ONCOL, V30, P863, DOI 10.1200/JCO.2011.35.6345; Cancer Genome Atlas Research Network, 2012, NATURE; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Cho J, 2011, CANCER RES, V71, P7587, DOI 10.1158/0008-5472.CAN-11-0821; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; EKSTRAND AJ, 1992, P NATL ACAD SCI USA, V89, P4309, DOI 10.1073/pnas.89.10.4309; Elsasser SJ, 2011, SCIENCE, V331, P1145, DOI 10.1126/science.1203280; Fisher S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r1; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Graubert TA, 2012, NAT GENET, V44, P53, DOI 10.1038/ng.1031; Grovdal LM, 2004, EXP CELL RES, V300, P388, DOI 10.1016/j.yexcr.2004.07.003; Hainaut P, 2001, CARCINOGENESIS, V22, P367, DOI 10.1093/carcin/22.3.367; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hashimoto YK, 2008, J CELL BIOCHEM, V104, P1724, DOI 10.1002/jcb.21737; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Ju YS, 2012, GENOME RES, V22, P436, DOI 10.1101/gr.133645.111; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kosaka T, 2009, J THORAC ONCOL, V4, P22, DOI 10.1097/JTO.0b013e3181914111; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Medvedev P, 2009, NAT METHODS, V6, pS13, DOI [10.1038/NMETH.1374, 10.1038/nmeth.1374]; Minna J.D., 2008, HARRISONS PRINCIPLES, P551; MITSUDOMI T, 1993, JNCI-J NATL CANCER I, V85, P2018, DOI 10.1093/jnci/85.24.2018; Nikolaev SI, 2012, NAT GENET, V44, P133, DOI 10.1038/ng.1026; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Pao W, 2012, NAT MED, V18, P349, DOI 10.1038/nm.2697; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Pines G, 2010, ONCOGENE, V29, P5850, DOI 10.1038/onc.2010.313; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273; SLEBOS RJC, 1991, J NATL CANCER I, V83, P1024, DOI 10.1093/jnci/83.14.1024; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Tanaka H, 2007, CANCER RES, V67, P6007, DOI 10.1158/0008-5472.CAN-06-4774; Totoki Y, 2011, NAT GENET, V43, P464, DOI 10.1038/ng.804; Travis WD, 2002, CLIN CHEST MED, V23, P65, DOI 10.1016/S0272-5231(03)00061-3; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wheeler M, 2001, MOL CELL BIOL, V21, P6660, DOI 10.1128/MCB.21.19.6660-6667.2001; World Health Organization, 2012, CANCER; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Yuza Y, 2007, CANCER BIOL THER, V6, P661, DOI 10.4161/cbt.6.5.4003; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246	56	1294	1338	5	150	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 14	2012	150	6					1107	1120		10.1016/j.cell.2012.08.029	http://dx.doi.org/10.1016/j.cell.2012.08.029			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22980975	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000308928100006
J	Fernandez, IE; Eickelberg, O				Fernandez, Isis E.; Eickelberg, Oliver			New cellular and molecular mechanisms of lung injury and fibrosis in idiopathic pulmonary fibrosis	LANCET			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; COLLAGEN-PRODUCING CELLS; PROSTAGLANDIN E-2; GASTROESOPHAGEAL-REFLUX; INTERSTITIAL PNEUMONIA; FIBROBLASTIC FOCI; SONIC HEDGEHOG; STEM-CELLS; ACTIVATION; RECEPTOR	Idiopathic pulmonary fibrosis is a serious and progressive chronic lung disease that is characterised by altered cellular composition and homoeostasis in the peripheral lung, leading to excessive accumulation of extracellular matrix and, ultimately, loss of lung function. It is the interstitial pneumonia with the worst prognosis-mortality 3-5 years after diagnosis is 50%. During the past decade, researchers have described several novel cellular and molecular mechanisms and signalling pathways implicated in the pathogenesis of idiopathic pulmonary fibrosis, resulting in the identification of new therapeutic targets. These advances will hopefully result in increased survival rates and improved quality of life for patients with this disorder in future.	[Eickelberg, Oliver] Univ Munich, Univ Hosp, Comprehens Pneumol Ctr, D-81377 Munich, Germany; [Fernandez, Isis E.; Eickelberg, Oliver] Helmholtz Ctr Munich, German Ctr Lung Res, D-81377 Munich, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Eickelberg, O (corresponding author), Univ Munich, Univ Hosp, Comprehens Pneumol Ctr, D-81377 Munich, Germany.	oliver.eickelberg@helmholtz-muenchen.de	Eickelberg, Oliver/A-5461-2013	Eickelberg, Oliver/0000-0001-7170-0360	Roche; Bayer; InterMune; Helmholtz Association	Roche(Roche Holding); Bayer(Bayer AG); InterMune; Helmholtz Association(Helmholtz Association)	Both authors have sponsored grants for fibrosis research from Roche. OE has received speaker's fees from Roche, Bayer, and InterMune.; We thank the Helmholtz Association for funding.	Amara N, 2010, THORAX, V65, P733, DOI 10.1136/thx.2009.113456; American Thoracic Society, 2002, Am J Respir Crit Care Med, V165, P277; Aoyagi-Ikeda K, 2011, AM J RESP CELL MOL, V45, P136, DOI 10.1165/rcmb.2010-0140OC; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Barry-Hamilton V, 2010, NAT MED, V16, P1009, DOI 10.1038/nm.2208; Bondi CD, 2010, J AM SOC NEPHROL, V21, P93, DOI 10.1681/ASN.2009020146; Bozyk PD, 2011, AM J RESP CELL MOL, V45, P445, DOI 10.1165/rcmb.2011-0025RT; Chapman HA, 2011, J CLIN INVEST, V121, P2855, DOI 10.1172/JCI57673; Chen ZH, 2010, P NATL ACAD SCI USA, V107, P18880, DOI 10.1073/pnas.1005574107; Chen ZH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003316; Cool CD, 2006, AM J RESP CRIT CARE, V174, P654, DOI 10.1164/rccm.200602-205OC; Coward William R, 2010, Ther Adv Respir Dis, V4, P367, DOI 10.1177/1753465810379801; Crosby LM, 2010, AM J PHYSIOL-LUNG C, V298, pL715, DOI 10.1152/ajplung.00361.2009; Dackor RT, 2011, AM J PHYSIOL-LUNG C, V301, pL645, DOI 10.1152/ajplung.00176.2011; Ding H, 2012, J AM SOC NEPHROL, V23, P801, DOI 10.1681/ASN.2011060614; Ebrahimkhani MR, 2011, NAT MED, V17, P1668, DOI 10.1038/nm.2490; Eickelberg O, 2010, AM J RESP CRIT CARE, V181, P883, DOI 10.1164/rccm.201001-0124UP; Enomoto N, 2006, CHEST, V130, P22, DOI 10.1378/chest.130.1.22; Fabian SL, 2012, AM J PATHOL, V180, P1441, DOI 10.1016/j.ajpath.2011.12.039; Fabre A, 2008, EUR RESPIR J, V32, P426, DOI 10.1183/09031936.00126907; Faner R, 2012, AM J RESP CRIT CARE, V186, P306, DOI 10.1164/rccm.201202-0282PP; Fang XJ, 2000, BIOCHEM J, V352, P135, DOI 10.1042/0264-6021:3520135; Fitch PM, 2011, INT J EXP PATHOL, V92, P8, DOI 10.1111/j.1365-2613.2010.00743.x; Flaherty KR, 2003, AM J RESP CRIT CARE, V167, P1410, DOI 10.1164/rccm.200204-373OC; Funke M, 2012, AM J RESP CELL MOL, V46, P355, DOI 10.1165/rcmb.2010-0155OC; Gardner A, 2012, AM J PATHOL, V180, P2293, DOI 10.1016/j.ajpath.2012.02.022; Ghosh M, 2011, AM J RESP CELL MOL, V45, P459, DOI 10.1165/rcmb.2010-0314OC; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Haspel JA, 2011, AM J RESP CRIT CARE, V184, P1237, DOI 10.1164/rccm.201106-0966CI; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Hinz Boris, 2009, Curr Rheumatol Rep, V11, P120; Huang XW, 2012, AM J RESP CELL MOL, V47, P340, DOI 10.1165/rcmb.2012-0050OC; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Jayachandran A, 2009, THORAX, V64, P1053, DOI 10.1136/thx.2009.121798; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Jiang X, 2010, FEBS J, V277, P2015, DOI 10.1111/j.1742-4658.2010.07632.x; Jin Y, 2012, AUTOPHAGY, V8, P426, DOI 10.4161/auto.19258; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Konigshoff M, 2011, EMBO MOL MED, V3, P575, DOI 10.1002/emmm.201100166; Konigshoff M, 2010, THORAX, V65, P949, DOI 10.1136/thx.2009.134353; Konigshoff M, 2010, AM J RESP CELL MOL, V42, P21, DOI 10.1165/rcmb.2008-0485TR; Konigshoff M, 2009, J CLIN INVEST, V119, P772, DOI 10.1172/JCI33950; Lasithiotaki I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027800; Latronico MVG, 2009, NAT REV CARDIOL, V6, P418, DOI 10.1038/nrcardio.2009.56; Lee JS, 2011, AM J RESP CRIT CARE, V184, P1390, DOI 10.1164/rccm.201101-0138OC; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Li YJ, 2011, J EXP MED, V208, P1459, DOI 10.1084/jem.20102510; Lin SL, 2008, AM J PATHOL, V173, P1617, DOI 10.2353/ajpath.2008.080433; Liu QH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032009; Liu TJ, 2009, AM J PATHOL, V174, P1745, DOI 10.2353/ajpath.2009.080618; Liu TJ, 2004, AM J PATHOL, V164, P1315, DOI 10.1016/S0002-9440(10)63218-X; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Lorenzen JM, 2011, NAT REV NEPHROL, V7, P286, DOI 10.1038/nrneph.2011.26; Maher TM, 2010, AM J RESP CRIT CARE, V182, P73, DOI 10.1164/rccm.200905-0674OC; Martin Thomas R, 2005, Proc Am Thorac Soc, V2, P214, DOI 10.1513/pats.200504-031AC; Milara J, 2012, THORAX, V67, P147, DOI 10.1136/thoraxjnl-2011-200026; Misumi Shigeki, 2006, Proc Am Thorac Soc, V3, P307, DOI 10.1513/pats.200602-018TK; Moeller A, 2008, INT J BIOCHEM CELL B, V40, P362, DOI 10.1016/j.biocel.2007.08.011; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; Mubarak KK, 2012, EUR RESPIR J, V39, P133, DOI 10.1183/09031936.00141010; Nasreen N, 2009, AM J PHYSIOL-LUNG C, V297, pL115, DOI 10.1152/ajplung.90587.2008; Oh CK, 2012, PULM MED, V2012, DOI 10.1155/2012/808260; Olsen KC, 2011, AM J RESP CRIT CARE, V184, P699, DOI 10.1164/rccm.201101-0013OC; Pandit KV, 2010, AM J RESP CRIT CARE, V182, P220, DOI 10.1164/rccm.200911-1698OC; Patel AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041394; Patel P, 2010, MATRIX BIOL, V29, P97, DOI 10.1016/j.matbio.2009.10.004; Pozharskaya V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007559; Que JW, 2008, P NATL ACAD SCI USA, V105, P16626, DOI 10.1073/pnas.0808649105; Raghu G, 2006, EUR RESPIR J, V27, P136, DOI 10.1183/09031936.06.00037005; Raghu G, 2012, NEW ENGL J MED, V366, P1968, DOI 10.1056/NEJMoa1113354; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rajkumar VS, 2006, AM J PATHOL, V169, P2254, DOI 10.2353/ajpath.2006.060196; Rock JR, 2011, P NATL ACAD SCI USA, V108, pE1475, DOI 10.1073/pnas.1117988108; Rock JR, 2011, CELL STEM CELL, V8, P639, DOI 10.1016/j.stem.2011.04.003; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Rodriguez HM, 2010, J BIOL CHEM, V285, P20964, DOI 10.1074/jbc.M109.094136; Ryter SW, 2012, ANNU REV PHYSIOL, V74, P377, DOI 10.1146/annurev-physiol-020911-153348; Selman M, 2008, PLOS MED, V5, P373, DOI 10.1371/journal.pmed.0050062; Strieter RM, 2009, CHEST, V136, P1364, DOI 10.1378/chest.09-0510; Sundberg C, 1996, LAB INVEST, V74, P452; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Tanjore H, 2009, AM J RESP CRIT CARE, V180, P657, DOI 10.1164/rccm.200903-0322OC; Taskar Varsha S, 2006, Proc Am Thorac Soc, V3, P293, DOI 10.1513/pats.200512-131TK; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Venkatesan N, 2011, AM J PHYSIOL-LUNG C, V300, pL191, DOI 10.1152/ajplung.00214.2010; Visscher Daniel W, 2006, Proc Am Thorac Soc, V3, P322, DOI 10.1513/pats.200602-019TK; Walker NM, 2012, AM J RESP CRIT CARE, V185, P77, DOI 10.1164/rccm.201105-0834OC; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Yang HZ, 2012, AM J PATHOL, V180, P275, DOI 10.1016/j.ajpath.2011.09.019; Yang SZ, 2012, AM J PATHOL, V180, P484, DOI 10.1016/j.ajpath.2011.10.005; Zhang Y, 2008, NAT GENET, V40, P862, DOI 10.1038/ng.157	95	293	310	17	115	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 18	2012	380	9842					680	688		10.1016/S0140-6736(12)61144-1	http://dx.doi.org/10.1016/S0140-6736(12)61144-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	991SE	22901889				2022-12-24	WOS:000307721000033
J	Kruidenier, L; Chung, CW; Cheng, ZJ; Liddle, J; Che, KH; Joberty, G; Bantscheff, M; Bountra, C; Bridges, A; Diallo, H; Eberhard, D; Hutchinson, S; Jones, E; Katso, R; Leveridge, M; Mander, PK; Mosley, J; Ramirez-Molina, C; Rowland, P; Schofield, CJ; Sheppard, RJ; Smith, JE; Swales, C; Tanner, R; Thomas, P; Tumber, A; Drewes, G; Oppermann, U; Patel, DJ; Lee, K; Wilson, DM				Kruidenier, Laurens; Chung, Chun-wa; Cheng, Zhongjun; Liddle, John; Che, KaHing; Joberty, Gerard; Bantscheff, Marcus; Bountra, Chas; Bridges, Angela; Diallo, Hawa; Eberhard, Dirk; Hutchinson, Sue; Jones, Emma; Katso, Roy; Leveridge, Melanie; Mander, Palwinder K.; Mosley, Julie; Ramirez-Molina, Cesar; Rowland, Paul; Schofield, Christopher J.; Sheppard, Robert J.; Smith, Julia E.; Swales, Catherine; Tanner, Robert; Thomas, Pamela; Tumber, Anthony; Drewes, Gerard; Oppermann, Udo; Patel, Dinshaw J.; Lee, Kevin; Wilson, David M.			A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response	NATURE			English	Article							HISTONE LYSINE DEMETHYLASES; SUBSTRATE-SPECIFICITY; STRUCTURAL INSIGHTS; GENE-EXPRESSION; JMJD3; METHYLATION; DISEASE; FAMILY; UTX	The jumonji (JMJ) family of histone demethylases are Fe2+ - and a-ketoglutarate-dependent oxygenases that are essential components of regulatory transcriptional chromatin complexes(1-4). These enzymes demethylate lysine residues in histones in a methylation-state and sequence-specific context(5). Considerable effort has been devoted to gaining a mechanistic understanding of the roles of histone lysine demethylases in eukaryotic transcription, genome integrity and epigenetic inheritance(2,4,6), as well as in development, physiology and disease(3,7). However, because of the absence of any selective inhibitors, the relevance of the demethylase activity of JMJ enzymes in regulating cellular responses remains poorly understood. Here we present a structure-guided small-molecule and chemoproteomics approach to elucidating the functional role of the H3K27me3-specific demethylase subfamily (KDM6 subfamily members JMJD3 and UTX)(8). The liganded structures of human and mouse JMJD3 provide novel insight into the specificity determinants for cofactor, substrate and inhibitor recognition by the KDM6 subfamily of demethylases. We exploited these structural features to generate the first small-molecule catalytic site inhibitor that is selective for the H3K27me3-specific JMJ subfamily. We demonstrate that this inhibitor binds in a novel manner and reduces lipopolysaccharide-induced proinflammatory cytokine production by human primary macrophages, a process that depends on both JMJD3 and UTX. Our results resolve the ambiguity associated with the catalytic function of H3K27-specific JMJs in regulating disease-relevant inflammatory responses and provide encouragement for designing small-molecule inhibitors to allow selective pharmacological intervention across the JMJ family.	[Kruidenier, Laurens; Liddle, John; Diallo, Hawa; Mander, Palwinder K.; Ramirez-Molina, Cesar; Sheppard, Robert J.; Smith, Julia E.; Lee, Kevin; Wilson, David M.] GlaxoSmithKline R&D, Med Res Ctr, Immunoinflammat Therapy Area, Epinova DPU, Stevenage SG1 2NY, Herts, England; [Chung, Chun-wa; Bridges, Angela; Hutchinson, Sue; Jones, Emma; Katso, Roy; Leveridge, Melanie; Mosley, Julie; Rowland, Paul; Tanner, Robert; Thomas, Pamela] GlaxoSmithKline R&D, Med Res Ctr, Platform Technol & Sci, Stevenage SG1 2NY, Herts, England; [Cheng, Zhongjun; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Che, KaHing; Bountra, Chas; Schofield, Christopher J.; Tumber, Anthony; Oppermann, Udo] Univ Oxford, Struct Genom Consortium, Headington OX3 7DQ, England; [Che, KaHing; Swales, Catherine; Oppermann, Udo] Univ Oxford, NIHR Biomed Res Unit, Botnar Res Ctr, Oxford OX3 7LD, England; [Joberty, Gerard; Bantscheff, Marcus; Eberhard, Dirk; Drewes, Gerard] Cellzome AG, D-69117 Heidelberg, Germany	GlaxoSmithKline; GlaxoSmithKline; Memorial Sloan Kettering Cancer Center; University of Oxford; University of Oxford; GlaxoSmithKline; Cellzome GmbH	Wilson, DM (corresponding author), GlaxoSmithKline R&D, Med Res Ctr, Immunoinflammat Therapy Area, Epinova DPU, Gunnels Wood Rd, Stevenage SG1 2NY, Herts, England.	david.m.wilson@gsk.com	Bantscheff, Marcus/AAQ-2903-2021	Bantscheff, Marcus/0000-0002-8343-8977; Drewes, Gerard/0000-0003-0575-6766; Schofield, Christopher/0000-0002-0290-6565; Sheppard, Robert/0000-0002-5876-5589	Starr Foundation; Abby Rockefeller Mauze Trust; Maloris Foundation; Canadian Institutes for Health Research; Canada Foundation for Innovation; Genome Canada; GlaxoSmithKline; Lilly Canada; Novartis Research Foundation; Pfizer; Takeda; Ontario Ministry of Economic Development and Innovation; Wellcome Trust; National Institute for Health and Research (NIHR) Biomedical Research Unit, Oxford; Versus Arthritis [18358] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Starr Foundation; Abby Rockefeller Mauze Trust; Maloris Foundation; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Genome Canada(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Lilly Canada(Eli Lilly); Novartis Research Foundation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); Ontario Ministry of Economic Development and Innovation; Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health and Research (NIHR) Biomedical Research Unit, Oxford(National Institute for Health Research (NIHR)); Versus Arthritis(Versus Arthritis); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the following colleagues for their help and advice in preparing the manuscript: A. Argyrou, S. Atkinson, M. Barker, M. Campbell, L. Gordon, R. Gregory, R. Grimley, P. Humphreys, P. Jeffrey, A. Kucik, B. Leavens, C. Lewis, V. Ludbrook, R. Prinjha, S. Ratcliffe, C. Sharp, D. Thomas, D. Tough and M. Woodrow. Help was also provided by N. Burgess-Brown, S. Ng, J. Dunford, A. Kawamura, N. Rose and M. Daniel. D. J. P. was supported by funds from the Starr Foundation, the Abby Rockefeller Mauze Trust and the Maloris Foundation. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canada Foundation for Innovation, Genome Canada, GlaxoSmithKline, Lilly Canada, the Novartis Research Foundation, Pfizer, Takeda, the Ontario Ministry of Economic Development and Innovation, and the Wellcome Trust. This study was supported by the National Institute for Health and Research (NIHR) Biomedical Research Unit, Oxford. Thanks also to M. Boesche and the Cellzome biochemistry and mass spectrometry teams for assistance with the chemoproteomics experiments. Finally, we acknowledge additional contributions from members of Platform Technology Sciences and the Epinova DPU and the JMJD3 programme team for supporting this research.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Bantscheff M, 2011, NAT BIOTECHNOL, V29, P255, DOI 10.1038/nbt.1759; Couture JF, 2007, NAT STRUCT MOL BIOL, V14, P689, DOI 10.1038/nsmb1273; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; De Santa F, 2009, EMBO J, V28, P3341, DOI 10.1038/emboj.2009.271; Gamo FJ, 2010, NATURE, V465, P305, DOI 10.1038/nature09107; Gehani SS, 2010, MOL CELL, V39, P886, DOI 10.1016/j.molcel.2010.08.020; Horton JR, 2010, NAT STRUCT MOL BIOL, V17, P38, DOI 10.1038/nsmb.1753; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Loenarz C, 2011, TRENDS BIOCHEM SCI, V36, P7, DOI 10.1016/j.tibs.2010.07.002; Mackeen MM, 2010, J PROTEOME RES, V9, P4082, DOI 10.1021/pr100269b; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; Mosammaparast N, 2010, ANNU REV BIOCHEM, V79, P155, DOI 10.1146/annurev.biochem.78.070907.103946; Ng SS, 2007, NATURE, V448, P87, DOI 10.1038/nature05971; Pedersen MT, 2010, TRENDS CELL BIOL, V20, P662, DOI 10.1016/j.tcb.2010.08.011; Sakurai M, 2010, MOL BIOSYST, V6, P357, DOI 10.1039/b912993f; Sengoku T, 2011, GENE DEV, V25, P2266, DOI 10.1101/gad.172296.111; Shi Y, 2007, NAT REV GENET, V8, P829, DOI 10.1038/nrg2218; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Trojer P, 2006, CELL, V125, P213, DOI 10.1016/j.cell.2006.04.003; Yang Y, 2010, CELL RES, V20, P886, DOI 10.1038/cr.2010.86; Yu M, 2006, BIOCHEMISTRY-US, V45, P14788, DOI 10.1021/bi061621t	25	630	652	4	109	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2012	488	7411					404	408		10.1038/nature11262	http://dx.doi.org/10.1038/nature11262			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OS	22842901	Green Accepted			2022-12-24	WOS:000307501000047
J	Lee, SH; Kwan, AC; Zhang, SY; Phoumthipphavong, V; Flannery, JG; Masmanidis, SC; Taniguchi, H; Huang, ZJ; Zhang, F; Boyden, ES; Deisseroth, K; Dan, Y				Lee, Seung-Hee; Kwan, Alex C.; Zhang, Siyu; Phoumthipphavong, Victoria; Flannery, John G.; Masmanidis, Sotiris C.; Taniguchi, Hiroki; Huang, Z. Josh; Zhang, Feng; Boyden, Edward S.; Deisseroth, Karl; Dan, Yang			Activation of specific interneurons improves V1 feature selectivity and visual perception	NATURE			English	Article							ORIENTATION SELECTIVITY; CORTICAL-NEURONS; ELECTRODE ARRAYS; CORTEX; INHIBITION; RESPONSES; INNERVATION; POPULATIONS; PERFORMANCE; MODULATION	Inhibitory interneurons are essential components of the neural circuits underlying various brain functions. In the neocortex, a large diversity of GABA (gamma-aminobutyric acid) interneurons has been identified on the basis of their morphology, molecular markers, biophysical properties and innervation pattern(1-3). However, how the activity of each subtype of interneurons contributes to sensory processing remains unclear. Here we show that optogenetic activation of parvalbumin-positive (PV+) interneurons in the mouse primary visual cortex (V1) sharpens neuronal feature selectivity and improves perceptual discrimination. Using multichannel recording with silicon probes(4,5) and channelrhodopsin-2 (ChR2)-mediated optical activation(6), we found that increased spiking of PV+ interneurons markedly sharpened orientation tuning and enhanced direction selectivity of nearby neurons. These effects were caused by the activation of inhibitory neurons rather than a decreased spiking of excitatory neurons, as archaerhodopsin-3 (Arch)-mediated optical silencing(7) of calcium/calmodulindependent protein kinase II alpha (CAMKII alpha)-positive excitatory neurons caused no significant change in V1 stimulus selectivity. Moreover, the improved selectivity specifically required PV+ neuron activation, as activating somatostatin or vasointestinal peptide interneurons had no significant effect. Notably, PV+ neuron activation in awake mice caused a significant improvement in their orientation discrimination, mirroring the sharpened V1 orientation tuning. Together, these results provide the first demonstration that visual coding and perception can be improved by increased spiking of a specific subtype of cortical inhibitory interneurons.	[Lee, Seung-Hee; Kwan, Alex C.; Zhang, Siyu; Phoumthipphavong, Victoria; Flannery, John G.; Dan, Yang] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Lee, Seung-Hee; Dan, Yang] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Masmanidis, Sotiris C.] CALTECH, Kavli Nanosci Inst, Broad Fellows Program Brain Circuitry, Pasadena, CA 91125 USA; [Taniguchi, Hiroki; Huang, Z. Josh] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Zhang, Feng; Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Dept Bioengn, Stanford, CA 94305 USA; [Boyden, Edward S.] MIT, Media Lab, Cambridge, MA 02139 USA; [Boyden, Edward S.] MIT, McGovern Inst, Cambridge, MA 02139 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; California Institute of Technology; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Stanford University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Dan, Y (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	ydan@berkeley.edu	Lee, Seung-Hee/J-5971-2013; Macrae, Rhiannon/AAX-1536-2020	Flannery, John/0000-0002-0720-8897; Dan, Yang/0000-0002-3818-877X; Huang, Z. Josh/0000-0003-0592-028X; Kwan, Alex/0000-0003-2169-1667; Zhang, Siyu/0000-0003-1745-2532; Zhang, Siyu/0000-0001-7298-1475	National Institutes of Health [R01 EY018861, PN2 EY018241]; National Science Foundation [22250400-42533]; NATIONAL EYE INSTITUTE [PN2EY018241, R01EY018861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067199] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Goard, L. Pinto, M. Xu and M. Viesel for help with experimental setup, A. Kaluszka for help with data analysis and H. Alitto and M. Poo for discussion and comments on the manuscript. This work was supported by National Institutes of Health grants R01 EY018861 and PN2 EY018241 and National Science Foundation grant 22250400-42533.	Andermann ML, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00003; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Ayaz A, 2009, J NEUROPHYSIOL, V101, P958, DOI 10.1152/jn.90547.2008; Blanche TJ, 2005, J NEUROPHYSIOL, V93, P2987, DOI 10.1152/jn.01023.2004; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Chen Y, 2008, NAT NEUROSCI, V11, P974, DOI 10.1038/nn.2147; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; David C, 2007, EUR J NEUROSCI, V25, P2329, DOI 10.1111/j.1460-9568.2007.05496.x; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Di Cristo G, 2004, NAT NEUROSCI, V7, P1184, DOI 10.1038/nn1334; Du JG, 2009, J NEUROPHYSIOL, V101, P1671, DOI 10.1152/jn.90992.2008; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; Green DM, 1966, SIGNAL DETECTION THE; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Hazan L, 2006, J NEUROSCI METH, V155, P207, DOI 10.1016/j.jneumeth.2006.01.017; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Kang KJ, 2004, J NEUROSCI, V24, P3726, DOI 10.1523/JNEUROSCI.4272-03.2004; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Ma WP, 2010, J NEUROSCI, V30, P14371, DOI 10.1523/JNEUROSCI.3248-10.2010; Maheshri N, 2006, NAT BIOTECHNOL, V24, P198, DOI 10.1038/nbt1182; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Mehaffey WH, 2005, J NEUROSCI, V25, P9968, DOI 10.1523/JNEUROSCI.2682-05.2005; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; NELSON S, 1994, SCIENCE, V265, P774, DOI 10.1126/science.8047882; O'Connor DH, 2010, J NEUROSCI, V30, P1947, DOI 10.1523/JNEUROSCI.3762-09.2010; Runyan CA, 2010, NEURON, V67, P847, DOI 10.1016/j.neuron.2010.08.006; Schmitzer-Torbert N, 2005, NEUROSCIENCE, V131, P1, DOI 10.1016/j.neuroscience.2004.09.066; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P287, DOI 10.1113/jphysiol.1975.sp011055; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Toledo-Rodriguez M, 2004, CEREB CORTEX, V14, P1310, DOI 10.1093/cercor/bhh092; Troyer TW, 1998, J NEUROSCI, V18, P5908; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Xu XM, 2010, J COMP NEUROL, V518, P389, DOI 10.1002/cne.22229; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226	36	386	387	7	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2012	488	7411					379	+		10.1038/nature11312	http://dx.doi.org/10.1038/nature11312			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OS	22878719	Green Accepted, Green Submitted			2022-12-24	WOS:000307501000042
J	Marteau, TM; Hollands, GJ; Fletcher, PC				Marteau, Theresa M.; Hollands, Gareth J.; Fletcher, Paul C.			Changing Human Behavior to Prevent Disease: The Importance of Targeting Automatic Processes	SCIENCE			English	Editorial Material							CHILDRENS TASTE; SOCIAL-BEHAVIOR; HABITS; METAANALYSIS; PREFERENCES; INTENTIONS; ALCOHOL	Much of the global burden of disease is associated with behaviors-overeating, smoking, excessive alcohol consumption, and physical inactivity-that people recognize as health-harming and yet continue to engage in, even when undesired consequences emerge. To date, interventions aimed at changing such behaviors have largely encouraged people to reflect on their behaviors. These approaches are often ineffectual, which is in keeping with the observation that much human behavior is automatic, cued by environmental stimuli, resulting in actions that are largely unaccompanied by conscious reflection. We propose that interventions targeting these automatic bases of behaviors may be more effective. We discuss specific interventions and suggest ways to determine whether and how interventions that target automatic processes can enhance global efforts to prevent disease.	[Marteau, Theresa M.; Hollands, Gareth J.] Univ Cambridge, Behav & Hlth Res Unit, Inst Publ Hlth, Cambridge CB2 0SR, England; [Fletcher, Paul C.] Univ Cambridge, Dept Psychiat, Cambridge CB2 0SR, England	University of Cambridge; University of Cambridge	Marteau, TM (corresponding author), Univ Cambridge, Behav & Hlth Res Unit, Inst Publ Hlth, Cambridge CB2 0SR, England.	theresa.marteau@medschl.cam.ac.uk	; Fletcher, Paul/F-5380-2011	Hollands, Gareth/0000-0002-0492-3924; Fletcher, Paul/0000-0001-8257-1517; Marteau, Theresa/0000-0003-3025-1129	Wellcome Trust [095692] Funding Source: Medline; Department of Health [107/0001] Funding Source: Medline	Wellcome Trust(Wellcome Trust); Department of Health		Bargh JA, 1996, J PERS SOC PSYCHOL, V71, P230, DOI 10.1037/0022-3514.71.2.230; Bargh JA, 2000, PSYCHOL BULL, V126, P925, DOI 10.1037//0033-2909.126.6.925; Benden ME, 2011, AM J PUBLIC HEALTH, V101, P1433, DOI 10.2105/AJPH.2010.300072; Cecchini M, 2010, LANCET, V376, P1775, DOI 10.1016/S0140-6736(10)61514-0; de Wit S, 2009, PSYCHOL RES-PSYCH FO, V73, P463, DOI 10.1007/s00426-009-0230-6; Dijksterhuis A, 2010, ANNU REV PSYCHOL, V61, P467, DOI 10.1146/annurev.psych.093008.100445; Engels RCME, 2009, ALCOHOL ALCOHOLISM, V44, P244, DOI 10.1093/alcalc/agp003; Everitt BJ, 2008, PHILOS T R SOC B, V363, P3125, DOI 10.1098/rstb.2008.0089; French SA, 2010, J OCCUP ENVIRON MED, V52, pS29, DOI 10.1097/JOM.0b013e3181c5c476; Gollwitzer PM, 2006, ADV EXP SOC PSYCHOL, V38, P69, DOI 10.1016/S0065-2601(06)38002-1; Harris JL, 2009, HEALTH PSYCHOL, V28, P404, DOI 10.1037/a0014399; Hollands G. J., 2012, ALTERING CHOICE ARCH; Hollands GJ, 2011, HEALTH PSYCHOL, V30, P195, DOI 10.1037/a0022261; Kahneman D., 2011, THINKING FAST SLOW; Kutner M, 2006, 2006483 NCES US DEP; Lancaster T, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001292.pub2, 10.1002/14651858.CD001292.pub3]; Marteau TM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007275.pub2; Moodie C, 2012, PLAIN TOBACCO PACKAG; Moors A, 2006, PSYCHOL BULL, V132, P297, DOI 10.1037/0033-2909.132.2.297; Neal DT, 2006, CURR DIR PSYCHOL SCI, V15, P198, DOI 10.1111/j.1467-8721.2006.00435.x; Papies EK, 2012, CURR OBES REP, V1, P99, DOI 10.1007/s13679-012-0009-8; Reitzel LR, 2011, AM J PUBLIC HEALTH, V101, P315, DOI 10.2105/AJPH.2010.191676; Roberto CA, 2010, PEDIATRICS, V126, P88, DOI 10.1542/peds.2009-3433; Robinson TN, 2007, ARCH PEDIAT ADOL MED, V161, P792, DOI 10.1001/archpedi.161.8.792; Rossen, 2003, SCAND J NUTR, V47, P26, DOI DOI 10.1080/11026480310004262; Rozin P, 2011, JUDGM DECIS MAK, V6, P323; Schnall S, 2010, PERCEPTION, V39, P464, DOI 10.1068/p6445; Shiv B, 1999, J CONSUM RES, V26, P278, DOI 10.1086/209563; Spears D, 2010, EC DECISION MAKING P; Strack F, 2004, PERS SOC PSYCHOL REV, V8, P220, DOI 10.1207/s15327957pspr0803_1; VANHOUTEN R, 1981, J APPL BEHAV ANAL, V14, P377, DOI 10.1901/jaba.1981.14-377; Wansink B, 2003, J CONSUM RES, V30, P455, DOI 10.1086/378621; Webb TL, 2006, PSYCHOL BULL, V132, P249, DOI 10.1037/0033-2909.132.2.249; Wiers RW, 2010, ADDICTION, V105, P279, DOI 10.1111/j.1360-0443.2009.02775.x; WILLIAMS J, 2003, SKILLS LIFE SURVEY N; Wood W, 2007, PSYCHOL REV, V114, P843, DOI 10.1037/0033-295X.114.4.843	36	476	482	4	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2012	337	6101					1492	1495		10.1126/science.1226918	http://dx.doi.org/10.1126/science.1226918			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	007UC	22997327	Green Published			2022-12-24	WOS:000308912900039
J	Running, SW				Running, Steven W.			A Measurable Planetary Boundary for the Biosphere	SCIENCE			English	Editorial Material							NET PRIMARY PRODUCTION; HUMAN APPROPRIATION; ECOSYSTEMS		Univ Montana, Numer Terradynam Simulat Grp, Missoula, MT 59812 USA	University of Montana System; University of Montana	Running, SW (corresponding author), Univ Montana, Numer Terradynam Simulat Grp, Missoula, MT 59812 USA.	swr@ntsg.umt.edu						Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Haberl H, 2007, P NATL ACAD SCI USA, V104, P12942, DOI 10.1073/pnas.0704243104; Meadows D.H., 1972, LIMITS GROWTH, P205; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Smith WK, 2012, BIOSCIENCE, V62, P911, DOI 10.1525/bio.2012.62.10.11; Tilman D, 2009, SCIENCE, V325, P270, DOI 10.1126/science.1177970; Turner GM, 2008, GLOBAL ENVIRON CHANG, V18, P397, DOI 10.1016/j.gloenvcha.2008.05.001; VITOUSEK PM, 1986, BIOSCIENCE, V36, P368, DOI 10.2307/1310258; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Zhao MS, 2010, SCIENCE, V329, P940, DOI [10.1126/science.1192666, 10.1126/science.1189590]	12	192	215	3	184	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2012	337	6101					1458	1459		10.1126/science.1227620	http://dx.doi.org/10.1126/science.1227620			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007UC	22997311				2022-12-24	WOS:000308912900025
J	Naik, S; Bouladoux, N; Wilhelm, C; Molloy, MJ; Salcedo, R; Kastenmuller, W; Deming, C; Quinones, M; Koo, L; Conlan, S; Spencer, S; Hall, JA; Dzutsev, A; Kong, H; Campbell, DJ; Trinchieri, G; Segre, JA; Belkaid, Y				Naik, Shruti; Bouladoux, Nicolas; Wilhelm, Christoph; Molloy, Michael J.; Salcedo, Rosalba; Kastenmuller, Wolfgang; Deming, Clayton; Quinones, Mariam; Koo, Lily; Conlan, Sean; Spencer, Sean; Hall, Jason A.; Dzutsev, Amiran; Kong, Heidi; Campbell, Daniel J.; Trinchieri, Giorgio; Segre, Julia A.; Belkaid, Yasmine			Compartmentalized Control of Skin Immunity by Resident Commensals	SCIENCE			English	Article							REGULATORY T-CELLS; HUMAN MICROBIOME; DENDRITIC CELLS; INNATE IMMUNITY; SYSTEM; RECOGNITION; DIVERSITY; INTESTINE; INFECTION; RESPONSES	Intestinal commensal bacteria induce protective and regulatory responses that maintain host-microbial mutualism. However, the contribution of tissue-resident commensals to immunity and inflammation at other barrier sites has not been addressed. We found that in mice, the skin microbiota have an autonomous role in controlling the local inflammatory milieu and tuning resident T lymphocyte function. Protective immunity to a cutaneous pathogen was found to be critically dependent on the skin microbiota but not the gut microbiota. Furthermore, skin commensals tuned the function of local T cells in a manner dependent on signaling downstream of the interleukin-1 receptor. These findings underscore the importance of the microbiota as a distinctive feature of tissue compartmentalization, and provide insight into mechanisms of immune system regulation by resident commensal niches in health and disease.	[Naik, Shruti; Bouladoux, Nicolas; Wilhelm, Christoph; Molloy, Michael J.; Spencer, Sean; Belkaid, Yasmine] NIAID, Mucosal Immun Sect, Parasit Dis Lab, Bethesda, MD 20892 USA; [Naik, Shruti; Spencer, Sean] Univ Penn, Immunol Grad Grp, Philadelphia, PA 19104 USA; [Salcedo, Rosalba; Dzutsev, Amiran; Trinchieri, Giorgio] NCI, Canc & Inflammat Program, Ctr Canc Res, Frederick, MD 21702 USA; [Salcedo, Rosalba; Dzutsev, Amiran] NCI, SAIC Frederick Inc, Frederick, MD 21701 USA; [Kastenmuller, Wolfgang] NIAID, Lymphocyte Biol Sect, Immunol Lab, Bethesda, MD 20892 USA; [Deming, Clayton; Conlan, Sean; Segre, Julia A.] NHGRI, Genet & Mol Biol Branch, Bethesda, MD 20892 USA; [Quinones, Mariam] NIAID, Bioinformat & Computat Biosci Branch, Bethesda, MD 20892 USA; [Koo, Lily] NIAID, Res Technol Branch, Bethesda, MD 20892 USA; [Hall, Jason A.] NYU, Sch Med, Skirball Inst Biomol Med, Kimmel Ctr Biol & Med,Mol Pathogenesis Program, New York, NY 10016 USA; [Kong, Heidi] NCI, Dermatol Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Campbell, Daniel J.] Benaroya Res Inst, Seattle, WA 98101 USA; [Campbell, Daniel J.] Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); New York University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Benaroya Research Institute; University of Washington; University of Washington Seattle	Belkaid, Y (corresponding author), NIAID, Mucosal Immun Sect, Parasit Dis Lab, Bethesda, MD 20892 USA.	ybelkaid@niaid.nih.gov	Trinchieri, Giorgio/F-9369-2015; Conlan, Sean/B-4401-2008; Wilhelm, Christoph/ABE-7176-2020; Kong, Heidi H/L-4856-2018	Trinchieri, Giorgio/0000-0001-5892-7464; Conlan, Sean/0000-0001-6848-3465; Wilhelm, Christoph/0000-0002-9839-0291; Kong, Heidi H/0000-0003-4424-064X; Spencer, Sean/0000-0002-7328-5399; Quinones, Mariam/0000-0002-8520-5114; Belkaid, Yasmine/0000-0001-9962-3571; Bouladoux, Nicolas/0000-0003-1593-671X	Division of Intramural Research of the National Institute of Allergy and Infectious Diseases (NIAID); National Human Genome Research Institute, the National Cancer Institute, NIH [F30 DK094708]; Human Frontier Science Program; NATIONAL CANCER INSTITUTE [ZIABC011153, ZIABC010938] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001115, R01AI085130, ZICAI001051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK094708] Funding Source: NIH RePORTER	Division of Intramural Research of the National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Human Genome Research Institute, the National Cancer Institute, NIH; Human Frontier Science Program(Human Frontier Science Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by the Division of Intramural Research of the National Institute of Allergy and Infectious Diseases (NIAID) and by the National Human Genome Research Institute, the National Cancer Institute, NIH grant F30 DK094708 (S. S.), and the Human Frontier Science Program (C. W.). We thank the NIAID gnotobiotic facility staff, in particular C. Acevedo and D. Trageser-Cesler; K. Holmes and the NIAID sorting facility; K. Beacht, B. Kelsall, T. Tamachi, C. Brown, J. Benchley, A. MacDonald, L. Mijares, K. Shenderov, and A. Sher; and Yakult Central Institute for Microbiological Research for sharing SFB via a material transfer agreement. DNA sequence data are available via GenBank (accession no. SRS345653). The data reported in this paper are tabulated in the main paper and in the supplementary materials.	Belkaid Y, 2000, J IMMUNOL, V165, P969, DOI 10.4049/jimmunol.165.2.969; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Cebra JJ, 1999, AM J CLIN NUTR, V69, p1046S, DOI 10.1093/ajcn/69.5.1046s; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; de Oliveira M R, 1999, Rev Inst Med Trop Sao Paulo, V41, P87, DOI 10.1590/S0036-46651999000200005; Gallo RL, 2011, J INVEST DERMATOL, V131, P1974, DOI 10.1038/jid.2011.182; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Guilliams M, 2010, BLOOD, V115, P1958, DOI 10.1182/blood-2009-09-245274; Guo LY, 2009, P NATL ACAD SCI USA, V106, P13463, DOI 10.1073/pnas.0906988106; Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009; Hill DA, 2010, MUCOSAL IMMUNOL, V3, P148, DOI 10.1038/mi.2009.132; Hu W, 2011, IMMUNITY, V35, P1010, DOI 10.1016/j.immuni.2011.10.013; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kong HDH, 2012, GENOME RES, V22, P850, DOI 10.1101/gr.131029.111; Lai YP, 2009, NAT MED, V15, P1377, DOI 10.1038/nm.2062; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Miller LS, 2006, IMMUNITY, V24, P79, DOI 10.1016/j.immuni.2005.11.011; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Shaw MH, 2012, J EXP MED, V209, P251, DOI 10.1084/jem.20111703; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Sumaria N, 2011, J EXP MED, V208, P505, DOI 10.1084/jem.20101824; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; UMESAKI Y, 1995, MICROBIOL IMMUNOL, V39, P555, DOI 10.1111/j.1348-0421.1995.tb02242.x; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wilson NS, 2008, IMMUNOL CELL BIOL, V86, P200, DOI 10.1038/sj.icb.7100125; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001	33	558	579	6	162	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2012	337	6098					1115	1119		10.1126/science.1225152	http://dx.doi.org/10.1126/science.1225152			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22837383	Green Accepted			2022-12-24	WOS:000308125800053
J	Litvak, V; Ratushny, AV; Lampano, AE; Schmitz, F; Huang, AC; Raman, A; Rust, AG; Bergthaler, A; Aitchison, JD; Aderem, A				Litvak, Vladimir; Ratushny, Alexander V.; Lampano, Aaron E.; Schmitz, Frank; Huang, Albert C.; Raman, Ayush; Rust, Alistair G.; Bergthaler, Andreas; Aitchison, John D.; Aderem, Alan			A FOXO3-IRF7 gene regulatory circuit limits inflammatory sequelae of antiviral responses	NATURE			English	Article							FORKHEAD TRANSCRIPTION FACTORS; HISTONE ACETYLATION; EXPRESSION; ACTIVATION; DATABASE; CELLS	Antiviral responses must be tightly regulated to defend rapidly against infection while minimizing inflammatory damage. Type 1 interferons (IFN-I) are crucial mediators of antiviral responses(1) and their transcription is regulated by a variety of transcription factors(2); principal among these is the family of interferon regulatory factors (IRFs)(3). The IRF gene regulatory networks are complex and contain multiple feedback loops. The tools of systems biology are well suited to elucidate the complex interactions that give rise to precise coordination of the interferon response. Here we have used an unbiased systems approach to predict that a member of the forkhead family of transcription factors, FOXO3, is a negative regulator of a subset of antiviral genes. This prediction was validated using macrophages isolated from Foxo3-null mice. Genome-wide location analysis combined with gene deletion studies identified the Irf7 gene as a critical target of FOXO3. FOXO3 was identified as a negative regulator of Irf7 transcription and we have further demonstrated that FOXO3, IRF7 and IFN-I forma coherent feed-forward regulatory circuit. Our data suggest that the FOXO3-IRF7 regulatory circuit represents a novel mechanism for establishing the requisite set points in the interferon pathway that balances the beneficial effects and deleterious sequelae of the antiviral response.	[Litvak, Vladimir; Ratushny, Alexander V.; Lampano, Aaron E.; Schmitz, Frank; Aitchison, John D.; Aderem, Alan] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Ratushny, Alexander V.; Huang, Albert C.; Raman, Ayush; Aitchison, John D.] Inst Syst Biol, Seattle, WA 98109 USA; [Rust, Alistair G.] Welcome Trust Sanger Inst, Cambridge CB10 1HH, England; [Bergthaler, Andreas] Austrian Acad Sci, Res Ctr Mol Med, A-1090 Vienna, Austria	Center for Infectious Disease Research; Institute for Systems Biology (ISB); Wellcome Trust Sanger Institute; Austrian Academy of Sciences	Aderem, A (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.	alan.aderem@seattlebiomed.org	Raman, Ayush/AAR-6165-2021; Bergthaler, Andreas/ABG-5047-2020	Raman, Ayush/0000-0003-2872-2307; Bergthaler, Andreas/0000-0003-0597-1976; Rust, Alistair/0000-0001-7287-192X	National Institutes of Health [R01AI025032, R01AI032972, HHSN272200700038C, HHSN272200800058C, U54GM103511]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR022220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI025032, U19AI100627, R01AI032972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM103511] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. A. Kennedy and J. J. Peschon for discussions and critical reading of the manuscript; and S. A. Danziger, T. Stolyar and E. van Gaver for technical assistance. This work was supported by grants and contracts from the National Institutes of Health (R01AI025032, R01AI032972, HHSN272200700038C, HHSN272200800058C and U54GM103511).	Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Benayoun BA, 2011, TRENDS GENET, V27, P224, DOI 10.1016/j.tig.2011.03.003; Biobase, TRANSFAC PROF V9 3; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Chiang D Y, 2001, Bioinformatics, V17 Suppl 1, pS49; Dejean AS, 2009, NAT IMMUNOL, V10, P504, DOI 10.1038/ni.1729; Dollar P., 2006, P DOLLARS IMAGE VIDE; Fallarino F, 2004, J EXP MED, V200, P1051, DOI 10.1084/jem.20040942; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Gilchrist M, 2004, BLOOD, V104, P462, DOI 10.1182/blood-2003-08-2990; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Kumagai Y, 2007, IMMUNITY, V27, P240, DOI 10.1016/j.immuni.2007.07.013; Liu SY, 2011, CURR OPIN IMMUNOL, V23, P57, DOI 10.1016/j.coi.2010.11.003; Lyles D. S., 2007, FIELDS VIROLOGY, V1, P1363; MCLAREN LC, 1959, J EXP MED, V109, P475, DOI 10.1084/jem.109.5.475; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Ning S, 2011, GENES IMMUN, V12, P399, DOI 10.1038/gene.2011.21; Ning SB, 2005, J BIOL CHEM, V280, P12262, DOI 10.1074/jbc.M404260200; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Parkinson H, 2007, NUCLEIC ACIDS RES, V35, pD747, DOI 10.1093/nar/gkl995; Plas DR, 2003, J BIOL CHEM, V278, P12361, DOI 10.1074/jbc.M213069200; Ramsey SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000021; Ramsey SA, 2010, BIOINFORMATICS, V26, P2071, DOI 10.1093/bioinformatics/btq405; Renault VM, 2009, CELL STEM CELL, V5, P527, DOI 10.1016/j.stem.2009.09.014; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Smith K, 2003, POETRY REV, V93, P5; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sullivan JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002533; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Thijs G, 2002, BIOINFORMATICS, V18, P331, DOI 10.1093/bioinformatics/18.2.331; Wang ST, 2011, GENE THER, V18, P372, DOI 10.1038/gt.2010.146	37	112	114	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2012	490	7420					421	+		10.1038/nature11428	http://dx.doi.org/10.1038/nature11428			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021XI	22982991	Green Accepted			2022-12-24	WOS:000309918500050
J	Blount, ZD; Barrick, JE; Davidson, CJ; Lenski, RE				Blount, Zachary D.; Barrick, Jeffrey E.; Davidson, Carla J.; Lenski, Richard E.			Genomic analysis of a key innovation in an experimental Escherichia coli population	NATURE			English	Article							TERM EXPERIMENTAL EVOLUTION; CITRATE UTILIZATION; GENE; SEQUENCES; PROMOTER; DUPLICATION; ADAPTATION; AMPLIFICATION; SUPPRESSION; CONTINGENCY	Evolutionary novelties have been important in the history of life, but their origins are usually difficult to examine in detail. We previously described the evolution of a novel trait, aerobic citrate utilization (Cit(+)), in an experimental population of Escherichia coli. Here we analyse genome sequences to investigate the history and genetic basis of this trait. At least three distinct clades coexisted for more than 10,000 generations before its emergence. The Cit(+) trait originated in one clade by a tandem duplication that captured an aerobically expressed promoter for the expression of a previously silent citrate transporter. The clades varied in their propensity to evolve this novel trait, although genotypes able to do so existed in all three clades, implying that multiple potentiating mutations arose during the population's history. Our findings illustrate the importance of promoter capture and altered gene regulation in mediating the exaptation events that often underlie evolutionary innovations.	[Blount, Zachary D.; Lenski, Richard E.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Blount, Zachary D.; Barrick, Jeffrey E.; Lenski, Richard E.] Michigan State Univ, BEACON Ctr Study Evolut Act, E Lansing, MI 48824 USA; [Barrick, Jeffrey E.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Barrick, Jeffrey E.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Davidson, Carla J.] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB T2N 4N1, Canada	Michigan State University; Michigan State University; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Calgary	Blount, ZD (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.	blountza@msu.edu; lenski@msu.edu	Blount, Zachary/L-3130-2019; Barrick, Jeffrey/A-3046-2012	Barrick, Jeffrey/0000-0003-0888-7358; Lenski, Richard/0000-0002-1064-8375; Blount, Zachary/0000-0001-5153-0034	US National Science Foundation [DEB-1019989]; BEACON Center for the Study of Evolution in Action [DBI-0939454]; US National Institutes of Health [K99-GM087550]; Defense Advanced Research Projects Agency [HR0011-09-1-0055]; Rudolf Hugh Fellowship; DuVall Family Award; Ronald M. and Sharon Rogowski Fellowship; Barnett Rosenberg Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM087550, K99GM087550] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); BEACON Center for the Study of Evolution in Action; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Rudolf Hugh Fellowship; DuVall Family Award; Ronald M. and Sharon Rogowski Fellowship; Barnett Rosenberg Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Hajela, M. Kauth and S. Sleight for assistance, J. Meyer and J. Plucain for discussion, and C. Turner for comments on the paper. Sequencing services were provided by the MSU Research Technology Support Facility. We acknowledge support from the US National Science Foundation (DEB-1019989 to R. E. L.) including the BEACON Center for the Study of Evolution in Action (DBI-0939454), the US National Institutes of Health (K99-GM087550 to J. E. B.), the Defense Advanced Research Projects Agency (HR0011-09-1-0055 to R. E. L.), a Rudolf Hugh Fellowship (to Z.D.B.), a DuVall Family Award (to Z.D.B.), a Ronald M. and Sharon Rogowski Fellowship (to Z.D.B.) and a Barnett Rosenberg Fellowship (to Z.D.B).	ADAM D, 1993, SCIENCE, V259, P816, DOI 10.1126/science.8430335; Andersson DI, 1998, SCIENCE, V282, P1133, DOI 10.1126/science.282.5391.1133; Barrick JE, 2009, COLD SH Q B, V74, P119, DOI 10.1101/sqb.2009.74.018; Barrick J. E., 2010, BRESEQ; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Beaumont HJE, 2009, NATURE, V462, P90, DOI 10.1038/nature08504; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Bergthorsson U, 2007, P NATL ACAD SCI USA, V104, P17004, DOI 10.1073/pnas.0707158104; Bjarnason J, 2003, J BACTERIOL, V185, P4973, DOI 10.1128/JB.185.16.4973-4982.2003; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; Bock R, 2008, BIOESSAYS, V30, P556, DOI 10.1002/bies.20761; CAMIN JH, 1965, EVOLUTION, V19, P311, DOI 10.2307/2406441; CHARLIER D, 1982, NUCLEIC ACIDS RES, V10, P5935, DOI 10.1093/nar/10.19.5935; Christensen W. B., 1949, RES B WELD COUNTY HL, V1, P3; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Fogle CA, 2008, GENETICS, V180, P2163, DOI 10.1534/genetics.108.090019; GLICKMAN BW, 1980, P NATL ACAD SCI-BIOL, V77, P1063, DOI 10.1073/pnas.77.2.1063; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; GUNSALUS RP, 1994, RES MICROBIOL, V145, P437, DOI 10.1016/0923-2508(94)90092-2; HALL BG, 1982, J BACTERIOL, V151, P269, DOI 10.1128/JB.151.1.269-273.1982; Hegreness M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-201; Herring CD, 2003, GENE, V311, P153, DOI 10.1016/S0378-1119(03)00585-7; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Jacob F., 1982, POSSIBLE ACTUAL; Janausch IG, 2002, BBA-BIOENERGETICS, V1553, P39, DOI 10.1016/S0005-2728(01)00233-X; Jeong H, 2009, J MOL BIOL, V394, P644, DOI 10.1016/j.jmb.2009.09.052; Koser SA, 1924, J BACTERIOL, V9, P59, DOI 10.1128/JB.9.1.59-77.1924; LARA FJS, 1952, J BACTERIOL, V63, P415, DOI 10.1128/JB.63.3.415-420.1952; Lenski R. E., 2004, PLANT BREED REV, V24, P225, DOI DOI 10.1002/9780470650288.CH8; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; Lenski RE, 2003, NATURE, V423, P139, DOI 10.1038/nature01568; LUTGENS M, 1980, J GEN MICROBIOL, V119, P63; Mayr E., 1960, EVOLUTION DARWIN, P349; Meyer JR, 2012, SCIENCE, V335, P428, DOI 10.1126/science.1214449; Nizam SA, 2009, BIOCHEM ENG J, V44, P240, DOI 10.1016/j.bej.2008.12.017; Patthy L, 1999, GENE, V238, P103, DOI 10.1016/S0378-1119(99)00228-0; Pigliucci M, 2008, PHILOS SCI, V75, P887, DOI 10.1086/594532; Pos KM, 1998, J BACTERIOL, V180, P4160, DOI 10.1128/JB.180.16.4160-4165.1998; Reams AB, 2010, GENETICS, V184, P1077, DOI 10.1534/genetics.109.111963; Rozen DE, 2005, J MOL EVOL, V61, P171, DOI 10.1007/s00239-004-0322-2; Scheutz F., 2005, BERGEYS MANUAL SYSTE, VTwo Part B, P607, DOI [10.1002/9781118960608.gbm01147, DOI 10.1002/9781118960608.GBM01147]; SHANKAR S, 1995, MOL MICROBIOL, V17, P935, DOI 10.1111/j.1365-2958.1995.mmi_17050935.x; Sniegowski PD, 1997, NATURE, V387, P703, DOI 10.1038/42701; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Treves DS, 1998, MOL BIOL EVOL, V15, P789, DOI 10.1093/oxfordjournals.molbev.a025984; True JR, 2002, ANNU REV CELL DEV BI, V18, P53, DOI 10.1146/annurev.cellbio.18.020402.140619; Usakin LA, 2005, MOL BIOL EVOL, V22, P1555, DOI 10.1093/molbev/msi147; WHORISKEY SK, 1987, GENE DEV, V1, P227, DOI 10.1101/gad.1.3.227; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zaslaver A, 2006, NAT METHODS, V3, P623, DOI 10.1038/NMETH895; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; ZHU LQ, 1992, GENE, V119, P101, DOI 10.1016/0378-1119(92)90072-W	52	369	372	3	240	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 27	2012	489	7417					513	+		10.1038/nature11514	http://dx.doi.org/10.1038/nature11514			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011LT	22992527	Green Accepted			2022-12-24	WOS:000309167100040
J	Hand, TW; Dos Santos, LM; Bouladoux, N; Molloy, MJ; Pagan, AJ; Pepper, M; Maynard, CL; Elson, CO; Belkaid, Y				Hand, Timothy W.; Dos Santos, Liliane M.; Bouladoux, Nicolas; Molloy, Michael J.; Pagan, Antonio J.; Pepper, Marion; Maynard, Craig L.; Elson, Charles O., III; Belkaid, Yasmine			Acute Gastrointestinal Infection Induces Long-Lived Microbiota-Specific T Cell Responses	SCIENCE			English	Article							GUT COMMENSAL BACTERIA; TOXOPLASMA-GONDII; CROHNS-DISEASE; INDUCTION; DOMINANT; EFFECTOR; IMMUNITY; NAIVE; IGA	The mammalian gastrointestinal tract contains a large and diverse population of commensal bacteria and is also one of the primary sites of exposure to pathogens. How the immune system perceives commensals in the context of mucosal infection is unclear. Here, we show that during a gastrointestinal infection, tolerance to commensals is lost, and microbiota-specific T cells are activated and differentiate to inflammatory effector cells. Furthermore, these T cells go on to form memory cells that are phenotypically and functionally consistent with pathogen-specific T cells. Our results suggest that during a gastrointestinal infection, the immune response to commensals parallels the immune response against pathogenic microbes and that adaptive responses against commensals are an integral component of mucosal immunity.	[Hand, Timothy W.; Dos Santos, Liliane M.; Bouladoux, Nicolas; Molloy, Michael J.; Belkaid, Yasmine] NIAID, Mucosal Immun Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Dos Santos, Liliane M.] Univ Fed Minas Gerais, Lab Gnotobiol & Immunol, BR-31270901 Belo Horizonte, MG, Brazil; [Pagan, Antonio J.; Pepper, Marion] Univ Minnesota, Microbiol Immunol & Canc Biol Program, Minneapolis, MN 55455 USA; [Pepper, Marion] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Maynard, Craig L.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Elson, Charles O., III] Univ Alabama Birmingham, Mucosal HIV & Immunobiol Ctr, Birmingham, AL 35294 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Universidade Federal de Minas Gerais; University of Minnesota System; University of Minnesota Twin Cities; University of Washington; University of Washington Seattle; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Belkaid, Y (corresponding author), NIAID, Mucosal Immun Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA.	ybelkaid@niaid.nih.gov	Hand, Timothy W/AAH-1216-2021; Pagan, Antonio/AAB-1604-2019; Santos, Liliane Martins dos/AAR-9220-2020	Hand, Timothy W/0000-0002-2684-9462; Santos, Liliane Martins dos/0000-0002-4466-8868; Bouladoux, Nicolas/0000-0003-1593-671X; Belkaid, Yasmine/0000-0001-9962-3571	Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID); CNPq-Brazil; NIH [DK071176, DK64400]; Crohn's and Colitis Foundation of America Career Development Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001115, T32AI007051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK071176, R24DK064400] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CNPq-Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America Career Development Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID) (T. W. H., L. M. D., N.B., M.J.M., and Y.B.), CNPq-Brazil (L. M. D.), NIH grants DK071176 and DK64400 (C.O.E.) and The Crohn's and Colitis Foundation of America Career Development Award (C. L. M.). The authors thank M. Jenkins, A. Poholek, S. Kaech, N. Peters, J. Monteiro and the members of the Belkaid Lab for critical discussion and reading of the manuscript; the NIH Tetramer Core Facility for the T. gondii Me49 hypothetical protein tetramers; C. Eigsti, T. Moyer, E. Stregevsky, K. Holmes, and the NIAID Flow Cytometry Core for assistance with sorting; L. Koo and the NIAID Microscopy Core for assistance with 16S fluorescence in situ hybridization (FISH) images; and the NIAID Protein Biochemistry Core for CBir1 peptide. We thank the University of Alabama-Birmingham for sharing the CBir1 Tg mice by material transfer agreement. The data reported in this paper are tabulated in the main text and in the supplementary materials. The authors declare that they have no conflict of interest.	Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Benson A, 2009, CELL HOST MICROBE, V6, P187, DOI 10.1016/j.chom.2009.06.005; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Cong YZ, 2009, P NATL ACAD SCI USA, V106, P19256, DOI 10.1073/pnas.0812681106; Duck LW, 2007, INFLAMM BOWEL DIS, V13, P1191, DOI 10.1002/ibd.20237; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Haas A, 2011, GUT, V60, P1506, DOI 10.1136/gut.2010.224774; Harrington LE, 2008, NATURE, V452, P356, DOI 10.1038/nature06672; Hataye J, 2006, SCIENCE, V312, P114, DOI 10.1126/science.1124228; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kosek M, 2003, B WORLD HEALTH ORGAN, V81, P197; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Lochner M, 2011, J IMMUNOL, V186, P1531, DOI 10.4049/jimmunol.1001723; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Macpherson AJ, 2009, SEMIN IMMUNOPATHOL, V31, P145, DOI 10.1007/s00281-009-0174-3; Marshall HD, 2011, IMMUNITY, V35, P633, DOI 10.1016/j.immuni.2011.08.016; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Munoz M, 2011, IMMUNOL REV, V240, P269, DOI 10.1111/j.1600-065X.2010.00992.x; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Pepper M, 2010, NAT IMMUNOL, V11, P83, DOI 10.1038/ni.1826; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Sallusto F, 2009, EUR J IMMUNOL, V39, P2076, DOI 10.1002/eji.200939722; Slack E, 2009, SCIENCE, V325, P617, DOI 10.1126/science.1172747; Vernacchio L, 2006, PEDIATR INFECT DIS J, V25, P2, DOI 10.1097/01.inf.0000195623.57945.87	31	263	272	2	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2012	337	6101					1553	1556		10.1126/science.1220961	http://dx.doi.org/10.1126/science.1220961			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007UC	22923434	Green Accepted			2022-12-24	WOS:000308912900055
J	Lefebvre, JL; Kostadinov, D; Chen, WSV; Maniatis, T; Sanes, JR				Lefebvre, Julie L.; Kostadinov, Dimitar; Chen, Weisheng V.; Maniatis, Tom; Sanes, Joshua R.			Protocadherins mediate dendritic self-avoidance in the mammalian nervous system	NATURE			English	Article							RETINAL GANGLION-CELLS; BAX-DEFICIENT MICE; MOUSE RETINA; GAMMA-PROTOCADHERINS; TRANSGENIC MICE; PURKINJE-CELLS; AMACRINE CELLS; REQUIRE DSCAM; AXON GUIDANCE; EXPRESSION	Dendritic arborizations of many neurons are patterned by a process called self-avoidance, in which branches arising from a single neuron repel each other(1-7). By minimizing gaps and overlaps within the arborization, self-avoidance facilitates complete coverage of a neuron's territory by its neurites(1-3). Remarkably, some neurons that display self-avoidance interact freely with other neurons of the same subtype, implying that they discriminate self from non-self. Here we demonstrate roles for the clustered protocadherins (Pcdhs) in dendritic self-avoidance and self/non-self discrimination. The Pcdh locus encodes 58 related cadherin-like transmembrane proteins, at least some of which exhibit isoform-specific homophilic adhesion in heterologous cells and are expressed stochastically and combinatorially in single neurons(7-11). Deletion of all 22 Pcdh genes in the mouse gamma-subcluster (Pcdhg genes) disrupts self-avoidance of dendrites in retinal starburst amacrine cells (SACs) and cerebellar Purkinje cells. Further genetic analysis of SACs showed that Pcdhg proteins act cell-autonomously during development, and that replacement of the 22 Pcdhg proteins with a single isoform restores self-avoidance. Moreover, expression of the same single isoform in all SACs decreases interactions among dendrites of neighbouring SACs (heteroneuronal interactions). These results suggest that homophilic Pcdhg interactions between sibling neurites (isoneuronal interactions) generate a repulsive signal that leads to self-avoidance. In this model, heteroneuronal interactions are normally permitted because dendrites seldom encounter a matched set of Pcdhg proteins unless they emanate from the same soma. In many respects, our results mirror those reported for Dscam1 (Down syndrome cell adhesion molecule) in Drosophila: this complex gene encodes thousands of recognition molecules that exhibit stochastic expression and isoform-specific interactions, and mediate both self-avoidance and self/non-self discrimination(4-7,12-15). Thus, although insect Dscam and vertebrate Pcdh proteins share no sequence homology, they seem to underlie similar strategies for endowing neurons with distinct molecular identities and patterning their arborizations.	[Lefebvre, Julie L.; Kostadinov, Dimitar; Sanes, Joshua R.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Lefebvre, Julie L.; Kostadinov, Dimitar; Sanes, Joshua R.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Chen, Weisheng V.; Maniatis, Tom] Columbia Univ, Med Ctr, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Harvard University; Harvard University; Columbia University	Sanes, JR (corresponding author), Harvard Univ, Ctr Brain Sci, 52 Oxford St, Cambridge, MA 02138 USA.	sanesj@mcb.harvard.edu		Kostadinov, Dimitar/0000-0001-7548-2209; Lefebvre, Julie/0000-0002-3110-860X	NIH [R01NS029169, R01EY022073, R01NS043915]; NARSAD; NATIONAL EYE INSTITUTE [R01EY022073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS078893, R01NS029169, R01NS043915] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD(NARSAD); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of our laboratory for providing advice and reagents, including D. Cai and K. Cohen (rAAV), I.-J. Kim (fstl4-line 1 mice) and M. Yamagata for modified Rosa-CAG targeting vector. We also thank B. Stevens (Children's Hospital) for advice on culture methods. This work was supported by grants from NIH to J.R.S. (R01NS029169 and R01EY022073) and T.M. (R01NS043915) and NARSAD Young Investigator Award to J.L.L.	Chen W. V., NEURON IN PRESS; Chen YC, 2008, J NEUROSCI METH, V171, P239, DOI 10.1016/j.jneumeth.2008.03.013; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Fuerst PG, 2008, NATURE, V451, P470, DOI 10.1038/nature06514; Fuerst PG, 2009, NEURON, V64, P484, DOI 10.1016/j.neuron.2009.09.027; Furuta Y, 2000, GENESIS, V26, P130, DOI 10.1002/(SICI)1526-968X(200002)26:2<130::AID-GENE9>3.0.CO;2-I; Grueber WB, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001750; Hattori D, 2009, NATURE, V461, P644, DOI 10.1038/nature08431; Hong YK, 2011, J COMP NEUROL, V519, P1691, DOI 10.1002/cne.22595; Hughes ME, 2007, NEURON, V54, P417, DOI 10.1016/j.neuron.2007.04.013; Jelinek HF, 1998, J NEUROSCI METH, V81, P9, DOI 10.1016/S0165-0270(98)00021-1; Kaneko M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020108; Kaneko R, 2006, J BIOL CHEM, V281, P30551, DOI 10.1074/jbc.M605677200; Kay JN, 2011, NAT NEUROSCI, V14, P965, DOI 10.1038/nn.2859; Kay JN, 2011, J NEUROSCI, V31, P7753, DOI 10.1523/JNEUROSCI.0907-11.2011; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; KRAMER AP, 1983, J NEUROSCI, V3, P2474; Kuchibhotla KV, 2008, NEURON, V59, P214, DOI 10.1016/j.neuron.2008.06.008; Lee S, 2006, NEURON, V51, P787, DOI 10.1016/j.neuron.2006.08.007; Lefebvre JL, 2008, DEVELOPMENT, V135, P4141, DOI 10.1242/dev.027912; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; MONTAGUE PR, 1991, J NEUROSCI, V11, P1440; MONTAGUE PR, 1989, P NATL ACAD SCI USA, V86, P7223, DOI 10.1073/pnas.86.18.7223; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; Prasad T, 2008, DEVELOPMENT, V135, P4153, DOI 10.1242/dev.026807; RODIECK RW, 1991, VISUAL NEUROSCI, V6, P95, DOI 10.1017/S095252380001049X; Rossi J, 2011, CELL METAB, V13, P195, DOI 10.1016/j.cmet.2011.01.010; Rowan S, 2004, DEV BIOL, V271, P388, DOI 10.1016/j.ydbio.2004.03.039; Sanes JR, 2010, NEURON, V66, P15, DOI 10.1016/j.neuron.2010.01.018; Schreiner D, 2010, P NATL ACAD SCI USA, V107, P14893, DOI 10.1073/pnas.1004526107; Smith TG, 1996, J NEUROSCI METH, V69, P123, DOI 10.1016/S0165-0270(96)00080-5; Soba P, 2007, NEURON, V54, P403, DOI 10.1016/j.neuron.2007.03.029; Srinivas S, 1999, DEV GENET, V24, P241; Stacy RC, 2003, J COMP NEUROL, V456, P154, DOI 10.1002/cne.10509; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Wang XZ, 2002, NEURON, V36, P843, DOI 10.1016/S0896-6273(02)01090-5; WASSLE H, 1981, NATURE, V292, P344, DOI 10.1038/292344a0; Weiner JA, 2005, P NATL ACAD SCI USA, V102, P8, DOI 10.1073/pnas.0407931101; White FA, 1998, J NEUROSCI, V18, P1428; Whitney IE, 2008, J COMP NEUROL, V508, P1, DOI 10.1002/cne.21630; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469; Yamagata M, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00018; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020; Zhang XM, 2004, GENESIS, V40, P45, DOI 10.1002/gene.20062; Zipursky SL, 2010, CELL, V143, P343, DOI 10.1016/j.cell.2010.10.009	50	279	285	2	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2012	488	7412					517	+		10.1038/nature11305	http://dx.doi.org/10.1038/nature11305			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992FS	22842903	Green Submitted, Bronze, Green Accepted			2022-12-24	WOS:000307761600038
J	Bulgarelli, D; Rott, M; Schlaeppi, K; van Themaat, EVL; Ahmadinejad, N; Assenza, F; Rauf, P; Huettel, B; Reinhardt, R; Schmelzer, E; Peplies, J; Gloeckner, FO; Amann, R; Eickhorst, T; Schulze-Lefert, P				Bulgarelli, Davide; Rott, Matthias; Schlaeppi, Klaus; van Themaat, Emiel Ver Loren; Ahmadinejad, Nahal; Assenza, Federica; Rauf, Philipp; Huettel, Bruno; Reinhardt, Richard; Schmelzer, Elmon; Peplies, Joerg; Gloeckner, Frank Oliver; Amann, Rudolf; Eickhorst, Thilo; Schulze-Lefert, Paul			Revealing structure and assembly cues for Arabidopsis root-inhabiting bacterial microbiota	NATURE			English	Article							CATALYZED REPORTER DEPOSITION; IN-SITU HYBRIDIZATION; DIVERSITY; ENDOPHYTES; PATTERNS	The plant root defines the interface between amulticellular eukaryote and soil, one of the richest microbial ecosystems on Earth(1). Notably, soil bacteria are able to multiply inside roots as benign endophytes and modulate plant growth and development(2), with implications ranging from enhanced crop productivity(3) to phytoremediation(4). Endophytic colonization represents an apparent paradox of plant innate immunity because plant cells can detect an array of microbeassociated molecular patterns (also known as MAMPs) to initiate immune responses to terminate microbial multiplication(5). Several studies attempted to describe the structure of bacterial root endophytes(6); however, different sampling protocols and low-resolution profiling methods make it difficult to infer general principles. Here we describemethodology to characterize and compare soil-and rootinhabiting bacterial communities, which reveals not only a function formetabolically active plant cells but also for inert cell-wall features in the selection of soil bacteria for host colonization. We showthat the roots ofArabidopsis thaliana, grown in different natural soils under controlled environmental conditions, are preferentially colonized by Proteobacteria, Bacteroidetes and Actinobacteria, and each bacterial phylum is represented by a dominating class or family. Soil type defines the composition of root-inhabiting bacterial communities and host genotype determines their ribotype profiles to a limited extent. The identification of soil-type-specific members within the root-inhabiting assemblies supports our conclusion that these represent soil-derived root endophytes. Surprisingly, plant cell-wall features of other tested plant species seem to provide a sufficient cue for the assembly of approximately 40% of the Arabidopsis bacterial root-inhabitingmicrobiota, with a bias for Betaproteobacteria. Thus, this root sub-community may not beArabidopsis-specific but saprophytic bacteria that would naturally be found on any plant root or plant debris in the tested soils. By contrast, colonization of Arabidopsis roots by members of the Actinobacteria depends on other cues from metabolically active host cells.	[Bulgarelli, Davide; Rott, Matthias; Schlaeppi, Klaus; van Themaat, Emiel Ver Loren; Ahmadinejad, Nahal; Assenza, Federica; Rauf, Philipp; Schulze-Lefert, Paul] Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, D-50829 Cologne, Germany; [Huettel, Bruno; Reinhardt, Richard] Max Planck Inst Plant Breeding Res, Max Planck Genome Ctr, D-50829 Cologne, Germany; [Peplies, Joerg; Gloeckner, Frank Oliver] Ribocon GmbH, D-28359 Bremen, Germany; [Gloeckner, Frank Oliver; Amann, Rudolf] Max Planck Inst Marine Microbiol, Dept Mol Ecol, D-28359 Bremen, Germany; [Eickhorst, Thilo] Univ Bremen, Fac Biol & Chem, D-28359 Bremen, Germany	Max Planck Society; Max Planck Society; Max Planck Society; University of Bremen	Schulze-Lefert, P (corresponding author), Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, D-50829 Cologne, Germany.	schlef@mpipz.mpg.de	Amann, Rudolf I/C-6534-2014; Schlaeppi, Klaus/ABE-6731-2020; Schlaeppi, Klaus/HCI-8011-2022; Eickhorst, Thilo/M-1200-2014; Schulze-Lefert, Paul/B-6707-2011	Amann, Rudolf I/0000-0002-0846-7372; Schlaeppi, Klaus/0000-0003-3620-0875; Schlaeppi, Klaus/0000-0003-3620-0875; Brocke-Ahmadinejad, Nahal/0000-0002-7335-6564; Bulgarelli, Davide/0000-0002-2020-6642; Reinhardt, Richard/0000-0001-9376-2132	Max Planck Society [M.IF. A. ZUCH8048]; Swiss National Science Foundation [PBFRP3-133544]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank R. Franzen and S. Schumacher for technical assistance, S. Wulfert for providing Arabidopsis liquid cultures, H. Schmidt for sharing the CARD-FISH protocol and performing the cell counts. We thank S. Klages and K. Stuber for support with bioinformatic pipelines. We are grateful to R. Panstruga and P. Bakker for comments on the manuscript. Golm soil was shipped by J. Schwachtje and J. van Dongen. This work was supported by funds from the Max Planck Society to P. S.-L. (M.IF. A. ZUCH8048). K. S. is supported by the Swiss National Science Foundation (PBFRP3-133544).	Basilio A, 2003, J APPL MICROBIOL, V95, P814, DOI 10.1046/j.1365-2672.2003.02049.x; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; BuchholzCleven BEE, 1997, SYST APPL MICROBIOL, V20, P301, DOI 10.1016/S0723-2020(97)80077-X; Chelius MK, 2001, MICROB ECOL, V41, P252, DOI 10.1007/s002480000087; Eickhorst T, 2008, SOIL BIOL BIOCHEM, V40, P1883, DOI 10.1016/j.soilbio.2008.03.024; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Gans J, 2005, SCIENCE, V309, P1387, DOI 10.1126/science.1112665; Hardoim PR, 2008, TRENDS MICROBIOL, V16, P463, DOI 10.1016/j.tim.2008.07.008; Hardoim PR, 2011, FEMS MICROBIOL ECOL, V77, P154, DOI 10.1111/j.1574-6941.2011.01092.x; Inceoglu O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023321; Kunin V, 2010, OPEN J, V1, P1; Mei Chuansheng, 2010, Recent Pat Biotechnol, V4, P81, DOI 10.2174/187220810790069523; Pernthaler A, 2002, APPL ENVIRON MICROB, V68, P3094, DOI 10.1128/AEM.68.6.3094-3101.2002; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Reinhold-Hurek B, 2011, CURR OPIN PLANT BIOL, V14, P435, DOI 10.1016/j.pbi.2011.04.004; Rosenblueth M, 2006, MOL PLANT MICROBE IN, V19, P827, DOI 10.1094/MPMI-19-0827; Timmusk S, 2005, APPL ENVIRON MICROB, V71, P7292, DOI 10.1128/AEM.71.11.7292-7300.2005; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Weyens N, 2009, CURR OPIN BIOTECH, V20, P248, DOI 10.1016/j.copbio.2009.02.012	21	1292	1377	74	1189	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 2	2012	488	7409					91	95		10.1038/nature11336	http://dx.doi.org/10.1038/nature11336			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ZE	22859207				2022-12-24	WOS:000307010700039
J	Archin, NM; Liberty, AL; Kashuba, AD; Choudhary, SK; Kuruc, JD; Crooks, AM; Parker, DC; Anderson, EM; Kearney, MF; Strain, MC; Richman, DD; Hudgens, MG; Bosch, RJ; Coffin, JM; Eron, JJ; Hazuda, DJ; Margolis, DM				Archin, N. M.; Liberty, A. L.; Kashuba, A. D.; Choudhary, S. K.; Kuruc, J. D.; Crooks, A. M.; Parker, D. C.; Anderson, E. M.; Kearney, M. F.; Strain, M. C.; Richman, D. D.; Hudgens, M. G.; Bosch, R. J.; Coffin, J. M.; Eron, J. J.; Hazuda, D. J.; Margolis, D. M.			Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy	NATURE			English	Article							HISTONE DEACETYLASE INHIBITORS; SUBEROYLANILIDE HYDROXAMIC ACID; VALPROIC ACID; IN-VIVO; TYPE-1; EXPRESSION; INFECTION; CELLS; PCR; ACTIVATION	Despite antiretroviral therapy, proviral latency of human immunodeficiency virus type 1 (HIV-1) remains a principal obstacle to curing the infection(1). Inducing the expression of latent genomes within resting CD4(+) T cells is the primary strategy to clear this reservoir(2,3). Although histone deacetylase inhibitors such as suberoylanilide hydroxamic acid (also known as vorinostat, VOR) can disrupt HIV-1 latency in vitro(4-6), the utility of this approach has never been directly proven in a translational clinical study of HIV-infected patients. Here we isolated the circulating resting CD4(+) T cells of patients in whom viraemia was fully suppressed by antiretroviral therapy, and directly studied the effect of VOR on this latent reservoir. In each of eight patients, a single dose of VOR increased both biomarkers of cellular acetylation, and simultaneously induced an increase in HIV RNA expression in resting CD4(+) cells (mean increase, 4.8-fold). This demonstrates that a molecular mechanism known to enforce HIV latency can be therapeutically targeted in humans, provides proof-of-concept for histone deacetylase inhibitors as a therapeutic class, and defines a precise approach to test novel strategies to attack and eradicate latent HIV infection directly.	[Archin, N. M.; Liberty, A. L.; Kashuba, A. D.; Choudhary, S. K.; Kuruc, J. D.; Crooks, A. M.; Parker, D. C.; Hudgens, M. G.; Eron, J. J.; Margolis, D. M.] Univ N Carolina, Chapel Hill, NC 27599 USA; [Anderson, E. M.; Kearney, M. F.; Coffin, J. M.] NCI, HIV Drug Resistance Program, NIH, Frederick, MD 21702 USA; [Strain, M. C.; Richman, D. D.] VA San Diego Healthcare Syst, San Diego, CA 92093 USA; [Strain, M. C.; Richman, D. D.] Univ Calif San Diego, San Diego, CA 92093 USA; [Bosch, R. J.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Hazuda, D. J.] Merck Res Labs, White Horse Junction, PA USA	University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; Harvard University; Harvard T.H. Chan School of Public Health; Merck & Company	Margolis, DM (corresponding author), Univ N Carolina, Chapel Hill, NC 27599 USA.	dmargo@med.unc.edu	Kearney, Mary/AAU-8132-2020; Margolis, David M./Y-2468-2019	Margolis, David M./0000-0001-5714-0002; Kearney, Mary/0000-0003-3839-6576; Parker, Daniel/0000-0001-8512-1044	National Institutes of Health [AI084553, AI095052, AI096113, RR024383, AI50410]; Merck Co; James B. Pendleton Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410, U01AI095052, U19AI096113, R34AI084553] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck Co(Merck & Company); James B. Pendleton Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health grants AI084553, AI095052 and AI096113, and by a grant from Merck & Co to D. M. M., National Institutes of Health grants RR024383 to the UNC TRaCS Institute, AI50410 to the UNC Center for AIDS Research, and an equipment grant from the James B. Pendleton Charitable Trust. Merck & Co provided VOR. The ClinicalTrials.gov identifier is NCT01319383. We thank N. P. Dahl, R. Sackmann, M. Cheema, A. Wiegand and N. White for technical support, Y. Park and the staff the UNC Blood Bank, R. J. Bedimo and C. M. van der Horst for study oversight, and J. Scepanski and A. Sugarbaker for patient follow-up and study coordination. We thank M. S. Cohen, J. V. Garcia-Martinez, W. C. Greene, J. Karn and R. F. Siliciano for discussions. Finally, we are grateful for the contributions of the patients who have participated in these studies.	Archin NM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009390; Archin NM, 2009, AIDS, V23, P1799, DOI 10.1097/QAD.0b013e32832ec1dc; Archin NM, 2009, AIDS RES HUM RETROV, V25, P207, DOI 10.1089/aid.2008.0191; Archin NM, 2008, AIDS, V22, P1131, DOI 10.1097/QAD.0b013e3282fd6df4; Blankson JN, 2002, ANNU REV MED, V53, P557, DOI 10.1146/annurev.med.53.082901.104024; Contreras X, 2009, J BIOL CHEM, V284, P6782, DOI 10.1074/jbc.M807898200; Du LH, 2005, RAPID COMMUN MASS SP, V19, P1779, DOI 10.1002/rcm.1984; Edelstein LC, 2009, AIDS RES HUM RETROV, V25, P883, DOI 10.1089/aid.2008.0294; Gui CY, 2004, P NATL ACAD SCI USA, V101, P1241, DOI 10.1073/pnas.0307708100; Hermankova M, 2003, J VIROL, V77, P7383, DOI 10.1128/JVI.77.13.7383-7392.2003; Israel-Ballard K, 2005, J CLIN VIROL, V34, P253, DOI 10.1016/j.jcv.2005.02.013; Keedy KS, 2009, J VIROL, V83, P4749, DOI 10.1128/JVI.02585-08; Lee JH, 2010, P NATL ACAD SCI USA, V107, P14639, DOI 10.1073/pnas.1008522107; Lee JH, 2011, P NATL ACAD SCI USA, V108, P19629, DOI 10.1073/pnas.1117544108; Lehrman G, 2005, LANCET, V366, P549, DOI 10.1016/S0140-6736(05)67098-5; Margolis DM, 2011, CURR OPIN HIV AIDS, V6, P25, DOI 10.1097/COH.0b013e328341242d; May R. C., 2012, U N CAROLINA CHAPEL; Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Robinson LH, 2002, J VIROL METHODS, V104, P147, DOI 10.1016/S0166-0934(02)00059-9; Rubin EH, 2006, CLIN CANCER RES, V12, P7039, DOI 10.1158/1078-0432.CCR-06-1802; Sagot-Lerolle N, 2008, AIDS, V22, P1125, DOI 10.1097/QAD.0b013e3282fd6ddc; Siliciano JD, 2007, J INFECT DIS, V195, P833, DOI 10.1086/511823; Tonelli R, 2006, LEUKEMIA, V20, P1307, DOI 10.1038/sj.leu.2404221; VanLint C, 1996, EMBO J, V15, P1112, DOI 10.1002/j.1460-2075.1996.tb00449.x	25	840	879	2	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2012	487	7408					482	U1650		10.1038/nature11286	http://dx.doi.org/10.1038/nature11286			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979KD	22837004	Green Accepted, Green Submitted			2022-12-24	WOS:000306815300038
J	Kirwan, ML; Mudd, SM				Kirwan, Matthew L.; Mudd, Simon M.			Response of salt-marsh carbon accumulation to climate change	NATURE			English	Article							COASTAL WETLANDS; SPARTINA-ALTERNIFLORA; DECOMPOSITION; PRODUCTIVITY; FEEDBACK; DIOXIDE; DRAG	About half of annual marine carbon burial takes place in shallow water ecosystems where geomorphic and ecological stability is driven by interactions between the flow of water, vegetation growth and sediment transport(1). Although the sensitivity of terrestrial and deep marine carbon pools to climate change has been studied for decades, there is little understanding of how coastal carbon accumulation rates will change and potentially feed back on climate(2,3). Here we develop a numerical model of salt marsh evolution, informed by recent measurements of productivity and decomposition, and demonstrate that competition between mineral sediment deposition and organic-matter accumulation determines the net impact of climate change on carbon accumulation in intertidal wetlands. We find that the direct impact of warming on soil carbon accumulation rates is more subtle than the impact of warming-driven sea level rise, although the impact of warming increases with increasing rates of sea level rise. Our simulations suggest that the net impact of climate change will be to increase carbon burial rates in the first half of the twenty-first century, but that carbon-climate feedbacks are likely to diminish over time.	[Kirwan, Matthew L.] Univ Virginia, Dept Environm Sci, Charlottesville, VA 24151 USA; [Mudd, Simon M.] Univ Edinburgh, Sch GeoSci, Edinburgh EH8 9XP, Midlothian, Scotland; [Mudd, Simon M.] Univ Calif Santa Barbara, Earth Res Inst, Santa Barbara, CA 93106 USA	University of Virginia; University of Edinburgh; University of California System; University of California Santa Barbara	Kirwan, ML (corresponding author), Univ Virginia, Dept Environm Sci, POB 400123, Charlottesville, VA 24151 USA.	mlk4n@virginia.edu	Mudd, Simon M/F-8521-2010	Mudd, Simon M/0000-0002-1357-8501	USGS Global Change Research Program	USGS Global Change Research Program(United States Geological Survey)	We appreciate reviews by S. Bridgham and L. Larsen. This work was supported by the USGS Global Change Research Program.	BAES CF, 1977, AM SCI, V65, P310; Baisden WT, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001823; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Bindoff NL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P385; Charles H, 2009, ECOL APPL, V19, P1758, DOI 10.1890/08-0172.1; Cherry JA, 2009, J ECOL, V97, P67, DOI 10.1111/j.1365-2745.2008.01449.x; Chmura GL, 2013, OCEAN COAST MANAGE, V83, P25, DOI 10.1016/j.ocecoaman.2011.09.006; Choi YH, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002261; CRAFT CB, 1991, ESTUARIES, V14, P175, DOI 10.2307/1351691; Duarte CM, 2005, BIOGEOSCIENCES, V2, P1, DOI 10.5194/bg-2-1-2005; Elsey-Quirk T, 2011, WETLANDS, V31, P87, DOI 10.1007/s13157-010-0139-2; Fagherazzi S, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000359; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Gedan KB, 2009, ANNU REV MAR SCI, V1, P117, DOI 10.1146/annurev.marine.010908.163930; Gedan KB, 2011, MAR ECOL PROG SER, V434, P229, DOI 10.3354/meps09084; Idaszkin YL, 2011, PLANT ECOL, V212, P553, DOI 10.1007/s11258-010-9844-4; Kirwan ML, 2011, BIOGEOSCIENCES, V8, P987, DOI 10.5194/bg-8-987-2011; Kirwan ML, 2012, J ECOL, V100, P764, DOI 10.1111/j.1365-2745.2012.01957.x; Kirwan ML, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045489; Kirwan ML, 2009, GLOBAL CHANGE BIOL, V15, P1982, DOI 10.1111/j.1365-2486.2008.01834.x; Langley JA, 2009, P NATL ACAD SCI USA, V106, P6182, DOI 10.1073/pnas.0807695106; Mcleod E, 2011, FRONT ECOL ENVIRON, V9, P552, DOI 10.1890/110004; Morris JT, 2002, ECOLOGY, V83, P2869, DOI 10.1890/0012-9658(2002)083[2869:ROCWTR]2.0.CO;2; Mudd SM, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001566; Mudd SM, 2009, ESTUAR COAST SHELF S, V82, P377, DOI 10.1016/j.ecss.2009.01.028; Nepf HM, 1999, WATER RESOUR RES, V35, P479, DOI 10.1029/1998WR900069; Powlson D. S., 1996, EVALUATION SOIL ORGA; Riebesell U, 2009, P NATL ACAD SCI USA, V106, P20602, DOI 10.1073/pnas.0813291106; Shugart H.H., 2011, GLOBAL CHANGE TERRES; Tanino Y, 2008, J HYDRAUL ENG-ASCE, V134, P34, DOI 10.1061/(ASCE)0733-9429(2008)134:1(34); Vermeer M, 2009, P NATL ACAD SCI USA, V106, P21527, DOI 10.1073/pnas.0907765106; Wolf AA, 2007, GLOBAL CHANGE BIOL, V13, P2036, DOI 10.1111/j.1365-2486.2007.01407.x	32	195	207	21	430	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 27	2012	489	7417					550	+		10.1038/nature11440	http://dx.doi.org/10.1038/nature11440			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011LT	23018965				2022-12-24	WOS:000309167100047
J	Yu, FX; Zhao, B; Panupinthu, N; Jewell, JL; Lian, I; Wang, LH; Zhao, JG; Yuan, HX; Tumaneng, K; Li, HR; Fu, XD; Mills, GB; Guan, KL				Yu, Fa-Xing; Zhao, Bin; Panupinthu, Nattapon; Jewell, Jenna L.; Lian, Ian; Wang, Lloyd H.; Zhao, Jiagang; Yuan, Haixin; Tumaneng, Karen; Li, Hairi; Fu, Xiang-Dong; Mills, Gordon B.; Guan, Kun-Liang			Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling	CELL			English	Article							LYSOPHOSPHATIDIC ACID RECEPTORS; YES-ASSOCIATED PROTEIN; ORGAN SIZE CONTROL; CELL-PROLIFERATION; HEPATOCELLULAR-CARCINOMA; TRANSCRIPTION FACTOR; GROWTH-CONTROL; TISSUE-GROWTH; F-ACTIN; TUMORIGENESIS	The Hippo pathway is crucial in organ size control, and its dysregulation contributes to tumorigenesis. However, upstream signals that regulate the mammalian Hippo pathway have remained elusive. Here, we report that the Hippo pathway is regulated by G-protein-coupled receptor (GPCR) signaling. Serum-borne lysophosphatidic acid (LPA) and sphingosine 1-phosphophate (S1P) act through G12/13-coupled receptors to inhibit the Hippo pathway kinases Lats1/2, thereby activating YAP and TAZ transcription coactivators, which are oncoproteins repressed by Lats1/2. YAP and TAZ are involved in LPA-induced gene expression, cell migration, and proliferation. In contrast, stimulation of Gs-coupled receptors by glucagon or epinephrine activates Lats1/2 kinase activity, thereby inhibiting YAP function. Thus, GPCR signaling can either activate or inhibit the Hippo-YAP pathway depending on the coupled G protein. Our study identifies extracellular diffusible signals that modulate the Hippo pathway and also establishes the Hippo-YAP pathway as a critical signaling branch downstream of GPCR.	[Yu, Fa-Xing; Jewell, Jenna L.; Lian, Ian; Wang, Lloyd H.; Zhao, Jiagang; Yuan, Haixin; Tumaneng, Karen; Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Yu, Fa-Xing; Jewell, Jenna L.; Lian, Ian; Wang, Lloyd H.; Zhao, Jiagang; Yuan, Haixin; Tumaneng, Karen; Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Li, Hairi; Fu, Xiang-Dong] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Zhao, Bin] Zhejiang Univ, Life Sci Inst, Hangzhou 310058, Zhejiang, Peoples R China; [Panupinthu, Nattapon; Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Zhejiang University; University of Texas System; UTMD Anderson Cancer Center	Guan, KL (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	kuguan@ucsd.edu	Guan, Kun-Liang/ADK-7088-2022	Yu, Fa-Xing/0000-0003-4834-9335	NIH [P30 CA23100]; CIRM; Breast Cancer Research Foundation; National Cancer Institute [T32CA121938];  [GM052872]; NATIONAL CANCER INSTITUTE [P30CA016672, P30CA023100, R01CA132809, T32CA121938, P50CA098258] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY022611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752, R01GM052872] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); Breast Cancer Research Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. Jack Dixon, Edward Dennis, Joan Heller Brown, and Jerold Chun for constructive comments; Dr. Rick Neubig for several G protein constructs; Drs. Ji Zhang, Richard Rivera, Zhongrui Zhou, Sunny Xiang, Andrew Markley, Dong Zhang, and Richard Harkewicz for technical help; and Jean Guan and Drs. Yanhui Xu and Ryan Russell for critical reading of the manuscript. This work was supported by grants from NIH and CIRM to K.-L.G. and GM052872 to X.-D.F. and a grant from Breast Cancer Research Foundation to G. B. M. J.L.J. was supported by the National Cancer Institute Training Grant T32CA121938. The cost of confocal imaging was partially supported by NIH Grant P30 CA23100.	Benhamouche S, 2010, GENE DEV, V24, P1718, DOI 10.1101/gad.1938710; Cai J, 2010, GENE DEV, V24, P2383, DOI 10.1101/gad.1978810; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Cao XW, 2008, GENE DEV, V22, P3320, DOI 10.1101/gad.1726608; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Fernandez BG, 2011, DEVELOPMENT, V138, P2337, DOI 10.1242/dev.063545; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kuang DH, 2005, J NEUROCHEM, V93, P383, DOI 10.1111/j.1471-4159.2005.03025.x; Lee CH, 2007, ANNU REV PHARMACOL, V47, P443, DOI 10.1146/annurev.pharmtox.47.120505.105359; Lee KP, 2010, P NATL ACAD SCI USA, V107, P8248, DOI 10.1073/pnas.0912203107; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Li L, 2007, MOL CELL NEUROSCI, V35, P76, DOI 10.1016/j.mcn.2007.02.004; Liu CY, 2010, J BIOL CHEM, V285, P37159, DOI 10.1074/jbc.M110.152942; Liu SY, 2009, CANCER CELL, V15, P539, DOI 10.1016/j.ccr.2009.03.027; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Ludwig A, 2011, J NEUROSCI, V31, P644, DOI 10.1523/JNEUROSCI.2006-10.2011; Ohta H, 2003, MOL PHARMACOL, V64, P994, DOI 10.1124/mol.64.4.994; Oury F, 2011, CELL, V144, P796, DOI 10.1016/j.cell.2011.02.004; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Prickett TD, 2011, NAT GENET, V43, P1119, DOI 10.1038/ng.950; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Rauskolb C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000624; Rosen H, 2009, ANNU REV BIOCHEM, V78, P743, DOI 10.1146/annurev.biochem.78.072407.103733; Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157; Shida D, 2003, CANCER RES, V63, P1706; Steinhardt AA, 2008, HUM PATHOL, V39, P1582, DOI 10.1016/j.humpath.2008.04.012; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; VANCORVEN EJ, 1989, CELL, V59, P45, DOI 10.1016/0092-8674(89)90868-4; Wellendorph P, 2005, MOL PHARMACOL, V67, P589, DOI 10.1124/mol.104.007559; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Xu MZ, 2009, CANCER-AM CANCER SOC, V115, P4576, DOI 10.1002/cncr.24495; Xu Y, 2010, CANCER RES, V70, P2455, DOI 10.1158/0008-5472.CAN-09-2505; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	47	1054	1100	7	274	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 17	2012	150	4					780	791		10.1016/j.cell.2012.06.037	http://dx.doi.org/10.1016/j.cell.2012.06.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22863277	Green Accepted, Bronze			2022-12-24	WOS:000308002300012
J	Liu, JG; Yang, W				Liu, Jianguo; Yang, Wu			Water Sustainability for China and Beyond	SCIENCE			English	Editorial Material							RESOURCES		[Liu, Jianguo; Yang, Wu] Michigan State Univ, Ctr Syst Integrat & Sustainabil, E Lansing, MI 48824 USA	Michigan State University	Liu, JG (corresponding author), Michigan State Univ, Ctr Syst Integrat & Sustainabil, E Lansing, MI 48824 USA.	liuji@msu.edu	Liu, Jianguo/G-5211-2015	Liu, Jianguo/0000-0001-6344-0087; Yang, Wu/0000-0002-1682-3349				Chen X., 2009, SANLIAN LIFE WKLY, V23, P40; Chinese Academy of Sciences, 2007, CHIN SUST DEV STRAT; Gleick P., 2008, WORLDS WATER 2008 20; Gleick PH, 2003, SCIENCE, V302, P1524, DOI 10.1126/science.1089967; Guo F., 2011, CHINA EC WKLY, V33, P26; He DM, 2000, INT RIVERS CHINA; Liu JG, 2003, NATURE, V421, P530, DOI 10.1038/nature01359; Liu JG, 2007, SCIENCE, V317, P1513, DOI 10.1126/science.1144004; Liu JG, 2010, CRIT REV ENV SCI TEC, V40, P823, DOI 10.1080/10643389.2010.502645; MEKONNEN M.M, 2011, NAT WAT FOOTPR ACC G; Ministry of Health of China, 2009, CHIN HLTH STAT YB 20; MWR, 2000, STAT B CHIN WAT ACT; Myint T., 2012, GOVERNING INT RIVERS; National Bureau of Statistics of China, 1985, CHIN STAT YB; National Development and Reform Commission, 2012, 12 5 YEAR PLAN DEV C; Piao SL, 2010, NATURE, V467, P43, DOI 10.1038/nature09364; Reynolds C. T., 2008, P WORLD ENV WAT RES, P1; Ward FA, 2008, P NATL ACAD SCI USA, V105, P18215, DOI 10.1073/pnas.0805554105; Xinhua News Agency, 2011, 400 MOR GOLF COURS H; Xinhua News Agency, 2011, INV WAT CONS CHIN RE; Yang C., 2005, WATER CONSERV EC, V23; Zhao SQ, 2006, FRONT ECOL ENVIRON, V4, P341, DOI 10.1890/1540-9295(2006)004[0341:ECORUE]2.0.CO;2	22	310	340	44	445	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2012	337	6095					649	650		10.1126/science.1219471	http://dx.doi.org/10.1126/science.1219471			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	986PE	22879488				2022-12-24	WOS:000307354500025
J	Tan-Wong, SM; Zaugg, JB; Camblong, J; Xu, ZY; Zhang, DW; Mischo, HE; Ansari, AZ; Luscombe, NM; Steinmetz, LM; Proudfoot, NJ				Tan-Wong, Sue Mei; Zaugg, Judith B.; Camblong, Jurgi; Xu, Zhenyu; Zhang, David W.; Mischo, Hannah E.; Ansari, Aseem Z.; Luscombe, Nicholas M.; Steinmetz, Lars M.; Proudfoot, Nick J.			Gene Loops Enhance Transcriptional Directionality	SCIENCE			English	Article							RNA-POLYMERASE-II; COMPLEX; METHYLATION; TERMINATION; PROMOTERS; SSU72; CEREVISIAE; INITIATION; UPSTREAM; RECRUITS	Eukaryotic genomes are extensively transcribed, forming both messenger RNAs (mRNAs) and noncoding RNAs (ncRNAs). ncRNAs made by RNA polymerase II often initiate from bidirectional promoters (nucleosome-depleted chromatin) that synthesize mRNA and ncRNA in opposite directions. We demonstrate that, by adopting a gene-loop conformation, actively transcribed mRNA encoding genes restrict divergent transcription of ncRNAs. Because gene-loop formation depends on a protein factor (Ssu72) that coassociates with both the promoter and the terminator, the inactivation of Ssu72 leads to increased synthesis of promoter-associated divergent ncRNAs, referred to as Ssu72-restricted transcripts (SRTs). Similarly, inactivation of individual gene loops by gene mutation enhances SRT synthesis. We demonstrate that gene-loop conformation enforces transcriptional directionality on otherwise bidirectional promoters.	[Xu, Zhenyu; Steinmetz, Lars M.] European Mol Biol Lab, Genome Biol Unit, D-69117 Heidelberg, Germany; [Tan-Wong, Sue Mei; Camblong, Jurgi; Mischo, Hannah E.; Proudfoot, Nick J.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Zaugg, Judith B.; Luscombe, Nicholas M.] European Bioinformat Inst, European Mol Biol Lab, Cambridge CB10 1SD, England; [Zhang, David W.; Ansari, Aseem Z.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Luscombe, Nicholas M.] UCL, Genet Inst, London WC1E 6BT, England; [Luscombe, Nicholas M.] Canc Res UK London Res Inst, London WC2A 3LY, England	European Molecular Biology Laboratory (EMBL); University of Oxford; European Molecular Biology Laboratory (EMBL); University of Wisconsin System; University of Wisconsin Madison; University of London; University College London; Cancer Research UK	Steinmetz, LM (corresponding author), European Mol Biol Lab, Genome Biol Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	larsms@embl.de; nicholas.proudfoot@path.ox.ac.uk	Ansari, Aseem/AAF-4945-2019	Proudfoot, Nicholas/0000-0001-8646-3222; Steinmetz, Lars/0000-0002-3962-2865; Zaugg, Judith B./0000-0001-8324-4040	Wellcome Trust; NIH; Deutsche Forschungsgemeinschaft; European Molecular Biology Laboratory; Swiss National Fonds; European Molecular Biology Organization; Direct For Biological Sciences [0747197] Funding Source: National Science Foundation; Cancer Research UK [16358] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Molecular Biology Laboratory; Swiss National Fonds(Swiss National Science Foundation (SNSF)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Cancer Research UK(Cancer Research UK)	We thank B. Dichtl and J. Kufel for strains and H. Wijayatilake for FMP27 and beta-globin 3C reagents. This work was supported by the Wellcome Trust (N.J.P.), the NIH and Deutsche Forschungsgemeinschaft (L. M. S.), European Molecular Biology Laboratory (J.B.Z., N.M.L., L. M. S.), and the Swiss National Fonds and European Molecular Biology Organization (J. C.). Genomic data are deposited at http://steinmetzlab.embl.de/proudfoot_lab/index.html (E-TABM-936).	Ansari A, 2005, GENE DEV, V19, P2969, DOI 10.1101/gad.1362305; Carninci P, 2009, NATURE, V457, P974, DOI 10.1038/457974b; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim T, 2009, CELL, V137, P259, DOI 10.1016/j.cell.2009.02.045; Mapendano CK, 2010, MOL CELL, V40, P410, DOI 10.1016/j.molcel.2010.10.012; Mattick JS, 2010, TRENDS GENET, V26, P21, DOI 10.1016/j.tig.2009.11.002; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Medler S, 2011, J BIOL CHEM, V286, P33709, DOI 10.1074/jbc.M110.193870; Murray SC, 2012, NUCLEIC ACIDS RES, V40, P2432, DOI 10.1093/nar/gkr1121; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; Pappas DL, 2000, MOL CELL BIOL, V20, P8343, DOI 10.1128/MCB.20.22.8343-8351.2000; Perkins KJ, 2008, MOL CELL, V29, P56, DOI 10.1016/j.molcel.2007.11.030; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Preker P, 2011, NUCLEIC ACIDS RES, V39, P7179, DOI 10.1093/nar/gkr370; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Rondon AG, 2009, MOL CELL, V36, P88, DOI 10.1016/j.molcel.2009.07.028; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Singh BN, 2007, MOL CELL, V27, P806, DOI 10.1016/j.molcel.2007.07.013; Steinmetz EJ, 2003, MOL CELL BIOL, V23, P6339, DOI 10.1128/MCB.23.18.6339-6349.2003; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Zhang DW, 2012, J BIOL CHEM, V287, P8541, DOI 10.1074/jbc.M111.335687	25	164	168	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2012	338	6107					671	675		10.1126/science.1224350	http://dx.doi.org/10.1126/science.1224350			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SM	23019609	Green Accepted, Green Submitted			2022-12-24	WOS:000310516000054
J	Li, P; Spolski, R; Liao, W; Wang, L; Murphy, TL; Murphy, KM; Leonard, WJ				Li, Peng; Spolski, Rosanne; Liao, Wei; Wang, Lu; Murphy, Theresa L.; Murphy, Kenneth M.; Leonard, Warren J.			BATF-JUN is critical for IRF4-mediated transcription in T cells	NATURE			English	Article							B-ATF; IL-21; GENE; DIFFERENTIATION; MODULATION; ACTIVATION; EXPRESSION; RESPONSES; IRF-4; STAT3	Interferon regulatory factor 4 (IRF4) is an IRF family transcription factor with critical roles in lymphoid development and in regulating the immune response(1,2). IRF4 binds DNA weakly owing to a carboxy-terminal auto-inhibitory domain, but cooperative binding with factors such as PU.1 or SPIB in B cells increases binding affinity(3), allowing IRF4 to regulate genes containing ETS-IRF composite elements (EICEs; 5'-GGAAnnGAAA-3')(1). Here we show that in mouse CD4(+) T cells, where PU.1/SPIB expression is low, and in B cells, where PU.1 is well expressed, IRF4 unexpectedly can cooperate with activator protein-1 (AP1) complexes to bind to AP1-IRF4 composite (5'-TGAnTCA/GAAA-3') motifs that we denote as AP1-IRF composite elements (AICEs). Moreover, BATF-JUN family protein complexes cooperate with IRF4 in binding to AICEs in pre-activated CD4(+) T cells stimulated with IL-21 and in T(H)17 differentiated cells. Importantly, BATF binding was diminished in Irf4(-/-) T cells and IRF4 binding was diminished in Batf(-/-) T cells, consistent with functional cooperation between these factors. Moreover, we show that AP1 and IRF complexes cooperatively promote transcription of the Il10 gene, which is expressed in T(H)17 cells and potently regulated by IL-21. These findings reveal that IRF4 can signal via complexes containing ETS or AP1 motifs depending on the cellular context, thus indicating new approaches for modulating IRF4-dependent transcription.	[Li, Peng; Spolski, Rosanne; Liao, Wei; Wang, Lu; Leonard, Warren J.] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Li, Peng; Spolski, Rosanne; Liao, Wei; Wang, Lu; Leonard, Warren J.] NHLBI, Ctr Immunol, NIH, Bethesda, MD 20892 USA; [Murphy, Theresa L.; Murphy, Kenneth M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL)	Li, P (corresponding author), NHLBI, Lab Mol Immunol, NIH, Bldg 10, Bethesda, MD 20892 USA.	lip3@nhlbi.nih.gov; wjl@helix.nih.gov	Leonard, Warren/AAA-1397-2022		Division of Intramural Research, National Heart, Lung, and Blood Institute, NIH; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIGHL006020, ZIAHL005402, ZICHL006058, ZIAHL005408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579] Funding Source: NIH RePORTER	Division of Intramural Research, National Heart, Lung, and Blood Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Division of Intramural Research, National Heart, Lung, and Blood Institute, NIH (P.L., R.S., W.L., L.W. and W.J.L.) and the Howard Hughes Medical Institute (T.L.M. and K.M.M.). We thank J.-X. Lin for valuable suggestions, critical comments and RNA-Seq data for pro-B/pre-B-enriched populations. We thank J. Zhu and Y. Wakabayashi, NHLBI DNA Sequencing Core, for excellent services, K. Ozato and Y. Hiroaki, NICHD, for Irf4<SUP>-/-</SUP> mice, and J. Thierry-Mieg and D. Thierry-Mieg, NCBI, for early analysis of ChIP-Seq data from ref. 14.	Altin JA, 2012, J IMMUNOL, V188, P5478, DOI 10.4049/jimmunol.1102994; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Brass AL, 1996, GENE DEV, V10, P2335, DOI 10.1101/gad.10.18.2335; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Chang HC, 2005, IMMUNITY, V22, P693, DOI 10.1016/j.immuni.2005.03.016; Chang HC, 2010, NAT IMMUNOL, V11, P527, DOI 10.1038/ni.1867; Dorsey MJ, 1995, ONCOGENE, V11, P2255; Echlin DR, 2000, ONCOGENE, V19, P1752, DOI 10.1038/sj.onc.1203491; Escalante CR, 2002, MOL CELL, V10, P1097, DOI 10.1016/S1097-2765(02)00703-7; Grossman A, 1996, GENOMICS, V37, P229, DOI 10.1006/geno.1996.0547; Grumont RJ, 2000, J EXP MED, V191, P1281, DOI 10.1084/jem.191.8.1281; Hu CM, 2002, J BIOL CHEM, V277, P49238, DOI 10.1074/jbc.M205895200; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee CG, 2009, MOL IMMUNOL, V46, P613, DOI 10.1016/j.molimm.2008.07.037; Liao W, 2011, NAT IMMUNOL, V12, P551, DOI 10.1038/ni.2030; Lin JX, 2012, IMMUNITY, V36, P586, DOI 10.1016/j.immuni.2012.02.017; Lohoff M, 2005, NAT REV IMMUNOL, V5, P125, DOI 10.1038/nri1552; Lohoff M, 2002, P NATL ACAD SCI USA, V99, P11808, DOI 10.1073/pnas.182425099; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Pernis AB, 2002, J INTERF CYTOK RES, V22, P111, DOI 10.1089/107999002753452728; Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233; Rengarajan J, 2002, J EXP MED, V195, P1003, DOI 10.1084/jem.20011128; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Spolski R, 2009, J IMMUNOL, V182, P2859, DOI 10.4049/jimmunol.0802978; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Tominaga N, 2003, INT IMMUNOL, V15, P1, DOI 10.1093/intimm/dxg001; Tussiwand R., 2012, NATURE; Zhang XK, 1999, MOL CELL BIOL, V19, P7138; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	33	278	286	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2012	490	7421					543	+		10.1038/nature11530	http://dx.doi.org/10.1038/nature11530			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NK	22992523	Green Accepted			2022-12-24	WOS:000310196200043
J	Iyer, G; Hanrahan, AJ; Milowsky, MI; Al-Ahmadie, H; Scott, SN; Janakiraman, M; Pirun, M; Sander, C; Socci, ND; Ostrovnaya, I; Viale, A; Heguy, A; Peng, LK; Chan, TA; Bochner, B; Bajorin, DF; Berger, MF; Taylor, BS; Solit, DB				Iyer, Gopa; Hanrahan, Aphrothiti J.; Milowsky, Matthew I.; Al-Ahmadie, Hikmat; Scott, Sasinya N.; Janakiraman, Manickam; Pirun, Mono; Sander, Chris; Socci, Nicholas D.; Ostrovnaya, Irina; Viale, Agnes; Heguy, Adriana; Peng, Luke; Chan, Timothy A.; Bochner, Bernard; Bajorin, Dean F.; Berger, Michael F.; Taylor, Barry S.; Solit, David B.			Genome Sequencing Identifies a Basis for Everolimus Sensitivity	SCIENCE			English	Article									[Iyer, Gopa; Hanrahan, Aphrothiti J.; Scott, Sasinya N.; Janakiraman, Manickam; Heguy, Adriana; Peng, Luke; Chan, Timothy A.; Solit, David B.] Human Oncol & Pathogenesis Program, Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Iyer, Gopa; Milowsky, Matthew I.; Solit, David B.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Iyer, Gopa; Milowsky, Matthew I.; Solit, David B.] Weill Med Coll Cornell Univ, Dept Med, New York, NY 10065 USA; [Al-Ahmadie, Hikmat; Berger, Michael F.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Pirun, Mono; Sander, Chris; Taylor, Barry S.] Mem Sloan Kettering Canc Ctr, Computat Biol, New York, NY 10065 USA; [Socci, Nicholas D.] Mem Sloan Kettering Canc Ctr, Bioinformat Core Lab, New York, NY 10065 USA; [Ostrovnaya, Irina] Mem Sloan Kettering Canc Ctr, Dept Biostat, New York, NY 10065 USA; [Viale, Agnes] Mem Sloan Kettering Canc Ctr, Genom Core Lab, New York, NY 10065 USA; [Bochner, Bernard] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Taylor, BS (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostatist, Dept Med, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94158 USA.	barry.taylor@ucsf.edu; solitd@mskcc.org	Solit, David B./AAC-5309-2019; Chan, Timothy A/ABD-5850-2021; Heguy, Adriana/GPP-3907-2022	Janakiraman, Manickam/0000-0003-4423-6237	NATIONAL CANCER INSTITUTE [T32CA009207] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA008748, R25 CA020449, T32 CA009207] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Krueger DA, 2010, NEW ENGL J MED, V363, P1801, DOI 10.1056/NEJMoa1001671; Lopez-Lago MA, 2009, MOL CELL BIOL, V29, P4235, DOI 10.1128/MCB.01578-08; Platt FM, 2009, CLIN CANCER RES, V15, P6008, DOI 10.1158/1078-0432.CCR-09-0898	3	532	541	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2012	338	6104					221	221		10.1126/science.1226344	http://dx.doi.org/10.1126/science.1226344			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	22923433	Green Accepted			2022-12-24	WOS:000309712300036
J	Murooka, TT; Deruaz, M; Marangoni, F; Vrbanac, VD; Seung, E; von Andrian, UH; Tager, AM; Luster, AD; Mempel, TR				Murooka, Thomas T.; Deruaz, Maud; Marangoni, Francesco; Vrbanac, Vladimir D.; Seung, Edward; von Andrian, Ulrich H.; Tager, Andrew M.; Luster, Andrew D.; Mempel, Thorsten R.			HIV-infected T cells are migratory vehicles for viral dissemination	NATURE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SEXUAL TRANSMISSION; IMMUNE-RESPONSES; DOWN-MODULATION; ENVELOPE; RECEPTOR; CD4(+); TYPE-1; ENV; MOTILITY	After host entry through mucosal surfaces, human immunodeficiency virus-1 (HIV-1) disseminates to lymphoid tissues to establish a generalized infection of the immune system. The mechanisms by which this virus spreads among permissive target cells locally during the early stages of transmission and systemically during subsequent dissemination are not known(1). In vitro studies suggest that the formation of virological synapses during stable contacts between infected and uninfected T cells greatly increases the efficiency of viral transfer(2). It is unclear, however, whether T-cell contacts are sufficiently stable in vivo to allow for functional synapse formation under the conditions of perpetual cell motility in epithelial(3) and lymphoid tissues(4). Here, using multiphoton intravital microscopy, we examine the dynamic behaviour of HIV-infected T cells in the lymph nodes of humanized mice. We find that most productively infected T cells migrate robustly, resulting in their even distribution throughout the lymph node cortex. A subset of infected cells formed multinucleated syncytia through HIV envelope-dependent cell fusion. Both uncoordinated motility of syncytia and adhesion to CD4(+) lymph node cells led to the formation of long membrane tethers, increasing cell lengths to up to ten times that of migrating uninfected T cells. Blocking the egress of migratory T cells from the lymph nodes into efferent lymph vessels, and thus interrupting T-cell recirculation, limited HIV dissemination and strongly reduced plasma viraemia. Thus, we have found that HIV-infected T cells are motile, form syncytia and establish tethering interactions that may facilitate cell-to-cell transmission through virological synapses. Migration of T cells in lymph nodes therefore spreads infection locally, whereas their recirculation through tissues is important for efficient systemic viral spread, suggesting new molecular targets to antagonize HIV infection.	[Murooka, Thomas T.; Deruaz, Maud; Marangoni, Francesco; Vrbanac, Vladimir D.; Seung, Edward; Tager, Andrew M.; Luster, Andrew D.; Mempel, Thorsten R.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Immunol & Inflammatory Dis, Boston, MA 02114 USA; [von Andrian, Ulrich H.] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [von Andrian, Ulrich H.] Harvard Univ, Sch Med, Dept Microbiol & Immunol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School	Mempel, TR (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Immunol & Inflammatory Dis, Boston, MA 02114 USA.	tmempel@mgh.harvard.edu	von Andrian, Ulrich H/A-5775-2008; Luster, Andrew/ABE-6504-2020; Marangoni, Francesco/I-9087-2012	Luster, Andrew/0000-0001-9679-7912; Marangoni, Francesco/0000-0002-2490-849X; Murooka, Thomas/0000-0002-3030-2726	National Institutes of Health (NIH) [P01 AI0178897, R56 AI097052, R01 CA150975, P30 AI060354]; Ragon Institute of Massachusetts General Hospital (MGH); Massachusetts Institute of Technology (MIT); Harvard; MGH ECOR Tosteson Postdoctoral Fellowship Award; NIH [T32 AI007387]; NATIONAL CANCER INSTITUTE [R01CA150975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI097052, R01AI097052, T32AI007387, P30AI060354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR042689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ragon Institute of Massachusetts General Hospital (MGH); Massachusetts Institute of Technology (MIT); Harvard; MGH ECOR Tosteson Postdoctoral Fellowship Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. Sodroski for the pSVIIIexE7 plasmid and A. Brown for HIV SF162R3; H. S. Shin, T. Tivey, K. Bankert and S. Tanno for technical assistance with the generation of humanized mice; A. Peixoto and D. Alvarez for management of the BL2<SUP>+</SUP> multiphoton microscopy facility; A. Brass, T. Allen and T. Dudek for assistance with virological techniques; and N. Elpek, M. Byrne and A. Finzi for technical assistance. Funding for this study was through National Institutes of Health (NIH) grants P01 AI0178897, R56 AI097052, R01 CA150975 and P30 AI060354, and a Platform Award from the Ragon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT) and Harvard. T. T. M. was supported by the MGH ECOR Tosteson Postdoctoral Fellowship Award and NIH training grant T32 AI007387.	Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Bondanza A, 2006, BLOOD, V107, P1828, DOI 10.1182/blood-2005-09-3716; Brainard DM, 2009, J VIROL, V83, P7305, DOI 10.1128/JVI.02207-08; Brown A, 2005, J LEUKOCYTE BIOL, V78, P675, DOI 10.1189/jlb.0505237; Casartelli N, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000955; Casola S, 2004, NAT IMMUNOL, V5, P317, DOI 10.1038/ni1036; Chen BK, 1996, J VIROL, V70, P6044, DOI 10.1128/JVI.70.9.6044-6053.1996; Chen P, 2007, J VIROL, V81, P12582, DOI 10.1128/JVI.00381-07; Debes GF, 2005, NAT IMMUNOL, V6, P889, DOI 10.1038/ni1238; Denton PW, 2008, PLOS MED, V5, P79, DOI 10.1371/journal.pmed.0050016; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Haase AT, 2011, ANNU REV MED, V62, P127, DOI 10.1146/annurev-med-080709-124959; Hubner W, 2009, SCIENCE, V323, P1743, DOI 10.1126/science.1167525; HWANG SS, 1991, SCIENCE, V253, P71, DOI 10.1126/science.1905842; Jolly C, 2004, J EXP MED, V199, P283, DOI 10.1084/jem.20030648; Kersh EN, 2009, J ANTIMICROB CHEMOTH, V63, P758, DOI 10.1093/jac/dkp008; Llewellyn GN, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001167; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Mostoslavsky G, 2006, P NATL ACAD SCI USA, V103, P16406, DOI 10.1073/pnas.0608130103; Murooka TT, 2011, METHODS MOL BIOL, V757, P247, DOI 10.1007/978-1-61779-166-6_16; Nobile C, 2010, J VIROL, V84, P2282, DOI 10.1128/JVI.02230-09; Pirounaki M, 2000, J VIROL METHODS, V85, P151, DOI 10.1016/S0166-0934(99)00163-9; Rudnicka D, 2009, J VIROL, V83, P6234, DOI 10.1128/JVI.00282-09; Sattentau Q, 2008, NAT REV MICROBIOL, V6, P815, DOI 10.1038/nrmicro1972; Schindler M, 2005, J VIROL, V79, P5489, DOI 10.1128/JVI.79.9.5489-5498.2005; Schindler M, 2003, J VIROL, V77, P10548, DOI 10.1128/JVI.77.19.10548-10556.2003; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Sherer NM, 2007, NAT CELL BIOL, V9, P310, DOI 10.1038/ncb1544; SODROSKI J, 1986, NATURE, V322, P470, DOI 10.1038/322470a0; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; Stolp B, 2009, CELL HOST MICROBE, V6, P174, DOI 10.1016/j.chom.2009.06.004; Sun ZF, 2007, J EXP MED, V204, P705, DOI 10.1084/jem.20062411; THALI M, 1991, J VIROL, V65, P5007, DOI 10.1128/JVI.65.9.5007-5012.1991; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Worbs T, 2007, J EXP MED, V204, P489, DOI 10.1084/jem.20061706; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353	38	234	235	1	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2012	490	7419					283	+		10.1038/nature11398	http://dx.doi.org/10.1038/nature11398			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019IY	22854780	Green Submitted, Green Accepted			2022-12-24	WOS:000309733300054
J	Schmitz, R; Young, RM; Ceribelli, M; Jhavar, S; Xiao, WM; Zhang, MZ; Wright, G; Shaffer, AL; Hodson, DJ; Buras, E; Liu, XL; Powell, J; Yang, YD; Xu, WH; Zhao, H; Kohlhammer, H; Rosenwald, A; Kluin, P; Muller-Hermelink, HK; Ott, G; Gascoyne, RD; Connors, JM; Rimsza, LM; Campo, E; Jaffe, ES; Delabie, J; Smeland, EB; Ogwang, MD; Reynolds, SJ; Fisher, RI; Braziel, RM; Tubbs, RR; Cook, JR; Weisenburger, DD; Chan, WC; Pittaluga, S; Wilson, W; Waldmann, TA; Rowe, M; Mbulaiteye, SM; Rickinson, AB; Staudt, LM				Schmitz, Roland; Young, Ryan M.; Ceribelli, Michele; Jhavar, Sameer; Xiao, Wenming; Zhang, Meili; Wright, George; Shaffer, Arthur L.; Hodson, Daniel J.; Buras, Eric; Liu, Xuelu; Powell, John; Yang, Yandan; Xu, Weihong; Zhao, Hong; Kohlhammer, Holger; Rosenwald, Andreas; Kluin, Philip; Mueller-Hermelink, Hans Konrad; Ott, German; Gascoyne, Randy D.; Connors, Joseph M.; Rimsza, Lisa M.; Campo, Elias; Jaffe, Elaine S.; Delabie, Jan; Smeland, Erlend B.; Ogwang, Martin D.; Reynolds, Steven J.; Fisher, Richard I.; Braziel, Rita M.; Tubbs, Raymond R.; Cook, James R.; Weisenburger, Dennis D.; Chan, Wing C.; Pittaluga, Stefania; Wilson, Wyndham; Waldmann, Thomas A.; Rowe, Martin; Mbulaiteye, Sam M.; Rickinson, Alan B.; Staudt, Louis M.			Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics	NATURE			English	Article							CELL; IMMUNOGLOBULIN; REGION	Burkitt's lymphoma (BL) can often be cured by intensive chemotherapy, but the toxicity of such therapy precludes its use in the elderly and in patients with endemic BL in developing countries, necessitating new strategies(1). The normal germinal centre B cell is the presumed cell of origin for both BL and diffuse large B-cell lymphoma (DLBCL), yet gene expression analysis suggests that these malignancies may use different oncogenic pathways(2). BL is subdivided into a sporadic subtype that is diagnosed in developed countries, the Epstein-Barr-virus-associated endemic subtype, and an HIV-associated subtype, but it is unclear whether these subtypes use similar or divergent oncogenic mechanisms. Here we used high-throughput RNA sequencing and RNA interference screening to discover essential regulatory pathways in BL that cooperate with MYC, the defining oncogene of this cancer. In 70% of sporadic BL cases, mutations affecting the transcription factor TCF3 (E2A) or its negative regulator ID3 fostered TCF3 dependency. TCF3 activated the pro-survival phosphatidylinositol-3-OH kinase pathway in BL, in part by augmenting tonic B-cell receptor signalling. In 38% of sporadic BL cases, oncogenic CCND3 mutations produced highly stable cyclin D3 isoforms that drive cell cycle progression. These findings suggest opportunities to improve therapy for patients with BL.	[Schmitz, Roland; Young, Ryan M.; Ceribelli, Michele; Jhavar, Sameer; Zhang, Meili; Shaffer, Arthur L.; Hodson, Daniel J.; Buras, Eric; Yang, Yandan; Xu, Weihong; Zhao, Hong; Kohlhammer, Holger; Wilson, Wyndham; Waldmann, Thomas A.; Staudt, Louis M.] NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Xiao, Wenming; Liu, Xuelu; Powell, John] NIH, Bioinformat & Mol Anal Sect, Div Computat Biosci, Ctr Informat Technol, Bethesda, MD 20892 USA; [Wright, George] NCI, Biometr Res Branch, DCTD, NIH, Bethesda, MD 20892 USA; [Rosenwald, Andreas; Mueller-Hermelink, Hans Konrad] Univ Wurzburg, Dept Pathol, D-97080 Wurzburg, Germany; [Kluin, Philip] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, NL-9713 GZ Groningen, Netherlands; [Ott, German] Robert Bosch Krankenhaus, Dept Clin Pathol, D-70376 Stuttgart, Germany; [Ott, German] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany; [Gascoyne, Randy D.; Connors, Joseph M.] British Columbia Canc Agcy, Vancouver, BC V5Z 1L3, Canada; [Rimsza, Lisa M.] Univ Arizona, Dept Pathol, Tucson, AZ 85724 USA; [Campo, Elias] Univ Barcelona, Hosp Clin, E-08036 Barcelona, Spain; [Jaffe, Elaine S.; Pittaluga, Stefania] NCI, Pathol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Delabie, Jan] Univ Hosp, Rikshosp, Pathol Clin, N-0372 Oslo, Norway; [Smeland, Erlend B.] Univ Hosp, Rikshosp, Inst Canc Res, N-0310 Oslo, Norway; [Smeland, Erlend B.] Univ Oslo, Norwegian Radium Hosp, Fac Div, Ctr Canc Biomed, N-0310 Oslo, Norway; [Ogwang, Martin D.] St Marys Hosp Lacor, Gulu 256, Uganda; [Reynolds, Steven J.] NIAID, Div Intramural Res, NIH, Bethesda, MD 20892 USA; [Fisher, Richard I.] Univ Rochester, Sch Med, James P Wilmot Canc Ctr, Rochester, NY 14642 USA; [Braziel, Rita M.] Oregon Hlth & Sci Univ, Portland, OR 97239 USA; [Tubbs, Raymond R.; Cook, James R.] Cleveland Clin, Pathol & Lab Med Inst, Cleveland, OH 44195 USA; [Weisenburger, Dennis D.; Chan, Wing C.] Univ Nebraska Med Ctr, Dept Pathol, Omaha, NE 68198 USA; [Weisenburger, Dennis D.; Chan, Wing C.] Univ Nebraska Med Ctr, Dept Microbiol, Omaha, NE 68198 USA; [Rowe, Martin; Rickinson, Alan B.] Univ Birmingham, Birmingham Canc Res UK Ctr, Sch Canc Sci, Birmingham B15 2TT, W Midlands, England; [Mbulaiteye, Sam M.] NCI, Infect & Immunoepidemiol Branch, Div Canc Epidemiol & Genet, NIH,US Dept HHS, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Wurzburg; University of Groningen; Bosch; Robert Bosch Krankenhaus; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; British Columbia Cancer Agency; University of Arizona; University of Barcelona; Hospital Clinic de Barcelona; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Rochester; Oregon Health & Science University; Cleveland Clinic Foundation; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Birmingham; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Staudt, LM (corresponding author), NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	lstaudt@mail.nih.gov	Gascoyne, Randy D/A-6009-2013; Smeland, Erlend/AAO-3214-2020; Waldmann, Thomas/AAT-5972-2021; Rowe, Martin/B-2880-2009; Hodson, Daniel J/K-6817-2016; Wright, George W/M-1660-2017; Mbulaiteye, Sam/O-3056-2019; Staudt, Louis/AAC-5324-2019; Connors, Joseph/AAF-5284-2019; Campo, Elias/AAC-5593-2019; Jaffe, Elaine/G-8981-2014	Gascoyne, Randy D/0000-0002-2610-5690; Waldmann, Thomas/0000-0003-4500-6660; Rowe, Martin/0000-0003-4139-7326; Hodson, Daniel J/0000-0001-6225-2033; Mbulaiteye, Sam/0000-0002-8273-9831; Connors, Joseph/0000-0002-1361-7531; Campo, Elias/0000-0001-9850-9793; Delabie, Jan/0000-0001-5023-0689; Jaffe, Elaine/0000-0003-4632-0301; Reynolds, Steven/0000-0002-5403-2759	NIH, National Cancer Institute, Center for Cancer Research, an NCI SPECS grant [UO1-CA 114778]; Foundation for NIH; Cancer Research UK; Lymphoma/Leukemia Molecular Profiling Project (LLMPP); Dr Mildred Scheel Stiftung fur Krebsforschung (Deutsche Krebshilfe); NCI [N01-C0-12400]; CENTER FOR INFORMATION TECHNOLOGY [ZIACT000260] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIASC004002, U01CA114778, ZIASC000550, ZIACP010176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001040, ZIAAI000361] Funding Source: NIH RePORTER; Medical Research Council [G9818340B] Funding Source: researchfish	NIH, National Cancer Institute, Center for Cancer Research, an NCI SPECS grant; Foundation for NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); Lymphoma/Leukemia Molecular Profiling Project (LLMPP); Dr Mildred Scheel Stiftung fur Krebsforschung (Deutsche Krebshilfe)(Deutsche Krebshilfe); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research, an NCI SPECS grant (UO1-CA 114778), by the Foundation for NIH, through a gift from the Richard A. Lauderbaugh Memorial Fund, and by Cancer Research UK. This study was conducted under the auspices of the Lymphoma/Leukemia Molecular Profiling Project (LLMPP). R.S. was supported by the Dr Mildred Scheel Stiftung fur Krebsforschung (Deutsche Krebshilfe). D.J.H. is a Kay Kendall Leukaemia Fund Intermediate research fellow. This study used the high-performance computational capabilities of the Biowulf Linux cluster at the National Institutes of Health (http://biowulf.nih.gov). We thank K. Meyer for help with the GEO submission, T. Ellenberger for the TCF3 crystal structure coordinates, B. Tran (Center for Cancer Research Sequencing Facility) and K. Hartman for DNA sequencing and K. Rajewsky for discussions. The DLBCL data set is part of the Cancer Genomics Characterization Initiative (CGCI), supported by NCI contract N01-C0-12400 (http://cgap.nci.nih.gov/cgci.html/) and was obtained from dbGaP at http://www.ncbi.nlm.nih.gov/gap. We thank the participants in the EMBLEM Study (http://emblem.cancer.gov/) in Uganda, the EMBLEM Study staff for collecting and processing the samples and data, and the Government of Uganda for allowing the study to be done and samples to be exported for research.	Cato MH, 2011, MOL CELL BIOL, V31, P127, DOI 10.1128/MCB.00650-10; Dave SS, 2006, NEW ENGL J MED, V354, P2431, DOI 10.1056/NEJMoa055759; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; ELLENBERGER T, 1994, GENE DEV, V8, P970, DOI 10.1101/gad.8.8.970; Kee BL, 2009, NAT REV IMMUNOL, V9, P175, DOI 10.1038/nri2507; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Orem J, 2008, TROP DOCT, V38, P7, DOI 10.1258/td.2007.060093; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Peled JU, 2010, CELL RES, V20, P631, DOI 10.1038/cr.2010.55; PESCE S, 1993, MOL CELL BIOL, V13, P7874, DOI 10.1128/MCB.13.12.7874; Sander S., 2012, CANC CELL; Srinivasan L, 2009, CELL, V139, P573, DOI 10.1016/j.cell.2009.08.041; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Yustein JT, 2007, CURR OPIN HEMATOL, V14, P375, DOI 10.1097/MOH.0b013e3281bccdee	21	562	574	2	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2012	490	7418					116	120		10.1038/nature11378	http://dx.doi.org/10.1038/nature11378			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015LG	22885699	Green Accepted, Green Submitted			2022-12-24	WOS:000309446800044
J	Angell, SY; Danel, I; DeCock, KM				Angell, S. Y.; Danel, I.; DeCock, K. M.			Global Indicators and Targets for Noncommunicable Diseases	SCIENCE			English	Editorial Material									[Angell, S. Y.; Danel, I.; DeCock, K. M.] Ctr Dis Control & Prevent, Ctr Global Hlth, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Angell, SY (corresponding author), Ctr Dis Control & Prevent, Ctr Global Hlth, Atlanta, GA 30333 USA.	sangell@cdc.gov						Bloom DE, 2011, GLOBAL EC BURDEN NON; Carin B., 2012, POST 2015 GOALS TARG; Edvardsson K, 2005, SOC CHOICE WELFARE, V24, P343, DOI 10.1007/s00355-003-0309-8; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; WHO, 2012, COMPR GLOB MON FRAM; WHO, 2011, PROP NONC DIS TARG W; World Health Organization, 2008, 2008 2013 ACT PLAN G; World Health Organization, 1998, HLTH PROM GLOSS; You D., 2011, LEVELS TRENDS CHILD, P33	9	13	16	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2012	337	6101					1456	1457		10.1126/science.1228293	http://dx.doi.org/10.1126/science.1228293			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007UC	22997310				2022-12-24	WOS:000308912900024
J	Lu, P; Wang, YZ; Graham, L; McHale, K; Gao, MY; Wu, D; Brock, J; Blesch, A; Rosenzweig, ES; Havton, LA; Zheng, BH; Conner, JM; Marsala, M; Tuszynski, MH				Lu, Paul; Wang, Yaozhi; Graham, Lori; McHale, Karla; Gao, Mingyong; Wu, Di; Brock, John; Blesch, Armin; Rosenzweig, Ephron S.; Havton, Leif A.; Zheng, Binhai; Conner, James M.; Marsala, Martin; Tuszynski, Mark H.			Long-Distance Growth and Connectivity of Neural Stem Cells after Severe Spinal Cord Injury	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; PROMOTE AXONAL REGENERATION; ADULT-RAT; NEUROTROPHIC FACTORS; FUNCTIONAL RECOVERY; WHITE-MATTER; NEURONS; FETAL; NOGO; DIFFERENTIATION	Neural stem cells (NSCs) expressing GFP were embedded into fibrin matrices containing growth factor cocktails and grafted to sites of severe spinal cord injury. Grafted cells differentiated into multiple cellular phenotypes, including neurons, which extended large numbers of axons over remarkable distances. Extending axons formed abundant synapses with host cells. Axonal growth was partially dependent on mammalian target of rapamycin (mTOR), but not Nogo signaling. Grafted neurons supported formation of electrophysiological relays across sites of complete spinal transection, resulting in functional recovery. Two human stem cell lines (566RSC and HUES7) embedded in growth-factor-containing fibrin exhibited similar growth, and 566RSC cells supported functional recovery. Thus, properties intrinsic to early-stage neurons can overcome the inhibitory milieu of the injured adult spinal cord to mount remarkable axonal growth, resulting in formation of new relay circuits that significantly improve function. These therapeutic properties extend across stem cell sources and species.	[Lu, Paul; Wang, Yaozhi; Graham, Lori; McHale, Karla; Gao, Mingyong; Wu, Di; Brock, John; Blesch, Armin; Rosenzweig, Ephron S.; Zheng, Binhai; Conner, James M.; Tuszynski, Mark H.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Marsala, Martin] Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA; [Lu, Paul; Tuszynski, Mark H.] Vet Adm Med Ctr, San Diego, CA 92161 USA; [Havton, Leif A.] Univ Calif Irvine, Dept Anesthesiol & Perioperat Care, Reeve Irvine Res Ctr, Irvine, CA 92697 USA; [Havton, Leif A.] Univ Calif Irvine, Dept Anat & Neurobiol, Reeve Irvine Res Ctr, Irvine, CA 92697 USA; [Blesch, Armin] Univ Heidelberg Hosp, Spinal Cord Injury Ctr, D-69120 Heidelberg, Germany	University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California Irvine; University of California System; University of California Irvine; Ruprecht Karls University Heidelberg	Lu, P (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.	plu@ucsd.edu; mtuszynski@ucsd.edu	Rosenzweig, Ephron/AAI-7541-2020	Blesch, Armin/0000-0003-1133-1174; Gao, Mingyong/0000-0002-8824-7600; Rosenzweig, Ephron/0000-0002-0370-9643	Veterans Administration; NIH [NS09881]; Canadian Spinal Research Organization; The Craig H. Neilsen Foundation; Bernard and Anne Spitzer Charitable Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049881, F31NS009881, R01NS054734] Funding Source: NIH RePORTER	Veterans Administration(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Spinal Research Organization; The Craig H. Neilsen Foundation; Bernard and Anne Spitzer Charitable Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Ramsey Samara for electrophysiological assistance; Janet Weber, Andrea Chan, and Jeffrey Kwan for technical assistance; the Rat Resource and Research Center, University of Missouri, Columbia, MO, for providing GFP rats; and Dr. Farquhar for use of the electron microscopy core facility. Human neural stem cells were a gift from NeuralStem, Inc. This work was supported by the Veterans Administration, NIH (NS09881), Canadian Spinal Research Organization, The Craig H. Neilsen Foundation, and the Bernard and Anne Spitzer Charitable Trust. The authors declare that they have no competing financial interests.	Bamber NI, 1999, NEURAL PLAST, V6, P103, DOI 10.1155/NP.1999.103; Baska KM, 2008, J CELL PHYSIOL, V215, P684, DOI 10.1002/jcp.21349; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Bonner JF, 2011, J NEUROSCI, V31, P4675, DOI 10.1523/JNEUROSCI.4130-10.2011; Boulis NM, 2012, NAT REV NEUROL, V8, P172, DOI 10.1038/nrneurol.2011.191; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Bregman BS, 1997, EXP NEUROL, V148, P475, DOI 10.1006/exnr.1997.6705; Bryda EC, 2006, BIOTECHNIQUES, V41, P715, DOI 10.2144/000112289; Buchli AD, 2005, ANN MED, V37, P556, DOI 10.1080/07853890500407520; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; Davies SJA, 1997, NATURE, V390, P680, DOI 10.1038/37776; Davies SJA, 1999, J NEUROSCI, V19, P5810, DOI 10.1523/JNEUROSCI.19-14-05810.1999; Fawcett JW, 2006, J NEUROTRAUM, V23, P371, DOI 10.1089/neu.2006.23.371; Filbin MT, 2006, PHILOS T R SOC B, V361, P1565, DOI 10.1098/rstb.2006.1885; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Gaillard A, 2007, NAT NEUROSCI, V10, P1294, DOI 10.1038/nn1970; Giovanini MA, 1997, EXP NEUROL, V148, P523, DOI 10.1006/exnr.1997.6703; Grumbles RM, 2009, J NEUROPATH EXP NEUR, V68, P736, DOI 10.1097/NEN.0b013e3181a9360f; Harris Joseph, 2007, J Vis Exp, P305, DOI 10.3791/305; He ZG, 2004, ANNU REV NEUROSCI, V27, P341, DOI 10.1146/annurev.neuro.27.070203.144340; Houle JD, 2006, J NEUROSCI, V26, P7405, DOI 10.1523/JNEUROSCI.1166-06.2006; JAKEMAN LB, 1991, J COMP NEUROL, V307, P311, DOI 10.1002/cne.903070211; Jin Y, 2002, EXP NEUROL, V177, P265, DOI 10.1006/exnr.2002.7980; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Josephson A, 2002, J COMP NEUROL, V453, P292, DOI 10.1002/cne.10408; Kadoya K, 2009, NEURON, V64, P165, DOI 10.1016/j.neuron.2009.09.016; Knott GW, 2009, NAT PROTOC, V4, P1145, DOI 10.1038/nprot.2009.114; Lepore AC, 2005, EXP NEUROL, V194, P230, DOI 10.1016/j.expneurol.2005.02.020; Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; MayerProschel M, 1997, NEURON, V19, P773, DOI 10.1016/S0896-6273(00)80960-5; Miller KE, 1998, BRAIN RES BULL, V47, P43, DOI 10.1016/S0361-9230(98)00065-3; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Steward O, 2003, J COMP NEUROL, V459, P1, DOI 10.1002/cne.10593; Sun F, 2011, NATURE, V480, P372, DOI 10.1038/nature10594; Theele DP, 1996, EXP NEUROL, V142, P128, DOI 10.1006/exnr.1996.0184; Tuszynski MH, 2008, CNS REGENERATION: BASIC SCIENCE AND CLINICAL ADVANCES, 2ND EDITION, P319, DOI 10.1016/B978-012373994-0.50015-4; WICTORIN K, 1990, NATURE, V347, P556, DOI 10.1038/347556a0; Willerth SM, 2007, STEM CELLS, V25, P2235, DOI 10.1634/stemcells.2007-0111; Yuan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017540	42	584	607	20	226	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 14	2012	150	6					1264	1273		10.1016/j.cell.2012.08.020	http://dx.doi.org/10.1016/j.cell.2012.08.020			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22980985	Green Accepted, Bronze			2022-12-24	WOS:000308928100018
J	Vilchez, D; Morantte, I; Liu, Z; Douglas, PM; Merkwirth, C; Rodrigues, APC; Manning, G; Dillin, A				Vilchez, David; Morantte, Ianessa; Liu, Zheng; Douglas, Peter M.; Merkwirth, Carsten; Rodrigues, Ana P. C.; Manning, Gerard; Dillin, Andrew			RPN-6 determines C. elegans longevity under proteotoxic stress conditions	NATURE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; HEAT-SHOCK FACTOR; CAENORHABDITIS-ELEGANS; LIFE-SPAN; STEM-CELLS; DAF-16; RESTRICTION; METABOLISM; AUTOPHAGY; GENE	Organisms that protect their germ-cell lineages from damage often do so at considerable cost: limited metabolic resources become partitioned away from maintenance of the soma, leaving the ageing somatic tissues to navigate survival amid an environment containing damaged and poorly functioning proteins. Historically, experimental paradigms that limit reproductive investment result in lifespan extension. We proposed that germline-deficient animals might exhibit heightened protection from proteotoxic stressors in somatic tissues. We find that the forced re-investment of resources from the germ line to the soma in Caenorhabditis elegans results in elevated somatic proteasome activity, clearance of damaged proteins and increased longevity. This activity is associated with increased expression of rpn-6, a subunit of the 19S proteasome, by the FOXO transcription factor DAF-16. Ectopic expression of rpn-6 is sufficient to confer proteotoxic stress resistance and extend lifespan, indicating that rpn-6 is a candidate to correct deficiencies in age-related protein homeostasis disorders.	[Vilchez, David; Morantte, Ianessa; Liu, Zheng; Douglas, Peter M.; Merkwirth, Carsten; Dillin, Andrew] Salk Inst Biol Studies, Howard Hughes Med Inst, Glenn Ctr Aging Res, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; [Rodrigues, Ana P. C.; Manning, Gerard] Salk Inst Biol Studies, Razavi Newman Ctr Bioinformat, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute; Salk Institute	Dillin, A (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, Glenn Ctr Aging Res, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	dillin@salk.edu	Merkwirth, Carsten/H-5992-2012; Vilchez, David/A-8446-2008; Manning, Gerard/C-8308-2009; Liu, Zheng/E-6302-2012	Merkwirth, Carsten/0000-0001-8895-3495; Vilchez, David/0000-0002-0801-0743; Douglas, Peter/0000-0002-0734-1049; Manning, Gerard/0000-0002-5087-9151; Liu, Zheng/0000-0002-7968-3849; Grant, Ana/0000-0002-5439-9331	HHMI; NIA; F.M. Kirby, Inc. Foundation Postdoctoral Scholar Award; Beatriu de Pinos (AGAUR) fellowship; NATIONAL INSTITUTE ON AGING [R01AG042679] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); F.M. Kirby, Inc. Foundation Postdoctoral Scholar Award; Beatriu de Pinos (AGAUR) fellowship; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S. Panowski for help with the generation of transgenic strains. We thank D. Joyce for proteasome activity assays and S. Wolff for comments on the manuscript. This work was supported by HHMI and the NIA. D. V. was a recipient of the F.M. Kirby, Inc. Foundation Postdoctoral Scholar Award and Beatriu de Pinos (AGAUR) fellowship.	Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Arantes-Oliveira N, 2002, SCIENCE, V295, P502, DOI 10.1126/science.1065768; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Berman JR, 2006, CELL, V124, P1055, DOI 10.1016/j.cell.2006.01.039; BRENNER S, 1974, GENETICS, V77, P71; Brignull HR, 2006, J NEUROSCI, V26, P7597, DOI 10.1523/JNEUROSCI.0990-06.2006; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Chai YH, 2002, P NATL ACAD SCI USA, V99, P9310, DOI 10.1073/pnas.152101299; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Gerisch B, 2001, DEV CELL, V1, P841, DOI 10.1016/S1534-5807(01)00085-5; Ghazi A, 2007, P NATL ACAD SCI USA, V104, P5947, DOI 10.1073/pnas.0700638104; Goudeau J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000599; Hamer G, 2010, NAT METHODS, V7, P473, DOI [10.1038/nmeth.1460, 10.1038/NMETH.1460]; Hansen M, 2005, PLOS GENET, V1, P119, DOI 10.1371/journal.pgen.0010017; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Kenyon C, 2010, ANN NY ACAD SCI, V1204, P156, DOI 10.1111/j.1749-6632.2010.05640.x; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; Kisselev AF, 2005, METHOD ENZYMOL, V398, P364, DOI 10.1016/S0076-6879(05)98030-0; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lapierre LR, 2012, AUTOPHAGY, V8, P144, DOI 10.4161/auto.8.1.18722; Li XJ, 2011, NEUROBIOL DIS, V43, P4, DOI 10.1016/j.nbd.2010.11.018; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; MITCHELL DH, 1979, J GERONTOL, V34, P28, DOI 10.1093/geronj/34.1.28; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Partridge L, 2005, CELL, V120, P461, DOI 10.1016/j.cell.2005.01.026; Pathare GR, 2012, P NATL ACAD SCI USA, V109, P149, DOI 10.1073/pnas.1117648108; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; PRIESS JR, 1987, CELL, V51, P601, DOI 10.1016/0092-8674(87)90129-2; Santamaria PG, 2003, J BIOL CHEM, V278, P6687, DOI 10.1074/jbc.M209420200; Shanley DP, 2000, EVOLUTION, V54, P740, DOI 10.1111/j.0014-3820.2000.tb00076.x; Vazquez-Manrique RP, 2005, FASEB J, V19, P172, DOI 10.1096/fj.05-4212fje; Wang MC, 2008, SCIENCE, V322, P957, DOI 10.1126/science.1162011; Wolff S, 2006, CELL, V124, P1039, DOI 10.1016/j.cell.2005.12.042; Zabel C, 2010, J PROTEOMICS, V73, P2230, DOI 10.1016/j.jprot.2010.08.008	47	286	294	0	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2012	489	7415					263	+		10.1038/nature11315	http://dx.doi.org/10.1038/nature11315			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003UC	22922647				2022-12-24	WOS:000308635900035
J	Formenti, SC; DeWyngaert, JK; Jozsef, G; Goldberg, JD				Formenti, Silvia C.; DeWyngaert, J. Keith; Jozsef, Gabor; Goldberg, Judith D.			Prone vs Supine Positioning for Breast Cancer Radiotherapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Formenti, Silvia C.; DeWyngaert, J. Keith; Jozsef, Gabor] NYU, Sch Med, Dept Radiat Oncol, New York, NY 10003 USA; [Goldberg, Judith D.] NYU, Sch Med, Dept Environm Med, New York, NY USA	New York University; New York University	Formenti, SC (corresponding author), NYU, Sch Med, Dept Radiat Oncol, New York, NY 10003 USA.	silvia.formenti@nyumc.org		Goldberg, Judith D./0000-0003-3758-6976				DARBY S, 2011, LANCET, V12, P1707, DOI DOI 10.1016/S0140-6736(11)61629-2; Darby SC, 2005, LANCET ONCOL, V6, P557, DOI 10.1016/S1470-2045(05)70251-5; Formenti SC, 2007, J CLIN ONCOL, V25, P2236, DOI 10.1200/JCO.2006.09.1041; Lymberis SC, 2012, INT J RADIAT ONCOL, V84, P902, DOI 10.1016/j.ijrobp.2012.01.040; Stegman LD, 2007, INT J RADIAT ONCOL, V68, P73, DOI 10.1016/j.ijrobp.2006.11.054	5	114	121	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2012	308	9					861	863		10.1001/2012.jama.10759	http://dx.doi.org/10.1001/2012.jama.10759			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999ET	22948692	Bronze			2022-12-24	WOS:000308292900010
J	Metcalf, WW; Griffin, BM; Cicchillo, RM; Gao, JT; Janga, SC; Cooke, HA; Circello, BT; Evans, BS; Martens-Habbena, W; Stahl, DA; van der Donk, WA				Metcalf, William W.; Griffin, Benjamin M.; Cicchillo, Robert M.; Gao, Jiangtao; Janga, Sarath Chandra; Cooke, Heather A.; Circello, Benjamin T.; Evans, Bradley S.; Martens-Habbena, Willm; Stahl, David A.; van der Donk, Wilfred A.			Synthesis of Methylphosphonic Acid by Marine Microbes: A Source for Methane in the Aerobic Ocean	SCIENCE			English	Article							HETEROLOGOUS EXPRESSION; MOLECULAR-CLONING; BIOSYNTHESIS; PHOSPHORUS	Relative to the atmosphere, much of the aerobic ocean is supersaturated with methane; however, the source of this important greenhouse gas remains enigmatic. Catabolism of methylphosphonic acid by phosphorus-starved marine microbes, with concomitant release of methane, has been suggested to explain this phenomenon, yet methylphosphonate is not a known natural product, nor has it been detected in natural systems. Further, its synthesis from known natural products would require unknown biochemistry. Here we show that the marine archaeon Nitrosopumilus maritimus encodes a pathway for methylphosphonate biosynthesis and that it produces cell-associated methylphosphonate esters. The abundance of a key gene in this pathway in metagenomic data sets suggests that methylphosphonate biosynthesis is relatively common in marine microbes, providing a plausible explanation for the methane paradox.	[Metcalf, William W.; Griffin, Benjamin M.; Cicchillo, Robert M.; Gao, Jiangtao; Janga, Sarath Chandra; Cooke, Heather A.; Circello, Benjamin T.; Evans, Bradley S.; van der Donk, Wilfred A.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Cicchillo, Robert M.; Gao, Jiangtao; Cooke, Heather A.; van der Donk, Wilfred A.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Cicchillo, Robert M.; Gao, Jiangtao; Cooke, Heather A.; van der Donk, Wilfred A.] Univ Illinois, Howard Hughes Med Inst, Urbana, IL 61801 USA; [Metcalf, William W.; Circello, Benjamin T.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Martens-Habbena, Willm; Stahl, David A.] Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98195 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Washington; University of Washington Seattle	Metcalf, WW (corresponding author), Univ Illinois, Inst Genom Biol, 1206 West Gregory, Urbana, IL 61801 USA.	metcalf@uiuc.edu; vddonk@illinois.edu	Evans, Bradley S/M-2842-2013; Martens-Habbena, Willm/AAK-1372-2021; Martens-Habbena, Willm/I-7656-2013; van der Donk, Wilfred/K-2961-2015	Evans, Bradley S/0000-0002-1207-9006; Martens-Habbena, Willm/0000-0002-8495-9125; Martens-Habbena, Willm/0000-0002-8495-9125; van der Donk, Wilfred/0000-0002-5467-7071; Gao, Jiangtao/0000-0002-9669-4718; Cooke, Heather/0000-0001-9742-5993; Janga, Sarath Chandra/0000-0001-7351-6268	NIH [GM PO1 GM077596, F32 GM095024]; Howard Hughes Medical Institute (HHMI); NSF [MCB-0604448, OCE-1046017, MCB-0920741]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR028833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM077596, F32GM095024] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); NSF(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH (grants GM PO1 GM077596 and F32 GM095024), the Howard Hughes Medical Institute (HHMI), and NSF (grants MCB-0604448, OCE-1046017, and MCB-0920741). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institute of General Medical Sciences, NIH, NSF, or HHMI. The authors thank L. Zhu (University of Illinois at Urbana-Champaign) for valuable help with NMR experiments.	Blodgett JAV, 2005, ANTIMICROB AGENTS CH, V49, P230, DOI 10.1128/AAC.49.1.230-240.2005; Borisova SA, 2010, CHEM BIOL, V17, P28, DOI 10.1016/j.chembiol.2009.11.017; Circello BT, 2010, CHEM BIOL, V17, P402, DOI 10.1016/j.chembiol.2010.03.007; Clark LL, 1998, NATURE, V393, P426, DOI 10.1038/30881; Clark LL, 1999, AM J SCI, V299, P724, DOI 10.2475/ajs.299.7-9.724; DAUGHTON CG, 1979, FEMS MICROBIOL LETT, V5, P91, DOI 10.1016/0378-1097(79)90191-5; Eliot AC, 2008, CHEM BIOL, V15, P765, DOI 10.1016/j.chembiol.2008.07.010; Hilderbrand R. L., 1983, ROLE PHOSPHONATES LI; Howard EC, 2008, ENVIRON MICROBIOL, V10, P2397, DOI 10.1111/j.1462-2920.2008.01665.x; Ilikchyan IN, 2009, ENVIRON MICROBIOL, V11, P1314, DOI 10.1111/j.1462-2920.2009.01869.x; Karl DM, 2008, NAT GEOSCI, V1, P473, DOI 10.1038/ngeo234; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Martinez A, 2010, ENVIRON MICROBIOL, V12, P222, DOI 10.1111/j.1462-2920.2009.02062.x; Metcalf WW, 2009, ANNU REV BIOCHEM, V78, P65, DOI 10.1146/annurev.biochem.78.091707.100215; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Reeburgh WS, 2007, CHEM REV, V107, P486, DOI 10.1021/cr050362v; Rogers J.E., 1991, MICROBIAL PRODUCTION; SEIDEL HM, 1988, NATURE, V335, P457, DOI 10.1038/335457a0; Shao ZY, 2008, J BIOL CHEM, V283, P23161, DOI 10.1074/jbc.M801788200; Tebby J. C., 1991, CRC HDB PHOSPHORUS 3; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016	23	181	193	7	189	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2012	337	6098					1104	1107		10.1126/science.1219875	http://dx.doi.org/10.1126/science.1219875			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22936780	Green Accepted, Green Submitted			2022-12-24	WOS:000308125800050
J	Saalmann, YB; Pinsk, MA; Wang, L; Li, X; Kastner, S				Saalmann, Yuri B.; Pinsk, Mark A.; Wang, Liang; Li, Xin; Kastner, Sabine			The Pulvinar Regulates Information Transmission Between Cortical Areas Based on Attention Demands	SCIENCE			English	Article							TOP-DOWN; NEURONAL OSCILLATIONS; VISUAL-PERCEPTION; CORTEX; FREQUENCY; MODULATION; MECHANISMS; MONKEY; SYNCHRONIZATION; SELECTION	Selective attention mechanisms route behaviorally relevant information through large-scale cortical networks. Although evidence suggests that populations of cortical neurons synchronize their activity to preferentially transmit information about attentional priorities, it is unclear how cortical synchrony across a network is accomplished. Based on its anatomical connectivity with the cortex, we hypothesized that the pulvinar, a thalamic nucleus, regulates cortical synchrony. We mapped pulvino-cortical networks within the visual system, using diffusion tensor imaging, and simultaneously recorded spikes and field potentials from these interconnected network sites in monkeys performing a visuospatial attention task. The pulvinar synchronized activity between interconnected cortical areas according to attentional allocation, suggesting a critical role for the thalamus not only in attentional selection but more generally in regulating information transmission across the visual cortex.	[Saalmann, Yuri B.; Pinsk, Mark A.; Wang, Liang; Li, Xin; Kastner, Sabine] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Saalmann, Yuri B.; Pinsk, Mark A.; Wang, Liang; Li, Xin; Kastner, Sabine] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA	Princeton University; Princeton University	Saalmann, YB (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.	saalmann@princeton.edu	Wang, Liang/AAC-7772-2019; Saalmann, Yuri B/AAW-5814-2021	Kastner, Sabine/0000-0002-9742-965X; Saalmann, Yuri/0000-0001-8880-6698	NIH [R21 EY021078]; NSF [BCS-1025149]; NATIONAL EYE INSTITUTE [R01EY017699, R21EY021078] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank C. D. Brody and C. J. Honey for useful comments on the manuscript and M. Ding for Granger causality routines. Supported by NIH (grant R21 EY021078) and NSF (grant BCS-1025149).	Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; BALEYDIER C, 1992, VISUAL NEUROSCI, V8, P391, DOI 10.1017/S0952523800004922; Bender DB, 2001, J NEUROPHYSIOL, V85, P219, DOI 10.1152/jn.2001.85.1.219; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Busch NA, 2009, J NEUROSCI, V29, P7869, DOI 10.1523/JNEUROSCI.0113-09.2009; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; DESIMONE R, 1990, COLD SPRING HARB SYM, V55, P963; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Hughes SW, 2005, NEUROSCIENTIST, V11, P357, DOI 10.1177/1073858405277450; Jensen O, 2007, TRENDS COGN SCI, V11, P267, DOI 10.1016/j.tics.2007.05.003; Jones EG, 2001, TRENDS NEUROSCI, V24, P595, DOI 10.1016/S0166-2236(00)01922-6; LABERGE D, 1990, J NEUROSCI, V10, P613; Mathewson KE, 2009, J NEUROSCI, V29, P2725, DOI 10.1523/JNEUROSCI.3963-08.2009; Molotchnikoff S, 1996, VISION RES, V36, P2037, DOI 10.1016/0042-6989(95)00311-8; Palva S, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00204; PETERSEN SE, 1985, J NEUROPHYSIOL, V54, P867, DOI 10.1152/jn.1985.54.4.867; PETERSEN SE, 1987, NEUROPSYCHOLOGIA, V25, P97, DOI 10.1016/0028-3932(87)90046-7; ROBINSON DL, 1992, TRENDS NEUROSCI, V15, P127, DOI 10.1016/0166-2236(92)90354-B; Saalmann YB, 2007, SCIENCE, V316, P1612, DOI 10.1126/science.1139140; Saalmann YB, 2011, NEURON, V71, P209, DOI 10.1016/j.neuron.2011.06.027; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Shipp S, 2003, PHILOS T R SOC B, V358, P1605, DOI 10.1098/rstb.2002.1213; Snow JC, 2009, P NATL ACAD SCI USA, V106, P4054, DOI 10.1073/pnas.0810086106; Theyel BB, 2010, NAT NEUROSCI, V13, P84, DOI 10.1038/nn.2449; von Stein A, 2000, P NATL ACAD SCI USA, V97, P14748, DOI 10.1073/pnas.97.26.14748; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Wrobel A, 2007, J NEUROSCI, V27, P2230, DOI 10.1523/JNEUROSCI.4004-06.2007	28	555	562	5	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2012	337	6095					753	756		10.1126/science.1223082	http://dx.doi.org/10.1126/science.1223082			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986PE	22879517	Green Accepted			2022-12-24	WOS:000307354500060
J	Sheridan, SL; Ware, RS; Grimwood, K; Lambert, SB				Sheridan, Sarah L.; Ware, Robert S.; Grimwood, Keith; Lambert, Stephen B.			Number and Order of Whole Cell Pertussis Vaccines in Infancy and Disease Protection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							VACCINATION		[Sheridan, Sarah L.; Ware, Robert S.; Grimwood, Keith; Lambert, Stephen B.] Univ Queensland, Queensland Childrens Med Res Inst, Brisbane, Qld, Australia	University of Queensland	Sheridan, SL (corresponding author), Univ Queensland, Queensland Childrens Med Res Inst, Brisbane, Qld, Australia.	s.sheridan@uq.edu.au	Lambert, Stephen/N-7819-2019; Hall, Madeline/AGZ-8446-2022; Hall, Madeline/D-1345-2017; Grimwood, Keith/F-9334-2011; Ware, Robert S./B-2024-2014	Lambert, Stephen/0000-0002-2709-193X; Hall, Madeline/0000-0003-1533-5594; Hall, Madeline/0000-0003-1533-5594; Ware, Robert S./0000-0002-6129-6736; Sheridan, Sarah/0000-0002-8451-3027; Grimwood, Keith/0000-0003-3174-9834				Cherry JD, 2010, CLIN VACCINE IMMUNOL, V17, P741, DOI 10.1128/CVI.00469-09; Mascart F, 2007, VACCINE, V25, P391, DOI 10.1016/j.vaccine.2006.06.046; Octavia S, 2012, J INFECT DIS, V205, P1220, DOI 10.1093/infdis/jis178; Torvaldsen S, 2003, EUR J EPIDEMIOL, V18, P63, DOI 10.1023/A:1022588118030; Witt MA, 2012, CLIN INFECT DIS, V54, P1730, DOI 10.1093/cid/cis287; Zhang LJ, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001478.pub4	6	203	206	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2012	308	5					454	456		10.1001/jama.2012.6364	http://dx.doi.org/10.1001/jama.2012.6364			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	981DQ	22851107	Bronze			2022-12-24	WOS:000306947400018
J	Schlebusch, CM; Skoglund, P; Sjodin, P; Gattepaille, LM; Hernandez, D; Jay, F; Li, S; De Jongh, M; Singleton, A; Blum, MGB; Soodyall, H; Jakobsson, M				Schlebusch, Carina M.; Skoglund, Pontus; Sjodin, Per; Gattepaille, Lucie M.; Hernandez, Dena; Jay, Flora; Li, Sen; De Jongh, Michael; Singleton, Andrew; Blum, Michael G. B.; Soodyall, Himla; Jakobsson, Mattias			Genomic Variation in Seven Khoe-San Groups Reveals Adaptation and Complex African History	SCIENCE			English	Article							POPULATIONS; GENOTYPE	The history of click-speaking Khoe-San, and African populations in general, remains poorly understood. We genotyped similar to 2.3 million single-nucleotide polymorphisms in 220 southern Africans and found that the Khoe-San diverged from other populations >= 100,000 years ago, but population structure within the Khoe-San dated back to about 35,000 years ago. Genetic variation in various sub-Saharan populations did not localize the origin of modern humans to a single geographic region within Africa; instead, it indicated a history of admixture and stratification. We found evidence of adaptation targeting muscle function and immune response; potential adaptive introgression of protection from ultraviolet light; and selection predating modern human diversification, involving skeletal and neurological development. These new findings illustrate the importance of African genomic diversity in understanding human evolutionary history.	[Schlebusch, Carina M.; Skoglund, Pontus; Sjodin, Per; Gattepaille, Lucie M.; Li, Sen; Jakobsson, Mattias] Uppsala Univ, Dept Evolutionary Biol, S-75236 Uppsala, Sweden; [Hernandez, Dena; Singleton, Andrew] NIA, Lab Neurogenet, NIH, Bethesda, MD 20892 USA; [Jay, Flora] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [De Jongh, Michael] Univ S Africa, Dept Anthropol & Archaeol, ZA-0001 Pretoria, South Africa; [Blum, Michael G. B.] Univ Grenoble 1, Ctr Natl Rech Sci, Lab TIMC IMAG UMR 5525, Grenoble, France; [Soodyall, Himla] Univ Witwatersrand, Human Genom Divers & Dis Res Unit, Div Human Genet, Sch Pathol,Fac Hlth Sci, Johannesburg, South Africa; [Soodyall, Himla] Natl Hlth Lab Serv, Johannesburg, South Africa; [Jakobsson, Mattias] Uppsala Univ, Sci Life Lab, S-75236 Uppsala, Sweden	Uppsala University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of California System; University of California Berkeley; University of South Africa; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); University of Witwatersrand; National Health Laboratory Service; Uppsala University	Schlebusch, CM (corresponding author), Uppsala Univ, Dept Evolutionary Biol, Norbyvagen 18D, S-75236 Uppsala, Sweden.	carina.schlebusch@ebc.uu.se; mattias.jakobsson@ebc.uu.se	Singleton, Andrew B/C-3010-2009; Jakobsson, Mattias/A-6116-2011; Blum, Michael/F-9978-2010; Gattepaille, Lucie/V-3229-2019; Schlebusch, Carina/B-3411-2010	Jakobsson, Mattias/0000-0001-7840-7853; Blum, Michael/0000-0003-4174-7373; Schlebusch, Carina/0000-0002-8160-9621; jay, flora/0000-0001-5884-4730; Skoglund, Pontus/0000-0002-3021-5913	Wenner-Gren Foundation; Intramural Research Program of the National Institute on Aging; NIH; U.S. Department of Health and Human Services [Z01 AG000932-04]; Medical Research Council of South Africa; National Health Laboratory Service; STINT; Swedish Research Council; Erik Philip Sorensen Foundation; NATIONAL INSTITUTE ON AGING [Z01AG000932] Funding Source: NIH RePORTER	Wenner-Gren Foundation; Intramural Research Program of the National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Health and Human Services; Medical Research Council of South Africa(South African Medical Research Council); National Health Laboratory Service; STINT; Swedish Research Council(Swedish Research CouncilEuropean Commission); Erik Philip Sorensen Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank participants who donated blood samples, T. Jenkins, and B. Henn. Approved by the Working Group of Indigenous Minorities in Southern Africa (WIMSA) and the South African San Council; we thank them for facilitating sampling trips. Computations were performed at the Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX) in Uppsala, Sweden (project number p2011187). This work was supported by the Wenner-Gren Foundation (C. S.); the Intramural Research Program of the National Institute on Aging, NIH, U.S. Department of Health and Human Services, grant Z01 AG000932-04 (A. S.); the Medical Research Council of South Africa and National Health Laboratory Service (H. S.); STINT (M. B. and M.J.); the Swedish Research Council (M.J.); and the Erik Philip Sorensen Foundation (M.J.). H. S. retains governance of the DNA samples. Author contributions were as follows: conception and design of study: C. M. S., P.Sk., and M.J.; sample collection, preparation, and description: C. M. S., M.D.J., and H. S.; genotyping: D. H. and A. S.; data preparation: C. M. S., P.Sk., D. H., and M.J.; population structure analysis: C. M. S., P.Sk., L. M. G., S. L., F.J., M. B., and M.J.; model-based inference: P.Sk. and M.J.; language/geography comparisons: F.J., C. M. S., and M. B.; diversity statistics: C. M. S., P.Sk., L. M. G., P.Sj., and M.J.; Selection scans: P.Sj., P.Sk., C. M. S., and M.J.. The paper was written by C. M. S., P.Sk., and M.J. with contributions from all authors. Genotype data are available at the Arrayexpress database (www.ebi.ac.uk/arrayexpress/, accession no. E-MTAB-1259) and at www.ebc.uu.se/Research/IEG/evbiol/research/Jakobsson/data/.	Abraham R, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-44; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bang ML, 2001, J CELL BIOL, V153, P413, DOI 10.1083/jcb.153.2.413; Barham L., 2008, 1 AFRICANS; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Blum MGB, 2011, MOL BIOL EVOL, V28, P889, DOI 10.1093/molbev/msq265; Falk D, 2012, P NATL ACAD SCI USA, V109, P8467, DOI 10.1073/pnas.1119752109; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Gronau I, 2011, NAT GENET, V43, P1031, DOI 10.1038/ng.937; Henn BM, 2011, P NATL ACAD SCI USA, V108, P5154, DOI 10.1073/pnas.1017511108; Hill AD, 2007, AM J MED GENET A, V143A, P1692, DOI 10.1002/ajmg.a.31776; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Kalus I, 2009, J CELL MOL MED, V13, P4505, DOI 10.1111/j.1582-4934.2008.00558.x; Lachance J, 2012, CELL, V150, P457, DOI 10.1016/j.cell.2012.07.009; Lawson DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002453; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Matsumura Y, 1998, HUM MOL GENET, V7, P969, DOI 10.1093/hmg/7.6.969; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nurse GT., 1985, PEOPLES SO AFRICA TH; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; Skoglund P, 2012, SCIENCE, V336, P466, DOI 10.1126/science.1216304; Stringer C, 2002, PHILOS T R SOC B, V357, P563, DOI 10.1098/rstb.2001.1057; Tishkoff SA, 2007, MOL BIOL EVOL, V24, P2180, DOI 10.1093/molbev/msm155; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Veeramah KR, 2012, MOL BIOL EVOL, V29, P617, DOI 10.1093/molbev/msr212; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Yang N, 2003, AM J HUM GENET, V73, P627, DOI 10.1086/377590	29	245	250	1	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2012	338	6105					374	379		10.1126/science.1227721	http://dx.doi.org/10.1126/science.1227721			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022JS	22997136	Green Accepted, Green Published			2022-12-24	WOS:000309955800039
J	Senovilla, L; Vitale, I; Martins, I; Tailler, M; Pailleret, C; Michaud, M; Galluzzi, L; Adjemian, S; Kepp, O; Niso-Santano, M; Shen, SS; Marino, G; Criollo, A; Boileve, A; Job, B; Ladoire, S; Ghiringhelli, F; Sistigu, A; Yamazaki, T; Rello-Varona, S; Locher, C; Poirier-Colame, V; Talbot, M; Valent, A; Berardinelli, F; Antoccia, A; Ciccosanti, F; Fimia, GM; Piacentini, M; Fueyo, A; Messina, NL; Li, M; Chan, CJ; Sigl, V; Pourcher, G; Ruckenstuhl, C; Carmona-Gutierrez, D; Lazar, V; Penninger, JM; Madeo, F; Lopez-Otin, C; Smyth, MJ; Zitvogel, L; Castedo, M; Kroemer, G				Senovilla, Laura; Vitale, Ilio; Martins, Isabelle; Tailler, Maximilien; Pailleret, Claire; Michaud, Mickael; Galluzzi, Lorenzo; Adjemian, Sandy; Kepp, Oliver; Niso-Santano, Mireia; Shen, Shensi; Marino, Guillermo; Criollo, Alfredo; Boileve, Alice; Job, Bastien; Ladoire, Sylvain; Ghiringhelli, Francois; Sistigu, Antonella; Yamazaki, Takahiro; Rello-Varona, Santiago; Locher, Clara; Poirier-Colame, Vichnou; Talbot, Monique; Valent, Alexander; Berardinelli, Francesco; Antoccia, Antonio; Ciccosanti, Fabiola; Fimia, Gian Maria; Piacentini, Mauro; Fueyo, Antonio; Messina, Nicole L.; Li, Ming; Chan, Christopher J.; Sigl, Verena; Pourcher, Guillaume; Ruckenstuhl, Christoph; Carmona-Gutierrez, Didac; Lazar, Vladimir; Penninger, Josef M.; Madeo, Frank; Lopez-Otin, Carlos; Smyth, Mark J.; Zitvogel, Laurence; Castedo, Maria; Kroemer, Guido			An Immunosurveillance Mechanism Controls Cancer Cell Ploidy	SCIENCE			English	Article							CALRETICULIN EXPOSURE; ADAPTIVE IMMUNITY; IMMUNOGENICITY; TETRAPLOIDY; CLEARANCE; MITOSIS; DEATH; P53	Cancer cells accommodate multiple genetic and epigenetic alterations that initially activate intrinsic (cell-autonomous) and extrinsic (immune-mediated) oncosuppressive mechanisms. Only once these barriers to oncogenesis have been overcome can malignant growth proceed unrestrained. Tetraploidization can contribute to oncogenesis because hyperploid cells are genomically unstable. We report that hyperploid cancer cells become immunogenic because of a constitutive endoplasmic reticulum stress response resulting in the aberrant cell surface exposure of calreticulin. Hyperploid, calreticulin-exposing cancer cells readily proliferated in immunodeficient mice and conserved their increased DNA content. In contrast, hyperploid cells injected into immunocompetent mice generated tumors only after a delay, and such tumors exhibited reduced DNA content, endoplasmic reticulum stress, and calreticulin exposure. Our results unveil an immunosurveillance system that imposes immunoselection against hyperploidy in carcinogen-and oncogene-induced cancers.	[Senovilla, Laura; Vitale, Ilio; Martins, Isabelle; Tailler, Maximilien; Pailleret, Claire; Michaud, Mickael; Galluzzi, Lorenzo; Adjemian, Sandy; Kepp, Oliver; Niso-Santano, Mireia; Shen, Shensi; Marino, Guillermo; Criollo, Alfredo; Boileve, Alice; Job, Bastien; Sistigu, Antonella; Yamazaki, Takahiro; Rello-Varona, Santiago; Locher, Clara; Poirier-Colame, Vichnou; Talbot, Monique; Lazar, Vladimir; Zitvogel, Laurence; Castedo, Maria; Kroemer, Guido] Inst Gustave Roussy, Villejuif, France; [Senovilla, Laura; Vitale, Ilio; Martins, Isabelle; Tailler, Maximilien; Pailleret, Claire; Michaud, Mickael; Galluzzi, Lorenzo; Adjemian, Sandy; Kepp, Oliver; Niso-Santano, Mireia; Shen, Shensi; Marino, Guillermo; Criollo, Alfredo; Boileve, Alice; Rello-Varona, Santiago; Castedo, Maria; Kroemer, Guido] INSERM, U848, Villejuif, France; [Senovilla, Laura; Vitale, Ilio; Martins, Isabelle; Tailler, Maximilien; Pailleret, Claire; Michaud, Mickael; Galluzzi, Lorenzo; Adjemian, Sandy; Kepp, Oliver; Niso-Santano, Mireia; Shen, Shensi; Marino, Guillermo; Criollo, Alfredo; Boileve, Alice; Sistigu, Antonella; Yamazaki, Takahiro; Rello-Varona, Santiago; Locher, Clara; Poirier-Colame, Vichnou; Pourcher, Guillaume; Zitvogel, Laurence; Castedo, Maria] Univ Paris 11, Fac Med, Le Kremlin Bicetre, France; [Job, Bastien; Lazar, Vladimir] Unite Genom Fonct & Bioinformat, Villejuif, France; [Job, Bastien; Lazar, Vladimir] Genom Platform, Villejuif, France; [Ladoire, Sylvain; Ghiringhelli, Francois] Georges Francois Leclerc Ctr, Dept Med Oncol, Dijon, France; [Ladoire, Sylvain; Ghiringhelli, Francois] Univ Burgundy, CRI 866, Avenir Team, INSERM, Dijon, France; [Sistigu, Antonella; Yamazaki, Takahiro; Locher, Clara; Poirier-Colame, Vichnou; Zitvogel, Laurence] INSERM, U1015, Villejuif, France; [Valent, Alexander] Dept Biol & Pathol Med, Villejuif, France; [Berardinelli, Francesco; Antoccia, Antonio] Univ Roma Tre, Dipartimento Biol, Rome, Italy; [Ciccosanti, Fabiola; Fimia, Gian Maria; Piacentini, Mauro] Natl Inst Infect Dis L Spallanzani, Rome, Italy; [Piacentini, Mauro] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Fueyo, Antonio] Univ Oviedo, Inst Univ Oncol IUOPA, Fac Med, Dept Biol Func, Oviedo, Spain; [Messina, Nicole L.; Li, Ming; Chan, Christopher J.; Smyth, Mark J.] Peter MacCallum Canc Ctr, Canc Immunol Program, Melbourne, Vic, Australia; [Messina, Nicole L.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia; [Chan, Christopher J.] Monash Univ, Dept Immunol, Prahran, Vic, Australia; [Sigl, Verena; Penninger, Josef M.] Austrian Acad Sci IMBA, Inst Mol Biotechnol, Vienna, Austria; [Pourcher, Guillaume] Antoine Beclere Hosp, AP HP, Dept Minimal Invas Surg, Clamart, France; [Pourcher, Guillaume] INSERM, U972, F-94275 Le Kremlin Bicetre, France; [Ruckenstuhl, Christoph; Carmona-Gutierrez, Didac; Madeo, Frank] Inst Mol Biosci, Graz, Austria; [Lopez-Otin, Carlos] Univ Oviedo, IUOPA, Fac Med, Dept Bioquim & Biol Mol, Oviedo, Spain; [Zitvogel, Laurence] Ctr Clin Invest Biotherapies Canc CICBT 507, Villejuif, France; [Kroemer, Guido] Ctr Rech Cordeliers, Paris, France; [Kroemer, Guido] Hop Europeen Georges Pompidou, AP HP, Paris, France; [Kroemer, Guido] Univ Paris 05, Paris, France	UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Centre Georges-Francois Leclerc; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Roma Tre University; IRCCS Lazzaro Spallanzani; University of Rome Tor Vergata; University of Oviedo; Instituto Universitario de Oncologia de Asturias; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; Monash University; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Oviedo; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Zitvogel, L (corresponding author), Inst Gustave Roussy, Villejuif, France.	zitvogel@igr.fr; castedo@igr.fr; kroemer@orange.fr	marino, guillermo/HGB-8664-2022; Berardinelli, Francesco/AAP-2355-2021; Galluzzi, Lorenzo/AAG-6432-2019; Rello-Varona, Santi/A-4882-2009; Galluzzi, Lorenzo/AAG-6294-2019; Fimia, Gian Maria/K-3232-2016; Kepp, Oliver/N-2763-2017; GARCÍA, GUILLERMO MARIÑO/J-1726-2012; Kepp, Oliver/GPX-8627-2022; Piacentini, Mauro/I-2411-2016; Locher, Clara/ABF-3635-2020; Vitale, Ilio/M-3960-2017; SHEN, Shensi/AAW-2735-2020; Lazar, Vladimir/AAV-2087-2020; Penninger, Josef M/I-6860-2013; Galluzzi, Lorenzo/AAH-3286-2021; Lazar, Vladimir/AAQ-2086-2020; KROEMER, Guido/B-4263-2013; López-Otín, Carlos/AAB-2106-2020; Kroemer, Guido/AAY-9859-2020; Fueyo, Antonio/ABH-3243-2020; Smyth, Mark J/H-8709-2014; Niso-Santano, Mireia/AAO-1285-2021; GARCÍA, GUILLERMO MARIÑO/AAI-8015-2020; ADJEMIAN, Sandy/K-7632-2012; Galluzzi, Lorenzo/K-2709-2012; Senovilla, Laura/AAX-5599-2021; Sistigu, Antonella/J-8934-2018; Ciccosanti, Fabiola/B-5284-2017	Berardinelli, Francesco/0000-0002-3094-4139; Rello-Varona, Santi/0000-0002-7500-5522; Fimia, Gian Maria/0000-0003-4438-3325; Kepp, Oliver/0000-0002-6081-9558; GARCÍA, GUILLERMO MARIÑO/0000-0003-1960-1677; Piacentini, Mauro/0000-0003-2919-1296; Locher, Clara/0000-0002-8212-4351; Vitale, Ilio/0000-0002-5918-1841; SHEN, Shensi/0000-0002-5087-8220; Penninger, Josef M/0000-0002-8194-3777; KROEMER, Guido/0000-0002-9334-4405; López-Otín, Carlos/0000-0001-6964-1904; Fueyo, Antonio/0000-0002-7121-9398; Smyth, Mark J/0000-0001-7098-7240; ADJEMIAN, Sandy/0000-0001-5594-5499; Galluzzi, Lorenzo/0000-0003-2257-8500; Sistigu, Antonella/0000-0002-2528-1238; Ciccosanti, Fabiola/0000-0003-0481-6878; ZITVOGEL, laurence/0000-0003-1596-0998; Niso-Santano, Mireia/0000-0002-6506-422X; Pourcher, Guillaume/0000-0001-9788-628X; Carmona-Gutierrez, Didac/0000-0001-7548-7771; Madeo, Frank/0000-0002-5070-1329; Senovilla, Laura/0000-0001-6887-2436; Criollo, Alfredo/0000-0002-2737-7751; LADOIRE, Sylvain/0000-0002-0331-9194; Messina, Nicole/0000-0001-8404-4462; Ruckenstuhl, Christoph/0000-0002-4338-4679; ghiringhelli, francois/0000-0002-5465-8305	Ligue Nationale contre le Cancer (LNC, Equipe labelisee); Agence Nationale pour la Recherche (ANR); European Commission (Active p53, Apo-Sys, ChemoRes, ApopTrain); Fondation pour la Recherche Medicale (FRM); Institut National du Cancer (INCa); Canceropole Ile-de-France; Fondation Bettencourt-Schueller; LabEx Immuno-Oncology; Fonds Zur Forderung der Wissenschaftlichen Forschung (FWF) [LIPOTOX, P23490-B12, P24381-B20, W 1226-B18]; FRM; LNC; Junta de Extremadura (Spain); European Molecular Biology Organization; National Health and Medical Research Council (NH and MRC) Australia; Leukemia Foundation of Australia, Monash University; Cancer Research Institute; Austrian Academy of Sciences; Advanced European Research Council; European Union INFLA-CARE network; Austrian Science Fund (FWF) [P 23490] Funding Source: researchfish	Ligue Nationale contre le Cancer (LNC, Equipe labelisee); Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); European Commission (Active p53, Apo-Sys, ChemoRes, ApopTrain); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Canceropole Ile-de-France(Region Ile-de-France); Fondation Bettencourt-Schueller; LabEx Immuno-Oncology; Fonds Zur Forderung der Wissenschaftlichen Forschung (FWF)(Austrian Science Fund (FWF)); FRM(Fondation pour la Recherche Medicale); LNC; Junta de Extremadura (Spain); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); National Health and Medical Research Council (NH and MRC) Australia; Leukemia Foundation of Australia, Monash University; Cancer Research Institute; Austrian Academy of Sciences; Advanced European Research Council(European Research Council (ERC)); European Union INFLA-CARE network; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We are grateful to M. L. Albert (Institut Pasteur, Paris) for Ifnar1<SUP>-/-</SUP> and Ifng<SUP>-/-</SUP> mice, M. Colonna (Washington University School of Medicine, St. Louis, MO) for Cd226<SUP>-/-</SUP> mice (Dnam-1<SUP>-/-</SUP> mice), S. B. Horwitz (Albert Einstein College of Medicine, New York) for epothilone B-resistant A549 cells, R. Prywes (Columbia University, New York) for the GFP-ATF6-encoding plasmid, J. Yuan (Massachusetts Institute of Technology, Boston) for the XBP1-DBD-Venus-encoding construct, T. Reid (NIH, Bethesda, MD) for DLD-1 and DLD1+7 cell lines, and D. Metivier for assistance with fluorescence-activated cell sorting (FACS) experiments. G. K. is supported by the Ligue Nationale contre le Cancer (LNC, Equipe labelisee), Agence Nationale pour la Recherche (ANR), European Commission (Active p53, Apo-Sys, ChemoRes, ApopTrain), Fondation pour la Recherche Medicale (FRM), Institut National du Cancer (INCa), Canceropole Ile-de-France, Fondation Bettencourt-Schueller, and the LabEx Immuno-Oncology. F. M. is grateful to the Fonds Zur Forderung der Wissenschaftlichen Forschung (FWF, grants LIPOTOX, P23490-B12, P24381-B20, and W 1226-B18). L. S. and M. M. are supported by FRM. I. V., I. M., M. T., and S. A. are supported by LNC. M. N.-S. is supported by a postdoctoral contract of Junta de Extremadura (Spain) and G. M. by European Molecular Biology Organization. M. J. S. was supported by National Health and Medical Research Council (NH and MRC) Australia and the Victorian Cancer Agency. C. J. C. was supported by Leukemia Foundation of Australia, Monash University. N. M. was supported by Cancer Research Institute. J. M. P. and V. S. are supported by the Austrian Academy of Sciences, an Advanced European Research Council grant, and the European Union INFLA-CARE network. L. S., I. V., I. M., M. T., C. P., M. M., S. A., O.K., M. N.-S., S. S., G. M., A. C., A. B., B.J., S. L., F. G., A. S., T.Y., S.R.-V., C. L., V.P.-C., M. T., A. V., F. B., A. A., F. C., G. M. F., M. P., A. F., N.L.M., M. L., C.J.C., V. S., G. P., V. L., J.M.P., C.L.-O., M.J.S., and M. C. performed experiments. L. S., C. R., D. C.-G., F. M., L.Z., M. C., and G. K. designed the study. L. S., L.Z., M. C., and G. K. analyzed results. L. S., L. G., and G. K. assembled the figures and wrote the paper. The authors declare no conflicts of interest.	Castedo M, 2004, ONCOGENE, V23, P4353, DOI 10.1038/sj.onc.1207573; Chao MP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001375; Davoli T, 2010, CELL, V141, P81, DOI 10.1016/j.cell.2010.01.031; Denkert C, 2010, J CLIN ONCOL, V28, P105, DOI 10.1200/JCO.2009.23.7370; Duelli D, 2007, NAT REV CANCER, V7, P968, DOI 10.1038/nrc2272; Duelli DM, 2007, CURR BIOL, V17, P431, DOI 10.1016/j.cub.2007.01.049; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Ganem NJ, 2007, CELL, V131, P437, DOI 10.1016/j.cell.2007.10.024; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Garg AD, 2012, EMBO J, V31, P1062, DOI 10.1038/emboj.2011.497; Gold LI, 2010, FASEB J, V24, P665, DOI 10.1096/fj.09-145482; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Kwon M, 2008, GENE DEV, V22, P2189, DOI 10.1101/gad.1700908; Ladoire S, 2011, CLIN BREAST CANCER, V11, P235, DOI 10.1016/j.clbc.2011.06.002; Ladoire S, 2011, J PATHOL, V224, P389, DOI 10.1002/path.2866; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Margolis RL, 2005, CANCER CELL, V8, P353, DOI 10.1016/j.ccr.2005.10.017; Martins I, 2011, ONCOGENE, V30, P1147, DOI 10.1038/onc.2010.500; Obeid M, 2007, CELL DEATH DIFFER, V14, P1848, DOI 10.1038/sj.cdd.4402201; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Panaretakis T, 2009, EMBO J, V28, P578, DOI 10.1038/emboj.2009.1; Raulet DH, 2009, NAT REV IMMUNOL, V9, P568, DOI 10.1038/nri2604; Sengupta K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000199; Taieb J, 2006, NAT MED, V12, P214, DOI 10.1038/nm1356; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Vitale I, 2011, CELL DEATH DIFFER, V18, P1403, DOI 10.1038/cdd.2010.145; Vitale I, 2011, NAT REV MOL CELL BIO, V12, P384, DOI 10.1038/nrm3115; Vitale I, 2010, EMBO J, V29, P1272, DOI 10.1038/emboj.2010.11; Wakita D, 2009, CARCINOGENESIS, V30, P1408, DOI 10.1093/carcin/bgp144; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Zitvogel L, 2010, CELL, V140, P798, DOI 10.1016/j.cell.2010.02.015	34	296	302	3	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2012	337	6102					1678	1684		10.1126/science.1224922	http://dx.doi.org/10.1126/science.1224922			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	23019653				2022-12-24	WOS:000309215400052
J	Papadopoulos, F; Kitsak, M; Serrano, MA; Boguna, M; Krioukov, D				Papadopoulos, Fragkiskos; Kitsak, Maksim; Angeles Serrano, M.; Boguna, Marian; Krioukov, Dmitri			Popularity versus similarity in growing networks	NATURE			English	Article							PREFERENTIAL ATTACHMENT; EMERGENCE; EVOLUTION; PAPER	The principle(1) that 'popularity is attractive' underlies preferential attachment(2), which is a common explanation for the emergence of scaling in growing networks. If new connections are made preferentially to more popular nodes, then the resulting distribution of the number of connections possessed by nodes follows power laws(3,4), as observed in many real networks(5,6). Preferential attachment has been directly validated for some real networks (including the Internet(7,8)), and can be a consequence of different underlying processes based on node fitness, ranking, optimization, random walks or duplication(9-16). Here we show that popularity is just one dimension of attractiveness; another dimension is similarity(17-24). We develop a framework in which new connections optimize certain trade-offs between popularity and similarity, instead of simply preferring popular nodes. The framework has a geometric interpretation in which popularity preference emerges from local optimization. As opposed to preferential attachment, our optimization framework accurately describes the large-scale evolution of technological (the Internet), social (trust relationships between people) and biological (Escherichia coli metabolic) networks, predicting the probability of new links with high precision. The framework that we have developed can thus be used for predicting new links in evolving networks, and provides a different perspective on preferential attachment as an emergent phenomenon.	[Papadopoulos, Fragkiskos] Cyprus Univ Technol, Dept Elect Engn Comp Engn & Informat, CY-3036 Limassol, Cyprus; [Kitsak, Maksim; Krioukov, Dmitri] Univ Calif San Diego, CAIDA, La Jolla, CA 92093 USA; [Angeles Serrano, M.; Boguna, Marian] Univ Barcelona, Dept Fis Fonamental, E-08028 Barcelona, Spain	Cyprus University of Technology; University of California System; University of California San Diego; University of Barcelona	Papadopoulos, F (corresponding author), Cyprus Univ Technol, Dept Elect Engn Comp Engn & Informat, 33 Saripolou St, CY-3036 Limassol, Cyprus.	f.papadopoulos@cut.ac.cy; dima@ucsd.edu	Serrano, M. Ángeles/AAS-8246-2020; Papadopoulos, Fragkiskos/B-6391-2014; Krioukov, Dmitri/K-7035-2017; Boguna, Marian/B-7795-2011; Serrano, M. Angeles/A-4198-2013	Papadopoulos, Fragkiskos/0000-0002-4072-5781; Krioukov, Dmitri/0000-0001-9478-8182; Boguna, Marian/0000-0001-7833-3487; Serrano, M. Angeles/0000-0001-8779-5931; Kitsak, Maksim/0000-0002-6862-6021	Marie Curie International Reintegration Grant within the 7th European Community Framework Programme; MICINN [FIS2010-21781-C02-02, BFU2010-21847-C02-02]; Generalitat de Catalunya [2009SGR838]; Ramon y Cajal programme of the Spanish Ministry of Science; ICREA Academia; Generalitat de Catalunya; NSF [CNS-0964236, CNS-1039646, CNS-0722070]; DHS [N66001-08-C-2029]; DARPA [HR0011-12-1-0012]; Cisco Systems; Direct For Computer & Info Scie & Enginr [0964236, 1039646] Funding Source: National Science Foundation	Marie Curie International Reintegration Grant within the 7th European Community Framework Programme(European Commission); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Generalitat de Catalunya(Generalitat de Catalunya); Ramon y Cajal programme of the Spanish Ministry of Science; ICREA Academia(ICREA); Generalitat de Catalunya(Generalitat de Catalunya); NSF(National Science Foundation (NSF)); DHS(United States Department of Homeland Security (DHS)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Cisco Systems; Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	We thank C. Elkan, G. Bianconi, P. Krapivsky, S. Redner, S. Havlin, E. Stanley and A.-L. Barabasi for discussions and suggestions. This work was supported by a Marie Curie International Reintegration Grant within the 7th European Community Framework Programme; MICINN Projects FIS2010-21781-C02-02 and BFU2010-21847-C02-02; Generalitat de Catalunya grant 2009SGR838; the Ramon y Cajal programme of the Spanish Ministry of Science; ICREA Academia prize 2010, funded by the Generalitat de Catalunya; NSF grants CNS-0964236, CNS-1039646, CNS-0722070; DHS grant N66001-08-C-2029; DARPA grant HR0011-12-1-0012; and Cisco Systems.	Adamic LA, 2000, SCIENCE, V287, DOI 10.1126/science.287.5461.2115a; [Anonymous], WWW INTERNET MODELS; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bianconi G, 2001, PHYS REV LETT, V86, P5632, DOI 10.1103/PhysRevLett.86.5632; Bollobas B, 2003, HANDBOOK OF GRAPHS AND NETWORKS: FROM THE GENOME TO THE INTERNET, P1; Bonahon F., 2009, LOW DIMENSIONAL GEOM; Borner K, 2004, P NATL ACAD SCI USA, V101, P5266, DOI 10.1073/pnas.0307625100; Caldarelli G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.258702; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Crandall David, 2008, P 14 ACM SIGKDD INT, P160, DOI DOI 10.1145/1401890.1401914; D'Souza RM, 2007, P NATL ACAD SCI USA, V104, P6112, DOI 10.1073/pnas.0606779104; Dorogovtsev S, 2010, COMPLEX NETWORKS; Dorogovtsev SN, 2000, PHYS REV LETT, V85, P4633, DOI 10.1103/PhysRevLett.85.4633; Dorogovtsev SN, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.062101; Fortunato S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.218701; Jeong H, 2003, EUROPHYS LETT, V61, P567, DOI 10.1209/epl/i2003-00166-9; Krapivsky PL, 2000, PHYS REV LETT, V85, P4629, DOI 10.1103/PhysRevLett.85.4629; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Menczer F, 2004, P NATL ACAD SCI USA, V101, P5261, DOI 10.1073/pnas.0307554100; Menczer F, 2002, P NATL ACAD SCI USA, V99, P14014, DOI 10.1073/pnas.212348399; Menon AK, 2011, LECT NOTES ARTIF INT, V6912, P437, DOI 10.1007/978-3-642-23783-6_28; Motter AE, 2007, CHAOS, V17, DOI 10.1063/1.2751266; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; Pastor-Satorras R, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.258701; Pastor-Satorras R, 2003, J THEOR BIOL, V222, P199, DOI 10.1016/S0022-5193(03)00028-6; Redner S, 1998, EUR PHYS J B, V4, P131, DOI 10.1007/s100510050359; Simsek O, 2008, P NATL ACAD SCI USA, V105, P12758, DOI 10.1073/pnas.0800497105; van Raan AFJ, 2000, SCIENTOMETRICS, V47, P347, DOI 10.1023/A:1005647328460; Vazquez A, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.056104; Watts DJ, 2002, SCIENCE, V296, P1302, DOI 10.1126/science.1070120	30	336	354	8	140	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 27	2012	489	7417					537	540		10.1038/nature11459	http://dx.doi.org/10.1038/nature11459			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011LT	22972194	Green Submitted			2022-12-24	WOS:000309167100044
J	Ryan, O; Shapiro, RS; Kurat, CF; Mayhew, D; Baryshnikova, A; Chin, B; Lin, ZY; Cox, MJ; Vizeacoumar, F; Cheung, D; Bahr, S; Tsui, K; Tebbji, F; Sellam, A; Istel, F; Schwarzmuller, T; Reynolds, TB; Kuchler, K; Gifford, DK; Whiteway, M; Giaever, G; Nislow, C; Costanzo, M; Gingras, AC; Mitra, RD; Andrews, B; Fink, GR; Cowen, LE; Boone, C				Ryan, Owen; Shapiro, Rebecca S.; Kurat, Christoph F.; Mayhew, David; Baryshnikova, Anastasia; Chin, Brian; Lin, Zhen-Yuan; Cox, Michael J.; Vizeacoumar, Frederick; Cheung, Doris; Bahr, Sondra; Tsui, Kyle; Tebbji, Faiza; Sellam, Adnane; Istel, Fabian; Schwarzmueller, Tobias; Reynolds, Todd B.; Kuchler, Karl; Gifford, David K.; Whiteway, Malcolm; Giaever, Guri; Nislow, Corey; Costanzo, Michael; Gingras, Anne-Claude; Mitra, Robi David; Andrews, Brenda; Fink, Gerald R.; Cowen, Leah E.; Boone, Charles			Global Gene Deletion Analysis Exploring Yeast Filamentous Growth	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; INVASIVE GROWTH; HYPHAL DEVELOPMENT; FUNGAL DEVELOPMENT; KINASE; FLO11; SPECIFICITY; PATHWAY	The dimorphic switch from a single-cell budding yeast to a filamentous form enables Saccharomyces cerevisiae to forage for nutrients and the opportunistic pathogen Candida albicans to invade human tissues and evade the immune system. We constructed a genome-wide set of targeted deletion alleles and introduced them into a filamentous S. cerevisiae strain, Sigma 1278b. We identified genes involved in morphologically distinct forms of filamentation: haploid invasive growth, biofilm formation, and diploid pseudohyphal growth. Unique genes appear to underlie each program, but we also found core genes with general roles in filamentous growth, including MFG1 (YDL233w), whose product binds two morphogenetic transcription factors, Flo8 and Mss11, and functions as a critical transcriptional regulator of filamentous growth in both S. cerevisiae and C. albicans.	[Chin, Brian; Gifford, David K.; Fink, Gerald R.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Ryan, Owen; Kurat, Christoph F.; Baryshnikova, Anastasia; Cox, Michael J.; Cheung, Doris; Bahr, Sondra; Nislow, Corey; Costanzo, Michael; Andrews, Brenda; Boone, Charles] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Ryan, Owen; Shapiro, Rebecca S.; Baryshnikova, Anastasia; Cox, Michael J.; Giaever, Guri; Nislow, Corey; Gingras, Anne-Claude; Andrews, Brenda; Cowen, Leah E.; Boone, Charles] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Ryan, Owen; Kurat, Christoph F.; Baryshnikova, Anastasia; Cox, Michael J.; Cheung, Doris; Bahr, Sondra; Tsui, Kyle; Giaever, Guri; Nislow, Corey; Costanzo, Michael; Andrews, Brenda; Boone, Charles] Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Mayhew, David; Mitra, Robi David] Washington Univ, Dept Genet, Sch Med, St Louis, MO 63108 USA; [Mayhew, David; Mitra, Robi David] Washington Univ, Ctr Genome Sci & Syst Biol, Sch Med, St Louis, MO 63108 USA; [Lin, Zhen-Yuan; Vizeacoumar, Frederick; Gingras, Anne-Claude] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Tsui, Kyle; Giaever, Guri] Univ Toronto, Dept Pharm, Toronto, ON M5S 3E1, Canada; [Tebbji, Faiza; Sellam, Adnane; Whiteway, Malcolm] Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada; [Tebbji, Faiza; Whiteway, Malcolm] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Sellam, Adnane] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 1B1, Canada; [Istel, Fabian; Schwarzmueller, Tobias; Kuchler, Karl] Med Univ Vienna, Christian Doppler Lab Infect Biol, Max F Perutz Labs, A-1030 Vienna, Austria; [Reynolds, Todd B.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Gifford, David K.; Fink, Gerald R.] MIT, Broad Inst, Cambridge, MA 02142 USA; [Gifford, David K.; Fink, Gerald R.] Harvard Univ, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Toronto; University of Toronto; University of Toronto; Washington University (WUSTL); Washington University (WUSTL); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; National Research Council Canada; McGill University; McGill University; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Tennessee System; University of Tennessee Knoxville; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Fink, GR (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	gfink@wi.mit.edu; leah.cowen@utoronto.ca; charlie.boone@utoronto.ca	Gingras, Anne-Claude/ABA-8341-2020; Young, Richard A/F-6495-2012; Shapiro, Rebecca/I-9247-2019; kuchler, karl/AAL-6937-2020; Sellam, Adnane/H-9765-2013; Gingras, Anne-Claude/E-9982-2010	Gingras, Anne-Claude/0000-0002-6090-4437; Young, Richard A/0000-0001-8855-8647; Shapiro, Rebecca/0000-0002-7119-8865; kuchler, karl/0000-0003-2719-5955; Gingras, Anne-Claude/0000-0002-6090-4437; Vizeacoumar, Frederick/0000-0002-4676-2911; Mitra, Robi/0000-0002-2680-4264; Reynolds, Todd/0000-0002-2867-7182; Sellam, Adnane/0000-0002-0506-7752; Cowen, Leah/0000-0001-5797-0110; Tebbji, Faiza/0000-0002-7359-727X; Kurat, Christoph/0000-0003-0962-3258	Canadian Institutes of Heath Research [MOP-97939]; Natural Sciences and Engineering Research Council (NSERC) of Canada [RGPIN 204899-05]; Howard Hughes Medical Institute Research Scholar; Burroughs Wellcome Fund; Canada Research Chair in Microbial Genomics and Infectious Disease; NSERC [355965-2009]; NIH [GM40266, GM035010]; National Human Genome Research Institute; European Molecular Biology Organization; Austrian Science Fund (FWF) [I 746] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040266, R01GM035010, R37GM035010] Funding Source: NIH RePORTER	Canadian Institutes of Heath Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Howard Hughes Medical Institute Research Scholar; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Canada Research Chair in Microbial Genomics and Infectious Disease(Canada Research Chairs); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Johnston for inspiring the calling-card analysis and M. Usaj for assistance with image and data processing. Supported by the Canadian Institutes of Heath Research (MOP-97939) (C. B. and B. A.), Natural Sciences and Engineering Research Council (NSERC) of Canada (RGPIN 204899-05) (C. B.), Howard Hughes Medical Institute Research Scholar (C. B.), Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund (L. E. C.), Canada Research Chair in Microbial Genomics and Infectious Disease (L. E. C.), NSERC Discovery Grant (355965-2009) (L. E. C.), and NIH (GM40266 and GM035010) (G. R. F.). C.N. and G. G. are supported by a grant from the National Human Genome Research Institute. R. S. S. is supported by an NSERC Canada Graduate Scholarship. C. F. K. is supported by a European Molecular Biology Organization long-term fellowship Raw images and data derived from haploid invasive growth, pseudohyphal growth and biofilm formation assays can be downloaded from http://spidey.ccbr.utoronto.ca/data/ryan_et_al/.	Barwell KJ, 2005, EUKARYOT CELL, V4, P890, DOI 10.1128/EC.4.5.890-899.2005; Bastidas RJ, 2009, P NATL ACAD SCI USA, V106, P351, DOI 10.1073/pnas.0811994106; Cao F, 2006, MOL BIOL CELL, V17, P295, DOI 10.1091/mbc.E05-06-0502; Cullen PJ, 2000, P NATL ACAD SCI USA, V97, P13619, DOI 10.1073/pnas.240345197; Cullen PJ, 2004, GENE DEV, V18, P1695, DOI 10.1101/gad.1178604; Dowell RD, 2010, SCIENCE, V328, P469, DOI 10.1126/science.1189015; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Guo B, 2000, P NATL ACAD SCI USA, V97, P12158, DOI 10.1073/pnas.220420397; Homann OR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000783; Lengeler KB, 2000, MICROBIOL MOL BIOL R, V64, P746, DOI 10.1128/MMBR.64.4.746-785.2000; Lo WS, 1998, MOL BIOL CELL, V9, P161, DOI 10.1091/mbc.9.1.161; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; Madhani HD, 1997, CELL, V91, P673, DOI 10.1016/S0092-8674(00)80454-7; Mosch HU, 1996, P NATL ACAD SCI USA, V93, P5352, DOI 10.1073/pnas.93.11.5352; Noble SM, 2010, NAT GENET, V42, P590, DOI 10.1038/ng.605; Pan XW, 2002, MOL CELL BIOL, V22, P3981, DOI 10.1128/MCB.22.12.3981-3993.2002; Reynolds TB, 2001, SCIENCE, V291, P878, DOI 10.1126/science.291.5505.878; Rupp S, 1999, EMBO J, V18, P1257, DOI 10.1093/emboj/18.5.1257; Shapiro RS, 2011, MICROBIOL MOL BIOL R, V75, P213, DOI 10.1128/MMBR.00045-10; Su C, 2009, EUKARYOT CELL, V8, P1780, DOI 10.1128/EC.00190-09; van Dyk D, 2005, GENETICS, V169, P91, DOI 10.1534/genetics.104.033704; Wang HY, 2011, GENOME RES, V21, P748, DOI 10.1101/gr.114850.110; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	23	137	142	2	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2012	337	6100					1353	1356		10.1126/science.1224339	http://dx.doi.org/10.1126/science.1224339			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	004TW	22984072				2022-12-24	WOS:000308705000045
J	van Werven, FJ; Neuert, G; Hendrick, N; Lardenois, A; Buratowski, S; van Oudenaarden, A; Primig, M; Amon, A				van Werven, Folkert J.; Neuert, Gregor; Hendrick, Natalie; Lardenois, Aurelie; Buratowski, Stephen; van Oudenaarden, Alexander; Primig, Michael; Amon, Angelika			Transcription of Two Long Noncoding RNAs Mediates Mating-Type Control of Gametogenesis in Budding Yeast	CELL			English	Article							ZINC-FINGER PROTEIN; SACCHAROMYCES-CEREVISIAE; MESSENGER-RNA; INTERGENIC TRANSCRIPTION; GENE-EXPRESSION; REPRESSION; MEIOSIS; METHYLATION; SPORULATION; ACTIVATOR	The cell-fate decision leading to gametogenesis is essential for sexual reproduction. In S. cerevisiae, only diploid MATa/alpha but not haploid MATa or MAT alpha cells undergo gametogenesis, known as sporulation. We find that transcription of two long noncoding RNAs (lncRNAs) mediates mating-type control of sporulation. In MATa or MAT alpha haploids, expression of IME1, the central inducer of gametogenesis, is inhibited in cis by transcription of the lncRNA IRT1, located in the IME1 promoter. IRT1 transcription recruits the Set2 histone methyltransferase and the Set3 histone deacetylase complex to establish repressive chromatin at the IME1 promoter. Inhibiting expression of IRT1 and an antisense transcript that antagonizes the expression of the meiotic regulator IME4 allows cells expressing the haploid mating type to sporulate with kinetics that are indistinguishable from that of MATa/alpha diploids. Conversely, expression of the two lncRNAs abolishes sporulation in MATa/alpha diploids. Thus, transcription of two lncRNAs governs mating-type control of gametogenesis in yeast.	[van Werven, Folkert J.; Hendrick, Natalie; Amon, Angelika] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [van Werven, Folkert J.; Hendrick, Natalie; Amon, Angelika] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Neuert, Gregor; van Oudenaarden, Alexander] MIT, Dept Biol, Cambridge, MA 02139 USA; [van Oudenaarden, Alexander] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [van Oudenaarden, Alexander] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Lardenois, Aurelie; Primig, Michael] Univ Rennes 1, Inst Natl Sante & Rech Med, Irset U1085, F-35042 Rennes, France; [Buratowski, Stephen] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Harvard University; Harvard Medical School	Amon, A (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	angelika@mit.edu	Primig, Michael/G-3175-2013; van Oudenaarden, Alexander/AAA-1705-2019; Lardenois, Aurélie/AAA-8961-2020	Primig, Michael/0000-0002-2061-0119; Amon, Angelika/0000-0001-9837-0314; van Werven, Folkert/0000-0002-6685-2084	Netherlands Organization for Scientific Research [GM62207, 825.09.004]; National Science Foundation [ECCS-0835623]; NIH/NCI Physical Sciences Oncology Center at MIT [U54CA143874]; Inserm Avenir [R07216NS]; CREATE [NR11016NN]; NATIONAL CANCER INSTITUTE [U54CA143874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046498, R01GM056663, R01GM062207] Funding Source: NIH RePORTER	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); National Science Foundation(National Science Foundation (NSF)); NIH/NCI Physical Sciences Oncology Center at MIT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Inserm Avenir(Institut National de la Sante et de la Recherche Medicale (Inserm)); CREATE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Sudeep Agarwala, Gerald Fink, and Vincent Guacci for reagents, Stacie Bumgardner for suggestions, and Stephen Bell, Frank Solomon, Gerald Fink, and members of the Amon lab for their critical reading of this manuscript. This work was supported by a grant GM62207 to A.A., by a Rubicon-grant (825.09.004) from the Netherlands Organization for Scientific Research to F.W., by grants from the National Science Foundation (ECCS-0835623) and NIH/NCI Physical Sciences Oncology Center at MIT (U54CA143874) to A.v.O. and G.N., and by the grants Inserm Avenir (R07216NS) and CREATE (NR11016NN) to M.P. A.A. is also an Investigator of the Howard Hughes Medical Institute.	Belli G, 1998, NUCLEIC ACIDS RES, V26, P942, DOI 10.1093/nar/26.4.942; Blumental-Perry A, 2002, MOL BIOL CELL, V13, P1709, DOI 10.1091/mbc.01-09-0468; Bumgarner SL, 2012, MOL CELL, V45, P470, DOI 10.1016/j.molcel.2011.11.029; Bumgarner SL, 2009, P NATL ACAD SCI USA, V106, P18321, DOI 10.1073/pnas.0909641106; Cairns BR, 2009, NATURE, V461, P193, DOI 10.1038/nature08450; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Clancy MJ, 2002, NUCLEIC ACIDS RES, V30, P4509, DOI 10.1093/nar/gkf573; COVITZ PA, 1991, GENE DEV, V5, P1982, DOI 10.1101/gad.5.11.1982; COVITZ PA, 1993, GENE DEV, V7, P1598, DOI 10.1101/gad.7.8.1598; COVITZ PA, 1994, GENETICS, V138, P577; Deng C, 2001, MOL GENET GENOMICS, V266, P497, DOI 10.1007/s004380100571; Deutschbauer AM, 2002, P NATL ACAD SCI USA, V99, P15530, DOI 10.1073/pnas.202604399; Ding DQ, 2012, SCIENCE, V336, P732, DOI 10.1126/science.1219518; Falk JE, 2010, DEV CELL, V19, P599, DOI 10.1016/j.devcel.2010.09.006; Gelfand B, 2011, MOL CELL BIOL, V31, P1701, DOI 10.1128/MCB.01071-10; Granovskaia MV, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r24; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hainer SJ, 2011, GENE DEV, V25, P29, DOI 10.1101/gad.1975011; Hirota K, 2008, NATURE, V456, P130, DOI 10.1038/nature07348; Hochwagen A, 2005, MOL CELL BIOL, V25, P4767, DOI 10.1128/MCB.25.11.4767-4781.2005; Hongay CF, 2006, CELL, V127, P735, DOI 10.1016/j.cell.2006.09.038; Horak CE, 2002, GENE DEV, V16, P3017, DOI 10.1101/gad.1039602; Houseley J, 2008, MOL CELL, V32, P685, DOI 10.1016/j.molcel.2008.09.027; Jambhekar A, 2008, CURR BIOL, V18, P969, DOI 10.1016/j.cub.2008.05.047; KASSIR Y, 1988, CELL, V52, P853, DOI 10.1016/0092-8674(88)90427-8; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim T, 2012, CELL, V150, P1158, DOI 10.1016/j.cell.2012.08.016; Kim T, 2009, CELL, V137, P259, DOI 10.1016/j.cell.2009.02.045; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Lardenois A, 2011, P NATL ACAD SCI USA, V108, P1058, DOI 10.1073/pnas.1016459108; Leza MA, 1999, GENETICS, V151, P531; Li B, 2007, GENE DEV, V21, P1422, DOI 10.1101/gad.1539307; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; MITCHELL AP, 1992, GENETICS, V131, P65; MITCHELL AP, 1986, NATURE, V319, P738, DOI 10.1038/319738a0; Pijnappel WWMP, 2001, GENE DEV, V15, P2991, DOI 10.1101/gad.207401; Pinskaya M, 2009, EMBO J, V28, P1697, DOI 10.1038/emboj.2009.108; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; SHAH JC, 1992, MOL CELL BIOL, V12, P1078, DOI 10.1128/MCB.12.3.1078; Shimizu M, 1998, NUCLEIC ACIDS RES, V26, P2329, DOI 10.1093/nar/26.10.2329; Shimizu M, 1997, P NATL ACAD SCI USA, V94, P790, DOI 10.1073/pnas.94.3.790; Thebault P, 2011, MOL CELL BIOL, V31, P1288, DOI 10.1128/MCB.01083-10; TOONE WM, 1995, EMBO J, V14, P5824, DOI 10.1002/j.1460-2075.1995.tb00270.x; Uhler JP, 2007, P NATL ACAD SCI USA, V104, P8011, DOI 10.1073/pnas.0702431104; van Dijk EL, 2011, NATURE, V475, P114, DOI 10.1038/nature10118; van Werven FJ, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl003; van Werven FJ, 2011, PHILOS T R SOC B, V366, P3521, DOI 10.1098/rstb.2011.0081; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Zhang LY, 2011, GENOME RES, V21, P875, DOI 10.1101/gr.117465.110; Zofall M, 2012, SCIENCE, V335, P96, DOI 10.1126/science.1211651	51	184	186	2	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 14	2012	150	6					1170	1181		10.1016/j.cell.2012.06.049	http://dx.doi.org/10.1016/j.cell.2012.06.049			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22959267	Green Accepted, Bronze			2022-12-24	WOS:000308928100011
J	Cloud, V; Chan, YL; Grubb, J; Budke, B; Bishop, DK				Cloud, Veronica; Chan, Yuen-Ling; Grubb, Jennifer; Budke, Brian; Bishop, Douglas K.			Rad51 Is an Accessory Factor for Dmc1-Mediated Joint Molecule Formation During Meiosis	SCIENCE			English	Article							MEIOTIC RECOMBINATION; PROTEIN COMPLEX; SACCHAROMYCES-CEREVISIAE; DNA-BINDING; DMC1; HOMOLOG; ROLES	Meiotic recombination in budding yeast requires two RecA-related proteins, Rad51 and Dmc1, both of which form filaments on DNA capable of directing homology search and catalyzing formation of homologous joint molecules (JMs) and strand exchange. With use of a separation-of-function mutant form of Rad51 that retains filament-forming but not JM-forming activity, we show that the JM activity of Rad51 is fully dispensable for meiotic recombination. The corresponding mutation in Dmc1 causes a profound recombination defect, demonstrating Dmc1's JM activity alone is responsible for meiotic recombination. We further provide biochemical evidence that Rad51 acts with Mei5-Sae3 as a Dmc1 accessory factor. Thus, Rad51 is a multifunctional protein that catalyzes recombination directly in mitosis and indirectly, via Dmc1, during meiosis.	[Cloud, Veronica; Bishop, Douglas K.] Univ Chicago, Cummings Life Sci Ctr, Comm Genet, Chicago, IL 60637 USA; [Cloud, Veronica; Chan, Yuen-Ling; Grubb, Jennifer; Budke, Brian; Bishop, Douglas K.] Univ Chicago, Cummings Life Sci Ctr, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA; [Bishop, Douglas K.] Univ Chicago, Cummings Life Sci Ctr, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Bishop, DK (corresponding author), Univ Chicago, Cummings Life Sci Ctr, Comm Genet, 920 E 58th St, Chicago, IL 60637 USA.	dbishop@uchicago.edu		Budke, Brian/0000-0001-6051-8416	National Institute for General Medical Sciences [GM50936]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050936] Funding Source: NIH RePORTER	National Institute for General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to A. Zhang and P. Rice for structural alignments, N. Hunter for critical reading of the manuscript and strains, P. Sung for plasmid pET11d-ScRad52, and W. Heyer for Rad54 protein. This work was supported by National Institute for General Medical Sciences grant GM50936.	BISHOP DK, 1994, CELL, V79, P1081, DOI 10.1016/0092-8674(94)90038-8; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Chi P, 2006, DNA REPAIR, V5, P381, DOI 10.1016/j.dnarep.2005.11.005; Ferrari SR, 2009, J BIOL CHEM, V284, P11766, DOI 10.1074/jbc.C900023200; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Gasior SL, 1998, GENE DEV, V12, P2208, DOI 10.1101/gad.12.14.2208; Hayase A, 2004, CELL, V119, P927, DOI 10.1016/j.cell.2004.10.031; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Kokabu Y, 2011, J BIOL CHEM, V286, P43569, DOI 10.1074/jbc.M111.303339; Kurumizaka H, 1999, ARCH BIOCHEM BIOPHYS, V365, P83, DOI 10.1006/abbi.1999.1166; MULLER B, 1990, J MOL BIOL, V212, P97, DOI 10.1016/0022-2836(90)90307-8; Oh SD, 2007, CELL, V130, P259, DOI 10.1016/j.cell.2007.05.035; Say AF, 2011, DNA REPAIR, V10, P586, DOI 10.1016/j.dnarep.2011.03.006; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; Sheridan S, 2006, GENE DEV, V20, P1685, DOI 10.1101/gad.1447606; Shinohara A, 1997, GENES CELLS, V2, P615, DOI 10.1046/j.1365-2443.1997.1480347.x; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Tsubouchi H, 2006, GENE DEV, V20, P1766, DOI 10.1101/gad.1422506	18	186	190	2	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2012	337	6099					1222	1225		10.1126/science.1219379	http://dx.doi.org/10.1126/science.1219379			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	000UJ	22955832	Green Accepted			2022-12-24	WOS:000308414000037
J	Towbin, BD; Gonzalez-Aguilera, C; Sack, R; Gaidatzis, D; Kalck, V; Meister, P; Askjaer, P; Gasser, SM				Towbin, Benjamin D.; Gonzalez-Aguilera, Cristina; Sack, Ragna; Gaidatzis, Dimos; Kalck, Veronique; Meister, Peter; Askjaer, Peter; Gasser, Susan M.			Step-Wise Methylation of Histone H3K9 Positions Heterochromatin at the Nuclear Periphery	CELL			English	Article							CAENORHABDITIS-ELEGANS; C-ELEGANS; LAMINA INTERACTIONS; LYSINE 9; HP1 PROTEINS; GERM-LINE; GENOME; CHROMATIN; COMPLEX; METHYLTRANSFERASES	The factors that sequester transcriptionally repressed heterochromatin at the nuclear periphery are currently unknown. In a genome-wide RNAi screen, we found that depletion of S-adenosylmethionine (SAM) synthetase reduces histone methylation globally and causes derepression and release of heterochromatin from the nuclear periphery in Caenorhabditis elegans embryos. Analysis of histone methyltransferases (HMTs) showed that elimination of two HMTs, MET-2 and SET-25, mimics the loss of SAM synthetase, abrogating the perinuclear attachment of heterochromatic transgenes and of native chromosomal arms rich in histone H3 lysine 9 methylation. The two HMTs target H3K9 in a consecutive fashion: MET-2, a SETDB1 homolog, mediates mono-and dimethylation, and SET-25, a previously uncharacterized HMT, deposits H3K9me3. SET-25 colocalizes with its own product in perinuclear foci, in a manner dependent on H3K9me3, but not on its catalytic domain. This colocalization suggests an autonomous, self-reinforcing mechanism for the establishment and propagation of repeat-rich heterochromatin.	[Towbin, Benjamin D.; Sack, Ragna; Gaidatzis, Dimos; Kalck, Veronique; Meister, Peter; Gasser, Susan M.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Towbin, Benjamin D.; Gasser, Susan M.] Univ Basel, Fac Sci, CH-4056 Basel, Switzerland; [Gonzalez-Aguilera, Cristina; Askjaer, Peter] Univ Pablo de Olavide, CABD, CSIC, Seville 41013, Spain	Friedrich Miescher Institute for Biomedical Research; University of Basel; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD)	Gasser, SM (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	susan.gasser@fmi.ch	Towbin, Benjamin D/C-8545-2018; Meister, Peter/B-4770-2010; Towbin, Benjamin D/AAO-8064-2021; Askjaer, Peter/I-3316-2012	Meister, Peter/0000-0002-6230-4216; Towbin, Benjamin D/0000-0001-7046-1257; Askjaer, Peter/0000-0003-3192-4428; Gonzalez- Aguilera, Cristina/0000-0003-4845-5744; Gasser, Susan/0000-0003-3610-9123	European Union Network of Excellence "Epigenome"; Novartis Research Foundation; Fondation Suisse de recherche sur les maladies musculaires; Spanish Ministry of Science and Innovation [BFU2010-15478]; EMBO [ASTF 478-2011]	European Union Network of Excellence "Epigenome"(European Commission); Novartis Research Foundation; Fondation Suisse de recherche sur les maladies musculaires; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); EMBO(European Molecular Biology Organization (EMBO))	We thank Y. Gruenbaum and T. Jenuwein for antibodies; M. Thomas, R. Arpagaus, R. Son, and T. Sakuragi for excellent technical assistance; I. Katic for help with injections; the Caenorhabditis Genetics Center; R. Horvitz, M. Tijsterman and F. Palladino for strains; D. Schubeler, A. Peters, and H. Ferreira for critical reading of the manuscript; and L. Hoerner for help with array hybridization. This work was supported by the European Union Network of Excellence "Epigenome", the Novartis Research Foundation, the "Fondation Suisse de recherche sur les maladies musculaires", the Spanish Ministry of Science and Innovation (BFU2010-15478 to P.A.), and EMBO (ASTF 478-2011 to C.G.A.).	Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; Andersen EC, 2007, DEVELOPMENT, V134, P2991, DOI 10.1242/dev.009373; Azzaria M, 1996, DEV BIOL, V178, P289, DOI 10.1006/dbio.1996.0219; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bender LB, 2006, DEVELOPMENT, V133, P3907, DOI 10.1242/dev.02584; Bender LB, 2004, CURR BIOL, V14, P1639, DOI 10.1016/j.cub.2004.08.062; Bessler JB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000830; Black JC, 2011, EPIGENETICS-US, V6, P13, DOI 10.4161/epi.6.1.13331; CAPOWSKI EE, 1991, GENETICS, V129, P1061; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Goldman RD, 2002, GENE DEV, V16, P533, DOI 10.1101/gad.960502; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Hsieh J, 2000, ANNU REV GENET, V34, P187, DOI 10.1146/annurev.genet.34.1.187; Ikegami K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r120; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kind J, 2010, CURR OPIN CELL BIOL, V22, P320, DOI 10.1016/j.ceb.2010.04.002; Koester-Eiserfunke N, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002017; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lehner B, 2006, NAT PROTOC, V1, P1617, DOI 10.1038/nprot.2006.245; Liu T, 2011, GENOME RES, V21, P227, DOI 10.1101/gr.115519.110; Loyola A, 2006, MOL CELL, V24, P309, DOI 10.1016/j.molcel.2006.08.019; Loyola A, 2009, EMBO REP, V10, P769, DOI 10.1038/embor.2009.90; Luo L, 2009, J CELL SCI, V122, P3729, DOI 10.1242/jcs.052555; Margalit A, 2007, TRENDS CELL BIOL, V17, P202, DOI 10.1016/j.tcb.2007.02.004; Martin David I. K., 1996, Bioessays, V18, P919, DOI 10.1002/bies.950181111; Mattout A, 2011, CURR BIOL, V21, P1603, DOI 10.1016/j.cub.2011.08.030; Meister P, 2010, GENE DEV, V24, P766, DOI 10.1101/gad.559610; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Pinheiro I, 2012, CELL, V150, P948, DOI 10.1016/j.cell.2012.06.048; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Sassi HE, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni164; Schott S, 2006, DEV BIOL, V298, P176, DOI 10.1016/j.ydbio.2006.06.039; Shevelyov YY, 2009, P NATL ACAD SCI USA, V106, P3282, DOI 10.1073/pnas.0811933106; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Ye Q, 1996, J BIOL CHEM, V271, P14653, DOI 10.1074/jbc.271.25.14653; Yuzyuk T, 2009, DEV CELL, V16, P699, DOI 10.1016/j.devcel.2009.03.008; Zhang K, 2008, NAT STRUCT MOL BIOL, V15, P381, DOI 10.1038/nsmb.1406	44	377	386	3	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 31	2012	150	5					934	947		10.1016/j.cell.2012.06.051	http://dx.doi.org/10.1016/j.cell.2012.06.051			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22939621	Bronze, Green Submitted			2022-12-24	WOS:000308500200009
J	Lundberg, DS; Lebeis, SL; Paredes, SH; Yourstone, S; Gehring, J; Malfatti, S; Tremblay, J; Engelbrektson, A; Kunin, V; del Rio, TG; Edgar, RC; Eickhorst, T; Ley, RE; Hugenholtz, P; Tringe, SG; Dangl, JL				Lundberg, Derek S.; Lebeis, Sarah L.; Paredes, Sur Herrera; Yourstone, Scott; Gehring, Jase; Malfatti, Stephanie; Tremblay, Julien; Engelbrektson, Anna; Kunin, Victor; del Rio, Tijana Glavina; Edgar, Robert C.; Eickhorst, Thilo; Ley, Ruth E.; Hugenholtz, Philip; Tringe, Susannah Green; Dangl, Jeffery L.			Defining the core Arabidopsis thaliana root microbiome	NATURE			English	Article							BACTERIAL ENDOPHYTES; RHIZOSPHERE; TRAITS; PLANTS	Land plants associate with a root microbiota distinct from the complex microbial community present in surrounding soil. The microbiota colonizing the rhizosphere (immediately surroundingthe root) and the endophytic compartment (within the root) contribute to plant growth, productivity, carbon sequestration and phytoremediation(1-3). Colonization of the root occurs despite a sophisticated plant immune system(4,5), suggesting finely tuned discrimination of mutualists and commensals from pathogens. Genetic principles governing the derivation of host-specific endophyte communities from soil communities are poorly understood. Here we report the pyrosequencing of the bacterial 16S ribosomal RNA gene of more than 600 Arabidopsis thaliana plants to test the hypotheses that the root rhizosphere and endophytic compartmentmicrobiota of plants grown under controlled conditions in natural soils are sufficiently dependent on the host to remain consistent across different soil types and developmental stages, and sufficiently dependent on host genotype to vary between inbred Arabidopsis accessions. We describe different bacterial communities in two geochemically distinct bulk soils and in rhizosphere and endophytic compartments prepared from roots grown in these soils. The communities in each compartment are strongly influenced by soil type. Endophytic compartments fromboth soils feature overlapping, low-complexity communities that are markedly enriched in Actinobacteria and specific families from other phyla, notably Proteobacteria. Some bacteria vary quantitatively between plants of different developmental stage and genotype. Our rigorous definition of an endophytic compartment microbiome should facilitate controlled dissection of plantmicrobe interactions derived from complex soil communities.	[Lundberg, Derek S.; Lebeis, Sarah L.; Paredes, Sur Herrera; Yourstone, Scott; Gehring, Jase; Dangl, Jeffery L.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Lundberg, Derek S.; Dangl, Jeffery L.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Yourstone, Scott] Univ N Carolina, Curriculum Bioinformat & Computat Biol, Chapel Hill, NC 27599 USA; [Malfatti, Stephanie; Tremblay, Julien; Engelbrektson, Anna; Kunin, Victor; del Rio, Tijana Glavina; Hugenholtz, Philip; Tringe, Susannah Green] DOE Joint Genome Inst, Walnut Creek, CA 94598 USA; [Edgar, Robert C.] Taxon Biosci Inc, Tiburon, CA 94920 USA; [Eickhorst, Thilo] Univ Bremen, Fac Biol & Chem, D-28359 Bremen, Germany; [Ley, Ruth E.] Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA; [Hugenholtz, Philip] Univ Queensland, Sch Chem & Mol Biosci, Australian Ctr Ecogen, Brisbane, Qld 4072, Australia; [Hugenholtz, Philip] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Dangl, Jeffery L.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Dangl, Jeffery L.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Dangl, Jeffery L.] Univ N Carolina, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; United States Department of Energy (DOE); University of Bremen; Cornell University; University of Queensland; University of Queensland; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill	Dangl, JL (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA.	dangl@email.unc.edu	Tringe, Susannah Green/T-9431-2019; Ariel, Pablo/AGJ-4118-2022; Engelbrektson, Anna/K-5563-2012; Ley, Ruth E/M-8542-2014; Eickhorst, Thilo/M-1200-2014; Engelbrektson, Anna/F-1687-2013; Paredes, Sur Herrera/I-8617-2019; Hugenholtz, Philip/AAD-9138-2019	Tringe, Susannah Green/0000-0001-6479-8427; Ley, Ruth E/0000-0002-9087-1672; Paredes, Sur Herrera/0000-0001-9246-8337; Hugenholtz, Philip/0000-0001-5386-7925; Lundberg, Derek/0000-0001-7970-1595; Kunin, Victor/0000-0002-8741-7866; Malfatti, Stephanie/0000-0003-4225-9857; Tremblay, Julien/0000-0002-6085-3481	US NSF [IOS-0958245]; JGI Director's Discretionary Grand Challenge Program; HHMI-GBMF Plant Science Program; Office of Science of the US Department of Energy [DE-AC02-05CH11231]; National Institutes of Health, Minority Opportunities in Research division of the National Institute of General Medical Sciences [K12GM000678]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000678] Funding Source: NIH RePORTER; Direct For Biological Sciences [0958245] Funding Source: National Science Foundation	US NSF(National Science Foundation (NSF)); JGI Director's Discretionary Grand Challenge Program; HHMI-GBMF Plant Science Program; Office of Science of the US Department of Energy(United States Department of Energy (DOE)); National Institutes of Health, Minority Opportunities in Research division of the National Institute of General Medical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank A. Smithlund, M. Gonek, V. Madden, H. Schmidt, M. Rott and N. Zvenigorodsky for technical assistance. We thank A. Spor, J. Pfeiffer and J. Rawls for discussions and C. Herring for research field soil. This work was supported by US NSF grant IOS-0958245 (J. L. D.), the JGI Director's Discretionary Grand Challenge Program and the HHMI-GBMF Plant Science Program. J. L. D. is an HHMI-GBMF Plant Science Investigator. Work conducted by the US Department of Energy Joint Genome Institute is supported by the Office of Science of the US Department of Energy under contract no. DE-AC02-05CH11231. S. L. L. was supported by the National Institutes of Health, Minority Opportunities in Research division of the National Institute of General Medical Sciences grant K12GM000678.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chi F, 2005, APPL ENVIRON MICROB, V71, P7271, DOI 10.1128/AEM.71.11.7271-7278.2005; De Deyn GB, 2008, ECOL LETT, V11, P516, DOI 10.1111/j.1461-0248.2008.01164.x; Dennis PG, 2010, FEMS MICROBIOL ECOL, V72, P313, DOI 10.1111/j.1574-6941.2010.00860.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Eickhorst T, 2008, SOIL BIOL BIOCHEM, V40, P1883, DOI 10.1016/j.soilbio.2008.03.024; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; Firakova S, 2007, BIOLOGIA, V62, P251, DOI 10.2478/s11756-007-0044-1; Gottel NR, 2011, APPL ENVIRON MICROB, V77, P5934, DOI 10.1128/AEM.05255-11; Hallmann J, 1997, CAN J MICROBIOL, V43, P895, DOI 10.1139/m97-131; Hardoim PR, 2008, TRENDS MICROBIOL, V16, P463, DOI 10.1016/j.tim.2008.07.008; Inceoglu O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023321; Inceoglu O, 2010, APPL ENVIRON MICROB, V76, P3675, DOI 10.1128/AEM.00040-10; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kunin V, 2010, OPEN J, V1, P1; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Levey S, 2005, PLANT CELL ENVIRON, V28, P223, DOI 10.1111/j.1365-3040.2004.01266.x; Loy A, 2007, NUCLEIC ACIDS RES, V35, pD800, DOI 10.1093/nar/gkl856; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; MARSCHNER H, 1986, Z PFLANZ BODENKUNDE, V149, P441, DOI 10.1002/jpln.19861490408; Masclaux C, 2000, PLANTA, V211, P510, DOI 10.1007/s004250000310; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; Motulsky H.J., 2003, PRISM 4 STAT GUIDE S; Oksanen J., 2011, VEGAN R FUNCTIONS VE; Redford AJ, 2010, ENVIRON MICROBIOL, V12, P2885, DOI 10.1111/j.1462-2920.2010.02258.x; Rodriguez RJ, 2008, ISME J, V2, P404, DOI 10.1038/ismej.2007.106; Schulz Barbara J. E., 2006, V9, P1; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Sul WJ, 2011, P NATL ACAD SCI USA, V108, P14637, DOI 10.1073/pnas.1111435108; van der Lelie D, 2009, CRIT REV PLANT SCI, V28, P346, DOI 10.1080/07352680903241204; VANELSAS JD, 1988, FEMS MICROBIOL ECOL, V53, P299, DOI 10.1016/0378-1097(88)90487-9; Warnes GR, 2011, GPLOTS VARIOUS R PRO	36	1512	1628	82	1502	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 2	2012	488	7409					86	+		10.1038/nature11237	http://dx.doi.org/10.1038/nature11237			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ZE	22859206	Green Submitted, Green Accepted			2022-12-24	WOS:000307010700038
J	Duncan, K; Sadanand, A; Davachi, L				Duncan, Katherine; Sadanand, Arhanti; Davachi, Lila			Memory's Penumbra: Episodic Memory Decisions Induce Lingering Mnemonic Biases	SCIENCE			English	Article							MEDIAL TEMPORAL-LOBE; RECOGNITION MEMORY; PROACTIVE-INTERFERENCE; PATTERN SEPARATION; NOVELTY DETECTION; HIPPOCAMPAL; MODULATION; RETRIEVAL; SYSTEMS; REGION	How do we decide if the people we meet and the things we see are familiar or new? If something is new, we need to encode it as a memory distinct from already stored episodes, using a process known as pattern separation. If familiar, it can be used to reactivate a previously stored memory, by a process known as pattern completion. To orchestrate these conflicting processes, current models propose that the episodic memory system uses environmental cues to establish processing biases that favor either pattern separation during encoding or pattern completion during retrieval. To assess this theory, we measured how people's memory formation and decisions are influenced by their recent engagement in episodic encoding and retrieval. We found that the recent encoding of novel objects improved subsequent identification of subtle changes, a task thought to rely on pattern separation. Conversely, recent retrieval of old objects increased the subsequent integration of stored information into new memories, a process thought to rely on pattern completion. These experiments provide behavioral evidence that episodic encoding and retrieval evoke lingering biases that influence subsequent mnemonic processing.	[Sadanand, Arhanti; Davachi, Lila] NYU, Dept Psychol, New York, NY 10003 USA; [Duncan, Katherine] Columbia Univ, Dept Psychol, New York, NY 10027 USA; [Davachi, Lila] NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University; Columbia University; New York University	Davachi, L (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	lila.davachi@nyu.edu		Davachi, Lila/0000-0003-4317-0889; Duncan, Katherine/0000-0003-0456-851X	NIH [RO1 MH074692]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074692] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by NIH grant RO1 MH074692 to L.D. We thank V. Skvortsova, A. Berners-Lee, and M. Inhoff for data collection assistance; K. Ochsner and E. Phelps for their helpful comments on an earlier draft of the manuscript; G. Chin for his useful editorial comments; and C. Stark and W. Suzuki for the use of stimuli developed by their labs.	Allan K, 2005, J NEUROSCI, V25, P8122, DOI 10.1523/JNEUROSCI.1304-05.2005; Atri A, 2004, BEHAV NEUROSCI, V118, P223, DOI 10.1037/0735-7044.118.1.223; Bakker A, 2008, SCIENCE, V319, P1640, DOI 10.1126/science.1152882; Davachi L, 2006, CURR OPIN NEUROBIOL, V16, P693, DOI 10.1016/j.conb.2006.10.012; De Rosa E, 2000, BEHAV NEUROSCI, V114, P32, DOI 10.1037/0735-7044.114.1.32; Duncan K, 2012, HIPPOCAMPUS, V22, P389, DOI 10.1002/hipo.20933; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Hall G, 2003, J EXP PSYCHOL GEN, V132, P266, DOI 10.1037/0096-3445.132.2.266; HASSELMO ME, 1995, J NEUROSCI, V15, P5249; HASSELMO ME, 1994, J NEUROSCI, V14, P3898; Hasselmo ME, 2001, J NEUROPHYSIOL, V86, P1792, DOI 10.1152/jn.2001.86.4.1792; Hasselmo ME, 1996, HIPPOCAMPUS, V6, P693, DOI 10.1002/(SICI)1098-1063(1996)6:6<693::AID-HIPO12>3.0.CO;2-W; Huijbers W, 2009, PLOS BIOL, V7, P63, DOI 10.1371/journal.pbio.1000011; Kirwan CB, 2007, LEARN MEMORY, V14, P625, DOI 10.1101/lm.663507; Kumaran D, 2007, HIPPOCAMPUS, V17, P735, DOI 10.1002/hipo.20326; Kunec S, 2005, J NEUROPHYSIOL, V94, P70, DOI 10.1152/jn.00731.2004; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Lisman J, 2011, TRENDS NEUROSCI, V34, P536, DOI 10.1016/j.tins.2011.07.006; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; MCDONALD RJ, 1993, BEHAV NEUROSCI, V107, P3, DOI 10.1037/0735-7044.107.1.3; Meeter M, 2004, HIPPOCAMPUS, V14, P722, DOI 10.1002/hipo.10214; Myers CE, 2003, J COGNITIVE NEUROSCI, V15, P185, DOI 10.1162/089892903321208123; Norman KA, 2003, PSYCHOL REV, V110, P611, DOI 10.1037/0033-295X.110.4.611; OREILLY RC, 1994, HIPPOCAMPUS, V4, P661, DOI 10.1002/hipo.450040605; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Shohamy D, 2008, NEURON, V60, P378, DOI 10.1016/j.neuron.2008.09.023; Squire LR, 2007, NAT REV NEUROSCI, V8, P872, DOI 10.1038/nrn2154; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Vinogradova OS, 2001, HIPPOCAMPUS, V11, P578, DOI 10.1002/hipo.1073	30	83	83	2	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2012	337	6093					485	487		10.1126/science.1221936	http://dx.doi.org/10.1126/science.1221936			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	979FS	22837528	Green Accepted			2022-12-24	WOS:000306802300048
J	Glasmacher, E; Agrawal, S; Chang, AB; Murphy, TL; Zeng, WW; Vander Lugt, B; Khan, AA; Ciofani, M; Spooner, CJ; Rutz, S; Hackney, J; Nurieva, R; Escalante, CR; Ouyang, WJ; Littman, DR; Murphy, KM; Singh, H				Glasmacher, Elke; Agrawal, Smita; Chang, Abraham B.; Murphy, Theresa L.; Zeng, Wenwen; Vander Lugt, Bryan; Khan, Aly A.; Ciofani, Maria; Spooner, Chauncey J.; Rutz, Sascha; Hackney, Jason; Nurieva, Roza; Escalante, Carlos R.; Ouyang, Wenjun; Littman, Dan R.; Murphy, Kenneth M.; Singh, Harinder			A Genomic Regulatory Element That Directs Assembly and Function of Immune-Specific AP-1-IRF Complexes	SCIENCE			English	Article							TRANSCRIPTION FACTOR IRF4; FACTOR BATF CONTROLS; CELL-DIFFERENTIATION; FAMILY; ACTIVATION; EXPRESSION; PROGRAM; ABSENCE; MEMBER; ROLES	Interferon regulatory factor 4 (IRF4) and IRF8 regulate B, T, macrophage, and dendritic cell differentiation. They are recruited to cis-regulatory Ets-IRF composite elements by PU.1 or Spi-B. How these IRFs target genes in most T cells is enigmatic given the absence of specific Ets partners. Chromatin immunoprecipitation sequencing in T helper 17 (T(H)17) cells reveals that IRF4 targets sequences enriched for activating protein 1 (AP-1)-IRF composite elements (AICEs) that are co-bound by BATF, an AP-1 factor required for T(H)17, B, and dendritic cell differentiation. IRF4 and BATF bind cooperatively to structurally divergent AICEs to promote gene activation and T(H)17 differentiation. The AICE motif directs assembly of IRF4 or IRF8 with BATF heterodimers and is also used in T(H)2, B, and dendritic cells. This genomic regulatory element and cognate factors appear to have evolved to integrate diverse immunomodulatory signals.	[Murphy, Theresa L.; Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Glasmacher, Elke; Agrawal, Smita; Chang, Abraham B.; Zeng, Wenwen; Vander Lugt, Bryan; Spooner, Chauncey J.; Rutz, Sascha; Ouyang, Wenjun; Singh, Harinder] Genentech Inc, Dept Discovery Immunol, San Francisco, CA 94080 USA; [Khan, Aly A.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Khan, Aly A.] Univ Chicago, Inst Syst & Genom Biol, Chicago, IL 60637 USA; [Ciofani, Maria] NYU, Howard Hughes Med Inst, Skirball Inst Biomol Med, New York, NY 10016 USA; [Hackney, Jason] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Nurieva, Roza] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77054 USA; [Escalante, Carlos R.] Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Richmond, VA 23219 USA	Howard Hughes Medical Institute; Washington University (WUSTL); Roche Holding; Genentech; University of Chicago; University of Chicago; Howard Hughes Medical Institute; New York University; Roche Holding; Genentech; University of Texas System; UTMD Anderson Cancer Center; Virginia Commonwealth University	Murphy, KM (corresponding author), Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Pathol & Immunol, St Louis, MO 63110 USA.	kmurphy@pathology.wustl.edu; harindsi@gene.com	Glasmacher, Elke/B-8939-2015; Ouyang, Wenjun/ABA-8763-2020; Zeng, Wenwen/D-7276-2017	Glasmacher, Elke/0000-0003-1265-2543; Zeng, Wenwen/0000-0001-8544-3318; Ciofani, Maria/0000-0001-6472-5260; Hackney, Jason/0000-0002-5922-563X; Ouyang, Wenjun/0000-0002-1811-5864	NIH [RC1 AI087266, RC4 AI092765]; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC4AI092765, RC1AI087266] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank K. Dong for insightful discussions and suggestions and the fluorescence-activated cell sorting (FACS), antibody engineering, DNA sequencing, microarray, and oligonucleotide synthesis facilities at Genentech for providing valuable reagents and technical assistance. The data presented in the manuscript are tabulated in the main paper and the supplementary materials. Reagents will be provided upon request. D.R.L. and K.M.M. are Howard Hughes Medical Institute investigators. D.R.L. also acknowledges funding from NIH grants RC1 AI087266 and RC4 AI092765, and M. C. was supported by a fellowship from the Crohn's and Colitis Foundation of America. Genentech, Incorporated, has filed a provisional patent application that is focused on targeting of IRF4-BATF complexes in the context of T<INF>H</INF>17-mediated inflammatory or autoimmune diseases. The complete gene expression and ChIPseq data sets can be accessed at www.ncbi.nlm.nih.gov/projects/geo/query/acc.cgi?acc=GSE40483.	Bollig N, 2012, P NATL ACAD SCI USA, V109, P8664, DOI 10.1073/pnas.1205834109; BOVOLENTA C, 1994, P NATL ACAD SCI USA, V91, P5046, DOI 10.1073/pnas.91.11.5046; Brass AL, 1999, EMBO J, V18, P977, DOI 10.1093/emboj/18.4.977; Brass AL, 1996, GENE DEV, V10, P2335, DOI 10.1101/gad.10.18.2335; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; De Silva NS, 2012, IMMUNOL REV, V247, P73, DOI 10.1111/j.1600-065X.2012.01113.x; EISENBEIS CF, 1995, GENE DEV, V9, P1377, DOI 10.1101/gad.9.11.1377; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kimura A, 2008, P NATL ACAD SCI USA, V105, P9721, DOI 10.1073/pnas.0804231105; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Lee CG, 2009, MOL IMMUNOL, V46, P613, DOI 10.1016/j.molimm.2008.07.037; Lohoff M, 2005, NAT REV IMMUNOL, V5, P125, DOI 10.1038/nri1552; Lohoff M, 2002, P NATL ACAD SCI USA, V99, P11808, DOI 10.1073/pnas.182425099; Macian F, 2000, EMBO J, V19, P4783, DOI 10.1093/emboj/19.17.4783; Mathur AN, 2007, J IMMUNOL, V178, P4901, DOI 10.4049/jimmunol.178.8.4901; MATSUYAMA T, 1995, NUCLEIC ACIDS RES, V23, P2127, DOI 10.1093/nar/23.12.2127; Rengarajan J, 2002, J EXP MED, V195, P1003, DOI 10.1084/jem.20011128; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Tussiwand R, 2012, NATURE, V490, P502, DOI 10.1038/nature11531; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674	27	232	240	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2012	338	6109					975	980		10.1126/science.1228309	http://dx.doi.org/10.1126/science.1228309			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	037DY	22983707	Green Accepted			2022-12-24	WOS:000311083600051
J	Novarino, G; El-Fishawy, P; Kayserili, H; Meguid, NA; Scott, EM; Schroth, J; Silhavy, JL; Kara, M; Khalil, RO; Ben-Omran, T; Ercan-Sencicek, AG; Hashish, AF; Sanders, SJ; Gupta, AR; Hashem, HS; Matern, D; Gabriel, S; Sweetman, L; Rahimi, Y; Harris, RA; State, MW; Gleeson, JG				Novarino, Gaia; El-Fishawy, Paul; Kayserili, Hulya; Meguid, Nagwa A.; Scott, Eric M.; Schroth, Jana; Silhavy, Jennifer L.; Kara, Majdi; Khalil, Rehab O.; Ben-Omran, Tawfeg; Ercan-Sencicek, A. Gulhan; Hashish, Adel F.; Sanders, Stephan J.; Gupta, Abha R.; Hashem, Hebatalla S.; Matern, Dietrich; Gabriel, Stacey; Sweetman, Larry; Rahimi, Yasmeen; Harris, Robert A.; State, Matthew W.; Gleeson, Joseph G.			Mutations in BCKD-kinase Lead to a Potentially Treatable Form of Autism with Epilepsy	SCIENCE			English	Article							SYRUP-URINE-DISEASE; DEHYDROGENASE KINASE; AMINO-ACIDS; METABOLISM; EXPRESSION; TRANSPORT; MICE	Autism spectrum disorders are a genetically heterogeneous constellation of syndromes characterized by impairments in reciprocal social interaction. Available somatic treatments have limited efficacy. We have identified inactivating mutations in the gene BCKDK (Branched Chain Ketoacid Dehydrogenase Kinase) in consanguineous families with autism, epilepsy, and intellectual disability. The encoded protein is responsible for phosphorylation-mediated inactivation of the E1 alpha subunit of branched-chain ketoacid dehydrogenase (BCKDH). Patients with homozygous BCKDK mutations display reductions in BCKDK messenger RNA and protein, E1 alpha phosphorylation, and plasma branched-chain amino acids. Bckdk knockout mice show abnormal brain amino acid profiles and neurobehavioral deficits that respond to dietary supplementation. Thus, autism presenting with intellectual disability and epilepsy caused by BCKDK mutations represents a potentially treatable syndrome.	[Novarino, Gaia; Scott, Eric M.; Schroth, Jana; Silhavy, Jennifer L.; Gleeson, Joseph G.] Univ Calif San Diego, Howard Hughes Med Inst, Neurogenet Lab, Dept Neurosci, La Jolla, CA 92093 USA; [Ercan-Sencicek, A. Gulhan; Sanders, Stephan J.; State, Matthew W.] Yale Univ, Ctr Child Study, Sch Med, Program Neurogenet,Dept Psychiat, New Haven, CT 06520 USA; [Kayserili, Hulya] Istanbul Univ, Istanbul Fac Med, Dept Med Genet, TR-34093 Faith Istanbul, Turkey; [Meguid, Nagwa A.; Khalil, Rehab O.; Hashish, Adel F.; Hashem, Hebatalla S.] Natl Res Ctr, Dept Res Children Special Needs, Cairo, Egypt; [Kara, Majdi] Tripoli Childrens Hosp, Dept Pediat, Tripoli, Libya; [Ben-Omran, Tawfeg] Hamad Med Corp, Dept Pediat, Clin & Metab Genet Div, Doha, Qatar; [Ercan-Sencicek, A. Gulhan; Sanders, Stephan J.; State, Matthew W.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Gupta, Abha R.] Yale Univ, Sch Med, Dept Pediat, Ctr Child Study, New Haven, CT 06520 USA; [Matern, Dietrich] Mayo Clin, Dept Lab Med & Pathol, Biochem Genet Lab, Rochester, MN 55905 USA; [Gabriel, Stacey] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Sweetman, Larry] Baylor Res Inst, Inst Metab Dis, Dallas, TX 75226 USA; [Rahimi, Yasmeen; Harris, Robert A.] Indiana Univ Sch Med, Roudebush VA Med Ctr, Indianapolis, IN 46202 USA; [Rahimi, Yasmeen; Harris, Robert A.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; Yale University; Istanbul University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Hamad Medical Corporation; Yale University; Yale University; Mayo Clinic; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Baylor Scott & White Health; Baylor University Medical Center; Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Indiana University System; Indiana University Bloomington	Novarino, G (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Neurogenet Lab, Dept Neurosci, La Jolla, CA 92093 USA.	gnovarino@ucsd.edu; jogleeson@ucsd.edu	meguid, nagwa/S-7099-2016; Sanders, Stephan/S-8645-2019; Kayserili, Hülya/AAA-5593-2021; State, Matthew/W-2256-2019	Kayserili, Hülya/0000-0003-0376-499X; State, Matthew/0000-0003-1624-8302; Sanders, Stephan/0000-0001-9112-5148; Meguid, Nagwa/0000-0002-7962-2501; HASHISH, ADEL/0000-0001-9549-2973	NIH [P01HD070494, R01NS048453, P30NS047101, RC2MH089956, K08MH087639, T32MH018268]; Broad Institute [U54HG003067]; Center for Inherited Disease Research for genotyping; Simons Foundation Autism Research Initiative; Veterans Administration Merit Award; German Research Foundation; American Academy of Child and Adolescent Psychiatry Pilot Research Award/Elaine Schlosser Lewis Fund; American Psychiatric Association/Lilly Research Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070494] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH077823, RC2MH089956, T32MH018268, K08MH087639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048453, R01NS041537, P30NS047101] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Broad Institute; Center for Inherited Disease Research for genotyping; Simons Foundation Autism Research Initiative; Veterans Administration Merit Award; German Research Foundation(German Research Foundation (DFG)); American Academy of Child and Adolescent Psychiatry Pilot Research Award/Elaine Schlosser Lewis Fund; American Psychiatric Association/Lilly Research Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the families for their participation; R. Weavers and E. Morava (Nijmegen Medical Center, Netherlands) and B. Barshop for providing patients; M. Kara's colleague for arranging shipment during the Libyan revolution; C. Lynch for the pSer293 antibody; the S. Taylor lab (UCSD) for help in protein modeling; M. Seashore, W. MacLean Jr., T. Cowan, and A. El-Gharabawy for suggestions; N. Wright-Davis, M. Murtha, M. Raubeson, N. DiLullo, M. Walker, Y. Song, N. Lifton, K. Bilguvar, A. Caglayan, Z. Omay, M. Choi, N. Carriero, R. D. Bjornson, P. Ventola, K. Koenig, and A. Bozik for technical assistance; the Yale Center for Genome Analysis (S. Mane); and the Sanford Burnham Institute. Supported by NIH grants P01HD070494, R01NS048453, and P30NS047101 (J.G.G.), RC2MH089956 (M. W. S.), K08MH087639 (A. R. G.), T32MH018268 and (P.E.-F.); Broad Institute grant U54HG003067 (E. L.); the Center for Inherited Disease Research for genotyping; the Simons Foundation Autism Research Initiative (J.G.G. and M. W. S.); a Veterans Administration Merit Award (R. A. H.); the German Research Foundation (G. N.); the American Academy of Child and Adolescent Psychiatry Pilot Research Award/Elaine Schlosser Lewis Fund (P.E.-F.); and the American Psychiatric Association/Lilly Research Fellowship (P.E.-F.). J.G.G. is an investigator of the Howard Hughes Medical Institute. Data have been deposited into dbGap (phs000288) and the NCBI Sequence Read Archive (SRS351252) (whole exome sequencing) and into GEO (GSE39447) (microarrays). J.G.G. is a consultant for Halozyme Therapeutics, a biopharmaceutical company that develops products targeting the extracellular matrix. M. W. S. is a consultant to Synapdx, that is developing diagnostic tests for autism, and to Pfizer Pharmaceuticals that is working to develop autism therapeutics. Bckdk gene trap mice are available for noncommercial research from R. A. H. under MTA agreement with Lexicon. J.G.G. and M. W. S. are inventors on a patent application filed 17 July 2012 by UCSD covering diagnostic and therapeutic strategies for patients with autism and epilepsy.	BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Doering CB, 1998, GENE, V212, P213, DOI 10.1016/S0378-1119(98)00182-6; Duelli R, 2000, J CEREBR BLOOD F MET, V20, P1557, DOI 10.1097/00004647-200011000-00005; Harris RA, 2005, J NUTR, V135, p1527S, DOI 10.1093/jn/135.6.1527S; Hawkins RA, 2006, J NUTR, V136, p218S, DOI 10.1093/jn/136.1.218S; Joshi MA, 2006, BIOCHEM J, V400, P153, DOI 10.1042/BJ20060869; Lepage N, 1997, CLIN CHEM, V43, P2397; Lynch CJ, 2003, AM J PHYSIOL-ENDOC M, V285, pE854, DOI 10.1152/ajpendo.00153.2003; Machius M, 2001, P NATL ACAD SCI USA, V98, P11218, DOI 10.1073/pnas.201220098; MENKES JH, 1954, PEDIATRICS, V14, P462; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/nmeth.1591, 10.1038/NMETH.1591]; Schmeisser MJ, 2012, NATURE, V486, P256, DOI 10.1038/nature11015; Seelow D, 2009, NUCLEIC ACIDS RES, V37, pW593, DOI 10.1093/nar/gkp369; SNYDERMAN SE, 1964, PEDIATRICS, V34, P454; Suryawan A, 1998, AM J CLIN NUTR, V68, P72, DOI 10.1093/ajcn/68.1.72; Tuchman R, 2002, LANCET NEUROL, V1, P352, DOI 10.1016/S1474-4422(02)00160-6; Verrey F, 2003, PFLUG ARCH EUR J PHY, V445, P529, DOI 10.1007/S00424-002-0973-Z; Wagner CA, 2001, AM J PHYSIOL-CELL PH, V281, pC1077, DOI 10.1152/ajpcell.2001.281.4.C1077; Yuan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017540; Zinnanti WJ, 2009, BRAIN, V132, P903, DOI 10.1093/brain/awp024	21	201	210	1	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 19	2012	338	6105					394	397		10.1126/science.1224631	http://dx.doi.org/10.1126/science.1224631			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022JS	22956686	Green Accepted			2022-12-24	WOS:000309955800044
J	Qiao, H; Shen, ZX; Huang, SSC; Schmitz, RJ; Urich, MA; Briggs, SP; Ecker, JR				Qiao, Hong; Shen, Zhouxin; Huang, Shao-shan Carol; Schmitz, Robert J.; Urich, Mark A.; Briggs, Steven P.; Ecker, Joseph R.			Processing and Subcellular Trafficking of ER-Tethered EIN2 Control Response to Ethylene Gas	SCIENCE			English	Article							ARABIDOPSIS-THALIANA; SEEDLINGS; PATHWAY; ACTIVATION; PROTEOMICS; REGULATOR; PROTEINS; RECEPTOR; FAMILY; CTR1	Ethylene gas is essential for many developmental processes and stress responses in plants. ETHYLENE INSENSITIVE2 (EIN2), an NRAMP-like integral membrane protein, plays an essential role in ethylene signaling, but its function remains enigmatic. Here we report that phosphorylation-regulated proteolytic processing of EIN2 triggers its endoplasmic reticulum (ER)-to-nucleus translocation. ER-tethered EIN2 shows CONSTITUTIVE TRIPLE RESPONSE1 (CTR1) kinase-dependent phosphorylation. Ethylene triggers dephosphorylation at several sites and proteolytic cleavage at one of these sites, resulting in nuclear translocation of a carboxyl-terminal EIN2 fragment (EIN2-C'). Mutations that mimic EIN2 dephosphorylation, or inactivate CTR1, show constitutive cleavage and nuclear localization of EIN2-C' and EIN3 and EIN3-LIKE1-dependent activation of ethylene responses. These findings uncover a mechanism of subcellular communication whereby ethylene stimulates phosphorylation-dependent cleavage and nuclear movement of the EIN2-C' peptide, linking hormone perception and signaling components in the ER with nuclear-localized transcriptional regulators.	[Qiao, Hong; Huang, Shao-shan Carol; Schmitz, Robert J.; Urich, Mark A.; Ecker, Joseph R.] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Shen, Zhouxin; Briggs, Steven P.] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Huang, Shao-shan Carol; Schmitz, Robert J.; Urich, Mark A.; Ecker, Joseph R.] Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA; [Huang, Shao-shan Carol; Ecker, Joseph R.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Salk Institute; University of California System; University of California San Diego; Salk Institute; Howard Hughes Medical Institute; Salk Institute	Ecker, JR (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA.	ecker@salk.edu	Schmitz, Robert/AAY-7659-2020; Ecker, Joseph R/B-9144-2008; qiao, hong/J-7796-2012	Schmitz, Robert/0000-0001-7538-6663; Ecker, Joseph R/0000-0001-5799-5895; 	NIH National Research Service Award postdoctoral fellowship [F32-HG004830]; NSF [MCB-0924871, MCB-1024999, DBI-0924023]; Direct For Biological Sciences [1024999] Funding Source: National Science Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG004830] Funding Source: NIH RePORTER	NIH National Research Service Award postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank L. Song, N. Benson, and R. O'Malley for comments; J. Lin for plant maintenance; J. Chory for access to, and N. Geldner for assistance with, confocal microscopy; and J. Harper for the antibody to ACA2. We thank J. Nery for assistance with next-generation sequencing. R. J. S. was supported by an NIH National Research Service Award postdoctoral fellowship (F32-HG004830). This work was supported by grants from NSF (MCB-0924871 and MCB-1024999 to J. R. E. and DBI-0924023 to S. P. B.). J. R. E is an Investigator of the Howard Hughes Medical Institute and the Gordon and Betty Moore Foundation. Sequence data can be downloaded from the National Center for Biotechnology Information's Sequence Read Archive (accession no. SRA052247).	Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; Binder BM, 2004, PLANT PHYSIOL, V136, P2921, DOI 10.1104/pp.104.050393; Bisson MMA, 2011, PLANT SIGNAL BEHAV, V6, P164, DOI [10.4161/psb.6.1.14034, 10.4161/psb.5.12.14034]; Bisson MMA, 2009, BIOCHEM J, V424, P1, DOI 10.1042/BJ20091102; CHANG C, 1993, SCIENCE, V262, P539, DOI 10.1126/science.8211181; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; Chen RQ, 2011, MOL BIOSYST, V7, P2637, DOI 10.1039/c1mb05159h; Chen YF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008640; Cravatt BF, 2007, NATURE, V450, P991, DOI 10.1038/nature06525; Dong CH, 2010, J BIOL CHEM, V285, P40706, DOI 10.1074/jbc.M110.146605; Hirayama T, 1999, CELL, V97, P383, DOI 10.1016/S0092-8674(00)80747-3; Hua J, 1998, CELL, V94, P261, DOI 10.1016/S0092-8674(00)81425-7; Huang YF, 2003, PLANT J, V33, P221, DOI 10.1046/j.1365-313X.2003.01620.x; Kendrick MD, 2008, CURR OPIN PLANT BIOL, V11, P479, DOI 10.1016/j.pbi.2008.06.011; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Lange V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.61; Li H, 2009, PROTEOMICS, V9, P1646, DOI 10.1002/pmic.200800420; Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560; Qiao H, 2009, GENE DEV, V23, P512, DOI 10.1101/gad.1765709; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; ROMAN G, 1995, GENETICS, V139, P1393; Sakai H, 1998, P NATL ACAD SCI USA, V95, P5812, DOI 10.1073/pnas.95.10.5812	22	316	342	11	186	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 19	2012	338	6105					390	393		10.1126/science.1225974	http://dx.doi.org/10.1126/science.1225974			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022JS	22936567	Green Accepted			2022-12-24	WOS:000309955800043
J	Church, GM; Gao, Y; Kosuri, S				Church, George M.; Gao, Yuan; Kosuri, Sriram			Next-Generation Digital Information Storage in DNA	SCIENCE			English	Article							GENOME		[Church, George M.; Kosuri, Sriram] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Church, George M.; Kosuri, Sriram] Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Gao, Yuan] Johns Hopkins Univ, Dept Biomed Engn, Neuroregenerat & Stem Cell Biol Program, Inst Cell Engn,Lieber Inst Brain Dev, Baltimore, MD 21205 USA	Harvard University; Harvard Medical School; Johns Hopkins University	Kosuri, S (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	sri.kosuri@wyss.harvard.edu		church, george/0000-0001-6232-9969; Kosuri, Sriram/0000-0002-4661-0600	U.S. Office of Naval Research [N000141010144]; Agilent Technologies; Wyss Institute	U.S. Office of Naval Research(Office of Naval Research); Agilent Technologies; Wyss Institute	This work was supported by U.S. Office of Naval Research (N000141010144), Agilent Technologies, and the Wyss Institute. Agilent Technologies is a commercial provider for DNA microchips. G. M. C. and S. K. designed and performed all experiments and analyses and wrote the manuscript; Y.G. performed the sequencing. We thank J. Aach, C. Fracchia, S. Raman, H. H. Wang, A. W. Briggs, J. Lee, T. Wu, and D. B. Goodman for helpful suggestions on the manuscript.	ADLEMAN LM, 1994, SCIENCE, V266, P1021, DOI 10.1126/science.7973651; Bancroft C, 2001, SCIENCE, V293, P1763; Benner SA, 2011, CR CHIM, V14, P372, DOI 10.1016/j.crci.2010.06.013; Bonnet J, 2010, NUCLEIC ACIDS RES, V38, P1531, DOI 10.1093/nar/gkp1060; Carr PA, 2009, NAT BIOTECHNOL, V27, P1151, DOI 10.1038/nbt.1590; Davis J, 1996, ART J, V55, P70, DOI 10.2307/777811; Gantz J., 2011, IDC IVIEW; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Kosuri S, 2012, ACS SYNTH BIOL, V1, P109, DOI 10.1021/sb300015f; LeProust EM, 2010, NUCLEIC ACIDS RES, V38, P2522, DOI 10.1093/nar/gkq163; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Pennisi E, 2012, SCIENCE, V336, P534, DOI 10.1126/science.336.6081.534; StJohn J., 2011, SEQPREP	13	577	657	54	521	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2012	337	6102					1628	1628		10.1126/science.1226355	http://dx.doi.org/10.1126/science.1226355			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	22903519	Bronze			2022-12-24	WOS:000309215400037
J	Taipale, M; Krykbaeva, I; Koeva, M; Kayatekin, C; Westover, KD; Karras, GI; Lindquist, S				Taipale, Mikko; Krykbaeva, Irina; Koeva, Martina; Kayatekin, Can; Westover, Kenneth D.; Karras, Georgios I.; Lindquist, Susan			Quantitative Analysis of Hsp90-Client Interactions Reveals Principles of Substrate Recognition	CELL			English	Article							HSP90; KINASE; PROTEIN; BINDING; INHIBITORS; CAPACITOR; RECEPTOR; SURFACE; KINOME; SRC	HSP90 is a molecular chaperone that associates with numerous substrate proteins called clients. It plays many important roles in human biology and medicine, but determinants of client recognition by HSP90 have remained frustratingly elusive. We systematically and quantitatively surveyed most human kinases, transcription factors, and E3 ligases for interaction with HSP90 and its cochaperone CDC37. Unexpectedly, many more kinases than transcription factors bound HSP90. CDC37 interacted with kinases, but not with transcription factors or E3 ligases. HSP90::kinase interactions varied continuously over a 100-fold range and provided a platform to study client protein recognition. In wild-type clients, HSP90 did not bind particular sequence motifs, but rather associated with intrinsically unstable kinases. Stabilization of the kinase in either its active or inactive conformation with diverse small molecules decreased HSP90 association. Our results establish HSP90 client recognition as a combinatorial process: CDC37 provides recognition of the kinase family, whereas thermodynamic parameters determine client binding within the family.	[Taipale, Mikko; Krykbaeva, Irina; Koeva, Martina; Kayatekin, Can; Karras, Georgios I.; Lindquist, Susan] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Westover, Kenneth D.] UT SW, Dept Biochem, Dallas, TX 75390 USA; [Lindquist, Susan] MIT, Dept Biol, Cambridge, MA 02142 USA; [Lindquist, Susan] MIT, Howard Hughes Med Inst, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Lindquist, S (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lindquist_admin@wi.mit.edu	Westover, Ken/AAZ-1795-2020; Kayatekin, Can/B-6618-2009	Westover, Ken/0000-0003-3653-5923; Taipale, Mikko/0000-0003-3811-1761; Karras, Georgios/0000-0002-6169-5569; Krykbaeva, Irina/0000-0003-1380-7607; Kayatekin, Can/0000-0002-4367-9645; Karras, Georgios/0000-0003-2933-1535	Academy of Finland; Sigrid Juselius Foundation; Human Frontier Science Program; EMBO; NIH Genomics Based Drug Discovery-Driving Medical Projects [UL1-DE019585]; NIH [RL1-GM084437, RL1-CA133834, RL1-HG004671]; NATIONAL CANCER INSTITUTE [RL1CA133834] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RL1HG004671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [UL1DE019585] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RL1GM084437] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Human Frontier Science Program(Human Frontier Science Program); EMBO(European Molecular Biology Organization (EMBO)); NIH Genomics Based Drug Discovery-Driving Medical Projects(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank D. F. Jarosz, L. Whitesell, and M. Mendillo for valuable comments, K. Salehi-Ashtiani and M. Vidal (Dana-Farber Cancer Institute) for the human ORFeome collection, D. Proia (Synta Pharmaceuticals) for ganetespib, and N.S. Gray (Dana-Farber Cancer Institute) for DPH. M.T. was supported by the Academy of Finland, Sigrid Juselius Foundation and the Human Frontier Science Program. G. I. K. was supported by an EMBO Long-Term Fellowship and the Human Frontier Science Program. S. L. is an investigator of the Howard Hughes Medical Institute. Support for this study was also provided by the NIH Genomics Based Drug Discovery-Driving Medical Projects grant UL1-DE019585, administratively linked to NIH grants RL1-GM084437, RL1-CA133834, and RL1-HG004671. M.T. and S.L. planned the project and designed the experiments. M. T. developed and validated LUMIER with BACON assay and performed all the experiments with the help of I. K. G. I. K. assayed HSP90 interactions against E3 ligases. K. D. W. and M. T. expressed and purified recombinant ABL, and C. K. and M. T. analyzed ABL with circular dichroism. M. T. and M. K. performed computational analyses of HSP90 interactions. M. T. and S. L. wrote the paper, with comments from all the coauthors.	Adrian FJ, 2006, NAT CHEM BIOL, V2, P95, DOI 10.1038/nchembio760; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Boulon S, 2010, MOL CELL, V39, P912, DOI 10.1016/j.molcel.2010.08.023; Buchner J, 2010, MOL MICROBIOL, V76, P540, DOI 10.1111/j.1365-2958.2010.07140.x; Caplan AJ, 2007, TRENDS CELL BIOL, V17, P87, DOI 10.1016/j.tcb.2006.12.002; Chen HB, 2007, MOL CELL, V27, P717, DOI 10.1016/j.molcel.2007.06.028; Citri A, 2006, J BIOL CHEM, V281, P14361, DOI 10.1074/jbc.M512613200; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Dias SD, 2005, CANCER RES, V65, P10686, DOI 10.1158/0008-5472.CAN-05-2632; Ehrlich ES, 2009, P NATL ACAD SCI USA, V106, P20330, DOI 10.1073/pnas.0810571106; Falsone SF, 2007, PROTEOMICS, V7, P2375, DOI 10.1002/pmic.200600996; Falsone SF, 2005, FEBS LETT, V579, P6350, DOI 10.1016/j.febslet.2005.10.020; Falsone SF, 2004, J MOL BIOL, V344, P281, DOI 10.1016/j.jmb.2004.08.091; Fan YX, 2008, J BIOL CHEM, V283, P1588, DOI 10.1074/jbc.M708116200; Fedorov O, 2007, P NATL ACAD SCI USA, V104, P20523, DOI 10.1073/pnas.0708800104; Fodor AA, 2004, PROTEINS, V56, P211, DOI 10.1002/prot.20098; Ghosh A, 2011, FASEB J, V25, P2049, DOI 10.1096/fj.10-180554; Grammatikakis N, 1999, MOL CELL BIOL, V19, P1661; Gray PJ, 2008, NAT REV CANCER, V8, P491, DOI 10.1038/nrc2420; Iacob RE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015929; Iwasaki S, 2010, MOL CELL, V39, P292, DOI 10.1016/j.molcel.2010.05.015; Krukenberg KA, 2011, Q REV BIOPHYS, V44, P229, DOI 10.1017/S0033583510000314; Mandal AK, 2007, J CELL BIOL, V176, P319, DOI 10.1083/jcb.200604106; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manning G, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r66; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Picard D, 2006, TRENDS ENDOCRIN MET, V17, P229, DOI 10.1016/j.tem.2006.06.003; Pratt WB, 2008, J BIOL CHEM, V283, P22885, DOI 10.1074/jbc.R800023200; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Richter K, 2008, J BIOL CHEM, V283, P17757, DOI 10.1074/jbc.M800540200; Ricketson D, 2007, J MOL BIOL, V368, P729, DOI 10.1016/j.jmb.2007.02.057; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Specchia V, 2010, NATURE, V463, P662, DOI 10.1038/nature08739; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Xu WP, 2005, NAT STRUCT MOL BIOL, V12, P120, DOI 10.1038/nsmb885; Xu Y, 1999, P NATL ACAD SCI USA, V96, P109, DOI 10.1073/pnas.96.1.109; Yang JS, 2011, CHEM BIOL, V18, P177, DOI 10.1016/j.chembiol.2010.12.013; Ying WW, 2012, MOL CANCER THER, V11, P475, DOI 10.1158/1535-7163.MCT-11-0755	39	572	584	10	111	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 31	2012	150	5					987	1001		10.1016/j.cell.2012.06.047	http://dx.doi.org/10.1016/j.cell.2012.06.047			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22939624	Green Accepted, Green Published, Bronze			2022-12-24	WOS:000308500200013
J	Walser, PJ; Ariotti, N; Howes, M; Ferguson, C; Webb, R; Schwudke, D; Leneva, N; Cho, KJ; Cooper, L; Rae, J; Floetenmeyer, M; Oorschot, VMJ; Skoglund, U; Simons, K; Hancock, JF; Parton, RG				Walser, Piers J.; Ariotti, Nicholas; Howes, Mark; Ferguson, Charles; Webb, Richard; Schwudke, Dominik; Leneva, Natalya; Cho, Kwang-Jin; Cooper, Leanne; Rae, James; Floetenmeyer, Matthias; Oorschot, Viola M. J.; Skoglund, Ulf; Simons, Kai; Hancock, John F.; Parton, Robert G.			Constitutive Formation of Caveolae in a Bacterium	CELL			English	Article							CLATHRIN-COATED PITS; C-TERMINAL DOMAIN; IN-VIVO; MOLECULAR DISSECTION; MEMBRANE-BINDING; COPII CAGE; NULL MICE; BIOGENESIS; PROTEINS; CELLS	Caveolin plays an essential role in the formation of characteristic surface pits, caveolae, which cover the surface of many animal cells. The fundamental principles of caveola formation are only slowly emerging. Here we show that caveolin expression in a prokaryotic host lacking any intracellular membrane system drives the formation of cytoplasmic vesicles containing polymeric caveolin. Vesicle formation is induced by expression of wild-type caveolins, but not caveolin mutants defective in caveola formation in mammalian systems. In addition, cryo-electron tomography shows that the induced membrane domains are equivalent in size and caveolin density to native caveolae and reveals a possible polyhedral arrangement of caveolin oligomers. The caveolin-induced vesicles or heterologous caveolae (h-caveolae) form by budding in from the cytoplasmic membrane, generating a membrane domain with distinct lipid composition. Periplasmic solutes are encapsulated in the budding h-caveola, and purified h-caveolae can be tailored to be targeted to specific cells of interest.	[Walser, Piers J.; Ariotti, Nicholas; Howes, Mark; Ferguson, Charles; Leneva, Natalya; Cho, Kwang-Jin; Hancock, John F.; Parton, Robert G.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Webb, Richard; Rae, James; Floetenmeyer, Matthias] Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld 4072, Australia; [Schwudke, Dominik; Cooper, Leanne; Parton, Robert G.] GKVK, Natl Ctr Biol Sci, TIFR, Bangalore 560065, Karnataka, India; [Oorschot, Viola M. J.] Univ Med Ctr Utrecht, Dept Cell Biol, Cell Microscopy Ctr, NL-3584 CX Utrecht, Netherlands; [Skoglund, Ulf] Grad Univ, Okinawa Inst Sci & Technol, Struct Cellular Biol Unit, Okinawa 9040495, Japan; [Simons, Kai] Tech Univ Dresden, Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	University of Queensland; University of Queensland; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Utrecht University; Utrecht University Medical Center; Okinawa Institute of Science & Technology Graduate University; Max Planck Society; Technische Universitat Dresden	Walser, PJ (corresponding author), NHSBT, Bristol Inst Transfus Sci, Bristol BS34 7QH, Avon, England.	piers.walser@nhsbt.nhs.uk; r.parton@imb.uq.edu.au	Ariotti, Nicholas/GXH-4833-2022; Cho, Kwang-jin/AAI-4923-2020; Schwudke, Dominik/B-3478-2013; Parton, Robert G/C-5673-2009; Skoglund, Ulf/B-5829-2015	Schwudke, Dominik/0000-0002-1379-9451; Parton, Robert G/0000-0002-7494-5248; Hancock, John/0000-0003-0542-4710; Floetenmeyer, Matthias/0000-0002-0133-1632; Leneva, Natalya/0000-0001-8102-9769; Ariotti, Nicholas/0000-0003-3901-0831; Skoglund, Ulf/0000-0002-3407-0053; Howes, Mark/0000-0002-9666-3364	National Health and Medical Research Council of Australia; Australian Research Council; Swiss National Science Foundation [PA00-109094]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by grants from the National Health and Medical Research Council of Australia (to R.G.P. and J.F.H.), the Australian Research Council (R.G.P.). P.J.W. was supported by a fellowship for advanced researchers by the Swiss National Science Foundation (PA00-109094). Confocal microscopy was performed at the Australian Cancer Research Foundation (ACRF)/Institute for Molecular Bioscience Dynamic Imaging Facility for Cancer Biology, which was established with the support of the ACRF. The Institute for Molecular Bioscience is a Special Research Centre of the Australian Research Council. The authors acknowledge the facilities as well as scientific and technical assistance from staff in the Australian Microscopy and Microanalysis Facility (AMMRF) at the Centre for Microscopy and Microanalysis at The University of Queensland. We would like to thank Alejandra Castillo-Alvarez and Angela Gardner for technical assistance. We are particularly grateful to Alasdair McDowall for help with preliminary cryo-TEM studies and Yoshinori Akiyama for providing ftsH depletion strain AD368. We thank Neil Marshall, Murray Stewart, Chris Fielding, Deborah Brown and for providing constructs.	Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Bastiani M, 2010, J CELL SCI, V123, P3831, DOI 10.1242/jcs.070102; Boucrot E, 2012, CELL, V149, P124, DOI 10.1016/j.cell.2012.01.047; Brett TJ, 2006, CURR OPIN CELL BIOL, V18, P395, DOI 10.1016/j.ceb.2006.06.014; Cheng YF, 2007, J MOL BIOL, V365, P892, DOI 10.1016/j.jmb.2006.10.036; Cronan JE, 2002, CURR OPIN MICROBIOL, V5, P202, DOI 10.1016/S1369-5274(02)00297-7; Das K, 1999, J BIOL CHEM, V274, P18721, DOI 10.1074/jbc.274.26.18721; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; DUPREE P, 1993, EMBO J, V12, P1597, DOI 10.1002/j.1460-2075.1993.tb05804.x; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036; Fernandez I, 2002, P NATL ACAD SCI USA, V99, P11193, DOI 10.1073/pnas.172196599; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; FORNSTEDT N, 1975, FEBS LETT, V57, P187, DOI 10.1016/0014-5793(75)80713-7; Fotin A, 2006, J STRUCT BIOL, V156, P453, DOI 10.1016/j.jsb.2006.07.001; FRA AM, 1995, P NATL ACAD SCI USA, V92, P8655, DOI 10.1073/pnas.92.19.8655; Fujimoto T, 2000, J CELL SCI, V113, P3509; Galbiati F, 2001, J BIOL CHEM, V276, P21425, DOI 10.1074/jbc.M100828200; Gurkan C, 2006, NAT REV MOL CELL BIO, V7, P727, DOI 10.1038/nrm2025; Hagiwara Y, 2000, HUM MOL GENET, V9, P3047, DOI 10.1093/hmg/9.20.3047; Hansen CG, 2011, J CELL SCI, V124, P2777, DOI 10.1242/jcs.084319; Hayashi K, 2001, CANCER RES, V61, P2361; Hayer A, 2010, TRAFFIC, V11, P361, DOI 10.1111/j.1600-0854.2009.01023.x; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Ito K, 2005, ANNU REV MICROBIOL, V59, P211, DOI 10.1146/annurev.micro.59.030804.121316; Kirkham M, 2008, J CELL SCI, V121, P2075, DOI 10.1242/jcs.024588; Lee C, 2010, CELL, V142, P123, DOI 10.1016/j.cell.2010.05.030; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; MONIER S, 1995, MOL BIOL CELL, V6, P911, DOI 10.1091/mbc.6.7.911; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Quiocho FA, 1997, STRUCTURE, V5, P997, DOI 10.1016/S0969-2126(97)00253-0; Razani B, 2001, J BIOL CHEM, V276, P38121; Ren XY, 2004, MOL BIOL CELL, V15, P4556, DOI 10.1091/mbc.E04-06-0480; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Russell C, 2010, TRAFFIC, V11, P303, DOI 10.1111/j.1600-0854.2009.01026.x; SARGIACOMO M, 1995, P NATL ACAD SCI USA, V92, P9407, DOI 10.1073/pnas.92.20.9407; Scheiffele P, 1998, J CELL BIOL, V140, P795, DOI 10.1083/jcb.140.4.795; Schlegel A, 2000, J BIOL CHEM, V275, P21605, DOI 10.1074/jbc.M002558200; Senju Y, 2011, J CELL SCI, V124, P2032, DOI 10.1242/jcs.086264; Song KS, 1997, J BIOL CHEM, V272, P4398, DOI 10.1074/jbc.272.7.4398; Stagg SM, 2007, CURR OPIN STRUC BIOL, V17, P221, DOI 10.1016/j.sbi.2007.03.010; Thomas CM, 2008, J CELL MOL MED, V12, P796, DOI 10.1111/j.1582-4934.2008.00295.x; Vogel U, 1998, J CELL SCI, V111, P825; Wanaski SP, 2003, BIOCHEMISTRY-US, V42, P42, DOI 10.1021/bi012097n	46	93	91	0	45	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 17	2012	150	4					752	763		10.1016/j.cell.2012.06.042	http://dx.doi.org/10.1016/j.cell.2012.06.042			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22901807	Bronze			2022-12-24	WOS:000308002300010
J	Li, MQ; Kao, E; Gao, X; Sandig, H; Limmer, K; Pavon-Eternod, M; Jones, TE; Landry, S; Pan, T; Weitzman, MD; David, M				Li, Manqing; Kao, Elaine; Gao, Xia; Sandig, Hilary; Limmer, Kirsten; Pavon-Eternod, Mariana; Jones, Thomas E.; Landry, Sebastien; Pan, Tao; Weitzman, Matthew D.; David, Michael			Codon-usage-based inhibition of HIV protein synthesis by human schlafen 11	NATURE			English	Article							INFLUENZA-A VIRUS; EXPORT PATHWAY; NUCLEAR EXPORT; MESSENGER-RNA; GENE; BIAS; IMMUNODEFICIENCY; ACTIVATION; EXPRESSION; SELECTION	In mammals, one of the most pronounced consequences of viral infection is the induction of type I interferons, cytokines with potent antiviral activity. Schlafen (Slfn) genes are a subset of interferon-stimulated early response genes (ISGs) that are also induced directly by pathogens via the interferon regulatory factor 3 (IRF3) pathway(1). However, many ISGs are of unknown or incompletely understood function. Here we show that human SLFN11 potently and specifically abrogates the production of retroviruses such as human immunodeficiency virus 1 (HIV-1). Our study revealed that SLFN11 has no effect on the early steps of the retroviral infection cycle, including reverse transcription, integration and transcription. Rather, SLFN11 acts at the late stage of virus production by selectively inhibiting the expression of viral proteins in a codon-usage-dependent manner. We further find that SLFN11 binds transfer RNA, and counteracts changes in the tRNA pool elicited by the presence of HIV. Our studies identified a novel antiviral mechanism within the innate immune response, in which SLFN11 selectively inhibits viral protein synthesis in HIV-infected cells by means of codon-bias discrimination.	[Li, Manqing; Kao, Elaine; Gao, Xia; Sandig, Hilary; Limmer, Kirsten; David, Michael] Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA; [Pavon-Eternod, Mariana; Jones, Thomas E.; Pan, Tao] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Landry, Sebastien; Weitzman, Matthew D.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [David, Michael] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of Chicago; Salk Institute; University of California System; University of California San Diego	David, M (corresponding author), Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA.	midavid@ucsd.edu		Li, Manqing/0000-0002-7593-7979	NIH [AI81019, AI074967, P01AI090935, R01GM101982, R21AI088490, P30AI36214]; HINT Program [NIH P01AI090935]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI090935, P30AI036214, R01AI074967, R21AI081019, R21AI088490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101982] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HINT Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Smith for help with the HIV replication studies; M. Wood for performing the electron microscope analysis; D. Xu and D.-Y. Song for technical assistance; and J. Young, J. Guatelli, D. Smith, M. Kaul and S. Chanda for discussion. This work was supported in part by NIH AI81019 and AI074967 to M. D. W., NIH P01AI090935, R01GM101982 and R21AI088490 to M. D., and by resources from the UCSD Center for AIDS Research, NIH P30AI36214, and the HINT Program, NIH P01AI090935. The authors declare no competing financial interests.	Berger M, 2010, NAT IMMUNOL, V11, P335, DOI 10.1038/ni.1847; BERKHOUT B, 1994, NUCLEIC ACIDS RES, V22, P1705, DOI 10.1093/nar/22.9.1705; COCCIA EM, 1994, J BIOL CHEM, V269, P23087; Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Dittmar KA, 2004, J MOL BIOL, V337, P31, DOI 10.1016/j.jmb.2004.01.024; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Forsberg R, 2003, MOL BIOL EVOL, V20, P1252, DOI 10.1093/molbev/msg149; Frelin L, 2004, GENE THER, V11, P522, DOI 10.1038/sj.gt.3302184; Fritz CC, 1996, CURR BIOL, V6, P848, DOI 10.1016/S0960-9822(02)00608-5; Ganser-Pornillos BK, 2008, CURR OPIN STRUC BIOL, V18, P203, DOI 10.1016/j.sbi.2008.02.001; Geserick P, 2004, INT IMMUNOL, V16, P1535, DOI 10.1093/intimm/dxh155; GRANTHAM R, 1986, NATURE, V319, P727, DOI 10.1038/319727b0; Haas J, 1996, CURR BIOL, V6, P315, DOI 10.1016/S0960-9822(02)00482-7; Kofman Alexander, 2003, Tsitologiia, V45, P86; KYPR J, 1987, NATURE, V327, P20, DOI 10.1038/327020a0; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; Meintjes Peter L., 2005, Journal of Bioinformatics and Computational Biology, V3, P157, DOI 10.1142/S0219720005000953; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Pavon-Eternod M, 2009, NUCLEIC ACIDS RES, V37, P7268, DOI 10.1093/nar/gkp787; Plotkin JB, 2003, P NATL ACAD SCI USA, V100, P7152, DOI 10.1073/pnas.1132114100; Schwarz DA, 1998, IMMUNITY, V9, P657, DOI 10.1016/S1074-7613(00)80663-9; Sohn WJ, 2007, MOL IMMUNOL, V44, P3273, DOI 10.1016/j.molimm.2007.03.001; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; van Weringh A, 2011, MOL BIOL EVOL, V28, P1827, DOI 10.1093/molbev/msr005; Wong EHM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-253; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Zhou T, 2005, BIOSYSTEMS, V81, P77, DOI 10.1016/j.biosystems.2005.03.002	28	212	221	2	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 1	2012	491	7422					125	U145		10.1038/nature11433	http://dx.doi.org/10.1038/nature11433			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	028PM	23000900	Green Accepted			2022-12-24	WOS:000310434500043
J	Sugihara, G; May, R; Ye, H; Hsieh, CH; Deyle, E; Fogarty, M; Munch, S				Sugihara, George; May, Robert; Ye, Hao; Hsieh, Chih-hao; Deyle, Ethan; Fogarty, Michael; Munch, Stephan			Detecting Causality in Complex Ecosystems	SCIENCE			English	Article							SARDINE SARDINOPS-SAGAX; PACIFIC SARDINE; ANCHOVY POPULATIONS; TIME-SERIES; FLUCTUATIONS; DYNAMICS; CHAOS; SYSTEMS	Identifying causal networks is important for effective policy and management recommendations on climate, epidemiology, financial regulation, and much else. We introduce a method, based on nonlinear state space reconstruction, that can distinguish causality from correlation. It extends to nonseparable weakly connected dynamic systems (cases not covered by the current Granger causality paradigm). The approach is illustrated both by simple models (where, in contrast to the real world, we know the underlying equations/relations and so can check the validity of our method) and by application to real ecological systems, including the controversial sardine-anchovy-temperature problem.	[Sugihara, George; Ye, Hao; Deyle, Ethan] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [May, Robert] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Hsieh, Chih-hao] Natl Taiwan Univ, Inst Oceanog, Taipei 106, Taiwan; [Hsieh, Chih-hao] Natl Taiwan Univ, Inst Ecol & Evolutionary Biol, Taipei 106, Taiwan; [Fogarty, Michael] NOAA, NE Fisheries Sci Ctr, Woods Hole, MA 02543 USA; [Munch, Stephan] NOAA, SW Fisheries Sci Ctr, Santa Cruz, CA 95060 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Oxford; National Taiwan University; National Taiwan University; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Sugihara, G (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, 9500 Gilman Dr, La Jolla, CA 92093 USA.	gsugihara@ucsd.edu; chsieh@ntu.edu.tw	Deyle, Ethan R/AAR-8749-2021; Ye, Hao/HGD-5399-2022; Hsieh, Chih-hao/B-3797-2008	Hsieh, Chih-hao/0000-0001-5935-7272; Ye, Hao/0000-0002-8630-1458	NSF [DEB-1020372]; NSF/NOAA CAMEO Award [NA08OAR4320894]; McQuown Chair in Natural Science; Sugihara Family Trust; National Taiwan University; National Science Council of Taiwan; NSF graduate research fellowships; EPA STAR graduate fellowship	NSF(National Science Foundation (NSF)); NSF/NOAA CAMEO Award; McQuown Chair in Natural Science; Sugihara Family Trust; National Taiwan University(National Taiwan University); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); NSF graduate research fellowships(National Science Foundation (NSF)); EPA STAR graduate fellowship(United States Environmental Protection Agency)	We thank S. Sandin, L. Kaufman, A. MacCall, J. Melack, J. Schnute, L. Richards, A. Rosenberg, M. Kumagai, H. Liu, I. Altman, B. Fissel, S. Glaser, B. Carr, E. Klein, L. Storch, S. Kealhofer, M. Kogler, and C. Perretti for their comments and assistance with this work, and P. Sugihara for developing and producing the initial animations for movies S1 and S2. Supported by NSF grant DEB-1020372, NSF/NOAA CAMEO Award NA08OAR4320894, the McQuown Chair in Natural Science, the Sugihara Family Trust, and Quantitative Advisors (http://qadvisors.com) (G. S.); National Taiwan University and the National Science Council of Taiwan (C. H.); NSF graduate research fellowships (H.Y. and E. D.); and an EPA STAR graduate fellowship (E.D.).	ASCIOTI FA, 1993, J PLANKTON RES, V15, P603, DOI 10.1093/plankt/15.6.603; BAUMGARTNER TR, 1992, CAL COOP OCEAN FISH, V33, P24; Berkeley G., 1710, TREATISE PRINCIPLES; Bischi G. I., 2010, NONLINEAR DYNAMICS E; BROCK WA, 1988, J MONETARY ECON, V22, P71, DOI 10.1016/0304-3932(88)90170-5; Casini M, 2009, P NATL ACAD SCI USA, V106, P197, DOI 10.1073/pnas.0806649105; Chen YH, 2006, J NEUROSCI METH, V150, P228, DOI 10.1016/j.jneumeth.2005.06.011; Committee on Major U. S. Oceanographic Research Programs, 1999, GLOB OC SCI INT APPR; Dixon PA, 1999, SCIENCE, V283, P1528, DOI 10.1126/science.283.5407.1528; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Grenfell BT, 1998, NATURE, V394, P674, DOI 10.1038/29291; Hsieh CH, 2005, NATURE, V435, P336, DOI 10.1038/nature03553; JACOBSON LD, 1995, CAN J FISH AQUAT SCI, V52, P566, DOI 10.1139/f95-057; Josic K, 2000, NONLINEARITY, V13, P1321, DOI 10.1088/0951-7715/13/4/318; Lasker R., 1983, P JOINT OC ASS 1982, P110; LLOYD AL, 1995, J THEOR BIOL, V173, P217, DOI 10.1006/jtbi.1995.0058; Lo TT, 2010, ATMOS SCI LETT, V11, P210, DOI 10.1002/asl.275; May RM, 2008, NATURE, V451, P893, DOI 10.1038/451893a; McClatchie S, 2010, CAN J FISH AQUAT SCI, V67, P1782, DOI 10.1139/F10-101; MORAN PAP, 1953, AUST J ZOOL, V1, P291, DOI 10.1071/ZO9530291; Murphy G. I., 1964, MIN M MAR RES COMM, V7, P1; Mysterud A, 2001, NATURE, V410, P1096, DOI 10.1038/35074099; PACKARD NH, 1980, PHYS REV LETT, V45, P712, DOI 10.1103/PhysRevLett.45.712; Patil DAS, 2001, MON WEATHER REV, V129, P2116, DOI 10.1175/1520-0493(2001)129<2116:ILDNBI>2.0.CO;2; Rodo X, 2002, P NATL ACAD SCI USA, V99, P12901, DOI 10.1073/pnas.182203999; Schwartzlose RA, 1999, S AFR J MARINE SCI, V21, P289; SUGIHARA G, 1990, NATURE, V344, P734, DOI 10.1038/344734a0; Takens F, 1981, LECT NOTES MATH, P366, DOI [10.1007/BFb0091924, DOI 10.1007/BFB0091924]; Veilleux B. G., 1976, THESIS U ALBERTA; Wagner BK, 2008, NAT BIOTECHNOL, V26, P343, DOI 10.1038/nbt1387	30	1023	1053	62	682	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2012	338	6106					496	500		10.1126/science.1227079	http://dx.doi.org/10.1126/science.1227079			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NH	22997134				2022-12-24	WOS:000310195800049
J	Jin, MS; Oldham, ML; Zhang, QJ; Chen, J				Jin, Mi Sun; Oldham, Michael L.; Zhang, Qiuju; Chen, Jue			Crystal structure of the multidrug transporter P-glycoprotein from Caenorhabditis elegans	NATURE			English	Article							DRUG-BINDING POCKET; ATPASE ACTIVITY; ALTERNATING ACCESS; NUCLEOTIDE-BINDING; MEMBRANE; RESISTANCE; MUTATIONS; MUTANTS; CELLS; PURIFICATION	P-glycoprotein (P-gp) is an ATP-binding cassette transporter that confers multidrug resistance in cancer cells(1,2). It also affects the absorption, distribution and clearance of cancer-unrelated drugs and xenobiotics. For these reasons, the structure and function of P-gp have been studied extensively for decades(3). Here we present biochemical characterization of P-gp from Caenorhabditis elegans and its crystal structure at a resolution of 3.4 angstroms. We find that the apparent affinities of P-gp for anticancer drugs actinomycin D and paclitaxel are approximately 4,000 and 100 times higher, respectively, in the membrane bilayer than in detergent. This affinity enhancement highlights the importance of membrane partitioning when a drug accesses the transporter in the membrane(4). Furthermore, the transporter in the crystal structure opens its drug pathway at the level of the membrane's inner leaflet. In the helices flanking the opening to the membrane, we observe extended loops that may mediate drug binding, function as hinges to gate the pathway or both. We also find that the interface between the transmembrane and nucleotide-binding domains, which couples ATP hydrolysis to transport, contains a ball-and-socket joint and salt bridges similar to the ATP-binding cassette importers(5), suggesting that ATP-binding cassette exporters and importers may use similar mechanisms to achieve alternating access for transport. Finally, a model of human P-gp derived from the structure of C. elegans P-gp not only is compatible with decades of biochemical analysis(6-12), but also helps to explain perplexing functional data regarding the Phe335Ala mutant(13,14). These results increase our understanding of the structure and function of this important molecule.	[Jin, Mi Sun; Chen, Jue] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Oldham, Michael L.; Zhang, Qiuju; Chen, Jue] Howard Hughes Med Inst, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Howard Hughes Medical Institute	Chen, J (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	chenjue@purdue.edu	zhang, qiu/GXG-5600-2022		Howard Hughes Medical Institute; Purdue Center for Cancer Research [NCI CCSG CA23168]; National Research Foundation of Korea; International Human Frontier Science Program; NATIONAL CANCER INSTITUTE [P30CA023168] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Purdue Center for Cancer Research; National Research Foundation of Korea(National Research Foundation of Korea); International Human Frontier Science Program(Human Frontier Science Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the beamline staff of the GM/CA CAT at the Advanced Photon System for assistance with data collection, Y.-K. Cho for assistance with protein purification and A. Davidson for comments on the manuscript. We also thank the MacKinnon laboratory for reagents and advice on the P. pastoris expression system. This work was supported by Howard Hughes Medical Institute (J.C.), Purdue Center for Cancer Research (NCI CCSG CA23168), and postdoctoral fellowships from the National Research Foundation of Korea and the International Human Frontier Science Program (M.S.J.).	Al-Shawi MK, 2003, J BIOL CHEM, V278, P52629, DOI 10.1074/jbc.M308175200; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; ALSHAWI MK, 1993, J BIOL CHEM, V268, P4197; Ambudkar SV, 1998, METHOD ENZYMOL, V292, P504; AZZARIA M, 1989, MOL CELL BIOL, V9, P5289, DOI 10.1128/MCB.9.12.5289; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GARRIGOS M, 1993, BIOCHEM BIOPH RES CO, V196, P1034, DOI 10.1006/bbrc.1993.2355; Gatlik-Landwojtowicz E, 2006, BIOCHEMISTRY-US, V45, P3020, DOI 10.1021/bi051380+; HAMADA H, 1988, J BIOL CHEM, V263, P1454; HIGGINS CF, 1992, TRENDS BIOCHEM SCI, V17, P18, DOI 10.1016/0968-0004(92)90419-A; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; Kim IW, 2008, MINI-REV MED CHEM, V8, P193; Litman T, 1997, BBA-MOL BASIS DIS, V1361, P159, DOI 10.1016/S0925-4439(97)00026-4; Loo TW, 2008, J BIOL CHEM, V283, P28190, DOI 10.1074/jbc.M805834200; Loo TW, 2007, J BIOL CHEM, V282, P32043, DOI 10.1074/jbc.M706175200; Loo TW, 2006, BIOCHEM J, V399, P351, DOI 10.1042/BJ20060715; Loo TW, 2006, BIOCHEM J, V396, P537, DOI 10.1042/BJ20060012; Loo TW, 2009, J BIOL CHEM, V284, P24074, DOI 10.1074/jbc.M109.023267; Loo TW, 2005, BIOCHEM BIOPH RES CO, V329, P419, DOI 10.1016/j.bbrc.2005.01.134; Loo TW, 2004, J BIOL CHEM, V279, P18232, DOI 10.1074/jbc.M400229200; Loo TW, 2004, J BIOL CHEM, V279, P7692, DOI 10.1074/jbc.M311825200; LOO TW, 1995, J BIOL CHEM, V270, P21449, DOI 10.1074/jbc.270.37.21449; LOO TW, 1993, J BIOL CHEM, V268, P19965; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mourez M, 1997, EMBO J, V16, P3066, DOI 10.1093/emboj/16.11.3066; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; SARKADI B, 1992, J BIOL CHEM, V267, P4854; Screpanti E, 2007, J STRUCT BIOL, V159, P261, DOI 10.1016/j.jsb.2007.01.011; Sharom FJ, 2011, ESSAYS BIOCHEM, V50, P161, DOI [10.1042/BSE0500161, 10.1042/bse0500161]; UEDA K, 1986, BIOCHEM BIOPH RES CO, V141, P956, DOI 10.1016/S0006-291X(86)80136-X; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Zolnerciks JK, 2007, FASEB J, V21, P3937, DOI 10.1096/fj.07-8610com	35	365	373	2	150	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2012	490	7421					566	+		10.1038/nature11448	http://dx.doi.org/10.1038/nature11448			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025NK	23000902	Green Accepted			2022-12-24	WOS:000310196200048
J	Freeman, MF; Gurgui, C; Helf, MJ; Morinaka, BI; Uria, AR; Oldham, NJ; Sahl, HG; Matsunaga, S; Piel, J				Freeman, Michael F.; Gurgui, Cristian; Helf, Maximilian J.; Morinaka, Brandon I.; Uria, Agustinus R.; Oldham, Neil J.; Sahl, Hans-Georg; Matsunaga, Shigeki; Piel, Joern			Metagenome Mining Reveals Polytheonamides as Posttranslationally Modified Ribosomal Peptides	SCIENCE			English	Article							MARINE SPONGE; ANTIMICROBIAL PEPTIDE; BACTERIAL SYMBIONT; GENE-CLUSTER; RADICAL SAM; BIOSYNTHESIS; SUPERFAMILY; FAMILY; ACIDS	It is held as a paradigm that ribosomally synthesized peptides and proteins contain only L-amino acids. We demonstrate a ribosomal origin of the marine sponge-derived polytheonamides, exceptionally potent, giant natural-product toxins. Isolation of the biosynthetic genes from the sponge metagenome revealed a bacterial gene architecture. Only six candidate enzymes were identified for 48 posttranslational modifications, including 18 epimerizations and 17 methylations of nonactivated carbon centers. Three enzymes were functionally validated, which showed that a radical S-adenosylmethionine enzyme is responsible for the unidirectional epimerization of multiple and different amino acids. Collectively, these complex alterations create toxins that function as unimolecular minimalistic ion channels with near-femtomolar activity. This study broadens the biosynthetic scope of ribosomal systems and creates new opportunities for peptide and protein bioengineering.	[Freeman, Michael F.; Gurgui, Cristian; Helf, Maximilian J.; Morinaka, Brandon I.; Uria, Agustinus R.; Piel, Joern] Univ Bonn, Kekule Inst Organ Chem & Biochem, D-53121 Bonn, Germany; [Oldham, Neil J.] Univ Nottingham, Sch Chem, Nottingham NG7 2RD, England; [Sahl, Hans-Georg] Univ Bonn, Inst Med Microbiol Immunol & Parasitol, D-53115 Bonn, Germany; [Matsunaga, Shigeki] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Piel, Joern] ETH, Inst Microbiol, CH-8093 Zurich, Switzerland	University of Bonn; University of Nottingham; University of Bonn; University of Tokyo; Swiss Federal Institutes of Technology Domain; ETH Zurich	Piel, J (corresponding author), Univ Bonn, Kekule Inst Organ Chem & Biochem, Gerhard Domagk Str 1, D-53121 Bonn, Germany.	joern.piel@uni-bonn.de	Freeman, Michael/AIA-1555-2022	Freeman, Michael/0000-0002-0491-9618; Uria, Agustinus R./0000-0002-9223-7464; Oldham, Neil/0000-0001-8024-4563; Morinaka, Brandon/0000-0001-8239-619X; Helf, Maximilian/0000-0002-1393-3999	German Federal Ministry of Education and Research (BMBF) [GenBioCom: 0315581I]; Deutsche Forschungsgemeinschaft [PI 430/8-1, PI 430/9-1, FOR 854, SFB 813]; Japan Society for the Promotion of Science; German Academic Exchange Service (DAAD); Humboldt Foundation; Human Frontier Science Program	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Humboldt Foundation(Alexander von Humboldt Foundation); Human Frontier Science Program(Human Frontier Science Program)	We thank M. Josten for antibiotic activity testing, M. Engeser and C. Sondag for MALDI measurements, A. Schneider for high-performance liquid chromatography measurements, U. Deppenmeier and P. Schweiger for Western blot analysis, and T. Gulder for comments on the manuscript. This work was supported by grants from the German Federal Ministry of Education and Research (BMBF) (GenBioCom: 0315581I) to J.P., the Deutsche Forschungsgemeinschaft to J.P. (PI 430/8-1, PI 430/9-1, FOR 854, SFB 813) and H.-G. S. (FOR 854), the Japan Society for the Promotion of Science to J.P. and S. M., and fellowships by the German Academic Exchange Service (DAAD) to A. R. U., the Humboldt Foundation to B. I. M., and the Human Frontier Science Program to M. F. F. The data reported in this paper are reported in the supplementary materials and archived in GenBank under accession no. JX456532. J.P., C. G., M. F. F., A. R. U., and M.J.H. are inventors on European Patent Application no. 11 180 107.2. filed by Rheinische Friedrich-Wilhelms-Universitat Bonn through PROvendis GmbH titled "Biosynthetic gene cluster for the production of peptide-protein analogs."	Claesen J, 2010, P NATL ACAD SCI USA, V107, P16297, DOI 10.1073/pnas.1008608107; Fisch KM, 2009, NAT CHEM BIOL, V5, P494, DOI 10.1038/nchembio.176; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Haft DH, 2011, J BACTERIOL, V193, P2745, DOI 10.1128/JB.00040-11; Haft DH, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-70; Hamada T, 2005, J AM CHEM SOC, V127, P110, DOI 10.1021/ja045749e; Hamada T, 2010, J AM CHEM SOC, V132, P12941, DOI 10.1021/ja104616z; Hrvatin S, 2007, J MICROBIOL METH, V68, P434, DOI 10.1016/j.mimet.2006.09.009; Inoue M, 2010, NAT CHEM, V2, P280, DOI [10.1038/nchem.554, 10.1038/NCHEM.554]; Iwamoto M, 2010, FEBS LETT, V584, P3995, DOI 10.1016/j.febslet.2010.08.007; Jilek A, 2008, MONATSH CHEM, V139, P1, DOI 10.1007/s00706-007-0780-5; Kelly WL, 2009, J AM CHEM SOC, V131, P4327, DOI 10.1021/ja807890a; Kusebauch B, 2009, ANGEW CHEM INT EDIT, V48, P5001, DOI 10.1002/anie.200900277; Long PF, 2005, CHEMBIOCHEM, V6, P1760, DOI 10.1002/cbic.200500210; MATSUNAGA S, 1984, TETRAHEDRON LETT, V25, P5165, DOI 10.1016/S0040-4039(01)81553-7; Matsuoka S, 2011, ANGEW CHEM, V123, P4981; McIntosh JA, 2009, NAT PROD REP, V26, P537, DOI 10.1039/b714132g; Murphy K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020852; Oman TJ, 2010, NAT CHEM BIOL, V6, P9, DOI [10.1038/NCHEMBIO.286, 10.1038/nchembio.286]; Piel J, 2002, P NATL ACAD SCI USA, V99, P14002, DOI 10.1073/pnas.222481399; Piel J, 2004, P NATL ACAD SCI USA, V101, P16222, DOI 10.1073/pnas.0405976101; Schmidt EW, 2005, P NATL ACAD SCI USA, V102, P7315, DOI 10.1073/pnas.0501424102; Scott JJ, 2008, SCIENCE, V322, P63, DOI 10.1126/science.1160423; Shen GZ, 2008, J BACTERIOL, V190, P4808, DOI 10.1128/JB.00436-08; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Strieker M, 2010, CURR OPIN STRUC BIOL, V20, P234, DOI 10.1016/j.sbi.2010.01.009; Ueoka R, 2010, J AM CHEM SOC, V132, P17692, DOI 10.1021/ja109275z; Velasquez JE, 2011, CHEM BIOL, V18, P857, DOI 10.1016/j.chembiol.2011.05.007; You YO, 2007, BIOCHEMISTRY-US, V46, P5991, DOI 10.1021/bi602663x; Zhang Q, 2012, ACCOUNTS CHEM RES, V45, P555, DOI 10.1021/ar200202c	30	222	224	3	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 19	2012	338	6105					387	390		10.1126/science.1226121	http://dx.doi.org/10.1126/science.1226121			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022JS	22983711				2022-12-24	WOS:000309955800042
J	de Vanssay, A; Bouge, AL; Boivin, A; Hermant, C; Teysset, L; Delmarre, V; Antoniewski, C; Ronsseray, S				de Vanssay, Augustin; Bouge, Anne-Laure; Boivin, Antoine; Hermant, Catherine; Teysset, Laure; Delmarre, Valerie; Antoniewski, Christophe; Ronsseray, Stephane			Paramutation in Drosophila linked to emergence of a piRNA-producing locus	NATURE			English	Article							P-ELEMENT REPRESSION; HETEROCHROMATIN FORMATION; B1 LOCUS; MAIZE; MELANOGASTER; TRANS; GENE; ESTABLISHMENT; SEQUENCES; CYTOTYPE	A paramutation is an epigenetic interaction between two alleles of a locus, through which one allele induces a heritable modification in the other allele without modifying the DNA sequence(1,2). The paramutated allele itself becomes paramutagenic, that is, capable of epigenetically converting a new paramutable allele. Here we describe a case of paramutation in animals showing long-term transmission over generations. We previously characterized a homology-dependent silencing mechanism referred to as the trans-silencing effect (TSE), involved in P-transposable-element repression in the germ line(3-5). We now show that clusters of P-element-derived transgenes that induce strong TSE6,7 can convert other homologous transgene clusters incapable of TSE into strong silencers, which transmit the acquired silencing capacity through 50 generations. The paramutation occurs without any need for chromosome pairing between the paramutagenic and the paramutated loci, and is mediated by maternal inheritance of cytoplasm carrying Piwi-interacting RNAs (piRNAs) homologous to the transgenes. The repression capacity of the paramutated locus is abolished by a loss-of-function mutation of the aubergine gene involved in piRNA biogenesis, but not by a loss-of-function mutation of the Dicer-2 gene involved in siRNA production. The paramutated cluster, previously producing barely detectable levels of piRNAs, is converted into a stable, strong piRNA-producing locus by the paramutation and becomes fully paramutagenic itself. Our work provides a genetic model for the emergence of piRNA loci, as well as for RNA-mediated trans-generational repression of transposable elements.	[de Vanssay, Augustin; Boivin, Antoine; Hermant, Catherine; Teysset, Laure; Delmarre, Valerie; Ronsseray, Stephane] Univ Paris 06, CNRS, UMR7622, Dev Biol Lab, F-75005 Paris, France; [Bouge, Anne-Laure; Antoniewski, Christophe] Inst Pasteur, CNRS, URA2578, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Ronsseray, S (corresponding author), Univ Paris 06, CNRS, UMR7622, Dev Biol Lab, 9 Quai St Bernard, F-75005 Paris, France.	christophe.antoniewski@upmc.fr; stephane.ronsseray@upmc.fr	Antoniewski, Christophe/G-4519-2011; Ronsseray, Stephane/AAD-6378-2021	Antoniewski, Christophe/0000-0001-7709-2116; Hermant, catherine/0000-0002-3906-2546; Teysset, Laure/0000-0002-7413-1850; Boivin, Antoine/0000-0001-8671-1599	Ministere de l'Enseignement Superieur et de la Recherche; Fondation pour la Recherche Medicale; Association Nationale de la Recherche (ANR); Association pour la Recherche contre le Cancer; ANR (project "Nuclear endosiRNAs")	Ministere de l'Enseignement Superieur et de la Recherche; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Association Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); ANR (project "Nuclear endosiRNAs")(French National Research Agency (ANR))	We thank O. Sismeiro, J.-Y. Copee, E. Mouchel-Vielh, V. Ribeiro, C. Pappatico and P. Graca for technical assistance, D. Dorer, S. Henikoff and the Bloomington Stock Center for providing stocks, and flybase.org for providing databases. We thank T. Josse for preliminary experiments. We thank J.-R. Huynh, V. Colot, N. Randsholt, A.-M. Pret, C. Carre and F. Peronnet for critical reading of the manuscript. S.R. thanks D. Anxolabehere and M. Lehmann for previous help. This work was supported by fellowships from the Ministere de l'Enseignement Superieur et de la Recherche to A.d.V. and C.H., from the Fondation pour la Recherche Medicale to A.d.V., from the Association Nationale de la Recherche (ANR) to A.-L.B., and by grants from the Association pour la Recherche contre le Cancer to S.R. and from the ANR (project "Nuclear endosiRNAs") to C.A.	Alleman M, 2006, NATURE, V442, P295, DOI 10.1038/nature04884; Arteaga-Vazquez M, 2010, P NATL ACAD SCI USA, V107, P12986, DOI 10.1073/pnas.1007972107; BIER E, 1989, GENE DEV, V3, P1273, DOI 10.1101/gad.3.9.1273; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; BRINK RA, 1956, GENETICS, V41, P872; Chandler VL, 2007, CELL, V128, P641, DOI 10.1016/j.cell.2007.02.007; COE EH, 1959, P NATL ACAD SCI USA, V45, P828, DOI 10.1073/pnas.45.6.828; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; DORER DR, 1994, CELL, V77, P993, DOI 10.1016/0092-8674(94)90439-1; Dorer DR, 1997, GENETICS, V147, P1181; Dorweiler JE, 2000, PLANT CELL, V12, P2101, DOI 10.1105/tpc.12.11.2101; Engels W. R., 1989, P ELEMENTS DROSOPHIL; Grandjean V, 2009, DEVELOPMENT, V136, P3647, DOI 10.1242/dev.041061; Harris AN, 2001, DEVELOPMENT, V128, P2823; HOLLICK JB, 1995, GENETICS, V141, P709; Josse T, 2007, PLOS GENET, V3, P1633, DOI 10.1371/journal.pgen.0030158; Josse T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003249; KIDWELL MG, 1977, GENETICS, V86, P813; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; LEMAITRE B, 1993, GENETICS, V135, P149; Marin L, 2000, GENETICS, V155, P1841; Muerdter F, 2012, RNA, V18, P42, DOI 10.1261/rna.029769.111; OKANE CJ, 1987, P NATL ACAD SCI USA, V84, P9123, DOI 10.1073/pnas.84.24.9123; Pilu R, 2009, HEREDITY, V102, P236, DOI 10.1038/hdy.2008.96; Poyhonen M, 2012, G3-GENES GENOM GENET, V2, P331, DOI 10.1534/g3.111.001925; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Roche SE, 1998, GENETICS, V149, P1839; Ronsseray S, 1996, GENETICS, V143, P1663; Ronsseray S, 2001, GENETICS, V159, P1631; SCHUPBACH T, 1991, GENETICS, V129, P1119; Sidorenko LV, 2001, PLANT CELL, V13, P319, DOI 10.1105/tpc.13.2.319; Stam M, 2002, GENE DEV, V16, P1906, DOI 10.1101/gad.1006702; Stam M, 2009, MOL PLANT, V2, P578, DOI 10.1093/mp/ssp020; Stuart JR, 2002, GENETICS, V162, P1641; Todeschini AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011032; Wilson JE, 1996, DEV GENET, V19, P199, DOI 10.1002/(SICI)1520-6408(1996)19:3<199::AID-DVG3>3.0.CO;2-4	37	149	154	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2012	490	7418					112	U132		10.1038/nature11416	http://dx.doi.org/10.1038/nature11416			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015LG	22922650	Green Published			2022-12-24	WOS:000309446800043
J	Perez, C; Koshy, C; Yildiz, O; Ziegler, C				Perez, Camilo; Koshy, Caroline; Yildiz, Oezkan; Ziegler, Christine			Alternating-access mechanism in conformationally asymmetric trimers of the betaine transporter BetP	NATURE			English	Article							NA+/BETAINE SYMPORTER BETP; CORYNEBACTERIUM-GLUTAMICUM; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; CARRIER BETP; OPEN STATES; K+; HOMOLOG; BINDING; SODIUM	Betaine and Na+ symport has been extensively studied in the osmotically regulated transporter BetP from Corynebacterium glutamicum, a member of the betaine/choline/carnitine transporter family, which shares the conserved LeuT-like fold of two inverted structural repeats(1). BetP adjusts its transport activity by sensing the cytoplasmic K+ concentration as a measure for hyperosmotic stress via the osmosensing carboxy-terminal domain(2,3). BetP needs to be in a trimeric state for communication between individual protomers through several intratrimeric interaction sites(4). Recently, crystal structures of inward-facing BetP trimers have contributed to our understanding of activity regulation on a molecular level(5,6). Here we report new crystal structures, which reveal two conformationally asymmetric BetP trimers(7), capturing among them three distinct transport states. We observe a total of four new conformations at once: an outward-open apo and an outward-occluded apo state, and two closed transition states-one in complex with betaine and one substrate-free. On the basis of these new structures, we identified local and global conformational changes in BetP that underlie the molecular transport mechanism, which partially resemble structural changes observed in other sodium-coupled LeuT-like fold transporters, but show differences we attribute to the osmolytic nature of betaine, the exclusive substrate specificity and the regulatory properties of BetP.	[Perez, Camilo; Koshy, Caroline; Yildiz, Oezkan; Ziegler, Christine] Max Planck Inst Biophys, Dept Biol Struct, D-60438 Frankfurt, Germany; [Ziegler, Christine] Univ Regensburg, Inst Biophys & Biophys Chem, D-93053 Regensburg, Germany	Max Planck Society; University of Regensburg	Ziegler, C (corresponding author), Max Planck Inst Biophys, Dept Biol Struct, D-60438 Frankfurt, Germany.	christine.ziegler@biophys.mpg.de	Perez, Camilo/AAA-8733-2021; Yildiz, Ozkan/P-9207-2016	Perez, Camilo/0000-0002-5800-0084; Yildiz, Ozkan/0000-0003-3659-2805; Ziegler, Christine Maria/0000-0003-3439-7213	International Max-Planck Research School; DFG (German Research Foundation), Collaborative Research Center 807 "Transport and Communication across Biological Membranes"	International Max-Planck Research School; DFG (German Research Foundation), Collaborative Research Center 807 "Transport and Communication across Biological Membranes"	We thank L. Forrest and R. Kramer for careful reading of the manuscript and suggestions and discussions. This work was supported by the International Max-Planck Research School (C.K. and C.P.), and by the DFG (German Research Foundation), Collaborative Research Center 807 "Transport and Communication across Biological Membranes" (C.Z.).	Bourot S, 2000, J BIOL CHEM, V275, P1050, DOI 10.1074/jbc.275.2.1050; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; Gartner RM, 2011, J MOL BIOL, V414, P327, DOI 10.1016/j.jmb.2011.10.013; Ge L, 2011, P NATL ACAD SCI USA, V108, pE890, DOI 10.1073/pnas.1109597108; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Ott V, 2008, BIOCHEMISTRY-US, V47, P12208, DOI 10.1021/bi801325r; Perez C, 2011, EMBO REP, V12, P804, DOI 10.1038/embor.2011.102; Perez C, 2011, EMBO J, V30, P1221, DOI 10.1038/emboj.2011.46; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Rubenhagen R, 2001, EMBO J, V20, P5412, DOI 10.1093/emboj/20.19.5412; Schiller D, 2004, BIOCHEMISTRY-US, V43, P5583, DOI 10.1021/bi0359628; Shi L, 2010, BIOPHYS J, V99, pL103, DOI 10.1016/j.bpj.2010.10.003; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Tsai CJ, 2011, J MOL BIOL, V407, P368, DOI 10.1016/j.jmb.2011.01.028; Watanabe A, 2010, NATURE, V468, P988, DOI 10.1038/nature09580; Wetzel KJ, 2011, FEMS IMMUNOL MED MIC, V61, P346, DOI 10.1111/j.1574-695X.2011.00781.x; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhao YF, 2010, NATURE, V465, P188, DOI 10.1038/nature09057; Ziegler C, 2004, J MOL BIOL, V337, P1137, DOI 10.1016/j.jmb.2004.02.026; Ziegler C, 2010, MOL MICROBIOL, V78, P13, DOI 10.1111/j.1365-2958.2010.07332.x	21	106	107	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2012	490	7418					126	130		10.1038/nature11403	http://dx.doi.org/10.1038/nature11403			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015LG	22940865				2022-12-24	WOS:000309446800046
J	Zhang, GF; Fang, XD; Guo, XM; Li, L; Luo, RB; Xu, F; Yang, PC; Zhang, LL; Wang, XT; Qi, HG; Xiong, ZQ; Que, HY; Xie, YL; Holland, PWH; Paps, J; Zhu, YB; Wu, FC; Chen, YX; Wang, JF; Peng, CF; Meng, J; Yang, L; Liu, J; Wen, B; Zhang, N; Huang, ZY; Zhu, QH; Feng, Y; Mount, A; Hedgecock, D; Xu, Z; Liu, YJ; Domazet-Loso, T; Du, YS; Sun, XQ; Zhang, SD; Liu, BH; Cheng, PZ; Jiang, XT; Li, J; Fan, DD; Wang, W; Fu, WJ; Wang, T; Wang, B; Zhang, JB; Peng, ZY; Li, YX; Li, N; Wang, JP; Chen, MS; He, Y; Tan, FJ; Song, XR; Zheng, QM; Huang, RL; Yang, HL; Du, XD; Chen, L; Yang, M; Gaffney, PM; Wang, S; Luo, LH; She, ZC; Ming, Y; Huang, W; Zhang, S; Huang, BY; Zhang, Y; Qu, T; Ni, PX; Miao, GY; Wang, JY; Wang, Q; Steinberg, CEW; Wang, HY; Li, N; Qian, LM; Zhang, GJ; Li, YR; Yang, HM; Liu, X; Wang, J; Yin, Y; Wang, J				Zhang, Guofan; Fang, Xiaodong; Guo, Ximing; Li, Li; Luo, Ruibang; Xu, Fei; Yang, Pengcheng; Zhang, Linlin; Wang, Xiaotong; Qi, Haigang; Xiong, Zhiqiang; Que, Huayong; Xie, Yinlong; Holland, Peter W. H.; Paps, Jordi; Zhu, Yabing; Wu, Fucun; Chen, Yuanxin; Wang, Jiafeng; Peng, Chunfang; Meng, Jie; Yang, Lan; Liu, Jun; Wen, Bo; Zhang, Na; Huang, Zhiyong; Zhu, Qihui; Feng, Yue; Mount, Andrew; Hedgecock, Dennis; Xu, Zhe; Liu, Yunjie; Domazet-Loso, Tomislav; Du, Yishuai; Sun, Xiaoqing; Zhang, Shoudu; Liu, Binghang; Cheng, Peizhou; Jiang, Xuanting; Li, Juan; Fan, Dingding; Wang, Wei; Fu, Wenjing; Wang, Tong; Wang, Bo; Zhang, Jibiao; Peng, Zhiyu; Li, Yingxiang; Li, Na; Wang, Jinpeng; Chen, Maoshan; He, Yan; Tan, Fengji; Song, Xiaorui; Zheng, Qiumei; Huang, Ronglian; Yang, Hailong; Du, Xuedi; Chen, Li; Yang, Mei; Gaffney, Patrick M.; Wang, Shan; Luo, Longhai; She, Zhicai; Ming, Yao; Huang, Wen; Zhang, Shu; Huang, Baoyu; Zhang, Yong; Qu, Tao; Ni, Peixiang; Miao, Guoying; Wang, Junyi; Wang, Qiang; Steinberg, Christian E. W.; Wang, Haiyan; Li, Ning; Qian, Lumin; Zhang, Guojie; Li, Yingrui; Yang, Huanming; Liu, Xiao; Wang, Jian; Yin, Ye; Wang, Jun			The oyster genome reveals stress adaptation and complexity of shell formation	NATURE			English	Article							TRANSPOSABLE ELEMENTS; CRASSOSTREA-GIGAS; BIVALVE MOLLUSKS; PARAHOX GENES; PROTEINS; SEQUENCE; EVOLUTION; DISCOVERY; APOPTOSIS; PATHWAY	The Pacific oyster Crassostrea gigas belongs to one of the most species-rich but genomically poorly explored phyla, the Mollusca. Here we report the sequencing and assembly of the oyster genome using short reads and a fosmid-pooling strategy, along with transcriptomes of development and stress response and the proteome of the shell. The oyster genome is highly polymorphic and rich in repetitive sequences, with some transposable elements still actively shaping variation. Transcriptome studies reveal an extensive set of genes responding to environmental stress. The expansion of genes coding for heat shock protein 70 and inhibitors of apoptosis is probably central to the oyster's adaptation to sessile life in the highly stressful intertidal zone. Our analyses also show that shell formation in molluscs is more complex than currently understood and involves extensive participation of cells and their exosomes. The oyster genome sequence fills a void in our understanding of the Lophotrochozoa.	[Fang, Xiaodong; Luo, Ruibang; Yang, Pengcheng; Xiong, Zhiqiang; Xie, Yinlong; Zhu, Yabing; Chen, Yuanxin; Peng, Chunfang; Yang, Lan; Wen, Bo; Huang, Zhiyong; Feng, Yue; Liu, Yunjie; Sun, Xiaoqing; Liu, Binghang; Jiang, Xuanting; Fan, Dingding; Fu, Wenjing; Wang, Bo; Peng, Zhiyu; Li, Na; Chen, Maoshan; Tan, Fengji; Zheng, Qiumei; Yang, Hailong; Chen, Li; Luo, Longhai; Ming, Yao; Zhang, Shu; Zhang, Yong; Ni, Peixiang; Wang, Junyi; Li, Ning; Zhang, Guojie; Li, Yingrui; Yang, Huanming; Wang, Jian; Yin, Ye; Wang, Jun] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Zhang, Guofan; Li, Li; Xu, Fei; Zhang, Linlin; Wang, Xiaotong; Qi, Haigang; Que, Huayong; Wu, Fucun; Wang, Jiafeng; Meng, Jie; Liu, Jun; Zhang, Na; Zhu, Qihui; Du, Yishuai; Zhang, Shoudu; Cheng, Peizhou; Li, Juan; Wang, Wei; Wang, Tong; Zhang, Jibiao; Li, Yingxiang; Wang, Jinpeng; Song, Xiaorui; Huang, Ronglian; Du, Xuedi; Yang, Mei; She, Zhicai; Huang, Wen; Huang, Baoyu; Qu, Tao; Miao, Guoying; Wang, Qiang; Wang, Haiyan; Liu, Xiao] Chinese Acad Sci, Inst Oceanol, Qingdao 266071, Peoples R China; [Guo, Ximing; He, Yan; Wang, Shan; Qian, Lumin] Rutgers State Univ, Inst Marine & Coastal Sci, Haskin Shellfish Res Lab, Port Norris, NJ 08349 USA; [Luo, Ruibang; Xie, Yinlong; Liu, Binghang] HKU BGI Bioinformat Algorithms & Core Technol Res, Hong Kong, Hong Kong, Peoples R China; [Holland, Peter W. H.; Paps, Jordi] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Mount, Andrew] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA; [Hedgecock, Dennis] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [Xu, Zhe] Atlantic Cape Community Coll, Mays Landing, NJ 08330 USA; [Domazet-Loso, Tomislav] Rudjer Boskovic Inst, Lab Evolutionary Genet, HR-10002 Zagreb, Croatia; [Gaffney, Patrick M.] Univ Delaware, Sch Marine Sci & Policy, Lewes, DE 19958 USA; [Steinberg, Christian E. W.] Humboldt Univ Berlin Arboretum, Inst Biol, D-12437 Berlin, Germany; [Wang, Jun] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Wang, Jun] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, DK-2200 Copenhagen, Denmark	Beijing Genomics Institute (BGI); Chinese Academy of Sciences; Institute of Oceanology, CAS; Rutgers State University New Brunswick; University of Hong Kong; University of Oxford; Clemson University; University of Southern California; Rudjer Boskovic Institute; University of Delaware; University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen	Wang, J (corresponding author), BGI Shenzhen, Shenzhen 518083, Peoples R China.	gzhang@qdio.ac.cn; xguo@hsrl.rutgers.edu; yinye@genomics.org.cn; wangj@genomics.org.cn	Li, Yingrui/K-1064-2015; Wu, Fucun/AAY-6115-2021; li, li/GPX-3938-2022; li, li/HII-4157-2022; Zhang, Guojie/J-7273-2019; Wang, Jun/A-7261-2013; Hedgecock, Dennis/I-8655-2012; Peng, Zhiyu/GXV-5301-2022; Zhang, Guojie/B-6188-2014; Xu, Fei/A-1736-2012; Steinberg, Christian/O-8572-2019; Zhang, Linlin/I-4970-2014; yang, hailong/GXH-9625-2022; Paps, Jordi/B-2098-2012; Fang, Xiaodong/K-6743-2018; LI, LI/GVS-5344-2022; Li, Li/AEM-3636-2022; wang, junyi/GYA-3213-2022; huang, wen/GXW-0661-2022; Wen, Bo/I-1259-2019; Yang, Pengcheng/N-1037-2014; Guo, Ximing/K-3804-2012; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Zhang, Guojie/0000-0001-6860-1521; Hedgecock, Dennis/0000-0002-3995-646X; Zhang, Guojie/0000-0001-6860-1521; Xu, Fei/0000-0002-0981-8429; Zhang, Linlin/0000-0003-0247-7710; Paps, Jordi/0000-0003-2636-6636; Fang, Xiaodong/0000-0001-7061-3337; Wen, Bo/0000-0003-2261-3150; Yang, Pengcheng/0000-0001-5496-8357; Guo, Ximing/0000-0002-6758-2709; liu, bh/0000-0002-4948-2835; Mount, Andrew/0000-0002-3376-1135; Steinberg, Christian E.W./0000-0002-3132-8901; Wang, Jun/0000-0002-2113-5874; Wang, Jinpeng/0000-0003-1892-0246; Li, Yingxiang/0000-0001-6671-2965; Luo, Ruibang/0000-0001-9711-6533; Wang, Jun/0000-0002-8540-8931; CHEN, MAOSHAN/0000-0002-3827-4969; Holland, Peter/0000-0003-1533-9376	National High-Technology Research and Development Program of China (863 program) [2010AA10A110]; National Basic Research Program of China (973 Program) [2010CB126401, 2010CB126402]; 863 program [2012AA10A405]; Basic Research Program by Shenzhen City [JC2010526019]; Shenzhen Key Laboratory of Transomics Biotechnologies [CXB201108250096A]; Mollusc Research and Development Center; CARS; Shenzhen Key Laboratory of Gene Bank for National Life Science; Taishan Scholar and Scholar Climbing Programs of Shandong; US Department of Agriculture [2009-35205-05052, NJ32108]; Chinese Academy of Science Marine Functional Genomics Oversea Team; Taishan Scholar Fund; European Research Council (EU FP7 ERC) [[268513]11]; Beatriu de Pinos of the Generalitat de Catalunya [2009 BP-DGR]; Dalian Zhangzidao Fishery Group Co. Ltd	National High-Technology Research and Development Program of China (863 program)(National High Technology Research and Development Program of China); National Basic Research Program of China (973 Program)(National Basic Research Program of China); 863 program(National High Technology Research and Development Program of China); Basic Research Program by Shenzhen City; Shenzhen Key Laboratory of Transomics Biotechnologies; Mollusc Research and Development Center; CARS; Shenzhen Key Laboratory of Gene Bank for National Life Science; Taishan Scholar and Scholar Climbing Programs of Shandong; US Department of Agriculture(United States Department of Agriculture (USDA)); Chinese Academy of Science Marine Functional Genomics Oversea Team; Taishan Scholar Fund; European Research Council (EU FP7 ERC)(European Research Council (ERC)); Beatriu de Pinos of the Generalitat de Catalunya; Dalian Zhangzidao Fishery Group Co. Ltd	We acknowledge H. Wu, F. Zhang, Q. Tang, Z. Zhu, X. Xu, H. Lin, J. Lei, Z. Xiang, N. Li, J. Xiang and J. Jia for their support of the oyster genome project. We thank F. Han, X. Liu, R. Wu, L. Wang, Y. Wu, L. Yan, H. Niu, H. Li, Y. Wang, J. Liang, Z. Jia, J. Davis and Taylor Shellfish Farms for assistance with DNA, RNA and protein extraction, data analysis and oyster culture, and Y. Lu, C. Lin, H. Peng, Y. Ren, X. Xu, R. Chen and D. Zhang for library construction and sequencing. We thank L. Song, B. Z. Liu, Q. Li, Z. Yu, C. Ke, J. Yu, B. Liu, X. Sun, R. W. Chapman, Y. Han, S. R. Wessler, D. Arendt, E. H. Davidson, J. S. Evans, B. Brown, P. Boudry and B. Lieb for discussions. We thank other faculty and staff at the Institute of Oceanology, Chinese Academy of Science, BGI-Shenzhen and Rutgers who contributed to the oyster genome project. We acknowledge grant support from the National High-Technology Research and Development Program of China (863 program; 2010AA10A110), National Basic Research Program of China (973 Program; 2010CB126401 and 2010CB126402), 863 program (2012AA10A405), Basic Research Program Supported by Shenzhen City (JC2010526019), Shenzhen Key Laboratory of Transomics Biotechnologies (CXB201108250096A), National Natural Science Foundation of China(40730845), Mollusc Research and Development Center, CARS, Shenzhen Key Laboratory of Gene Bank for National Life Science, Taishan Scholar and Scholar Climbing Programs of Shandong. X.G. acknowledges funding from the US Department of Agriculture (2009-35205-05052 and NJ32108) and the Chinese Academy of Science Marine Functional Genomics Oversea Team and Taishan Scholar Fund; P.W.H.H. acknowledges funding from the European Research Council (EU FP7 ERC grant [268513]11); and J.P. acknowledges funding from Beatriu de Pinos of the Generalitat de Catalunya (2009 BP-DGR). We are grateful to Dalian Zhangzidao Fishery Group Co. Ltd for providing support.	Barucca M, 2003, GENE, V317, P97, DOI 10.1016/S0378-1119(03)00657-7; Bender CE, 2012, P NATL ACAD SCI USA, V109, P4904, DOI 10.1073/pnas.1120680109; Bonasio R, 2010, SCIENCE, V329, P1068, DOI 10.1126/science.1192428; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Carland TM, 2010, DEV COMP IMMUNOL, V34, P785, DOI 10.1016/j.dci.2010.02.014; Chang TS, 2009, INT J MOL SCI, V10, P2440, DOI 10.3390/ijms10062440; Dalloul RA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000475; Ferrier DEK, 2002, MOL PHYLOGENET EVOL, V24, P412, DOI 10.1016/S1055-7903(02)00204-X; Furuhashi T, 2009, COMP BIOCHEM PHYS B, V154, P351, DOI 10.1016/j.cbpb.2009.07.011; Gaffney PM, 2003, J MOL EVOL, V56, P308, DOI 10.1007/s00239-002-2402-5; Galtsoff P.S., 1964, FISHERY B FISH WILDL, V64, P1, DOI DOI 10.1111/J.1439-0388.2007.00702.X; Goldstone JV, 2006, DEV BIOL, V300, P366, DOI 10.1016/j.ydbio.2006.08.066; Han YJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq862; Hanington PC, 2011, J INNATE IMMUN, V3, P17, DOI 10.1159/000321882; Harris R. S., 2007, THESIS PENNSYLVANIA; Hedgecock D, 2005, J SHELLFISH RES, V24, P429, DOI 10.2983/0730-8000(2005)24[429:TCFSTP]2.0.CO;2; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Kitzman J. O., 2010, NAT BIOTECHNOL, V29, P59; Kourtis N, 2011, EMBO J, V30, P2520, DOI 10.1038/emboj.2011.162; Lee EF, 2011, P NATL ACAD SCI USA, V108, P6999, DOI 10.1073/pnas.1100652108; Lemmon CA, 2009, BIOPHYS J, V96, P729, DOI 10.1016/j.bpj.2008.10.009; Li B., 2012, GENOME DARWINS FINCH, DOI [10.5524/100040, DOI 10.5524/100040]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LI RQ, 2010, GENOME RES, V20, P265, DOI DOI 10.1101/GR.097261.109; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8; Mathivanan S, 2012, NUCLEIC ACIDS RES, V40, pD1241, DOI 10.1093/nar/gkr828; McGoldrick DJ, 1997, GENETICS, V146, P321; Mosser DD, 1997, MOL CELL BIOL, V17, P5317, DOI 10.1128/MCB.17.9.5317; Mount AS, 2004, SCIENCE, V304, P297, DOI 10.1126/science.1090506; Mount AS, 2010, US patent, Patent No. [2010/0150982 A1, 20100150982]; Nagai K, 2007, COMP BIOCHEM PHYS B, V146, P207, DOI 10.1016/j.cbpb.2006.10.105; Ponder Winston F., 2008, P1; Sauvage C, 2007, GENE, V406, P13, DOI 10.1016/j.gene.2007.05.011; Sauvage E, 2008, FEMS MICROBIOL REV, V32, P234, DOI 10.1111/j.1574-6976.2008.00105.x; Small KS, 2007, P NATL ACAD SCI USA, V104, P5698, DOI 10.1073/pnas.0700890104; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Star B, 2011, NATURE, V477, P207, DOI 10.1038/nature10342; Stark M, 2007, BIOMACROMOLECULES, V8, P1695, DOI 10.1021/bm070049y; Suk EK, 2011, GENOME RES, V21, P1672, DOI 10.1101/gr.125047.111; Talmage SC, 2010, P NATL ACAD SCI USA, V107, P17246, DOI 10.1073/pnas.0913804107; WAITE JH, 1983, MOLLUSCA, V1, P467; Walters ET, 2009, BRAIN BEHAV EVOLUT, V74, P206, DOI 10.1159/000258667; WEINER S, 1984, PHILOS T ROY SOC B, V304, P425, DOI 10.1098/rstb.1984.0036; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Zhang SM, 2004, SCIENCE, V305, P251, DOI 10.1126/science.1088069	47	1475	1580	48	676	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2012	490	7418					49	54		10.1038/nature11413	http://dx.doi.org/10.1038/nature11413			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015LG	22992520	Green Accepted, hybrid, Green Published			2022-12-24	WOS:000309446800030
J	Oda, Y; Fukuda, H				Oda, Yoshihisa; Fukuda, Hiroo			Initiation of Cell Wall Pattern by a Rho- and Microtubule-Driven Symmetry Breaking	SCIENCE			English	Article							ARABIDOPSIS; PLANTS; POLARITY; GTPASE; ROP; GROWTH; EXPRESSION; PROTEINS; FAMILY; DOMAIN	A specifically patterned cell wall is a determinant of plant cell shape. Yet, the precise mechanisms that underlie initiation of cell wall patterning remain elusive. By using a reconstitution assay, we revealed that ROPGEF4 (Rho of plant guanine nucleotide exchange factor 4) and ROPGAP3 [ROP guanosine triphosphatase (GTPase)-activating protein 3] mediate local activation of the plant Rho GTPase ROP11 to initiate distinct pattern of secondary cell walls in xylem cells. The activated ROP11 recruits MIDD1 to induce local disassembly of cortical microtubules. Conversely, cortical microtubules eliminate active ROP11 from the plasma membrane through MIDD1. Such a mutual inhibitory interaction between active ROP domains and cortical microtubules establishes the distinct pattern of secondary cell walls. This Rho-based regulatory mechanism shows how plant cells initiate and control cell wall patterns to form various cell shapes.	[Oda, Yoshihisa; Fukuda, Hiroo] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Oda, Yoshihisa] Japan Sci & Technol Corp JST, PRESTO, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Oda, Y (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan.	oda@biol.s.u-tokyo.ac.jp; fukuda@biol.s.u-tokyo.ac.jp		Oda, Yoshihisa/0000-0001-6934-4424	Ministry of Education, Science, Sports and Culture of Japan [19060009]; Japan Society for the Promotion of Science [23227001, 22870005]; NC-CARP project; JST, Precursory Research for Embryonic Science and Technology (PRESTO) [20103]; Grants-in-Aid for Scientific Research [19060016] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NC-CARP project; JST, Precursory Research for Embryonic Science and Technology (PRESTO); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank N. Chua of the Rockefeller University for providing the pER8 vector; U. Grossniklaus of the University of Zurich for providing the pMDC7 vector; T. Nakagawa of Shimane University for providing the pGWB vectors; Y. Ohya of the University of Tokyo for critical reading of this manuscript; A. Nakano, T. Ueda, and S. Betsuyaku of the University of Tokyo for technical advice; and Y. Nakashima for technical assistance. This work was supported partly by Grants-in-Aid from the Ministry of Education, Science, Sports and Culture of Japan (19060009) to H. F.; from the Japan Society for the Promotion of Science to H. F. (23227001) and Y.O. (22870005) and the NC-CARP project; and from JST, Precursory Research for Embryonic Science and Technology (PRESTO) to Y.O. (20103).	Berken A, 2005, NATURE, V436, P1176, DOI 10.1038/nature03883; Dettmer J, 2011, CURR OPIN CELL BIOL, V23, P686, DOI 10.1016/j.ceb.2011.09.006; Dong JA, 2010, CURR TOP DEV BIOL, V91, P267, DOI 10.1016/S0070-2153(10)91009-0; Gu Y, 2006, PLANT CELL, V18, P366, DOI 10.1105/tpc.105.036434; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Kozubowski L, 2008, CURR BIOL, V18, P1719, DOI 10.1016/j.cub.2008.09.060; Lavy M, 2007, CURR BIOL, V17, P947, DOI 10.1016/j.cub.2007.04.038; Lavy M, 2006, PLANT J, V46, P934, DOI 10.1111/j.1365-313X.2006.02749.x; Li SD, 2008, MOL PLANT, V1, P1021, DOI 10.1093/mp/ssn051; Moores CA, 2006, J CELL SCI, V119, P3905, DOI 10.1242/jcs.03224; Mucha E, 2010, EUR J CELL BIOL, V89, P906, DOI 10.1016/j.ejcb.2010.08.003; Oda Y, 2010, CURR BIOL, V20, P1197, DOI 10.1016/j.cub.2010.05.038; Ohashi-Ito K, 2010, PLANT CELL, V22, P3461, DOI 10.1105/tpc.110.075036; Perez P, 2010, BIOCHEM J, V426, P243, DOI 10.1042/BJ20091823; Rasmussen CG, 2011, ANNU REV PLANT BIOL, V62, P387, DOI 10.1146/annurev-arplant-042110-103802; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Wu G, 2000, PLANT PHYSIOL, V124, P1625, DOI 10.1104/pp.124.4.1625; Yamaguchi M, 2011, PLANT J, V66, P579, DOI 10.1111/j.1365-313x.2011.04514.x; Yang ZB, 2008, ANNU REV CELL DEV BI, V24, P551, DOI 10.1146/annurev.cellbio.23.090506.123233; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P18830, DOI 10.1073/pnas.0705874104; Zheng ZL, 2000, PLANT MOL BIOL, V44, P1, DOI 10.1023/A:1006402628948; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	23	172	186	6	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2012	337	6100					1333	1336		10.1126/science.1222597	http://dx.doi.org/10.1126/science.1222597			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	004TW	22984069				2022-12-24	WOS:000308705000040
J	Song, J; Zhong, C; Bonaguidi, MA; Sun, GJ; Hsu, D; Gu, Y; Meletis, K; Huang, ZJ; Ge, SY; Enikolopov, G; Deisseroth, K; Luscher, B; Christian, KM; Ming, GL; Song, HJ				Song, Juan; Zhong, Chun; Bonaguidi, Michael A.; Sun, Gerald J.; Hsu, Derek; Gu, Yan; Meletis, Konstantinos; Huang, Z. Josh; Ge, Shaoyu; Enikolopov, Grigori; Deisseroth, Karl; Luscher, Bernhard; Christian, Kimberly M.; Ming, Guo-li; Song, Hongjun			Neuronal circuitry mechanism regulating adult quiescent neural stem-cell fate decision	NATURE			English	Article							NEWLY GENERATED NEURONS; IMMUNOREACTIVE NEURONS; NEUROGENESIS; BRAIN; RECEPTORS; SYSTEM	Adult neurogenesis arises from neural stem cells within specialized niches(1-3). Neuronal activity and experience, presumably acting on this local niche, regulate multiple stages of adult neurogenesis, from neural progenitor proliferation to new neuron maturation, synaptic integration and survival(1,3). It is unknown whether local neuronal circuitry has a direct impact on adult neural stem cells. Here we show that, in the adult mouse hippocampus, nestin-expressing radial glia-like quiescent neural stem cells(4-9) (RGLs) respond tonically to the neurotransmitter gamma-aminobutyric acid (GABA) by means of gamma(2)-subunit-containing GABA(A) receptors. Clonal analysis(9) of individual RGLs revealed a rapid exit from quiescence and enhanced symmetrical self-renewal after conditional deletion of gamma(2). RGLs are in close proximity to terminals expressing 67-kDa glutamic acid decarboxylase (GAD67) of parvalbumin-expressing (PV+) interneurons and respond tonically to GABA released from these neurons. Functionally, optogenetic control of the activity of dentate PV+ interneurons, but not that of somatostatin-expressing or vasoactive intestinal polypeptide (VIP)-expressing interneurons, can dictate the RGL choice between quiescence and activation. Furthermore, PV+ interneuron activation restores RGL quiescence after social isolation, an experience that induces RGL activation and symmetrical division(8). Our study identifies a niche cell-signal-receptor trio and a local circuitry mechanism that control the activation and self-renewal mode of quiescent adult neural stem cells in response to neuronal activity and experience.	[Song, Juan; Zhong, Chun; Bonaguidi, Michael A.; Sun, Gerald J.; Hsu, Derek; Christian, Kimberly M.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA; [Song, Juan; Zhong, Chun; Bonaguidi, Michael A.; Christian, Kimberly M.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Sun, Gerald J.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Gu, Yan; Ge, Shaoyu] SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA; [Meletis, Konstantinos] Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden; [Huang, Z. Josh; Enikolopov, Grigori] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Luscher, Bernhard] Penn State Univ, Dept Biol, University Pk, PA 16802 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Karolinska Institutet; Cold Spring Harbor Laboratory; Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Song, HJ (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA.	gming1@jhmi.edu; shongju1@jhmi.edu	Meletis, Konstantinos/ABE-6777-2020; Luscher, Bernhard/C-3528-2009; Ming, Guo-li/J-7880-2013; Enikolopov, Grigori/P-5731-2019; Core, Vector/CAF-4832-2022; Gu, Yan/K-4702-2017	Luscher, Bernhard/0000-0003-1375-1906; Enikolopov, Grigori/0000-0001-8178-8917; Gu, Yan/0000-0001-5562-6279; Huang, Z. Josh/0000-0003-0592-028X; Meletis, Konstantinos/0000-0001-5665-4781	National Institutes of Health (NIH) [NS047344, NS048271, HD069184, MH089111, AG040209]; National Alliance for Research on Schizophrenia and Depression; Adelson Medical Research Foundation; New York State Stem Cell Science; Ellison Medical Foundation; Life Sciences Research Foundation; Maryland Stem Cell Research Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES021957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RC1MH089111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048271, R56NS047344, R01NS065915, R01NS047344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040209] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Alliance for Research on Schizophrenia and Depression(NARSAD); Adelson Medical Research Foundation; New York State Stem Cell Science; Ellison Medical Foundation(Lawrence Ellison Foundation); Life Sciences Research Foundation; Maryland Stem Cell Research Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank L. H. Tsai for initial help in the study; members of the Song and Ming laboratories for discussion; H. Davoudi for help; and Q. Hussaini, Y. Cai and L. Liu for technical support. This work was supported by grants from the National Institutes of Health (NIH) (NS047344) to H. S., the NIH (NS048271, HD069184), the National Alliance for Research on Schizophrenia and Depression and the Adelson Medical Research Foundation to G. L. M., the NIH (MH089111) to B. L., the NIH (AG040209) and New York State Stem Cell Science and the Ellison Medical Foundation to G. E., and by postdoctoral fellowships from the Life Sciences Research Foundation to J.S. and from the Maryland Stem Cell Research Fund to J.S., C.Z. and K.C.	Andang M, 2008, NATURE, V451, P460, DOI 10.1038/nature06488; Andre V, 2001, HIPPOCAMPUS, V11, P452, DOI 10.1002/hipo.1060.abs; BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Caraiscos VB, 2004, P NATL ACAD SCI USA, V101, P3662, DOI 10.1073/pnas.0307231101; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Dranovsky A, 2011, NEURON, V70, P908, DOI 10.1016/j.neuron.2011.05.022; Encinas JM, 2006, P NATL ACAD SCI USA, V103, P8233, DOI 10.1073/pnas.0601992103; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Fernando RN, 2011, P NATL ACAD SCI USA, V108, P5837, DOI 10.1073/pnas.1014993108; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gasser EMS, 2006, NAT PROTOC, V1, P1887, DOI 10.1038/nprot.2006.265; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gonzalez-Burgos G, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/723184; Ibi D, 2008, J NEUROCHEM, V105, P921, DOI 10.1111/j.1471-4159.2007.05207.x; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Jagasia R, 2009, J NEUROSCI, V29, P7966, DOI 10.1523/JNEUROSCI.1054-09.2009; Kim JY, 2009, NEURON, V63, P761, DOI 10.1016/j.neuron.2009.08.008; Knable MB, 2004, MOL PSYCHIATR, V9, P609, DOI 10.1038/sj.mp.4001471; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; LOLOVA I, 1992, MECH AGEING DEV, V66, P195, DOI 10.1016/0047-6374(92)90136-2; Masiulis I, 2011, MOL NEUROBIOL, V44, P287, DOI 10.1007/s12035-011-8207-z; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; SATOH J, 1991, ACTA NEUROPATHOL, V81, P388, DOI 10.1007/BF00293459; Schweizer C, 2003, MOL CELL NEUROSCI, V24, P442, DOI 10.1016/S1044-7431(03)00202-1; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	30	349	362	4	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2012	489	7414					150	U216		10.1038/nature11306	http://dx.doi.org/10.1038/nature11306			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999WW	22842902	Green Accepted			2022-12-24	WOS:000308347000053
J	Forsberg, KJ; Reyes, A; Bin, W; Selleck, EM; Sommer, MOA; Dantas, G				Forsberg, Kevin J.; Reyes, Alejandro; Wang, Bin; Selleck, Elizabeth M.; Sommer, Morten O. A.; Dantas, Gautam			The Shared Antibiotic Resistome of Soil Bacteria and Human Pathogens	SCIENCE			English	Article							RESISTANCE GENES; KLUYVERA; ECOLOGY; SPREAD; BUGS	Soil microbiota represent one of the ancient evolutionary origins of antibiotic resistance and have been proposed as a reservoir of resistance genes available for exchange with clinical pathogens. Using a high-throughput functional metagenomic approach in conjunction with a pipeline for the de novo assembly of short-read sequence data from functional selections (termed PARFuMS), we provide evidence for recent exchange of antibiotic resistance genes between environmental bacteria and clinical pathogens. We describe multidrug-resistant soil bacteria containing resistance cassettes against five classes of antibiotics (beta-lactams, aminoglycosides, amphenicols, sulfonamides, and tetracyclines) that have perfect nucleotide identity to genes from diverse human pathogens. This identity encompasses noncoding regions as well as multiple mobilization sequences, offering not only evidence of lateral exchange but also a mechanism by which antibiotic resistance disseminates.	[Sommer, Morten O. A.] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Forsberg, Kevin J.; Reyes, Alejandro; Wang, Bin; Dantas, Gautam] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA; [Wang, Bin; Dantas, Gautam] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63108 USA; [Selleck, Elizabeth M.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Sommer, Morten O. A.] Novo Nordisk Fdn Ctr Biosustainabil, DK-2900 Horsholm, Denmark	Technical University of Denmark; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Technical University of Denmark	Sommer, MOA (corresponding author), Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark.	msom@bio.dtu.dk; dantas@wustl.edu	Reyes, Alejandro/AAD-8445-2022	Reyes, Alejandro/0000-0003-2907-3265; Dantas, Gautam/0000-0003-0455-8370; Selleck Fiore, Elizabeth/0000-0003-0213-1250; Sommer, Morten Otto Alexander/0000-0003-4005-5674; Forsberg, Kevin/0000-0002-1545-8925	Children's Discovery Institute [MD-II-2011-117]; International Center for Advanced Renewable Energy and Sustainability at Washington University; National Academies Keck Futures Initiatives, Synthetic Biology-SB2; Lundbeck foundation; European Union [282004]; NSF [DGE-1143954]; International Fulbright Science and Technology Award; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007067] Funding Source: NIH RePORTER	Children's Discovery Institute; International Center for Advanced Renewable Energy and Sustainability at Washington University; National Academies Keck Futures Initiatives, Synthetic Biology-SB2; Lundbeck foundation(Lundbeckfonden); European Union(European Commission); NSF(National Science Foundation (NSF)); International Fulbright Science and Technology Award; Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Mitra for initial discussions regarding simulations of metagenomic assembly; T. Druley for discussions surrounding the use of the six beta-lactamase control fragments; J. Fay for discussions on dating horizontal gene transfer; J. Gordon for support, thoughtful discussion, and as the advisor to A. R.; A. Moore for naming PARFuMS; and the Genome Technology Access Center at Washington University in St. Louis for generating Illumina sequence data. This work was supported by awards to G. D. through the Children's Discovery Institute (award MD-II-2011-117), the International Center for Advanced Renewable Energy and Sustainability at Washington University, and the National Academies Keck Futures Initiatives, Synthetic Biology-SB2. M.O.A.S. received funding from the Lundbeck foundation and the European Union FP7-HEALTH-2011-single-stage grant agreement 282004, EvoTAR. K. J. F. is a NSF graduate research fellow (award DGE-1143954). A. R. is the recipient of an International Fulbright Science and Technology Award. The data reported in this paper are described in the supplementary materials. Raw sequencing reads have been deposited to MG-RAST with accession nos. 4489630-39, 4489641-43, 4489645-46, 4489648-49, 4489650-51, 4489653-57, 4489659, 4489661-63, 4489665, and 4489667-68. Assembled sequences have been deposited to GenBank with accession nos. JX009202 to JX009380. The authors declare no competing financial interests.	Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Allen HK, 2009, ISME J, V3, P243, DOI 10.1038/ismej.2008.86; Aminov RI, 2007, FEMS MICROBIOL LETT, V271, P147, DOI 10.1111/j.1574-6968.2007.00757.x; Arias CA, 2009, NEW ENGL J MED, V360, P439, DOI 10.1056/NEJMp0804651; BENVENISTE R, 1973, P NATL ACAD SCI USA, V70, P2276, DOI 10.1073/pnas.70.8.2276; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Chain PSG, 2011, J BACTERIOL, V193, P4274, DOI 10.1128/JB.05335-11; CLARK VL, 1977, ANTIMICROB AGENTS CH, V11, P871, DOI 10.1128/AAC.11.5.871; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; Dantas G, 2008, SCIENCE, V320, P100, DOI 10.1126/science.1155157; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Donato JJ, 2010, APPL ENVIRON MICROB, V76, P4396, DOI 10.1128/AEM.01763-09; FARMER JJ, 1981, J CLIN MICROBIOL, V13, P919, DOI 10.1128/JCM.13.5.919-933.1981; Heuer H, 2011, CURR OPIN MICROBIOL, V14, P236, DOI 10.1016/j.mib.2011.04.009; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483; McManus PS, 2002, ANNU REV PHYTOPATHOL, V40, P443, DOI 10.1146/annurev.phyto.40.120301.093927; Poirel L, 2005, ANTIMICROB AGENTS CH, V49, P3593, DOI 10.1128/AAC.49.8.3593-3597.2005; Poirel L, 2002, ANTIMICROB AGENTS CH, V46, P4038, DOI 10.1128/AAC.46.12.4038-4040.2002; Rezzonico F, 2004, APPL ENVIRON MICROB, V70, P5119, DOI 10.1128/AEM.70.9.5119-5131.2004; Romano S, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-267; Silby MW, 2011, FEMS MICROBIOL REV, V35, P652, DOI 10.1111/j.1574-6976.2011.00269.x; Smillie CS, 2011, NATURE, V480, P241, DOI 10.1038/nature10571; Sommer MOA, 2009, SCIENCE, V325, P1128, DOI 10.1126/science.1176950; Stalder T, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00119; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219	28	930	988	40	859	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2012	337	6098					1107	1111		10.1126/science.1220761	http://dx.doi.org/10.1126/science.1220761			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22936781	Green Accepted			2022-12-24	WOS:000308125800051
J	Mendillo, ML; Santagata, S; Koeva, M; Bell, GW; Hu, R; Tamimi, RM; Fraenkel, E; Ince, TA; Whitesell, L; Lindquist, S				Mendillo, Marc L.; Santagata, Sandro; Koeva, Martina; Bell, George W.; Hu, Rong; Tamimi, Rulla M.; Fraenkel, Ernest; Ince, Tan A.; Whitesell, Luke; Lindquist, Susan			HSF1 Drives a Transcriptional Program Distinct from Heat Shock to Support Highly Malignant Human Cancers	CELL			English	Article							INVASIVE BREAST-CANCER; GENOME-WIDE ANALYSIS; GENE-EXPRESSION; FACTOR-1; STRESS; TRANSFORMATION; ACTIVATION; RESPONSES; PROTEINS; GROWTH	Heat-Shock Factor 1 (HSF1), master regulator of the heat-shock response, facilitates malignant transformation, cancer cell survival, and proliferation in model systems. The common assumption is that these effects are mediated through regulation of heat-shock protein (HSP) expression. However, the transcriptional network that HSF1 coordinates directly in malignancy and its relationship to the heat-shock response have never been defined. By comparing cells with high and low malignant potential alongside their nontransformed counterparts, we identify an HSF1-regulated transcriptional program specific to highly malignant cells and distinct from heat shock. Cancer-specific genes in this program support oncogenic processes: cell-cycle regulation, signaling, metabolism, adhesion and translation. HSP genes are integral to this program, however, many are uniquely regulated in malignancy. This HSF1 cancer program is active in breast, colon and lung tumors isolated directly from human patients and is strongly associated with metastasis and death. Thus, HSF1 rewires the transcriptome in tumorigenesis, with prognostic and therapeutic implications.	[Mendillo, Marc L.; Santagata, Sandro; Koeva, Martina; Bell, George W.; Whitesell, Luke; Lindquist, Susan] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Santagata, Sandro] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Koeva, Martina; Fraenkel, Ernest] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Lindquist, Susan] MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Hu, Rong; Tamimi, Rulla M.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Hu, Rong; Tamimi, Rulla M.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Hu, Rong; Tamimi, Rulla M.] Brigham & Womens Hosp, Channing Lab, Dept Med, Boston, MA 02115 USA; [Ince, Tan A.] Univ Miami, Miller Sch Med, Dept Pathol, Braman Family Breast Canc Inst, Miami, FL 33136 USA; [Ince, Tan A.] Univ Miami, Miller Sch Med, Interdisciplinary Stem Cell Inst, Miami, FL 33136 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Brigham & Women's Hospital; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Miami; University of Miami	Whitesell, L (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	whitesell@wi.mit.edu; lindquist_admin@wi.mit.edu		Fraenkel, Ernest/0000-0001-9249-8181; Mendillo, Marc/0000-0001-8128-0128; Santagata, Sandro/0000-0002-7528-9668; Ince, Tan/0000-0003-0315-6425	J&J COSAT focused funding program; Marble Fund; American Cancer Society New England Division-SpinOdyssey [PF-09-253-01-DMC]; NIH [K08NS064168]; Brain Science Foundation; V Foundation; GSK [WE234 EPI40307]; Public Health Service Grants [CA087969]; SPORE in Breast Cancer NCI, NIH, Dept. of Health and Human Services [CA089393]; Breast Cancer Research Foundation, NCI [R01-CA146445-01]; DoD-CDMRP Breast Cancer Research Program [W81XWH-08-1-0282 BC-07456]; NATIONAL CANCER INSTITUTE [R01CA146445, P01CA087969, P50CA089393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS064168] Funding Source: NIH RePORTER	J&J COSAT focused funding program; Marble Fund; American Cancer Society New England Division-SpinOdyssey; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain Science Foundation; V Foundation; GSK(GlaxoSmithKline); Public Health Service Grants(United States Department of Health & Human ServicesUnited States Public Health Service); SPORE in Breast Cancer NCI, NIH, Dept. of Health and Human Services; Breast Cancer Research Foundation, NCI; DoD-CDMRP Breast Cancer Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank G. Frampton, I. Barrasa and S.Gupta for bioinformatic assistance. We thank T. Mazor, T. Volkert and the WIBR-GTC for sequencing support. We thank the Lindquist lab and T. Lee for discussion and K. Allendoerfer, B. Bevis, G. Karras, R. Shouval and K. Matlack for comments. The work was supported by the J&J COSAT focused funding program (L. W.) and the Marble Fund (S. L.). S. L. is an Investigator of the Howard Hughes Medical Institute. M. L. M. is supported by American Cancer Society New England Division-SpinOdyssey (PF-09-253-01-DMC). S. S. is supported by NIH (K08NS064168), the Brain Science Foundation and the V Foundation. Additional support was provided by GSK (WE234 EPI40307); Public Health Service Grants CA087969, and SPORE in Breast Cancer CA089393, from the NCI, NIH, Dept. of Health and Human Services. T. A. I is supported by the Breast Cancer Research Foundation, NCI (R01-CA146445-01) and DoD-CDMRP Breast Cancer Research Program (W81XWH-08-1-0282 BC-07456). T. A. Ince receivse royalty payments for WIT medium and was a consultant to Stemgent Inc. during 2008-2010. We thank the participants and staff of the NHS, and state cancer registries: AL, AZ, AR, CA, CO, CT, DE, FL, GA, ID, IL, IN, IA, KY, LA, ME, MD, MA, MI, NE, NH, NJ, NY, NC, ND, OH, OK, OR, PA, RI, SC, TN, TX, VA, WA, WY.	Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; Chiang WC, 2012, CELL, V148, P322, DOI 10.1016/j.cell.2011.12.019; Christians ES, 2002, CRIT CARE MED, V30, pS43, DOI 10.1097/00003246-200201001-00006; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Day A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008491; Dowhan DH, 2005, MOL CELL, V17, P429, DOI 10.1016/j.molcel.2004.12.025; Guettouche Toumy, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-4; Hahn JS, 2004, J BIOL CHEM, V279, P5169, DOI 10.1074/jbc.M311005200; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Hu R, 2011, CLIN CANCER RES, V17, P1867, DOI 10.1158/1078-0432.CCR-10-2021; Ince TA, 2007, CANCER CELL, V12, P160, DOI 10.1016/j.ccr.2007.06.013; Ishikawa N, 2007, CANCER RES, V67, P11601, DOI 10.1158/0008-5472.CAN-07-3243; Jin XJ, 2011, CELL METAB, V14, P91, DOI 10.1016/j.cmet.2011.03.025; Kalager M, 2012, ANN INTERN MED, V156, P491, DOI 10.7326/0003-4819-156-7-201204030-00005; Khaleque M, 2008, ONCOGENE, V27, P1886, DOI 10.1038/sj.onc.1210834; Kim C, 2010, NAT REV CLIN ONCOL, V7, P340, DOI 10.1038/nrclinonc.2010.61; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Lee YJ, 2008, ONCOGENE, V27, P2999, DOI 10.1038/sj.onc.1210966; Liberal V, 2012, P NATL ACAD SCI USA, V109, P2754, DOI 10.1073/pnas.1102434108; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; MacIsaac KD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000773; Maruyama M, 2010, BIOCHEM BIOPH RES CO, V402, P75, DOI 10.1016/j.bbrc.2010.09.117; Meng L, 2010, ONCOGENE, V29, P5204, DOI 10.1038/onc.2010.277; Min JN, 2007, ONCOGENE, V26, P5086, DOI 10.1038/sj.onc.1210317; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Page TJ, 2006, MOL BIOSYST, V2, P627, DOI 10.1039/b606129j; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; PELHAM HRB, 1982, CELL, V30, P517, DOI 10.1016/0092-8674(82)90249-5; RITOSSA F, 1962, EXPERIENTIA, V18, P571, DOI 10.1007/BF02172188; Rokavec M, 2012, MOL CELL, V45, P777, DOI 10.1016/j.molcel.2012.01.015; Sakurai H, 2010, FEBS J, V277, P4140, DOI 10.1111/j.1742-4658.2010.07829.x; Santagata S, 2012, ACS CHEM BIOL, V7, P339, DOI 10.1021/cb200353m; Santagata S, 2011, P NATL ACAD SCI USA, V108, P18378, DOI 10.1073/pnas.1115031108; Scott KL, 2011, CANCER CELL, V20, P92, DOI 10.1016/j.ccr.2011.05.025; Shamovsky I, 2008, CELL MOL LIFE SCI, V65, P855, DOI 10.1007/s00018-008-7458-y; Solimini NL, 2007, CELL, V130, P986, DOI 10.1016/j.cell.2007.09.007; Stanhill A, 2006, ONCOGENE, V25, P1485, DOI 10.1038/sj.onc.1209193; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tamimi RM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2128; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240; Volovik Y, 2012, AGING CELL, V11, P491, DOI 10.1111/j.1474-9726.2012.00811.x; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Xiao XZ, 1999, EMBO J, V18, P5943, DOI 10.1093/emboj/18.21.5943; Zhao YH, 2009, ONCOGENE, V28, P3689, DOI 10.1038/onc.2009.229; Zhao YH, 2011, CANCER RES, V71, P4585, DOI 10.1158/0008-5472.CAN-11-0127; Zhou JD, 2008, CHINESE MED J-PEKING, V121, P1269, DOI 10.1097/00029330-200807020-00004	49	456	468	2	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 3	2012	150	3					549	562		10.1016/j.cell.2012.06.031	http://dx.doi.org/10.1016/j.cell.2012.06.031			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	985WO	22863008	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000307301400014
J	Meyer, M; Kircher, M; Gansauge, MT; Li, H; Racimo, F; Mallick, S; Schraiber, JG; Jay, F; Prufer, K; de Filippo, C; Sudmant, PH; Alkan, C; Fu, QM; Do, R; Rohland, N; Tandon, A; Siebauer, M; Green, RE; Bryc, K; Briggs, AW; Stenzel, U; Dabney, J; Shendure, J; Kitzman, J; Hammer, MF; Shunkov, MV; Derevianko, AP; Patterson, N; Andres, AM; Eichler, EE; Slatkin, M; Reich, D; Kelso, J; Paabo, S				Meyer, Matthias; Kircher, Martin; Gansauge, Marie-Theres; Li, Heng; Racimo, Fernando; Mallick, Swapan; Schraiber, Joshua G.; Jay, Flora; Pruefer, Kay; de Filippo, Cesare; Sudmant, Peter H.; Alkan, Can; Fu, Qiaomei; Do, Ron; Rohland, Nadin; Tandon, Arti; Siebauer, Michael; Green, Richard E.; Bryc, Katarzyna; Briggs, Adrian W.; Stenzel, Udo; Dabney, Jesse; Shendure, Jay; Kitzman, Jacob; Hammer, Michael F.; Shunkov, Michael V.; Derevianko, Anatoli P.; Patterson, Nick; Andres, Aida M.; Eichler, Evan E.; Slatkin, Montgomery; Reich, David; Kelso, Janet; Paeaebo, Svante			A High-Coverage Genome Sequence from an Archaic Denisovan Individual	SCIENCE			English	Article							NEANDERTHAL GENOME; PATTERNS; HISTORY; HOMININ; SIBERIA; ORIGIN; ASIA	We present a DNA library preparation method that has allowed us to reconstruct a high-coverage (30x) genome sequence of a Denisovan, an extinct relative of Neandertals. The quality of this genome allows a direct estimation of Denisovan heterozygosity indicating that genetic diversity in these archaic hominins was extremely low. It also allows tentative dating of the specimen on the basis of "missing evolution" in its genome, detailed measurements of Denisovan and Neandertal admixture into present-day human populations, and the generation of a near-complete catalog of genetic changes that swept to high frequency in modern humans since their divergence from Denisovans.	[Meyer, Matthias; Kircher, Martin; Gansauge, Marie-Theres; Racimo, Fernando; Pruefer, Kay; de Filippo, Cesare; Fu, Qiaomei; Siebauer, Michael; Stenzel, Udo; Dabney, Jesse; Andres, Aida M.; Kelso, Janet; Paeaebo, Svante] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany; [Li, Heng; Mallick, Swapan; Do, Ron; Rohland, Nadin; Tandon, Arti; Patterson, Nick; Reich, David] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA 02142 USA; [Mallick, Swapan; Rohland, Nadin; Tandon, Arti; Bryc, Katarzyna; Briggs, Adrian W.; Reich, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Schraiber, Joshua G.; Jay, Flora; Slatkin, Montgomery] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Alkan, Can] Bilkent Univ, Dept Comp Engn, TR-06800 Ankara, Turkey; [Sudmant, Peter H.; Alkan, Can; Shendure, Jay; Kitzman, Jacob; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Fu, Qiaomei] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, CAS MPS Joint Lab Human Evolut, Beijing 100044, Peoples R China; [Green, Richard E.] Univ Calif Santa Cruz, Jack Baskin Sch Engn, Santa Cruz, CA 95064 USA; [Hammer, Michael F.] Univ Arizona, Arizona Res Labs, Div Biotechnol, Tucson, AZ 85721 USA; [Shunkov, Michael V.; Derevianko, Anatoli P.] Russian Acad Sci, Siberian Branch, Inst Archaeol & Ethnog, Palaeolith Dept, Novosibirsk 630090, Russia; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	Max Planck Society; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; University of California System; University of California Berkeley; Ihsan Dogramaci Bilkent University; University of Washington; University of Washington Seattle; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; University of California System; University of California Santa Cruz; University of Arizona; Russian Academy of Sciences; Institute of Archaeology & Ethnography, Siberian Branch of Russian Academy of Sciences; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Meyer, M (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany.	mmeyer@eva.mpg.de; reich@genetics.med.harvard.edu; paabo@eva.mpg.de	Li, Heng/D-9344-2011; Alkan, Can/D-2982-2009; Derevianko, Anatoly P./Q-5975-2016; Kircher, Martin/H-6909-2019; Andres, Aida/B-4088-2014; Dabney, Jesse/Y-8889-2019; Shendure, Jay/AAU-3684-2021; Kircher, Martin/HDL-9392-2022; Kelso, Janet/N-1812-2019; Shunkov, Mikhail V./Q-6576-2016	Li, Heng/0000-0003-4874-2874; Alkan, Can/0000-0002-5443-0706; Derevianko, Anatoly P./0000-0003-1156-8331; Kircher, Martin/0000-0001-9278-5471; Andres, Aida/0000-0002-8590-9672; Dabney, Jesse/0000-0001-8893-1245; Kelso, Janet/0000-0002-3618-322X; Shunkov, Mikhail V./0000-0003-1388-2308; Sudmant, Peter/0000-0002-9573-8248; Kitzman, Jacob/0000-0002-6145-882X; Shendure, Jay/0000-0002-1516-1865; Green, Richard/0000-0003-0516-5827; jay, flora/0000-0001-5884-4730; Racimo, Fernando/0000-0002-5025-2607	Max Planck Society; NSF HOMINID [1032255]; NIH [GM100233, R01-GM40282]; HHMI International Student Fellowship; German Academic Exchange Service (DAAD); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100233, R01GM040282] Funding Source: NIH RePORTER	Max Planck Society(Max Planck Society); NSF HOMINID; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI International Student Fellowship; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Denisovan sequence reads are available from the European Nucleotide Archive (ENA) under study accession ERP001519. The present-day human sequence reads are available from the Short Read Archive (SRA) under accession SRA047577. Alignments and genotype calls for each of the sequenced individuals are available at www.eva.mpg.de/denisova/. In addition, the Denisovan sequence reads and alignments are available as a public data set via Amazon Web Services (AWS) at http://aws.amazon.com/datasets/2357/ and as a track in the University of California, Santa Cruz genome browser. We thank D. Falush, P. Johnson, J. Krause, M. Lachmann, S. Sawyer, L. Vigilant and B. Viola for comments, help, and suggestions; A. Aximu, B. Hober, B. Hoffner, A. Weihmann, T. Kratzer, and R. Roesch for expert technical assistance; R. Schultz for help with data management; and M. Schreiber for improvement of graphics. The Presidential Innovation Fund of the Max Planck Society made this project possible. D. R. and N.P. are grateful for support from NSF HOMINID grant no. 1032255 and NIH grant GM100233. J. G. S., F. J., and M. S. were supported by NIH grant R01-GM40282 to M. S. P. H. S. is supported by an HHMI International Student Fellowship. F. R. is supported by a German Academic Exchange Service (DAAD) study scholarship. E. E. E. is on the scientific advisory boards for Pacific Biosciences, Inc., SynapDx Corp, and DNAnexus, Inc.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Burbano HA, 2010, SCIENCE, V328, P723, DOI 10.1126/science.1188046; Cerqueira CCS, 2012, AM J HUM BIOL, V24, P705, DOI 10.1002/ajhb.22263; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Coyne J.A., 1989, P180; Currat M, 2011, P NATL ACAD SCI USA, V108, P15129, DOI 10.1073/pnas.1107450108; Enard W, 2009, CELL, V137, P961, DOI 10.1016/j.cell.2009.03.041; Gibbons A, 2011, SCIENCE, V333, P1084, DOI 10.1126/science.333.6046.1084; Goodman M, 1999, AM J HUM GENET, V64, P31, DOI 10.1086/302218; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Hublin JJ, 2009, P NATL ACAD SCI USA, V106, P16022, DOI 10.1073/pnas.0904119106; IJDO JW, 1991, P NATL ACAD SCI USA, V88, P9051, DOI 10.1073/pnas.88.20.9051; KIDD JR, 1991, HUM BIOL, V63, P775; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; Krause J, 2010, NATURE, V464, P894, DOI 10.1038/nature08976; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Orlando L, 2011, GENOME RES, V21, P1705, DOI 10.1101/gr.122747.111; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Pickrell J., 2012, NATURE PRECEDINGS; Reich D, 2011, AM J HUM GENET, V89, P516, DOI 10.1016/j.ajhg.2011.09.005; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Skoglund P, 2011, P NATL ACAD SCI USA, V108, P18301, DOI 10.1073/pnas.1108181108; Vernes SC, 2008, NEW ENGL J MED, V359, P2337, DOI 10.1056/NEJMoa0802828	27	1072	1102	34	544	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2012	338	6104					222	226		10.1126/science.1224344	http://dx.doi.org/10.1126/science.1224344			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	22936568	Green Accepted, Green Submitted			2022-12-24	WOS:000309712300037
J	Baudouin, SJ; Gaudias, J; Gerharz, S; Hatstatt, L; Zhou, KK; Punnakkal, P; Tanaka, KF; Spooren, W; Hen, R; De Zeeuw, CI; Vogt, K; Scheiffele, P				Baudouin, Stephane J.; Gaudias, Julien; Gerharz, Stefan; Hatstatt, Laetitia; Zhou, Kuikui; Punnakkal, Pradeep; Tanaka, Kenji F.; Spooren, Will; Hen, Rene; De Zeeuw, Chris I.; Vogt, Kaspar; Scheiffele, Peter			Shared Synaptic Pathophysiology in Syndromic and Nonsyndromic Rodent Models of Autism	SCIENCE			English	Article							LONG-TERM DEPRESSION; RARE DE-NOVO; NEUROLIGIN-3; MUTATIONS; RECEPTOR; PROTEIN	The genetic heterogeneity of autism poses a major challenge for identifying mechanism-based treatments. A number of rare mutations are associated with autism, and it is unclear whether these result in common neuronal alterations. Monogenic syndromes, such as fragile X, include autism as one of their multifaceted symptoms and have revealed specific defects in synaptic plasticity. We discovered an unexpected convergence of synaptic pathophysiology in a nonsyndromic form of autism with those in fragile X syndrome. Neuroligin-3 knockout mice (a model for nonsyndromic autism) exhibited disrupted heterosynaptic competition and perturbed metabotropic glutamate receptor-dependent synaptic plasticity, a hallmark of fragile X. These phenotypes could be rescued by reexpression of neuroligin-3 in juvenile mice, highlighting the possibility of reverting neuronal circuit alterations in autism after the completion of development.	[Baudouin, Stephane J.; Gaudias, Julien; Gerharz, Stefan; Hatstatt, Laetitia; Punnakkal, Pradeep; Vogt, Kaspar; Scheiffele, Peter] Univ Basel, Biozentrum, Basel, Switzerland; [Zhou, Kuikui; De Zeeuw, Chris I.] Erasmus MC, Dept Neurosci, Rotterdam, Netherlands; [Tanaka, Kenji F.; Hen, Rene] Columbia Univ, Dept Neurosci, New York, NY USA; [Tanaka, Kenji F.] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Spooren, Will] Hoffmann La Roche AG, Basel, Switzerland; [De Zeeuw, Chris I.] Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Amsterdam, Netherlands	University of Basel; Erasmus University Rotterdam; Erasmus MC; Columbia University; Keio University; Roche Holding; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Scheiffele, P (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.	peter.scheiffele@unibas.ch	baudouin, stephane/I-4372-2012	Scheiffele, Peter/0000-0002-9516-9399; Vogt, Kaspar/0000-0002-0859-876X; baudouin, stephane/0000-0001-6902-6071; Tanaka, Kenji/0000-0003-2511-0057	Dutch Organization for Medical Sciences (ZonMw); Life Sciences (ALW); Senter (NeuroBasic); Prinses Beatrix Fonds; European Research Council (European Community); SystemsX grant; EU-AIMS (European Autism Interventions); Innovative Medicines Initiative [115300]; European Union; European Federation of Pharmaceutical Industries and Associations companies'; NCCR Synapsy; Swiss National Science Foundation; Kanton Basel-Stadt	Dutch Organization for Medical Sciences (ZonMw)(Netherlands Organization for Health Research and Development); Life Sciences (ALW); Senter (NeuroBasic); Prinses Beatrix Fonds; European Research Council (European Community)(European CommissionEuropean Research Council (ERC)); SystemsX grant; EU-AIMS (European Autism Interventions); Innovative Medicines Initiative; European Union(European Commission); European Federation of Pharmaceutical Industries and Associations companies'; NCCR Synapsy; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Kanton Basel-Stadt	We are grateful to our colleagues Arber, Barde, Gosh, Sylwestrak, Witte, and Xiao for comments on the manuscript; to Ponti, Genoud, Sauder, Ahrne, Ehrenfeuchter, and Stiefvater for technical help; and Zeilhofer, Fritschy, Brose, and Sans for sharing reagents. C.D.Z. was supported by the Dutch Organization for Medical Sciences (ZonMw); Life Sciences (ALW); Senter (NeuroBasic); Prinses Beatrix Fonds; and the European Research Council-advanced, CEREBNET, and C7 programs (European Community). This work was supported by a SystemsX grant (P.S. and W.S.); by EU-AIMS (European Autism Interventions), which receives support from the Innovative Medicines Initiative Joint Undertaking under grant agreement no. 115300, the resources of which are composed of financial contributions from the European Union's Seventh Framework Programme (grant FP7/2007-2013), from the European Federation of Pharmaceutical Industries and Associations companies' in-kind contributions, and from Autism Speaks, resulting in a total of (sic)29.6 million; by NCCR Synapsy; the Swiss National Science Foundation; and Kanton Basel-Stadt.	American Psychiatric Association. American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; Budreck EC, 2007, EUR J NEUROSCI, V26, P1738, DOI 10.1111/j.1460-9568.2007.05842.x; Cesa R, 2009, NEUROSCIENCE, V162, P624, DOI 10.1016/j.neuroscience.2009.02.061; Chadman KK, 2008, AUTISM RES, V1, P147, DOI 10.1002/aur.22; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chih B, 2004, HUM MOL GENET, V13, P1471, DOI 10.1093/hmg/ddh158; Etherton M, 2011, P NATL ACAD SCI USA, V108, P13764, DOI 10.1073/pnas.1111093108; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Jacquemont S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001708; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kano M, 2008, PHILOS T R SOC B, V363, P2173, DOI 10.1098/rstb.2008.2270; Koekkoek SKE, 2005, NEURON, V47, P339, DOI 10.1016/j.neuron.2005.07.005; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Luscher C, 2010, NEURON, V65, P445, DOI 10.1016/j.neuron.2010.01.016; Mabb AM, 2010, ANNU REV CELL DEV BI, V26, P179, DOI 10.1146/annurev-cellbio-100109-104129; Mostofsky SH, 2009, BRAIN, V132, P2413, DOI 10.1093/brain/awp088; Radyushkin K, 2009, GENES BRAIN BEHAV, V8, P416, DOI 10.1111/j.1601-183X.2009.00487.x; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Schmahmann JD, 2007, CEREBELLUM, V6, P254, DOI 10.1080/14734220701490995; Schonewille M, 2011, NEURON, V70, P43, DOI 10.1016/j.neuron.2011.02.044; Steinberg JP, 2006, NEURON, V49, P845, DOI 10.1016/j.neuron.2006.02.025; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Tanaka KF, 2010, BIOL PSYCHIAT, V67, P770, DOI 10.1016/j.biopsych.2009.12.020; Toro R, 2010, TRENDS GENET, V26, P363, DOI 10.1016/j.tig.2010.05.007; Tsai PT, 2012, NATURE, V488, P647, DOI 10.1038/nature11310; Van Der Giessen RS, 2008, NEURON, V58, P599, DOI 10.1016/j.neuron.2008.03.016; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Zoghbi HY, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a009886	30	208	212	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2012	338	6103					128	132		10.1126/science.1224159	http://dx.doi.org/10.1126/science.1224159			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	22983708				2022-12-24	WOS:000309457400069
J	Hwang, SW; Tao, H; Kim, DH; Cheng, HY; Song, JK; Rill, E; Brenckle, MA; Panilaitis, B; Won, SM; Kim, YS; Song, YM; Yu, KJ; Ameen, A; Li, R; Su, YW; Yang, MM; Kaplan, DL; Zakin, MR; Slepian, MJ; Huang, YG; Omenetto, FG; Rogers, JA				Hwang, Suk-Won; Tao, Hu; Kim, Dae-Hyeong; Cheng, Huanyu; Song, Jun-Kyul; Rill, Elliott; Brenckle, Mark A.; Panilaitis, Bruce; Won, Sang Min; Kim, Yun-Soung; Song, Young Min; Yu, Ki Jun; Ameen, Abid; Li, Rui; Su, Yewang; Yang, Miaomiao; Kaplan, David L.; Zakin, Mitchell R.; Slepian, Marvin J.; Huang, Yonggang; Omenetto, Fiorenzo G.; Rogers, John A.			A Physically Transient Form of Silicon Electronics	SCIENCE			English	Article							CRYSTALLINE SILICON; SILK FIBROIN; OXIDE	A remarkable feature of modern silicon electronics is its ability to remain physically invariant, almost indefinitely for practical purposes. Although this characteristic is a hallmark of applications of integrated circuits that exist today, there might be opportunities for systems that offer the opposite behavior, such as implantable devices that function for medically useful time frames but then completely disappear via resorption by the body. We report a set of materials, manufacturing schemes, device components, and theoretical design tools for a silicon-based complementary metal oxide semiconductor (CMOS) technology that has this type of transient behavior, together with integrated sensors, actuators, power supply systems, and wireless control strategies. An implantable transient device that acts as a programmable nonantibiotic bacteriocide provides a system-level example.	[Tao, Hu; Brenckle, Mark A.; Panilaitis, Bruce; Yang, Miaomiao; Kaplan, David L.; Omenetto, Fiorenzo G.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Hwang, Suk-Won; Rill, Elliott; Kim, Yun-Soung; Song, Young Min; Ameen, Abid; Rogers, John A.] Univ Illinois, Dept Mat Sci & Engn, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Hwang, Suk-Won; Rill, Elliott; Kim, Yun-Soung; Song, Young Min; Ameen, Abid; Rogers, John A.] Univ Illinois, Frederick Seitz Mat Res Lab, Urbana, IL 61801 USA; [Kim, Dae-Hyeong] Seoul Natl Univ, Sch Chem & Biol Engn, Ctr Nanoparticle Res,Inst Basic Sci, WCU Program Chem Convergence Energy & Environm, Seoul 151741, South Korea; [Cheng, Huanyu; Li, Rui; Su, Yewang; Huang, Yonggang] Northwestern Univ, Dept Mech Engn, Evanston, IL 60208 USA; [Cheng, Huanyu; Li, Rui; Su, Yewang; Huang, Yonggang] Northwestern Univ, Dept Civil & Environm Engn, Evanston, IL 60208 USA; [Song, Jun-Kyul; Rogers, John A.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Won, Sang Min; Yu, Ki Jun; Rogers, John A.] Univ Illinois, Dept Elect & Comp Engn, Urbana, IL 61801 USA; [Li, Rui] Dalian Univ Technol, State Key Lab Struct Anal Ind Equipment, Dept Engn Mech, Dalian 116024, Peoples R China; [Zakin, Mitchell R.] Nano Terra, Brighton, MA 02135 USA; [Slepian, Marvin J.] Univ Arizona, Dept Med, Sarver Heart Ctr, Tucson, AZ 85724 USA; [Slepian, Marvin J.] Univ Arizona, Dept Biomed Engn, Sarver Heart Ctr, Tucson, AZ 85724 USA; [Omenetto, Fiorenzo G.] Tufts Univ, Dept Phys, Medford, MA 02155 USA	Tufts University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Institute for Basic Science - Korea (IBS); Seoul National University (SNU); Northwestern University; Northwestern University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Dalian University of Technology; University of Arizona; University of Arizona; Tufts University	Omenetto, FG (corresponding author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.	fiorenzo.omenetto@tufts.edu; jrogers@uiuc.edu	Li, Rui/C-2155-2009; Song, Young Min/B-2215-2010; Cheng, Huanyu/J-7379-2015; Brenckle, Mark/I-5931-2014; Sunny, QI/M-5188-2019; Huang, Yonggang/B-6998-2009; Slepian, Marvin/ABG-8305-2020; Su, Yewang/GXF-2357-2022; Rogers, John/L-2798-2016; Tao, Hu/C-1528-2013; huang, yonggang/O-6236-2019; HWANG, SUKWON/Q-8329-2018	Song, Young Min/0000-0002-4473-6883; Cheng, Huanyu/0000-0001-6075-4208; Brenckle, Mark/0000-0002-5535-1110; Sunny, QI/0000-0002-5817-1609; Slepian, Marvin/0000-0002-7864-6691; Kim, Dae-Hyeong/0000-0002-4722-1893; HWANG, SUKWON/0000-0002-6883-201X; Li, Rui/0000-0001-6051-4204	Defense Advanced Research Projects Agency; NSF INSPIRE; Air Force Office of Scientific Research Multi University Research Initiative program; National Institutes of Health [EB002520]; U.S. Department of Energy; Division Of Materials Research [1242240] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002520] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NSF INSPIRE; Air Force Office of Scientific Research Multi University Research Initiative program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy(United States Department of Energy (DOE)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The work on materials, integration schemes, manufacturing approaches, and design strategies was supported by the Defense Advanced Research Projects Agency. The theoretical analysis and associated experiments were supported by an NSF INSPIRE grant. The techniques for creating and manipulating Si nanomembranes were developed in work supported by an Air Force Office of Scientific Research Multi University Research Initiative program. The animal studies were funded by the National Institutes of Health (grant EB002520). The facilities for characterization and analysis were provided by the Material Research Laboratory and Center for Microanalysis of Materials at the University of Illinois at Urbana-Champaign, both of which are supported by the U.S. Department of Energy.	Anderson DD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005839; [Anonymous], 1996, Am J Infect Control, V24, P380; Bettinger CJ, 2010, ADV MATER, V22, P651, DOI 10.1002/adma.200902322; Chung HJ, 2011, ADV FUNCT MATER, V21, P3029, DOI 10.1002/adfm.201100124; Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a; ILER RK, 1973, J COLLOID INTERF SCI, V43, P399, DOI 10.1016/0021-9797(73)90386-X; Irimia-Vladu M, 2010, ADV FUNCT MATER, V20, P4069, DOI 10.1002/adfm.201001031; Kim DH, 2011, SCIENCE, V333, P838, DOI 10.1126/science.1206157; Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/NMAT2745, 10.1038/nmat2745]; Legnani C, 2008, THIN SOLID FILMS, V517, P1016, DOI 10.1016/j.tsf.2008.06.011; Levine RD, 2005, MOL REACTION DYNAMIC, DOI 10.1017/CBO9780511614125; MORITA M, 1990, J APPL PHYS, V68, P1272, DOI 10.1063/1.347181; RIMSTIDT JD, 1980, GEOCHIM COSMOCHIM AC, V44, P1683, DOI 10.1016/0016-7037(80)90220-3; Santra S, 2010, IEEE SENS J, V10, P997, DOI 10.1109/JSEN.2009.2037822; SEIDEL H, 1990, J ELECTROCHEM SOC, V137, P3612, DOI 10.1149/1.2086277; Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002; Won SM, 2011, IEEE T ELECTRON DEV, V58, P4074, DOI 10.1109/TED.2011.2164923	17	855	892	38	854	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2012	337	6102					1640	1644		10.1126/science.1226325	http://dx.doi.org/10.1126/science.1226325			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	23019646	Green Accepted			2022-12-24	WOS:000309215400041
J	Neph, S; Stergachis, AB; Reynolds, A; Sandstrom, R; Borenstein, E; Stamatoyannopoulos, JA				Neph, Shane; Stergachis, Andrew B.; Reynolds, Alex; Sandstrom, Richard; Borenstein, Elhanan; Stamatoyannopoulos, John A.			Circuitry and Dynamics of Human Transcription Factor Regulatory Networks	CELL			English	Article							PROTEIN-DNA; IN-VIVO; GLUCOCORTICOID-RECEPTOR; ERYTHROID LINEAGE; STEM-CELLS; CHROMATIN; GENE; DATABASE; EXPRESSION; DIFFERENTIATION	The combinatorial cross-regulation of hundreds of sequence-specific transcription factors (TFs) defines a regulatory network that underlies cellular identity and function. Here we use genome-wide maps of in vivo DNaseI footprints to assemble an extensive core human regulatory network comprising connections among 475 sequence-specific TFs and to analyze the dynamics of these connections across 41 diverse cell and tissue types. We find that human TF networks are highly cell selective and are driven by cohorts of factors that include regulators with previously unrecognized roles in control of cellular identity. Moreover, we identify many widely expressed factors that impact transcriptional regulatory networks in a cell-selective manner. Strikingly, in spite of their inherent diversity, all cell-type regulatory networks independently converge on a common architecture that closely resembles the topology of living neuronal networks. Together, our results provide an extensive description of the circuitry, dynamics, and organizing principles of the human TF regulatory network.	[Neph, Shane; Stergachis, Andrew B.; Reynolds, Alex; Sandstrom, Richard; Borenstein, Elhanan; Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Borenstein, Elhanan] Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA; [Stamatoyannopoulos, John A.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Borenstein, Elhanan] Santa Fe Inst, Santa Fe, NM 87501 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; The Santa Fe Institute	Borenstein, E (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	elbo@uw.edu; jstam@uw.edu		Sandstrom, Richard/0000-0002-3356-1547	NIH [HG004592]; NIDDK F30 fellowship [FDK095678A]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK095678] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK F30 fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr. Sam John for critical reading of the manuscript and our colleagues for many helpful and insightful observations and discussions. This work was supported by NIH grant HG004592 to J.A.S. All data are available through the ENCODE data repository at the UCSC genome browser (http://genome.ucsc.edu). E.B. is an Alfred P. Sloan Research Fellow. A.B.S. was supported by an NIDDK F30 fellowship (FDK095678A).	Alon U., 2006, INTRO SYSTEMS BIOL D; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Davidson EH, 2002, DEV BIOL, V246, P162, DOI 10.1006/dbio.2002.0635; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; GRIGNANI F, 1993, CELL, V74, P423, DOI 10.1016/0092-8674(93)80044-F; GROUDINE M, 1982, CELL, V30, P131, DOI 10.1016/0092-8674(82)90019-8; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Jolma A, 2010, GENOME RES, V20, P861, DOI 10.1101/gr.100552.109; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; KARIN M, 1984, NATURE, V308, P513, DOI 10.1038/308513a0; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; KUO MT, 1979, NUCLEIC ACIDS RES, V7, P2105, DOI 10.1093/nar/7.8.2105; MacNeill C, 2000, DEV BIOL, V217, P62, DOI 10.1006/dbio.1999.9539; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; NAIDU PS, 1995, MOL CELL BIOL, V15, P2707; Neph S.J., 2012, NATURE; Newburger DE, 2009, NUCLEIC ACIDS RES, V37, pD77, DOI 10.1093/nar/gkn660; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; ORKIN SH, 1995, J BIOL CHEM, V270, P4955, DOI 10.1074/jbc.270.10.4955; PFEIFER GP, 1991, GENE DEV, V5, P1102, DOI 10.1101/gad.5.6.1102; Ramachandran B, 2008, J BIOL CHEM, V283, P10318, DOI 10.1074/jbc.M707623200; Reece-Hoyes JS, 2011, NAT METHODS, V8, P1059, DOI [10.1038/NMETH.1748, 10.1038/nmeth.1748]; RIGAUD G, 1991, CELL, V67, P977, DOI 10.1016/0092-8674(91)90370-E; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Serov VN, 1998, BIOINFORMATICS, V14, P546, DOI 10.1093/bioinformatics/14.6.546; Shimazaki T, 1999, EMBO J, V18, P444, DOI 10.1093/emboj/18.2.444; Slattery M, 2011, CELL, V147, P1270, DOI 10.1016/j.cell.2011.10.053; Spemann H, 1918, ARCH ENTWICKLUNG ORG, V43, P448, DOI 10.1007/BF02267308; STALDER J, 1980, CELL, V20, P451, DOI 10.1016/0092-8674(80)90631-5; Sucov HM, 1996, BIOCHEM SOC SYMP, P143; Swiers G, 2006, DEV BIOL, V294, P525, DOI 10.1016/j.ydbio.2006.02.051; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; The ENCODE Project Consortium, 2012, NATURE; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Waddington C.H., 1940, ORG GENES; Waddington C H, 1957, STRATEGY GENES DISCU; Waddington C. H., 1939, INTRO MODERN GENETIC; Walhout AJM, 2006, GENOME RES, V16, P1445, DOI 10.1101/gr.5321506; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; WU C, 1979, CELL, V16, P797, DOI 10.1016/0092-8674(79)90095-3; Xing YM, 2010, DEVELOPMENT, V137, P825, DOI 10.1242/dev.040535; YUH CH, 1994, MECH DEVELOP, V47, P165, DOI 10.1016/0925-4773(94)90088-4; Yun KS, 1996, CURR OPIN CELL BIOL, V8, P877, DOI 10.1016/S0955-0674(96)80091-3	62	295	304	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 14	2012	150	6					1274	1286		10.1016/j.cell.2012.04.040	http://dx.doi.org/10.1016/j.cell.2012.04.040			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22959076	Green Accepted, Bronze			2022-12-24	WOS:000308928100019
J	Mattison, JA; Roth, GS; Beasley, TM; Tilmont, EM; Handy, AM; Herbert, RL; Longo, DL; Allison, DB; Young, JE; Bryant, M; Barnard, D; Ward, WF; Qi, WB; Ingram, DK; de Cabo, R				Mattison, Julie A.; Roth, George S.; Beasley, T. Mark; Tilmont, Edward M.; Handy, April M.; Herbert, Richard L.; Longo, Dan L.; Allison, David B.; Young, Jennifer E.; Bryant, Mark; Barnard, Dennis; Ward, Walter F.; Qi, Wenbo; Ingram, Donald K.; de Cabo, Rafael			Impact of caloric restriction on health and survival in rhesus monkeys from the NIA study	NATURE			English	Article							T-CELL SENESCENCE; DIETARY RESTRICTION; LIFE-SPAN; AGE; MORTALITY; DISEASE; MODEL; RATS; MICE; INFLAMMATION	Calorie restriction (CR), a reduction of 10-40% in intake of a nutritious diet, is often reported as the most robust non-genetic mechanism to extend lifespan and healthspan. CR is frequently used as a tool to understand mechanisms behind ageing and age-associated diseases. In addition to and independently of increasing lifespan, CR has been reported to delay or prevent the occurrence of many chronic diseases in a variety of animals. Beneficial effects of CR on outcomes such as immune function(1,2), motor coordination(3) and resistance to sarcopenia(4) in rhesus monkeys have recently been reported. We report here that a CR regimen implemented in young and older age rhesus monkeys at the National Institute on Aging (NIA) has not improved survival outcomes. Our findings contrast with an ongoing study at the Wisconsin National Primate Research Center (WNPRC), which reported improved survival associated with 30% CR initiated in adult rhesus monkeys (7-14 years)(5) and a preliminary report with a small number of CR monkeys(6). Over the years, both NIA and WNPRC have extensively documented beneficial health effects of CR in these two apparently parallel studies. The implications of the WNPRC findings were important as they extended CR findings beyond the laboratory rodent and to a long-lived primate. Our study suggests a separation between health effects, morbidity andmortality, and similar to what has been shown in rodents(7-9), study design, husbandry and diet composition may strongly affect the life-prolonging effect of CR in a long-lived nonhuman primate.	[Mattison, Julie A.; Tilmont, Edward M.; Handy, April M.; Young, Jennifer E.] NIA, Lab Expt Gerontol, NIH, Anim Ctr, Dickerson, MD 20842 USA; [Roth, George S.] GeroScience, Pylesville, MD 21132 USA; [Beasley, T. Mark] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Handy, April M.] SoBran Inc, Burtonsville, MD 20866 USA; [Herbert, Richard L.] NIAID, NIH, Anim Ctr, Dickerson, MD 20842 USA; [Longo, Dan L.] NIA, Lab Mol Biol & Immunol, NIH, Baltimore, MD 21224 USA; [Allison, David B.] Univ Alabama Birmingham, Off Energet, Birmingham, AL 35294 USA; [Bryant, Mark; Barnard, Dennis] NIH, Off Director, Diagnost & Res Serv Branch, Bethesda, MD 20814 USA; [Ward, Walter F.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA; [Qi, Wenbo] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Ingram, Donald K.] Louisiana State Univ, Pennington Biomed Res Ctr, Nutr Neurosci & Aging Lab, Baton Rouge, LA 70808 USA; [de Cabo, Rafael] NIA, Lab Expt Gerontol, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Mattison, JA (corresponding author), NIA, Lab Expt Gerontol, NIH, Anim Ctr, 16701 Elmer Sch Rd,Bldg 103, Dickerson, MD 20842 USA.	mattisonj@mail.nih.gov; Donald.Ingram@pbrc.edu; deCaboRa@grc.nia.nih.gov	de Cabo, Rafael Carlos/J-5230-2016; Longo, Dan L./F-6022-2011; de Cabo, Rafael/E-7996-2010; de Cabo, Rafael/J-5230-2016	de Cabo, Rafael Carlos/0000-0003-2830-5693; de Cabo, Rafael/0000-0003-2830-5693; Allison, David/0000-0003-3566-9399; de Cabo, Rafael/0000-0002-3354-2442	NIH, National Institute on Aging; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIGAI001047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000368, ZIAAG000371] Funding Source: NIH RePORTER	NIH, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the animal care staff and technicians, both past and present, especially J. Travis and M. Szarowicz; K. Vaughan for her editorial help; and the many collaborators that have contributed to this project. This research was supported by the Intramural Research Program of the NIH, National Institute on Aging.	Allison P. D., 1995, SURVIVAL ANAL USING; [Anonymous], 2006, SAS MIXED MODELS; Bodkin NL, 2003, J GERONTOL A-BIOL, V58, P212; Branch-Mays GL, 2008, J PERIODONTOL, V79, P1184, DOI 10.1902/jop.2008.070629 ; Colman R. J., 1998, METHODS AGING RES, P249; Colman RJ, 2008, J GERONTOL A-BIOL, V63, P556, DOI 10.1093/gerona/63.6.556; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Duffy PH, 2001, AGING-CLIN EXP RES, V13, P263; Forster MJ, 2003, FASEB J, V17, P690, DOI 10.1096/fj.02-0533fje; Harper JM, 2006, AGING CELL, V5, P441, DOI 10.1111/j.1474-9726.2006.00236.x; INGRAM DK, 1990, J GERONTOL, V45, pB148, DOI 10.1093/geronj/45.5.B148; Kastman EK, 2010, J NEUROSCI, V30, P7940, DOI 10.1523/JNEUROSCI.0835-10.2010; LANE MA, 1995, J NUTR, V125, P1600; Liao CY, 2010, AGING CELL, V9, P92, DOI 10.1111/j.1474-9726.2009.00533.x; Lomba A, 2009, J NUTRIGENET NUTRIGE, V2, P267, DOI 10.1159/000308465; Mattison JA, 2005, NEUROBIOL AGING, V26, P1117, DOI 10.1016/j.neurobiolaging.2004.09.013; Messaoudi I, 2006, P NATL ACAD SCI USA, V103, P19448, DOI 10.1073/pnas.0606661103; Messaoudi I, 2010, CALORIE RESTRICTION, AGING AND LONGEVITY, P55, DOI 10.1007/978-90-481-8556-6_4; Messaoudi I, 2008, AGING CELL, V7, P908, DOI 10.1111/j.1474-9726.2008.00440.x; MURTAGHMARK CM, 1995, J GERONTOL A-BIOL, V50, pB148, DOI 10.1093/gerona/50A.3.B148; Nadon NL, 2006, AGING CELL, V5, P9, DOI 10.1111/j.1474-9726.2006.00185.x; Omodei D, 2011, FEBS LETT, V585, P1537, DOI 10.1016/j.febslet.2011.03.015; Raman A, 2007, AM J PHYSIOL-ENDOC M, V292, pE101, DOI 10.1152/ajpendo.00127.2006; Redman LM, 2011, ANTIOXID REDOX SIGN, V14, P275, DOI 10.1089/ars.2010.3253; Roncal-Jimenez CA, 2011, METABOLISM, V60, P1259, DOI 10.1016/j.metabol.2011.01.008; Roth GS, 2004, SCIENCE, V305, P1423, DOI 10.1126/science.1102541; Speakman JR, 2007, J NUTR, V137, P1078, DOI 10.1093/jn/137.4.1078; Swindell WR, 2012, AGEING RES REV, V11, P254, DOI 10.1016/j.arr.2011.12.006; Ward WF, 2005, J GERONTOL A-BIOL, V60, P847, DOI 10.1093/gerona/60.7.847; [No title captured]	30	726	745	10	235	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2012	489	7415					318	+		10.1038/nature11432	http://dx.doi.org/10.1038/nature11432			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003UC	22932268	Green Accepted			2022-12-24	WOS:000308635900047
J	Doege, CA; Inoue, K; Yamashita, T; Rhee, DB; Travis, S; Fujita, R; Guarnieri, P; Bhagat, G; Vanti, WB; Shih, A; Levine, RL; Nik, S; Chen, EI; Abeliovich, A				Doege, Claudia A.; Inoue, Keiichi; Yamashita, Toru; Rhee, David B.; Travis, Skylar; Fujita, Ryousuke; Guarnieri, Paolo; Bhagat, Govind; Vanti, William B.; Shih, Alan; Levine, Ross L.; Nik, Sara; Chen, Emily I.; Abeliovich, Asa			Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2	NATURE			English	Article							CHROMATIN-STRUCTURE; DNA DEMETHYLATION; SELF-RENEWAL; 5-HYDROXYMETHYLCYTOSINE; MAPS; 5-METHYLCYTOSINE; PLURIPOTENT; CONVERSION; REVEALS; GENES	Somatic cells can be reprogrammed into induced pluripotent stem cells (iPSCs) by using the pluripotency factors Oct4, Sox2, Klf4 and c-Myc (together referred to as OSKM)(1). iPSC reprogramming erases somatic epigenetic signatures-as typified by DNA methylation or histone modification at silent pluripotency loci-and establishes alternative epigenetic marks of embryonic stem cells (ESCs)(2). Here we describe an early and essential stage of somatic cell reprogramming, preceding the induction of transcription at endogenous pluripotency loci such as Nanog and Esrrb. By day 4 after transduction with OSKM, two epigenetic modification factors necessary for iPSC generation, namely poly(ADP-ribose) polymerase-1 (Parp1) and ten-eleven translocation-2 (Tet2), are recruited to the Nanog and Esrrb loci. These epigenetic modification factors seem to have complementary roles in the establishment of early epigenetic marks during somatic cell reprogramming: Parp1 functions in the regulation of 5-methylcytosine (5mC) modification, whereas Tet2 is essential for the early generation of 5-hydroxymethylcytosine (5hmC) by the oxidation of 5mC (refs 3,4). Although 5hmC has been proposed to serve primarily as an intermediate in 5mC demethylation to cytosine in certain contexts(5-7), our data, and also studies of Tet2-mutant human tumour cells(8), argue in favour of a role for 5hmC as an epigenetic mark distinct from 5mC. Consistent with this, Parp1 and Tet2 are each needed for the early establishment of histone modifications that typify an activated chromatin state at pluripotency loci, whereas Parp1 induction further promotes accessibility to the Oct4 reprogramming factor. These findings suggest that Parp1 and Tet2 contribute to an epigenetic program that directs subsequent transcriptional induction at pluripotency loci during somatic cell reprogramming.	[Doege, Claudia A.; Inoue, Keiichi; Yamashita, Toru; Rhee, David B.; Travis, Skylar; Fujita, Ryousuke; Bhagat, Govind; Vanti, William B.; Abeliovich, Asa] Columbia Univ, Dept Pathol & Cell Biol, Taub Inst Aging, New York, NY 10032 USA; [Doege, Claudia A.; Inoue, Keiichi; Yamashita, Toru; Rhee, David B.; Travis, Skylar; Fujita, Ryousuke; Bhagat, Govind; Vanti, William B.; Abeliovich, Asa] Columbia Univ, Dept Neurol, Taub Inst Aging, New York, NY 10032 USA; [Guarnieri, Paolo] Columbia Univ, Bioinformat Div, New York, NY 10032 USA; [Guarnieri, Paolo; Bhagat, Govind] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; [Shih, Alan; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10016 USA; [Nik, Sara; Chen, Emily I.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Chen, Emily I.] SUNY Stony Brook, Prote Ctr, Sch Med, Stony Brook, NY 11794 USA	Columbia University; Columbia University; Columbia University; Columbia University; Memorial Sloan Kettering Cancer Center; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Abeliovich, A (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, Taub Inst Aging, New York, NY 10032 USA.	aa900@columbia.edu	Bhagat, Govind/AAE-9493-2021; Vanti, William/E-6518-2016; levine, ross/AAE-7658-2019	Bhagat, Govind/0000-0001-6250-048X; Vanti, William/0000-0002-5591-5350; Inoue, Keiichi/0000-0002-7101-486X; Yamashita, Toru/0000-0003-3634-5679	New York State Stem Cell Science (NYSTEM) [C024402, C024403]; National Institutes of Health (NIH) [RO1 NS064433]; NYSTEM Institution Development [N08G-071]; NIH [RO1 138424]; NIH/National Center for Research Resources [1 S10 RR023680-1]; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA173636] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064433] Funding Source: NIH RePORTER	New York State Stem Cell Science (NYSTEM); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYSTEM Institution Development; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank G. Q. Daley, A. P. Feinberg, A. Doi, R. M. Santella and M. A. Kappil for reagents and for technical assistance with pyrosequencing; A. Califano and A. Lachmann for assistance with the bioinformatics analyses; E. O. Mazzoni for assistance with the ChIP analyses; and O. Hobert for critical reading of the manuscript. This work was supported by New York State Stem Cell Science (NYSTEM) grants C024402 and C024403 and National Institutes of Health (NIH) grant RO1 NS064433 to A. A., NYSTEM Institution Development Grant N08G-071 to E. I. C., NIH grant RO1 138424 to R. L. L, and a shared NIH/National Center for Research Resources instrument grant for mass spectrometry, 1 S10 RR023680-1.	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042; Davis T, 2011, JOVE-J VIS EXP, DOI 10.3791/2661; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Langelier MF, 2010, J BIOL CHEM, V285, P18877, DOI 10.1074/jbc.M110.105668; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Smith ZD, 2010, NAT BIOTECHNOL, V28, P521, DOI 10.1038/nbt.1632; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wacker DA, 2007, MOL CELL BIOL, V27, P7475, DOI 10.1128/MCB.01314-07; WANG ZQ, 1995, GENE DEV, V9, P509, DOI 10.1101/gad.9.5.509; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; Yildirim O, 2011, CELL, V147, P1498, DOI 10.1016/j.cell.2011.11.054	30	288	301	0	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2012	488	7413					652	655		10.1038/nature11333	http://dx.doi.org/10.1038/nature11333			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996NC	22902501	Green Accepted			2022-12-24	WOS:000308095100055
J	Chen, J; Li, YJ; Yu, TS; McKay, RM; Burns, DK; Kernie, SG; Parada, LF				Chen, Jian; Li, Yanjiao; Yu, Tzong-Shiue; McKay, Renee M.; Burns, Dennis K.; Kernie, Steven G.; Parada, Luis F.			A restricted cell population propagates glioblastoma growth after chemotherapy	NATURE			English	Article							EXPRESSING PROGENITORS; INITIATING CELLS; MOUSE MODELS; STEM-CELLS; NEUROGENESIS; GLIOMA; ASTROCYTOMAS; BRAIN; RARE	Glioblastoma multiforme is the most common primary malignant brain tumour, with a median survival of about one year(1). This poor prognosis is due to therapeutic resistance and tumour recurrence after surgical removal. Precisely how recurrence occurs is unknown. Using a genetically engineered mouse model of glioma, here we identify a subset of endogenous tumour cells that are the source of new tumour cells after the drug temozolomide (TMZ) is administered to transiently arrest tumour growth. A nestin-Delta TK-IRES-GFP (Nes-Delta TK-GFP) transgene that labels quiescent subventricular zone adult neural stem cells also labels a subset of endogenous glioma tumour cells. On arrest of tumour cell proliferation with TMZ, pulse-chase experiments demonstrate a tumour re-growth cell hierarchy originating with the Nes-Delta TK-GFP transgene subpopulation. Ablation of the GFP(+) cells with chronic ganciclovir administration significantly arrested tumour growth, and combined TMZ and ganciclovir treatment impeded tumour development. Thus, a relatively quiescent subset of endogenous glioma cells, with properties similar to those proposed for cancer stem cells, is responsible for sustaining long-term tumour growth through the production of transient populations of highly proliferative cells.	[Chen, Jian; Li, Yanjiao; Yu, Tzong-Shiue; McKay, Renee M.; Kernie, Steven G.; Parada, Luis F.] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Chen, Jian; Li, Yanjiao; Yu, Tzong-Shiue; McKay, Renee M.; Kernie, Steven G.; Parada, Luis F.] Univ Texas SW Med Ctr Dallas, Kent Waldrep Ctr Basic Res Nerve Growth & Regener, Dallas, TX 75390 USA; [Yu, Tzong-Shiue; Kernie, Steven G.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Burns, Dennis K.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Parada, LF (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA.	luis.parada@utsouthwestern.edu	Parada, luis F/B-9400-2014; Kernie, Steven/AAT-9912-2020	Kernie, Steven/0000-0003-1371-0549; Yu, Tzong-Shiue/0000-0003-4277-6213	James S. McDonnell Foundation [JSMF-220020206]; Goldhirsh Foundation; Cancer Prevention Research Institute of Texas [RP 100782]; National Institutes of Health [R01 CA131313];  [RO1 NS048192-01]; NATIONAL CANCER INSTITUTE [R01CA131313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048192] Funding Source: NIH RePORTER	James S. McDonnell Foundation; Goldhirsh Foundation; Cancer Prevention Research Institute of Texas; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank S. McKinnon, A. Deshaw, L. McClellan, S. Kennedy and P. Leake for technical assistance, and Parada laboratory members for helpful suggestions and discussion. CldU and IdU preparation and staining protocol was provided by D.A. Peterson at Rosalind Franklin University. This work was supported by grants awarded to S.G.K. (RO1 NS048192-01) and to L.F.P. by the Goldhirsh Foundation, the James S. McDonnell Foundation (JSMF-220020206), Cancer Prevention Research Institute of Texas (RP 100782) and the National Institutes of Health (R01 CA131313). L.F.P. is an American Cancer Society Research Professor.	Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Chen J, 2012, CELL, V149, P36, DOI 10.1016/j.cell.2012.03.009; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Deng W, 2009, J NEUROSCI, V29, P13532, DOI 10.1523/JNEUROSCI.3362-09.2009; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; IshiiMorita H, 1997, GENE THER, V4, P244, DOI 10.1038/sj.gt.3300379; Ishizawa K, 2010, CELL STEM CELL, V7, P279, DOI 10.1016/j.stem.2010.08.009; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kwon CH, 2008, CANCER RES, V68, P3286, DOI 10.1158/0008-5472.CAN-07-6867; Liu C, 2011, CELL, V146, P209, DOI 10.1016/j.cell.2011.06.014; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Singer BH, 2011, P NATL ACAD SCI USA, V108, P5437, DOI 10.1073/pnas.1015425108; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Vega CJ, 2005, NAT METHODS, V2, P167, DOI 10.1038/NMETH741; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Zhu Y, 2005, CANCER CELL, V8, P119, DOI 10.1016/j.ccr.2005.07.004	19	1483	1542	8	321	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2012	488	7412					522	+		10.1038/nature11287	http://dx.doi.org/10.1038/nature11287			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992FS	22854781	Green Accepted			2022-12-24	WOS:000307761600039
J	Franco, SJ; Gil-Sanz, C; Martinez-Garay, I; Espinosa, A; Harkins-Perry, SR; Ramos, C; Muller, U				Franco, Santos J.; Gil-Sanz, Cristina; Martinez-Garay, Isabel; Espinosa, Ana; Harkins-Perry, Sarah R.; Ramos, Cynthia; Mueller, Ulrich			Fate-Restricted Neural Progenitors in the Mammalian Cerebral Cortex	SCIENCE			English	Article							INTERMEDIATE PROGENITORS; LAMINAR FATE; STEM-CELLS; NEOCORTEX; NEURONS; MOUSE; CRE; RECOMBINATION; SPECIFICATION; EXPRESSION	During development of the mammalian cerebral cortex, radial glial cells (RGCs) generate layer-specific subtypes of excitatory neurons in a defined temporal sequence, in which lower-layer neurons are formed before upper-layer neurons. It has been proposed that neuronal subtype fate is determined by birthdate through progressive restriction of the neurogenic potential of a common RGC progenitor. Here, we demonstrate that the murine cerebral cortex contains RGC sublineages with distinct fate potentials. Using in vivo genetic fate mapping and in vitro clonal analysis, we identified an RGC lineage that is intrinsically specified to generate only upper-layer neurons, independently of niche and birthdate. Because upper cortical layers were expanded during primate evolution, amplification of this RGC pool may have facilitated human brain evolution.	[Mueller, Ulrich] Scripps Res Inst, Dorris Neurosci Ctr, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Muller, U (corresponding author), Scripps Res Inst, Dorris Neurosci Ctr, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	umueller@scripps.edu	Gil-Sanz, Cristina/K-9859-2017; Gil-Sanz, Cristina/AAX-3558-2021; Garay, Isabel Martinez/AAI-8951-2021; Franco, Santos/V-3413-2019; Espinosa Martínez, Ana Belén/AAD-4487-2021	Gil-Sanz, Cristina/0000-0002-7827-5480; Gil-Sanz, Cristina/0000-0002-7827-5480; Garay, Isabel Martinez/0000-0001-6849-7496; Franco, Santos/0000-0002-4478-5634; Espinosa Martínez, Ana Belén/0000-0002-3738-3514	NIH [NS060355, NS046456, MH078833]; Generalitat Valenciana [APOSTD/2010/064]; Ministerio de Educacion [EX2009-0416, FU-2006-1238]; CIRM; Skaggs Institute for Chemical Biology; Dorris Neuroscience Center; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH078833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS060355, R01NS046456] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Ministerio de Educacion; CIRM(California Institute for Regenerative Medicine); Skaggs Institute for Chemical Biology; Dorris Neuroscience Center; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank G. Fishell for Nestin-CreERT2 mice; H. Zeng for Ai9 reporter mice; P. Chambon for pCreERT2; A. Maximov for the FLEx backbone; T. Wagner, S. Courtes, and P. Kazmierczak for experiments that did not appear in the final manuscript; and F. Polleux, E. Grove, N. Grillet, and S. Courtes for critical comments. This work was supported by the NIH (S.J.F., NS060355; U. M., NS046456 and MH078833), Generalitat Valenciana (C.G.-S., APOSTD/2010/064), Ministerio de Educacion (C.G.-S., EX2009-0416; I. M.-G., FU-2006-1238), CIRM training grant (I. M.-G. and A. E.), the Skaggs Institute for Chemical Biology (U. M.), and the Dorris Neuroscience Center (U. M.). S.J.F., I. M.-G., C.G.-S., and U. M. conceived the project; S.J.F., C.G.-S., I. M.-G., and A. E. designed, performed, and analyzed experiments with assistance from S. R. H.-P. and C. R.; and S.J.F. and U. M. prepared the manuscript, with revisions from C.G.-S., I. M.-G., and A.E.	Alcamo EA, 2008, NEURON, V57, P364, DOI 10.1016/j.neuron.2007.12.012; Balordi F, 2007, J NEUROSCI, V27, P14248, DOI 10.1523/JNEUROSCI.4531-07.2007; Britanova O, 2008, NEURON, V57, P378, DOI 10.1016/j.neuron.2007.12.028; Costa MR, 2009, CEREB CORTEX, V19, pI135, DOI 10.1093/cercor/bhp046; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Franco SJ, 2011, NEURON, V69, P482, DOI 10.1016/j.neuron.2011.01.003; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hevner RF, 2003, DEV NEUROSCI-BASEL, V25, P139, DOI 10.1159/000072263; Kowalczyk T, 2009, CEREB CORTEX, V19, P2439, DOI 10.1093/cercor/bhn260; Leone DP, 2008, CURR OPIN NEUROBIOL, V18, P28, DOI 10.1016/j.conb.2008.05.006; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; Schnutgen F, 2003, NAT BIOTECHNOL, V21, P562, DOI 10.1038/nbt811; Takahashi T, 1999, J NEUROSCI, V19, P10357; Woodhead GJ, 2006, J NEUROSCI, V26, P12620, DOI 10.1523/JNEUROSCI.3180-06.2006; Yoon KJ, 2008, NEURON, V58, P519, DOI 10.1016/j.neuron.2008.03.018; Zervas M, 2004, NEURON, V43, P345, DOI 10.1016/j.neuron.2004.07.010; Zimmer C, 2004, CEREB CORTEX, V14, P1408, DOI 10.1093/cercor/bhh102	20	213	214	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2012	337	6095					746	749		10.1126/science.1223616	http://dx.doi.org/10.1126/science.1223616			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986PE	22879516	Green Accepted			2022-12-24	WOS:000307354500058
J	Koren, O; Goodrich, JK; Cullender, TC; Spor, A; Laitinen, K; Backhed, HK; Gonzalez, A; Werner, JJ; Angenent, LT; Knight, R; Backhed, F; Isolauri, E; Salminen, S; Ley, RE				Koren, Omry; Goodrich, Julia K.; Cullender, Tyler C.; Spor, Ayme; Laitinen, Kirsi; Backhed, Helene Kling; Gonzalez, Antonio; Werner, Jeffrey J.; Angenent, Largus T.; Knight, Rob; Backhed, Fredrik; Isolauri, Erika; Salminen, Seppo; Ley, Ruth E.			Host Remodeling of the Gut Microbiome and Metabolic Changes during Pregnancy	CELL			English	Article							MATERNAL METABOLISM; INSULIN-RESISTANCE; OBESITY; ASSOCIATIONS; INFLAMMATION; MECHANISMS; CYTOKINES; WEIGHT; DIET	Many of the immune and metabolic changes occurring during normal pregnancy also describe metabolic syndrome. Gut microbiota can cause symptoms of metabolic syndrome in nonpregnant hosts. Here, to explore their role in pregnancy, we characterized fecal bacteria of 91 pregnant women of varying prepregnancy BMIs and gestational diabetes status and their infants. Similarities between infant-mother microbiotas increased with children's age, and the infant microbiota was unaffected by mother's health status. Gut microbiota changed dramatically from first (T1) to third (T3) trimesters, with vast expansion of diversity between mothers, an overall increase in Proteobacteria and Actinobacteria, and reduced richness. T3 stool showed strongest signs of inflammation and energy loss; however, microbiome gene repertoires were constant between trimesters. When transferred to germ-free mice, T3 microbiota induced greater adiposity and insulin insensitivity compared to T1. Our findings indicate that host-microbial interactions that impact host metabolism can occur and may be beneficial in pregnancy.	[Koren, Omry; Goodrich, Julia K.; Cullender, Tyler C.; Spor, Ayme; Ley, Ruth E.] Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA; [Koren, Omry; Goodrich, Julia K.; Cullender, Tyler C.; Spor, Ayme; Ley, Ruth E.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Werner, Jeffrey J.; Angenent, Largus T.] Cornell Univ, Dept Biol & Environm Engn, Ithaca, NY 14853 USA; [Laitinen, Kirsi] Univ Turku, Inst Biomed, Turku 20610, Finland; [Laitinen, Kirsi; Salminen, Seppo] Univ Turku, Funct Foods Forum, Turku 20610, Finland; [Isolauri, Erika] Turku Univ Hosp, Dept Pediat, Turku 20521, Finland; [Backhed, Helene Kling; Backhed, Fredrik] Sahlgrenska Ctr Cardiovasc & Metab Res, Wallenberg Lab, SE-41345 Gothenburg, Sweden; [Backhed, Helene Kling; Backhed, Fredrik] Univ Gothenburg, Dept Mol & Clin Med, SE-40530 Gothenburg, Sweden; [Gonzalez, Antonio] Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA; [Knight, Rob] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Knight, Rob] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA	Cornell University; Cornell University; Cornell University; University of Turku; University of Turku; University of Turku; University of Gothenburg; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Ley, RE (corresponding author), Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA.	rel222@cornell.edu	Koren, Omry/A-5222-2016; Angenent, Largus T/A-6219-2018; Goodrich, Julia/ABD-8368-2021; Ley, Ruth E/M-8542-2014; Spor, Aymé/A-6271-2012; Knight, Rob/D-1299-2010; Backhed, Fredrik/ABE-6613-2020; Gonzalez, Antonio/A-6421-2018	Koren, Omry/0000-0002-7738-1337; Angenent, Largus T/0000-0003-0180-1865; Ley, Ruth E/0000-0002-9087-1672; Spor, Aymé/0000-0002-4707-9559; Backhed, Fredrik/0000-0002-4871-8818; Laitinen, Kirsi/0000-0001-5245-8118; Knight, Rob/0000-0002-0975-9019	Hartwell Foundation; NIH Human Microbiome Project DACC; David and Lucile Packard Foundation; Arnold and Mabel Beckman Foundation; Cornell Center for Comparative Population Genomics; Ragnar Soderberg Foundation; Paivikki and Sakari Sohlberg Foundation; Academy of Finland; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093595] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007444] Funding Source: NIH RePORTER	Hartwell Foundation; NIH Human Microbiome Project DACC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Arnold and Mabel Beckman Foundation; Cornell Center for Comparative Population Genomics; Ragnar Soderberg Foundation; Paivikki and Sakari Sohlberg Foundation; Academy of Finland(Academy of Finland); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Mary-Claire King, Andrew Clark, and Andrew Gewirtz for their contributions to the manuscript, and we thank Daniel McDonlad and Nick Scalfone for technical assistance. This research was supported by The Hartwell Foundation, the NIH Human Microbiome Project DACC, the David and Lucile Packard Foundation, the Arnold and Mabel Beckman Foundation, the Cornell Center for Comparative Population Genomics, the Ragnar Soderberg Foundation, the Paivikki and Sakari Sohlberg Foundation, and the Academy of Finland.	Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Barbour LA, 2007, DIABETES CARE, V30, pS112, DOI 10.2337/dc07-s202; Beigi RH, 2007, J INFECT DIS, V196, P1355, DOI 10.1086/521628; Caesar R, 2012, GUT; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Collado MC, 2010, AM J CLIN NUTR, V92, P1023, DOI 10.3945/ajcn.2010.29877; Carvalho FA, 2012, CELL HOST MICROBE; Collado MC, 2008, AM J CLIN NUTR, V88, P894, DOI 10.1093/ajcn/88.4.894; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Di Cianni G, 2003, DIABETES-METAB RES, V19, P259, DOI 10.1002/dmrr.390; Greenblum S, 2012, P NATL ACAD SCI USA, V109, P594, DOI 10.1073/pnas.1116053109; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132; Kirwan JP, 2002, DIABETES, V51, P2207, DOI 10.2337/diabetes.51.7.2207; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Kuczynski J, 2012, NAT REV GENET, V13, P47, DOI 10.1038/nrg3129; Lain KY, 2007, CLIN OBSTET GYNECOL, V50, P938, DOI 10.1097/GRF.0b013e31815a5494; Laitinen K, 2009, BRIT J NUTR, V101, P1679, DOI 10.1017/S0007114508111461; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Mor G, 2010, AM J REPROD IMMUNOL, V63, P425, DOI 10.1111/j.1600-0897.2010.00836.x; Mukhopadhya I, 2012, NAT REV GASTRO HEPAT, V9, P219, DOI 10.1038/nrgastro.2012.14; Nelson SM, 2010, HUM REPROD UPDATE, V16, P255, DOI 10.1093/humupd/dmp050; Newbern D, 2011, CURR OPIN ENDOCRINOL, V18, P409, DOI 10.1097/MED.0b013e32834c800d; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Saiki T, 1998, SCAND J GASTROENTERO, V33, P616; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Sim K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032543; Slack E, 2009, SCIENCE, V325, P617, DOI 10.1126/science.1172747; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Straka M, 2011, NEUROENDOCRINOL LETT, V32, P34; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; van Nimwegen FA, 2011, J ALLERGY CLIN IMMUN, V128, P948, DOI 10.1016/j.jaci.2011.07.027; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	46	1080	1180	19	355	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 3	2012	150	3					470	480		10.1016/j.cell.2012.07.008	http://dx.doi.org/10.1016/j.cell.2012.07.008			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	985WO	22863002	Green Accepted, Bronze			2022-12-24	WOS:000307301400008
J	Neeland, IJ; Turer, AT; Ayers, CR; Powell-Wiley, TM; Vega, GL; Farzaneh-Far, R; Grundy, SM; Khera, A; McGuire, DK; de Lemos, JA				Neeland, Ian J.; Turer, Aslan T.; Ayers, Colby R.; Powell-Wiley, Tiffany M.; Vega, Gloria L.; Farzaneh-Far, Ramin; Grundy, Scott M.; Khera, Amit; McGuire, Darren K.; de Lemos, James A.			Dysfunctional Adiposity and the Risk of Prediabetes and Type 2 Diabetes in Obese Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; INSULIN-RESISTANCE; SEX-DIFFERENCES; PLASMA-LEVELS; ASSOCIATION; TISSUE; POPULATION; PREVALENCE; PREDICTION; MORTALITY	Context The risk of type 2 diabetes mellitus is heterogeneous among obese individuals. Factors that discriminate prediabetes or diabetes risk within this population have not been well characterized. A dysfunctional adiposity phenotype, characterized by excess visceral fat and insulin resistance, may contribute to diabetes development in those with obesity. Objective To investigate associations between adiposity phenotypes and risk for incident prediabetes and diabetes in a multiethnic, population-based cohort of obese adults. Design, Setting, and Participants Among 732 obese participants (body mass index >= 30) aged 30 to 65 years without diabetes or cardiovascular disease enrolled between 2000 and 2002 in the Dallas Heart Study, we measured body composition by dual energy x-ray absorptiometry and magnetic resonance imaging (MRI); circulating adipokines and biomarkers of insulin resistance, dyslipidemia, and inflammation; and subclinical atherosclerosis and cardiac structure and function by computed tomography and MRI. Main Outcome Measures Incidence of diabetes through a median 7.0 years (interquartile range, 6.6-7.6) of follow-up. In a subgroup of 512 participants with normal fasting glucose values at baseline, incidence of the composite of prediabetes or diabetes was determined. Results Of the 732 participants (mean age, 43 years; 65% women; 71% non-white), 84 (11.5%) developed diabetes. In multivariable analysis, higher baseline visceral fat mass (odds ratio [OR] per 1 SD [1.4 kg], 2.4; 95% CI, 1.6-3.7), fructosamine level (OR per 1 SD [1.1 mu mol/L], 2.0; 95% CI, 1.4-2.7), fasting glucose level (OR per 1 SD [1.1 mu mol/L], 1.9; 95% CI, 1.4-2.6), family history of diabetes (OR, 2.3; 95% CI, 1.3-4.3), systolic blood pressure (OR per 10 mm Hg, 1.3; 95% CI, 1.1-1.5), and weight gain over follow-up (OR per 1 kg, 1.06; 95% CI, 1.02-1.10) were independently associated with diabetes, with no associations observed for body mass index, total body fat, or abdominal subcutaneous fat. Among the 512 participants with normal baseline glucose values, the composite outcome of prediabetes or diabetes occurred in 39.1% and was independently associated with baseline measurements of visceral fat mass; levels of fasting glucose, insulin, and fructosamine; older age; non-white race; family history of diabetes; and weight gain over follow-up (P < .05 for each) but not with measurements of general adiposity. Conclusion Excess visceral fat and insulin resistance, but not general adiposity, were independently associated with incident prediabetes and type 2 diabetes mellitus in obese adults. JAMA. 2012;308(11):1150-1159 www.jama.com	[Neeland, Ian J.; Turer, Aslan T.; Ayers, Colby R.; Farzaneh-Far, Ramin; Khera, Amit; McGuire, Darren K.; de Lemos, James A.] Univ Texas SW Med Ctr Dallas, Div Cardiol, Dallas, TX 75390 USA; [Ayers, Colby R.; McGuire, Darren K.] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Vega, Gloria L.; Grundy, Scott M.] Univ Texas SW Med Ctr Dallas, Ctr Human Nutr, Dallas, TX 75390 USA; [Powell-Wiley, Tiffany M.] NHLBI, Cardiovasc & Pulm Branch, NIH, Bethesda, MD 20892 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	de Lemos, JA (corresponding author), Univ Texas SW Med Ctr Dallas, Div Cardiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	james.delemos@utsouthwestern.edu	de Lemos, James/ABD-6669-2021; McGuire, Darren K./AAL-4172-2021		F. Hoffmann LaRoche; Genentech; sanofi-aventis; Daiichi Sankyo; Novo Nordisk; Tethys Bioscience; Roche Diagnostics; Abbott Diagnostics; Alere; AstraZeneca; Donald W. Reynolds Foundation; US Public Health Service General Clinical Research Center [M01-RR00633]; National Institutes of Health (NIH) [UL1DE019584, PL1DK081182]; National Heart, Lung, and Blood Institute (NHLBI) [T32HL007360]; Division of Intramural Research of the NHLBI of the NIH; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000633] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [UL1DE019584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [PL1DK081182] Funding Source: NIH RePORTER	F. Hoffmann LaRoche(Hoffmann-La Roche); Genentech(Roche HoldingGenentech); sanofi-aventis(Sanofi-Aventis); Daiichi Sankyo(Daiichi Sankyo Company Limited); Novo Nordisk(Novo Nordisk); Tethys Bioscience; Roche Diagnostics; Abbott Diagnostics(Abbott Laboratories); Alere; AstraZeneca(AstraZeneca); Donald W. Reynolds Foundation; US Public Health Service General Clinical Research Center(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Division of Intramural Research of the NHLBI of the NIH; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr McGuire reported having received consulting income from F. Hoffmann LaRoche, Genentech, sanofi-aventis, Daiichi Sankyo, Novo Nordisk, and Tethys Bioscience. Dr de Lemos reported having received grant support from Roche Diagnostics, Abbott Diagnostics, and Alere; consulting income from Tethys Bioscience, AstraZeneca, and Daiichi Sankyo; and lecture honoraria from Bristol-Myers Squibb/sanofi-aventis. No other disclosures were reported.; Grant support for the Dallas Heart Study was provided by the Donald W. Reynolds Foundation and by US Public Health Service General Clinical Research Center grant M01-RR00633, with additional support for the present study provided by grants UL1DE019584 and PL1DK081182 from the National Institutes of Health (NIH). Dr Neeland is supported by award T32HL007360 from the National Heart, Lung, and Blood Institute (NHLBI). Dr Powell-Wiley is funded by the Division of Intramural Research of the NHLBI of the NIH. Biomarker measurements were supported by investigator-initiated grants from Alere and Roche Diagnostics.	Abate N, 1997, AM J CLIN NUTR, V65, P403, DOI 10.1093/ajcn/65.2.403; Abdullah SM, 2007, ATHEROSCLEROSIS, V195, P404, DOI 10.1016/j.atherosclerosis.2006.10.022; Abdullah SM, 2005, AM J CARDIOL, V96, P1284, DOI 10.1016/j.amjcard.2005.06.073; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Barr ELM, 2007, CIRCULATION, V116, P151, DOI 10.1161/CIRCULATIONAHA.106.685628; Bluher M, 2010, CURR OPIN LIPIDOL, V21, P38, DOI 10.1097/MOL.0b013e3283346ccc; Boyko EJ, 2000, DIABETES CARE, V23, P465, DOI 10.2337/diacare.23.4.465; Cornier MA, 2011, CIRCULATION, V124, P1996, DOI 10.1161/CIR.0b013e318233bc6a; de Lemos JA, 2010, JAMA-J AM MED ASSOC, V304, P2503, DOI 10.1001/jama.2010.1768; Deo R, 2004, J AM COLL CARDIOL, V44, P1812, DOI 10.1016/j.jacc.2004.07.047; Drazner MH, 2005, HYPERTENSION, V46, P124, DOI 10.1161/01.HYP.0000169972.96201.8e; Ferrannini E, 1997, J CLIN INVEST, V100, P1166, DOI 10.1172/JCI119628; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Fox CS, 2006, CIRCULATION, V113, P2914, DOI 10.1161/CIRCULATIONAHA.106.613828; Garber Alan J, 2008, Endocr Pract, V14, P933; Genuth S, 2003, DIABETES CARE, V26, P3160; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Jain T, 2004, J AM COLL CARDIOL, V44, P1011, DOI 10.1016/j.jacc.2004.05.069; Jeyarajah EJ, 2006, CLIN LAB MED, V26, P847, DOI 10.1016/j.cll.2006.07.006; Khera A, 2009, J CLIN ENDOCR METAB, V94, P3251, DOI 10.1210/jc.2008-2406; Liu JK, 2010, J CLIN ENDOCR METAB, V95, P5419, DOI 10.1210/jc.2010-1378; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McLaughlin T, 2011, J CLIN ENDOCR METAB, V96, pE1756, DOI 10.1210/jc.2011-0615; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI [10.1001/jama.289.1.76, DOI 10.1001/JAMA.289.1.76]; Preis SR, 2010, OBESITY, V18, P2191, DOI 10.1038/oby.2010.59; Rexrode KM, 2001, INT J OBESITY, V25, P1047, DOI 10.1038/sj.ijo.0801615; Rohatgi A, 2009, ATHEROSCLEROSIS, V203, P569, DOI 10.1016/j.atherosclerosis.2008.07.015; Ross R, 2002, AM J PHYSIOL-ENDOC M, V282, pE657, DOI 10.1152/ajpendo.00469.2001; Schmidt MI, 2005, DIABETES CARE, V28, P2013, DOI 10.2337/diacare.28.8.2013; Szczepaniak LS, 1999, AM J PHYSIOL-ENDOC M, V276, pE977, DOI 10.1152/ajpendo.1999.276.5.E977; Tan CY, 2008, BIOCHEM SOC T, V36, P935, DOI 10.1042/BST0360935; Tikuisis P, 2001, EUR J APPL PHYSIOL, V85, P264, DOI 10.1007/s004210100484; Tran TT, 2008, CELL METAB, V7, P410, DOI 10.1016/j.cmet.2008.04.004; Turer AT, 2011, DIABETOLOGIA, V54, P2515, DOI 10.1007/s00125-011-2252-z; Vega GL, 2006, J CLIN ENDOCR METAB, V91, P4459, DOI 10.1210/jc.2006-0814; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058; Wijeysundera HC, 2010, JAMA-J AM MED ASSOC, V303, P1841, DOI 10.1001/jama.2010.580; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068	40	411	431	5	48	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	2012	308	11					1150	1159		10.1001/2012.jama.11132	http://dx.doi.org/10.1001/2012.jama.11132			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007AL	22990274	Green Accepted, Bronze			2022-12-24	WOS:000308861000031
J	Schepers, AG; Snippert, HJ; Stange, DE; van den Born, M; van Es, JH; van de Wetering, M; Clevers, H				Schepers, Arnout G.; Snippert, Hugo J.; Stange, Daniel E.; van den Born, Maaike; van Es, Johan H.; van de Wetering, Marc; Clevers, Hans			Lineage Tracing Reveals Lgr5(+) Stem Cell Activity in Mouse Intestinal Adenomas	SCIENCE			English	Article							COLORECTAL-CANCER; HUMAN COLON; DIFFERENTIATION; IDENTIFICATION; ORIGIN; TUMORS; GENE; MICE	The concept that tumors are maintained by dedicated stem cells, the so-called cancer stem cell hypothesis, has attracted great interest but remains controversial. Studying mouse models, we provide direct, functional evidence for the presence of stem cell activity within primary intestinal adenomas, a precursor to intestinal cancer. By "lineage retracing" using the multicolor Cre-reporter R26R-Confetti, we demonstrate that the crypt stem cell marker Lgr5 (leucine-rich repeat-containing heterotrimeric guanine nucleotide-binding protein-coupled receptor 5) also marks a subpopulation of adenoma cells that fuel the growth of established intestinal adenomas. These Lgr5(+) cells, which represent about 5 to 10% of the cells in the adenomas, generate additional Lgr5(+) cells as well as all other adenoma cell types. The Lgr5(+) cells are intermingled with Paneth cells near the adenoma base, a pattern reminiscent of the architecture of the normal crypt niche.	[Clevers, Hans] Koninklijke Nederlandse Akad Wetenschappen, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Clevers, H (corresponding author), Koninklijke Nederlandse Akad Wetenschappen, Hubrecht Inst, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	h.clevers@hubrecht.eu	Stange, Daniel E/O-1837-2015; van+Es, Johan/ABD-5411-2021	Stange, Daniel E/0000-0003-4246-2230; 	KWF (the Dutch Cancer Society); CBG (the Centre for Biomedical Genetics); TI Pharma	KWF (the Dutch Cancer Society); CBG (the Centre for Biomedical Genetics); TI Pharma	We thank C. Kroon-Veenboer for help with mouse experiments. A. G. S and H.J.S. were funded by KWF (the Dutch Cancer Society); D. E. S. by CBG (the Centre for Biomedical Genetics); and M.vdB., J.vE., and M.vdW. by TI Pharma. Array data sets are deposited at Gene Expression Omnibus (accession no. GSE37926).	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dalerba P, 2011, NAT BIOTECHNOL, V29, P1120, DOI 10.1038/nbt.2038; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Ireland H, 2005, DEV DYNAM, V233, P1332, DOI 10.1002/dvdy.20446; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Merritt AJ, 1997, P NATL ACAD SCI USA, V94, P13927, DOI 10.1073/pnas.94.25.13927; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Novelli MR, 1996, SCIENCE, V272, P1187, DOI 10.1126/science.272.5265.1187; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; PIERCE GB, 1988, CANCER RES, V48, P1996; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rothenberg ME, 2012, GASTROENTEROLOGY, V142, P1195, DOI 10.1053/j.gastro.2012.02.006; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	24	778	816	1	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2012	337	6095					730	735		10.1126/science.1224676	http://dx.doi.org/10.1126/science.1224676			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986PE	22855427				2022-12-24	WOS:000307354500054
J	Korkhov, VM; Mireku, SA; Locher, KP				Korkhov, Vladimir M.; Mireku, Samantha A.; Locher, Kaspar P.			Structure of AMP-PNP-bound vitamin B-12 transporter BtuCD-F	NATURE			English	Article							ABC TRANSPORTER; ATP-BINDING; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; PROTEIN COMPLEX; MECHANISM; DOMAIN; INTERMEDIATE; SUGGEST; SYSTEM	The ATP-binding cassette (ABC) transporter BtuCD mediates the uptake of vitamin B-12 across the inner membrane of Escherichia coli. Previous structures have shown the conformations of apo states, but the transport mechanism has remained unclear. Here we report the 3.5 angstrom crystal structure of the transporter-binding protein complex BtuCD-BtuF (BtuCD-F) trapped in an beta-gamma-imidoadenosine 5'-phosphate (AMP-PNP)-bound intermediate state. Although the ABC domains (BtuD subunits) form the expected closed sandwich dimer, the membrane-spanning BtuC subunits adopt a new conformation, with the central translocation pathway sealed by a previously unrecognized cytoplasmic gate. A fully enclosed cavity is thus formed approximately halfway across the membrane. It is large enough to accommodate a vitamin B-12 molecule, and radioligand trapping showed that liposome-reconstituted BtuCD-F indeed contains bound B-12 in the presence of AMP-PNP. In combination with engineered disulphide crosslinking and functional assays, our data suggest an unexpected peristaltic transport mechanism that is distinct from those observed in other ABC transporters.	[Korkhov, Vladimir M.; Mireku, Samantha A.; Locher, Kaspar P.] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Locher, KP (corresponding author), ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.	locher@mol.biol.ethz.ch		Korkhov, Volodymyr/0000-0002-0962-9433	NCCR Structural Biology Zurich; Swiss National Science Foundation [SNF 31003A-131075/1]	NCCR Structural Biology Zurich; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank the beamline staff at the Swiss Light Source for assistance with data collection. We are grateful to R. Schibli and M. Badertscher for access to the gamma counter. This research was supported by the NCCR Structural Biology Zurich and Swiss National Science Foundation (grant SNF 31003A-131075/1).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Borths EL, 2005, BIOCHEMISTRY-US, V44, P16301, DOI 10.1021/bi0513103; Borths EL, 2002, P NATL ACAD SCI USA, V99, P16642, DOI 10.1073/pnas.262659699; CHIFFLET S, 1988, ANAL BIOCHEM, V168, P1, DOI 10.1016/0003-2697(88)90002-4; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Dawson RJP, 2007, MOL MICROBIOL, V65, P250, DOI 10.1111/j.1365-2958.2007.05792.x; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; DEVEAUX LC, 1985, J BACTERIOL, V162, P888, DOI 10.1128/JB.162.3.888-896.1985; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erkens GB, 2011, NAT STRUCT MOL BIOL, V18, P755, DOI 10.1038/nsmb.2073; Geertsma ER, 2008, NAT PROTOC, V3, P256, DOI 10.1038/nprot.2007.519; Goetz BA, 2009, FEBS LETT, V583, P266, DOI 10.1016/j.febslet.2008.12.020; Holland I. B., 2003, ABC PROTEINS BACTERI; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; Janakiraman A, 2000, MOL MICROBIOL, V35, P1146, DOI 10.1046/j.1365-2958.2000.01783.x; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Joseph B, 2011, J BIOL CHEM, V286, P41008, DOI 10.1074/jbc.M111.269472; Karpowich NK, 2003, J BIOL CHEM, V278, P8429, DOI 10.1074/jbc.M212239200; Klein JS, 2011, METALLOMICS, V3, P1098, DOI 10.1039/c1mt00073j; Korkhov VM, 2012, FEBS LETT, V586, P972, DOI 10.1016/j.febslet.2012.02.042; Lewinson O, 2010, NAT STRUCT MOL BIOL, V17, P332, DOI 10.1038/nsmb.1770; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Newstead S, 2009, STRUCTURE, V17, P1213, DOI 10.1016/j.str.2009.07.009; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Pattery T, 1999, MOL MICROBIOL, V33, P791, DOI 10.1046/j.1365-2958.1999.01526.x; Patzlaff JS, 2003, J BIOL CHEM, V278, P29546, DOI 10.1074/jbc.M304796200; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; Procko E, 2006, MOL CELL, V24, P51, DOI 10.1016/j.molcel.2006.07.034; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; REYNOLDS PR, 1980, J BIOL CHEM, V255, P4313; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; Standfuss J, 2007, J MOL BIOL, V372, P1179, DOI 10.1016/j.jmb.2007.03.007; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657	44	123	126	2	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2012	490	7420					367	+		10.1038/nature11442	http://dx.doi.org/10.1038/nature11442			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021XI	23000901				2022-12-24	WOS:000309918500038
J	Ekiert, DC; Kashyap, AK; Steel, J; Rubrum, A; Bhabha, G; Khayat, R; Lee, JH; Dillon, MA; O'Neil, RE; Faynboym, AM; Horowitz, M; Horowitz, L; Ward, AB; Palese, P; Webby, R; Lerner, RA; Bhatt, RR; Wilson, IA				Ekiert, Damian C.; Kashyap, Arun K.; Steel, John; Rubrum, Adam; Bhabha, Gira; Khayat, Reza; Lee, Jeong Hyun; Dillon, Michael A.; O'Neil, Ryann E.; Faynboym, Aleksandr M.; Horowitz, Michael; Horowitz, Lawrence; Ward, Andrew B.; Palese, Peter; Webby, Richard; Lerner, Richard A.; Bhatt, Ramesh R.; Wilson, Ian A.			Cross-neutralization of influenza A viruses mediated by a single antibody loop	NATURE			English	Article							POTENT NEUTRALIZATION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; HEMAGGLUTININ; EPITOPE; SYSTEM; BROAD; RECOGNITION; INSERTIONS; DELETIONS	Immune recognition of protein antigens relies on the combined interaction of multiple antibody loops, which provide a fairly large footprint and constrain the size and shape of protein surfaces that can be targeted. Single protein loops can mediate extremely high-affinity binding, but it is unclear whether such a mechanism is available to antibodies. Here we report the isolation and characterization of an antibody called C05, which neutralizes strains from multiple subtypes of influenza A virus, including H1, H2 and H3. X-ray and electron microscopy structures show that C05 recognizes conserved elements of the receptor-binding site on the haemagglutinin surface glycoprotein. Recognition of the haemagglutinin receptor-binding site is dominated by a single heavy-chain complementarity-determining region 3 loop, with minor contacts from heavy-chain complementarity-determining region 1, and is sufficient to achieve nanomolar binding with a minimal footprint. Thus, binding predominantly with a single loop can allow antibodies to target small, conserved functional sites on otherwise hypervariable antigens.	[Ekiert, Damian C.; Bhabha, Gira; Khayat, Reza; Lee, Jeong Hyun; Ward, Andrew B.; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Kashyap, Arun K.; Dillon, Michael A.; O'Neil, Ryann E.; Faynboym, Aleksandr M.; Horowitz, Michael; Horowitz, Lawrence; Bhatt, Ramesh R.] Sea Lane Biotechnol, Mountain View, CA 94043 USA; [Steel, John; Palese, Peter] Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA; [Rubrum, Adam; Webby, Richard] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Lerner, Richard A.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Icahn School of Medicine at Mount Sinai; St Jude Children's Research Hospital; Scripps Research Institute; Scripps Research Institute	Wilson, IA (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ramesh.bhatt@sealanebio.com; wilson@scripps.edu	Ward, Andrew/ABD-7728-2021; Ward, Andrew B/F-9203-2014; Webby, Richard J/N-5657-2018	Ward, Andrew/0000-0001-7153-3769; Ward, Andrew B/0000-0001-7153-3769; Palese, Peter/0000-0002-0337-5823; Lee, Jeong Hyun/0000-0001-7371-845X; Ekiert, Damian/0000-0002-2570-0404	National Institutes of Health (NIH) [P01AI058113]; Achievement Rewards for College Scientists Foundation [GM080209]; NIH Molecular Evolution Training Program; Skaggs Institute; Northeast Biodefense Center [U54-AI057158-Lipkin]; National Institute of Allergy and Infectious Diseases (NIAID) [U01AI070373]; Center for Research on Influenza Pathogenesis NIAID [HHSN266200700010C]; DOE Office of Biological and Environmental Research; NIH, National Center for Research Resources, Biomedical Technology Program; National Institute of General Medical Sciences (NIGMS); National Cancer Institute [Y1-CO-1020]; NIGMS [Y1-GM-1104]; US Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; NIH though the P41 program at the National Center for Research Resources [RR017573]; NIH [U54 GM094586]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158, P01AI058113, U01AI070373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094586, T32GM080209] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Achievement Rewards for College Scientists Foundation(General Electric); NIH Molecular Evolution Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute; Northeast Biodefense Center; National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Center for Research on Influenza Pathogenesis NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH, National Center for Research Resources, Biomedical Technology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NIH though the P41 program at the National Center for Research Resources; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Tien and D. Marciano for automated crystal screening, the staff of the Advanced Photon Source (APS) GM/CA-CAT and Stanford Synchrotron Radiation Lightsource (SSRL) BL11-1 for beamline support, X. Dai and R. Stanfield for assistance with data collection and processing, M. Hothorn for assistance with ITC experiments, J. Paulson and D. Burton for comments and discussion, A. Estelles and R. Briante, L. Xu, S. Wang and D. Corn for technical support and P. Foremanfor assistance with animal study design. This project was funded in part by National Institutes of Health (NIH) grant P01AI058113 (I. A. W.), a predoctoral fellowship from the Achievement Rewards for College Scientists Foundation (D. C. E.), grant GM080209 from the NIH Molecular Evolution Training Program (D. C. E.), the Skaggs Institute (I. A. W.), a career development fellowship from the Northeast Biodefense Center (U54-AI057158-Lipkin) (J. S.), National Institute of Allergy and Infectious Diseases (NIAID) grant U01AI070373 (R. W.), and Center for Research on Influenza Pathogenesis NIAID contract HHSN266200700010C (P. P.). Portions of this research were carried out at the SSRL, a national user facility operated by Stanford University on behalf of the US Department of Energy (DOE), Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by the NIH, National Center for Research Resources, Biomedical Technology Program, and the National Institute of General Medical Sciences (NIGMS). The GM/CA-CAT 23-ID-B beamline has been funded in whole or in part with federal funds from the National Cancer Institute (Y1-CO-1020) and NIGMS (Y1-GM-1104). Use of the APS was supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract no. DE-AC02-06CH11357. The electron microscopy data presented here was collected at the National Resource for Automated Molecular Microscopy, which is supported by the NIH though the P41 program (RR017573) at the National Center for Research Resources. The JCSG is supported by NIH grant U54 GM094586. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIGMS or the NIH. This is publication 21421 from The Scripps Research Institute.	Abhinandan KR, 2008, MOL IMMUNOL, V45, P3832, DOI 10.1016/j.molimm.2008.05.022; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Barbey-Martin C, 2002, VIROLOGY, V294, P70, DOI 10.1006/viro.2001.1320; Brown PH, 2004, J MOL BIOL, V337, P857, DOI 10.1016/j.jmb.2004.01.041; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; de Wildt RMT, 1999, J MOL BIOL, V294, P701, DOI 10.1006/jmbi.1999.3289; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Fleury D, 1999, NAT STRUCT BIOL, V6, P530, DOI 10.1038/9299; Fleury D, 1998, NAT STRUCT BIOL, V5, P119, DOI 10.1038/nsb0298-119; Fleury D, 2000, PROTEINS, V40, P572; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Kashyap AK, 2008, P NATL ACAD SCI USA, V105, P5986, DOI 10.1073/pnas.0801367105; Kashyap AK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000990; Krause JC, 2011, MBIO, V2, DOI 10.1128/mBio.00345-10; Labrijn AF, 2003, J VIROL, V77, P10557, DOI 10.1128/JVI.77.19.10557-10565.2003; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Lee HK, 2004, ANGEW CHEM INT EDIT, V43, P1000, DOI 10.1002/anie.200353105; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; MIYAZAKI J, 1989, GENE, V79, P269; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Ohshima N, 2011, J VIROL, V85, P11048, DOI 10.1128/JVI.05397-11; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pejchal R, 2010, P NATL ACAD SCI USA, V107, P11483, DOI 10.1073/pnas.1004600107; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RUHLMANN A, 1973, J MOL BIOL, V77, P417, DOI 10.1016/0022-2836(73)90448-8; Smith T, 1996, BRIT MED J, V312, P383; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; Whittle JRR, 2011, P NATL ACAD SCI USA, V108, P14216, DOI 10.1073/pnas.1111497108; Wilson PC, 1998, J EXP MED, V187, P59, DOI 10.1084/jem.187.1.59; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Yoshida R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000350; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	50	342	371	3	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 27	2012	489	7417					526	+		10.1038/nature11414	http://dx.doi.org/10.1038/nature11414			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011LT	22982990	Green Accepted			2022-12-24	WOS:000309167100042
J	Petruk, S; Sedkov, Y; Johnston, DM; Hodgson, JW; Black, KL; Kovermann, SK; Beck, S; Canaani, E; Brock, HW; Mazo, A				Petruk, Svetlana; Sedkov, Yurii; Johnston, Danika M.; Hodgson, Jacob W.; Black, Kathryn L.; Kovermann, Sina K.; Beck, Samantha; Canaani, Eli; Brock, Hugh W.; Mazo, Alexander			TrxG and PcG Proteins but Not Methylated Histones Remain Associated with DNA through Replication	CELL			English	Article							POLYCOMB RESPONSE ELEMENT; EPIGENETIC INHERITANCE; METHYLTRANSFERASE ACTIVITY; CHROMATIN; DROSOPHILA; TRITHORAX; COMPLEX; BINDING; GENES; SITES	Propagation of gene-expression patterns through the cell cycle requires the existence of an epigenetic mark that re-establishes the chromatin architecture of the parental cell in the daughter cells. We devised assays to determine which potential epigenetic marks associate with epigenetic maintenance elements during DNA replication in Drosophila embryos. Histone H3 trimethylated at lysines 4 or 27 is present during transcription but, surprisingly, is replaced by nonmethylated H3 following DNA replication. Methylated H3 is detected on DNA only in nuclei not in S phase. In contrast, the TrxG and PcG proteins Trithorax and Enhancer-of-Zeste, which are H3K4 and H3K27 methylases, and Polycomb continuously associate with their response elements on the newly replicated DNA. We suggest that histone modification enzymes may re-establish the histone code on newly assembled unmethylated histones and thus may act as epigenetic marks.	[Petruk, Svetlana; Sedkov, Yurii; Johnston, Danika M.; Black, Kathryn L.; Mazo, Alexander] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Petruk, Svetlana; Sedkov, Yurii; Johnston, Danika M.; Black, Kathryn L.; Mazo, Alexander] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Hodgson, Jacob W.; Kovermann, Sina K.; Beck, Samantha; Brock, Hugh W.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [Canaani, Eli] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel	Jefferson University; Jefferson University; University of British Columbia; Weizmann Institute of Science	Mazo, A (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA.	mazo@mail.jci.tju.edu			Canadian Institutes of Health Research;  [NIH R01GM075141];  [NIH P01CA129242]; NATIONAL CANCER INSTITUTE [P01CA129242, P01CA050507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075141] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Valerio Orlando, Nicole Francis, Richard Jones, and Yi Zhang for antibodies. This work was supported by the following grants: NIH R01GM075141, NIH P01CA129242 to A.M., and a grant from the Canadian Institutes of Health Research to H.W.B.	Beisel C, 2007, P NATL ACAD SCI USA, V104, P16615, DOI 10.1073/pnas.0701538104; BROWN DD, 1984, PHILOS T ROY SOC B, V307, P297, DOI 10.1098/rstb.1984.0130; Buchenau P, 1998, J CELL BIOL, V141, P469, DOI 10.1083/jcb.141.2.469; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cavalli G, 1998, CELL, V93, P505, DOI 10.1016/S0092-8674(00)81181-2; Corpet A, 2009, TRENDS CELL BIOL, V19, P29, DOI 10.1016/j.tcb.2008.10.002; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; Dellino GI, 2002, INT J DEV BIOL, V46, P133; Dietzel S, 1999, CHROMOSOMA, V108, P83, DOI 10.1007/s004120050355; Fanti L, 2008, CHROMOSOMA, V117, P25, DOI 10.1007/s00412-007-0123-7; Floer M, 2010, CELL, V141, P407, DOI 10.1016/j.cell.2010.03.048; Fonseca JP, 2012, GENE DEV, V26, P857, DOI 10.1101/gad.184648.111; Francis NJ, 2009, CELL, V137, P110, DOI 10.1016/j.cell.2009.02.017; Gullerova M, 2008, CELL, V132, P983, DOI 10.1016/j.cell.2008.02.040; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Henikoff S, 2011, TRENDS GENET, V27, P389, DOI 10.1016/j.tig.2011.06.006; Hernandez-Munoz I, 2005, MOL CELL BIOL, V25, P11047, DOI 10.1128/MCB.25.24.11047-11058.2005; Hervouet E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011333; Huen MSY, 2008, J BIOL CHEM, V283, P11073, DOI 10.1074/jbc.C700242200; JACKSON V, 1976, J MOL BIOL, V104, P471, DOI 10.1016/0022-2836(76)90282-5; JACKSON V, 1985, BIOCHEMISTRY-US, V24, P6930, DOI 10.1021/bi00345a027; Kaneko S, 2010, GENE DEV, V24, P2615, DOI 10.1101/gad.1983810; KASSIS JA, 1994, GENETICS, V136, P1025; Krajewski WA, 2005, MOL CELL BIOL, V25, P1891, DOI 10.1128/MCB.25.5.1891-1899.2005; KRIEGSTEIN HJ, 1974, P NATL ACAD SCI USA, V71, P135, DOI 10.1073/pnas.71.1.135; Lanzuolo C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002370; Loyola A, 2006, MOL CELL, V24, P309, DOI 10.1016/j.molcel.2006.08.019; Mishra RK, 2001, MOL CELL BIOL, V21, P1311, DOI 10.1128/MCB.21.4.1311-1318.2001; Muller J, 2006, CURR OPIN GENET DEV, V16, P476, DOI 10.1016/j.gde.2006.08.005; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Ng RK, 2008, CELL CYCLE, V7, P1173, DOI 10.4161/cc.7.9.5791; Petruk S, 2006, CELL, V127, P1209, DOI 10.1016/j.cell.2006.10.039; Puschendorf M, 2008, NAT GENET, V40, P411, DOI 10.1038/ng.99; Radman-Livaja M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001075; Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723; Rozovskaia T, 2000, ONCOGENE, V19, P351, DOI 10.1038/sj.onc.1203307; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; Scharf AND, 2009, NUCLEIC ACIDS RES, V37, P5032, DOI 10.1093/nar/gkp518; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Shermoen AW, 2010, CURR BIOL, V20, P2067, DOI 10.1016/j.cub.2010.10.021; Smith ST, 2004, NAT CELL BIOL, V6, P162, DOI 10.1038/ncb1088; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; Tillib S, 1999, MOL CELL BIOL, V19, P5189	44	179	186	0	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 31	2012	150	5					922	933		10.1016/j.cell.2012.06.046	http://dx.doi.org/10.1016/j.cell.2012.06.046			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22921915	Bronze, Green Accepted			2022-12-24	WOS:000308500200008
J	Lang, M; Murat, S; Clark, AG; Gouppil, G; Blais, C; Matzkin, LM; Guittard, E; Yoshiyama-Yanagawa, T; Kataoka, H; Niwa, R; Lafont, R; Dauphin-Villemant, C; Orgogozo, V				Lang, Michael; Murat, Sophie; Clark, Andrew G.; Gouppil, Geraldine; Blais, Catherine; Matzkin, Luciano M.; Guittard, Emilie; Yoshiyama-Yanagawa, Takuji; Kataoka, Hiroshi; Niwa, Ryusuke; Lafont, Rene; Dauphin-Villemant, Chantal; Orgogozo, Virginie			Mutations in the neverland Gene Turned Drosophila pachea into an Obligate Specialist Species	SCIENCE			English	Article							CACTUS; OXYGENASE; PATHWAYS; STEROL	Most living species exploit a limited range of resources. However, little is known about how tight associations build up during evolution between such specialist species and the hosts they use. We examined the dependence of Drosophila pachea on its single host, the senita cactus. Several amino acid changes in the Neverland oxygenase rendered D. pachea unable to transform cholesterol into 7-dehydrocholesterol (the first reaction in the steroid hormone biosynthetic pathway in insects) and thus made D. pachea dependent on the uncommon sterols of its host plant. The neverland mutations increase survival on the cactus's unusual sterols and are in a genomic region that faced recent positive selection. This study illustrates how relatively few genetic changes in a single gene may restrict the ecological niche of a species.	[Lang, Michael; Murat, Sophie; Gouppil, Geraldine; Orgogozo, Virginie] Univ Paris Diderot, CNRS, Sorbonne Paris Cite, Inst Jacques Monod,UMR7592, F-75205 Paris 13, France; [Murat, Sophie; Blais, Catherine; Guittard, Emilie; Lafont, Rene; Dauphin-Villemant, Chantal; Orgogozo, Virginie] Univ Paris 06, CNRS, F-75005 Paris, France; [Clark, Andrew G.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Matzkin, Luciano M.] Univ Alabama, Dept Biol Sci, Huntsville, AL 35899 USA; [Yoshiyama-Yanagawa, Takuji; Niwa, Ryusuke] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Yoshiyama-Yanagawa, Takuji; Kataoka, Hiroshi] Univ Tokyo, Dept Integrated Biosci, Grad Sch Frontier Sci, Kashiwa, Chiba 2778562, Japan	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Cornell University; University of Alabama System; University of Alabama Huntsville; University of Tsukuba; University of Tokyo	Orgogozo, V (corresponding author), Univ Paris Diderot, CNRS, Sorbonne Paris Cite, Inst Jacques Monod,UMR7592, 15 Rue Helene Brion, F-75205 Paris 13, France.	virginie.orgogozo@normalesup.org	LAFONT, Rene/GYA-4891-2022; Matzkin, Luciano/B-3168-2013; Matzkin, Luciano/AAI-2913-2020	Matzkin, Luciano/0000-0002-3580-9171; Lang, Michael/0000-0002-2297-5680; Crilat, Emilie/0000-0001-8796-5582; Courtier-Orgogozo, Virginie/0000-0002-9297-9230	CNRS ATIP-AVENIR; French Foreign Ministry postdoctoral fellowship; NIH [AI064950]; Japan-France Bilateral Cooperating Program from the Japan Society for the Promotion of Science (JSPS); NSF [DEB-1020009]; JSPS; Ministry of Education, Culture, Sports, Science and Technology in Japan; Amylin Endowment; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064950] Funding Source: NIH RePORTER	CNRS ATIP-AVENIR; French Foreign Ministry postdoctoral fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan-France Bilateral Cooperating Program from the Japan Society for the Promotion of Science (JSPS); NSF(National Science Foundation (NSF)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Amylin Endowment; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Joron for the linkage disequilibrium heat map; M.-A. Felix, N. Gompel, and C. Desplan for comments on the manuscript; C. Parada for help with field work; T. A. Markow for D. pachea samples; C. S. Thummel and the San Diego Drosophila Species Stock Center for flies; Y. Hiromi for reagents; T. Blasco for liquid chromatography tandem mass spectrometry analyses; and M. Gho for hosting V.O. in 2009-2010. Supported by CNRS ATIP-AVENIR (to V.O.), French Foreign Ministry postdoctoral fellowship (to M. L.), NIH grant AI064950 (to A. G. C.), Japan-France Bilateral Cooperating Program from the Japan Society for the Promotion of Science (JSPS) (to H. K. and C. D.-V.), NSF award DEB-1020009 (to L. M. M.), JSPS postdoctoral fellowship (to T.Y.-Y.), Special Coordination Funds for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science and Technology in Japan (to R. N.), and Amylin Endowment (to T. A. Markow). The nvd sequences were deposited in GenBank under accession nos. JF764559 to JF764595 and JX066807 to JX067384. The authors declare no conflict of interest. V.O. conceived the study and wrote the paper. M. L., C. B., R. L., C. D.-V., L. M. M., H. K., and R. N. provided technical support and conceptual advice for designing the experiments. V.O., M. L., G. G., S. M., L. M. M., C. B., E. G., T.Y.-Y., C. D.-V., and R. N. performed the experiments. A. G. C. did the population genetics analysis.	Blais C, 2010, J CHROMATOGR B, V878, P925, DOI 10.1016/j.jchromb.2010.02.018; CAMPBELL CE, 1980, PHYTOCHEMISTRY, V19, P2777, DOI 10.1016/S0031-9422(00)83969-2; Fogleman JC, 2001, AM ZOOL, V41, P877, DOI 10.1668/0003-1569(2001)041[0877:CIITCM]2.0.CO;2; GOODNIGHT KC, 1971, LIPIDS, V6, P166, DOI 10.1007/BF02533031; HEED WB, 1965, SCIENCE, V149, P758, DOI 10.1126/science.149.3685.758; Huang X, 2008, J GENET GENOMICS, V35, P1, DOI 10.1016/S1673-8527(08)60001-6; Kim Y, 2004, GENETICS, V167, P1513, DOI 10.1534/genetics.103.025387; Lafont R., 2005, COMPREHENSIVE MOL IN, V3, P125, DOI DOI 10.1016/B0-44-451924-6/00035-1; Lwoff A, 1944, EVOLUTION PHYSL ETUD; Mittapalli O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013708; PITNICK S, 1994, ANN ENTOMOL SOC AM, V87, P307, DOI 10.1093/aesa/87.3.307; Romero P, 2005, GENOME BIOL, V6; Rottiers V, 2006, DEV CELL, V10, P473, DOI 10.1016/j.devcel.2006.02.008; Voet D., 1995, BIOCHEMISTRY; Yoshiyama T, 2006, DEVELOPMENT, V133, P2565, DOI 10.1242/dev.02428; Yoshiyama-Yanagawa T, 2011, J BIOL CHEM, V286, P25756, DOI 10.1074/jbc.M111.244384	16	64	64	3	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2012	337	6102					1658	1661		10.1126/science.1224829	http://dx.doi.org/10.1126/science.1224829			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	23019649	Green Accepted			2022-12-24	WOS:000309215400046
J	Lane, JE; Kruuk, LEB; Charmantier, A; Murie, JO; Dobson, FS				Lane, Jeffrey E.; Kruuk, Loeske E. B.; Charmantier, Anne; Murie, Jan O.; Dobson, F. Stephen			Delayed phenology and reduced fitness associated with climate change in a wild hibernator	NATURE			English	Article							COLUMBIAN GROUND-SQUIRRELS; SPERMOPHILUS-COLUMBIANUS; PHENOTYPIC PLASTICITY; SPRING EMERGENCE; MIGRATORY BIRD; BODY-MASS; POPULATION; PATTERNS	The most commonly reported ecological effects of climate change are shifts in phenologies, in particular of warmer spring temperatures leading to earlier timing of key events(1,2). Among animals, however, these reports have been heavily biased towards avian phenologies, whereas we still know comparatively little about other seasonal adaptations, such as mammalian hibernation. Here we show a significant delay (0.47 days per year, over a 20-year period) in the hibernation emergence date of adult females in a wild population of Columbian ground squirrels in Alberta, Canada. This finding was related to the climatic conditions at our study location: owing to within-individual phenotypic plasticity, females emerged later during years of lower spring temperature and delayed snowmelt. Although there has not been a significant annual trend in spring temperature, the date of snowmelt has become progressively later owing to an increasing prevalence of late-season snowstorms. Importantly, years of later emergence were also associated with decreased individual fitness. There has consequently been a decline in mean fitness (that is, population growth rate) across the past two decades. Our results show that plastic responses to climate change may be driven by climatic trends other than increasing temperature, and may be associated with declines in individual fitness and, hence, population viability.	[Lane, Jeffrey E.; Kruuk, Loeske E. B.] Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland; [Lane, Jeffrey E.; Charmantier, Anne; Dobson, F. Stephen] CNRS, Ctr Ecol Fonct & Evolut, Unite Mixte Rech 5175, F-34293 Montpellier 5, France; [Lane, Jeffrey E.; Murie, Jan O.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Dobson, F. Stephen] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA	University of Edinburgh; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; University of Alberta; Auburn University System; Auburn University	Lane, JE (corresponding author), Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland.	u.columbianus@hotmail.com	Kruuk, Loeske/AAB-8714-2019; Dobson, F. Stephen/R-7310-2019; Murie, Jan/F-3663-2014; Kruuk, Loeske E. B./J-3295-2012	Kruuk, Loeske/0000-0001-8588-1123; Murie, Jan/0000-0002-2658-4986; Kruuk, Loeske E. B./0000-0001-8588-1123; Dobson, F. Stephen/0000-0001-5562-6316	Natural Sciences and Engineering Research Council of Canada (NSERC); National Science Foundation [DEB-0089473]; Royal Society of London; Agence Nationale de la Recherche of France [ANR-08-JCJC-0041-01]; Alberta Conservation Association	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Science Foundation(National Science Foundation (NSF)); Royal Society of London(Royal Society of London); Agence Nationale de la Recherche of France(French National Research Agency (ANR)); Alberta Conservation Association	We thank the volunteers and assistants who helped with fieldwork, and the University of Calgary for providing accommodation at the Biogeosciences Institute (E. Johnson and J. Buchanan-Mappin). D. Stralberg, S. Boutin and E. Bayne provided comments and assistance that improved an earlier version of this paper, and M. Low wrote the R script to calculate the spring temperature climate window. Funding was provided by the Natural Sciences and Engineering Research Council of Canada (NSERC) (J.O.M. and S. Boutin (University of Alberta)), National Science Foundation (DEB-0089473) (F. S. D.), the Royal Society of London (J. E. L. and L. E. B. K) and Agence Nationale de la Recherche of France (ANR-08-JCJC-0041-01) (A. C., F. S. D. and J. E. L.) and the Alberta Conservation Association (J. E. L.). All protocols were approved by the Life and Environmental Sciences Animal Care Committee at the University of Calgary as well as the Animal Care and Use Committee at the University of Alberta (1992 to 1998) or the Institutional Animal Care and Use Committee at Auburn University (1999 to 2011).	BOAG DA, 1981, CAN J ZOOL, V59, P999, DOI 10.1139/z81-139; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Both C, 2009, J ANIM ECOL, V78, P73, DOI 10.1111/j.1365-2656.2008.01458.x; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; CHRISTENSEN JH, 2007, PHYS SCI BASIS CONTR, P847; Dai B., 2008, IME4 LINEAR MIXED EF; DOBSON FS, 1992, CAN J ZOOL, V70, P1364, DOI 10.1139/z92-192; DOBSON FS, 1987, AM NAT, V129, P382, DOI 10.1086/284643; GEISER F, 1995, PHYSIOL ZOOL, V68, P935, DOI 10.1086/physzool.68.6.30163788; Humphries MM, 2003, PHYSIOL BIOCHEM ZOOL, V76, P165, DOI 10.1086/367950; Intergovernmental Panel on Climate Change, 2007, PHYS SCI BAS CONTR W; LANDE R, 1983, EVOLUTION, V37, P1210, DOI [10.1111/j.1558-5646.1983.tb00236.x, 10.2307/2408842]; Lane JE, 2011, J EVOLUTION BIOL, V24, P1949, DOI 10.1111/j.1420-9101.2011.02334.x; MICHENER GR, 1983, BEHAV ECOL SOCIOBIOL, V14, P29, DOI 10.1007/BF00366653; MICHENER GR, 1977, CAN J ZOOL, V55, P693, DOI 10.1139/z77-091; Moller AP, 2008, P NATL ACAD SCI USA, V105, P16195, DOI 10.1073/pnas.0803825105; MURIE JO, 1982, J MAMMAL, V63, P431, DOI 10.2307/1380440; MURIE JO, 1980, J MAMMAL, V61, P237, DOI 10.2307/1380044; Nussey DH, 2007, J EVOLUTION BIOL, V20, P831, DOI 10.1111/j.1420-9101.2007.01300.x; Ozgul A, 2010, NATURE, V466, P482, DOI 10.1038/nature09210; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Qvarnstrom A, 2006, NATURE, V441, P84, DOI 10.1038/nature04564; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Saether BE, 1999, J ANIM ECOL, V68, P628, DOI 10.1046/j.1365-2656.1999.00314.x; Saino N, 2011, P ROY SOC B-BIOL SCI, V278, P835, DOI 10.1098/rspb.2010.1778; Thackeray SJ, 2010, GLOBAL CHANGE BIOL, V16, P3304, DOI 10.1111/j.1365-2486.2010.02165.x; van de Pol MV, 2009, ANIM BEHAV, V77, P753, DOI 10.1016/j.anbehav.2008.11.006; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997; Whiteman C.D., 2000, MOUNTAIN METEOROLOGY; WIGGETT DR, 1989, CAN J ZOOL, V67, P42, DOI 10.1139/z89-007	31	168	172	4	266	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2012	489	7417					554	+		10.1038/nature11335	http://dx.doi.org/10.1038/nature11335			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	046RG	22878721				2022-12-24	WOS:000311781500001
J	Spracklen, DV; Arnold, SR; Taylor, CM				Spracklen, D. V.; Arnold, S. R.; Taylor, C. M.			Observations of increased tropical rainfall preceded by air passage over forests	NATURE			English	Article							AMAZON DEFORESTATION; CLIMATE-CHANGE; LEAF-AREA; IMPACT; CLOUDS; BASIN	Vegetation affects precipitation patterns by mediating moisture, energy and trace-gas fluxes between the surface and atmosphere(1). When forests are replaced by pasture or crops, evapotranspiration of moisture from soil and vegetation is often diminished, leading to reduced atmospheric humidity and potentially suppressing precipitation(2,3). Climate models predict that large-scale tropical deforestation causes reduced regional precipitation(4-10), although the magnitude of the effect is model(9,11) and resolution(8) dependent. In contrast, observational studies have linked deforestation to increased precipitation locally(12-14) but have been unable to explore the impact of large-scale deforestation. Here we use satellite remote-sensing data of tropical precipitation and vegetation, combined with simulated atmospheric transport patterns, to assess the pan-tropical effect of forests on tropical rainfall. We find that for more than 60 per cent of the tropical land surface (latitudes 30 degrees south to 30 degrees north), air that has passed over extensive vegetation in the preceding few days produces at least twice as much rain as air that has passed over little vegetation. We demonstrate that this empirical correlation is consistent with evapotranspiration maintaining atmospheric moisture in air that passes over extensive vegetation. We combine these empirical relationships with current trends of Amazonian deforestation to estimate reductions of 12 and 21 per cent in wet-season and dry-season precipitation respectively across the Amazon basin by 2050, due to less-efficient moisture recycling. Our observation-based results complement similar estimates from climate models(4-10), in which the physical mechanisms and feedbacks at work could be explored in more detail.	[Spracklen, D. V.; Arnold, S. R.] Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England; [Taylor, C. M.] Ctr Ecol & Hydrol, Oxford OX10 8BB, England	University of Leeds; UK Centre for Ecology & Hydrology (UKCEH)	Spracklen, DV (corresponding author), Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England.	d.v.spracklen@leeds.ac.uk	Spracklen, Dominick/AAA-6257-2019; Taylor, Christopher/Y-7529-2019; Arnold, Steve/B-8856-2014; Taylor, Chris/K-2319-2012; Spracklen, Dominick V/B-4890-2014	Taylor, Chris/0000-0002-0120-3198; Arnold, Steve/0000-0002-4881-5685	Natural Environment Research Council [NE/G015015/1]; Natural Environment Research Council [NE/B505538/1, NE/F00060X/1, NE/G018499/1, ceh010023, earth010002] Funding Source: researchfish; NERC [NE/G018499/1, NE/F00060X/1, earth010002] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	D.V.S. acknowledges a Natural Environment Research Council grant (NE/G015015/1). The GLDAS data used in this study were acquired as part of the mission of NASA's Earth Science Division and were archived and distributed by the Goddard Earth Sciences Data and Information Services Center.	Andreae MO, 2004, SCIENCE, V303, P1337, DOI 10.1126/science.1092779; [Anonymous], TECH REP; Aragao LEOC, 2005, IEEE T GEOSCI REMOTE, V43, P2526, DOI 10.1109/TGRS.2005.856632; Aragao LEOC, 2005, FOREST ECOL MANAG, V211, P240, DOI 10.1016/j.foreco.2005.02.062; Aragao LEOC, 2007, GEOPHYS RES LETT, V34, DOI [10.1029/2006GL028946., 10.1029/2006GL028946]; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Butt N, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015174; Chagnon FJF, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022722; Da Silva RR, 2008, J CLIMATE, V21, P1153, DOI 10.1175/2007JCLI1304.1; Davidson EA, 2012, NATURE, V481, P321, DOI 10.1038/nature10717; ELTAHIR EAB, 1994, Q J ROY METEOR SOC, V120, P861, DOI 10.1002/qj.49712051806; Garcia-Carreras L, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049099; Gimeno L, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043712; Hasler N, 2009, J CLIMATE, V22, P1124, DOI 10.1175/2008JCLI2157.1; HENDERSON-SELLERS A, 1984, CLIMATIC CHANGE, V6, P231, DOI 10.1007/BF00142475; Huffman GJ, 2007, J HYDROMETEOROL, V8, P38, DOI 10.1175/JHM560.1; Huffman GJ, 1997, J APPL METEOROL, V36, P1191, DOI 10.1175/1520-0450(1997)036<1191:EORMSR>2.0.CO;2; Koren I, 2012, NAT GEOSCI, V5, P118, DOI [10.1038/ngeo1364, 10.1038/NGEO1364]; LEAN J, 1989, NATURE, V342, P411, DOI 10.1038/342411a0; Myneni RB, 2002, REMOTE SENS ENVIRON, V83, P214, DOI 10.1016/S0034-4257(02)00074-3; Negri AJ, 2004, J CLIMATE, V17, P1306, DOI 10.1175/1520-0442(2004)017&lt;1306:TIOADO&gt;2.0.CO;2; Nobre P, 2009, J CLIMATE, V22, P5686, DOI 10.1175/2009JCLI2757.1; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Pitman AJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039076; Rodell M, 2004, B AM METEOROL SOC, V85, P381, DOI 10.1175/BAMS-85-3-381; SHUKLA J, 1990, SCIENCE, V247, P1322, DOI 10.1126/science.247.4948.1322; SHUKLA J, 1982, SCIENCE, V215, P1498, DOI 10.1126/science.215.4539.1498; Smith TM, 2006, J HYDROMETEOROL, V7, P841, DOI 10.1175/JHM524.1; Soares BS, 2006, NATURE, V440, P520, DOI 10.1038/nature04389; van der Ent RJ, 2010, WATER RESOUR RES, V46, DOI 10.1029/2010WR009127; Wang JF, 2000, J HYDROMETEOROL, V1, P267, DOI 10.1175/1525-7541(2000)001<0267:TIOODO>2.0.CO;2; Werth D, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000717	32	362	368	12	258	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 13	2012	489	7415					282	U127		10.1038/nature11390	http://dx.doi.org/10.1038/nature11390			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003UC	22951966				2022-12-24	WOS:000308635900039
J	Vilchez, D; Boyer, L; Morantte, I; Lutz, M; Merkwirth, C; Joyce, D; Spencer, B; Page, L; Masliah, E; Berggren, WT; Gage, FH; Dillin, A				Vilchez, David; Boyer, Leah; Morantte, Ianessa; Lutz, Margaret; Merkwirth, Carsten; Joyce, Derek; Spencer, Brian; Page, Lesley; Masliah, Eliezer; Berggren, W. Travis; Gage, Fred H.; Dillin, Andrew			Increased proteasome activity in human embryonic stem cells is regulated by PSMD11	NATURE			English	Article							DIFFERENTIATION; PROTEOSTASIS; SUBUNIT; MUTANT; RPN6P; CORE	Embryonic stem cells can replicate continuously in the absence of senescence and, therefore, are immortal in culture(1,2). Although genome stability is essential for the survival of stem cells, proteome stability may have an equally important role in stem-cell identity and function. Furthermore, with the asymmetric divisions invoked by stem cells, the passage of damaged proteins to daughter cells could potentially destroy the resulting lineage of cells. Therefore, a firm understanding of how stem cells maintain their proteome is of central importance. Here we show that human embryonic stem cells (hESCs) exhibit high proteasome activity that is correlated with increased levels of the 19S proteasome subunit PSMD11 (known as RPN-6 in Caenorhabditis elegans)(3-5) and a corresponding increased assembly of the 26S/30S proteasome. Ectopic expression of PSMD11 is sufficient to increase proteasome assembly and activity. FOXO4, an insulin/insulin-like growth factor-I (IGF-I) responsive transcription factor associated with long lifespan in invertebrates(6,7), regulates proteasome activity by modulating the expression of PSMD11 in hESCs. Proteasome inhibition in hESCs affects the expression of pluripotency markers and the levels of specific markers of the distinct germ layers. Our results suggest a new regulation of proteostasis in hESCs that links longevity and stress resistance in invertebrates to hESC function and identity.	[Vilchez, David; Morantte, Ianessa; Merkwirth, Carsten; Joyce, Derek; Dillin, Andrew] Salk Inst Biol Studies, Howard Hughes Med Inst, Glenn Ctr Aging Res, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; [Boyer, Leah; Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Lutz, Margaret; Berggren, W. Travis] Salk Inst Biol Studies, Stem Cell Core, La Jolla, CA 92037 USA; [Spencer, Brian; Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Page, Lesley] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute; Salk Institute; Salk Institute; University of California System; University of California San Diego; Scripps Research Institute	Dillin, A (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, Glenn Ctr Aging Res, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	dillin@salk.edu	Merkwirth, Carsten/H-5992-2012; Vilchez, David/A-8446-2008	Merkwirth, Carsten/0000-0001-8895-3495; Vilchez, David/0000-0002-0801-0743; Boyer, Leah/0000-0002-0546-4344	Howard Hughes Medical Institute; F.M. Kirby, Inc. Foundation Postdoctoral Scholar Award; Beatriu de Pinos (AGAUR) fellowship; NATIONAL INSTITUTE ON AGING [R37AG018440, P01AG031097] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); F.M. Kirby, Inc. Foundation Postdoctoral Scholar Award; Beatriu de Pinos (AGAUR) fellowship; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank W. E. Balch for critical comments on this work. We thank A. Stauffer and V. Modesto for their help with BrdU assays and cell culture, respectively. We thank S. Ruiz for advice on hESC culture and lentiviral infection. This work was supported by the Howard Hughes Medical Institute. D. V. was a recipient of the F.M. Kirby, Inc. Foundation Postdoctoral Scholar Award and Beatriu de Pinos (AGAUR) fellowship. F. H. G. acknowledges the Helmsley Foundation, JPB Foundation, Mathers Foundation, Lookout Fund and California Institute for Regenerative Medicine.	Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Isono E, 2005, J BIOL CHEM, V280, P6537, DOI 10.1074/jbc.M409364200; Itoh M, 2011, P NATL ACAD SCI USA, V108, P8797, DOI 10.1073/pnas.1100332108; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kisselev AF, 2005, METHOD ENZYMOL, V398, P364, DOI 10.1016/S0076-6879(05)98030-0; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Matsuzaki H, 2005, J BIOCHEM, V138, P485, DOI 10.1093/jb/mvi146; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Panopoulos AD, 2011, CELL STEM CELL, V8, P347, DOI 10.1016/j.stem.2011.03.003; Pathare GR, 2012, P NATL ACAD SCI USA, V109, P149, DOI 10.1073/pnas.1117648108; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Santamaria PG, 2003, J BIOL CHEM, V278, P6687, DOI 10.1074/jbc.M209420200; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tiscornia G, 2006, NAT PROTOC, V1, P234, DOI 10.1038/nprot.2006.36; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	26	270	277	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2012	489	7415					304	+		10.1038/nature11468	http://dx.doi.org/10.1038/nature11468			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003UC	22972301	Green Accepted			2022-12-24	WOS:000308635900044
J	Previs, MJ; Previs, SB; Gulick, J; Robbins, J; Warshaw, DM				Previs, M. J.; Previs, S. Beck; Gulick, J.; Robbins, J.; Warshaw, D. M.			Molecular Mechanics of Cardiac Myosin-Binding Protein C in Native Thick Filaments	SCIENCE			English	Article							KINASE-A PHOSPHORYLATION; CMYBP-C; MUSCLE; ACTIN; ACCELERATION; ACTIVATION; MICROSCOPY; KNOCKOUT; DOMAIN	The heart's pumping capacity results from highly regulated interactions of actomyosin molecular motors. Mutations in the gene for a potential regulator of these motors, cardiac myosin-binding protein C (cMyBP-C), cause hypertrophic cardiomyopathy. However, cMyBP-C's ability to modulate cardiac contractility is not well understood. Using single-particle fluorescence imaging techniques, transgenic protein expression, proteomics, and modeling, we found that cMyBP-C slowed actomyosin motion generation in native cardiac thick filaments. This mechanical effect was localized to where cMyBP-C resides within the thick filament (i.e., the C-zones) and was modulated by phosphorylation and site-specific proteolytic degradation. These results provide molecular insight into why cMyBP-C should be considered a member of a tripartite complex with actin and myosin that allows fine tuning of cardiac muscle contraction.	[Previs, M. J.; Previs, S. Beck; Warshaw, D. M.] Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA; [Gulick, J.; Robbins, J.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [Gulick, J.; Robbins, J.] Cincinnati Childrens Hosp Med Ctr, Inst Heart, Cincinnati, OH 45229 USA	University of Vermont; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Warshaw, DM (corresponding author), Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA.	david.warshaw@uvm.edu			NIH [HL007647, HL059408]; Vermont Genetics Network [8P20GM103449]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086728, P01HL059408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103449] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vermont Genetics Network; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIH funds supported M. P. (HL007647); J.G., J.R., and D. W. (HL059408); and the Vermont Genetics Network for the LC-MS instrumentation (8P20GM103449). We thank B. Palmer and Y. Wang for mouse colony management; S. Tremble for technical assistance; M. Jennings for LC-MS expertise; M. Von Turkovich and the University of Vermont Microscopy Imaging Center for electron microscopy assistance; and G. Kennedy, from the Instrumentation and Modeling Facility, for imaging expertise. Data described in the paper are presented in the supplementary materials.	Decker RS, 2005, CIRCULATION, V111, P906, DOI 10.1161/01.CIR.0000155609.95618.75; GAUTEL M, 1995, EMBO J, V14, P1952, DOI 10.1002/j.1460-2075.1995.tb07187.x; Govindan S, 2012, J MOL CELL CARDIOL, V52, P154, DOI 10.1016/j.yjmcc.2011.09.011; Harris SP, 2011, CIRC RES, V108, P751, DOI 10.1161/CIRCRESAHA.110.231670; HOFMANN PA, 1991, J PHYSIOL-LONDON, V439, P701, DOI 10.1113/jphysiol.1991.sp018689; Jacques AM, 2008, J MOL CELL CARDIOL, V45, P209, DOI 10.1016/j.yjmcc.2008.05.020; Jia WT, 2010, J PROTEOME RES, V9, P1843, DOI 10.1021/pr901006h; Karsai A, 2011, BIOPHYS J, V101, P1968, DOI 10.1016/j.bpj.2011.08.030; Korte FS, 2003, CIRC RES, V93, P752, DOI 10.1161/01.RES.0000096363.85588.9A; Luther PK, 2008, J MOL BIOL, V384, P60, DOI 10.1016/j.jmb.2008.09.013; Luther PK, 2011, P NATL ACAD SCI USA, V108, P11423, DOI 10.1073/pnas.1103216108; Mun JY, 2011, J MOL BIOL, V410, P214, DOI 10.1016/j.jmb.2011.05.010; Ratti J, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.156646; Razumova MV, 2006, J BIOL CHEM, V281, P35846, DOI 10.1074/jbc.M606949200; Sadayappan S, 2005, CIRC RES, V97, P1156, DOI 10.1161/01.RES.0000190605.79013.4d; Sadayappan S, 2006, P NATL ACAD SCI USA, V103, P16918, DOI 10.1073/pnas.0607069103; Sadayappan S, 2009, CIRCULATION, V119, P1253, DOI 10.1161/CIRCULATIONAHA.108.798983; Stelzer JE, 2006, CIRC RES, V99, P884, DOI 10.1161/01.RES.0000245191.34690.66; Tong CW, 2008, CIRC RES, V103, P974, DOI 10.1161/CIRCRESAHA.108.177683; Weith A, 2012, J MOL CELL CARDIOL, V52, P219, DOI 10.1016/j.yjmcc.2011.09.019; Winegrad S, 1999, CIRC RES, V84, P1117, DOI 10.1161/01.RES.84.10.1117; Zoghbi ME, 2008, P NATL ACAD SCI USA, V105, P2386, DOI 10.1073/pnas.0708912105	22	119	121	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 7	2012	337	6099					1215	1218		10.1126/science.1223602	http://dx.doi.org/10.1126/science.1223602			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	000UJ	22923435	Green Accepted			2022-12-24	WOS:000308414000035
J	Andersson, LS; Larhammar, M; Memic, F; Wootz, H; Schwochow, D; Rubin, CJ; Patra, K; Arnason, T; Wellbring, L; Hjalm, G; Imsland, F; Petersen, JL; McCue, ME; Mickelson, JR; Cothran, G; Ahituv, N; Roepstorff, L; Mikko, S; Vallstedt, A; Lindgren, G; Andersson, L; Kullander, K				Andersson, Lisa S.; Larhammar, Martin; Memic, Fatima; Wootz, Hanna; Schwochow, Doreen; Rubin, Carl-Johan; Patra, Kalicharan; Arnason, Thorvaldur; Wellbring, Lisbeth; Hjalm, Goran; Imsland, Freyja; Petersen, Jessica L.; McCue, Molly E.; Mickelson, James R.; Cothran, Gus; Ahituv, Nadav; Roepstorff, Lars; Mikko, Sofia; Vallstedt, Anna; Lindgren, Gabriella; Andersson, Leif; Kullander, Klas			Mutations in DMRT3 affect locomotion in horses and spinal circuit function in mice	NATURE			English	Article							LAMINA-VIII INTERNEURONS; PATTERN GENERATION; CORD; NETWORKS; DIFFERENTIATION; PATHWAYS; WALKING; GENES; CAT	Locomotion in mammals relies on a central pattern-generating circuitry of spinal interneurons established during development that coordinates limb movement(1). These networks produce left-right alternation of limbs as well as coordinated activation of flexor and extensor muscles(2). Here we show that a premature stop codon in the DMRT3 gene has a major effect on the pattern of locomotion in horses. The mutation is permissive for the ability to perform alternate gaits and has a favourable effect on harness racing performance. Examination of wild-type and Dmrt3-null mice demonstrates that Dmrt3 is expressed in the dI6 subdivision of spinal cord neurons, takes part in neuronal specification within this subdivision, and is critical for the normal development of a coordinated locomotor network controlling limb movements. Our discovery positions Dmrt3 in a pivotal role for configuring the spinal circuits controlling stride in vertebrates. The DMRT3 mutation has had a major effect on the diversification of the domestic horse, as the altered gait characteristics of a number of breeds apparently require this mutation.	[Andersson, Lisa S.; Schwochow, Doreen; Wellbring, Lisbeth; Mikko, Sofia; Lindgren, Gabriella; Andersson, Leif] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, SE-75124 Uppsala, Sweden; [Larhammar, Martin; Memic, Fatima; Wootz, Hanna; Patra, Kalicharan; Vallstedt, Anna; Kullander, Klas] Uppsala Univ, Dept Neurosci, SE-75124 Uppsala, Sweden; [Rubin, Carl-Johan; Hjalm, Goran; Imsland, Freyja; Andersson, Leif] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Arnason, Thorvaldur] Agr Univ Iceland, Fac Land & Anim Resources, IS-311 Borgarnes, Iceland; [Petersen, Jessica L.; McCue, Molly E.; Mickelson, James R.] Univ Minnesota, Coll Vet Med, St Paul, MN 55108 USA; [Cothran, Gus] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, College Stn, TX 77483 USA; [Ahituv, Nadav] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Ahituv, Nadav] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Roepstorff, Lars] Swedish Univ Agr Sci, Unit Equine Studies, SE-75007 Uppsala, Sweden	Swedish University of Agricultural Sciences; Uppsala University; Uppsala University; University of Minnesota System; University of Minnesota Twin Cities; Texas A&M University System; Texas A&M University College Station; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Swedish University of Agricultural Sciences	Andersson, LS (corresponding author), Swedish Univ Agr Sci, Dept Anim Breeding & Genet, SE-75124 Uppsala, Sweden.	leif.andersson@imbim.uu.se	Petersen, Jessica/ABF-2462-2020; Mikko, Sofia/F-1347-2017	Petersen, Jessica/0000-0001-5438-8555; Mikko, Sofia/0000-0002-6375-1376; Roepstorff, Lars/0000-0002-4109-9284; Lindgren, Gabriella/0000-0001-6046-9669; Imsland, Freyja/0000-0002-9452-5566; Kullander, Klas/0000-0001-6418-5460; Ahituv, Nadav/0000-0002-7434-8144; Mickelson, James/0000-0001-6951-0234; McCue, Molly/0000-0002-6807-0318; Rubin, Carl-Johan/0000-0001-8238-5052	Swedish Foundation for Strategic Research; Swedish Research Council Formas [221-2009-1631]; Swedish Research Council Medicine and Health [2007-3630/4479, 2010-4394]; Swedish Society for Medical Research; National Institute of Child Health & Human Development [R01HD059862]; Swedish Brain Foundation; Uppsala University and Hospital, SciLife Lab - Uppsala and the Swedish Research Council [80576801, 70374401]; Knut and Alice Wallenberg Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059862] Funding Source: NIH RePORTER	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Swedish Research Council Medicine and Health; Swedish Society for Medical Research; National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Swedish Brain Foundation; Uppsala University and Hospital, SciLife Lab - Uppsala and the Swedish Research Council; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Thanks to S. Mikulovic and E. Restrepo for valuable input, C. Birchmeier for Lbx1 antibody, L. Enquist and J. Martin for PRV152, S. Ewart for horse samples, and B. Agerup for access to race horses. The work was supported by grants from the Swedish Foundation for Strategic Research, the Swedish Research Council Formas (221-2009-1631), Swedish Research Council Medicine and Health (2007-3630/4479, 2010-4394), Swedish Society for Medical Research (H. W.), National Institute of Child Health & Human Development R01HD059862 (N.A.), and the Swedish Brain Foundation. Sequencing was performed by the SNP&SEQ Technology Platform, supported by Uppsala University and Hospital, SciLife Lab - Uppsala and the Swedish Research Council (80576801 and 70374401). Computer resources were supplied by UPPMAX. K. K. is a Royal Swedish Academy of Sciences Research Fellow supported by a grant from the Knut and Alice Wallenberg Foundation.	Ahituv N, 2007, PLOS BIOL, V5, P1906, DOI 10.1371/journal.pbio.0050234; Alaynick WA, 2011, CELL, V146, P178, DOI 10.1016/j.cell.2011.06.038; Albertsdottir E, 2011, J ANIM BREED GENET, V128, P124, DOI 10.1111/j.1439-0388.2010.00902.x; Burrill JD, 1997, DEVELOPMENT, V124, P4493; COWLEY KC, 1995, J NEUROPHYSIOL, V74, P1109, DOI 10.1152/jn.1995.74.3.1109; Culbertson MR, 2003, CURR OPIN GENET DEV, V13, P207, DOI 10.1016/S0959-437X(03)00014-5; Gallarda BW, 2010, ANN NY ACAD SCI, V1198, P133, DOI 10.1111/j.1749-6632.2010.05437.x; Gezelius H, 2006, J PHYSIOL-PARIS, V100, P297, DOI 10.1016/j.jphysparis.2007.05.001; Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608; GRILLNER S, 1980, ACTA PHYSIOL SCAND, V110, P103, DOI 10.1111/j.1748-1716.1980.tb06637.x; Grillner S, 2006, NEURON, V52, P751, DOI 10.1016/j.neuron.2006.11.008; Gross MK, 2002, NEURON, V34, P535, DOI 10.1016/S0896-6273(02)00690-6; HARRISON PJ, 1986, J PHYSIOL-LONDON, V371, P147, DOI 10.1113/jphysiol.1986.sp015965; Hong CS, 2007, DEV BIOL, V310, P1, DOI 10.1016/j.ydbio.2007.07.035; JANKOWSKA E, 1990, BRAIN RES, V535, P327, DOI 10.1016/0006-8993(90)91618-Q; Jankowska E, 2005, J PHYSIOL-LONDON, V565, P645, DOI 10.1113/jphysiol.2005.083014; JOSTES B, 1990, MECH DEVELOP, V33, P27, DOI 10.1016/0925-4773(90)90132-6; Jovanovic K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011743; Kullander K, 2005, TRENDS NEUROSCI, V28, P239, DOI 10.1016/j.tins.2005.03.001; Kullander K, 2003, SCIENCE, V299, P1889, DOI 10.1126/science.1079641; Lanuza GM, 2004, NEURON, V42, P375, DOI 10.1016/S0896-6273(04)00249-1; Mor Y, 2007, J NEUROPHYSIOL, V98, P2807, DOI 10.1152/jn.00740.2007; Moran-Rivard L, 2001, NEURON, V29, P385, DOI 10.1016/S0896-6273(01)00213-6; Muller T, 2002, NEURON, V34, P551, DOI 10.1016/S0896-6273(02)00689-X; Pierani A, 2001, NEURON, V29, P367, DOI 10.1016/S0896-6273(01)00212-4; Rabe N, 2009, J NEUROSCI, V29, P15642, DOI 10.1523/JNEUROSCI.5096-09.2009; Vallstedt A, 2001, NEURON, V31, P743, DOI 10.1016/S0896-6273(01)00412-3	27	255	269	1	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2012	488	7413					642	646		10.1038/nature11399	http://dx.doi.org/10.1038/nature11399			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996NC	22932389	Green Accepted, hybrid, Green Published			2022-12-24	WOS:000308095100053
J	Levendorf, MP; Kim, CJ; Brown, L; Huang, PY; Havener, RW; Muller, DA; Park, J				Levendorf, Mark P.; Kim, Cheol-Joo; Brown, Lola; Huang, Pinshane Y.; Havener, Robin W.; Muller, David A.; Park, Jiwoong			Graphene and boron nitride lateral heterostructures for atomically thin circuitry	NATURE			English	Article							CHEMICAL-VAPOR-DEPOSITION; MONOLAYER GRAPHENE; GRAIN-BOUNDARIES; HIGH-QUALITY; TRANSISTORS; GROWTH; FILMS	Precise spatial control over the electrical properties of thin films is the key capability enabling the production of modern integrated circuitry. Although recent advances in chemical vapour deposition methods have enabled the large-scale production of both intrinsic and doped graphene(1-6), as well as hexagonal boron nitride (h-BN)(7-10), controlled fabrication of lateral heterostructures in these truly atomically thin systems has not been achieved. Graphene/h-BN interfaces are of particular interest, because it is known that areas of different atomic compositions may coexist within continuous atomically thin films(5,10) and that, with proper control, the bandgap and magnetic properties can be precisely engineered(11-13). However, previously reported approaches for controlling these interfaces have fundamental limitations and cannot be easily integrated with conventional lithography(14-16). Here we report a versatile and scalable process, which we call 'patterned regrowth', that allows for the spatially controlled synthesis of lateral junctions between electrically conductive graphene and insulating h-BN, as well as between intrinsic and substitutionally doped graphene. We demonstrate that the resulting films form mechanically continuous sheets across these heterojunctions. Conductance measurements confirm laterally insulating behaviour for h-BN regions, while the electrical behaviour of both doped and undoped graphene sheets maintain excellent properties, with low sheet resistances and high carrier mobilities. Our results represent an important step towards developing atomically thin integrated circuitry and enable the fabrication of electrically isolated active and passive elements embedded in continuous, one-atom-thick sheets, which could be manipulated and stacked to form complex devices at the ultimate thickness limit.	[Levendorf, Mark P.; Kim, Cheol-Joo; Brown, Lola; Park, Jiwoong] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Huang, Pinshane Y.; Havener, Robin W.; Muller, David A.] Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA; [Muller, David A.; Park, Jiwoong] Cornell Nanoscale Sci, Kavli Inst, Ithaca, NY 14853 USA	Cornell University; Cornell University	Park, J (corresponding author), Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA.	jpark@cornell.edu	Park, Jiwoong/C-2327-2013; Muller, David/A-7745-2010; Kim, Cheol-Joo/A-2217-2010	Muller, David/0000-0003-4129-0473; Kim, Cheol-Joo/0000-0002-4312-3866; Huang, Pinshane/0000-0002-1095-1833	AFOSR [FA9550-09-1-0691, FA9550-10-1-0410]; NSF through the Cornell Centers for Materials Research [NSF DMR-1120296]; Alfred P. Sloan Foundation; Fullbright scholarship; NSF Graduate Research Fellowship; National Science Foundation [ECS-0335765]	AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NSF through the Cornell Centers for Materials Research; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Fullbright scholarship; NSF Graduate Research Fellowship(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF))	We thank P. McEuen and M. Spencer for discussions. This work was mainly supported by AFOSR grants (FA9550-09-1-0691 and FA9550-10-1-0410) and the NSF through the Cornell Centers for Materials Research (NSF DMR-1120296), which also provided the electron microscopy facilities. Additional funding was provided by the Alfred P. Sloan Foundation. L. B. was partially supported by a Fullbright scholarship; R. W. H. and P.Y.H. were supported by an NSF Graduate Research Fellowship. Device fabrication was performed at the Cornell NanoScale Facility, a member of the National Nanotechnology Infrastructure Network, which is supported by the National Science Foundation (grant ECS-0335765).	Britnell L, 2012, NANO LETT, V12, P1707, DOI 10.1021/nl3002205; Chen SS, 2011, ACS NANO, V5, P1321, DOI 10.1021/nn103028d; Ci L, 2010, NAT MATER, V9, P430, DOI [10.1038/nmat2711, 10.1038/NMAT2711]; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; Dresselhaus MS, 2010, NANO LETT, V10, P751, DOI 10.1021/nl904286r; Huang PY, 2011, NATURE, V469, P389, DOI 10.1038/nature09718; Jin Z, 2011, ACS NANO, V5, P4112, DOI 10.1021/nn200766e; Kim KK, 2012, NANO LETT, V12, P161, DOI 10.1021/nl203249a; Kim K, 2011, ACS NANO, V5, P2142, DOI 10.1021/nn1033423; Kim YJ, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3266836; Kubota Y, 2007, SCIENCE, V317, P932, DOI 10.1126/science.1144216; Lee GH, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3662043; Li XS, 2009, SCIENCE, V324, P1312, DOI 10.1126/science.1171245; Liang XL, 2011, ACS NANO, V5, P9144, DOI 10.1021/nn203377t; Liu YY, 2011, NANO LETT, V11, P3113, DOI 10.1021/nl2011142; Meric I, 2008, NAT NANOTECHNOL, V3, P654, DOI 10.1038/nnano.2008.268; MIYAMOTO Y, 1994, PHYS REV B, V50, P4976, DOI 10.1103/PhysRevB.50.4976; Moser J, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2789673; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Pruneda JM, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.161409; Radisavljevic B, 2011, NAT NANOTECHNOL, V6, P147, DOI 10.1038/NNANO.2010.279; Sanchez-Yamagishi JD, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.076601; Song L, 2010, NANO LETT, V10, P3209, DOI 10.1021/nl1022139; Sun ZZ, 2010, NATURE, V468, P549, DOI 10.1038/nature09579; Tsen AW, 2012, SCIENCE, V336, P1143, DOI 10.1126/science.1218948; Wehling TO, 2008, NANO LETT, V8, P173, DOI [10.1021/nl072364w, 10.1021/nL072364w]; Williams JR, 2007, SCIENCE, V317, P638, DOI 10.1126/science.1144657; Yu QK, 2011, NAT MATER, V10, P443, DOI [10.1038/nmat3010, 10.1038/NMAT3010]; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235; Zhao LY, 2011, SCIENCE, V333, P999, DOI 10.1126/science.1208759	31	667	683	17	879	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2012	488	7413					627	632		10.1038/nature11408	http://dx.doi.org/10.1038/nature11408			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996NC	22932386				2022-12-24	WOS:000308095100050
J	Seshagiri, S; Stawiski, EW; Durinck, S; Modrusan, Z; Storm, EE; Conboy, CB; Chaudhuri, S; Guan, YH; Janakiraman, V; Jaiswal, BS; Guillory, J; Ha, C; Dijkgraaf, GJP; Stinson, J; Gnad, F; Huntley, MA; Degenhardt, JD; Haverty, PM; Bourgon, R; Wang, WR; Koeppen, H; Gentleman, R; Starr, TK; Zhang, ZM; Largaespada, DA; Wu, TD; de Sauvage, FJ				Seshagiri, Somasekar; Stawiski, Eric W.; Durinck, Steffen; Modrusan, Zora; Storm, Elaine E.; Conboy, Caitlin B.; Chaudhuri, Subhra; Guan, Yinghui; Janakiraman, Vasantharajan; Jaiswal, Bijay S.; Guillory, Joseph; Ha, Connie; Dijkgraaf, Gerrit J. P.; Stinson, Jeremy; Gnad, Florian; Huntley, Melanie A.; Degenhardt, Jeremiah D.; Haverty, Peter M.; Bourgon, Richard; Wang, Weiru; Koeppen, Hartmut; Gentleman, Robert; Starr, Timothy K.; Zhang, Zemin; Largaespada, David A.; Wu, Thomas D.; de Sauvage, Frederic J.			Recurrent R-spondin fusions in colon cancer	NATURE			English	Article							CIRCULAR BINARY SEGMENTATION; COLORECTAL-CANCER; WNT/BETA-CATENIN; HUMAN BREAST; RECEPTORS; LGR5; MUTATIONS; ALGORITHM; DISCOVERY; SEQUENCES	Identifying and understanding changes in cancer genomes is essential for the development of targeted therapeutics(1). Here we analyse systematically more than 70 pairs of primary human colon tumours by applying next-generation sequencing to characterize their exomes, transcriptomes and copy-number alterations. We have identified 36,303 protein-altering somatic changes that include several new recurrent mutations in the Wnt pathway gene TCF7L2, chromatin-remodelling genes such as TET2 and TET3 and receptor tyrosine kinases including ERBB3. Our analysis for significantly mutated cancer genes identified 23 candidates, including the cell cycle checkpoint kinase ATM. Copy-number and RNA-seq data analysis identified amplifications and corresponding overexpression of IGF2 in a subset of colon tumours. Furthermore, using RNA-seq data we identified multiple fusion transcripts including recurrent gene fusions involving R-spondin family members RSPO2 and RSPO3 that together occur in 10% of colon tumours. The RSPO fusions were mutually exclusive with APC mutations, indicating that they probably have a role in the activation of Wnt signalling and tumorigenesis. Consistent with this we show that the RSPO fusion proteins were capable of potentiating Wnt signalling. The R-spondin gene fusions and several other gene mutations identified in this study provide new potential opportunities for therapeutic intervention in colon cancer.	[Seshagiri, Somasekar; Stawiski, Eric W.; Durinck, Steffen; Modrusan, Zora; Storm, Elaine E.; Chaudhuri, Subhra; Guan, Yinghui; Janakiraman, Vasantharajan; Jaiswal, Bijay S.; Guillory, Joseph; Ha, Connie; Dijkgraaf, Gerrit J. P.; Stinson, Jeremy; de Sauvage, Frederic J.] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Conboy, Caitlin B.; Largaespada, David A.] Univ Minnesota, Masonic Canc Ctr, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Gnad, Florian; Huntley, Melanie A.; Degenhardt, Jeremiah D.; Haverty, Peter M.; Bourgon, Richard; Gentleman, Robert; Zhang, Zemin; Wu, Thomas D.] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Wang, Weiru] Genentech Inc, Dept Biol Struct, San Francisco, CA 94080 USA; [Koeppen, Hartmut] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Starr, Timothy K.] Univ Minnesota, Masonic Canc Ctr, Dept Obstet Gynecol & Womens Hlth, Minneapolis, MN 55455 USA	Roche Holding; Genentech; University of Minnesota System; University of Minnesota Twin Cities; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; University of Minnesota System; University of Minnesota Twin Cities	Seshagiri, S (corresponding author), Genentech Inc, Dept Mol Biol, 1 DNA Way, San Francisco, CA 94080 USA.	sekar@gene.com; sauvage@gene.com	Largaespada, David/C-9832-2014; de Sauvage, Frederic/ABE-8400-2020; Starr, Tim/AAX-9342-2021	de Sauvage, Frederic/0000-0002-5275-2584; Seshagiri, Somasekar/0000-0003-4272-6443; Conboy, Caitlin/0000-0001-8280-056X; Starr, Timothy/0000-0002-6308-3451; Gnad, Florian/0000-0002-2287-2251; Bourgon, Richard/0000-0002-5890-4374; Wang, Weiru/0000-0001-8845-301X	National Institutes of Health [R01-CA134759]; NATIONAL CANCER INSTITUTE [R01CA134759, T32CA009138, R00CA151672, R01CA113636] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors would like to acknowledge Genentech DNA Sequencing, Oligo, Microarray and gCell laboratories for their help with the project. We thank the Genentech Bioinformatics group for informatics infrastructure support and the Pathology Core Labs for providing histology, immunohistochemistry and tissue-management support. We also thank M. Costa, M. Callow, P. Polakis and the de Sauvage and Seshagiri laboratories for comments and suggestions. Work in the Largaespada laboratory was supported by National Institutes of Health grant R01-CA134759 (to D.A.L.).	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Chin L, 2011, NAT MED, V17, P297, DOI 10.1038/nm.2323; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Greenman CD, 2010, BIOSTATISTICS, V11, P164, DOI 10.1093/biostatistics/kxp045; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kaneda H, 2010, CANCER RES, V70, P2053, DOI 10.1158/0008-5472.CAN-09-2161; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; March HN, 2011, NAT GENET, V43, P1202, DOI 10.1038/ng.990; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Mohr F, 2011, EXP HEMATOL, V39, P272, DOI 10.1016/j.exphem.2010.12.004; Morgan M, 2009, BIOINFORMATICS, V25, P2607, DOI 10.1093/bioinformatics/btp450; Nacu S, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-11; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Pichiorri F, 2008, FUTURE ONCOL, V4, P815, DOI 10.2217/14796694.4.6.815; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Starr TK, 2009, SCIENCE, V323, P1747, DOI 10.1126/science.1163040; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Timmermann B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015661; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Yoon JK, 2012, CELL SIGNAL, V24, P369, DOI 10.1016/j.cellsig.2011.09.023; Yue P, 2010, HUM MUTAT, V31, P264, DOI 10.1002/humu.21194; Zhang YN, 2009, NAT CHEM BIOL, V5, P217, DOI 10.1038/nchembio.152	38	678	735	1	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2012	488	7413					660	+		10.1038/nature11282	http://dx.doi.org/10.1038/nature11282			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996NC	22895193	Green Accepted, hybrid			2022-12-24	WOS:000308095100057
J	Grover, S; Kastrinos, F; Steyerberg, EW; Cook, EF; Dewanwala, A; Burbidge, LA; Wenstrup, RJ; Syngal, S				Grover, Shilpa; Kastrinos, Fay; Steyerberg, Ewout W.; Cook, E. Francis; Dewanwala, Akriti; Burbidge, Lynn Anne; Wenstrup, Richard J.; Syngal, Sapna			Prevalence and Phenotypes of APC and MUTYH Mutations in Patients With Multiple Colorectal Adenomas	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GERM-LINE MUTATIONS; MYH GENE-MUTATIONS; POLYPOSIS PATIENTS; CANCER PATIENTS; FAMILIES; FAP; CHROMOSOME-5Q21; IDENTIFICATION; EXPRESSION; GUIDELINES	Context Patients with multiple colorectal adenomas may carry germline mutations in the APC or MUTYH genes. Objectives To determine the prevalence of pathogenic APC and MUTYH mutations in patients with multiple colorectal adenomas who had undergone genetic testing and to compare the prevalence and clinical characteristics of APC and MUTYH mutation carriers. Design, Setting, and Participants Cross-sectional study conducted among 8676 individuals who had undergone full gene sequencing and large rearrangement analysis of the APC gene and targeted sequence analysis for the 2 most common MUTYH mutations (Y179C and G396D) between 2004 and 2011. Individuals with either mutation underwent full MUTYH gene sequencing. APC and MUTYH mutation prevalence was evaluated by polyp burden; the clinical characteristics associated with a pathogenic mutation were evaluated using logistic regression analyses. Main Outcome Measure Prevalence of pathogenic mutations in APC and MUTYH genes. Results Colorectal adenomas were reported in 7225 individuals; 1457 with classic polyposis (>= 100 adenomas) and 3253 with attenuated polyposis (20-99 adenomas). The prevalence of pathogenic APC and biallelic MUTYH mutations was 95 of 119 (80% [95% CI, 71%-87%]) and 2 of 119 (2% [95% CI, 0.2%-6%]), respectively, among individuals with 1000 or more adenomas, 756 of 1338 (56% [95% CI, 54%-59%]) and 94 of 1338 (7% [95% CI, 6%-8%]) among those with 100 to 999 adenomas, 326 of 3253 (10% [95% CI, 9%-11%]) and 233 of 3253 (7% [95% CI, 6%-8%]) among those with 20 to 99 adenomas, and 50 of 970 (5% [95% CI, 4%-7%]) and 37 of 970 (4% [95% CI, 3%-5%]) among those with 10 to 19 adenomas. Adenoma count was strongly associated with a pathogenic mutation in multivariable analyses. Conclusions Among patients with multiple colorectal adenomas, pathogenic APC and MUTYH mutation prevalence varied considerably by adenoma count, including within those with a classic polyposis phenotype. APC mutations predominated in patients with classic polyposis, whereas prevalence of APC and MUTYH mutations was similar in attenuated polyposis. These findings require external validation. JAMA. 2012;308(5):485-492 www.jama.com	[Grover, Shilpa; Dewanwala, Akriti; Syngal, Sapna] Dana Farber Canc Inst, Div Populat Sci, Boston, MA 02215 USA; [Grover, Shilpa; Syngal, Sapna] Brigham & Womens Hosp, Div Gastroenterol, Boston, MA 02115 USA; [Grover, Shilpa; Syngal, Sapna] Harvard Univ, Sch Med, Boston, MA USA; [Cook, E. Francis] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Grover, Shilpa] Massachusetts Gen Hosp, Program Canc Outcomes Res Training, Boston, MA 02114 USA; [Kastrinos, Fay] Columbia Univ, Med Ctr, New York, NY USA; [Kastrinos, Fay] Herbert Irving Comprehens Canc Ctr, New York, NY USA; [Steyerberg, Ewout W.] Erasmus MC, Ctr Med Decis Making, Rotterdam, Netherlands; [Burbidge, Lynn Anne; Wenstrup, Richard J.] Myriad Genet Labs Inc, Salt Lake City, UT USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Columbia University; Erasmus University Rotterdam; Erasmus MC; Myriad Genetics, Inc	Syngal, S (corresponding author), Dana Farber Canc Inst, Div Populat Sci, 450 Brookline Ave, Boston, MA 02215 USA.	ssyngal@partners.org	Steyerberg, Ewout/C-1509-2018	Steyerberg, Ewout/0000-0002-7787-0122	National Cancer Institute [R25 CA 092203, K07 CA151769]; National Institutes of Health [K24113433]; Myriad Genetics Laboratories Inc.; NATIONAL CANCER INSTITUTE [R25CA092203, K07CA151769, K24CA113433] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Myriad Genetics Laboratories Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Cancer Institute grants R25 CA 092203 (Dr Grover) and K07 CA151769 (Dr Kastrinos) and by National Institutes of Health grant K24113433 (Dr Syngal).; Independent Statistical Analysis: Data sets were forwarded by investigators at Myriad Genetics Laboratories Inc to independent investigators at the Dana-Farber Cancer Institute, Boston, Massachusetts (Drs Grover and Syngal) and the Herbert Irving Comprehensive Cancer Center, New York, New York (Dr Kastrinos). Drs Grover, Kastrinos, and Steyerberg (Center for Medical Decision Making, Erasmus Medical Center, Rotterdam, the Netherlands) performed independent statistical analyses. All results reported in the article are from the independent statistical analyses. None of the coauthors not employed by Myriad Genetics Laboratories Inc received any funding for the study from Myriad Genetics Laboratories Inc.	Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828; Armstrong JG, 1997, HUM MUTAT, V10, P376, DOI 10.1002/(SICI)1098-1004(1997)10:5<376::AID-HUMU7>3.0.CO;2-D; Balaguer F, 2008, GASTROENTEROLOGY, V134, P39, DOI 10.1053/j.gastro.2007.10.042; Balmana J, 2006, JAMA-J AM MED ASSOC, V296, P1469, DOI 10.1001/jama.296.12.1469; Boparai KS, 2008, GASTROENTEROLOGY, V135, P2014, DOI 10.1053/j.gastro.2008.09.020; Burt RW, 2010, J NATL COMPR CANC NE, V8, P8, DOI 10.6004/jnccn.2010.0003; Bussey H.J.R., 1975, FAMILIAL POLYPOSIS C; Castellsague E, 2010, GASTROENTEROLOGY, V139, P439, DOI 10.1053/j.gastro.2010.04.047; Cleary SP, 2009, GASTROENTEROLOGY, V136, P1251, DOI 10.1053/j.gastro.2008.12.050; Croitoru ME, 2007, J SURG ONCOL, V95, P499, DOI 10.1002/jso.20724; Croitoru ME, 2004, JNCI-J NATL CANCER I, V96, P1631, DOI 10.1093/jnci/djh288; Farrington SM, 2005, AM J HUM GENET, V77, P112, DOI 10.1086/431213; Filipe B, 2009, CLIN GENET, V76, P242, DOI 10.1111/j.1399-0004.2009.01241.x; Fleischmann C, 2004, INT J CANCER, V109, P554, DOI 10.1002/ijc.20020; Giardiello FM, 1997, NEW ENGL J MED, V336, P823, DOI 10.1056/NEJM199703203361202; Giardiello FM, 2001, GASTROENTEROLOGY, V121, P198, DOI 10.1053/gast.2001.25581; Giarola M, 1999, HUM MUTAT, V13, P116, DOI 10.1002/(SICI)1098-1004(1999)13:2<116::AID-HUMU3>3.0.CO;2-2; Gismondi V, 2004, INT J CANCER, V109, P680, DOI 10.1002/ijc.20054; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Jo WS, 2005, CLIN GASTROENTEROL H, V3, P1022, DOI 10.1016/S1542-3565(05)00411-8; Jones S, 2002, HUM MOL GENET, V11, P2961, DOI 10.1093/hmg/11.23.2961; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; MIYOSHI Y, 1992, P NATL ACAD SCI USA, V89, P4452, DOI 10.1073/pnas.89.10.4452; Nagase Hiroki, 1992, Human Mutation, V1, P467, DOI 10.1002/humu.1380010603; Nielsen M, 2007, CLIN GENET, V71, P427, DOI 10.1111/j.1399-0004.2007.00766.x; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; POWELL SM, 1993, NEW ENGL J MED, V329, P1982, DOI 10.1056/NEJM199312303292702; Rex DK, 2009, AM J GASTROENTEROL, V104, P739, DOI 10.1038/ajg.2009.104; Russell AM, 2006, INT J CANCER, V118, P1937, DOI 10.1002/ijc.21470; Sampson JR, 2003, LANCET, V362, P39, DOI 10.1016/S0140-6736(03)13805-6; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Sieber OM, 2003, NEW ENGL J MED, V348, P791, DOI 10.1056/NEJMoa025283; vanderLuijt RB, 1997, HUM MUTAT, V9, P7, DOI 10.1002/(SICI)1098-1004(1997)9:1<7::AID-HUMU2>3.0.CO;2-8; Vasen HFA, 2008, GUT, V57, DOI 10.1136/gut.2007.136127; Venesio T, 2004, GASTROENTEROLOGY, V126, P1681, DOI 10.1053/j.gastro.2004.02.022; Wang L, 2004, GASTROENTEROLOGY, V127, P9, DOI 10.1053/j.gastro.2004.03.070	36	128	130	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2012	308	5					485	492		10.1001/jama.2012.8780	http://dx.doi.org/10.1001/jama.2012.8780			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	981DQ	22851115	Bronze, Green Accepted			2022-12-24	WOS:000306947400026
J	Lavzin, M; Rapoport, S; Polsky, A; Garion, L; Schiller, J				Lavzin, Maria; Rapoport, Sophia; Polsky, Alon; Garion, Liora; Schiller, Jackie			Nonlinear dendritic processing determines angular tuning of barrel cortex neurons in vivo	NATURE			English	Article							PRIMARY VISUAL-CORTEX; 5 PYRAMIDAL NEURONS; BASAL DENDRITES; THALAMOCORTICAL SYNAPSES; DIRECTION SELECTIVITY; SOMATOSENSORY CORTEX; NMDA SPIKES; LAYER-IV; CELLS; ORGANIZATION	Layer 4 neurons in primary sensory cortices receive direct sensory information from the external world(1,2). A general feature of these neurons is their selectivity to specific features of the sensory stimulation(3-5). Various theories try to explain the manner in which these neurons are driven by their incoming sensory information(6-11). In all of these theories neurons are regarded as simple elements summing small biased inputs to create tuned output through the axosomatic amplification mechanism(12). However, the possible role of active dendritic integration(13-15) in further amplifying the sensory responses and sharpening the tuning curves of neurons(16-19) is disregarded. Our findings show that dendrites of layer 4 spiny stellate neurons in the barrel cortex can generate local and global multi-branch N-methyl-D-aspartate (NMDA) spikes, which are the main regenerative events in these dendrites. In turn, these NMDA receptor (NMDAR) regenerative mechanisms can sum supralinearly the coactivated thalamocortical and corticocortical inputs. Using in vivo whole-cell recordings combined with an intracellular NMDAR blocker and membrane hyperpolarization, we show that dendritic NMDAR-dependent regenerative responses contribute substantially to the angular tuning of layer 4 neurons by preferentially amplifying the preferred angular directions over non-preferred angles. Taken together, these findings indicate that dendritic NMDAR regenerative amplification mechanisms contribute markedly to sensory responses and critically determine the tuning of cortical neurons.	[Lavzin, Maria; Rapoport, Sophia; Garion, Liora; Schiller, Jackie] Technion Israel Inst Technol, Rappaport Fac Med, Dept Physiol, IL-31096 Haifa, Israel; [Lavzin, Maria; Rapoport, Sophia; Garion, Liora; Schiller, Jackie] Technion Israel Inst Technol, Res Inst, IL-31096 Haifa, Israel; [Polsky, Alon] NINDS, Synapt Physiol Sect, NIH, Bethesda, MD 20892 USA	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Schiller, J (corresponding author), Technion Israel Inst Technol, Rappaport Fac Med, Dept Physiol, IL-31096 Haifa, Israel.	Jackie@tx.technion.ac.il		Poleg-Polsky, Alon/0000-0003-1327-5129	Israel Science Foundation (ISF); Rappaport Foundation	Israel Science Foundation (ISF)(Israel Science Foundation); Rappaport Foundation	We thank Y. Schiller and G. Major for their helpful comments and discussions on the manuscript. We thank A. Korngreen and C. de Kock for help with Neurolucida reconstructions, U. Dubin for help in programming the stimulus and analysis programs, O. Schiff for help with Igor software and R. Azouz for help with the passive stimulus. We thank I. Reiter for her technical help, particularly with histology. We also thank R. Bruno for sharing his knowledge of in vivo patch clamp recordings. This study was supported by the Israel Science Foundation (ISF) and the Rappaport Foundation (J.S.).	Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; Archie KA, 2000, NAT NEUROSCI, V3, P54, DOI 10.1038/71125; BENSHALOM G, 1986, J COMP NEUROL, V253, P303, DOI 10.1002/cne.902530303; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Branco T, 2010, CURR OPIN NEUROBIOL, V20, P494, DOI 10.1016/j.conb.2010.07.009; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Bruno RM, 2003, J NEUROSCI, V23, P9565; Fleidervish IA, 1998, NEURON, V21, P1055, DOI 10.1016/S0896-6273(00)80623-6; Gil Z, 1999, NEURON, V23, P385, DOI 10.1016/S0896-6273(00)80788-6; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; Kremer Y, 2011, J NEUROSCI, V31, P10689, DOI 10.1523/JNEUROSCI.6541-10.2011; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Magee J, 1998, ANNU REV PHYSIOL, V60, P327, DOI 10.1146/annurev.physiol.60.1.327; Major G, 2008, J NEUROPHYSIOL, V99, P2584, DOI 10.1152/jn.00011.2008; Poirazi P, 2001, NEURON, V29, P779, DOI 10.1016/S0896-6273(01)00252-5; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; Polsky A, 2009, J NEUROSCI, V29, P11891, DOI 10.1523/JNEUROSCI.5250-08.2009; Priebe NJ, 2008, NEURON, V57, P482, DOI 10.1016/j.neuron.2008.02.005; Priebe NJ, 2005, NEURON, V45, P133, DOI 10.1016/j.neuron.2004.12.024; Sarid L, 2007, P NATL ACAD SCI USA, V104, P16353, DOI 10.1073/pnas.0707853104; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Schiller J, 2001, CURR OPIN NEUROBIOL, V11, P343, DOI 10.1016/S0959-4388(00)00217-8; Stratford KJ, 1996, NATURE, V382, P258, DOI 10.1038/382258a0; Wang HP, 2010, SCIENCE, V328, P106, DOI 10.1126/science.1183108; WHITE EL, 1980, J NEUROCYTOL, V9, P615, DOI 10.1007/BF01205029; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X	29	165	170	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2012	490	7420					397	401		10.1038/nature11451	http://dx.doi.org/10.1038/nature11451			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021XI	22940864				2022-12-24	WOS:000309918500045
J	Broz, P; Ruby, T; Belhocine, K; Bouley, DM; Kayagaki, N; Dixit, VM; Monack, DM				Broz, Petr; Ruby, Thomas; Belhocine, Kamila; Bouley, Donna M.; Kayagaki, Nobuhiko; Dixit, Vishva M.; Monack, Denise M.			Caspase-11 increases susceptibility to Salmonella infection in the absence of caspase-1	NATURE			English	Article							INFLAMMASOME RECEPTORS; HOST-DEFENSE; INTERLEUKIN-1-BETA; ACTIVATION; TYPHIMURIUM; FLAGELLIN; NEUTROPHILS; SECRETION; ADAPTERS; FAMILY	Inflammasomes are cytosolic multiprotein complexes assembled by intracellular nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs) and they initiate innate immune responses to invading pathogens and danger signals by activating caspase-1 (ref. 1). Caspase-1 activation leads to the maturation and release of the pro-inflammatory cytokines interleukin (IL)-1 beta and IL-18, as well as lytic inflammatory cell death known as pyroptosis(2). Recently, a new non-canonical inflammasome was described that activates caspase-11, a pro-inflammatory caspase required for lipopolysaccharide-induced lethality(3). This study also highlighted that previously generated caspase-1 knockout mice lack a functional allele of Casp11 (also known as Casp4), making them functionally Casp1 Casp11 double knockouts(3-6). Previous studies have shown that these mice are more susceptible to infections with microbial pathogens(1), including the bacterial pathogen Salmonella enterica serovar Typhimurium (S. typhimurium)(7,8), but the individual contributions of caspase-1 and caspase-11 to this phenotype are not known. Here we show that non-canonical caspase-11 activation contributes to macrophage death during S. typhimurium infection. Toll-like receptor 4 (TLR4)-dependent and TIR-domaincontaining adaptor-inducing interferon-beta (TRIF)-dependent interferon-beta production is crucial for caspase-11 activation in macrophages, but is only partially required for pro-caspase-11 expression, consistent with the existence of an interferon-inducible activator of caspase-11. Furthermore, Casp1(-/-) mice were significantly more susceptible to infection with S. typhimurium than mice lacking both pro-inflammatory caspases (Casp1(-/-) Casp11(-/-)). This phenotype was accompanied by higher bacterial counts, the formation of extracellular bacterial microcolonies in the infected tissue and a defect in neutrophil-mediated clearance. These results indicate that caspase-11-dependent cell death is detrimental to the host in the absence of caspase-1-mediated innate immunity, resulting in extracellular replication of a facultative intracellular bacterial pathogen.	[Broz, Petr; Ruby, Thomas; Belhocine, Kamila; Monack, Denise M.] Stanford Univ, Dept Microbiol & Immunol, Stanford Sch Med, Stanford, CA 94305 USA; [Bouley, Donna M.] Stanford Univ, Dept Comparat Med, Stanford Sch Med, Stanford, CA 94305 USA; [Kayagaki, Nobuhiko; Dixit, Vishva M.] Genentech Inc, San Francisco, CA 94080 USA	Stanford University; Stanford University; Roche Holding; Genentech	Monack, DM (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Stanford Sch Med, Stanford, CA 94305 USA.	dmonack@stanford.edu	Broz, Petr/AAC-7940-2019; dixit, vishva m/A-4496-2012	Broz, Petr/0000-0002-2334-7790; dixit, vishva m/0000-0001-6983-0326; Monack, Denise/0000-0003-3804-2209	National Institute of Allergy and Infectious Diseases (NIAID) [AI095396, AI08972]; Stanford Digestive Disease Center (DDC) pilot grant; Human Frontiers in Science Program (HFSP) [LT000636/2009-L]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI008972, R01AI095396, R01AI089722] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Stanford Digestive Disease Center (DDC) pilot grant; Human Frontiers in Science Program (HFSP)(Human Frontier Science Program); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Dong, M. Wong, P. Chu and H. Matthew for technical support, G. Barton for Tlr4<SUP>-/-</SUP> and Tlr2<SUP>-/-</SUP> mice, and all members of the Monack laboratory for discussions and help with animal experiments. This work was supported by awards AI095396 and AI08972 from the National Institute of Allergy and Infectious Diseases (NIAID) to D. M. M., a Stanford Digestive Disease Center (DDC) pilot grant to P. B. and a long-term fellowship (LT000636/2009-L) from the Human Frontiers in Science Program (HFSP) to P.B.	Akhter A, 2012, IMMUNITY; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Conlan JW, 1996, INFECT IMMUN, V64, P1043, DOI 10.1128/IAI.64.3.1043-1047.1996; Conlan JW, 1997, INFECT IMMUN, V65, P630, DOI 10.1128/IAI.65.2.630-635.1997; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Kang SJ, 2000, J CELL BIOL, V149, P613, DOI 10.1083/jcb.149.3.613; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Lamkanfi M, 2011, NAT REV IMMUNOL, V11, P213, DOI 10.1038/nri2936; Lara-Tejero M, 2006, J EXP MED, V203, P1407, DOI 10.1084/jem.20060206; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Monack DM, 2001, CELL MICROBIOL, V3, P825, DOI 10.1046/j.1462-5822.2001.00162.x; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Raupach B, 2006, INFECT IMMUN, V74, P4922, DOI 10.1128/IAI.00417-06; Schauvliege R, 2002, J BIOL CHEM, V277, P41624, DOI 10.1074/jbc.M207852200; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Valdez Y, 2009, CURR TOP MICROBIOL, V337, P93, DOI 10.1007/978-3-642-01846-6_4; Wang SY, 1996, J BIOL CHEM, V271, P20580, DOI 10.1074/jbc.271.34.20580; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	23	380	387	3	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2012	490	7419					288	+		10.1038/nature11419	http://dx.doi.org/10.1038/nature11419			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019IY	22895188	Green Accepted			2022-12-24	WOS:000309733300055
J	Qi, QB; Chu, AY; Kang, JH; Jensen, MK; Curhan, GC; Pasquale, LR; Ridker, PM; Hunter, DJ; Willett, WC; Rimm, EB; Chasman, DI; Hu, FB; Qi, L				Qi, Qibin; Chu, Audrey Y.; Kang, Jae H.; Jensen, Majken K.; Curhan, Gary C.; Pasquale, Louis R.; Ridker, Paul M.; Hunter, David J.; Willett, Walter C.; Rimm, Eric B.; Chasman, Daniel I.; Hu, Frank B.; Qi, Lu			Sugar-Sweetened Beverages and Genetic Risk of Obesity	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BODY-MASS INDEX; GENOME-WIDE ASSOCIATION; PHYSICAL-ACTIVITY; WEIGHT-GAIN; FOOD-INTAKE; VARIANTS; HEALTH; REPRODUCIBILITY; VALIDITY; DISEASE	BACKGROUND Temporal increases in the consumption of sugar-sweetened beverages have paralleled the rise in obesity prevalence, but whether the intake of such beverages interacts with the genetic predisposition to adiposity is unknown. METHODS We analyzed the interaction between genetic predisposition and the intake of sugar-sweetened beverages in relation to body-mass index (BMI; the weight in kilograms divided by the square of the height in meters) and obesity risk in 6934 women from the Nurses' Health Study (NHS) and in 4423 men from the Health Professionals Follow-up Study (HPFS) and also in a replication cohort of 21,740 women from the Women's Genome Health Study (WGHS). The genetic-predisposition score was calculated on the basis of 32 BMI-associated loci. The intake of sugar-sweetened beverages was examined prospectively in relation to BMI. RESULTS In the NHS and HPFS cohorts, the genetic association with BMI was stronger among participants with higher intake of sugar-sweetened beverages than among those with lower intake. In the combined cohorts, the increases in BMI per increment of 10 risk alleles were 1.00 for an intake of less than one serving per month, 1.12 for one to four servings per month, 1.38 for two to six servings per week, and 1.78 for one or more servings per day (P < 0.001 for interaction). For the same categories of intake, the relative risks of incident obesity per increment of 10 risk alleles were 1.19 (95% confidence interval [CI], 0.90 to 1.59), 1.67 (95% CI, 1.28 to 2.16), 1.58 (95% CI, 1.01 to 2.47), and 5.06 (95% CI, 1.66 to 15.5) (P = 0.02 for interaction). In the WGHS cohort, the increases in BMI per increment of 10 risk alleles were 1.39, 1.64, 1.90, and 2.53 across the four categories of intake (P = 0.001 for interaction); the relative risks for incident obesity were 1.40 (95% CI, 1.19 to 1.64), 1.50 (95% CI, 1.16 to 1.93), 1.54 (95% CI, 1.21 to 1.94), and 3.16 (95% CI, 2.03 to 4.92), respectively (P = 0.007 for interaction). CONCLUSIONS The genetic association with adiposity appeared to be more pronounced with greater intake of sugar-sweetened beverages. (Funded by the National Institutes of Health and others.)	[Qi, Qibin; Jensen, Majken K.; Hunter, David J.; Willett, Walter C.; Rimm, Eric B.; Hu, Frank B.; Qi, Lu] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Curhan, Gary C.; Hunter, David J.; Willett, Walter C.; Rimm, Eric B.; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Chu, Audrey Y.; Ridker, Paul M.; Chasman, Daniel I.] Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02115 USA; [Ridker, Paul M.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc Dis, Boston, MA 02115 USA; [Chasman, Daniel I.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Kang, Jae H.; Curhan, Gary C.; Pasquale, Louis R.; Hunter, David J.; Willett, Walter C.; Rimm, Eric B.; Hu, Frank B.; Qi, Lu] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Pasquale, Louis R.] Harvard Univ, Sch Med, Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Qi, L (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.	nhlqi@channing.harvard.edu	Qi, Qibin/H-9055-2012	Jensen, Majken Karoline/0000-0003-4729-7545; Venkatasubramanian, Siddharth/0000-0002-5860-0768	National Institutes of Health; National Institutes of Health [DK091718, HL071981, HL073168, CA87969, CA49449, CA055075, HL34594, HL088521, U01HG004399, DK080140, 5P30DK46200, U54CA155626, DK58845, U01HG004728-02, EY015473, DK70756, DK46200, HL043851, HL69757, CA047988]; Merck Research Laboratories; American Heart Association Scientist Development Award [0730094N]; Research to Prevent Blindness award; Harvard Ophthalmology Scholar Award; Harvard Glaucoma Center of Excellence; Amgen; Genzyme; Isis Pharmaceuticals; Vascular Biogenics; Merck; Abbott; Novartis; AstraZeneca; Novo Nordisk; California Walnut Commission; Kellogg; NATIONAL CANCER INSTITUTE [P01CA055075, P01CA087969, R01CA049449, U01CA049449, U54CA155626, R01CA047988] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY015473] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U19HL069757, R01HL034594, R01HL071981, T32HL007575, R01HL073168, R01HL088521, U01HL069757, R01HL043851] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004728, U01HG004399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK070756, K24DK080140, R01DK091718, R01DK058845, P30DK046200] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck Research Laboratories(Merck & Company); American Heart Association Scientist Development Award(American Heart Association); Research to Prevent Blindness award(Research to Prevent Blindness (RPB)); Harvard Ophthalmology Scholar Award; Harvard Glaucoma Center of Excellence; Amgen(Amgen); Genzyme(Sanofi-AventisGenzyme Corporation); Isis Pharmaceuticals; Vascular Biogenics; Merck(Merck & Company); Abbott(Abbott Laboratories); Novartis(Novartis); AstraZeneca(AstraZeneca); Novo Nordisk(Novo Nordisk); California Walnut Commission; Kellogg; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by the National Institutes of Health and others.; Supported by grants (DK091718, HL071981, HL073168, CA87969, CA49449, CA055075, HL34594, HL088521, U01HG004399, DK080140, 5P30DK46200, U54CA155626, DK58845, U01HG004728-02, EY015473, DK70756, and DK46200) from the National Institutes of Health, with additional support for genotyping from Merck Research Laboratories; an American Heart Association Scientist Development Award (0730094N, to Dr. L. Qi); and a Research to Prevent Blindness award and a Harvard Ophthalmology Scholar Award (both to Dr. Pasquale) from the Harvard Glaucoma Center of Excellence. The WGHS is supported by grants (HL043851, HL69757, and CA047988) from the National Institutes of Health, with collaborative scientific support and funding for genotyping provided by Amgen.; Dr. Ridker reports receiving consulting fees from Genzyme, Isis Pharmaceuticals, Vascular Biogenics, Merck, and Abbott and grant support to his institution from Novartis and AstraZeneca and being listed as a co-inventor on patents held by his institution that relate to the use of inflammatory biomarkers in cardiovascular disease and diabetes (patent and royalty payments are received by Brigham and Women's Hospital); Dr. Hu, receiving consulting fees from Novo Nordisk and grant support to his institution from Merck and the California Walnut Commission; and Dr. L. Qi, receiving lecture fees from Kellogg. No other potential conflict of interest relevant to this article was reported.	Ahmad T, 2011, DIABETES CARE, V34, P675, DOI 10.2337/dc10-0948; Andreasen CH, 2008, DIABETES, V57, P95, DOI 10.2337/db07-0910; Colditz GA, 1997, J WOMENS HEALTH, V6, P49, DOI 10.1089/jwh.1997.6.49; Cornelis MC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002033; de Ruyter JC, 2012, NEW ENGL J MED, V367, P1397, DOI 10.1056/NEJMoa1203034; DiMeglio DP, 2000, INT J OBESITY, V24, P794, DOI 10.1038/sj.ijo.0801229; Ebbeling CB, 2012, NEW ENGL J MED, V367, P1407, DOI 10.1056/NEJMoa1203388; FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Hakanen M, 2009, J CLIN ENDOCR METAB, V94, P1281, DOI 10.1210/jc.2008-1199; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Jensen MK, 2011, CIRC-CARDIOVASC GENE, V4, P549, DOI 10.1161/CIRCGENETICS.111.960393; Jonsson A, 2010, DIABETOLOGIA, V53, P1244, DOI 10.1007/s00125-010-1709-9; Kilpelainen TO, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001116; Li SX, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000332; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Malik VS, 2011, AM J CLIN NUTR, V94, P1161, DOI 10.3945/ajcn.111.025676; Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185; Manolio TA, 2006, NAT REV GENET, V7, P812, DOI 10.1038/nrg1919; Mattes Richard D., 1996, Physiology and Behavior, V59, P179, DOI 10.1016/0031-9384(95)02007-1; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; McCullough ML, 2002, AM J CLIN NUTR, V76, P1261, DOI 10.1093/ajcn/76.6.1261; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; PIRIE P, 1981, J AM DIET ASSOC, V78, P601; Popkin BM, 2010, PHYSIOL BEHAV, V100, P4, DOI 10.1016/j.physbeh.2009.12.022; Qi L, 2008, NUTR REV, V66, P684, DOI 10.1111/j.1753-4887.2008.00128.x; Qi L, 2010, HUM MOL GENET, V19, P2706, DOI 10.1093/hmg/ddq156; Rampersaud E, 2009, ARCH INTERN MED, V169, P453; Rampersaud E, 2008, ARCH INTERN MED, V168, P1791, DOI 10.1001/archinte.168.16.1791; Ridker PM, 2008, CLIN CHEM, V54, P249, DOI 10.1373/clinchem.2007.099366; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W; Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927; Schulze MB, 2004, AM J CLIN NUTR, V80, P348, DOI 10.1093/ajcn/80.2.348; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stanhope KL, 2009, J CLIN INVEST, V119, P1322, DOI 10.1172/JCI37385; Tan JT, 2008, DIABETES, V57, P2851, DOI 10.2337/db08-0214; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782; Weinstein AR, 2004, JAMA-J AM MED ASSOC, V292, P1188, DOI 10.1001/jama.292.10.1188; Wiggs JL, 2011, HUM MOL GENET, V20, P4707, DOI 10.1093/hmg/ddr382; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991	44	368	381	4	78	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 11	2012	367	15					1387	1396		10.1056/NEJMoa1203039	http://dx.doi.org/10.1056/NEJMoa1203039			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	018ID	22998338	Green Accepted			2022-12-24	WOS:000309652700005
J	Woo, DH; Han, KS; Shim, JW; Yoon, BE; Kim, E; Bae, JY; Oh, SJ; Hwang, EM; Marmorstein, AD; Bae, YC; Park, JY; Lee, CJ				Woo, Dong Ho; Han, Kyung-Seok; Shim, Jae Wan; Yoon, Bo-Eun; Kim, Eunju; Bae, Jin Young; Oh, Soo-Jin; Hwang, Eun Mi; Marmorstein, Alan D.; Bae, Yong Chul; Park, Jae-Yong; Lee, C. Justin			TREK-1 and Best1 Channels Mediate Fast and Slow Glutamate Release in Astrocytes upon GPCR Activation	CELL			English	Article							RAT HIPPOCAMPAL SLICES; K+ CHANNELS; SYNAPTIC-TRANSMISSION; ANION CHANNEL; RECEPTORS; EXOCYTOSIS; INHIBITION; NEURONS; CA2+; FREQUENCY	Astrocytes release glutamate upon activation of various GPCRs to exert important roles in synaptic functions. However, the molecular mechanism of release has been controversial. Here, we report two kinetically distinct modes of nonvesicular, channel-mediated glutamate release. The fast mode requires activation of G(alpha i), dissociation of G(beta gamma), and subsequent opening of glutamate-permeable, two-pore domain potassium channel TREK-1 through direct interaction between G(beta gamma) and N terminus of TREK-1. The slow mode is Ca2+ dependent and requires G(alpha q) activation and opening of glutamate-permeable, Ca2+-activated anion channel Best1. Ultrastructural analyses demonstrate that TREK-1 is preferentially localized at cell body and processes, whereas Best1 is mostly found in microdomains of astrocytes near synapses. Diffusion modeling predicts that the fast mode can target neuronal mGluR with peak glutamate concentration of 100 mu M, whereas slow mode targets neuronal NMDA receptors at around 1 mu M. Our results reveal two distinct sources of astrocytic glutamate that can differentially influence neighboring neurons.	[Woo, Dong Ho; Han, Kyung-Seok; Yoon, Bo-Eun; Kim, Eunju; Oh, Soo-Jin; Hwang, Eun Mi; Park, Jae-Yong; Lee, C. Justin] Korea Inst Sci & Technol, Ctr Neural Sci, Seoul 136791, South Korea; [Woo, Dong Ho; Han, Kyung-Seok; Yoon, Bo-Eun; Kim, Eunju; Oh, Soo-Jin; Hwang, Eun Mi; Park, Jae-Yong; Lee, C. Justin] Korea Inst Sci & Technol, WCI Ctr Funct Connect, Seoul 136791, South Korea; [Woo, Dong Ho; Han, Kyung-Seok; Yoon, Bo-Eun; Lee, C. Justin] Univ Sci & Technol UST, Neurosci Program, Taejon 305350, South Korea; [Shim, Jae Wan] Korea Inst Sci & Technol, Future Convergence Res Div, Seoul 136791, South Korea; [Shim, Jae Wan] Univ Sci & Technol, Seoul 136791, South Korea; [Park, Jae-Yong] Gyeongsang Natl Univ, Med Res Ctr Neural Dysfunct, Inst Hlth Sci, Dept Physiol,Sch Med, Jinju 660751, South Korea; [Bae, Jin Young; Bae, Yong Chul] Kyungpook Natl Univ, Sch Dent, Dept Oral Anat & Neurobiol, BK21, Taegu 700412, South Korea; [Oh, Soo-Jin] Seoul Natl Univ, Dent Res Inst, Sch Dent, Dept Cell & Dev Biol, Seoul 110749, South Korea; [Marmorstein, Alan D.] Univ Arizona, Coll Med, Dept Ophthalmol & Vis Sci, Tucson, AZ 85711 USA; [Marmorstein, Alan D.] Univ Arizona, Coll Opt Sci, Tucson, AZ 85711 USA	Korea Institute of Science & Technology (KIST); Korea Institute of Science & Technology (KIST); University of Science & Technology (UST); Korea Institute of Science & Technology (KIST); Gyeongsang National University; Kyungpook National University; Seoul National University (SNU); University of Arizona; University of Arizona	Park, JY (corresponding author), Korea Inst Sci & Technol, Ctr Neural Sci, Seoul 136791, South Korea.	jaeyong@gnu.ac.kr; cjl@kist.re.kr	Lee, C. Justin/AAC-1663-2019; Hwang, Eun Mi/HHN-3030-2022	Lee, C Justin/0000-0002-3555-0980; Park, Jae-Yong/0000-0001-7698-7890	World Class Institute [WCI 2009-003]; MRC [2012-0000305]; NRF [2010-0029460]; MEST of Korea; NIH [R01-EY013160]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY013160] Funding Source: NIH RePORTER	World Class Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NRF; MEST of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the World Class Institute (WCI 2009-003), MRC (2012-0000305), and Basic Science Research (2010-0029460) Programs of the NRF funded by the MEST of Korea and also by NIH (R01-EY013160) and a grant from Research to Prevent Blindness to the Department of Ophthalmology and Vision Science at the University of Arizona. We thank George Augustine, Larry Cohen, and Keiko Tanaka for careful editing of the manuscript. We thank Taekeun Kim for technical support for immunocytochemistry, Nammi Park for technical support for Y2H, Lucie Langevin for providing clone of pRK-beta-Ark-C terminus, and Nevin A. Lambert for pCDNA3.1-SS-ECFP-TM-Gi1-CG(GiCG) and pCDNA3.1-SS-ECFP-TM-Gs.	Agulhon C, 2010, SCIENCE, V327, P1250, DOI 10.1126/science.1184821; Araque A, 2000, J NEUROSCI, V20, P666, DOI 10.1523/JNEUROSCI.20-02-00666.2000; Araque A, 1998, J NEUROSCI, V18, P6822; BEKKERS JM, 1995, J NEUROPHYSIOL, V73, P1145, DOI 10.1152/jn.1995.73.3.1145; Bezzi P, 2004, NAT NEUROSCI, V7, P613, DOI 10.1038/nn1246; Binshtok AM, 2007, NATURE, V449, P607, DOI 10.1038/nature06191; Bluml K, 1997, EMBO J, V16, P4908, DOI 10.1093/emboj/16.16.4908; Brenner T, 2008, AM J PHYSIOL-ENDOC M, V295, pE1480, DOI 10.1152/ajpendo.90652.2008; Cavelier P, 2005, J PHYSIOL-LONDON, V564, P397, DOI 10.1113/jphysiol.2004.082131; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; Domercq M, 2006, J BIOL CHEM, V281, P30684, DOI 10.1074/jbc.M606429200; FARINELLI SE, 1992, J NEUROCHEM, V58, P1905, DOI 10.1111/j.1471-4159.1992.tb10068.x; Fiacco TA, 2004, J NEUROSCI, V24, P722, DOI 10.1523/JNEUROSCI.2859-03.2004; Greenwood IA, 2007, TRENDS PHARMACOL SCI, V28, P1, DOI 10.1016/j.tips.2006.11.004; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; Halassa MM, 2007, TRENDS MOL MED, V13, P54, DOI 10.1016/j.molmed.2006.12.005; Hamilton NB, 2010, NAT REV NEUROSCI, V11, P227, DOI 10.1038/nrn2803; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Heximer SP, 1997, P NATL ACAD SCI USA, V94, P14389, DOI 10.1073/pnas.94.26.14389; Hollenberg MD, 1997, CAN J PHYSIOL PHARM, V75, P832, DOI 10.1139/cjpp-75-7-832; HUANG CL, 1995, NEURON, V15, P1133, DOI 10.1016/0896-6273(95)90101-9; Innocenti B, 2000, J NEUROSCI, V20, P1800; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Junge CE, 2004, EXP NEUROL, V188, P94, DOI 10.1016/j.expneurol.2004.02.018; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Kim E, 2010, BIOCHEM BIOPH RES CO, V395, P244, DOI 10.1016/j.bbrc.2010.03.171; KOCH WJ, 1993, J BIOL CHEM, V268, P8256; Lee CJ, 2007, J PHYSIOL-LONDON, V581, P1057, DOI 10.1113/jphysiol.2007.130377; Lee S, 2010, SCIENCE, V330, P790, DOI 10.1126/science.1184334; Li DD, 2012, J PHYSIOL-LONDON, V590, P855, DOI 10.1113/jphysiol.2011.219345; Li X, 2005, J BIOL CHEM, V280, P23945, DOI 10.1074/jbc.M414078200; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; Marmorstein LY, 2006, J GEN PHYSIOL, V127, P577, DOI 10.1085/jgp.200509473; Nedergaard M, 2002, NAT REV NEUROSCI, V3, P748, DOI 10.1038/nrn916; O'Driscoll KE, 2009, BIOCHEM BIOPH RES CO, V384, P476, DOI 10.1016/j.bbrc.2009.05.008; Obrenovitch TP, 2001, METHODS, V23, P63, DOI 10.1006/meth.2000.1106; Park H, 2009, J NEUROSCI, V29, P13063, DOI 10.1523/JNEUROSCI.3193-09.2009; Parpura V, 2000, P NATL ACAD SCI USA, V97, P8629, DOI 10.1073/pnas.97.15.8629; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Sorensen SD, 2003, MOL PHARMACOL, V64, P1199, DOI 10.1124/mol.64.5.1199; Takano T, 2005, P NATL ACAD SCI USA, V102, P16466, DOI 10.1073/pnas.0506382102; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Virginio C, 1999, NAT NEUROSCI, V2, P315, DOI 10.1038/7225; Wang HS, 1997, CIRC RES, V81, P711; WEST RE, 1985, J BIOL CHEM, V260, P4428; Ye ZC, 2003, J NEUROSCI, V23, P3588, DOI 10.1523/jneurosci.23-09-03588.2003; Yoon BE, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-42; Zhang YW, 2010, HUM MOL GENET, V19, P1108, DOI 10.1093/hmg/ddp583; Zhou M, 2009, J NEUROSCI, V29, P8551, DOI 10.1523/JNEUROSCI.5784-08.2009	51	216	218	0	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 28	2012	151	1					25	40		10.1016/j.cell.2012.09.005	http://dx.doi.org/10.1016/j.cell.2012.09.005			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	23021213	Bronze			2022-12-24	WOS:000309544200008
J	Trasande, L; Attina, TM; Blustein, J				Trasande, Leonardo; Attina, Teresa M.; Blustein, Jan			Association Between Urinary Bisphenol A Concentration and Obesity Prevalence in Children and Adolescents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ENDOCRINE-DISRUPTING CHEMICALS; TEMPORAL VARIABILITY; PRESCHOOL-CHILDREN; ADIPOSE-TISSUE; TOBACCO-SMOKE; UNITED-STATES; EXPOSURE; WOMEN; ADIPOCYTES; DISEASE	Context Bisphenol A (BPA), a manufactured chemical, is found in canned food, polycarbonate-bottled liquids, and other consumer products. In adults, elevated urinary BPA concentrations are associated with obesity and incident coronary artery disease. BPA exposure is plausibly linked to childhood obesity, but evidence is lacking to date. Objective To examine associations between urinary BPA concentration and body mass outcomes in children. Design, Setting, and Participants Cross-sectional analysis of a nationally representative subsample of 2838 participants aged 6 through 19 years randomly selected for measurement of urinary BPA concentration in the 2003-2008 National Health and Nutrition Examination Surveys. Main Outcome Measures Body mass index (BMI), converted to sex-and age-standardized z scores and used to classify participants as overweight (BMI >= 85th percentile for age/sex) or obese (BMI >= 95th percentile). Results Median urinary BPA concentration was 2.8 ng/mL (interquartile range, 1.5-5.6). Of the participants, 1047 (34.1% [SE, 1.5%]) were overweight and 590 (17.8% [SE, 1.3%]) were obese. Controlling for race/ethnicity, age, caregiver education, poverty to income ratio, sex, serum cotinine level, caloric intake, television watching, and urinary creatinine level, children in the lowest urinary BPA quartile had a lower estimated prevalence of obesity (10.3% [95% CI, 7.5%-13.1%]) than those in quartiles 2 (20.1% [95% CI, 14.5%-25.6%]), 3 (19.0% [95% CI, 13.7%-24.2%]), and 4 (22.3% [95% CI, 16.6%-27.9%]). Similar patterns of association were found in multivariable analyses examining the association between quartiled urinary BPA concentration and BMI z score and in analyses that examined the logarithm of urinary BPA concentration and the prevalence of obesity. Obesity was not associated with exposure to other environmental phenols commonly used in other consumer products, such as sunscreens and soaps. In stratified analysis, significant associations between urinary BPA concentrations and obesity were found among whites (P < .001) but not among blacks or Hispanics. Conclusions Urinary BPA concentration was significantly associated with obesity in this cross-sectional study of children and adolescents. Explanations of the association cannot rule out the possibility that obese children ingest food with higher BPA content or have greater adipose stores of BPA. JAMA. 2012;308(11):1113-1121 www.jama.com	[Trasande, Leonardo; Attina, Teresa M.] NYU, Dept Pediat, Sch Med, New York, NY 10016 USA; [Trasande, Leonardo] NYU, Dept Environm Med, Sch Med, New York, NY 10016 USA; [Blustein, Jan] NYU, Dept Populat Hlth, Sch Med, New York, NY 10016 USA; [Trasande, Leonardo; Blustein, Jan] NYU, Wagner Sch Publ Serv, New York, NY 10016 USA	New York University; New York University; New York University; New York University	Trasande, L (corresponding author), NYU, Dept Pediat, Sch Med, 227 E 30th St,Room 711, New York, NY 10016 USA.	leonardo.trasande@nyumc.org	Trasande, Leonardo/ABE-6339-2020	Trasande, Leonardo/0000-0002-1928-597X				[Anonymous], NHANES 2003 2004 ENV; BEARER CF, 1995, ENVIRON HEALTH PERSP, V103, P7, DOI 10.2307/3432337; Birnbaum LS, 2012, ENVIRON HEALTH PERSP, V120, pA143, DOI 10.1289/ehp.1205179; Braun JM, 2011, PEDIATRICS, V128, P873, DOI 10.1542/peds.2011-1335; Braun JM, 2011, ENVIRON HEALTH PERSP, V119, P131, DOI 10.1289/ehp.1002366; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; Carwile JL, 2011, ENVIRON RES, V111, P825, DOI 10.1016/j.envres.2011.05.014; Centers for Disease Control and Prevention, 2012, OV NHANES SURV DES W; Centers for Disease Control and Prevention, MEAS GUID DIET REC I; Chapin RE, 2008, BIRTH DEFECTS RES B, V83, P157, DOI 10.1002/bdrb.20147; Elobeid MA, 2008, CURR OPIN ENDOCRINOL, V15, P403, DOI 10.1097/MED.0b013e32830ce95c; Fernandez MF, 2007, REPROD TOXICOL, V24, P259, DOI 10.1016/j.reprotox.2007.06.007; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; FLEISS JL, 1977, AM J PUBLIC HEALTH, V67, P1188, DOI 10.2105/AJPH.67.12.1188; Grun F, 2009, MOL ENDOCRINOL, V23, P1127, DOI 10.1210/me.2008-0485; Howdeshell KL, 1999, NATURE, V401, P763, DOI 10.1038/44517; Hugo ER, 2008, ENVIRON HEALTH PERSP, V116, P1642, DOI 10.1289/ehp.11537; Janesick A, 2011, BIRTH DEFECTS RES C, V93, P34, DOI 10.1002/bdrc.20197; Lakind JS, 2011, J EXPO SCI ENV EPID, V21, P272, DOI 10.1038/jes.2010.9; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Lim DS, 2009, J TOXICOL ENV HEAL A, V72, P1327; Lohman T.J., 1998, ANTHROPOMETRIC STAND; Mahalingaiah S, 2008, ENVIRON HEALTH PERSP, V116, P173, DOI 10.1289/ehp.10605; Masuno H, 2002, J LIPID RES, V43, P676; Mauvais-Jarvis F, 2011, TRENDS ENDOCRIN MET, V22, P24, DOI 10.1016/j.tem.2010.10.002; Melzer D, 2012, CIRCULATION, V125, P1482, DOI 10.1161/CIRCULATIONAHA.111.069153; Melzer D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008673; Mendoza JA, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-44; Nepomnaschy PA, 2009, ENVIRON RES, V109, P734, DOI 10.1016/j.envres.2009.04.004; Ogden CL, 2002, PEDIATRICS, V109, P45, DOI 10.1542/peds.109.1.45; Saal FSV, 2012, MOL CELL ENDOCRINOL, V354, P74, DOI 10.1016/j.mce.2012.01.001; Sakurai K, 2004, BRIT J PHARMACOL, V141, P209, DOI 10.1038/sj.bjp.0705520; Schecter A, 2010, ENVIRON SCI TECHNOL, V44, P9425, DOI 10.1021/es102785d; Stahlhut RW, 2009, ENVIRON HEALTH PERSP, V117, P784, DOI 10.1289/ehp.0800376; Tavernise S., 2012, NY TIMES        1121; Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010; Thomson BM, 2005, FOOD ADDIT CONTAM, V22, P65, DOI 10.1080/02652030400027920; Trasande L, 2009, ENVIRON HEALTH PERSP, V117, P159, DOI 10.1289/ehp.11839; Update on Bisphenol A for Use in Food Contact Applications, 2012, UPD BISPH US FOOD CO; USDA, 2010, DIET GUID AM, DOI DOI 10.HTTP://WWW.CNPP.USDA.G0V/PUBLICATI0NS/DIETARYGUIDELINES/2010/P0LICYD0C/P0LICYD0C.PDF; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050; Vokel W, 2002, CHEM RES TOXICOL, V15, P1281, DOI 10.1021/tx025548t; Weitzman M, 2005, CIRCULATION, V112, P862, DOI 10.1161/CIRCULATIONAHA.104.520650; White House Task Force on Childhood Obesity, 2010, SOLV PROBL CHILDH OB; Wilson KM, 2011, NICOTINE TOB RES, V13, P800, DOI 10.1093/ntr/ntr076; Wilson NK, 2007, ENVIRON RES, V103, P9, DOI 10.1016/j.envres.2006.04.006; Ye XB, 2008, ENVIRON RES, V108, P260, DOI 10.1016/j.envres.2008.07.014	47	327	345	4	140	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	2012	308	11					1113	1121		10.1001/2012.jama.11461	http://dx.doi.org/10.1001/2012.jama.11461			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	007AL	22990270	Bronze			2022-12-24	WOS:000308861000027
J	Tayi, AS; Shveyd, AK; Sue, ACH; Szarko, JM; Rolczynski, BS; Cao, D; Kennedy, TJ; Sarjeant, AA; Stern, CL; Paxton, WF; Wu, W; Dey, SK; Fahrenbach, AC; Guest, JR; Mohseni, H; Chen, LX; Wang, KL; Stoddart, JF; Stupp, SI				Tayi, Alok S.; Shveyd, Alexander K.; Sue, Andrew C-H; Szarko, Jodi M.; Rolczynski, Brian S.; Cao, Dennis; Kennedy, T. Jackson; Sarjeant, Amy A.; Stern, Charlotte L.; Paxton, Walter F.; Wu, Wei; Dey, Sanjeev K.; Fahrenbach, Albert C.; Guest, Jeffrey R.; Mohseni, Hooman; Chen, Lin X.; Wang, Kang L.; Stoddart, J. Fraser; Stupp, Samuel I.			Room-temperature ferroelectricity in supramolecular networks of charge-transfer complexes	NATURE			English	Article							IONIC PHASE-TRANSITION; TETRATHIAFULVALENE-CHLORANIL; MOLECULAR-CRYSTAL; STACK	Materials exhibiting a spontaneous electrical polarization(1,2) that can be switched easily between antiparallel orientations are of potential value for sensors, photonics and energy-efficient memories. In this context, organic ferroelectrics(3,4) are of particular interest because they promise to be lightweight, inexpensive and easily processed into devices. A recently identified family of organic ferroelectric structures is based on intermolecular charge transfer, where donor and acceptor molecules co-crystallize in an alternating fashion known as a mixed stack(5-8): in the crystalline lattice, a collective transfer of electrons from donor to acceptor molecules results in the formation of dipoles that can be realigned by an external field as molecules switch partners in the mixed stack. Although mixed stacks have been investigated extensively, only three systems are known(9,10) to show ferroelectric switching, all below 71 kelvin. Here we describe supramolecular charge-transfer networks that undergo ferroelectric polarization switching with a ferroelectric Curie temperature above room temperature. These polar and switchable systems utilize a structural synergy between a hydrogen-bonded network and charge-transfer complexation of donor and acceptor molecules in a mixed stack. This supramolecular motif could help guide the development of other functional organic systems that can switch polarization under the influence of electric fields at ambient temperatures.	[Shveyd, Alexander K.; Sue, Andrew C-H; Szarko, Jodi M.; Rolczynski, Brian S.; Cao, Dennis; Sarjeant, Amy A.; Stern, Charlotte L.; Paxton, Walter F.; Dey, Sanjeev K.; Fahrenbach, Albert C.; Chen, Lin X.; Stoddart, J. Fraser; Stupp, Samuel I.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Tayi, Alok S.; Stupp, Samuel I.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA; [Sue, Andrew C-H; Wang, Kang L.] Univ Calif Los Angeles, Dept Elect Engn, Los Angeles, CA 90095 USA; [Szarko, Jodi M.; Rolczynski, Brian S.; Chen, Lin X.] Northwestern Univ, ANSER Ctr, Evanston, IL 60208 USA; [Szarko, Jodi M.; Rolczynski, Brian S.; Chen, Lin X.] Argonne Natl Lab, Chem Sci & Engn Div, Argonne, IL 60439 USA; [Cao, Dennis; Fahrenbach, Albert C.; Stoddart, J. Fraser] Korea Adv Inst Sci & Technol, Grad Sch EEWS, Taejon 305701, South Korea; [Kennedy, T. Jackson] Northwestern Univ, Dept Phys, Evanston, IL 60208 USA; [Wu, Wei; Mohseni, Hooman] Northwestern Univ, Dept Elect Engn, Evanston, IL 60208 USA; [Guest, Jeffrey R.] Argonne Natl Lab, Ctr Nanoscale Mat, Argonne, IL 60439 USA; [Stupp, Samuel I.] Northwestern Univ, Dept Med, Chicago, IL 60611 USA; [Stupp, Samuel I.] Northwestern Univ, Inst BioNanotechnol Med, Chicago, IL 60611 USA	Northwestern University; Northwestern University; University of California System; University of California Los Angeles; Northwestern University; United States Department of Energy (DOE); Argonne National Laboratory; Korea Advanced Institute of Science & Technology (KAIST); Northwestern University; Northwestern University; United States Department of Energy (DOE); Argonne National Laboratory; Northwestern University; Northwestern University	Stoddart, JF (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.	stoddart@northwestern.edu; s-stupp@northwestern.edu	Mohseni, Hooman/AAZ-5878-2020; Mohseni, Hooman/AAX-7824-2021; Masino, Matteo/O-5429-2015; Fahrenbach, Albert/B-3042-2014; Stupp, Samuel/AGV-1942-2022; Mohseni, Hooman/B-7253-2009; Cao, Dennis/C-2240-2013; Guest, Jeffrey R/B-2715-2009; Stupp, Samuel/B-6737-2009; Sue, Andrew C.-H./K-1641-2015; Stoddart, James Fraser/H-1518-2011; Paxton, Walter/AAP-8682-2021; Szarko, Jodi/L-1497-2015	Mohseni, Hooman/0000-0002-0183-4213; Masino, Matteo/0000-0002-5869-6800; Cao, Dennis/0000-0002-0315-1619; Guest, Jeffrey R/0000-0002-9756-8801; Sue, Andrew C.-H./0000-0001-9557-2658; Stoddart, James Fraser/0000-0003-3161-3697; Paxton, Walter/0000-0002-2438-4542; Szarko, Jodi/0000-0002-2181-9408	Non-equilibrium Energy Research Center (NERC) at Northwestern University; US Department of Energy (DOE), Office of Basic Energy Sciences [DE-SC0000989]; Materials Research Science and Engineering Centre (MRSEC) at Northwestern University; National Science Foundation (NSF); WCU program at KAIST in Korea [R-31-2008-000-10055-0]; US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NERC; Initiative for Sustainability and Energy at Northwestern (ISEN)	Non-equilibrium Energy Research Center (NERC) at Northwestern University(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); US Department of Energy (DOE), Office of Basic Energy Sciences(United States Department of Energy (DOE)); Materials Research Science and Engineering Centre (MRSEC) at Northwestern University(National Science Foundation (NSF)); National Science Foundation (NSF)(National Science Foundation (NSF)); WCU program at KAIST in Korea; US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Initiative for Sustainability and Energy at Northwestern (ISEN)	This work was supported by the Non-equilibrium Energy Research Center (NERC) at Northwestern University, funded by the US Department of Energy (DOE), Office of Basic Energy Sciences under award number DE-SC0000989. A.K.S. received support from the Materials Research Science and Engineering Centre (MRSEC) at Northwestern University, funded by the National Science Foundation (NSF). D.C., A.C.F. and J.F.S. were supported by the WCU program (R-31-2008-000-10055-0) at KAIST in Korea. Use of the Center for Nanoscale Materials was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract no. DE-AC02-06CH11357. D.C. and A.C.F. were supported by NSF Graduate Research Fellowships. A.K.S. and A.C.-H.S. were supported by a fellowship from the NERC. A.S.T. was supported by a fellowship from the Initiative for Sustainability and Energy at Northwestern (ISEN) and NERC. We thank J.B. Ketterson and O. Chernyashevskyy (Northwestern University) for discussions and advice, Y.D. Shah (Northwestern University) for assistance with ferroelectricity measurements, A.M.Z. Slawin (University of St Andrews) for initial help with crystallographic data collection and refinement, M. Mara (Northwestern University) for assistance with spectroscopy, Y. Liu (The Molecular Foundry, Lawrence Berkeley National Laboratory) for discussions, and the Integrated Molecular Structure Education and Research Centre (IMSERC) and the Magnet and Low Temperature Facility at Northwestern University for providing access to equipment for the relevant experiments. Molecular crystal images were produced using the UCSF Chimera package from the Resource for Biocomputing, Visualisation and Informatics at the University of California, San Francisco.	[Anonymous], 2007, CRYST EXPL V 2 1; Collet E, 2003, SCIENCE, V300, P612, DOI 10.1126/science.1082001; GIRLANDO A, 1985, SOLID STATE COMMUN, V54, P753, DOI 10.1016/0038-1098(85)90279-0; GIRLANDO A, 1983, J CHEM PHYS, V79, P1075, DOI 10.1063/1.445833; Hamilton DG, 1997, AUST J CHEM, V50, P439, DOI 10.1071/C97033; Horiuchi S, 2003, SCIENCE, V299, P229, DOI 10.1126/science.1076129; Horiuchi S, 2008, NAT MATER, V7, P357, DOI 10.1038/nmat2137; Horiuchi S, 2010, NATURE, V463, P789, DOI 10.1038/nature08731; Kagawa F, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.227602; Kobayashi K, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.237601; KUWATA-GONOKAMI M, 1994, NATURE, V367, P47, DOI 10.1038/367047a0; McKinnon JJ, 2004, ACTA CRYSTALLOGR B, V60, P627, DOI 10.1107/S0108768104020300; Meneghetti M, 1996, J CHEM PHYS, V105, P397, DOI 10.1063/1.471916; Miyajima D, 2012, SCIENCE, V336, P209, DOI 10.1126/science.1217954; Nielsen MB, 1999, EUR J ORG CHEM, V1999, P2807; OKAMOTO H, 1991, PHYS REV B, V43, P8224, DOI 10.1103/PhysRevB.43.8224; Saha S, 2005, CHEM-EUR J, V11, P6846, DOI 10.1002/chem.200500371; Soos ZG, 2007, CHEM PHYS LETT, V440, P87, DOI 10.1016/j.cplett.2007.04.024; Stupp SI, 1997, SCIENCE, V276, P384, DOI 10.1126/science.276.5311.384; TOKURA Y, 1989, PHYS REV LETT, V63, P2405, DOI 10.1103/PhysRevLett.63.2405; TORRANCE JB, 1979, ACCOUNTS CHEM RES, V12, P79, DOI 10.1021/ar50135a001; TORRANCE JB, 1981, PHYS REV LETT, V46, P253, DOI 10.1103/PhysRevLett.46.253; TORRANCE JB, 1981, PHYS REV LETT, V47, P1747, DOI 10.1103/PhysRevLett.47.1747; Zhang QM, 1998, SCIENCE, V280, P2101, DOI 10.1126/science.280.5372.2101	24	367	375	13	570	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2012	488	7412					485	489		10.1038/nature11395	http://dx.doi.org/10.1038/nature11395			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992FS	22914165				2022-12-24	WOS:000307761600031
J	Kadauke, S; Udugama, MI; Pawlicki, JM; Achtman, JC; Jain, DP; Cheng, Y; Hardison, RC; Blobel, GA				Kadauke, Stephan; Udugama, Maheshi I.; Pawlicki, Jan M.; Achtman, Jordan C.; Jain, Deepti P.; Cheng, Yong; Hardison, Ross C.; Blobel, Gerd A.			Tissue-Specific Mitotic Bookmarking by Hematopoietic Transcription Factor GATA1	CELL			English	Article							LOCUS-CONTROL REGION; ZINC-FINGER PROTEIN; ACTIVE GENES; HISTONE H3; DYNAMIC CHANGES; LIVING CELLS; STEM-CELLS; CHROMATIN; MITOSIS; CHROMOSOMES	Tissue-specific transcription patterns are preserved throughout cell divisions to maintain lineage fidelity. We investigated whether transcription factor GATA1 plays a role in transmitting hematopoietic gene expression programs through mitosis when transcription is transiently silenced. Live-cell imaging revealed that a fraction of GATA1 is retained focally within mitotic chromatin. ChIP-seq of highly purified mitotic cells uncovered that key hematopoietic regulatory genes are occupied by GATA1 in mitosis. The GATA1 coregulators FOG1 and TAL1 dissociate from mitotic chromatin, suggesting that GATA1 functions as platform for their postmitotic recruitment. Mitotic GATA1 target genes tend to reactivate more rapidly upon entry into G1 than genes from which GATA1 dissociates. Mitosis-specific destruction of GATA1 delays reactivation selectively of genes that retain GATA1 during mitosis. These studies suggest a requirement of mitotic "bookmarking" by GATA1 for the faithful propagation of cell-type-specific transcription programs through cell division.	[Kadauke, Stephan; Udugama, Maheshi I.; Pawlicki, Jan M.; Achtman, Jordan C.; Blobel, Gerd A.] Childrens Hosp, Div Hematol, Philadelphia, PA 19104 USA; [Kadauke, Stephan; Blobel, Gerd A.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Jain, Deepti P.; Cheng, Yong; Hardison, Ross C.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Blobel, GA (corresponding author), Childrens Hosp, Div Hematol, Philadelphia, PA 19104 USA.	blobel@email.chop.edu	cheng, yong/I-4270-2012; Kadauke, Stephan/V-6197-2019; Hardison, Ross C/G-1142-2010	Hardison, Ross C/0000-0003-4084-7516; Udugama, Maheshi/0000-0003-0412-4142; Kadauke, Stephan/0000-0003-2996-8034	AHA predoctoral fellowship [90PRE2300139]; NIH [DK058044, DK054937, DK065806, HG005573]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK065806, R01DK058044, R01DK065806, R37DK058044, R01DK054937] Funding Source: NIH RePORTER	AHA predoctoral fellowship(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Alan Lau, Margaret Chou, Jordan Orange, Aline Disimone, Paul Gadue, Rena Zheng, Joanna Balcerek, Chris Thom, Ariel Yang, and Merav Socolovsky for technical assistance and advice; and Christopher Vakoc, Mitchell Weiss, Mitchell Lazar, and members of the laboratory for comments on the manuscript. This work was supported by an AHA predoctoral fellowship (90PRE2300139, S. K.), NIH grants DK058044 and DK054937 (G. A. B.), and DK065806 and HG005573 (R. C. H.). Author contributions: S. K., M. I. U., J.M.P., J.C.A. performed experiments; S. K., D.P.J., Y.C. performed computational analyses; S. K., R. C. H. and G. A. B. conceived the study and wrote the manuscript.	Aoto T, 2008, J BIOL CHEM, V283, P18905, DOI 10.1074/jbc.M709322200; Blobel GA, 2009, MOL CELL, V36, P970, DOI 10.1016/j.molcel.2009.12.001; Bonenfant D, 2007, MOL CELL PROTEOMICS, V6, P1917, DOI 10.1074/mcp.M700070-MCP200; Bruce K, 2005, NUCLEIC ACIDS RES, V33, P5633, DOI 10.1093/nar/gki874; Chang AN, 2002, P NATL ACAD SCI USA, V99, P9237, DOI 10.1073/pnas.142302099; Chen DY, 2005, J CELL BIOL, V168, P41, DOI 10.1083/jcb.200407182; Chen DY, 2002, MOL BIOL CELL, V13, P276, DOI 10.1091/mbc.01-10-0523; Cheng Y, 2009, GENOME RES, V19, P2172, DOI 10.1101/gr.098921.109; Christova R, 2002, NAT CELL BIOL, V4, P79, DOI 10.1038/ncb733; Delcuve GP, 2008, J CELL BIOCHEM, V105, P1, DOI 10.1002/jcb.21806; Dey A, 2000, MOL CELL BIOL, V20, P6537, DOI 10.1128/MCB.20.17.6537-6549.2000; Dey A, 2009, MOL BIOL CELL, V20, P4899, DOI 10.1091/mbc.E09-05-0380; Egli D, 2008, NAT REV MOL CELL BIO, V9, P505, DOI 10.1038/nrm2439; Elnitski L, 1997, J BIOL CHEM, V272, P369; Ferreira R, 2005, MOL CELL BIOL, V25, P1215, DOI 10.1128/MCB.25.4.1215-1227.2005; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Gottesfeld JM, 1997, TRENDS BIOCHEM SCI, V22, P197, DOI 10.1016/S0968-0004(97)01045-1; Grass JA, 2003, P NATL ACAD SCI USA, V100, P8811, DOI 10.1073/pnas.1432147100; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; HOLLOWAY SL, 1993, CELL, V73, P1393, DOI 10.1016/0092-8674(93)90364-V; Jing HI, 2008, MOL CELL, V29, P232, DOI 10.1016/j.molcel.2007.11.020; Johnson KD, 2007, BLOOD, V109, P5230, DOI 10.1182/blood-2007-02-072983; Kanno T, 2004, MOL CELL, V13, P33, DOI 10.1016/S1097-2765(03)00482-9; Kelly TK, 2010, MOL CELL, V39, P901, DOI 10.1016/j.molcel.2010.08.026; Komura JI, 2007, P NATL ACAD SCI USA, V104, P15741, DOI 10.1073/pnas.0702363104; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; Kruhlak MJ, 2001, J BIOL CHEM, V276, P38307; KUO MT, 1982, NUCLEIC ACIDS RES, V10, P4565, DOI 10.1093/nar/10.15.4565; Lecuyer E, 2004, EXP HEMATOL, V32, P11, DOI 10.1016/j.exphem.2003.10.010; Letting DL, 2004, P NATL ACAD SCI USA, V101, P476, DOI 10.1073/pnas.0306315101; Letting DL, 2003, MOL CELL BIOL, V23, P1334, DOI 10.1128/MCB.23.4.1334-1340.2003; MARTINEZBALBAS MA, 1995, CELL, V83, P29, DOI 10.1016/0092-8674(95)90231-7; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; McManus KJ, 2006, J BIOL CHEM, V281, P8888, DOI 10.1074/jbc.M505323200; Michelotti EF, 1997, NATURE, V388, P895, DOI 10.1038/42282; Munugalavadla V, 2005, MOL CELL BIOL, V25, P6747, DOI 10.1128/MCB.25.15.6747-6759.2005; Nichols KE, 2000, NAT GENET, V24, P266, DOI 10.1038/73480; Pal S, 2004, P NATL ACAD SCI USA, V101, P980, DOI 10.1073/pnas.0307612100; Pilon AM, 2011, BLOOD, V118, pE139, DOI 10.1182/blood-2011-05-355107; Pop R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000484; Porcher C, 1999, DEVELOPMENT, V126, P4603; PRESCOTT DM, 1962, EXP CELL RES, V26, P260, DOI 10.1016/0014-4827(62)90176-3; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Sarge KD, 2009, CELL CYCLE, V8, P818, DOI 10.4161/cc.8.6.7849; Sasaki K, 2009, P NATL ACAD SCI USA, V106, P16257, DOI 10.1073/pnas.0902150106; Segil N, 1996, GENE DEV, V10, P2389, DOI 10.1101/gad.10.19.2389; STAMATOYANNOPOULOS JA, 1995, EMBO J, V14, P106, DOI 10.1002/j.1460-2075.1995.tb06980.x; TAYLOR JH, 1960, ANN NY ACAD SCI, V90, P409, DOI 10.1111/j.1749-6632.1960.tb23259.x; Tripic T, 2009, BLOOD, V113, P2191, DOI 10.1182/blood-2008-07-169417; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; Valls E, 2005, J BIOL CHEM, V280, P42592, DOI 10.1074/jbc.M507407200; Varier RA, 2010, EMBO J, V29, P3967, DOI 10.1038/emboj.2010.261; Wechsler J, 2002, NAT GENET, V32, P148, DOI 10.1038/ng955; WEISS MJ, 1994, GENE DEV, V8, P1184, DOI 10.1101/gad.8.10.1184; Weiss MJ, 1997, MOL CELL BIOL, V17, P1642, DOI 10.1128/MCB.17.3.1642; Welch JJ, 2004, BLOOD, V104, P3136, DOI 10.1182/blood-2004-04-1603; Wu WS, 2011, GENOME RES, V21, P1659, DOI 10.1101/gr.125088.111; Xin L, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-31; Xing HY, 2008, NAT CELL BIOL, V10, P1318, DOI 10.1038/ncb1790; Xing HY, 2005, SCIENCE, V307, P421, DOI 10.1126/science.1106478; Yan JZ, 2006, MOL CELL BIOL, V26, P155, DOI 10.1128/MCB.26.1.155-168.2006; Yang ZY, 2008, MOL CELL BIOL, V28, P967, DOI 10.1128/MCB.01020-07; Young DW, 2007, P NATL ACAD SCI USA, V104, P3189, DOI 10.1073/pnas.0611419104; Young DW, 2007, NATURE, V445, P442, DOI 10.1038/nature05473; Zaidi SK, 2010, NAT REV GENET, V11, P583, DOI 10.1038/nrg2827; Zaidi SK, 2003, P NATL ACAD SCI USA, V100, P14852, DOI 10.1073/pnas.2533076100	67	160	162	0	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 17	2012	150	4					725	737		10.1016/j.cell.2012.06.038	http://dx.doi.org/10.1016/j.cell.2012.06.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22901805	Bronze, Green Accepted			2022-12-24	WOS:000308002300008
J	Georgianna, DR; Mayfield, SP				Georgianna, D. Ryan; Mayfield, Stephen P.			Exploiting diversity and synthetic biology for the production of algal biofuels	NATURE			English	Review							TECHNOECONOMIC ANALYSIS; BIODIESEL PRODUCTION; MASS CULTIVATION; MICROALGAE; TEMPERATURE; BIOMASS; OIL; PHOTOSYNTHESIS; BIOSYNTHESIS; ACCUMULATION	Modern life is intimately linked to the availability of fossil fuels, which continue to meet the world's growing energy needs even though their use drives climate change, exhausts finite reserves and contributes to global political strife. Biofuels made from renewable resources could be a more sustainable alternative, particularly if sourced from organisms, such as algae, that can be farmed without using valuable arable land. Strain development and process engineering are needed to make algal biofuels practical and economically viable.	[Georgianna, D. Ryan; Mayfield, Stephen P.] Univ Calif San Diego, Div Biol Sci, San Diego Ctr Algae Biotechnol SD CAB, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Mayfield, SP (corresponding author), Univ Calif San Diego, Div Biol Sci, San Diego Ctr Algae Biotechnol SD CAB, 9500 Gilman Dr, La Jolla, CA 92093 USA.	smayfield@ucsd.edu			US Department of Energy [DE-EE-0003373]; California Energy Commission Initiative for Large Molecule Sustainable Fuels [500-10-039]	US Department of Energy(United States Department of Energy (DOE)); California Energy Commission Initiative for Large Molecule Sustainable Fuels	This work was supported by the US Department of Energy, grant number DE-EE-0003373, and the California Energy Commission Initiative for Large Molecule Sustainable Fuels, Agreement Number: 500-10-039.	Amer L, 2011, BIORESOURCE TECHNOL, V102, P9350, DOI 10.1016/j.biortech.2011.08.010; Amin S, 2009, ENERG CONVERS MANAGE, V50, P1834, DOI 10.1016/j.enconman.2009.03.001; Andrianov V, 2010, PLANT BIOTECHNOL J, V8, P277, DOI 10.1111/j.1467-7652.2009.00458.x; Atsumi S, 2009, NAT BIOTECHNOL, V27, P1177, DOI 10.1038/nbt.1586; Bechet Q, 2010, ENVIRON SCI TECHNOL, V44, P2197, DOI 10.1021/es903214u; Beckmann J, 2009, J BIOTECHNOL, V142, P70, DOI 10.1016/j.jbiotec.2009.02.015; Boyle NR, 2012, J BIOL CHEM, V287, P15811, DOI 10.1074/jbc.M111.334052; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; 배진희, 2011, Fisheries and Aquatic Sciences, V14, P323; Butterwick C, 2005, FRESHWATER BIOL, V50, P291; Cardol P, 2008, P NATL ACAD SCI USA, V105, P7881, DOI 10.1073/pnas.0802762105; Castruita M, 2011, PLANT CELL, V23, P1273, DOI 10.1105/tpc.111.084400; Chen H, 2004, P NATL ACAD SCI USA, V101, P5048, DOI 10.1073/pnas.0401416101; Chen YH, 2011, BIOTECHNOL LETT, V33, P1973, DOI 10.1007/s10529-011-0672-y; Chowdhury R, 2012, BIORESOURCE TECHNOL, V108, P102, DOI 10.1016/j.biortech.2011.12.099; Christenson L, 2011, BIOTECHNOL ADV, V29, P686, DOI 10.1016/j.biotechadv.2011.05.015; Coleman AW, 1997, J MOL EVOL, V45, P168, DOI 10.1007/PL00006217; Darzins A., 2010, IEA BIOENERGY TASK, V39; Davis R, 2011, APPL ENERG, V88, P3524, DOI 10.1016/j.apenergy.2011.04.018; Doucha J, 2012, J APPL PHYCOL, V24, P35, DOI 10.1007/s10811-010-9643-2; Duan PG, 2011, BIORESOURCE TECHNOL, V102, P1899, DOI 10.1016/j.biortech.2010.08.013; Eroglu E, 2010, BIORESOURCE TECHNOL, V101, P2359, DOI 10.1016/j.biortech.2009.11.043; Gachon CMM, 2010, TRENDS PLANT SCI, V15, P633, DOI 10.1016/j.tplants.2010.08.005; Genkov T, 2010, J BIOL CHEM, V285, P19833, DOI 10.1074/jbc.M110.124230; Gilbert N, 2009, NATURE, V461, P716, DOI 10.1038/461716a; Gonzalez-Ballester D, 2010, PLANT CELL, V22, P2058, DOI 10.1105/tpc.109.071167; Grabski K, 2008, J APPL PHYCOL, V20, P323, DOI 10.1007/s10811-007-9260-x; Griffiths MJ, 2009, J APPL PHYCOL, V21, P493, DOI 10.1007/s10811-008-9392-7; Guschina IA, 2006, PROG LIPID RES, V45, P160, DOI 10.1016/j.plipres.2006.01.001; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Jaycor, 1985, REV EV IMM ALG SYST; Johnson X, 2011, PLANT MOL BIOL, V76, P397, DOI 10.1007/s11103-011-9783-z; Keasling JD, 2008, NAT BIOTECHNOL, V26, P298, DOI 10.1038/nbt0308-298; Khoo HH, 2011, BIORESOURCE TECHNOL, V102, P5800, DOI 10.1016/j.biortech.2011.02.055; Kilian O, 2011, P NATL ACAD SCI USA, V108, P21265, DOI 10.1073/pnas.1105861108; Knothe G, 2009, ENERG ENVIRON SCI, V2, P759, DOI 10.1039/b903941d; La Russa M, 2012, J BIOTECHNOL; Lan EI, 2012, P NATL ACAD SCI USA, V109, P6018, DOI 10.1073/pnas.1200074109; Larkum AWD, 2012, TRENDS BIOTECHNOL, V30, P198, DOI 10.1016/j.tibtech.2011.11.003; Lee JT, 2009, APPL ENVIRON MICROB, V75, P1703, DOI 10.1128/AEM.02081-08; Legrand C, 2003, PHYCOLOGIA, V42, P406, DOI 10.2216/i0031-8884-42-4-406.1; Leonard A, 2011, CHEM SOC REV, V40, P860, DOI 10.1039/c0cs00024h; Levine RB, 2010, ENERG FUEL, V24, P5235, DOI 10.1021/ef1008314; Li Q, 2012, METAB ENG, V14, P1, DOI 10.1016/j.ymben.2011.12.003; Lohr M, 2012, PLANT SCI, V185, P9, DOI 10.1016/j.plantsci.2011.07.018; Luo Y, 2010, FUEL PROCESS TECHNOL, V91, P613, DOI 10.1016/j.fuproc.2010.01.007; Melis A, 2000, PLANT PHYSIOL, V122, P127, DOI 10.1104/pp.122.1.127; Miller R, 2010, PLANT PHYSIOL, V154, P1737, DOI 10.1104/pp.110.165159; MIYAMOTO K, 1979, APPL ENVIRON MICROB, V37, P454, DOI 10.1128/AEM.37.3.454-458.1979; Montagnes DJS, 2008, AQUAT MICROB ECOL, V53, P211, DOI 10.3354/ame01245; Moose SP, 2008, PLANT PHYSIOL, V147, P969, DOI 10.1104/pp.108.118232; Moseley JL, 2002, EMBO J, V21, P6709, DOI 10.1093/emboj/cdf666; Murphy CF, 2011, ENVIRON SCI TECHNOL, V45, P5861, DOI 10.1021/es200109z; Mutanda T, 2011, BIORESOURCE TECHNOL, V102, P57, DOI 10.1016/j.biortech.2010.06.077; Natrah FMI, 2011, AQUACULTURE, V317, P53, DOI 10.1016/j.aquaculture.2011.04.038; NYSE Euronext, 2012, LOND INT FIN FUT OPT; O'Neill BM, 2012, NUCLEIC ACIDS RES, V40, P2782, DOI 10.1093/nar/gkr1008; Ort DR, 2011, PLANT PHYSIOL, V155, P79, DOI 10.1104/pp.110.165886; Pohnert G, 2007, TRENDS ECOL EVOL, V22, P198, DOI 10.1016/j.tree.2007.01.005; Radakovits R, 2010, EUKARYOT CELL, V9, P486, DOI 10.1128/EC.00364-09; Rajamani S, 2008, MOL PLANT MICROBE IN, V21, P1184, DOI 10.1094/MPMI-21-9-1184; Ras M, 2011, BIORESOURCE TECHNOL, V102, P200, DOI 10.1016/j.biortech.2010.06.146; Rodolfi L, 2009, BIOTECHNOL BIOENG, V102, P100, DOI 10.1002/bit.22033; Rosch C, 2012, BIORESOURCE TECHNOL, V107, P191, DOI 10.1016/j.biortech.2011.12.016; Savage N, 2011, NATURE, V474, pS15, DOI 10.1038/474S015a; Scott SA, 2010, CURR OPIN BIOTECH, V21, P277, DOI 10.1016/j.copbio.2010.03.005; Searchinger T, 2008, SCIENCE, V319, P1238, DOI 10.1126/science.1151861; Shen Y, 2009, T ASABE, V52, P1275, DOI 10.13031/2013.27771; Shirvani T, 2011, ENERG ENVIRON SCI, V4, P3773, DOI 10.1039/c1ee01791h; STITT M, 1994, PLANT CELL ENVIRON, V17, P465, DOI 10.1111/j.1365-3040.1994.tb00144.x; Sukenik A, 2009, AQUAT MICROB ECOL, V56, P297, DOI 10.3354/ame01309; Teplitski M, 2004, PLANT PHYSIOL, V134, P137, DOI 10.1104/pp.103.029918; Tirichine L, 2011, PLANT J, V66, P45, DOI 10.1111/j.1365-313X.2011.04540.x; U.S. Department of Energy, 2010, NAT ALG BIOF TECHN R; US Department of Energy, 2010, SOL INT BIOR DIS FUE; VANETTEN JL, 1983, SCIENCE, V219, P994, DOI 10.1126/science.219.4587.994; Vardi A, 2006, PLOS BIOL, V4, P411, DOI 10.1371/journal.pbio.0040060; Vardi A, 2007, ENVIRON MICROBIOL, V9, P360, DOI 10.1111/j.1462-2920.2006.01146.x; Wahlen BD, 2011, BIORESOURCE TECHNOL, V102, P2724, DOI 10.1016/j.biortech.2010.11.026; Wei D, 2004, BIOTECHNOL APPL BIOC, V40, P187, DOI 10.1042/BA20030142; Wigmosta MS, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR009966; Wijffels RH, 2010, SCIENCE, V329, P796, DOI 10.1126/science.1189003; WOLF FR, 1985, PHYTOCHEMISTRY, V24, P733; Wu ZC, 2012, BIORESOURCE TECHNOL, V110, P496, DOI 10.1016/j.biortech.2012.01.101; Yang Y, 2011, BIORESOURCE TECHNOL, V102, P5076, DOI 10.1016/j.biortech.2011.02.014; Zamalloa C, 2012, APPL ENERG, V92, P733, DOI 10.1016/j.apenergy.2011.08.017; Zhu XG, 2010, ANNU REV PLANT BIOL, V61, P235, DOI 10.1146/annurev-arplant-042809-112206	87	478	502	19	642	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2012	488	7411					329	335		10.1038/nature11479	http://dx.doi.org/10.1038/nature11479			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OS	22895338				2022-12-24	WOS:000307501000032
J	Girirajan, S; Rosenfeld, JA; Coe, BP; Parikh, S; Friedman, N; Goldstein, A; Filipink, RA; McConnell, JS; Angle, B; Meschino, WS; Nezarati, MM; Asamoah, A; Jackson, KE; Gowans, GC; Martin, JA; Carmany, EP; Stockton, DW; Schnur, RE; Penney, LS; Martin, DM; Raskin, S; Leppig, K; Thiese, H; Smith, R; Aberg, E; Niyazov, DM; Escobar, LF; El-Khechen, D; Johnson, KD; Lebel, RR; Siefkas, K; Ball, S; Shur, N; McGuire, M; Brasington, CK; Spence, JE; Martin, LS; Clericuzio, C; Ballif, BC; Shaffer, LG; Eichler, EE				Girirajan, Santhosh; Rosenfeld, Jill A.; Coe, Bradley P.; Parikh, Sumit; Friedman, Neil; Goldstein, Amy; Filipink, Robyn A.; McConnell, Juliann S.; Angle, Brad; Meschino, Wendy S.; Nezarati, Marjan M.; Asamoah, Alexander; Jackson, Kelly E.; Gowans, Gordon C.; Martin, Judith A.; Carmany, Erin P.; Stockton, David W.; Schnur, Rhonda E.; Penney, Lynette S.; Martin, Donna M.; Raskin, Salmo; Leppig, Kathleen; Thiese, Heidi; Smith, Rosemarie; Aberg, Erika; Niyazov, Dmitriy M.; Escobar, Luis F.; El-Khechen, Dima; Johnson, Kisha D.; Lebel, Robert R.; Siefkas, Kiana; Ball, Susie; Shur, Natasha; McGuire, Marianne; Brasington, Campbell K.; Spence, J. Edward; Martin, Laura S.; Clericuzio, Carol; Ballif, Blake C.; Shaffer, Lisa G.; Eichler, Evan E.			Phenotypic Heterogeneity of Genomic Disorders and Rare Copy-Number Variants	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SMITH-MAGENIS-SYNDROME; MICRODELETION SYNDROME; DEVELOPMENTAL DELAY; MENTAL-RETARDATION; MULTIPLE GENES; AUTISM; SCHIZOPHRENIA; 16P11.2; MICRODUPLICATIONS; REARRANGEMENTS	Background Some copy-number variants are associated with genomic disorders with extreme phenotypic heterogeneity. The cause of this variation is unknown, which presents challenges in genetic diagnosis, counseling, and management. Methods We analyzed the genomes of 2312 children known to carry a copy- number variant associated with intellectual disability and congenital abnormalities, using array comparative genomic hybridization. Results Among the affected children, 10.1% carried a second large copy-number variant in addition to the primary genetic lesion. We identified seven genomic disorders, each defined by a specific copy-number variant, in which the affected children were more likely to carry multiple copy-number variants than were controls. We found that syndromic disorders could be distinguished from those with extreme phenotypic heterogeneity on the basis of the total number of copy-number variants and whether the variants are inherited or de novo. Children who carried two large copy-number variants of unknown clinical significance were eight times as likely to have developmental delay as were controls (odds ratio, 8.16; 95% confidence interval, 5.33 to 13.07; P = 2.11x10(-38)). Among affected children, inherited copy-number variants tended to co-occur with a second-site large copy-number variant (Spearman correlation coefficient, 0.66; P < 0.001). Boys were more likely than girls to have disorders of phenotypic heterogeneity (P < 0.001), and mothers were more likely than fathers to transmit second-site copy-number variants to their offspring (P = 0.02). Conclusions Multiple, large copy-number variants, including those of unknown pathogenic significance, compound to result in a severe clinical presentation, and secondary copy-number variants are preferentially transmitted from maternal carriers. (Funded by the Simons Foundation Autism Research Initiative and the National Institutes of Health.)	[Eichler, Evan E.] Univ Washington, Sch Med, Howard Hughes Med Inst, Dept Genome Sci, Seattle, WA 98195 USA; [Rosenfeld, Jill A.; Ballif, Blake C.; Shaffer, Lisa G.] PerkinElmer, Signature Genom Labs, Spokane, WA USA; [Martin, Judith A.] Providence Sacred Heart Hosp, Spokane, WA USA; [Leppig, Kathleen; Thiese, Heidi] Grp Hlth Cooperat Puget Sound, Seattle, WA USA; [Siefkas, Kiana; Ball, Susie] Yakima Valley Mem Hosp, Yakima, WA USA; [Parikh, Sumit; Friedman, Neil] Cleveland Clin, Cleveland, OH USA; [Goldstein, Amy; Filipink, Robyn A.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Div Child Neurol, Med Ctr, Pittsburgh, PA 15213 USA; [McConnell, Juliann S.; McGuire, Marianne] Univ Pittsburgh, Childrens Hosp Pittsburgh, Dept Pediat, Med Ctr, Pittsburgh, PA 15213 USA; [McGuire, Marianne] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; [Angle, Brad] Rush Univ, Med Ctr, Ann & Robert H Lurie Childrens Hosp, Chicago, IL 60612 USA; [Johnson, Kisha D.] Rush Univ, Med Ctr, Dept Pediat, Chicago, IL 60612 USA; [Meschino, Wendy S.; Nezarati, Marjan M.] N York Gen Hosp, Toronto, ON, Canada; [Penney, Lynette S.] Dalhousie Univ, Dept Pediat, Halifax, NS, Canada; [Aberg, Erika] Izaak Walton Killam Hlth Ctr, Halifax, NS, Canada; [Asamoah, Alexander; Jackson, Kelly E.; Gowans, Gordon C.] Univ Louisville, Dept Pediat, Weisskopf Child Evaluat Ctr, Louisville, KY 40292 USA; [Carmany, Erin P.; Stockton, David W.] Childrens Hosp Michigan, Detroit, MI 48201 USA; [Martin, Donna M.] Univ Michigan, Med Ctr, Dept Pediat, Ann Arbor, MI 48109 USA; [Martin, Donna M.] Univ Michigan, Med Ctr, Dept Human Genet, Ann Arbor, MI 48109 USA; [Schnur, Rhonda E.] Rowan Univ, Cooper Med Sch, Dept Pediat, Div Genet, Camden, NJ USA; [Raskin, Salmo] Pontificia Univ Catolica Parana, Ctr Biol & Hlth Sci, Grad Program Hlth Sci, Grp Adv Mol Invest, Curitiba, Parana, Brazil; [Raskin, Salmo] Ctr Aconselhamento & Lab Genet, Curitiba, Parana, Brazil; [Niyazov, Dmitriy M.] Ochsner Clin Fdn, Dept Pediat, New Orleans, LA USA; [Escobar, Luis F.; El-Khechen, Dima] Peyton Manning Childrens Hosp St Vincent, Indianapolis, IN USA; [Lebel, Robert R.] SUNY Upstate Med Univ, Syracuse, NY USA; [Shur, Natasha] Rhode Isl Hosp, Hasbro Childrens Hosp, Providence, RI USA; [Brasington, Campbell K.; Spence, J. Edward] Carolinas Med Ctr, Levine Childrens Hosp, Dept Pediat, Charlotte, NC 28203 USA; [Martin, Laura S.] Nemours Childrens Clin, Jacksonville, FL USA; [Clericuzio, Carol] Univ New Mexico, Div Pediat Genet, Hlth Sci Ctr, Div Clin Genet Dysmorphol, Albuquerque, NM 87131 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Group Health Cooperative; Cleveland Clinic Foundation; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Ann & Robert H. Lurie Children's Hospital of Chicago; Rush University; Rush University; University of Toronto; University Toronto Affiliates; North York General Hospital; Dalhousie University; Dalhousie University; University of Louisville; Children's Hospital of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Rowan University; Cooper Medical School of Rowan University; Pontificia Universidade Catolica do Parana; Ochsner Health System; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Hasbro Children's Hospital; Lifespan Health Rhode Island; Rhode Island Hospital; Carolinas Medical Center; University of New Mexico; University of New Mexico's Health Sciences Center	Eichler, EE (corresponding author), Univ Washington, Sch Med, Howard Hughes Med Inst, Dept Genome Sci, Foege S-413A,Box 355065,3720 15th Ave NE, Seattle, WA 98195 USA.	eee@gs.washington.edu	Coe, Bradley/A-2878-2009; Raskin, Salmo/C-4155-2013; Girirajan, Santhosh/AAR-3659-2020	Coe, Bradley/0000-0001-8471-4016; Martin, Donna/0000-0002-8070-2007; Friedman, Neil/0000-0002-7349-7981	Simons Foundation Autism Research Initiative; National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD065285] Funding Source: NIH RePORTER	Simons Foundation Autism Research Initiative; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funded by the Simons Foundation Autism Research Initiative and the National Institutes of Health.	Andrieux J, 2009, AM J MED GENET A, V149A, P2813, DOI 10.1002/ajmg.a.33097; Antonell A, 2010, J MED GENET, V47, P312, DOI 10.1136/jmg.2009.071712; Ballif BC, 2008, CLIN GENET, V74, P469, DOI 10.1111/j.1399-0004.2008.01094.x; Ballif BC, 2008, MOL CYTOGENET, V1, DOI 10.1186/1755-8166-1-8; Bruno DL, 2010, J MED GENET, V47, P299, DOI 10.1136/jmg.2009.069906; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; de Vries BBA, 2001, J MED GENET, V38, P145, DOI 10.1136/jmg.38.3.145; Dipple KM, 2000, AM J HUM GENET, V66, P1729, DOI 10.1086/302938; Duker AL, 2010, EUR J HUM GENET, V18, P1196, DOI 10.1038/ejhg.2010.102; Feenstra I, 2011, EUR J HUM GENET, V19, P1152, DOI 10.1038/ejhg.2011.120; Girirajan S, 2006, GENET MED, V8, P417, DOI 10.1097/01.gim.0000228215.32110.89; Girirajan S, 2010, HUM MOL GENET, V19, pR176, DOI 10.1093/hmg/ddq366; Girirajan S, 2010, NAT GENET, V42, P203, DOI 10.1038/ng.534; Greenway SC, 2009, NAT GENET, V41, P931, DOI 10.1038/ng.415; Helbig I, 2009, NAT GENET, V41, P160, DOI 10.1038/ng.292; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Kaminsky EB, 2011, GENET MED, V13, P777, DOI 10.1097/GIM.0b013e31822c79f9; Leonard H, 2002, MENT RETARD DEV D R, V8, P117, DOI 10.1002/mrdd.10031; Liburd N, 2001, HUM GENET, V109, P535, DOI 10.1007/s004390100604; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; Mefford HC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000962; Mefford HC, 2009, GENOME RES, V19, P1579, DOI 10.1101/gr.094987.109; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Pagnamenta AT, 2009, EUR J HUM GENET, V17, P687, DOI 10.1038/ejhg.2008.228; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Ropers HH, 2010, ANNU REV GENOM HUM G, V11, P161, DOI 10.1146/annurev-genom-082509-141640; Rosenfeld JA, 2011, EUR J HUM GENET, V19, P547, DOI 10.1038/ejhg.2010.237; Rosenfeld JA, 2010, J NEURODEV DISORD, V2, P26, DOI 10.1007/s11689-009-9037-4; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Sarasua SM, 2011, J MED GENET, V48, P761, DOI 10.1136/jmedgenet-2011-100225; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sharp AJ, 2008, NAT GENET, V40, P322, DOI 10.1038/ng.93; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Walters RG, 2010, NATURE, V463, P671, DOI 10.1038/nature08727; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974	38	392	403	0	44	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 4	2012	367	14					1321	1331		10.1056/NEJMoa1200395	http://dx.doi.org/10.1056/NEJMoa1200395			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	014WJ	22970919	Green Accepted			2022-12-24	WOS:000309406100008
J	Kaess, BM; Rong, J; Larson, MG; Hamburg, NM; Vita, JA; Levy, D; Benjamin, EJ; Vasan, RS; Mitchell, GF				Kaess, Bernhard M.; Rong, Jian; Larson, Martin G.; Hamburg, Naomi M.; Vita, Joseph A.; Levy, Daniel; Benjamin, Emelia J.; Vasan, Ramachandran S.; Mitchell, Gary F.			Aortic Stiffness, Blood Pressure Progression, and Incident Hypertension	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PULSE-WAVE VELOCITY; FLOW-MEDIATED DILATION; CORONARY-HEART-DISEASE; ARTERIAL STIFFNESS; CARDIOVASCULAR EVENTS; RISK-FACTORS; INDEPENDENT PREDICTOR; COMMUNITY; INCREASE; ADULTS	Context Vascular stiffness increases with advancing age and is a major risk factor for age-related morbidity and mortality. Vascular stiffness and blood pressure pulsatility are related; however, temporal relationships between vascular stiffening and blood pressure elevation have not been fully delineated. Objective To examine temporal relationships among vascular stiffness, central hemodynamics, microvascular function, and blood pressure progression. Design, Setting, and Participants Longitudinal community-based cohort study conducted in Framingham, Massachusetts. The present investigation is based on the 2 latest examination cycles (cycle 7: 1998-2001; cycle 8: 2005-2008 [last visit: January 25, 2008]) of the Framingham Offspring study (recruited: 1971-1975). Temporal relationships among blood pressure and 3 measures of vascular stiffness and pressure pulsatility derived from arterial tonometry (carotid-femoral pulse wave velocity [CFPWV], forward wave amplitude [FWA], and augmentation index) were examined over a 7-year period in 1759 participants (mean [SD] age: 60 [9] years; 974 women). Main Outcome Measures The primary outcomes were blood pressure and incident hypertension during examination cycle 8. The secondary outcomes were CFPWV, FWA, and augmentation index during examination cycle 8. Results In a multivariable-adjusted regression model, higher FWA (beta, 1.3 [95% CI, 0.5-2.1] mm Hg per 1 SD; P = .002) and higher CFPWV (beta, 1.5 [95% CI, 0.5-2.6] mm Hg per 1 SD; P = .006) during examination cycle 7 were jointly associated with systolic blood pressure during examination cycle 8. Similarly, in a model that included systolic and diastolic blood pressure and additional risk factors during examination cycle 7, higher FWA (odds ratio [OR], 1.6 [95% CI, 1.3-2.0] per 1 SD; P < .001), augmentation index (OR, 1.7 [95% CI, 1.4-2.0] per 1 SD; P < .001), and CFPWV (OR, 1.3 [95% CI, 1.0-1.6] per 1 SD; P = .04) were associated with incident hypertension during examination cycle 8 (338 cases [32%] in 1048 participants without hypertension during examination cycle 7). Conversely, blood pressure during examination cycle 7 was not associated with CFPWV during examination cycle 8. Higher resting brachial artery flow (OR, 1.23 [95% CI, 1.04-1.46]) and lower flow-mediated dilation (OR, 0.80 [95% CI, 0.67-0.96]) during examination cycle 7 were associated with incident hypertension (in models that included blood pressure and tonometry measures collected during examination cycle 7). Conclusion In this cohort, higher aortic stiffness, FWA, and augmentation index were associated with higher risk of incident hypertension; however, initial blood pressure was not independently associated with risk of progressive aortic stiffening. JAMA. 2012;308(9):875-881	[Mitchell, Gary F.] Cardiovasc Engn Inc, Norwood, MA 02062 USA; [Kaess, Bernhard M.; Rong, Jian; Levy, Daniel; Benjamin, Emelia J.; Vasan, Ramachandran S.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Kaess, Bernhard M.] Univ Hosp Regensburg, Klin & Poliklin Innere Med 2, Regensburg, Germany; [Larson, Martin G.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Larson, Martin G.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Benjamin, Emelia J.; Vasan, Ramachandran S.] Boston Univ, Prevent Med & Epidemiol Sect, Boston, MA 02215 USA; [Benjamin, Emelia J.; Vasan, Ramachandran S.] Boston Univ, Cardiol Sect, Boston, MA 02215 USA; [Hamburg, Naomi M.; Vita, Joseph A.; Benjamin, Emelia J.; Vasan, Ramachandran S.] Boston Univ, Sch Med, Evans Dept Med, Boston, MA 02118 USA; [Hamburg, Naomi M.; Vita, Joseph A.; Benjamin, Emelia J.; Vasan, Ramachandran S.] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Levy, Daniel] NHLBI, Bethesda, MD 20892 USA	Cardiovascular Engineering; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Regensburg; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Mitchell, GF (corresponding author), Cardiovasc Engn Inc, 1 Edgewater Dr,Ste 201A, Norwood, MA 02062 USA.	garyfmitchell@mindspring.com	Hamburg, Naomi/AAY-6685-2020; Levy, Daniel/ABF-6873-2021; Levy, Daniel/ABB-2752-2021; Ramachandran, Vasan/Y-2527-2019; Stefanadis, Christodoulos/ABH-2232-2020; Benjamin, Emelia/E-7103-2011	Levy, Daniel/0000-0003-1843-8724; Ramachandran, Vasan/0000-0001-7357-5970; Hamburg, Naomi/0000-0001-5504-5589; Larson, Martin/0000-0002-9631-1254; Vita, Joseph/0000-0001-5607-1797; Stefanadis, Christodoulos/0000-0001-5974-6454; Benjamin, Emelia/0000-0003-4076-2336	National Institutes of Health, National Heart, Lung, and Blood Institute [NO1-HC25195, HL076784, AG028321, HL070100, HL060040, HL080124, HL071039, HL077447, HL107385]; Donald W. Reynolds Foundation; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070100, R01HL077447, ZIAHL006001, R01HL107385, R01HL071039, R01HL080124, R01HL076784, R01HL060040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028321] Funding Source: NIH RePORTER	National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Donald W. Reynolds Foundation; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported through contracts NO1-HC25195, HL076784, AG028321, HL070100, HL060040, HL080124, HL071039, HL077447, and HL107385 with the National Institutes of Health, National Heart, Lung, and Blood Institute, and a grant from the Donald W. Reynolds Foundation.	Aatola H, 2010, HYPERTENSION, V55, P806, DOI 10.1161/HYPERTENSIONAHA.109.145102; Benetos A, 2002, CIRCULATION, V105, P1202, DOI 10.1161/hc1002.105135; Benjamin EJ, 2004, CIRCULATION, V109, P613, DOI 10.1161/01.CIR.0000112565.60887.1E; Cavalcante JL, 2011, J AM COLL CARDIOL, V57, P1511, DOI 10.1016/j.jacc.2010.12.017; Dernellis J, 2005, HYPERTENSION, V45, P426, DOI 10.1161/01.HYP.0000157818.58878.93; Hansen TW, 2006, CIRCULATION, V113, P664, DOI 10.1161/CIRCULATIONAHA.105.579342; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Li SX, 2004, HYPERTENSION, V43, P541, DOI 10.1161/01.HYP.0000115922.98155.23; Liao DP, 1999, HYPERTENSION, V34, P201, DOI 10.1161/01.HYP.34.2.201; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235; McEniery CM, 2010, HYPERTENSION, V56, P36, DOI 10.1161/HYPERTENSIONAHA.110.150896; Mitchell GF, 2007, CIRCULATION, V115, P2628, DOI 10.1161/CIRCULATIONAHA.106.667733; Mitchell GF, 2010, CIRCULATION, V122, P1379, DOI 10.1161/CIRCULATIONAHA.109.914507; Mitchell GF, 2009, ARTERY RES, V3, P56, DOI 10.1016/j.artres.2009.02.002; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; Mitchell GF, 2005, CIRCULATION, V112, P3722, DOI 10.1161/CIRCULATIONAHA.105.551168; Mitchell GF, 2004, HYPERTENSION, V44, P134, DOI 10.1161/01.HYP.0000137305.77635.68; Mitchell GF, 2004, HYPERTENSION, V43, P1239, DOI 10.1161/01.HYP.0000128420.01881.aa; Najjar SS, 2008, J AM COLL CARDIOL, V51, P1377, DOI 10.1016/j.jacc.2007.10.065; Sutton-Tyrrell K, 2005, CIRCULATION, V111, P3384, DOI 10.1161/CIRCULATIONAHA.104.483628; Sutton-Tyrrell K, 2001, HYPERTENSION, V38, P429, DOI 10.1161/01.HYP.38.3.429; Takase H, 2011, AM J HYPERTENS, V24, P667, DOI 10.1038/ajh.2011.19; Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061	26	674	694	0	57	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 5	2012	308	9					875	881		10.1001/2012.jama.10503	http://dx.doi.org/10.1001/2012.jama.10503			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	999ET	22948697	Green Accepted, Bronze			2022-12-24	WOS:000308292900017
J	Huang, J; Roberts, AJ; Leschziner, AE; Reck-Peterson, SL				Huang, Julie; Roberts, Anthony J.; Leschziner, Andres E.; Reck-Peterson, Samara L.			Lis1 Acts as a "Clutch" between the ATPase and Microtubule-Binding Domains of the Dynein Motor	CELL			English	Article							CYTOPLASMIC DYNEIN; HEAVY-CHAIN; ASPERGILLUS-NIDULANS; INTRACELLULAR-TRANSPORT; ORGANELLE TRANSPORT; NEURONAL MIGRATION; LISSENCEPHALY GENE; CRYSTAL-STRUCTURE; PLUS-ENDS; NDEL1	The lissencephaly protein Lis1 has been reported to regulate the mechanical behavior of cytoplasmic dynein, the primary minus-end-directed microtubule motor. However, the regulatory mechanism remains poorly understood. Here, we address this issue using purified proteins from Saccharomyces cerevisiae and a combination of techniques, including single-molecule imaging and single-particle electron microscopy. We show that rather than binding to the main ATPase site within dynein's AAA+ ring or its microtubule-binding stalk directly, Lis1 engages the interface between these elements. Lis1 causes individual dynein motors to remain attached to microtubules for extended periods, even during cycles of ATP hydrolysis that would canonically induce detachment. Thus, Lis1 operates like a "clutch" that prevents dynein's ATPase domain from transmitting a detachment signal to its track-binding domain. We discuss how these findings provide a conserved mechanism for dynein functions in living cells that require prolonged microtubule attachments.	[Huang, Julie; Roberts, Anthony J.; Reck-Peterson, Samara L.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Roberts, Anthony J.] Univ Leeds, Astbury Ctr Struct Mol Biol, Sch Mol & Cellular Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England; [Huang, Julie; Roberts, Anthony J.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; University of Leeds; Harvard University	Reck-Peterson, SL (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	reck-peterson@hms.harvard.edu		Reck-Peterson, Samara/0000-0002-1553-465X; Leschziner, Andres/0000-0002-7732-7023	Reck-Peterson lab; University of Leeds [092436/Z/10/Z]; Alfred P. Sloan Foundation; Rita Allen Foundation; Giovanni Armenise-Harvard Foundation; National Institutes of Health [1 DP2 OD004268-01]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004268] Funding Source: NIH RePORTER	Reck-Peterson lab; University of Leeds; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Rita Allen Foundation; Giovanni Armenise-Harvard Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Andrew P. Carter, Peter J. Knight, Tom A. Rapoport, James R. Sellers, Katerina Toropova, and Xin Xiang for critical comments on the manuscript; the Nikon Imaging Center at Harvard Medical School for technical assistance; Priscilla Yang's lab for sharing equipment; Stephen Hinshaw for initial experiments and suggesting the clutch analogy; Weihong Qiu for initial experiments; Brian Goodman for kinesin; and the Reck-Peterson lab for support. A. J. R. is funded by a Sir Henry Wellcome Postdoctoral Fellowship (092436/Z/10/Z) sponsored by Peter J. Knight and Stan A. Burgess (University of Leeds). A.E.L. is funded in part by a research fellowship from the Alfred P. Sloan Foundation. S.R.-P. is funded by the Rita Allen Foundation, the Giovanni Armenise-Harvard Foundation, and a National Institutes of Health New Innovator award (1 DP2 OD004268-01).	Allan VJ, 2011, BIOCHEM SOC T, V39, P1169, DOI 10.1042/BST0391169; Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Cho C, 2008, J BIOL CHEM, V283, P25839, DOI 10.1074/jbc.M802951200; Cho C, 2012, BBA-MOL CELL RES, V1823, P182, DOI 10.1016/j.bbamcr.2011.10.009; Delanoue R, 2005, CELL, V122, P97, DOI 10.1016/j.cell.2005.04.033; Ding C, 2009, J CELL SCI, V122, P2820, DOI 10.1242/jcs.048777; Efimov VP, 2003, MOL BIOL CELL, V14, P871, DOI 10.1091/mbc.E02-06-0359; Egan MJ, 2012, J CELL BIOL, V197, P971, DOI 10.1083/jcb.201112101; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020; Feng YY, 2000, NEURON, V28, P665, DOI 10.1016/S0896-6273(00)00145-8; Gerdes JM, 2005, CELL MOL LIFE SCI, V62, P1556, DOI 10.1007/s00018-005-5007-5; GIBBONS IR, 1991, NATURE, V352, P640, DOI 10.1038/352640a0; Imamula K, 2007, P NATL ACAD SCI USA, V104, P16134, DOI 10.1073/pnas.0702370104; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; Kon T, 2005, NAT STRUCT MOL BIOL, V12, P513, DOI 10.1038/nsmb930; Kon T, 2004, BIOCHEMISTRY-US, V43, P11266, DOI 10.1021/bi048985a; Kon T, 2012, NATURE, V484, P345, DOI 10.1038/nature10955; Kon T, 2009, NAT STRUCT MOL BIOL, V16, P325, DOI 10.1038/nsmb.1555; Lam C, 2010, J CELL SCI, V123, P202, DOI 10.1242/jcs.059337; Lee WL, 2003, J CELL BIOL, V160, P355, DOI 10.1083/jcb.200209022; Lenz JH, 2006, EMBO J, V25, P2275, DOI 10.1038/sj.emboj.7601119; Li J, 2005, NAT CELL BIOL, V7, P686, DOI 10.1038/ncb1273; Markus SM, 2011, DEV CELL, V20, P639, DOI 10.1016/j.devcel.2011.04.011; Markus SM, 2009, CURR BIOL, V19, P196, DOI 10.1016/j.cub.2008.12.047; McKenney RJ, 2011, J BIOL CHEM, V286, P39615, DOI 10.1074/jbc.M111.289017; McKenney RJ, 2010, CELL, V141, P304, DOI 10.1016/j.cell.2010.02.035; Mesngon MT, 2006, J NEUROSCI, V26, P2132, DOI 10.1523/JNEUROSCI.5095-05.2006; Neuwald AF, 1999, GENOME RES, V9, P27; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Pandey JP, 2011, J NEUROSCI, V31, P17207, DOI 10.1523/JNEUROSCI.4108-11.2011; Qiu WH, 2012, NAT STRUCT MOL BIOL, V19, P193, DOI 10.1038/nsmb.2205; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Roberts A.J., 2012, STRUCTURE IN PRESS; Roberts AJ, 2009, CELL, V136, P485, DOI 10.1016/j.cell.2008.11.049; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Schmidt H, 2012, NAT STRUCT MOL BIOL, V19, P492, DOI 10.1038/nsmb.2272; Sheeman B, 2003, CURR BIOL, V13, P364, DOI 10.1016/S0960-9822(03)00013-7; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; Tarricone C, 2004, NEURON, V44, P809, DOI 10.1016/S0896-6273(04)00751-2; Torisawa T, 2011, J BIOL CHEM, V286, P1959, DOI 10.1074/jbc.M110.169847; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Vallee RB, 2012, NAT CELL BIOL, V14, P224, DOI 10.1038/ncb2420; Wang SS, 2011, J BIOL CHEM, V286, P587, DOI 10.1074/jbc.M110.181578; Woodruff JB, 2009, MOL BIOL CELL, V20, P3003, DOI 10.1091/mbc.E09-03-0186; Yamada M, 2008, EMBO J, V27, P2471, DOI 10.1038/emboj.2008.182; Yi JY, 2011, J CELL BIOL, V195, P193, DOI 10.1083/jcb.201104076; Zhang J, 2002, MOL MICROBIOL, V44, P381, DOI 10.1046/j.1365-2958.2002.02900.x; Zhuang L, 2007, GENETICS, V175, P1185, DOI 10.1534/genetics.106.069013; Zylkiewicz E, 2011, J CELL BIOL, V192, P433, DOI 10.1083/jcb.201011142	54	147	148	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 31	2012	150	5					975	986		10.1016/j.cell.2012.07.022	http://dx.doi.org/10.1016/j.cell.2012.07.022			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22939623	hybrid, Green Published			2022-12-24	WOS:000308500200012
J	Nam, H; Lewis, NE; Lerman, JA; Lee, DH; Chang, RL; Kim, D; Palsson, BO				Nam, Hojung; Lewis, Nathan E.; Lerman, Joshua A.; Lee, Dae-Hee; Chang, Roger L.; Kim, Donghyuk; Palsson, Bernhard O.			Network Context and Selection in the Evolution to Enzyme Specificity	SCIENCE			English	Article							ESCHERICHIA-COLI; METABOLIC NETWORK; GENE-EXPRESSION; FLUXES; YEAST; RECONSTRUCTION; PROMISCUITY; PERSPECTIVE; MODELS	Enzymes are thought to have evolved highly specific catalytic activities from promiscuous ancestral proteins. By analyzing a genome-scale model of Escherichia coli metabolism, we found that 37% of its enzymes act on a variety of substrates and catalyze 65% of the known metabolic reactions. However, it is not apparent why these generalist enzymes remain. Here, we show that there are marked differences between generalist enzymes and specialist enzymes, known to catalyze a single chemical reaction on one particular substrate in vivo. Specialist enzymes (i) are frequently essential, (ii) maintain higher metabolic flux, and (iii) require more regulation of enzyme activity to control metabolic flux in dynamic environments than do generalist enzymes. Furthermore, these properties are conserved in Archaea and Eukarya. Thus, the metabolic network context and environmental conditions influence enzyme evolution toward high specificity.	[Nam, Hojung; Lewis, Nathan E.; Lee, Dae-Hee; Kim, Donghyuk; Palsson, Bernhard O.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Lerman, Joshua A.; Chang, Roger L.] Univ Calif San Diego, Bioinformat & Syst Biol Grad Program, La Jolla, CA 92093 USA; [Lewis, Nathan E.] Harvard Univ, Wyss Inst Biol Inspired Engn, Sch Med, Boston, MA 02115 USA; [Lewis, Nathan E.] Harvard Univ, Dept Genet, Sch Med, Boston, MA 02115 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Lewis, NE (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	nlewis@genetics.med.harvard.edu; palsson@ucsd.edu	Kim, Donghyuk/AAS-9141-2020; LEE, DAE-HEE/O-5243-2018; Nam, Hojung/AAR-4065-2020; Lewis, Nathan/ABE-7290-2020	LEE, DAE-HEE/0000-0002-0423-9057; Nam, Hojung/0000-0002-5109-9114; Lewis, Nathan/0000-0001-7700-3654; Palsson, Bernhard/0000-0003-2357-6785; Lerman, Joshua/0000-0003-0377-2674; Chang, Roger/0000-0003-1630-6584	NIH; NSF; U.S. Department of Energy [2R01GM057089-13, NSF GK-12 742551, DE-SC0004917, DE-FG02-09ER25917]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057089] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Zielinski for insightful discussion on this work. This work was supported by NIH, NSF, and U.S. Department of Energy grants 2R01GM057089-13, NSF GK-12 742551, DE-SC0004917, and DE-FG02-09ER25917. Data are available at the NCBI Gene Expression Omnibus (GEO) database (GSE34631).	Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; Almaas E, 2005, PLOS COMPUT BIOL, V1, P557, DOI 10.1371/journal.pcbi.0010068; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; Bordel S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000859; Carbonell P, 2011, J BIOL CHEM, V286, P43994, DOI 10.1074/jbc.M111.274050; Chang RL, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.52; Copley SD, 2012, J BIOL CHEM, V287, P3, DOI 10.1074/jbc.R111.254714; Deutscher D, 2006, NAT GENET, V38, P993, DOI 10.1038/ng1856; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Feist AM, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100046; Gerosa L, 2011, CURR OPIN BIOTECH, V22, P566, DOI 10.1016/j.copbio.2011.04.016; Gur E, 2011, NAT REV MICROBIOL, V9, P839, DOI 10.1038/nrmicro2669; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Khersonsky O, 2011, BIOCHEMISTRY-US, V50, P2683, DOI 10.1021/bi101763c; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Lewis NE, 2012, NAT REV MICROBIOL, V10, P291, DOI 10.1038/nrmicro2737; Lewis NE, 2009, J BACTERIOL, V191, P3437, DOI 10.1128/JB.00034-09; Mo ML, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-37; Morar M, 2010, ANNU REV GENET, V44, P25, DOI 10.1146/annurev-genet-102209-163517; Nam H, 2011, CURR OPIN BIOTECH, V22, P595, DOI 10.1016/j.copbio.2011.03.006; Papp B, 2004, NATURE, V429, P661, DOI 10.1038/nature02636; Papp B, 2011, NAT REV GENET, V12, P591, DOI 10.1038/nrg3033; Schuetz R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100162; Wagner A, 2007, J EXP ZOOL PART B, V308B, P322, DOI 10.1002/jez.b.21152; Zhang ZH, 2011, NAT CHEM BIOL, V7, P58, DOI [10.1038/nchembio.495, 10.1038/NCHEMBIO.495]	28	199	202	1	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2012	337	6098					1101	1104		10.1126/science.1216861	http://dx.doi.org/10.1126/science.1216861			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22936779	Green Accepted			2022-12-24	WOS:000308125800049
J	Nour-Eldin, HH; Andersen, TG; Burow, M; Madsen, SR; Jorgensen, ME; Olsen, CE; Dreyer, I; Hedrich, R; Geiger, D; Halkier, BA				Nour-Eldin, Hussam Hassan; Andersen, Tonni Grube; Burow, Meike; Madsen, Svend Roesen; Jorgensen, Morten Egevang; Olsen, Carl Erik; Dreyer, Ingo; Hedrich, Rainer; Geiger, Dietmar; Halkier, Barbara Ann			NRT/PTR transporters are essential for translocation of glucosinolate defence compounds to seeds	NATURE			English	Article							ARABIDOPSIS-THALIANA; PHLOEM; ACCUMULATION; PRODUCTS; PATHWAY; NITRATE; CLONING; GROWTH; FIBER; FOOD	In plants, transport processes are important for the reallocation of defence compounds to protect tissues of high value(1), as demonstrated in the plant model Arabidopsis, in which the major defence compounds, glucosinolates(2), are translocated to seeds on maturation(3). The molecular basis for long-distance transport of glucosinolates and other defence compounds, however, remains unknown. Here we identify and characterize two members of the nitrate/peptide transporter family, GTR1 and GTR2, as high-affinity, proton-dependent glucosinolate-specific transporters. The gtr1 gtr2 double mutant did not accumulate glucosinolates in seeds and had more than tenfold over-accumulation in source tissues such as leaves and silique walls, indicating that both plasma membrane-localized transporters are essential for long-distance transport of glucosinolates. We propose that GTR1 and GTR2 control the loading of glucosinolates from the apoplasm into the phloem. Identification of the glucosinolate transporters has agricultural potential as a means to control allocation of defence compounds in a tissue-specific manner.	[Nour-Eldin, Hussam Hassan; Andersen, Tonni Grube; Burow, Meike; Madsen, Svend Roesen; Jorgensen, Morten Egevang; Olsen, Carl Erik; Halkier, Barbara Ann] Univ Copenhagen, Fac Sci, Dept Plant & Environm Sci, VKR Res Ctr Proact Plants, DK-1871 Frederiksberg C, Denmark; [Nour-Eldin, Hussam Hassan; Andersen, Tonni Grube; Burow, Meike; Madsen, Svend Roesen; Jorgensen, Morten Egevang; Olsen, Carl Erik; Halkier, Barbara Ann] Univ Copenhagen, Fac Sci, Dept Plant & Environm Sci, DynaMo Ctr Excellence, DK-1871 Frederiksberg C, Denmark; [Dreyer, Ingo] Univ Politecn Madrid, Ctr Plant Biotechnol & Genom, E-28223 Pozuelo De Alarcon, Madrid, Spain; [Hedrich, Rainer; Geiger, Dietmar] Univ Wurzburg, Julius von Sachs Inst, D-97082 Wurzburg, Germany	University of Copenhagen; University of Copenhagen; Universidad Politecnica de Madrid; Centro de Investigacion en Biotecnologia Genomica de Plantas (CBGP); University of Wurzburg	Halkier, BA (corresponding author), Univ Copenhagen, Fac Sci, Dept Plant & Environm Sci, VKR Res Ctr Proact Plants, Thorvaldsensvej 40, DK-1871 Frederiksberg C, Denmark.	bah@life.ku.dk	Geiger, Dietmar/D-6914-2014; Geiger, Dietmar/AAH-8140-2019; Hedrich, Rainer/G-8771-2011; Halkier, Barbara A/H-3196-2014; Dreyer, Ingo/N-4747-2014; Jørgensen, Morten Egevang/A-2795-2016; Olsen, Carl E/H-3031-2014; Nour-Eldin, Hussam/I-1214-2014; Burow, Meike/A-6949-2010	Geiger, Dietmar/0000-0003-0715-5710; Geiger, Dietmar/0000-0003-0715-5710; Hedrich, Rainer/0000-0003-3224-1362; Halkier, Barbara A/0000-0002-3742-702X; Dreyer, Ingo/0000-0002-2781-0359; Jørgensen, Morten Egevang/0000-0001-6503-0495; Olsen, Carl E/0000-0002-2275-0596; Nour-Eldin, Hussam/0000-0001-6660-0509; Burow, Meike/0000-0002-2350-985X; Andersen, Tonni/0000-0002-8905-0850	Danish Research Council for Technology and Production (FTP) [09-065827/274-08-0354]; Marie Curie fellowship [PIEF-GA-2008-221236]; European Union [303674]; Deutsche Forschungsgemeinschaft [GE2195/1-1, FOR 1061]; Villum Kann Rasmussen Foundation; Danish National Research Foundation	Danish Research Council for Technology and Production (FTP); Marie Curie fellowship(European Commission); European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Villum Kann Rasmussen Foundation(Villum Fonden); Danish National Research Foundation(Danmarks Grundforskningsfond)	We thank M. Palmgren, A. Schulz and D. Kliebenstein for comments on the manuscript and H. K. S. Jepsen, L. B. Moller and A. Kraus for technical assistance. We thank D. Klaerke and technicians T. K. Soland, B. L. Christensen, M. Olsen and C. Derrer for providing X. laevis oocytes. We thank the Salk, Stanford, Plant Gene Expression Center (SSP) Consortium and the RIKEN Genome Science Center for providing full-length cDNAs. Imaging data were achieved at the Center for Advanced Bioimaging, University of Copenhagen. H.H.N-.E. was supported by the Danish Research Council for Technology and Production (FTP) grant 09-065827/274-08-0354. M.B. was supported by a Marie Curie fellowship (grant PIEF-GA-2008-221236). I.D. was supported by a Marie-Curie Career Integration Grant of the European Union (FP7-PEOPLE-2011-CIG No. 303674 (Regopoc)). D.G. was supported by the Deutsche Forschungsgemeinschaft grant GE2195/1-1 and R.H. by Deutsche Forschungsgemeinschaft grants within FOR 1061. B.A.H. is partner of The VKR Research Centre for Pro-Active Plants funded by the Villum Kann Rasmussen Foundation. Funding for DynaMo Center of Excellence is provided by the Danish National Research Foundation.	Balbi V, 2008, NEW PHYTOL, V177, P301, DOI 10.1111/j.1469-8137.2007.02292.x; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Brown PD, 2003, PHYTOCHEMISTRY, V62, P471, DOI 10.1016/S0031-9422(02)00549-6; Chen SX, 2001, PLANT PHYSIOL, V127, P194, DOI 10.1104/pp.127.1.194; Clarke DB, 2010, ANAL METHODS-UK, V2, P310, DOI 10.1039/b9ay00280d; Ellerbrock BLJ, 2007, PLANT SIGNAL BEHAV, V2, P282, DOI 10.4161/psb.2.4.4014; Fan SC, 2009, PLANT CELL, V21, P2750, DOI 10.1105/tpc.109.067603; Feeny P., 1976, BIOCH INTERACTION PL, P1, DOI [DOI 10.1007/978-1-4684-2646-5_1, 10.1007/978-1-4684-2646-5_1]; Foster R, 2009, NUTR BULL, V34, P4, DOI 10.1111/j.1467-3010.2008.01738.x; Geu-Flores F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm106; Gottwald JR, 2000, P NATL ACAD SCI USA, V97, P13979, DOI 10.1073/pnas.250473797; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Koroleva OA, 2000, PLANT PHYSIOL, V124, P599, DOI 10.1104/pp.124.2.599; Mailer RJ, 2008, J AM OIL CHEM SOC, V85, P937, DOI 10.1007/s11746-008-1268-0; MCKEY D, 1974, AM NAT, V108, P305, DOI 10.1086/282909; Norholm MHH, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-21; Nour-Eldin HH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl635; Nour-Eldin HH, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-17; Nour-Eldin HH, 2009, PHYTOCHEM REV, V8, P53, DOI 10.1007/s11101-008-9110-8; Ohnmeiss TE, 2000, ECOLOGY, V81, P1765, DOI 10.1890/0012-9658(2000)081[1765:ODTPTO]2.0.CO;2; Snowdon R., 2007, Oilseeds, P55; Townsend BJ, 2007, TRENDS BIOTECHNOL, V25, P239, DOI 10.1016/j.tibtech.2007.03.012; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; Wang YY, 2011, PLANT CELL, V23, P1945, DOI 10.1105/tpc.111.083618; WINK M, 1983, Z NATURFORSCH C, V38, P905; Wittkop B, 2009, EUPHYTICA, V170, P131, DOI 10.1007/s10681-009-9940-5; Wu SQ, 2008, CURR OPIN BIOTECH, V19, P145, DOI 10.1016/j.copbio.2008.02.007; Zhang JX, 2011, PHYTOCHEMISTRY, V72, P1767, DOI 10.1016/j.phytochem.2011.06.002; Zust T, 2011, P ROY SOC B-BIOL SCI, V278, P2598, DOI 10.1098/rspb.2010.2475	30	312	326	10	231	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 23	2012	488	7412					531	534		10.1038/nature11285	http://dx.doi.org/10.1038/nature11285			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992FS	22864417				2022-12-24	WOS:000307761600041
J	Gao, H; Chakraborty, G; Lee-Lim, AP; Mo, QX; Decker, M; Vonica, A; Shen, RL; Brogi, E; Brivanlou, AH; Giancotti, FG				Gao, Hua; Chakraborty, Goutam; Lee-Lim, Ai Ping; Mo, Qianxing; Decker, Markus; Vonica, Alin; Shen, Ronglai; Brogi, Edi; Brivanlou, Ali H.; Giancotti, Filippo G.			The BMP Inhibitor Coco Reactivates Breast Cancer Cells at Lung Metastatic Sites	CELL			English	Article							GENE-EXPRESSION SIGNATURE; STEM-CELLS; TGF-BETA; PROLIFERATION; DISSEMINATION; SURVIVAL; GROWTH; NICHE	The mechanistic underpinnings of metastatic dormancy and reactivation are poorly understood. A gain-of-function cDNA screen reveals that Coco, a secreted antagonist of TGF-beta ligands, induces dormant breast cancer cells to undergo reactivation in the lung. Mechanistic studies indicate that Coco exerts this effect by blocking lung-derived BMP ligands. Whereas Coco enhances the manifestation of traits associated with cancer stem cells, BMP signaling suppresses it. Coco induces a discrete gene expression signature, which is strongly associated with metastatic relapse to the lung, but not to the bone or brain in patients. Experiments in mouse models suggest that these latter organs contain niches devoid of bioactive BMP. These findings reveal that metastasis-initiating cells need to overcome organ-specific antimetastatic signals in order to undergo reactivation.	[Gao, Hua; Chakraborty, Goutam; Lee-Lim, Ai Ping; Decker, Markus; Giancotti, Filippo G.] Mem Sloan Kettering Canc Ctr, Cell Biol Program, Sloan Kettering Inst Canc Res, New York, NY 10065 USA; [Mo, Qianxing; Shen, Ronglai] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA; [Brogi, Edi] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Vonica, Alin; Brivanlou, Ali H.] Rockefeller Univ, Lab Mol Embryol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Rockefeller University	Giancotti, FG (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, Sloan Kettering Inst Canc Res, New York, NY 10065 USA.	f-giancotti@ski.mskcc.org	Chakraborty, Goutam/U-5559-2019; Chakraborty, Goutam/B-5099-2014	Gao, Hua/0000-0002-9698-5830	Geoffrey Beene Cancer Center at MSKCC; NIH [P01 CA094060]; NATIONAL CANCER INSTITUTE [P01CA094060, R01CA175712] Funding Source: NIH RePORTER	Geoffrey Beene Cancer Center at MSKCC; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank G. Daley, J. Massague, and F. Miller for reagents, X. Zhang and X. Jing for help with X-ray imaging, M. Akram for Coco staining of human TMAs, members of the Giancotti laboratory for discussions, and the staff of the Genomics and the Molecular Cytology Facilities for their help. This work was supported by the Geoffrey Beene Cancer Center at MSKCC and NIH grant P01 CA094060.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bell E, 2003, DEVELOPMENT, V130, P1381, DOI 10.1242/dev.00344; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Birkenkamp-Demtroder K, 2011, BRIT J CANCER, V105, P552, DOI 10.1038/bjc.2011.268; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Buijs JT, 2012, ONCOGENE, V31, P2164, DOI 10.1038/onc.2011.400; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Danesh SM, 2009, GENE EXPR PATTERNS, V9, P255, DOI 10.1016/j.gep.2009.04.002; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Ellen TP, 2008, CARCINOGENESIS, V29, P2, DOI 10.1093/carcin/bgm200; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Gupta GP, 2007, P NATL ACAD SCI USA, V104, P19506, DOI 10.1073/pnas.0709185104; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Hata A, 1998, GENE DEV, V12, P186, DOI 10.1101/gad.12.2.186; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Kobielak K, 2007, P NATL ACAD SCI USA, V104, P10063, DOI 10.1073/pnas.0703004104; Koh EY, 2004, ONCOGENE, V23, P1214, DOI 10.1038/sj.onc.1207209; Koh EY, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf142; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Lo PK, 2012, ONCOGENE, V31, P2614, DOI [10.1038/onc.2011.439, 10.1038/onc.2012.147]; Lu X, 2011, CANCER CELL, V20, P701, DOI 10.1016/j.ccr.2011.11.002; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Pang R, 2010, CELL STEM CELL, V6, P603, DOI 10.1016/j.stem.2010.04.001; Pearce JJH, 1999, DEV BIOL, V209, P98, DOI 10.1006/dbio.1999.9240; Pylayeva Y, 2009, J CLIN INVEST, V119, P252, DOI 10.1172/JCI37160; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Shibue T, 2009, P NATL ACAD SCI USA, V106, P10290, DOI 10.1073/pnas.0904227106; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Varga AC, 2005, ONCOGENE, V24, P5713, DOI 10.1038/sj.onc.1208919; Walsh DW, 2010, TRENDS CELL BIOL, V20, P244, DOI 10.1016/j.tcb.2010.01.008; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017	46	291	295	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 17	2012	150	4					764	779		10.1016/j.cell.2012.06.035	http://dx.doi.org/10.1016/j.cell.2012.06.035			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22901808	Green Accepted, Bronze			2022-12-24	WOS:000308002300011
J	Hashimoto, T; Perlot, T; Rehman, A; Trichereau, J; Ishiguro, H; Paolino, M; Sigl, V; Hanada, T; Hanada, R; Lipinski, S; Wild, B; Camargo, SMR; Singer, D; Richter, A; Kuba, K; Fukamizu, A; Schreiber, S; Clevers, H; Verrey, F; Rosenstiel, P; Penninger, JM				Hashimoto, Tatsuo; Perlot, Thomas; Rehman, Ateequr; Trichereau, Jean; Ishiguro, Hiroaki; Paolino, Magdalena; Sigl, Verena; Hanada, Toshikatsu; Hanada, Reiko; Lipinski, Simone; Wild, Birgit; Camargo, Simone M. R.; Singer, Dustin; Richter, Andreas; Kuba, Keiji; Fukamizu, Akiyoshi; Schreiber, Stefan; Clevers, Hans; Verrey, Francois; Rosenstiel, Philip; Penninger, Josef M.			ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation	NATURE			English	Article							ANGIOTENSIN-CONVERTING-ENZYME; MAMMALIAN TARGET; HARTNUP DISORDER; CROHNS-DISEASE; BLOOD-PRESSURE; IN-VIVO; MICE; COLITIS; CARBOXYPEPTIDASE; RAPAMYCIN	Malnutrition affects up to one billion people in the world and is a major cause of mortality(1,2). In many cases, malnutrition is associated with diarrhoea and intestinal inflammation, further contributing to morbidity and death(2). The mechanisms by which unbalanced dietary nutrients affect intestinal homeostasis are largely unknown. Here we report that deficiency in murine angiotensin I converting enzyme (peptidyl-dipeptidase A) 2 (Ace2), which encodes a key regulatory enzyme of the renin-angiotensin system (RAS), results in highly increased susceptibility to intestinal inflammation induced by epithelial damage. The RAS is known to be involved in acute lung failure(3), cardiovascular functions(4) and SARS infections(5). Mechanistically, ACE2 has a RAS-independent function, regulating intestinal amino acid homeostasis, expression of antimicrobial peptides, and the ecology of the gut microbiome. Transplantation of the altered microbiota from Ace2 mutant mice into germ-free wild-type hosts was able to transmit the increased propensity to develop severe colitis. ACE2-dependent changes in epithelial immunity and the gut microbiota can be directly regulated by the dietary amino acid tryptophan. Our results identify ACE2 as a key regulator of dietary amino acid homeostasis, innate immunity, gut microbial ecology, and transmissible susceptibility to colitis. These results provide a molecular explanation for how amino acid malnutrition can cause intestinal inflammation and diarrhoea.	[Hashimoto, Tatsuo; Perlot, Thomas; Trichereau, Jean; Paolino, Magdalena; Sigl, Verena; Hanada, Toshikatsu; Hanada, Reiko; Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol, IMBA, A-1030 Vienna, Austria; [Hashimoto, Tatsuo; Ishiguro, Hiroaki] Yokohama City Univ, Grad Sch Med, Dept Med Sci & Cardiorenal Med, Yokohama, Kanagawa 2360004, Japan; [Hashimoto, Tatsuo; Ishiguro, Hiroaki] Sch Med, Yokohama, Kanagawa 2360004, Japan; [Rehman, Ateequr; Lipinski, Simone; Schreiber, Stefan; Rosenstiel, Philip] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Wild, Birgit; Richter, Andreas] Univ Vienna, Ctr Ecol, Dept Chem Ecol & Ecosyst Res, A-1090 Vienna, Austria; [Camargo, Simone M. R.; Singer, Dustin; Verrey, Francois] Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland; [Camargo, Simone M. R.; Singer, Dustin; Verrey, Francois] Univ Zurich, Ctr Integrat Human Physiol, CH-8057 Zurich, Switzerland; [Kuba, Keiji] Akita Univ, Grad Sch Med, Dept Biol Informat & Expt Therapeut, Akita 0108543, Japan; [Fukamizu, Akiyoshi] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058577, Japan; [Clevers, Hans] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Yokohama City University; University of Kiel; University of Vienna; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Akita University; University of Tsukuba; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Penninger, JM (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, IMBA, A-1030 Vienna, Austria.	p.rosenstiel@mucosa.de; josef.penninger@imba.oeaw.ac.at	Lipinski, Simone/L-9818-2017; Rosenstiel, Philip/A-5137-2009; Penninger, Josef M/I-6860-2013; Richter, Andreas/D-8483-2012; Wild, Birgit/E-6476-2012; Paolino, Magdalena/AAN-9417-2020; fukamizu, akiyoshi/J-5350-2012; Rehman, Ateequr/O-3727-2016	Lipinski, Simone/0000-0002-9322-7372; Rosenstiel, Philip/0000-0002-9692-8828; Penninger, Josef M/0000-0002-8194-3777; Richter, Andreas/0000-0003-3282-4808; Wild, Birgit/0000-0002-9611-0815; fukamizu, akiyoshi/0000-0002-8786-6020; Rehman, Ateequr/0000-0002-5664-4628; Paolino, Magdalena/0000-0001-9724-9029; Verrey, Francois/0000-0003-3250-9824; Camargo, Simone/0000-0003-0091-7380	European Respiratory Society; EuGeneHeart; SENSHIN; Marie Curie IIF; IMBA; Austrian Ministry of Sciences; Austrian Academy of Sciences; GEN-AU (AustroMouse); EU ERC; EU network grants EuGeneHeart, ApoSys and INFLA-Care; BMBF Network 'Systematic genomics of chronic inflammation'; DFG Cluster of Excellence Inflammation at Interfaces [SPP1399, SFB877]; DFG [RO1394]	European Respiratory Society; EuGeneHeart; SENSHIN(SENSHIN Medical Research FoundationKayamori FoundationKayamori Foundation of Informational Science AdvancementMukai Science and Technology FoundationFukuda Foundation for Medical TechnologyInoue Foundation for Science); Marie Curie IIF(European Commission); IMBA; Austrian Ministry of Sciences; Austrian Academy of Sciences; GEN-AU (AustroMouse); EU ERC(European Research Council (ERC)European Commission); EU network grants EuGeneHeart, ApoSys and INFLA-Care; BMBF Network 'Systematic genomics of chronic inflammation'(Federal Ministry of Education & Research (BMBF)); DFG Cluster of Excellence Inflammation at Interfaces(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	We thank all members of our laboratories for discussions. T. Hashimoto was supported by grants from the European Respiratory Society, EuGeneHeart, and SENSHIN. T. P. was supported by a Marie Curie IIF. J.M.P. was supported by grants from IMBA, the Austrian Ministry of Sciences, the Austrian Academy of Sciences, GEN-AU (AustroMouse), an EU ERC Advanced Grant, and the EU network grants EuGeneHeart, ApoSys and INFLA-Care. P. R. was supported by the BMBF Network 'Systematic genomics of chronic inflammation', the DFG Cluster of Excellence Inflammation at Interfaces, SPP1399, SFB877, and the DFG project RO1394.	AbuQurshin R, 1997, AM J MED SCI, V313, P111, DOI 10.1097/00000441-199702000-00008; Attia E, 2005, BIOL PSYCHIAT, V57, P674, DOI 10.1016/j.biopsych.2004.11.045; Broer A, 2011, J BIOL CHEM, V286, P26638, DOI 10.1074/jbc.M111.241323; Camargo SMR, 2009, GASTROENTEROLOGY, V136, P872, DOI 10.1053/j.gastro.2008.10.055; Chalaris A, 2010, J EXP MED, V207, P1617, DOI 10.1084/jem.20092366; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; COOPER HS, 1993, LAB INVEST, V69, P238; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Danilczyk U, 2006, NATURE, V444, P1088, DOI 10.1038/nature05475; DARBY WJ, 1975, NUTR REV, V33, P289; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Farkas S, 2006, INT J COLORECTAL DIS, V21, P747, DOI 10.1007/s00384-005-0793-7; Ghosh HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009199; Giongo A, 2010, ISME J, V4, P852, DOI 10.1038/ismej.2010.16; HAMMER O, 2004, PALAEONTOL ELECTRON, V4; Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712; Ishida J, 2004, J BIOL CHEM, V279, P26274, DOI 10.1074/jbc.M404149200; ITO M, 1995, P NATL ACAD SCI USA, V92, P3521, DOI 10.1073/pnas.92.8.3521; Khan Y, 2010, PEDIATR CLIN N AM, V57, P1409, DOI 10.1016/j.pcl.2010.09.016; Kleta R, 2004, NAT GENET, V36, P999, DOI 10.1038/ng1405; Kowalczuk S, 2008, FASEB J, V22, P2880, DOI 10.1096/fj.08-107300; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; Kuba K, 2007, CIRC RES, V101, pE32, DOI 10.1161/CIRCRESAHA.107.158659; Mastroianni JR, 2009, J BIOL CHEM, V284, P27848, DOI 10.1074/jbc.M109.050773; McCaffery DM, 1999, GUT, V45, P864, DOI 10.1136/gut.45.6.864; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Osterreicher CH, 2009, HEPATOLOGY, V50, P929, DOI 10.1002/hep.23104; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rehman A, 2011, GUT, V60, P1354, DOI 10.1136/gut.2010.216259; Reinisch W, 2008, AM J GASTROENTEROL, V103, P2284, DOI 10.1111/j.1572-0241.2008.02024.x; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2004, MICROBIOL MOL BIOL R, V68, P686, DOI 10.1128/MMBR.68.4.686-691.2004; SEGAL I, 1986, INT J COLORECTAL DIS, V1, P238, DOI 10.1007/BF01648345; STRATIGOS JD, 1977, BRIT J DERMATOL, V96, P99, DOI 10.1111/j.1365-2133.1977.tb05197.x; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tipnis SR, 2000, J BIOL CHEM, V275, P33238, DOI 10.1074/jbc.M002615200; Vickers C, 2002, J BIOL CHEM, V277, P14838, DOI 10.1074/jbc.M200581200; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weichhart T, 2012, METHODS MOL BIOL, V821, P1, DOI 10.1007/978-1-61779-430-8_1; Weisstaub G, 2008, J PEDIATR GASTR NUTR, V47, pS10, DOI 10.1097/MPG.0b013e3181818e78	43	731	790	12	191	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 26	2012	487	7408					477	U89		10.1038/nature11228	http://dx.doi.org/10.1038/nature11228			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979KD	22837003	Green Accepted, Green Published			2022-12-24	WOS:000306815300037
J	Koike, N; Yoo, SH; Huang, HC; Kumar, V; Lee, C; Kim, TK; Takahashi, JS				Koike, Nobuya; Yoo, Seung-Hee; Huang, Hung-Chung; Kumar, Vivek; Lee, Choogon; Kim, Tae-Kyung; Takahashi, Joseph S.			Transcriptional Architecture and Chromatin Landscape of the Core Circadian Clock in Mammals	SCIENCE			English	Article							RNA-POLYMERASE-II; REV-ERB-ALPHA; GENE-EXPRESSION; HUMAN GENOME; PROTEIN DBP; METABOLISM; PROMOTERS; DEGRADATION; MECHANISMS; REPRESSION	The mammalian circadian clock involves a transcriptional feedback loop in which CLOCK and BMAL1 activate the Period and Cryptochrome genes, which then feed back and repress their own transcription. We have interrogated the transcriptional architecture of the circadian transcriptional regulatory loop on a genome scale in mouse liver and find a stereotyped, time-dependent pattern of transcription factor binding, RNA polymerase II (RNAPII) recruitment, RNA expression, and chromatin states. We find that the circadian transcriptional cycle of the clock consists of three distinct phases: a poised state, a coordinated de novo transcriptional activation state, and a repressed state. Only 22% of messenger RNA (mRNA) cycling genes are driven by de novo transcription, suggesting that both transcriptional and posttranscriptional mechanisms underlie the mammalian circadian clock. We also find that circadian modulation of RNAPII recruitment and chromatin remodeling occurs on a genome-wide scale far greater than that seen previously by gene expression profiling.	[Koike, Nobuya; Yoo, Seung-Hee; Huang, Hung-Chung; Kumar, Vivek; Kim, Tae-Kyung; Takahashi, Joseph S.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Lee, Choogon] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA; [Takahashi, Joseph S.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; State University System of Florida; Florida State University; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Takahashi, JS (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA.	joseph.takahashi@utsouthwestern.edu	Takahashi, Joseph S./Y-2781-2019; Kim, Tae-Kyung/AAX-4230-2020; Koike, Nobuya/G-1116-2016; Takahashi, Joseph S/E-8482-2012; Kumar, Vivek/P-8749-2014	Takahashi, Joseph S./0000-0003-0384-8878; Kim, Tae-Kyung/0000-0001-5161-9864; Takahashi, Joseph S/0000-0003-0384-8878; Kumar, Vivek/0000-0001-6643-7465	Howard Hughes Medical Institute; Whitehall Foundation grant; NIH [R01 NS053616, F32 DA024556]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA024556] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Whitehall Foundation grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Howard Hughes Medical Institute (J.S.T.), Whitehall Foundation grant (T.-K.K.), and NIH grants R01 NS053616 (C. L.) and F32 DA024556 (V. K.). We thank H. Hobbs and D. Mangelsdorf for helpful discussions and support; B. Crider, V. Schmid, A. Guillory, S. Hildebrand, J. Knepper, J. Denton, S. Niu, and the McDermott Next Generation Sequencing Facility for outstanding technical and computational support; and S. L. McKnight for NPAS2 antibody. J. S. T. is an Investigator and S.-H.Y. and V. K. were Associates in the Howard Hughes Medical Institute. J. S. T. is a cofounder of, a Scientific Advisory Board member of, and a paid consultant for Reset Therapeutics, Incorporated, a biotechnology company aimed at discovering small-molecule therapies that modulate circadian activity for a variety of disease indications. ChIP-seq and RNA-seq data sets have been deposited in National Center for Biotechnology Information's Gene Expression Omnibus and are accessible through GEO Series accession number GSE39860 (www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE39860).	Ameur A, 2011, NAT STRUCT MOL BIOL, V18, P1435, DOI 10.1038/nsmb.2143; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bugge A, 2012, GENE DEV, V26, P657, DOI 10.1101/gad.186858.112; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Duong HA, 2011, SCIENCE, V332, P1436, DOI 10.1126/science.1196766; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Feng D, 2012, MOL CELL, V47, P158, DOI 10.1016/j.molcel.2012.06.026; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hatanaka F, 2010, MOL CELL BIOL, V30, P5636, DOI 10.1128/MCB.00781-10; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hogenesch JB, 2011, NAT REV GENET, V12, P407, DOI 10.1038/nrg2972; Hosoda H, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-34; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Jones JC, 2004, J BIOL CHEM, V279, P24957, DOI 10.1074/jbc.M402218200; Katada S, 2010, NAT STRUCT MOL BIOL, V17, P1414, DOI 10.1038/nsmb.1961; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kojima S, 2011, J CELL SCI, V124, P311, DOI 10.1242/jcs.065771; Kramer C, 2003, NATURE, V421, P948, DOI 10.1038/nature01427; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lamia KA, 2011, NATURE, V480, P552, DOI 10.1038/nature10700; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee Y, 2010, J CELL SCI, V123, P3547, DOI 10.1242/jcs.070300; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; Masri S, 2010, NAT NEUROSCI, V13, P1324, DOI 10.1038/nn.2668; Menet JS, 2010, GENE DEV, V24, P358, DOI 10.1101/gad.1883910; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Padmanabhan K, 2012, SCIENCE, V337, P599, DOI 10.1126/science.1221592; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Reischl S, 2007, J BIOL RHYTHM, V22, P375, DOI 10.1177/0748730407303926; Rey G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000595; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Salmon-Divon M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-415; Schmutz I, 2010, GENE DEV, V24, P345, DOI 10.1101/gad.564110; Shirogane T, 2005, J BIOL CHEM, V280, P26863, DOI 10.1074/jbc.M502862200; Siepka S. M., 2007, CELL, V129, P1011; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Staiger D, 2011, CELL MOL LIFE SCI, V68, P71, DOI 10.1007/s00018-010-0513-5; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Stratmann M, 2010, GENE DEV, V24, P1317, DOI 10.1101/gad.578810; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; WUARIN J, 1992, J CELL SCI, P123; Ye R, 2011, J BIOL CHEM, V286, P25891, DOI 10.1074/jbc.M111.254680; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	62	883	909	5	154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2012	338	6105					349	354		10.1126/science.1226339	http://dx.doi.org/10.1126/science.1226339			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022JS	22936566	Green Accepted			2022-12-24	WOS:000309955800033
J	Seifert, AW; Kiama, SG; Seifert, MG; Goheen, JR; Palmer, TM; Maden, M				Seifert, Ashley W.; Kiama, Stephen G.; Seifert, Megan G.; Goheen, Jacob R.; Palmer, Todd M.; Maden, Malcolm			Skin shedding and tissue regeneration in African spiny mice (Acomys)	NATURE			English	Article							HAIR FOLLICLE DEVELOPMENT; LIMB REGENERATION; WOUND REPAIR; DIFFERENTIATION; EXPRESSION; AUTOTOMY; NEWT	Evolutionary modification has produced a spectrum of animal defence traits to escape predation, including the ability to autotomize body parts to elude capture(1,2). After autotomy, the missing part is either replaced through regeneration (for example, in urodeles, lizards, arthropods and crustaceans) or permanently lost (such as in mammals). Although most autotomy involves the loss of appendages (legs, chelipeds, antennae or tails, for example), skin autotomy can occur in certain taxa of scincid and gekkonid lizards(3). Here we report the first demonstration of skin autotomy in Mammalia (African spiny mice, Acomys). Mechanical testing showed a propensity for skin to tear under very low tension and the absence of a fracture plane. After skin loss, rapid wound contraction was followed by hair follicle regeneration in dorsal skin wounds. Notably, we found that regenerative capacity in Acomys was extended to ear holes, where the mice exhibited complete regeneration of hair follicles, sebaceous glands, dermis and cartilage. Salamanders capable of limb regeneration form a blastema (a mass of lineage-restricted progenitor cells(4)) after limb loss, and our findings suggest that ear tissue regeneration in Acomys may proceed through the assembly of a similar structure. This study underscores the importance of investigating regenerative phenomena outside of conventional model organisms, and suggests that mammals may retain a higher capacity for regeneration than was previously believed. As re-emergent interest in regenerative medicine seeks to isolate molecular pathways controlling tissue regeneration in mammals, Acomys may prove useful in identifying mechanisms to promote regeneration in lieu of fibrosis and scarring.	[Seifert, Ashley W.; Seifert, Megan G.; Palmer, Todd M.; Maden, Malcolm] Univ Florida, Dept Biol, Gainesville, FL 32610 USA; [Seifert, Ashley W.; Kiama, Stephen G.] Univ Nairobi, Dept Vet Anat & Physiol, Nairobi 00010, Kenya; [Seifert, Ashley W.; Seifert, Megan G.; Goheen, Jacob R.; Palmer, Todd M.] Mpala Res Ctr, Nanyuki 10400, Kenya; [Goheen, Jacob R.] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; [Goheen, Jacob R.] Univ Wyoming, Dept Bot, Laramie, WY 82071 USA	State University System of Florida; University of Florida; University of Nairobi; University of Wyoming; University of Wyoming	Seifert, AW (corresponding author), Univ Florida, Dept Biol, 223 Bartram Hall,POB 118525, Gainesville, FL 32610 USA.	seifert@ufl.edu	Palmer, Todd/GRS-0639-2022; Kiama, Stephen Gitahi/C-9595-2016	Seifert, Ashley/0000-0001-6576-3664; Kiama, Stephen Gitahi/0000-0002-0217-6283; Palmer, Todd/0000-0001-5710-9750	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK074367] Funding Source: NIH RePORTER; NIDDK NIH HHS [T32 DK074367] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; [Anonymous], 1979, STEREOLOGICAL METHOD; BAUER AM, 1989, J EXP BIOL, V145, P79; BILLINGHAM RE, 1956, NATURE, V177, P791, DOI 10.1038/177791b0; BORGENS RB, 1982, SCIENCE, V217, P747, DOI 10.1126/science.7100922; Botchkarev VA, 2004, DIFFERENTIATION, V72, P512, DOI 10.1111/j.1432-0436.2004.07209005.x; BREEDIS C, 1954, CANCER RES, V14, P575; Calve S, 2010, DEV BIOL, V344, P259, DOI 10.1016/j.ydbio.2010.05.007; CHALKLEY DT, 1954, J MORPHOL, V94, P21, DOI 10.1002/jmor.1050940103; Clark LD, 1998, CLIN IMMUNOL IMMUNOP, V88, P35, DOI 10.1006/clin.1998.4519; Dang CM, 2003, PLAST RECONSTR SURG, V111, P2273, DOI 10.1097/01.PRS.0000060102.57809.DA; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Driskell RR, 2009, DEVELOPMENT, V136, P2815, DOI 10.1242/dev.038620; DUBOST G, 1987, J ZOOL, V212, P563, DOI 10.1111/j.1469-7998.1987.tb02924.x; GLOBUS M, 1980, DEV BIOL, V75, P358, DOI 10.1016/0012-1606(80)90169-4; GUNDERSEN HJG, 1977, J MICROSC-OXFORD, V111, P219, DOI 10.1111/j.1365-2818.1977.tb00062.x; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Kiama SG, 2001, J ZOOL, V254, P521, DOI 10.1017/S0952836901001029; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Maginnis TL, 2006, BEHAV ECOL, V17, P857, DOI 10.1093/beheco/arl010; McGowan KM, 1998, J CELL BIOL, V143, P469, DOI 10.1083/jcb.143.2.469; Muneoka Ken, 2008, Birth Defects Research, V84, P265, DOI 10.1002/bdrc.20137; Neufeld DA, 1996, ANAT RECORD, V246, P155; Satoh A, 2011, DEV BIOL, V355, P263, DOI 10.1016/j.ydbio.2011.04.017; Seifert AW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032875; Shargal E, 1999, J ZOOL, V249, P187, DOI 10.1111/j.1469-7998.1999.tb00757.x; Soo C, 2000, PLAST RECONSTR SURG, V105, P638, DOI 10.1097/00006534-200002000-00024; VOGEL HG, 1974, CONNECT TISSUE RES, V2, P177, DOI 10.3109/03008207409152242; Vorontsova M. A., 1960, ASEXUAL PROPAGATION, P377; Yannas I.V., 2001, REGENERATION SKIN	31	327	333	8	348	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2012	489	7417					561	+		10.1038/nature11499	http://dx.doi.org/10.1038/nature11499			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	046RG	23018966	Green Accepted			2022-12-24	WOS:000311781500003
J	Thompson, AW; Foster, RA; Krupke, A; Carter, BJ; Musat, N; Vaulot, D; Kuypers, MMM; Zehr, JP				Thompson, Anne W.; Foster, Rachel A.; Krupke, Andreas; Carter, Brandon J.; Musat, Niculina; Vaulot, Daniel; Kuypers, Marcel M. M.; Zehr, Jonathan P.			Unicellular Cyanobacterium Symbiotic with a Single-Celled Eukaryotic Alga	SCIENCE			English	Article							PHYTOPLANKTON; FIXATION	Symbioses between nitrogen (N)(2)-fixing prokaryotes and photosynthetic eukaryotes are important for nitrogen acquisition in N-limited environments. Recently, a widely distributed planktonic uncultured nitrogen-fixing cyanobacterium (UCYN-A) was found to have unprecedented genome reduction, including the lack of oxygen-evolving photosystem II and the tricarboxylic acid cycle, which suggested partnership in a symbiosis. We showed that UCYN-A has a symbiotic association with a unicellular prymnesiophyte, closely related to calcifying taxa present in the fossil record. The partnership is mutualistic, because the prymnesiophyte receives fixed N in exchange for transferring fixed carbon to UCYN-A. This unusual partnership between a cyanobacterium and a unicellular alga is a model for symbiosis and is analogous to plastid and organismal evolution, and if calcifying, may have important implications for past and present oceanic N-2 fixation.	[Thompson, Anne W.; Carter, Brandon J.; Zehr, Jonathan P.] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; [Foster, Rachel A.; Krupke, Andreas; Musat, Niculina; Kuypers, Marcel M. M.] Max Planck Inst Marine Mikrobiol, D-28359 Bremen, Germany; [Vaulot, Daniel] Univ Paris 06, F-29680 Roscoff, France; [Vaulot, Daniel] CNRS, UMR 7144, Biol Stn, F-29680 Roscoff, France	University of California System; University of California Santa Cruz; Max Planck Society; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite	Zehr, JP (corresponding author), Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA.	zehrj@ucsc.edu	Musat, Niculina/ABA-2180-2021; Zehr, Jonathan P/B-3513-2014; Vaulot, Daniel/T-6649-2019	Musat, Niculina/0000-0001-9539-189X; Zehr, Jonathan P/0000-0002-5691-5408; Vaulot, Daniel/0000-0002-0717-5685; Thompson, Anne/0000-0002-2022-9553; Foster, Rachel/0000-0002-8696-1835	Gordon and Betty Moore Foundation; NSF Center for Microbial Oceanography: Research and Education (C-MORE); Max Planck Society; PHYTOMETAGENE (JST-CNRS); METAPICO (Genoscope); Micro B3; European Union [287589]	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NSF Center for Microbial Oceanography: Research and Education (C-MORE)(National Science Foundation (NSF)); Max Planck Society(Max Planck SocietyFoundation CELLEX); PHYTOMETAGENE (JST-CNRS); METAPICO (Genoscope); Micro B3; European Union(European Commission)	D. Bottjer and M. Hogan provided advice for <SUP>15</SUP>N<INF>2</INF> additions. Water samples were collected with the help of S. Curless, M. Church, S. Wilson, S. Tozzi, and the captain and crew of the research vessel Kilo Moana. On-board flow cytometry was made possible by K. Doggett and D. Karl. Funding was provided by the Gordon and Betty Moore Foundation (J.P.Z.) and the NSF Center for Microbial Oceanography: Research and Education (C-MORE). The Max Planck Society sponsored the HISH-SIMS analysis. We thank G. Lavik (Max Planck Institute, Bremen) for advice and suggestions for data analysis. J. Waterbury provided the scientific name for UCYN-A. D. V. was supported by PHYTOMETAGENE (JST-CNRS), METAPICO (Genoscope), and Micro B3 (funded by the European Union, contract 287589). BIOSOPE metagenome sequencing was performed at Genoscope (French National Sequencing Center) by J. Poulain. We thank H. Claustre, A. Sciandra, D. Marie, and all other BIOSOPE cruise participants. GenBank accession nos.: JX291679 to JX291804 and JX291547 to JX291678 (see table S4 for details).	Allen LZ, 2012, ISME J, V6, P1403, DOI 10.1038/ismej.2011.201; Bothe H, 2010, ARCH MICROBIOL, V192, P783, DOI 10.1007/s00203-010-0621-5; Bown PR, 2004, COCCOLITHOPHORES: FROM MOLECULAR PROCESSES TO GLOBAL IMPACT, P481; Carpenter EJ, 2002, CYANOBACTERIA IN SYMBIOSIS, P11; Church MJ, 2005, APPL ENVIRON MICROB, V71, P5362, DOI 10.1128/AEM.71.9.5362-5370.2005; Cuvelier ML, 2010, P NATL ACAD SCI USA, V107, P14679, DOI 10.1073/pnas.1001665107; DEFLANDRE G, 1947, CR HEBD ACAD SCI, V225, P439; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Edvardsen B, 2011, EUR J PHYCOL, V46, P202, DOI 10.1080/09670262.2011.594095; Foster RA, 2006, J PHYCOL, V42, P453, DOI 10.1111/j.1529-8817.2006.00206.x; Foster RA, 2011, ISME J, V5, P1484, DOI 10.1038/ismej.2011.26; GRAN H. H., 1935, JOUR BIOL BD CANADA, V1, P279; GREEN JC, 1972, J MAR BIOL ASSOC UK, V52, P469, DOI 10.1017/S002531540001883X; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Hagino K, 2009, MAR MICROPALEONTOL, V72, P210, DOI 10.1016/j.marmicro.2009.06.001; Jardillier L, 2010, ISME J, V4, P1180, DOI 10.1038/ismej.2010.36; Karl DM, 2012, P NATL ACAD SCI USA, V109, P1842, DOI 10.1073/pnas.1120312109; Medlin LK, 2008, MAR MICROPALEONTOL, V67, P69, DOI 10.1016/j.marmicro.2007.08.007; Moisander PH, 2010, SCIENCE, V327, P1512, DOI 10.1126/science.1185468; Moon-van der Staay SY, 2001, NATURE, V409, P607, DOI 10.1038/35054541; Musat N, 2008, P NATL ACAD SCI USA, V105, P17861, DOI 10.1073/pnas.0809329105; Paasche E, 2001, PHYCOLOGIA, V40, P503, DOI 10.2216/i0031-8884-40-6-503.1; Saez AG, 2004, COCCOLITHOPHORES: FROM MOLECULAR PROCESSES TO GLOBAL IMPACT, P251; Shi XL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007657; Siesser W.G., 1992, Proceedings of the Ocean Drilling Program Scientific Results, V122, P653, DOI 10.2973/odp.proc.sr.122.163.1992; Takano Y, 2006, MAR MICROPALEONTOL, V60, P145, DOI 10.1016/j.marmicro.2006.04.002; TAYLOR FJR, 1982, ANN I OCEANOGR PARIS, V58, P61; Tripp HJ, 2010, NATURE, V464, P90, DOI 10.1038/nature08786; Unrein F, 2007, LIMNOL OCEANOGR, V52, P456, DOI 10.4319/lo.2007.52.1.0456; Vaulot D, 2008, FEMS MICROBIOL REV, V32, P795, DOI 10.1111/j.1574-6976.2008.00121.x; Zehr JP, 2008, SCIENCE, V322, P1110, DOI 10.1126/science.1165340; Zubkov MV, 2008, NATURE, V455, P224, DOI 10.1038/nature07236	32	316	329	6	321	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2012	337	6101					1546	1550		10.1126/science.1222700	http://dx.doi.org/10.1126/science.1222700			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007UC	22997339				2022-12-24	WOS:000308912900053
J	Timmann, C; Thye, T; Vens, M; Evans, J; May, J; Ehmen, C; Sievertsen, J; Muntau, B; Ruge, G; Loag, W; Ansong, D; Antwi, S; Asafo-Adjei, E; Nguah, SB; Kwakye, KO; Akoto, AOY; Sylverken, J; Brendel, M; Schuldt, K; Loley, C; Franke, A; Meyer, CG; Agbenyega, T; Ziegler, A; Horstmann, RD				Timmann, Christian; Thye, Thorsten; Vens, Maren; Evans, Jennifer; May, Juergen; Ehmen, Christa; Sievertsen, Juergen; Muntau, Birgit; Ruge, Gerd; Loag, Wibke; Ansong, Daniel; Antwi, Sampson; Asafo-Adjei, Emanuel; Nguah, Samuel Blay; Kwakye, Kingsley Osei; Akoto, Alex Osei Yaw; Sylverken, Justice; Brendel, Michael; Schuldt, Kathrin; Loley, Christina; Franke, Andre; Meyer, Christian G.; Agbenyega, Tsiri; Ziegler, Andreas; Horstmann, Rolf D.			Genome-wide association study indicates two novel resistance loci for severe malaria	NATURE			English	Article							CEREBRAL MALARIA; ACTIVATION; DISEASES	Malaria causes approximately one million fatalities per year, mostly among African children(1). Although highlighted by the strong protective effect of the sickle-cell trait(2,3), the full impact of human genetics on resistance to the disease remains largely unexplored(4). Genome-wide association (GWA) studies are designed to unravel relevant genetic variants comprehensively; however, in malaria, as in other infectious diseases, these studies have been only partly successful(5). Here we identify two previously unknown loci associated with severe falciparum malaria in patients and controls from Ghana, West Africa. We applied the GWA approach to the diverse clinical syndromes of severe falciparum malaria, thereby targeting human genetic variants influencing any step in the complex pathogenesis of the disease. One of the loci was identified on chromosome 1q32 within the ATP2B4 gene, which encodes the main calcium pump of erythrocytes(6), the host cells of the pathogenic stage of malaria parasites. The second was indicated by an intergenic single nucleotide polymorphism on chromosome 16q22.2, possibly linked to a neighbouring gene encoding the tight-junction protein MARVELD3. The protein is expressed on endothelial cells(7) and might therefore have a role in microvascular damage caused by endothelial adherence of parasitized erythrocytes. We also confirmed previous reports on protective effects of the sickle-cell trait and blood group O-5,O-8,O-9. Our findings underline the potential of the GWA approach to provide candidates for the development of control measures against infectious diseases in humans.	[Timmann, Christian; Thye, Thorsten; Evans, Jennifer; Ehmen, Christa; Sievertsen, Juergen; Muntau, Birgit; Ruge, Gerd; Brendel, Michael; Schuldt, Kathrin; Meyer, Christian G.; Horstmann, Rolf D.] Bernhard Nocht Inst Trop Med, Dept Mol Med, D-20359 Hamburg, Germany; [Timmann, Christian; Thye, Thorsten; Vens, Maren; Brendel, Michael; Loley, Christina; Ziegler, Andreas] Med Univ Lubeck, Inst Med Biometry & Stat, D-23562 Lubeck, Germany; [Evans, Jennifer] Kumasi Ctr Collaborat Res Trop Med, Kumasi, Ghana; [May, Juergen; Loag, Wibke] Bernhard Nocht Inst Trop Med, Infect Dis Epidemiol Grp, D-20359 Hamburg, Germany; [Ansong, Daniel; Antwi, Sampson; Asafo-Adjei, Emanuel; Nguah, Samuel Blay; Kwakye, Kingsley Osei; Akoto, Alex Osei Yaw; Sylverken, Justice; Agbenyega, Tsiri] Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Kumasi, Ghana; [Franke, Andre] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany	Bernhard Nocht Institut fur Tropenmedizin; University of Lubeck; Kumasi Center for Collaborative Research; Bernhard Nocht Institut fur Tropenmedizin; Kwame Nkrumah University Science & Technology; University of Kiel	Timmann, C (corresponding author), Bernhard Nocht Inst Trop Med, Dept Mol Med, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.	timmann@bnitm.de	Franke, Andre/B-2151-2010; Nguah, Samuel/AAQ-9725-2020; Ziegler, Andreas/G-4246-2012	Franke, Andre/0000-0003-1530-5811; Ziegler, Andreas/0000-0002-8386-5397; ANSONG, Daniel/0000-0003-1328-9117; May, Jurgen/0000-0001-7831-8420	National Genome Research Network of the German Ministry for Education and Research (BMBF) [NGFN1, NGFN2]; Wellcome Trust [WT077383/Z/05/Z]; Foundation for the National Institutes of Health, Bill & Melinda Gates' Grand Challenges in Global Health Initiative [566]	National Genome Research Network of the German Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Wellcome Trust(Wellcome TrustEuropean Commission); Foundation for the National Institutes of Health, Bill & Melinda Gates' Grand Challenges in Global Health Initiative	We thank the participating children, their parents and guardians; L. N. Badu, S. Opoku, M. Attan-Ayibo and D. Sambian for technical assistance. Ethical approval was obtained from the Committee for Research, Publications and Ethics of the School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana. Informed consent was obtained from the parents or guardians of the children and documented by signature, or thumbprint in cases of illiteracy. The study complied with the Ethical Principles for Medical Research Involving Human Subjects as laid out in the Declaration of Helsinki. The study was supported by the National Genome Research Network (NGFN1, NGFN2) of the German Ministry for Education and Research (BMBF). In addition, this study makes use of data generated by MalariaGEN<SUP>5</SUP>. A full list of the investigators who contributed to the generation of the data is available from http://www.malariagen.net. The MalariaGEN Project is supported by the Wellcome Trust (WT077383/Z/05/Z) and by the Foundation for the National Institutes of Health (566) as part of the Bill & Melinda Gates' Grand Challenges in Global Health Initiative.	[Anonymous], 2010, LANCET INFECT DIS, V10, P577, DOI 10.1016/S1473-3099(10)70171-7; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Bridges DJ, 2010, BLOOD, V115, P1472, DOI 10.1182/blood-2009-07-235150; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; Cinel I, 2007, CURR OPIN INFECT DIS, V20, P345, DOI 10.1097/QCO.0b013e32818be70a; de Bakker PIW, 2010, NAT GENET, V42, P731, DOI 10.1038/ng0910-731; Fry AE, 2008, HUM MOL GENET, V17, P567, DOI 10.1093/hmg/ddm331; Gazarini ML, 2003, J CELL BIOL, V161, P103, DOI 10.1083/jcb.200212130; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Idro R, 2010, PEDIATR RES, V68, P267, DOI 10.1203/00006450-201011001-00524; Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Loscertales MP, 2007, ADV PARASIT, V65, P1, DOI 10.1016/S0065-308X(07)65001-5; Mackinnon MJ, 2005, PLOS MED, V2, P1253, DOI 10.1371/journal.pmed.0020340; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; May J, 2007, JAMA-J AM MED ASSOC, V297, P2220, DOI 10.1001/jama.297.20.2220; McMorran BJ, 2009, SCIENCE, V323, P797, DOI 10.1126/science.1166296; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; MOLYNEUX ME, 1989, Q J MED, V71, P441; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; STAUFFER TP, 1995, J BIOL CHEM, V270, P12184, DOI 10.1074/jbc.270.20.12184; Steed E, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-95; Szewczyk MM, 2007, J CELL MOL MED, V11, P129, DOI 10.1111/j.1582-4934.2007.00010.x; Varga-Szabo D, 2009, J THROMB HAEMOST, V7, P1057, DOI 10.1111/j.1538-7836.2009.03455.x; Wassmer SC, 2005, PLOS MED, V2, P885, DOI 10.1371/journal.pmed.0020245	27	165	165	1	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 20	2012	489	7416					443	446		10.1038/nature11334	http://dx.doi.org/10.1038/nature11334			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AK	22895189				2022-12-24	WOS:000308860900048
J	Pal, A; Barber, TM; Van de Bunt, M; Rudge, SA; Zhang, QF; Lachlan, KL; Cooper, NS; Linden, H; Levy, JC; Wakelam, MJO; Walker, L; Karpe, F; Gloyn, AL				Pal, Aparna; Barber, Thomas M.; Van de Bunt, Martijn; Rudge, Simon A.; Zhang, Qifeng; Lachlan, Katherine L.; Cooper, Nicola S.; Linden, Helen; Levy, Jonathan C.; Wakelam, Michael J. O.; Walker, Lisa; Karpe, Fredrik; Gloyn, Anna L.			PTEN Mutations as a Cause of Constitutive Insulin Sensitivity and Obesity	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ORAL GLUCOSE-TOLERANCE; PROSTATE-CANCER RISK; PLASMA ADIPONECTIN; TUMOR-SUPPRESSOR; RESISTANCE; HOMEOSTASIS; DELETION; PTEN/MMAC1; PROTECTS; MODEL	Background Epidemiologic and genetic evidence links type 2 diabetes, obesity, and cancer. The tumor-suppressor phosphatase and tensin homologue (PTEN) has roles in both cellular growth and metabolic signaling. Germline PTEN mutations cause a cancer-predisposition syndrome, providing an opportunity to study the effect of PTEN haploinsufficiency in humans. Methods We measured insulin sensitivity and beta-cell function in 15 PTEN mutation carriers and 15 matched controls. Insulin signaling was measured in muscle and adipose-tissue biopsy specimens from 5 mutation carriers and 5 well-matched controls. We also assessed the effect of PTEN haploinsufficiency on obesity by comparing anthropometric indexes between the 15 patients and 2097 controls from a population-based study of healthy adults. Body composition was evaluated by means of dual-emission x-ray absorptiometry and skinfold thickness. Results Measures of insulin resistance were lower in the patients with a PTEN mutation than in controls (e.g., mean fasting plasma insulin level, 29 pmol per liter [range, 9 to 99] vs. 74 pmol per liter [range, 22 to 185]; P = 0.001). This finding was confirmed with the use of hyperinsulinemic euglycemic clamping, showing a glucose infusion rate among carriers 2 times that among controls (P = 0.009). The patients' insulin sensitivity could be explained by the presence of enhanced insulin signaling through the PI3K-AKT pathway, as evidenced by increased AKT phosphorylation. The PTEN mutation carriers were obese as compared with population-based controls (mean body-mass index [the weight in kilograms divided by the square of the height in meters], 32 [range, 23 to 42] vs. 26 [range, 15 to 48]; P<0.001). This increased body mass in the patients was due to augmented adiposity without corresponding changes in fat distribution. Conclusions PTEN haploinsufficiency is a monogenic cause of profound constitutive insulin sensitization that is apparently obesogenic. We demonstrate an apparently divergent effect of PTEN mutations: increased risks of obesity and cancer but a decreased risk of type 2 diabetes owing to enhanced insulin sensitivity. (Funded by the Wellcome Trust and others.)	[Pal, Aparna; Barber, Thomas M.; Van de Bunt, Martijn; Levy, Jonathan C.; Karpe, Fredrik; Gloyn, Anna L.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LE, England; [Pal, Aparna; Levy, Jonathan C.; Karpe, Fredrik; Gloyn, Anna L.] Churchill Hosp, Oxford Natl Inst Hlth Res, Biomed Res Ctr, Oxford OX3 7LJ, England; [Linden, Helen; Walker, Lisa] Churchill Hosp, Oxford Reg Genet Ctr, Oxford OX3 7LJ, England; [Rudge, Simon A.; Zhang, Qifeng; Wakelam, Michael J. O.] Inositide Lab, Cambridge, England; [Rudge, Simon A.; Zhang, Qifeng; Wakelam, Michael J. O.] Babraham Inst, Cambridge, England; [Lachlan, Katherine L.] Southampton Univ Hosp, Wessex Clin Genet Serv, Southampton, Hants, England; [Lachlan, Katherine L.] Univ Southampton, Fac Med, Dept Human Genet & Genom Med, Southampton SO9 5NH, Hants, England; [Cooper, Nicola S.] Birmingham Womens Hosp, W Midlands Reg Clin Genet Serv, Birmingham, W Midlands, England	University of Oxford; University of Oxford; University of Oxford; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Southampton; University of Southampton; Birmingham Women's Hospital	Gloyn, AL (corresponding author), Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LE, England.	anna.gloyn@drl.ox.ac.uk	LACHLAN, KATHERINE/ABH-6991-2020	LACHLAN, KATHERINE/0000-0002-3816-7346; Levy, Jonathan/0000-0002-9486-1885; Karpe, Fredrik/0000-0002-2751-1770; Gloyn, Anna/0000-0003-1205-1844; Wakelam, Michael/0000-0003-4059-9276; van de Bunt, Martijn/0000-0002-6744-6125	Wellcome Trust [095101/Z/10Z]; Medical Research Council [G0700222, G0800467]; National Institute for Health Research Oxford Biomedical Research Centre; Biotechnology and Biological Sciences Research Council; European Union Seventh Framework Program LipodomicNet [202272]; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0415, BBS/E/B/000C0413, BBS/E/B/0000C227] Funding Source: researchfish; BBSRC [BBS/E/B/000C0415, BBS/E/B/0000C227, BBS/E/B/000C0413] Funding Source: UKRI; MRC [G0800467, G0700222] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union Seventh Framework Program LipodomicNet; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funded by the Wellcome Trust and others.; Supported by grants from the Wellcome Trust (095101/Z/10Z, to Dr. Gloyn), the Medical Research Council (G0700222, to Dr. Gloyn; and G0800467, to Drs. Pal and Gloyn), the National Institute for Health Research Oxford Biomedical Research Centre (to Drs. Pal, Karpe, and Gloyn), the Biotechnology and Biological Sciences Research Council (to Drs. Rudge, Zhang, and Wakelam), and the European Union Seventh Framework Program LipodomicNet (202272, for adipocyte signaling work, to Drs. Wakelam and Karpe).	Agalliu I, 2008, PROSTATE, V68, P740, DOI 10.1002/pros.20732; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Barb D, 2006, EXPERT OPIN INV DRUG, V15, P917, DOI 10.1517/13543784.15.8.917; Berger AH, 2011, NATURE, V476, P163, DOI 10.1038/nature10275; Blumenthal GM, 2008, EUR J HUM GENET, V16, P1289, DOI 10.1038/ejhg.2008.162; Cohen P, 2006, NAT REV MOL CELL BIO, V7, P867, DOI 10.1038/nrm2043; COLE TRP, 1991, AM J MED GENET, V41, P115, DOI 10.1002/ajmg.1320410128; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Garcia-Cao I, 2012, CELL, V149, P49, DOI 10.1016/j.cell.2012.02.030; Goberdhan DCI, 2003, HUM MOL GENET, V12, pR239, DOI 10.1093/hmg/ddg288; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Holly JMP, 2008, BEST PRACT RES CL EN, V22, P539, DOI 10.1016/j.beem.2008.07.007; Iida S, 2000, ANTICANCER RES, V20, P1901; Karpe F, 2005, BIOCHEM SOC T, V33, P1045, DOI 10.1042/BST0331045; Kloting N, 2010, AM J PHYSIOL-ENDOC M, V299, pE506, DOI 10.1152/ajpendo.00586.2009; Kurlawalla-Martinez C, 2005, MOL CELL BIOL, V25, P2498, DOI 10.1128/MCB.25.6.2498-2510.2005; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Nguyen KTT, 2006, MOL CELL BIOL, V26, P4511, DOI 10.1128/MCB.00238-06; PHILLIPS DIW, 1994, DIABETIC MED, V11, P286, DOI 10.1111/j.1464-5491.1994.tb00273.x; Semple RK, 2006, J CLIN ENDOCR METAB, V91, P3219, DOI 10.1210/jc.2006-0166; Smith U, 2010, DIABETOLOGIA, V53, P1541, DOI 10.1007/s00125-010-1815-8; Stiles B, 2004, P NATL ACAD SCI USA, V101, P5180, DOI 10.1073/pnas.0401220101; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; Stiles BL, 2006, MOL CELL BIOL, V26, P2772, DOI 10.1128/MCB.26.7.2772-2781.2006; Stumvoll M, 2000, DIABETES CARE, V23, P295, DOI 10.2337/diacare.23.3.295; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Wei EK, 2005, JNCI-J NATL CANCER I, V97, P1688, DOI 10.1093/jnci/dji376; Wijesekara N, 2005, MOL CELL BIOL, V25, P1135, DOI 10.1128/MCB.25.3.1135-1145.2005; Wong JT, 2007, DIABETOLOGIA, V50, P395, DOI 10.1007/s00125-006-0531-x	32	164	168	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2012	367	11					1002	1011		10.1056/NEJMoa1113966	http://dx.doi.org/10.1056/NEJMoa1113966			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003ZE	22970944	Green Accepted			2022-12-24	WOS:000308649100006
J	Barthelme, D; Sauer, RT				Barthelme, Dominik; Sauer, Robert T.			Identification of the Cdc48 center dot 20S Proteasome as an Ancient AAA+ Proteolytic Machine	SCIENCE			English	Article							REGULATORY PARTICLE; N-DOMAIN; ATPASE; DEGRADATION; P97/VCP; P97	Proteasomes are the major energy-dependent proteolytic machines in the eukaryotic and archaeal domains of life. To execute protein degradation, the 20S core peptidase combines with the AAA+ ring of the 19S regulatory particle in eukarya or with the AAA+ proteasome-activating nucleotidase ring in some archaea. Here, we find that Cdc48 and 20S from the archaeon Thermoplasma acidophilum interact to form a functional proteasome. Cdc48 is an abundant and essential double-ring AAA+ molecular machine ubiquitously present in archaea, where its function has been uncertain, and in eukarya where Cdc48 participates by largely unknown mechanisms in diverse cellular processes, including multiple proteolytic pathways. Thus, proteolysis in collaboration with the 20S peptidase may represent an ancestral function of the Cdc48 family.	[Barthelme, Dominik; Sauer, Robert T.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Sauer, RT (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	bobsauer@mit.edu	Barthelme, Dominik/E-8452-2010	Sauer, Robert/0000-0002-1719-5399	NIH [AI-16892]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI016892] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank C. Hill, A. Horwich, H. Huber, S. Kim, K. Schmitz, B. Stinson, and M. Wohlever for materials and discussions. Supported by NIH grant AI-16892. The data reported in this manuscript are presented in the main paper and supplementary materials.	Davies JM, 2008, STRUCTURE, V16, P715, DOI 10.1016/j.str.2008.02.010; Gerega A, 2005, J BIOL CHEM, V280, P42856, DOI 10.1074/jbc.M510592200; Kenniston JA, 2003, CELL, V114, P511, DOI 10.1016/S0092-8674(03)00612-3; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Niwa H, 2012, J BIOL CHEM, V287, P8561, DOI 10.1074/jbc.M111.302778; Religa TL, 2010, SCIENCE, V328, P98, DOI 10.1126/science.1184991; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019; Stadtmueller BM, 2011, MOL CELL, V41, P8, DOI 10.1016/j.molcel.2010.12.020; Stadtmueller BM, 2010, J BIOL CHEM, V285, P13, DOI 10.1074/jbc.C109.070425; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Tang WK, 2010, EMBO J, V29, P2217, DOI 10.1038/emboj.2010.104; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Zhang F, 2009, MOL CELL, V34, P473, DOI 10.1016/j.molcel.2009.04.021; Zhou GY, 2008, J BACTERIOL, V190, P8096, DOI 10.1128/JB.01180-08; Zwickl P, 1999, J BIOL CHEM, V274, P26008, DOI 10.1074/jbc.274.37.26008	17	89	92	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2012	337	6096					843	846		10.1126/science.1224352	http://dx.doi.org/10.1126/science.1224352			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	989BQ	22837385	Green Accepted, Green Submitted			2022-12-24	WOS:000307535600043
J	Watson, RO; Manzanillo, PS; Cox, JS				Watson, Robert O.; Manzanillo, Paolo S.; Cox, Jeffery S.			Extracellular M. tuberculosis DNA Targets Bacteria for Autophagy by Activating the Host DNA-Sensing Pathway	CELL			English	Article							INNATE IMMUNE-RESPONSE; ESX-1 SECRETION SYSTEM; MYCOBACTERIUM-TUBERCULOSIS; PHAGOSOME MATURATION; IL-1-BETA PRODUCTION; MYELOID CELLS; BCG; MACROPHAGES; RECOGNITION; INFECTION	Eukaryotic cells sterilize the cytosol by using autophagy to route invading bacterial pathogens to the lysosome. During macrophage infection with Mycobacterium tuberculosis, a vacuolar pathogen, exogenous induction of autophagy can limit replication, but the mechanism of autophagy targeting and its role in natural infection remain unclear. Here we show that phagosomal permeabilization mediated by the bacterial ESX-1 secretion system allows cytosolic components of the ubiquitin-mediated autophagy pathway access to phagosomal M. tuberculosis. Recognition of extracelluar bacterial DNA by the STING-dependent cytosolic pathway is required for marking bacteria with ubiquitin, and delivery of bacilli to autophagosomes requires the ubiquitin-autophagy receptors p62 and NDP52 and the DNA-responsive kinase TBK1. Remarkably, mice with monocytes incapable of delivering bacilli to the autophagy pathway are extremely susceptible to infection. Our results reveal an unexpected link between DNA sensing, innate immunity, and autophagy and indicate a major role for this autophagy pathway in resistance to M. tuberculosis infection.	[Watson, Robert O.; Manzanillo, Paolo S.; Cox, Jeffery S.] Univ Calif San Francisco, Dept Microbiol & Immunol, Program Microbial Pathogenesis & Host Def, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Cox, JS (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, Program Microbial Pathogenesis & Host Def, San Francisco, CA 94158 USA.	jeffery.cox@ucsf.edu			NIH [PO1 AI063302, RO1 AI081727]; Heiser Foundation Fellowship; Genentech Research Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081727, P01AI063302] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heiser Foundation Fellowship; Genentech Research Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Vance, G. Barton, D. Monack, G. Barber, N. Mizushima, H. Virgin, and J. Debnath for mice and reagents. We are grateful to S. Johnson and J. Rubenstein for use of their microscopes. We thank S. Bell for critical reading of the manuscript. This work was supported by NIH grants PO1 AI063302 and RO1 AI081727, the Heiser Foundation Fellowship, and the Genentech Research Fellowship.	ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; Barber GN, 2011, NAT IMMUNOL, V12, P929, DOI 10.1038/ni.2118; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Lerena MC, 2011, CELL MICROBIOL, V13, P814, DOI 10.1111/j.1462-5822.2011.01581.x; Cemma M, 2011, AUTOPHAGY, V7, P341, DOI 10.4161/auto.7.3.14046; Collins CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000430; de Jonge MI, 2007, J BACTERIOL, V189, P6028, DOI 10.1128/JB.00469-07; Deretic V, 2009, CURR TOP MICROBIOL, V335, P169, DOI 10.1007/978-3-642-00302-8_8; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hagstrom JE, 1997, J CELL SCI, V110, P2323; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Jagannath C, 2009, NAT MED, V15, P267, DOI 10.1038/nm.1928; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Kudchodkar SB, 2009, REV MED VIROL, V19, P359, DOI 10.1002/rmv.630; Kumar D, 2010, CELL, V140, P731, DOI 10.1016/j.cell.2010.02.012; MacGurn JA, 2007, INFECT IMMUN, V75, P2668, DOI 10.1128/IAI.01872-06; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Manzanillo PS, 2012, CELL HOST MICROBE, V11, P469, DOI 10.1016/j.chom.2012.03.007; McFarlane S, 2011, J VIROL, V85, P4212, DOI 10.1128/JVI.02435-10; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Ohol YM, 2010, CELL HOST MICROBE, V7, P210, DOI 10.1016/j.chom.2010.02.006; Okabe Y, 2009, NATURE, V460, P520, DOI 10.1038/nature08138; Py BF, 2007, AUTOPHAGY, V3, P117, DOI 10.4161/auto.3618; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; Rasmussen SB, 2011, J IMMUNOL, V187, P5268, DOI 10.4049/jimmunol.1100949; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Ryzhakov G, 2007, EMBO J, V26, P3180, DOI 10.1038/sj.emboj.7601743; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Singh R, 2008, NATURE, V455, P1244, DOI 10.1038/nature07344; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Smith J, 2008, INFECT IMMUN, V76, P5478, DOI 10.1128/IAI.00614-08; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; SturgillKoszycki S, 1996, EMBO J, V15, P6960, DOI 10.1002/j.1460-2075.1996.tb01088.x; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tan T, 2006, CELL MICROBIOL, V8, P1417, DOI 10.1111/j.1462-5822.2006.00721.x; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Tsuchida T, 2010, IMMUNITY, V33, P765, DOI 10.1016/j.immuni.2010.10.013; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Wong KW, 2011, CELL MICROBIOL, V13, P1371, DOI 10.1111/j.1462-5822.2011.01625.x; Yoshikawa Y, 2009, NAT CELL BIOL, V11, P1233, DOI 10.1038/ncb1967; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Yuk JM, 2009, CELL HOST MICROBE, V6, P231, DOI 10.1016/j.chom.2009.08.004; Zhao ZJ, 2008, CELL HOST MICROBE, V4, P458, DOI 10.1016/j.chom.2008.10.003; Zheng YT, 2009, J IMMUNOL, V183, P5909, DOI 10.4049/jimmunol.0900441	55	516	535	4	94	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 17	2012	150	4					803	815		10.1016/j.cell.2012.06.040	http://dx.doi.org/10.1016/j.cell.2012.06.040			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22901810	Green Accepted, Bronze			2022-12-24	WOS:000308002300014
J	Yang, WW; Xia, Y; Hawke, D; Li, XJ; Liang, J; Xing, DM; Aldape, K; Hunter, T; Yung, WKA; Lu, ZM				Yang, Weiwei; Xia, Yan; Hawke, David; Li, Xinjian; Liang, Ji; Xing, Dongming; Aldape, Kenneth; Hunter, Tony; Yung, W. K. Alfred; Lu, Zhimin			PKM2 Phosphorylates Histone H3 and Promotes Gene Transcription and Tumorigenesis	CELL			English	Article							PYRUVATE-KINASE M2; BETA-CATENIN TRANSACTIVATION; NUCLEAR TRANSLOCATION; DOWN-REGULATION; METABOLISM; ACTIVATION; EXPRESSION; MITOSIS; GROWTH; EGFR	Tumor-specific pyruvate kinase M2 (PKM2) is essential for the Warburg effect. In addition to its well-established role in aerobic glycolysis, PKM2 directly regulates gene transcription. However, the mechanism underlying this nonmetabolic function of PKM2 remains elusive. We show here that PKM2 directly binds to histone H3 and phosphorylates histone H3 at T11 upon EGF receptor activation. This phosphorylation is required for the dissociation of HDAC3 from the CCND1 and MYC promoter regions and subsequent acetylation of histone H3 at K9. PKM2-dependent histone H3 modifications are instrumental in EGF-induced expression of cyclin D1 and c-Myc, tumor cell proliferation, cell-cycle progression, and brain tumorigenesis. In addition, levels of histone H3 T11 phosphorylation correlate with nuclear PKM2 expression levels, glioma malignancy grades, and prognosis. These findings highlight the role of PKM2 as a protein kinase in its nonmetabolic functions of histone modification, which is essential for its epigenetic regulation of gene expression and tumorigenesis.	[Yang, Weiwei; Xia, Yan; Li, Xinjian; Liang, Ji; Yung, W. K. Alfred; Lu, Zhimin] Univ Texas MD Anderson Canc Ctr, Brain Tumor Ctr, Houston, TX 77030 USA; [Yang, Weiwei; Xia, Yan; Li, Xinjian; Liang, Ji; Yung, W. K. Alfred; Lu, Zhimin] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA; [Hawke, David] Univ Texas MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA; [Aldape, Kenneth] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Lu, Zhimin] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Xing, Dongming] Tsinghua Univ, Sch Life Sci, Lab Pharmaceut Sci, Beijing 100084, Peoples R China; [Hunter, Tony] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; [Lu, Zhimin] Univ Texas Grad Sch Biomed Sci Houston, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Tsinghua University; Salk Institute	Lu, ZM (corresponding author), Univ Texas MD Anderson Canc Ctr, Brain Tumor Ctr, Houston, TX 77030 USA.	zhiminlu@mdanderson.org		Yang, Weiwei/0000-0002-1661-9137; Hawke, David/0000-0002-6102-7843	National Cancer Institute [2R01CA109035, 5 P50 CA127001-03, CA16672, 2R01CA082683]; Cancer Prevention and Research Institute of Texas (CPRIT) [RP110252]; American Cancer Society Research Scholar Award [RSG-09-277-01-CSM]; University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE [R01CA109035, P30CA016672, P50CA127001, R01CA082683] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Prevention and Research Institute of Texas (CPRIT); American Cancer Society Research Scholar Award(American Cancer Society); University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute grants 2R01CA109035 (Z.L.), 5 P50 CA127001-03, and CA16672 (Cancer Center Support Grant); a research grant (RP110252; Z.L.) from the Cancer Prevention and Research Institute of Texas (CPRIT); an American Cancer Society Research Scholar Award RSG-09-277-01-CSM (Z.L.); and a Sister Institution Network Fund from The University of Texas MD Anderson Cancer Center (Z.L.). T. H. is a Frank and Else Schilling American Cancer Society Professor, and work in his group was supported by National Cancer Institute grant 2R01CA082683.	Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Baek SH, 2011, MOL CELL, V42, P274, DOI 10.1016/j.molcel.2011.03.022; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Dombrauckas JD, 2005, BIOCHEMISTRY-US, V44, P9417, DOI 10.1021/bi0474923; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; Gomez-Manzano C, 2006, CLIN CANCER RES, V12, P556, DOI 10.1158/1078-0432.CCR-05-1892; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hoshino A, 2007, J BIOL CHEM, V282, P17706, DOI 10.1074/jbc.M700094200; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Ji HT, 2009, MOL CELL, V36, P547, DOI 10.1016/j.molcel.2009.09.034; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Lee JS, 2010, CELL, V142, P682, DOI 10.1016/j.cell.2010.08.011; Lee JW, 2008, INT J BIOCHEM CELL B, V40, P1043, DOI 10.1016/j.biocel.2007.11.009; Lu ZM, 2004, CELL CYCLE, V3, P571; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Lu ZM, 1998, MOL CELL BIOL, V18, P839, DOI 10.1128/MCB.18.2.839; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Mazurek S, 2008, ERNST SCHERING FOUND, V4, P99, DOI 10.1007/2789_2008_091; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; MELLATI AA, 1992, CANCER BIOCHEM BIOPH, V13, P33; Metzger E, 2008, NAT CELL BIOL, V10, P53, DOI 10.1038/ncb1668; MOSCATELLO DK, 1995, CANCER RES, V55, P5536; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; NOGUCHI T, 1986, J BIOL CHEM, V261, P3807; Perez-Cadahia B, 2009, BIOCHEM CELL BIOL, V87, P695, DOI 10.1139/O09-053; Preuss U, 2003, NUCLEIC ACIDS RES, V31, P878, DOI 10.1093/nar/gkg176; RESNITZKY D, 1995, MOL CELL BIOL, V15, P3463; Shimada M, 2008, CELL CYCLE, V7, P1555, DOI 10.4161/cc.7.11.6062; Shimada M, 2008, CELL, V132, P221, DOI 10.1016/j.cell.2007.12.013; Stetak A, 2007, CANCER RES, V67, P1602, DOI 10.1158/0008-5472.CAN-06-2870; Suganuma T, 2008, CELL, V135, P604, DOI 10.1016/j.cell.2008.10.036; Taus T, 2011, J PROTEOME RES, V10, P5354, DOI 10.1021/pr200611n; WILLIAMSON JR, 1966, P NATL ACAD SCI USA, V56, P247, DOI 10.1073/pnas.56.1.247; Wykosky Jill, 2011, Chin J Cancer, V30, P5; Xia Y, 2007, MOL CELL, V25, P219, DOI 10.1016/j.molcel.2007.01.005; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598	42	512	533	4	128	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 17	2012	150	4					685	696		10.1016/j.cell.2012.07.018	http://dx.doi.org/10.1016/j.cell.2012.07.018			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22901803	Green Accepted, Bronze			2022-12-24	WOS:000308002300005
J	Abrams, EW; Zhang, H; Marlow, FL; Kapp, L; Lu, SM; Mullins, MC				Abrams, Elliott W.; Zhang, Hong; Marlow, Florence L.; Kapp, Lee; Lu, Sumei; Mullins, Mary C.			Dynamic Assembly of Brambleberry Mediates Nuclear Envelope Fusion during Early Development	CELL			English	Article							MITOTIC SPINDLE; MEMBRANE-FUSION; PROTEIN; ZEBRAFISH; TRANSITION; CLEAVAGE; ZYGOTE; REORGANIZATION; CONGRESSION; INTERPHASE	To accommodate the large cells following zygote formation, early blastomeres employ modified cell divisions. Karyomeres are one such modification, mitotic intermediates wherein individual chromatin masses are surrounded by nuclear envelope; the karyomeres then fuse to form a single mononucleus. We identified brambleberry, a maternal-effect zebrafish mutant that disrupts karyomere fusion, resulting in formation of multiple micronuclei. As karyomeres form, Brambleberry protein localizes to the nuclear envelope, with prominent puncta evident near karyomere-karyomere interfaces corresponding to membrane fusion sites. brambleberry corresponds to an unannotated gene with similarity to Kar5p, a protein that participates in nuclear fusion in yeast. We also demonstrate that Brambleberry is required for pronuclear fusion following fertilization in zebrafish. Our studies provide insight into the machinery required for karyomere fusion and suggest that specialized proteins are necessary for proper nuclear division in large dividing blastomeres.	[Abrams, Elliott W.; Zhang, Hong; Marlow, Florence L.; Kapp, Lee; Lu, Sumei; Mullins, Mary C.] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Mullins, MC (corresponding author), Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, 1211 BRB 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	mullins@mail.med.upenn.edu			NRSA postdoctoral fellowships [5F32GM77835, 1F32GM080926, DRG1826-04];  [R21HD062952];  [R01HD050901];  [R01HD065600];  [T32-HD007516]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007516, R01HD065600] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD050901, R21HD062952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM077835, F32GM080926] Funding Source: NIH RePORTER	NRSA postdoctoral fellowships; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank V. Lemon for technical assistance; P. Klein, E. Bi, S. DiNardo, and P. Tran for critical reading of the manuscript; the Mullins Lab for thoughtful discussions; and the fish facility staff for maintaining the fish stocks. This work was supported by grants R21HD062952, R01HD050901, and R01HD065600 to M.C.M., training grant T32-HD007516 to E.W.A., and NRSA postdoctoral fellowships 5F32GM77835 to E. W. A., 1F32GM080926 to L. K., and DRG1826-04 to F.L.M.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Anderson DJ, 2008, J CELL BIOL, V182, P911, DOI 10.1083/jcb.200805140; Anderson DJ, 2007, NAT CELL BIOL, V9, P1160, DOI 10.1038/ncb1636; Balakier H, 1997, HUM REPROD, V12, P800, DOI 10.1093/humrep/12.4.800; Baur T, 2007, J CELL SCI, V120, P2895, DOI 10.1242/jcs.010181; Beh CT, 1997, J CELL BIOL, V139, P1063, DOI 10.1083/jcb.139.5.1063; Bownds C, 2010, J EXP BIOL, V213, P3796, DOI 10.1242/jeb.043356; Buch C, 2009, J CELL SCI, V122, P2100, DOI 10.1242/jcs.047373; BURKE B, 1986, CELL, V44, P639, DOI 10.1016/0092-8674(86)90273-4; Cummins J M, 2002, Reprod Biomed Online, V4, P176; Dekens MPS, 2003, DEVELOPMENT, V130, P3907, DOI 10.1242/dev.00606; Dosch R, 2004, DEV CELL, V6, P771, DOI 10.1016/j.devcel.2004.05.002; Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193; FERNANDEZ J, 1995, DEV BIOL, V171, P541, DOI 10.1006/dbio.1995.1303; Fichtman B, 2010, MOL BIOL CELL, V21, P4197, DOI 10.1091/mbc.E10-04-0309; Gard DL, 1995, CURR TOP DEV BIOL, V31, P383; GONDOS B, 1972, J CELL SCI, V10, P61; Griffin Jeanine, 2006, J Exp Clin Assist Reprod, V3, P2, DOI 10.1186/1743-1050-3-2; GULYAS BJ, 1972, J CELL BIOL, V55, P533, DOI 10.1083/jcb.55.3.533; HAREL A, 1989, J CELL SCI, V94, P463; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; Hetzer MW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000539; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Huang QM, 2010, BIOCHEM BIOPH RES CO, V391, P542, DOI 10.1016/j.bbrc.2009.11.094; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jasik Krzysztof, 2006, Wiadomosci Parazytologiczne, V52, P291; Knapik EW, 1996, DEVELOPMENT, V123, P451; KURIHARA LJ, 1994, J CELL BIOL, V126, P911, DOI 10.1083/jcb.126.4.911; Larijani B, 2009, ANNU REV BIOPHYS, V38, P107, DOI 10.1146/annurev.biophys.050708.133625; Lemaitre JM, 1998, J CELL BIOL, V142, P1159, DOI 10.1083/jcb.142.5.1159; LONGO FJ, 1972, J MORPHOL, V138, P207, DOI 10.1002/jmor.1051380206; Lu L, 2011, J CELL BIOL, V194, P425, DOI 10.1083/jcb.201012063; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Malhas A, 2011, TRENDS CELL BIOL, V21, P362, DOI 10.1016/j.tcb.2011.03.008; Melloy P, 2009, MOL BIOL CELL, V20, P3773, DOI 10.1091/mbc.E09-02-0163; MONTAG M, 1988, CHROMOSOMA, V96, P187, DOI 10.1007/BF00302357; Mora-Bermudez F, 2007, NAT CELL BIOL, V9, P822, DOI 10.1038/ncb1606; NEWPORT J, 1992, J CELL BIOL, V116, P295, DOI 10.1083/jcb.116.2.295; NEWPORT J, 1987, CELL, V48, P205, DOI 10.1016/0092-8674(87)90424-7; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; Ohsugi M, 2008, CELL, V132, P771, DOI 10.1016/j.cell.2008.01.029; Pelegri F, 2004, METHOD CELL BIOL, V77, P21; Ramadan K, 2007, NATURE, V450, P1258, DOI 10.1038/nature06388; Rotem A, 2009, MOL BIOL CELL, V20, P4031, DOI 10.1091/mbc.E09-02-0150; ROTHMAN JE, 1994, CURR BIOL, V4, P220, DOI 10.1016/S0960-9822(00)00051-8; Schoft VK, 2003, J CELL SCI, V116, P2505, DOI 10.1242/jcs.00450; TELFORD NA, 1990, MOL REPROD DEV, V26, P90, DOI 10.1002/mrd.1080260113; Tokai N, 1996, EMBO J, V15, P457, DOI 10.1002/j.1460-2075.1996.tb00378.x; Wuhr M, 2008, CURR BIOL, V18, P1256, DOI 10.1016/j.cub.2008.07.092; Wuhr M, 2010, CURR BIOL, V20, P2040, DOI 10.1016/j.cub.2010.10.024; ZAMBONI L, 1972, BIOL REPROD, V7, P170, DOI 10.1093/biolreprod/7.2.170	51	35	36	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 3	2012	150	3					521	532		10.1016/j.cell.2012.05.048	http://dx.doi.org/10.1016/j.cell.2012.05.048			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	985WO	22863006	Green Accepted, Bronze			2022-12-24	WOS:000307301400012
J	Han, S; Tai, C; Westenbroek, RE; Yu, FH; Cheah, CS; Potter, GB; Rubenstein, JL; Scheuer, T; de la Iglesia, HO; Catterall, WA				Han, Sung; Tai, Chao; Westenbroek, Ruth E.; Yu, Frank H.; Cheah, Christine S.; Potter, Gregory B.; Rubenstein, John L.; Scheuer, Todd; de la Iglesia, Horacio O.; Catterall, William A.			Autistic-like behaviour in Scn1a(+/-) mice and rescue by enhanced GABA-mediated neurotransmission	NATURE			English	Article							SEVERE MYOCLONIC EPILEPSY; DE-NOVO MUTATIONS; REDUCED SODIUM CURRENT; FRAGILE-X-SYNDROME; DRAVET-SYNDROME; MOUSE MODEL; SPECTRUM DISORDERS; NA(V)1.1 CHANNELS; RETT-SYNDROME; INFANCY	Haploinsufficiency of the SCN1A gene encoding voltage-gated sodium channel Na(V)1.1 causes Dravet's syndrome, a childhood neuropsychiatric disorder including recurrent intractable seizures, cognitive deficit and autism-spectrum behaviours. The neural mechanisms responsible for cognitive deficit and autism-spectrum behaviours in Dravet's syndrome are poorly understood. Here we report that mice with Scn1a haploinsufficiency exhibit hyperactivity, stereotyped behaviours, social interaction deficits and impaired context-dependent spatial memory. Olfactory sensitivity is retained, but novel food odours and social odours are aversive to Scn1a(+/-) mice. GABAergic neurotransmission is specifically impaired by this mutation, and selective deletion of Na(V)1.1 channels in forebrain interneurons is sufficient to cause these behavioural and cognitive impairments. Remarkably, treatment with low-dose clonazepam, a positive allosteric modulator of GABA(A) receptors, completely rescued the abnormal social behaviours and deficits in fear memory in the mouse model of Dravet's syndrome, demonstrating that they are caused by impaired GABAergic neurotransmission and not by neuronal damage from recurrent seizures. These results demonstrate a critical role for Na(V)1.1 channels in neuropsychiatric functions and provide a potential therapeutic strategy for cognitive deficit and autism-spectrum behaviours in Dravet's syndrome.	[Han, Sung; de la Iglesia, Horacio O.; Catterall, William A.] Univ Washington, Graduate Program Neurobiol & Behav, Seattle, WA 98195 USA; [Han, Sung; Tai, Chao; Westenbroek, Ruth E.; Yu, Frank H.; Cheah, Christine S.; Scheuer, Todd; Catterall, William A.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Han, Sung; de la Iglesia, Horacio O.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Potter, Gregory B.; Rubenstein, John L.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco	Catterall, WA (corresponding author), Univ Washington, Graduate Program Neurobiol & Behav, Seattle, WA 98195 USA.	horaciod@uw.edu; wcatt@uw.edu		Yu, Frank/0000-0001-9306-1731; Potter, Gregory/0000-0002-0585-6575	National Institutes of Health [R01 NS25704, R01 MH075016, R37 MH049428]; McKnight Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH049428, R01MH075016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025704] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Research Grants R01 NS25704 (W. A. C.), R01 MH075016 (H.O.d.) and R37 MH049428 (J.L.R.) from the National Institutes of Health and by a grant from the McKnight Foundation (W. A. C.). The authors thank E. Strakbein in the Machine Division at the University of Washington for making all the mazes for the behavioural experiments in this study.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; BESAG FMC, 2004, EPILEPSY BEHAV, V5, P3; Brunklaus A, 2011, EPILEPSIA, V52, P1476, DOI 10.1111/j.1528-1167.2011.03129.x; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Catterall WA, 2010, J PHYSIOL-LONDON, V588, P1849, DOI 10.1113/jphysiol.2010.187484; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Cheah C. S., P NATL ACAD IN PRESS; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; Genton P, 2011, EPILEPSIA, V52, P44, DOI 10.1111/j.1528-1167.2011.03001.x; Geschwind DH, 2011, TRENDS COGN SCI, V15, P409, DOI 10.1016/j.tics.2011.07.003; Gomot M, 2006, NEUROIMAGE, V29, P475, DOI 10.1016/j.neuroimage.2005.07.027; Han S, 2012, P NATL ACAD SCI USA, V109, pE368, DOI 10.1073/pnas.1115729109; Hussman JP, 2001, J AUTISM DEV DISORD, V31, P247, DOI 10.1023/A:1010715619091; Kalume F, 2007, J NEUROSCI, V27, P11065, DOI 10.1523/JNEUROSCI.2162-07.2007; Li BM, 2011, EPILEPSY BEHAV, V21, P291, DOI 10.1016/j.yebeh.2011.04.060; Long J.E., 2009, CEREB CORTEX, V19, pi96, DOI [10.1093/cercor/bhp045, DOI 10.1093/CERCOR/BHP045]; Low K, 2000, SCIENCE, V290, P131, DOI 10.1126/science.290.5489.131; Mahoney K, 2009, SEIZURE-EUR J EPILEP, V18, P492, DOI 10.1016/j.seizure.2009.04.009; Markram K, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00224; Moretti P, 2005, HUM MOL GENET, V14, P205, DOI 10.1093/hmg/ddi016; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Oakley JC, 2009, P NATL ACAD SCI USA, V106, P3994, DOI 10.1073/pnas.0813330106; Ogiwara I, 2007, J NEUROSCI, V27, P5903, DOI 10.1523/JNEUROSCI.5270-06.2007; Paluszkiewicz SM, 2011, DEV NEUROSCI-BASEL, V33, P349, DOI 10.1159/000329420; Paluszkiewicz SM, 2011, J NEUROPHYSIOL, V106, P2264, DOI 10.1152/jn.00421.2011; Penagarikano O, 2011, CELL, V147, P235, DOI 10.1016/j.cell.2011.08.040; Pescucci C, 2007, EUR J MED GENET, V50, P21, DOI 10.1016/j.ejmg.2006.09.001; Potter GB, 2009, MOL CELL NEUROSCI, V40, P167, DOI 10.1016/j.mcn.2008.10.003; Ramoz N, 2008, AM J MED GENET B, V147B, P1152, DOI 10.1002/ajmg.b.30739; Rossignol E, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/649325; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Rudolph U, 2011, NAT REV DRUG DISCOV, V10, P685, DOI 10.1038/nrd3502; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Stockhorst U, 2004, PHYSIOL BEHAV, V83, P3, DOI 10.1016/j.physbeh.2004.07.018; Van Wart A, 2007, J COMP NEUROL, V500, P339, DOI 10.1002/cne.21173; Wang ZS, 2006, J NEUROSCI, V26, P7375, DOI 10.1523/JNEUROSCI.1967-06.2006; Weiss LA, 2003, MOL PSYCHIATR, V8, P186, DOI 10.1038/sj.mp.4001241; WESTENBROEK RE, 1989, NEURON, V3, P695, DOI 10.1016/0896-6273(89)90238-9; Wolff M, 2006, EPILEPSIA, V47, P45, DOI 10.1111/j.1528-1167.2006.00688.x; YAKOUB M, 1992, BRAIN DEV-JPN, V14, P299, DOI 10.1016/S0387-7604(12)80147-1; Yang M, 2012, PHYSL BEHAV; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Yu FH, 2006, NAT NEUROSCI, V9, P1142, DOI 10.1038/nn1754	44	408	427	4	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2012	489	7416					385	390		10.1038/nature11356	http://dx.doi.org/10.1038/nature11356			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AK	22914087	Green Accepted, Green Submitted			2022-12-24	WOS:000308860900036
J	Zalatan, JG; Coyle, SM; Rajan, S; Sidhu, SS; Lim, WA				Zalatan, Jesse G.; Coyle, Scott M.; Rajan, Saravanan; Sidhu, Sachdev S.; Lim, Wendell A.			Conformational Control of the Ste5 Scaffold Protein Insulates Against MAP Kinase Misactivation	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; SIGNALING SPECIFICITY; CASCADE ACTIVATION; YEAST; PATHWAYS; MODULES; DOMAIN; TRANSDUCTION; ORGANIZATION; COMPONENTS	Cells reuse signaling proteins in multiple pathways, raising the potential for improper cross talk. Scaffold proteins are thought to insulate against such miscommunication by sequestering proteins into distinct physical complexes. We show that the scaffold protein Ste5, which organizes the yeast mating mitogen-activated protein kinase (MAPK) pathway, does not use sequestration to prevent misactivation of the mating response. Instead, Ste5 appears to use a conformation mechanism: Under basal conditions, an intramolecular interaction of the pleckstrin homology (PH) domain with the von Willebrand type A (VWA) domain blocks the ability to coactivate the mating-specific MAPK Fus3. Pheromone-induced membrane binding of Ste5 triggers release of this autoinhibition. Thus, in addition to serving as a conduit guiding kinase communication, Ste5 directly receives input information to decide if and when signal can be transmitted to mating output.	[Zalatan, Jesse G.; Coyle, Scott M.; Lim, Wendell A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Coyle, Scott M.] Univ Calif San Francisco, Program Biol Sci, San Francisco, CA 94158 USA; [Lim, Wendell A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Rajan, Saravanan; Sidhu, Sachdev S.] Univ Toronto, Dept Mol Genet, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Rajan, Saravanan; Sidhu, Sachdev S.] Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of Toronto; University of Toronto	Lim, WA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, 600 16th St, San Francisco, CA 94158 USA.	lim@cmp.ucsf.edu		Zalatan, Jesse/0000-0002-1458-0654	Damon Runyon Cancer Research Foundation [DRG 2012-09]; National Science Foundation; Canadian Institutes for Health Research [MOPS-93725]; NIH [RO1 GM55040, RO1 GM62583, PN2 EY016546, P50 GM081879]; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY016546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081879, R01GM055040, R01GM062583] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; National Science Foundation(National Science Foundation (NSF)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	J.G.Z. is supported by the Damon Runyon Cancer Research Foundation (DRG 2012-09). S. M. C. is supported by a National Science Foundation Graduate Research Fellowship. S. S. S. and S. R. are supported by a grant from the Canadian Institutes for Health Research (MOPS-93725). This work was also supported by NIH grants RO1 GM55040, RO1 GM62583, PN2 EY016546, and P50 GM081879 (W. A. L.) and by the Howard Hughes Medical Institute (W. A. L.). We thank G. Narlikar, H. Madhani, and M. Good for helpful discussions and comments; N. Helman and S. Vidal for plasmids; H. Madhani for providing yeast strains; and C. Waddling for assistance with x-ray data collection. Coordinates have been submitted to the Protein Data Bank (4F2H).	Bao MZ, 2004, CELL, V119, P991, DOI 10.1016/j.cell.2004.11.052; Bardwell L, 2005, PEPTIDES, V26, P337, DOI 10.1016/j.peptides.2004.10.001; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; CAIRNS BR, 1992, GENE DEV, V6, P1305, DOI 10.1101/gad.6.7.1305; CHOI KY, 1994, CELL, V78, P499; Chou S, 2004, CELL, V119, P981, DOI 10.1016/j.cell.2004.11.053; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; ELION EA, 1991, P NATL ACAD SCI USA, V88, P9392, DOI 10.1073/pnas.88.21.9392; Flatauer LJ, 2005, MOL CELL BIOL, V25, P1793, DOI 10.1128/MCB.25.5.1793-1803.2005; Garrenton LS, 2006, GENE DEV, V20, P1946, DOI 10.1101/gad.1413706; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; Good M, 2009, CELL, V136, P1085, DOI 10.1016/j.cell.2009.01.049; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Harris K, 2001, CURR BIOL, V11, P1815, DOI 10.1016/S0960-9822(01)00567-X; Inouye C, 1997, GENETICS, V147, P479; Inouye C, 1997, SCIENCE, V278, P103, DOI 10.1126/science.278.5335.103; Jansen G, 2001, MOL GENET GENOMICS, V265, P102, DOI 10.1007/s004380000394; Lamson RE, 2006, CURR BIOL, V16, P618, DOI 10.1016/j.cub.2006.02.060; Lyons DM, 1996, MOL CELL BIOL, V16, P4095; MARCUS S, 1994, P NATL ACAD SCI USA, V91, P7762, DOI 10.1073/pnas.91.16.7762; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Qi MS, 2005, J CELL SCI, V118, P3569, DOI 10.1242/jcs.02470; Saito H, 2010, CURR OPIN MICROBIOL, V13, P677, DOI 10.1016/j.mib.2010.09.001; Schwartz MA, 2004, ANNU REV GENET, V38, P725, DOI 10.1146/annurev.genet.39.073003.112634; Shaw AS, 2009, NAT REV IMMUNOL, V9, P47, DOI 10.1038/nri2473; TAYLOR SS, 1993, TRENDS BIOCHEM SCI, V18, P84, DOI 10.1016/0968-0004(93)80001-R; Whitmarsh AJ, 1998, TRENDS BIOCHEM SCI, V23, P481, DOI 10.1016/S0968-0004(98)01309-7	28	59	61	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2012	337	6099					1218	1222		10.1126/science.1220683	http://dx.doi.org/10.1126/science.1220683			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	000UJ	22878499	Green Accepted			2022-12-24	WOS:000308414000036
J	Gerstein, MB; Kundaje, A; Hariharan, M; Landt, SG; Yan, KK; Cheng, C; Mu, XJ; Khurana, E; Rozowsky, J; Alexander, R; Min, RQ; Alves, P; Abyzov, A; Addleman, N; Bhardwaj, N; Boyle, AP; Cayting, P; Charos, A; Chen, DZ; Cheng, Y; Clarke, D; Eastman, C; Euskirchen, G; Frietze, S; Fu, Y; Gertz, J; Grubert, F; Harmanci, A; Jain, P; Kasowski, M; Lacroute, P; Leng, J; Lian, J; Monahan, H; O'Geen, H; Ouyang, ZQ; Partridge, EC; Patacsil, D; Pauli, F; Raha, D; Ramirez, L; Reddy, TE; Reed, B; Shi, MY; Slifer, T; Wang, J; Wu, LF; Yang, XQ; Yip, KY; Zilberman-Schapira, G; Batzoglou, S; Sidow, A; Farnham, PJ; Myers, RM; Weissman, SM; Snyder, M				Gerstein, Mark B.; Kundaje, Anshul; Hariharan, Manoj; Landt, Stephen G.; Yan, Koon-Kiu; Cheng, Chao; Mu, Xinmeng Jasmine; Khurana, Ekta; Rozowsky, Joel; Alexander, Roger; Min, Renqiang; Alves, Pedro; Abyzov, Alexej; Addleman, Nick; Bhardwaj, Nitin; Boyle, Alan P.; Cayting, Philip; Charos, Alexandra; Chen, David Z.; Cheng, Yong; Clarke, Declan; Eastman, Catharine; Euskirchen, Ghia; Frietze, Seth; Fu, Yao; Gertz, Jason; Grubert, Fabian; Harmanci, Arif; Jain, Preti; Kasowski, Maya; Lacroute, Phil; Leng, Jing; Lian, Jin; Monahan, Hannah; O'Geen, Henriette; Ouyang, Zhengqing; Partridge, E. Christopher; Patacsil, Dorrelyn; Pauli, Florencia; Raha, Debasish; Ramirez, Lucia; Reddy, Timothy E.; Reed, Brian; Shi, Minyi; Slifer, Teri; Wang, Jing; Wu, Linfeng; Yang, Xinqiong; Yip, Kevin Y.; Zilberman-Schapira, Gili; Batzoglou, Serafim; Sidow, Arend; Farnham, Peggy J.; Myers, Richard M.; Weissman, Sherman M.; Snyder, Michael			Architecture of the human regulatory network derived from ENCODE data	NATURE			English	Article							EMBRYONIC STEM-CELLS; HIERARCHICAL STRUCTURE; TRANSCRIPTION FACTORS; ESCHERICHIA-COLI; GENOMIC ANALYSIS; MOTIFS; CHROMATIN; BINDING; SPECIFICITY; EXPRESSION	Transcription factors bind in a combinatorial fashion to specify the on-and-off states of genes; the ensemble of these binding events forms a regulatory network, constituting the wiring diagram for a cell. To examine the principles of the human transcriptional regulatory network, we determined the genomic binding information of 119 transcription-related factors in over 450 distinct experiments. We found the combinatorial, co-association of transcription factors to be highly context specific: distinct combinations of factors bind at specific genomic locations. In particular, there are significant differences in the binding proximal and distal to genes. We organized all the transcription factor binding into a hierarchy and integrated it with other genomic information (for example, microRNA regulation), forming a dense meta-network. Factors at different levels have different properties; for instance, top-level transcription factors more strongly influence expression and middle-level ones co-regulate targets to mitigate information-flow bottlenecks. Moreover, these co-regulations give rise to many enriched network motifs (for example, noise-buffering feed-forward loops). Finally, more connected network components are under stronger selection and exhibit a greater degree of allele-specific activity (that is, differential binding to the two parental alleles). The regulatory information obtained in this study will be crucial for interpreting personal genome sequences and understanding basic principles of human biology and disease.	[Gerstein, Mark B.; Yan, Koon-Kiu; Cheng, Chao; Mu, Xinmeng Jasmine; Khurana, Ekta; Alexander, Roger; Min, Renqiang; Alves, Pedro; Abyzov, Alexej; Bhardwaj, Nitin; Fu, Yao; Harmanci, Arif; Leng, Jing; Wang, Jing; Yip, Kevin Y.; Zilberman-Schapira, Gili] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; [Gerstein, Mark B.; Yan, Koon-Kiu; Cheng, Chao; Khurana, Ekta; Rozowsky, Joel; Alexander, Roger; Min, Renqiang; Abyzov, Alexej; Bhardwaj, Nitin; Harmanci, Arif; Yip, Kevin Y.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Gerstein, Mark B.; Chen, David Z.] Yale Univ, Dept Commun Sci, New Haven, CT 06511 USA; [Kundaje, Anshul; Batzoglou, Serafim] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Hariharan, Manoj; Landt, Stephen G.; Addleman, Nick; Boyle, Alan P.; Cayting, Philip; Cheng, Yong; Eastman, Catharine; Euskirchen, Ghia; Grubert, Fabian; Kasowski, Maya; Lacroute, Phil; Ouyang, Zhengqing; Patacsil, Dorrelyn; Ramirez, Lucia; Shi, Minyi; Slifer, Teri; Wu, Linfeng; Yang, Xinqiong; Snyder, Michael] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Min, Renqiang] NEC Labs Amer, Dept Machine Learning, Princeton, NJ 08540 USA; [Charos, Alexandra; Monahan, Hannah; Raha, Debasish; Reed, Brian] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Clarke, Declan] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Frietze, Seth; Farnham, Peggy J.] Univ So Calif, Dept Biochem & Mol Biol, Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA; [Gertz, Jason; Jain, Preti; Partridge, E. Christopher; Pauli, Florencia; Reddy, Timothy E.; Myers, Richard M.] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Lian, Jin; Weissman, Sherman M.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [O'Geen, Henriette] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Yip, Kevin Y.] Chinese Univ Hong Kong, Dept Comp Sci & Engn, Hong Kong, Hong Kong, Peoples R China; [Sidow, Arend] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA	Yale University; Yale University; Yale University; Stanford University; Stanford University; NEC Corporation; Yale University; Yale University; University of Southern California; HudsonAlpha Institute for Biotechnology; Yale University; University of California System; University of California Davis; Chinese University of Hong Kong; Stanford University	Gerstein, MB (corresponding author), Yale Univ, Program Computat Biol & Bioinformat, Bass 432,266 Whitney Ave, New Haven, CT 06520 USA.	Mark.gerstein@yale.edu; mpsnyder@stanford.edu	Abyzov, Alexej/M-4284-2013; cheng, yong/I-4270-2012; Kundaje, Anshul/Y-2739-2019; Yan, Koon-Kiu/A-5940-2009; Mu, Xinmeng/P-2562-2016; Abyzov, Alexej/AAT-4615-2020; Khurana, Ekta/C-4933-2013; Yip, Kevin/AAT-4771-2020; Kundaje, Anshul/Y-2598-2019; Boyle, Alan/I-1848-2014; Hariharan, Manoj/N-2855-2015	Kundaje, Anshul/0000-0003-3084-2287; Mu, Xinmeng/0000-0002-8079-0828; Yip, Kevin/0000-0001-5516-9944; Kundaje, Anshul/0000-0003-3084-2287; Boyle, Alan/0000-0002-2081-1105; Hariharan, Manoj/0000-0002-1006-5372; Rozowsky, Joel/0000-0002-3565-0762; Alexander, Roger/0000-0002-2967-7395; Pauli Behn, Florencia/0000-0002-8984-4044; Reddy, Timothy/0000-0002-7629-061X; Farnham, Peggy/0000-0003-4469-7914; Snyder, Michael/0000-0003-0784-7987; Gertz, Jason/0000-0001-7568-6789; Abyzov, Alexej/0000-0001-5405-6729	ENCODE Project (National Institutes of Health/National Human Genome Research Institute (NIH/NHGRI)); NIH Predoctoral Training Program in Biophysics [T32 GM008283-24]; Sackler institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004695, U54HG004558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205, T32GM008283] Funding Source: NIH RePORTER	ENCODE Project (National Institutes of Health/National Human Genome Research Institute (NIH/NHGRI)); NIH Predoctoral Training Program in Biophysics; Sackler institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the ENCODE Project (National Institutes of Health/National Human Genome Research Institute (NIH/NHGRI)) for funding. We thank P. Bickel and B. Brown for conversations. Funding has also been provided by the NIH Predoctoral Training Program in Biophysics (D. C.; T32 GM008283-24) and the Sackler institute (G.Z.-S.). M. H. thanks G. Nair for designing database operations.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Balaji S, 2007, J MOL BIOL, V372, P1108, DOI 10.1016/j.jmb.2007.06.084; Balaji S, 2006, J MOL BIOL, V360, P204, DOI 10.1016/j.jmb.2006.04.026; Balazsi G, 2005, P NATL ACAD SCI USA, V102, P7841, DOI 10.1073/pnas.0500365102; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; BARON MH, 1994, MOL CELL BIOL, V14, P3108, DOI 10.1128/MCB.14.5.3108; Barski A, 2009, GENOME RES, V19, P1742, DOI 10.1101/gr.090951.109; Beyer A, 2007, NAT REV GENET, V8, P699, DOI 10.1038/nrg2144; Bhardwaj N, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001014; Bhardwaj N, 2010, P NATL ACAD SCI USA, V107, P6841, DOI 10.1073/pnas.0910867107; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Burda Z, 2011, P NATL ACAD SCI USA, V108, P17263, DOI 10.1073/pnas.1109435108; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cheng C., 2012, GENOME RES; Cheng C, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002190; Cheng C, 2011, BIOINFORMATICS, V27, P3221, DOI 10.1093/bioinformatics/btr552; Chinenov Y, 2001, ONCOGENE, V20, P2438, DOI 10.1038/sj.onc.1204385; Cosentino Lagomarsino M, 2007, P NATL ACAD SCI USA, V104, P5516, DOI 10.1073/pnas.0609023104; CURRAN T, 1988, CELL, V55, P395, DOI 10.1016/0092-8674(88)90024-4; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Hu ZZ, 2007, NAT GENET, V39, P683, DOI 10.1038/ng2012; Jothi R, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.52; Kerenyi MA, 2010, J EXP MED, V207, P2537, DOI 10.1084/jem.20102260; Kim HD, 2009, SCIENCE, V325, P429, DOI 10.1126/science.1171347; Kim PM, 2007, P NATL ACAD SCI USA, V104, P20274, DOI 10.1073/pnas.0710183104; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Ma HW, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-199; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; McDaniell R, 2010, SCIENCE, V328, P235, DOI 10.1126/science.1184655; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Reed BD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000133; Rozowsky J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.54; Rubio ED, 2008, P NATL ACAD SCI USA, V105, P8309, DOI 10.1073/pnas.0801273105; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Yip KY, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r48; Yu HY, 2006, P NATL ACAD SCI USA, V103, P14724, DOI 10.1073/pnas.0508637103; Yu HY, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r55; Zhou JX, 2011, TRENDS GENET, V27, P55, DOI 10.1016/j.tig.2010.11.002	47	1016	1038	4	168	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2012	489	7414					91	100		10.1038/nature11245	http://dx.doi.org/10.1038/nature11245			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999WW	22955619	Green Accepted, hybrid			2022-12-24	WOS:000308347000042
J	Chan, KL; Roig, MB; Hu, B; Beckouet, F; Metson, J; Nasmyth, K				Chan, Kok-Lung; Roig, Maurici B.; Hu, Bin; Beckouet, Frederic; Metson, Jean; Nasmyth, Kim			Cohesin's DNA Exit Gate Is Distinct from Its Entrance Gate and Is Regulated by Acetylation	CELL			English	Article							SISTER-CHROMATID COHESION; SACCHAROMYCES-CEREVISIAE; CHROMOSOME ARMS; ATP HYDROLYSIS; REPLICATION; YEAST; PROTEINS; COMPLEX; BINDING; ESTABLISHMENT	Sister chromatid cohesion is mediated by entrapment of sister DNAs by a tripartite ring composed of cohesin's Smc1, Smc3, and alpha-kleisin subunits. Cohesion requires acetylation of Smc3 by Eco1, whose role is to counteract an inhibitory (antiestablishment) activity associated with cohesin's Wapl subunit. We show that mutations abrogating antiestablishment activity also reduce turnover of cohesin on pericentric chromatin. Our results reveal a "releasing" activity inherent to cohesin complexes transiently associated with Wapl that catalyzes their dissociation from chromosomes. Fusion of Smc3's nucleotide binding domain to alpha-kleisin's N-terminal domain also reduces cohesin turnover within pericentric chromatin and permits establishment of Wapl-resistant cohesion in the absence of Eco1. We suggest that releasing activity opens the Smc3/alpha-kleisin interface, creating a DNA exit gate distinct from its proposed entry gate at the Smc1/3 interface. According to this notion, the function of Smc3 acetylation is to block its dissociation from alpha-kleisin. The functional implications of regulated ring opening are discussed.	[Chan, Kok-Lung; Roig, Maurici B.; Hu, Bin; Beckouet, Frederic; Metson, Jean; Nasmyth, Kim] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Oxford	Nasmyth, K (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	kim.nasmyth@bioch.ox.ac.uk	Beckouet, Frederic/P-5389-2016; Hu, Bin/GWZ-8912-2022	Beckouet, Frederic/0000-0002-9009-1852; Hu, Bin/0000-0001-6316-2830; Nasmyth, Kim/0000-0001-7030-4403; chan, kok-lung/0000-0002-8796-8385	Cancer Research UK; Wellcome Trust; Croucher Foundation Fellowship; Cancer Research UK [12386] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); Croucher Foundation Fellowship; Cancer Research UK(Cancer Research UK)	This study is supported by Cancer Research UK and Wellcome Trust. We thank all members of the Nasmyth group for invaluable discussion; Raquel Oliveira for critical comments on the manuscript; MICRON unit for microscopy support. We specially thank Mike Tyers for a gift of sic1(9 m) plasmid, Haruo Takahashi for the plasmids of the improved galactose-inducible system, and Tongli Zhang for advice and discussion of photobleaching data. K.-L.C. was supported by the Croucher Foundation Fellowship.	Arumugam P, 2003, CURR BIOL, V13, P1941, DOI 10.1016/j.cub.2003.10.036; Beckouet F, 2010, MOL CELL, V39, P689, DOI 10.1016/j.molcel.2010.08.008; Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Farcas AM, 2011, MOL CELL, V44, P97, DOI 10.1016/j.molcel.2011.07.034; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Gerlich D, 2006, CURR BIOL, V16, P1571, DOI 10.1016/j.cub.2006.06.068; Gruber S, 2006, CELL, V127, P523, DOI 10.1016/j.cell.2006.08.048; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Haering CH, 2004, MOL CELL, V15, P951, DOI 10.1016/j.molcel.2004.08.030; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Hu B, 2011, CURR BIOL, V21, P12, DOI 10.1016/j.cub.2010.12.004; Ivanov D, 2002, CURR BIOL, V12, P323, DOI 10.1016/S0960-9822(02)00681-4; Ivanov D, 2007, MOL CELL, V27, P300, DOI 10.1016/j.molcel.2007.07.002; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kucej M, 2010, NUCLEUS-PHILA, V1, P4, DOI 10.4161/nucl.1.1.10010; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Matsuyama T, 2011, J BIOSCI BIOENG, V111, P175, DOI 10.1016/j.jbiosc.2010.09.014; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Mishra A, 2010, CURR BIOL, V20, P279, DOI 10.1016/j.cub.2009.12.059; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Nasmyth K, 2004, PHILOS T R SOC B, V359, P99, DOI 10.1098/rstb.2003.1417; Nasmyth K, 2011, NAT CELL BIOL, V13, P1170, DOI 10.1038/ncb2349; Panizza S, 2000, CURR BIOL, V10, P1557, DOI 10.1016/S0960-9822(00)00854-X; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Pauli A, 2008, DEV CELL, V14, P239, DOI 10.1016/j.devcel.2007.12.009; Pehlivan D, 2012, GENET MED, V14, P313, DOI 10.1038/gim.2011.13; Rowland BD, 2009, MOL CELL, V33, P763, DOI 10.1016/j.molcel.2009.02.028; Seitan VC, 2011, NATURE, V476, P467, DOI 10.1038/nature10312; Shintomi K, 2009, GENE DEV, V23, P2224, DOI 10.1101/gad.1844309; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Sutani T, 2009, CURR BIOL, V19, P492, DOI 10.1016/j.cub.2009.01.062; Tachibana-Konwalski K, 2010, GENE DEV, V24, P2505, DOI 10.1101/gad.605910; Tanaka K, 2001, EMBO J, V20, P5779, DOI 10.1093/emboj/20.20.5779; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880; Weitzer S, 2003, CURR BIOL, V13, P1930, DOI 10.1016/j.cub.2003.10.030; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Yeh E, 2008, CURR BIOL, V18, P81, DOI 10.1016/j.cub.2007.12.019; Zhang JL, 2008, MOL CELL, V31, P143, DOI 10.1016/j.molcel.2008.06.006; Zhang NG, 2008, J CELL BIOL, V183, P1019, DOI 10.1083/jcb.200801157	49	161	162	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 31	2012	150	5					961	974		10.1016/j.cell.2012.07.028	http://dx.doi.org/10.1016/j.cell.2012.07.028			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22901742	Green Submitted, Green Published, hybrid			2022-12-24	WOS:000308500200011
J	Havugimana, PC; Hart, GT; Nepusz, T; Yang, HX; Turinsky, AL; Li, ZH; Wang, PI; Boutz, DR; Fong, V; Phanse, S; Babu, M; Craig, SA; Hu, PZ; Wan, CH; Vlasblom, J; Dar, VUN; Bezginov, A; Clark, GW; Wu, GC; Wodak, SJ; Tillier, ERM; Paccanaro, A; Marcotte, EM; Emili, A				Havugimana, Pierre C.; Hart, G. Traver; Nepusz, Tamas; Yang, Haixuan; Turinsky, Andrei L.; Li, Zhihua; Wang, Peggy I.; Boutz, Daniel R.; Fong, Vincent; Phanse, Sadhna; Babu, Mohan; Craig, Stephanie A.; Hu, Pingzhao; Wan, Cuihong; Vlasblom, James; Dar, Vaqaar-un-Nisa; Bezginov, Alexandr; Clark, Gregory W.; Wu, Gabriel C.; Wodak, Shoshana J.; Tillier, Elisabeth R. M.; Paccanaro, Alberto; Marcotte, Edward M.; Emili, Andrew			A Census of Human Soluble Protein Complexes	CELL			English	Article							SYSTEMATIC ANALYSIS; INTERACTION NETWORK; CELL; ORGANIZATION; GENES; SCALE; MUTATIONS; DISCOVERY; 8Q24; MAP	Cellular processes often depend on stable physical associations between proteins. Despite recent progress, knowledge of the composition of human protein complexes remains limited. To close this gap, we applied an integrative global proteomic profiling approach, based on chromatographic separation of cultured human cell extracts into more than one thousand biochemical fractions that were subsequently analyzed by quantitative tandem mass spectrometry, to systematically identify a network of 13,993 high-confidence physical interactions among 3,006 stably associated soluble human proteins. Most of the 622 putative protein complexes we report are linked to core biological processes and encompass both candidate disease genes and unannotated proteins to inform on mechanism. Strikingly, whereas larger multiprotein assemblies tend to be more extensively annotated and evolutionarily conserved, human protein complexes with five or fewer subunits are far more likely to be functionally unannotated or restricted to vertebrates, suggesting more recent functional innovations.	[Nepusz, Tamas; Yang, Haixuan; Paccanaro, Alberto] Univ London, Dept Comp Sci, Egham TW20 0EX, Surrey, England; [Havugimana, Pierre C.; Hart, G. Traver; Fong, Vincent; Phanse, Sadhna; Babu, Mohan; Hu, Pingzhao; Wan, Cuihong; Emili, Andrew] Univ Toronto, Banting & Best Dept Med Res, Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Havugimana, Pierre C.; Hart, G. Traver; Vlasblom, James; Wodak, Shoshana J.; Emili, Andrew] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada; [Wodak, Shoshana J.] Univ Toronto, Dept Biochem, Toronto, ON M5S 3E1, Canada; [Turinsky, Andrei L.; Vlasblom, James; Wodak, Shoshana J.] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Li, Zhihua; Wang, Peggy I.; Boutz, Daniel R.; Craig, Stephanie A.; Wu, Gabriel C.; Marcotte, Edward M.] Univ Texas Austin, Dept Chem & Biochem, Ctr Syst & Synthet Biol, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Dar, Vaqaar-un-Nisa; Bezginov, Alexandr; Clark, Gregory W.; Tillier, Elisabeth R. M.] Univ Toronto, Campbell Family Inst Canc Res, Ontario Canc Inst, Univ Hlth Network, Toronto, ON M5G 1L7, Canada	University of London; Royal Holloway University London; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Texas System; University of Texas Austin; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Paccanaro, A (corresponding author), Univ London, Dept Comp Sci, Egham TW20 0EX, Surrey, England.	alberto.paccanaro@cs.rhul.ac.uk; marcotte@icmb.utexas.edu; andrew.emili@utoronto.ca	Mohan, Babu P./I-7362-2019; Nepusz, Tamás/E-2832-2016; Paccanaro, Alberto/AAW-5625-2020; Boutz, Daniel/M-4872-2013	Nepusz, Tamás/0000-0002-1451-338X; Boutz, Daniel/0000-0001-7462-4105; Clark, Greg/0000-0002-9805-4300; Hu, Pingzhao/0000-0002-9546-2245; wodak, shoshana/0000-0002-0701-6545; Hart, Traver/0000-0002-1880-3341; Marcotte, Edward/0000-0001-8808-180X; Tillier, Elisabeth/0000-0003-2194-9058; Phanse, Sadhna/0000-0001-6306-0551	University of Toronto; Royal Society [NF080750]; Biotechnology and Biological Sciences Research Council [BB/F00964X/1, BB/K004131/1]; Canada Institutes of Health Research [MOP 82940]; SickKids Foundation; National Institutes of Health; National Science Foundation; Cancer Prevention Research Institute of Texas; Welch Foundation [F1515]; Packard Foundation; Ontario Ministry of Research and Innovation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP1GM106408, R01GM076536, R01GM067779, R01GM088624] Funding Source: NIH RePORTER; BBSRC [BB/K004131/1, BB/F00964X/1] Funding Source: UKRI	University of Toronto(University of Toronto); Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Canada Institutes of Health Research; SickKids Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Cancer Prevention Research Institute of Texas; Welch Foundation(The Welch Foundation); Packard Foundation(The David & Lucile Packard Foundation); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank R. Isserlin, Z. Ni, H. Guo, D. Merico and A. Alpert for technical assistance and J. Parkinson, G. Bader, A. Wilde, and J. Greenblatt for critical suggestions. P.C.H. was a recipient of a University of Toronto Open Fellowship, T.N. was supported by the Newton International Fellowship Scheme of the Royal Society, A.E. is an Ontario Research Chair, and S.J.W. is a Canada Research Chair Tier 1. This work was supported by grants from the Biotechnology and Biological Sciences Research Council (BB/F00964X/1 and BB/K004131/1) and the Royal Society (NF080750) to A.P., the Canada Institutes of Health Research (MOP 82940) and the SickKids Foundation to S.J.W., the National Institutes of Health, National Science Foundation, Cancer Prevention Research Institute of Texas, and Welch (F1515) and Packard Foundations to E.M.M., and the Ontario Ministry of Research and Innovation to A.E.	Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Babu M., 2012, NATURE; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Deardorff MA, 2012, AM J HUM GENET, V90, P1014, DOI 10.1016/j.ajhg.2012.04.019; DeScipio C, 2005, AM J MED GENET A, V137A, P276, DOI 10.1002/ajmg.a.30857; Eng JK, 2008, J PROTEOME RES, V7, P4598, DOI 10.1021/pr800420s; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Geiger T, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014050; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Guruharsha KG, 2011, CELL, V147, P690, DOI 10.1016/j.cell.2011.08.047; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Havugimana PC, 2007, J CHROMATOGR B, V847, P54, DOI 10.1016/j.jchromb.2006.10.075; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hu PZ, 2009, PLOS BIOL, V7, P929, DOI 10.1371/journal.pbio.1000096; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Jansen R, 2004, CURR OPIN MICROBIOL, V7, P535, DOI 10.1016/j.mib.2004.08.012; Jeronimo C, 2007, MOL CELL, V27, P262, DOI 10.1016/j.molcel.2007.06.027; Kislinger T, 2003, MOL CELL PROTEOMICS, V2, P96, DOI 10.1074/mcp.M200074-MCP200; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kuhner S, 2009, SCIENCE, V326, P1235, DOI 10.1126/science.1176343; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Lee I, 2011, GENOME RES, V21, P1109, DOI 10.1101/gr.118992.110; Mak AB, 2010, MOL CELL PROTEOMICS, V9, P811, DOI 10.1074/mcp.M000002-MCP201; Malovannaya A, 2011, CELL, V145, P787, DOI 10.1016/j.cell.2011.05.006; Masters JR, 2002, NAT REV CANCER, V2, P315, DOI 10.1038/nrc775; McBrien J, 2008, AM J MED GENET A, V146A, P1587, DOI 10.1002/ajmg.a.32347; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Nepusz T, 2012, NAT METHODS, V9, P471, DOI [10.1038/nmeth.1938, 10.1038/NMETH.1938]; Oliver S, 2000, NATURE, V403, P601, DOI 10.1038/35001165; Pesquita C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000443; Pie J, 2010, AM J MED GENET A, V152A, P924, DOI 10.1002/ajmg.a.33348; Popow J, 2011, SCIENCE, V331, P760, DOI 10.1126/science.1197847; Ramani AK, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.19; Rhodes DR, 2005, NAT BIOTECHNOL, V23, P951, DOI 10.1038/nbt1103; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Sardiu ME, 2008, P NATL ACAD SCI USA, V105, P1454, DOI 10.1073/pnas.0706983105; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Tillier ERM, 2009, GENOME RES, V19, P1861, DOI 10.1101/gr.092452.109; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Wessels HJCT, 2009, PROTEOMICS, V9, P4221, DOI 10.1002/pmic.200900157; Wuyts W, 2002, AM J MED GENET, V113, P326, DOI 10.1002/ajmg.10845; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yang HX, 2012, BIOINFORMATICS, V28, P1383, DOI 10.1093/bioinformatics/bts129	51	561	571	3	93	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 31	2012	150	5					1068	1081		10.1016/j.cell.2012.08.011	http://dx.doi.org/10.1016/j.cell.2012.08.011			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	001ZU	22939629	Bronze, Green Accepted			2022-12-24	WOS:000308500200019
J	Odoardi, F; Sie, C; Streyl, K; Ulaganathan, VK; Schlager, C; Lodygin, D; Heckelsmiller, K; Nietfeld, W; Ellwart, J; Klinkert, WEF; Lottaz, C; Nosov, M; Brinkmann, V; Spang, R; Lehrach, H; Vingron, M; Wekerle, H; Flugel-Koch, C; Flugel, A				Odoardi, Francesca; Sie, Christopher; Streyl, Kristina; Ulaganathan, Vijay K.; Schlaeger, Christian; Lodygin, Dmitri; Heckelsmiller, Klaus; Nietfeld, Wilfried; Ellwart, Joachim; Klinkert, Wolfgang E. F.; Lottaz, Claudio; Nosov, Mikhail; Brinkmann, Volker; Spang, Rainer; Lehrach, Hans; Vingron, Martin; Wekerle, Hartmut; Fluegel-Koch, Cassandra; Fluegel, Alexander			T cells become licensed in the lung to enter the central nervous system	NATURE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; ADHESION MOLECULE; MICROARRAY DATA; MYELOID CELLS; LYMPHOCYTES; MIGRATION; ANTIGEN; CNS; INFECTIONS	The blood-brain barrier (BBB) and the environment of the central nervous system (CNS) guard the nervous tissue from peripheral immune cells. In the autoimmune disease multiple sclerosis, myelin-reactive T-cell blasts are thought to transgress the BBB1,2 and create a pro-inflammatory environment in the CNS, thereby making possible a second autoimmune attack that starts from the leptomeningeal vessels and progresses into the parenchyma(3-6). Using a Lewis rat model of experimental autoimmune encephalomyelitis, we show here that contrary to the expectations of this concept, T-cell blasts do not efficiently enter the CNS and are not required to prepare the BBB for immune-cell recruitment. Instead, intravenously transferred T-cell blasts gain the capacity to enter the CNS after residing transiently within the lung tissues. Inside the lung tissues, they move along and within the airways to bronchus-associated lymphoid tissues and lung-draining mediastinal lymph nodes before they enter the blood circulation from where they reach the CNS. Effector T cells transferred directly into the airways showed a similar migratory pattern and retained their full pathogenicity. On their way the T cells fundamentally reprogrammed their gene-expression profile, characterized by downregulation of their activation program and upregulation of cellular locomotion molecules together with chemokine and adhesion receptors. The adhesion receptors include ninjurin 1, which participates in T-cell intravascular crawling on cerebral blood vessels. We detected that the lung constitutes a niche not only for activated T cells but also for resting myelin-reactive memory T cells. After local stimulation in the lung, these cells strongly proliferate and, after assuming migratory properties, enter the CNS and induce paralytic disease. The lung could therefore contribute to the activation of potentially autoaggressive T cells and their transition to a migratory mode as a prerequisite to entering their target tissues and inducing autoimmune disease.	[Odoardi, Francesca; Sie, Christopher; Schlaeger, Christian; Lodygin, Dmitri; Fluegel, Alexander] Gemeinnutzige Hertie Stiftung, Inst Multiple Sclerosis Res, Dept Neuroimmunol, D-37073 Gottingen, Germany; [Odoardi, Francesca; Sie, Christopher; Schlaeger, Christian; Lodygin, Dmitri; Fluegel, Alexander] Univ Med Ctr Gottingen, D-37073 Gottingen, Germany; [Streyl, Kristina; Ulaganathan, Vijay K.; Heckelsmiller, Klaus; Klinkert, Wolfgang E. F.; Wekerle, Hartmut] Max Planck Inst Neurobiol, D-82152 Martinsried, Germany; [Nietfeld, Wilfried; Lehrach, Hans; Vingron, Martin] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Ellwart, Joachim] Helmholtz Zentrum Munchen, Inst Mol Immunol, D-81377 Munich, Germany; [Lottaz, Claudio; Spang, Rainer] Univ Regensburg, Inst Funct Genom, D-93053 Regensburg, Germany; [Nosov, Mikhail] Natl Univ Ireland, Natl Ctr Biomed Engn Sci, Regenerat Med Inst, Coll Med Nursing & Hlth Sci, Galway, Ireland; [Brinkmann, Volker] Autoimmun Novartis Inst BioMed Res, CH-4056 Basel, Switzerland; [Brinkmann, Volker] Transplantat Novartis Inst BioMed Res, CH-4056 Basel, Switzerland; [Brinkmann, Volker] Inflammat Novartis Inst BioMed Res, CH-4056 Basel, Switzerland; [Fluegel-Koch, Cassandra] Univ Erlangen Nurnberg, Inst Anat 2, D-91054 Erlangen, Germany	University of Gottingen; Max Planck Society; Max Planck Society; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Regensburg; Ollscoil na Gaillimhe-University of Galway; Novartis; Novartis; Novartis; University of Erlangen Nuremberg	Flugel, A (corresponding author), Gemeinnutzige Hertie Stiftung, Inst Multiple Sclerosis Res, Dept Neuroimmunol, D-37073 Gottingen, Germany.	fluegel@med.uni-goettingen.de	Ulaganathan, Vijay Kumar/AAO-6077-2020	Ulaganathan, Vijay Kumar/0000-0002-4717-6228; Spang, Rainer/0000-0002-1326-4297; Lottaz, Claudio/0000-0003-0781-4827	Deutsche Forschungsgemeinschaft [TRR-SFB43, FORR 1336]; Bundesministerium fur Bildung und Forschung ('UNDERSTAND MS'); Hertie Foundation [1.01.1/11/004]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung ('UNDERSTAND MS')(Federal Ministry of Education & Research (BMBF)); Hertie Foundation	The authors thank A. Stas, S. Hamann, N. Meyer and I. Haarmann for technical assistance. N. Plesnila supported this work with advice in surgical preparations; T. Issekutz provided anti-CXCR3 and anti-VLA4 monoclonal antibodies. We are grateful to D. Johnson and F. Luhder for critical reading of the manuscript. We thank W. Leibold for critical discussions. We thank C. Ludwig for text editing. Hartmut Wekerle is Senior Research Professor of the Hertie Foundation. This work was supported by the Deutsche Forschungsgemeinschaft (TRR-SFB43, FORR 1336), the Bundesministerium fur Bildung und Forschung ('UNDERSTAND MS') and the Hertie Foundation (grant 1.01.1/11/004).	Ahn BJ, 2009, BIOCHEM BIOPH RES CO, V387, P321, DOI 10.1016/j.bbrc.2009.07.019; Araki T, 1997, J BIOL CHEM, V272, P21373, DOI 10.1074/jbc.272.34.21373; Araki T, 1996, NEURON, V17, P353, DOI 10.1016/S0896-6273(00)80166-X; Asperti-Boursin F, 2007, J EXP MED, V204, P1167, DOI 10.1084/jem.20062079; Bartholomaus I, 2009, NATURE, V462, P94, DOI 10.1038/nature08478; BENNUN A, 1981, EUR J IMMUNOL, V11, P195, DOI 10.1002/eji.1830110307; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Brown DA, 2007, J COMP NEUROL, V502, P236, DOI 10.1002/cne.21307; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Cordiglieri C, 2010, BRAIN, V133, P1930, DOI 10.1093/brain/awq135; Dahlquist KD, 2002, NAT GENET, V31, P19, DOI 10.1038/ng0502-19; Eylar E H, 1974, Methods Enzymol, V32, P323; Flugel A, 1999, NAT MED, V5, P843, DOI 10.1038/10567; Flugel A, 2001, IMMUNITY, V14, P547, DOI 10.1016/s1074-7613(01)00143-1; Glabinski AR, 1995, BRAIN BEHAV IMMUN, V9, P315, DOI 10.1006/brbi.1995.1030; HICKEY WF, 1991, J NEUROSCI RES, V28, P254, DOI 10.1002/jnr.490280213; Hogan RJ, 2001, J EXP MED, V193, P981, DOI 10.1084/jem.193.8.981; Huber W., 2003, STAT APPL GENET MOL, V2, pARTICL, DOI [10.2202/1544-6115.1008, DOI 10.2202/1544-6115.1008]; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Ifergan I, 2011, ANN NEUROL, V70, P751, DOI 10.1002/ana.22519; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; KARIN N, 1993, J IMMUNOL, V150, P4116; Kataoka H, 2005, CELL MOL IMMUNOL, V2, P439; Kawakami N, 2005, J IMMUNOL, V175, P69, DOI 10.4049/jimmunol.175.1.69; Kawakami N, 2005, J EXP MED, V201, P1805, DOI 10.1084/jem.20050011; Kawakami N, 2004, J EXP MED, V199, P185, DOI 10.1084/jem.20031064; Kivisakk P, 2009, ANN NEUROL, V65, P457, DOI 10.1002/ana.21379; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; Lo JC, 2003, J CLIN INVEST, V112, P1495, DOI 10.1172/JCI200319188; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Odoardi F, 2007, P NATL ACAD SCI USA, V104, P920, DOI 10.1073/pnas.0608383104; Pham THM, 2008, IMMUNITY, V28, P122, DOI 10.1016/j.immuni.2007.11.017; Pintelon I, 2005, CELL TISSUE RES, V321, P21, DOI 10.1007/s00441-005-1111-y; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; SIBLEY WA, 1985, LANCET, V1, P1313; Sporici R, 2010, EUR J IMMUNOL, V40, P2751, DOI 10.1002/eji.200939975; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Tham EL, 2002, J IMMUNOL, V168, P1190, DOI 10.4049/jimmunol.168.3.1190; WEKERLE H, 1986, TRENDS NEUROSCI, V9, P271, DOI 10.1016/0166-2236(86)90077-9; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0; Zheng HM, 2011, INFLAMM RES, V60, P759, DOI 10.1007/s00011-011-0331-8	44	280	287	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2012	488	7413					675	+		10.1038/nature11337	http://dx.doi.org/10.1038/nature11337			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996NC	22914092	Green Published			2022-12-24	WOS:000308095100060
J	Wilson, NR; Runyan, CA; Wang, FL; Sur, M				Wilson, Nathan R.; Runyan, Caroline A.; Wang, Forea L.; Sur, Mriganka			Division and subtraction by distinct cortical inhibitory networks in vivo	NATURE			English	Article							CAT VISUAL-CORTEX; ORIENTATION SELECTIVITY; DIRECTION SELECTIVITY; NORMALIZATION MODEL; NEURONS; INTERNEURONS; EXCITATION; DYNAMICS; INPUT; MOUSE	Brain circuits process information through specialized neuronal subclasses interacting within a network. Revealing their interplay requires activating specific cells while monitoring others in a functioning circuit. Here we use a new platform for two-way light-based circuit interrogation in visual cortex in vivo to show the computational implications of modulating different subclasses of inhibitory neurons during sensory processing. We find that soma-targeting, parvalbumin-expressing (PV) neurons principally divide responses but preserve stimulus selectivity, whereas dendrite-targeting, somatostatin-expressing (SOM) neurons principally subtract from excitatory responses and sharpen selectivity. Visualized in vivo cell-attached recordings show that division by PV neurons alters response gain, whereas subtraction by SOM neurons shifts response levels. Finally, stimulating identified neurons while scanning many target cells reveals that single PV and SOM neurons functionally impact only specific subsets of neurons in their projection fields. These findings provide direct evidence that inhibitory neuronal subclasses have distinct and complementary roles in cortical computations.	[Wilson, Nathan R.; Runyan, Caroline A.; Wang, Forea L.; Sur, Mriganka] MIT, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health	Sur, M (corresponding author), MIT, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	nathan1@mit.edu; msur@mit.edu			US National Institutes of Health (NIH); Simons Foundation; NIH; NATIONAL EYE INSTITUTE [R01EY007023, R01EY018648] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank J. Huang for providing the SOM-Cre mouse line; C. Le for performing animal care support and viral injections; S. Yan and Y. Deng for help in the development of optogenetics and imaging methods in vitro; S. El-Boustani for collecting data for in vivo deconvolution; J. Sharma, M. Goard and A. Banerjee for comments and discussions on the manuscript; L.-H. Tsai, K. Meletis and M. Carlen for early provision of viral constructs and PV-Cre viral injections; and James Schummers and Hiroki Sugihara for participating in early pilot experiments testing optogenetics stimulation in vivo. This work was supported by postdoctoral fellowships from the US National Institutes of Health (NIH) and the Simons Foundation (N.R.W.), an NIH predoctoral fellowship (C. A. R.) and grants from the NIH and the Simons Foundation (M.S.).	Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; CARANDINI M, 1994, SCIENCE, V264, P1333, DOI 10.1126/science.8191289; Crook JM, 1998, EUR J NEUROSCI, V10, P2056, DOI 10.1046/j.1460-9568.1998.00218.x; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; Fino E, 2011, NEURON, V69, P1188, DOI 10.1016/j.neuron.2011.02.025; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gentet LJ, 2010, NEURON, V65, P422, DOI 10.1016/j.neuron.2010.01.006; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Hofer SB, 2011, NAT NEUROSCI, V14, P1045, DOI 10.1038/nn.2876; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Katzner S, 2011, J NEUROSCI, V31, P5931, DOI 10.1523/JNEUROSCI.5753-10.2011; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; KOCH C, 1983, P NATL ACAD SCI-BIOL, V80, P2799, DOI 10.1073/pnas.80.9.2799; Kulik A, 2006, J NEUROSCI, V26, P4289, DOI 10.1523/JNEUROSCI.4178-05.2006; Lewis DA, 2000, BRAIN RES REV, V31, P270, DOI 10.1016/S0165-0173(99)00042-9; Lillis KP, 2008, J NEUROSCI METH, V172, P178, DOI 10.1016/j.jneumeth.2008.04.024; Liu BH, 2011, NEURON, V71, P542, DOI 10.1016/j.neuron.2011.06.017; Louie K, 2010, J NEUROSCI, V30, P5498, DOI 10.1523/JNEUROSCI.5742-09.2010; Mao R, 2012, CEREB CORTEX, V22, P493, DOI 10.1093/cercor/bhr057; Marino J, 2005, NAT NEUROSCI, V8, P194, DOI 10.1038/nn1391; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; NELSON S, 1994, SCIENCE, V265, P774, DOI 10.1126/science.8047882; Nusser Z, 1996, P NATL ACAD SCI USA, V93, P11939, DOI 10.1073/pnas.93.21.11939; Ohshiro T, 2011, NAT NEUROSCI, V14, P775, DOI 10.1038/nn.2815; Okun M, 2008, NAT NEUROSCI, V11, P535, DOI 10.1038/nn.2105; Packer AM, 2011, J NEUROSCI, V31, P13260, DOI 10.1523/JNEUROSCI.3131-11.2011; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Rudy B, 2011, DEV NEUROBIOL, V71, P45, DOI 10.1002/dneu.20853; Runyan CA, 2010, NEURON, V67, P847, DOI 10.1016/j.neuron.2010.08.006; Schummers J, 2008, SCIENCE, V320, P1638, DOI 10.1126/science.1156120; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Tan AYY, 2011, J NEUROSCI, V31, P12339, DOI 10.1523/JNEUROSCI.2039-11.2011; Tan AYY, 2004, J NEUROPHYSIOL, V92, P630, DOI 10.1152/jn.01020.2003; TSUMOTO T, 1979, EXP BRAIN RES, V34, P351; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Xing DJ, 2011, J NEUROSCI, V31, P15972, DOI 10.1523/JNEUROSCI.2245-11.2011; Xu XM, 2010, J COMP NEUROL, V518, P389, DOI 10.1002/cne.22229; Yazaki-Sugiyama Y, 2009, NATURE, V462, P218, DOI 10.1038/nature08485; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565	45	354	354	1	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2012	488	7411					343	348		10.1038/nature11347	http://dx.doi.org/10.1038/nature11347			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OS	22878717	Green Published, Green Accepted			2022-12-24	WOS:000307501000034
J	Van Handel, B; Montel-Hagen, A; Sasidharan, R; Nakano, H; Ferrari, R; Boogerd, CJ; Schredelseker, J; Wang, YL; Hunter, S; Org, T; Zhou, J; Li, XM; Pellegrini, M; Chen, JN; Orkin, SH; Kurdistani, SK; Evans, SM; Nakano, A; Mikkola, HKA				Van Handel, Ben; Montel-Hagen, Amelie; Sasidharan, Rajkumar; Nakano, Haruko; Ferrari, Roberto; Boogerd, Cornelis J.; Schredelseker, Johann; Wang, Yanling; Hunter, Sean; Org, Tonis; Zhou, Jian; Li, Xinmin; Pellegrini, Matteo; Chen, Jau-Nian; Orkin, Stuart H.; Kurdistani, Siavash K.; Evans, Sylvia M.; Nakano, Atsushi; Mikkola, Hanna K. A.			Scl Represses Cardiomyogenesis in Prospective Hemogenic Endothelium and Endocardium	CELL			English	Article							HEMATOPOIETIC STEM-CELLS; AORTIC ENDOTHELIUM; PROGENITOR CELLS; CARDIOVASCULAR PROGENITORS; HAEMOGENIC ENDOTHELIUM; DEFINED FACTORS; SMOOTH-MUSCLE; MOUSE EMBRYO; DIFFERENTIATION; BLOOD	Endothelium in embryonic hematopoietic tissues generates hematopoietic stem/progenitor cells; however, it is unknown how its unique potential is specified. We show that transcription factor Scl/Tal1 is essential for both establishing the hematopoietic transcriptional program in hemogenic endothelium and preventing its misspecification to a cardiomyogenic fate. Scl(-/-) embryos activated a cardiac transcriptional program in yolk sac endothelium, leading to the emergence of CD31(+)Pdgfr alpha(+) cardiogenic precursors that generated spontaneously beating cardiomyocytes. Ectopic cardiogenesis was also observed in Scl(-/-) hearts, where the disorganized endocardium precociously differentiated into cardiomyocytes. Induction of mosaic deletion of Scl in Scl(fl/fl)Rosa26Cre-ERT2 embryos revealed a cell-intrinsic, temporal requirement for Scl to prevent cardiomyogenesis from endothelium. Scl(-/-) endothelium also upregulated the expression of Wnt antagonists, which promoted rapid cardiomyocyte differentiation of ectopic cardiogenic cells. These results reveal unexpected plasticity in embryonic endothelium such that loss of a single master regulator can induce ectopic cardiomyogenesis from endothelial cells.	[Van Handel, Ben; Montel-Hagen, Amelie; Sasidharan, Rajkumar; Nakano, Haruko; Schredelseker, Johann; Wang, Yanling; Hunter, Sean; Org, Tonis; Pellegrini, Matteo; Chen, Jau-Nian; Nakano, Atsushi; Mikkola, Hanna K. A.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Ferrari, Roberto; Kurdistani, Siavash K.] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Zhou, Jian; Li, Xinmin] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Pellegrini, Matteo; Kurdistani, Siavash K.; Nakano, Atsushi; Mikkola, Hanna K. A.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Pellegrini, Matteo; Kurdistani, Siavash K.; Nakano, Atsushi; Mikkola, Hanna K. A.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Pellegrini, Matteo; Kurdistani, Siavash K.; Nakano, Atsushi; Mikkola, Hanna K. A.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Mikkola, Hanna K. A.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Boogerd, Cornelis J.; Evans, Sylvia M.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Boogerd, Cornelis J.; Evans, Sylvia M.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Orkin, Stuart H.] Harvard Univ, Sch Med, Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Orkin, Stuart H.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Orkin, Stuart H.] Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California San Diego; University of California System; University of California San Diego; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute	Mikkola, HKA (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	hmikkola@mcdb.ucla.edu	Ferrari, Roberto/O-8143-2015; Boogerd, Cornelis/A-7470-2016; Org, Tõnis/E-8596-2010; Boogerd, Cornelis J/D-3244-2009; Evans, Sylvia/G-1980-2015; Chen, Jau-Nian/AAM-7808-2020	Ferrari, Roberto/0000-0002-0453-0899; Org, Tõnis/0000-0003-3071-2183; Boogerd, Cornelis J/0000-0002-7119-5381; Chen, Jau-Nian/0000-0001-8807-3607; Pellegrini, Matteo/0000-0001-9355-9564; Schredelseker, Johann/0000-0002-6657-0466; Yamada-Hunter, Sean/0000-0002-4372-6587	California Institute for Regenerative Medicine (CIRM) New Faculty Award; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA Innovation Award; NIH [HL097766-01]; Ruth L. Kirschstein National Research Service Award [GM07185]; NIH/National Heart, Lung, and Blood Institute [T32 HL69766]; European Molecular Biology Organisation; Human Frontier Science Program; CIRM; Netherlands Organization for Scientific Research [825.10.016]; European Union [MJD284]; Center of Excellence in Molecular Hematology award from the National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097766, T32HL069766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine (CIRM) New Faculty Award; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA Innovation Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); European Molecular Biology Organisation; Human Frontier Science Program(Human Frontier Science Program); CIRM(California Institute for Regenerative Medicine); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Union(European Commission); Center of Excellence in Molecular Hematology award from the National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Joshua Bloomekatz and Dr. Deborah Yelon for critical reading of the manuscript and sharing unpublished data and Guillaume Hagen for preparing the movies. The authors thank the Broad Stem Cell Research Center Flow Cytometry Core for FACS sorting. This work was funded by the California Institute for Regenerative Medicine (CIRM) New Faculty Award, the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA Innovation Award and NIH/RO1 (HL097766-01) grants to H. K. A. M. B. V. H. was supported by the Ruth L. Kirschstein National Research Service Award GM07185 and NIH/National Heart, Lung, and Blood Institute Grant T32 HL69766. A. M.-H was supported by successive fellowships from the European Molecular Biology Organisation and the Human Frontier Science Program. R. F. was funded in part by a CIRM grant to S. K. K. C.J.B. was funded by Rubicon Grant 825.10.016 from the Netherlands Organization for Scientific Research. T.O. was supported by the European Union through the European Social Fund (Mobilitas Grant No. MJD284). S.H.O., an Investigator of the Howard Hughes Medical Institute, is supported in part by a Center of Excellence in Molecular Hematology award from the National Institute of Diabetes and Digestive and Kidney Diseases.	Ahnfelt-Ronne J, 2007, J HISTOCHEM CYTOCHEM, V55, P925, DOI 10.1369/jhc.7A7226.2007; Alva JA, 2006, DEV DYNAM, V235, P759, DOI 10.1002/dvdy.20643; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Bertrand JY, 2005, P NATL ACAD SCI USA, V102, P134, DOI 10.1073/pnas.0402270102; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; David R, 2008, NAT CELL BIOL, V10, P338, DOI 10.1038/ncb1696; de Lange FJ, 2004, CIRC RES, V95, P645, DOI 10.1161/01.RES.0000141429.13560.cb; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Ismailoglu I, 2008, EXP HEMATOL, V36, P1593, DOI 10.1016/j.exphem.2008.07.005; Jaspard B, 2000, MECH DEVELOP, V90, P263, DOI 10.1016/S0925-4773(99)00236-1; Kassouf MT, 2010, GENOME RES, V20, P1064, DOI 10.1101/gr.104935.110; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Kinder SJ, 2001, TRENDS CARDIOVAS MED, V11, P177, DOI 10.1016/S1050-1738(01)00091-3; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; Lindsley RC, 2008, CELL STEM CELL, V3, P55, DOI 10.1016/j.stem.2008.04.004; Mikkola HKA, 2003, BLOOD, V101, P508, DOI 10.1182/blood-2002-06-1699; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Nostro MC, 2008, CELL STEM CELL, V2, P60, DOI 10.1016/j.stem.2007.10.011; Palencia-Desai S, 2011, DEVELOPMENT, V138, P4721, DOI 10.1242/dev.064998; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Qyang Y, 2007, CELL STEM CELL, V1, P165, DOI 10.1016/j.stem.2007.05.018; Rasmussen TL, 2011, DEVELOPMENT, V138, P4801, DOI 10.1242/dev.070912; Rhodes KE, 2008, CELL STEM CELL, V2, P252, DOI 10.1016/j.stem.2008.01.001; Schlaeger TM, 2005, BLOOD, V105, P3871, DOI 10.1182/blood-2004-11-4467; Schneider VA, 2001, GENE DEV, V15, P304, DOI 10.1101/gad.855601; Schoenebeck JJ, 2007, DEV CELL, V13, P254, DOI 10.1016/j.devcel.2007.05.012; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; Simoes FC, 2011, DEVELOPMENT, V138, P3235, DOI 10.1242/dev.059634; Souroullas GP, 2009, CELL STEM CELL, V4, P180, DOI 10.1016/j.stem.2009.01.001; Stadtfeld M, 2005, DEVELOPMENT, V132, P203, DOI 10.1242/dev.01558; Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039; Tian Y, 2010, DEV CELL, V18, P275, DOI 10.1016/j.devcel.2010.01.008; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; Visvader JE, 1998, GENE DEV, V12, P473, DOI 10.1101/gad.12.4.473; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Yamagishi T, 2009, ANAT SCI INT, V84, P77, DOI 10.1007/s12565-009-0027-0; Zeigler BM, 2006, DEVELOPMENT, V133, P4183, DOI 10.1242/dev.02596; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	47	118	120	1	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 3	2012	150	3					590	605		10.1016/j.cell.2012.06.026	http://dx.doi.org/10.1016/j.cell.2012.06.026			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	985WO	22863011	Bronze, Green Accepted			2022-12-24	WOS:000307301400017
J	Ward, LD; Kellis, M				Ward, Lucas D.; Kellis, Manolis			Evidence of Abundant Purifying Selection in Humans for Recently Acquired Regulatory Functions	SCIENCE			English	Article							HUMAN GENOME; NONCODING SEQUENCES; ELEMENTS; EVOLUTION; INNOVATION; DYNAMICS; REVEALS; PROJECT; GENES; MAP	Although only 5% of the human genome is conserved across mammals, a substantially larger portion is biochemically active, raising the question of whether the additional elements evolve neutrally or confer a lineage-specific fitness advantage. To address this question, we integrate human variation information from the 1000 Genomes Project and activity data from the ENCODE Project. A broad range of transcribed and regulatory nonconserved elements show decreased human diversity, suggesting lineage-specific purifying selection. Conversely, conserved elements lacking activity show increased human diversity, suggesting that some recently became nonfunctional. Regulatory elements under human constraint in nonconserved regions were found near color vision and nerve-growth genes, consistent with purifying selection for recently evolved functions. Our results suggest continued turnover in regulatory regions, with at least an additional 4% of the human genome subject to lineage-specific constraint.	[Ward, Lucas D.; Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Ward, Lucas D.; Kellis, Manolis] Broad Inst MIT & Harvard, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Kellis, M (corresponding author), MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	manoli@mit.edu	Kellis, Manolis/ABE-7385-2020	Kellis, Manolis/0000-0001-7113-9630; Ward, Lucas/0000-0002-8017-809X	NIH [R01HG004037, RC1HG005334]; NSF CAREER [0644282]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC1HG005334, R01HG004037] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [0644282] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank the ENCODE Project Consortium data producers and the ENCODE Data Analysis Center for coordinating access and performing quality control and peak-calling analysis; the Analysis Working Group of the ENCODE Project Consortium for feedback throughout this project, especially E. Birney, I. Dunham, M. Gerstein, R. Hardison, J. Stamatoyannopoulos, J. Herrero, S. Parker, P. Sabeti, S. Sunyaev, R. Altshuler, P. Kheradpour, and J. Ernst; and other members of the Kellis laboratory for discussions. L. D. W. and M. K. were funded by NIH grants R01HG004037 and RC1HG005334 and NSF CAREER grant 0644282. Data from the ENCODE consortium are available from the UCSC Genome Browser at http://genome.ucsc.edu/ENCODE, and data from the 1000 Genomes Project is available at www.1000genomes.org/data. ENCODE annotations, mammalian constraint, human diversity, background selection, and filtering information for every SNP and every human nucleotide are available at http://compbio.mit.edu/human-constraint. L. D. W. and M. K. designed the study, analyzed data, and wrote the paper.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Asthana S, 2007, P NATL ACAD SCI USA, V104, P12410, DOI 10.1073/pnas.0705140104; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Dorus S, 2004, CELL, V119, P1027, DOI 10.1016/j.cell.2004.11.040; Drake JA, 2006, NAT GENET, V38, P223, DOI 10.1038/ng1710; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eddy SR, 2005, PLOS BIOL, V3, P95, DOI 10.1371/journal.pbio.0030010; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Jacobs GH, 2012, ADV EXP MED BIOL, V739, P156, DOI 10.1007/978-1-4614-1704-0_10; Katzman S, 2007, SCIENCE, V317, P915, DOI 10.1126/science.1142430; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Lomelin D, 2010, GENOME RES, V20, P311, DOI 10.1101/gr.094151.109; Lowe CB, 2011, SCIENCE, V333, P1019, DOI 10.1126/science.1202702; McVicker G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000471; Meader S, 2010, GENOME RES, V20, P1335, DOI 10.1101/gr.108795.110; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Mu XJ, 2011, NUCLEIC ACIDS RES, V39, P7058, DOI 10.1093/nar/gkr342; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Ponting CP, 2011, GENOME RES, V21, P1769, DOI 10.1101/gr.116814.110; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Torgerson DG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000592	29	136	140	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2012	337	6102					1675	1678		10.1126/science.1225057	http://dx.doi.org/10.1126/science.1225057			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	22956687	Green Submitted, Green Accepted			2022-12-24	WOS:000309215400051
J	Babu, MM; Kriwacki, RW; Pappu, RV				Babu, M. Madan; Kriwacki, Richard W.; Pappu, Rohit V.			Versatility from Protein Disorder	SCIENCE			English	Editorial Material							INTRINSICALLY UNSTRUCTURED PROTEINS; RECOGNITION; CHARGE; MOTIFS		[Babu, M. Madan] MRC Lab Mol Biol, Cambridge CB2 0QH, England; [Kriwacki, Richard W.] St Jude Childrens Res Hosp, Dept Struct Biol, Memphis, TN 38105 USA; [Pappu, Rohit V.] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA	MRC Laboratory Molecular Biology; St Jude Children's Research Hospital; Washington University (WUSTL)	Babu, MM (corresponding author), MRC Lab Mol Biol, Hills Rd, Cambridge CB2 0QH, England.	madanm@mrc-lmb.cam.ac.uk; richard.kriwacki@stjude.org; pappu@wustl.edu	Mohan, Babu P./I-7362-2019; Kriwacki, Richard/N-8154-2018	Kriwacki, Richard/0000-0002-9798-6018	MRC [MC_U105185859] Funding Source: UKRI; Div Of Molecular and Cellular Bioscience [1121867] Funding Source: National Science Foundation; Medical Research Council [MC_U105185859] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Babu MM, 2011, CURR OPIN STRUC BIOL, V21, P432, DOI 10.1016/j.sbi.2011.03.011; Buljan M, 2012, MOL CELL, V46, P871, DOI 10.1016/j.molcel.2012.05.039; Chothia C, 2003, SCIENCE, V300, P1701, DOI 10.1126/science.1085371; Crick SL, 2006, P NATL ACAD SCI USA, V103, P16764, DOI 10.1073/pnas.0608175103; Davey NE, 2012, MOL BIOSYST, V8, P268, DOI 10.1039/c1mb05231d; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Galea CA, 2008, BIOCHEMISTRY-US, V47, P7598, DOI 10.1021/bi8006803; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Mao AH, 2010, P NATL ACAD SCI USA, V107, P8183, DOI 10.1073/pnas.0911107107; Mitrea D. M., 2012, PAC S BIOCOMPUT, V17, P152; Mittag T, 2010, J MOL RECOGNIT, V23, P105, DOI 10.1002/jmr.961; Muller-Spath S, 2010, P NATL ACAD SCI USA, V107, P14609, DOI 10.1073/pnas.1001743107; Mukhopadhyay S, 2007, P NATL ACAD SCI USA, V104, P2649, DOI 10.1073/pnas.0611503104; Pajkos M, 2012, MOL BIOSYST, V8, P296, DOI 10.1039/c1mb05246b; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747	16	158	159	2	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2012	337	6101					1460	1461		10.1126/science.1228775	http://dx.doi.org/10.1126/science.1228775			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007UC	22997313				2022-12-24	WOS:000308912900027
J	Dreyfus, C; Laursen, NS; Kwaks, T; Zuijdgeest, D; Khayat, R; Ekiert, DC; Lee, JH; Metlagel, Z; Bujny, MV; Jongeneelen, M; van der Vlugt, R; Lamrani, M; Korse, HJWM; Geelen, E; Sahin, O; Sieuwerts, M; Brakenhoff, JPJ; Vogels, R; Li, OTW; Poon, LLM; Peiris, M; Koudstaal, W; Ward, AB; Wilson, IA; Goudsmit, J; Friesen, RHE				Dreyfus, Cyrille; Laursen, Nick S.; Kwaks, Ted; Zuijdgeest, David; Khayat, Reza; Ekiert, Damian C.; Lee, Jeong Hyun; Metlagel, Zoltan; Bujny, Miriam V.; Jongeneelen, Mandy; van der Vlugt, Remko; Lamrani, Mohammed; Korse, Hans J. W. M.; Geelen, Eric; Sahin, Ozcan; Sieuwerts, Martijn; Brakenhoff, Just P. J.; Vogels, Ronald; Li, Olive T. W.; Poon, Leo L. M.; Peiris, Malik; Koudstaal, Wouter; Ward, Andrew B.; Wilson, Ian A.; Goudsmit, Jaap; Friesen, Robert H. E.			Highly Conserved Protective Epitopes on Influenza B Viruses	SCIENCE			English	Article							A VIRUSES; ANTIBODY; HEMAGGLUTININ; BROAD; NEUTRALIZATION; RECOGNIZES; LINEAGES; HIV-1; CELLS	Identification of broadly neutralizing antibodies against influenza A viruses has raised hopes for the development of monoclonal antibody-based immunotherapy and "universal" vaccines for influenza. However, a substantial part of the annual flu burden is caused by two cocirculating, antigenically distinct lineages of influenza B viruses. Here, we report human monoclonal antibodies, CR8033, CR8071, and CR9114, that protect mice against lethal challenge from both lineages. Antibodies CR8033 and CR8071 recognize distinct conserved epitopes in the head region of the influenza B hemagglutinin (HA), whereas CR9114 binds a conserved epitope in the HA stem and protects against lethal challenge with influenza A and B viruses. These antibodies may inform on development of monoclonal antibody-based treatments and a universal flu vaccine for all influenza A and B viruses.	[Dreyfus, Cyrille; Laursen, Nick S.; Khayat, Reza; Ekiert, Damian C.; Lee, Jeong Hyun; Metlagel, Zoltan; Ward, Andrew B.; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Laursen, Nick S.] Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus, Denmark; [Kwaks, Ted; Zuijdgeest, David; Bujny, Miriam V.; Jongeneelen, Mandy; van der Vlugt, Remko; Lamrani, Mohammed; Korse, Hans J. W. M.; Geelen, Eric; Sahin, Ozcan; Sieuwerts, Martijn; Brakenhoff, Just P. J.; Vogels, Ronald; Koudstaal, Wouter; Goudsmit, Jaap; Friesen, Robert H. E.] Janssen Ctr Excellence Immunoprophylaxis, Crucell Vaccine Inst, NL-2301 CA Leiden, Netherlands; [Li, Olive T. W.; Poon, Leo L. M.; Peiris, Malik] Univ Hong Kong, State Key Lab Emerging Infect Dis, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China; [Li, Olive T. W.; Poon, Leo L. M.; Peiris, Malik] Univ Hong Kong, Sch Publ Hlth, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Aarhus University; University of Hong Kong; University of Hong Kong; Scripps Research Institute	Wilson, IA (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wilson@scripps.edu; jaap.goudsmit@crucell.com	Ward, Andrew B/F-9203-2014; Laursen, Nick Stub/Q-5051-2017; Ward, Andrew/ABD-7728-2021; Poon, Leo/AAP-6887-2020; Poon, Leo Lit Man/C-4382-2009; Peiris, Joseph Sriyal Malik/C-4380-2009	Ward, Andrew B/0000-0001-7153-3769; Laursen, Nick Stub/0000-0002-7512-2649; Ward, Andrew/0000-0001-7153-3769; Poon, Leo Lit Man/0000-0002-9101-7953; Ekiert, Damian/0000-0002-2570-0404; Kwaks, Ted/0000-0003-1608-9372; Lee, Jeong Hyun/0000-0001-7371-845X; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995	National Institute of General Medical Sciences (NIGMS) Protein Structure Initiative [U54 GM094586]; NIH through the National Center for Research Resources' P41 program [RR017573]; Area of Excellence Scheme of the University Grants Committee, Hong Kong [AoE/M-12/06]; Achievement Rewards for College Scientists Foundation; NIH Molecular Evolution Training Program [GM080209]; Danish Council for Independent Research, Natural Sciences; Skaggs Institute; DOE Office of Biological and Environmental Research; NIH, National Center for Research Resources, Biomedical Technology Program [P41RR001209]; NIGMS [Y1-GM-1104]; National Cancer Institute [Y1-CO-1020]; DOE, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; Office of Science, Office of Basic Energy Sciences, of the DOE [DE-AC02-05CH11231]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573, P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080209, U54GM094586] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS) Protein Structure Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH through the National Center for Research Resources' P41 program; Area of Excellence Scheme of the University Grants Committee, Hong Kong; Achievement Rewards for College Scientists Foundation(General Electric); NIH Molecular Evolution Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Council for Independent Research, Natural Sciences(Det Frie Forskningsrad (DFF)); Skaggs Institute; DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH, National Center for Research Resources, Biomedical Technology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DOE, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); Office of Science, Office of Basic Energy Sciences, of the DOE(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Juraszek; B. Brandenburg; M. Koldijk; K. Hegmans; J. Meijer; N. Hafkemeier; A. Apetri; J. Dulos; L. Dekking; H. Vietsch; G. Perdok; H. Tien; D. Marciano; the staff of the Advanced Photon Source (APS) GM/CA-CAT 23ID-B and 23ID-D, Stanford Synchrotron Radiation Lightsource (SSRL) BL11-1 and SSRL BL7-1, and Advanced Light Source (ALS); X. Dai; R. Stanfield; W. Yu; J. P. Julien; R. N. Kirchdoerfer; and E. Brown of Ottawa University, Canada, for the mouse-adapted A/Hong Kong/1/68 strain. Crystallization experiments were carried out on the Rigaku Crystalmation system at the Joint Center for Structural Genomics, which is supported by the National Institute of General Medical Sciences (NIGMS) Protein Structure Initiative U54 GM094586. The EM and image analysis was conducted by R. K., J. H. L., and Z.M. at the National Resource for Automated Molecular Microscopy, which is supported by NIH through the National Center for Research Resources' P41 program (RR017573). This project has been funded in part by the Area of Excellence Scheme of the University Grants Committee, Hong Kong (grant AoE/M-12/06); a predoctoral fellowship from the Achievement Rewards for College Scientists Foundation (D. C. E.); grant GM080209 from the NIH Molecular Evolution Training Program (D. C. E.); a Saper Aude Postdoc grant from the Danish Council for Independent Research, Natural Sciences (N. S. L.), and the Skaggs Institute (I. A. W.). Portions of this research were carried out at the SSRL, a national user facility operated by Stanford University on behalf of the U.S. Department of Energy (DOE), Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by NIH, National Center for Research Resources, Biomedical Technology Program (P41RR001209), and the NIGMS. The GM/CA CAT 23-ID-B beamline has been funded in whole or in part with federal funds from National Cancer Institute (Y1-CO-1020) and NIGMS (Y1-GM-1104). Use of the APS was supported by the DOE, Basic Energy Sciences, Office of Science, under contract no. DE-AC02-06CH11357. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIGMS or the NIH. The ALS is supported by the director, Office of Science, Office of Basic Energy Sciences, of the DOE under contract no. DE-AC02-05CH11231. Coordinates and structure factors are deposited in the Protein Data Bank (PDB code 4FQH for CR9114 Fab, 4FQI for CR9114 Fab-A/H5 HA, 4FQJ for CR8071 Fab-B/Florida HA1, 4FQK for CR8059 Fab-B/Brisbane HA, 4FQL for CR8033 Fab, 4FQM for B/Brisbane HA, 4FQY for CR9114 Fab-A/H3 HA, and 4FQV for CR9114 Fab-A/H7 HA). Image reconstructions have been deposited at the EMDataBank under accession numbers EMD-2143 (CR8033/Florida), EMD-2144 (CR8071/Florida), EMD-2145 (CR8071/Malaysia), EMD-2146 (CR9114/Florida), EMD-2147 (CR9114/H1), EMD-2148 (CR9114/H3), EMD-2149 (CR9114/H9), and EMD-2150 (CR9114/H7). Nucleotide sequences for the CR8033, CR8059 (CR8071), and CR9114 variable regions have been deposited in GenBank [accession numbers JX213635 (CR8033, VH), JX213636 (CR8033, Vk), JX213637 (CR8059, VH), JX213638 (CR8059, Vl), JX213639 (CR9114, VH), and JX213640 (CR9114, Vl)]. Patent applications relating to antibodies CR8033, CR8059, CR8071, and CR9114 have been filed (CR8033, CR8059, and CR8071 are claimed in EP 12158525.1 and U.S. 61/608,414. CR9114 is claimed in EP 11173953.8 and U.S. 61/572,417). Sharing will be subject to standard material transfer agreements.; This is publication 21741 from the Scripps Research Institute.	Ambrose CS, 2012, HUM VACC IMMUNOTHER, V8, P81, DOI 10.4161/hv.8.1.17623; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Gubareva LV, 2000, LANCET, V355, P827, DOI 10.1016/S0140-6736(99)11433-8; Ha Y, 2003, VIROLOGY, V309, P209, DOI 10.1016/S0042-6822(03)00068-0; Krause JC, 2011, J VIROL, V85, P10905, DOI 10.1128/JVI.00700-11; Lowen Anice C., 2007, Infectious Disorders - Drug Targets, V7, P318; Osterhaus ADME, 2000, SCIENCE, V288, P1051, DOI 10.1126/science.288.5468.1051; ROTA PA, 1990, VIROLOGY, V175, P59, DOI 10.1016/0042-6822(90)90186-U; Salzberg S, 2008, NATURE, V454, P160, DOI 10.1038/454160a; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang QH, 2008, J VIROL, V82, P3011, DOI 10.1128/JVI.02477-07; Wang TT, 2009, NAT STRUCT MOL BIOL, V16, P233, DOI 10.1038/nsmb.1574; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; Whittle JRR, 2011, P NATL ACAD SCI USA, V108, P14216, DOI 10.1073/pnas.1111497108; World Health Organization (WHO), 2009, FACT SHEET 211 INFL; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; YAMASHITA M, 1988, VIROLOGY, V163, P112, DOI 10.1016/0042-6822(88)90238-3; Yang H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001081; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	25	544	590	8	131	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2012	337	6100					1343	1348		10.1126/science.1222908	http://dx.doi.org/10.1126/science.1222908			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	004TW	22878502	Green Accepted			2022-12-24	WOS:000308705000043
J	Cordero, OX; Wildschutte, H; Kirkup, B; Proehl, S; Ngo, L; Hussain, F; Le Roux, F; Mincer, T; Polz, MF				Cordero, Otto X.; Wildschutte, Hans; Kirkup, Benjamin; Proehl, Sarah; Ngo, Lynn; Hussain, Fatima; Le Roux, Frederique; Mincer, Tracy; Polz, Martin F.			Ecological Populations of Bacteria Act as Socially Cohesive Units of Antibiotic Production and Resistance	SCIENCE			English	Article							ANTAGONISTIC INTERACTIONS; MARINE; DIFFERENTIATION; DIVERSITY	In animals and plants, social structure can reduce conflict within populations and bias aggression toward competing populations; however, for bacteria in the wild it remains unknown whether such population-level organization exists. Here, we show that environmental bacteria are organized into socially cohesive units in which antagonism occurs between rather than within ecologically defined populations. By screening approximately 35,000 possible mutual interactions among Vibrionaceae isolates from the ocean, we show that genotypic clusters known to have cohesive habitat association also act as units in terms of antibiotic production and resistance. Genetic analyses show that within populations, broad-range antibiotics are produced by few genotypes, whereas all others are resistant, suggesting cooperation between conspecifics. Natural antibiotics may thus mediate competition between populations rather than solely increase the success of individuals.	[Cordero, Otto X.; Wildschutte, Hans; Kirkup, Benjamin; Proehl, Sarah; Ngo, Lynn; Hussain, Fatima; Polz, Martin F.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Le Roux, Frederique] IFREMER, Lab Genet & Pathol BP 133, F-17390 La Tremblade, France; [Mincer, Tracy] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA	Massachusetts Institute of Technology (MIT); Ifremer; Woods Hole Oceanographic Institution	Polz, MF (corresponding author), MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	mpolz@mit.edu	Polz, Martin/ABE-7199-2020; Kirkup, Benjamin/C-3610-2009	Kirkup, Benjamin/0000-0002-8722-6218; /0000-0001-9296-3733; Mincer, Tracy/0000-0002-4644-5609; Le Roux, Frederique/0000-0002-9112-6199; Polz, Martin/0000-0002-4975-2946	Gordon and Betty Moore Foundation; Broad Institute's Scientific Planning and Allocation of Resources Committee (SPARC); NSF [DEB 0821391]; Netherlands Organisation for Scientific Research; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Broad Institute's Scientific Planning and Allocation of Resources Committee (SPARC); NSF(National Science Foundation (NSF)); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank W. Hanage and E. Alm for valuable suggestions. Funding was provided by the Gordon and Betty Moore Foundation, the Broad Institute's Scientific Planning and Allocation of Resources Committee (SPARC) program, NSF grant DEB 0821391, and the NSF-sponsored Woods Hole Center for Oceans and Human Health. Support for O.X.C. was provided by the Netherlands Organisation for Scientific Research. Whole Genome Shotgun projects have been deposited at DDBJ/EMBL/GenBank under the accessions AJWN00000000, AJYD00000000 to AJYZ00000000, and AJZA00000000 to AJZQ00000000 (table S4).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BURKHOLDER PR, 1966, APPL MICROBIOL, V14, P649, DOI 10.1128/AEM.14.4.649-653.1966; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Doolittle WF, 2009, COLD SH Q B, V74, P197, DOI 10.1101/sqb.2009.74.002; Doolittle WF, 2010, BIOSCIENCE, V60, P102, DOI 10.1525/bio.2010.60.2.5; Hunt DE, 2008, SCIENCE, V320, P1081, DOI 10.1126/science.1157890; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; Koeppel A, 2008, P NATL ACAD SCI USA, V105, P2504, DOI 10.1073/pnas.0712205105; Long RA, 2005, APPL ENVIRON MICROB, V71, P8531, DOI 10.1128/AEM.71.12.8531-8536.2005; Long RA, 2001, APPL ENVIRON MICROB, V67, P4975, DOI 10.1128/AEM.67.11.4975-4983.2001; Preheim SP, 2011, APPL ENVIRON MICROB, V77, P7195, DOI 10.1128/AEM.00665-11; Preheim SP, 2011, ENVIRON MICROBIOL, V13, P265, DOI 10.1111/j.1462-2920.2010.02328.x; Raaijmakers JM, 2010, FEMS MICROBIOL REV, V34, P1037, DOI 10.1111/j.1574-6976.2010.00221.x; Shapiro BJ, 2012, SCIENCE, V336, P48, DOI 10.1126/science.1218198; Tarnita CE, 2009, P NATL ACAD SCI USA, V106, P8601, DOI 10.1073/pnas.0903019106; Thompson JR, 2005, SCIENCE, V307, P1311, DOI 10.1126/science.1106028; Vetsigian K, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001184	17	199	203	5	169	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2012	337	6099					1228	1231		10.1126/science.1219385	http://dx.doi.org/10.1126/science.1219385			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	000UJ	22955834	Green Submitted			2022-12-24	WOS:000308414000039
J	Hyman, AA; Simons, K				Hyman, Anthony A.; Simons, Kai			Beyond Oil and Water-Phase Transitions in Cells	SCIENCE			English	Editorial Material							PROTEINS; GRANULES; RNA; ASSEMBLIES		[Hyman, Anthony A.; Simons, Kai] Max Planck Inst Mol Cell Biol & Genet, D-01309 Dresden, Germany	Max Planck Society	Hyman, AA (corresponding author), Max Planck Inst Mol Cell Biol & Genet, D-01309 Dresden, Germany.	hyman@mpi-cbg.de; simons@mpi-cbg.de	Hyman, Anthony A/B-3917-2017; Hyman, Tony/F-1923-2011	Hyman, Anthony A/0000-0003-3664-154X; Simons, Kai/0000-0002-9231-9996				Ball P., 2004, CRITICAL MASS ONE TH; Brangwynne CP, 2011, P NATL ACAD SCI USA, V108, P4334, DOI 10.1073/pnas.1017150108; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Choi YH, 2011, PLANT PHYSIOL, V156, P1701, DOI 10.1104/pp.111.178426; Coskun U, 2011, STRUCTURE, V19, P1543, DOI 10.1016/j.str.2011.10.010; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Hanazawa M, 2011, J CELL BIOL, V192, P929, DOI 10.1083/jcb.201010106; Hyman AA, 2011, DEV CELL, V21, P14, DOI 10.1016/j.devcel.2011.06.013; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Narayanaswamy R, 2009, P NATL ACAD SCI USA, V106, P10147, DOI 10.1073/pnas.0812771106; Oparin, 1936, ORIGINS LIFE EVOL B; Sear RP, 2008, FARADAY DISCUSS, V139, P21, DOI 10.1039/b713076g; Weber SC, 2012, CELL, V149, P1188, DOI 10.1016/j.cell.2012.05.022; Wilson E. B., 1899, Science, Vx, P33	16	177	178	3	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2012	337	6098					1047	1049		10.1126/science.1223728	http://dx.doi.org/10.1126/science.1223728			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22936764				2022-12-24	WOS:000308125800031
J	Halpern, BS; Longo, C; Hardy, D; McLeod, KL; Samhouri, JF; Katona, SK; Kleisner, K; Lester, SE; O'Leary, J; Ranelletti, M; Rosenberg, AA; Scarborough, C; Selig, ER; Best, BD; Brumbaugh, DR; Chapin, FS; Crowder, LB; Daly, KL; Doney, SC; Elfes, C; Fogarty, MJ; Gaines, SD; Jacobsen, KI; Karrer, LB; Leslie, HM; Neeley, E; Pauly, D; Polasky, S; Ris, B; St Martin, K; Stone, GS; Sumaila, UR; Zeller, D				Halpern, Benjamin S.; Longo, Catherine; Hardy, Darren; McLeod, Karen L.; Samhouri, Jameal F.; Katona, Steven K.; Kleisner, Kristin; Lester, Sarah E.; O'Leary, Jennifer; Ranelletti, Marla; Rosenberg, Andrew A.; Scarborough, Courtney; Selig, Elizabeth R.; Best, Benjamin D.; Brumbaugh, Daniel R.; Chapin, F. Stuart; Crowder, Larry B.; Daly, Kendra L.; Doney, Scott C.; Elfes, Cristiane; Fogarty, Michael J.; Gaines, Steven D.; Jacobsen, Kelsey I.; Karrer, Leah Bunce; Leslie, Heather M.; Neeley, Elizabeth; Pauly, Daniel; Polasky, Stephen; Ris, Bud; St Martin, Kevin; Stone, Gregory S.; Sumaila, U. Rashid; Zeller, Dirk			An index to assess the health and benefits of the global ocean	NATURE			English	Article							SAFE OPERATING SPACE; ECOSYSTEM HEALTH; INDICATORS; FRAMEWORK; IMPACTS	The ocean plays a critical role in supporting human well-being, from providing food, livelihoods and recreational opportunities to regulating the global climate. Sustainable management aimed at maintaining the flow of a broad range of benefits from the ocean requires a comprehensive and quantitative method to measure and monitor the health of coupled human-ocean systems. We created an index comprising ten diverse public goals for a healthy coupled human-ocean system and calculated the index for every coastal country. Globally, the overall index score was 60 out of 100 (range 36-86), with developed countries generally performing better than developing countries, but with notable exceptions. Only 5% of countries scored higher than 70, whereas 32% scored lower than 50. The index provides a powerful tool to raise public awareness, direct resource management, improve policy and prioritize scientific research.	[Halpern, Benjamin S.; Longo, Catherine; Hardy, Darren; O'Leary, Jennifer; Ranelletti, Marla; Scarborough, Courtney] Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA; [Halpern, Benjamin S.] Univ Calif Santa Barbara, Ctr Marine Assessment & Planning, Santa Barbara, CA 93106 USA; [McLeod, Karen L.] Oregon State Univ, Dept Zool, COMPASS, Corvallis, OR 97331 USA; [Samhouri, Jameal F.] NOAA, Conservat Biol Div, NW Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98112 USA; [Katona, Steven K.; Rosenberg, Andrew A.; Selig, Elizabeth R.; Karrer, Leah Bunce; Stone, Gregory S.] Conservat Int, Arlington, VA 22202 USA; [Kleisner, Kristin; Pauly, Daniel; Sumaila, U. Rashid; Zeller, Dirk] Univ British Columbia, Fisheries Ctr, Sea Us Project, Vancouver, BC V6T 1Z4, Canada; [Lester, Sarah E.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Lester, Sarah E.; Gaines, Steven D.; Jacobsen, Kelsey I.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Best, Benjamin D.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Brumbaugh, Daniel R.] Amer Museum Nat Hist, Ctr Biodivers & Conservat, New York, NY 10024 USA; [Chapin, F. Stuart] Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK 99775 USA; [Crowder, Larry B.] Stanford Univ, Ctr Ocean Solut, Monterey, CA 93940 USA; [Crowder, Larry B.] Stanford Univ, Hopkins Marine Stn, Monterey, CA 93940 USA; [Daly, Kendra L.] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33705 USA; [Doney, Scott C.] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; [Elfes, Cristiane] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Elfes, Cristiane] Conservat Int, IUCN Global Species Programme, Biodivers Assessment Unit, Arlington, VA 22202 USA; [Fogarty, Michael J.] NE Fisheries Sci Ctr, Woods Hole, MA 02453 USA; [Leslie, Heather M.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Leslie, Heather M.] Brown Univ, Ctr Environm Studies, Providence, RI 02912 USA; [Neeley, Elizabeth] Univ Washington, Sch Aquat & Fisheries Sci, COMPASS, Seattle, WA 98195 USA; [Polasky, Stephen] Univ Minnesota, Dept Appl Econ, St Paul, MN 55108 USA; [Ris, Bud] New England Aquarium, Cent Wharf, Boston, MA 02110 USA; [St Martin, Kevin] Rutgers State Univ, Dept Geog, Piscataway, NJ 08854 USA	National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; Oregon State University; National Oceanic Atmospheric Admin (NOAA) - USA; Conservation International; University of British Columbia; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Duke University; American Museum of Natural History (AMNH); University of Alaska System; University of Alaska Fairbanks; Stanford University; Stanford University; State University System of Florida; University of South Florida; Woods Hole Oceanographic Institution; University of California System; University of California Santa Barbara; Conservation International; National Oceanic Atmospheric Admin (NOAA) - USA; Brown University; Brown University; University of Washington; University of Washington Seattle; University of Minnesota System; University of Minnesota Twin Cities; Rutgers State University New Brunswick	Halpern, BS (corresponding author), Natl Ctr Ecol Anal & Synth, 735 State St,Suite 300, Santa Barbara, CA 93101 USA.	halpern@nceas.ucsb.edu	Gaines, Steven/Y-3234-2019; Doney, Scott C/F-9247-2010; Polasky, Stephen/AAC-5341-2019; Sumaila, U. Rashid/ABE-6475-2020; O'Leary, Jennifer/C-9653-2013; Chapin, F Stuart/AAZ-3931-2020; Pauly, Daniel Marc/AAY-2316-2021; Neeley, Liz/AAT-2019-2020; Leslie, Heather M./I-7812-2019; Leslie, Heather/B-4980-2014	Doney, Scott C/0000-0002-3683-2437; O'Leary, Jennifer/0000-0002-1975-7893; Chapin, F Stuart/0000-0002-2558-9910; Neeley, Liz/0000-0002-3031-1470; Leslie, Heather M./0000-0003-4512-9417; St. Martin, Kevin/0000-0003-3775-1601; Scarborough, Courtney/0000-0001-7270-9228; Pauly, Daniel/0000-0003-3756-4793; Zeller, Dirk/0000-0001-7304-4125	Pacific Life Foundation; Thomas W. Haas Fund of the New Hampshire Charitable Foundation; Oak Foundation; Akiko Shiraki Dynner Fund for Ocean Exploration and Conservation; Darden Restaurants Inc. Foundation; Conservation International; New England Aquarium; National Geographic; National Center for Ecological Analysis and Synthesis; David and Lucile Packard Foundation; Pew Charitable Trusts; Direct For Social, Behav & Economic Scie [0949710] Funding Source: National Science Foundation	Pacific Life Foundation; Thomas W. Haas Fund of the New Hampshire Charitable Foundation; Oak Foundation; Akiko Shiraki Dynner Fund for Ocean Exploration and Conservation; Darden Restaurants Inc. Foundation; Conservation International; New England Aquarium; National Geographic(National Geographic Society); National Center for Ecological Analysis and Synthesis; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Pew Charitable Trusts; Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	B. Wrigley and H. Wrigley provided the founding grant. Additional financial and in-kind support was provided by the Pacific Life Foundation, Thomas W. Haas Fund of the New Hampshire Charitable Foundation, the Oak Foundation, Akiko Shiraki Dynner Fund for Ocean Exploration and Conservation, Darden Restaurants Inc. Foundation, Conservation International, New England Aquarium, National Geographic, and the National Center for Ecological Analysis and Synthesis, which supported the Ecosystem Health Working Group as part of the Science of Ecosystem-Based Management project funded by the David and Lucile Packard Foundation. We would like to thank L. Bergen, J. Bort, B. Bronson, C. Costello, N. Crone, A. Dickson, J. Francis, A. Ghermandi, R. Haskell, L. Kaufman, K. Law, L. Madin, P. Nunes, D. Obura, L. Onofri, J. Packard, R. Portela, N. Rao, J. Regetz, S. Running, K. Selkoe, L. Speer, B. Spitzer, P. Stevick, H. Tallis, H. Tausig, S. Troeng and D. Zeyen for helpful discussions and logistical support during development of the index. Individual authors also acknowledge additional support from NSF, NASA, NOAA, Stanford's Center for Ocean Solutions and the Jaffe Family Foundation. K. K., D. P., U. R. S. and D.Z. thank the Sea Around Us Project, with support from the Pew Charitable Trusts. Data reported in this paper are tabulated in the Supplementary Information and archived at http://ohi.nceas.ucsb.edu/data. Results can be explored and visualized at http://oceanhealthindex.org.	Alder J, 2010, MAR POLICY, V34, P468, DOI 10.1016/j.marpol.2009.10.001; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; CAIRNS J, 1993, HYDROBIOLOGIA, V263, P1, DOI 10.1007/BF00006084; Convention on Biological Diversity, 2010, STRAT PLAN BIOD 2011; Costanza R, 1992, ECOSYSTEM HLTH NEW G, P239; Donoghue J., 1997, ANN M AM SOC INT LAW; Emerson J., 2008, STATE NATIONS ECOSYS; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Glover D. M., 2011, MODELING METHODS MAR; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2009, CONSERV LETT, V2, P138, DOI 10.1111/j.1755-263X.2009.00058.x; Heinz H.J, 2013, STATE NATIONS ECOSYS; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kareiva P, 2011, NATURAL CAPITAL: THEORY & PRACTICE OF MAPPING ECOSYSTEM SERVICES, P1, DOI 10.1093/acprof:oso/9780199588992.001.0001; Kareiva P, 2007, SCIENCE, V316, P1866, DOI 10.1126/science.1140170; KELLY JR, 1990, ENVIRON MANAGE, V14, P527, DOI 10.1007/BF02394708; Kershner J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025248; McLeod K., 2009, ECOSYSTEM BASED MANA; Michelle Marvier, 2011, BREAKTHROUGH J; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING SY; Munoz-Erickson TA, 2007, ECOL SOC, V12; National Ocean Council, 2012, DRAFT NAT OC POL IMP; Nellemann C., 2008, DEAD WATER MERGING C; Newton AC, 2011, CONSERV LETT, V4, P264, DOI 10.1111/j.1755-263X.2011.00167.x; Niemeijer D, 2008, ECOL INDIC, V8, P14, DOI 10.1016/j.ecolind.2006.11.012; Obama Barack H., 2010, 13547 ADM BH OB; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Rapport DJ, 1998, TRENDS ECOL EVOL, V13, P397, DOI 10.1016/S0169-5347(98)01449-9; Rapport DJ, 1999, ECOSYST HEALTH, V5, P82, DOI 10.1046/j.1526-0992.1999.09913.x; Rice JC, 2005, ICES J MAR SCI, V62, P516, DOI 10.1016/j.icesjms.2005.01.003; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Samhouri JF, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00366.1; Shackeroff J. M., 2009, ECOSYSTEM BASED MANA, P33; United Nations Development Programme, 2010, HUM DEV REP; World Bank Group, 2010, WORLDW GOV IND; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	37	577	620	34	645	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 30	2012	488	7413					615	+		10.1038/nature11397	http://dx.doi.org/10.1038/nature11397			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996NC	22895186				2022-12-24	WOS:000308095100048
J	Yuan, W; Wu, T; Fu, H; Dai, C; Wu, H; Liu, N; Li, X; Xu, M; Zhang, ZQ; Niu, TH; Han, ZF; Chai, JJ; Zhou, XJ; Gao, SR; Zhu, B				Yuan, Wen; Wu, Tong; Fu, Hang; Dai, Chao; Wu, Hui; Liu, Nan; Li, Xiang; Xu, Mo; Zhang, Zhuqiang; Niu, Tianhui; Han, Zhifu; Chai, Jijie; Zhou, Xianghong Jasmine; Gao, Shaorong; Zhu, Bing			Dense Chromatin Activates Polycomb Repressive Complex 2 to Regulate H3 Lysine 27 Methylation	SCIENCE			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; GROUP PROTEIN SUZ12; HUMAN GENOME; MARKS; GENE; ENHANCER; CELLS	Polycomb repressive complex 2 (PRC2)-mediated histone H3 lysine 27 (H3K27) methylation is vital for Polycomb gene silencing, a classic epigenetic phenomenon that maintains transcriptional silencing throughout cell divisions. We report that PRC2 activity is regulated by the density of its substrate nucleosome arrays. Neighboring nucleosomes activate the PRC2 complex with a fragment of their H3 histones (Ala(31) to Arg(42)). We also identified mutations on PRC2 subunit Su(z)12, which impair its binding and response to the activating peptide and its ability in establishing H3K27 trimethylation levels in vivo. In mouse embryonic stem cells, local chromatin compaction occurs before the formation of trimethylated H3K27 upon transcription cessation of the retinoic acid-regulated gene CYP26a1. We propose that PRC2 can sense the chromatin environment to exert its role in the maintenance of transcriptional states.	[Yuan, Wen; Wu, Tong; Fu, Hang; Niu, Tianhui] China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China; [Yuan, Wen; Wu, Tong; Fu, Hang; Wu, Hui; Liu, Nan; Li, Xiang; Xu, Mo; Zhang, Zhuqiang; Niu, Tianhui; Han, Zhifu; Chai, Jijie; Gao, Shaorong; Zhu, Bing] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Dai, Chao; Zhou, Xianghong Jasmine] Univ So Calif, Program Mol & Computat Biol, Los Angeles, CA 90089 USA; [Wu, Hui; Li, Xiang; Xu, Mo] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Wu, Hui; Li, Xiang; Xu, Mo] Peking Union Med Coll, Beijing 100730, Peoples R China; [Liu, Nan] Beijing Normal Univ, Beijing 100875, Peoples R China; [Chai, Jijie] Tsinghua Univ, Beijing 10084, Peoples R China	China Agricultural University; National Institute of Biological Sciences, Beijing; University of Southern California; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Beijing Normal University; Tsinghua University	Gao, SR (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	gaoshaorong@nibs.ac.cn; zhubing@nibs.ac.cn	Zhang, Zhuqiang/P-7329-2019; li, ran/K-1896-2012	Zhang, Zhuqiang/0000-0001-6513-2854; Chai, Jijie/0000-0001-7591-3873; yuan, wen/0000-0003-0029-2544	Chinese Ministry of Science and Technology [2011CB812700, 2011CB965300, 2010CB944900, 2011CB964800, 2010CB835300]; Howard Hughes Medical Institute International Early Career Scientist Program; NSF [0747475]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Howard Hughes Medical Institute International Early Career Scientist Program; NSF(National Science Foundation (NSF))	We appreciate K. Helin and Y. Shinkai for providing the Su(z)12 null and TT2 ES cells. This work was supported by the Chinese Ministry of Science and Technology (grants 2011CB812700 and 2011CB965300 to B.Z.; 2010CB944900 and 2011CB964800 to S. G.; and 2010CB835300 to J.C.), the Howard Hughes Medical Institute International Early Career Scientist Program (to B.Z.), and NSF Career award 0747475 (to X.J.Z.).	Allis C. D., 2006, EPIGENETICS; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Birve A, 2001, DEVELOPMENT, V128, P3371; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Burdine L, 2004, J AM CHEM SOC, V126, P11442, DOI 10.1021/ja045982c; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Gillespie RF, 2007, J MOL BIOL, V372, P298, DOI 10.1016/j.jmb.2007.06.079; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Ketel CS, 2005, MOL CELL BIOL, V25, P6857, DOI 10.1128/MCB.25.16.6857-6868.2005; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Martin C, 2006, J BIOL CHEM, V281, P8365, DOI 10.1074/jbc.M513425200; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Rao SH, 2001, J IMMUNOL, V167, P4494, DOI 10.4049/jimmunol.167.8.4494; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schwartz YB, 2008, CURR OPIN CELL BIOL, V20, P266, DOI 10.1016/j.ceb.2008.03.002; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Yuan W, 2011, J BIOL CHEM, V286, P7983, DOI 10.1074/jbc.M110.194027	26	193	198	5	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2012	337	6097					971	975		10.1126/science.1225237	http://dx.doi.org/10.1126/science.1225237			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992VI	22923582				2022-12-24	WOS:000307807600047
J	Muller, FL; Colla, S; Aquilanti, E; Manzo, VE; Genovese, G; Lee, J; Eisenson, D; Narurkar, R; Deng, PN; Nezi, L; Lee, MA; Hu, BL; Hu, J; Sahin, E; Ong, D; Fletcher-Sananikone, E; Ho, D; Kwong, L; Brennan, C; Wang, YA; Chin, L; DePinho, RA				Muller, Florian L.; Colla, Simona; Aquilanti, Elisa; Manzo, Veronica E.; Genovese, Giannicola; Lee, Jaclyn; Eisenson, Daniel; Narurkar, Rujuta; Deng, Pingna; Nezi, Luigi; Lee, Michelle A.; Hu, Baoli; Hu, Jian; Sahin, Ergun; Ong, Derrick; Fletcher-Sananikone, Eliot; Ho, Dennis; Kwong, Lawrence; Brennan, Cameron; Wang, Y. Alan; Chin, Lynda; DePinho, Ronald A.			Passenger deletions generate therapeutic vulnerabilities in cancer	NATURE			English	Article							ENOLASE DEFICIENCY; INHIBITION; REGIONS; CELLS	Inactivation of tumour-suppressor genes by homozygous deletion is a prototypic event in the cancer genome, yet such deletions often encompass neighbouring genes. We propose that homozygous deletions in such passenger genes can expose cancer-specific therapeutic vulnerabilities when the collaterally deleted gene is a member of a functionally redundant family of genes carrying out an essential function. The glycolytic gene enolase 1 (ENO1) in the 1p36 locus is deleted in glioblastoma (GBM), which is tolerated by the expression of ENO2. Here we show that short-hairpin-RNA-mediated silencing of ENO2 selectively inhibits growth, survival and the tumorigenic potential of ENO1-deleted GBM cells, and that the enolase inhibitor phosphonoacetohydroxamate is selectively toxic to ENO1-deleted GBM cells relative to ENO1-intact GBM cells or normal astrocytes. The principle of collateral vulnerability should be applicable to other passenger-deleted genes encoding functionally redundant essential activities and provide an effective treatment strategy for cancers containing such genomic events.	[Muller, Florian L.; Colla, Simona; Aquilanti, Elisa; Manzo, Veronica E.; Genovese, Giannicola; Lee, Jaclyn; Eisenson, Daniel; Narurkar, Rujuta; Deng, Pingna; Nezi, Luigi; Lee, Michelle A.; Hu, Baoli; Hu, Jian; Sahin, Ergun; Ong, Derrick; Fletcher-Sananikone, Eliot; Ho, Dennis; Kwong, Lawrence; Wang, Y. Alan; Chin, Lynda; DePinho, Ronald A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Muller, Florian L.; Colla, Simona; Genovese, Giannicola; Deng, Pingna; Nezi, Luigi; Hu, Baoli; Hu, Jian; Ong, Derrick; Fletcher-Sananikone, Eliot; Kwong, Lawrence; Wang, Y. Alan; Chin, Lynda] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Muller, Florian L.; Colla, Simona; Hu, Jian; Sahin, Ergun; Ong, Derrick; Ho, Dennis; DePinho, Ronald A.] Harvard Univ, Sch Med, Dept Genet & Med, Boston, MA 02115 USA; [Lee, Michelle A.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Hu, Baoli; Wang, Y. Alan; Chin, Lynda; DePinho, Ronald A.] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA; [Brennan, Cameron] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10065 USA; [DePinho, Ronald A.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	Harvard University; Dana-Farber Cancer Institute; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Memorial Sloan Kettering Cancer Center; University of Texas System; UTMD Anderson Cancer Center	DePinho, RA (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	rdepinho@mdanderson.org	Nezi, Luigi/AAB-1957-2019; Brennan, Cameron/R-7082-2019	Nezi, Luigi/0000-0002-4670-7656; Brennan, Cameron/0000-0003-4064-8891; DePinho, Ronald/0000-0002-5625-577X; Lee, Jaclyn/0000-0001-9804-6995; Genovese, Giannicola/0000-0003-1392-9954; Colla, Simona/0000-0001-6583-8910; Eisenson, Daniel/0000-0003-3868-0403; Muller, Florian/0000-0001-7568-2948	National Institutes of Health (NIH) [T32-CA009361, P01CA95616]; American Cancer Society [115992-PF-08-261-01-TBE]; Dana-Farber Cancer Institute/Harvard Cancer Center Myeloma SPORE career development grant; Howard Hughes Medical Institute Medical Research Fellowship [57006984]; Harvard PRISE fellowship; Diversity in Health-Related research award [3 P01 CA095616-08S1]; Ben and Catherine Ivy Foundation; NATIONAL CANCER INSTITUTE [T32CA009361, P01CA095616] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Dana-Farber Cancer Institute/Harvard Cancer Center Myeloma SPORE career development grant; Howard Hughes Medical Institute Medical Research Fellowship(Howard Hughes Medical Institute); Harvard PRISE fellowship; Diversity in Health-Related research award; Ben and Catherine Ivy Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank K. Ligon, C. Maire, D. N. Louis, J. Kimand G. Mohapatra for sharing bioinformatics data from their tumour neurosphere banks. We also thank D. Bigner for sharing the D423-MG and D502-MG cell lines and D. N. Louis and J. Kim for sharing the Gli56 cell line. We thank G. Chu and D. Jakubosky for assistance with necropsy and histopathological analysis. F. L. M. was supported by a training grant from the National Institutes of Health (NIH T32-CA009361) and a fellowship from the American Cancer Society (115992-PF-08-261-01-TBE). S. C. was supported by a Dana-Farber Cancer Institute/Harvard Cancer Center Myeloma SPORE career development grant. E. A. was supported by a Howard Hughes Medical Institute Medical Research Fellowship (57006984). V. M. was supported by a Harvard PRISE fellowship. M. A. L. was supported by a Diversity in Health-Related research award (3 P01 CA095616-08S1). F. L. M. thanks J. Mohr for assistance with figure preparations. We also thank K. Muller for assistance with manuscript editing. We thank all members of the DePinho and Chin laboratories for suggestions and discussions. This work is supported by the NIH (P01CA95616 to C. B., L. C. and R. A. D.) and by the Ben and Catherine Ivy Foundation (to R. A. D. and L.C.).	ANDERSON VE, 1984, BIOCHEMISTRY-US, V23, P2779, DOI 10.1021/bi00307a038; Bagchi A, 2008, CANCER RES, V68, P2551, DOI 10.1158/0008-5472.CAN-07-2095; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Brookfield JFY, 1997, ADV GENET, V36, P137, DOI 10.1016/S0065-2660(08)60308-9; Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Comi GP, 2001, ANN NEUROL, V50, P202, DOI 10.1002/ana.1095; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Cox C, 2005, P NATL ACAD SCI USA, V102, P4542, DOI 10.1073/pnas.0408593102; De Soto Joseph A, 2006, Int J Med Sci, V3, P117; DeLuna A, 2008, NAT GENET, V40, P676, DOI 10.1038/ng.123; Deutscher D, 2006, NAT GENET, V38, P993, DOI 10.1038/ng1856; Druker BJ, 2008, BLOOD, V112, P4808, DOI 10.1182/blood-2008-07-077958; Duncan CD, 2010, ADVANCED CRIME SCENE PHOTOGRAPHY, P1; Guha M, 2011, NAT BIOTECHNOL, V29, P373, DOI 10.1038/nbt0511-373; GuhaChowdhury N, 1997, ORAL MICROBIOL IMMUN, V12, P91, DOI 10.1111/j.1399-302X.1997.tb00623.x; Henrich KO, 2011, CANCER RES, V71, P3142, DOI 10.1158/0008-5472.CAN-10-3014; Jing M, 2007, AM J PHYSIOL-CELL PH, V292, pC477, DOI 10.1152/ajpcell.00196.2006; Joseph J, 1996, J NEUROCHEM, V66, P2484; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Kotliarov Y, 2006, CANCER RES, V66, P9428, DOI 10.1158/0008-5472.CAN-06-1691; Mueller W, 2007, ONCOGENE, V26, P583, DOI 10.1038/sj.onc.1209805; Navarro MVDS, 2007, FEBS J, V274, P5077, DOI 10.1111/j.1742-4658.2007.06027.x; Peng W. X., 2007, CANCER SCI, V96, P661; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; POYNER RR, 1992, BIOCHEMISTRY-US, V31, P7166, DOI 10.1021/bi00146a020; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; STEFANINI M, 1972, AM J CLIN PATHOL, V58, P408; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Vavouri T, 2008, TRENDS GENET, V24, P485, DOI 10.1016/j.tig.2008.08.005; Weidle UH, 2011, CANCER GENOM PROTEOM, V8, P159; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Yin D, 2009, MOL CANCER RES, V7, P665, DOI 10.1158/1541-7786.MCR-08-0270; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443	37	224	235	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2012	488	7411					337	+		10.1038/nature11331	http://dx.doi.org/10.1038/nature11331			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OS	22895339	Green Accepted			2022-12-24	WOS:000307501000033
J	Lachance, J; Vernot, B; Elbers, CC; Ferwerda, B; Froment, A; Bodo, JM; Lema, G; Fu, WQ; Nyambo, TB; Rebbeck, TR; Zhang, K; Akey, JM; Tishkoff, SA				Lachance, Joseph; Vernot, Benjamin; Elbers, Clara C.; Ferwerda, Bart; Froment, Alain; Bodo, Jean-Marie; Lema, Godfrey; Fu, Wenqing; Nyambo, Thomas B.; Rebbeck, Timothy R.; Zhang, Kun; Akey, Joshua M.; Tishkoff, Sarah A.			Evolutionary History and Adaptation from High-Coverage Whole-Genome Sequences of Diverse African Hunter-Gatherers	CELL			English	Article							POPULATION-STRUCTURE; GROWTH-HORMONE; MODERN HUMANS; GENETIC-VARIATION; WIDE ASSOCIATION; DISORDERS; MUTATIONS; ADMIXTURE; SELECTION; VARIANCE	To reconstruct modern human evolutionary history and identify loci that have shaped hunter-gatherer adaptation, we sequenced the whole genomes of five individuals in each of three different hunter-gatherer populations at >60x coverage: Pygmies from Cameroon and Khoesan-speaking Hadza and Sandawe from Tanzania. We identify 13.4 million variants, substantially increasing the set of known human variation. We found evidence of archaic intro-gression in all three populations, and the distribution of time to most recent common ancestors from these regions is similar to that observed for introgressed regions in Europeans. Additionally, we identify numerous loci that harbor signatures of local adaptation, including genes involved in immunity, metabolism, olfactory and taste perception, reproduction, and wound healing. Within the Pygmy population, we identify multiple highly differentiated loci that play a role in growth and anterior pituitary function and are associated with height.	[Lachance, Joseph; Elbers, Clara C.; Ferwerda, Bart; Tishkoff, Sarah A.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Lachance, Joseph; Elbers, Clara C.; Ferwerda, Bart; Tishkoff, Sarah A.] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; [Rebbeck, Timothy R.] Univ Penn, Abramson Canc Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA; [Vernot, Benjamin; Fu, Wenqing; Akey, Joshua M.] Univ Washington, Dept Genome Sci, Seattle, WA 98185 USA; [Froment, Alain] Musee Homme Paris, IRD MNHN, F-75116 Paris, France; [Bodo, Jean-Marie] Minist Rech Sci & Innovat, Yaounde, Cameroon; [Lema, Godfrey; Nyambo, Thomas B.] Muhimbili Univ, Dept Biochem, Coll Hlth Sci, Dar Es Salaam, Tanzania; [Zhang, Kun] Univ Calif San Diego, Inst Genom Med, Dept Bioengn, San Diego, CA 92093 USA; [Zhang, Kun] Univ Calif San Diego, Inst Engn Med, San Diego, CA 92093 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Washington; University of Washington Seattle; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); University of California System; University of California San Diego; University of California System; University of California San Diego	Tishkoff, SA (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	tishkoff@mail.med.upenn.edu	Rebbeck, Timothy/GLU-8348-2022; Zhang, Kun/ABE-6349-2020; Vernot, Benjamin/ABH-1495-2021	Rebbeck, Timothy/0000-0002-4799-1900; Zhang, Kun/0000-0002-7596-5224; Vernot, Benjamin/0000-0002-6820-2181; Akey, Joshua/0000-0002-4411-1330; Ferwerda, Bart/0000-0002-7050-5931; Lachance, Joseph/0000-0002-4650-3741	NSF [BCS-0827436]; NIH [R01GM076637, 8 DP1 ES022577-04]; NIH NRSA postdoctoral fellowship [F32HG006648-01]; Netherlands Organization of Scientific Research; Center of Excellence in Environmental Toxicology at the University of Pennsylvania [P30-ES013508-07]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG006648] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508, DP1ES022577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076637] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NRSA postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organization of Scientific Research(Netherlands Organization for Scientific Research (NWO)); Center of Excellence in Environmental Toxicology at the University of Pennsylvania; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NSF (BCS-0827436) and NIH (R01GM076637, 8 DP1 ES022577-04) grants to S.A.T., an NIH NRSA postdoctoral fellowship (F32HG006648-01) to J.L., Rubicon Grants of the Netherlands Organization of Scientific Research to C.C.E. and B.F., and support from the Center of Excellence in Environmental Toxicology at the University of Pennsylvania, P30-ES013508-07. We thank J. Hirbo, J. Jarvis, A. Rawlings, L. Scheinfeld, and S. Soi for their critical feedback and advice and K. Addya, D. Baldwin, and B. Beggs for assistance in genotyping the samples. We also thank the 15 individuals who graciously supplied their DNA.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; Barreiro LB, 2010, NAT REV GENET, V11, P17, DOI 10.1038/nrg2698; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Berniell-Lee G, 2009, MOL BIOL EVOL, V26, P1581, DOI 10.1093/molbev/msp069; Brickman JM, 2001, DEVELOPMENT, V128, P5189; Burger R, 2011, THEOR POPUL BIOL, V80, P272, DOI 10.1016/j.tpb.2011.07.002; Campbell MC, 2010, CURR BIOL, V20, pR166, DOI 10.1016/j.cub.2009.11.050; Dattani MT, 2005, CLIN ENDOCRINOL, V63, P121, DOI 10.1111/j.1365-2265.2005.02289.x; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Falush D, 2003, GENETICS, V164, P1567; Galli GG, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002711; Gat-Yablonski G, 2009, HORM RES, V72, P302, DOI 10.1159/000245932; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Hammer MF, 2011, P NATL ACAD SCI USA, V108, P15123, DOI 10.1073/pnas.1109300108; Henn BM, 2011, P NATL ACAD SCI USA, V108, P5154, DOI 10.1073/pnas.1017511108; Henn BM, 2010, HUM MOL GENET, V19, pR221, DOI 10.1093/hmg/ddq403; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hudson RR, 2007, J MOL EVOL, V64, P702, DOI 10.1007/s00239-006-0261-1; Hunsaker TL, 2012, J MOL BIOL, V415, P29, DOI 10.1016/j.jmb.2011.11.001; Jarvis JP, 2012, PLOS GENET, V8, P299, DOI 10.1371/journal.pgen.1002641; JONES NGB, 1992, AM J PHYS ANTHROPOL, V89, P159, DOI 10.1002/ajpa.1330890204; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kiess W, 2011, HORM RES PAEDIAT, V76, P11, DOI 10.1159/000330140; Lam HYK, 2012, NAT BIOTECHNOL, V30, P78, DOI 10.1038/nbt.2065; Lohmueller KE, 2008, NATURE, V451, P994, DOI 10.1038/nature06611; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Mantovani G, 2006, MOL CELL ENDOCRINOL, V247, P135, DOI 10.1016/j.mce.2005.12.036; Marlowe F., 2010, HADZA HUNTER GATHERE, DOI DOI 10.1152/physiol.00027.2018; Migliano AB, 2007, P NATL ACAD SCI USA, V104, P20216, DOI 10.1073/pnas.0708024105; Pemberton T.J., 2012, AM J HUM GENET; Perry GH, 2009, TRENDS ECOL EVOL, V24, P218, DOI 10.1016/j.tree.2008.11.008; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Plagnol V, 2006, PLOS GENET, V2, P972, DOI 10.1371/journal.pgen.0020105; Rand DM, 1996, MOL BIOL EVOL, V13, P735, DOI 10.1093/oxfordjournals.molbev.a025634; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Rosenbloom KR, 2012, NUCLEIC ACIDS RES, V40, pD912, DOI 10.1093/nar/gkr1012; Sands B., 1998, LANGUAGE IDENTITY CO, P265; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; Shimada MK, 2007, MOL BIOL EVOL, V24, P687, DOI 10.1093/molbev/msl196; Shriver Mark D, 2004, Hum Genomics, V1, P274; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Teo YY, 2010, NAT REV GENET, V11, P149, DOI 10.1038/nrg2731; Thomson R, 2000, P NATL ACAD SCI USA, V97, P7360, DOI 10.1073/pnas.97.13.7360; Tishkoff SA, 2007, MOL BIOL EVOL, V24, P2180, DOI 10.1093/molbev/msm155; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Veeramah KR, 2012, MOL BIOL EVOL, V29, P617, DOI 10.1093/molbev/msr212; Verdu P, 2009, CURR BIOL, V19, P312, DOI 10.1016/j.cub.2008.12.049; Wall JD, 2009, MOL BIOL EVOL, V26, P1823, DOI 10.1093/molbev/msp096; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]	53	207	210	0	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 3	2012	150	3					457	469		10.1016/j.cell.2012.07.009	http://dx.doi.org/10.1016/j.cell.2012.07.009			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	985WO	22840920	Green Accepted, Bronze			2022-12-24	WOS:000307301400007
J	Lemos, JC; Wanat, MJ; Smith, JS; Reyes, BAS; Hollon, NG; Van Bockstaele, EJ; Chavkin, C; Phillips, PEM				Lemos, Julia C.; Wanat, Matthew J.; Smith, Jeffrey S.; Reyes, Beverly A. S.; Hollon, Nick G.; Van Bockstaele, Elisabeth J.; Chavkin, Charles; Phillips, Paul E. M.			Severe stress switches CRF action in the nucleus accumbens from appetitive to aversive	NATURE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; DOPAMINERGIC-NEURONS; FACTOR RECEPTORS; BEHAVIOR; ANXIETY; ACTIVATION; DEPRESSION; MOUSE	Stressors motivate an array of adaptive responses ranging from 'fight or flight' to an internal urgency signal facilitating long-term goals(1). However, traumatic or chronic uncontrollable stress promotes the onset of major depressive disorder, in which acute stressors lose their motivational properties and are perceived as insurmountable impediments(2). Consequently, stress-induced depression is a debilitating human condition characterized by an affective shift from engagement of the environment to withdrawal(3). An emerging neurobiological substrate of depression and associated pathology is the nucleus accumbens, a region with the capacity to mediate a diverse range of stress responses by interfacing limbic, cognitive and motor circuitry(4). Here we report that corticotropin-releasing factor (CRF), a neuropeptide released in response to acute stressors(5) and other arousing environmental stimuli(6), acts in the nucleus accumbens of naive mice to increase dopamine release through coactivation of the receptors CRFR1 and CRFR2. Remarkably, severe-stress exposure completely abolished this effect without recovery for at least 90 days. This loss of CRF's capacity to regulate dopamine release in the nucleus accumbens is accompanied by a switch in the reaction to CRF from appetitive to aversive, indicating a diametric change in the emotional response to acute stressors. Thus, the current findings offer a biological substrate for the switch in affect which is central to stress-induced depressive disorders.	[Lemos, Julia C.; Wanat, Matthew J.; Hollon, Nick G.; Phillips, Paul E. M.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Lemos, Julia C.; Wanat, Matthew J.; Smith, Jeffrey S.; Hollon, Nick G.; Chavkin, Charles; Phillips, Paul E. M.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Lemos, Julia C.; Hollon, Nick G.; Chavkin, Charles; Phillips, Paul E. M.] Univ Washington, Program Neurobiol & Behav, Seattle, WA 98195 USA; [Reyes, Beverly A. S.; Van Bockstaele, Elisabeth J.] Thomas Jefferson Univ, Farber Inst Neurosci, Dept Neurosci, Philadelphia, PA 19107 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Jefferson University	Phillips, PEM (corresponding author), Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA.	pemp@uw.edu	Phillips, Paul E. M./A-4463-2008; Phillips, Paul/E-7813-2013	Phillips, Paul E. M./0000-0002-8749-7026; Phillips, Paul/0000-0002-8749-7026; Wanat, Matthew/0000-0003-1643-6557; Lemos, Julia/0000-0002-5442-8876; Hollon, Nick/0000-0003-4827-1582; Smith, Jeffrey/0000-0003-2840-2899	National Institutes of Health [F31-MH086269, F32-DA026273, R01-DA009082, R01-DA030074, R01-MH079292, R01-DA016782]; National Science Foundation; NARSAD; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH086269, R01MH079292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA026273, K05DA020570, R01DA030074, R01DA016782, R01DA009082] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NARSAD(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants F31-MH086269 (J.C.L.), F32-DA026273 (M.J.W.), R01-DA009082 (E.J.V.B.), R01-DA030074 (C. C.), R01-MH079292 and R01-DA016782 (P. E. M. P.), the National Science Foundation (N.G.H.) and NARSAD (P. E. M. P.). We thank C. Zietz, M. Miyatake and P. Groblewski for assisting with histological verification of cannula placement, H. Gill for help with data analysis, D. Messinger for breeding and genotyping mice and N. Stella for use of a microscope. We thank M. Darvas and R. Palmiter for providing Th<SUP>fs/fs</SUP>; Dbh<SUP>Th/+</SUP> mice. We thank R. Sapolsky, J. Day, S. Sesack, M. Soden, C. Walker and E. Horne for useful suggestions and insights.	Aragona BJ, 2006, NAT NEUROSCI, V9, P133, DOI 10.1038/nn1613; Bale TL, 2000, NAT GENET, V24, P410, DOI 10.1038/74263; Bale TL, 2006, HORM BEHAV, V50, P529, DOI 10.1016/j.yhbeh.2006.06.033; Beck AT, 2008, AM J PSYCHIAT, V165, P969, DOI 10.1176/appi.ajp.2008.08050721; Bruchas MR, 2007, J NEUROSCI, V27, P11614, DOI 10.1523/JNEUROSCI.3769-07.2007; Bruchas MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008528; Bruchas MR, 2010, PSYCHOPHARMACOLOGY, V210, P137, DOI 10.1007/s00213-010-1806-y; CADOR M, 1992, BRAIN RES, V597, P304, DOI 10.1016/0006-8993(92)91487-Y; Chaki S, 2004, EUR J PHARMACOL, V485, P145, DOI 10.1016/j.ejphar.2003.11.032; Clark DA, 2010, TRENDS COGN SCI, V14, P418, DOI 10.1016/j.tics.2010.06.007; CORYELL W, 1994, ARCH GEN PSYCHIAT, V51, P405; Cryan JF, 2004, MOL PSYCHIATR, V9, P326, DOI 10.1038/sj.mp.4001457; FINK JS, 1980, NEUROSCI LETT, V17, P61, DOI 10.1016/0304-3940(80)90062-2; Gallagher JP, 2008, EUR J PHARMACOL, V583, P215, DOI 10.1016/j.ejphar.2007.11.075; Gelenberg Alan J, 2010, J Clin Psychiatry, V71, pe02, DOI 10.4088/JCP.8001tx16c; Iredale PA, 1997, MOL PHARMACOL, V51, P794, DOI 10.1124/mol.51.5.794; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P768; Korte SM, 2005, NEUROSCI BIOBEHAV R, V29, P3, DOI 10.1016/j.neubiorev.2004.08.009; Lex A, 2008, LEARN MEMORY, V15, P483, DOI 10.1101/lm.978708; Lim MM, 2007, HORM BEHAV, V51, P508, DOI 10.1016/j.yhbeh.2007.01.006; Merali Z, 2004, NEUROPSYCHOPHARMACOL, V29, P1409, DOI 10.1038/sj.npp.1300441; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; OLDFIELD EH, 1985, NEUROENDOCRINOLOGY, V40, P84, DOI 10.1159/000124056; Pecina S, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-8; Peters A, 1996, J NEUROCYTOL, V25, P687, DOI 10.1007/BF02284835; Peters A., 1991, FINE STRUCTURE NERVO; Refojo D, 2011, SCIENCE, V333, P1903, DOI 10.1126/science.1202107; Reyes BAS, 2008, ENDOCRINOLOGY, V149, P122, DOI 10.1210/en.2007-0705; Reyes BAS, 2006, EUR J NEUROSCI, V23, P2991, DOI 10.1111/j.1460-9568.2006.04820.x; Steckler T, 1999, BIOL PSYCHIAT, V46, P1480, DOI 10.1016/S0006-3223(99)00170-5; Timpl P, 1998, NAT GENET, V19, P162, DOI 10.1038/520; Torres G, 1998, NEUROSCIENCE, V87, P463, DOI 10.1016/S0306-4522(98)00147-X; VANBOCKSTAELE EJ, 1994, J COMP NEUROL, V341, P1, DOI 10.1002/cne.903410102; Wang B, 2005, J NEUROSCI, V25, P5389, DOI 10.1523/JNEUROSCI.0955-05.2005; Waselus M, 2009, BIOL PSYCHIAT, V66, P76, DOI 10.1016/j.biopsych.2009.02.014	35	185	189	5	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2012	490	7420					402	+		10.1038/nature11436	http://dx.doi.org/10.1038/nature11436			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021XI	22992525	Green Accepted, Green Published			2022-12-24	WOS:000309918500046
J	Mallam, AL; Del Campo, M; Gilman, B; Sidote, DJ; Lambowitz, AM				Mallam, Anna L.; Del Campo, Mark; Gilman, Benjamin; Sidote, David J.; Lambowitz, Alan M.			Structural basis for RNA-duplex recognition and unwinding by the DEAD-box helicase Mss116p	NATURE			English	Article							CRYSTAL-STRUCTURE; PROTEIN MSS116P; ATP HYDROLYSIS; GROUP-I; ACTIVATION; MECHANISM; RIBOSE; ROLES	DEAD-box proteins are the largest family of nucleic acid helicases, and are crucial to RNA metabolism throughout all domains of life(1,2). They contain a conserved 'helicase core' of two RecA-like domains (domains (D)1 and D2), which uses ATP to catalyse the unwinding of short RNA duplexes by non-processive, local strand separation(3). This mode of action differs from that of translocating helicases and allows DEAD-box proteins to remodel large RNAs and RNA-protein complexes without globally disrupting RNA structure(4). However, the structural basis for this distinctive mode of RNA unwinding remains unclear. Here, structural, biochemical and genetic analyses of the yeast DEAD-box protein Mss116p indicate that the helicase core domains have modular functions that enable a novel mechanism for RNA-duplex recognition and unwinding. By investigating D1 and D2 individually and together, we find that D1 acts as an ATP-binding domain and D2 functions as an RNA-duplex recognition domain. D2 contains a nucleic-acid-binding pocket that is formed by conserved DEAD-box protein sequence motifs and accommodates A-form but not B-form duplexes, providing a basis for RNA substrate specificity. Upon a conformational change in which the two core domains join to form a 'closed state' with an ATPase active site, conserved motifs in D1 promote the unwinding of duplex substrates bound to D2 by excluding one RNA strand and bending the other. Our results provide a comprehensive structural model for how DEAD-box proteins recognize and unwind RNA duplexes. This model explains key features of DEAD-box protein function and affords a new perspective on how the evolutionarily related cores of other RNA and DNA helicases diverged to use different mechanisms.	[Mallam, Anna L.; Del Campo, Mark; Gilman, Benjamin; Sidote, David J.; Lambowitz, Alan M.] Univ Texas Austin, Dept Chem & Biochem, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Mallam, Anna L.; Del Campo, Mark; Gilman, Benjamin; Sidote, David J.; Lambowitz, Alan M.] Univ Texas Austin, Sch Biol Sci, Sect Mol Genet & Microbiol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Lambowitz, AM (corresponding author), Univ Texas Austin, Dept Chem & Biochem, Inst Cellular & Mol Biol, Austin, TX 78712 USA.	lambowitz@austin.utexas.edu			National Institutes of Health (NIH), National Institute of General Medical Sciences; Howard Hughes Medical Institute; Office of Science, Office of Basic Energy Sciences, of the US Department of Energy [DE-AC02-05CH11231]; EMBO [ALTF 389-2010]; NIH [GM037951]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM037951, R01GM037951] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Office of Science, Office of Basic Energy Sciences, of the US Department of Energy(United States Department of Energy (DOE)); EMBO(European Molecular Biology Organization (EMBO)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Monzingo (University of Texas at Austin Macromolecular Crystallography Facility) for help with X-ray diffraction data collection, and R. Russell (University of Texas at Austin) and E. Jankowsky (Case Western Reserve University) for comments on the manuscript. X-ray diffraction data were collected at the Berkeley Center for Structural Biology, which is supported in part by the National Institutes of Health (NIH), National Institute of General Medical Sciences and the Howard Hughes Medical Institute. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the US Department of Energy under contract no. DE-AC02-05CH11231. A.L.M. is the recipient of an EMBO long-term fellowship (ALTF 389-2010). This work was supported by NIH grant GM037951.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andersen CBF, 2006, SCIENCE, V313, P1968, DOI 10.1126/science.1131981; Cao WX, 2011, J MOL BIOL, V409, P399, DOI 10.1016/j.jmb.2011.04.004; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen YF, 2008, P NATL ACAD SCI USA, V105, P20203, DOI 10.1073/pnas.0811075106; Del Campo M, 2009, MOL CELL, V35, P598, DOI 10.1016/j.molcel.2009.07.032; Del Campo M, 2009, J MOL BIOL, V389, P674, DOI 10.1016/j.jmb.2009.04.043; EGLI M, 1993, BIOCHEMISTRY-US, V32, P3221, DOI 10.1021/bi00064a004; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; Halls C, 2007, J MOL BIOL, V365, P835, DOI 10.1016/j.jmb.2006.09.083; Henn A, 2010, P NATL ACAD SCI USA, V107, P4046, DOI 10.1073/pnas.0913081107; Huang HR, 2005, P NATL ACAD SCI USA, V102, P163, DOI 10.1073/pnas.0407896101; Jarmoskaite I, 2011, WIRES RNA, V2, P135, DOI 10.1002/wrna.50; Jiang FG, 2011, NATURE, V479, P423, DOI 10.1038/nature10537; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Liu F, 2008, P NATL ACAD SCI USA, V105, P20209, DOI 10.1073/pnas.0811115106; Luo DH, 2011, CELL, V147, P409, DOI 10.1016/j.cell.2011.09.023; Mallam AL, 2011, P NATL ACAD SCI USA, V108, P12254, DOI 10.1073/pnas.1109566108; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mohr G, 2011, J MOL BIOL, V413, P952, DOI 10.1016/j.jmb.2011.09.015; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ozalp VC, 2010, J BIOL CHEM, V285, P37579, DOI 10.1074/jbc.M110.155119; Pan C, 2010, RNA BIOL, V7, P667, DOI 10.4161/rna.7.6.13571; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Potratz JP, 2011, J MOL BIOL, V411, P661, DOI 10.1016/j.jmb.2011.05.047; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Rudolph MG, 2006, J MOL BIOL, V361, P731, DOI 10.1016/j.jmb.2006.06.065; Schutz P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012791; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Tang GQ, 2005, J BIOL CHEM, V280, P40707, DOI 10.1074/jbc.M508013200; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Wahl MC, 2000, NUCLEIC ACIDS RES, V28, P4356, DOI 10.1093/nar/28.21.4356; Wang S, 2008, BIOPHYS J, V94, pL1, DOI 10.1529/biophysj.107.120709; Wilkins MR, 1999, METH MOL B, V112, P531; Yang Q, 2007, MOL CELL, V28, P253, DOI 10.1016/j.molcel.2007.08.016	41	81	87	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2012	490	7418					121	+		10.1038/nature11402	http://dx.doi.org/10.1038/nature11402			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015LG	22940866	Green Accepted			2022-12-24	WOS:000309446800045
J	Sun, JY; Zhao, XH; Illeperuma, WRK; Chaudhuri, O; Oh, KH; Mooney, DJ; Vlassak, JJ; Suo, ZG				Sun, Jeong-Yun; Zhao, Xuanhe; Illeperuma, Widusha R. K.; Chaudhuri, Ovijit; Oh, Kyu Hwan; Mooney, David J.; Vlassak, Joost J.; Suo, Zhigang			Highly stretchable and tough hydrogels	NATURE			English	Article							DOUBLE-NETWORK GELS; HIGH MECHANICAL STRENGTH; LARGE-STRAIN; FRACTURE; HYSTERESIS; FATIGUE; MODEL	Hydrogels are used as scaffolds for tissue engineering(1), vehicles for drug delivery(2), actuators for optics and fluidics(3), and model extracellular matrices for biological studies(4). The scope of hydrogel applications, however, is often severely limited by their mechanical behaviour(5). Most hydrogels do not exhibit high stretchability; for example, an alginate hydrogel ruptures when stretched to about 1.2 times its original length. Some synthetic elastic hydrogels(6,7) have achieved stretches in the range 10-20, but these values are markedly reduced in samples containing notches. Most hydrogels are brittle, with fracture energies of about 10 J m(-2) (ref. 8), as compared with similar to 1,000 J m(-2) for cartilage(9) and similar to 10,000 J m(-2) for natural rubbers(10). Intense efforts are devoted to synthesizing hydrogels with improved mechanical properties(11-18); certain synthetic gels have reached fracture energies of 100-1,000 J m(-2) (refs 11, 14, 17). Here we report the synthesis of hydrogels from polymers forming ionically and covalently crosslinked networks. Although such gels contain similar to 90% water, they can be stretched beyond 20 times their initial length, and have fracture energies of similar to 9,000 J m(-2). Even for samples containing notches, a stretch of 17 is demonstrated. We attribute the gels' toughness to the synergy of two mechanisms: crack bridging by the network of covalent crosslinks, and hysteresis by unzipping the network of ionic crosslinks. Furthermore, the network of covalent crosslinks preserves the memory of the initial state, so that much of the large deformation is removed on unloading. The unzipped ionic crosslinks cause internal damage, which heals by re-zipping. These gels may serve as model systems to explore mechanisms of deformation and energy dissipation, and expand the scope of hydrogel applications.	[Sun, Jeong-Yun; Illeperuma, Widusha R. K.; Chaudhuri, Ovijit; Mooney, David J.; Vlassak, Joost J.; Suo, Zhigang] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Sun, Jeong-Yun; Oh, Kyu Hwan] Seoul Natl Univ, Dept Mat Sci & Engn, Seoul 151742, South Korea; [Zhao, Xuanhe] Duke Univ, Dept Mech Engn & Mat Sci, Durham, NC 27708 USA; [Mooney, David J.] Harvard Univ, Wyss Inst Biologically Inspired Engn, Cambridge, MA 02138 USA; [Suo, Zhigang] Harvard Univ, Kavli Inst Bionano Sci & Technol, Cambridge, MA 02138 USA	Harvard University; Seoul National University (SNU); Duke University; Harvard University; Harvard University	Suo, ZG (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	suo@seas.harvard.edu	Suo, Zhigang/B-1067-2008; oh, kyuhwan/H-5265-2018; Sun, Jeong-Yun/AAR-4630-2020; Zhao, Xuanhe/B-1532-2008; Sun, Jeong-Yun/F-5662-2012	Suo, Zhigang/0000-0002-4068-4844; Zhao, Xuanhe/0000-0001-5387-6186; Mooney, David/0000-0001-6299-1194; Chaudhuri, Ovijit/0000-0002-9287-3401	ARO [W911NF-09-1-0476]; NSF [CMMI-0800161]; DARPA [W911NF-10-1-0113]; NIH [R37 DE013033]; MRSEC [DMR-0820484]; NSF Research Triangle MRSEC [DMR-1121107]; Haythornthwaite Research Initiation grants; National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [R11-2005-065]; Alexander von Humboldt Award; Harvard University; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE013033, R01DE013033] Funding Source: NIH RePORTER	ARO; NSF(National Science Foundation (NSF)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRSEC(National Science Foundation (NSF)); NSF Research Triangle MRSEC; Haythornthwaite Research Initiation grants; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Alexander von Humboldt Award(Alexander von Humboldt Foundation); Harvard University; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The work at Harvard was supported by ARO (W911NF-09-1-0476), NSF (CMMI-0800161), DARPA (W911NF-10-1-0113), NIH (R37 DE013033) and MRSEC (DMR-0820484). X.Z. acknowledges the support of the NSF Research Triangle MRSEC (DMR-1121107) and Haythornthwaite Research Initiation grants. K.H.O. is supported by the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (R11-2005-065). Z.S. acknowledges a sabbatical leave at the Karlsruhe Institute of Technology funded by the Alexander von Humboldt Award and by Harvard University.	Baumberger T, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3078267; Brown HR, 2007, MACROMOLECULES, V40, P3815, DOI 10.1021/ma062642y; Calvert P, 2009, ADV MATER, V21, P743, DOI 10.1002/adma.200800534; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Dong L, 2006, NATURE, V442, P551, DOI 10.1038/nature05024; EVANS AG, 1990, J AM CERAM SOC, V73, P187, DOI 10.1111/j.1151-2916.1990.tb06493.x; Gong JP, 2003, ADV MATER, V15, P1155, DOI 10.1002/adma.200304907; Haque MA, 2011, MACROMOLECULES, V44, P8916, DOI 10.1021/ma201653t; Haraguchi K, 2002, ADV MATER, V14, P1120, DOI 10.1002/1521-4095(20020816)14:16<1120::AID-ADMA1120>3.0.CO;2-9; Henderson KJ, 2010, MACROMOLECULES, V43, P6193, DOI 10.1021/ma100963m; Hernandez RM, 2010, ADV DRUG DELIVER REV, V62, P711, DOI 10.1016/j.addr.2010.02.004; Huang T, 2007, ADV MATER, V19, P1622, DOI 10.1002/adma.200602533; Hui CY, 2003, P ROY SOC A-MATH PHY, V459, P1489, DOI 10.1098/rspa.2002.1057; JACKSON AP, 1990, BIOMATERIALS, V11, P403, DOI 10.1016/0142-9612(90)90095-8; Kong HJ, 2003, MACROMOLECULES, V36, P4582, DOI 10.1021/ma034137w; LAKE GJ, 1967, PROC R SOC LON SER-A, V300, P108, DOI 10.1098/rspa.1967.0160; LAKE GJ, 1995, RUBBER CHEM TECHNOL, V68, P435, DOI 10.5254/1.3538750; Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x; Lin WC, 2010, MACROMOLECULES, V43, P2554, DOI 10.1021/ma901937r; Maldonado-Codina C, 2004, OPHTHAL PHYSL OPT, V24, P551, DOI 10.1111/j.1475-1313.2004.00236.x; Okumura Y, 2001, ADV MATER, V13, P485, DOI 10.1002/1521-4095(200104)13:7<485::AID-ADMA485>3.0.CO;2-T; Qiu Y, 2001, ADV DRUG DELIVER REV, V53, P321, DOI 10.1016/S0169-409X(01)00203-4; Sakai T, 2008, MACROMOLECULES, V41, P5379, DOI 10.1021/ma800476x; Seitz ME, 2009, SOFT MATTER, V5, P447, DOI 10.1039/b810041a; Simha N. K., 2003, J MATER SCI-MATER M, V14, P631; Tanaka Y, 2007, EPL-EUROPHYS LETT, V78, DOI 10.1209/0295-5075/78/56005; Tuncaboylu DC, 2011, MACROMOLECULES, V44, P4997, DOI 10.1021/ma200579v; Wang Q, 2010, NATURE, V463, P339, DOI 10.1038/nature08693; Webber RE, 2007, MACROMOLECULES, V40, P2919, DOI 10.1021/ma062924y; Yu QM, 2009, MACROMOLECULES, V42, P3852, DOI 10.1021/ma900622s	30	3255	3371	420	6330	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2012	489	7414					133	136		10.1038/nature11409	http://dx.doi.org/10.1038/nature11409			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999WW	22955625	Green Accepted			2022-12-24	WOS:000308347000049
J	Thurman, RE; Rynes, E; Humbert, R; Vierstra, J; Maurano, MT; Haugen, E; Sheffield, NC; Stergachis, AB; Wang, H; Vernot, B; Garg, K; John, S; Sandstrom, R; Bates, D; Boatman, L; Canfield, TK; Diegel, M; Dunn, D; Ebersol, AK; Frum, T; Giste, E; Johnson, AK; Johnson, EM; Kutyavin, T; Lajoie, B; Lee, BK; Lee, K; London, D; Lotakis, D; Neph, S; Neri, F; Nguyen, ED; Qu, HZ; Reynolds, AP; Roach, V; Safi, A; Sanchez, ME; Sanyal, A; Shafer, A; Simon, JM; Song, LY; Vong, S; Weaver, M; Yan, YQ; Zhang, ZC; Zhang, ZZ; Lenhard, B; Tewari, M; Dorschner, MO; Hansen, RS; Navas, PA; Stamatoyannopoulos, G; Iyer, VR; Lieb, JD; Sunyaev, SR; Akey, JM; Sabo, PJ; Kaul, R; Furey, TS; Dekker, J; Crawford, GE; Stamatoyannopoulos, JA				Thurman, Robert E.; Rynes, Eric; Humbert, Richard; Vierstra, Jeff; Maurano, Matthew T.; Haugen, Eric; Sheffield, Nathan C.; Stergachis, Andrew B.; Wang, Hao; Vernot, Benjamin; Garg, Kavita; John, Sam; Sandstrom, Richard; Bates, Daniel; Boatman, Lisa; Canfield, Theresa K.; Diegel, Morgan; Dunn, Douglas; Ebersol, Abigail K.; Frum, Tristan; Giste, Erika; Johnson, Audra K.; Johnson, Ericka M.; Kutyavin, Tanya; Lajoie, Bryan; Lee, Bum-Kyu; Lee, Kristen; London, Darin; Lotakis, Dimitra; Neph, Shane; Neri, Fidencio; Nguyen, Eric D.; Qu, Hongzhu; Reynolds, Alex P.; Roach, Vaughn; Safi, Alexias; Sanchez, Minerva E.; Sanyal, Amartya; Shafer, Anthony; Simon, Jeremy M.; Song, Lingyun; Vong, Shinny; Weaver, Molly; Yan, Yongqi; Zhang, Zhancheng; Zhang, Zhuzhu; Lenhard, Boris; Tewari, Muneesh; Dorschner, Michael O.; Hansen, R. Scott; Navas, Patrick A.; Stamatoyannopoulos, George; Iyer, Vishwanath R.; Lieb, Jason D.; Sunyaev, Shamil R.; Akey, Joshua M.; Sabo, Peter J.; Kaul, Rajinder; Furey, Terrence S.; Dekker, Job; Crawford, Gregory E.; Stamatoyannopoulos, John A.			The accessible chromatin landscape of the human genome	NATURE			English	Article							LOCUS-CONTROL REGION; BETA-GLOBIN LOCUS; TRANSCRIPTION; BINDING; DISTINCT; PROTEIN; NF-E2	DNase I hypersensitive sites (DHSs) are markers of regulatory DNA and have underpinned the discovery of all classes of cis-regulatory elements including enhancers, promoters, insulators, silencers and locus control regions. Here we present the first extensive map of human DHSs identified through genome-wide profiling in 125 diverse cell and tissue types. We identify similar to 2.9 million DHSs that encompass virtually all known experimentally validated cis-regulatory sequences and expose a vast trove of novel elements, most with highly cell-selective regulation. Annotating these elements using ENCODE data reveals novel relationships between chromatin accessibility, transcription, DNA methylation and regulatory factor occupancy patterns. We connect similar to 580,000 distal DHSs with their target promoters, revealing systematic pairing of different classes of distal DHSs and specific promoter types. Patterning of chromatin accessibility at many regulatory regions is organized with dozens to hundreds of co-activated elements, and the transcellular DNase I sensitivity pattern at a given region can predict cell-type-specific functional behaviours. The DHS landscape shows signatures of recent functional evolutionary constraint. However, the DHS compartment in pluripotent and immortalized cells exhibits higher mutation rates than that in highly differentiated cells, exposing an unexpected link between chromatin accessibility, proliferative potential and patterns of human variation.	[Thurman, Robert E.; Rynes, Eric; Humbert, Richard; Vierstra, Jeff; Maurano, Matthew T.; Haugen, Eric; Stergachis, Andrew B.; Wang, Hao; Vernot, Benjamin; John, Sam; Sandstrom, Richard; Bates, Daniel; Canfield, Theresa K.; Diegel, Morgan; Dunn, Douglas; Giste, Erika; Johnson, Audra K.; Kutyavin, Tanya; Lee, Kristen; Neph, Shane; Neri, Fidencio; Qu, Hongzhu; Reynolds, Alex P.; Roach, Vaughn; Shafer, Anthony; Vong, Shinny; Weaver, Molly; Akey, Joshua M.; Sabo, Peter J.; Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Sheffield, Nathan C.; London, Darin; Safi, Alexias; Song, Lingyun; Crawford, Gregory E.] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Garg, Kavita; Tewari, Muneesh] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; [Boatman, Lisa; Ebersol, Abigail K.; Frum, Tristan; Johnson, Ericka M.; Lotakis, Dimitra; Nguyen, Eric D.; Sanchez, Minerva E.; Yan, Yongqi; Hansen, R. Scott; Navas, Patrick A.; Stamatoyannopoulos, George; Kaul, Rajinder] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Lajoie, Bryan; Sanyal, Amartya; Dekker, Job] Univ Massachusetts, Program Syst Biol, Sch Med, Worcester, MA 01605 USA; [Lee, Bum-Kyu; Iyer, Vishwanath R.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Qu, Hongzhu] Chinese Acad Sci, Lab Dis Genom & Individualized Med, Beijing Inst Genom, Beijing 100029, Peoples R China; [Simon, Jeremy M.; Zhang, Zhancheng; Zhang, Zhuzhu; Lieb, Jason D.; Furey, Terrence S.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Lenhard, Boris] Univ Bergen, Dept Biol, N-5008 Bergen, Norway; [Lenhard, Boris] Univ Bergen, Bergen Ctr Computat Sci, N-5008 Bergen, Norway; [Dorschner, Michael O.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Sunyaev, Shamil R.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Sunyaev, Shamil R.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Stamatoyannopoulos, John A.] Univ Washington, Dept Med, Div Oncol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Duke University; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Massachusetts System; University of Massachusetts Worcester; University of Texas System; University of Texas Austin; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; University of North Carolina; University of North Carolina Chapel Hill; University of Bergen; University of Bergen; University of Washington; University of Washington Seattle; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Washington; University of Washington Seattle	Stamatoyannopoulos, JA (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	jstam@uw.edu	Sheffield, Nathan/ABG-8124-2020; Vernot, Benjamin/ABH-1495-2021; SANYAL, AMARTYA/D-7240-2015	Sheffield, Nathan/0000-0001-5643-4068; Vernot, Benjamin/0000-0002-6820-2181; SANYAL, AMARTYA/0000-0002-2109-4478; Lenhard, Boris/0000-0002-1114-1509; Sandstrom, Richard/0000-0002-3356-1547; Kaul, Rajinder/0000-0002-7895-9284; Lieb, Jason/0000-0001-7601-8061; Akey, Joshua/0000-0002-4411-1330; Lee, Bum Kyu/0000-0001-7835-419X; Furey, Terry/0000-0001-5546-9672; Haugen, Eric/0000-0001-7444-8981; FRUM, Tristan/0000-0003-3452-8762; Vierstra, Jeff/0000-0001-6406-8563; Nguyen, Eric/0000-0002-0516-2434	National Institutes of Health [HG004592, HG004563, GM076036, R01MH084676]; National Science Foundation Graduate Research Fellowship [DGE-0718124]; National Science Foundation; Research Council of Norway; caBIG In Silico Center of Excellence, NCI/NIH [HHSN261200800001E]; MRC [MC_UP_1102/1] Funding Source: UKRI; Medical Research Council [MC_UP_1102/1] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004592, R01HG003143, U54HG004563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK095678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084676] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); Research Council of Norway(Research Council of Norway); caBIG In Silico Center of Excellence, NCI/NIH; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank our ENCODE colleagues for many insights into the data types generated by different centres and for help with coordinated analyses. We thank I. Stanaway for assistance with the variation analysis, and many colleagues, particularly F. Urnov, for helpful critiques of the manuscript and figures. This work was funded by National Institutes of Health grants HG004592 (J.A.S.), HG004563 (G. E. C.), GM076036 (J.M.A.) and R01MH084676 (S. R. S), and J.V. is supported by the National Science Foundation Graduate Research Fellowship under grant no. DGE-0718124. N.C.S. is supported by a National Science Foundation Graduate Research Fellowship and the Research Council of Norway. M. T. and K. G. acknowledge funding support from the caBIG In Silico Center of Excellence, NCI/NIH contract no. HHSN261200800001E.	Biggin MD, 2011, DEV CELL, V21, P611, DOI 10.1016/j.devcel.2011.09.008; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Dahle O, 2004, EXP CELL RES, V297, P118, DOI 10.1016/j.yexcr.2004.03.014; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Felsenfeld G, 1996, P NATL ACAD SCI USA, V93, P9384, DOI 10.1073/pnas.93.18.9384; Forsberg EC, 2000, BLOOD, V96, P334, DOI 10.1182/blood.V96.1.334.013k17_334_339; Frietze S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015082; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Harrow J., GENOME RES IN PRESS; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li QL, 1999, TRENDS GENET, V15, P403, DOI 10.1016/S0168-9525(99)01780-1; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Rasheed ZA, 2002, EXP CELL RES, V277, P152, DOI 10.1006/excr.2002.5550; REDDY PMS, 1994, J BIOL CHEM, V269, P8287; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Siegfried Z, 1999, NAT GENET, V22, P203, DOI 10.1038/9727; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Stergachis AB, 2011, NAT METHODS, V8, P1041, DOI [10.1038/NMETH.1770, 10.1038/nmeth.1770]; TALBOT D, 1991, EMBO J, V10, P1391, DOI 10.1002/j.1460-2075.1991.tb07659.x; TUAN D, 1992, P NATL ACAD SCI USA, V89, P11219, DOI 10.1073/pnas.89.23.11219; Vernot B., GENOME RES IN PRESS; WEISBROD S, 1979, P NATL ACAD SCI USA, V76, P630, DOI 10.1073/pnas.76.2.630	32	1719	1773	8	210	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2012	489	7414					75	82		10.1038/nature11232	http://dx.doi.org/10.1038/nature11232			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999WW	22955617	Green Accepted, Green Submitted, hybrid			2022-12-24	WOS:000308347000040
J	Turnhout, E; Bloomfield, B; Hulme, M; Vogel, J; Wynne, B				Turnhout, Esther; Bloomfield, Bob; Hulme, Mike; Vogel, Johannes; Wynne, Brian			Listen to the voices of experience	NATURE			English	Editorial Material									[Turnhout, Esther] Wageningen Univ, Forest & Nat Conservat Policy Grp, Wageningen, Netherlands; [Bloomfield, Bob] Nat Hist Museum, Sci Soc, London SW7 5BD, England; [Hulme, Mike] Univ E Anglia, Sch Environm Sci, Sci Soc & Sustainabil Grp, Norwich NR4 7TJ, Norfolk, England; [Vogel, Johannes] Museum Nat Kunde, Berlin, Germany; [Wynne, Brian] Univ Lancaster, UK ESRC Ctr Econ & Social Aspects Genom, Lancaster LA1 4YW, England	Wageningen University & Research; Natural History Museum London; University of East Anglia; Leibniz Institut fur Evolutions und Biodiversitatsforschung; Lancaster University; UK Research & Innovation (UKRI); Economic & Social Research Council (ESRC)	Turnhout, E (corresponding author), Wageningen Univ, Forest & Nat Conservat Policy Grp, Wageningen, Netherlands.	esther.turnhout@wur.nl	Turnhout, Esther/K-9338-2017; Hulme, Mike/F-9012-2010	Turnhout, Esther/0000-0002-2190-2076; Hulme, Mike/0000-0002-1273-7662				AGRAWAL A, 1995, DEV CHANGE, V26, P413, DOI 10.1111/j.1467-7660.1995.tb00560.x; Hayden Cori., 2003, NATURE GOES PUBLIC M; Karanth KU, 2003, ANIM CONSERV, V6, P141, DOI 10.1017/S1367943003003184; Pinheiro S., 2009, EARTHSCAN READER SUS, P352; *ROYAL SOC, 2003, MEAS BIOD CONS; Van der Pleog J., 1993, ANTHR CRITIQUE DEV G, P209, DOI DOI 10.1525/AE.1995.22.3.02A00190; Walker S, 2009, CONSERV LETT, V2, P149, DOI 10.1111/j.1755-263X.2009.00061.x; Waterton C., 2003, SALMO TRUTTA, V6, P56; William W. B., 2003, IOWA LAW REV, V89, P3; Wynne B., 1989, ENV THREATS PERCEPTI, P233	10	152	159	0	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2012	488	7412					454	455		10.1038/488454a	http://dx.doi.org/10.1038/488454a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	992FS	22914151	Bronze			2022-12-24	WOS:000307761600016
J	Elde, NC; Child, SJ; Eickbush, MT; Kitzman, JO; Rogers, KS; Shendure, J; Geballe, AP; Malik, HS				Elde, Nels C.; Child, Stephanie J.; Eickbush, Michael T.; Kitzman, Jacob O.; Rogers, Kelsey S.; Shendure, Jay; Geballe, Adam P.; Malik, Harmit S.			Poxviruses Deploy Genomic Accordions to Adapt Rapidly against Host Antiviral Defenses	CELL			English	Article							DOUBLE-STRANDED-RNA; PROTEIN-KINASE PKR; VACCINIA VIRUS; GENE AMPLIFICATION; EXPERIMENTAL EVOLUTION; SEQUENCE; RESISTANCE; MUTATION; K3L; DUPLICATION	In contrast to RNA viruses, double-stranded DNA viruses have low mutation rates yet must still adapt rapidly in response to changing host defenses. To determine mechanisms of adaptation, we subjected the model poxvirus vaccinia to serial propagation in human cells, where its antihost factor K3L is malad-apted against the antiviral protein kinase R (PKR). Viruses rapidly acquired higher fitness via recurrent K3L gene amplifications, incurring up to 7%-10% increases in genome size. These transient gene expansions were necessary and sufficient to counteract human PKR and facilitated the gain of an adaptive amino acid substitution in K3L that also defeats PKR. Subsequent reductions in gene amplifications offset the costs associated with larger genome size while retaining adaptive substitutions. Our discovery of viral "gene-accordions" explains how poxviruses can rapidly adapt to defeat different host defenses despite low mutation rates and reveals how classical Red Queen conflicts can progress through unrecognized intermediates.	[Elde, Nels C.; Eickbush, Michael T.; Malik, Harmit S.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Child, Stephanie J.; Geballe, Adam P.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; [Geballe, Adam P.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; [Elde, Nels C.; Rogers, Kelsey S.] Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84112 USA; [Kitzman, Jacob O.; Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Geballe, Adam P.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Geballe, Adam P.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Malik, Harmit S.] Howard Hughes Med Inst, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Utah System of Higher Education; University of Utah; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute	Elde, NC (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.	nelde@genetics.utah.edu; hsmalik@fhcrc.org	Shendure, Jay/AAU-3684-2021; Malik, Harmit S/I-5591-2019; Malik, Harmit S/E-8519-2012	Malik, Harmit S/0000-0001-6005-0016; Child, Stephanie/0000-0002-1987-9540; Shendure, Jay/0000-0002-1516-1865; Kitzman, Jacob/0000-0002-6145-882X; Eickbush, Michael/0000-0001-9057-9156	National Institutes of Health (NIH) [GM090042, 1R21CA160080-01, AI26672]; National Science Foundation (NSF) Graduate Research Fellowship; NSF CAREER award; NATIONAL CANCER INSTITUTE [R21CA160080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026672, R29AI026672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM090042, R00GM090042] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF) Graduate Research Fellowship(National Science Foundation (NSF)); NSF CAREER award(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Jacobs for virus strains, J. Tartaglia for K3L antibody, B. Moss for vaccinia-reactive rabbit serum, and G. Smith for RecBCD and advice on recombination. We thank M. Daugherty, M. Dunham, M. Emerman, A. Frost, J. Kerns, M. Patel, and S. Sawyer for critical reading of the manuscript and B. Stackhouse for technical assistance with sequencing library preparation. This work is supported by the National Institutes of Health (NIH) K99/R00 award (GM090042 to N.C.E.), NIH grant (1R21CA160080-01 to J. S.), NIH grant (AI26672 to A. P. G.), a National Science Foundation (NSF) Graduate Research Fellowship (J.O.K.), and an NSF CAREER award (H. S. M.). H. S. M. is an Early Career Scientist of Howard Hughes Medical Institute. J. S. is a member of the scientific advisory board or serves as a consultant for Ariosa Diagnostics, Stratos Genomics, Good Start Genetics, and Adaptive TCR.	Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119; Afonso CL, 2000, J VIROL, V74, P3815, DOI 10.1128/JVI.74.8.3815-3831.2000; Andersson DI, 1998, SCIENCE, V282, P1133, DOI 10.1126/science.282.5391.1133; Bahar MW, 2011, J STRUCT BIOL, V175, P127, DOI 10.1016/j.jsb.2011.03.010; BEATTIE E, 1995, J VIROL, V69, P499, DOI 10.1128/JVI.69.1.499-505.1995; Beaumont HJE, 2009, NATURE, V462, P90, DOI 10.1038/nature08504; Bergthorsson U, 2007, P NATL ACAD SCI USA, V104, P17004, DOI 10.1073/pnas.0707158104; Bratke KA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-67; CAIRNS J, 1988, NATURE, V335, P142, DOI 10.1038/335142a0; Crotty S, 2001, P NATL ACAD SCI USA, V98, P6895, DOI 10.1073/pnas.111085598; Dar AC, 2002, MOL CELL, V10, P295, DOI 10.1016/S1097-2765(02)00590-7; DAVIES MV, 1993, J VIROL, V67, P1688, DOI 10.1128/JVI.67.3.1688-1692.1993; DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081; Demuth JP, 2009, BIOESSAYS, V31, P29, DOI 10.1002/bies.080085; Drake JW, 1999, P NATL ACAD SCI USA, V96, P13910, DOI 10.1073/pnas.96.24.13910; Drake JW, 1998, GENETICS, V148, P1667; Drummond JT, 1997, P NATL ACAD SCI USA, V94, P10144, DOI 10.1073/pnas.94.19.10144; Dunham MJ, 2002, P NATL ACAD SCI USA, V99, P16144, DOI 10.1073/pnas.242624799; EICHLER DC, 1977, J BIOL CHEM, V252, P499; Elde NC, 2009, NAT REV MICROBIOL, V7, P787, DOI 10.1038/nrmicro2222; Elde NC, 2009, NATURE, V457, P485, DOI 10.1038/nature07529; Emerman M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000301; ESPOSITO J, 1981, J VIROL METHODS, V2, P175, DOI 10.1016/0166-0934(81)90036-7; Esposito JJ, 2006, SCIENCE, V313, P807, DOI 10.1126/science.1125134; FOSTER PL, 1994, GENETICS, V138, P253; Goebel S.J., 1990, VIROLOGY, V179, P517; GOEBEL SJ, 1990, VIROLOGY, V179, P247, DOI 10.1016/0042-6822(90)90294-2; Hakki M, 2005, J VIROL, V79, P7311, DOI 10.1128/JVI.79.12.7311-7318.2005; Harrison SC, 2004, P NATL ACAD SCI USA, V101, P11178, DOI 10.1073/pnas.0403600101; Hastings PJ, 2000, CELL, V103, P723, DOI 10.1016/S0092-8674(00)00176-8; Hendrickson H, 2002, P NATL ACAD SCI USA, V99, P2164, DOI 10.1073/pnas.032680899; Hendrickson RC, 2010, VIRUSES-BASEL, V2, P1933, DOI 10.3390/v2091933; Kaufman RJ, 2000, COLD SPRING HARBOR M, V39, P503; KawagishiKobayashi M, 1997, MOL CELL BIOL, V17, P4146, DOI 10.1128/MCB.17.7.4146; Kerr PJ, 2010, VET MICROBIOL, V143, P167, DOI 10.1016/j.vetmic.2009.11.025; Kugelberg E, 2010, GENETICS, V185, P65, DOI 10.1534/genetics.110.114074; Langland J.O., 2002, BIOINFORMATICS, V299, P133; Li Y, 2007, P NATL ACAD SCI USA, V104, P15787, DOI 10.1073/pnas.0609268104; Lipinski KJ, 2011, CURR BIOL, V21, P306, DOI 10.1016/j.cub.2011.01.026; Lynch M, 2008, P NATL ACAD SCI USA, V105, P9272, DOI 10.1073/pnas.0803466105; McLysaght A, 2003, P NATL ACAD SCI USA, V100, P15655, DOI 10.1073/pnas.2136653100; Meisinger-Henschel C, 2007, J GEN VIROL, V88, P3249, DOI 10.1099/vir.0.83156-0; Meyer JR, 2012, SCIENCE, V335, P428, DOI 10.1126/science.1214449; Meyerson NR, 2011, TRENDS MICROBIOL, V19, P286, DOI 10.1016/j.tim.2011.03.006; Montville R, 2005, PLOS BIOL, V3, P1939, DOI 10.1371/journal.pbio.0030381; MOSS B, 1981, P NATL ACAD SCI-BIOL, V78, P1614, DOI 10.1073/pnas.78.3.1614; Moss B, 2007, FIELDS VIROLOGY; Nair S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000243; Pfeiffer JK, 2005, PLOS PATHOG, V1, P102, DOI 10.1371/journal.ppat.0010011; Pranting M, 2011, MOL MICROBIOL, V79, P305, DOI 10.1111/j.1365-2958.2010.07458.x; Rothenburg S, 2009, NAT STRUCT MOL BIOL, V16, P63, DOI 10.1038/nsmb.1529; Sandegren L, 2009, NAT REV MICROBIOL, V7, P578, DOI 10.1038/nrmicro2174; SCHIMKE RT, 1986, CANCER, V57, P1912, DOI 10.1002/1097-0142(19860515)57:10<1912::AID-CNCR2820571004>3.0.CO;2-O; Searles RP, 1999, J VIROL, V73, P3040, DOI 10.1128/JVI.73.4.3040-3053.1999; SLABAUGH MB, 1986, J VIROL, V60, P506, DOI 10.1128/JVI.60.2.506-514.1986; SLABAUGH MB, 1989, NUCLEIC ACIDS RES, V17, P7073, DOI 10.1093/nar/17.17.7073; SMITH GL, 1983, GENE, V25, P21, DOI 10.1016/0378-1119(83)90163-4; SMITH GR, 1995, PHILOS T ROY SOC B, V347, P13, DOI 10.1098/rstb.1995.0003; Stambuk BU, 2009, GENOME RES, V19, P2271, DOI 10.1101/gr.094276.109; Sun S, 2009, GENETICS, V182, P1183, DOI 10.1534/genetics.109.103028; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Vignuzzi M, 2005, VIRUS RES, V107, P173, DOI 10.1016/j.virusres.2004.11.007; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Werden SJ, 2008, ADV VIRUS RES, V71, P135, DOI 10.1016/S0065-3527(08)00003-1; Wichman HA, 1999, SCIENCE, V285, P422, DOI 10.1126/science.285.5426.422	66	190	193	2	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 17	2012	150	4					831	841		10.1016/j.cell.2012.05.049	http://dx.doi.org/10.1016/j.cell.2012.05.049			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22901812	Bronze, Green Accepted			2022-12-24	WOS:000308002300016
J	Wang, ET; Cody, NAL; Jog, S; Biancolella, M; Wang, TT; Treacy, DJ; Luo, SJ; Schroth, GP; Housman, DE; Reddy, S; Lecuyer, E; Burge, CB				Wang, Eric T.; Cody, Neal A. L.; Jog, Sonali; Biancolella, Michela; Wang, Thomas T.; Treacy, Daniel J.; Luo, Shujun; Schroth, Gary P.; Housman, David E.; Reddy, Sita; Lecuyer, Eric; Burge, Christopher B.			Transcriptome-wide Regulation of Pre-mRNA Splicing and mRNA Localization by Muscleblind Proteins	CELL			English	Article							MYOTONIC-DYSTROPHY; ENDOPLASMIC-RETICULUM; GENE-EXPRESSION; STEM-CELLS; SYNAPSE FORMATION; MBNL1; TRANSLATION; DROSOPHILA; REVEALS; BINDING	The muscleblind-like (Mbnl) family of RNA-binding proteins plays important roles in muscle and eye development and in myotonic dystrophy (DM), in which expanded CUG or CCUG repeats functionally deplete Mbnl proteins. We identified transcriptome-wide functional and biophysical targets of Mbnl proteins in brain, heart, muscle, and myoblasts by using RNA-seq and CLIP-seq approaches. This analysis identified several hundred splicing events whose regulation depended on Mbnl function in a pattern indicating functional interchangeability between Mbnl1 and Mbnl2. A nucleotide resolution RNA map associated repression or activation of exon splicing with Mbnl binding near either 30 splice site or near the downstream 50 splice site, respectively. Transcriptomic analysis of subcellular compartments uncovered a global role for Mbnls in regulating localization of mRNAs in both mouse and Drosophila cells, and Mbnl-dependent translation and protein secretion were observed for a subset of mRNAs with Mbnl-dependent localization. These findings hold several new implications for DM pathogenesis.	[Wang, Eric T.; Wang, Thomas T.; Treacy, Daniel J.; Housman, David E.; Burge, Christopher B.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Wang, Eric T.; Housman, David E.; Burge, Christopher B.] MIT, Div Hlth Sci & Technol, Cambridge, MA 02142 USA; [Wang, Eric T.; Wang, Thomas T.; Housman, David E.; Burge, Christopher B.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA; [Burge, Christopher B.] MIT, Dept Biol Engn, Cambridge, MA 02142 USA; [Cody, Neal A. L.; Lecuyer, Eric] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Jog, Sonali; Biancolella, Michela; Reddy, Sita] Univ So Calif, Los Angeles, CA 90033 USA; [Luo, Shujun; Schroth, Gary P.] Illumina Inc, Hayward, CA 94545 USA; [Lecuyer, Eric] Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; University of Southern California; Illumina; Universite de Montreal	Burge, CB (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02142 USA.	cburge@mit.edu	Burge, Christopher B./AAH-2177-2020		Poitras Fellowship; National Science Foundation [0821391]; National Institutes of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005624, R01HG002439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085319] Funding Source: NIH RePORTER	Poitras Fellowship; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Tom Cooper for the anti-Mbnl1 antibody used to perform CLIP. We thank Andy Berglund and David Brook for insightful conversations about muscleblinds and Phil Sharp and Bob Brown Jr. for their comments and suggestions to perform cellular fractionation experiments. We thank Michael Zuker for suggestions on depleting ribosomal RNAs during ribosome footprint library preparation. We thank the MIT Biomicro Center and the IRCM molecular biology core facility for assistance with deep sequencing and the Koch Institute Swanson Biotechnology Center for microscopy assistance. This work was supported by a Poitras Fellowship (E. T. W.), by equipment grant 0821391 from the National Science Foundation, and by grants from the National Institutes of Health to C. B. B. E. T. W. performed CLIP-seq, cellular fractionation of mouse cells, ribosome footprint profiling, and luciferase assays and also analyzed RNA-seq, CLIP-seq, and footprint data. N.A.L.C. performed cellular fractionation of fly cells. S.J., M. B., and S. R. isolated RNA from mouse tissues and performed splicing RT-PCR assays. T. T. W. performed lentiviral knockdown of Mbnls in mouse cells. D.J.T. and S. L. prepared RNA-seq libraries. N.C., E. L., S. R., D. E. H., and G. P. S. contributed to study design. E. T. W. and C. B. B. designed the study and wrote the paper with contributions from E. L. and N.C.	Adereth Y, 2005, NAT CELL BIOL, V7, P1240, DOI 10.1038/ncb1335; Amenta AR, 2012, J NEUROSCI, V32, P2324, DOI 10.1523/JNEUROSCI.4610-11.2012; Andreassi C, 2009, TRENDS CELL BIOL, V19, P465, DOI 10.1016/j.tcb.2009.06.001; Artero R, 1998, DEV BIOL, V195, P131, DOI 10.1006/dbio.1997.8833; ASHIZAWA T, 1993, NEUROLOGY, V43, P2674, DOI 10.1212/WNL.43.12.2674; Begemann G, 1997, DEVELOPMENT, V124, P4321; BERGERON JJM, 1994, TRENDS BIOCHEM SCI, V19, P124, DOI 10.1016/0968-0004(94)90205-4; Besse F, 2008, NAT REV MOL CELL BIO, V9, P971, DOI 10.1038/nrm2548; BLOBEL G, 1975, J CELL BIOL, V67, P852, DOI 10.1083/jcb.67.3.852; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; Cenik C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001366; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; Du HQ, 2010, NAT STRUCT MOL BIOL, V17, P187, DOI 10.1038/nsmb.1720; Fardaei M, 2002, HUM MOL GENET, V11, P805, DOI 10.1093/hmg/11.7.805; FFRENCHCONSTANT C, 1989, J CELL BIOL, V109, P903, DOI 10.1083/jcb.109.2.903; FFRENCHCONSTANT C, 1989, DEVELOPMENT, V106, P375; Goers ES, 2010, NUCLEIC ACIDS RES, V38, P2467, DOI 10.1093/nar/gkp1209; Gunning PW, 2005, TRENDS CELL BIOL, V15, P333, DOI 10.1016/j.tcb.2005.04.007; HESKETH J, 1994, MOL BIOL REP, V19, P233, DOI 10.1007/BF00986965; Hino S, 2007, HUM MOL GENET, V16, P2834, DOI 10.1093/hmg/ddm239; Ho TH, 2004, EMBO J, V23, P3103, DOI 10.1038/sj.emboj.7600300; Holt I, 2009, AM J PATHOL, V174, P216, DOI 10.2353/ajpath.2009.080520; Horne-Badovinac S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040008; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Jagannathan S, 2011, METHODS MOL BIOL, V714, P301, DOI 10.1007/978-1-61779-005-8_19; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Kanadia RN, 2003, GENE EXPR PATTERNS, V3, P459, DOI 10.1016/S1567-133X(03)00064-4; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kishore S, 2011, NAT METHODS, V8, P559, DOI [10.1038/NMETH.1608, 10.1038/nmeth.1608]; Kislauskis EH, 1997, J CELL BIOL, V136, P1263, DOI 10.1083/jcb.136.6.1263; Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Lecuyer E, 2009, CURR OPIN CELL BIOL, V21, P409, DOI 10.1016/j.ceb.2009.01.027; Lin XY, 2006, HUM MOL GENET, V15, P2087, DOI 10.1093/hmg/ddl132; Marteyn A, 2011, CELL STEM CELL, V8, P434, DOI 10.1016/j.stem.2011.02.004; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Martin KC, 2006, J NEUROSCI, V26, P7131, DOI 10.1523/JNEUROSCI.1801-06.2006; Masuda A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00209; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Myotonic Dystrophy Foundation, 2017, VOIC PAT REP MYOT DY; Osborne RJ, 2009, HUM MOL GENET, V18, P1471, DOI 10.1093/hmg/ddp058; PACHTER J S, 1992, Critical Reviews in Eukaryotic Gene Expression, V2, P1; Palazzo AF, 2007, PLOS BIOL, V5, P2862, DOI 10.1371/journal.pbio.0050322; Panaite PA, 2008, J NEUROPATH EXP NEUR, V67, P763, DOI 10.1097/NEN.0b013e318180ec64; Pascual M, 2006, DIFFERENTIATION, V74, P65, DOI 10.1111/j.1432-0436.2006.00060.x; Pizon V, 2002, J CELL SCI, V115, P4469, DOI 10.1242/jcs.00131; Pyhtila B, 2008, RNA, V14, P445, DOI 10.1261/rna.721108; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Sen S, 2010, J BIOL CHEM, V285, P25426, DOI 10.1074/jbc.M109.095224; Spilker KA, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-7; Squillace RM, 2002, DEV BIOL, V250, P218, DOI 10.1006/dbio.2002.0798; SUNDELL CL, 1991, SCIENCE, V253, P1275, DOI 10.1126/science.1891715; Teplova M, 2008, NAT STRUCT MOL BIOL, V15, P1343, DOI 10.1038/nsmb.1519; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; VEDELER A, 1991, MOL CELL BIOCHEM, V100, P183; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang ZF, 2006, MOL CELL, V23, P61, DOI 10.1016/j.molcel.2006.05.018; Wang Z, 2009, METHODS, V48, P287, DOI 10.1016/j.ymeth.2009.02.021; Warf MB, 2007, RNA, V13, P2238, DOI 10.1261/rna.610607; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; Zhang CL, 2010, SCIENCE, V329, P439, DOI 10.1126/science.1191150; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999	65	332	338	3	53	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 17	2012	150	4					710	724		10.1016/j.cell.2012.06.041	http://dx.doi.org/10.1016/j.cell.2012.06.041			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22901804	Green Accepted, Green Published, Bronze			2022-12-24	WOS:000308002300007
J	Koch, C				Koch, Christof			Modular Biological Complexity	SCIENCE			English	Editorial Material									[Koch, Christof] Allen Inst Brain Sci, Seattle, WA 98103 USA; [Koch, Christof] CALTECH, Div Biol, Pasadena, CA 91125 USA	Allen Institute for Brain Science; California Institute of Technology	Koch, C (corresponding author), Allen Inst Brain Sci, Seattle, WA 98103 USA.	christofk@alleninstitute.org		Koch, Christof/0000-0001-6482-8067	Paul G. Allen Family Foundation	Paul G. Allen Family Foundation	I thank N. Joshi for the plot. Supported by the Paul G. Allen Family Foundation.	Allen P. G., 2011, TECHNOL REV, V12; Balduzzi D, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000091; Buxhoeveden DP, 2002, BRAIN, V125, P935, DOI 10.1093/brain/awf110; DE BRUIJIN N.G, 1958, ASYMPTOTIC METHODS A; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Koch C, 2012, NATURE, V483, P397, DOI 10.1038/483397a; Kurzweil R., 2005, SINGULARITY IS NEAR; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Qian JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017013; Sanchez C, 1999, NUCLEIC ACIDS RES, V27, P89, DOI 10.1093/nar/27.1.89	10	37	38	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2012	337	6094					531	532		10.1126/science.1218616	http://dx.doi.org/10.1126/science.1218616			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982PU	22859475				2022-12-24	WOS:000307058700027
J	Maitre, JL; Berthoumieux, H; Krens, SFG; Salbreux, G; Julicher, F; Paluch, E; Heisenberg, CP				Maitre, Jean-Leon; Berthoumieux, Helene; Krens, Simon Frederik Gabriel; Salbreux, Guillaume; Juelicher, Frank; Paluch, Ewa; Heisenberg, Carl-Philipp			Adhesion Functions in Cell Sorting by Mechanically Coupling the Cortices of Adhering Cells	SCIENCE			English	Article							E-CADHERIN; TENSION; HYPOTHESIS; CONTACTS; CATENIN; FORCES; RETINA	Differential cell adhesion and cortex tension are thought to drive cell sorting by controlling cell-cell contact formation. Here, we show that cell adhesion and cortex tension have different mechanical functions in controlling progenitor cell-cell contact formation and sorting during zebrafish gastrulation. Cortex tension controls cell-cell contact expansion by modulating interfacial tension at the contact. By contrast, adhesion has little direct function in contact expansion, but instead is needed to mechanically couple the cortices of adhering cells at their contacts, allowing cortex tension to control contact expansion. The coupling function of adhesion is mediated by E-cadherin and limited by the mechanical anchoring of E-cadherin to the cortex. Thus, cell adhesion provides the mechanical scaffold for cell cortex tension to drive cell sorting during gastrulation.	[Paluch, Ewa] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Paluch, Ewa] Int Inst Mol & Cell Biol, Warsaw, Poland; [Maitre, Jean-Leon; Krens, Simon Frederik Gabriel; Heisenberg, Carl-Philipp] IST Austria, Klosterneuburg, Austria; [Berthoumieux, Helene; Salbreux, Guillaume; Juelicher, Frank] Max Planck Inst Phys Komplexer Syst, Dresden, Germany; [Berthoumieux, Helene] Univ Paris 06, CNRS, Lab Phys Theor Mat Condensee, UMR 7600, Paris, France	Max Planck Society; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Institute of Science & Technology - Austria; Max Planck Society; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite	Paluch, E (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.	paluch@mpi-cbg.de; heisenberg@ist.ac.at	Maître, Jean-Léon/C-4372-2017; Krens, Gabriel/U-6760-2017; Julicher, Frank/B-1828-2009	Maître, Jean-Léon/0000-0002-3688-1474; Krens, Gabriel/0000-0003-4761-5996; Julicher, Frank/0000-0003-4731-9185; Salbreux, Guillaume/0000-0001-7041-1292; Heisenberg, Carl-Philipp/0000-0002-0912-4566; Paluch, Ewa/0000-0003-4691-2323	Max-Planck-Society; Polish Ministry of Science and Higher Education [454/N-MPG/2009/0]; Human Frontier Science Program [RGY0067/2008]; Fonds zur Forderung der wissenschaftlichen Forschung (FWF) [HE3231/6, I812-B12]; Austrian Science Fund (FWF) [I 812] Funding Source: researchfish	Max-Planck-Society(Max Planck Society); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Human Frontier Science Program(Human Frontier Science Program); Fonds zur Forderung der wissenschaftlichen Forschung (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank M. Biro, J.-Y. Tinevez, and J. Ronsch for technical assistance, V. Barone for critical reading of earlier versions of this manuscript, and the facilities of the MPI-CBG and IST Austria for their continuous support. This work was supported by the Max-Planck-Society and grants from the Polish Ministry of Science and Higher Education to E. P. (454/N-MPG/2009/0), the Human Frontier Science Program to E. P. (RGY0067/2008), and the Fonds zur Forderung der wissenschaftlichen Forschung (FWF) to C.-P. H. (HE3231/6; I812-B12).	Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Borghi N, 2012, P NATL ACAD SCI USA, V109, P12568, DOI 10.1073/pnas.1204390109; Brodland GW, 2002, J BIOMECH ENG-T ASME, V124, P188, DOI 10.1115/1.1449491; Chu YS, 2004, J CELL BIOL, V167, P1183, DOI 10.1083/jcb.200403043; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; Hayashi T, 2004, NATURE, V431, P647, DOI 10.1038/nature02952; Kafer J, 2007, P NATL ACAD SCI USA, V104, P18549, DOI 10.1073/pnas.0704235104; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; le Duc Q, 2010, J CELL BIOL, V189, P1107, DOI 10.1083/jcb.201001149; Maitre JL, 2011, CURR OPIN CELL BIOL, V23, P508, DOI 10.1016/j.ceb.2011.07.004; Manning ML, 2010, P NATL ACAD SCI USA, V107, P12517, DOI 10.1073/pnas.1003743107; Martin AC, 2010, J CELL BIOL, V188, P735, DOI 10.1083/jcb.200910099; Seifert U, 2000, PHYS REV LETT, V84, P2750, DOI 10.1103/PhysRevLett.84.2750; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055	15	352	354	2	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2012	338	6104					253	256		10.1126/science.1225399	http://dx.doi.org/10.1126/science.1225399			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	22923438				2022-12-24	WOS:000309712300045
J	Buganim, Y; Faddah, DA; Cheng, AW; Itskovich, E; Markoulaki, S; Ganz, K; Klemm, SL; van Oudenaarden, A; Jaenisch, R				Buganim, Yosef; Faddah, Dina A.; Cheng, Albert W.; Itskovich, Elena; Markoulaki, Styliani; Ganz, Kibibi; Klemm, Sandy L.; van Oudenaarden, Alexander; Jaenisch, Rudolf			Single-Cell Expression Analyses during Cellular Reprogramming Reveal an Early Stochastic and a Late Hierarchic Phase	CELL			English	Article							PLURIPOTENT STEM-CELLS; FIBROBLASTS; MOUSE; GENERATION; NETWORKS; STATE	During cellular reprogramming, only a small fraction of cells become induced pluripotent stem cells (iPSCs). Previous analyses of gene expression during reprogramming were based on populations of cells, impeding single-cell level identification of reprogramming events. We utilized two gene expression technologies to profile 48 genes in single cells at various stages during the reprogramming process. Analysis of early stages revealed considerable variation in gene expression between cells in contrast to late stages. Expression of Esrrb, Utf1, Lin28, and Dppa2 is a better predictor for cells to progress into iPSCs than expression of the previously suggested reprogramming markers Fbxo15, Fgf4, and Oct4. Stochastic gene expression early in reprogramming is followed by a late hierarchical phase with Sox2 being the upstream factor in a gene expression hierarchy. Finally, downstream factors derived from the late phase, which do not include Oct4, Sox2, Klf4, c-Myc, and Nanog, can activate the pluripotency circuitry.	[Buganim, Yosef; Faddah, Dina A.; Cheng, Albert W.; Itskovich, Elena; Markoulaki, Styliani; Ganz, Kibibi; Jaenisch, Rudolf] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Faddah, Dina A.; van Oudenaarden, Alexander; Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA 02139 USA; [Cheng, Albert W.] MIT, Dept Computat & Syst Biol, Cambridge, MA 02139 USA; [van Oudenaarden, Alexander] MIT, Dept Phys, Cambridge, MA 02139 USA; [Klemm, Sandy L.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [van Oudenaarden, Alexander] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [van Oudenaarden, Alexander] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu	van Oudenaarden, Alexander/AAA-1705-2019	Cheng, Albert/0000-0003-2653-5743	NIH Kirschstein NRSA [1 F32 GM099153-01A1]; NSF; Jerome and Florence Brill Graduate Student Fellowship; Croucher and Ludwig Research Fellowship; NIH [HD 045022, R37CA084198, 1DP1OD003936]; NIH/NCI Physical Sciences Oncology Center at MIT [U54CA143874]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD045022] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA084198, R37CA084198, U54CA143874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM099153] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003936] Funding Source: NIH RePORTER	NIH Kirschstein NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Jerome and Florence Brill Graduate Student Fellowship; Croucher and Ludwig Research Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCI Physical Sciences Oncology Center at MIT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Yarden Katz, Sovan Sarkar, Malkiel Cohen, Bryce Carey, and Jonathan Friedman for fruitful discussions, Patti Wisniewski and Chad Araneo for their help with cell sorting, and Stuart Levine for help with pilot Fluidigm experiments. Y.B. was supported by an NIH Kirschstein NRSA (1 F32 GM099153-01A1). D.A.F. is a Vertex Scholar and was supported by an NSF Graduate Research Fellowship and Jerome and Florence Brill Graduate Student Fellowship. A.W.C. was supported by a Croucher and Ludwig Research Fellowship. R.J. is an adviser to Stemgent and cofounder of Fate Therapeutics. This work was supported by NIH grants HD 045022 and R37CA084198 to R.J. and the NIH/NCI Physical Sciences Oncology Center at MIT (U54CA143874) and a NIH Pioneer award (1DP1OD003936) to A.v.O.	Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Boiani M, 2002, GENE DEV, V16, P1209, DOI 10.1101/gad.966002; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Dalerba P, 2011, NAT BIOTECHNOL, V29, P1120, DOI 10.1038/nbt.2038; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Egli D, 2008, NAT REV MOL CELL BIO, V9, P505, DOI 10.1038/nrm2439; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Itzkovitz S, 2012, NAT CELL BIOL, V14, P106, DOI 10.1038/ncb2384; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115; Macfarlan TS, 2011, GENE DEV, V25, P594, DOI 10.1101/gad.2008511; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mansour AA, 2012, NATURE, V488, P409, DOI 10.1038/nature11272; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Narsinh KH, 2011, J CLIN INVEST, V121, P1217, DOI 10.1172/JCI44635; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Smith ZD, 2010, NAT BIOTECHNOL, V28, P521, DOI 10.1038/nbt.1632; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267	43	606	630	9	165	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 14	2012	150	6					1209	1222		10.1016/j.cell.2012.08.023	http://dx.doi.org/10.1016/j.cell.2012.08.023			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22980981	Green Accepted, Green Published, Bronze			2022-12-24	WOS:000308928100014
J	Kastenmuller, W; Torabi-Parizi, P; Subramanian, N; Lammermann, T; Germain, RN				Kastenmueller, Wolfgang; Torabi-Parizi, Parizad; Subramanian, Naeha; Laemmermann, Tim; Germain, Ronald N.			A Spatially-Organized Multicellular Innate Immune Response in Lymph Nodes Limits Systemic Pathogen Spread	CELL			English	Article							CD8(+) T-CELLS; VACCINIA VIRUS; MACROPHAGE POLARIZATION; SUBCAPSULAR SINUS; MIGRATION; INFECTION; RECOGNITION; LYMPHOCYTES; ACTIVATION; MECHANISM	The lymphatic network that transports interstitial fluid and antigens to lymph nodes constitutes a conduit system that can be hijacked by invading pathogens to achieve systemic spread unless dissemination is blocked in the lymph node itself. Here, we show that a network of diverse lymphoid cells (natural killer cells, gamma delta T cells, natural killer T cells, and innate-like CD8+ T cells) are spatially prepositioned close to lymphatic sinus-lining sentinel macrophages where they can rapidly and efficiently receive inflammasome-generated IL-18 and additional cytokine signals from the pathogen-sensing phagocytes. This leads to rapid IFN gamma secretion by the strategically positioned innate lymphocytes, fostering antimicrobial resistance in the macrophage population. Interference with this innate immune response loop allows systemic spread of lymph-borne bacteria. These findings extend our understanding of the functional significance of cellular positioning and local intercellular communication within lymph nodes while emphasizing the role of these organs as highly active locations of innate host defense.	[Kastenmueller, Wolfgang; Torabi-Parizi, Parizad; Subramanian, Naeha; Laemmermann, Tim; Germain, Ronald N.] NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, Bethesda, MD 20892 USA; [Torabi-Parizi, Parizad] NIH, Dept Crit Care Med, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Kastenmuller, W (corresponding author), NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, Bethesda, MD 20892 USA.	kastenmullerw@mail.nih.gov; rgermain@nih.gov	Germain, Ronald N./Z-1945-2019; Germain, Ronald/ABE-7090-2020; Lämmermann, Tim/AAD-7453-2022	Subramanian, Naeha/0000-0003-3754-0521	NIAID; NIH; DFG; International Human Frontier Science Program;  [KA 3091/1-1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000545] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DFG(German Research Foundation (DFG)); International Human Frontier Science Program(Human Frontier Science Program); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program, NIAID, NIH, DFG, KA 3091/1-1 to W.K. and by a fellowship grant from the International Human Frontier Science Program to T.L. We thank A. Sher, Y. Belkaid, and K. Abdi for kindly providing mouse strains, B. Moss for generously providing pLW-73, E. Miao and B. Borlee for generously providing PA strains and E. Long for critically reading this manuscript. The authors would also like to thank Austin Rinker for technical support.	Alitalo K, 2011, NAT MED, V17, P1371, DOI 10.1038/nm.2545; Asano K, 2011, IMMUNITY, V34, P85, DOI 10.1016/j.immuni.2010.12.011; Bajenoff M, 2006, J EXP MED, V203, P619, DOI 10.1084/jem.20051474; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Barral P, 2010, NAT IMMUNOL, V11, P303, DOI 10.1038/ni.1853; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; BODEY GP, 1983, REV INFECT DIS, V5, P279; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; Cahalan MD, 2006, CURR OPIN IMMUNOL, V18, P476, DOI 10.1016/j.coi.2006.05.013; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Chtanova T, 2008, IMMUNITY, V29, P487, DOI 10.1016/j.immuni.2008.07.012; Clark RA, 2006, J IMMUNOL, V176, P4431, DOI 10.4049/jimmunol.176.7.4431; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; Dayer JM, 2003, EUR RESPIR J, V22, p10S, DOI 10.1183/09031936.03.00000403b; de Veerdonk FLV, 2011, TRENDS IMMUNOL, V32, P110, DOI 10.1016/j.it.2011.01.003; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Germain RN, 2008, IMMUNOL REV, V221, P163, DOI 10.1111/j.1600-065X.2008.00591.x; Gretz JE, 1997, IMMUNOL REV, V156, P11, DOI 10.1111/j.1600-065X.1997.tb00955.x; Guo LY, 2009, P NATL ACAD SCI USA, V106, P13463, DOI 10.1073/pnas.0906988106; Hayday AC, 2009, IMMUNITY, V31, P184, DOI 10.1016/j.immuni.2009.08.006; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Kastenmuller W, 2010, EUR J IMMUNOL, V40, P2103, DOI 10.1002/eji.201040482; Kastenmuller W, 2007, J EXP MED, V204, P2187, DOI 10.1084/jem.20070489; Kettle S, 1997, J GEN VIROL, V78, P677, DOI 10.1099/0022-1317-78-3-677; Kupz A, 2012, NAT IMMUNOL, V13, P162, DOI 10.1038/ni.2195; Lammermann T, 2008, IMMUNOL REV, V221, P26, DOI 10.1111/j.1600-065X.2008.00592.x; Lee YJ, 2011, TRENDS IMMUNOL, V32, P50, DOI 10.1016/j.it.2010.12.004; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Miao EA, 2008, P NATL ACAD SCI USA, V105, P2562, DOI 10.1073/pnas.0712183105; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Miller LS, 2007, J IMMUNOL, V179, P6933, DOI 10.4049/jimmunol.179.10.6933; Moayeri M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001222; Norbury CC, 2002, NAT IMMUNOL, V3, P265, DOI 10.1038/ni762; Okada T, 2006, CURR OPIN IMMUNOL, V18, P278, DOI 10.1016/j.coi.2006.02.005; Pereira JP, 2010, INT IMMUNOL, V22, P413, DOI 10.1093/intimm/dxq047; Robinson D, 1997, IMMUNITY, V7, P571, DOI 10.1016/S1074-7613(00)80378-7; SENKEVICH TG, 1995, J VIROL, V69, P4103, DOI 10.1128/JVI.69.7.4103-4111.1995; Shi FD, 2011, NAT REV IMMUNOL, V11, P658, DOI 10.1038/nri3065; Sumen C, 2004, IMMUNITY, V21, P315, DOI 10.1016/S1074-7613(04)00237-7; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Swartz MA, 2001, ADV DRUG DELIVER REV, V50, P3, DOI 10.1016/S0169-409X(01)00150-8; Symons JA, 2002, J GEN VIROL, V83, P2833, DOI 10.1099/0022-1317-83-11-2833; Unutmaz D, 2000, J IMMUNOL, V165, P3284, DOI 10.4049/jimmunol.165.6.3284; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Wakim LM, 2010, P NATL ACAD SCI USA, V107, P17872, DOI 10.1073/pnas.1010201107; Weinreich MA, 2010, NAT IMMUNOL, V11, P709, DOI 10.1038/ni.1898; Wu LC, 2005, SCIENCE, V309, P774, DOI 10.1126/science.1112422; Wyatt LS, 2009, J VIROL, V83, P7176, DOI 10.1128/JVI.00687-09; Yang JF, 2001, NAT IMMUNOL, V2, P157, DOI 10.1038/84264	55	263	265	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 14	2012	150	6					1235	1248		10.1016/j.cell.2012.07.021	http://dx.doi.org/10.1016/j.cell.2012.07.021			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22980983	Bronze, Green Accepted, Green Submitted			2022-12-24	WOS:000308928100016
J	Djebali, S; Davis, CA; Merkel, A; Dobin, A; Lassmann, T; Mortazavi, A; Tanzer, A; Lagarde, J; Lin, W; Schlesinger, F; Xue, CH; Marinov, GK; Khatun, J; Williams, BA; Zaleski, C; Rozowsky, J; Roder, M; Kokocinski, F; Abdelhamid, RF; Alioto, T; Antoshechkin, I; Baer, MT; Bar, NS; Batut, P; Bell, K; Bell, I; Chakrabortty, S; Chen, X; Chrast, J; Curado, J; Derrien, T; Drenkow, J; Dumais, E; Dumais, J; Duttagupta, R; Falconnet, E; Fastuca, M; Fejes-Toth, K; Ferreira, P; Foissac, S; Fullwood, MJ; Gao, H; Gonzalez, D; Gordon, A; Gunawardena, H; Howald, C; Jha, S; Johnson, R; Kapranov, P; King, B; Kingswood, C; Luo, OJ; Park, E; Persaud, K; Preall, JB; Ribeca, P; Risk, B; Robyr, D; Sammeth, M; Schaffer, L; See, LH; Shahab, A; Skancke, J; Suzuki, AM; Takahashi, H; Tilgner, H; Trout, D; Walters, N; Wang, H; Wrobel, J; Yu, YB; Ruan, XA; Hayashizaki, Y; Harrow, J; Gerstein, M; Hubbard, T; Reymond, A; Antonarakis, SE; Hannon, G; Giddings, MC; Ruan, YJ; Wold, B; Carninci, P; Guigo, R; Gingeras, TR				Djebali, Sarah; Davis, Carrie A.; Merkel, Angelika; Dobin, Alex; Lassmann, Timo; Mortazavi, Ali; Tanzer, Andrea; Lagarde, Julien; Lin, Wei; Schlesinger, Felix; Xue, Chenghai; Marinov, Georgi K.; Khatun, Jainab; Williams, Brian A.; Zaleski, Chris; Rozowsky, Joel; Roeder, Maik; Kokocinski, Felix; Abdelhamid, Rehab F.; Alioto, Tyler; Antoshechkin, Igor; Baer, Michael T.; Bar, Nadav S.; Batut, Philippe; Bell, Kimberly; Bell, Ian; Chakrabortty, Sudipto; Chen, Xian; Chrast, Jacqueline; Curado, Joao; Derrien, Thomas; Drenkow, Jorg; Dumais, Erica; Dumais, Jacqueline; Duttagupta, Radha; Falconnet, Emilie; Fastuca, Meagan; Fejes-Toth, Kata; Ferreira, Pedro; Foissac, Sylvain; Fullwood, Melissa J.; Gao, Hui; Gonzalez, David; Gordon, Assaf; Gunawardena, Harsha; Howald, Cedric; Jha, Sonali; Johnson, Rory; Kapranov, Philipp; King, Brandon; Kingswood, Colin; Luo, Oscar J.; Park, Eddie; Persaud, Kimberly; Preall, Jonathan B.; Ribeca, Paolo; Risk, Brian; Robyr, Daniel; Sammeth, Michael; Schaffer, Lorian; See, Lei-Hoon; Shahab, Atif; Skancke, Jorgen; Suzuki, Ana Maria; Takahashi, Hazuki; Tilgner, Hagen; Trout, Diane; Walters, Nathalie; Wang, Huaien; Wrobel, John; Yu, Yanbao; Ruan, Xiaoan; Hayashizaki, Yoshihide; Harrow, Jennifer; Gerstein, Mark; Hubbard, Tim; Reymond, Alexandre; Antonarakis, Stylianos E.; Hannon, Gregory; Giddings, Morgan C.; Ruan, Yijun; Wold, Barbara; Carninci, Piero; Guigo, Roderic; Gingeras, Thomas R.			Landscape of transcription in human cells	NATURE			English	Article							RNA; GENOME; IDENTIFICATION; ENHANCERS; MAPS	Eukaryotic cells make many types of primary and processed RNAs that are found either in specific subcellular compartments or throughout the cells. A complete catalogue of these RNAs is not yet available and their characteristic subcellular localizations are also poorly understood. Because RNA represents the direct output of the genetic information encoded by genomes and a significant proportion of a cell's regulatory capabilities are focused on its synthesis, processing, transport, modification and translation, the generation of such a catalogue is crucial for understanding genome function. Here we report evidence that three-quarters of the human genome is capable of being transcribed, as well as observations about the range and levels of expression, localization, processing fates, regulatory regions and modifications of almost all currently annotated and thousands of previously unannotated RNAs. These observations, taken together, prompt a redefinition of the concept of a gene.	[Djebali, Sarah; Merkel, Angelika; Tanzer, Andrea; Lagarde, Julien; Roeder, Maik; Alioto, Tyler; Curado, Joao; Derrien, Thomas; Ferreira, Pedro; Gonzalez, David; Johnson, Rory; King, Brandon; Kingswood, Colin; Ribeca, Paolo; Sammeth, Michael; Skancke, Jorgen; Tilgner, Hagen; Guigo, Roderic] Ctr Gen Regulat, Barcelona 08003, Catalonia, Spain; [Djebali, Sarah; Merkel, Angelika; Tanzer, Andrea; Lagarde, Julien; Roeder, Maik; Alioto, Tyler; Curado, Joao; Derrien, Thomas; Ferreira, Pedro; Gonzalez, David; Johnson, Rory; King, Brandon; Kingswood, Colin; Ribeca, Paolo; Sammeth, Michael; Skancke, Jorgen; Tilgner, Hagen; Guigo, Roderic] UPF, Barcelona 08003, Catalonia, Spain; [Davis, Carrie A.; Dobin, Alex; Lin, Wei; Schlesinger, Felix; Xue, Chenghai; Zaleski, Chris; Baer, Michael T.; Batut, Philippe; Bell, Kimberly; Chakrabortty, Sudipto; Drenkow, Jorg; Fastuca, Meagan; Fejes-Toth, Kata; Gordon, Assaf; Jha, Sonali; Persaud, Kimberly; Preall, Jonathan B.; See, Lei-Hoon; Wang, Huaien; Hannon, Gregory; Gingeras, Thomas R.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11742 USA; [Lassmann, Timo; Abdelhamid, Rehab F.; Suzuki, Ana Maria; Takahashi, Hazuki; Hayashizaki, Yoshihide; Carninci, Piero] RIKEN Omics Sci Ctr, RIKEN Yokohama Inst, Tsurumi ku, Yokohama, Kanagawa 2300045, Japan; [Mortazavi, Ali; Marinov, Georgi K.; Williams, Brian A.; Antoshechkin, Igor; King, Brandon; Schaffer, Lorian; Trout, Diane; Wold, Barbara] CALTECH, Beckman Inst 2, Div Biol, Pasadena, CA 91125 USA; [Mortazavi, Ali; Park, Eddie] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; [Khatun, Jainab; Risk, Brian; Wrobel, John] Boise State Univ, Coll Arts & Sci, Boise, ID 83725 USA; [Rozowsky, Joel; Gerstein, Mark] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; [Rozowsky, Joel; Gerstein, Mark] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Kokocinski, Felix; Harrow, Jennifer; Hubbard, Tim] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Alioto, Tyler; Kingswood, Colin; Ribeca, Paolo; Sammeth, Michael] CNAG, Barcelona 08028, Catalonia, Spain; [Bar, Nadav S.; Skancke, Jorgen] Norwegian Univ Sci & Technol, Dept Chem Engn, NO-7491 Trondheim, Norway; [Bell, Ian; Dumais, Erica; Dumais, Jacqueline; Duttagupta, Radha; Foissac, Sylvain; Gao, Hui; Kapranov, Philipp; Gingeras, Thomas R.] Affymetrix Inc, Santa Clara, CA 95051 USA; [Chen, Xian; Gunawardena, Harsha; Yu, Yanbao; Giddings, Morgan C.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Chrast, Jacqueline; Howald, Cedric; Walters, Nathalie; Reymond, Alexandre] Univ Lausanne, Ctr Integrat Gen, CH-1015 Lausanne, Switzerland; [Falconnet, Emilie; Robyr, Daniel; Antonarakis, Stylianos E.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Falconnet, Emilie; Robyr, Daniel; Antonarakis, Stylianos E.] IGE3 Inst Genet & Genom Geneva, CH-1211 Geneva, Switzerland; [Fullwood, Melissa J.; Luo, Oscar J.; Shahab, Atif; Ruan, Xiaoan; Ruan, Yijun] Genome Inst Singapore, Singapore 138672, Singapore; [Kapranov, Philipp] St Laurent Inst, Cambridge, MA 02141 USA; [Gerstein, Mark] Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA; [Guigo, Roderic] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Barcelona, Catalonia, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Cold Spring Harbor Laboratory; RIKEN; California Institute of Technology; University of California System; University of California Irvine; Idaho; Boise State University; Yale University; Yale University; Wellcome Trust Sanger Institute; Norwegian University of Science & Technology (NTNU); Affymetrix; University of North Carolina; University of North Carolina Chapel Hill; University of Lausanne; University of Geneva; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Yale University; Pompeu Fabra University	Guigo, R (corresponding author), Ctr Gen Regulat, Doctor Aiguader 88, Barcelona 08003, Catalonia, Spain.	roderic.guigo@crg.eu; gingeras@cshl.edu	Luo, Junhong/N-8583-2019; Djebali, Sarah/O-9817-2014; Gao, Hui/AAF-9770-2019; Yu, Yanbao/G-3035-2010; Lin, Wei/AAH-9924-2019; Derrien, Thomas/ABD-6197-2020; Takahashi, Hazuki/F-9007-2017; Alioto, Tyler/AAF-6342-2020; Sammeth, Michael/C-1157-2014; Guigo, Roderic/D-1303-2010; Ferreira, Pedro/HDO-1346-2022; Lassmann, Timo/A-8271-2008; Fullwood, Melissa/G-5713-2011; Tanzer, Andrea/AAY-5431-2021; Johnson, Rory/H-2961-2015; Hubbard, Tim J/C-2567-2008; Lagarde, Julien/AAI-1686-2020; Johnson, Rory/ABE-2503-2021; Ferreira, Pedro G/J-6379-2013; Hubbard, Tim J.P./AAT-4571-2020; Tanzer, Andrea/L-3147-2015; Luo, Oscar Junhong/G-3293-2018; Hannon, Gregory/AAB-3568-2019; Carninci, Piero/K-1568-2014; Alioto, Tyler/K-7267-2015; Lassmann, Timo/HCH-4313-2022; Kutalik, Zoltan/HHZ-5697-2022; Antonarakis, Stylianos E/N-8866-2014	Djebali, Sarah/0000-0002-0599-1267; Yu, Yanbao/0000-0003-2994-1974; Lin, Wei/0000-0002-7506-3466; Takahashi, Hazuki/0000-0001-7315-7349; Alioto, Tyler/0000-0002-2960-5420; Sammeth, Michael/0000-0002-6528-9883; Guigo, Roderic/0000-0002-5738-4477; Lassmann, Timo/0000-0002-0138-2691; Fullwood, Melissa/0000-0003-0321-7865; Tanzer, Andrea/0000-0003-2873-4236; Johnson, Rory/0000-0003-4607-2782; Hubbard, Tim J/0000-0002-1767-9318; Lagarde, Julien/0000-0002-0290-7445; Johnson, Rory/0000-0003-4607-2782; Ferreira, Pedro G/0000-0003-3838-8664; Hubbard, Tim J.P./0000-0002-1767-9318; Tanzer, Andrea/0000-0003-2873-4236; Carninci, Piero/0000-0001-7202-7243; Alioto, Tyler/0000-0002-2960-5420; Lassmann, Timo/0000-0002-0138-2691; Kutalik, Zoltan/0000-0001-8285-7523; Antonarakis, Stylianos E/0000-0001-8907-5823; park, eddie/0000-0001-5651-1481; Dobin, Alexander/0000-0002-4115-9128; Harrow, Jennifer/0000-0003-0338-3070; Kapranov, Philipp/0000-0003-2647-4856; Marinov, Georgi/0000-0003-1822-7273; Kokocinski, Felix/0000-0002-8472-9207; Bell, Kimberly/0000-0003-2204-8569; Luo, Oscar Junhong/0000-0002-1266-3069; Batut, Philippe/0000-0003-4250-0663; Reymond, Alexandre/0000-0003-1030-8327; Curado, Joao/0000-0003-3916-0936; Gingeras, Thomas/0000-0001-9106-3573; Rozowsky, Joel/0000-0002-3565-0762; Merkel, Angelika/0000-0001-5164-6803; Derrien, Thomas/0000-0002-8211-5789; Foissac, Sylvain/0000-0002-2631-5356	National Human Genome Research Institute (NHGRI) [U54HG004557, U54HG004555, U54HG004576, U54HG004558]; NHGRI pilot grant [R01HG003700]; NHGRI ARRA stimulus grant [1RC2HG005591]; National Science Foundation (SNF) [127375]; European Research Council (ERC) [249968]; Japanese Ministry of Education, Culture, Sports, Science and Technology; INB GNV-1 from the Spanish Ministry of Science;  [BIO2011-26205];  [CSD2007-00050]; NATIONAL CANCER INSTITUTE [P30CA045508] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004576, U54HG004557, RC2HG005591, U54HG007004, U54HG004555, U01HG003147, U54HG004558, R01HG003700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM062534] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI pilot grant; NHGRI ARRA stimulus grant; National Science Foundation (SNF); European Research Council (ERC)(European Research Council (ERC)); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); INB GNV-1 from the Spanish Ministry of Science; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Human Genome Research Institute (NHGRI) production grants U54HG004557, U54HG004555, U54HG004576 and U54HG004558, and by the NHGRI pilot grant R01HG003700. It was also supported by the NHGRI ARRA stimulus grant 1RC2HG005591, the National Science Foundation (SNF) grant 127375, the European Research Council (ERC) grant 249968, a research grant for the RIKEN Omics Science Center from the Japanese Ministry of Education, Culture, Sports, Science and Technology, and grants BIO2011-26205, CSD2007-00050 and INB GNV-1 from the Spanish Ministry of Science. We would also like to thank C. Gunter and W. Spitzer for editorial assistance with the manuscript.	Ameur A, 2011, NAT STRUCT MOL BIOL, V18, P1435, DOI 10.1038/nsmb.2143; Arvey A., GENOME RES IN PRESS; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Coffey AJ, 2011, EUR J HUM GENET, V19, P827, DOI 10.1038/ejhg.2011.28; Cole C, 2009, RNA, V15, P2147, DOI 10.1261/rna.1738409; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Fu YG, 2011, GENOME RES, V21, P741, DOI 10.1101/gr.115295.110; Harrow J., GENOME RES IN PRESS; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Hoffman M., GENOME RES IN PRESS; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; KATINAKIS PK, 1980, FEBS LETT, V116, P1, DOI 10.1016/0014-5793(80)80515-1; Kawaji H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-157; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kodzius R, 2006, NAT METHODS, V3, P211, DOI 10.1038/nmeth0306-211; Kundaje A., GENOME RES IN PRESS; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Mattick JS, 2011, SEMIN CELL DEV BIOL, V22, P327, DOI 10.1016/j.semcdb.2011.05.002; MILCAREK C, 1974, CELL, V3, P1, DOI 10.1016/0092-8674(74)90030-0; Miller B., GENOME RES IN PRESS; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ng P, 2005, NAT METHODS, V2, P105, DOI 10.1038/NMETH733; Park E., 1943, GENOME RES IN PRESS; Ren B, 2010, NATURE, V465, P173, DOI 10.1038/465173a; Rozowsky J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.54; SALDITTGEORGIEFF M, 1981, MOL CELL BIOL, V1, P179, DOI 10.1128/MCB.1.2.179; Tilgner H., GENOME RES IN PRESS; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wang J., GENOME RES IN PRESS; Yip K. Y., GENOME BIOL IN PRESS	36	3421	3559	8	399	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2012	489	7414					101	108		10.1038/nature11233	http://dx.doi.org/10.1038/nature11233			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999WW	22955620	Green Accepted, Green Published, hybrid			2022-12-24	WOS:000308347000043
J	Stringhini, S; Tabak, AG; Akbaraly, TN; Sabia, S; Shipley, MJ; Marmot, MG; Brunner, EJ; Batty, GD; Bovet, P; Kivimaki, M				Stringhini, Silvia; Tabak, Adam G.; Akbaraly, Tasnime N.; Sabia, Severine; Shipley, Martin J.; Marmot, Michael G.; Brunner, Eric J.; Batty, G. David; Bovet, Pascal; Kivimaeki, Mika			Contribution of modifiable risk factors to social inequalities in type 2 diabetes: prospective Whitehall II cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; SOCIOECONOMIC POSITION; PHYSICAL-ACTIVITY; LIFE-STYLE; FOLLOW-UP; HEALTH BEHAVIORS; AFRICAN-AMERICAN; NATIONAL-HEALTH; MORTALITY; MELLITUS	Objective To assess the contribution of modifiable risk factors to social inequalities in the incidence of type 2 diabetes when these factors are measured at study baseline or repeatedly over follow-up and when long term exposure is accounted for. Design Prospective cohort study with risk factors (health behaviours (smoking, alcohol consumption, diet, and physical activity), body mass index, and biological risk markers (systolic blood pressure, triglycerides and high density lipoprotein cholesterol)) measured four times and diabetes status assessed seven times between 1991-93 and 2007-09. Setting Civil service departments in London (Whitehall II study). Participants 7237 adults without diabetes (mean age 49.4 years; 2196 women). Main outcome measures Incidence of type 2 diabetes and contribution of risk factors to its association with socioeconomic status. Results Over a mean follow-up of 14.2 years, 818 incident cases of diabetes were identified. Participants in the lowest occupational category had a 1.86-fold (hazard ratio 1.86, 95% confidence interval 1.48 to 2.32) greater risk of developing diabetes relative to those in the highest occupational category. Health behaviours and body mass index explained 33% (-1% to 78%) of this socioeconomic differential when risk factors were assessed at study baseline (attenuation of hazard ratio from 1.86 to 1.51), 36% (22% to 66%) when they were assessed repeatedly over the follow-up (attenuated hazard ratio 1.48), and 45% (28% to 75%) when long term exposure over the follow-up was accounted for (attenuated hazard ratio 1.41). With additional adjustment for biological risk markers, a total of 53% (29% to 88%) of the socioeconomic differential was explained (attenuated hazard ratio 1.35, 1.05 to 1.72). Conclusions Modifiable risk factors such as health behaviours and obesity, when measured repeatedly over time, explain almost half of the social inequalities in incidence of type 2 diabetes. This is more than was seen in previous studies based on single measurement of risk factors.	[Stringhini, Silvia; Bovet, Pascal] Univ Lausanne Hosp, Inst Social & Prevent Med, CH-1010 Lausanne, Switzerland; [Tabak, Adam G.; Akbaraly, Tasnime N.; Sabia, Severine; Shipley, Martin J.; Marmot, Michael G.; Brunner, Eric J.; Batty, G. David; Kivimaeki, Mika] UCL, Dept Epidemiol & Publ Hlth, London, England; [Tabak, Adam G.] Semmelweis Univ, Fac Med, Dept Med 1, H-1085 Budapest, Hungary; [Akbaraly, Tasnime N.] INSERM, U1061, Montpellier, France; [Akbaraly, Tasnime N.] Univ Montpellier I, Montpellier, France; [Batty, G. David] Univ Edinburgh, MRC Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of London; University College London; Semmelweis University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; University of Edinburgh	Stringhini, S (corresponding author), Univ Lausanne Hosp, Inst Social & Prevent Med, CH-1010 Lausanne, Switzerland.	silvia.stringhini@chuv.ch	Kivimaki, Mika/B-3607-2012; Brunner, Eric/H-2114-2011; Sabia, Séverine/G-2966-2017; Batty, GD/Y-4401-2018; Bovet, Pascal/F-4477-2011; Stringhini, Silvia/B-4899-2013; AKBARALY, Tasnime/H-1389-2018; Tabak, Adam/A-5007-2012; Marmot, M G/Y-3920-2019	Kivimaki, Mika/0000-0002-4699-5627; Brunner, Eric/0000-0002-0595-4474; Sabia, Séverine/0000-0003-3109-9720; Batty, GD/0000-0003-1822-5753; Bovet, Pascal/0000-0002-0242-4259; AKBARALY, Tasnime/0000-0002-2150-4190; Marmot, M G/0000-0002-2431-6419; Tabak, Adam/0000-0002-6234-3936	Swiss School of Public Health; UK Medical Research Council (MRC); US National Institutes of Health (NIH) [R01HL036310, R01AG034454]; EU New OSH ERA Research Programme; Economic and Social Research Council (ESRC); National Heart, Lung, and Blood Institute [R01HL036310]; National Institute of Aging, NIH [R01AG034454]; British Heart Foundation; MRC; British Health and Safety Executive; British Department of Health; UK research council call for lifelong health and wellbeing; MRC [G0902037] Funding Source: UKRI; British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Medical Research Council [G0902037, G19/35, G0100222, G8802774] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034454] Funding Source: NIH RePORTER	Swiss School of Public Health; UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU New OSH ERA Research Programme; Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Aging, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Health and Safety Executive; British Department of Health; UK research council call for lifelong health and wellbeing; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	SStringhini is supported by a postdoctoral fellowship awarded by the Swiss School of Public Health. MK is supported by the UK Medical Research Council (MRC), the US National Institutes of Health (NIH) (R01HL036310; R01AG034454), the EU New OSH ERA Research Programme, and an Economic and Social Research Council (ESRC) professorship. DB is a Wellcome Trust fellow. TA is supported by the National Heart, Lung, and Blood Institute (R01HL036310). SSabia is supported by a grant from the National Institute of Aging, NIH (R01AG034454). MS is supported by the British Heart Foundation. The Whitehall II study has been supported by grants from the MRC; the British Heart Foundation; the British Health and Safety Executive; the British Department of Health; the National Heart, Lung, and Blood Institute (R01HL036310); and the National Institute on Aging, NIH. The University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology is funded as part of the joint UK research council call for lifelong health and wellbeing. The funding organisations or sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the manuscript.	Agardh EE, 2004, DIABETES CARE, V27, P716, DOI 10.2337/diacare.27.3.716; Agardh E, 2011, INT J EPIDEMIOL, V40, P804, DOI 10.1093/ije/dyr029; Aim-High I., 2011, NEW ENGL J MED, V365, P2255, DOI DOI 10.1056/NEJM0A1107579; Akbaraly TN, 2011, AM J CLIN NUTR, V94, P247, DOI 10.3945/ajcn.111.013128; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Am Diabetes Assoc, 1999, CIRCULATION, V100, P1132, DOI 10.1161/01.cir.100.10.1132; [Anonymous], 2007, CHALL OB WHO EUR REG; Astrup A, 2000, Obes Rev, V1, P57, DOI 10.1046/j.1467-789x.2000.00013.x; Athyros VG, 2010, EXPERT OPIN PHARMACO, V11, P1965, DOI 10.1517/14656566.2010.489553; Barker DJP, 1999, ANN INTERN MED, V130, P322, DOI 10.7326/0003-4819-130-4-199902160-00019; Britton A, 2004, AM J EPIDEMIOL, V160, P240, DOI 10.1093/aje/kwh206; Brown AF, 2004, EPIDEMIOL REV, V26, P63, DOI 10.1093/epirev/mxh002; Carnethon MR, 2003, AM J EPIDEMIOL, V158, P416, DOI 10.1093/aje/kwg172; Chinn DJ, 1999, J EPIDEMIOL COMMUN H, V53, P191, DOI 10.1136/jech.53.3.191; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Coughlin SS, 2004, AM J EPIDEMIOL, V159, P1160, DOI 10.1093/aje/kwh161; Danaei G, 2006, LANCET, V368, P1651, DOI 10.1016/S0140-6736(06)69700-6; De Irala-Estevez J, 2000, EUR J CLIN NUTR, V54, P706, DOI 10.1038/sj.ejcn.1601080; De Silva NMG, 2011, DIABETES, V60, P1008, DOI 10.2337/db10-1317; Elovainio M, 2011, AM J EPIDEMIOL, V174, P779, DOI 10.1093/aje/kwr149; Espelt A, 2011, CURR DIABETES REV, V7, P148, DOI 10.2174/157339911795843131; EVERHART JE, 1992, DIABETES, V41, P235, DOI 10.2337/diabetes.41.2.235; Hardoon SL, 2012, EUR HEART J, V33, P478, DOI 10.1093/eurheartj/ehr142; Hu G, 2004, ARCH INTERN MED, V164, P892, DOI 10.1001/archinte.164.8.892; Imkampe AK, 2011, EUR J PUBLIC HEALTH, V21, P484, DOI 10.1093/eurpub/ckq106; International Diabetes Federation, 2006, DIAB ALL; Kivimaki M, 2008, LANCET, V372, P1648, DOI 10.1016/S0140-6736(08)61688-8; Kumari M, 2004, ARCH INTERN MED, V164, P1873, DOI 10.1001/archinte.164.17.1873; Lawlor DA, 2002, BRIT MED J, V325, P805, DOI 10.1136/bmj.325.7368.805; Lawlor DA, 2006, OBESITY, V14, P2294, DOI 10.1038/oby.2006.269; Marmot MG, 2008, DIABETOLOGIA, V51, P1980, DOI 10.1007/s00125-008-1144-3; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; Matsushima M, 1996, DIABETOLOGIA, V39, P710; Maty SC, 2005, INT J EPIDEMIOL, V34, P1274, DOI 10.1093/ije/dyi167; McCullough ML, 2002, AM J CLIN NUTR, V76, P1261, DOI 10.1093/ajcn/76.6.1261; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; Narayan KMV, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P591; National Cholesterol Education Program, 2002, 3 NAT CHOL ED PROGR; OSLER M, 1993, PUBLIC HEALTH, V107, P251, DOI 10.1016/S0033-3506(05)80504-9; Pan A, 2010, ARCH INTERN MED, V170, P1884, DOI 10.1001/archinternmed.2010.356; PERRY IJ, 1995, BRIT MED J, V310, P560, DOI 10.1136/bmj.310.6979.560; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Robbins JM, 2001, AM J PUBLIC HEALTH, V91, P76, DOI 10.2105/AJPH.91.1.76; Sabia S, 2012, AM J PUBLIC HEALTH, V102, P698, DOI 10.2105/AJPH.2011.300257; Samuel-Hodge CD, 2004, DIABETES CARE, V27, P663, DOI 10.2337/diacare.27.3.663; Shah S, 2001, J HYPERTENS, V19, P1333, DOI 10.1097/00004872-200107000-00020; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Stringhini S, 2010, JAMA-J AM MED ASSOC, V303, P1159, DOI 10.1001/jama.2010.297; Tabak AG, 2009, LANCET, V373, P2215, DOI 10.1016/S0140-6736(09)60619-X; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Wan Q, 2010, DIABETIC MED, V27, P1312, DOI 10.1111/j.1464-5491.2010.03107.x; WHO, 2011, DIAB; Wikstrom K, 2011, EUR J PUBLIC HEALTH, V21, P768, DOI 10.1093/eurpub/ckq164; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; Williams ED, 2010, DIABETOLOGIA, V53, P2538, DOI 10.1007/s00125-010-1888-4; Wooldridge JM, 2007, J ECONOMETRICS, V141, P1281, DOI 10.1016/j.jeconom.2007.02.002; Zhang P, 2004, ANN INTERN MED, V140, P972, DOI 10.7326/0003-4819-140-11-200406010-00039; Zins M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026531	58	106	107	0	32	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 21	2012	345								e5452	10.1136/bmj.e5452	http://dx.doi.org/10.1136/bmj.e5452			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	996GP	22915665	hybrid, Green Submitted, Green Published			2022-12-24	WOS:000308073200002
J	Bedell, VM; Wang, Y; Campbell, JM; Poshusta, TL; Starker, CG; Krug, RG; Tan, WF; Penheiter, SG; Ma, AC; Leung, AYH; Fahrenkrug, SC; Carlson, DF; Voytas, DF; Clark, KJ; Essner, JJ; Ekker, SC				Bedell, Victoria M.; Wang, Ying; Campbell, Jarryd M.; Poshusta, Tanya L.; Starker, Colby G.; Krug, Randall G., II; Tan, Wenfang; Penheiter, Sumedha G.; Ma, Alvin C.; Leung, Anskar Y. H.; Fahrenkrug, Scott C.; Carlson, Daniel F.; Voytas, Daniel F.; Clark, Karl J.; Essner, Jeffrey J.; Ekker, Stephen C.			In vivo genome editing using a high-efficiency TALEN system	NATURE			English	Article							ZINC-FINGER NUCLEASES; TARGETED GENE DISRUPTION; DNA-BINDING SPECIFICITY; ZEBRAFISH; EFFECTORS; CELLS	The zebrafish (Danio rerio) is increasingly being used to study basic vertebrate biology and human disease with a rich array of in vivo genetic and molecular tools. However, the inability to readily modify the genome in a targeted fashion has been a bottleneck in the field. Here we show that improvements in artificial transcription activator-like effector nucleases (TALENs) provide a powerful new approach for targeted zebrafish genome editing and functional genomic applications(1-5). Using the GoldyTALEN modified scaffold and zebrafish delivery system, we show that this enhanced TALEN toolkit has a high efficiency in inducing locus-specific DNA breaks in somatic and germline tissues. At some loci, this efficacy approaches 100%, including biallelic conversion in somatic tissues that mimics phenotypes seen using morpholino-based targeted gene knockdowns(6). With this updated TALEN system, we successfully used single-stranded DNA oligonucleotides to precisely modify sequences at predefined locations in the zebrafish genome through homology-directed repair, including the introduction of a custom-designed EcoRV site and a modified loxP (mloxP) sequence into somatic tissue in vivo. We further show successful germline transmission of both EcoRV and mloxP engineered chromosomes. This combined approach offers the potential to model genetic variation as well as to generate targeted conditional alleles.	[Bedell, Victoria M.; Campbell, Jarryd M.; Poshusta, Tanya L.; Krug, Randall G., II; Penheiter, Sumedha G.; Ma, Alvin C.; Clark, Karl J.; Ekker, Stephen C.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Wang, Ying; Essner, Jeffrey J.] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA; [Starker, Colby G.; Tan, Wenfang; Fahrenkrug, Scott C.; Carlson, Daniel F.; Voytas, Daniel F.] Univ Minnesota, Ctr Genome Engn, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Starker, Colby G.; Tan, Wenfang; Fahrenkrug, Scott C.; Carlson, Daniel F.; Voytas, Daniel F.] Univ Minnesota, Dept Anim Sci, Minneapolis, MN 55455 USA; [Ma, Alvin C.; Leung, Anskar Y. H.] Univ Hong Kong, LKS Fac Med, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Fahrenkrug, Scott C.; Carlson, Daniel F.] Recombinetics Inc, St Paul, MN 55114 USA	Mayo Clinic; Iowa State University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Hong Kong	Ekker, SC (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	ekker.stephen@mayo.edu	Ma, Alvin/AAM-5951-2021; Leung, Andrew Yee Tak/X-4743-2019	Ekker, Stephen/0000-0003-0726-4212; Essner, Jeffrey/0000-0001-8816-3848; Starker, Colby/0000-0002-6774-7227; /0000-0002-4800-2844; Bedell, Victoria/0000-0002-8959-6431; Clark, Karl/0000-0002-9637-0967; Voytas, Daniel/0000-0002-4944-1224; Fahrenkrug, Scott/0000-0002-7176-6551	State of Minnesota [H001274506]; NIH [GM63904, P30DK084567, DK083219, DA032194, R41HL108440, GM088424]; Mayo Foundation; NSF [DBI0923827]; Research Grant Council, The University of Hong Kong [HKU771611, HKU771110, HKU769809M]; Tang King Yin Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R41HL108440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567, F30DK083219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM063904, R01GM088424, R01GM063904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA032194] Funding Source: NIH RePORTER	State of Minnesota(University of Minnesota System); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; NSF(National Science Foundation (NSF)); Research Grant Council, The University of Hong Kong; Tang King Yin Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	State of Minnesota grant H001274506 to S. C. E. and D. F. V.; NIH GM63904 to S. C. E.; NIH grant P30DK084567 to S. C. E. and K.J.C.; NIH grant DK083219 to V. M. B.; Mayo Foundation; NIH DA032194 to K.J.C.; NIH grant R41HL108440 to D. F. C. and S. C. F.; NIH grant GM088424 to J.J.E.; NSF grant DBI0923827 to D. F. V.; General Research Fund (HKU771611, HKU771110, HKU769809M) from the Research Grant Council, The University of Hong Kong and the Tang King Yin Research Fund to A. C. M. and A.Y.H.L. We thank G. Davis for discussion on ssDNA use with custom restriction enzymes, H. J. Fadel for in vitro RNA synthesis, and S. Westcot for comments on this manuscript. We thank G. Moulder for help in DNA analyses and members of the Mayo Clinic Zebrafish Core Facility for excellent animal care.	Bedell VM, 2012, DEVELOPMENT, V139, P793, DOI 10.1242/dev.071720; Blum Y, 2008, DEV BIOL, V316, P312, DOI 10.1016/j.ydbio.2008.01.038; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Cade L, 2012, NUCLEIC ACIDS RES, V40, P8001, DOI 10.1093/nar/gks518; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Doyon Y, 2011, NAT METHODS, V8, P74, DOI 10.1038/NMETH.1539; Foley JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004348; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Hyatt TM, 1999, METHOD CELL BIOL, V59, P117; Lawson ND, 2011, DEV CELL, V21, P48, DOI 10.1016/j.devcel.2011.06.007; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; Meeker ND, 2007, BIOTECHNIQUES, V43, P610, DOI 10.2144/000112619; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Moore FE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037877; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Radecke S, 2010, MOL THER, V18, P743, DOI 10.1038/mt.2009.304; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Thomson JG, 2003, GENESIS, V36, P162, DOI 10.1002/gene.10211; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Wang Y, 2010, DEVELOPMENT, V137, P3119, DOI 10.1242/dev.048785	27	695	823	12	475	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 1	2012	491	7422					114	U133		10.1038/nature11537	http://dx.doi.org/10.1038/nature11537			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	028PM	23000899	Green Published, Green Accepted, Green Submitted			2022-12-24	WOS:000310434500041
J	Quint, M; Drost, HG; Gabel, A; Ullrich, KK; Bonn, M; Grosse, I				Quint, Marcel; Drost, Hajk-Georg; Gabel, Alexander; Ullrich, Kristian Karsten; Boenn, Markus; Grosse, Ivo			A transcriptomic hourglass in plant embryogenesis	NATURE			English	Article							GENE-EXPRESSION; ARABIDOPSIS; BEGINNINGS; EVOLUTION	Animal and plant development starts with a constituting phase called embryogenesis, which evolved independently in both lineages(1). Comparative anatomy of vertebrate development-based on the Meckel-Serres law(2) and von Baer's laws of embryology(3) from the early nineteenth century-shows that embryos from various taxa appear different in early stages, converge to a similar form during mid-embryogenesis, and again diverge in later stages. This morphogenetic series is known as the embryonic 'hourglass'(4,5), and its bottleneck of high conservation in mid-embryogenesis is referred to as the phylotypic stage(6). Recent analyses in zebrafish and Drosophila embryos provided convincing molecular support for the hourglass model, because during the phylotypic stage the transcriptome was dominated by ancient genes(7) and global gene expression profiles were reported to be most conserved(8). Although extensively explored in animals, an embryonic hourglass has not been reported in plants, which represent the second major kingdom in the tree of life that evolved embryogenesis. Here we provide phylotranscriptomic evidence for a molecular embryonic hourglass in Arabidopsis thaliana, using two complementary approaches. This is particularly significant because the possible absence of an hourglass based on morphological features in plants suggests that morphological and molecular patterns might be uncoupled. Together with the reported developmental hourglass patterns in animals, these findings indicate convergent evolution of the molecular hourglass and a conserved logic of embryogenesis across kingdoms.	[Quint, Marcel; Ullrich, Kristian Karsten] Leibniz Inst Plant Biochem, Independent Jr Res Grp, Dept Mol Signal Proc, D-06120 Halle, Saale, Germany; [Drost, Hajk-Georg; Gabel, Alexander; Boenn, Markus; Grosse, Ivo] Univ Halle Wittenberg, Inst Comp Sci, D-06120 Halle, Saale, Germany; [Boenn, Markus] UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, D-06120 Halle, Saale, Germany	Leibniz Institut fur Pflanzenbiochemie; Martin Luther University Halle Wittenberg; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Quint, M (corresponding author), Leibniz Inst Plant Biochem, Independent Jr Res Grp, Dept Mol Signal Proc, Weinberg 3, D-06120 Halle, Saale, Germany.	mquint@ipb-halle.de	Ullrich, Kristian/AAP-6724-2021; Drost, Hajk-Georg/G-2632-2015; quint, marcel/J-8483-2012	Ullrich, Kristian/0000-0003-4308-9626; Drost, Hajk-Georg/0000-0002-1567-306X; Quint, Marcel/0000-0003-2935-4083	'Exzellenznetzwerk fur Biowissenschaften' of the Federal State of Sachsen-Anhalt, Germany	'Exzellenznetzwerk fur Biowissenschaften' of the Federal State of Sachsen-Anhalt, Germany	We are grateful to S. Abel, L. I. A. Calderon Villalobos, C. Delker, T. Greb, D. Grubb, J. J. Harada, D. Jackson, R. Paxton, A. Soro and C. Wasternack for discussions, to S. Neumann for support with the IPB-cluster, and the 'Exzellenznetzwerk fur Biowissenschaften' of the Federal State of Sachsen-Anhalt, Germany, for financial support of M.Q.	Arakaki M, 2011, P NATL ACAD SCI USA, V108, P8379, DOI 10.1073/pnas.1100628108; Baer v., 1828, ENTWICKLUNGSGESCHICH; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; De Smet I, 2010, PLANT J, V61, P959, DOI 10.1111/j.1365-313X.2010.04143.x; Domazet-Loso T, 2007, TRENDS GENET, V23, P533, DOI 10.1016/j.tig.2007.08.014; Domazet-Loso T, 2010, NATURE, V468, P815, DOI 10.1038/nature09632; DUBOULE D, 1994, DEVELOPMENT, P135; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Irie N, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1248; Irie N, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-1; Kalinka AT, 2010, NATURE, V468, P811, DOI 10.1038/nature09634; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Koch MA, 2005, AM J BOT, V92, P761, DOI 10.3732/ajb.92.4.761; Koch MA, 2000, MOL BIOL EVOL, V17, P1483, DOI 10.1093/oxfordjournals.molbev.a026248; Lau S, 2012, ANNU REV PLANT BIOL, V63, P483, DOI 10.1146/annurev-arplant-042811-105507; Le BH, 2010, P NATL ACAD SCI USA, V107, P8063, DOI 10.1073/pnas.1003530107; Levin M, 2012, DEV CELL, V22, P1101, DOI 10.1016/j.devcel.2012.04.004; Meckel JF, 1811, BEYTRAGE VERGLEICHEN; Meyerowitz EM, 2002, SCIENCE, V295, P1482, DOI 10.1126/science.1066609; Nodine MD, 2012, NATURE, V482, P94, DOI 10.1038/nature10756; Oh DH, 2010, PLANT PHYSIOL, V154, P1040, DOI 10.1104/pp.110.163923; Park Soornin, 2008, V427, P3, DOI 10.1007/978-1-59745-273-1_1; Peris CIL, 2010, CURR TOP DEV BIOL, V91, P1, DOI 10.1016/S0070-2153(10)91001-6; Raff R. A., 1996, SHAPE LIFE GENES DEV; Sander K., 1983, DEV EVOLUTION, P137; SLACK JMW, 1993, NATURE, V361, P490, DOI 10.1038/361490a0; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Thornton K, 2003, BIOINFORMATICS, V19, P2325, DOI 10.1093/bioinformatics/btg316; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Xiang DQ, 2011, PLANT PHYSIOL, V156, P346, DOI 10.1104/pp.110.171702; Zuber H, 2010, PLANT PHYSIOL, V154, P913, DOI 10.1104/pp.110.162123	31	123	126	1	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2012	490	7418					98	+		10.1038/nature11394	http://dx.doi.org/10.1038/nature11394			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015LG	22951968				2022-12-24	WOS:000309446800040
J	Zhen, Y; Aardema, ML; Medina, EM; Schumer, M; Andolfatto, P				Zhen, Ying; Aardema, Matthew L.; Medina, Edgar M.; Schumer, Molly; Andolfatto, Peter			Parallel Molecular Evolution in an Herbivore Community	SCIENCE			English	Article							OUABAIN-BINDING-SITE; CARDIAC-GLYCOSIDES; MORPHOLOGICAL EVOLUTION; GASTRIC H,K-ATPASE; DANAUS-PLEXIPPUS; K+-ATPASE; EVO-DEVO; INSENSITIVITY; NA+,K+-ATPASE; NA,K-ATPASE	Numerous insects have independently evolved the ability to feed on plants that produce toxic secondary compounds called cardenolides and can sequester these compounds for use in their defense. We surveyed the protein target for cardenolides, the alpha subunit of the sodium pump, Na+, K+-ATPase (ATP alpha), in 14 species that feed on cardenolide-producing plants and 15 outgroups spanning three insect orders. Despite the large number of potential targets for modulating cardenolide sensitivity, amino acid substitutions associated with host-plant specialization are highly clustered, with many parallel substitutions. Additionally, we document four independent duplications of ATPa with convergent tissue-specific expression patterns. We find that unique substitutions are disproportionately associated with recent duplications relative to parallel substitutions. Together, these findings support the hypothesis that adaptation tends to take evolutionary paths that minimize negative pleiotropy.	[Zhen, Ying; Aardema, Matthew L.; Schumer, Molly; Andolfatto, Peter] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Zhen, Ying; Andolfatto, Peter] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Medina, Edgar M.] Univ Los Andes, Dept Ciencias Biol, Bogota 11001, Colombia	Princeton University; Princeton University; Universidad de los Andes (Colombia)	Andolfatto, P (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	pandolfa@princeton.edu	Zhen, Ying/M-4705-2016	Schumer, Molly/0000-0002-2075-5668; Medina, Edgar M./0000-0002-5518-5933; Andolfatto, Peter/0000-0003-3393-4574	International Centre for Genetic Engineering and Biotechnology (ICGEB) [CRP/COL09-01]; NSF [DEB-0946398]; NIH [R01-GM083228]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083228] Funding Source: NIH RePORTER	International Centre for Genetic Engineering and Biotechnology (ICGEB); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Thanks to M. and K. Kardestuncer for collecting the hickory tussock moths; A. Briscoe for providing queen, solider, and tiger-mimic queen butterfly tissue samples; D. Stern for the suggestion of trying de novo assembly of RNA-seq data; and M. Przeworski for helpful discussions and comments on the manuscript. Funded in part by an International Centre for Genetic Engineering and Biotechnology (ICGEB) Research Grant (No. CRP/COL09-01) to E. M. M. and NSF grant DEB-0946398 and NIH grant R01-GM083228 to P. A. All raw sequence data generated in this study can be downloaded at http://genomics-pubs. princeton.edu/insect_genomics/data.shtml, and assemblies of ATP alpha have been submitted to GenBank under accession nos. JQ771496 to 527.	Aardema ML, 2012, MOL ECOL, V21, P340, DOI 10.1111/j.1365-294X.2011.05379.x; Agrawal AA, 2004, AM NAT, V164, P113, DOI 10.1086/420980; ALROBAI AA, 1993, COMP BIOCHEM PHYS B, V106, P805, DOI 10.1016/0305-0491(93)90034-3; CANFIELD VA, 1992, NEW BIOL, V4, P339; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Christin PA, 2010, TRENDS GENET, V26, P400, DOI 10.1016/j.tig.2010.06.005; Crow JF, 2008, ANNU REV GENET, V42, P1, DOI 10.1146/annurev.genet.42.110807.091612; De Pont JJHHM, 2009, PFLUG ARCH EUR J PHY, V457, P623, DOI 10.1007/s00424-008-0467-8; Dobler S, 2011, PHYTOCHEMISTRY, V72, P1593, DOI 10.1016/j.phytochem.2011.04.015; DUFFEY SS, 1980, ANNU REV ENTOMOL, V25, P447, DOI 10.1146/annurev.en.25.010180.002311; Freeman MR, 2006, TRENDS NEUROSCI, V29, P82, DOI 10.1016/j.tins.2005.12.002; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; HOLZINGER F, 1992, FEBS LETT, V314, P477, DOI 10.1016/0014-5793(92)81530-Y; Holzinger F, 1996, J CHEM ECOL, V22, P1921, DOI 10.1007/BF02028512; Kimura MA, 1985, NEUTRAL THEORY MOL E; Labeyrie E, 2004, MOL BIOL EVOL, V21, P218, DOI 10.1093/molbev/msg240; Lynch M, 2007, ORIGINS GENOME ARCHI; Manceau M, 2010, PHILOS T R SOC B, V365, P2439, DOI 10.1098/rstb.2010.0104; Mebs D, 2000, CHEMOECOLOGY, V10, P201, DOI 10.1007/PL00001823; Moore DJ, 2009, BIOL LETTERS, V5, P513, DOI 10.1098/rsbl.2009.0281; Nishida R, 2002, ANNU REV ENTOMOL, V47, P57, DOI 10.1146/annurev.ento.47.091201.145121; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; Prassas I, 2008, NAT REV DRUG DISCOV, V7, P926, DOI 10.1038/nrd2682; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; Qiu LY, 2005, J BIOL CHEM, V280, P32349, DOI 10.1074/jbc.M505168200; Riehle MM, 2001, P NATL ACAD SCI USA, V98, P525, DOI 10.1073/pnas.021448998; SHULL GE, 1986, BIOCHEMISTRY-US, V25, P8125, DOI 10.1021/bi00373a001; Stern DL, 2011, EVOLUTION DEV PREDIC; Sucena E, 2003, NATURE, V424, P935, DOI 10.1038/nature01768; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; VAUGHAN GL, 1977, J INSECT PHYSIOL, V23, P585, DOI 10.1016/0022-1910(77)90052-X; Wright S., 1968, EVOLUTION GENETICS P, P373; Yatime L, 2011, J STRUCT BIOL, V174, P296, DOI 10.1016/j.jsb.2010.12.004; Zhan S, 2011, CELL, V147, P1171, DOI 10.1016/j.cell.2011.09.052	34	172	174	2	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2012	337	6102					1634	1637		10.1126/science.1226630	http://dx.doi.org/10.1126/science.1226630			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	23019645	Green Accepted			2022-12-24	WOS:000309215400039
J	Bar-Peled, L; Schweitzer, LD; Zoncu, R; Sabatini, DM				Bar-Peled, Liron; Schweitzer, Lawrence D.; Zoncu, Roberto; Sabatini, David M.			Ragulator Is a GEF for the Rag GTPases that Signal Amino Acid Levels tomTORC1	CELL			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; GTP-BINDING PROTEINS; SACCHAROMYCES-CEREVISIAE; TRANSLATIONAL CONTROL; CENTROSOME DYNAMICS; STRUCTURAL-ANALYSIS; CRYSTAL-STRUCTURE; CELLULAR TARGET; LATE ENDOSOMES; COMPLEX	The mTOR Complex 1 (mTORC1) pathway regulates cell growth in response to numerous cues, including amino acids, which promote mTORC1 translocation to the lysosomal surface, its site of activation. The heterodimeric RagA/B-RagC/D GTPases, the Ragulator complex that tethers the Rags to the lysosome, and the v-ATPase form a signaling system that is necessary for amino acid sensing by mTORC1. Amino acids stimulate the binding of guanosine triphosphate to RagA and RagB but the factors that regulate Rag nucleotide loading are unknown. Here, we identify HBXIP and C7orf59 as two additional Ragulator components that are required for mTORC1 activation by amino acids. The expanded Ragulator has nucleotide exchange activity toward RagA and RagB and interacts with the Rag heterodimers in an amino acid-and v-ATPase-dependent fashion. Thus, we provide mechanistic insight into how mTORC1 senses amino acids by identifying Ragulator as a guanine nucleotide exchange factor (GEF) for the Rag GTPases.	[Bar-Peled, Liron; Schweitzer, Lawrence D.; Zoncu, Roberto; Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Bar-Peled, Liron; Schweitzer, Lawrence D.; Zoncu, Roberto; Sabatini, David M.] MIT, Cambridge Ctr 9, Dept Biol, Cambridge, MA 02142 USA; [Bar-Peled, Liron; Schweitzer, Lawrence D.; Zoncu, Roberto; Sabatini, David M.] Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Sabatini, David M.] MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu		/0000-0002-1446-7256	NIH [CA103866, AI47389]; Department of Defense [W81XWH-07-0448]; LAM Foundation; NCI [F31CA167872]; Jane Coffin Childs Memorial Fund for Medical Research; NATIONAL CANCER INSTITUTE [R01CA129105, F31CA167872, R01CA103866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047389, R37AI047389] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); LAM Foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Jane Coffin Childs Memorial Fund for Medical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank all members of the Sabatini Lab for helpful suggestions, John Doench for technical assistance, and Eric Spooner for mass spectrometric analyses of samples. This work was supported by grants from the NIH (CA103866 and AI47389) and Department of Defense (W81XWH-07-0448) to D.M.S., awards from the LAM Foundation to D.M.S., and fellowship support from the NCI (F31CA167872) to L.D.S. and from the LAM Foundation and the Jane Coffin Childs Memorial Fund for Medical Research to R.Z.D. M.S. is an investigator of the Howard Hughes Medical Institute.	Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Bowman AB, 1999, J CELL BIOL, V146, P165; Bowman EJ, 2004, J BIOL CHEM, V279, P33131, DOI 10.1074/jbc.M404638200; Cai YY, 2008, CELL, V133, P1202, DOI 10.1016/j.cell.2008.04.049; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Dubouloz F, 2005, MOL CELL, V19, P15, DOI 10.1016/j.molcel.2005.05.020; Feig LA, 1999, NAT CELL BIOL, V1, pE25, DOI 10.1038/10018; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; Fiegen D., 2006, PROTEINS CELL REGUL, V4, P45; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; FRECH M, 1994, BIOCHEMISTRY-US, V33, P3237, DOI 10.1021/bi00177a014; Fujii R, 2006, CANCER RES, V66, P9099, DOI 10.1158/0008-5472.CAN-06-1886; Gao MG, 2006, NAT CELL BIOL, V8, P657, DOI 10.1038/ncb1419; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Garcia-Saez I, 2011, J MOL BIOL, V405, P331, DOI 10.1016/j.jmb.2010.10.046; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Gong R, 2011, GENE DEV, V25, P1668, DOI 10.1101/gad.16968011; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hirose E, 1998, J CELL SCI, V111, P11; HOFFENBERG S, 1995, BIOCHEM BIOPH RES CO, V215, P241, DOI 10.1006/bbrc.1995.2459; Howell JJ, 2011, TRENDS ENDOCRIN MET, V22, P94, DOI 10.1016/j.tem.2010.12.003; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Jennings MD, 2010, NATURE, V465, P378, DOI 10.1038/nature09003; JOHN J, 1993, J BIOL CHEM, V268, P923; Jones S, 2000, MOL BIOL CELL, V11, P4403, DOI 10.1091/mbc.11.12.4403; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P12543, DOI 10.1021/bi00039a008; Koonin EV, 2000, CURR BIOL, V10, pR774, DOI 10.1016/S0960-9822(00)00774-0; KRENGEL U, 1990, CELL, V62, P539, DOI 10.1016/0092-8674(90)90018-A; Kurzbauer R, 2004, P NATL ACAD SCI USA, V101, P10984, DOI 10.1073/pnas.0403435101; Lenzen C, 1998, BIOCHEMISTRY-US, V37, P7420, DOI 10.1021/bi972621j; Lunin VV, 2004, J BIOL CHEM, V279, P23422, DOI 10.1074/jbc.M401648200; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Marusawa H, 2003, EMBO J, V22, P2729, DOI 10.1093/emboj/cdg263; Melegari M, 1998, J VIROL, V72, P1737, DOI 10.1128/JVI.72.3.1737-1743.1998; Miertzschke M, 2011, EMBO J, V30, P4185, DOI 10.1038/emboj.2011.291; Nada S, 2009, EMBO J, V28, P477, DOI 10.1038/emboj.2008.308; Roccio M, 2006, ONCOGENE, V25, P657, DOI 10.1038/sj.onc.1209106; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Schmidt G, 1996, ONCOGENE, V12, P87; SCHURMANN A, 1995, J BIOL CHEM, V270, P28982, DOI 10.1074/jbc.270.48.28982; Sekiguchi T, 2001, J BIOL CHEM, V276, P7246, DOI 10.1074/jbc.M004389200; Selyunin AS, 2011, NATURE, V469, P107, DOI 10.1038/nature09593; Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Wang FZ, 2007, ACTA PHARMACOL SIN, V28, P431, DOI 10.1111/j.1745-7254.2007.00531.x; Wang W, 2000, J CELL BIOL, V151, P289, DOI 10.1083/jcb.151.2.289; Wanschers B, 2008, CELL MOTIL CYTOSKEL, V65, P183, DOI 10.1002/cm.20254; Wen YF, 2008, J BIOL CHEM, V283, P2793, DOI 10.1074/jbc.M708419200; Wunderlich W, 2001, J CELL BIOL, V152, P765, DOI 10.1083/jcb.152.4.765; Xie XS, 2004, J BIOL CHEM, V279, P19755, DOI 10.1074/jbc.M313796200; Zhang BL, 2005, BIOCHEMISTRY-US, V44, P2566, DOI 10.1021/bi048755w; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	59	610	644	5	88	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 14	2012	150	6					1196	1208		10.1016/j.cell.2012.07.032	http://dx.doi.org/10.1016/j.cell.2012.07.032			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22980980	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000308928100013
J	Kim, T; Sandra, ZYX; Clauder-Munster, S; Steinmetz, LM; Buratowski, S				Kim, TaeSoo; Sandra, Zhenyu Xu; Clauder-Muenster, Sandra; Steinmetz, Lars M.; Buratowski, Stephen			Set3 HDAC Mediates Effects of Overlapping Noncoding Transcription on Gene Induction Kinetics	CELL			English	Article							HISTONE H3; SACCHAROMYCES-CEREVISIAE; METHYLATION; RNA; PHD; ACETYLATION; DEACETYLASE; EXPRESSION; CHROMATIN; LYSINE-4	The Set3 histone deacetylase complex (Set3C) binds histone H3 dimethylated at lysine 4 (H3K4me2) to mediate deacetylation of histones in 50-transcribed regions. To discern how Set3C affects gene expression, genome-wide transcription was analyzed in yeast undergoing a series of carbon source shifts. Deleting SET3 primarily caused changes during transition periods, as genes were induced or repressed. Surprisingly, a majority of Set3-affected genes are overlapped by noncoding RNA (ncRNA) transcription. Many Set3-repressed genes have H3K4me2 instead of me3 over promoter regions, due to either reduced H3K4me3 or ncRNA transcription from distal or antisense promoters. Set3C also represses internal cryptic promoters, but in different regions of genes than the Set2/Rpd3S pathway. Finally, Set3C stimulates some genes by repressing an overlapping antagonistic antisense transcript. These results show that overlapping noncoding transcription can fine-tune gene expression, not via the ncRNA but by depositing H3K4me2 to recruit the Set3C deacetylase.	[Kim, TaeSoo; Buratowski, Stephen] Harvard Univ, Dept Biol Chem & Mol Pharmacol, Sch Med, Boston, MA 02115 USA; [Sandra, Zhenyu Xu; Clauder-Muenster, Sandra; Steinmetz, Lars M.] European Mol Biol Lab, Genome Biol Unit, D-69117 Heidelberg, Germany	Harvard University; Harvard Medical School; European Molecular Biology Laboratory (EMBL)	Buratowski, S (corresponding author), Harvard Univ, Dept Biol Chem & Mol Pharmacol, Sch Med, 240 Longwood Ave, Boston, MA 02115 USA.	steveb@hms.harvard.edu		Clauder-Muenster, Sandra/0000-0002-9530-2938; Steinmetz, Lars/0000-0002-3962-2865; Kim, TaeSoo/0000-0002-3902-1058	US National Institutes of Health [GM068717, GM46498, GM56663]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM046498, R01GM046498, R01GM056663, R01GM068717] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Angelika Amon (MIT) for sharing unpublished work, Sebastian Marquardt for the northern blot analysis protocol, and Ollie Rando (University of Massachusetts, Worcester) and all members of the Buratowski lab for helpful advice and discussions. T.K. is a Special Fellow of the Leukemia and Lymphoma Society. This research was supported by grants GM068717 to L.M.S. and GM46498 and GM56663 to S.B. from the US National Institutes of Health.	Alejandro-Osorio AL, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r57; Bumgarner SL, 2012, MOL CELL, V45, P470, DOI 10.1016/j.molcel.2011.11.029; Bumgarner SL, 2009, P NATL ACAD SCI USA, V106, P18321, DOI 10.1073/pnas.0909641106; Buratowski S., 2011, COLD SPRING HARB SYM, V75, P95; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Cheung V, 2008, PLOS BIOL, V6, P2550, DOI 10.1371/journal.pbio.0060277; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Gomez-del Arco P, 2010, IMMUNITY, V33, P685, DOI 10.1016/j.immuni.2010.11.008; Govind CK, 2010, MOL CELL, V39, P234, DOI 10.1016/j.molcel.2010.07.003; Hang MD, 2011, GENETICS, V187, P1053, DOI 10.1534/genetics.110.125419; Hongay CF, 2006, CELL, V127, P735, DOI 10.1016/j.cell.2006.09.038; Hung T, 2009, MOL CELL, V33, P248, DOI 10.1016/j.molcel.2008.12.016; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim T, 2009, CELL, V137, P259, DOI 10.1016/j.cell.2009.02.045; Kirmizis A, 2007, NATURE, V449, P928, DOI 10.1038/nature06160; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kowalczyk MS, 2012, MOL CELL, V45, P447, DOI 10.1016/j.molcel.2011.12.021; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Lenstra TL, 2011, MOL CELL, V42, P536, DOI 10.1016/j.molcel.2011.03.026; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Li B, 2007, GENE DEV, V21, P1422, DOI 10.1101/gad.1539307; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Li JX, 2002, J BIOL CHEM, V277, P49383, DOI 10.1074/jbc.M209294200; Liang G, 2007, NAT STRUCT MOL BIOL, V14, P243, DOI 10.1038/nsmb1204; Marquardt S, 2011, TRANSCR-AUSTIN, V2, P145, DOI 10.4161/trns.2.3.16298; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Nishizawa M, 2008, PLOS BIOL, V6, P2817, DOI 10.1371/journal.pbio.0060326; Pijnappel WWMP, 2001, GENE DEV, V15, P2991, DOI 10.1101/gad.207401; Pinskaya M, 2009, EMBO J, V28, P1697, DOI 10.1038/emboj.2009.108; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Ruiz-Roig C, 2010, MOL MICROBIOL, V76, P1049, DOI 10.1111/j.1365-2958.2010.07167.x; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Storici F, 2001, NAT BIOTECHNOL, V19, P773, DOI 10.1038/90837; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Taverna SD, 2006, MOL CELL, V24, P785, DOI 10.1016/j.molcel.2006.10.026; van Dijk EL, 2011, NATURE, V475, P114, DOI 10.1038/nature10118; van Werven FJ, 2012, CELL, V150, P1170, DOI 10.1016/j.cell.2012.06.049; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Villa-Garcia MJ, 2011, MOL GENET GENOMICS, V285, P125, DOI 10.1007/s00438-010-0592-x; Wang A, 2002, SCIENCE, V298, P1412, DOI 10.1126/science.1077790; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Weinberger L, 2012, MOL CELL, V47, P193, DOI 10.1016/j.molcel.2012.05.008; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728	50	138	140	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 14	2012	150	6					1158	1169		10.1016/j.cell.2012.08.016	http://dx.doi.org/10.1016/j.cell.2012.08.016			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22959268	Green Accepted, Bronze			2022-12-24	WOS:000308928100010
J	Shiba, Y; Fernandes, S; Zhu, WZ; Filice, D; Muskheli, V; Kim, J; Palpant, NJ; Gantz, J; Moyes, KW; Reinecke, H; Van Biber, B; Dardas, T; Mignone, JL; Izawa, A; Hanna, R; Viswanathan, M; Gold, JD; Kotlikoff, MI; Sarvazyan, N; Kay, MW; Murry, CE; Laflamme, MA				Shiba, Yuji; Fernandes, Sarah; Zhu, Wei-Zhong; Filice, Dominic; Muskheli, Veronica; Kim, Jonathan; Palpant, Nathan J.; Gantz, Jay; Moyes, Kara White; Reinecke, Hans; Van Biber, Benjamin; Dardas, Todd; Mignone, John L.; Izawa, Atsushi; Hanna, Ramy; Viswanathan, Mohan; Gold, Joseph D.; Kotlikoff, Michael I.; Sarvazyan, Narine; Kay, Matthew W.; Murry, Charles E.; Laflamme, Michael A.			Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts	NATURE			English	Article							EMBRYONIC STEM-CELLS; RAT HEARTS; INFARCTION; TRANSPLANTATION; BLEBBISTATIN; REPERFUSION; INTEGRATION; MYOCARDIUM; INDICATORS; MYOCYTES	Transplantation studies in mice and rats have shown that human embryonic-stem-cell-derived cardiomyocytes (hESC-CMs) can improve the function of infarcted hearts(1-3), but two critical issues related to their electrophysiological behaviour in vivo remain unresolved. First, the risk of arrhythmias following hESC-CM transplantation in injured hearts has not been determined. Second, the electromechanical integration of hESC-CMs in injured hearts has not been demonstrated, so it is unclear whether these cells improve contractile function directly through addition of new force-generating units. Here we use a guinea-pig model to show that hESC-CM grafts in injured hearts protect against arrhythmias and can contract synchronously with host muscle. Injured hearts with hESC-CM grafts show improved mechanical function and a significantly reduced incidence of both spontaneous and induced ventricular tachycardia. To assess the activity of hESC-CM grafts in vivo, we transplanted hESC-CMs expressing the genetically encoded calcium sensor, GCaMP3 (refs 4, 5). By correlating the GCaMP3 fluorescent signal with the host ECG, we found that grafts in uninjured hearts have consistent 1:1 host-graft coupling. Grafts in injured hearts are more heterogeneous and typically include both coupled and uncoupled regions. Thus, human myocardial grafts meet physiological criteria for true heart regeneration, providing support for the continued development of hESC-based cardiac therapies for both mechanical and electrical repair.	[Shiba, Yuji; Fernandes, Sarah; Zhu, Wei-Zhong; Filice, Dominic; Muskheli, Veronica; Kim, Jonathan; Palpant, Nathan J.; Gantz, Jay; Moyes, Kara White; Reinecke, Hans; Van Biber, Benjamin; Murry, Charles E.; Laflamme, Michael A.] Univ Washington, Dept Pathol, Ctr Cardiovasc Biol, Inst Stem Cell & Regenerat Med, Seattle, WA 98109 USA; [Shiba, Yuji; Izawa, Atsushi] Shinshu Univ, Dept Cardiovasc Med, Matsumoto, Nagano 3908621, Japan; [Filice, Dominic; Gantz, Jay; Murry, Charles E.] Univ Washington, Inst Stem Cell & Regenerat Med, Ctr Cardiovasc Biol, Dept Bioengn, Seattle, WA 98109 USA; [Dardas, Todd; Mignone, John L.; Hanna, Ramy; Viswanathan, Mohan; Murry, Charles E.] Univ Washington, Inst Stem Cell & Regenerat Med, Ctr Cardiovasc Biol, Dept Med & Cardiol, Seattle, WA 98195 USA; [Gold, Joseph D.] Geron Corp, Menlo Pk, CA 94025 USA; [Kotlikoff, Michael I.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA; [Sarvazyan, Narine; Kay, Matthew W.] George Washington Univ, Dept Pharmacol & Physiol, Washington, DC 20037 USA; [Kay, Matthew W.] George Washington Univ, Dept Elect & Comp Engn, Washington, DC 20037 USA	University of Washington; University of Washington Seattle; Shinshu University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Geron Corporation; Cornell University; George Washington University; George Washington University	Laflamme, MA (corresponding author), Univ Washington, Dept Pathol, Ctr Cardiovasc Biol, Inst Stem Cell & Regenerat Med, 850 Republican St, Seattle, WA 98109 USA.	murry@uw.edu; laflamme@u.washington.edu	Zhu, Wei-Zhong/G-4919-2011; Palpant, Nathan/B-1641-2017; Laflamme, Michael/AAV-6791-2021; Gantz, Jay A/B-3581-2009; Kay, Matthew Wyatt/AAH-7336-2019	Palpant, Nathan/0000-0002-9334-8107; Laflamme, Michael/0000-0001-5908-880X; Kay, Matthew Wyatt/0000-0003-2756-5055; Sarvazyan, Narine/0000-0002-2002-5630; Kay, Mark/0000-0002-2799-2615; Shiba, Yuji/0000-0002-0311-2919	Geron Corporation; US National Institutes of Health [K08-HL80431, R01-HL064387, P01-HL094374, R01-HL084642, P01-GM81619, U01-HL100405, R01-HL095828]; University of Washington's Mouse Metabolic Phenotyping Center [U24-DK076126]; Grants-in-Aid for Scientific Research [23591035] Funding Source: KAKEN; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084642, R01HL064387, K08HL080431, P01HL094374, U01HL100405, R01HL095828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK076126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081619] Funding Source: NIH RePORTER	Geron Corporation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington's Mouse Metabolic Phenotyping Center; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Tallini, L. Linares, B. Johnson and S. Dupras for advice and technical assistance. This work was partly supported by a grant from Geron Corporation(M. A. L.), as well as by US National Institutes of Health grants K08-HL80431 (M. A. L.), R01-HL064387 (M. A. L. and C. E. M.), P01-HL094374 (M. A. L. and C. E. M.), R01-HL084642 (C. E. M.), P01-GM81619 (C. E. M.), U01-HL100405 (M. A. L. and C. E. M.) and R01-HL095828 (N.S. and M. W. K.). Animal experiments were supported in part by the University of Washington's Mouse Metabolic Phenotyping Center, U24-DK076126.	Asfour H, 2011, IEEE T BIO-MED ENG, V58, P2083, DOI 10.1109/TBME.2011.2143713; Biermann M, 1998, J CARDIOVASC ELECTR, V9, P1348, DOI 10.1111/j.1540-8167.1998.tb00110.x; Caspi O, 2007, J AM COLL CARDIOL, V50, P1884, DOI 10.1016/j.jacc.2007.07.054; Chen HSV, 2009, CIRCULATION, V120, P2496, DOI 10.1161/CIRCULATIONAHA.107.751412; Fedorov VV, 2007, HEART RHYTHM, V4, P619, DOI 10.1016/j.hrthm.2006.12.047; Fernandes S, 2010, J MOL CELL CARDIOL, V49, P941, DOI 10.1016/j.yjmcc.2010.09.008; Gepstein L, 2011, STEM CELLS, V29, P1475, DOI 10.1002/stem.702; Gutstein DE, 2003, AM J PHYSIOL-HEART C, V285, pH1091, DOI 10.1152/ajpheart.00100.2003; He JQ, 2003, CIRC RES, V93, P32, DOI 10.1161/01.RES.0000080317.92718.99; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Jonsson MKB, 2010, STEM CELL RES, V4, P189, DOI 10.1016/j.scr.2010.02.001; Kay M, 2008, AM J PHYSIOL-HEART C, V294, pH2400, DOI 10.1152/ajpheart.01158.2007; Kehat I, 2004, NAT BIOTECHNOL, V22, P1282, DOI 10.1038/nbt1014; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Kolega J, 2004, BIOCHEM BIOPH RES CO, V320, P1020, DOI 10.1016/j.bbrc.2004.06.045; Kotlikoff MI, 2007, J PHYSIOL-LONDON, V578, P55, DOI 10.1113/jphysiol.2006.120212; Kuznetsov SA, 2001, J CELL BIOL, V153, P1133, DOI 10.1083/jcb.153.5.1133; Laflamme MA, 2005, AM J PATHOL, V167, P663, DOI 10.1016/S0002-9440(10)62041-X; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Laurita KR, 2001, AM J PHYSIOL-HEART C, V280, pH2053, DOI 10.1152/ajpheart.2001.280.5.H2053; Li Y, 2005, BIOTECHNOL BIOENG, V91, P688, DOI 10.1002/bit.20536; Liao SY, 2010, HEART RHYTHM, V7, P1852, DOI 10.1016/j.hrthm.2010.09.006; Lieu DK, 2009, STEM CELLS DEV, V18, P1493, DOI 10.1089/scd.2009.0052; Mandel Y, 2012, CIRCULATION, V125, P883, DOI 10.1161/CIRCULATIONAHA.111.045146; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; Roell W, 2007, NATURE, V450, P819, DOI 10.1038/nature06321; Shiotani Motohiro, 2005, Journal of Toxicological Sciences, V30, P239, DOI 10.2131/jts.30.239; Shiotani Motohiro, 2007, Journal of Pharmacological and Toxicological Methods, V55, P27, DOI 10.1016/j.vascn.2006.04.008; Swift L, 2008, PHYSIOL MEAS, V29, P269, DOI 10.1088/0967-3334/29/2/009; Swoap SJ, 2004, AM J PHYSIOL-REG I, V287, pR391, DOI 10.1152/ajpregu.00731.2003; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; van Laake LW, 2007, STEM CELL RES, V1, P9, DOI 10.1016/j.scr.2007.06.001; WALKER MJA, 1988, CARDIOVASC RES, V22, P447, DOI 10.1093/cvr/22.7.447; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu CH, 2011, REGEN MED, V6, P53, DOI 10.2217/RME.10.91; Xue T, 2005, CIRCULATION, V111, P11, DOI 10.1161/01.CIR.0000151313.18547.A2; Zhu WZ, 2011, METHODS MOL BIOL, V767, P419, DOI 10.1007/978-1-61779-201-4_31; Zhu WZ, 2010, CIRC RES, V107, P776, DOI 10.1161/CIRCRESAHA.110.223917	40	505	526	2	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2012	489	7415					322	+		10.1038/nature11317	http://dx.doi.org/10.1038/nature11317			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003UC	22864415	Green Accepted			2022-12-24	WOS:000308635900048
J	Wrighton, KC; Thomas, BC; Sharon, I; Miller, CS; Castelle, CJ; VerBerkmoes, NC; Wilkins, MJ; Hettich, RL; Lipton, MS; Williams, KH; Long, PE; Banfield, JF				Wrighton, Kelly C.; Thomas, Brian C.; Sharon, Itai; Miller, Christopher S.; Castelle, Cindy J.; VerBerkmoes, Nathan C.; Wilkins, Michael J.; Hettich, Robert L.; Lipton, Mary S.; Williams, Kenneth H.; Long, Philip E.; Banfield, Jillian F.			Fermentation, Hydrogen, and Sulfur Metabolism in Multiple Uncultivated Bacterial Phyla	SCIENCE			English	Article							PYROCOCCUS-FURIOSUS; MICROBIAL COMMUNITY; DIVISION OP11; GENOMES; RECONSTRUCTION; ARCHAEAL; OKLAHOMA; GENES	BD1-5, OP11, and OD1 bacteria have been widely detected in anaerobic environments, but their metabolisms remain unclear owing to lack of cultivated representatives and minimal genomic sampling. We uncovered metabolic characteristics for members of these phyla, and a new lineage, PER, via cultivation-independent recovery of 49 partial to near-complete genomes from an acetate-amended aquifer. All organisms were nonrespiring anaerobes predicted to ferment. Three augment fermentation with archaeal-like hybrid type II/III ribulose-1,5-bisphosphate carboxylase-oxygenase (RuBisCO) that couples adenosine monophosphate salvage with CO2 fixation, a pathway not previously described in Bacteria. Members of OD1 reduce sulfur and may pump protons using archaeal-type hydrogenases. For six organisms, the UGA stop codon is translated as tryptophan. All bacteria studied here may play previously unrecognized roles in hydrogen production, sulfur cycling, and fermentation of refractory sedimentary carbon.	[Wrighton, Kelly C.; Thomas, Brian C.; Sharon, Itai; Miller, Christopher S.; Banfield, Jillian F.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Castelle, Cindy J.; Williams, Kenneth H.; Long, Philip E.; Banfield, Jillian F.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [VerBerkmoes, Nathan C.; Hettich, Robert L.] Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA; [Wilkins, Michael J.; Lipton, Mary S.] Pacific NW Natl Lab, Richland, WA 99352 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Banfield, JF (corresponding author), Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA.	jbanfield@berkeley.edu	Lipton, Mary S/H-3913-2012; Long, Philip E/F-5728-2013; Williams, Kenneth Hurst/O-5181-2014; Wilkins, Michael/A-9358-2013; Wrighton, Kelly C/ABD-6621-2021; Hettich, Robert L/N-1458-2016	Long, Philip E/0000-0003-4152-5682; Williams, Kenneth Hurst/0000-0002-3568-1155; Wrighton, Kelly C/0000-0003-0434-4217; Hettich, Robert L/0000-0001-7708-786X; Wilkins, Michael/0000-0002-3595-0853; Miller, Christopher/0000-0002-9448-8144; Banfield, Jill/0000-0001-8203-8771	U.S. Department of Energy (DOE) Subsurface Biogeochemistry Program; DOE Knowledgebase Program; EMBO; U.S. DOE [DE-AC02-05CH11231]	U.S. Department of Energy (DOE) Subsurface Biogeochemistry Program; DOE Knowledgebase Program; EMBO(European Molecular Biology Organization (EMBO)); U.S. DOE(United States Department of Energy (DOE))	We thank F. Larimer for RuBisCO analyses input; M. Shah for proteomic support; C. Thrash, P. Hugenholtz, and J. Eisen for manuscript suggestions; and the U.S. Department of Energy (DOE) Subsurface Biogeochemistry Program for funding, the DOE Knowledgebase Program for funding GGkbase, and EMBO for a fellowship to I. S. The Rifle, Colorado, Integrated Field Research Center Project is managed by Lawrence Berkeley National Laboratory for the U.S. DOE (contract no. DE-AC02-05CH11231). Portions of this work were performed in the Environmental Molecular Science Laboratory, a DOE national scientific user facility at Pacific Northwest National Laboratory. The sequences were deposited in the National Center for Biotechnology Information Sequence Read Archive (accession no. SRA050978.1). This Whole-Genome Shotgun project has been deposited at GenBank under the accession no. AMFJ00000000. The version described in this paper is the first version, AMFJ01000000. Genomic and proteomic data can be accessed via http://geomicrobiology.berkeley.edu/rifle/acd_ggkbase.html.	Anderson RT, 2003, APPL ENVIRON MICROB, V69, P5884, DOI 10.1128/AEM.69.10.5884-5891.2003; Briee C, 2007, RES MICROBIOL, V158, P213, DOI 10.1016/j.resmic.2006.12.012; Dick GJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r85; Elshahed MS, 2005, APPL ENVIRON MICROB, V71, P7598, DOI 10.1128/AEM.71.11.7598-7602.2005; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Harris JK, 2004, APPL ENVIRON MICROB, V70, P845, DOI 10.1128/AEM.70.2.845-849.2004; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Hugenholtz P, 1998, J BACTERIOL, V180, P366, DOI 10.1128/JB.180.2.366-376.1998; Iverson V, 2012, SCIENCE, V335, P587, DOI 10.1126/science.1212665; Kanai T, 2011, J BACTERIOL, V193, P3109, DOI 10.1128/JB.01072-10; MA K, 1993, P NATL ACAD SCI USA, V90, P5341, DOI 10.1073/pnas.90.11.5341; Mai XH, 1996, J BACTERIOL, V178, P5897, DOI 10.1128/jb.178.20.5897-5903.1996; McCutcheon JP, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000565; Miller CS, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r44; Pagani I, 2012, NUCLEIC ACIDS RES, V40, pD571, DOI 10.1093/nar/gkr1100; Peura S, 2012, ISME J, V6, P1640, DOI 10.1038/ismej.2012.21; Raes J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r10; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Sapra R, 2003, P NATL ACAD SCI USA, V100, P7545, DOI 10.1073/pnas.1331436100; Sato T, 2007, SCIENCE, V315, P1003, DOI 10.1126/science.1135999; Schocke L, 1998, EUR J BIOCHEM, V256, P589, DOI 10.1046/j.1432-1327.1998.2560589.x; Silva PJ, 2000, EUR J BIOCHEM, V267, P6541, DOI 10.1046/j.1432-1327.2000.01745.x; Tabita FR, 2008, PHILOS T R SOC B, V363, P2629, DOI 10.1098/rstb.2008.0023; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; van Haaster DJ, 2008, J BACTERIOL, V190, P1584, DOI 10.1128/JB.01562-07; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Wu DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018011; Youssef NH, 2011, APPL ENVIRON MICROB, V77, P7804, DOI 10.1128/AEM.06059-11	28	429	435	10	298	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2012	337	6102					1661	1665		10.1126/science.1224041	http://dx.doi.org/10.1126/science.1224041			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	23019650				2022-12-24	WOS:000309215400047
J	Lingwood, D; McTamney, PM; Yassine, HM; Whittle, JRR; Guo, XT; Boyington, JC; Wei, CJ; Nabel, GJ				Lingwood, Daniel; McTamney, Patrick M.; Yassine, Hadi M.; Whittle, James R. R.; Guo, Xiaoti; Boyington, Jeffrey C.; Wei, Chih-Jen; Nabel, Gary J.			Structural and genetic basis for development of broadly neutralizing influenza antibodies	NATURE			English	Article							CELL ANTIGEN RECEPTOR; VIRUS; SPECIFICITY; VACCINATION; ACTIVATION; INDUCTION; LYMPHOMAS; IMMUNITY; DENSITY; HIV-1	Influenza viruses take a yearly toll on human life despite efforts to contain them with seasonal vaccines. These viruses evade human immunity through the evolution of variants that resist neutralization. The identification of antibodies that recognize invariant structures on the influenza haemagglutinin (HA) protein have invigorated efforts to develop universal influenza vaccines. Specifically, antibodies to the highly conserved stem region of HA neutralize diverse viral subtypes. These antibodies largely derive from a specific antibody gene, heavy-chain variable region IGHV1-69, after limited affinity maturation from their germline ancestors(1,2), but how HA stimulates naive B cells to mature and induce protective immunity is unknown. To address this question, we analysed the structural and genetic basis for their engagement and maturation into broadly neutralizing antibodies. Here we show that the germline-encoded precursors of these antibodies act as functional B-cell antigen receptors (BCRs) that initiate subsequent affinity maturation. Neither the germline precursor of a prototypic antibody, CR6261 (ref. 3), nor those of two other natural human IGHV1-69 antibodies, bound HA as soluble immunoglobulin-G(IgG). However, all three IGHV1-69 precursors engaged HA when the antibody was expressed as cell surface IgM. HA triggered BCR-associated tyrosine kinase signalling by germline transmembrane IgM. Recognition and virus neutralization was dependent solely on the heavy chain, and affinity maturation of CR6261 required only seven amino acids in the complementarity-determining region (CDR) H1 and framework region 3 (FR3) to restore full activity. These findings provide insight into the initial events that lead to the generation of broadly neutralizing antibodies to influenza, informing the rational design of vaccines to elicit such antibodies and providing a model relevant to other infectious diseases, including human immunodeficiency virus/AIDS. The data further suggest that selected immunoglobulin genes recognize specific protein structural 'patterns' that provide a substrate for further affinity maturation.	[Lingwood, Daniel; McTamney, Patrick M.; Yassine, Hadi M.; Whittle, James R. R.; Guo, Xiaoti; Boyington, Jeffrey C.; Wei, Chih-Jen; Nabel, Gary J.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Nabel, GJ (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	gnabel@nih.gov	YASSINE, HADI M./AAW-6475-2020; Wei, Chih/GVT-5734-2022	YASSINE, HADI M./0000-0001-7592-2788; 	US Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; Intramural Research Program of the Vaccine Research Center, NIAID, National Institutes of Health	US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Intramural Research Program of the Vaccine Research Center, NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank N. Longo for help with JOINSOLVER analysis, Z.-Y. Yang for the design of membrane-bound IgM antibody, and X. Chen for technical support. We also thank A. Tislerics for manuscript preparation, B. Hartman and J. Farrar for preparation of figures, members of the G. J. N. laboratory and P. Kwong for advice and discussions. Use of the Advanced Photon Source was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract no. W-31-109-Eng-38. This research was supported by the Intramural Research Program of the Vaccine Research Center, NIAID, National Institutes of Health.	AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; BENJAMIN D, 1982, J IMMUNOL, V129, P1336; Chan CH, 2001, BLOOD, V97, P1023, DOI 10.1182/blood.V97.4.1023; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Fahmy TM, 2001, IMMUNITY, V14, P135, DOI 10.1016/S1074-7613(09)00099-5; Gustchina E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001182; Haid S, 2009, J BIOL CHEM, V284, P17657, DOI 10.1074/jbc.M109.014647; Heizmann B, 2010, P NATL ACAD SCI USA, V107, P18563, DOI 10.1073/pnas.1009048107; Huang CC, 2004, P NATL ACAD SCI USA, V101, P2706, DOI 10.1073/pnas.0308527100; Huppa JB, 2010, NATURE, V463, P963, DOI 10.1038/nature08746; Kabat EA, 1991, SEQUENCES PROTEINS I; KLEIN G, 1975, INTERVIROLOGY, V5, P319, DOI 10.1159/000149930; Kong WP, 2006, P NATL ACAD SCI USA, V103, P15987, DOI 10.1073/pnas.0607564103; Ledgerwood JE, 2011, LANCET INFECT DIS, V11, P916, DOI 10.1016/S1473-3099(11)70240-7; Liu WL, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002295; Luftig MA, 2006, NAT STRUCT MOL BIOL, V13, P740, DOI 10.1038/nsmb1127; METZGER H, 1992, J IMMUNOL, V149, P1477; Muller R, 2000, P NATL ACAD SCI USA, V97, P8451, DOI 10.1073/pnas.97.15.8451; Nabel GJ, 2010, NAT MED, V16, P1389, DOI 10.1038/nm1210-1389; Prabakaran P, 2006, J BIOL CHEM, V281, P15829, DOI 10.1074/jbc.M600697200; Souto-Carneiro MM, 2004, J IMMUNOL, V172, P6790, DOI 10.4049/jimmunol.172.11.6790; Sui J, 2011, CLIN INFECT DIS, V52, P1003, DOI 10.1093/cid/cir121; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Wei CJ, 2008, J VIROL, V82, P6200, DOI 10.1128/JVI.00187-08; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; Wienands J, 1996, P NATL ACAD SCI USA, V93, P7865, DOI 10.1073/pnas.93.15.7865; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Xiao XD, 2009, BIOCHEM BIOPH RES CO, V390, P404, DOI 10.1016/j.bbrc.2009.09.029; Yang ZY, 2007, SCIENCE, V317, P825, DOI 10.1126/science.1135165	31	182	187	1	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2012	489	7417					566	+		10.1038/nature11371	http://dx.doi.org/10.1038/nature11371			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	046RG	22932267	Green Published			2022-12-24	WOS:000311781500004
J	Rasmussen, TA; Jorgensen, MRS; Bjerrum, S; Jensen-Fangel, S; Stovring, H; Ostergaard, L; Sogaard, OS				Rasmussen, Thomas A.; Jorgensen, Martin R. S.; Bjerrum, Stephanie; Jensen-Fangel, Soren; Stovring, Henrik; Ostergaard, Lars; Sogaard, Ole S.			Use of population based background rates of disease to assess vaccine safety in childhood and mass immunisation in Denmark: nationwide population based cohort study	BRITISH MEDICAL JOURNAL			English	Article							GUILLAIN-BARRE-SYNDROME; INFLUENZA-A H1N1; RUBELLA VACCINATION; TRANSVERSE MYELITIS; MULTIPLE-SCLEROSIS; FEBRILE SEIZURES; MMR VACCINATION; ADVERSE EVENTS; AUTISM; MEASLES	Objectives To predict the number of selected outcomes temporally associated but not caused by vaccination, to aid causality assessment of adverse events arising after mass immunisation in a paediatric population. Design Nationwide population based cohort study. Setting Denmark. Participants All liveborn infants delivered after 1 January 1980. Study population was followed from date of birth until hospital admission for selected outcome diagnoses, death, first emigration, age 18 years, or 31 December 2009. The study population was subject to vaccines used in standard childhood immunisation in Denmark, with 82-93% vaccine coverage. Main outcome measures Incidence of acute infectious and post-infectious polyneuritis (Guillain-Barre syndrome), acute transverse myelitis, optic polyneuritis, facial nerve palsy, anaphylactic shock, seizure, multiple sclerosis, autoimmune thrombocytopenia, type 1 diabetes mellitus, juvenile and rheumatoid arthritis, narcolepsy, and death of unknown cause stratified by sex, age, and season. We predicted the number of events for a hypothetical vaccine cohort of 1 000 000 people for follow-up periods of up to 182 days. Results The study included 2 300 227 liveborn infants, yielding 37 262 404 person years of follow-up; median follow-up was 16.8 person years. Incidence of outcome diagnoses spanned from 0.32 per 100 000 patient years for autoimmune thrombocytopenia to 189.82 per 100 000 patient years for seizure. Seasonal differences were most pronounced for anaphylactic shock, seizure, and multiple sclerosis. Even for rare outcomes, numerous events were predicted in the hypothetical vaccine cohort. We predicted that 20 cases of type 1 diabetes mellitus, 19 of juvenile or rheumatoid arthritis, eight of facial nerve palsy, and five of multiple sclerosis per 1 000 000 children would occur within 42 days after vaccination. Conclusions Incorporating exact background rates of disease based on age, sex, and seasonal distribution could strengthen vaccine safety assessment, and provides an evidence based focus for discussing the incremental risk of newly introduced vaccines.	[Rasmussen, Thomas A.; Jensen-Fangel, Soren; Ostergaard, Lars; Sogaard, Ole S.] Aarhus Univ Hosp, Dept Infect Dis, DK-8200 Aarhus N, Denmark; [Jorgensen, Martin R. S.] Aarhus Univ Hosp, Aalborg Hosp, Dept Infect Dis, Aalborg, Denmark; [Bjerrum, Stephanie] Hvidovre Univ Hosp, Dept Infect Dis, DK-2650 Hvidovre, Denmark; [Stovring, Henrik] Aarhus Univ, Dept Publ Hlth, Aarhus, Denmark	Aarhus University; Aalborg University; Aalborg University Hospital; Aarhus University; University of Copenhagen; Aarhus University	Rasmussen, TA (corresponding author), Aarhus Univ Hosp, Dept Infect Dis, DK-8200 Aarhus N, Denmark.	thomrasm@rm.dk	Ostergaard, Lars/AAA-3020-2020; Søgaard, Ole Schmeltz/AEP-7968-2022; Søgaard, Ole S/P-6058-2016; Støvring, Henrik/H-5754-2019; Støvring, Henrik/I-4683-2012	Ostergaard, Lars/0000-0003-2459-0511; Søgaard, Ole Schmeltz/0000-0001-9107-2023; Støvring, Henrik/0000-0002-5821-2351; Støvring, Henrik/0000-0002-5821-2351; Rasmussen, Thomas Aagaard/0000-0001-5354-2442; Bjerrum, Stephanie/0000-0002-9046-6255; Ostergaard, Lars/0000-0002-7619-605X	Department of Infectious Diseases, Aarhus University Hospital, Denmark; Aarhus University Hospital	Department of Infectious Diseases, Aarhus University Hospital, Denmark; Aarhus University Hospital	The study was funded by the Department of Infectious Diseases, Aarhus University Hospital, Denmark.; All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: support from Aarhus University Hospital for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous 3 years; no other relationships or activities that could appear to have influenced the submitted work.	[Anonymous], 2011, PRESCRIRE INT, V20, P154; Bardage C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5956; Berlin JA, 2008, AM J PUBLIC HEALTH, V98, P1366, DOI 10.2105/AJPH.2007.124537; Black S, 2009, LANCET, V374, P2115, DOI 10.1016/S0140-6736(09)61877-8; Choe YJ, 2011, VACCINE, V29, P2066, DOI 10.1016/j.vaccine.2011.01.007; Christiansen CF, 2010, NEUROEPIDEMIOLOGY, V35, P267, DOI 10.1159/000320245; Deeks SL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-329; DeStefano F, 2010, LANCET, V375, P1146, DOI 10.1016/S0140-6736(09)61917-6; Dieleman J, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3908; Arcond MF, 2011, MEDICINA-BUENOS AIRE, V71, P161; Folkenberg M, 2011, VACCINE, V29, P1180, DOI 10.1016/j.vaccine.2010.12.008; Haba-Rubio J, 2011, REV NEUROL-FRANCE, V167, P563, DOI 10.1016/j.neurol.2011.04.003; Honda H, 2005, J CHILD PSYCHOL PSYC, V46, P572, DOI 10.1111/j.1469-7610.2005.01425.x; Huang WT, 2010, LANCET, V375, P1164, DOI 10.1016/S0140-6736(10)60515-6; Hviid A, 2008, AM J EPIDEMIOL, V168, P1277, DOI 10.1093/aje/kwn253; Institute of Medicine, 2010, ADV EFF VACC EV CAUS; Jansen VAA, 2003, SCIENCE, V301, P804, DOI 10.1126/science.1086726; Jiang GX, 1997, J NEUROL NEUROSUR PS, V62, P447, DOI 10.1136/jnnp.62.5.447; Klein NP, 2010, VACCINE, V28, P1062, DOI 10.1016/j.vaccine.2009.10.115; Kokia ES, 2007, VACCINE, V25, P8557, DOI 10.1016/j.vaccine.2007.10.021; Larson HJ, 2011, LANCET, V378, P526, DOI 10.1016/S0140-6736(11)60678-8; Lieu TA, 2007, MED CARE, V45, pS89, DOI 10.1097/MLR.0b013e3180616c0a; Lower Johannes, 2008, MMW Fortschr Med, V150, P6; Madsen KM, 2004, DRUG SAFETY, V27, P831, DOI 10.2165/00002018-200427120-00001; Madsen KM, 2002, NEW ENGL J MED, V347, P1477, DOI 10.1056/NEJMoa021134; Mitrakrishnan S, 2011, VACCINE, V29, P6369, DOI 10.1016/j.vaccine.2011.04.126; Norgaard M, 2007, PHARMACOEPIDEM DR S, V16, pS220; Norgaard M, 2011, BLOOD, V117, P3514, DOI 10.1182/blood-2010-10-312819; Salmon DA, 2011, PEDIATRICS, V127, pS78, DOI 10.1542/peds.2010-1722L; Sato N, 2011, INTERNAL MED, V50, P503, DOI 10.2169/internalmedicine.50.4340; Siegrist CA, 2007, PEDIATR INFECT DIS J, V26, P979, DOI 10.1097/INF.0b013e318149dfea; Statens Serum Institut, 2011, HPV VACC COV 2010; Statens Serum Institut, 2011, PCV COV INV PNEUM DI; Statens Serum Institut, VACC SURV; Statens Serum Institut, 2011, DTAP IPV HIB VACC CO; Statens Serum Institut, 2011, MMR VACC COV 2010; Sun YL, 2012, JAMA-J AM MED ASSOC, V307, P823, DOI 10.1001/jama.2012.165; Svanstrom H, 2010, DRUG SAFETY, V33, P1015, DOI 10.2165/11537630-000000000-00000; Thomsen RW, 2004, DIABETES CARE, V27, P70, DOI 10.2337/diacare.27.1.70; Vestergaard M, 2006, J CLIN EPIDEMIOL, V59, P61, DOI 10.1016/j.jclinepi.2005.05.008; Wakefield AJ, 1999, LANCET, V354, P949, DOI 10.1016/S0140-6736(05)75696-8; Wijnans L, 2011, VACCINE, V29, P7559, DOI 10.1016/j.vaccine.2011.08.016; Williams SE, 2011, VACCINE; Wu JA, 2010, NEW ENGL J MED, V363, P2416, DOI 10.1056/NEJMoa1006736; Yin JK, 2011, INFLUENZA OTHER RESP, V5, P299, DOI 10.1111/j.1750-2659.2011.00229.x	45	16	16	0	49	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 17	2012	345								e5823	10.1136/bmj.e5823	http://dx.doi.org/10.1136/bmj.e5823			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	011JG	22988304	Green Published, hybrid			2022-12-24	WOS:000309160300001
J	Mattiroli, F; Vissers, JHA; van Dijk, WJ; Ikpa, P; Citterio, E; Vermeulen, W; Marteijn, JA; Sixma, TK				Mattiroli, Francesca; Vissers, Joseph H. A.; van Dijk, Willem J.; Ikpa, Pauline; Citterio, Elisabetta; Vermeulen, Wim; Marteijn, Jurgen A.; Sixma, Titia K.			RNF168 Ubiquitinates K13-15 on H2A/H2AX to Drive DNA Damage Signaling	CELL			English	Article							X-RAY SOLUTION; DEPENDENT MONOUBIQUITYLATION; HOMOLOGOUS RECOMBINATION; HISTONE UBIQUITYLATION; H2A UBIQUITINATION; CONTAINING PROTEIN; 53BP1 RECRUITMENT; RING FINGER; LIGASE; REPAIR	Ubiquitin-dependent signaling during the DNA damage response (DDR) to double-strand breaks (DSBs) is initiated by two E3 ligases, RNF8 and RNF168, targeting histone H2A and H2AX. RNF8 is the first ligase recruited to the damage site, and RNF168 follows RNF8-dependent ubiquitination. This suggests that RNF8 initiates H2A/H2AX ubiquitination with K63-linked ubiquitin chains and RNF168 extends them. Here, we show that RNF8 is inactive toward nucleosomal H2A, whereas RNF168 catalyzes the monoubiquitination of the histones specifically on K13-15. Structure-based mutagenesis of RNF8 and RNF168 RING domains shows that a charged residue determines whether nucleosomal proteins are recognized. We find that K63 ubiquitin chains are conjugated to RNF168-dependent H2A/H2AX monoubiquitination at K13-15 and not on K118-119. Using a mutant of RNF168 unable to target histones but still catalyzing ubiquitin chains at DSBs, we show that ubiquitin chains per se are insufficient for signaling, but RNF168 target ubiquitination is required for DDR.	[Mattiroli, Francesca; van Dijk, Willem J.; Ikpa, Pauline; Sixma, Titia K.] Netherlands Canc Inst, Div Biochem, NL-1066 CX Amsterdam, Netherlands; [Mattiroli, Francesca; van Dijk, Willem J.; Ikpa, Pauline; Sixma, Titia K.] Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands; [Vissers, Joseph H. A.; Citterio, Elisabetta] Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; [Vermeulen, Wim; Marteijn, Jurgen A.] Erasmus MC, Dept Genet, NL-3015 GE Rotterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Erasmus University Rotterdam; Erasmus MC	Sixma, TK (corresponding author), Netherlands Canc Inst, Div Biochem, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	t.sixma@nki.nl	Marteijn, Jurgen A/B-5696-2014; Vissers, Joseph/AAB-7160-2019; Vermeulen, Wim/W-8708-2019; Mattiroli, Francesca/AAT-1489-2020	Marteijn, Jurgen A/0000-0001-9321-518X; Vissers, Joseph/0000-0003-0435-6824; Vermeulen, Wim/0000-0003-3616-734X; Mattiroli, Francesca/0000-0002-1574-7217; Ikpa, Pauline/0000-0002-3523-6318; Sixma, Titia K/0000-0001-6180-0632; Citterio, Elisabetta/0000-0003-2347-3495	ERC; EU project Ubiregulators [KWF 2006-3476]; Dutch Organization for Scientific Research ZonMW Veni [917-96-120]; NWO Vidi [864.08.011]; KWF [2007-3877]	ERC(European Research Council (ERC)European Commission); EU project Ubiregulators; Dutch Organization for Scientific Research ZonMW Veni; NWO Vidi(Netherlands Organization for Scientific Research (NWO)); KWF	We thank A. Perrakis, P. Rucktooa, and R. Joosten for crystallography support, J. Smit for contribution to E1 and E2 purifications, M. Uckelmann for contribution to in vitro specificity, D. Svergun and F. Groothuizen for assistance in SAXS measurements and analysis, J. Lukas, R. Klevit, L. Penengo, K. Luger, M. Peuscher, and J. Jacobs for plasmids, J. van der Knaap for providing Drosophila oligonucleosomes enriched in ubiquitinated H2B, G. Smeenk for help with gH2AX IPs, R. Hibbert for PCNA and Rad6 samples, J. Chen for anti-RAP80 antibodies, A. Nussenzweig for H2ax<SUP>-/-</SUP> MEFs, Genentech for K63-specific antibodies, W.A. van Cappellen of the Optical Imaging Centre, ErasmusMC, for help with the quantification of foci, and T. Brummelkamp, F. van Leeuwen, colleagues and members of the Sixma laboratory for critical reading of the manuscript. These studies were funded by the ERC Advanced grant, EU project Ubiregulators, KWF 2006-3476 to T.K.S., Dutch Organization for Scientific Research ZonMW Veni 917-96-120 to J.A.M., NWO Vidi 864.08.011 to E.C., and KWF 2007-3877. F.M. designed and performed all experiments and wrote the manuscript. J.H.A.V. contributed to cell-based experiments and discussions. J.A.M., W.V., and E.C. supervised immunofluorescence experiments and imaging. J.A.M. performed quantifications of immunofluorescence data. W.J.vD. assisted in purification and western blots. P.I. cloned and purified the RNF8 RING domain. T.K.S. designed and supervised experiments and wrote the manuscript. All authors critically read the paper.	Acs K, 2011, NAT STRUCT MOL BIOL, V18, P1345, DOI 10.1038/nsmb.2188; Al-Hakim A, 2010, DNA REPAIR, V9, P1229, DOI 10.1016/j.dnarep.2010.09.011; Bekker-Jensen S, 2011, FEBS LETT, V585, P2914, DOI 10.1016/j.febslet.2011.05.056; Bekker-Jensen S, 2010, NAT CELL BIOL, V12, P80, DOI 10.1038/ncb2008; Bensimon A, 2011, FEBS LETT, V585, P1625, DOI 10.1016/j.febslet.2011.05.013; Bentley ML, 2011, EMBO J, V30, P3285, DOI 10.1038/emboj.2011.243; Bergink S, 2006, GENE DEV, V20, P1343, DOI 10.1101/gad.373706; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Brzovic PS, 2003, P NATL ACAD SCI USA, V100, P5646, DOI 10.1073/pnas.0836054100; Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Campbell SJ, 2012, J BIOL CHEM, V287, P23900, DOI 10.1074/jbc.M112.359653; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chagraoui J, 2011, P NATL ACAD SCI USA, V108, P5284, DOI 10.1073/pnas.1014263108; Chou DM, 2010, P NATL ACAD SCI USA, V107, P18475, DOI 10.1073/pnas.1012946107; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Facchino S, 2010, J NEUROSCI, V30, P10096, DOI 10.1523/JNEUROSCI.1634-10.2010; Feng L, 2012, NAT STRUCT MOL BIOL, V19, P201, DOI 10.1038/nsmb.2211; Ginjala V, 2011, MOL CELL BIOL, V31, P1972, DOI 10.1128/MCB.00981-10; GOLDKNOPF IL, 1977, P NATL ACAD SCI USA, V74, P864, DOI 10.1073/pnas.74.3.864; Hibbert RG, 2009, DNA REPAIR, V8, P525, DOI 10.1016/j.dnarep.2009.01.014; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Huang AD, 2011, J MOL BIOL, V410, P424, DOI 10.1016/j.jmb.2011.04.051; Huang J, 2009, NAT CELL BIOL, V11, P592, DOI 10.1038/ncb1865; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; HUNT LT, 1977, BIOCHEM BIOPH RES CO, V74, P650, DOI 10.1016/0006-291X(77)90352-7; Ismail IH, 2010, J CELL BIOL, V191, P45, DOI 10.1083/jcb.201003034; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Li ZZ, 2006, J BIOL CHEM, V281, P20643, DOI 10.1074/jbc.M602461200; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mallette FA, 2012, EMBO J, V31, P1865, DOI 10.1038/emboj.2012.47; Marteijn JA, 2009, J CELL BIOL, V186, P835, DOI 10.1083/jcb.200902150; Masuda Y, 2012, NUCLEIC ACIDS RES, V40, P1065, DOI 10.1093/nar/gkr805; Meerang M, 2011, NAT CELL BIOL, V13, P1376, DOI 10.1038/ncb2367; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Moyal L, 2011, MOL CELL, V41, P529, DOI 10.1016/j.molcel.2011.02.015; Nakamura K, 2011, MOL CELL, V41, P515, DOI 10.1016/j.molcel.2011.02.002; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Pan MR, 2011, J BIOL CHEM, V286, P28599, DOI 10.1074/jbc.M111.256297; Panier S, 2009, DNA REPAIR, V8, P436, DOI 10.1016/j.dnarep.2009.01.013; Pinato S, 2011, MOL CELL BIOL, V31, P118, DOI 10.1128/MCB.00818-10; Pinato S, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-55; Poulsen M, 2012, J CELL BIOL, V197, P189, DOI 10.1083/jcb.201109100; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Ramadan K, 2012, CELL CYCLE, V11, P1062, DOI 10.4161/cc.11.6.19446; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Shiloh Y, 2011, FEBS LETT, V585, P2795, DOI 10.1016/j.febslet.2011.07.034; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wu CY, 2011, J BIOL CHEM, V286, P30806, DOI 10.1074/jbc.M111.257469; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Yan J, 2007, CANCER RES, V67, P6647, DOI 10.1158/0008-5472.CAN-07-0924; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023; Zhang SF, 2008, CELL CYCLE, V7, P3399, DOI 10.4161/cc.7.21.6949; Zhao GY, 2007, MOL CELL, V25, P663, DOI 10.1016/j.molcel.2007.01.029	62	419	453	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 14	2012	150	6					1182	1195		10.1016/j.cell.2012.08.005	http://dx.doi.org/10.1016/j.cell.2012.08.005			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22980979	Bronze			2022-12-24	WOS:000308928100012
J	Klein, NP; Bartlett, J; Rowhani-Rahbar, A; Fireman, B; Baxter, R				Klein, Nicola P.; Bartlett, Joan; Rowhani-Rahbar, Ali; Fireman, Bruce; Baxter, Roger			Waning Protection after Fifth Dose of Acellular Pertussis Vaccine in Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WHOLE-CELL; UNITED-STATES; INFANTS; ADOLESCENTS; RATES; RISK	Background In the United States, children receive five doses of diphtheria, tetanus, and acellular pertussis (DTaP) vaccine before 7 years of age. The duration of protection after five doses of DTaP is unknown. Methods We assessed the risk of pertussis in children in California relative to the time since the fifth dose of DTaP from 2006 to 2011. This period included a large outbreak in 2010. We conducted a case-control study involving members of Kaiser Permanente Northern California who were vaccinated with DTaP at 47 to 84 months of age. We compared children with pertussis confirmed by a positive polymerase-chain-reaction (PCR) assay with two sets of controls: those who were PCR-negative for pertussis and closely matched controls from the general population of health-plan members. We used logistic regression to examine the risk of pertussis in relation to the duration of time since the fifth DTaP dose. Children who received whole- cell pertussis vaccine during infancy or who received any pertussis-containing vaccine after their fifth dose of DTaP were excluded. Results We compared 277 children, 4 to 12 years of age, who were PCR-positive for pertussis with 3318 PCR-negative controls and 6086 matched controls. PCR-positive children were more likely to have received the fifth DTaP dose earlier than PCR-negative controls (P<0.001) or matched controls (P = 0.005). Comparison with PCR-negative controls yielded an odds ratio of 1.42 (95% confidence interval, 1.21 to 1.66), indicating that after the fifth dose of DTaP, the odds of acquiring pertussis increased by an average of 42% per year. Conclusions Protection against pertussis waned during the 5 years after the fifth dose of DTaP. (Funded by Kaiser Permanente).	[Klein, Nicola P.; Bartlett, Joan; Rowhani-Rahbar, Ali; Fireman, Bruce; Baxter, Roger] Kaiser Permanente, Vaccine Study Ctr, Oakland, CA 94612 USA	Kaiser Permanente	Klein, NP (corresponding author), Kaiser Permanente, Vaccine Study Ctr, 1 Kaiser Plaza,16th Fl, Oakland, CA 94612 USA.	nicola.klein@kp.org		Rowhani-Rahbar, Ali/0000-0002-2705-4485	Kaiser Permanente; Sanofi Pasteur; GlaxoSmithKline; Novartis; Merck; Pfizer	Kaiser Permanente; Sanofi Pasteur; GlaxoSmithKline(GlaxoSmithKline); Novartis(Novartis); Merck(Merck & Company); Pfizer(Pfizer)	Funded by Kaiser Permanente.; Drs. Klein and Baxter report receiving grant support to their institution from Sanofi Pasteur, GlaxoSmithKline, Novartis, Merck, and Pfizer. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 1992, MMWR Recomm Rep, V41, P1; [Anonymous], 2010, MMWR MORB MORTAL WKL, V59, P817; [Anonymous], 2007, MMWR MORB MORTAL WKL, V54, P1; [Anonymous], 2006, PEDIATRICS, V117, P965; Cherry JD, 2010, CLIN INFECT DIS, V51, P663, DOI 10.1086/655826; Cherry JD, 1988, PEDIATRICS S, V81, pS933; CODY CL, 1981, PEDIATRICS, V68, P650; Elliott MN, 2008, HEALTH SERV RES, V43, P1722, DOI 10.1111/j.1475-6773.2008.00854.x; FARIZO KM, 1992, CLIN INFECT DIS, V14, P708, DOI 10.1093/clinids/14.3.708; Guris D, 1999, CLIN INFECT DIS, V28, P1230, DOI 10.1086/514776; Gustafsson L, 2006, PEDIATRICS, V118, P978, DOI 10.1542/peds.2005-2746; Khan FN, 2006, PEDIATR INFECT DIS J, V25, P1132, DOI 10.1097/01.inf.0000245099.01427.93; Lacombe K, 2004, VACCINE, V23, P623, DOI 10.1016/j.vaccine.2004.07.007; Lavine J, 2010, VACCINE, V29, P11, DOI 10.1016/j.vaccine.2010.10.029; Lugauer S, 2002, EUR J PEDIATR, V161, P142, DOI 10.1007/s00431-001-0893-5; Matheson A J, 2000, Paediatr Drugs, V2, P139, DOI 10.2165/00128072-200002020-00007; Moore David M, 2002, Can J Infect Dis, V13, P305; MORTIMER EA, 1979, REV INFECT DIS, V1, P927; Olin P, 2003, VACCINE, V21, P2015, DOI 10.1016/S0264-410X(02)00777-6; Prevention and control of tuberculosis in correctional and detention facilities: recommendations from CDC, 2006, MMWR RECOMM REP, V55, P1; Salmaso S, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.5.e81; Simondon F, 1997, VACCINE, V15, P1606, DOI 10.1016/S0264-410X(97)00100-X; Vickers D, 2006, CAN MED ASSOC J, V175, P1213, DOI 10.1503/cmaj.051637; 2011, MMWR MORB MORTAL WKL, V60, P13	24	389	397	0	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2012	367	11					1012	1019		10.1056/NEJMoa1200850	http://dx.doi.org/10.1056/NEJMoa1200850			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	003ZE	22970945				2022-12-24	WOS:000308649100007
J	Petreanu, L; Gutnisky, DA; Huber, D; Xu, NL; O'Connor, DH; Tian, L; Looger, L; Svoboda, K				Petreanu, Leopoldo; Gutnisky, Diego A.; Huber, Daniel; Xu, Ning-long; O'Connor, Dan H.; Tian, Lin; Looger, Loren; Svoboda, Karel			Activity in motor-sensory projections reveals distributed coding in somatosensation	NATURE			English	Article							OBJECT LOCALIZATION; ACTION-POTENTIALS; NEURAL ACTIVITY; LAYER-I; CORTEX; RAT; ORGANIZATION; PLASTICITY; CIRCUITS; DYNAMICS	Cortical-feedback projections to primary sensory areas terminate most heavily in layer 1 (L1) of the neocortex(1,2), where they make synapses with tuft dendrites of pyramidal neurons. L1 input is thought to provide 'contextual' information(3), but the signals transmitted by L1 feedback remain uncharacterized. In the rodent somatosensory system, the spatially diffuse(4) feedback projection from vibrissal motor cortex (vM1) to vibrissal somatosensory cortex (vS1, also known as the barrel cortex) may allow whisker touch to be interpreted in the context of whisker position to compute object location(5,6). When mice palpate objects with their whiskers to localize object features(7,8), whisker touch excites vS1(9) and later vM1 in a somatotopic manner(10-13). Here we use axonal calcium imaging to track activity in vM1 -> vS1 afferents in L1 of the barrel cortex while mice performed whisker-dependent object localization. Spatially intermingled individual axons represent whisker movements, touch and other behavioural features. In a subpopulation of axons, activity depends on object location and persists for seconds after touch. Neurons in the barrel cortex thus have information to integrate movements and touches of multiple whiskers over time, key components of object identification and navigation by active touch.	[Petreanu, Leopoldo; Gutnisky, Diego A.; Huber, Daniel; Xu, Ning-long; O'Connor, Dan H.; Tian, Lin; Looger, Loren; Svoboda, Karel] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Svoboda, K (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA 20147 USA.	svobodak@janelia.hhmi.org	Gutnisky, Diego/E-3846-2012; Xu, Ning-long/U-8665-2019; Huber, Daniel/C-2932-2013	Gutnisky, Diego/0000-0002-8578-0039; Xu, Ning-long/0000-0002-1651-401X; Tian, Lin/0000-0001-7012-6926; Petreanu, Leopoldo/0000-0003-1434-4691; Huber, Daniel/0000-0002-0744-7679				Anjum F, 2006, P NATL ACAD SCI USA, V103, P16544, DOI 10.1073/pnas.0605573103; Birdwell JA, 2007, J NEUROPHYSIOL, V98, P2439, DOI 10.1152/jn.00707.2006; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Carvell GE, 1996, SOMATOSENS MOT RES, V13, P115, DOI 10.3109/08990229609051399; Cauller L, 1995, BEHAV BRAIN RES, V71, P163, DOI 10.1016/0166-4328(95)00032-1; CAULLER LJ, 1994, J NEUROSCI, V14, P751; Clack NG, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002591; Cox CL, 2000, P NATL ACAD SCI USA, V97, P9724, DOI 10.1073/pnas.170278697; DAVIDSON PW, 1972, J EXP PSYCHOL, V93, P43, DOI 10.1037/h0032632; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; DeFelipe J, 1997, CEREB CORTEX, V7, P619, DOI 10.1093/cercor/7.7.619; DUDA RO, 2001, PATTERN CLASSIFICATI; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI DOI 10.1007/978-0-387-84858-7; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; Hernandez A, 2010, NEURON, V66, P300, DOI 10.1016/j.neuron.2010.03.031; Hill DN, 2008, J NEUROSCI, V28, P3438, DOI 10.1523/JNEUROSCI.5008-07.2008; Hill DN, 2011, NEURON, V72, P344, DOI 10.1016/j.neuron.2011.09.020; Hooks BM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000572; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Kaneko M, 2008, NAT NEUROSCI, V11, P497, DOI 10.1038/nn2068; Kleinfeld D, 2002, NEURON, V34, P1021, DOI 10.1016/S0896-6273(02)00732-8; Knutsen PM, 2006, J NEUROSCI, V26, P8451, DOI 10.1523/JNEUROSCI.1516-06.2006; Knutsen PM, 2009, TRENDS NEUROSCI, V32, P101, DOI 10.1016/j.tins.2008.10.002; Koester HJ, 2000, J PHYSIOL-LONDON, V529, P625, DOI 10.1111/j.1469-7793.2000.00625.x; Komiyama T, 2010, NATURE, V464, P1182, DOI 10.1038/nature08897; Krupa DJ, 2001, J NEUROSCI, V21, P5752, DOI 10.1523/JNEUROSCI.21-15-05752.2001; Larkum ME, 2004, CEREB CORTEX, V14, P1059, DOI 10.1093/cercor/bhh065; Mao TY, 2011, NEURON, V72, P111, DOI 10.1016/j.neuron.2011.07.029; MASINO SA, 1993, P NATL ACAD SCI USA, V90, P9998, DOI 10.1073/pnas.90.21.9998; O'Connor DH, 2010, NEURON, V67, P1048, DOI 10.1016/j.neuron.2010.08.026; O'Connor DH, 2010, J NEUROSCI, V30, P1947, DOI 10.1523/JNEUROSCI.3762-09.2010; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Suter Benjamin A, 2010, Front Neural Circuits, V4, P100, DOI 10.3389/fncir.2010.00100; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Veinante P, 2003, J COMP NEUROL, V464, P98, DOI 10.1002/cne.10769; Vogelstein JT, 2010, J NEUROPHYSIOL, V104, P3691, DOI 10.1152/jn.01073.2009; Voigts J, 2008, J NEUROPHYSIOL, V100, P504, DOI 10.1152/jn.00012.2008	41	216	216	0	57	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 13	2012	489	7415					299	+		10.1038/nature11321	http://dx.doi.org/10.1038/nature11321			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003UC	22922646	Green Published, Green Accepted			2022-12-24	WOS:000308635900043
J	Cappa, CD; Onasch, TB; Massoli, P; Worsnop, DR; Bates, TS; Cross, ES; Davidovits, P; Hakala, J; Hayden, KL; Jobson, BT; Kolesar, KR; Lack, DA; Lerner, BM; Li, SM; Mellon, D; Nuaaman, I; Olfert, JS; Petaja, T; Quinn, PK; Song, C; Subramanian, R; Williams, EJ; Zaveri, RA				Cappa, Christopher D.; Onasch, Timothy B.; Massoli, Paola; Worsnop, Douglas R.; Bates, Timothy S.; Cross, Eben S.; Davidovits, Paul; Hakala, Jani; Hayden, Katherine L.; Jobson, B. Tom; Kolesar, Katheryn R.; Lack, Daniel A.; Lerner, Brian M.; Li, Shao-Meng; Mellon, Daniel; Nuaaman, Ibraheem; Olfert, Jason S.; Petaja, Tuukka; Quinn, Patricia K.; Song, Chen; Subramanian, R.; Williams, Eric J.; Zaveri, Rahul A.			Radiative Absorption Enhancements Due to the Mixing State of Atmospheric Black Carbon	SCIENCE			English	Article							CITY METROPOLITAN-AREA; LIGHT-ABSORPTION; CROSS-SECTION; AEROSOL; SOOT; MODELS; IMPACT; BROWN	Atmospheric black carbon (BC) warms Earth's climate, and its reduction has been targeted for near-term climate change mitigation. Models that include forcing by BC assume internal mixing with non-BC aerosol components that enhance BC absorption, often by a factor of similar to 2; such model estimates have yet to be clearly validated through atmospheric observations. Here, direct in situ measurements of BC absorption enhancements (E-abs) and mixing state are reported for two California regions. The observed E-abs is small-6% on average at 532 nm-and increases weakly with photochemical aging. The E-abs is less than predicted from observationally constrained theoretical calculations, suggesting that many climate models may overestimate warming by BC. These ambient observations stand in contrast to laboratory measurements that show substantial E-abs for BC are possible.	[Cappa, Christopher D.; Kolesar, Katheryn R.; Mellon, Daniel] Univ Calif Davis, Dept Civil & Environm Engn, Davis, CA 95616 USA; [Onasch, Timothy B.; Massoli, Paola; Worsnop, Douglas R.] Aerodyne Res, Billerica, MA 01821 USA; [Onasch, Timothy B.; Cross, Eben S.; Davidovits, Paul] Boston Coll, Dept Chem, Boston, MA 02467 USA; [Worsnop, Douglas R.; Hakala, Jani; Petaja, Tuukka] Univ Helsinki, Dept Phys, FI-00014 Helsinki, Finland; [Bates, Timothy S.; Quinn, Patricia K.] NOAA, Pacific Marine Environm Lab, Seattle, WA 98115 USA; [Hayden, Katherine L.; Li, Shao-Meng; Nuaaman, Ibraheem] Environm Canada, Air Qual Res Div, Toronto, ON M3H 5T4, Canada; [Jobson, B. Tom] Washington State Univ, Dept Civil & Environm Engn, Pullman, WA 99164 USA; [Lack, Daniel A.; Lerner, Brian M.; Williams, Eric J.] NOAA, Earth Syst Res Lab, Boulder, CO 80305 USA; [Lack, Daniel A.; Lerner, Brian M.] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Nuaaman, Ibraheem] York Univ, Ctr Atmospher Chem, Toronto, ON M3J 1P3, Canada; [Olfert, Jason S.] Univ Alberta, Dept Mech Engn, Edmonton, AB T6G 2R3, Canada; [Song, Chen; Zaveri, Rahul A.] Pacific NW Natl Lab, Atmospher Sci & Global Change Div, Richland, WA 99354 USA; [Subramanian, R.] RTI Int, Res Triangle Pk, NC 27709 USA	University of California System; University of California Davis; Aerodyne Research; Boston College; University of Helsinki; National Oceanic Atmospheric Admin (NOAA) - USA; Environment & Climate Change Canada; Washington State University; National Oceanic Atmospheric Admin (NOAA) - USA; University of Colorado System; University of Colorado Boulder; York University - Canada; University of Alberta; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Research Triangle Institute	Cappa, CD (corresponding author), Univ Calif Davis, Dept Civil & Environm Engn, Davis, CA 95616 USA.	cdcappa@ucdavis.edu; onasch@aerodyne.com	Lerner, Brian M/H-6556-2013; Lack, Daniel/I-9053-2012; Quinn, Patricia/R-1493-2016; Subramanian, R/A-4913-2013; Bates, Timothy S/L-6080-2016; Worsnop, Douglas R/D-2817-2009; Petäjä, Tuukka/A-8009-2008; Onasch, Tim/AAY-4998-2020; Zaveri, Rahul/G-4076-2014	Lerner, Brian M/0000-0001-8721-8165; Quinn, Patricia/0000-0003-0337-4895; Subramanian, R/0000-0002-5553-5913; Worsnop, Douglas R/0000-0002-8928-8017; Petäjä, Tuukka/0000-0002-1881-9044; Onasch, Tim/0000-0001-7796-7840; Jobson, Bertram/0000-0003-1812-9745; Olfert, Jason/0000-0002-9681-5428; Zaveri, Rahul/0000-0001-9874-8807; Li, Shao-Meng/0000-0002-7628-6581; Cappa, Christopher/0000-0002-3528-3368	American River College; NOAA Climate Program Office [NA09OAR4310124, NA09OAR4310125]; U.S. Environmental Protection Agency [RD834558]; NSF Atmospheric Chemistry; California Air Resources Board; U.S. Department of Energy (DOE) Atmospheric System Research (ASR) program; DOE Atmospheric Radiation Measurement (ARM) Climate Research Facility; Canadian Federal Government (PERD) [C12.007]; Natural Sciences and Engineering Research Council of Canada; Div Atmospheric & Geospace Sciences [0904292] Funding Source: National Science Foundation	American River College; NOAA Climate Program Office(National Oceanic Atmospheric Admin (NOAA) - USA); U.S. Environmental Protection Agency(United States Environmental Protection Agency); NSF Atmospheric Chemistry(National Science Foundation (NSF)); California Air Resources Board; U.S. Department of Energy (DOE) Atmospheric System Research (ASR) program(United States Department of Energy (DOE)); DOE Atmospheric Radiation Measurement (ARM) Climate Research Facility; Canadian Federal Government (PERD); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The authors thank the crew of the R/V Atlantis, the support at American River College and Cambustion for loan of the centrifugal particle mass analyzer (CPMA). This work was supported by the NOAA Climate Program Office (NA09OAR4310124 and NA09OAR4310125), U.S. Environmental Protection Agency (RD834558), NSF Atmospheric Chemistry, California Air Resources Board, U.S. Department of Energy (DOE) Atmospheric System Research (ASR) program and DOE Atmospheric Radiation Measurement (ARM) Climate Research Facility, the Canadian Federal Government (PERD Project C12.007), and the Natural Sciences and Engineering Research Council of Canada.	Adachi K, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012868; Andreae MO, 2006, ATMOS CHEM PHYS, V6, P3131, DOI 10.5194/acp-6-3131-2006; Barnard JC, 2008, ATMOS CHEM PHYS, V8, P6665, DOI 10.5194/acp-8-6665-2008; Bond TC, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2006JD007315; Chung SH, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005441; Cross ES, 2010, AEROSOL SCI TECH, V44, P592, DOI 10.1080/02786826.2010.482113; Dickerson RR, 1997, SCIENCE, V278, P827, DOI 10.1126/science.278.5339.827; Doran C, 2007, ATMOS CHEM PHYS, V7, P2197, DOI 10.5194/acp-7-2197-2007; Ghan SJ, 2007, B AM METEOROL SOC, V88, P1059, DOI 10.1175/BAMS-88-7-1059; Grieshop AP, 2009, NAT GEOSCI, V2, P533, DOI 10.1038/ngeo595; Hansen J, 2007, CLIM DYNAM, V29, P661, DOI 10.1007/s00382-007-0255-8; Jacobson MZ, 1999, J GEOPHYS RES-ATMOS, V104, P3527, DOI 10.1029/1998JD100054; Jacobson MZ, 2001, NATURE, V409, P695, DOI 10.1038/35055518; Johnson KS, 2005, ATMOS CHEM PHYS, V5, P3033, DOI 10.5194/acp-5-3033-2005; Knox A, 2009, AEROSOL SCI TECH, V43, P522, DOI 10.1080/02786820902777207; Koch D, 2009, ATMOS CHEM PHYS, V9, P9001, DOI 10.5194/acp-9-9001-2009; Lack DA, 2010, ATMOS CHEM PHYS, V10, P4207, DOI 10.5194/acp-10-4207-2010; Li J, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002106; Myhre G, 2009, SCIENCE, V325, P187, DOI 10.1126/science.1174461; Onasch TB, 2012, AEROSOL SCI TECH, V46, P804, DOI 10.1080/02786826.2012.663948; Ramanathan V, 2008, NAT GEOSCI, V1, P221, DOI 10.1038/ngeo156; Schnaiter M, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD006046; Shindell D, 2012, SCIENCE, V335, P183, DOI 10.1126/science.1210026; Shindell DT, 2009, SCIENCE, V326, P716, DOI 10.1126/science.1174760; Zaveri RA, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013616	25	455	472	31	489	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2012	337	6098					1078	1081		10.1126/science.1223447	http://dx.doi.org/10.1126/science.1223447			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22936774				2022-12-24	WOS:000308125800042
J	Treon, SP; Xu, L; Yang, G; Zhou, YS; Liu, X; Cao, Y; Sheehy, P; Manning, RJ; Patterson, CJ; Tripsas, C; Arcaini, L; Pinkus, GS; Rodig, SJ; Sohani, AR; Harris, NL; Laramie, JM; Skifter, DA; Lincoln, SE; Hunter, ZR				Treon, Steven P.; Xu, Lian; Yang, Guang; Zhou, Yangsheng; Liu, Xia; Cao, Yang; Sheehy, Patricia; Manning, Robert J.; Patterson, Christopher J.; Tripsas, Christina; Arcaini, Luca; Pinkus, Geraldine S.; Rodig, Scott J.; Sohani, Aliyah R.; Harris, Nancy Lee; Laramie, Jason M.; Skifter, Donald A.; Lincoln, Stephen E.; Hunter, Zachary R.			MYD88 L265P Somatic Mutation in Waldenstrom's Macroglobulinemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MONOCLONAL GAMMOPATHIES; FREQUENT MUTATION; KAPPA-B; GENOME; ARID1A; BORTEZOMIB; DISORDERS; EVOLUTION; DISCOVERY; COMPLEX	BACKGROUND Waldenstrom's macroglobulinemia is an incurable, IgM-secreting lymphoplasmacytic lymphoma (LPL). The underlying mutation in this disorder has not been delineated. METHODS We performed whole-genome sequencing of bone marrow LPL cells in 30 patients with Waldenstrom's macroglobulinemia, with paired normal-tissue and tumor-tissue sequencing in 10 patients. Sanger sequencing was used to validate the findings in samples from an expanded cohort of patients with LPL, those with other B-cell disorders that have some of the same features as LPL, and healthy donors. RESULTS Among the patients with Waldenstrom's macroglobulinemia, a somatic variant (T -> C) in LPL cells was identified at position 38182641 at 3p22.2 in the samples from all 10 patients with paired tissue samples and in 17 of 20 samples from patients with unpaired samples. This variant predicted an amino acid change (L265P) in MYD88, a mutation that triggers IRAK-mediated NF-kappa B signaling. Sanger sequencing identified MYD88 L265P in tumor samples from 49 of 54 patients with Waldenstrom's macroglobulinemia and in 3 of 3 patients with non-IgM-secreting LPL (91% of all patients with LPL). MYD88 L265P was absent in paired normal tissue samples from patients with Waldenstrom's macroglobulinemia or non-IgM LPL and in B cells from healthy donors and was absent or rarely expressed in samples from patients with multiple myeloma, marginal-zone lymphoma, or IgM monoclonal gammopathy of unknown significance. Inhibition of MYD88 signaling reduced I kappa B alpha and NF-kappa B p65 phosphorylation, as well as NF-kappa B nuclear staining, in Waldenstrom's macroglobulinemia cells expressing MYD88 L265P. Somatic variants in ARID1A in 5 of 30 patients (17%), leading to a premature stop or frameshift, were also identified and were associated with an increased disease burden. In addition, 2 of 3 patients with Waldenstrom's macroglobulinemia who had wild-type MYD88 had somatic variants in MLL2. CONCLUSIONS MYD88 L265P is a commonly recurring mutation in patients with Waldenstrom's macroglobulinemia that can be useful in differentiating Waldenstrom's macroglobulinemia and non-IgM LPL from B-cell disorders that have some of the same features. (Funded by the Peter and Helen Bing Foundation and others.)	[Treon, Steven P.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Bing Ctr Waldenstroms Macroglobulinemia, Boston, MA 02115 USA; [Pinkus, Geraldine S.; Rodig, Scott J.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA USA; [Sohani, Aliyah R.; Harris, Nancy Lee] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Boston, MA USA; [Hunter, Zachary R.] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA; [Arcaini, Luca] Univ Pavia, Sch Med, Dept Hematol Oncol, I-27100 Pavia, Italy; [Arcaini, Luca] Policlin San Matteo, Fdn Ist Ricovero & Cura Carattere Sci IRCCS, I-27100 Pavia, Italy; [Laramie, Jason M.; Skifter, Donald A.; Lincoln, Stephen E.] Complete Genom, Mountain View, CA USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Boston University; University of Pavia; IRCCS Fondazione San Matteo	Treon, SP (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Bing Ctr Waldenstroms Macroglobulinemia, M547,450 Brookline Ave, Boston, MA 02115 USA.	steven_treon@dfci.harvard.edu	Rodig, Scott/Y-3889-2019; Hunter, Zachary Richard/H-3018-2013; Arcaini, Luca/P-8913-2015	Hunter, Zachary Richard/0000-0002-1689-1691; Arcaini, Luca/0000-0002-9504-991X; Yang, Guang/0000-0003-3049-4200	Peter and Helen Bing Foundation; International Waldenstrom's Macroglobulinemia Foundation; Coyote Fund for Waldenstrom's Macroglobulinemia; Waldenstrom's Cancer Fund; Bailey Family Fund for Waldenstrom's Macroglobulinemia; D'Amato Family Fund for Genomic Discovery; Edward and Linda Nelson Fund for Waldenstrom's Macroglobulinemia Research; Bauman Family Trust; Tannenhauser Family Foundation	Peter and Helen Bing Foundation; International Waldenstrom's Macroglobulinemia Foundation; Coyote Fund for Waldenstrom's Macroglobulinemia; Waldenstrom's Cancer Fund; Bailey Family Fund for Waldenstrom's Macroglobulinemia; D'Amato Family Fund for Genomic Discovery; Edward and Linda Nelson Fund for Waldenstrom's Macroglobulinemia Research; Bauman Family Trust; Tannenhauser Family Foundation	Funded by the Peter and Helen Bing Foundation and others.; Supported by the Peter and Helen Bing Foundation, the International Waldenstrom's Macroglobulinemia Foundation, the Coyote Fund for Waldenstrom's Macroglobulinemia, the Waldenstrom's Cancer Fund, the Bailey Family Fund for Waldenstrom's Macroglobulinemia, the D'Amato Family Fund for Genomic Discovery, the Edward and Linda Nelson Fund for Waldenstrom's Macroglobulinemia Research, the Bauman Family Trust, and the Tannenhauser Family Foundation.	Arcaini L, 2011, CL LYMPH MYELOM LEUK, V11, P103, DOI 10.3816/CLML.2011.n.020; Baldini L, 2005, J CLIN ONCOL, V23, P4662, DOI 10.1200/JCO.2005.06.147; Carnevali P, 2012, J COMPUT BIOL, V19, P279, DOI 10.1089/cmb.2011.0201; Cohen L, 1998, NATURE, V395, P292, DOI 10.1038/26254; Dimopoulos MA, 2010, CL LYMPH MYELOM LEUK, V10, P110, DOI 10.3816/CLML.2010.n.015; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Euskirchen GM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002008; Jones S, 2012, HUM MUTAT, V33, P100, DOI 10.1002/humu.21633; Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606; Kristinsson SY, 2008, BLOOD, V112, P3052, DOI 10.1182/blood-2008-06-162768; Kyle RA, 2003, BLOOD, V102, P3759, DOI 10.1182/blood-2003-03-0801; Kyrtsonis MC, 2011, CL LYMPH MYELOM LEUK, V11, P99, DOI 10.3816/CLML.2011.n.019; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Leleu X, 2008, BLOOD, V111, P5068, DOI 10.1182/blood-2007-09-115170; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Loiarro M, 2005, J BIOL CHEM, V280, P15809, DOI 10.1074/jbc.C400613200; Loiarro M, 2009, J BIOL CHEM, V284, P28093, DOI 10.1074/jbc.M109.004465; Mamo A, 2012, ONCOGENE, V31, P2090, DOI 10.1038/onc.2011.386; McMaster ML, 2007, CLIN CANCER RES, V13, P5063, DOI 10.1158/1078-0432.CCR-07-0299; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Morra E, 2004, LEUKEMIA, V18, P1512, DOI 10.1038/sj.leu.2403442; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Owen RG, 2003, SEMIN ONCOL, V30, P110, DOI 10.1053/sonc.2003.50082; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Pottier N, 2008, JNCI-J NATL CANCER I, V100, P1792, DOI 10.1093/jnci/djn416; Powers JP, 2006, BIOORG MED CHEM LETT, V16, P2842, DOI 10.1016/j.bmcl.2006.03.020; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Swerdlow SH, 2008, WHO CLASSIFICATION T, P194; Treon SP, 2006, ANN ONCOL, V17, P488, DOI 10.1093/annonc/mdj111; Treon SP, 2007, CLIN CANCER RES, V13, P3320, DOI 10.1158/1078-0432.CCR-06-2511; Treon SP, 2009, BLOOD, V114, P2375, DOI 10.1182/blood-2009-05-174359; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Watters TM, 2007, IMMUNOL CELL BIOL, V85, P411, DOI 10.1038/sj.icb.7100095	35	818	883	3	40	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 30	2012	367	9					826	833		10.1056/NEJMoa1200710	http://dx.doi.org/10.1056/NEJMoa1200710			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	996EN	22931316	Bronze			2022-12-24	WOS:000308067400004
J	Hulsmann, BB; Labokha, AA; Gorlich, D				Huelsmann, Bastian B.; Labokha, Aksana A.; Goerlich, Dirk			The Permeability of Reconstituted Nuclear Pores Provides Direct Evidence for the Selective Phase Model	CELL			English	Article							REPEAT REGIONS; IMPORTIN-BETA; NUCLEOPORIN NUP98; STRUCTURAL BASIS; DNA-REPLICATION; SINGLE-MOLECULE; XENOPUS EGGS; COMPLEX; TRANSPORT; PROTEIN	Nuclear pore complexes (NPCs) maintain a permeability barrier between the nucleus and the cytoplasm through FG-repeat-containing nucleoporins (Nups). We previously proposed a "selective phase model" in which the FG repeats interact with one another to form a sieve-like barrier that can be locally disrupted by the binding of nuclear transport receptors (NTRs), but not by inert macromolecules, allowing selective passage of NTRs and associated cargo. Here, we provide direct evidence for this model in a physiological context. By using NPCs reconstituted from Xenopus laevis egg extracts, we show that Nup98 is essential for maintaining the permeability barrier. Specifically, the multivalent cohesion between FG repeats is required, including cohesive FG repeats close to the anchorage point to the NPC scaffold. Our data exclude alternative models that are based solely on an interaction between the FG repeats and NTRs and indicate that the barrier is formed by a sieve-like FG hydrogel.	[Huelsmann, Bastian B.; Labokha, Aksana A.; Goerlich, Dirk] Max Planck Inst Biophys Chem, Abt Zellulare Logist, D-37077 Gottingen, Germany	Max Planck Society	Gorlich, D (corresponding author), Max Planck Inst Biophys Chem, Abt Zellulare Logist, Fassberg 11, D-37077 Gottingen, Germany.	goerlich@mpibpc.mpg.de	Görlich, Dirk/B-8296-2017	Görlich, Dirk/0000-0002-4343-5210				Ader C, 2010, P NATL ACAD SCI USA, V107, P6281, DOI 10.1073/pnas.0910163107; Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Bayliss R, 1999, J MOL BIOL, V293, P579, DOI 10.1006/jmbi.1999.3166; Belgareh N, 2001, J CELL BIOL, V154, P1147, DOI 10.1083/jcb.200101081; BLOW JJ, 1986, CELL, V47, P577, DOI 10.1016/0092-8674(86)90622-7; Brohawn SG, 2009, STRUCTURE, V17, P1156, DOI 10.1016/j.str.2009.07.014; Clarkson WD, 1996, J MOL BIOL, V263, P517, DOI 10.1006/jmbi.1996.0594; CORDES VC, 1995, EUR J CELL BIOL, V68, P240; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; FINLAY DR, 1991, J CELL BIOL, V114, P169, DOI 10.1083/jcb.114.1.169; FINLAY DR, 1990, CELL, V60, P17, DOI 10.1016/0092-8674(90)90712-N; FORBES DJ, 1983, CELL, V34, P13, DOI 10.1016/0092-8674(83)90132-0; Fornerod M, 1997, EMBO J, V16, P807, DOI 10.1093/emboj/16.4.807; Frey S, 2007, CELL, V130, P512, DOI 10.1016/j.cell.2007.06.024; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Gorlich D, 2003, EMBO J, V22, P1088, DOI 10.1093/emboj/cdg113; Gorlich D, 1996, EMBO J, V15, P1810, DOI 10.1002/j.1460-2075.1996.tb00530.x; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Griffis ER, 2003, MOL BIOL CELL, V14, P600, DOI 10.1091/mbc.E02-09-0582; GROTE M, 1995, J CELL SCI, V108, P2963; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Hetzer M, 2000, MOL CELL, V5, P1013, DOI 10.1016/S1097-2765(00)80266-X; Hetzer MW, 2009, DEV CELL, V17, P606, DOI 10.1016/j.devcel.2009.10.007; Hodel AE, 2002, MOL CELL, V10, P347, DOI 10.1016/S1097-2765(02)00589-0; Hu TH, 1996, J CELL BIOL, V134, P589, DOI 10.1083/jcb.134.3.589; HURT EC, 1988, EMBO J, V7, P4323, DOI 10.1002/j.1460-2075.1988.tb03331.x; Iovine MK, 1995, J CELL BIOL, V131, P1699, DOI 10.1083/jcb.131.6.1699; Isgro TA, 2005, STRUCTURE, V13, P1869, DOI 10.1016/j.str.2005.09.007; Krull S, 2004, MOL BIOL CELL, V15, P4261, DOI 10.1091/mbc.E04-03-0165; Kubitscheck U, 2005, J CELL BIOL, V168, P233, DOI 10.1083/jcb.200411005; Kustanovich T, 2004, BIOPHYS J, V86, P2008, DOI 10.1016/S0006-3495(04)74262-9; Laurell E, 2011, CELL, V144, P539, DOI 10.1016/j.cell.2011.01.012; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Lim RYH, 2007, SCIENCE, V318, P640, DOI 10.1126/science.1145980; LOHKA MJ, 1983, SCIENCE, V220, P719, DOI 10.1126/science.6601299; Lowe AR, 2010, NATURE, V467, P600, DOI 10.1038/nature09285; Lu ZH, 1997, J CELL SCI, V110, P2745; Lubas WA, 2000, J BIOL CHEM, V275, P10983, DOI 10.1074/jbc.275.15.10983; MACAULAY C, 1995, J BIOL CHEM, V270, P254, DOI 10.1074/jbc.270.1.254; Milles S, 2011, BIOPHYS J, V101, P1710, DOI 10.1016/j.bpj.2011.08.025; Mohr D, 2009, EMBO J, V28, P2541, DOI 10.1038/emboj.2009.200; Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308; Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044; Peters R, 2005, TRAFFIC, V6, P421, DOI 10.1111/j.1600-0854.2005.00287.x; POWERS MA, 1995, J CELL BIOL, V128, P721, DOI 10.1083/jcb.128.5.721; RADU A, 1995, CELL, V81, P215, DOI 10.1016/0092-8674(95)90331-3; Rao FV, 2006, EMBO J, V25, P1569, DOI 10.1038/sj.emboj.7601026; REXACH M, 1995, CELL, V83, P683, DOI 10.1016/0092-8674(95)90181-7; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Rout MP, 2003, TRENDS CELL BIOL, V13, P622, DOI 10.1016/j.tcb.2003.10.007; Schrader N, 2008, MOL CELL, V29, P46, DOI 10.1016/j.molcel.2007.10.022; Stavru F, 2006, J CELL BIOL, V173, P509, DOI 10.1083/jcb.200601001; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; Terry LJ, 2009, EUKARYOT CELL, V8, P1814, DOI 10.1128/EC.00225-09; Tu LC, 2011, BBA-MOL CELL RES, V1813, P1607, DOI 10.1016/j.bbamcr.2010.12.011; Vasu S, 2001, J CELL BIOL, V155, P339, DOI 10.1083/jcb.200108007; Walde S, 2010, TRENDS CELL BIOL, V20, P461, DOI 10.1016/j.tcb.2010.05.001; WATSON ML, 1954, BIOCHIM BIOPHYS ACTA, V15, P475, DOI 10.1016/0006-3002(54)90004-9; Weis K, 2007, CELL, V130, P405, DOI 10.1016/j.cell.2007.07.029; WENTE SR, 1992, J CELL BIOL, V119, P705, DOI 10.1083/jcb.119.4.705; Yamada J, 2010, MOL CELL PROTEOMICS, V9, P2205, DOI 10.1074/mcp.M000035-MCP201; Yang WD, 2004, P NATL ACAD SCI USA, V101, P12887, DOI 10.1073/pnas.0403675101; Zhou HX, 2001, J PHYS CHEM B, V105, P6763, DOI 10.1021/jp011355n	64	191	192	1	74	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 17	2012	150	4					738	751		10.1016/j.cell.2012.07.019	http://dx.doi.org/10.1016/j.cell.2012.07.019			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22901806	Bronze			2022-12-24	WOS:000308002300009
J	Chen, XF; Cui, DD; Papusha, A; Zhang, XT; Chu, CD; Tang, JW; Chen, KF; Pan, XW; Ira, G				Chen, Xuefeng; Cui, Dandan; Papusha, Alma; Zhang, Xiaotian; Chu, Chia-Dwo; Tang, Jiangwu; Chen, Kaifu; Pan, Xuewen; Ira, Grzegorz			The Fun30 nucleosome remodeller promotes resection of DNA double-strand break ends	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; HOMOLOGOUS RECOMBINATION; CHECKPOINT ACTIVATION; H2A PHOSPHORYLATION; BUDDING YEAST; REPAIR; CHROMATIN; HELICASE; SGS1; MRE11-RAD50-XRS2	Chromosomal double-strand breaks (DSBs) are resected by 5' nucleases to form 3' single-stranded DNA substrates for binding by homologous recombination and DNA damage checkpoint proteins. Two redundant pathways of extensive resection have been described both in cells(1-3) and in vitro(4-6), one relying on Exo1 exonuclease and the other on Sgs1 helicase and Dna2 nuclease. However, it remains unknown how resection proceeds within the context of chromatin, where histones and histone-bound proteins represent barriers for resection enzymes. Here we identify the yeast nucleosome-remodelling enzyme Fun30 as a factor promoting DSB end resection. Fun30 is the major nucleosome remodeller promoting extensive Exo1- and Sgs1-dependent resection of DSBs. The RSC and INO80 chromatin-remodelling complexes and Fun30 have redundant roles in resection adjacent to DSB ends. ATPase and helicase domains of Fun30, which are needed for nucleosome remodelling(7), are also required for resection. Fun30 is robustly recruited to DNA breaks and spreads along the DSB coincident with resection. Fun30 becomes less important for resection in the absence of the histone-bound Rad9 checkpoint adaptor protein known to block 5' strand processing(8) and in the absence of either histone H3 K79 methylation or gamma-H2A, which mediate recruitment of Rad9 (refs 9, 10). Together these data suggest that Fun30 helps to overcome the inhibitory effect of Rad9 on DNA resection.	[Cui, Dandan; Tang, Jiangwu; Chen, Kaifu; Pan, Xuewen] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Chen, Xuefeng; Papusha, Alma; Zhang, Xiaotian; Chu, Chia-Dwo; Ira, Grzegorz] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Pan, XW (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	xuewenp@bcm.edu; gira@bcm.edu	Chen, Xuefeng/C-3410-2013	Zhang, Xiaotian/0000-0002-9533-4761	National Institutes of Health [GM080600, HG004840]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Sung, W.-D. Heyer and A. Pellicioli for antibodies; S.-E. Lee, S. Kron and M. Osley for strains; B. Llorente for sharing unpublished data; and J. Tyler, P. Sung and S. E. Lee for comments on the manuscript. This work was supported by the National Institutes of Health grants GM080600 (to G. I.) and HG004840 (to X.P.).	Alexeev A, 2003, NAT STRUCT BIOL, V10, P182, DOI 10.1038/nsb901; Awad S, 2010, J BIOL CHEM, V285, P9477, DOI 10.1074/jbc.M109.082149; Bothmer A, 2011, MOL CELL, V42, P319, DOI 10.1016/j.molcel.2011.03.019; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Cejka P, 2010, NATURE, V467, P112, DOI 10.1038/nature09355; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; Chen XF, 2011, NAT STRUCT MOL BIOL, V18, P1015, DOI 10.1038/nsmb.2105; Chung WH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000948; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Hammet A, 2007, EMBO REP, V8, P851, DOI 10.1038/sj.embor.7401036; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; IVANOV EL, 1994, MOL CELL BIOL, V14, P3414, DOI 10.1128/MCB.14.5.3414; Kalocsay M, 2009, MOL CELL, V33, P335, DOI 10.1016/j.molcel.2009.01.016; Lambert JP, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.104; Lazzaro F, 2008, EMBO J, V27, P1502, DOI 10.1038/emboj.2008.81; LYDALL D, 1995, SCIENCE, V270, P1488, DOI 10.1126/science.270.5241.1488; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Neves-Costa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008111; Nicolette ML, 2010, NAT STRUCT MOL BIOL, V17, P1478, DOI 10.1038/nsmb.1957; Niu HY, 2010, NATURE, V467, P108, DOI 10.1038/nature09318; Okazaki N, 2008, J MOL BIOL, V382, P257, DOI 10.1016/j.jmb.2008.07.031; Prakash R, 2009, GENE DEV, V23, P67, DOI 10.1101/gad.1737809; Shim EY, 2007, MOL CELL BIOL, V27, P1602, DOI 10.1128/MCB.01956-06; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Toh GWL, 2006, DNA REPAIR, V5, P693, DOI 10.1016/j.dnarep.2006.03.005; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Yu Q, 2011, J BIOL CHEM, V286, P14659, DOI 10.1074/jbc.M110.183269; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	34	173	179	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2012	489	7417					576	+		10.1038/nature11355	http://dx.doi.org/10.1038/nature11355			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	046RG	22960743	Green Accepted			2022-12-24	WOS:000311781500006
J	Costelloe, T; Louge, R; Tomimatsu, N; Mukherjee, B; Martini, E; Khadaroo, B; Dubois, K; Wiegant, WW; Thierry, A; Burma, S; van Attikum, H; Llorente, B				Costelloe, Thomas; Louge, Raphael; Tomimatsu, Nozomi; Mukherjee, Bipasha; Martini, Emmanuelle; Khadaroo, Basheer; Dubois, Kenny; Wiegant, Wouter W.; Thierry, Agnes; Burma, Sandeep; van Attikum, Haico; Llorente, Bertrand			The yeast Fun30 and human SMARCAD1 chromatin remodellers promote DNA end resection	NATURE			English	Article							DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; DISTINCT ROLES; DAMAGE; EXO1; REPAIR; RECOMBINATION; MUTANTS; GENES; SGS1	Several homology-dependent pathways can repair potentially lethal DNA double-strand breaks (DSBs). The first step common to all homologous recombination reactions is the 5'-3' degradation of DSB ends that yields the 39 single-stranded DNA required for the loading of checkpoint and recombination proteins. In yeast, the Mre11-Rad50-Xrs2 complex (Xrs2 is known as NBN or NBS1 in humans) and Sae2 (known as RBBP8 or CTIP in humans) initiate end resection, whereas long-range resection depends on the exonuclease Exo1, or the helicase-topoisomerase complex Sgs1-Top3-Rmi1 together with the endonuclease Dna2 (refs 1-6). DSBs occur in the context of chromatin, but how the resection machinery navigates through nucleosomal DNA is a process that is not well understood(7). Here we show that the yeast Saccharomyces cerevisiae Fun30 protein and its human counterpart SMARCAD1 (ref. 8), two poorly characterized ATP-dependent chromatin remodellers of the Snf2 ATPase family, are directly involved in the DSB response. Fun30 physically associates with DSB ends and directly promotes both Exo1- and Sgs1-dependent end resection through a mechanism involving its ATPase activity. The function of Fun30 in resection facilitates the repair of camptothecin-induced DNA lesions, although it becomes dispensable when Exo1 is ectopically overexpressed. Interestingly, SMARCAD1 is also recruited to DSBs, and the kinetics of recruitment is similar to that of EXO1. The loss of SMARCAD1 impairs end resection and recombinational DNA repair, and renders cells hypersensitive to DNA damage resulting from camptothecin or poly(ADP-ribose) polymerase inhibitor treatments. These findings unveil an evolutionarily conserved role for the Fun30 and SMARCAD1 chromatin remodellers in controlling end resection, homologous recombination and genome stability in the context of chromatin.	[Louge, Raphael; Khadaroo, Basheer; Dubois, Kenny; Llorente, Bertrand] Ctr Rech Cancerol Marseille, CNRS, Unite Mixte Rech 7258, F-13009 Marseille, France; [Costelloe, Thomas; Wiegant, Wouter W.; van Attikum, Haico] Leiden Univ, Med Ctr, Dept Toxicogenet, NL-2333 ZC Leiden, Netherlands; [Louge, Raphael; Khadaroo, Basheer; Dubois, Kenny; Llorente, Bertrand] Aix Marseille Univ, Unite Mixte Rech 7258, F-13284 Marseille, France; [Tomimatsu, Nozomi; Mukherjee, Bipasha; Burma, Sandeep] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Div Mol Radiat Biol, Dallas, TX 75390 USA; [Martini, Emmanuelle] CEA DSV Inst Radiobiol Cellulaire & Mol, F-92265 Fontenay Aux Roses, France; [Thierry, Agnes] Inst Pasteur, CNRS, Unite Genet Mol Levures, F-75724 Paris 15, France; [Thierry, Agnes] Univ Paris 06, F-75724 Paris 15, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; UDICE-French Research Universities; Aix-Marseille Universite; University of Texas System; University of Texas Southwestern Medical Center Dallas; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite	Llorente, B (corresponding author), Ctr Rech Cancerol Marseille, CNRS, Unite Mixte Rech 7258, F-13009 Marseille, France.	h.van.attikum@lumc.nl; bllorente@ifr88.cnrs-mrs.fr	van Attikum, Haico/A-4596-2010; llorente, bertrand/M-3501-2016	martini, emmanuelle/0000-0003-2005-0796; Van Attikum, Haico/0000-0001-8590-0240; Llorente, Bertrand/0000-0002-6291-5797	National Institutes of Health [RO1 CA149461]; National Aeronautics and Space Administration [NNX10AE08G]; Cancer Prevention and Research Institute of Texas [RP100644]; Netherlands Organization for Scientific Research (NWO-VIDI grant); Human Frontiers Science Program(HFSP-CDA grant); CNRS (ATIP); Agence Nationale de la Recherche [ANR-10-BLAN-1606-03]; NATIONAL CANCER INSTITUTE [R01CA149461] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Cancer Prevention and Research Institute of Texas; Netherlands Organization for Scientific Research (NWO-VIDI grant)(Netherlands Organization for Scientific Research (NWO)); Human Frontiers Science Program(HFSP-CDA grant); CNRS (ATIP)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank G. Ira for sharing unpublished data and S. Janicki, R. Greenberg, L. Symington and all the laboratories from the Centre National de la Recherche Scientifique (CNRS) UPR3081 for providing reagents. We thank S. Coulon for help in the analysis of the fun30 repressible allele, I. Lafontaine for support in statistical analyses, C. V. Camacho for generating the V5-EXO1 constructs and A. Guenole, R. Srivas, T. Ideker, K. Vreeken and M. Vermeulen for help in searching for Fun30 interactors. B. L. is grateful to B. Dujon for hosting him and providing the opportunity to perform the BIR screen. S. B. is supported by grants from the National Institutes of Health (RO1 CA149461), National Aeronautics and Space Administration (NNX10AE08G) and the Cancer Prevention and Research Institute of Texas (RP100644). H.v.A. receives funding from the Netherlands Organization for Scientific Research (NWO-VIDI grant) and Human Frontiers Science Program(HFSP-CDA grant). B. L. is supported by grants from the CNRS (ATIP) and the Agence Nationale de la Recherche (ANR-10-BLAN-1606-03).	Awad S, 2010, J BIOL CHEM, V285, P9477, DOI 10.1074/jbc.M109.082149; Bartsch S, 2000, MOL CELL BIOL, V20, P1194, DOI 10.1128/MCB.20.4.1194-1205.2000; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Beli P, 2012, MOL CELL, V46, P212, DOI 10.1016/j.molcel.2012.01.026; Bolderson E, 2010, NUCLEIC ACIDS RES, V38, P1821, DOI 10.1093/nar/gkp1164; Burke D., 2005, METHODS YEAST GENETI; Cejka P, 2010, NATURE, V467, P112, DOI 10.1038/nature09355; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; Clerici M, 2006, EMBO REP, V7, P212, DOI 10.1038/sj.embor.7400593; Decourty L, 2008, P NATL ACAD SCI USA, V105, P5821, DOI 10.1073/pnas.0710533105; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; Grandin N, 2007, NUCLEIC ACIDS RES, V35, P822, DOI 10.1093/nar/gkl1081; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; HERSKOWITZ I, 1991, METHOD ENZYMOL, V194, P132; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Marrero VA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001007; Martini EMD, 2002, GENETICS, V160, P1375; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Moreau S, 2001, GENETICS, V159, P1423; Neves-Costa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008111; Nicolette ML, 2010, NAT STRUCT MOL BIOL, V17, P1478, DOI 10.1038/nsmb.1957; Niu HY, 2010, NATURE, V467, P108, DOI 10.1038/nature09318; Ooi SL, 2001, SCIENCE, V294, P2552, DOI 10.1126/science.1065672; Ouspenski II, 1999, NUCLEIC ACIDS RES, V27, P3001, DOI 10.1093/nar/27.15.3001; Pardo B, 2006, GENETICS, V172, P2689, DOI 10.1534/genetics.105.053512; Rowbotham SP, 2011, MOL CELL, V42, P285, DOI 10.1016/j.molcel.2011.02.036; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Shim EY, 2010, EMBO J, V29, P3370, DOI 10.1038/emboj.2010.219; Sinha M, 2009, EPIGENOMICS-UK, V1, P371, DOI 10.2217/epi.09.22; Sporbert A, 2002, MOL CELL, V10, P1355, DOI 10.1016/S1097-2765(02)00729-3; Stralfors A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001334; Tomimatsu N, 2012, DNA REPAIR, V11, P441, DOI 10.1016/j.dnarep.2012.01.006; Tomimatsu N, 2009, EMBO REP, V10, P629, DOI 10.1038/embor.2009.60; van Attikum H, 2007, EMBO J, V26, P4113, DOI 10.1038/sj.emboj.7601835; WHITE CI, 1990, EMBO J, V9, P663, DOI 10.1002/j.1460-2075.1990.tb08158.x; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037; Zubko MK, 2004, GENETICS, V168, P103, DOI 10.1534/genetics.104.027904	38	185	189	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 27	2012	489	7417					581	+		10.1038/nature11353	http://dx.doi.org/10.1038/nature11353			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	046RG	22960744	Green Accepted			2022-12-24	WOS:000311781500007
J	Dunham, I; Kundaje, A; Aldred, SF; Collins, PJ; Davis, C; Doyle, F; Epstein, CB; Frietze, S; Harrow, J; Kaul, R; Khatun, J; Lajoie, BR; Landt, SG; Lee, BK; Pauli, F; Rosenbloom, KR; Sabo, P; Safi, A; Sanyal, A; Shoresh, N; Simon, JM; Song, L; Trinklein, ND; Altshuler, RC; Birney, E; Brown, JB; Cheng, C; Djebali, S; Dong, XJ; Dunham, I; Ernst, J; Furey, TS; Gerstein, M; Giardine, B; Greven, M; Hardison, RC; Harris, RS; Herrero, J; Hoffman, MM; Iyer, S; Kellis, M; Khatun, J; Kheradpour, P; Kundaje, A; Lassmann, T; Li, QH; Lin, X; Marinov, GK; Merkel, A; Mortazavi, A; Parker, SCJ; Reddy, TE; Rozowsky, J; Schlesinger, F; Thurman, RE; Wang, J; Ward, LD; Whitfield, TW; Wilder, SP; Wu, W; Xi, HLS; Yip, KY; Zhuang, JL; Bernstein, BE; Birney, E; Dunham, I; Green, ED; Gunter, C; Snyder, M; Pazin, MJ; Lowdon, RF; Dillon, LAL; Adams, LB; Kelly, CJ; Zhang, J; Wexler, JR; Green, ED; Good, PJ; Feingold, EA; Bernstein, BE; Birney, E; Crawford, GE; Dekker, J; Elnitski, L; Farnham, PJ; Gerstein, M; Giddings, MC; Gingeras, TR; Green, ED; Guigo, R; Hardison, RC; Hubbard, TJ; Kellis, M; Kent, WJ; Lieb, JD; Margulies, EH; Myers, RM; Snyder, M; Stamatoyannopoulos, JA; Tenenbaum, SA; Weng, ZP; White, KP; Wold, B; Khatun, J; Yu, Y; Wrobel, J; Risk, BA; Gunawardena, HP; Kuiper, HC; Maier, CW; Xie, L; Chen, X; Giddings, MC; Bernstein, BE; Epstein, CB; Shoresh, N; Ernst, J; Kheradpour, P; Mikkelsen, TS; Gillespie, S; Goren, A; Ram, O; Zhang, XL; Wang, L; Issner, R; Coyne, MJ; Durham, T; Ku, M; Truong, T; Ward, LD; Altshuler, RC; Eaton, ML; Kellis, M; Djebali, S; Davis, CA; Merkel, A; Dobin, A; Lassmann, T; Mortazavi, A; Tanzer, A; Lagarde, J; Lin, W; Schlesinger, F; Xue, CH; Marinov, GK; Khatun, J; Williams, BA; Zaleski, C; Rozowsky, J; Roeder, M; Kokocinski, F; Abdelhamid, RF; Alioto, T; Antoshechkin, I; Baer, MT; Batut, P; Bell, I; Bell, K; Chakrabortty, S; Chen, X; Chrast, J; Curado, J; Derrien, T; Drenkow, J; Dumais, E; Dumais, J; Duttagupta, R; Fastuca, M; Fejes-Toth, K; Ferreira, P; Foissac, S; Fullwood, MJ; Gao, H; Gonzalez, D; Gordon, A; Gunawardena, HP; Howald, C; Jha, S; Johnson, R; Kapranov, P; King, B; Kingswood, C; Li, GL; Luo, OJ; Park, E; Preall, JB; Presaud, K; Ribeca, P; Risk, BA; Robyr, D; Ruan, XA; Sammeth, M; Sandhu, KS; Schaeffer, L; See, LH; Shahab, A; Skancke, J; Suzuki, AM; Takahashi, H; Tilgner, H; Trout, D; Walters, N; Wang, HE; Wrobel, J; Yu, YB; Hayashizaki, Y; Harrow, J; Gerstein, M; Hubbard, TJ; Reymond, A; Antonarakis, SE; Hannon, GJ; Giddings, MC; Ruan, YJ; Wold, B; Carninci, P; Guigo, R; Gingeras, TR; Rosenbloom, KR; Sloan, CA; Learned, K; Malladi, VS; Wong, MC; Barber, G; Cline, MS; Dreszer, TR; Heitner, SG; Karolchik, D; Kent, WJ; Kirkup, VM; Meyer, LR; Long, JC; Maddren, M; Raney, BJ; Furey, TS; Song, LY; Grasfeder, LL; Giresi, PG; Lee, BK; Battenhouse, A; Sheffield, NC; Simon, JM; Showers, KA; Safi, A; London, D; Bhinge, AA; Shestak, C; Schaner, MR; Kim, SK; Zhang, ZZZ; Mieczkowski, PA; Mieczkowska, JO; Liu, Z; McDaniell, RM; Ni, YY; Rashid, NU; Kim, MJ; Adar, S; Zhang, ZC; Wang, TY; Winter, D; Keefe, D; Birney, E; Iyer, VR; Lieb, JD; Crawford, GE; Li, GL; Sandhu, KS; Zheng, MZ; Wang, P; Luo, OJ; Shahab, A; Fullwood, MJ; Ruan, XA; Ruan, YJ; Myers, RM; Pauli, F; Williams, BA; Gertz, J; Marinov, GK; Reddy, TE; Vielmetter, J; Partridge, EC; Trout, D; Varley, KE; Gasper, C; Bansal, A; Pepke, S; Jain, P; Amrhein, H; Bowling, KM; Anaya, M; Cross, MK; King, B; Muratet, MA; Antoshechkin, I; Newberry, KM; Mccue, K; Nesmith, AS; Fisher-Aylor, KI; Pusey, B; DeSalvo, G; Parker, SL; Balasubramanian, S; Davis, NS; Meadows, SK; Eggleston, T; Gunter, C; Newberry, JS; Levy, SE; Absher, DM; Mortazavi, A; Wong, WH; Wold, B; Blow, MJ; Visel, A; Pennachio, LA; Elnitski, L; Margulies, EH; Parker, SCJ; Petrykowska, HM; Abyzov, A; Aken, B; Barrell, D; Barson, G; Berry, A; Bignell, A; Boychenko, V; Bussotti, G; Chrast, J; Davidson, C; Derrien, T; Despacio-Reyes, G; Diekhans, M; Ezkurdia, I; Frankish, A; Gilbert, J; Gonzalez, JM; Griffiths, E; Harte, R; Hendrix, DA; Howald, C; Hunt, T; Jungreis, I; Kay, M; Khurana, E; Kokocinski, F; Leng, J; Lin, MF; Loveland, J; Lu, Z; Manthravadi, D; Mariotti, M; Mudge, J; Mukherjee, G; Notredame, C; Pei, BK; Rodriguez, JM; Saunders, G; Sboner, A; Searle, S; Sisu, C; Snow, C; Steward, C; Tanzer, A; Tapanari, E; Tress, ML; van Baren, MJ; Walters, N; Washietl, S; Wilming, L; Zadissa, A; Zhang, ZD; Brent, M; Haussler, D; Kellis, M; Valencia, A; Gerstein, M; Reymond, A; Guigo, R; Harrow, J; Hubbard, TJ; Landt, SG; Frietze, S; Abyzov, A; Addleman, N; Alexander, RP; Auerbach, RK; Balasubramanian, S; Bettinger, K; Bhardwaj, N; Boyle, AP; Cao, AR; Cayting, P; Charos, A; Cheng, Y; Cheng, C; Eastman, C; Euskirchen, G; Fleming, JD; Grubert, F; Habegger, L; Hariharan, M; Harmanci, A; Iyengar, S; Jin, VX; Karczewski, KJ; Kasowski, M; Lacroute, P; Lam, H; Lamarre-Vincent, N; Leng, J; Lian, J; Lindahl-Allen, M; Min, RQ; Miotto, B; Monahan, H; Moqtaderi, Z; Mu, XMJ; O'Geen, H; Ouyang, ZQ; Patacsil, D; Pei, BK; Raha, D; Ramirez, L; Reed, B; Rozowsky, J; Sboner, A; Shi, MY; Sisu, C; Slifer, T; Witt, H; Wu, LF; Xu, XQ; Yan, KK; Yang, XQ; Yip, KY; Zhang, ZD; Struhl, K; Weissman, SM; Gerstein, M; Farnham, PJ; Snyder, M; Tenenbaum, SA; Penalva, LO; Doyle, F; Karmakar, S; Landt, SG; Bhanvadia, RR; Choudhury, A; Domanus, M; Ma, LJ; Moran, J; Patacsil, D; Slifer, T; Victorsen, A; Yang, XQ; Snyder, M; White, KP; Auer, T; Centanin, L; Eichenlaub, M; Gruhl, F; Heermann, S; Hoeckendorf, B; Inoue, D; Kellner, T; Kirchmaier, S; Mueller, C; Reinhardt, R; Schertel, L; Schneider, S; Sinn, R; Wittbrodt, B; Wittbrodt, J; Weng, ZP; Whitfield, TW; Wang, J; Collins, PJ; Aldred, SF; Trinklein, ND; Partridge, EC; Myers, RM; Dekker, J; Jain, G; Lajoie, BR; Sanyal, A; Balasundaram, G; Bates, DL; Byron, R; Canfield, TK; Diegel, MJ; Dunn, D; Ebersol, AK; Frum, T; Garg, K; Gist, E; Hansen, RS; Boatman, L; Haugen, E; Humbert, R; Jain, G; Johnson, AK; Johnson, EM; Kutyavin, TV; Lajoie, BR; Lee, K; Lotakis, D; Maurano, MT; Neph, SJ; Neri, FV; Nguyen, ED; Qu, HZ; Reynolds, AP; Roach, V; Rynes, E; Sabo, P; Sanchez, ME; Sandstrom, RS; Sanyal, A; Shafer, AO; Stergachis, AB; Thomas, S; Thurman, RE; Vernot, B; Vierstra, J; Vong, S; Wang, H; Weaver, MA; Yan, YQ; Zhang, MH; Akey, JM; Bender, M; Dorschner, MO; Groudine, M; MacCoss, MJ; Navas, P; Stamatoyannopoulos, G; Kaul, R; Dekker, J; Stamatoyannopoulos, JA; Dunham, I; Beal, K; Brazma, A; Flicek, P; Herrero, J; Johnson, N; Keefe, D; Lukk, M; Luscombe, NM; Sobral, D; Vaquerizas, JM; Wilder, SP; Batzoglou, S; Sidow, A; Hussami, N; Kyriazopoulou-Panagiotopoulou, S; Libbrecht, MW; Schaub, MA; Kundaje, A; Hardison, RC; Miller, W; Giardine, B; Harris, RS; Wu, W; Bickel, PJ; Banfai, B; Boley, NP; Brown, JB; Huang, HY; Li, QH; Li, JJ; Noble, WS; Bilmes, JA; Buske, OJ; Hoffman, MM; Sahu, AD; Kharchenko, PV; Park, PJ; Baker, D; Taylor, J; Weng, ZP; Iyer, S; Dong, XJ; Greven, M; Lin, XY; Wang, J; Xi, HLS; Zhuang, JL; Gerstein, M; Alexander, RP; Balasubramanian, S; Cheng, C; Harmanci, A; Lochovsky, L; Min, R; Mu, XMJ; Rozowsky, J; Yan, KK; Yip, KY; Birney, E				Dunham, Ian; Kundaje, Anshul; Aldred, Shelley F.; Collins, Patrick J.; Davis, CarrieA.; Doyle, Francis; Epstein, Charles B.; Frietze, Seth; Harrow, Jennifer; Kaul, Rajinder; Khatun, Jainab; Lajoie, Bryan R.; Landt, Stephen G.; Lee, Bum-Kyu; Pauli, Florencia; Rosenbloom, Kate R.; Sabo, Peter; Safi, Alexias; Sanyal, Amartya; Shoresh, Noam; Simon, Jeremy M.; Song, Lingyun; Trinklein, Nathan D.; Altshuler, Robert C.; Birney, Ewan; Brown, James B.; Cheng, Chao; Djebali, Sarah; Dong, Xianjun; Dunham, Ian; Ernst, Jason; Furey, Terrence S.; Gerstein, Mark; Giardine, Belinda; Greven, Melissa; Hardison, Ross C.; Harris, Robert S.; Herrero, Javier; Hoffman, Michael M.; Iyer, Sowmya; Kellis, Manolis; Khatun, Jainab; Kheradpour, Pouya; Kundaje, Anshul; Lassmann, Timo; Li, Qunhua; Lin, Xinying; Marinov, Georgi K.; Merkel, Angelika; Mortazavi, Ali; Parker, Stephen C. J.; Reddy, Timothy E.; Rozowsky, Joel; Schlesinger, Felix; Thurman, Robert E.; Wang, Jie; Ward, Lucas D.; Whitfield, Troy W.; Wilder, Steven P.; Wu, Weisheng; Xi, Hualin S.; Yip, Kevin Y.; Zhuang, Jiali; Bernstein, Bradley E.; Birney, Ewan; Dunham, Ian; Green, Eric D.; Gunter, Chris; Snyder, Michael; Pazin, Michael J.; Lowdon, Rebecca F.; Dillon, Laura A. L.; Adams, Leslie B.; Kelly, Caroline J.; Zhang, Julia; Wexler, Judith R.; Green, Eric D.; Good, Peter J.; Feingold, Elise A.; Bernstein, Bradley E.; Birney, Ewan; Crawford, Gregory E.; Dekker, Job; Elnitski, Laura; Farnham, Peggy J.; Gerstein, Mark; Giddings, Morgan C.; Gingeras, Thomas R.; Green, Eric D.; Guigo, Roderic; Hardison, Ross C.; Hubbard, Timothy J.; Kellis, Manolis; Kent, W. James; Lieb, Jason D.; Margulies, Elliott H.; Myers, Richard M.; Snyder, Michael; Stamatoyannopoulos, John A.; Tenenbaum, Scott A.; Weng, Zhiping; White, Kevin P.; Wold, Barbara; Khatun, Jainab; Yu, Yanbao; Wrobel, John; Risk, Brian A.; Gunawardena, Harsha P.; Kuiper, Heather C.; Maier, Christopher W.; Xie, Ling; Chen, Xian; Giddings, Morgan C.; Bernstein, Bradley E.; Epstein, Charles B.; Shoresh, Noam; Ernst, Jason; Kheradpour, Pouya; Mikkelsen, Tarjei S.; Gillespie, Shawn; Goren, Alon; Ram, Oren; Zhang, Xiaolan; Wang, Li; Issner, Robbyn; Coyne, Michael J.; Durham, Timothy; Ku, Manching; Truong, Thanh; Ward, Lucas D.; Altshuler, Robert C.; Eaton, Matthew L.; Kellis, Manolis; Djebali, Sarah; Davis, Carrie A.; Merkel, Angelika; Dobin, Alex; Lassmann, Timo; Mortazavi, Ali; Tanzer, Andrea; Lagarde, Julien; Lin, Wei; Schlesinger, Felix; Xue, Chenghai; Marinov, Georgi K.; Khatun, Jainab; Williams, Brian A.; Zaleski, Chris; Rozowsky, Joel; Roeder, Maik; Kokocinski, Felix; Abdelhamid, Rehab F.; Alioto, Tyler; Antoshechkin, Igor; Baer, Michael T.; Batut, Philippe; Bell, Ian; Bell, Kimberly; Chakrabortty, Sudipto; Chen, Xian; Chrast, Jacqueline; Curado, Joao; Derrien, Thomas; Drenkow, Jorg; Dumais, Erica; Dumais, Jackie; Duttagupta, Radha; Fastuca, Megan; Fejes-Toth, Kata; Ferreira, Pedro; Foissac, Sylvain; Fullwood, Melissa J.; Gao, Hui; Gonzalez, David; Gordon, Assaf; Gunawardena, Harsha P.; Howald, Cedric; Jha, Sonali; Johnson, Rory; Kapranov, Philipp; King, Brandon; Kingswood, Colin; Li, Guoliang; Luo, Oscar J.; Park, Eddie; Preall, Jonathan B.; Presaud, Kimberly; Ribeca, Paolo; Risk, Brian A.; Robyr, Daniel; Ruan, Xiaoan; Sammeth, Michael; Sandhu, Kuljeet Singh; Schaeffer, Lorain; See, Lei-Hoon; Shahab, Atif; Skancke, Jorgen; Suzuki, Ana Maria; Takahashi, Hazuki; Tilgner, Hagen; Trout, Diane; Walters, Nathalie; Wang, Huaien; Wrobel, John; Yu, Yanbao; Hayashizaki, Yoshihide; Harrow, Jennifer; Gerstein, Mark; Hubbard, Timothy J.; Reymond, Alexandre; Antonarakis, Stylianos E.; Hannon, Gregory J.; Giddings, Morgan C.; Ruan, Yijun; Wold, Barbara; Carninci, Piero; Guigo, Roderic; Gingeras, Thomas R.; Rosenbloom, Kate R.; Sloan, Cricket A.; Learned, Katrina; Malladi, Venkat S.; Wong, Matthew C.; Barber, Galtp.; Cline, Melissa S.; Dreszer, Timothy R.; Heitner, Steven G.; Karolchik, Donna; Kent, W. James; Kirkup, Vanessa M.; Meyer, Laurence R.; Long, Jeffrey C.; Maddren, Morgan; Raney, Brian J.; Furey, Terrence S.; Song, Lingyun; Grasfeder, Linda L.; Giresi, Paul G.; Lee, Bum-Kyu; Battenhouse, Anna; Sheffield, Nathan C.; Simon, Jeremy M.; Showers, Kimberly A.; Safi, Alexias; London, Darin; Bhinge, Akshay A.; Shestak, Christopher; Schaner, Matthew R.; Kim, Seul Ki; Zhang, Zhuzhu Z.; Mieczkowski, Piotr A.; Mieczkowska, Joanna O.; Liu, Zheng; McDaniell, Ryan M.; Ni, Yunyun; Rashid, Naim U.; Kim, Min Jae; Adar, Sheera; Zhang, Zhancheng; Wang, Tianyuan; Winter, Deborah; Keefe, Damian; Birney, Ewan; Iyer, Vishwanath R.; Lieb, Jason D.; Crawford, Gregory E.; Li, Guoliang; Sandhu, Kuljeet Singh; Zheng, Meizhen; Wang, Ping; Luo, Oscar J.; Shahab, Atif; Fullwood, Melissa J.; Ruan, Xiaoan; Ruan, Yijun; Myers, Richard M.; Pauli, Florencia; Williams, Brian A.; Gertz, Jason; Marinov, Georgi K.; Reddy, Timothy E.; Vielmetter, Jost; Partridge, E. Christopher; Trout, Diane; Varley, Katherine E.; Gasper, Clarke; Bansal, Anita; Pepke, Shirley; Jain, Preti; Amrhein, Henry; Bowling, Kevin M.; Anaya, Michael; Cross, Marie K.; King, Brandon; Muratet, Michael A.; Antoshechkin, Igor; Newberry, Kimberly M.; Mccue, Kenneth; Nesmith, Amy S.; Fisher-Aylor, Katherine I.; Pusey, Barbara; DeSalvo, Gilberto; Parker, Stephanie L.; Balasubramanian, Sreeram; Davis, Nicholas S.; Meadows, Sarah K.; Eggleston, Tracy; Gunter, Chris; Newberry, J. Scott; Levy, Shawn E.; Absher, Devin M.; Mortazavi, Ali; Wong, Wing H.; Wold, Barbara; Blow, Matthew J.; Visel, Axel; Pennachio, Len A.; Elnitski, Laura; Margulies, Elliott H.; Parker, Stephen C. J.; Petrykowska, Hanna M.; Abyzov, Alexej; Aken, Bronwen; Barrell, Daniel; Barson, Gemma; Berry, Andrew; Bignell, Alexandra; Boychenko, Veronika; Bussotti, Giovanni; Chrast, Jacqueline; Davidson, Claire; Derrien, Thomas; Despacio-Reyes, Gloria; Diekhans, Mark; Ezkurdia, Iakes; Frankish, Adam; Gilbert, James; Gonzalez, Jose Manuel; Griffiths, Ed; Harte, Rachel; Hendrix, David A.; Howald, Cedric; Hunt, Toby; Jungreis, Irwin; Kay, Mike; Khurana, Ekta; Kokocinski, Felix; Leng, Jing; Lin, Michael F.; Loveland, Jane; Lu, Zhi; Manthravadi, Deepa; Mariotti, Marco; Mudge, Jonathan; Mukherjee, Gaurab; Notredame, Cedric; Pei, Baikang; Rodriguez, Jose Manuel; Saunders, Gary; Sboner, Andrea; Searle, Stephen; Sisu, Cristina; Snow, Catherine; Steward, Charlie; Tanzer, Andrea; Tapanari, Electra; Tress, Michael L.; van Baren, Marijke J.; Walters, Nathalie; Washietl, Stefan; Wilming, Laurens; Zadissa, Amonida; Zhang, Zhengdong; Brent, Michael; Haussler, David; Kellis, Manolis; Valencia, Alfonso; Gerstein, Mark; Reymond, Alexandre; Guigo, Roderic; Harrow, Jennifer; Hubbard, Timothy J.; Landt, Stephen G.; Frietze, Seth; Abyzov, Alexej; Addleman, Nick; Alexander, Roger P.; Auerbach, Raymond K.; Balasubramanian, Suganthi; Bettinger, Keith; Bhardwaj, Nitin; Boyle, Alan P.; Cao, Alina R.; Cayting, Philip; Charos, Alexandra; Cheng, Yong; Cheng, Chao; Eastman, Catharine; Euskirchen, Ghia; Fleming, Joseph D.; Grubert, Fabian; Habegger, Lukas; Hariharan, Manoj; Harmanci, Arif; Iyengar, Sushma; Jin, Victor X.; Karczewski, Konrad J.; Kasowski, Maya; Lacroute, Phil; Lam, Hugo; Lamarre-Vincent, Nathan; Leng, Jing; Lian, Jin; Lindahl-Allen, Marianne; Min, Renqiang; Miotto, Benoit; Monahan, Hannah; Moqtaderi, Zarmik; Mu, Xinmeng J.; O'Geen, Henriette; Ouyang, Zhengqing; Patacsil, Dorrelyn; Pei, Baikang; Raha, Debasish; Ramirez, Lucia; Reed, Brian; Rozowsky, Joel; Sboner, Andrea; Shi, Minyi; Sisu, Cristina; Slifer, Teri; Witt, Heather; Wu, Linfeng; Xu, Xiaoqin; Yan, Koon-Kiu; Yang, Xinqiong; Yip, Kevin Y.; Zhang, Zhengdong; Struhl, Kevin; Weissman, Sherman M.; Gerstein, Mark; Farnham, Peggy J.; Snyder, Michael; Tenenbaum, Scott A.; Penalva, Luiz O.; Doyle, Francis; Karmakar, Subhradip; Landt, Stephen G.; Bhanvadia, Raj R.; Choudhury, Alina; Domanus, Marc; Ma, Lijia; Moran, Jennifer; Patacsil, Dorrelyn; Slifer, Teri; Victorsen, Alec; Yang, Xinqiong; Snyder, Michael; White, Kevin P.; Auer, Thomas; Centanin, Lazaro; Eichenlaub, Michael; Gruhl, Franziska; Heermann, Stephan; Hoeckendorf, Burkhard; Inoue, Daigo; Kellner, Tanja; Kirchmaier, Stephan; Mueller, Claudia; Reinhardt, Robert; Schertel, Lea; Schneider, Stephanie; Sinn, Rebecca; Wittbrodt, Beate; Wittbrodt, Jochen; Weng, Zhiping; Whitfield, Troy W.; Wang, Jie; Collins, Patrick J.; Aldred, Shelley F.; Trinklein, Nathan D.; Partridge, E. Christopher; Myers, Richard M.; Dekker, Job; Jain, Gaurav; Lajoie, Bryan R.; Sanyal, Amartya; Balasundaram, Gayathri; Bates, Daniel L.; Byron, Rachel; Canfield, Theresa K.; Diegel, Morgan J.; Dunn, Douglas; Ebersol, Abigail K.; Frum, Tristan; Garg, Kavita; Gist, Erica; Hansen, R. Scott; Boatman, Lisa; Haugen, Eric; Humbert, Richard; Jain, Gaurav; Johnson, Audra K.; Johnson, Ericka M.; Kutyavin, Tattyana V.; Lajoie, Bryan R.; Lee, Kristen; Lotakis, Dimitra; Maurano, Matthew T.; Neph, Shane J.; Neri, Fiedencio V.; Nguyen, Eric D.; Qu, Hongzhu; Reynolds, Alex P.; Roach, Vaughn; Rynes, Eric; Sabo, Peter; Sanchez, Minerva E.; Sandstrom, Richard S.; Sanyal, Amartya; Shafer, Anthony O.; Stergachis, Andrew B.; Thomas, Sean; Thurman, Robert E.; Vernot, Benjamin; Vierstra, Jeff; Vong, Shinny; Wang, Hao; Weaver, Molly A.; Yan, Yongqi; Zhang, Miaohua; Akey, Joshua M.; Bender, Michael; Dorschner, Michael O.; Groudine, Mark; MacCoss, Michael J.; Navas, Patrick; Stamatoyannopoulos, George; Kaul, Rajinder; Dekker, Job; Stamatoyannopoulos, John A.; Dunham, Ian; Beal, Kathryn; Brazma, Alvis; Flicek, Paul; Herrero, Javier; Johnson, Nathan; Keefe, Damian; Lukk, Margus; Luscombe, Nicholas M.; Sobral, Daniel; Vaquerizas, Juan M.; Wilder, Steven P.; Batzoglou, Serafim; Sidow, Arend; Hussami, Nadine; Kyriazopoulou-Panagiotopoulou, Sofia; Libbrecht, Max W.; Schaub, Marc A.; Kundaje, Anshul; Hardison, Ross C.; Miller, Webb; Giardine, Belinda; Harris, Robert S.; Wu, Weisheng; Bickel, Peter J.; Banfai, Balazs; Boley, Nathan P.; Brown, James B.; Huang, Haiyan; Li, Qunhua; Li, Jingyi Jessica; Noble, William Stafford; Bilmes, Jeffrey A.; Buske, Orion J.; Hoffman, Michael M.; Sahu, Avinash D.; Kharchenko, Peter V.; Park, Peter J.; Baker, Dannon; Taylor, James; Weng, Zhiping; Iyer, Sowmya; Dong, Xianjun; Greven, Melissa; Lin, Xinying; Wang, Jie; Xi, Hualin S.; Zhuang, Jiali; Gerstein, Mark; Alexander, Roger P.; Balasubramanian, Suganthi; Cheng, Chao; Harmanci, Arif; Lochovsky, Lucas; Min, Renqiang; Mu, Xinmeng J.; Rozowsky, Joel; Yan, Koon-Kiu; Yip, Kevin Y.; Birney, Ewan		ENCODE Project Consortium	An integrated encyclopedia of DNA elements in the human genome	NATURE			English	Article							TRANSCRIPTION FACTOR-BINDING; CHROMOSOME CONFORMATION CAPTURE; HUMAN-CELLS; IN-VIVO; CHROMATIN; REGIONS; MOUSE; MAPS; WIDE; DETERMINANTS	The human genome encodes the blueprint of life, but the function of the vast majority of its nearly three billion bases is unknown. The Encyclopedia of DNA Elements (ENCODE) project has systematically mapped regions of transcription, transcription factor association, chromatin structure and histone modification. These data enabled us to assign biochemical functions for 80% of the genome, in particular outside of the well-studied protein-coding regions. Many discovered candidate regulatory elements are physically associated with one another and with expressed genes, providing new insights into the mechanisms of gene regulation. The newly identified elements also show a statistical correspondence to sequence variants linked to human disease, and can thereby guide interpretation of this variation. Overall, the project provides new insights into the organization and regulation of our genes and genome, and is an expansive resource of functional annotations for biomedical research.	[Dunham, Ian; Birney, Ewan; Herrero, Javier; Wilder, Steven P.; Keefe, Damian; Brazma, Alvis; Flicek, Paul; Lukk, Margus; Sobral, Daniel] European Bioinformat Inst EMBL EBI, Vertebrate Genom Grp, Hinxton CB10 1SD, Cambs, England; [Kundaje, Anshul; Batzoglou, Serafim; Sidow, Arend; Hussami, Nadine; Kyriazopoulou-Panagiotopoulou, Sofia; Libbrecht, Max W.; Schaub, Marc A.] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Aldred, Shelley F.; Collins, Patrick J.; Trinklein, Nathan D.] SwitchGear Genom, Menlo Pk, CA 94025 USA; [Davis, CarrieA.; Schlesinger, Felix; Gingeras, Thomas R.; Davis, Carrie A.; Dobin, Alex; Lin, Wei; Xue, Chenghai; Zaleski, Chris; Baer, Michael T.; Batut, Philippe; Bell, Kimberly; Chakrabortty, Sudipto; Drenkow, Jorg; Fastuca, Megan; Fejes-Toth, Kata; Gordon, Assaf; Jha, Sonali; Preall, Jonathan B.; Presaud, Kimberly; See, Lei-Hoon; Wang, Huaien; Hannon, Gregory J.; Frankish, Adam; Ebersol, Abigail K.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Doyle, Francis; Bernstein, Bradley E.; Tenenbaum, Scott A.] SUNY Albany, Albany, NY 12203 USA; [Epstein, Charles B.; Shoresh, Noam; Bernstein, Bradley E.; Mikkelsen, Tarjei S.; Zhang, Xiaolan; Wang, Li; Issner, Robbyn; Coyne, Michael J.; Durham, Timothy; Truong, Thanh; Loveland, Jane] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Frietze, Seth; Farnham, Peggy J.; Witt, Heather] USC Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA; [Harrow, Jennifer; Hubbard, Timothy J.; Kokocinski, Felix; Aken, Bronwen; Barrell, Daniel; Barson, Gemma; Berry, Andrew; Bignell, Alexandra; Boychenko, Veronika; Davidson, Claire; Despacio-Reyes, Gloria; Frankish, Adam; Gilbert, James; Gonzalez, Jose Manuel; Griffiths, Ed; Hunt, Toby; Kay, Mike; Manthravadi, Deepa; Mudge, Jonathan; Mukherjee, Gaurab; Saunders, Gary; Searle, Stephen; Snow, Catherine; Steward, Charlie; Tapanari, Electra; Wilming, Laurens; Zadissa, Amonida] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; [Kaul, Rajinder] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Khatun, Jainab; Giddings, Morgan C.; Wrobel, John; Risk, Brian A.] Boise State Univ, Coll Arts & Sci, Boise, ID 83725 USA; [Lajoie, Bryan R.; Sanyal, Amartya; Dekker, Job; Jain, Gaurav] Univ Massachusetts, Sch Med, Program Syst Biol, Program Gene Funct & Express,Dept Biochem & Mol P, Worcester, MA 01605 USA; [Landt, Stephen G.; Snyder, Michael; Addleman, Nick; Bettinger, Keith; Boyle, Alan P.; Cayting, Philip; Cheng, Yong; Eastman, Catharine; Euskirchen, Ghia; Grubert, Fabian; Hariharan, Manoj; Karczewski, Konrad J.; Kasowski, Maya; Lacroute, Phil; Lam, Hugo; Ouyang, Zhengqing; Patacsil, Dorrelyn; Ramirez, Lucia; Shi, Minyi; Slifer, Teri; Wu, Linfeng; Yang, Xinqiong; Ebersol, Abigail K.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Lee, Bum-Kyu; Battenhouse, Anna; Bhinge, Akshay A.; Liu, Zheng; McDaniell, Ryan M.; Ni, Yunyun; Adar, Sheera; Zhang, Zhancheng; Wang, Tianyuan; Iyer, Vishwanath R.] Univ Texas Austin, Ctr Syst & Synthet Biol, Inst Cellular & Mol Biol, Sect Mol Genet & Microbiol, Austin, TX 78712 USA; [Pauli, Florencia; Reddy, Timothy E.; Gunter, Chris; Myers, Richard M.; Gertz, Jason; Partridge, E. Christopher; Varley, Katherine E.; Bansal, Anita; Bowling, Kevin M.; Cross, Marie K.; Muratet, Michael A.; Newberry, Kimberly M.; Nesmith, Amy S.; Pusey, Barbara; Parker, Stephanie L.; Davis, Nicholas S.; Meadows, Sarah K.; Eggleston, Tracy; Newberry, J. Scott; Levy, Shawn E.; Absher, Devin M.] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Rosenbloom, Kate R.; Kent, W. James; Sloan, Cricket A.; Learned, Katrina; Malladi, Venkat S.; Wong, Matthew C.; Barber, Galtp.; Cline, Melissa S.; Dreszer, Timothy R.; Heitner, Steven G.; Karolchik, Donna; Kirkup, Vanessa M.; Meyer, Laurence R.; Long, Jeffrey C.; Maddren, Morgan; Raney, Brian J.; Diekhans, Mark; Harte, Rachel] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Sabo, Peter; Hoffman, Michael M.; Thurman, Robert E.; Bates, Daniel L.; Canfield, Theresa K.; Diegel, Morgan J.; Dunn, Douglas; Gist, Erica; Haugen, Eric; Humbert, Richard; Johnson, Audra K.; Kutyavin, Tattyana V.; Lee, Kristen; Maurano, Matthew T.; Neph, Shane J.; Neri, Fiedencio V.; Qu, Hongzhu; Reynolds, Alex P.; Roach, Vaughn; Rynes, Eric; Sandstrom, Richard S.; Shafer, Anthony O.; Stergachis, Andrew B.; Thomas, Sean; Vernot, Benjamin; Vierstra, Jeff; Vong, Shinny; Wang, Hao; Weaver, Molly A.; Akey, Joshua M.; MacCoss, Michael J.; Buske, Orion J.; Sahu, Avinash D.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Safi, Alexias; Song, Lingyun; Crawford, Gregory E.; Sheffield, Nathan C.; London, Darin] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Simon, Jeremy M.; Lieb, Jason D.; Grasfeder, Linda L.; Giresi, Paul G.; Showers, Kimberly A.; Shestak, Christopher; Schaner, Matthew R.; Kim, Seul Ki; Zhang, Zhuzhu Z.; Mieczkowska, Joanna O.; Kim, Min Jae] Univ N Carolina, Dept Biol, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Altshuler, Robert C.; Ernst, Jason; Kellis, Manolis; Kheradpour, Pouya; Ward, Lucas D.; Eaton, Matthew L.; Hendrix, David A.; Jungreis, Irwin; Lin, Michael F.; Washietl, Stefan] MIT, Comp Sci & Artificial Intelligence Lab, Broad Inst MIT & Harvard, Cambridge, MA 02139 USA; [Brown, James B.; Li, Qunhua; Bickel, Peter J.; Banfai, Balazs; Boley, Nathan P.; Huang, Haiyan; Li, Jingyi Jessica] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Cheng, Chao; Gerstein, Mark; Rozowsky, Joel; Yip, Kevin Y.; Abyzov, Alexej; Khurana, Ekta; Leng, Jing; Pei, Baikang; Sisu, Cristina; Alexander, Roger P.; Auerbach, Raymond K.; Balasubramanian, Suganthi; Bhardwaj, Nitin; Harmanci, Arif; Min, Renqiang; Mu, Xinmeng J.; Yan, Koon-Kiu; Lochovsky, Lucas] Yale Univ, Computat Biol & Bioinformat Program, New Haven, CT 06520 USA; [Djebali, Sarah; Merkel, Angelika; Tanzer, Andrea; Lagarde, Julien; Roeder, Maik; Curado, Joao; Derrien, Thomas; Ferreira, Pedro; Gonzalez, David; Johnson, Rory; Kingswood, Colin; Skancke, Jorgen; Tilgner, Hagen; Bussotti, Giovanni; Mariotti, Marco; Notredame, Cedric] Ctr Genom Regulat, Barcelona 08003, Catalonia, Spain; [Dong, Xianjun; Greven, Melissa; Lin, Xinying; Wang, Jie; Whitfield, Troy W.; Zhuang, Jiali; Weng, Zhiping] Univ Massachusetts, Program Bioinformat & Integrat Biol, Sch Med, Worcester, MA 01605 USA; [Furey, Terrence S.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Giardine, Belinda; Hardison, Ross C.; Harris, Robert S.; Wu, Weisheng; Miller, Webb] Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA; [Hardison, Ross C.; Hardison, Ross C.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Iyer, Sowmya] Boston Univ, Program Bioinformat, Boston, MA 02215 USA; [Lassmann, Timo; Abdelhamid, Rehab F.; Suzuki, Ana Maria; Takahashi, Hazuki; Hayashizaki, Yoshihide; Carninci, Piero] RIKEN Yokohama Inst, RIKEN Omics Sci Ctr, Tsurumi ku, Yokohama, Kanagawa 2300045, Japan; [Marinov, Georgi K.; Williams, Brian A.; Antoshechkin, Igor; King, Brandon; Schaeffer, Lorain; Trout, Diane; Vielmetter, Jost; Amrhein, Henry; Mccue, Kenneth] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Mortazavi, Ali; Park, Eddie] Univ Calif Irvine, Ctr Complex Biol Syst, Irvine, CA 92697 USA; [Margulies, Elliott H.] NHGRI, Genome Technol Branch, Bethesda, MD 20892 USA; [Xi, Hualin S.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Bernstein, Bradley E.; Bernstein, Bradley E.; Gillespie, Shawn; Goren, Alon; Ram, Oren; Ku, Manching] Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; [Bernstein, Bradley E.; Bernstein, Bradley E.; Gillespie, Shawn; Goren, Alon; Ram, Oren; Ku, Manching] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Bernstein, Bradley E.; Bernstein, Bradley E.; Gillespie, Shawn; Goren, Alon; Ram, Oren; Ku, Manching] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Green, Eric D.] NHGRI, NIH, Bethesda, MD 20892 USA; [Pazin, Michael J.; Lowdon, Rebecca F.; Dillon, Laura A. L.; Adams, Leslie B.; Kelly, Caroline J.; Zhang, Julia; Wexler, Judith R.; Good, Peter J.; Feingold, Elise A.] NHGRI, NIH, Bethesda, MD 20892 USA; Duke Univ, Dept Pediat, Div Med Genet, Sch Med, Durham, NC 27710 USA; [Elnitski, Laura; Petrykowska, Hanna M.] NHGRI, NIH, Rockville, MD 20892 USA; [Gingeras, Thomas R.; Gingeras, Thomas R.] Affymetrix Inc, Santa Clara, CA 95051 USA; [Guigo, Roderic] Univ Pompeu Fabra, Dept Ciencies Expt Salut, Barcelona 08002, Catalonia, Spain; [Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Stamatoyannopoulos, John A.] Univ Washington, Dept Med, Div Oncol, Seattle, WA 98195 USA; [White, Kevin P.; Karmakar, Subhradip; Bhanvadia, Raj R.; Choudhury, Alina; Domanus, Marc; Ma, Lijia; Moran, Jennifer; Victorsen, Alec; Ebersol, Abigail K.] Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA; [Wold, Barbara; Gasper, Clarke; Anaya, Michael; Fisher-Aylor, Katherine I.; DeSalvo, Gilberto; Balasubramanian, Sreeram] CALTECH, Beckman Inst, Pasadena, CA 91125 USA; [Yu, Yanbao; Gunawardena, Harsha P.; Kuiper, Heather C.; Maier, Christopher W.; Xie, Ling; Chen, Xian] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Alioto, Tyler; Ribeca, Paolo; Sammeth, Michael] CNAG, Barcelona 08028, Catalonia, Spain; [Bell, Ian; Dumais, Erica; Dumais, Jackie; Duttagupta, Radha; Foissac, Sylvain; Gao, Hui; Kapranov, Philipp; Reymond, Alexandre] Affymetrix Inc, Genom, Santa Clara, CA 95051 USA; [Chrast, Jacqueline; Howald, Cedric; Walters, Nathalie] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Fullwood, Melissa J.; Luo, Oscar J.; Ruan, Xiaoan; Sandhu, Kuljeet Singh; Shahab, Atif; Ruan, Yijun; Zheng, Meizhen; Wang, Ping] Genome Inst Singapore, Singapore 138672, Singapore; [Li, Guoliang; Reymond, Alexandre] Genome Inst Singapore, Singapore 138672, Singapore; [Robyr, Daniel; Antonarakis, Stylianos E.] Univ Geneva, Dept Genet Med & Dev, Sch Med, CH-1211 Geneva 4, Switzerland; [Robyr, Daniel; Antonarakis, Stylianos E.] Univ Hosp Geneva, CH-1211 Geneva 4, Switzerland; [Mieczkowski, Piotr A.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Rashid, Naim U.; Winter, Deborah] Univ N Carolina, Dept Biostat, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA; [Pepke, Shirley] CALTECH, Ctr Adv Comp Res, Pasadena, CA 91125 USA; [Wong, Wing H.] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Blow, Matthew J.] DOE Joint Genome Inst, Walnut Creek, CA USA; [Visel, Axel; Pennachio, Len A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94720 USA; [Ezkurdia, Iakes; Rodriguez, Jose Manuel; Tress, Michael L.; Valencia, Alfonso] Spanish Natl Canc Res Ctr CNIO, Madrid 28029, Spain; [Lu, Zhi] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Sboner, Andrea] Weill Cornell Med Coll, Dept Pathol & Lab Med, Inst Computat Biomed, New York, NY 10065 USA; [van Baren, Marijke J.; Brent, Michael] Washington Univ, St Louis, MO 63130 USA; [Zhang, Zhengdong] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Haussler, David] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; [Cao, Alina R.; O'Geen, Henriette; Xu, Xiaoqin] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Charos, Alexandra; Monahan, Hannah; Raha, Debasish; Reed, Brian] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA; [Fleming, Joseph D.; Lamarre-Vincent, Nathan; Lindahl-Allen, Marianne; Miotto, Benoit; Moqtaderi, Zarmik; Struhl, Kevin] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Iyengar, Sushma] Univ So Calif, Los Angeles, CA 90089 USA; [Jin, Victor X.] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA; [Lian, Jin; Weissman, Sherman M.] Yale Univ, Dept Genet, Sch Med, New Haven, CT 06510 USA; [Penalva, Luiz O.] Childrens Canc Res Inst UTHSCSA, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Auer, Thomas; Centanin, Lazaro; Eichenlaub, Michael; Gruhl, Franziska; Heermann, Stephan; Hoeckendorf, Burkhard; Inoue, Daigo; Kellner, Tanja; Kirchmaier, Stephan; Mueller, Claudia; Reinhardt, Robert; Schertel, Lea; Schneider, Stephanie; Sinn, Rebecca; Wittbrodt, Beate; Wittbrodt, Jochen] Heidelberg Univ, Ctr Organismal Studies, D-69120 Heidelberg, Germany; [Balasundaram, Gayathri; Byron, Rachel; Zhang, Miaohua; Bender, Michael; Groudine, Mark] Fred Hutchinson Canc Res Ctr, Basic Sci Div, Seattle, WA 98109 USA; [Ebersol, Abigail K.; Frum, Tristan; Hansen, R. Scott; Boatman, Lisa; Johnson, Ericka M.; Lotakis, Dimitra; Nguyen, Eric D.; Sanchez, Minerva E.; Yan, Yongqi; Navas, Patrick; Stamatoyannopoulos, George] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Garg, Kavita] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; [Dorschner, Michael O.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Beal, Kathryn; Johnson, Nathan] European Bioinformat Inst EMBL EBI, Microarray Informat Grp, Hinxton CB10 1SD, Cambs, England; [Keefe, Damian; Luscombe, Nicholas M.; Vaquerizas, Juan M.] European Bioinformat Inst EMBL EBI, Genom & Regulatory Syst Grp, Hinxton CB10 1SD, Cambs, England; [Keefe, Damian] Stanford Univ, Dept Genet, Dept Pathol, Stanford, CA 94305 USA; [Noble, William Stafford] Dept Comp Sci & Engn, Seattle, WA 98195 USA; [Bilmes, Jeffrey A.] Univ Washington, Dept Elect Engn, Seattle, WA 98195 USA; [Kharchenko, Peter V.; Park, Peter J.] Harvard Univ, Ctr Biomed Informat, Sch Med, Boston, MA 02115 USA; [Baker, Dannon; Taylor, James] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Baker, Dannon; Taylor, James] Emory Univ, Dept Math & Comp Sci, Atlanta, GA 30322 USA	European Molecular Biology Laboratory (EMBL); Stanford University; Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Southern California; Wellcome Trust Sanger Institute; University of Washington; University of Washington Seattle; Idaho; Boise State University; University of Massachusetts System; University of Massachusetts Worcester; Stanford University; University of Texas System; University of Texas Austin; HudsonAlpha Institute for Biotechnology; University of California System; University of California Santa Cruz; University of Washington; University of Washington Seattle; Duke University; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of California System; University of California Berkeley; Yale University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); University of Massachusetts System; University of Massachusetts Worcester; University of North Carolina; University of North Carolina Chapel Hill; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Boston University; RIKEN; California Institute of Technology; University of California System; University of California Irvine; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Duke University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Affymetrix; Pompeu Fabra University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Chicago; California Institute of Technology; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Affymetrix; University of Lausanne; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of Geneva; University of Geneva; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; California Institute of Technology; Stanford University; United States Department of Energy (DOE); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Centro Nacional de Investigaciones Oncologicas (CNIO); Tsinghua University; Cornell University; Washington University (WUSTL); Yeshiva University; Albert Einstein College of Medicine; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz; University of California System; University of California Davis; Yale University; Harvard University; Harvard Medical School; University of Southern California; University System of Ohio; Ohio State University; Yale University; University of Texas System; University of Texas Health San Antonio; Ruprecht Karls University Heidelberg; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Stanford University; University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School; Emory University; Emory University	Dunham, I (corresponding author), European Bioinformat Inst EMBL EBI, Vertebrate Genom Grp, Hinxton CB10 1SD, Cambs, England.		Ganesh, Dunna Sai/AGX-5170-2022; Ferreira, Pedro/HDO-1346-2022; Yan, Koon-Kiu/A-5940-2009; Sisu, Cristina/K-8994-2019; Winter, Deborah R./AAQ-9253-2020; Miotto, Benoit/CAF-2937-2022; Adams, Leslie/AAZ-9323-2020; Dong, Xianjun/N-3867-2014; Ferreira, Pedro G/J-6379-2013; Lassmann, Timo/HCH-4313-2022; Hubbard, Tim J.P./AAT-4571-2020; Karmakar, Subhradip/AAF-7678-2021; Tanzer, Andrea/L-3147-2015; Carninci, Piero/K-1568-2014; Alioto, Tyler/AAF-6342-2020; Vaquerizas, Juan M/F-2676-2011; Abyzov, Alexej/AAT-4615-2020; Raney, Brian/ABE-6267-2020; Sheffield, Nathan/ABG-8124-2020; Lagarde, Julien/AAI-1686-2020; Fullwood, Melissa/G-5713-2011; Boyle, Alan/I-1848-2014; Sammeth, Michael/C-1157-2014; Mikkelsen, Tarjei S/A-1306-2007; Sobral, Daniel/B-4786-2014; Herrero, Javier/H-6971-2019; Karmakar, Subhradip/AAP-6043-2020; Takahashi, Hazuki/F-9007-2017; wang, baocheng/B-7805-2008; Sboner, Andrea/C-6487-2008; Rodriguez, Jose josemrc/R-4018-2018; Wittbrodt, Joachim/D-4735-2014; Khurana, Ekta/C-4933-2013; Li, Jingyi Jessica/K-2037-2012; Ezkurdia, Iakes/H-9334-2015; Valencia, Alfonso/I-3127-2015; Heermann, Stephan/J-8586-2015; Vaquerizas, Juan M/AAY-2339-2020; Derrien, Thomas/ABD-6197-2020; Johnson, Rory/ABE-2503-2021; Abyzov, Alexej/M-4284-2013; Vernot, Benjamin/ABH-1495-2021; Gao, Hui/AAF-9770-2019; Luo, Junhong/N-8583-2019; Lassmann, Timo/A-8271-2008; Yip, Kevin/AAT-4771-2020; Tanzer, Andrea/AAY-5431-2021; Mu, Xinmeng/P-2562-2016; Kundaje, Anshul/Y-2598-2019; Li, Guoliang/D-8014-2012; Johnson, Rory/H-2961-2015; Miotto, Benoit/I-6040-2018; Hardison, Ross C/G-1142-2010; Luo, Oscar Junhong/G-3293-2018; Hariharan, Manoj/N-2855-2015; Guigo, Roderic/D-1303-2010; zhang, zheng/HCH-9684-2022; Blow, Matthew/G-6369-2012; Brown, James/H-2971-2015; Brent, Michael/AAK-3702-2020; Gunter, Chris/AHA-7271-2022; Kundaje, Anshul/Y-2739-2019; Elnitski, Laura/AAD-3595-2021; Lin, Wei/AAH-9924-2019; Taylor, James/F-1026-2011; Mariotti, Marco/AAB-7136-2019; SANYAL, AMARTYA/D-7240-2015; cheng, yong/I-4270-2012; Visel, Axel/A-9398-2009; Djebali, Sarah/O-9817-2014; Antonarakis, Stylianos E/N-8866-2014; Sobral, Daniel/K-3097-2019; Kellis, Manolis/ABE-7385-2020; Hubbard, Tim J/C-2567-2008; Hannon, Gregory/AAB-3568-2019; Alexander, Roger/A-8643-2008; Alioto, Tyler/K-7267-2015; Rodriguez, Jose/AAS-4147-2021; Yu, Yanbao/G-3035-2010; Parker, Stephen/ABF-1063-2021; Hoffman, Michael M./I-1924-2012; Li, Jingyi Jessica/I-2779-2019; Tenenbaum, Scott A/H-4744-2019; notredame, cedric/G-3868-2010; Karczewski, Jakub/L-7326-2018; Bussotti, Giovanni/C-3082-2019	Sisu, Cristina/0000-0001-9371-0797; Winter, Deborah R./0000-0003-1806-673X; Miotto, Benoit/0000-0003-2857-2126; Adams, Leslie/0000-0003-4956-271X; Dong, Xianjun/0000-0002-8052-9320; Ferreira, Pedro G/0000-0003-3838-8664; Lassmann, Timo/0000-0002-0138-2691; Hubbard, Tim J.P./0000-0002-1767-9318; Tanzer, Andrea/0000-0003-2873-4236; Carninci, Piero/0000-0001-7202-7243; Alioto, Tyler/0000-0002-2960-5420; Vaquerizas, Juan M/0000-0002-6583-6541; Sheffield, Nathan/0000-0001-5643-4068; Lagarde, Julien/0000-0002-0290-7445; Fullwood, Melissa/0000-0003-0321-7865; Boyle, Alan/0000-0002-2081-1105; Sammeth, Michael/0000-0002-6528-9883; Mikkelsen, Tarjei S/0000-0002-8133-3135; Sobral, Daniel/0000-0003-3955-0117; Herrero, Javier/0000-0001-7313-717X; Karmakar, Subhradip/0000-0002-4757-8729; Takahashi, Hazuki/0000-0001-7315-7349; wang, baocheng/0000-0002-8236-8014; Sboner, Andrea/0000-0001-6915-3070; Rodriguez, Jose josemrc/0000-0002-9948-5073; Wittbrodt, Joachim/0000-0001-8550-7377; Li, Jingyi Jessica/0000-0002-9288-5648; Ezkurdia, Iakes/0000-0001-9074-5302; Valencia, Alfonso/0000-0002-8937-6789; Vaquerizas, Juan M/0000-0002-6583-6541; Johnson, Rory/0000-0003-4607-2782; Vernot, Benjamin/0000-0002-6820-2181; Lassmann, Timo/0000-0002-0138-2691; Yip, Kevin/0000-0001-5516-9944; Tanzer, Andrea/0000-0003-2873-4236; Mu, Xinmeng/0000-0002-8079-0828; Kundaje, Anshul/0000-0003-3084-2287; Li, Guoliang/0000-0003-1601-6640; Johnson, Rory/0000-0003-4607-2782; Miotto, Benoit/0000-0003-2857-2126; Hardison, Ross C/0000-0003-4084-7516; Hariharan, Manoj/0000-0002-1006-5372; Guigo, Roderic/0000-0002-5738-4477; Blow, Matthew/0000-0002-8844-9149; Brent, Michael/0000-0002-8689-0299; Kundaje, Anshul/0000-0003-3084-2287; Lin, Wei/0000-0002-7506-3466; Taylor, James/0000-0001-5079-840X; Mariotti, Marco/0000-0002-7411-4161; SANYAL, AMARTYA/0000-0002-2109-4478; Visel, Axel/0000-0002-4130-7784; Djebali, Sarah/0000-0002-0599-1267; Antonarakis, Stylianos E/0000-0001-8907-5823; Sobral, Daniel/0000-0003-3955-0117; Kellis, Manolis/0000-0001-7113-9630; Hubbard, Tim J/0000-0002-1767-9318; Alexander, Roger/0000-0002-2967-7395; Alioto, Tyler/0000-0002-2960-5420; Rodriguez, Jose/0000-0002-9948-5073; Yu, Yanbao/0000-0003-2994-1974; Hoffman, Michael M./0000-0002-4517-1562; Li, Jingyi Jessica/0000-0002-9288-5648; Marinov, Georgi/0000-0003-1822-7273; Fisher-Aylor, Katherine/0000-0003-3371-2947; Haugen, Eric/0000-0001-7444-8981; Tress, Michael/0000-0001-9046-6370; Snyder, Michael/0000-0003-0784-7987; Pazin, Michael/0000-0002-7561-3640; Bell, Kimberly/0000-0003-2204-8569; Meyer, Laurence/0000-0003-1430-7225; Anaya, Michael/0000-0002-6944-3614; Brazma, Alvis/0000-0001-5988-7409; Barrell, Daniel/0000-0002-0977-0963; Aken, Bronwen/0000-0002-3032-4095; Abyzov, Alexej/0000-0001-5405-6729; Snow, Catherine/0000-0002-1672-3532; Karczewski, Konrad/0000-0003-2878-4671; Bignell, alexandra/0000-0002-5926-7020; Sandhu, Kuljeet/0000-0001-7632-6339; Lukk, Margus/0000-0002-0701-5358; Foissac, Sylvain/0000-0002-2631-5356; Derrien, Thomas/0000-0002-8211-5789; Tapanari, Electra/0000-0002-9329-0996; Banfai, Balazs/0000-0003-0422-7977; Akey, Joshua/0000-0002-4411-1330; Gonzalez, Jose M/0000-0001-5569-0705; Farnham, Peggy/0000-0003-4469-7914; Dunham, Ian/0000-0003-2525-5598; Kirchmaier, Stephan/0000-0002-3870-8624; Flicek, Paul/0000-0002-3897-7955; Buske, Orion/0000-0002-9064-092X; Lee, Bum Kyu/0000-0001-7835-419X; Davidson, Claire/0000-0002-4910-8202; notredame, cedric/0000-0003-1461-0988; Park, Peter/0000-0001-9378-960X; FRUM, Tristan/0000-0003-3452-8762; Altshuler, Robert/0000-0001-5096-1932; park, eddie/0000-0001-5651-1481; Elnitski, Laura/0000-0003-1065-019X; Auer, Thomas Oliver/0000-0003-3442-0567; Frankish, Adam/0000-0002-4333-628X; Collins, Patrick/0000-0002-7141-7503; Centanin, Lazaro/0000-0003-3889-4524; Gilbert, James/0000-0001-8079-3159; Kaul, Rajinder/0000-0002-7895-9284; Furey, Terry/0000-0001-5546-9672; Birney, Ewan/0000-0001-8314-8497; Hunt, Toby/0000-0001-8377-0841; Bhinge, Akshay/0000-0003-2939-099X; Gertz, Jason/0000-0001-7568-6789; Luo, Oscar Junhong/0000-0002-1266-3069; Penalva, Luiz/0000-0003-4491-6769; Karczewski, Jakub/0000-0001-9322-7842; Rozowsky, Joel/0000-0002-3565-0762; Gunter, Chris/0000-0001-9369-7537; Pauli Behn, Florencia/0000-0002-8984-4044; Loveland, Jane/0000-0002-7669-2934; Foss, Kimberly/0000-0003-3996-7895; Epstein, Charles B./0000-0001-8358-8345; Gillespie, Shawn/0000-0003-1913-0860; Nguyen, Eric/0000-0002-0516-2434; Balasubramanian, Suganthi/0000-0003-2243-5948; Saunders, Gary/0000-0002-7468-0008; Despacio-Reyes, Gloria/0000-0001-5906-8999; Bussotti, Giovanni/0000-0002-4078-7413; Victorsen, Alec/0000-0003-2326-0916; Moran, Jennifer/0000-0002-5664-4716; Johnson, Nathan/0000-0002-2783-9047; Reymond, Alexandre/0000-0003-1030-8327; Mieczkowska, Joanna/0000-0002-6482-336X; Wilder, Steven/0000-0001-8049-2559; Varley, Katherine/0000-0003-1622-5290; Mieczkowski, Piotr/0000-0003-2418-0096; zheng, meizhen/0000-0001-5569-1812; Zadissa, Amonida/0000-0001-5310-8830; Dobin, Alexander/0000-0002-4115-9128; Curado, Joao/0000-0003-3916-0936; Levy, Shawn/0000-0002-1369-5740; Wilming, Laurens/0000-0002-4154-7358; Vierstra, Jeff/0000-0001-6406-8563; Whitfield, Troy/0000-0002-2026-4201; Berry, Andrew/0000-0001-5096-7701; Harrow, Jennifer/0000-0003-0338-3070; Merkel, Angelika/0000-0001-5164-6803; Kay, Mike/0000-0002-3282-0834; Kapranov, Philipp/0000-0003-2647-4856; Ward, Lucas/0000-0002-8017-809X; Gingeras, Thomas/0000-0001-9106-3573; Sandstrom, Richard/0000-0002-3356-1547; Dreszer, Timothy/0000-0002-7328-1283; Sahu, Avinash/0000-0002-2193-6276; Steward, Charles/0000-0001-8829-5349; Mudge, Jonathan/0000-0003-4789-7495; Kokocinski, Felix/0000-0002-8472-9207; Batut, Philippe/0000-0003-4250-0663	NHGRI [U54HG004570, U01HG004695, U54HG004563, U54HG004557, U54HG004555, U41HG004568, U54HG004576, U54HG004558, U54HG004592]; American Recovery and Reinvestment Act (ARRA) funds from the NHGRI [U54HG004570, U54HG004563, U41HG004568, U54HG004592, R01HG003143, RC2HG005591, U01HG004561, RC2HG005679, R01HG003541, R01HG003988]; Intramural Research Program of the NHGRI [ZIAHG200323, ZIAHG200341]; United States Department of Energy Joint Genome Institute, Department of Energy, University of California [DE-AC02-05CH11231];  [R01HG003700];  [R01HG004456-03];  [U01HG004571]; NATIONAL CANCER INSTITUTE [P30CA045508, P30CA016086] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004557, U01HG004571, ZIAHG200323, U54HG004555, U54HG004563, R01HG003541, U54HG004576, U01HG004695, RC2HG005679, RC2HG005573, U54HG004570, R01HG003143, RC2HG005591, U01HG004561, R01HG003700, R01HG003988, K99HG006698, U41HG004568, ZIAHG200341, R01HG004456, U54HG004592, U54HG004558, R01HG005085] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065806, R37DK044746, R01DK054369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); American Recovery and Reinvestment Act (ARRA) funds from the NHGRI; Intramural Research Program of the NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); United States Department of Energy Joint Genome Institute, Department of Energy, University of California; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank additional members of our laboratories and institutions who have contributed to the experimental and analytical components of this project. We thank D. Leja for assistance with production of the figures. The Consortium is funded by grants from the NHGRI as follows: production grants: U54HG004570 (B. E. Bernstein); U01HG004695 (E. Birney); U54HG004563 (G. E. Crawford); U54HG004557 (T. R. Gingeras); U54HG004555 (T. J. Hubbard); U41HG004568 (W. J. Kent); U54HG004576 (R. M. Myers); U54HG004558 (M. Snyder); U54HG004592 (J. A. Stamatoyannopoulos). Pilot grants: R01HG003143 (J. Dekker); RC2HG005591 and R01HG003700 (M. C. Giddings); R01HG004456-03 (Y. Ruan); U01HG004571 (S. A. Tenenbaum); U01HG004561 (Z. Weng); RC2HG005679 (K. P. White). This project was supported in part by American Recovery and Reinvestment Act (ARRA) funds from the NHGRI through grants U54HG004570, U54HG004563, U41HG004568, U54HG004592, R01HG003143, RC2HG005591, R01HG003541, U01HG004561, RC2HG005679 and R01HG003988(L. Pennacchio). In addition, work from NHGRI Groups was supported by the Intramural Research Program of the NHGRI (L. Elnitski, ZIAHG200323; E. H. Margulies, ZIAHG200341). Research in the Pennachio laboratory was performed at Lawrence Berkeley National Laboratory and at the United States Department of Energy Joint Genome Institute, Department of Energy Contract DE-AC02-05CH11231, University of California.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Asthana S, 2007, P NATL ACAD SCI USA, V104, P12410, DOI 10.1073/pnas.0705140104; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bickel PJ, 2010, ANN APPL STAT, V4, P1660, DOI 10.1214/10-AOAS363; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Borneman AR, 2007, SCIENCE, V317, P815, DOI 10.1126/science.1140748; Boyle A. P., 2012, GENOME RES; Boyle AP, 2011, GENOME RES, V21, P456, DOI 10.1101/gr.112656.110; Cheng C., 2012, GENOME RES; Chiaromonte F, 2003, COLD SPRING HARB SYM, V68, P245, DOI 10.1101/sqb.2003.68.245; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Dekker J, 2008, SCIENCE, V319, P1793, DOI 10.1126/science.1152850; Derrien T, 2012, GENOME RES; Dong XJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r53; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Frietze S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r52; Frietze S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015082; Fu YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000138; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Harismendy O, 2011, NATURE, V470, P264, DOI 10.1038/nature09753; Harrow J, 2012, GENOME RES; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hoffman MM, 2012, NAT METHODS, V9, P473, DOI [10.1038/NMETH.1937, 10.1038/nmeth.1937]; Hon G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000566; Hon GC, 2009, HUM MOL GENET, V18, pR195, DOI 10.1093/hmg/ddp409; Howald C., 2012, GENOME RES; Huff JT, 2010, NAT STRUCT MOL BIOL, V17, P1495, DOI 10.1038/nsmb.1924; Kaplan T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001290; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Koch F, 2011, NAT STRUCT MOL BIOL, V18, P956, DOI 10.1038/nsmb.2085; KORNBERG RD, 1988, NUCLEIC ACIDS RES, V16, P6677, DOI 10.1093/nar/16.14.6677; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kundaje A., 2012, GENOME RES; Lajoie BR, 2009, NAT METHODS, V6, P690, DOI 10.1038/nmeth1009-690; Landt S. G., 2012, GENOME RES; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Li XY, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r34; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Parker SCJ, 2009, SCIENCE, V324, P389, DOI 10.1126/science.1169050; Pei BK, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r51; Pheasant M, 2007, GENOME RES, V17, P1245, DOI 10.1101/gr.6406307; Pique-Regi R, 2011, GENOME RES, V21, P447, DOI 10.1101/gr.112623.110; Ponting CP, 2011, GENOME RES, V21, P1769, DOI 10.1101/gr.116814.110; Rozowsky J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.54; Schaub M. A., 2012, GENOME RES; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; Spivakov M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r49; Tilgner H., 2012, GENOME RES; Urnov FD, 2003, J CELL BIOCHEM, V88, P684, DOI 10.1002/jcb.10397; Valouev A, 2011, NATURE, V474, P516, DOI 10.1038/nature10002; Vernot B., 2012, GENOME RES; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Whitfield TW, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r50; Yip KY, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r48; Zhang Y, 2009, NUCLEIC ACIDS RES, V37, P7024, DOI 10.1093/nar/gkp747; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	75	10142	10378	67	1643	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2012	489	7414					57	74		10.1038/nature11247	http://dx.doi.org/10.1038/nature11247			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999WW	22955616	Green Accepted, Green Published, Green Submitted, hybrid			2022-12-24	WOS:000308347000039
J	Neph, S; Vierstra, J; Stergachis, AB; Reynolds, AP; Haugen, E; Vernot, B; Thurman, RE; John, S; Sandstrom, R; Johnson, AK; Maurano, MT; Humbert, R; Rynes, E; Wang, H; Vong, S; Lee, K; Bates, D; Diegel, M; Roach, V; Dunn, D; Neri, J; Schafer, A; Hansen, RS; Kutyavin, T; Giste, E; Weaver, M; Canfield, T; Sabo, P; Zhang, MH; Balasundaram, G; Byron, R; MacCoss, MJ; Akey, JM; Bender, MA; Groudine, M; Kaul, R; Stamatoyannopoulos, JA				Neph, Shane; Vierstra, Jeff; Stergachis, Andrew B.; Reynolds, Alex P.; Haugen, Eric; Vernot, Benjamin; Thurman, Robert E.; John, Sam; Sandstrom, Richard; Johnson, Audra K.; Maurano, Matthew T.; Humbert, Richard; Rynes, Eric; Wang, Hao; Vong, Shinny; Lee, Kristen; Bates, Daniel; Diegel, Morgan; Roach, Vaughn; Dunn, Douglas; Neri, Jun; Schafer, Anthony; Hansen, R. Scott; Kutyavin, Tanya; Giste, Erika; Weaver, Molly; Canfield, Theresa; Sabo, Peter; Zhang, Miaohua; Balasundaram, Gayathri; Byron, Rachel; MacCoss, Michael J.; Akey, Joshua M.; Bender, M. A.; Groudine, Mark; Kaul, Rajinder; Stamatoyannopoulos, John A.			An expansive human regulatory lexicon encoded in transcription factor footprints	NATURE			English	Article							IN-VIVO; DNA; PROTEIN; GENE; EXPRESSION; CHROMATIN; DIFFERENTIATION; ERYTHROPOIESIS; INDUCTION; REQUIRES	Regulatory factor binding to genomic DNA protects the underlying sequence from cleavage by DNase I, leaving nucleotide-resolution 'footprints'. Using genomic DNase I footprinting across 41 diverse cell and tissue types, we detected 45 million transcription factor occupancy events within regulatory regions, representing differential binding to 8.4 million distinct short sequence elements. Here we show that this small genomic sequence compartment, roughly twice the size of the exome, encodes an expansive repertoire of conserved recognition sequences for DNA-binding proteins that nearly doubles the size of the human cis-regulatory lexicon. We find that genetic variants affecting allelic chromatin states are concentrated in footprints, and that these elements are preferentially sheltered from DNA methylation. High-resolution DNase I cleavage patterns mirror nucleotide-level evolutionary conservation and track the crystallographic topography of protein-DNA interfaces, indicating that transcription factor structure has been evolutionarily imprinted on the human genome sequence. We identify a stereotyped 50-base-pair footprint that precisely defines the site of transcript origination within thousands of human promoters. Finally, we describe a large collection of novel regulatory factor recognition motifs that are highly conserved in both sequence and function, and exhibit cell-selective occupancy patterns that closely parallel major regulators of development, differentiation and pluripotency.	[Neph, Shane; Vierstra, Jeff; Stergachis, Andrew B.; Reynolds, Alex P.; Haugen, Eric; Vernot, Benjamin; Thurman, Robert E.; John, Sam; Sandstrom, Richard; Johnson, Audra K.; Maurano, Matthew T.; Humbert, Richard; Rynes, Eric; Wang, Hao; Vong, Shinny; Lee, Kristen; Bates, Daniel; Diegel, Morgan; Roach, Vaughn; Dunn, Douglas; Neri, Jun; Schafer, Anthony; Hansen, R. Scott; Kutyavin, Tanya; Giste, Erika; Weaver, Molly; Canfield, Theresa; Sabo, Peter; MacCoss, Michael J.; Akey, Joshua M.; Kaul, Rajinder; Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Hansen, R. Scott; Kaul, Rajinder] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Zhang, Miaohua; Balasundaram, Gayathri; Byron, Rachel; Bender, M. A.; Groudine, Mark] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Bender, M. A.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Groudine, Mark] Univ Washington, Dept Med, Dept Radiat Oncol, Seattle, WA 98195 USA; [Stamatoyannopoulos, John A.] Univ Washington, Dept Med, Div Oncol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Stamatoyannopoulos, JA (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	jstam@uw.edu	Vernot, Benjamin/ABH-1495-2021	Vernot, Benjamin/0000-0002-6820-2181; Vierstra, Jeff/0000-0001-6406-8563; Haugen, Eric/0000-0001-7444-8981; Sandstrom, Richard/0000-0002-3356-1547; Akey, Joshua/0000-0002-4411-1330; Kaul, Rajinder/0000-0002-7895-9284	National Institutes of Health (NIH) [HG004592, RC2HG005654]; National Science Foundation [DGE-071824]; University of Washington Proteomics Resource [UWPR95794]; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005654, U54HG004592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK044746, F30DK095678] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); University of Washington Proteomics Resource(University of Washington); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) grants HG004592 (J.A.S.) and RC2HG005654 (J.A.S. and M. G.). J.V. is supported by a National Science Foundation Graduate Research Fellowship under grant no. DGE-071824. Additional support was provided in part by the University of Washington Proteomics Resource (UWPR95794). We thank F. Urnov for critical reading of the manuscript and many discussions, and S. Thomas for insights.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; CHAN JY, 1993, P NATL ACAD SCI USA, V90, P11371, DOI 10.1073/pnas.90.23.11371; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; FERREDAMARE AR, 1994, EMBO J, V13, P180, DOI 10.1002/j.1460-2075.1994.tb06247.x; GALAS DJ, 1978, NUCLEIC ACIDS RES, V5, P3157, DOI 10.1093/nar/5.9.3157; GILBERT W, 1966, P NATL ACAD SCI USA, V56, P1891, DOI 10.1073/pnas.56.6.1891; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Halupa A, 2005, BLOOD, V105, P552, DOI 10.1182/blood-2003-09-3237; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kim TK, 1997, P NATL ACAD SCI USA, V94, P12268, DOI 10.1073/pnas.94.23.12268; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mukherjee S, 2004, NAT GENET, V36, P1331, DOI 10.1038/ng1473; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Newburger DE, 2009, NUCLEIC ACIDS RES, V37, pD77, DOI 10.1093/nar/gkn660; PELLEGRINI L, 1995, NATURE, V376, P490, DOI 10.1038/376490a0; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; PUGH BF, 1991, GENE DEV, V5, P1935, DOI 10.1101/gad.5.11.1935; Rockman MV, 2002, MOL BIOL EVOL, V19, P1991, DOI 10.1093/oxfordjournals.molbev.a004023; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Sabo PJ, 2004, P NATL ACAD SCI USA, V101, P16837, DOI 10.1073/pnas.0407387101; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; TATE PH, 1993, CURR OPIN GENET DEV, V3, P226, DOI 10.1016/0959-437X(93)90027-M; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Treisman R., 1985, DNA CELL BIOL, V315, P73; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; Yun KS, 1996, CURR OPIN CELL BIOL, V8, P877, DOI 10.1016/S0955-0674(96)80091-3; Zhou Z, 2010, J BIOL CHEM, V285, P15894, DOI 10.1074/jbc.M109.098376	42	526	548	0	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2012	489	7414					83	90		10.1038/nature11212	http://dx.doi.org/10.1038/nature11212			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999WW	22955618	Green Accepted, hybrid			2022-12-24	WOS:000308347000041
J	Berenyi, A; Belluscio, M; Mao, D; Buzsaki, G				Berenyi, Antal; Belluscio, Mariano; Mao, Dun; Buzsaki, Gyoergy			Closed-Loop Control of Epilepsy by Transcranial Electrical Stimulation	SCIENCE			English	Article							DEEP BRAIN-STIMULATION; SLEEP; SPINDLES; MEMORY; SPIKE; RATS	Many neurological and psychiatric diseases are associated with clinically detectable, altered brain dynamics. The aberrant brain activity, in principle, can be restored through electrical stimulation. In epilepsies, abnormal patterns emerge intermittently, and therefore, a closed-loop feedback brain control that leaves other aspects of brain functions unaffected is desirable. Here, we demonstrate that seizure-triggered, feedback transcranial electrical stimulation (TES) can dramatically reduce spike-and-wave episodes in a rodent model of generalized epilepsy. Closed-loop TES can be an effective clinical tool to reduce pathological brain patterns in drug-resistant patients.	[Berenyi, Antal; Belluscio, Mariano; Mao, Dun; Buzsaki, Gyoergy] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA; [Berenyi, Antal; Buzsaki, Gyoergy] NYU, Sch Med, Inst Neurosci, New York, NY 10016 USA; [Berenyi, Antal] Univ Szeged, Dept Physiol, H-6720 Szeged, Hungary	Rutgers State University Newark; Rutgers State University New Brunswick; New York University; Szeged University	Buzsaki, G (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA.	gyorgy.buzsaki@nyumc.org	Berényi, Antal/A-9174-2013; Mao, Dun/AAK-2653-2021	Berényi, Antal/0000-0003-0084-8530; Mao, Dun/0000-0001-5523-657X; Buzsaki, Gyorgy/0000-0002-3100-4800	NIH [NS34994, MH54671, NS074015]; Human Frontier Science Program; J. D. McDonnell Foundation; European Community [254780]; Rosztoczy Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074015, R01NS034994] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); J. D. McDonnell Foundation; European Community(European Commission); Rosztoczy Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants NS34994, MH54671, and NS074015; the Human Frontier Science Program; and the J. D. McDonnell Foundation. A. B. was supported by a Marie Curie FP7-PEOPLE-2009-IOF grant within the 7th European Community Framework Programme (no. 254780) and by the Rosztoczy Foundation.	Engel J, 2003, EPILEPSIA, V44, P741, DOI 10.1046/j.1528-1157.2003.48202.x; Fisher R, 2010, EPILEPSIA, V51, P899, DOI 10.1111/j.1528-1167.2010.02536.x; Fisher RS, 2012, ANN NEUROL, V71, P157, DOI 10.1002/ana.22621; Frohlich F, 2010, NEURON, V67, P129, DOI 10.1016/j.neuron.2010.06.005; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Hammond C, 2007, TRENDS NEUROSCI, V30, P357, DOI 10.1016/j.tins.2007.05.004; Hatsopoulos NG, 2009, ANNU REV NEUROSCI, V32, P249, DOI 10.1146/annurev.neuro.051508.135241; Hughes JR, 2009, EPILEPSY BEHAV, V15, P404, DOI 10.1016/j.yebeh.2009.06.007; Jackson A, 2011, IEEE T NEUR SYS REH, V19, P534, DOI 10.1109/TNSRE.2011.2158586; Joundi RA, 2012, CURR BIOL, V22, P403, DOI 10.1016/j.cub.2012.01.024; Kandel A, 1997, J NEUROSCI, V17, P6783; KOSTOPOULOS G, 1981, EXP NEUROL, V73, P55, DOI 10.1016/0014-4886(81)90045-5; Makeyev O., 2011, C P IEEE ENG MED BIO, V2011, P7560; MARESCAUX C, 1992, J NEURAL TRANSM-GEN, P37; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Morrell MJ, 2011, NEUROLOGY, V77, P1295, DOI 10.1212/WNL.0b013e3182302056; Motamedi GK, 2002, EPILEPSIA, V43, P836, DOI 10.1046/j.1528-1157.2002.24901.x; Najib U, 2011, NEUROSURG CLIN N AM, V22, P233, DOI 10.1016/j.nec.2011.01.002; Nitsche MA, 2009, NEUROTHERAPEUTICS, V6, P244, DOI 10.1016/j.nurt.2009.01.003; Ozen S, 2010, J NEUROSCI, V30, P11476, DOI 10.1523/JNEUROSCI.5252-09.2010; Perlmutter JS, 2006, ANNU REV NEUROSCI, V29, P229, DOI 10.1146/annurev.neuro.29.051605.112824; Rosin B, 2011, NEURON, V72, P370, DOI 10.1016/j.neuron.2011.08.023; Rotenberg A, 2009, CLIN NEUROPHYSIOL, V120, P1417, DOI 10.1016/j.clinph.2009.05.004; SCHIFF SJ, 1994, NATURE, V370, P615, DOI 10.1038/370615a0; Steriade M, 2005, TRENDS NEUROSCI, V28, P317, DOI 10.1016/j.tins.2005.03.007; Varga ET, 2011, EPILEPSY RES, V97, P142, DOI 10.1016/j.eplepsyres.2011.07.016	27	296	309	2	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2012	337	6095					735	737		10.1126/science.1223154	http://dx.doi.org/10.1126/science.1223154			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986PE	22879515	Green Accepted			2022-12-24	WOS:000307354500055
J	Zhong, FL; Batista, LFZ; Freund, A; Pech, MF; Venteicher, AS; Artandi, SE				Zhong, Franklin L.; Batista, Luis F. Z.; Freund, Adam; Pech, Matthew F.; Venteicher, Andrew S.; Artandi, Steven E.			TPP1 OB-Fold Domain Controls Telomere Maintenance by Recruiting Telomerase to Chromosome Ends	CELL			English	Article							CAJAL BODIES; REVERSE-TRANSCRIPTASE; CATALYTIC SUBUNIT; LENGTH REGULATOR; POT1; RNA; PROTECTION; LOCALIZATION; MUTATIONS; TRF1	Telomere synthesis in cancer cells and stem cells involves trafficking of telomerase to Cajal bodies, and telomerase is thought to be recruited to telomeres through interactions with telomere-binding proteins. Here, we show that the OB-fold domain of the telomere-binding protein TPP1 recruits telomerase to telomeres through an association with the telomerase reverse transcriptase TERT. When tethered away from telomeres and other telomere-binding proteins, the TPP1 OB-fold domain is sufficient to recruit telomerase to a heterologous chromatin locus. Expression of a minimal TPP1 OB-fold inhibits telomere maintenance by blocking access of telomerase to its cognate binding site at telomeres. We identify amino acids required for the TPP1-telomerase interaction, including specific loop residues within the TPP1 OB-fold domain and individual residues within TERT, some of which are mutated in a subset of pulmonary fibrosis patients. These data define a potential interface for telomerase-TPP1 interaction required for telomere maintenance and implicate defective telomerase recruitment in telomerase-related disease.	[Zhong, Franklin L.; Batista, Luis F. Z.; Freund, Adam; Pech, Matthew F.; Venteicher, Andrew S.; Artandi, Steven E.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Zhong, Franklin L.; Freund, Adam; Pech, Matthew F.; Artandi, Steven E.] Stanford Univ, Canc Biol Program, Sch Med, Stanford, CA 94305 USA; [Venteicher, Andrew S.] Stanford Univ, Biophys Program, Sch Med, Stanford, CA 94305 USA; [Artandi, Steven E.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Artandi, SE (corresponding author), Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA.	sartandi@stanford.edu	Venteicher, Andrew/AAN-5666-2021	Venteicher, Andrew/0000-0003-0643-0493; Zhong, Franklin/0000-0002-0516-6021; Batista, Luis/0000-0002-7538-3240	Agency for Science, Technology, and Research (A*STAR), Singapore; California Institute of Regenerative Medicine; NIH [5T32 CA09302, AG033747, CA125453, CA111691]; NSF; Leukemia and Lymphoma Society; Glenn Foundation for Medical Research; NATIONAL CANCER INSTITUTE [R01CA125453, T32CA009302, R01CA111691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG033747, R01AG033747] Funding Source: NIH RePORTER	Agency for Science, Technology, and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR)); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Glenn Foundation for Medical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Amy Li for technical assistance and members of the Artandi lab for helpful discussion. F.L.Z. was supported by a fellowship from the Agency for Science, Technology, and Research (A*STAR), Singapore. L.F.Z.B. was supported by a fellowship from the California Institute of Regenerative Medicine. A. F. was supported by NIH 5T32 CA09302. M. F. P. is the recipient of an NSF graduate research fellowship. This work was supported by NIH grants AG033747, CA125453, and CA111691, by a SCOR grant from the Leukemia and Lymphoma Society, and by the Glenn Foundation for Medical Research.	Abreu E, 2010, MOL CELL BIOL, V30, P2971, DOI 10.1128/MCB.00240-10; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Armbruster BN, 2003, MOL CELL BIOL, V23, P3237, DOI 10.1128/MCB.23.9.3237-3246.2003; Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Banik SSR, 2002, MOL CELL BIOL, V22, P6234, DOI 10.1128/MCB.22.17.6234-6246.2002; Batista LFZ, 2011, NATURE, V474, P399, DOI 10.1038/nature10084; Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; Cech TR, 2004, CELL, V116, P273, DOI 10.1016/S0092-8674(04)00038-8; Chan A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000236; Collins K, 2008, MECH AGEING DEV, V129, P91, DOI 10.1016/j.mad.2007.10.008; Cristofari G, 2006, EMBO J, V25, P565, DOI 10.1038/sj.emboj.7600952; Cristofari G, 2007, MOL CELL, V27, P882, DOI 10.1016/j.molcel.2007.07.020; Darzacq X, 2006, J CELL BIOL, V173, P207, DOI 10.1083/jcb.200601105; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Egan ED, 2012, MOL CELL BIOL, V32, P2428, DOI 10.1128/MCB.00286-12; Gall JG, 2000, ANNU REV CELL DEV BI, V16, P273, DOI 10.1146/annurev.cellbio.16.1.273; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Houghtaling BR, 2004, CURR BIOL, V14, P1621, DOI 10.1016/j.cub.2004.08.052; Jady BE, 2004, J CELL BIOL, V164, P647, DOI 10.1083/jcb.200310138; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Kelleher C, 2005, MOL CELL BIOL, V25, P808, DOI 10.1128/MCB.25.2.808-818.2005; Kibe T, 2010, MOL CELL BIOL, V30, P1059, DOI 10.1128/MCB.01498-09; Latrick CM, 2010, EMBO J, V29, P924, DOI 10.1038/emboj.2009.409; Lee J, 2008, NAT STRUCT MOL BIOL, V15, P990, DOI 10.1038/nsmb.1472; Lei M, 2004, NAT STRUCT MOL BIOL, V11, P1223, DOI 10.1038/nsmb867; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; O'Sullivan RJ, 2010, NAT REV MOL CELL BIO, V11, P171, DOI 10.1038/nrm2848; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pennock E, 2001, CELL, V104, P387, DOI 10.1016/S0092-8674(01)00226-4; Podlevsky JD, 2012, MUTAT RES-FUND MOL M, V730, P3, DOI 10.1016/j.mrfmmm.2011.11.002; Rai R, 2011, NAT STRUCT MOL BIOL, V18, P1400, DOI 10.1038/nsmb.2172; Savage SA, 2008, MECH AGEING DEV, V129, P35, DOI 10.1016/j.mad.2007.11.002; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; Stern JL, 2012, MOL CELL BIOL, V32, P2384, DOI 10.1128/MCB.00379-12; Taggart AKP, 2002, SCIENCE, V297, P1023, DOI 10.1126/science.1074968; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Takai KK, 2011, MOL CELL, V44, P647, DOI 10.1016/j.molcel.2011.08.043; Tejera AM, 2010, DEV CELL, V18, P775, DOI [10.1016/j.devcel.2010.03.011, 10.1016/j.devce1.2010.03.011]; Tomlinson RL, 2008, MOL BIOL CELL, V19, P3793, DOI 10.1091/mbc.E08-02-0184; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Tsang AR, 2012, AGING CELL, V11, P482, DOI 10.1111/j.1474-9726.2012.00810.x; Tycowski KT, 2009, MOL CELL, V34, P47, DOI 10.1016/j.molcel.2009.02.020; Venteicher AS, 2009, SCIENCE, V323, P644, DOI 10.1126/science.1165357; Verdun RE, 2007, NATURE, V447, P924, DOI 10.1038/nature05976; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Xin HW, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-232; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404; Ye JZS, 2004, NAT GENET, V36, P618, DOI 10.1038/ng1360; Yu EY, 2008, NAT STRUCT MOL BIOL, V15, P985, DOI 10.1038/nsmb.1471; Zappulla DC, 2006, COLD SPRING HARB SYM, V71, P217, DOI 10.1101/sqb.2006.71.011; Zaug AJ, 2010, GENE DEV, V24, P613, DOI 10.1101/gad.1881810; Zhong F, 2011, GENE DEV, V25, P11, DOI 10.1101/gad.2006411; Zhu YS, 2004, MOL BIOL CELL, V15, P81, DOI 10.1091/mbc.E03-07-0525	57	204	209	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 3	2012	150	3					481	494		10.1016/j.cell.2012.07.012	http://dx.doi.org/10.1016/j.cell.2012.07.012			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	985WO	22863003	Bronze, Green Accepted			2022-12-24	WOS:000307301400009
J	Arthur, JC; Perez-Chanona, E; Muhlbauer, M; Tomkovich, S; Uronis, JM; Fan, TJ; Campbell, BJ; Abujamel, T; Dogan, B; Rogers, AB; Rhodes, JM; Stintzi, A; Simpson, KW; Hansen, JJ; Keku, TO; Fodor, AA; Jobin, C				Arthur, Janelle C.; Perez-Chanona, Ernesto; Muehlbauer, Marcus; Tomkovich, Sarah; Uronis, Joshua M.; Fan, Ting-Jia; Campbell, Barry J.; Abujamel, Turki; Dogan, Belgin; Rogers, Arlin B.; Rhodes, Jonathan M.; Stintzi, Alain; Simpson, Kenneth W.; Hansen, Jonathan J.; Keku, Temitope O.; Fodor, Anthony A.; Jobin, Christian			Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota	SCIENCE			English	Article							ESCHERICHIA-COLI STRAINS; DOUBLE-STRAND BREAKS; COLORECTAL-CANCER; CROHNS-DISEASE; COMMENSAL BACTERIA; BOWEL-DISEASE; IN-VIVO; CELLS; MICE; EXPRESSION	Inflammation alters host physiology to promote cancer, as seen in colitis-associated colorectal cancer (CRC). Here, we identify the intestinal microbiota as a target of inflammation that affects the progression of CRC. High-throughput sequencing revealed that inflammation modifies gut microbial composition in colitis-susceptible interleukin-10-deficient (Il10(-/-)) mice. Monocolonization with the commensal Escherichia coli NC101 promoted invasive carcinoma in azoxymethane (AOM)-treated Il10(-/-) mice. Deletion of the polyketide synthase (pks) genotoxic island from E. coli NC101 decreased tumor multiplicity and invasion in AOM/Il10(-/-) mice, without altering intestinal inflammation. Mucosa-associated pks(+) E. coli were found in a significantly high percentage of inflammatory bowel disease and CRC patients. This suggests that in mice, colitis can promote tumorigenesis by altering microbial composition and inducing the expansion of microorganisms with genotoxic capabilities.	[Arthur, Janelle C.; Perez-Chanona, Ernesto; Muehlbauer, Marcus; Tomkovich, Sarah; Uronis, Joshua M.; Fan, Ting-Jia; Hansen, Jonathan J.; Keku, Temitope O.; Jobin, Christian] Univ N Carolina, Dept Med Pharmacol & Immunol Microbiol, Chapel Hill, NC 27599 USA; [Campbell, Barry J.; Rhodes, Jonathan M.] Univ Liverpool, Dept Gastroenterol, Liverpool L69 3BX, Merseyside, England; [Abujamel, Turki; Stintzi, Alain] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa Inst Syst Biol, Ottawa, ON K1H 8M5, Canada; [Abujamel, Turki] King Abdulaziz Univ, Fac Appl Med Sci, Dept Med Technol, Jeddah 21589, Saudi Arabia; [Dogan, Belgin; Simpson, Kenneth W.] Cornell Univ, Dept Clin Sci, Ithaca, NY 14853 USA; [Rogers, Arlin B.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Fodor, Anthony A.] Univ N Carolina, Dept Bioinformat & Genom, Charlotte, NC 28223 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Liverpool; University of Ottawa; King Abdulaziz University; Cornell University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Charlotte	Jobin, C (corresponding author), Univ N Carolina, Dept Med Pharmacol & Immunol Microbiol, Chapel Hill, NC 27599 USA.	job@med.unc.edu	Abujamel, Turki/GRS-5606-2022; Tomkovich, Sarah/ABF-7952-2020	Tomkovich, Sarah/0000-0003-1638-5307; Arthur, Janelle/0000-0002-4796-0207	NIH [T32 DK007737, R01 DK73338, R01 DK47700, R01 CA136887, R01 DK53347-11]; American Institute for Cancer Research; UNC University Cancer Research Fund; New York Presbyterian/Weill Cornell Medical College; Crohn's and Colitis foundation UK; NIH Research Specialist Biomedical Research Center in Microbial Disease; North West Cancer Research Fund UK; Canadian Institutes of Health Research MOP [114872]; King Abdulaziz University, through the Saudi Arabian Cultural Bureau in Canada; NATIONAL CANCER INSTITUTE [R01CA136887, P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007737, R01DK053347, R01DK073338, R01DK047700, P30DK034987] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Institute for Cancer Research; UNC University Cancer Research Fund; New York Presbyterian/Weill Cornell Medical College; Crohn's and Colitis foundation UK; NIH Research Specialist Biomedical Research Center in Microbial Disease; North West Cancer Research Fund UK; Canadian Institutes of Health Research MOP(Canadian Institutes of Health Research (CIHR)); King Abdulaziz University, through the Saudi Arabian Cultural Bureau in Canada; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Bower and S. Tonkonogy of the National Gnotobiotic Rodent Resource Center at University of North Carolina (UNC) and North Carolina State University for assistance with gnotobiotic mice (NIH P40 R018603). Histology was performed at the Center for Gastrointestinal Biology and Diseases histology core (P30 DK034987). This work was supported by funding from NIH T32 DK007737 (J.C.A.), R01 DK73338 (C.J.), R01 DK47700 (C.J.), R01 CA136887 (T.O.K.), R01 DK53347-11 (K.W.S./A.B.S.), the American Institute for Cancer Research (C.J.), UNC University Cancer Research Fund (C.J.), New York Presbyterian/Weill Cornell Medical College (K.W.S.), Crohn's and Colitis foundation UK (B.J.C.), the NIH Research Specialist Biomedical Research Center in Microbial Disease (J.M.R.), the North West Cancer Research Fund UK (B.J.C.), and the Canadian Institutes of Health Research MOP#114872 (A.S.). T.A. is supported by a scholarship from King Abdulaziz University, through the Saudi Arabian Cultural Bureau in Canada. J.M.R. is a member of advisory boards for Atlantic, Procter and Gamble, and Falk and has received speaking honoraria from Abbott, Falk, Ferring, GlaxoSmithKline, Procter and Gamble, Schering Plough, Shire, and Wyeth. All data presented in this manuscript are tabulated in the main paper and in the supplementary materials. Illumina sequencing data are deposited in National Center for Biotechnology Information's (NCBI's) sequence read archive (SRA) and are accessible under SRA055272. Inflammation PCR array data are deposited in NCBI's Gene Expression Omnibus (GEO) and are accessible through GEO series accession no. GSE39085. This work is in the memory of Mathieu Jobin, Lyne Gauthier, and Janine Drysdale.	Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Cuevas-Ramos G, 2010, P NATL ACAD SCI USA, V107, P11537, DOI 10.1073/pnas.1001261107; Danese S, 2010, ONCOGENE, V29, P3313, DOI 10.1038/onc.2010.109; Darfeuille-Michaud A, 1998, GASTROENTEROLOGY, V115, P1405, DOI 10.1016/S0016-5085(98)70019-8; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; Homburg S, 2007, FEMS MICROBIOL LETT, V275, P255, DOI 10.1111/j.1574-6968.2007.00889.x; Inaba Y, 2010, INFLAMM BOWEL DIS, V16, P1488, DOI 10.1002/ibd.21253; Kim SC, 2005, GASTROENTEROLOGY, V128, P891, DOI 10.1053/j.gastro.2005.02.009; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Luperchio SA, 2001, MICROBES INFECT, V3, P333, DOI 10.1016/S1286-4579(01)01387-9; MARSHALL BJ, 1995, JAMA-J AM MED ASSOC, V274, P1064, DOI 10.1001/jama.274.13.1064; Martin HM, 2004, GASTROENTEROLOGY, V127, P80, DOI 10.1053/j.gastro.2004.03.054; Masseret E, 2001, GUT, V48, P320, DOI 10.1136/gut.48.3.320; Nougayrede JP, 2006, SCIENCE, V313, P848, DOI 10.1126/science.1127059; Putze J, 2009, INFECT IMMUN, V77, P4696, DOI 10.1128/IAI.00522-09; Rhodes JM, 2002, TRENDS MOL MED, V8, P10, DOI 10.1016/S1471-4914(01)02194-3; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Schwerbrock NMJ, 2004, INFLAMM BOWEL DIS, V10, P811, DOI 10.1097/00054725-200411000-00016; Shen XJ, 2010, GUT MICROBES, V1, P138, DOI 10.4161/gmic.1.3.12360; Swidsinski A, 1998, GASTROENTEROLOGY, V115, P281, DOI 10.1016/S0016-5085(98)70194-5; Ullman TA, 2011, GASTROENTEROLOGY, V140, P1807, DOI 10.1053/j.gastro.2011.01.057; Uronis JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006026	24	1310	1380	15	355	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2012	338	6103					120	123		10.1126/science.1224820	http://dx.doi.org/10.1126/science.1224820			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	22903521	Green Submitted, Green Accepted			2022-12-24	WOS:000309457400067
J	Miyoshi, H; Ajima, R; Luo, CT; Yamaguchi, TP; Stappenbeck, TS				Miyoshi, Hiroyuki; Ajima, Rieko; Luo, Christine T.; Yamaguchi, Terry P.; Stappenbeck, Thaddeus S.			Wnt5a Potentiates TGF-beta Signaling to Promote Colonic Crypt Regeneration After Tissue Injury	SCIENCE			English	Article							STEM-CELLS; IN-VITRO; WNT/BETA-CATENIN; SMALL-INTESTINE; PATHWAY; MOUSE; CRE; RECOMBINATION; ELONGATION; EXPRESSION	Reestablishing homeostasis after tissue damage depends on the proper organization of stem cells and their progeny, though the repair mechanisms are unclear. The mammalian intestinal epithelium is well suited to approach this problem, as it is composed of well-delineated units called crypts of Lieberkuhn. We found that Wnt5a, a noncanonical Wnt ligand, was required for crypt regeneration after injury in mice. Unlike controls, Wnt5a-deficient mice maintained an expanded population of proliferative epithelial cells in the wound. We used an in vitro system to enrich for intestinal epithelial stem cells to discover that Wnt5a inhibited proliferation of these cells. Surprisingly, the effects of Wnt5a were mediated by activation of transforming growth factor-beta (TGF-beta) signaling. These findings suggest a Wnt5a-dependent mechanism for forming new crypt units to reestablish homeostasis.	[Ajima, Rieko; Yamaguchi, Terry P.; Stappenbeck, Thaddeus S.] NCI, Canc & Dev Biol Lab, Ctr Canc Res, NIH, Frederick, MD 21702 USA; [Miyoshi, Hiroyuki; Luo, Christine T.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Washington University (WUSTL)	Yamaguchi, TP (corresponding author), NCI, Canc & Dev Biol Lab, Ctr Canc Res, NIH, Frederick, MD 21702 USA.	stappenb@pathology.wustl.edu; yamagute@mail.nih.gov		Miyoshi, Hiroyuki/0000-0001-7400-0714	NIH [DK90251]; Pew Scholars Program in the Biomedical Sciences; Trans-National Institute of Diabetes and Digestive and Kidney Diseases Short-Term Training for Medical Students [5T35DK074375]; Washington Univ. Digestive Disease Research Core (NIH) [P30-DK52574]; NIH, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574, T35DK074375, R01DK071619] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholars Program in the Biomedical Sciences; Trans-National Institute of Diabetes and Digestive and Kidney Diseases Short-Term Training for Medical Students; Washington Univ. Digestive Disease Research Core (NIH); NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank R. Kopan for comments on the manuscript, W. Pu for reagents, and R. Head and C. Storer for the microarray analysis. This work was funded by the NIH (grant DK90251); the Pew Scholars Program in the Biomedical Sciences; grant 5T35DK074375 (Trans-National Institute of Diabetes and Digestive and Kidney Diseases Short-Term Training for Medical Students); the Washington Univ. Digestive Disease Research Core (NIH grant P30-DK52574); and the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. Microarray data are available on Array Express (accession no. E-MTAB-1175). Materials transfer agreements will be required for the acquisition of the Wnt5a<SUP>f/f</SUP> mice from the National Cancer Institute and the L-WRN cell line from the Washington Univ. Medical School. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Cervantes S, 2009, DEV BIOL, V326, P285, DOI 10.1016/j.ydbio.2008.11.020; CHANG WWL, 1971, AM J ANAT, V131, P101, DOI 10.1002/aja.1001310106; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Gough Nancy R, 2008, Sci Signal, V1, peg8, DOI 10.1126/scisignal.146eg8; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Iavarone A, 1997, NATURE, V387, P417; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Lanza R, 2009, ESSENTIALS OF STEM CELL BIOLOGY, 2ND EDITION, pXV, DOI 10.1016/B978-0-12-374729-7.00073-1; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; MOSES HL, 1990, CELL, V63, P245, DOI 10.1016/0092-8674(90)90155-8; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; PARK HS, 1995, AM J PATHOL, V147, P1416; Philipp I, 2009, P NATL ACAD SCI USA, V106, P4290, DOI 10.1073/pnas.0812847106; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Sato A, 2010, EMBO J, V29, P41, DOI 10.1038/emboj.2009.322; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Seno H, 2009, P NATL ACAD SCI USA, V106, P256, DOI 10.1073/pnas.0803343106; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stappenbeck TS, 2009, SCIENCE, V324, P1666, DOI 10.1126/science.1172687; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Walker MR, 2009, J PATHOL, V217, P169, DOI 10.1002/path.2474; Wilm B, 2005, DEVELOPMENT, V132, P5317, DOI 10.1242/dev.02141; Yamada M, 2010, DEV DYNAM, V239, P941, DOI 10.1002/dvdy.22212; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060	37	296	299	4	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2012	338	6103					108	113		10.1126/science.1223821	http://dx.doi.org/10.1126/science.1223821			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	22956684	Green Accepted			2022-12-24	WOS:000309457400064
J	Deardorff, MA; Bando, M; Nakato, R; Watrin, E; Itoh, T; Minamino, M; Saitoh, K; Komata, M; Katou, Y; Clark, D; Cole, KE; De Baere, E; Decroos, C; Di Donato, N; Ernst, S; Francey, LJ; Gyftodimou, Y; Hirashima, K; Hullings, M; Ishikawa, Y; Jaulin, C; Kaur, M; Kiyono, T; Lombardi, PM; Magnaghi-Jaulin, L; Mortier, GR; Nozaki, N; Petersen, MB; Seimiya, H; Siu, VM; Suzuki, Y; Takagaki, K; Wilde, JJ; Willems, PJ; Prigent, C; Gillessen-Kaesbach, G; Christianson, DW; Kaiser, FJ; Jackson, LG; Hirota, T; Krantz, ID; Shirahige, K				Deardorff, Matthew A.; Bando, Masashige; Nakato, Ryuichiro; Watrin, Erwan; Itoh, Takehiko; Minamino, Masashi; Saitoh, Katsuya; Komata, Makiko; Katou, Yuki; Clark, Dinah; Cole, Kathryn E.; De Baere, Elfride; Decroos, Christophe; Di Donato, Nataliya; Ernst, Sarah; Francey, Lauren J.; Gyftodimou, Yolanda; Hirashima, Kyotaro; Hullings, Melanie; Ishikawa, Yuuichi; Jaulin, Christian; Kaur, Maninder; Kiyono, Tohru; Lombardi, Patrick M.; Magnaghi-Jaulin, Laura; Mortier, Geert R.; Nozaki, Naohito; Petersen, Michael B.; Seimiya, Hiroyuki; Siu, Victoria M.; Suzuki, Yutaka; Takagaki, Kentaro; Wilde, Jonathan J.; Willems, Patrick J.; Prigent, Claude; Gillessen-Kaesbach, Gabriele; Christianson, David W.; Kaiser, Frank J.; Jackson, Laird G.; Hirota, Toru; Krantz, Ian D.; Shirahige, Katsuhiko			HDAC8 mutations in Cornelia de Lange syndrome affect the cohesin acetylation cycle	NATURE			English	Article							SISTER-CHROMATID COHESION; X-CHROMOSOME-INACTIVATION; S-PHASE; HUMAN GENOME; NIPPED-B; RNA-SEQ; BINDING; COMPLEX; PROTEINS; NIPBL	Cornelia de Lange syndrome (CdLS) is a dominantly inherited congenital malformation disorder, caused by mutations in the cohesin-loading protein NIPBL1,2 for nearly 60% of individuals with classical CdLS3-5, and by mutations in the core cohesin components SMC1A (similar to 5%) and SMC3 (<1%) for a smaller fraction of probands(6,7). In humans, the multisubunit complex cohesin is made up of SMC1, SMC3, RAD21 and a STAG protein. These form a ring structure that is proposed to encircle sister chromatids to mediate sister chromatid cohesion(8) and also has key roles in gene regulation(9). SMC3 is acetylated during S-phase to establish cohesiveness of chromatin-loaded cohesin(10-13), and in yeast, the class I histone deacetylase Hos1 deacetylates SMC3 during anaphase(14-16). Here we identify HDAC8 as the vertebrate SMC3 deacetylase, as well as loss-of-function HDAC8 mutations in six CdLS probands. Loss of HDAC8 activity results in increased SMC3 acetylation and inefficient dissolution of the 'used' cohesin complex released from chromatin in both prophase and anaphase. SMC3 with retained acetylation is loaded onto chromatin, and chromatin immunoprecipitation sequencing analysis demonstrates decreased occupancy of cohesin localization sites that results in a consistent pattern of altered transcription seen in CdLS cell lines with either NIPBL or HDAC8 mutations.	[Deardorff, Matthew A.; Clark, Dinah; Ernst, Sarah; Francey, Lauren J.; Hullings, Melanie; Kaur, Maninder; Wilde, Jonathan J.; Jackson, Laird G.; Krantz, Ian D.] Childrens Hosp Philadelphia, Div Human Genet & Mol Biol, Philadelphia, PA 19104 USA; [Deardorff, Matthew A.; Krantz, Ian D.] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Bando, Masashige; Nakato, Ryuichiro; Minamino, Masashi; Saitoh, Katsuya; Komata, Makiko; Katou, Yuki; Shirahige, Katsuhiko] Univ Tokyo, Inst Mol & Cellular Biosci, Res Ctr Epigenet Dis, Tokyo 1130032, Japan; [Watrin, Erwan; Jaulin, Christian; Magnaghi-Jaulin, Laura; Prigent, Claude] Fac Med, Ctr Natl Rech Sci CNRS, Res Inst Genet & Dev IGDR, F-35043 Rennes, France; [Itoh, Takehiko] Tokyo Inst Technol, Sch & Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 2268503, Japan; [Cole, Kathryn E.; Decroos, Christophe; Lombardi, Patrick M.; Christianson, David W.] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [De Baere, Elfride] Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium; [Di Donato, Nataliya] Tech Univ Dresden, Inst Klin Genet, D-01307 Dresden, Germany; [Gyftodimou, Yolanda; Petersen, Michael B.] Inst Child Hlth, Dept Genet, Athens 11527, Greece; [Hirashima, Kyotaro; Seimiya, Hiroyuki] Japanese Fdn Canc Res, Div Mol Biotherapy, Tokyo 1358550, Japan; [Ishikawa, Yuuichi] Japanese Fdn Canc Res, Dept Pathol, Tokyo 1358550, Japan; [Kiyono, Tohru] Natl Canc Ctr, Res Inst, Div Virol, Tokyo 1040045, Japan; [Mortier, Geert R.] Univ Antwerp Hosp, Dept Med Genet, B-2650 Antwerp, Belgium; [Mortier, Geert R.] Univ Antwerp, B-2650 Antwerp, Belgium; [Nozaki, Naohito] Tokyo Inst Technol, Biofrontier Res Ctr, Yokohama, Kanagawa 2268503, Japan; [Petersen, Michael B.] Aarhus Univ Hosp, Aalborg Hosp, Dept Clin Genet, DK-9100 Aalborg, Denmark; [Siu, Victoria M.] Univ Western Ontario, London, ON N6A 5W9, Canada; [Suzuki, Yutaka; Hirota, Toru] Univ Tokyo, Grad Sch Frontier Sci, Tokyo 2778561, Japan; [Willems, Patrick J.] GENDIA, B-2020 Antwerp, Belgium; [Gillessen-Kaesbach, Gabriele; Kaiser, Frank J.] Med Univ Lubeck, Inst Humangenet Lubeck, D-23538 Lubeck, Germany; [Jackson, Laird G.] Drexel Univ, Sch Med, Dept Obstet & Gynecol, Philadelphia, PA 19102 USA; [Shirahige, Katsuhiko] JST, CREST, Chiyoda Ku, Tokyo 1020076, Japan	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Tokyo; Centre National de la Recherche Scientifique (CNRS); Tokyo Institute of Technology; University of Pennsylvania; Ghent University; Ghent University Hospital; Technische Universitat Dresden; Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research; National Cancer Center - Japan; University of Antwerp; University of Antwerp; Tokyo Institute of Technology; Aalborg University; Aalborg University Hospital; Aarhus University; Western University (University of Western Ontario); University of Tokyo; University of Lubeck; Drexel University; Japan Science & Technology Agency (JST)	Deardorff, MA (corresponding author), Childrens Hosp Philadelphia, Div Human Genet & Mol Biol, Philadelphia, PA 19104 USA.	deardorff@email.chop.edu; ian2@mail.med.upenn.edu; kshirahi@iam.u-tokyo.ac.jp	Jaulin, Christian/L-9126-2018; De Baere, Elfride/E-7405-2017; Nakato, Ryuichiro/AAV-6405-2020; Mortier, Geert/D-2542-2012; Di Donato, Nataliya/G-2357-2019; Petersen, Michael Bjørn B/D-1483-2017; Itoh, Takehiko/E-8873-2014	De Baere, Elfride/0000-0002-5609-6895; Nakato, Ryuichiro/0000-0003-3019-5817; Mortier, Geert/0000-0001-9871-4578; Di Donato, Nataliya/0000-0001-9439-4677; Petersen, Michael Bjørn B/0000-0003-0316-8207; Itoh, Takehiko/0000-0002-6113-557X; Shirahige, Katsuhiko/0000-0002-7862-1144; Francey, Lauren J/0000-0002-9700-2277; watrin, erwan/0000-0002-4582-6493; Takagaki, Kentaro/0000-0001-8085-6201; Seimiya, Hiroyuki/0000-0003-3314-9736; Wilde, Jonathan/0000-0002-0800-8854	US and International Cornelia de Lange Syndrome Foundations; National Institutes of Health [K08HD055488, GM49758, P01 HD052860]; US CdLS Foundation; Children's Hospital of Philadelphia; University of Lubeck (Schwerpunktprogramm, Medizinische Genetik: Von seltenen Varianten zur Krankheitsentstehung); Research Program of Innovative Cell Biology by Innovative Technology; MEXT; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD052860] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD055488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049758] Funding Source: NIH RePORTER	US and International Cornelia de Lange Syndrome Foundations; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US CdLS Foundation; Children's Hospital of Philadelphia; University of Lubeck (Schwerpunktprogramm, Medizinische Genetik: Von seltenen Varianten zur Krankheitsentstehung); Research Program of Innovative Cell Biology by Innovative Technology; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the individuals and families with Cornelia de Lange syndrome who participated in this study, as well as to the referring physicians and colleagues who have contributed samples and clinical information. We thank Riken Omics Science Center, K. Nakagawa, S. Watanabe, M. Albrecht and J. Eckhold for technical support. We thank J.-M. Peters for the sororin and RAD21 antibodies. We thank F. Beckouet and K. Nasmyth for sharing unpublished results. We are indebted to the continued support of the US and International Cornelia de Lange Syndrome Foundations. This work was supported by National Institutes of Health grants K08HD055488 (NICHD, M. A. D.), GM49758 (D. W. C.) and P01 HD052860 (NICHD; I. D. K.), research grants from the US CdLS Foundation, institutional funds from the Children's Hospital of Philadelphia, Intramural funding from the University of Lubeck (Schwerpunktprogramm, Medizinische Genetik: Von seltenen Varianten zur Krankheitsentstehung; F. J. K., G.G.-K.), Research Program of Innovative Cell Biology by Innovative Technology, Grant-in-Aid for Scientific Research (S) and for innovative science from MEXT (K.Sh.).	ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Amos-Landgraf JM, 2006, AM J HUM GENET, V79, P493, DOI 10.1086/507565; [Anonymous], 2012, PYMOL MOL GRAPH SYST; Beckouet F, 2010, MOL CELL, V39, P689, DOI 10.1016/j.molcel.2010.08.008; Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; Borges V, 2010, MOL CELL, V39, P677, DOI 10.1016/j.molcel.2010.08.009; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Deardorff MA, 2007, AM J HUM GENET, V80, P485, DOI 10.1086/511888; Dorsett D, 2011, CURR OPIN GENET DEV, V21, P199, DOI 10.1016/j.gde.2011.01.018; Dowling DP, 2008, BIOCHEMISTRY-US, V47, P13554, DOI 10.1021/bi801610c; Eddy S R, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P114; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Gantt SL, 2006, BIOCHEMISTRY-US, V45, P6170, DOI 10.1021/bi060212u; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gillespie PJ, 2004, CURR BIOL, V14, P1598, DOI 10.1016/j.cub.2004.07.053; Gillis LA, 2004, AM J HUM GENET, V75, P610, DOI 10.1086/424698; Gimenez-Abian JF, 2004, CURR BIOL, V14, P1187, DOI 10.1016/j.cub.2004.06.052; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; Heidinger-Pauli JM, 2009, MOL CELL, V34, P311, DOI 10.1016/j.molcel.2009.04.008; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Krantz ID, 2004, NAT GENET, V36, P631, DOI 10.1038/ng1364; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liu JL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000119; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Musio A, 2006, NAT GENET, V38, P528, DOI 10.1038/ng1779; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Nishiyama T, 2010, CELL, V143, P737, DOI 10.1016/j.cell.2010.10.031; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Takahashi TS, 2004, NAT CELL BIOL, V6, P991, DOI 10.1038/ncb1177; Tonkin ET, 2004, NAT GENET, V36, P636, DOI 10.1038/ng1363; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880; Vannini A, 2007, EMBO REP, V8, P879, DOI 10.1038/sj.embor.7401047; Wang XL, 2007, NAT GENET, V39, P836, DOI 10.1038/ng2057; Wang YL, 2000, TRENDS BIOCHEM SCI, V25, P300, DOI 10.1016/S0968-0004(00)01561-9; Watrin E, 2006, CURR BIOL, V16, P863, DOI 10.1016/j.cub.2006.03.049; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Xiong B, 2010, CURR BIOL, V20, P1660, DOI 10.1016/j.cub.2010.08.019; Zhang B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005232; Zhang JL, 2008, MOL CELL, V31, P143, DOI 10.1016/j.molcel.2008.06.006	44	381	395	2	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2012	489	7415					313	+		10.1038/nature11316	http://dx.doi.org/10.1038/nature11316			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003UC	22885700	Green Accepted			2022-12-24	WOS:000308635900046
J	Plechanovova, A; Jaffray, EG; Tatham, MH; Naismith, JH; Hay, RT				Plechanovova, Anna; Jaffray, Ellis G.; Tatham, Michael H.; Naismith, James H.; Hay, Ronald T.			Structure of a RING E3 ligase and ubiquitin-loaded E2 primed for catalysis	NATURE			English	Article							DNA-DAMAGE; COMPLEX; RNF4; DEGRADATION; INSIGHTS; UBIQUITYLATION; DETERMINANTS; MECHANISM; PATHWAY; BINDING	Ubiquitin modification is mediated by a large family of specificity determining ubiquitin E3 ligases. To facilitate ubiquitin transfer, RING E3 ligases bind both substrate and a ubiquitin E2 conjugating enzyme linked to ubiquitin via a thioester bond, but the mechanism of transfer has remained elusive. Here we report the crystal structure of the dimeric RING domain of rat RNF4 in complex with E2 (UbcH5A) linked by an isopeptide bond to ubiquitin. While the E2 contacts a single protomer of the RING, ubiquitin is folded back onto the E2 by contacts from both RING protomers. The carboxy-terminal tail of ubiquitin is locked into an active site groove on the E2 by an intricate network of interactions, resulting in changes at the E2 active site. This arrangement is primed for catalysis as it can deprotonate the incoming substrate lysine residue and stabilize the consequent tetrahedral transition-state intermediate.	[Plechanovova, Anna; Jaffray, Ellis G.; Tatham, Michael H.; Hay, Ronald T.] Univ Dundee, Coll Life Sci, Wellcome Trust Ctr Gene Regulat & Express, Dundee DD1 5EH, Scotland; [Naismith, James H.] Univ St Andrews, St Andrews KY16 9ST, Fife, Scotland	University of Dundee; University of St Andrews	Hay, RT (corresponding author), Univ Dundee, Coll Life Sci, Wellcome Trust Ctr Gene Regulat & Express, Dundee DD1 5EH, Scotland.	r.t.hay@dundee.ac.uk	Hay, Ronald/S-3233-2019; Tatham, Michael H/E-9622-2010; Naismith, James Henderson/AAB-8614-2020; Naismith, James Henderson/H-3408-2012	Hay, Ronald/0000-0001-7113-9024; Tatham, Michael H/0000-0001-6986-1691; Naismith, James Henderson/0000-0001-6744-5061; Naismith, James Henderson/0000-0001-6744-5061	Wellcome Trust; Cancer Research UK; Scottish Funding Council [SULSA]; Cancer Research UK [13067] Funding Source: researchfish; Wellcome Trust [098391/Z/12/Z] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); Scottish Funding Council; Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank M. Alphey and E. Branigan for assistance with data collection. His-UBE1 was a gift from the Division of Signal Transduction Therapy, University of Dundee. CHIP was a gift from A. Knebel and P. Cohen. A. P. was funded by the Wellcome Trust. This work was supported by a grant to R. T. H. from Cancer Research UK. Structural biology was supported by Scottish Funding Council (ref SULSA) and Wellcome Trust (program grant JHN).	Bentley ML, 2011, EMBO J, V30, P3285, DOI 10.1038/emboj.2011.243; Bosanac I, 2011, J MOL BIOL, V408, P420, DOI 10.1016/j.jmb.2011.03.011; Bosanac I, 2010, MOL CELL, V40, P548, DOI 10.1016/j.molcel.2010.10.009; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Budhidarmo R, 2012, TRENDS BIOCHEM SCI, V37, P58, DOI 10.1016/j.tibs.2011.11.001; Calabrese MF, 2011, NAT STRUCT MOL BIOL, V18, P947, DOI 10.1038/nsmb.2086; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Galanty Y, 2012, GENE DEV, V26, P1179, DOI 10.1101/gad.188284.112; Gareau JR, 2012, J BIOL CHEM, V287, P4740, DOI 10.1074/jbc.M111.321141; Hamilton KS, 2001, STRUCTURE, V9, P897, DOI 10.1016/S0969-2126(01)00657-8; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Kravtsova-Ivantsiv Y, 2012, J CELL SCI, V125, P539, DOI 10.1242/jcs.093567; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Lebedev AA, 2012, ACTA CRYSTALLOGR D, V68, P431, DOI 10.1107/S090744491200251X; Liew CW, 2010, BIOCHEM J, V431, P23, DOI 10.1042/BJ20100957; Luo KT, 2012, EMBO J, V31, P3008, DOI 10.1038/emboj.2012.158; Mace PD, 2008, J BIOL CHEM, V283, P31633, DOI 10.1074/jbc.M804753200; Martin SF, 2007, ANAL BIOCHEM, V363, P83, DOI 10.1016/j.ab.2006.12.018; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nielsen ML, 2008, NAT METHODS, V5, P459, DOI 10.1038/nmeth0608-459; Plechanovova A, 2011, NAT STRUCT MOL BIOL, V18, P1052, DOI 10.1038/nsmb.2108; Pruneda JN, 2011, BIOCHEMISTRY-US, V50, P1624, DOI 10.1021/bi101913m; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Saha A, 2011, MOL CELL, V42, P75, DOI 10.1016/j.molcel.2011.03.016; Sakata E, 2010, STRUCTURE, V18, P138, DOI 10.1016/j.str.2009.11.007; Schreiber A, 2011, NATURE, V470, P227, DOI 10.1038/nature09756; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu PY, 2003, EMBO J, V22, P5241, DOI 10.1093/emboj/cdg501; Yin YL, 2012, GENE DEV, V26, P1196, DOI 10.1101/gad.189274.112; Yunus AA, 2006, NAT STRUCT MOL BIOL, V13, P491, DOI 10.1038/nsmb1104; Yunus AA, 2009, MOL CELL, V35, P669, DOI 10.1016/j.molcel.2009.07.013; Zhang L, 2011, GENE DEV, V25, P1262, DOI 10.1101/gad.2056211; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023	41	354	358	4	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2012	489	7414					115	U135		10.1038/nature11376	http://dx.doi.org/10.1038/nature11376			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999WW	22842904	Green Accepted			2022-12-24	WOS:000308347000045
J	Wang, TA; Yu, YV; Govindaiah, G; Ye, XY; Artinian, L; Coleman, TP; Sweedler, JV; Cox, CL; Gillette, MU				Wang, Tongfei A.; Yu, Yanxun V.; Govindaiah, Gubbi; Ye, Xiaoying; Artinian, Liana; Coleman, Todd P.; Sweedler, Jonathan V.; Cox, Charles L.; Gillette, Martha U.			Circadian Rhythm of Redox State Regulates Excitability in Suprachiasmatic Nucleus Neurons	SCIENCE			English	Article							CLOCK; TRANSCRIPTION; METABOLISM; COMPONENT; NPAS2	Daily rhythms of mammalian physiology, metabolism, and behavior parallel the day-night cycle. They are orchestrated by a central circadian clock in the brain, the suprachiasmatic nucleus (SCN). Transcription of clock genes is sensitive to metabolic changes in reduction and oxidation (redox); however, circadian cycles in protein oxidation have been reported in anucleate cells, where no transcription occurs. We investigated whether the SCN also expresses redox cycles and how such metabolic oscillations might affect neuronal physiology. We detected self-sustained circadian rhythms of SCN redox state that required the molecular clockwork. The redox oscillation could determine the excitability of SCN neurons through nontranscriptional modulation of multiple potassium (K+) channels. Thus, dynamic regulation of SCN excitability appears to be closely tied to metabolism that engages the clockwork machinery.	[Wang, Tongfei A.; Govindaiah, Gubbi; Artinian, Liana; Sweedler, Jonathan V.; Cox, Charles L.; Gillette, Martha U.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Yu, Yanxun V.; Sweedler, Jonathan V.; Cox, Charles L.; Gillette, Martha U.] Univ Illinois, Neurosci Program, Urbana, IL 61801 USA; [Govindaiah, Gubbi; Ye, Xiaoying; Sweedler, Jonathan V.; Cox, Charles L.; Gillette, Martha U.] Univ Illinois, Beckman Inst, Urbana, IL 61801 USA; [Ye, Xiaoying; Sweedler, Jonathan V.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Coleman, Todd P.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Gillette, Martha U.] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California San Diego; University of Illinois System; University of Illinois Urbana-Champaign	Gillette, MU (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA.	mgillett@illinois.edu	Sweedler, Jonathan V/A-9405-2009; Wang, Tongfei/C-1394-2015	Sweedler, Jonathan V/0000-0003-3107-9922; Wang, Tongfei/0000-0002-6306-7371; Coleman, Todd/0000-0002-2144-2495; Cox, Charles/0000-0002-1179-7014	National Heart, Lung, and Blood Institute [RO1HL092571 Z ARRA, RO1HL086870]; National Eye Institute [EY014024]; National Institute on Drug Abuse [P30DA018310]; National Science Foundation [CHE 11-11705, CCF09-39370]; NATIONAL EYE INSTITUTE [R01EY014024, R56EY014024] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086870, R01HL092571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018310] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Science Foundation(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank S.-H. Tyan for insightful discussions at the inception of this work; G. Robinson, R. Gillette, and J. M. Mitchell for critical feedback; J. M. Ding and G. F. Buchanan for data support; K. E. Weis and J. M. Arnold for technical support; S. C. Liu for data analysis consultation; and M. C. Holtz for manuscript preparation. Research was supported by the National Heart, Lung, and Blood Institute (RO1HL092571 Z ARRA, RO1HL086870) to M.U.G., the National Eye Institute (EY014024) to C.L.C., the National Institute on Drug Abuse (P30DA018310) to J.V.S., and the National Science Foundation (CHE 11-11705 to J.V.S. and CCF09-39370 to T.P.C.). Content is solely the responsibility of the authors and does not necessarily represent the official views of NIH or NSF.	Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Belle MDC, 2009, SCIENCE, V326, P281, DOI 10.1126/science.1169657; Brown TM, 2007, PROG NEUROBIOL, V82, P229, DOI 10.1016/j.pneurobio.2007.05.002; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; de Jeu M, 2002, J NEUROPHYSIOL, V88, P869, DOI 10.1152/jn.2002.88.2.869; Dioum EM, 2002, SCIENCE, V298, P2385, DOI 10.1126/science.1078456; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Golombek DA, 2010, PHYSIOL REV, V90, P1063, DOI 10.1152/physrev.00009.2009; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Harrisingh MC, 2007, J NEUROSCI, V27, P12489, DOI 10.1523/JNEUROSCI.3680-07.2007; Huang SH, 2002, BIOPHYS J, V82, P2811, DOI 10.1016/S0006-3495(02)75621-X; Itri JN, 2010, J NEUROPHYSIOL, V103, P632, DOI 10.1152/jn.00670.2009; Itri JN, 2005, NAT NEUROSCI, V8, P650, DOI 10.1038/nn1448; Kim WS, 2002, ANAL CHEM, V74, P5614, DOI 10.1021/ac025917q; Ko CH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000513; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; O'Neill JS, 2008, SCIENCE, V320, P949, DOI 10.1126/science.1152506; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; O'Neill JS, 2011, NATURE, V469, P554, DOI 10.1038/nature09654; PROSSER RA, 1991, BRAIN RES, V568, P185, DOI 10.1016/0006-8993(91)91396-I; Rice ME, 2000, TRENDS NEUROSCI, V23, P209, DOI 10.1016/S0166-2236(99)01543-X; Robles MS, 2010, SCIENCE, V327, P463, DOI 10.1126/science.1180067; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Sullivan DM, 2002, METHOD ENZYMOL, V353, P101; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750	27	139	145	5	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2012	337	6096					839	842		10.1126/science.1222826	http://dx.doi.org/10.1126/science.1222826			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	989BQ	22859819	Green Accepted			2022-12-24	WOS:000307535600042
J	Heijnsdijk, EAM; Wever, EM; Auvinen, A; Hugosson, J; Ciatto, S; Nelen, V; Kwiatkowski, M; Villers, A; Paez, A; Moss, SM; Zappa, M; Tammela, TLJ; Makinen, T; Carlsson, S; Korfage, IJ; Essink-Bot, ML; Otto, SJ; Draisma, G; Bangma, CH; Roobol, MJ; Schroder, FH; de Koning, HJ				Heijnsdijk, Eveline A. M.; Wever, Elisabeth M.; Auvinen, Anssi; Hugosson, Jonas; Ciatto, Stefano; Nelen, Vera; Kwiatkowski, Maciej; Villers, Arnauld; Paez, Alvaro; Moss, Sue M.; Zappa, Marco; Tammela, Teuvo L. J.; Makinen, Tuukka; Carlsson, Sigrid; Korfage, Ida J.; Essink-Bot, Marie-Louise; Otto, Suzie J.; Draisma, Gerrit; Bangma, Chris H.; Roobol, Monique J.; Schroder, Fritz H.; de Koning, Harry J.			Quality-of-Life Effects of Prostate-Specific Antigen Screening	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COMBINED ANDROGEN BLOCKADE; ACTIVE SURVEILLANCE; COST-EFFECTIVENESS; RADICAL PROSTATECTOMY; CANCER SURVIVORS; RANDOMIZED-TRIAL; LEAD TIME; FOLLOW-UP; OUTCOMES; HEALTH	Background After 11 years of follow-up, the European Randomized Study of Screening for Prostate Cancer (ERSPC) reported a 29% reduction in prostate-cancer mortality among men who underwent screening for prostate-specific antigen (PSA) levels. However, the extent to which harms to quality of life resulting from overdiagnosis and treatment counterbalance this benefit is uncertain. Methods On the basis of ERSPC follow-up data, we used Microsimulation Screening Analysis (MISCAN) to predict the number of prostate cancers, treatments, deaths, and quality-adjusted life-years (QALYs) gained after the introduction of PSA screening. Various screening strategies, efficacies, and quality-of-life assumptions were modeled. Results Per 1000 men of all ages who were followed for their entire life span, we predicted that annual screening of men between the ages of 55 and 69 years would result in nine fewer deaths from prostate cancer (28% reduction), 14 fewer men receiving palliative therapy (35% reduction), and a total of 73 life-years gained (average, 8.4 years per prostate-cancer death avoided). The number of QALYs that were gained was 56 (range, -21 to 97), a reduction of 23% from unadjusted life-years gained. To prevent one prostate-cancer death, 98 men would need to be screened and 5 cancers would need to be detected. Screening of all men between the ages of 55 and 74 would result in more life-years gained (82) but the same number of QALYs (56). Conclusions The benefit of PSA screening was diminished by loss of QALYs owing to postdiagnosis long-term effects. Longer follow-up data from both the ERSPC and quality-of-life analyses are essential before universal recommendations regarding screening can be made. (Funded by the Netherlands Organization for Health Research and Development and others.)	[Heijnsdijk, Eveline A. M.; Wever, Elisabeth M.; Korfage, Ida J.; Otto, Suzie J.; Draisma, Gerrit; de Koning, Harry J.] Erasmus MC, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands; [Bangma, Chris H.; Roobol, Monique J.; Schroder, Fritz H.] Erasmus MC, Dept Urol, NL-3000 CA Rotterdam, Netherlands; [Essink-Bot, Marie-Louise] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, NL-1105 AZ Amsterdam, Netherlands; [Auvinen, Anssi] Univ Tampere, Tampere Sch Hlth Sci, FIN-33101 Tampere, Finland; [Tammela, Teuvo L. J.] Univ Tampere, Dept Urol, Tampere Univ Hosp, FIN-33101 Tampere, Finland; [Makinen, Tuukka] Seinajoki Cent Hosp, Dept Surg, Seinajoki, Finland; [Auvinen, Anssi] Int Agcy Res Canc, F-69372 Lyon, France; [Villers, Arnauld] Ctr Hosp Reg & Univ Lille, Dept Urol, F-59037 Lille, France; [Hugosson, Jonas] Sahlgrens Univ Hosp, Dept Urol, Gothenburg, Sweden; Inst Canc Prevent, Dept Diagnost Med Imaging, Florence, Italy; [Zappa, Marco] Inst Canc Prevent, Epidemiol Unit, Florence, Italy; [Nelen, Vera] Prov Inst Hyg, Antwerp, Belgium; [Kwiatkowski, Maciej] Kantonsspital Aarau, Dept Urol, Aarau, Switzerland; [Paez, Alvaro] Hosp Fuenlabrada, Dept Urol, Madrid, Spain; [Moss, Sue M.] Queen Mary Univ London, Ctr Canc Prevent, London, England; Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam; Tampere University; Tampere University; Tampere University Hospital; Seinajoki Central Hospital; World Health Organization; International Agency for Research on Cancer (IARC); Universite de Lille - ISITE; CHU Lille; Sahlgrenska University Hospital; Kantonsspital Aarau AG (KSA); Hospital Universitario Fuenlabrada; University of London; Queen Mary University London; Memorial Sloan Kettering Cancer Center	Heijnsdijk, EAM (corresponding author), Erasmus MC, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands.	e.heijnsdijk@erasmusmc.nl	Auvinen, Anssi/AAD-9311-2020; Auvinen, Anssi/AAL-2111-2020; zappa, marco/AAB-3294-2019; Arnauld, VILLERS A/K-6629-2016; PAEZ, ALVARO/G-5458-2012; de+Koning, Harry/AAF-9062-2019	Auvinen, Anssi/0000-0003-1125-4818; zappa, marco/0000-0002-6606-9786; Arnauld, VILLERS A/0000-0002-6298-7758; de+Koning, Harry/0000-0003-4682-3646; Essink-Bot, Marie-Louise/0000-0002-4650-5886; Carlsson, Sigrid/0000-0003-3553-5710	Netherlands Organization for Health Research and Development, Europe against Cancer; fifth and sixth framework program of the European Union; agencies or health authorities in the participating countries; Beckman Coulter; Abbott Pharmaceuticals; GlaxoSmithKline; Astellas Pharma; Amgen; Pfizer; Orion Pharma; Abbott; 365/ArboNed; Ferring; Societe International d'Urologie; European Association of Urology; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Netherlands Organization for Health Research and Development, Europe against Cancer; fifth and sixth framework program of the European Union; agencies or health authorities in the participating countries; Beckman Coulter; Abbott Pharmaceuticals(Abbott Laboratories); GlaxoSmithKline(GlaxoSmithKline); Astellas Pharma(Astellas Pharmaceuticals); Amgen(Amgen); Pfizer(Pfizer); Orion Pharma; Abbott(Abbott Laboratories); 365/ArboNed; Ferring(Ferring Pharmaceuticals); Societe International d'Urologie; European Association of Urology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by grants from the Netherlands Organization for Health Research and Development, Europe against Cancer, and the fifth and sixth framework program of the European Union; by grants from agencies or health authorities in the participating countries; and by unconditional grants from Beckman Coulter.; Dr. Heijnsdijk reports receiving consulting fees from Beckman Coulter; Dr. Hugosson, receiving lecture fees from Abbott Pharmaceuticals and GlaxoSmithKline; Dr. Kwiatkowski, receiving consulting fees from GlaxoSmithKline; Dr. Villers, serving as a board member of GlaxoSmithKline and receiving travel support from Ferring; Dr. Tammela, receiving consulting fees from Astellas Pharma, GlaxoSmithKline, Amgen, Pfizer, and Orion Pharma, lecture fees from Abbott, GlaxoSmithKline, and Amgen, and travel support from Amgen; Dr. Essink-Bot, receiving lecture fees from 365/ArboNed; Dr. Draisma, receiving consulting fees from Beckman Coulter; Dr. Schorder, serving as a board member for European Urology, receiving consulting fees from GlaxoSmithKline and Ferring, and receiving lecture fees and travel support from GlaxoSmithKline, Ferring, Societe International d'Urologie, and the European Association of Urology; and Dr. de Koning, receiving consulting fees from Beckman Coulter. No other potential conflict of interest relevant to this article was reported.	Albertsen PC, 2005, JAMA-J AM MED ASSOC, V293, P2095, DOI 10.1001/jama.293.17.2095; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; [Anonymous], FDSF; [Anonymous], EUR STAND POP; Auvinen A, 2009, CANCER EPIDEM BIOMAR, V18, P2000, DOI 10.1158/1055-9965.EPI-09-0146; Bennett CL, 1996, CANCER-AM CANCER SOC, V77, P1854; Bill-Axelson A, 2008, J NATL CANCER I, V100, P1144, DOI 10.1093/jnci/djn255; Boorjian SA, 2011, CANCER-AM CANCER SOC, V117, P2883, DOI 10.1002/cncr.25900; Calvert NW, 2003, BRIT J CANCER, V88, P31, DOI 10.1038/sj.bjc.6600630; Carlsson S, 2011, EUR J CANCER, V47, P545, DOI 10.1016/j.ejca.2010.10.016; Chen RC, 2009, J CLIN ONCOL, V27, P3916, DOI 10.1200/JCO.2008.18.6486; Cooperberg MR, 2011, CANCER-AM CANCER SOC, V117, P2825, DOI 10.1002/cncr.25914; Cooperberg MR, 2011, J CLIN ONCOL, V29, P3669, DOI 10.1200/JCO.2011.34.9738; Crawford ED, 2008, EUR UROL, V54, P262, DOI 10.1016/j.eururo.2008.05.032; Damber JE, 2008, LANCET, V371, P1710, DOI 10.1016/S0140-6736(08)60729-1; DEHAES JCJM, 1991, INT J CANCER, V49, P538, DOI 10.1002/ijc.2910490411; Draisma G, 2003, J NATL CANCER I, V95, P868, DOI 10.1093/jnci/95.12.868; Draisma G, 2009, JNCI-J NATL CANCER I, V101, P374, DOI 10.1093/jnci/djp001; Essink-Bot ML, 1998, J NATL CANCER I, V90, P925, DOI 10.1093/jnci/90.12.925; Hayes JH, 2011, JAMA-J AM MED ASSOC, V305, P1862, DOI 10.1001/jama.2011.587; Hugosson J, 2000, BJU INT, V85, P1078, DOI 10.1046/j.1464-410x.2000.00679.x; Hugosson J, 2010, LANCET ONCOL, V11, P725, DOI 10.1016/S1470-2045(10)70146-7; Ilic D, 2007, CANCER CAUSE CONTROL, V18, P279, DOI 10.1007/s10552-006-0087-6; Institute for Clinical Research and Health Policy Studies, COST EFF AN REG; Johansson E, 2011, LANCET ONCOL, V12, P891, DOI 10.1016/S1470-2045(11)70162-0; Klotz L, 2010, J CLIN ONCOL, V28, P126, DOI 10.1200/JCO.2009.24.2180; Konski A, 2006, CANCER, V106, P51, DOI 10.1002/cncr.21575; Konski A, 2005, INT J RADIAT ONCOL, V63, P788, DOI 10.1016/j.ijrobp.2005.03.010; Korfage IJ, 2006, SOC SCI MED, V63, P911, DOI 10.1016/j.socscimed.2006.01.027; Korfage IJ, 2005, INT J CANCER, V116, P291, DOI 10.1002/ijc.21043; Korfage IJ, 2006, EUR J CANCER, V42, P165, DOI 10.1016/j.ejca.2005.10.011; Madalinska JB, 2001, J CLIN ONCOL, V19, P1619, DOI 10.1200/JCO.2001.19.6.1619; Moeremans K, 2004, VALUE HEALTH, V7, P472, DOI 10.1111/j.1524-4733.2004.74010.x; Mols F, 2009, INT J RADIAT ONCOL, V73, P30, DOI 10.1016/j.ijrobp.2008.04.004; Penson DF, 2005, J UROLOGY, V174, P547, DOI 10.1097/01.ju.0000165569.48372.4c; Potosky AL, 2004, J NATL CANCER I, V96, P1358, DOI 10.1093/jnci/djh259; Ramsey S, 2005, UROLOGY, V66, P835, DOI 10.1016/j.urology.2005.04.028; Roobol MJ, 2010, EUR UROL, V57, P79, DOI 10.1016/j.eururo.2009.08.025; Roobol MJ, 2009, EUR UROL, V56, P584, DOI 10.1016/j.eururo.2009.07.018; Sanda MG, 2008, NEW ENGL J MED, V358, P1250, DOI 10.1056/NEJMoa074311; Schroder FH, 2003, BJU INT, V92, P1, DOI 10.1111/j.1464-410X.2003.04389.x; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Smith DP, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4817; Stattin P, 2008, J UROLOGY, V180, P2423, DOI 10.1016/j.juro.2008.08.044; Stewart ST, 2005, MED CARE, V43, P347, DOI 10.1097/01.mlr.0000156862.33341.45; Steyerberg EW, 2007, J UROLOGY, V177, P107, DOI 10.1016/j.juro.2006.08.068; Telesca D, 2008, BIOMETRICS, V64, P10, DOI 10.1111/j.1541-0420.2007.00825.x; Thong MSY, 2010, BJU INT, V105, P652, DOI 10.1111/j.1464-410X.2009.08815.x; van den Bergh RCN, 2007, EUR UROL, V52, P1560, DOI 10.1016/j.eururo.2007.05.011; van den Bergh RCN, 2009, EUR UROL, V55, P1, DOI 10.1016/j.eururo.2008.09.007; Wolters T, 2010, INT J CANCER, V126, P2387, DOI 10.1002/ijc.24870; Zappa M, 1998, ANN ONCOL, V9, P1297, DOI 10.1023/A:1008492013196; Zeliadt SB, 2005, AM J MED, V118, P850, DOI 10.1016/j.amjmed.2005.03.001	54	299	312	3	48	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 16	2012	367	7					595	605		10.1056/NEJMoa1201637	http://dx.doi.org/10.1056/NEJMoa1201637			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	988NB	22894572	Green Accepted			2022-12-24	WOS:000307496600003
J	Hammerman, PS; Lawrence, MS; Voet, D; Jing, R; Cibulskis, K; Sivachenko, A; Stojanov, P; McKenna, A; Lander, ES; Gabriel, S; Getz, G; Sougnez, C; Imielinski, M; Helman, E; Hernandez, B; Pho, NH; Meyerson, M; Chu, A; Chun, HJE; Mungall, AJ; Pleasance, E; Robertson, AG; Sipahimalani, P; Stoll, D; Balasundaram, M; Birol, I; Butterfield, YSN; Chuah, E; Coope, RJN; Corbett, R; Dhalla, N; Guin, R; Hirst, AC; Hirst, M; Holt, RA; Lee, D; Li, HI; Mayo, M; Moore, RA; Mungall, K; Nip, KM; Olshen, A; Schein, JE; Slobodan, JR; Tam, A; Thiessen, N; Varhol, R; Zeng, T; Zhao, Y; Jones, SJM; Marra, MA; Saksena, G; Cherniack, AD; Schumacher, SE; Tabak, B; Carter, SL; Pho, NH; Nguyen, H; Onofrio, RC; Crenshaw, A; Ardlie, K; Beroukhim, R; Winckler, W; Hammerman, PS; Getz, G; Meyerson, M; Protopopov, A; Zhang, JH; Hadjipanayis, A; Lee, S; Xi, RB; Yang, LX; Ren, XJ; Zhang, HL; Shukla, S; Chen, PC; Haseley, P; Lee, E; Chin, L; Park, PJ; Kucherlapati, R; Socci, ND; Liang, YP; Schultz, N; Borsu, L; Lash, AE; Viale, A; Sander, C; Ladanyi, M; Auman, JT; Hoadley, KA; Wilkerson, MD; Shi, Y; Liquori, C; Meng, SW; Li, L; Turman, YJ; Topal, MD; Tan, DH; Waring, S; Buda, E; Walsh, J; Jones, CD; Mieczkowski, PA; Singh, D; Wu, J; Gulabani, A; Dolina, P; Bodenheimer, T; Hoyle, AP; Simons, JV; Soloway, MG; Mose, LE; Jefferys, SR; Balu, S; O'Connor, BD; Prins, JF; Liu, J; Chiang, DY; Hayes, DN; Perou, CM; Cope, L; Danilova, L; Weisenberger, DJ; Maglinte, DT; Pan, F; den Berg, DJ; Triche, T; Herman, JG; Baylin, SB; Laird, PW; Getz, G; Noble, M; Voet, D; Saksena, G; Gehlenborg, N; DiCara, D; Zhang, JH; Zhang, HL; Wu, CJ; Liu, SY; Lawrence, MS; Zou, LH; Sivachenko, A; Lin, P; Stojanov, P; Jing, R; Cho, J; Nazaire, MD; Robinson, J; Thorvaldsdottir, H; Mesirov, J; Park, PJ; Chin, L; Schultz, N; Sinha, R; Ciriello, G; Cerami, E; Gross, B; Jacobsen, A; Gao, J; Aksoy, BA; Weinhold, N; Ramirez, R; Taylor, BS; Antipin, Y; Reva, B; Shen, RL; Mo, Q; Seshan, V; Paik, PK; Ladanyi, M; Sander, C; Akbani, R; Zhang, NX; Broom, BM; Casasent, T; Unruh, A; Wakefield, C; Cason, RC; Baggerly, KA; Weinstein, JN; Haussler, D; Benz, CC; Stuart, JM; Zhu, JC; Szeto, C; Scott, GK; Yau, C; Ng, S; Goldstein, T; Waltman, P; Sokolov, A; Ellrott, K; Collisson, EA; Zerbino, D; Wilks, C; Ma, S; Craft, B; Wilkerson, MD; Auman, JT; Hoadley, KA; Du, Y; Cabanski, C; Walter, V; Singh, D; Wu, JY; Gulabani, A; Bodenheimer, T; Hoyle, AP; Simons, JV; Soloway, MG; Mose, LE; Jefferys, SR; Balu, S; Marron, JS; Liu, Y; Wang, K; Liu, J; Prins, JF; Hayes, DN; Perou, CM; Creighton, CJ; Zhang, YQ; Travis, WD; Rekhtman, N; Yi, J; Aubry, MC; Cheney, R; Dacic, S; Flieder, D; Funkhouser, W; Illei, P; Myers, J; Tsao, MS; Penny, R; Mallery, D; Shelton, T; Hatfield, M; Morris, S; Yena, P; Shelton, C; Sherman, M; Paulauskis, J; Meyerson, M; Baylin, SB; Govindan, R; Akbani, R; Azodo, I; Beer, D; Bose, R; Byers, LA; Carbone, D; Chang, LW; Chiang, D; Chu, A; Chun, E; Collisson, E; Cope, L; Creighton, CJ; Danilova, L; Ding, L; Getz, G; Hammerman, PS; Hayes, DN; Hernandez, B; Herman, JG; Heymach, J; Ida, C; Imielinski, M; Johnson, B; Jurisica, I; Kaufman, J; Kosari, F; Kucherlapati, R; Kwiatkowski, D; Ladanyi, M; Lawrence, MS; Maher, CA; Mungall, A; Ng, S; Pao, W; Peifer, M; Penny, R; Robertson, G; Rusch, V; Sander, C; Schultz, N; Shen, RL; Siegfried, J; Sinha, R; Sivachenko, A; Sougnez, C; Stoll, D; Stuart, J; Thomas, RK; Tomaszek, S; Tsao, MS; Travis, WD; Vaske, C; Weinstein, JN; Weisenberger, D; Wheeler, D; Wigle, DA; Wilkerson, MD; Wilks, C; Yang, P; Zhang, JJ; Jensen, MA; Sfeir, R; Kahn, AB; Chu, AL; Kothiyal, P; Wang, Z; Snyder, EE; Pontius, J; Pihl, TD; Ayala, B; Backus, M; Walton, J; Baboud, J; Berton, DL; Nicholls, MC; Srinivasan, D; Raman, R; Girshik, S; Kigonya, PA; Alonso, S; Sanbhadti, RN; Barletta, SP; Greene, JM; Pot, DA; Tsao, MS; Bandarchi-Chamkhaleh, B; Boyd, J; Weaver, J; Wigle, DA; Azodo, IA; Tomaszek, SC; Aubry, MC; Ida, CM; Yang, P; Kosari, F; Brock, MV; Rogers, K; Rutledge, M; Brown, T; Lee, B; Shin, J; Trusty, D; Dhir, R; Siegfried, JM; Potapova, O; Fedosenko, KV; Nemirovich-Danchenko, E; Rusch, V; Zakowski, M; Iacocca, MV; Brown, J; Rabeno, B; Czerwinski, C; Petrelli, N; Fan, Z; Todaro, N; Eckman, J; Myers, J; Rathmell, WK; Thorne, LB; Huang, M; Boice, L; Hill, A; Penny, R; Mallery, D; Curley, E; Shelton, C; Yena, P; Morrison, C; Gaudioso, C; Bartlett, JS; Kodeeswaran, S; Zanke, B; Sekhon, H; David, K; Juhl, H; Van Le, X; Kohl, B; Thorp, R; Tien, NV; Van Bang, N; Sussman, H; Phu, BD; Hajek, R; PhiHung, N; Khan, KZ; Muley, T; Shaw, KRM; Sheth, M; Yang, L; Buetow, K; Davidsen, T; Demchok, JA; Eley, G; Ferguson, M; Dillon, LAL; Schaefer, C; Guyer, MS; Ozenberger, BA; Palchik, JD; Peterson, J; Sofia, HJ; Thomson, E; Meyerson, M				Hammerman, Peter S.; Lawrence, Michael S.; Voet, Douglas; Jing, Rui; Cibulskis, Kristian; Sivachenko, Andrey; Stojanov, Petar; McKenna, Aaron; Lander, Eric S.; Gabriel, Stacey; Getz, Gad; Sougnez, Carrie; Imielinski, Marcin; Helman, Elena; Hernandez, Bryan; Pho, Nam H.; Meyerson, Matthew; Chu, Andy; Chun, Hye-Jung E.; Mungall, Andrew J.; Pleasance, Erin; Robertson, A. Gordon; Sipahimalani, Payal; Stoll, Dominik; Balasundaram, Miruna; Birol, Inanc; Butterfield, Yaron S. N.; Chuah, Eric; Coope, Robin J. N.; Corbett, Richard; Dhalla, Noreen; Guin, Ranabir; Hirst, Anhe Carrie; Hirst, Martin; Holt, Robert A.; Lee, Darlene; Li, Haiyan I.; Mayo, Michael; Moore, Richard A.; Mungall, Karen; Nip, Ka Ming; Olshen, Adam; Schein, Jacqueline E.; Slobodan, Jared R.; Tam, Angela; Thiessen, Nina; Varhol, Richard; Zeng, Thomas; Zhao, Yongjun; Jones, Steven J. M.; Marra, Marco A.; Saksena, Gordon; Cherniack, Andrew D.; Schumacher, Stephen E.; Tabak, Barbara; Carter, Scott L.; Pho, Nam H.; Nguyen, Huy; Onofrio, Robert C.; Crenshaw, Andrew; Ardlie, Kristin; Beroukhim, Rameen; Winckler, Wendy; Hammerman, Peter S.; Getz, Gad; Meyerson, Matthew; Protopopov, Alexei; Zhang, Jianhua; Hadjipanayis, Angela; Lee, Semin; Xi, Ruibin; Yang, Lixing; Ren, Xiaojia; Zhang, Hailei; Shukla, Sachet; Chen, Peng-Chieh; Haseley, Psalm; Lee, Eunjung; Chin, Lynda; Park, Peter J.; Kucherlapati, Raju; Socci, Nicholas D.; Liang, Yupu; Schultz, Nikolaus; Borsu, Laetitia; Lash, Alex E.; Viale, Agnes; Sander, Chris; Ladanyi, Marc; Auman, J. Todd; Hoadley, Katherine A.; Wilkerson, Matthew D.; Shi, Yan; Liquori, Christina; Meng, Shaowu; Li, Ling; Turman, Yidi J.; Topal, Michael D.; Tan, Donghui; Waring, Scot; Buda, Elizabeth; Walsh, Jesse; Jones, Corbin D.; Mieczkowski, Piotr A.; Singh, Darshan; Wu, Junyuan; Gulabani, Anisha; Dolina, Peter; Bodenheimer, Tom; Hoyle, Alan P.; Simons, Janae V.; Soloway, Matthew G.; Mose, Lisle E.; Jefferys, Stuart R.; Balu, Saianand; O'Connor, Brian D.; Prins, Jan F.; Liu, Jinze; Chiang, Derek Y.; Hayes, D. Neil; Perou, Charles M.; Cope, Leslie; Danilova, Ludmila; Weisenberger, Daniel J.; Maglinte, Dennis T.; Pan, Fei; Van den Berg, David J.; Triche, Timothy; Herman, James G.; Baylin, Stephen B.; Laird, Peter W.; Getz, Gad; Noble, Michael; Voet, Doug; Saksena, Gordon; Gehlenborg, Nils; DiCara, Daniel; Zhang, Jinhua; Zhang, Hailei; Wu, Chang-Jiun; Liu, Spring Yingchun; Lawrence, Michael S.; Zou, Lihua; Sivachenko, Andrey; Lin, Pei; Stojanov, Petar; Jing, Rui; Cho, Juok; Nazaire, Marc-Danie; Robinson, Jim; Thorvaldsdottir, Helga; Mesirov, Jill; Park, Peter J.; Chin, Lynda; Schultz, Nikolaus; Sinha, Rileen; Ciriello, Giovanni; Cerami, Ethan; Gross, Benjamin; Jacobsen, Anders; Gao, Jianjiong; Aksoy, B. Arman; Weinhold, Nils; Ramirez, Ricardo; Taylor, Barry S.; Antipin, Yevgeniy; Reva, Boris; Shen, Ronglai; Mo, Qianxing; Seshan, Venkatraman; Paik, Paul K.; Ladanyi, Marc; Sander, Chris; Akbani, Rehan; Zhang, Nianxiang; Broom, Bradley M.; Casasent, Tod; Unruh, Anna; Wakefield, Chris; Cason, R. Craig; Baggerly, Keith A.; Weinstein, John N.; Haussler, David; Benz, Christopher C.; Stuart, Joshua M.; Zhu, Jingchun; Szeto, Christopher; Scott, Gary K.; Yau, Christina; Ng, Sam; Goldstein, Ted; Waltman, Peter; Sokolov, Artem; Ellrott, Kyle; Collisson, Eric A.; Zerbino, Daniel; Wilks, Christopher; Ma, Singer; Craft, Brian; Wilkerson, Matthew D.; Auman, J. Todd; Hoadley, Katherine A.; Du, Ying; Cabanski, Christopher; Walter, Vonn; Singh, Darshan; Wu, Junyuan; Gulabani, Anisha; Bodenheimer, Tom; Hoyle, Alan P.; Simons, Janae V.; Soloway, Matthew G.; Mose, Lisle E.; Jefferys, Stuart R.; Balu, Saianand; Marron, J. S.; Liu, Yufeng; Wang, Kai; Liu, Jinze; Prins, Jan F.; Hayes, D. Neil; Perou, Charles M.; Creighton, Chad J.; Zhang, Yiqun; Travis, William D.; Rekhtman, Natasha; Yi, Joanne; Aubry, Marie C.; Cheney, Richard; Dacic, Sanja; Flieder, Douglas; Funkhouser, William; Illei, Peter; Myers, Jerome; Tsao, Ming-Sound; Penny, Robert; Mallery, David; Shelton, Troy; Hatfield, Martha; Morris, Scott; Yena, Peggy; Shelton, Candace; Sherman, Mark; Paulauskis, Joseph; Meyerson, Matthew; Baylin, Stephen B.; Govindan, Ramaswamy; Akbani, Rehan; Azodo, Ijeoma; Beer, David; Bose, Ron; Byers, Lauren A.; Carbone, David; Chang, Li-Wei; Chiang, Derek; Chu, Andy; Chun, Elizabeth; Collisson, Eric; Cope, Leslie; Creighton, Chad J.; Danilova, Ludmila; Ding, Li; Getz, Gad; Hammerman, Peter S.; Hayes, D. Neil; Hernandez, Bryan; Herman, James G.; Heymach, John; Ida, Cristiane; Imielinski, Marcin; Johnson, Bruce; Jurisica, Igor; Kaufman, Jacob; Kosari, Farhad; Kucherlapati, Raju; Kwiatkowski, David; Ladanyi, Marc; Lawrence, Michael S.; Maher, Christopher A.; Mungall, Andy; Ng, Sam; Pao, William; Peifer, Martin; Penny, Robert; Robertson, Gordon; Rusch, Valerie; Sander, Chris; Schultz, Nikolaus; Shen, Ronglai; Siegfried, Jill; Sinha, Rileen; Sivachenko, Andrey; Sougnez, Carrie; Stoll, Dominik; Stuart, Joshua; Thomas, Roman K.; Tomaszek, Sandra; Tsao, Ming-Sound; Travis, William D.; Vaske, Charles; Weinstein, John N.; Weisenberger, Daniel; Wheeler, David; Wigle, Dennis A.; Wilkerson, Matthew D.; Wilks, Christopher; Yang, Ping; Zhang, Jianjua John; Jensen, Mark A.; Sfeir, Robert; Kahn, Ari B.; Chu, Anna L.; Kothiyal, Prachi; Wang, Zhining; Snyder, Eric E.; Pontius, Joan; Pihl, Todd D.; Ayala, Brenda; Backus, Mark; Walton, Jessica; Baboud, Julien; Berton, Dominique L.; Nicholls, Matthew C.; Srinivasan, Deepak; Raman, Rohini; Girshik, Stanley; Kigonya, Peter A.; Alonso, Shelley; Sanbhadti, Rashmi N.; Barletta, Sean P.; Greene, John M.; Pot, David A.; Tsao, Ming-Sound; Bandarchi-Chamkhaleh, Bizhan; Boyd, Jeff; Weaver, JoEllen; Wigle, Dennis A.; Azodo, Ijeoma A.; Tomaszek, Sandra C.; Aubry, Marie Christine; Ida, Christiane M.; Yang, Ping; Kosari, Farhad; Brock, Malcolm V.; Rogers, Kristen; Rutledge, Marian; Brown, Travis; Lee, Beverly; Shin, James; Trusty, Dante; Dhir, Rajiv; Siegfried, Jill M.; Potapova, Olga; Fedosenko, Konstantin V.; Nemirovich-Danchenko, Elena; Rusch, Valerie; Zakowski, Maureen; Iacocca, Mary V.; Brown, Jennifer; Rabeno, Brenda; Czerwinski, Christine; Petrelli, Nicholas; Fan, Zhen; Todaro, Nicole; Eckman, John; Myers, Jerome; Rathmell, W. Kimryn; Thorne, Leigh B.; Huang, Mei; Boice, Lori; Hill, Ashley; Penny, Robert; Mallery, David; Curley, Erin; Shelton, Candace; Yena, Peggy; Morrison, Carl; Gaudioso, Carmelo; Bartlett, Johnm. S.; Kodeeswaran, Sugy; Zanke, Brent; Sekhon, Harman; David, Kerstin; Juhl, Hartmut; Van Le, Xuan; Kohl, Bernard; Thorp, Richard; Tien, Nguyen Viet; Van Bang, Nguyen; Sussman, Howard; Phu, Bui Duc; Hajek, Richard; PhiHung, Nguyen; Khan, Khurram Z.; Muley, Thomas; Shaw, Kenna R. Mills; Sheth, Margi; Yang, Liming; Buetow, Ken; Davidsen, Tanja; Demchok, John A.; Eley, Greg; Ferguson, Martin; Dillon, Laura A. L.; Schaefer, Carl; Guyer, Mark S.; Ozenberger, Bradley A.; Palchik, Jacqueline D.; Peterson, Jane; Sofia, Heidi J.; Thomson, Elizabeth; Meyerson, Matthew		Canc Genome Atlas Res Network	Comprehensive genomic characterization of squamous cell lung cancers	NATURE			English	Article							COPY-NUMBER ALTERATION; THERAPEUTIC TARGET; MUTATIONS; GENE; AMPLIFICATION; CARCINOMA; SENSITIVITY; LANDSCAPE; GEFITINIB; ONCOGENE	Lung squamous cell carcinoma is a common type of lung cancer, causing approximately 400,000 deaths per year worldwide. Genomic alterations in squamous cell lung cancers have not been comprehensively characterized, and no molecularly targeted agents have been specifically developed for its treatment. As part of The Cancer Genome Atlas, here we profile 178 lung squamous cell carcinomas to provide a comprehensive landscape of genomic and epigenomic alterations. We show that the tumour type is characterized by complex genomic alterations, with a mean of 360 exonic mutations, 165 genomic rearrangements, and 323 segments of copy number alteration per tumour. We find statistically recurrent mutations in 11 genes, including mutation of TP53 in nearly all specimens. Previously unreported loss-of-function mutations are seen in the HLA-A class I major histocompatibility gene. Significantly altered pathways included NFE2L2 and KEAP1 in 34%, squamous differentiation genes in 44%, phosphatidylinositol-3-OH kinase pathway genes in 47%, and CDKN2A and RB1 in 72% of tumours. We identified a potential therapeutic target in most tumours, offering new avenues of investigation for the treatment of squamous cell lung cancers.	[Sivachenko, Andrey; McKenna, Aaron; Cherniack, Andrew D.; Crenshaw, Andrew; Hadjipanayis, Angela; Chen, Peng-Chieh; Kucherlapati, Raju] MIT, Eli & Edythe L Broad Inst, Cambridge, MA 02142 USA; [Hammerman, Peter S.; Meyerson, Matthew; Beroukhim, Rameen; Hammerman, Peter S.; Meyerson, Matthew; Johnson, Bruce] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Lander, Eric S.; Sougnez, Carrie] Harvard Univ, Dept Syst Biol, Boston, MA 02115 USA; [Gabriel, Stacey; Getz, Gad; Sougnez, Carrie; Onofrio, Robert C.; Ardlie, Kristin] Harvard Univ, Genet Anal Platform, Cambridge, MA 02142 USA; [Imielinski, Marcin; Meyerson, Matthew; Meyerson, Matthew; Imielinski, Marcin] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Chu, Andy; Chun, Hye-Jung E.; Mungall, Andrew J.; Pleasance, Erin; Robertson, A. Gordon; Sipahimalani, Payal; Stoll, Dominik; Balasundaram, Miruna; Birol, Inanc; Chuah, Eric; Guin, Ranabir; Hirst, Anhe Carrie; Hirst, Martin; Lee, Darlene; Li, Haiyan I.; Mayo, Michael; Mungall, Karen; Nip, Ka Ming; Schein, Jacqueline E.; Slobodan, Jared R.; Thiessen, Nina; Marra, Marco A.; Chun, Elizabeth; Mungall, Andy; Robertson, Gordon] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z, Canada; [Olshen, Adam] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Olshen, Adam] Dana Farber Canc Inst, Boston, MA 02115 USA; [Protopopov, Alexei; Zhang, Jianhua; Ren, Xiaojia; Zhang, Hailei; Shukla, Sachet; Zhang, Jinhua; Chin, Lynda] Univ Texas MD Anderson Canc Ctr, Inst Appl Canc Sci, Dept Genom Med, Houston, TX 77030 USA; [Hadjipanayis, Angela; Ren, Xiaojia; Chen, Peng-Chieh; Haseley, Psalm; Lee, Eunjung; Park, Peter J.; Kucherlapati, Raju] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Lee, Semin; Xi, Ruibin; Yang, Lixing; Haseley, Psalm; Lee, Eunjung; Gehlenborg, Nils] Harvard Univ, Ctr Biomed Informat, Sch Med, Boston, MA 02115 USA; [Park, Peter J.] Childrens Hosp, Informat Program, Boston, MA 02115 USA; [Socci, Nicholas D.; Liang, Yupu; Schultz, Nikolaus; Borsu, Laetitia; Lash, Alex E.; Viale, Agnes; Sander, Chris; Sinha, Rileen; Ciriello, Giovanni; Cerami, Ethan; Gross, Benjamin; Jacobsen, Anders; Gao, Jianjiong; Aksoy, B. Arman; Weinhold, Nils; Ramirez, Ricardo; Taylor, Barry S.; Antipin, Yevgeniy; Reva, Boris] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10065 USA; [Ladanyi, Marc; Ladanyi, Marc] Mem Sloan Kettering Canc Ctr, Dept Mol Oncol, New York, NY 10065 USA; [Ladanyi, Marc; Ladanyi, Marc] Mem Sloan Kettering Canc Ctr, Dept Pathol & Human Oncol, New York, NY 10065 USA; [Auman, J. Todd] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA; [Auman, J. Todd; Zerbino, Daniel; Auman, J. Todd] Univ N Carolina, Inst Pharmacogenet & Individualized Therapy, Chapel Hill, NC 27599 USA; [Hoadley, Katherine A.; Mieczkowski, Piotr A.; Chiang, Derek Y.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Hoadley, Katherine A.; Mose, Lisle E.; Jefferys, Stuart R.; Perou, Charles M.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Hoadley, Katherine A.; Wilkerson, Matthew D.; Liquori, Christina; Li, Ling; Buda, Elizabeth; Walsh, Jesse; Singh, Darshan; Wu, Junyuan; Gulabani, Anisha; Dolina, Peter; Hoyle, Alan P.; Simons, Janae V.; Soloway, Matthew G.; Collisson, Eric A.; Craft, Brian; Cabanski, Christopher; Prins, Jan F.; Chiang, Derek; Hayes, D. Neil] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Tan, Donghui; Liu, Yufeng] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Jones, Corbin D.; Hayes, D. Neil] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Balu, Saianand; Prins, Jan F.] Univ N Carolina, Dept Comp Sci, Chapel Hill, NC 27599 USA; [Liu, Jinze] Univ Kentucky, Dept Comp Sci, Lexington, KY 40506 USA; [Hayes, D. Neil] Univ N Carolina, Dept Internal Med, Div Med Oncol, Chapel Hill, NC 27599 USA; [Cope, Leslie; Danilova, Ludmila; Herman, James G.; Baylin, Stephen B.] Johns Hopkins Univ, Canc Biol Div, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; [Weisenberger, Daniel J.; Maglinte, Dennis T.; Pan, Fei; Van den Berg, David J.; Triche, Timothy; Laird, Peter W.; Weisenberger, Daniel; Wilks, Christopher] Univ So Calif, Calif Epigenome Ctr, Los Angeles, CA 90033 USA; [Akbani, Rehan; Zhang, Nianxiang; Broom, Bradley M.; Unruh, Anna; Wakefield, Chris; Baggerly, Keith A.; Weinstein, John N.; Weinstein, John N.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Cason, R. Craig] Univ Texas MD Anderson Canc Ctr, Div Pathol & Lab Med, Houston, TX 77030 USA; [Weinstein, John N.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Haussler, David; Stuart, Joshua M.; Zhu, Jingchun; Szeto, Christopher; Ng, Sam; Waltman, Peter; Sokolov, Artem; Ellrott, Kyle; Stuart, Joshua; Vaske, Charles] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Haussler, David; Stuart, Joshua M.; Zhu, Jingchun; Szeto, Christopher; Goldstein, Ted; Waltman, Peter; Sokolov, Artem; Ellrott, Kyle; Stuart, Joshua; Vaske, Charles] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; [Benz, Christopher C.; Scott, Gary K.; Yau, Christina] Buck Inst Age Res, Novato, CA 94945 USA; [Collisson, Eric] Univ Calif San Francisco, Div Hematol Oncol, San Francisco, CA 94143 USA; [Marron, J. S.] Univ N Carolina, Dept Stat & Operat Res, Chapel Hill, NC 27599 USA; [Creighton, Chad J.; Zhang, Yiqun] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Zhang, Yiqun] Baylor Coll Med, Dan L Duncan Canc Ctr, Div Biostat, Houston, TX 77030 USA; [Travis, William D.; Rekhtman, Natasha] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Yi, Joanne; Aubry, Marie C.; Ida, Cristiane] Mayo Clin, Dept Pathol, Rochester, MN 55905 USA; [Cheney, Richard; Shelton, Candace; Yena, Peggy; Morrison, Carl; Gaudioso, Carmelo] Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY 14263 USA; [Dacic, Sanja] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15213 USA; [Flieder, Douglas; Boyd, Jeff; Weaver, JoEllen] Fox Chase Canc Ctr, Dept Pathol, Philadelphia, PA 19111 USA; [Funkhouser, William] Univ N Carolina, Dept Pathol, Med Ctr, Chapel Hill, NC 27599 USA; [Illei, Peter] Johns Hopkins Univ, Dept Pathol, Sch Med, Baltimore, MD 21287 USA; [Myers, Jerome] Penrose St Francis Hlth Syst, Dept Pathol, Colorado Springs, CO 80907 USA; [Tsao, Ming-Sound; Bandarchi-Chamkhaleh, Bizhan] Ontario Canc Inst, Dept Pathol & Med Biophys, Toronto, ON M5G 2MY, Canada; [Tsao, Ming-Sound; Bandarchi-Chamkhaleh, Bizhan] Princess Margaret Hosp, Toronto, ON M5G 2MY, Canada; [Penny, Robert; Mallery, David; Shelton, Troy; Hatfield, Martha; Morris, Scott; Yena, Peggy; Shelton, Candace; Sherman, Mark; Paulauskis, Joseph; Hill, Ashley; Curley, Erin] Int Genom Consortium, Phoenix, AZ 85004 USA; [Govindan, Ramaswamy; Bose, Ron; Chang, Li-Wei; Ding, Li; Maher, Christopher A.] Washington Univ, Dept Med, Div Oncol, Sch Med, St Louis, MO 63110 USA; [Beer, David] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Carbone, David; Kaufman, Jacob; Pao, William] Vanderbilt Univ, Dept Hematol, Nashville, TN 37232 USA; [Jurisica, Igor; Brock, Malcolm V.] IBM Life Sci Discovery Ctr, Ontario Canc Inst, Toronto, ON M5G 1L7, Canada; [Peifer, Martin; Thomas, Roman K.] Univ Cologne, Dept Translat Genom, D-50931 Cologne, Germany; [Rusch, Valerie] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10065 USA; [Siegfried, Jill; Siegfried, Jill M.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Med Ctr, Pittsburgh, PA 15232 USA; [Thomas, Roman K.] Univ Cologne, Dept Translat Canc Genom, Ctr Integrated Oncol, D-50924 Cologne, Germany; [Wheeler, David] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Ida, Christiane M.] Mayo Clin, Dept Lab Med, Rochester, MN 55905 USA; [Yang, Ping] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Rogers, Kristen; Brown, Travis] Johns Hopkins Sch Med, Dept Surg, Baltimore, MD 21287 USA; [Rutledge, Marian; Lee, Beverly] Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD 21287 USA; [Shin, James; Trusty, Dante] Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD 21287 USA; [Dhir, Rajiv] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15213 USA; [Potapova, Olga; Nemirovich-Danchenko, Elena] Cureline, San Francisco, CA 94080 USA; [Fedosenko, Konstantin V.] City Clin Oncol Dispensary, St Petersburg 197022, Russia; [Zakowski, Maureen] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Iacocca, Mary V.; Brown, Jennifer; Rabeno, Brenda; Czerwinski, Christine; Petrelli, Nicholas] Helen F Graham Canc Ctr, Newark, DE 19713 USA; [Fan, Zhen; Todaro, Nicole; Huang, Mei] St Joseph Med Ctr, Towson, MD 21204 USA; [Thorne, Leigh B.] UNC Lineberger Canc Ctr, UNC Tissue Procurement Facil, Dept Pathol, Chapel Hill, NC 27599 USA; [Kodeeswaran, Sugy; Zanke, Brent] Ontario Inst Canc Res, Ontario Tumour Bank, Toronto, ON M5G 0A3, Canada; [David, Kerstin] Indivumed GmbH, D-20251 Hamburg, Germany; [Juhl, Hartmut] Indivumed Inc, Kensington, MD 20895 USA; [Van Le, Xuan; Kohl, Bernard; Thorp, Richard] ILSBio LLC, Chestertown, MD 21620 USA; [Tien, Nguyen Viet] Minist Hlth, Hanoi, Vietnam; [Van Bang, Nguyen] Hue Cent Hosp, Hue City, Vietnam; [Sussman, Howard] Stanford Univ, Med Ctr, Stanford, CA 94305 USA; [Hajek, Richard] Univ Texas MD Anderson Canc Ctr, Ctr Minor Hlth Res, Houston, TX 77030 USA; [Phu, Bui Duc; PhiHung, Nguyen] Natl Canc Inst, Hanoi, Vietnam; [Khan, Khurram Z.] ILSBio LLC, Chestertown, MD 21620 USA; [Muley, Thomas] Univ Heidelberg Hosp, ThoraxKlin, D-69126 Heidelberg, Germany; [Shaw, Kenna R. Mills; Sheth, Margi; Yang, Liming; Demchok, John A.; Dillon, Laura A. L.] NCI, Canc Genome Atlas Program Off, Bethesda, MD 20892 USA; [Buetow, Ken; Davidsen, Tanja; Eley, Greg; Schaefer, Carl] NCI, CBIIT, NIH, Rockville, MD 20852 USA; [Guyer, Mark S.; Ozenberger, Bradley A.; Palchik, Jacqueline D.; Peterson, Jane; Sofia, Heidi J.; Thomson, Elizabeth] NHGRI, NIH, Bethesda, MD 20892 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; Harvard University; Harvard Medical School; British Columbia Cancer Agency; University of California System; University of California San Francisco; Harvard University; Dana-Farber Cancer Institute; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Kentucky; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; Johns Hopkins Medicine; University of Southern California; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz; Buck Institute for Research on Aging; University of California System; University of California San Francisco; University of North Carolina; University of North Carolina Chapel Hill; Baylor College of Medicine; Baylor College of Medicine; Memorial Sloan Kettering Cancer Center; Mayo Clinic; Roswell Park Cancer Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Fox Chase Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; International Genomics Consortium; Washington University (WUSTL); University of Michigan System; University of Michigan; Vanderbilt University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Cologne; Memorial Sloan Kettering Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Cologne; Baylor College of Medicine; Mayo Clinic; Mayo Clinic; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Memorial Sloan Kettering Cancer Center; Helen F. Graham Cancer Center & Research Institute; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; Stanford University; University of Texas System; UTMD Anderson Cancer Center; Ruprecht Karls University Heidelberg; International Genomics Consortium; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Meyerson, M (corresponding author), MIT, Eli & Edythe L Broad Inst, Cambridge, MA 02142 USA.	matthew_meyerson@dfci.harvard.edu	Mesirov, Jill/AGF-7626-2022; Tsao, Ming-Sound/M-3503-2017; Marra, Marco A/B-5987-2008; Muley, Thomas/AAY-9200-2020; Van Den Berg, David J/G-8598-2017; Auman, James/AAY-7748-2020; Noble, Michelle M/C-4653-2011; Reva, Boris A./B-6436-2014; Lee, Semin/S-2629-2016; Weisenberger, Daniel/AAA-8314-2020; Mungall, Andrew J./U-7067-2018; Stojanov, Petar/GQI-4462-2022; Vaske, Charles/D-6018-2013; Hirst, Martin/B-7684-2016; Akbani, Rehan/AAG-1490-2019; Schumacher, Steven/E-9821-2013; Birol, Inanc/G-5440-2011; Yang, Lixing/A-7073-2013; Walter, Vonn/AAI-3450-2021; Wheeler, David A/M-9740-2018; Cibulskis, Kristian/AAC-7380-2019; Lawrence, Michael/AAC-8202-2020; Heymach, John/AAG-2361-2019; Gao, JianJiong/B-5673-2016; Laird, Peter W/G-8683-2012; Jones, Steven J/C-3621-2009; Cherniack, Andrew/AAC-5310-2019; Perou, Charles M/H-9934-2014; Skanderup, Anders Jacobsen/K-1081-2013; Schultz, Nikolaus/ABE-6347-2020; Cherniack, Andrew D./AAY-8132-2020; Kucherlapati, Raju/ABC-8807-2021; Chiang, Derek/L-6452-2019; Zhang, YiQun/HCI-2427-2022; Ladanyi, Marc/AAG-8585-2019; , Pathology Services Core/CEZ-2246-2022; Reva, Boris/AAB-8932-2022; Tsao, Ming Sound/AFQ-7332-2022; Schein, Jacquie E/G-3674-2015; Holt, Robert A/C-3303-2009	Marra, Marco A/0000-0001-7146-7175; Van Den Berg, David J/0000-0002-5404-5218; Noble, Michelle M/0000-0001-6820-1034; Reva, Boris A./0000-0002-8805-389X; Lee, Semin/0000-0002-9015-6046; Weisenberger, Daniel/0000-0001-8303-2603; Mungall, Andrew J./0000-0002-0905-2742; Stojanov, Petar/0000-0001-7815-776X; Vaske, Charles/0000-0001-8151-6612; Schumacher, Steven/0000-0002-6819-5647; Birol, Inanc/0000-0003-0950-7839; Walter, Vonn/0000-0001-6114-6714; Wheeler, David A/0000-0002-9056-6299; Heymach, John/0000-0001-9068-8942; Gao, JianJiong/0000-0002-5739-1781; Laird, Peter W/0000-0001-9117-3641; Jones, Steven J/0000-0003-3394-2208; Perou, Charles M/0000-0001-9827-2247; Skanderup, Anders Jacobsen/0000-0001-6847-4980; Cherniack, Andrew D./0000-0003-0470-0111; Tsao, Ming Sound/0000-0002-9160-5405; Holt, Robert A/0000-0002-7259-1247; Meyerson, Matthew/0000-0002-9133-8108; Triche, Tim/0000-0001-5665-946X; Stuart, Joshua/0000-0002-2171-565X; Rusch, Valerie/0000-0003-2345-6900; O'Connor, Brian/0000-0002-7681-6415; Casasent, Anna/0000-0002-7857-179X; Weinstein, John/0000-0001-9401-6908; Lash, Alex/0000-0003-3787-1590; Schultz, Nikolaus/0000-0002-0131-4904; Gehlenborg, Nils/0000-0003-0327-8297; Xi, Ruibin/0000-0001-7545-7361; Zerbino, Daniel/0000-0001-5350-3056; Hoadley, Katherine/0000-0002-1216-477X; Jensen, Mark/0000-0001-5215-101X; Pot, David/0000-0002-1480-9826; Hayes, D. Neil/0000-0001-6203-7771; Sinha, Rileen/0000-0001-5497-5055; Ciriello, Giovanni/0000-0003-2021-8683; Chen, Peng-Chieh ( Jessica )/0000-0002-2060-1765; Auman, James/0000-0002-9328-8829; Park, Peter/0000-0001-9378-960X; Mieczkowski, Piotr/0000-0003-2418-0096; Peifer, Martin/0000-0002-5243-5503; Cibulskis, Kristian/0000-0003-1343-1582; Stoll, Dominik/0000-0003-0701-4301	NIH [U24 CA126561, U24 CA126551, U24 CA126554, U24 CA126543, U24 CA126546, U24 CA126563, U24 CA126544, U24 CA143845, U24 CA143858, U24 CA144025, U24 CA143882, U24 CA143866, U24 CA143867, U24 CA143848, U24 CA143840, U24 CA143835, U24 CA143799, U24 CA143883, U24 CA143843, U54 HG003067, U54 HG003079, U54 HG003273]; NATIONAL CANCER INSTITUTE [K08CA137153, U24CA143845, U24CA126554, U24CA126563, U24CA144025, U24CA126543, P30CA016086, U24CA143858, U24CA143882, U24CA126551, U24CA126546, U24CA143840, R01CA149569, U24CA143799, U24CA126561, T32CA009172, P30CA016672, U24CA143843, U24CA143835, U24CA143848, U24CA143866, U24CA143867, R01CA094143, U24CA126544, R00CA149182, U24CA143883] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273, R01HG006272, U54HG003079, U54HG003067] Funding Source: NIH RePORTER; Emerging Frontiers [0850237] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Emerging Frontiers(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was supported by NIH grants U24 CA126561, U24 CA126551, U24 CA126554, U24 CA126543, U24 CA126546, U24 CA126563, U24 CA126544, U24 CA143845, U24 CA143858, U24 CA144025, U24 CA143882, U24 CA143866, U24 CA143867, U24 CA143848, U24 CA143840, U24 CA143835, U24 CA143799, U24 CA143883, U24 CA143843, U54 HG003067, U54 HG003079 and U54 HG003273.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Aster JC, 2011, J PATHOL, V223, P262, DOI 10.1002/path.2789; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bishop JA, 2011, MODERN PATHOL, V24, p405A; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Ciriello G, 2012, GENOME RES, V22, P398, DOI 10.1101/gr.125567.111; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dutt A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020351; Felip E, 2011, ANN ONCOL, V22, P1507, DOI 10.1093/annonc/mdr150; Govindan R, 2010, J THORAC ONCOL, V5, pS433, DOI 10.1097/JTO.0b013e3181fd6fe1; Hammerman PS, 2011, CANCER DISCOV, V1, P78, DOI 10.1158/2159-8274.CD-11-0005; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Ju YS, 2012, GENOME RES, V22, P436, DOI 10.1101/gr.133645.111; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kancha RK, 2011, J THORAC ONCOL, V6, P387, DOI 10.1097/JTO.0b013e3182021f3e; Kenfield SA, 2008, TOB CONTROL, V17, P198, DOI 10.1136/tc.2007.022582; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Massion PP, 2003, CANCER RES, V63, P7113; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Morris PG, 2010, J CLIN ONCOL, V28, P3154, DOI 10.1200/JCO.2009.27.5743; Osada H, 2005, CANCER RES, V65, P10680, DOI 10.1158/0008-5472.CAN-05-1404; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Ramos AH, 2009, CANCER BIOL THER, V8, P2042, DOI 10.4161/cbt.8.21.9764; Rekhtman N, 2012, CLIN CANCER RES, V18, P1167, DOI 10.1158/1078-0432.CCR-11-2109; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Shen RL, 2009, BIOINFORMATICS, V25, P2906, DOI 10.1093/bioinformatics/btp543; Shibata T, 2008, P NATL ACAD SCI USA, V105, P13568, DOI 10.1073/pnas.0806268105; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Singh A, 2010, ANTIOXID REDOX SIGN, V13, P1627, DOI 10.1089/ars.2010.3219; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182; Wang NJ, 2011, P NATL ACAD SCI USA, V108, P17761, DOI 10.1073/pnas.1114669108; Weiss J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001451; Wikman H, 2006, EXPERT REV ANTICANC, V6, P515, DOI 10.1586/14737140.6.4.515; Wilkerson MD, 2010, CLIN CANCER RES, V16, P4864, DOI 10.1158/1078-0432.CCR-10-0199; World Health Organization, CANCER	46	2595	2639	16	334	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 27	2012	489	7417					519	525		10.1038/nature11404	http://dx.doi.org/10.1038/nature11404			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011LT	22960745	Green Submitted, hybrid, Green Accepted, Green Published			2022-12-24	WOS:000309167100041
J	Hawrylycz, MJ; Lein, ES; Guillozet-Bongaarts, AL; Shen, EH; Ng, L; Miller, JA; van de Lagemaat, LN; Smith, KA; Ebbert, A; Riley, ZL; Abajian, C; Beckmann, CF; Bernard, A; Bertagnolli, D; Boe, AF; Cartagena, PM; Chakravarty, MM; Chapin, M; Chong, J; Dalley, RA; Daly, BD; Dang, C; Datta, S; Dee, N; Dolbeare, TA; Faber, V; Feng, D; Fowler, DR; Goldy, J; Gregor, BW; Haradon, Z; Haynor, DR; Hohmann, JG; Horvath, S; Howard, RE; Jeromin, A; Jochim, JM; Kinnunen, M; Lau, C; Lazarz, ET; Lee, C; Lemon, TA; Li, L; Li, Y; Morris, JA; Overly, CC; Parker, PD; Parry, SE; Reding, M; Royall, JJ; Schulkin, J; Sequeira, PA; Slaughterbeck, CR; Smith, SC; Sodt, AJ; Sunkin, SM; Swanson, BE; Vawter, MP; Williams, D; Wohnoutka, P; Zielke, HR; Geschwind, DH; Hof, PR; Smith, SM; Koch, C; Grant, SGN; Jones, AR				Hawrylycz, Michael J.; Lein, Ed S.; Guillozet-Bongaarts, Angela L.; Shen, Elaine H.; Ng, Lydia; Miller, Jeremy A.; van de lagemaat, Louie N.; Smith, Kimberly A.; Ebbert, Amanda; Riley, Zackery L.; Abajian, Chris; Beckmann, Christian F.; Bernard, Amy; Bertagnolli, Darren; Boe, Andrew F.; Cartagena, Preston M.; Chakravarty, M. Mallar; Chapin, Mike; Chong, Jimmy; Dalley, Rachel A.; Daly, Barry David; Dang, Chinh; Datta, Suvro; Dee, Nick; Dolbeare, Tim A.; Faber, Vance; Feng, David; Fowler, David R.; Goldy, Jeff; Gregor, Benjamin W.; Haradon, Zeb; Haynor, David R.; Hohmann, John G.; Horvath, Steve; Howard, Robert E.; Jeromin, Andreas; Jochim, Jayson M.; Kinnunen, Marty; Lau, Christopher; Lazarz, Evan T.; Lee, Changkyu; Lemon, Tracy A.; Li, Ling; Li, Yang; Morris, John A.; Overly, Caroline C.; Parker, Patrick D.; Parry, Sheana E.; Reding, Melissa; Royall, Joshua J.; Schulkin, Jay; Sequeira, Pedro Adolfo; Slaughterbeck, Clifford R.; Smith, Simon C.; Sodt, Andy J.; Sunkin, Susan M.; Swanson, Beryl E.; Vawter, Marquis P.; Williams, Derric; Wohnoutka, Paul; Zielke, H. Ronald; Geschwind, Daniel H.; Hof, Patrick R.; Smith, Stephen M.; Koch, Christof; Grant, Seth G. N.; Jones, Allan R.			An anatomically comprehensive atlas of the adult human brain transcriptome	NATURE			English	Article							LISTS	Neuroanatomically precise, genome-wide maps of transcript distributions are critical resources to complement genomic sequence data and to correlate functional and genetic brain architecture. Here we describe the generation and analysis of a transcriptional atlas of the adult human brain, comprising extensive histological analysis and comprehensive microarray profiling of similar to 900 neuroanatomically precise subdivisions in two individuals. Transcriptional regulation varies enormously by anatomical location, with different regions and their constituent cell types displaying robust molecular signatures that are highly conserved between individuals. Analysis of differential gene expression and gene co-expression relationships demonstrates that brain-wide variation strongly reflects the distributions of major cell classes such as neurons, oligodendrocytes, astrocytes and microglia. Local neighbourhood relationships between fine anatomical subdivisions are associated with discrete neuronal subtypes and genes involved with synaptic transmission. The neocortex displays a relatively homogeneous transcriptional pattern, but with distinct features associated selectively with primary sensorimotor cortices and with enriched frontal lobe expression. Notably, the spatial topography of the neocortex is strongly reflected in its molecular topography-the closer two cortical regions, the more similar their transcriptomes. This freely accessible online data resource forms a high-resolution transcriptional baseline for neurogenetic studies of normal and abnormal human brain function.	[Hawrylycz, Michael J.; Lein, Ed S.; Guillozet-Bongaarts, Angela L.; Shen, Elaine H.; Ng, Lydia; Miller, Jeremy A.; Smith, Kimberly A.; Ebbert, Amanda; Riley, Zackery L.; Abajian, Chris; Bernard, Amy; Bertagnolli, Darren; Boe, Andrew F.; Chakravarty, M. Mallar; Chapin, Mike; Chong, Jimmy; Dalley, Rachel A.; Dang, Chinh; Datta, Suvro; Dee, Nick; Dolbeare, Tim A.; Faber, Vance; Feng, David; Goldy, Jeff; Gregor, Benjamin W.; Haradon, Zeb; Hohmann, John G.; Howard, Robert E.; Jochim, Jayson M.; Kinnunen, Marty; Lau, Christopher; Lazarz, Evan T.; Lee, Changkyu; Lemon, Tracy A.; Li, Yang; Morris, John A.; Overly, Caroline C.; Parker, Patrick D.; Parry, Sheana E.; Reding, Melissa; Royall, Joshua J.; Slaughterbeck, Clifford R.; Sodt, Andy J.; Sunkin, Susan M.; Swanson, Beryl E.; Williams, Derric; Wohnoutka, Paul; Koch, Christof; Jones, Allan R.] Allen Inst Brain Sci, Seattle, WA 98103 USA; [van de lagemaat, Louie N.; Grant, Seth G. N.] Univ Edinburgh, Genes Cognit Programme, Edinburgh EH16 4SB, Midlothian, Scotland; [Beckmann, Christian F.] Univ Twente, MIRA Inst, Nijmegen, Netherlands; [Beckmann, Christian F.] Radboud Univ Nijmegen, Donders Inst, NL-6525 ED Nijmegen, Netherlands; [Cartagena, Preston M.] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92697 USA; [Chakravarty, M. Mallar] Ctr Addict & Mental Hlth Toronto, Kimel Family Translat Imaging Genet Lab, Toronto, ON M5S 2S1, Canada; [Daly, Barry David] Univ Maryland, Sch Med, Dept Diagnost Radiol, Med Ctr, Baltimore, MD 21201 USA; [Fowler, David R.] Univ Maryland, Dept Pathol, Sch Med, Baltimore, MD 21201 USA; [Haynor, David R.] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Horvath, Steve] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Gonda Res Ctr, Los Angeles, CA 90095 USA; [Jeromin, Andreas] Banyan Biomarkers Inc, Alachua, FL 32615 USA; [Li, Ling] Off Chief Med Examiner, Baltimore, MD USA; [Li, Ling] Univ Maryland, Dept Pediat, Baltimore, MD 21201 USA; [Schulkin, Jay] Georgetown Univ, Sch Med, Dept Neurosci, Washington, DC 20007 USA; [Sequeira, Pedro Adolfo; Vawter, Marquis P.] Univ Calif Irvine, Funct Genom Lab, Dept Psychiat & Human Behav, Sch Med, Irvine, CA 92697 USA; [Smith, Simon C.] Histion LLC, Everett, WA 98204 USA; [Zielke, H. Ronald] Univ Maryland, Eunice Kennedy Shriver NICHD Brain & Tissue Bank, Baltimore, MD 21201 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Program Neurogenet, Dept Neurol, Los Angeles, CA 90095 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst, Los Angeles, CA 90095 USA; [Hof, Patrick R.] Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY 10029 USA; [Hof, Patrick R.] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY 10029 USA; [Smith, Stephen M.] Univ Oxford, FMRIB, Oxford OX3 9DU, England; [Koch, Christof] CALTECH, Pasadena, CA 91125 USA	Allen Institute for Brain Science; University of Edinburgh; Radboud University Nijmegen; University of California System; University of California Irvine; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Banyan Biomarkers Inc.; University System of Maryland; University of Maryland Baltimore; Georgetown University; University of California System; University of California Irvine; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University System of Maryland; University of Maryland Baltimore; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Oxford; California Institute of Technology	Hawrylycz, MJ (corresponding author), Allen Inst Brain Sci, Seattle, WA 98103 USA.	mikeh@alleninstitute.org	Beckmann, Christian F./E-6374-2012; Sequeira, Adolfo/K-7278-2015	Beckmann, Christian F./0000-0002-3373-3193; Sequeira, Adolfo/0000-0003-3040-1190; Koch, Christof/0000-0001-6482-8067; Smith, Stephen/0000-0001-8166-069X; Parker, Patrick/0000-0001-5217-107X; Feng, David/0000-0002-4920-8123; Dee, Nick/0000-0002-2831-9254; Arnold, James/0000-0001-7011-591X; Bernard, Amy/0000-0003-2540-1153; Grant, Seth/0000-0001-8732-8735	Department of Health and Human Services Health Resources and Services Administration Awards [1C76HF15069-01-00, 1 1C76HF19619-01-00]; MRCD; Wellcome Trust; European Union Seventh Framework Programme [241498 EUROSPIN, 242167 SynSys, 241995 GENCODYS]; Medical Research Council [G0700399, G0802238] Funding Source: researchfish; MRC [G0700399, G0802238] Funding Source: UKRI; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085801, R37MH060233] Funding Source: NIH RePORTER	Department of Health and Human Services Health Resources and Services Administration Awards; MRCD(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); European Union Seventh Framework Programme(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We wish to thank the Allen Institute founders, P. G. Allen and J. Allen, for their vision, encouragement, and support. We express our gratitude to past and present Allen Institute staff members R. Adams, K. Aiona, A. Alpisa, J. Arnold, C. Bennet, K. Brouner, S. Butler, E. Byrnes, S. Caldejon, J. Campiche, A. Carey, J. Chen, C. Copeland, C. Cuhaciyan, T. Desta, N. Dotson, S. Faber, T. Fliss, E. Fulfs, G. Gee, T. Gilbert, L. Gourley, G. Gu, J. Heilman, N. Ivanov, K. Keyser, A. Kriedberg, J. Laoenkue, F. Lee, S. Levine, L. Luong, N. Mastan, N. Mosqueda, E. Mott, N. Motz, D. Muzia, K. Ngo, A. Oldre, E. Olson, J. Parente, J. Phillips, L. Potekhina, T. Roberts, K. Roll, D. Rosen, M. Sarreal, S. Shapouri, N. Shapovalova, C. Simpson, D. Simpson, M. Smith, N. Stewart, K. Sweeney, A. Szafer, L. Velasquez, U. Wagley, W. Wakeman, C. White and B. Youngstrom for their technical assistance. We thank C. Long for mechanical engineering contract work. We thank R. Gullapalli, A. McMillan and R. Morales for post-mortem magnetic resonance imaging and radiology interpretation of MR data; J. Cottrell, M. Davis, R. Johnson, K. Moraniec, R. Vigorito, A. Weldon and the NICHD Brain and Tissue Bank for Developmental Disorders for tissue acquisition and processing; J. Davis for donor coordination; F. Mamdani, M. Martin, E. Moon, L. Morgan, B. Rollins and D. Walsh for tissue processing and psychological autopsy (DW); D. Patel for magnetic resonance imaging; and J. Sonnen for consultation on tissue microneuropathology. We also thank the External RNA Controls Consortium (ERCC), the US National Institute of Standards (NIST) and Technology, and M. Salit for access to ERCC transcripts during Phase V testing. We are grateful to Beckman Coulter Genomics (formerly Cogenics) and their staff P. Hurban, E. Lobenhofer, K. Phillips, A. Rouse and S. Beaver for microarray data generation and design of the custom Agilent array. We also wish to thank the Allen Human Brain Atlas Advisory Council members D. Geschwind, R. Gibbs, P. Hof, E. Jones, C. Koch, C. Saper, L. Swanson, A. Toga and D. Van Essen for their scientific guidance and dedication to the successful execution of this project. The project described was supported in part by Grant Numbers 1C76HF15069-01-00 and 1 1C76HF19619-01-00 from the Department of Health and Human Services Health Resources and Services Administration Awards and its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Department of Health and Human Services Health Resources and Services Administration Awards. S. G. N. G and L. V. L. were supported by the MRCD, Wellcome Trust and European Union Seventh Framework Programme under grants 241498 EUROSPIN, 242167 SynSys, and 241995 GENCODYS Projects.	Amaral D. G., 1990, HUMAN NERVOUS SYSTEM, P771; Ameur A, 2011, NAT STRUCT MOL BIOL, V18, P1435, DOI 10.1038/nsmb.2143; Baldock RA, 2003, NEUROINFORMATICS, V1, P309, DOI 10.1385/NI:1:4:309; Bayes A, 2011, NAT NEUROSCI, V14, P19, DOI 10.1038/nn.2719; Belgard TG, 2011, NEURON, V71, P605, DOI 10.1016/j.neuron.2011.06.039; Bentivoglio M, 2005, HAND CHEM N, V21, P1; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; Bernard A, 2012, NEURON, V73, P1083, DOI 10.1016/j.neuron.2012.03.002; Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524; DeFelipe J., 1988, CAJAL CEREBRAL CORTE; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Evans A C, 1992, Neuroimage, V1, P43, DOI 10.1016/1053-8119(92)90006-9; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Hawrylycz M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001065; Herculano-Houzel S, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.031.2009; HOF PR, 1995, J COMP NEUROL, V362, P109, DOI 10.1002/cne.903620107; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hurd Y. L., 2005, HDB CHEM NEUROANATOM, P525; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Langfelder P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001057; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Markou A, 2009, NEUROPSYCHOPHARMACOL, V34, P74, DOI 10.1038/npp.2008.173; Miller JA, 2010, P NATL ACAD SCI USA, V107, P12698, DOI 10.1073/pnas.0914257107; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Shattuck DW, 2008, NEUROIMAGE, V39, P1064, DOI 10.1016/j.neuroimage.2007.09.031; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Zeng HK, 2012, CELL, V149, P483, DOI 10.1016/j.cell.2012.02.052; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zilles K, 2002, EUR NEUROPSYCHOPHARM, V12, P587, DOI 10.1016/S0924-977X(02)00108-6	35	1398	1415	9	189	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 20	2012	489	7416					391	399		10.1038/nature11405	http://dx.doi.org/10.1038/nature11405			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AK	22996553	Green Accepted			2022-12-24	WOS:000308860900037
J	Ioannou, CC; Guttal, V; Couzin, ID				Ioannou, C. C.; Guttal, V.; Couzin, I. D.			Predatory Fish Select for Coordinated Collective Motion in Virtual Prey	SCIENCE			English	Article							INDIVIDUAL-BASED MODEL; ANIMAL GROUPS; SELFISH HERD; BEHAVIOR; DYNAMICS; SPARROWHAWKS; STRATEGIES; CONFUSION; ATTACK	Movement in animal groups is highly varied and ranges from seemingly disordered motion in swarms to coordinated aligned motion in flocks and schools. These social interactions are often thought to reduce risk from predators, despite a lack of direct evidence. We investigated risk-related selection for collective motion by allowing real predators ( bluegill sunfish) to hunt mobile virtual prey. By fusing simulated and real animal behavior, we isolated predator effects while controlling for confounding factors. Prey with a tendency to be attracted toward, and to align direction of travel with, near neighbors tended to form mobile coordinated groups and were rarely attacked. These results demonstrate that collective motion could evolve as a response to predation, without prey being able to detect and respond to predators.	[Ioannou, C. C.; Guttal, V.; Couzin, I. D.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Ioannou, C. C.] Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England; [Guttal, V.] Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India	Princeton University; University of Bristol; Indian Institute of Science (IISC) - Bangalore	Ioannou, CC (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	C.C.Ioannou@bristol.ac.uk; icouzin@princeton.edu	Couzin, Iain D./Q-6862-2018; Guttal, Vishwesha/A-3007-2008	Couzin, Iain D./0000-0001-8556-4558; Guttal, Vishwesha/0000-0002-2677-857X; Ioannou, Christos/0000-0002-9739-889X	Office of Naval Research [N00014-09-1-1074]; NSF [PHY-0848755]; Searle Scholar award [08-SPP-201]; Army Research Office [W911NG-11-1-0385]; Defense Advanced Research Projects Agency [HR0011-05-1-0057]; Leverhulme Trust; Department of Biotechnology, Government of India; Division Of Physics [0848755] Funding Source: National Science Foundation	Office of Naval Research(Office of Naval Research); NSF(National Science Foundation (NSF)); Searle Scholar award; Army Research Office; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Leverhulme Trust(Leverhulme Trust); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank A. Hundal, M. Jiang, and M. Singh for assistance and A. S. I. Wade, the Couzin lab, and three anonymous reviewers for comments on the manuscript. Funded by Office of Naval Research award N00014-09-1-1074, NSF award PHY-0848755, Searle Scholar award 08-SPP-201, and Army Research Office grant W911NG-11-1-0385 (I. D. C.); Defense Advanced Research Projects Agency grant HR0011-05-1-0057 (Princeton University); Leverhulme Trust Early Career Fellowship (C. C. I.); and a Ramalingaswami Fellowship from the Department of Biotechnology, Government of India (V. G.). All experiments were conducted in accordance with federal and state regulations and were approved by the Princeton University Institutional Animal Care and Use Committee. Data and code are freely available at http://icouzin.princeton.edu.	Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; Bazazi S, 2008, CURR BIOL, V18, P735, DOI 10.1016/j.cub.2008.04.035; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; Couzin ID, 2003, ADV STUD BEHAV, V32, P1, DOI 10.1016/S0065-3454(03)01001-5; Cresswell W, 2004, OIKOS, V104, P71, DOI 10.1111/j.0030-1299.2004.12814.x; Cresswell W, 1996, IBIS, V138, P684, DOI 10.1111/j.1474-919X.1996.tb04770.x; EHLINGER TJ, 1988, P NATL ACAD SCI USA, V85, P1878, DOI 10.1073/pnas.85.6.1878; Grunbaum D, 1998, EVOL ECOL, V12, P503, DOI 10.1023/A:1006574607845; Guttal V, 2010, P NATL ACAD SCI USA, V107, P16172, DOI 10.1073/pnas.1006874107; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Handegard NO, 2012, CURR BIOL, V22, P1213, DOI 10.1016/j.cub.2012.04.050; Ioannou CC, 2008, BEHAV ECOL, V19, P126, DOI 10.1093/beheco/arm109; Jones KA, 2011, BEHAV ECOL, V22, P831, DOI 10.1093/beheco/arr062; Katz Y, 2011, P NATL ACAD SCI USA, V108, P18720, DOI 10.1073/pnas.1107583108; Krause J, 2002, LIVING GROUPS; Lukeman R, 2010, P NATL ACAD SCI USA, V107, P12576, DOI 10.1073/pnas.1001763107; Parrish JK, 1999, SCIENCE, V284, P99, DOI 10.1126/science.284.5411.99; Romey WL, 2008, BEHAV ECOL, V19, P74, DOI 10.1093/beheco/arm105; Ruxton GD, 2007, BEHAV ECOL, V18, P590, DOI 10.1093/beheco/arm009; Sayama H, 2009, IEEE SYMP ART LIFE, P85, DOI 10.1109/ALIFE.2009.4937698; Tosh CR, 2011, J THEOR BIOL, V281, P24, DOI 10.1016/j.jtbi.2011.04.014; TREHERNE JE, 1982, ANIM BEHAV, V30, P536, DOI 10.1016/S0003-3472(82)80066-3; Vabo R, 1997, FISH OCEANOGR, V6, P155, DOI 10.1046/j.1365-2419.1997.00037.x; Wood AJ, 2007, P R SOC B, V274, P1637, DOI 10.1098/rspb.2007.0306	26	203	210	5	191	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 7	2012	337	6099					1212	1215		10.1126/science.1218919	http://dx.doi.org/10.1126/science.1218919			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	000UJ	22903520	Green Submitted			2022-12-24	WOS:000308414000034
J	Imai, KS; Daido, Y; Kusakabe, TG; Satou, Y				Imai, Kaoru S.; Daido, Yutaka; Kusakabe, Takehiro G.; Satou, Yutaka			Cis-Acting Transcriptional Repression Establishes a Sharp Boundary in Chordate Embryos	SCIENCE			English	Article							DORSALIZING-MORPHOGENETIC-PROTEIN; ORGANIZER; ADMP; GENE; EXPRESSION	The function of bone morphogenetic protein (BMP) signaling in dorsoventral (DV) patterning of animal embryos is conserved among Bilateria. In vertebrates, the BMP ligand antidorsalizing morphogenetic protein (Admp) is expressed dorsally and moves to the opposite side to specify the ventral fate. Here, we show that Pinhead is an antagonist specific for Admp with a role in establishing the DV axis of the trunk epidermis in embryos of the ascidian Ciona intestinalis. Pinhead and Admp exist in tandem in the genomes of various animals from arthropods to vertebrates. This genomic configuration is important for mutually exclusive expression of these genes, because Pinhead transcription directly disturbs the action of the Admp enhancer. Our data suggest that this dual negative regulatory mechanism is widely conserved in animals.	[Imai, Kaoru S.; Satou, Yutaka] Kyoto Univ, Grad Sch Sci, Dept Zool, Sakyo Ku, Kyoto 6068502, Japan; [Imai, Kaoru S.] Kyoto Univ, Grad Sch Sci, Dept Biodivers, Sakyo Ku, Kyoto 6068502, Japan; [Daido, Yutaka; Kusakabe, Takehiro G.] Konan Univ, Fac Sci & Engn, Dept Biol, Kobe, Hyogo 6588501, Japan	Kyoto University; Kyoto University; Konan University	Satou, Y (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Zool, Sakyo Ku, Kyoto 6068502, Japan.	yutaka@ascidian.zool.kyoto-u.ac.jp	Kusakabe, Takehiro/H-7178-2012; Satou, Yutaka/AAJ-2194-2021; Satou, Yutaka/K-7131-2012	Kusakabe, Takehiro/0000-0002-8325-3665; Satou, Yutaka/0000-0001-5193-0708; Satou, Yutaka/0000-0001-5193-0708; Imai, Kaoru/0000-0001-9113-6074	Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science (JSPS) [22870018, 22310120, 21671004]; Global Center of Excellence program [A06]; Restart Postdoctoral Fellowship (RPD) from JSPS; Grants-in-Aid for Scientific Research [21671004, 22310120] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Global Center of Excellence program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Restart Postdoctoral Fellowship (RPD) from JSPS; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology and the Japan Society for the Promotion of Science (JSPS) to K. S. I. (22870018), T. G. K. (22310120), and Y.S. (21671004) and also in part by the Global Center of Excellence program (A06) to Kyoto University. K. S. I. was supported by a Restart Postdoctoral Fellowship (RPD) from JSPS. The cDNA sequences for Admp and Pinhead are available under accession nos. AB210298 and AK113761 in the DDBJ/EMBL/GenBank database. We are grateful to K. Hirayama for her assistance with this research.	Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dickmeis T, 2001, DEV GENES EVOL, V211, P568, DOI 10.1007/s00427-001-0190-3; Dosch R, 2000, MECH DEVELOP, V90, P195, DOI 10.1016/S0925-4773(99)00245-2; Gavino MA, 2011, CURR BIOL, V21, P294, DOI 10.1016/j.cub.2011.01.017; Imai KS, 2006, SCIENCE, V312, P1183, DOI 10.1126/science.1123404; Imai KS, 2004, DEVELOPMENT, V131, P4047, DOI 10.1242/dev.01270; Joubin K, 1999, CELL, V98, P559, DOI 10.1016/S0092-8674(00)80044-6; Kenwrick S, 2004, DEV DYNAM, V229, P289, DOI 10.1002/dvdy.10440; Lele Z, 2001, DEV DYNAM, V222, P681, DOI 10.1002/dvdy.1222; Lemaire P, 2008, CURR BIOL, V18, pR620, DOI 10.1016/j.cub.2008.05.039; Pasini A, 2006, PLOS BIOL, V4, P1173, DOI 10.1371/journal.pbio.0040225; Reversade B, 2005, CELL, V123, P1147, DOI 10.1016/j.cell.2005.08.047; Satou Y, 2008, DEV GENES EVOL, V218, P715, DOI 10.1007/s00427-008-0219-y; Willot V, 2002, DEV BIOL, V241, P59, DOI 10.1006/dbio.2001.0494	14	20	21	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 24	2012	337	6097					964	967		10.1126/science.1222488	http://dx.doi.org/10.1126/science.1222488			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992VI	22923581				2022-12-24	WOS:000307807600045
J	Sarov, M; Murray, JI; Schanze, K; Pozniakovski, A; Niu, W; Angermann, K; Hasse, S; Rupprecht, M; Vinis, E; Tinney, M; Preston, E; Zinke, A; Enst, S; Teichgraber, T; Janette, J; Reis, K; Janosch, S; Schloissnig, S; Ejsmont, RK; Slightam, C; Xu, X; Kim, SK; Reinke, V; Stewart, AF; Snyder, M; Waterston, RH; Hyman, AA				Sarov, Mihail; Murray, John I.; Schanze, Kristin; Pozniakovski, Andrei; Niu, Wei; Angermann, Karolin; Hasse, Susanne; Rupprecht, Michaela; Vinis, Elisabeth; Tinney, Matthew; Preston, Elicia; Zinke, Andrea; Enst, Susanne; Teichgraber, Tina; Janette, Judith; Reis, Kadri; Janosch, Stephan; Schloissnig, Siegfried; Ejsmont, Radoslaw K.; Slightam, Cindie; Xu, Xiao; Kim, Stuart K.; Reinke, Valerie; Stewart, A. Francis; Snyder, Michael; Waterston, Robert H.; Hyman, Anthony A.			A Genome-Scale Resource for In Vivo Tag-Based Protein Function Exploration in C. elegans	CELL			English	Article							CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; SYSTEMATIC ANALYSIS; POSTGENOMIC ERA; GLOBAL ANALYSIS; HIGH-THROUGHPUT; COMPLEXES; YEAST; FATE; RECOMBINATION	Understanding the in vivo dynamics of protein localization and their physical interactions is important for many problems in biology. To enable systematic protein function interrogation in a multicellular context, we built a genome-scale transgenic platform for in vivo expression of fluorescent-and affinity-tagged proteins in Caenorhabditis elegans under endogenous cis regulatory control. The platform combines computer-assisted transgene design, massively parallel DNA engineering, and next-generation sequencing to generate a resource of 14,637 genomic DNA transgenes, which covers 73% of the proteome. The multipurpose tag used allows any protein of interest to be localized in vivo or affinity purified using standard tag-based assays. We illustrate the utility of the resource by systematic chromatin immunopurification and automated 4D imaging, which produced detailed DNA binding and cell/tissue distribution maps for key transcription factor proteins.	[Sarov, Mihail; Schanze, Kristin; Angermann, Karolin; Hasse, Susanne; Rupprecht, Michaela; Vinis, Elisabeth; Tinney, Matthew; Reis, Kadri; Janosch, Stephan; Schloissnig, Siegfried] Max Planck Inst Mol Cell Biol & Genet, Transgene Unit, D-01307 Dresden, Germany; [Murray, John I.; Preston, Elicia; Waterston, Robert H.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Niu, Wei; Janette, Judith; Reinke, Valerie] Yale Univ, Dept Genet, New Haven, CT 06520 USA; [Slightam, Cindie; Xu, Xiao; Kim, Stuart K.] Stanford Univ, Med Ctr, Dept Dev Biol, Stanford, CA 94305 USA; [Snyder, Michael] Stanford Univ, Med Ctr, Dept Genet, Stanford, CA 94305 USA; [Stewart, A. Francis] Tech Univ Dresden, Dept Genom, D-01307 Dresden, Germany	Max Planck Society; University of Washington; University of Washington Seattle; Yale University; Stanford University; Stanford University; Technische Universitat Dresden	Sarov, M (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Transgene Unit, D-01307 Dresden, Germany.	sarov@mpi-cbg.de	Hyman, Anthony A/B-3917-2017; Hyman, Tony/F-1923-2011; Stewart, A. Francis/E-7789-2010	Hyman, Anthony A/0000-0003-3664-154X; Snyder, Michael/0000-0003-0784-7987; Ejsmont, Radoslaw/0000-0001-7176-7848; Reis, Kadri/0000-0002-2144-5856; Janosch, Stephan/0000-0002-2401-6862; Schloissnig, Siegfried/0000-0003-4574-8330	Max Planck Society Initiative "BAC TransgeneOmics"; NIH initiative "modENCODE"; NIH; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004263, U54HG007002, U01HG004267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072675] Funding Source: NIH RePORTER	Max Planck Society Initiative "BAC TransgeneOmics"; NIH initiative "modENCODE"; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The TransgeneOme project was partially funded by the Max Planck Society Initiative "BAC TransgeneOmics." The NIH initiative "modENCODE" funded grants to M.Sn. and R. H. W. J.I.M. was a fellow of the Jane Coffin Childs Memorial Fund for Medical Research and received funding from the NIH. A. F. S. is a shareholder of Gene Bridges GmbH, which holds the exclusive commercial rights to the Red/ET recombineering methodologies. M. Sa. holds the distribution rights for the transgenic constructs collection. M.Sn. is a member of the scientific advisory board of Personalis and Genapsys and is a consultant for Illumina.	Bao ZR, 2006, P NATL ACAD SCI USA, V103, P2707, DOI 10.1073/pnas.0511111103; Bates EA, 2006, J NEUROSCI, V26, P2830, DOI 10.1523/JNEUROSCI.3344-05.2006; BOWERMAN B, 1992, CELL, V68, P1061, DOI 10.1016/0092-8674(92)90078-Q; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CHEESEMAN IM, 2005, SCI STKE; CHEN LS, 1994, DEVELOPMENT, V120, P1631; Ciotta G, 2011, METHODS, V53, P113, DOI 10.1016/j.ymeth.2010.09.003; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Cowing D, 1996, NATURE, V382, P353, DOI 10.1038/382353a0; de Souza N, 2012, NAT METHODS, V9, P27, DOI 10.1038/nmeth.1848; Dolphin CT, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl352; Dunn RK, 2007, MOL CELL, V28, P708, DOI 10.1016/j.molcel.2007.11.022; Ejsmont RK, 2009, NAT METHODS, V6, P435, DOI [10.1038/NMETH.1334, 10.1038/nmeth.1334]; Ejsmont RK, 2011, METHODS MOL BIOL, V772, P445, DOI 10.1007/978-1-61779-228-1_26; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Fukushige T, 2005, DEVELOPMENT, V132, P1795, DOI 10.1242/dev.01774; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Greenwald I, 1998, GENE DEV, V12, P1751, DOI 10.1101/gad.12.12.1751; Hallam S, 2000, DEVELOPMENT, V127, P4239; Hillier LW, 2005, GENOME RES, V15, P1651, DOI 10.1101/gr.3729105; Hofemeister H, 2011, METHODS, V53, P437, DOI 10.1016/j.ymeth.2010.12.026; Huang JY, 2010, BBA-PROTEINS PROTEOM, V1804, P1645, DOI 10.1016/j.bbapap.2009.12.021; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Hunter CP, 1996, CELL, V87, P217, DOI 10.1016/S0092-8674(00)81340-9; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Janke DL, 1997, GENOME RES, V7, P974, DOI 10.1101/gr.7.10.974; Kelly WG, 1998, DEVELOPMENT, V125, P2451; KRAUSE M, 1990, CELL, V63, P907, DOI 10.1016/0092-8674(90)90494-Y; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Long FH, 2009, NAT METHODS, V6, P667, DOI [10.1038/NMETH.1366, 10.1038/nmeth.1366]; Murray JI, 2008, NAT METHODS, V5, P703, DOI 10.1038/nmeth.1228; Murray JI, 2012, GENOME RES, V22, P1282, DOI 10.1101/gr.131920.111; Muyrers JPP, 1999, NUCLEIC ACIDS RES, V27, P1555, DOI 10.1093/nar/27.6.1555; Nedelkova M, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr668; Niu W, 2011, GENOME RES, V21, P245, DOI 10.1101/gr.114587.110; Nov D, 2007, CURR OPIN BIOTECH, V18, P411, DOI 10.1016/j.copbio.2007.07.013; Petersen SC, 2011, J NEUROSCI, V31, P15362, DOI 10.1523/JNEUROSCI.3181-11.2011; Polanowska J, 2004, BIOTECHNIQUES, V36, P778, DOI 10.2144/04365BM05; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Pothof J, 2003, GENE DEV, V17, P443, DOI 10.1101/gad.1060703; Praitis V, 2001, GENETICS, V157, P1217; Priess James R, 2005, WormBook, P1; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Ristevski S, 2005, MOL BIOTECHNOL, V29, P153, DOI 10.1385/MB:29:2:153; Robert V, 2007, EMBO J, V26, P170, DOI 10.1038/sj.emboj.7601463; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Saarikangas J, 2009, CURR BIOL, V19, P95, DOI 10.1016/j.cub.2008.12.029; Saghatelian A, 2005, NAT CHEM BIOL, V1, P130, DOI 10.1038/nchembio0805-130; Sarov M, 2005, TRENDS BIOTECHNOL, V23, P446, DOI 10.1016/j.tibtech.2005.06.007; Sarov M, 2006, NAT METHODS, V3, P839, DOI 10.1038/nmeth933; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; STRUHL G, 1993, CELL, V74, P331, DOI 10.1016/0092-8674(93)90424-O; Tursun B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004625; Voutev R, 2009, FEBS LETT, V583, P456, DOI 10.1016/j.febslet.2008.12.046; Wilm T, 1999, GENE, V229, P31, DOI 10.1016/S0378-1119(99)00043-8; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417; Zhong M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000848	62	165	168	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 17	2012	150	4					855	866		10.1016/j.cell.2012.08.001	http://dx.doi.org/10.1016/j.cell.2012.08.001			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22901814	Green Accepted, Bronze			2022-12-24	WOS:000308002300018
J	Cocucci, E; Aguet, F; Boulant, S; Kirchhausen, T				Cocucci, Emanuele; Aguet, Francois; Boulant, Steeve; Kirchhausen, Tom			The First Five Seconds in the Life of a Clathrin-Coated Pit	CELL			English	Article							MEDIATED ENDOCYTOSIS; LIVING CELLS; DYNAMICS; ADAPTER; RECRUITMENT; ACTIN; MEMBRANE; PROTEINS; RECEPTOR; CARGO	Coated pits assemble by growth of a clathrin lattice, which is linked by adaptors to the underlying membrane. How does this process start? We used live-cell TIRF imaging with single-molecule EGFP sensitivity and high temporal resolution to detect arrival of the clathrin triskelions and AP2 adaptors that initiate coat assembly. Unbiased object identification and trajectory tracking, together with a statistical model, yield the arrival times and numbers of individual proteins, as well as experimentally confirmed estimates of the extent of substitution of endogenous by expressed, fluorescently tagged proteins. Pits initiate by coordinated arrival of clathrin and AP2, which is usually detected as two sequential steps, each of one triskelion with two adaptors. PI-4,5-P-2 is essential for initiation. The accessory proteins FCHo1/2 are not; instead, they are required for sustained growth. This objective picture of coated pit initiation also shows that methods outlined here will be broadly useful for studies of dynamic assemblies in living cells.	[Cocucci, Emanuele; Aguet, Francois; Boulant, Steeve; Kirchhausen, Tom] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Cocucci, Emanuele; Boulant, Steeve; Kirchhausen, Tom] Boston Childrens Hosp, Immune Dis Inst, Boston, MA 02115 USA; [Cocucci, Emanuele; Boulant, Steeve; Kirchhausen, Tom] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM)	Kirchhausen, T (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	kirchhausen@crystal.harvard.edu	Boulant, Steeve/W-3754-2019	Boulant, Steeve/0000-0001-8614-4993; Cocucci, Emanuele/0000-0002-0088-9845	NIH [GM-075252, GM-073165, U54 AI057159]; GlaxoSmithKline; Swiss National Science Foundation; Harvard Digestive Disease Consortium Feasibility Award; New England Regional Center of Excellence in Biodefense and Emerging Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073165, R01GM075252] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GlaxoSmithKline(GlaxoSmithKline); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Harvard Digestive Disease Consortium Feasibility Award; New England Regional Center of Excellence in Biodefense and Emerging Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM-075252 (T. K.), a GlaxoSmithKline Fellowship (E. C.), a Swiss National Science Foundation fellowship (F. A.) and partial support from NIH grant GM-073165 (to G. Danuser, Harvard Medical School) (F. A.), and a Harvard Digestive Disease Consortium Feasibility Award (S. B.). We thank E. Marino (supported by NIH grant U54 AI057159, New England Regional Center of Excellence in Biodefense and Emerging Infectious Diseases) for maintaining the imaging resources, G. Findlay for qtPCR determinations, Janet Iwasa for the graphical abstract, and S. C. Harrison for editorial assistance. We gratefully acknowledge G. Danuser, K. Jaqaman, S. C. Harrison, and members of the Kirchhausen lab for thought-provoking discussions. E. C. and T. K. designed experiments; E. C. and S. B. performed experiments; E. C. and F. A. designed and implemented the computational methods; and E. C. and F. A. analyzed data. E. C., F. A., and T. K. discussed the results and contributed to the final manuscript.	Antonescu CN, 2011, MOL BIOL CELL, V22, P2588, DOI 10.1091/mbc.E11-04-0362; Bocking T, 2011, NAT STRUCT MOL BIOL, V18, P295, DOI 10.1038/nsmb.1985; Boucrot E, 2006, EXP CELL RES, V312, P4036, DOI 10.1016/j.yexcr.2006.09.025; Boucrot E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010597; Boulant S, 2011, NAT CELL BIOL, V13, P1124, DOI 10.1038/ncb2307; Cureton DK, 2012, J VIROL, V86, P5330, DOI 10.1128/JVI.07194-11; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; Gaidarov I, 1999, NAT CELL BIOL, V1, P1, DOI 10.1038/8971; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Gottfried I, 2009, CELL MOL LIFE SCI, V66, P2897, DOI 10.1007/s00018-009-0077-4; Harrison SC, 2010, NATURE, V466, P1048, DOI 10.1038/4661048a; Henne WM, 2010, SCIENCE, V328, P1281, DOI 10.1126/science.1188462; Hinrichsen L, 2006, P NATL ACAD SCI USA, V103, P8715, DOI 10.1073/pnas.0600312103; Howarth M, 2008, NAT PROTOC, V3, P534, DOI 10.1038/nprot.2008.20; Howarth M, 2008, NAT METHODS, V5, P397, DOI [10.1038/nmeth.1206, 10.1038/NMETH.1206]; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; Jaqaman K, 2006, NAT REV MOL CELL BIO, V7, P813, DOI 10.1038/nrm2030; Kirchhausen T, 2009, TRENDS CELL BIOL, V19, P596, DOI 10.1016/j.tcb.2009.09.002; Lee DW, 2006, J CELL SCI, V119, P3502, DOI 10.1242/jcs.03092; Loerke D, 2011, TRAFFIC, V12, P815, DOI 10.1111/j.1600-0854.2011.01197.x; Loerke D, 2009, PLOS BIOL, V7, P628, DOI 10.1371/journal.pbio.1000057; Massol RH, 2006, P NATL ACAD SCI USA, V103, P10265, DOI 10.1073/pnas.0603369103; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Mettlen M, 2010, J CELL BIOL, V188, P919, DOI 10.1083/jcb.200908078; Miller SE, 2011, CELL, V147, P1118, DOI 10.1016/j.cell.2011.10.038; Nunez D, 2011, TRAFFIC, V12, P1868, DOI 10.1111/j.1600-0854.2011.01273.x; Rapoport I, 1997, EMBO J, V16, P2240, DOI 10.1093/emboj/16.9.2240; Reider A, 2009, EMBO J, V28, P3103, DOI 10.1038/emboj.2009.248; Saffarian S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000191; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Smith DA, 1998, PHILOS T R SOC B, V353, P1969, DOI 10.1098/rstb.1998.0348; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Tebar F, 1996, J BIOL CHEM, V271, P28727, DOI 10.1074/jbc.271.46.28727; Toshima JY, 2006, P NATL ACAD SCI USA, V103, P5793, DOI 10.1073/pnas.0601042103; Traub LM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000192; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Yu A, 2007, DEV CELL, V12, P129, DOI 10.1016/j.devcel.2006.10.015; Zoncu R, 2007, P NATL ACAD SCI USA, V104, P3793, DOI 10.1073/pnas.0611733104	41	237	238	1	73	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 3	2012	150	3					495	507		10.1016/j.cell.2012.05.047	http://dx.doi.org/10.1016/j.cell.2012.05.047			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	985WO	22863004	Green Accepted, Bronze			2022-12-24	WOS:000307301400010
J	Heckel, DG				Heckel, David G.			Insecticide Resistance After Silent Spring	SCIENCE			English	Editorial Material							BT COTTON; EVOLUTION; MUTATIONS; APHID		Max Planck Inst Chem Ecol, Dept Entomol, D-07745 Jena, Germany	Max Planck Society	Heckel, DG (corresponding author), Max Planck Inst Chem Ecol, Dept Entomol, Hans Knoll Str 8, D-07745 Jena, Germany.	heckel@ice.mpg.de	Heckel, David G/K-2138-2013	Heckel, David G/0000-0001-8991-2150				Bariami V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001692; Bass C, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-51; Beckie HJ, 2011, PEST MANAG SCI, V67, P1037, DOI 10.1002/ps.2195; Carson Rachel, 1994, SILENT SPRING; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; Devonshire AL, 1998, PHILOS T R SOC B, V353, P1677, DOI 10.1098/rstb.1998.0318; Downes S, 2012, J INVERTEBR PATHOL, V110, P281, DOI 10.1016/j.jip.2012.04.005; Ffrench-Constant RH, 2000, ANNU REV ENTOMOL, V45, P449, DOI 10.1146/annurev.ento.45.1.449; Guillette LJ, 2012, SCIENCE, V337, P1614, DOI 10.1126/science.1226985; James C., 2004, GLOBAL STATUS COMMER; Labbe P, 2007, PLOS GENET, V3, P2190, DOI 10.1371/journal.pgen.0030205; Mahon RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039192; Newcomb RD, 1997, P NATL ACAD SCI USA, V94, P7464, DOI 10.1073/pnas.94.14.7464; Perry T, 2012, PESTIC BIOCHEM PHYS, V102, P56, DOI 10.1016/j.pestbp.2011.10.010; Puinean AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000999; RAYMOND M, 1991, NATURE, V350, P151, DOI 10.1038/350151a0; Schmidt JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000998; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2011, NAT BIOTECHNOL, V29, P1128, DOI 10.1038/nbt.1988; Van Leeuwen T, 2008, P NATL ACAD SCI USA, V105, P5980, DOI 10.1073/pnas.0802224105; Van Leeuwen T, 2012, P NATL ACAD SCI USA, V109, P4407, DOI 10.1073/pnas.1200068109; Zhang HN, 2012, P NATL ACAD SCI USA, V109, P10275, DOI 10.1073/pnas.1200156109	22	134	141	6	146	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2012	337	6102					1613	1614		10.1126/science.1226994	http://dx.doi.org/10.1126/science.1226994			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	23019637	Green Submitted			2022-12-24	WOS:000309215400030
J	Redwine, WB; Hernandez-Lopez, R; Zou, SR; Huang, JL; Reck-Peterson, SL; Leschziner, AE				Redwine, William B.; Hernandez-Lopez, Rogelio; Zou, Sirui; Huang, Julie; Reck-Peterson, Samara L.; Leschziner, Andres E.			Structural Basis for Microtubule Binding and Release by Dynein	SCIENCE			English	Article							MOLECULAR-DYNAMICS; NUCLEOTIDE-BINDING; CRYSTAL-STRUCTURE; COILED-COIL; ACTIVATION; MICROSCOPY; MECHANISM; TRANSPORT; FAMILY; DOMAIN	Cytoplasmic dynein is a microtubule-based motor required for intracellular transport and cell division. Its movement involves coupling cycles of track binding and release with cycles of force-generating nucleotide hydrolysis. How this is accomplished given the similar to 25 nanometers separating dynein's track- and nucleotide-binding sites is not understood. Here, we present a subnanometer-resolution structure of dynein's microtubule-binding domain bound to microtubules by cryo-electron microscopy that was used to generate a pseudo-atomic model of the complex with molecular dynamics. We identified large rearrangements triggered by track binding and specific interactions, confirmed by mutagenesis and single-molecule motility assays, which tune dynein's affinity for microtubules. Our results provide a molecular model for how dynein's binding to microtubules is communicated to the rest of the motor.	[Redwine, William B.; Hernandez-Lopez, Rogelio; Leschziner, Andres E.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Redwine, William B.; Zou, Sirui; Huang, Julie; Reck-Peterson, Samara L.] Harvard Univ, Dept Cell Biol, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard Medical School	Leschziner, AE (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 52 Oxford St, Cambridge, MA 02138 USA.	aleschziner@mcb.harvard.edu	Zou, Sirui/R-1437-2017	Zou, Sirui/0000-0002-3282-6064; Reck-Peterson, Samara/0000-0002-1553-465X; Leschziner, Andres/0000-0002-7732-7023; Hernandez-Lopez, Rogelio/0000-0003-3968-4908	National Science Foundation [ECS-0335765]; Rita Allen Foundation; Harvard Armenise Foundation; NIH [1 DP2 OD004268-1]; Alfred P. Sloan Foundation; Consejo Nacional de Ciencia y Tecnologia; Fundacion Mexico en Harvard; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004268] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Rita Allen Foundation; Harvard Armenise Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Fundacion Mexico en Harvard; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. Carter (Laboratory of Molecular Biology-Medical Research Council) for reagents and advice, C. Sindelar (Yale), V. Ramey [University of California (UC)-Berkeley], E. Egelman (University of Virginia), and R. Sinkovits (UC-San Diego) for sharing processing scripts and helpful advice; M. Sotomayor (Harvard) and R. Gaudet (Harvard) for advice concerning MD; J. Hogle (Harvard), M. Strauss (Harvard), and M. Wolf (Harvard) for help with film and the use of a film scanner; and E. Nogales (UC-Berkeley), N. Francis (Harvard), and D. Pellman (Harvard) for critically reading the manuscript, as well as all the members of the Leschziner and Reck-Peterson Labs for advice and helpful discussions. EM data were collected at the Center for Nanoscale Systems (CNS), a member of the National Nanotechnology Infrastructure Network (NNIN), which is supported by the National Science Foundation under NSF award no. ECS-0335765. CNS is part of Harvard University. MD simulations were run on the Odyssey cluster supported by the Faculty of Arts and Sciences Science Division Research Computing Group, Harvard University. S.L.R.-P. is funded by the Rita Allen Foundation, the Harvard Armenise Foundation, and an NIH New Innovator award (1 DP2 OD004268-1). A.E.L. was funded in part by a Research Fellowship from the Alfred P. Sloan Foundation. R.H.-L. was supported in part by Consejo Nacional de Ciencia y Tecnologia and Fundacion Mexico en Harvard. The cryo-EM map was deposited at the EM Data Bank (EMDB-5439) and pseudo-atomic models at the Protein Data Bank (PDB-3J1T and -3J1U).	Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Carter AP, 2011, SCIENCE, V331, P1159, DOI 10.1126/science.1202393; Carter AP, 2008, SCIENCE, V322, P1691, DOI 10.1126/science.1164424; Dagenbach EM, 2004, J CELL SCI, V117, P3, DOI 10.1242/jcs.00875; Gee MA, 1997, NATURE, V390, P636, DOI 10.1038/37663; Gibbons IR, 2005, J BIOL CHEM, V280, P23960, DOI 10.1074/jbc.M501636200; GIBBONS IR, 1995, CELL MOTIL CYTOSKEL, V32, P136, DOI 10.1002/cm.970320214; GIBBONS IR, 1991, NATURE, V352, P640, DOI 10.1038/352640a0; Hook P, 2006, J CELL SCI, V119, P4369, DOI 10.1242/jcs.03176; Iomini C, 2001, J CELL BIOL, V153, P13, DOI 10.1083/jcb.153.1.13; Kon T, 2004, BIOCHEMISTRY-US, V43, P11266, DOI 10.1021/bi048985a; Kon T, 2012, NATURE, V484, P345, DOI 10.1038/nature10955; Kon T, 2011, NAT STRUCT MOL BIOL, V18, P638, DOI 10.1038/nsmb.2074; Kon T, 2009, NAT STRUCT MOL BIOL, V16, P325, DOI 10.1038/nsmb.1555; Koonce MP, 2000, MOL BIOL CELL, V11, P523, DOI 10.1091/mbc.11.2.523; Koonce MP, 1997, J BIOL CHEM, V272, P19714, DOI 10.1074/jbc.272.32.19714; Laib JA, 2009, P NATL ACAD SCI USA, V106, P3190, DOI 10.1073/pnas.0809849106; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; McNaughton L, 2010, J BIOL CHEM, V285, P15994, DOI 10.1074/jbc.M109.083535; Mizuno N, 2004, EMBO J, V23, P2459, DOI 10.1038/sj.emboj.7600240; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Reck-Peterson SL, 2004, P NATL ACAD SCI USA, V101, P1491, DOI 10.1073/pnas.2637011100; Roberts AJ, 2009, CELL, V136, P485, DOI 10.1016/j.cell.2008.11.049; SCHLITTER J, 1994, J MOL GRAPHICS, V12, P84, DOI 10.1016/0263-7855(94)80072-3; Shima T, 2006, P NATL ACAD SCI USA, V103, P17736, DOI 10.1073/pnas.0606794103; Sindelar CV, 2007, J CELL BIOL, V177, P377, DOI 10.1083/jcb.200612090; Sindelar CV, 2010, P NATL ACAD SCI USA, V107, P4111, DOI 10.1073/pnas.0911208107; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Trabuco LG, 2009, METHODS, V49, P174, DOI 10.1016/j.ymeth.2009.04.005; Uchimura S, 2010, EMBO J, V29, P1167, DOI 10.1038/emboj.2010.25; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; Vallee RB, 2009, TRENDS CELL BIOL, V19, P347, DOI 10.1016/j.tcb.2009.03.009; WANG Z., 2000, BIOPHYS J, V78, P1955; Wells DB, 2010, BIOPHYS J, V99, P629, DOI 10.1016/j.bpj.2010.04.038; Welte MA, 2004, CURR BIOL, V14, pR525, DOI 10.1016/j.cub.2004.06.045	36	113	113	0	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2012	337	6101					1532	1536		10.1126/science.1224151	http://dx.doi.org/10.1126/science.1224151			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007UC	22997337	Green Accepted, Green Published			2022-12-24	WOS:000308912900050
J	Venkatesh, S; Smolle, M; Li, H; Gogol, MM; Saint, M; Kumar, S; Natarajan, K; Workman, JL				Venkatesh, Swaminathan; Smolle, Michaela; Li, Hua; Gogol, Madelaine M.; Saint, Malika; Kumar, Shambhu; Natarajan, Krishnamurthy; Workman, Jerry L.			Set2 methylation of histone H3 lysine 36 suppresses histone exchange on transcribed genes	NATURE			English	Article							RNA-POLYMERASE-II; CHROMATIN; ACETYLATION; REGIONS; COMPLEX; DEACETYLATION; ELONGATION; HISTORIES; RECRUITS; DIRECTS	Set2-mediated methylation of histone H3 at Lys 36 (H3K36me) is a co-transcriptional event that is necessary for the activation of the Rpd3S histone deacetylase complex, thereby maintaining the coding region of genes in a hypoacetylated state(1,2). In the absence of Set2, H3K36 or Rpd3S acetylated histones accumulate on open reading frames (ORFs), leading to transcription initiation from cryptic promoters within ORFs(1,3). Although the co-transcriptional deacetylation pathway is well characterized, the factors responsible for acetylation are as yet unknown. Here we show that, in yeast, co-transcriptional acetylation is achieved in part by histone exchange over ORFs. In addition to its function of targeting and activating the Rpd3S complex, H3K36 methylation suppresses the interaction of H3 with histone chaperones, histone exchange over coding regions and the incorporation of new acetylated histones. Thus, Set2 functions both to suppress the incorporation of acetylated histones and to signal for the deacetylation of these histones in transcribed genes. By suppressing spurious cryptic transcripts from initiating within ORFs, this pathway is essential to maintain the accuracy of transcription by RNA polymerase II.	[Venkatesh, Swaminathan; Smolle, Michaela; Li, Hua; Gogol, Madelaine M.; Workman, Jerry L.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Saint, Malika; Kumar, Shambhu; Natarajan, Krishnamurthy] Jawarharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India	Stowers Institute for Medical Research; Jawaharlal Nehru University, New Delhi	Workman, JL (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	jlw@stowers.org	Kumar, Shambhu/K-1260-2019	Kumar, Shambhu/0000-0003-1225-1790; Smolle, Michaela/0000-0001-8900-1541; Gogol, Madelaine/0000-0002-8738-0995; Saint, Malika/0000-0001-7509-0619; Venkatesh, Swaminathan/0000-0001-9837-1501	National Institutes of Health [R01GM04867]; Stowers Institute for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047867] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stowers Institute for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank F. Winston and O. Rando for providing yeast strains used in this study, members of the Workman laboratory for discussion, and J. Chatfield and G. Dialynas for critical reading of our manuscript. This work was supported by National Institutes of Health grant R01GM04867 to J. L. W. and the Stowers Institute for Medical Research.	Adkins MW, 2006, MOL CELL, V21, P405, DOI 10.1016/j.molcel.2005.12.010; Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Ai X, 2004, MOL CELL, V14, P195, DOI 10.1016/S1097-2765(04)00184-4; Arnold KM, 2011, BIOCHEMISTRY-US, V50, P727, DOI 10.1021/bi101355a; Burgess RJ, 2010, MOL CELL, V37, P469, DOI 10.1016/j.molcel.2010.01.020; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Cheung V, 2008, PLOS BIOL, V6, P2550, DOI 10.1371/journal.pbio.0060277; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Drouin S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001173; Duina AA, 2004, MOL CELL BIOL, V24, P561, DOI 10.1128/MCB.24.2.561-572.2004; Fillingham J, 2008, MOL CELL BIOL, V28, P4342, DOI 10.1128/MCB.00182-08; Govind CK, 2010, MOL CELL, V39, P234, DOI 10.1016/j.molcel.2010.07.003; Hewawasam G, 2010, MOL CELL, V40, P444, DOI 10.1016/j.molcel.2010.10.014; Jamai A, 2009, MOL CELL, V35, P377, DOI 10.1016/j.molcel.2009.07.001; Kaplan T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000270; Katan-Khaykovich Y, 2011, P NATL ACAD SCI USA, V108, P1296, DOI 10.1073/pnas.1018308108; Kim T, 2009, CELL, V137, P259, DOI 10.1016/j.cell.2009.02.045; Kristjuhan A, 2004, EMBO J, V23, P4243, DOI 10.1038/sj.emboj.7600433; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Li B, 2007, GENE DEV, V21, P1422, DOI 10.1101/gad.1539307; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Lin LJ, 2010, MOL CELL BIOL, V30, P1116, DOI 10.1128/MCB.01229-09; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Mosley AL, 2009, MOL CELL, V34, P168, DOI 10.1016/j.molcel.2009.02.025; Nakanishi S, 2008, NAT STRUCT MOL BIOL, V15, P881, DOI 10.1038/nsmb.1454; Pattenden SG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012927; Rufiange A, 2007, MOL CELL, V27, P393, DOI 10.1016/j.molcel.2007.07.011; Schwabish MA, 2004, MOL CELL BIOL, V24, P10111, DOI 10.1128/MCB.24.23.10111-10117.2004; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tsubota T, 2007, MOL CELL, V25, P703, DOI 10.1016/j.molcel.2007.02.006; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4; Williams SK, 2008, P NATL ACAD SCI USA, V105, P9000, DOI 10.1073/pnas.0800057105; Workman JL, 2006, GENE DEV, V20, P2009, DOI 10.1101/gad.1435706	35	213	220	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2012	489	7416					452	U145		10.1038/nature11326	http://dx.doi.org/10.1038/nature11326			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	007AK	22914091				2022-12-24	WOS:000308860900050
J	Yang, JY; Zhao, XB; Cheng, K; Du, HY; Ouyang, YD; Chen, JJ; Qiu, SQ; Huang, JY; Jiang, YH; Jiang, LW; Ding, JH; Wang, J; Xu, CG; Li, XH; Zhang, QF				Yang, Jiangyi; Zhao, Xiaobo; Cheng, Ke; Du, Hongyi; Ouyang, Yidan; Chen, Jiongjiong; Qiu, Shuqing; Huang, Jianyan; Jiang, Yunhe; Jiang, Liwen; Ding, Jihua; Wang, Jia; Xu, Caiguo; Li, Xianghua; Zhang, Qifa			A Killer-Protector System Regulates Both Hybrid Sterility and Segregation Distortion in Rice	SCIENCE			English	Article							PROGRAMMED CELL-DEATH; INDICA-JAPONICA HYBRIDS; ORYZA-SATIVA L.; WIDE-COMPATIBILITY; REPRODUCTIVE BARRIER; S-5 LOCUS; GENE; INCOMPATIBILITY; ARABIDOPSIS; STRESS	Hybrid sterility is a major form of postzygotic reproductive isolation that restricts gene flow between populations. Cultivated rice (Oryza sativa L.) consists of two subspecies, indica and japonica; inter-subspecific hybrids are usually sterile. We show that a killer-protector system at the S5 locus encoded by three tightly linked genes [Open Reading Frame 3 (ORF3) to ORF5] regulates fertility in indica-japonica hybrids. During female sporogenesis, the action of ORF5+ (killer) and ORF4+ (partner) causes endoplasmic reticulum (ER) stress. ORF3+ (protector) prevents ER stress and produces normal gametes, but ORF3- cannot prevent ER stress, resulting in premature programmed cell death and leads to embryo-sac abortion. Preferential transmission of ORF3+ gametes results in segregation distortion in the progeny. These results add to our understanding of differences between indica and japonica rice and may aid in rice genetic improvement.	[Yang, Jiangyi; Zhao, Xiaobo; Cheng, Ke; Du, Hongyi; Ouyang, Yidan; Chen, Jiongjiong; Qiu, Shuqing; Huang, Jianyan; Jiang, Yunhe; Ding, Jihua; Wang, Jia; Xu, Caiguo; Li, Xianghua; Zhang, Qifa] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Peoples R China; [Yang, Jiangyi; Zhao, Xiaobo; Cheng, Ke; Du, Hongyi; Ouyang, Yidan; Chen, Jiongjiong; Qiu, Shuqing; Huang, Jianyan; Jiang, Yunhe; Ding, Jihua; Wang, Jia; Xu, Caiguo; Li, Xianghua; Zhang, Qifa] Huazhong Agr Univ, Natl Ctr Plant Gene Res, Wuhan 430070, Peoples R China; [Jiang, Liwen] Chinese Univ Hong Kong, Sch Life Sci, Shatin 999077, Hong Kong, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Chinese University of Hong Kong	Zhang, QF (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Peoples R China.	qifazh@mail.hzau.edu.cn	Zhao, Xiaobo/K-4182-2012; Yang, Jiangyi/J-5383-2013; Zhao, Xiaobo/AAR-3217-2021; Zhao, Xiaobo/AAZ-5503-2021; JIANG, Liwen/S-6046-2018	Zhao, Xiaobo/0000-0002-6012-0261; JIANG, Liwen/0000-0002-7829-1472; Jiang, Yunhe/0000-0002-7599-1422; Yang, Jiangyi/0000-0002-5626-1037	National Natural Science Foundation [31130032, 30921091]; 863 Project [2012AA100103]; 111 Project of China [B07041]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); 863 Project(National High Technology Research and Development Program of China); 111 Project of China(Ministry of Education, China - 111 Project)	We thank D. S. Brar of the International Rice Research Institute for providing the rice seeds, and S. Luan of University of California, Berkeley, USA for discussion. This research was supported by grants from the National Natural Science Foundation (31130032 and 30921091), the 863 Project (2012AA100103), and the 111 Project (B07041) of China. All of the DNA sequences obtained in this study have been deposited in the GenBank from accession codes JX138498 to JX138505. A patent for the ORF5 sequence has been approved by the State Intellectual Property Office of China (ZL200710053552.9).	Alcazar R, 2009, P NATL ACAD SCI USA, V106, P334, DOI 10.1073/pnas.0811734106; Bikard D, 2009, SCIENCE, V323, P623, DOI 10.1126/science.1165917; Blanvillain R, 2011, EMBO J, V30, P1173, DOI 10.1038/emboj.2011.14; Bomblies K, 2007, NAT REV GENET, V8, P382, DOI 10.1038/nrg2082; Bomblies K, 2010, ANNU REV PLANT BIOL, V61, P109, DOI 10.1146/annurev-arplant-042809-112146; Burt A, 2006, GENES CONFLICT BIOL; Chen JJ, 2008, P NATL ACAD SCI USA, V105, P11436, DOI 10.1073/pnas.0804761105; Coyne JA, 2004, SPECIATION, V37; Du HY, 2011, NEW PHYTOL, V191, P275, DOI 10.1111/j.1469-8137.2011.03691.x; Hayashi S, 2012, PLANT J, V69, P946, DOI 10.1111/j.1365-313X.2011.04844.x; Ikehashi H., 1986, Rice genetics. Proceedings of the International Rice Genetics Symposium, 27-31 May, 1985, Manila, Philippines., P119, DOI 10.1142/9789812814265_0011; Koide Y, 2008, GENETICS, V180, P409, DOI 10.1534/genetics.108.090126; Lee S, 2004, PLANT MOL BIOL, V54, P755, DOI 10.1023/B:PLAN.0000040904.15329.29; Li H, 2011, PLANT PHYSIOL, V156, P615, DOI 10.1104/pp.111.175760; Liu KD, 1996, EUPHYTICA, V90, P275, DOI 10.1007/BF00027476; Liu KD, 1997, THEOR APPL GENET, V95, P809, DOI 10.1007/s001220050629; Long YM, 2008, P NATL ACAD SCI USA, V105, P18871, DOI 10.1073/pnas.0810108105; LYTTLE TW, 1991, ANNU REV GENET, V25, P511, DOI 10.1146/annurev.ge.25.120191.002455; Matsumura H, 2003, PLANT J, V33, P425, DOI 10.1046/j.1365-313X.2003.01639.x; Mizuta Y, 2010, P NATL ACAD SCI USA, V107, P20417, DOI 10.1073/pnas.1003124107; Oono Y, 2010, PLANT BIOTECHNOL J, V8, P691, DOI 10.1111/j.1467-7652.2010.00502.x; Ouyang YD, 2010, CURR OPIN PLANT BIOL, V13, P186, DOI 10.1016/j.pbi.2010.01.002; Ouyang YD, 2009, CHINESE SCI BULL, V54, P2332, DOI 10.1007/s11434-009-0371-4; Pontier D, 1998, MOL PLANT MICROBE IN, V11, P544, DOI 10.1094/MPMI.1998.11.6.544; Qiu SQ, 2005, THEOR APPL GENET, V111, P1080, DOI 10.1007/s00122-005-0033-0; Wakasa Y, 2011, PLANT J, V65, P675, DOI 10.1111/j.1365-313X.2010.04453.x; Wang CM, 2005, GENET RES, V86, P97, DOI 10.1017/S0016672305007779; Wang L, 2010, PLANT J, V61, P752, DOI 10.1111/j.1365-313X.2009.04100.x; Watanabe N, 2008, J BIOL CHEM, V283, P3200, DOI 10.1074/jbc.M706659200; Yamagata Y, 2010, P NATL ACAD SCI USA, V107, P1494, DOI 10.1073/pnas.0908283107; YANAGIHARA S, 1995, THEOR APPL GENET, V90, P182, DOI 10.1007/BF00222200; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4	32	171	210	14	262	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2012	337	6100					1336	1340		10.1126/science.1223702	http://dx.doi.org/10.1126/science.1223702			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	004TW	22984070				2022-12-24	WOS:000308705000041
J	Gerbode, SJ; Puzey, JR; McCormick, AG; Mahadevan, L				Gerbode, Sharon J.; Puzey, Joshua R.; McCormick, Andrew G.; Mahadevan, L.			How the Cucumber Tendril Coils and Overwinds	SCIENCE			English	Article							GELATINOUS FIBERS; CLIMBING PLANTS; CURVATURE; GENERATION; PERVERSION; MECHANISM; HELIX; FORCE; WOOD	The helical coiling of plant tendrils has fascinated scientists for centuries, yet the underlying mechanism remains elusive. Moreover, despite Darwin's widely accepted interpretation of coiled tendrils as soft springs, their mechanical behavior remains unknown. Our experiments on cucumber tendrils demonstrate that tendril coiling occurs via asymmetric contraction of an internal fiber ribbon of specialized cells. Under tension, both extracted fiber ribbons and old tendrils exhibit twistless overwinding rather than unwinding, with an initially soft response followed by strong strain-stiffening at large extensions. We explain this behavior using physical models of prestrained rubber strips, geometric arguments, and mathematical models of elastic filaments. Collectively, our study illuminates the origin of tendril coiling, quantifies Darwin's original proposal, and suggests designs for biomimetic twistless springs with tunable mechanical responses.	[Gerbode, Sharon J.; Mahadevan, L.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Gerbode, Sharon J.; Mahadevan, L.] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA; [Gerbode, Sharon J.] Harvey Mudd Coll, Dept Phys, Claremont, CA 91711 USA; [Puzey, Joshua R.; Mahadevan, L.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [McCormick, Andrew G.; Mahadevan, L.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Harvard University; Claremont Colleges; Harvey Mudd College; Harvard University; Harvard University	Mahadevan, L (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	lm@seas.harvard.edu		Puzey, Joshua/0000-0001-8019-9993	MacArthur Foundation; Wyss Institute; Kavli Institute	MacArthur Foundation; Wyss Institute; Kavli Institute	This research was supported by funding from the MacArthur Foundation, the Wyss Institute, and the Kavli Institute. S.J.G., J.R.P., and L. M. designed the study. S.J.G., J.R.P., A. G. M., and L. M. conducted the research. S.J.G. and J.R.P. performed the biological and biophysical experiments. S.J.G., A. G. M., and L. M. handled biophysical theory. S.J.G., J.R.P., A. G. M., and L. M. contributed analytical tools and reagents and analyzed data. S.J.G., J.R.P., and L. M. wrote the paper. Harvard University has filed a patent application relating to a tunable, twistless overwinding spring based on the results of this study.	Armon S, 2011, SCIENCE, V333, P1726, DOI 10.1126/science.1203874; Bowling AJ, 2009, AM J BOT, V96, P719, DOI 10.3732/ajb.0800373; Chen Z, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3530441; Darwin C., 1865, MOVEMENTS HABITS CLI; Dastur RH, 1931, ANN BOT-LONDON, V45, P279; Goriely A, 1998, PHYS REV LETT, V80, P1564, DOI 10.1103/PhysRevLett.80.1564; Goswami L, 2008, PLANT J, V56, P531, DOI 10.1111/j.1365-313X.2008.03617.x; Gray A., 1880, STRUCTURAL BOT ORGAN; Isnard S, 2009, AM J BOT, V96, P1205, DOI 10.3732/ajb.0900045; Isnard S, 2009, P R SOC B, V276, P2643, DOI 10.1098/rspb.2009.0380; JAFFE MJ, 1968, ANN REV PLANT PHYSIO, V19, P417, DOI 10.1146/annurev.pp.19.060168.002221; Keller J.B., 1980, LECT MATH LIFE SCI, V13, P257; Lisk H, 1924, BOT GAZ, V78, P85, DOI 10.1086/333357; Love AEH, 1944, TREATISE MATH THEORY, V4; MacDougal DT., 1896, ANN BOT-LONDON, V10, P373; McMillen T, 2002, J NONLINEAR SCI, V12, P241, DOI 10.1007/s00332-002-0493-1; Meloche CG, 2007, PLANTA, V225, P485, DOI 10.1007/s00425-006-0363-4; Nath U, 2003, SCIENCE, V299, P1404, DOI 10.1126/science.1079354; Savin T, 2011, NATURE, V476, P57, DOI 10.1038/nature10277; Scher JL, 2001, PLANTA, V213, P192, DOI 10.1007/s004250000503; SILK WK, 1978, AM J BOT, V65, P310, DOI 10.2307/2442271; Von Mohl H, 1852, PRINCIPLES ANATOMY P; WILSON BF, 1977, ANNU REV PLANT PHYS, V28, P23, DOI 10.1146/annurev.pp.28.060177.000323	23	261	265	27	256	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2012	337	6098					1087	1091		10.1126/science.1223304	http://dx.doi.org/10.1126/science.1223304			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	996WP	22936777	Green Published			2022-12-24	WOS:000308125800045
J	Emlen, DJ; Warren, IA; Johns, A; Dworkin, I; Lavine, LC				Emlen, Douglas J.; Warren, Ian A.; Johns, Annika; Dworkin, Ian; Lavine, Laura Corley			A Mechanism of Extreme Growth and Reliable Signaling in Sexually Selected Ornaments and Weapons	SCIENCE			English	Article							STATIC ALLOMETRY; CONDITION DEPENDENCE; HANDICAP PRINCIPLE; EVOLUTION; SIZE; SHAPE; EXPRESSION; PATTERNS; CAPTURE; TRAITS	Many male animals wield ornaments or weapons of exaggerated proportions. We propose that increased cellular sensitivity to signaling through the insulin/insulin-like growth factor (IGF) pathway may be responsible for the extreme growth of these structures. We document how rhinoceros beetle horns, a sexually selected weapon, are more sensitive to nutrition and more responsive to perturbation of the insulin/IGF pathway than other body structures. We then illustrate how enhanced sensitivity to insulin/IGF signaling in a growing ornament or weapon would cause heightened condition sensitivity and increased variability in expression among individuals-critical properties of reliable signals of male quality. The possibility that reliable signaling arises as a by-product of the growth mechanism may explain why trait exaggeration has evolved so many different times in the context of sexual selection.	[Emlen, Douglas J.; Johns, Annika] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Warren, Ian A.; Lavine, Laura Corley] Washington State Univ, Dept Entomol, Pullman, WA 99164 USA; [Dworkin, Ian] Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA	University of Montana System; University of Montana; Washington State University; Michigan State University	Emlen, DJ (corresponding author), Univ Montana, Div Biol Sci, 104 Hlth Sci Bldg, Missoula, MT 59812 USA.	doug.emlen@mso.umt.edu		Lavine, Laura/0000-0002-0262-359X; Dworkin, Ian/0000-0002-2874-287X	National Science Foundation [IOS-0919781, IOS-0919730, IOS-0920142]; Direct For Biological Sciences [0919781] Funding Source: National Science Foundation; Division Of Integrative Organismal Systems [0920142] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank C. E. Allen, C. Breuner, K. L. Bright, S. T. Emlen, E. McCullough, A. Perkins, A. Shingleton, and three anonymous reviewers for helpful comments on the manuscript; Y. Hongo, H. Gotoh, and N. Kubota for help purchasing beetles; E. Paul (Echo Medical Media) for artwork on Figs. 1B, 2, and 3; and the National Science Foundation (IOS-0919781, IOS-0919730, and IOS-0920142) for funding. Images in Fig. 1A used under license from Shutterstock.com (rhinoceros beetle, NH; widowbird, Simon_g; elk, W. Aston; stag beetle, H. Larsson; fiddler crab, Manamana). Sequences are deposited in GenBank (accession nos. JX141307 to JX141311).	ALATALO RV, 1988, BIOL J LINN SOC, V34, P363, DOI 10.1111/j.1095-8312.1988.tb01969.x; ANDERSSON M, 1986, EVOLUTION, V40, P804, DOI 10.1111/j.1558-5646.1986.tb00540.x; Bonduriansky R, 2005, EVOLUTION, V59, P138, DOI 10.1111/j.0014-3820.2005.tb00901.x; Bonduriansky R, 2003, EVOLUTION, V57, P2450, DOI 10.1111/j.0014-3820.2003.tb01490.x; Bonduriansky R, 2007, AM NAT, V169, P9, DOI 10.1086/510214; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; Cotton S, 2004, P ROY SOC B-BIOL SCI, V271, P771, DOI 10.1098/rspb.2004.2688; Cotton S, 2004, EVOLUTION, V58, P1038, DOI 10.1111/j.0014-3820.2004.tb00437.x; Cuervo JJ, 2009, J EVOLUTION BIOL, V22, P1503, DOI 10.1111/j.1420-9101.2009.01758.x; Darwin G., 1871, P423; ENQUIST M, 1983, J THEOR BIOL, V102, P387, DOI 10.1016/0022-5193(83)90376-4; Fitzpatrick S, 1997, BIOL J LINN SOC, V62, P145; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; Husak JF, 2011, BEHAVIOUR, V148, P1, DOI 10.1163/000579510X541265; Iwasa Y, 1999, J THEOR BIOL, V200, P97, DOI 10.1006/jtbi.1999.0979; JOHNSTONE RA, 1995, BIOL REV, V70, P1, DOI 10.1111/j.1469-185X.1995.tb01439.x; Knell RJ, 1999, ECOL ENTOMOL, V24, P323, DOI 10.1046/j.1365-2311.1999.00200.x; Kodric-Brown A, 2006, P NATL ACAD SCI USA, V103, P8733, DOI 10.1073/pnas.0602994103; Kotiaho JS, 2001, BIOL REV, V76, P365, DOI 10.1017/S1464793101005711; Lorch PD, 2003, EVOL ECOL RES, V5, P867; Oufiero CE, 2007, FUNCT ECOL, V21, P676, DOI 10.1111/j.1365-2435.2007.01259.x; PARKER GA, 1974, J THEOR BIOL, V47, P223, DOI 10.1016/0022-5193(74)90111-8; POMIANKOWSKI A, 1987, PROC R SOC SER B-BIO, V231, P123, DOI 10.1098/rspb.1987.0038; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; Searcy W.N.S, 2005, EVOLUTION ANIMAL COM; Shingleton AW, 2008, P ROY SOC B-BIOL SCI, V275, P1875, DOI 10.1098/rspb.2008.0227; Shingleton AW, 2007, BIOESSAYS, V29, P536, DOI 10.1002/bies.20584; Shingleton AW, 2005, PLOS BIOL, V3, P1607, DOI 10.1371/journal.pbio.0030289; Smith JM, 2004, ANIMAL SIGNALS, V1; Tang HY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002373; Tomkins JL, 2004, TRENDS ECOL EVOL, V19, P323, DOI 10.1016/j.tree.2004.03.029; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	32	317	321	7	232	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2012	337	6096					860	864		10.1126/science.1224286	http://dx.doi.org/10.1126/science.1224286			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	989BQ	22837386				2022-12-24	WOS:000307535600048
J	Gudjonsson, T; Altmeyer, M; Savic, V; Toledo, L; Dinant, C; Grofte, M; Bartkova, J; Poulsen, M; Oka, Y; Bekker-Jensen, S; Mailand, N; Neumann, B; Heriche, JK; Shearer, R; Saunders, D; Bartek, J; Lukas, J; Lukas, C				Gudjonsson, Thorkell; Altmeyer, Matthias; Savic, Velibor; Toledo, Luis; Dinant, Christoffel; Grofte, Merete; Bartkova, Jirina; Poulsen, Maria; Oka, Yasuyoshi; Bekker-Jensen, Simon; Mailand, Niels; Neumann, Beate; Heriche, Jean-Karim; Shearer, Robert; Saunders, Darren; Bartek, Jiri; Lukas, Jiri; Lukas, Claudia			TRIP12 and UBR5 Suppress Spreading of Chromatin Ubiquitylation at Damaged Chromosomes	CELL			English	Article							E3 UBIQUITIN LIGASE; DOUBLE-STRAND BREAKS; END RULE PATHWAY; DNA-DAMAGE; HOMOLOGOUS RECOMBINATION; GENOMIC INSTABILITY; S-PHASE; 53BP1; REPAIR; EDD	Histone ubiquitylation is a prominent response to DNA double-strand breaks (DSBs), but how these modifications are confined to DNA lesions is not understood. Here, we show that TRIP12 and UBR5, two HECT domain ubiquitin E3 ligases, control accumulation of RNF168, a rate-limiting component of a pathway that ubiquitylates histones after DNA breakage. We find that RNF168 can be saturated by increasing amounts of DSBs. Depletion of TRIP12 and UBR5 allows accumulation of RNF168 to supra-physiological levels, followed by massive spreading of ubiquitin conjugates and hyperaccumulation of ubiquitin-regulated genome caretakers such as 53BP1 and BRCA1. Thus, regulatory and proteolytic ubiquitylations are wired in a self-limiting circuit that promotes histone ubiquitylation near the DNA lesions but at the same time counteracts its excessive spreading to undamaged chromosomes. We provide evidence that this mechanism is vital for the homeostasis of ubiquitin-controlled events after DNA breakage and can be subverted during tumorigenesis.	[Gudjonsson, Thorkell; Altmeyer, Matthias; Savic, Velibor; Toledo, Luis; Grofte, Merete; Lukas, Jiri; Lukas, Claudia] Danish Canc Soc Res Ctr, Chromosome Biol Unit, DK-2100 Copenhagen, Denmark; [Dinant, Christoffel; Bartkova, Jirina; Bartek, Jiri] Danish Canc Soc Res Ctr, Genome Integr Unit, DK-2100 Copenhagen, Denmark; [Dinant, Christoffel; Bartkova, Jirina; Bartek, Jiri] Ctr Genotox Stress Res, DK-2100 Copenhagen, Denmark; [Poulsen, Maria; Oka, Yasuyoshi; Bekker-Jensen, Simon; Mailand, Niels; Lukas, Jiri] Univ Copenhagen, Novo Nordisk Fdn, Ctr Prot Res, DK-2200 Copenhagen, Denmark; [Neumann, Beate; Heriche, Jean-Karim] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Shearer, Robert; Saunders, Darren] Univ New S Wales, Canc Res Program, Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia; [Shearer, Robert; Saunders, Darren] Univ New S Wales, St Vincents Clin Sch, Fac Med, Darlinghurst, NSW 2010, Australia; [Bartek, Jiri] Palacky Univ, Fac Med, Inst Mol & Translat Med, CZ-77515 Olomouc, Czech Republic	Danish Cancer Society; Danish Cancer Society; Novo Nordisk Foundation; University of Copenhagen; European Molecular Biology Laboratory (EMBL); Garvan Institute of Medical Research; University of New South Wales Sydney; University of New South Wales Sydney; Palacky University Olomouc	Lukas, J (corresponding author), Danish Canc Soc Res Ctr, Chromosome Biol Unit, Strandblvd 49, DK-2100 Copenhagen, Denmark.	jiri.lukas@cpr.ku.dk	Saunders, Darren/B-7677-2008; Toledo, Luis/M-6685-2019; Bartek, Jiri/G-5870-2014; Toledo, Luis/R-2065-2016; Altmeyer, Matthias/AAE-8186-2019	Toledo, Luis/0000-0001-9509-9944; Toledo, Luis/0000-0001-9509-9944; Altmeyer, Matthias/0000-0003-3780-1170; Gudjonsson, Thorarinn/0000-0001-9645-9665; Dinant, Christoffel/0000-0001-7531-183X; Lukas, Jiri/0000-0001-9087-506X; Neumann, Beate/0000-0002-6899-502X; Lukas, Claudia/0000-0001-7169-6883; Savic, Velibor/0000-0002-4830-3591; Bekker-Jensen, Simon/0000-0002-7308-4597; Heriche, Jean-Karim/0000-0001-6867-9425; Saunders, Darren/0000-0003-0924-0513; Gudjonsson, Thorkell/0000-0002-5230-4263	Danish Cancer Society; Danish National Research Foundation; Lundbeck Foundation [R44-A4400]; Novo Nordisk Foundation; Danish Council for Independent Research-Medical Sciences; John and Birthe Meyer Foundation; European Commission (DDR Response, Biomedreg, and Infla-Care); Cancer Institute NSW; NSW Office of Science and Medical Research; EMBO fellowships	Danish Cancer Society(Danish Cancer Society); Danish National Research Foundation(Danmarks Grundforskningsfond); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Council for Independent Research-Medical Sciences(Det Frie Forskningsrad (DFF)); John and Birthe Meyer Foundation; European Commission (DDR Response, Biomedreg, and Infla-Care)(European Commission); Cancer Institute NSW; NSW Office of Science and Medical Research; EMBO fellowships	We thank D. Durocher, X. Yu, T. Halazonetis, E. Soutoglou, J. Lippincott Schwartz, S. Watanabe, T. Kohno, and R. Strauss for reagents and technical advice, and we thank members of the Center Genotoxic Stress Research for helpful discussions. This work was supported by the Danish Cancer Society, the Danish National Research Foundation, the Lundbeck Foundation (R44-A4400), the Novo Nordisk Foundation, the Danish Council for Independent Research-Medical Sciences, the John and Birthe Meyer Foundation, European Commission (DDR Response, Biomedreg, and Infla-Care), Cancer Institute NSW, and the NSW Office of Science and Medical Research. M. A., L. T., and C. D. are recipients of long-term EMBO fellowships. Special thanks go to Jan Ellenberg, Rainer Pepperkok, and the Advanced Light Microscopy Facility (ALMF) at EMBL, Heidelberg, for generously supporting this project and for providing the siRNA arrays.	Acs K, 2011, NAT STRUCT MOL BIOL, V18, P1345, DOI 10.1038/nsmb.2188; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Bekker-Jensen S, 2010, NAT CELL BIOL, V12, P80, DOI 10.1038/ncb2008; Bothmer A, 2011, MOL CELL, V42, P319, DOI 10.1016/j.molcel.2011.03.019; Bothmer A, 2010, J EXP MED, V207, P855, DOI 10.1084/jem.20100244; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Bunting SF, 2012, MOL CELL, V46, P125, DOI 10.1016/j.molcel.2012.02.015; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Cao L, 2009, MOL CELL, V35, P534, DOI 10.1016/j.molcel.2009.06.037; Chen DL, 2010, NATURE, V464, P624, DOI 10.1038/nature08820; Clancy JL, 2003, ONCOGENE, V22, P5070, DOI 10.1038/sj.onc.1206775; Coleman KA, 2011, J BIOL CHEM, V286, P13669, DOI 10.1074/jbc.M110.213728; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Goodarzi AA, 2010, DNA REPAIR, V9, P1273, DOI 10.1016/j.dnarep.2010.09.013; Harrigan JA, 2011, J CELL BIOL, V193, P97, DOI 10.1083/jcb.201011083; Henderson MJ, 2006, J BIOL CHEM, V281, P39990, DOI 10.1074/jbc.M602818200; Henderson MJ, 2002, J BIOL CHEM, V277, P26468, DOI 10.1074/jbc.M203527200; Hu YD, 2011, GENE DEV, V25, P685, DOI 10.1101/gad.2011011; Hwang CS, 2010, NAT CELL BIOL, V12, P1177, DOI 10.1038/ncb2121; Hwang CS, 2009, P NATL ACAD SCI USA, V106, P2142, DOI 10.1073/pnas.0812316106; Keppler BR, 2010, J BIOL CHEM, V285, P35665, DOI 10.1074/jbc.M110.173997; Lau IF, 2003, MOL MICROBIOL, V49, P731, DOI 10.1046/j.1365-2958.2003.03640.x; Lilley CE, 2010, EMBO J, V29, P943, DOI 10.1038/emboj.2009.400; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Matsuda K, 2011, HISTOPATHOLOGY, V59, P441, DOI 10.1111/j.1365-2559.2011.03963.x; Meerang M, 2011, NAT CELL BIOL, V13, P1376, DOI 10.1038/ncb2367; Moudry P, 2012, CELL DEATH DIFFER, V19, P798, DOI 10.1038/cdd.2011.150; Munoz MA, 2007, CELL CYCLE, V6, P3070, DOI 10.4161/cc.6.24.5021; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Nicassio F, 2007, CURR BIOL, V17, P1972, DOI 10.1016/j.cub.2007.10.034; O'Brien PM, 2008, BRIT J CANCER, V98, P1085, DOI 10.1038/sj.bjc.6604281; Park Y, 2008, BIOCHEM BIOPH RES CO, V374, P294, DOI 10.1016/j.bbrc.2008.07.019; Pegoraro G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031684; Peuscher MH, 2011, NAT CELL BIOL, V13, P1139, DOI 10.1038/ncb2326; Pinato S, 2011, MOL CELL BIOL, V31, P118, DOI 10.1128/MCB.00818-10; Poulsen M, 2012, J CELL BIOL, V197, P189, DOI 10.1083/jcb.201109100; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Shao G, 2009, P NATL ACAD SCI USA, V106, P3166, DOI 10.1073/pnas.0807485106; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Varshavsky A, 2011, PROTEIN SCI, V20, P1298, DOI 10.1002/pro.666; Yoo NJ, 2011, PATHOLOGY, V43, P753, DOI 10.1097/PAT.0b013e32834c7e78	47	221	231	1	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 17	2012	150	4					697	709		10.1016/j.cell.2012.06.039	http://dx.doi.org/10.1016/j.cell.2012.06.039			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22884692	Bronze			2022-12-24	WOS:000308002300006
J	Rabinovich, L; Sigal, N; Borovok, I; Nir-Paz, R; Herskovits, AA				Rabinovich, Lev; Sigal, Nadejda; Borovok, Ilya; Nir-Paz, Ran; Herskovits, Anat A.			Prophage Excision Activates Listeria Competence Genes that Promote Phagosomal Escape and Virulence	CELL			English	Article							DEVELOPMENTAL TRANSCRIPTION FACTOR; SUBTILIS K-STATE; BACILLUS-SUBTILIS; DNA UPTAKE; REGULATORY PROTEIN; ESCHERICHIA-COLI; MONOCYTOGENES; HEMOLYSIN; BACTERIA; SYSTEM	The DNA uptake competence (Com) system of the intracellular bacterial pathogen Listeria monocytogenes is considered nonfunctional. There are no known conditions for DNA transformation, and the Com master activator gene, comK, is interrupted by a temperate prophage. Here, we show that the L. monocytogenes Com system is required during infection to promote bacterial escape from macrophage phagosomes in a manner that is independent of DNA uptake. Further, we find that regulation of the Com system relies on the formation of a functional comK gene via prophage excision. Prophage excision is specifically induced during intracellular growth, primarily within phagosomes, yet, in contrast to classic prophage induction, progeny virions are not produced. This study presents the characterization of an active prophage that serves as a genetic switch to modulate the virulence of its bacterial host in the course of infection.	[Rabinovich, Lev; Sigal, Nadejda; Borovok, Ilya; Herskovits, Anat A.] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel; [Nir-Paz, Ran] Hadassah Hebrew Univ, Med Ctr, Dept Clin Microbiol & Infect Dis, IL-91120 Jerusalem, Israel	Tel Aviv University; Hebrew University of Jerusalem; Hadassah University Medical Center	Herskovits, AA (corresponding author), Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel.	anathe@post.tau.ac.il	BOROVOK, ILYA/ABB-7370-2022; Nir-Paz, Ran/I-5003-2012; Nir-Paz, Ran/Q-6244-2019; Nir-Paz, Ran/GYA-4148-2022	Nir-Paz, Ran/0000-0002-1567-2550; BOROVOK, ILYA/0000-0003-1602-4499	ERA-NET PathoGenoMics; Israel Science Foundation; European Union FP7 (IRG) program; Legacy Heritage Fund, Israel Science Foundation	ERA-NET PathoGenoMics; Israel Science Foundation(Israel Science Foundation); European Union FP7 (IRG) program; Legacy Heritage Fund, Israel Science Foundation	We thank Avigdor Eldar, Martin Kupiec, and Gil Segal for critical reviews of the manuscript; Tamar Burg Golani and Millie Kaplan Zeevi for their kind help; and Daniel Portnoy, Howard Goldfine, and Helene Marquis for supplying us with antibodies. This study was partially funded by grants from the ERA-NET PathoGenoMics, the Israel Science Foundation and European Union FP7 (IRG) program (to A. A. H.), and the Legacy Heritage Fund, Israel Science Foundation (to R.N.-P.).	Berka RM, 2002, MOL MICROBIOL, V43, P1331, DOI 10.1046/j.1365-2958.2002.02833.x; Birmingham CL, 2008, NATURE, V451, P350, DOI 10.1038/nature06479; Borezee E, 2000, J BACTERIOL, V182, P5931, DOI 10.1128/JB.182.20.5931-5934.2000; Borezee E, 2001, MICROBIOL-SGM, V147, P2913, DOI 10.1099/00221287-147-11-2913; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; Claverys JP, 2006, ANNU REV MICROBIOL, V60, P451, DOI 10.1146/annurev.micro.60.080805.142139; COSSART P, 1989, INFECT IMMUN, V57, P3629, DOI 10.1128/IAI.57.11.3629-3636.1989; Dorscht J, 2009, J BACTERIOL, V191, P7206, DOI 10.1128/JB.01041-09; Dubnau D, 1999, ANNU REV MICROBIOL, V53, P217, DOI 10.1146/annurev.micro.53.1.217; Fronzes R, 2009, NAT REV MICROBIOL, V7, P703, DOI 10.1038/nrmicro2218; Glomski IJ, 2002, J CELL BIOL, V156, P1029, DOI 10.1083/jcb.200201081; GOLDEN JW, 1985, NATURE, V314, P419, DOI 10.1038/314419a0; Grundling A, 2003, J BACTERIOL, V185, P6295, DOI 10.1128/JB.185.21.6295-6307.2003; Hahn J, 2005, CELL, V122, P59, DOI 10.1016/j.cell.2005.04.035; Hamoen LW, 1998, GENE DEV, V12, P1539, DOI 10.1101/gad.12.10.1539; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; Herskovits AA, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030051; Hodgson DA, 2000, MOL MICROBIOL, V35, P312, DOI 10.1046/j.1365-2958.2000.01643.x; JOHNSON AD, 1981, NATURE, V294, P217, DOI 10.1038/294217a0; KATHARIOU S, 1987, J BACTERIOL, V169, P1291, DOI 10.1128/jb.169.3.1291-1297.1987; KIRBY JE, 1994, J BACTERIOL, V176, P2068, DOI 10.1128/jb.176.7.2068-2081.1994; KROOS L, 1989, SCIENCE, V243, P526, DOI 10.1126/science.2492118; KUNKEL B, 1990, GENE DEV, V4, P525, DOI 10.1101/gad.4.4.525; Lauer P, 2002, J BACTERIOL, V184, P4177, DOI 10.1128/JB.184.15.4177-4186.2002; Leber JH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040006; LITTLE JW, 1982, CELL, V29, P11, DOI 10.1016/0092-8674(82)90085-X; Loessner MJ, 2000, MOL MICROBIOL, V35, P324, DOI 10.1046/j.1365-2958.2000.01720.x; LOESSNER MJ, 1995, MOL MICROBIOL, V16, P1231, DOI 10.1111/j.1365-2958.1995.tb02345.x; Maamar H, 2005, MOL MICROBIOL, V56, P615, DOI 10.1111/j.1365-2958.2005.04592.x; Miner MD, 2008, MICROBIOL-SGM, V154, P3579, DOI 10.1099/mic.0.2008/021063-0; O'Riordan M, 2002, P NATL ACAD SCI USA, V99, P13861, DOI 10.1073/pnas.202476699; PORTNOY DA, 1988, J EXP MED, V167, P1459, DOI 10.1084/jem.167.4.1459; Ripio MT, 1997, J BACTERIOL, V179, P7174, DOI 10.1128/jb.179.22.7174-7180.1997; Scott J, 2008, J BACTERIOL, V190, P6290, DOI 10.1128/JB.01569-07; SMITH GA, 1995, INFECT IMMUN, V63, P4231, DOI 10.1128/IAI.63.11.4231-4237.1995; STRAGIER P, 1989, SCIENCE, V243, P507, DOI 10.1126/science.2536191; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; VANSINDEREN D, 1995, MOL MICROBIOL, V15, P455; Wendlinger G, 1996, MICROBIOL-UK, V142, P985, DOI 10.1099/00221287-142-4-985; ZINK R, 1992, APPL ENVIRON MICROB, V58, P296, DOI 10.1128/AEM.58.1.296-302.1992	41	145	149	2	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 17	2012	150	4					792	802		10.1016/j.cell.2012.06.036	http://dx.doi.org/10.1016/j.cell.2012.06.036			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	995IT	22901809	Bronze			2022-12-24	WOS:000308002300013
J	Yoshiba, S; Shiratori, H; Kuo, IY; Kawasumi, A; Shinohara, K; Nonaka, S; Asai, Y; Sasaki, G; Belo, JA; Sasaki, H; Nakai, J; Dworniczak, B; Ehrlich, BE; Pennekamp, P; Hamada, H				Yoshiba, Satoko; Shiratori, Hidetaka; Kuo, Ivana Y.; Kawasumi, Aiko; Shinohara, Kyosuke; Nonaka, Shigenori; Asai, Yasuko; Sasaki, Genta; Belo, Jose Antonio; Sasaki, Hiroshi; Nakai, Junichi; Dworniczak, Bernd; Ehrlich, Barbara E.; Pennekamp, Petra; Hamada, Hiroshi			Cilia at the Node of Mouse Embryos Sense Fluid Flow for Left-Right Determination via Pkd2	SCIENCE			English	Article							LEFT-RIGHT ASYMMETRY; LEFT-RIGHT AXIS; POLYCYSTIN-2; MICE; EXPRESSION; RELEASE; LACKING; KIF3A	Unidirectional fluid flow plays an essential role in the breaking of left-right (L-R) symmetry in mouse embryos, but it has remained unclear how the flow is sensed by the embryo. We report that the Ca2+ channel Polycystin-2 (Pkd2) is required specifically in the perinodal crown cells for sensing the nodal flow. Examination of mutant forms of Pkd2 shows that the ciliary localization of Pkd2 is essential for correct L-R patterning. Whereas Kif3a mutant embryos, which lack all cilia, failed to respond to an artificial flow, restoration of primary cilia in crown cells rescued the response to the flow. Our results thus suggest that nodal flow is sensed in a manner dependent on Pkd2 by the cilia of crown cells located at the edge of the node.	[Dworniczak, Bernd; Pennekamp, Petra] Univ Klinikum Munster, Inst Humangenet, D-48149 Munster, Germany; [Pennekamp, Petra] Univ Klinikum Muenster, Klin Kinder & Jugendmed, D-48149 Munster, Germany; [Yoshiba, Satoko; Shiratori, Hidetaka; Kawasumi, Aiko; Shinohara, Kyosuke; Asai, Yasuko; Sasaki, Genta; Hamada, Hiroshi] Osaka Univ, Grad Sch Frontier Biosci, Dev Genet Grp, Suita, Osaka 5650871, Japan; [Yoshiba, Satoko; Shiratori, Hidetaka; Kawasumi, Aiko; Shinohara, Kyosuke; Asai, Yasuko; Sasaki, Genta; Hamada, Hiroshi] Japan Sci & Technol Corp JST, Japan Sci & Technol Agcy CREST, Core Res Evolut Sci & Technol, Suita, Osaka 5650871, Japan; [Kuo, Ivana Y.; Ehrlich, Barbara E.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Nonaka, Shigenori] Natl Inst Basic Biol, Lab Spatiotemporal Regulat, Okazaki, Aichi 4448585, Japan; [Belo, Jose Antonio] Univ Algarve, Regenerat Med Program, Dept Ciencias Biomed & Med, P-8005135 Faro, Portugal; [Belo, Jose Antonio] Univ Algarve, IBB Inst Biotechnol & Bioengn, P-8005135 Faro, Portugal; [Sasaki, Hiroshi] RIKEN Ctr Dev Biol, Lab Embryon Induct, Kobe, Hyogo 6500047, Japan; [Nakai, Junichi] Saitama Univ, Brain Sci Inst, Sakura Ku, Saitama 3388570, Japan	University of Munster; University of Munster; Osaka University; Japan Science & Technology Agency (JST); Yale University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Universidade do Algarve; Universidade do Algarve; RIKEN; Saitama University	Pennekamp, P (corresponding author), Univ Klinikum Munster, Inst Humangenet, Vesaliusweg 12-14, D-48149 Munster, Germany.	petra.pennekamp@uni-muenster.de; hamada@fbs.osaka-u.ac.jp	Shinohara, Kyosuke/AAU-2471-2020; Nakai, Junichi/GQZ-6415-2022; Belo, José A. A/F-4444-2012; Yoshiba, Satoko/AAD-1546-2019; Shinohara, Kyosuke/I-1470-2016; Hamada, Hiroshi/N-6374-2015; Sasaki, Hiroshi/AAY-5939-2020; Kawasumi, Aiko/D-1324-2017; Nonaka, Shigenori/I-2132-2013; /AAX-8408-2021	Shinohara, Kyosuke/0000-0002-6350-1684; Belo, José A. A/0000-0001-7384-0949; Hamada, Hiroshi/0000-0002-7196-5948; Sasaki, Hiroshi/0000-0001-8752-6846; Kawasumi, Aiko/0000-0002-8118-8548; Nonaka, Shigenori/0000-0002-8093-0325; /0000-0001-9657-9704; Yoshiba, Satoko/0000-0002-9415-3619; Kuo, Ivana/0000-0002-9867-2408	CREST of the Japan Science and Technology Corporation; NIH [P30 DK090744]; Human Frontier Science Program [ST00246/2003C]; Deutsche Forschungsgemeinschaft [PE 853/2]; Japan Society for the Promotion of Science; American Heart Association [R10682]; Grants-in-Aid for Scientific Research [24113004, 22770215] Funding Source: KAKEN; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087844, P30DK090744, P50DK057328] Funding Source: NIH RePORTER	CREST of the Japan Science and Technology Corporation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); American Heart Association(American Heart Association); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Y. Cai for YCB9 antibodies to Pkd2; S. Somlo for very helpful comments on Pkd2 function; D. P. Norris for Pkd1l1-CC-GFP plasmid; and A. Fukumoto, Y. Ikawa, K. Miyama, K. Mochida, H. Nishimura, and S. Ohishi for technical assistance. This work was supported by a grant from CREST of the Japan Science and Technology Corporation to H. H., an NIH grant P30 DK090744 to B. E. E., and Human Frontier Science Program grant ST00246/2003C and the Deutsche Forschungsgemeinschaft grant PE 853/2 to P. P. S. Y. was supported by a fellowship from the Japan Society for the Promotion of Science for Japanese Junior Scientists. I. Y. K. was supported by the American Heart Association Postdoctoral Fellowship R10682.	AbouAlaiwi WA, 2009, CIRC RES, V104, P860, DOI 10.1161/CIRCRESAHA.108.192765; Collignon J, 1996, NATURE, V381, P155, DOI 10.1038/381155a0; Ermakov A, 2009, DEV DYNAM, V238, P581, DOI 10.1002/dvdy.21874; Field S, 2011, DEVELOPMENT, V138, P1131, DOI 10.1242/dev.058149; Geng L, 2006, J CELL SCI, V119, P1383, DOI 10.1242/jcs.02818; Gonzalez-Perrett S, 2001, P NATL ACAD SCI USA, V98, P1182, DOI 10.1073/pnas.021456598; Hirokawa N, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000802; Kamura K, 2011, DEVELOPMENT, V138, P1121, DOI 10.1242/dev.058271; Kawasumi A, 2011, DEV BIOL, V353, P321, DOI 10.1016/j.ydbio.2011.03.009; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; Marques S, 2004, GENE DEV, V18, P2342, DOI 10.1101/gad.306504; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; McGrath J, 2003, CELL, V114, P61, DOI 10.1016/S0092-8674(03)00511-7; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Pazour GJ, 2002, CURR BIOL, V12, pR378, DOI 10.1016/S0960-9822(02)00877-1; Pennekamp P, 2002, CURR BIOL, V12, P938, DOI 10.1016/S0960-9822(02)00869-2; Rankin CT, 2000, NAT GENET, V24, P262, DOI 10.1038/73472; Reynolds DM, 1999, J AM SOC NEPHROL, V10, P2342; Schweickert A, 2010, CURR BIOL, V20, P738, DOI 10.1016/j.cub.2010.02.061; Shinohara K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1624; Shiratori H, 2006, DEVELOPMENT, V133, P2095, DOI 10.1242/dev.02384; Tabin CJ, 2003, GENE DEV, V17, P1, DOI 10.1101/gad.1053803; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Tanaka C, 2007, GENE DEV, V21, P3272, DOI 10.1101/gad.1623907; Tanaka Y, 2005, NATURE, V435, P172, DOI 10.1038/nature03494	27	198	208	0	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2012	338	6104					226	231		10.1126/science.1222538	http://dx.doi.org/10.1126/science.1222538			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019BQ	22983710	Green Submitted, Green Accepted			2022-12-24	WOS:000309712300038
J	van Loenhout, MTJ; de Grunt, MV; Dekker, C				van Loenhout, M. T. J.; de Grunt, M. V.; Dekker, C.			Dynamics of DNA Supercoils	SCIENCE			English	Article							DOUBLE-STRANDED DNA; FLUCTUATIONS; RESOLVASE; MOLECULES; SYNAPSIS; FORCE	DNA in cells exhibits a supercoiled state in which the double helix is additionally twisted to form extended intertwined loops called plectonemes. Although supercoiling is vital to many cellular processes, its dynamics remain elusive. In this work, we directly visualize the dynamics of individual plectonemes. We observe that multiple plectonemes can be present and that their number depends on applied stretching force and ionic strength. Plectonemes moved along DNA by diffusion or, unexpectedly, by a fast hopping process that facilitated very rapid (<20 milliseconds) long-range plectoneme displacement by nucleating a new plectoneme at a distant position. These observations directly reveal the dynamics of plectonemes and identify a mode of movement that allows long-distance reorganization of the conformation of the genome on a millisecond time scale.	[van Loenhout, M. T. J.; de Grunt, M. V.; Dekker, C.] Delft Univ Technol, Dept Bionanosci, Kavli Inst Nanosci, NL-2628 CJ Delft, Netherlands	Delft University of Technology	Dekker, C (corresponding author), Delft Univ Technol, Dept Bionanosci, Kavli Inst Nanosci, Lorentzweg 1, NL-2628 CJ Delft, Netherlands.	c.dekker@tudelft.nl		Dekker, Cees/0000-0001-6273-071X	European Research Council [247072]	European Research Council(European Research Council (ERC)European Commission)	We thank M. Emanuel and H. Schiessel for discussions on plectoneme energetics, I. De Vlaminck for discussions, D. van der Vlies for experimental assistance, S. Hage and B. Cross for DNA constructs, and J. van der Does for mechanical modifications to the magnetic tweezers. This work has been supported in part by the European Research Council research grant NanoforBio (no. 247072).	Aitken CE, 2008, BIOPHYS J, V94, P1826, DOI 10.1529/biophysj.107.117689; Bao XR, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.265506; BOLES TC, 1990, J MOL BIOL, V213, P931, DOI 10.1016/S0022-2836(05)80272-4; Brutzer H, 2010, BIOPHYS J, V98, P1267, DOI 10.1016/j.bpj.2009.12.4292; De Vlaminck I, 2010, NUCLEIC ACIDS RES, V38, P4133, DOI 10.1093/nar/gkq067; GARTENBERG MR, 1992, P NATL ACAD SCI USA, V89, P11461, DOI 10.1073/pnas.89.23.11461; Kimura K, 1997, CELL, V90, P625, DOI 10.1016/S0092-8674(00)80524-3; Kouzine F, 2008, NAT STRUCT MOL BIOL, V15, P146, DOI 10.1038/nsmb.1372; LAUNDON CH, 1988, CELL, V52, P545, DOI 10.1016/0092-8674(88)90467-9; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; MARKO JF, 1994, SCIENCE, V265, P506, DOI 10.1126/science.8036491; Marko JF, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.011908; Neukirch S, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.138104; Oram M, 1997, J MOL BIOL, V270, P396, DOI 10.1006/jmbi.1997.1109; PARKER CN, 1991, CELL, V66, P781, DOI 10.1016/0092-8674(91)90121-E; Roca J, 2011, CHROMOSOMA, V120, P323, DOI 10.1007/s00412-011-0324-y; STIGTER D, 1977, BIOPOLYMERS, V16, P1435, DOI 10.1002/bip.1977.360160705; Strick TR, 2003, REP PROG PHYS, V66, P1, DOI 10.1088/0034-4885/66/1/201; Strick TR, 1996, SCIENCE, V271, P1835, DOI 10.1126/science.271.5257.1835; VOLOGODSKII AV, 1992, J MOL BIOL, V227, P1224, DOI 10.1016/0022-2836(92)90533-P; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Zuccheri G, 1998, APPL PHYS A-MATER, V66, pS585, DOI 10.1007/s003390051206; ZWANZIG R, 1988, P NATL ACAD SCI USA, V85, P2029, DOI 10.1073/pnas.85.7.2029	23	133	134	2	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2012	338	6103					94	97		10.1126/science.1225810	http://dx.doi.org/10.1126/science.1225810			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015PC	22983709				2022-12-24	WOS:000309457400060
J	Calarco, JP; Borges, F; Donoghue, MTA; Van Ex, F; Jullien, PE; Lopes, T; Gardner, R; Berger, F; Feijo, JA; Becker, JD; Martienssen, RA				Calarco, Joseph P.; Borges, Filipe; Donoghue, Mark T. A.; Van Ex, Frederic; Jullien, Pauline E.; Lopes, Telma; Gardner, Rui; Berger, Frederic; Feijo, Jose A.; Becker, Joerg D.; Martienssen, Robert A.			Reprogramming of DNA Methylation in Pollen Guides Epigenetic Inheritance via Small RNA	CELL			English	Article							TRANSPOSABLE ELEMENTS; GENE-EXPRESSION; ARABIDOPSIS; PLANT; DEMETHYLATION; REVEALS; HETEROCHROMATIN; MAINTENANCE; INVOLVEMENT; ENDOSPERM	Epigenetic inheritance is more widespread in plants than in mammals, in part because mammals erase epigenetic information by germline reprogramming. We sequenced the methylome of three haploid cell types from developing pollen: the sperm cell, the vegetative cell, and their precursor, the postmeiotic microspore, and found that unlike in mammals the plant germline retains CG and CHG DNA methylation. However, CHH methylation is lost from retrotransposons in microspores and sperm cells and restored by de novo DNA methyltransferase guided by 24 nt small interfering RNA, both in the vegetative nucleus and in the embryo after fertilization. In the vegetative nucleus, CG methylation is lost from targets of DEMETER (DME), REPRESSOR OF SILENCING 1 (ROS1), and their homologs, which include imprinted loci and recurrent epialleles that accumulate corresponding small RNA and are premethylated in sperm. Thus genome reprogramming in pollen contributes to epigenetic inheritance, transposon silencing, and imprinting, guided by small RNA.	[Calarco, Joseph P.; Donoghue, Mark T. A.; Van Ex, Frederic; Martienssen, Robert A.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Gordon & Betty Moore Fdn, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Borges, Filipe; Lopes, Telma; Gardner, Rui; Feijo, Jose A.; Becker, Joerg D.] Inst Gulbenkian Ciencias, P-2780156 Oeiras, Portugal; [Jullien, Pauline E.; Berger, Frederic] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117604, Singapore; [Feijo, Jose A.] Univ Lisbon, Fac Ciencias, Dept Biol Vegetal, P-1749016 Lisbon, Portugal	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Instituto Gulbenkian de Ciencia; National University of Singapore; Universidade de Lisboa	Martienssen, RA (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, Gordon & Betty Moore Fdn, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA.	martiens@cshl.edu	Becker, Jorg/A-5930-2011; jullien, pauline emilie/AAN-6932-2021; Jullien, Pauline/B-7271-2009; Feijo, Jose A./ADM-0262-2022; Lopes, Telma/Q-9767-2016	Becker, Jorg/0000-0002-6845-6122; jullien, pauline emilie/0000-0003-1212-3246; Jullien, Pauline/0000-0003-1212-3246; Feijo, Jose A./0000-0002-1100-5478; Lopes, Telma/0000-0003-3816-4708; Berger, Frederic/0000-0002-3609-8260; Van Ex, Frederic/0000-0003-2481-0115; Borges, Filipe/0000-0002-7388-2118	NIH [R01 GM067014]; Fundacao para a Ciencia e a Tecnologia (FCT) [PTDC/AGR-GPL/103778/2008, PTDC/BIA-BCM/103787/2008, PTDC/BIA-BCM/108044/2008, SFRH/BD/48761/2008]; Temasek Lifescience Laboratory; NSERC; Fred C. Gloeckner Foundation; Belgian American Educational Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067014] Funding Source: NIH RePORTER; Direct For Biological Sciences [1025830] Funding Source: National Science Foundation; Fundação para a Ciência e a Tecnologia [PTDC/BIA-BCM/108044/2008, PTDC/AGR-GPL/103778/2008, PTDC/BIA-BCM/103787/2008] Funding Source: FCT	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Temasek Lifescience Laboratory; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fred C. Gloeckner Foundation; Belgian American Educational Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Fundação para a Ciência e a Tecnologia	We thank Michael Regulski, Jude Kendall, Evan Ernst, Emily Hodges, and Antoine Molaro for advice with bisulfite sequencing and analysis; Vincent Colot, Arp Schnittger, and Daniel Bouyer for helpful discussions; and Shiran Pasternak for help with graphic presentation. This work was supported by NIH grant R01 GM067014 to R.A.M., grants PTDC/AGR-GPL/103778/2008 and PTDC/BIA-BCM/103787/2008 from Fundacao para a Ciencia e a Tecnologia (FCT) to J.D.B. and FCT grant PTDC/BIA-BCM/108044/2008 to J.A.F. F. Berger and P.E.J. were supported by Temasek Lifescience Laboratory. J.P.C. was supported by a graduate student fellowship from NSERC and by a grant from the Fred C. Gloeckner Foundation, F. Borges was supported by a FCT PhD fellowship SFRH/BD/48761/2008, and F.V.E. was funded by a Herbert Hoover postdoctoral fellowship from the Belgian American Educational Foundation.	Bartolomei Marisa S, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a002592; Becker C, 2011, NATURE, V480, P245, DOI 10.1038/nature10555; Becker JD, 2003, PLANT PHYSIOL, V133, P713, DOI 10.1104/pp.103.028241; Berger F, 2011, ANNU REV PLANT BIOL, V62, P461, DOI 10.1146/annurev-arplant-042110-103824; Boavida LC, 2005, INT J DEV BIOL, V49, P595, DOI 10.1387/ijdb.052019lb; Borges F, 2008, PLANT PHYSIOL, V148, P1168, DOI 10.1104/pp.108.125229; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Castaneda J, 2011, MUTAT RES-FUND MOL M, V714, P95, DOI 10.1016/j.mrfmmm.2011.05.002; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; GALBRAITH DW, 1983, SCIENCE, V220, P1049, DOI 10.1126/science.220.4601.1049; Gehring M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023687; Gehring M, 2009, SCIENCE, V324, P1447, DOI 10.1126/science.1171609; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; Grant-Downton R, 2009, MOL PLANT, V2, P500, DOI 10.1093/mp/ssp003; Haag JR, 2011, NAT REV MOL CELL BIO, V12, P483, DOI 10.1038/nrm3152; Henderson IR, 2008, GENE DEV, V22, P1597, DOI 10.1101/gad.1667808; Honys D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r85; Hsieh TF, 2011, P NATL ACAD SCI USA, V108, P1755, DOI 10.1073/pnas.1019273108; Hsieh TF, 2009, SCIENCE, V324, P1451, DOI [10.1126/science.1172417, 10.1126/science.112417]; Josefsson C, 2006, CURR BIOL, V16, P1322, DOI 10.1016/j.cub.2006.05.045; Jullien PE, 2006, PLANT CELL, V18, P1360, DOI 10.1105/tpc.106.041178; Jullien PE, 2012, CURR BIOL, V22, P1825, DOI 10.1016/j.cub.2012.07.061; Jullien PE, 2009, CURR OPIN PLANT BIOL, V12, P637, DOI 10.1016/j.pbi.2009.07.004; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lorkovic ZJ, 2012, CURR BIOL, V22, P933, DOI 10.1016/j.cub.2012.03.061; Lu J, 2012, P NATL ACAD SCI USA, V109, P5529, DOI 10.1073/pnas.1203094109; Makarevich G, 2008, J CELL SCI, V121, P906, DOI 10.1242/jcs.023077; MARTIENSSEN R, 1990, GENE DEV, V4, P331, DOI 10.1101/gad.4.3.331; MARTIENSSEN R, 1994, GENETICS, V136, P1157; Martienssen RA, 2001, SCIENCE, V293, P1070, DOI 10.1126/science.293.5532.1070; MCCLINTOCK B, 1965, BROOKHAVEN SYM BIOL, P162; McKeown PC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-113; Moissiard G, 2012, SCIENCE, V336, P1448, DOI 10.1126/science.1221472; Mosher RA, 2009, NATURE, V460, P283, DOI 10.1038/nature08084; Ortega-Galisteo AP, 2008, PLANT MOL BIOL, V67, P671, DOI 10.1007/s11103-008-9346-0; Pina C, 2005, PLANT PHYSIOL, V138, P744, DOI 10.1104/pp.104.057935; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Radford EJ, 2011, FEBS LETT, V585, P2059, DOI 10.1016/j.febslet.2011.05.063; Raissig MT, 2011, PLANT CELL, V23, P16, DOI 10.1105/tpc.110.081018; Salvaing J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038156; Saze H, 2003, NAT GENET, V34, P65, DOI 10.1038/ng1138; Scheid OM, 2002, P NATL ACAD SCI USA, V99, P13659, DOI 10.1073/pnas.202380499; Schmitz RJ, 2011, SCIENCE, V334, P369, DOI 10.1126/science.1212959; Schoft VK, 2011, P NATL ACAD SCI USA, V108, P8042, DOI 10.1073/pnas.1105117108; Schoft VK, 2009, EMBO REP, V10, P1015, DOI 10.1038/embor.2009.152; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Teixeira FK, 2010, HEREDITY, V105, P14, DOI 10.1038/hdy.2010.52; Teixeira FK, 2009, SCIENCE, V323, P1600, DOI 10.1126/science.1165313; Vaillant I, 2006, EMBO REP, V7, P1273, DOI 10.1038/sj.embor.7400791; Wolff P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002126; Zhang P, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096073	56	373	390	3	180	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 28	2012	151	1					194	205		10.1016/j.cell.2012.09.001	http://dx.doi.org/10.1016/j.cell.2012.09.001			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	016UE	23000270	Green Accepted, Bronze			2022-12-24	WOS:000309544200020
J	Wiig, JA; Hu, YL; Lee, CC; Ribbe, MW				Wiig, Jared A.; Hu, Yilin; Lee, Chi Chung; Ribbe, Markus W.			Radical SAM-Dependent Carbon Insertion into the Nitrogenase M-Cluster	SCIENCE			English	Article							IRON-MOLYBDENUM COFACTOR; FEMO-COFACTOR; PROTEIN; NIFEN; MECHANISM; PRECURSOR; ENZYMES; LIGAND; HYDROGENASE; SUPERFAMILY	The active site of nitrogenase, the M-cluster, is a metal-sulfur cluster containing a carbide at its core. Using radiolabeling experiments, we show that this carbide originates from the methyl group of S-adenosylmethionine (SAM) and that it is inserted into the M-cluster by the assembly protein NifB. Our SAM cleavage and deuterium substitution analyses suggest a similarity between the mechanism of carbon insertion by NifB and the proposed mechanism of RNA methylation by the radical SAM enzymes RlmN and Cfr, which involves methyl transfer from one SAM equivalent, followed by hydrogen atom abstraction from the methyl group by a 5'-deoxyadenosyl radical generated from a second SAM equivalent. This work is an initial step toward unraveling the importance of the interstitial carbide and providing insights into the nitrogenase mechanism.	[Wiig, Jared A.; Hu, Yilin; Lee, Chi Chung; Ribbe, Markus W.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA	University of California System; University of California Irvine	Hu, YL (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.	yilinh@uci.edu; mribbe@uci.edu			National Institutes of Health [GM 67626]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067626] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant GM 67626 (M.W.R.).	Banerjee R, 2003, CHEM REV, V103, P2083, DOI 10.1021/cr0204395; Boal AK, 2011, SCIENCE, V332, P1089, DOI 10.1126/science.1205358; Burgess BK, 1996, CHEM REV, V96, P2983, DOI 10.1021/cr950055x; Corbett MC, 2006, P NATL ACAD SCI USA, V103, P1238, DOI 10.1073/pnas.0507853103; DUKES GR, 1975, J AM CHEM SOC, V97, P528, DOI 10.1021/ja00836a011; Einsle O, 2002, SCIENCE, V297, P1696, DOI 10.1126/science.1073877; Fay AW, 2011, ANGEW CHEM INT EDIT, V50, P7787, DOI 10.1002/anie.201102724; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Grove TL, 2011, SCIENCE, V332, P604, DOI 10.1126/science.1200877; HANCOCK RD, 1989, CHEM REV, V89, P1875, DOI 10.1021/cr00098a011; Hartman F. C., 1989, J BIOL CHEM, V246, P11784; Hu YL, 2006, P NATL ACAD SCI USA, V103, P17119, DOI 10.1073/pnas.0602647103; Hu YL, 2006, P NATL ACAD SCI USA, V103, P17125, DOI 10.1073/pnas.0602651103; Hu YL, 2005, P NATL ACAD SCI USA, V102, P3236, DOI 10.1073/pnas.0409201102; JOB RC, 1975, P NATL ACAD SCI USA, V72, P2478, DOI 10.1073/pnas.72.7.2478; Kaiser JT, 2011, SCIENCE, V331, P91, DOI 10.1126/science.1196954; Lancaster KM, 2011, SCIENCE, V334, P974, DOI 10.1126/science.1206445; Pavlov M, 1998, J AM CHEM SOC, V120, P548, DOI 10.1021/ja971681+; Reed GH, 2004, CURR OPIN CHEM BIOL, V8, P477, DOI 10.1016/j.cbpa.2004.08.008; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Spatzal T, 2011, SCIENCE, V334, P940, DOI 10.1126/science.1214025; van der Kamp MW, 2010, J PHYS CHEM B, V114, P11303, DOI 10.1021/jp104069t; Wiig JA, 2011, P NATL ACAD SCI USA, V108, P8623, DOI 10.1073/pnas.1102773108; Yan F, 2011, P NATL ACAD SCI USA, V108, P3930, DOI 10.1073/pnas.1017781108; Yan F, 2010, J AM CHEM SOC, V132, P3953, DOI 10.1021/ja910850y; Yang XZ, 2009, J AM CHEM SOC, V131, P10901, DOI 10.1021/ja902689n	27	179	181	7	159	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2012	337	6102					1672	1675		10.1126/science.1224603	http://dx.doi.org/10.1126/science.1224603			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	012DJ	23019652	Green Accepted			2022-12-24	WOS:000309215400050
J	Talchai, C; Xuan, SH; Lin, HV; Sussel, L; Accili, D				Talchai, Chutima; Xuan, Shouhong; Lin, Hua V.; Sussel, Lori; Accili, Domenico			Pancreatic beta Cell Dedifferentiation as a Mechanism of Diabetic beta Cell Failure	CELL			English	Article							INSULIN-RECEPTOR; ALPHA-CELL; ISLET CELLS; STEM-CELLS; FOXO1; ENDOCRINE; DIFFERENTIATION; MICE; PROGENITORS; RESISTANCE	Diabetes is associated with beta cell failure. But it remains unclear whether the latter results from reduced beta cell number or function. FoxO1 integrates beta cell proliferation with adaptive beta cell function. We interrogated the contribution of these two processes to b cell dysfunction, using mice lacking FoxO1 in b cells. FoxO1 ablation caused hyperglycemia with reduced beta cell mass following physiologic stress, such as multiparity and aging. Surprisingly, lineage-tracing experiments demonstrated that loss of beta cell mass was due to beta cell dedifferentiation, not death. Dedifferentiated beta cells reverted to progenitor-like cells expressing Neurogenin3, Oct4, Nanog, and L-Myc. A subset of FoxO1-deficient beta cells adopted the alpha cell fate, resulting in hyperglucagonemia. Strikingly, we identify the same sequence of events as a feature of different models of murine diabetes. We propose that dedifferentiation trumps endocrine cell death in the natural history of beta cell failure and suggest that treatment of beta cell dysfunction should restore differentiation, rather than promoting beta cell replication.	[Talchai, Chutima; Accili, Domenico] Columbia Univ, Dept Med, New York, NY 10032 USA; [Xuan, Shouhong; Sussel, Lori] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; [Talchai, Chutima] Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Fac Med, Bangkok 10330, Thailand; [Lin, Hua V.] Lilly China Res & Dev Ctr, Shanghai 201203, Peoples R China	Columbia University; Columbia University; Chulalongkorn University	Accili, D (corresponding author), Columbia Univ, Dept Med, New York, NY 10032 USA.	da230@columbia.edu		Lin, Hua/0000-0001-5001-5567	Druckenmiller Fellowship of the New York Stem Cell Foundation; NIH [DK64819, DK58282, DK63608]; Brehm Coalition; Russell Berrie Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL087123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058282, R37DK058282, R01DK064819, R01DK057539, R01DK082590, P30DK063608] Funding Source: NIH RePORTER	Druckenmiller Fellowship of the New York Stem Cell Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brehm Coalition; Russell Berrie Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Druckenmiller Fellowship of the New York Stem Cell Foundation to C.T., by NIH Grants DK64819, DK58282, and DK63608 (Columbia University Diabetes Research Center), the Brehm Coalition, and the Russell Berrie Foundation. We thank Drs. J.Y. Kim-Muller, T. Mastracci, H. Hua (Columbia University Medical Center), and S. Cinti (Universita Politecnica delle Marche) for advice and reagents and Q. Xu for excellent technical support. We thank members of the Accili laboratory for insightful discussion and critical reading of the manuscript.	Accili D, 2010, DIABETES OBES METAB, V12, P1, DOI 10.1111/j.1463-1326.2010.01296.x; Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; Al-Masri M, 2010, DIABETOLOGIA, V53, P699, DOI 10.1007/s00125-009-1632-0; Basu-Roy U, 2012, ONCOGENE, V31, P2270, DOI 10.1038/onc.2011.405; Butler PC, 2007, NAT CLIN PRACT ENDOC, V3, P758, DOI 10.1038/ncpendmet0647; Collombat P, 2007, J CLIN INVEST, V117, P961, DOI 10.1172/JCI29115; Dhawan S, 2011, DEV CELL, V20, P419, DOI 10.1016/j.devcel.2011.03.012; Dror V, 2007, DIABETOLOGIA, V50, P2504, DOI 10.1007/s00125-007-0835-5; Dunning BE, 2007, ENDOCR REV, V28, P253, DOI 10.1210/er.2006-0026; Elghazi L, 2009, GASTROENTEROLOGY, V136, P1091, DOI 10.1053/j.gastro.2008.11.043; Ferrannini E, 2010, CELL METAB, V11, P349, DOI 10.1016/j.cmet.2010.04.009; Gao N, 2007, CELL METAB, V6, P267, DOI 10.1016/j.cmet.2007.08.015; Gershengorn MC, 2004, SCIENCE, V306, P2261, DOI 10.1126/science.1101968; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Hang Y, 2011, TRENDS ENDOCRIN MET, V22, P364, DOI 10.1016/j.tem.2011.05.003; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Hur KY, 2010, DIABETES OBES METAB, V12, P20, DOI 10.1111/j.1463-1326.2010.01278.x; Jonas JC, 1999, J BIOL CHEM, V274, P14112, DOI 10.1074/jbc.274.20.14112; Kawamori D, 2006, J BIOL CHEM, V281, P1091, DOI 10.1074/jbc.M508510200; Kido Y, 2000, J CLIN INVEST, V105, P199, DOI 10.1172/JCI7917; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Kitamura T, 2009, MOL CELL BIOL, V29, P4417, DOI 10.1128/MCB.01622-08; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Kobayashi M, 2012, AM J PHYSIOL-ENDOC M, V302, pE603, DOI 10.1152/ajpendo.00469.2011; Lin HV, 2011, DIABETES, V60, P700, DOI 10.2337/db10-1056; Martinez SC, 2006, DIABETES, V55, P1581, DOI 10.2337/db05-0678; Matsuda T, 2010, J CLIN INVEST, V120, P115, DOI 10.1172/JCI39721; Movassat J, 1997, DIABETES, V46, P1445, DOI 10.2337/diabetes.46.9.1445; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nakagawa M, 2010, P NATL ACAD SCI USA, V107, P14152, DOI 10.1073/pnas.1009374107; Okamoto H, 2006, J CLIN INVEST, V116, P775, DOI 10.1172/JCI24967; Padilla SL, 2010, NAT MED, V16, P403, DOI 10.1038/nm.2126; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Papizan JB, 2011, GENE DEV, V25, P2291, DOI 10.1101/gad.173039.111; Rahier J, 2008, DIABETES OBES METAB, V10, P32, DOI 10.1111/j.1463-1326.2008.00969.x; Rankin MM, 2010, ISLETS, V2, P345, DOI 10.4161/isl.2.6.13376; Rieck S, 2009, MOL ENDOCRINOL, V23, P1702, DOI 10.1210/me.2009-0144; Robertson RP, 2004, J BIOL CHEM, V279, P42351, DOI 10.1074/jbc.R400019200; Russ HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025566; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; Talchai C, 2009, DIABETES OBES METAB, V11, P38, DOI 10.1111/j.1463-1326.2009.01115.x; Talchai C, 2012, NAT GENET, V44, P406, DOI 10.1038/ng.2215; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Wang S, 2008, DEV BIOL, V317, P531, DOI 10.1016/j.ydbio.2008.02.052; Wang S, 2009, P NATL ACAD SCI USA, V106, P9715, DOI 10.1073/pnas.0904247106; Weinberg N, 2007, FORBES, V179, P56; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Weng JP, 2008, LANCET, V371, P1753, DOI 10.1016/S0140-6736(08)60762-X; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; White P, 2008, DIABETES, V57, P654, DOI 10.2337/db07-1362; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Xuan SH, 2010, J BIOL CHEM, V285, P41044, DOI 10.1074/jbc.M110.144790; Zhang X, 2011, NAT CELL BIOL, V13, P1092, DOI 10.1038/ncb2293; Zhao M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002666; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; Zulewski H, 2001, DIABETES, V50, P521, DOI 10.2337/diabetes.50.3.521	57	904	948	14	150	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 14	2012	150	6					1223	1234		10.1016/j.cell.2012.07.029	http://dx.doi.org/10.1016/j.cell.2012.07.029			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	007ZY	22980982	Bronze, Green Accepted			2022-12-24	WOS:000308928100015
J	Sanyal, A; Lajoie, BR; Jain, G; Dekker, J				Sanyal, Amartya; Lajoie, Bryan R.; Jain, Gaurav; Dekker, Job			The long-range interaction landscape of gene promoters	NATURE			English	Article							CHROMOSOMAL INTERACTIONS; CHROMATIN CONFORMATION; ELEMENTS; BINDING; DOMAIN; 5C	The vast non-coding portion of the human genome is full of functional elements and disease-causing regulatory variants. The principles defining the relationships between these elements and distal target genes remain unknown. Promoters and distal elements can engage in looping interactions that have been implicated in gene regulation(1). Here we have applied chromosome conformation capture carbon copy (5C(2)) to interrogate comprehensively interactions between transcription start sites (TSSs) and distal elements in 1% of the human genome representing the ENCODE pilot project regions(3). 5C maps were generated for GM12878, K562 and HeLa-S3 cells and results were integrated with data from the ENCODE consortium(4). In each cell line we discovered >1,000 long-range interactions between promoters and distal sites that include elements resembling enhancers, promoters and CTCF-bound sites. We observed significant correlations between gene expression, promoter-enhancer interactions and the presence of enhancer RNAs. Long-range interactions show marked asymmetry with a bias for interactions with elements located similar to 120 kilobases upstream of the TSS. Long-range interactions are often not blocked by sites bound by CTCF and cohesin, indicating that many of these sites do not demarcate physically insulated gene domains. Furthermore, only similar to 7% of looping interactions are with the nearest gene, indicating that genomic proximity is not a simple predictor for long-range interactions. Finally, promoters and distal elements are engaged in multiple long-range interactions to form complex networks. Our results start to place genes and regulatory elements in three-dimensional context, revealing their functional relationships.	[Sanyal, Amartya; Lajoie, Bryan R.; Jain, Gaurav; Dekker, Job] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Program Syst Biol,Program Gene Funct & Express, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Dekker, J (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Program Syst Biol,Program Gene Funct & Express, 364 Plantat St, Worcester, MA 01605 USA.	job.dekker@umassmed.edu	Peng, Bo/A-6920-2009; SANYAL, AMARTYA/D-7240-2015	Peng, Bo/0000-0001-8225-2284; SANYAL, AMARTYA/0000-0002-2109-4478	National Institutes of Health, National Human Genome Research Institute [HG003143, HG003143-06S1]; W.M Keck Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003143] Funding Source: NIH RePORTER	National Institutes of Health, National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); W.M Keck Foundation(W.M. Keck Foundation); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the University of Massachusetts Medical School Deep Sequencing core for sequencing 5C libraries, and R. Thurman and J. Stamatoyannopoulos for discussion and help with peak calling analysis. We thank M. Walhout and members of the Dekker laboratory for discussions. This work was supported by grants from the National Institutes of Health, National Human Genome Research Institute (HG003143 and HG003143-06S1) and a W.M Keck Foundation Distinguished Young scholar in Medical Research award to J.D.	Bau D, 2011, NAT STRUCT MOL BIOL, V18, P107, DOI 10.1038/nsmb.1936; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dekker J, 2008, SCIENCE, V319, P1793, DOI 10.1126/science.1152850; Dong X., GENOME BIOL IN PRESS; Dostie J, 2007, NAT PROTOC, V2, P988, DOI 10.1038/nprot.2007.116; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gheldof N, 2006, P NATL ACAD SCI USA, V103, P12463, DOI 10.1073/pnas.0605343103; Harrow J, 2012, GENOME RES; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Lajoie BR, 2009, NAT METHODS, V6, P690, DOI 10.1038/nmeth1009-690; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Miele A, 2008, MOL BIOSYST, V4, P1046, DOI 10.1039/b803580f; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Vavouri T, 2006, TRENDS GENET, V22, P5, DOI 10.1016/j.tig.2005.10.005; Vernimmen D, 2007, EMBO J, V26, P2041, DOI 10.1038/sj.emboj.7601654; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	26	985	1022	7	177	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2012	489	7414					109	U127		10.1038/nature11279	http://dx.doi.org/10.1038/nature11279			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	999WW	22955621	Green Published, Green Accepted, hybrid			2022-12-24	WOS:000308347000044
J	Kong, A; Frigge, ML; Masson, G; Besenbacher, S; Sulem, P; Magnusson, G; Gudjonsson, SA; Sigurdsson, A; Jonasdottir, A; Jonasdottir, A; Wong, WSW; Sigurdsson, G; Walters, GB; Steinberg, S; Helgason, H; Thorleifsson, G; Gudbjartsson, DF; Helgason, A; Magnusson, OT; Thorsteinsdottir, U; Stefansson, K				Kong, Augustine; Frigge, Michael L.; Masson, Gisli; Besenbacher, Soren; Sulem, Patrick; Magnusson, Gisli; Gudjonsson, Sigurjon A.; Sigurdsson, Asgeir; Jonasdottir, Aslaug; Jonasdottir, Adalbjorg; Wong, Wendy S. W.; Sigurdsson, Gunnar; Walters, G. Bragi; Steinberg, Stacy; Helgason, Hannes; Thorleifsson, Gudmar; Gudbjartsson, Daniel F.; Helgason, Agnar; Magnusson, Olafur Th.; Thorsteinsdottir, Unnur; Stefansson, Kari			Rate of de novo mutations and the importance of father's age to disease risk	NATURE			English	Article							AUTISM SPECTRUM DISORDERS; SCHIZOPHRENIA; HUMANS; CONSEQUENCES; NUCLEOTIDE; PATTERNS; NRXN1	Mutations generate sequence diversity and provide a substrate for selection. The rate of de novo mutations is therefore of major importance to evolution. Here we conduct a study of genome-wide mutation rates by sequencing the entire genomes of 78 Icelandic parent-offspring trios at high coverage. We show that in our samples, with an average father's age of 29.7, the average de novo mutation rate is 1.20 x 10(-8) per nucleotide per generation. Most notably, the diversity in mutation rate of single nucleotide polymorphisms is dominated by the age of the father at conception of the child. The effect is an increase of about two mutations per year. An exponential model estimates paternal mutations doubling every 16.5 years. After accounting for random Poisson variation, father's age is estimated to explain nearly all of the remaining variation in the de novo mutation counts. These observations shed light on the importance of the father's age on the risk of diseases such as schizophrenia and autism.	[Kong, Augustine; Frigge, Michael L.; Masson, Gisli; Besenbacher, Soren; Sulem, Patrick; Magnusson, Gisli; Gudjonsson, Sigurjon A.; Sigurdsson, Asgeir; Jonasdottir, Aslaug; Jonasdottir, Adalbjorg; Sigurdsson, Gunnar; Walters, G. Bragi; Steinberg, Stacy; Helgason, Hannes; Thorleifsson, Gudmar; Gudbjartsson, Daniel F.; Helgason, Agnar; Magnusson, Olafur Th.; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE Genet, IS-101 Reykjavik, Iceland; [Besenbacher, Soren] Aarhus Univ, Bioinformat Res Ctr, DK-8000 Aarhus, Denmark; [Wong, Wendy S. W.] Illumina Cambridge Ltd, Saffron Walden CB10 1XL, Essex, England; [Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland	Aarhus University; Illumina; University of Iceland	Kong, A (corresponding author), deCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	kong@decode.is; kari.stefansson@decode.is	Helgason, Agnar/K-1522-2015; Stefansson, Kari/AAE-7187-2019; Walters, G. Bragi/L-4215-2013	Walters, G. Bragi/0000-0002-5415-6487; Gudjonsson, Sigurjon A./0000-0001-9314-7412; Kong, Augustine/0000-0001-8193-5438; Besenbacher, Soren/0000-0003-1455-1738; Helgason, Agnar/0000-0002-8545-3767; Gudbjartsson, Daniel/0000-0002-5222-9857	National Institutes of Health [MH071425]; European Community [HEALTH-F2-2009-223423, IAPP-MC-251592]; European Community IMI grant EU-AIMS [115300]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Community(European Commission); European Community IMI grant EU-AIMS; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was partly funded by The National Institutes of Health grant MH071425 (K.S.); the European Community's Seventh Framework Programme, PsychCNVs project, grant agreement HEALTH-F2-2009-223423, and NextGene project, grant agreement IAPP-MC-251592; The European Community IMI grant EU-AIMS, grant agreement 115300.	Boyden LM, 2012, NATURE, V482, P98, DOI 10.1038/nature10814; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; Croen LA, 2007, ARCH PEDIAT ADOL MED, V161, P334, DOI 10.1001/archpedi.161.4.334; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Duong L, 2012, AM J MED GENET B, V159B, P354, DOI 10.1002/ajmg.b.32036; Gauthier J, 2011, HUM GENET, V130, P563, DOI 10.1007/s00439-011-0975-z; Holm H, 2011, NAT GENET, V43, P316, DOI 10.1038/ng.781; Keightley PD, 2012, GENETICS, V190, P295, DOI 10.1534/genetics.111.134668; Keightley PD, 2009, GENOME RES, V19, P1195, DOI 10.1101/gr.091231.109; Kirov G, 2008, HUM MOL GENET, V17, P458, DOI 10.1093/hmg/ddm323; Kondrashov AS, 2003, HUM MUTAT, V21, P12, DOI 10.1002/humu.10147; Kong A, 2004, NAT GENET, V36, P1203, DOI 10.1038/ng1445; Levinson DF, 2011, AM J PSYCHIAT, V168, P302, DOI 10.1176/appi.ajp.2010.10060876; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Malaspina D, 2001, SCHIZOPHRENIA BULL, V27, P379, DOI 10.1093/oxfordjournals.schbul.a006882; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nachman MW, 2000, GENETICS, V156, P297; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Rafnar T, 2011, NAT GENET, V43, P1104, DOI 10.1038/ng.955; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Rujescu D, 2009, HUM MOL GENET, V18, P988, DOI 10.1093/hmg/ddn351; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sulem P, 2011, NAT GENET, V43, P1127, DOI 10.1038/ng.972; Xue YL, 2009, CURR BIOL, V19, P1453, DOI 10.1016/j.cub.2009.07.032	27	1251	1281	5	361	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2012	488	7412					471	475		10.1038/nature11396	http://dx.doi.org/10.1038/nature11396			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992FS	22914163	Green Accepted			2022-12-24	WOS:000307761600028
J	Jarrell, TA; Wang, Y; Bloniarz, AE; Brittin, CA; Xu, M; Thomson, JN; Albertson, DG; Hall, DH; Emmons, SW				Jarrell, Travis A.; Wang, Yi; Bloniarz, Adam E.; Brittin, Christopher A.; Xu, Meng; Thomson, J. Nichol; Albertson, Donna G.; Hall, David H.; Emmons, Scott W.			The Connectome of a Decision-Making Neural Network	SCIENCE			English	Article							MALE MATING-BEHAVIOR; CAENORHABDITIS-ELEGANS MALE; C-ELEGANS; ULTRASTRUCTURAL ANALYSIS; SENSORY REGULATION; MODEL; NEURONS; GENERATION; DYNAMICS; MALES	In order to understand the nervous system, it is necessary to know the synaptic connections between the neurons, yet to date, only the wiring diagram of the adult hermaphrodite of the nematode Caenorhabditis elegans has been determined. Here, we present the wiring diagram of the posterior nervous system of the C. elegans adult male, reconstructed from serial electron micrograph sections. This region of the male nervous system contains the sexually dimorphic circuits for mating. The synaptic connections, both chemical and gap junctional, form a neural network with four striking features: multiple, parallel, short synaptic pathways directly connecting sensory neurons to end organs; recurrent and reciprocal connectivity among sensory neurons; modular substructure; and interneurons acting in feedforward loops. These features help to explain how the network robustly and rapidly selects and executes the steps of a behavioral program on the basis of the inputs from multiple sensory neurons.	[Jarrell, Travis A.; Wang, Yi; Bloniarz, Adam E.; Brittin, Christopher A.; Xu, Meng; Emmons, Scott W.] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Thomson, J. Nichol; Albertson, Donna G.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Hall, David H.; Emmons, Scott W.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; MRC Laboratory Molecular Biology; Yeshiva University; Albert Einstein College of Medicine	Emmons, SW (corresponding author), Albert Einstein Coll Med, Dept Genet, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	scott.emmons@einstein.yu.edu			MRC; U.S. NIH [R21MH63223, OD 010943]; G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH063223] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD010943] Funding Source: NIH RePORTER	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	H. Eckholdt played a key role in the early stages of this project. Contributions were also made by Z. Martirosyan, A. Singh, T. Stephney, and M. Zhang. C. Crocker made the figures. We thank J. White for encouragement and interest; A. Bergman, M. Chklovskii, D. Faber, A. Massimi, and S. Seung for helpful discussions; N. Baker, H. Buelow, D. Faber, R. Garcia, Z. Kaprielian, R. Lints, D. Portman, J. Sze, and J. Vijg for comments on the manuscript; and J. White and J. Hodgkin for their help in transferring archival transmission EM data from the U.K. Medical Research Council (MRC)-Laboratory of Molecular Biology to the Hall lab at Einstein for long-term curation and study. This work was supported by MRC, the U.S. NIH (R21MH63223 to S.W.E. and OD 010943 to D.H.H.), and by the G. Harold and Leila Y. Mathers Charitable Foundation.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Barr MM, 1999, NATURE, V401, P386, DOI 10.1038/43916; BARR MM, 2006, WORMBOOK; Barrios A, 2008, CURR BIOL, V18, P1865, DOI 10.1016/j.cub.2008.10.050; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; BRENNER S, 1974, GENETICS, V77, P71; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; de Bono M, 2005, ANNU REV NEUROSCI, V28, P451, DOI 10.1146/annurev.neuro.27.070203.144259; de Bono M, 2007, COLD SPRING HARB MON, V49, P437; Garcia LR, 2007, GENETICS, V175, P1761, DOI 10.1534/genetics.106.068304; Garcia LR, 2001, CELL, V107, P777, DOI 10.1016/S0092-8674(01)00600-6; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; Haykin S., 2009, NEURAL NETWORKS LEAR; Hertz JA, 2018, INTRO THEORY NEURAL; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Jezek K, 2011, NATURE, V478, P246, DOI 10.1038/nature10439; Kleemann GA, 2007, ANIM BEHAV, V74, P1339, DOI 10.1016/j.anbehav.2007.02.031; KLEINFELD D, 1986, P NATL ACAD SCI USA, V83, P9469, DOI 10.1073/pnas.83.24.9469; KLEINFELD D, 1988, BIOPHYS J, V54, P1039, DOI 10.1016/S0006-3495(88)83041-8; Koo PK, 2011, J NEUROSCI, V31, P7497, DOI 10.1523/JNEUROSCI.6153-10.2011; Leicht EA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118703; Lichtman JW, 2008, CURR OPIN NEUROBIOL, V18, P346, DOI 10.1016/j.conb.2008.08.010; Lipton J, 2004, J NEUROSCI, V24, P7427, DOI 10.1523/JNEUROSCI.1746-04.2004; Liu K., 1995, THESIS CALTECH; LIU KS, 1995, NEURON, V14, P79, DOI 10.1016/0896-6273(95)90242-2; Liu YS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001326; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Mishchenko Y, 2010, NEURON, V67, P1009, DOI 10.1016/j.neuron.2010.08.014; Nagarajan N, 2008, CURR BIOL, V18, pR756, DOI 10.1016/j.cub.2008.06.043; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Niessing J, 2010, NATURE, V465, P47, DOI 10.1038/nature08961; ROSENBLATT F, 1958, PSYCHOL REV, V65, P386, DOI 10.1037/h0042519; Schikorski T, 1997, J NEUROSCI, V17, P5858; Seung HS, 2009, NEURON, V62, P17, DOI 10.1016/j.neuron.2009.03.020; Seung S., 2012, CONNECTOME BRAINS WI; Simon JM, 2002, P NATL ACAD SCI USA, V99, P1598, DOI 10.1073/pnas.032225799; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; SULSTON JE, 1980, DEV BIOL, V78, P542, DOI 10.1016/0012-1606(80)90352-8; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; Wang XJ, 2008, NEURON, V60, P215, DOI 10.1016/j.neuron.2008.09.034; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; White JQ, 2007, CURR BIOL, V17, P1847, DOI 10.1016/j.cub.2007.09.011; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Whittaker AJ, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-33; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905	45	272	274	4	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2012	337	6093					437	444		10.1126/science.1221762	http://dx.doi.org/10.1126/science.1221762			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979FS	22837521				2022-12-24	WOS:000306802300035
J	Singer, T				Singer, Thea			NUTRITION The vitamin D complex	NATURE			English	Editorial Material							OBSTRUCTIVE PULMONARY-DISEASE; D DEFICIENCY; COPD											Banerjee A, 2012, CURR OPIN PHARMACOL, V12, P266, DOI 10.1016/j.coph.2012.01.014; Gold DR, 2012, ANN INTERN MED, V156, P156, DOI 10.7326/0003-4819-156-2-201201170-00013; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Janssens W, 2011, VITAM HORM, V86, P379, DOI 10.1016/B978-0-12-386960-9.00017-4; Janssens W, 2010, THORAX, V65, P215, DOI 10.1136/thx.2009.120659; Lehouck A, 2012, ANN INTERN MED, V156, P105, DOI 10.7326/0003-4819-156-2-201201170-00004; Merlino LA, 2004, ARTHRITIS RHEUM-US, V50, P72, DOI 10.1002/art.11434; Persson LJ, 2012, AM J RESP CRIT CARE, V185, pA3889; Zosky GR, 2011, AM J RESP CRIT CARE, V183, P1336, DOI 10.1164/rccm.201010-1596OC	9	6	6	2	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2012	489	7417					S10	S11		10.1038/489S10a	http://dx.doi.org/10.1038/489S10a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011LT	23013708	Bronze			2022-12-24	WOS:000309167100006
J	Dance, A				Dance, Amber			HEALTH IMPACT Breathless	NATURE			English	Editorial Material																			0	69	72	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2012	489	7417					S2	S2		10.1038/489S2a	http://dx.doi.org/10.1038/489S2a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	011LT	23013713	Bronze			2022-12-24	WOS:000309167100002
